PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	ARVEILER, B; DESAINTBASILE, G; FISCHER, A; GRISCELLI, C; MANDEL, JL				ARVEILER, B; DESAINTBASILE, G; FISCHER, A; GRISCELLI, C; MANDEL, JL			GERM-LINE MOSAICISM SIMULATES GENETIC-HETEROGENEITY IN WISKOTT-ALDRICH SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									FAC MED STRASBOURG, CNRS, GENET MOLEC EUCARYOTES LAB, INSERM, U184, STRASBOURG, FRANCE; HOP NECKER ENFANTS MALAD, INSERM, U132, F-75730 PARIS 15, FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite			de Saint Basile, Genevieve/G-9731-2017	de Saint Basile, Genevieve/0000-0002-1913-5269				ALDRICH RA, 1954, PEDIATRICS, V13, P133; ARVEILER B, 1987, Genomics, V1, P60, DOI 10.1016/0888-7543(87)90105-4; BAKKER E, 1987, NATURE, V329, P554, DOI 10.1038/329554a0; BASILE GD, 1989, LANCET, V2, P1319; BOYD Y, 1988, J MED GENET, V25, P645; BYERS PH, 1988, AM J HUM GENET, V42, P237; CHEN JD, 1989, GENOMICS, V4, P105, DOI 10.1016/0888-7543(89)90322-4; DARRAS BT, 1988, AM J HUM GENET, V43, P620; DARRAS BT, 1987, NATURE, V329, P556, DOI 10.1038/329556a0; DAVIES KE, 1987, CYTOGENET CELL GENET, V46, P277, DOI 10.1159/000132481; FEARON ER, 1988, BLOOD, V72, P1735; FRASER NJ, 1989, GENOMICS, V5, P144, DOI 10.1016/0888-7543(89)90099-2; FRASER NJ, 1987, NUCLEIC ACIDS RES, V15, P9616, DOI 10.1093/nar/15.22.9616; FRYNS JP, 1983, CLIN GENET, V24, P156; GEALY WJ, 1980, LANCET, V1, P63; GITSCHIER J, 1988, AM J HUM GENET, V43, P274; GREER WL, 1989, GENOMICS, V4, P60, DOI 10.1016/0888-7543(89)90315-7; HALL JG, 1988, AM J HUM GENET, V43, P355; HENDRIKS RW, 1989, HUM GENET, V83, P267, DOI 10.1007/BF00285169; KEITH DH, 1986, MOL CELL BIOL, V6, P4122, DOI 10.1128/MCB.6.11.4122; KOHN DB, 1987, PEDIATR RES, V21, pA313; KWAN S-P, 1988, Genomics, V3, P39, DOI 10.1016/0888-7543(88)90156-5; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MADDALENA A, 1988, NEW ENGL J MED, V319, P999, DOI 10.1056/NEJM198810133191507; MANDEL JL, 1989, CYTOGENET CELL GENET, V51, P384, DOI 10.1159/000132801; MCKUSICK VA, 1988, MENDELIAN INHERITANC; MENSINK EJBM, 1987, CLIN GENET, V31, P91; MENSINK EJBM, 1986, HUM GENET, V73, P327, DOI 10.1007/BF00279095; MENTZER SJ, 1987, J EXP MED, V165, P1383, DOI 10.1084/jem.165.5.1383; OBERLE I, 1986, HUM GENET, V72, P43, DOI 10.1007/BF00278816; OPITZ JM, 1984, AM J MED GENET, V19, P251, DOI 10.1002/ajmg.1320190207; PALLANT A, 1989, P NATL ACAD SCI USA, V86, P1328, DOI 10.1073/pnas.86.4.1328; PARKMAN R, 1978, NEW ENGL J MED, V298, P922, DOI 10.1056/NEJM197804272981701; PARKMAN R, 1981, LANCET, V2, P1387; PEACOCKE M, 1987, P NATL ACAD SCI USA, V84, P3430, DOI 10.1073/pnas.84.10.3430; REISER CA, 1984, AM J MED GENET, V19, P245, DOI 10.1002/ajmg.1320190206; REMOLDODONNELL E, 1984, J EXP MED, V159, P1705, DOI 10.1084/jem.159.6.1705; ROSEN F S, 1983, Clinical Immunology and Immunopathology, V28, P450, DOI 10.1016/0090-1229(83)90112-5; SHELLEY CS, 1989, P NATL ACAD SCI USA, V86, P2819, DOI 10.1073/pnas.86.8.2819; VOGELSTEIN B, 1987, CANCER RES, V47, P4806; WISKOTT A, 1937, MONATSSCHR KINDERH, V68, P212; WOOD S, 1988, HUM GENET, V78, P282, DOI 10.1007/BF00291677	43	32	32	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1990	46	5					906	911						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DD896	1971143				2022-12-18	WOS:A1990DD89600007
J	BASTA, M; MORTON, NE; MULVIHILL, JJ; RADOVANOVIC, Z; RADOJICIC, C; MARINKOVIC, D				BASTA, M; MORTON, NE; MULVIHILL, JJ; RADOVANOVIC, Z; RADOJICIC, C; MARINKOVIC, D			INHERITANCE OF ACUTE APPENDICITIS - FAMILIAL AGGREGATION AND EVIDENCE OF POLYGENIC TRANSMISSION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV BELGRADE, INST MOTHER & CHILD HLTH, DEPT PEDIAT SURG, BELGRADE, YUGOSLAVIA; UNIV BELGRADE, SCH MED, INST EPIDEMIOL, BELGRADE, YUGOSLAVIA; UNIV BELGRADE, MIL MED ACAD, BELGRADE, YUGOSLAVIA; UNIV BELGRADE, FAC SCI, BELGRADE, YUGOSLAVIA; MEM SLOAN KETTERING CANC CTR, DIV GENET EPIDEMIOL, NEW YORK, NY 10021 USA; NCI, CLIN EPIDEMIOL BRANCH, BETHESDA, MD 20205 USA	University of Belgrade; University of Belgrade; University of Belgrade; University of Belgrade; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)				Basta, Milan/0000-0001-5958-9241	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036295] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ANDERSSON N, 1979, BRIT MED J, V2, P697, DOI 10.1136/bmj.2.6192.697; Arnbjornsson E, 1982, Curr Surg, V39, P18; BASTA M, 1986, American Journal of Human Genetics, V39, pA50; BIERMAN HR, 1968, CANCER, V21, P109, DOI 10.1002/1097-0142(196801)21:1<109::AID-CNCR2820210117>3.0.CO;2-#; BRENDER JD, 1985, AM J DIS CHILD, V139, P338, DOI 10.1001/archpedi.1985.02140060020016; BURKITT DP, 1971, BRIT J SURG, V58, P695, DOI 10.1002/bjs.1800580916; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Fitz RH, 1886, AM J SCI, V188, P321, DOI [10.1056/nejm193508082130601, DOI 10.1056/NEJM193508082130601]; FLEISS JL, 1984, STATISTICAL METHODS; JACOB ET, 1975, LANCET, V2, P1032; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LILIENFELD AM, 1980, F EPIDEMIOLOGY; MCKUSICK VA, 1988, MENDELIAN INHERITANC; MORTON NE, 1974, AM J HUM GENET, V26, P489; PERTY T, 1939, AM J SURG, V46, P259; Robbins S. L., 1984, PATHOLOGIC BASIS DIS; SILEN W, 1987, HARRISONS PRINCIPLES, P1304; Wangensteen OH, 1937, ARCH SURG-CHICAGO, V34, P496, DOI 10.1001/archsurg.1937.01190090121006; 1984, STATISTICAL YB CITY	20	32	32	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1990	46	2					377	382						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CM938	2301403				2022-12-18	WOS:A1990CM93800019
J	OHURA, T; KRAUS, JP; ROSENBERG, LE				OHURA, T; KRAUS, JP; ROSENBERG, LE			UNEQUAL SYNTHESIS AND DIFFERENTIAL DEGRADATION OF PROPIONYL COA CARBOXYLASE SUBUNITS IN CELLS FROM NORMAL AND PROPIONIC ACIDEMIA PATIENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									YALE UNIV,SCH MED,DEPT HUMAN GENET,333 CEDAR ST,POB 3333,NEW HAVEN,CT 06510	Yale University					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK012579, R37DK012579] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK12579] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FENTON WA, 1984, J BIOL CHEM, V259, P6616; FENTON WA, 1987, P NATL ACAD SCI USA, V84, P1421, DOI 10.1073/pnas.84.5.1421; FINOCCHIARO G, 1988, J BIOL CHEM, V263, P15773; GOODALL GJ, 1985, ANN NY ACAD SCI, V47, P396; GRAVEL RA, 1977, AM J HUM GENET, V29, P378; GREEVER RF, 1981, P NATL ACAD SCI USA, V78, P5081; HAASE FC, 1984, EUR J BIOCHEM, V140, P147, DOI 10.1111/j.1432-1033.1984.tb08078.x; HSIA YE, 1971, J CLIN INVEST, V50, P127, DOI 10.1172/JCI106466; IKEDA Y, 1985, P NATL ACAD SCI USA, V82, P7081, DOI 10.1073/pnas.82.20.7081; Johnson D. A., 1984, Gene Analysis Techniques, V1, P3, DOI 10.1016/0735-0651(84)90049-9; KALOUSEK F, 1980, J BIOL CHEM, V255, P60; KRAUS JP, 1986, P NATL ACAD SCI USA, V83, P8049, DOI 10.1073/pnas.83.21.8049; KRAUS JP, 1981, AM J HUM GENET, V33, pA47; KRAUS JP, 1986, P NATL ACAD SCI USA, V83, P2047, DOI 10.1073/pnas.83.7.2047; KRAUS JP, 1983, J BIOL CHEM, V258, P7248; LAMHONWAH AM, 1986, P NATL ACAD SCI USA, V83, P4864, DOI 10.1073/pnas.83.13.4864; LAMHONWAH AM, 1987, AM J HUM GENET, V41, P1124; LEHNERT ME, 1988, J CELL BIOL, V107, P413, DOI 10.1083/jcb.107.2.413; Maniatis T., 1982, MOL CLONING; ROSENBERG LE, 1983, METABOLIC BASIS INHE, P474; ROZEN R, 1985, NATURE, V313, P815, DOI 10.1038/313815a0; SAUNDERS M, 1979, J CLIN INVEST, V64, P1695, DOI 10.1172/JCI109632; SKOVBY F, 1984, AM J HUM GENET, V36, P452; SKOVBY F, 1982, AM J HUM GENET, V34, P73; TAHARA T, 1988, American Journal of Human Genetics, V43, pA97; TOWBIN H, 1984, P NATL ACAD SCI USA, V176, P4350; WAH AMLH, 1983, AM J HUM GENET, V35, P889; WEXLER ID, 1988, P NATL ACAD SCI USA, V85, P7336, DOI 10.1073/pnas.85.19.7336; WOLF B, 1978, J CLIN INVEST, V62, P931, DOI 10.1172/JCI109221	30	32	32	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1989	45	1					33	40						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AE779	2741949				2022-12-18	WOS:A1989AE77900005
J	COX, DW; BILLINGSLEY, GD				COX, DW; BILLINGSLEY, GD			RARE DEFICIENCY TYPES OF ALPHA-1-ANTITRYPSIN - ELECTROPHORETIC VARIATION AND DNA HAPLOTYPES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TORONTO,DEPT PAEDIAT,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV TORONTO,DEPT MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA	University of Toronto; University of Toronto	COX, DW (corresponding author), HOSP SICK CHILDREN,RES INST,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA.							ARNAUD P, 1977, J IMMUNOL METHODS, V16, P221, DOI 10.1016/0022-1759(77)90200-9; ARNAUD PH, 1975, INSERM (Institut National de la Sante et de la Recherche Medicale) Colloque, V40, P109; BRANTLY M, 1988, AM J MED, V84, P13; COX DW, 1987, AM J HUM GENET, V41, P891; COX DW, 1988, AM REV RESPIR DIS, V137, P371, DOI 10.1164/ajrccm/137.2.371; COX DW, 1981, AM J HUM GENET, V33, P354; COX DW, 1980, HUM GENET, V53, P429, DOI 10.1007/BF00287070; COX DW, 1976, AM REV RESPIR DIS, V113, P601; COX DW, 1985, NATURE, V316, P79, DOI 10.1038/316079a0; COX DW, 1986, FEBS LETT, V205, P255, DOI 10.1016/0014-5793(86)80908-5; COX DW, 1987, NUCLEIC ACIDS RES, V15, P4701, DOI 10.1093/nar/15.11.4701; COX DW, 1987, PROTIDES BIOL FLUIDS, V35, P123; COX DW, 1976, PROTIDES BIOL FLUIDS, V23, P375; COX DW, 1981, ELECTROPHORESIS, P500; COX DW, IN PRESS METABOLIC B; CURIE D, 1988, AM REV RESPIR DIS, V135, pA210; FELDMANN G, 1975, GUT, V16, P796, DOI 10.1136/gut.16.10.796; FRAZIER GC, 1989, AM J HUM GENET, V44, P894; GARVER RI, 1986, NEW ENGL J MED, V314, P762, DOI 10.1056/NEJM198603203141207; HODGSON I, 1987, J MED GENET, V24, P47, DOI 10.1136/jmg.24.1.47; HOFKER MH, IN PRESS HUM GENET; JEPPSSON JO, 1978, EUR J BIOCHEM, V83, P143, DOI 10.1111/j.1432-1033.1978.tb12078.x; JEPPSSON JO, 1981, CLIN CHEM, V28, P219; JOHANSSON BG, 1972, SCAND J CLIN LAB INV, V29, P7, DOI 10.3109/00365517209102747; KIDD VJ, 1983, NATURE, V304, P230, DOI 10.1038/304230a0; KRAMPS JA, 1981, HUM GENET, V59, P104, DOI 10.1007/BF00293055; KUEPPERS F, 1977, J MED GENET, V14, P183, DOI 10.1136/jmg.14.3.183; LANGLEY CE, 1979, JOHNS HOPKINS MED J, V144, P161; LAURELL CB, 1963, SCAND J CLIN LAB INV, V15, P132, DOI 10.3109/00365516309051324; LAURELL CB, 1966, ANAL BIOCHEM, V15, P45, DOI 10.1016/0003-2697(66)90246-6; LAURELL CB, 1975, AM J HUM GENET, V27, P213; LIEBERMAN J, 1976, AM REV RESPIR DIS, V113, P31; MADISEN L, 1987, AM J MED GENET, V27, P379, DOI 10.1002/ajmg.1320270216; MARTIN JP, 1975, HUMANGENETIK, V30, P121, DOI 10.1007/BF00291944; MUENSCH H, 1986, AM J HUM GENET, V38, P898; NUKIWA T, 1987, J BIOL CHEM, V262, P11999; PETERSEN KB, 1988, NUCLEIC ACIDS RES, V16, P352, DOI 10.1093/nar/16.1.352; PIERCE JA, 1975, JAMA-J AM MED ASSOC, V231, P609, DOI 10.1001/jama.231.6.609; ROBERTS EA, 1984, AM J CLIN PATHOL, V82, P424, DOI 10.1093/ajcp/82.4.424; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SATOH K, 1988, AM J HUM GENET, V42, P77; SHARP HL, 1969, J LAB CLIN MED, V73, P934; SHARP HL, 1971, HOSP PRACT, V5, P83; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TAKAHASHI H, 1988, J BIOL CHEM, V263, P15528; TALAMO RC, 1973, SCIENCE, V181, P70, DOI 10.1126/science.181.4094.70; WEIDINGER S, 1985, HUM GENET, V71, P27, DOI 10.1007/BF00295662	48	32	32	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1989	44	6					844	854						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	U8549	2786333				2022-12-18	WOS:A1989U854900010
J	MIGEON, BR; AXELMAN, J; STETTEN, G				MIGEON, BR; AXELMAN, J; STETTEN, G			CLONAL EVOLUTION IN HUMAN LYMPHOBLAST CULTURES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT GYNECOL & OBSTET,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University					NICHD NIH HHS [HD 05465] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ABRUZZO MA, 1986, CYTOGENET CELL GENET, V42, P169, DOI 10.1159/000132271; DAVIDSON RG, 1963, P NATL ACAD SCI USA, V50, P481, DOI 10.1073/pnas.50.3.481; FIALKOW PJ, 1973, ANN HUM GENET, V37, P39, DOI 10.1111/j.1469-1809.1973.tb01813.x; LYON MF, 1972, BIOL REV, V47, P1; MIGEON BR, 1981, P NATL ACAD SCI-BIOL, V78, P5066, DOI 10.1073/pnas.78.8.5066; MIGEON BR, 1985, P NATL ACAD SCI USA, V82, P3390, DOI 10.1073/pnas.82.10.3390; MOORE GE, 1967, J AMER MED ASSOC, V199, P519, DOI 10.1001/jama.199.8.519; NYHAN WL, 1970, P NATL ACAD SCI USA, V65, P214, DOI 10.1073/pnas.65.1.214; POVEY S, 1973, ANN HUM GENET, V36, P247, DOI 10.1111/j.1469-1809.1973.tb00588.x; STEEL CM, 1980, J NATL CANCER I, V65, P95; STETTEN G, 1986, AM J HUM GENET, V39, P245; ZAVALA C, 1978, EXP CELL RES, V117, P137, DOI 10.1016/0014-4827(78)90436-6	12	32	32	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1988	42	5					742	747						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N1438	3358424				2022-12-18	WOS:A1988N143800010
J	BERNHARDT, BA; WEINER, J; FOSTER, EC; TUMPSON, JE; PYERITZ, RE				BERNHARDT, BA; WEINER, J; FOSTER, EC; TUMPSON, JE; PYERITZ, RE			THE ECONOMICS OF CLINICAL GENETICS SERVICES .2. A TIME ANALYSIS OF A MEDICAL GENETICS CLINIC	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHNS HOPKINS UNIV,SCH MED,DEPT MED,MOORE CLIN,BALTIMORE,MD 21205	Johns Hopkins University	BERNHARDT, BA (corresponding author), JOHNS HOPKINS UNIV HOSP,DIV MED GENET,BALTIMORE,MD 21205, USA.		Pyeritz, Reed/A-1364-2010		PHS HHS [MCJ-241004] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		CLOUSER SB, 1985, PHYSICIANS CURRENT P; EPSTEIN CJ, 1975, AM J HUM GENET, V27, P322; EPSTEIN CJ, 1977, GENETIC COUNSELING, P333; FRASER FC, 1974, AM J HUM GENET, V26, P636; HOLTZMAN NA, 1983, AM J MED GENET, V15, P353, DOI 10.1002/ajmg.1320150225; JACKSON LG, 1979, SERVICE ED MED GENET, P137; MYERS TL, 1987, AM J MED GENET, V26, P521, DOI 10.1002/ajmg.1320260303; PYERITZ RE, AM J HUM GENET, V41, P549; Pyeritz Reed E., 1984, BIRTH DEFECTS, V20, P230; Riccardi V. M., 1977, GENETIC APPROACH HUM; Rimoin D L, 1977, Birth Defects Orig Artic Ser, V13, P105; ROLLNICK BR, 1984, STRATEGIES GENETIC C, P208; SORENSON JR, 1981, REPRODUCTIVE PASTS R; YOUNG RS, 1986, J CRAN GENET DEV BIO, V6, P3; 1986, GUIDE HUMAN GENETICS	15	32	32	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1987	41	4					559	565						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	K4621	3116845				2022-12-18	WOS:A1987K462100005
J	GEMMILL, RM; PEARCEBIRGE, L; BIXENMAN, H; HECHT, BK; ALLANSON, JE				GEMMILL, RM; PEARCEBIRGE, L; BIXENMAN, H; HECHT, BK; ALLANSON, JE			Y-CHROMOSOME SPECIFIC DNA-SEQUENCES IN TURNER-SYNDROME MOSAICISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									SW BIOMED RES INST,CTR CANC,TEMPE,AZ 85281		GEMMILL, RM (corresponding author), SW BIOMED RES INST,CTR GENET,6401 E THOMAS RD,TEMPE,AZ 85281, USA.							BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BUCKLE V, 1985, NATURE, V317, P739, DOI 10.1038/317739a0; BURK RD, 1985, MOL CELL BIOL, V5, P576, DOI 10.1128/MCB.5.3.576; COOKE HJ, 1985, NATURE, V317, P687, DOI 10.1038/317687a0; DEUGAU K V, 1978, American Journal of Human Genetics, V30, p78A; GOODFELLOW P, 1985, J MED GENET, V22, P329, DOI 10.1136/jmg.22.5.329; GOODFELLOW PN, 1985, CYTOGENET CELL GENET, V40, P296, DOI 10.1159/000132178; LAU YF, 1984, LANCET, V1, P14; MAGENIS E, 1982, HUM GENET, V60, P133, DOI 10.1007/BF00569699; MAGENIS RE, 1985, Y CHROMOSOME A, P537; MANUEL M, 1976, AM J OBSTET GYNECOL, V124, P293, DOI 10.1016/0002-9378(76)90160-5; MUNKE M, 1985, AM J MED GENET, V22, P361, DOI 10.1002/ajmg.1320220221; PAGE DC, 1984, NATURE, V311, P119, DOI 10.1038/311119a0; SANDBERG AA, 1985, Y CHROMOSOME B, P377; SEABRIGH.M, 1971, LANCET, V2, P971; SIMMLER MC, 1985, NATURE, V317, P692, DOI 10.1038/317692a0; Simpson J L, 1976, Birth Defects Orig Artic Ser, V12, P15; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WARNER BA, 1985, HUM GENET, V69, P79, DOI 10.1007/BF00295534; WOLMAN SR, 1985, Y CHROMOSOME A, P477; WYANDT HE, 1976, EXP CELL RES, V102, P85, DOI 10.1016/0014-4827(76)90302-5; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746	22	32	32	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1987	41	2					157	167						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	J7575	3475977				2022-12-18	WOS:A1987J757500007
J	GREENBERG, DA				GREENBERG, DA			THE EFFECT OF PROBAND DESIGNATION ON SEGREGATION ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF LOS ANGELES,SCH MED,DEPT BIOMATH,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	GREENBERG, DA (corresponding author), VET ADM WADSWORTH MED CTR,NEUROL SERV,ROOM 3405,LOS ANGELES,CA 90073, USA.				NIADDK NIH HHS [AM31775] Funding Source: Medline; NINDS NIH HHS [NS21908] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM031775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS021908] Funding Source: NIH RePORTER	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BOEHNKE M, 1984, AM J HUM GENET, V36, P1298; DAVIE AM, 1979, ANN HUM GENET, V42, P506; ELSTON RC, 1979, AM J HUM GENET, V31, P62; EWENS WJ, UNPUB RESOLUTION ASC, V1; GREENBERG DA, 1984, AM J HUM GENET, V36, P167; GREENBERG DA, 1985, AM J MED GENET, V21, P357, DOI 10.1002/ajmg.1320210219; HODGE SE, 1980, BIOMETRICS, V36, P27, DOI 10.2307/2530492; MORTON NE, 1959, AM J HUM GENET, V11, P1; STENE J, 1978, ANN HUM GENET, V42, P219, DOI 10.1111/j.1469-1809.1978.tb00654.x; STENE J, 1977, BIOMETRICS, V33, P523, DOI 10.2307/2529367	10	32	32	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1986	39	3					329	339						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	E3644	3766539				2022-12-18	WOS:A1986E364400005
J	BROWNELL, E; KOZAK, CA; FOWLE, JR; MODI, WS; RICE, NR; OBRIEN, SJ				BROWNELL, E; KOZAK, CA; FOWLE, JR; MODI, WS; RICE, NR; OBRIEN, SJ			COMPARATIVE GENETIC-MAPPING OF CELLULAR REL SEQUENCES IN MAN, MOUSE, AND THE DOMESTIC CAT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NIAID,MOLEC MICROBIOL LAB,BETHESDA,MD 20205; NCI,VIRAL CARCINOGENESIS LAB,FREDERICK,MD 21701; US EPA,OFF RES & DEV,REPROD EFFECTS ASSESSMENT GRP,WASHINGTON,DC 20460	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Environmental Protection Agency	BROWNELL, E (corresponding author), LITTON BIONET INC,FREDERICK CANC RES FACIL,MOLEC VIROL & CARCINOGENESIS LAB,FREDERICK,MD 21701, USA.		OBRIEN, STEPHEN/ABD-1346-2020	OBRIEN, STEPHEN/0000-0001-7857-0757	NCI NIH HHS [N01-CO-23909] Funding Source: Medline; OFFICE OF THE DIRECTOR, NCI [N01CO023909] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BROWNELL E, 1985, MOL CELL BIOL, V5, P2826, DOI 10.1128/MCB.5.10.2826; DELACHAPELLE A, 1984, CYTOGENET CELL GENET, V37, P274, DOI 10.1159/000132012; ERIKSON J, 1983, P NATL ACAD SCI-BIOL, V80, P7581, DOI 10.1073/pnas.80.24.7581; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; HEISTERKAMP N, 1983, NATURE, V306, P239, DOI 10.1038/306239a0; KLEIN G, 1983, CELL, V32, P311, DOI 10.1016/0092-8674(83)90449-X; Klein G, 1981, NATURE, V294, P313, DOI 10.1038/294313a0; KOZAK C, 1984, J VIROL, V49, P297, DOI 10.1128/JVI.49.1.297-299.1984; KOZAK CA, 1977, EXP CELL RES, V105, P109, DOI 10.1016/0014-4827(77)90156-2; NADEAU JH, 1984, P NATL ACAD SCI-BIOL, V81, P814, DOI 10.1073/pnas.81.3.814; NASH WG, 1982, P NATL ACAD SCI-BIOL, V79, P6631, DOI 10.1073/pnas.79.21.6631; OBRIEN SJ, 1982, SCIENCE, V216, P257, DOI 10.1126/science.7063884; OBRIEN SJ, 1984, GENETIC MAPS, V3; OBRIEN SJ, 1982, TECHNIQUES SOMATIC C, P513; OBRIEN SJ, 1986, EVOLUTIONARY BIOL; RODERICK TH, 1984, CYTOGENET CELL GENET, V37, P312, DOI 10.1159/000132013; SILVER J, 1985, MOL CELL BIOL, V5, P1784, DOI 10.1128/MCB.5.7.1784; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WILHELMSEN KC, 1984, J VIROL, V52, P172, DOI 10.1128/JVI.52.1.172-182.1984; YUNIS JJ, 1983, SCIENCE, V221, P227, DOI 10.1126/science.6336310; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746; YUNIS JJ, 1984, SCIENCE, V226, P1199, DOI 10.1126/science.6239375; ZABEL BU, 1984, P NATL ACAD SCI-BIOL, V81, P4874, DOI 10.1073/pnas.81.15.4874	23	32	32	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1986	39	2					194	202						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	E1459	3529946				2022-12-18	WOS:A1986E145900005
J	TROFATTER, JA; HAINES, JL; CONNEALLY, PM				TROFATTER, JA; HAINES, JL; CONNEALLY, PM			LIPIN - AN INTERACTIVE DATA-ENTRY AND MANAGEMENT PROGRAM FOR LIPED	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter											TROFATTER, JA (corresponding author), INDIANA UNIV,JAMES WHITCOMB RILEY HOSP CHILDREN,MED CTR,DEPT MED GENET,RR 129,702 BARNHILL DR,INDIANAPOLIS,IN 46223, USA.							LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; OTT J, 1974, AM J HUM GENET, V26, P773	2	32	32	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1986	39	1					147	148						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D9615	3755866				2022-12-18	WOS:A1986D961500017
J	WALLACE, DC; YANG, JH; YE, JH; LOTT, MT; OLIVER, NA; MCCARTHY, J				WALLACE, DC; YANG, JH; YE, JH; LOTT, MT; OLIVER, NA; MCCARTHY, J			COMPUTER-PREDICTION OF PEPTIDE MAPS - ASSIGNMENT OF POLYPEPTIDES TO HUMAN AND MOUSE MITOCHONDRIAL-DNA GENES BY ANALYSIS OF 2-DIMENSIONAL-PROTEOLYTIC DIGEST GELS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									EMORY UNIV,SCH MED,DEPT PEDIAT,ATLANTA,GA 30322; STANFORD UNIV,MED CTR,SCH MED,STANFORD,CA 94305; WHITEHEAD INST,CAMBRIDGE,MA 02142	Emory University; Stanford University; Massachusetts Institute of Technology (MIT); Whitehead Institute	WALLACE, DC (corresponding author), EMORY UNIV,SCH MED,DEPT BIOCHEM,DIV MED GENET,WOODRUFF MEM BLDG,ATLANTA,GA 30322, USA.			Lott, Marie/0000-0003-2035-479X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021328] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM33022] Funding Source: Medline; NINDS NIH HHS [NS21328] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; BEATTIE DS, 1979, BIOCHEMISTRY-US, V18, P2400, DOI 10.1021/bi00578a040; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; BIRD AG, 1981, NATURE, V289, P300, DOI 10.1038/289300a0; BORDIER C, 1979, J BIOL CHEM, V254, P2565; CHING E, 1982, BIOCHEMISTRY-US, V21, P3188, DOI 10.1021/bi00256a024; CHOMYN A, 1985, NATURE, V314, P592, DOI 10.1038/314592a0; CHOMYN A, 1983, P NATL ACAD SCI-BIOL, V80, P5535, DOI 10.1073/pnas.80.18.5535; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; EGGER J, 1983, NEW ENGL J MED, V309, P142, DOI 10.1056/NEJM198307213090304; ERICKSON RP, 1972, AM J HUM GENET, V24, P348; GEY GO, 1952, CANCER RES, V12, P264; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; HARE JF, 1980, BIOCHEMISTRY-US, V19, P2023, DOI 10.1021/bi00551a003; HOUMARD J, 1972, P NATL ACAD SCI USA, V69, P3506, DOI 10.1073/pnas.69.12.3506; KLEBE RJ, 1970, J CELL BIOL, V45, P74, DOI 10.1083/jcb.45.1.74; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAM KS, 1980, ANAL BIOCHEM, V108, P220, DOI 10.1016/0003-2697(80)90572-2; LOTT TJ, 1986, COMP APPL BIOSCI; MACREADIE IG, 1983, NUCLEIC ACIDS RES, V11, P4435, DOI 10.1093/nar/11.13.4435; MARIOTTINI P, 1983, CELL, V32, P1269, DOI 10.1016/0092-8674(83)90308-2; MONTOYA J, 1982, P NATL ACAD SCI-BIOL, V79, P7195, DOI 10.1073/pnas.79.23.7195; MONTOYA J, 1981, NATURE, V290, P465, DOI 10.1038/290465a0; NOVOTNY EJ, 1986, NEUROLOGY; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; OLIVER N, 1984, SOMAT CELL MOLEC GEN, V10, P639, DOI 10.1007/BF01535230; OLIVER NA, 1982, MOL CELL BIOL, V2, P30, DOI 10.1128/MCB.2.1.30; OLIVER NA, 1983, J BIOL CHEM, V258, P5834; OLIVER NA, 1982, THESIS STANFORD U ST; PEPE G, 1983, BIOCHEM INT, V6, P553; ROSING HS, 1985, ANN NEUROL, V17, P228, DOI 10.1002/ana.410170303; SPINNER NB, 1983, AM J HUM GENET, V35, pA208; TIJSSEN P, 1983, ANAL BIOCHEM, V128, P26, DOI 10.1016/0003-2697(83)90339-1; WALBERG MW, 1983, J BIOL CHEM, V258, P1268; WALLACE DC, 1981, MOL CELL BIOL, V1, P697, DOI 10.1128/MCB.1.8.697	36	32	33	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1986	38	4					461	481						21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	C4893	3518425				2022-12-18	WOS:A1986C489300006
J	BECHHANSEN, NT; COX, DW				BECHHANSEN, NT; COX, DW			DUPLICATION OF THE HUMAN-IMMUNOGLOBULIN HEAVY-CHAIN GAMMA-2 GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TORONTO,DEPT MED BIOPHYS,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV TORONTO,DEPT MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV TORONTO,DEPT PAEDIAT,TORONTO M5S 1A1,ONTARIO,CANADA	University of Toronto; University of Toronto; University of Toronto	BECHHANSEN, NT (corresponding author), HOSP SICK CHILDREN,RES INST,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA.							BECHHANSEN NT, 1983, P NATL ACAD SCI-BIOL, V80, P6952, DOI 10.1073/pnas.80.22.6952; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; ELLISON J, 1982, P NATL ACAD SCI-BIOL, V79, P1984, DOI 10.1073/pnas.79.6.1984; ELLISON J, 1981, DNA-J MOLEC CELL BIO, V1, P11, DOI 10.1089/dna.1.1981.1.11; ELLISON J, 1983, ADV HUM GENET, V14, P113; FLANAGAN JG, 1982, NATURE, V300, P709, DOI 10.1038/300709a0; LEFRANC MP, 1982, NATURE, V300, P760, DOI 10.1038/300760a0; LINSLEY PS, 1983, P NATL ACAD SCI-BIOL, V80, P1997, DOI 10.1073/pnas.80.7.1997; MIGONE N, 1985, AM J HUM GENET, V37, P1146; MIGONE N, 1984, P NATL ACAD SCI-BIOL, V81, P5811, DOI 10.1073/pnas.81.18.5811; NATVIG JB, 1972, ADV HUM IMMUNOL, V20, P1; SCHANFIELD MS, 1975, PATERNITY TESTING, P44; SHIMIZU A, 1982, NATURE, V298, P82, DOI 10.1038/298082a0; TAKAHASHI N, 1982, CELL, V29, P671, DOI 10.1016/0092-8674(82)90183-0; VANLOGHEM E, 1980, J IMMUNOGENET, V7, P285	15	32	32	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1986	38	1					67	74						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AYP17	3004204				2022-12-18	WOS:A1986AYP1700007
J	BENYOSEPH, Y; REID, JE; SHAPIRO, B; NADLER, HL				BENYOSEPH, Y; REID, JE; SHAPIRO, B; NADLER, HL			DIAGNOSIS AND CARRIER DETECTION OF TAY-SACHS DISEASE - DIRECT DETERMINATION OF HEXOSAMINIDASE-A USING 4-METHYLUMBELLIFERYL DERIVATIVES OF BETA-N-ACETYLGLUCOSAMINE-6-SULFATE AND BETA-N-ACETYLGALACTOSAMINE-6-SULFATE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WAYNE STATE UNIV,CS MOTT CTR HUMAN GROWTH & DEV,SCH MED,DEPT PEDIAT,DETROIT,MI 48201; WAYNE STATE UNIV,CS MOTT CTR HUMAN GROWTH & DEV,SCH MED,DEPT OBSTET GYNECOL,DETROIT,MI 48201	Wayne State University; Wayne State University	BENYOSEPH, Y (corresponding author), WAYNE STATE UNIV,CS MOTT CTR HUMAN GROWTH & DEV,SCH MED,DEPT BIOCHEM,DETROIT,MI 48201, USA.							BAYLERAN J, 1984, CLIN CHIM ACTA, V143, P73, DOI 10.1016/0009-8981(84)90215-8; BENYOSEPH Y, 1983, J INHERIT METAB DIS, V6, P95, DOI 10.1007/BF01800733; BEUTLER E, 1975, J LAB CLIN MED, V86, P195; BOAS NF, 1953, J BIOL CHEM, V204, P553; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DODGSON KS, 1961, BIOCHEM J, V78, P312, DOI 10.1042/bj0780312; FUCHS W, 1983, CLIN CHIM ACTA, V133, P253, DOI 10.1016/0009-8981(83)90269-3; GEIGER B, 1978, BIOCHEMISTRY-US, V17, P1713, DOI 10.1021/bi00602a020; GILBERT F, 1975, P NATL ACAD SCI USA, V72, P263, DOI 10.1073/pnas.72.1.263; HASILIK A, 1980, J BIOL CHEM, V255, P4937; INUI K, 1984, CLIN GENET, V26, P318; KABACK MM, 1972, METHOD ENZYMOL, V28, P862; KRESSE H, 1981, J BIOL CHEM, V256, P2926; LALLEY PA, 1974, P NATL ACAD SCI USA, V71, P1569, DOI 10.1073/pnas.71.4.1569; LI YT, 1983, AM J HUM GENET, V35, P520; LLOYD AG, 1962, BIOCHEM J, V83, P455, DOI 10.1042/bj0830455; MAHURAN DJ, 1982, P NATL ACAD SCI-BIOL, V79, P1602, DOI 10.1073/pnas.79.5.1602; MOMOI T, 1978, PEDIATR RES, V12, P77, DOI 10.1203/00006450-197802000-00001; NAVON R, 1981, AM J HUM GENET, V33, P907; OBRIEN JS, 1970, NEW ENGL J MED, V283, P15, DOI 10.1056/NEJM197007022830104; OBRIEN JS, 1983, METABOLIC BASIS INHE, P945; POULOS A, 1982, CLIN CHIM ACTA, V120, P331, DOI 10.1016/0009-8981(82)90374-6	22	32	33	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	4					733	740						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	APR18	9556661				2022-12-18	WOS:A1985APR1800010
J	GAHL, WA; BASHAN, N; TIETZE, F; SCHULMAN, JD				GAHL, WA; BASHAN, N; TIETZE, F; SCHULMAN, JD			LYSOSOMAL CYSTINE COUNTER-TRANSPORT IN HETEROZYGOTES FOR CYSTINOSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NICHHD,HUMAN GENET BRANCH,BIOCHEM GENET SECT,BETHESDA,MD 20205; NIADDKD,INTERMEDIARY METAB SECT,BETHESDA,MD 20205	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	GAHL, WA (corresponding author), NIH,CTR CLIN,INTERINST GENET PROGRAM,BETHESDA,MD 20205, USA.							GAHL WA, 1983, BIOCHEM J, V216, P393, DOI 10.1042/bj2160393; GAHL WA, 1982, J BIOL CHEM, V257, P9570; GAHL WA, 1982, SCIENCE, V217, P1263, DOI 10.1126/science.7112129; JONAS AJ, 1982, J BIOL CHEM, V257; LOWRY OH, 1951, J BIOL CHEM, V193, P265; OSHIMA RG, 1974, J BIOL CHEM, V249, P6033; SCHNEIDER JA, 1967, BIOCHEM BIOPH RES CO, V29, P527, DOI 10.1016/0006-291X(67)90516-5; SCHNEIDER JA, 1967, SCIENCE, V157, P1321, DOI 10.1126/science.157.3794.1321; SCHNEIDER JA, 1983, METABOLIC BASIS INHE, P1844; SCHULMAN JD, 1973, DHEW NIH72249 PUBL; STEINHERZ R, 1982, J BIOL CHEM, V257, P6041; STEINHERZ R, 1982, P NATL ACAD SCI-BIOL, V79, P4446, DOI 10.1073/pnas.79.14.4446; STEINHERZ R, 1982, NEW ENGL J MED, V306, P1468, DOI 10.1056/NEJM198206173062407; WILBRANDT W, 1961, PHARMACOL REV, V13, P109	14	32	35	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	2					277	282						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SM324	6711558				2022-12-18	WOS:A1984SM32400002
J	KNOLL, JH; CHUDLEY, AE; GERRARD, JW				KNOLL, JH; CHUDLEY, AE; GERRARD, JW			FRAGILE (X) X-LINKED MENTAL-RETARDATION .2. FREQUENCY AND REPLICATION PATTERN OF FRAGILE (X) (Q28) IN HETEROZYGOTES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV SASKATCHEWAN HOSP,DIV MED GENET,SASKATOON S7N 0W8,SASKATCHEWAN,CANADA; UNIV SASKATCHEWAN,DEPT PEDIAT,SASKATOON S7N 0W0,SASKATCHEWAN,CANADA	University of Saskatchewan; University of Saskatchewan								BRONDUMNIELSEN K, 1981, HUM GENET, V59, P23; BRONDUMNIELSEN K, 1983, HUM GENET, V64, P240; CARPENTER NJ, 1981, PEDIATR RES, V15, pA560; CHUDLEY AE, 1983, AM J MED GENET, V14, P699, DOI 10.1002/ajmg.1320140412; DEROOVER J, 1977, ANN GENET-PARIS, V20, P263; HOWARDPEEBLES PN, 1980, AM J MED GENET, V7, P497, DOI 10.1002/ajmg.1320070410; JACOBS PA, 1980, AM J MED GENET, V7, P471, DOI 10.1002/ajmg.1320070408; JENNINGS M, 1980, AM J MED GENET, V7, P417, DOI 10.1002/ajmg.1320070404; Martin JP, 1943, J NEUROL PSYCHIATRY, V6, P154, DOI 10.1136/jnnp.6.3-4.154; PROOPS R, 1981, J MED GENET, V18, P366, DOI 10.1136/jmg.18.5.366; RUVALCABA RHA, 1977, JAMA-J AM MED ASSOC, V238, P1646, DOI 10.1001/jama.238.15.1646; SNYDER RD, 1969, CLIN PEDIATR, V8, P669, DOI 10.1177/000992286900801114; TURNER G, 1980, NEW ENGL J MED, V303, P662, DOI 10.1056/NEJM198009183031202; TURNER G, 1980, J PEDIATR-US, V96, P837, DOI 10.1016/S0022-3476(80)80552-X; UCHIDA IA, 1982, AM J HUM GENET, V34, P286; UCHIDA IA, 1983, AM J HUM GENET, V35, P861; WEBB GC, 1982, J MED GENET, V19, P44, DOI 10.1136/jmg.19.1.44; WILLARD HF, 1976, AM J HUM GENET, V28, P213; WOLFF G, 1978, AM J MED GENET, V2, P217, DOI 10.1002/ajmg.1320020302	19	32	32	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	3					640	645						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	SY119	6731439				2022-12-18	WOS:A1984SY11900013
J	CLONINGER, CR; RAO, DC; RICE, J; REICH, T; MORTON, NE				CLONINGER, CR; RAO, DC; RICE, J; REICH, T; MORTON, NE			A DEFENSE OF PATH-ANALYSIS IN GENETIC EPIDEMIOLOGY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review									WASHINGTON UNIV,JEWISH HOSP,SCH MED,DEPT GENET,ST LOUIS,MO 63178; WASHINGTON UNIV,SCH MED,DEPT PREVENT MED,DIV BIOSTAT,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT PSYCHIAT,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT GENET,ST LOUIS,MO 63110; JEWISH HOSP,DEPT PREVENT MED,DIV BIOSTAT,ST LOUIS,MO 63178; UNIV HAWAII,POPULAT GENET LAB,HONOLULU,HI 96822	Barnes-Jewish Hospital; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Barnes-Jewish Hospital; University of Hawaii System	CLONINGER, CR (corresponding author), WASHINGTON UNIV,JEWISH HOSP,SCH MED,DEPT PSYCHIAT,ST LOUIS,MO 63178, USA.		Cloninger, Claude/F-5357-2012	Cloninger, Claude/0000-0003-3096-4807	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA003539] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA-03539] Funding Source: Medline; NIGMS NIH HHS [GM-28719, GM-17173] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aitken, 1934, P EDINBURGH MATH SOC, V4, P106, DOI [DOI 10.1017/S0013091500008063, 10.1017/S0013091500008063]; BEATY TH, 1982, ANN HUM GENET, V46, P355, DOI 10.1111/j.1469-1809.1982.tb01586.x; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; CLONINGER CR, 1979, AM J HUM GENET, V31, P366; CLONINGER CR, 1979, AM J HUM GENET, V31, P176; CLONINGER CR, 1980, GENET RES, V36, P133, DOI 10.1017/S0016672300019765; CLONINGER CR, 1983, PSYCHIATR DEV; COMSTOCK R. E., 1963, NATL ACAD SCI NATL RES COUNC PUBL, V982, P164; Duncan O.D., 1975, INTRO STRUCTURAL EQU; EAVES LJ, 1972, BEHAV GENET, V2, P241, DOI 10.1007/BF01065692; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Falconer D. S., 1981, INTRO QUANTITATIVE G; FALCONER DS, 1955, COLD SPRING HARB SYM, V20, P178, DOI 10.1101/SQB.1955.020.01.018; FANG C, 1983, STATISTICS PROBABILI, P249; Fisher R.A., 1921, METRON, V1, P3, DOI DOI 10.1093/BIOMET/9.1-2.22; GERRARD JW, 1978, AM J HUM GENET, V30, P46; Goldberger A.S, 1973, STRUCTURAL EQUATION, P1; GOLDBERGER AS, 1978, AM J HUM GENET, V30, P442; GOLDBERGER AS, 1978, GENETIC EPIDEMIOLOGY; GULBRANDSEN CL, 1979, HUM GENET, V50, P307, DOI 10.1007/BF00399397; HALDANE JBS, 1964, PERSPECT BIOL MED, V7, P343; HARRISON GA, 1964, ANN HUM GENET, V28, P27, DOI 10.1111/j.1469-1809.1964.tb00457.x; HASSTEDT SJ, 1983, AM J MED GENET, V14, P61, DOI 10.1002/ajmg.1320140110; HASSTEDT SJ, 1982, COMPUT BIOMED RES, V15, P295, DOI 10.1016/0010-4809(82)90064-7; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; Jencks C., 1972, INEQUALITY; KANG KM, 1980, DEV STATISTICS, V3, P217; KARLIN S, 1979, THEOR POPUL BIOL, V15, P356, DOI 10.1016/0040-5809(79)90045-5; KARLIN S, 1983, AM J HUM GENET, V35, P695; KRIEGER H, 1980, HUM GENET, V53, P415, DOI 10.1007/BF00287065; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LALOUEL JM, 1983, METHODS GENETIC EPID; LANGE K, 1976, ANN HUM GENET, V39, P485, DOI 10.1111/j.1469-1809.1976.tb00156.x; LEVINE RS, 1982, AM J EPIDEMIOL, V116, P759, DOI 10.1093/oxfordjournals.aje.a113465; Li C., 1975, PATH ANAL A PRIMER; LI CC, 1978, GENETIC EPIDEMIOLOGY; MCGUE M, UNPUB PATH ANAL GENE; MCGUE M, 1983, GENET RES; MIELKE JH, 1980, CURRENT DEV ANTHR GE, V1; MOLL PP, 1979, ANN HUM GENET, V42, P343, DOI 10.1111/j.1469-1809.1979.tb00668.x; Morton N. E., 1982, OUTLINE GENETIC EPID; Morton N.E., 1983, METHODS GENETIC EPID; Morton N. E., 1978, GENETIC EPIDEMIOLOGY; MORTON NE, 1955, AM J HUM GENET, V7, P277; MORTON NE, 1974, AM J HUM GENET, V26, P489; MORTON NE, 1980, HUM GENET, V53, P261; MORTON NE, 1981, HUM HERED, V31, P3, DOI 10.1159/000153168; MORTON NE, 1982, AM J HUM GENET, V34, P489; MORTON NE, 1974, AM J HUM GENET, V26, P318; MORTON NE, 1979, GENETIC ANAL COMMON; MURPHY EA, 1982, GENETIC BASIS EPILEP, P333; NANCE WE, 1978, GENETIC EPIDEMIOLOGY, P195; NEEL JV, 1965, US DHEW PHS PUBLICAT, V1163; ORR JD, 1981, J CHRON DIS, V34, P545, DOI 10.1016/0021-9681(81)90017-5; OTT J, 1974, AM J HUM GENET, V26, P588; RAO DC, 1976, AM J HUM GENET, V28, P228; RAO DC, 1982, HUM GENET, V60, P257, DOI 10.1007/BF00303013; RAO DC, 1979, ANN HUM GENET, V42, P467, DOI 10.1111/j.1469-1809.1979.tb00680.x; RAO DC, 1982, GENET RES, V39, P187, DOI 10.1017/S0016672300020875; RAO DC, 1979, GENET RES, V33, P175, DOI 10.1017/S0016672300018310; RAO DC, 1974, AM J HUM GENET, V26, P331; RAO DC, 1978, AM J HUM GENET, V30, P445; RAO DC, 1982, AM J HUM GENET, V34, P888; RAO DC, 1974, AM J HUM GENET, V26, P267; RAO DC, 1978, GENETIC EPIDEMIOLOGY, P145; RAO DC, 1983, HUMAN POPULATION GEN; RICE J, 1980, BEHAV GENET, V10, P73, DOI 10.1007/BF01067320; RICE J, 1978, AM J HUM GENET, V30, P618; SING CF, 1978, AM J HUM GENET, V30, P491; SING CF, 1976, AM J HUM GENET, V28, P453; SING CF, 1979, GENETIC ANAL COMMON; SING CF, 1979, GENETIC ANAL COMMON, P597; van Eerdewegh, 1982, THESIS WASHINGTON U; Wallace B., 1981, BASIC POPULATION GEN; WETTE R, UNPUB DISTRIBUTION Z; WILLIAMS WR, 1983, CLIN GENET; WRIGHT S, 1983, AM J HUM GENET, V35, P757; Wright S., 1968, EVOLUTION GENETICS P, P373; WRIGHT S, 1983, HUMAN POPULATION GEN; WRIGHT S, 1978, GENETIC EPIDEMIOLOGY	80	32	32	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	4					733	756						24	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RG731	6349336				2022-12-18	WOS:A1983RG73100016
J	FERRARIS, AM; GIUNTINI, P; GALIANO, S; GAETANI, GF				FERRARIS, AM; GIUNTINI, P; GALIANO, S; GAETANI, GF			2-DEOXY-GLUCOSE-6-PHOSPHATE UTILIZATION IN THE STUDY OF GLUCOSE-6-PHOSPHATE-DEHYDROGENASE MOSAICISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note											FERRARIS, AM (corresponding author), UNIV GENOA,SCH MED,DEPT HEMATOL,I-16132 GENOA,ITALY.							[Anonymous], 1967, WHO TECH REP SER, V366, P1; BEUTLER E, 1971, SEMIN HEMATOL, V8, P311; EDGELL CJS, 1978, AM J HUM GENET, V30, P80; FAIRBANKS VF, 1968, BLOOD, V31, P589, DOI 10.1182/blood.V31.5.589.589; FIALKOW PJ, 1979, ANNU REV MED, V30, P135, DOI 10.1146/annurev.me.30.020179.001031; FIALKOW PJ, 1976, BIOCHIM BIOPHYS ACTA, V458, P283, DOI 10.1016/0304-419X(76)90003-2; FIALKOW PJ, 1978, J CLIN INVEST, V62, P815, DOI 10.1172/JCI109193; GALL JC, 1965, AM J HUM GENET, V17, P359; GANDINI E, 1969, NATURE, V224, P599, DOI 10.1038/224599a0; GANDINI E, 1973, AM J HUM GENET, V25, P74; GARTLER SM, 1971, ANN HUM GENET, V35, P1, DOI 10.1111/j.1469-1809.1956.tb01372.x; GEALY WJ, 1980, LANCET, V8159, P63; GLOCK GE, 1953, BIOCHEM J, V55, P400, DOI 10.1042/bj0550400; KIRKMAN HN, 1964, J LAB CLIN MED, V63, P726; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lyon M. F., 1968, Annual review of genetics. Vol. 2, P31, DOI 10.1146/annurev.ge.02.120168.000335; SANSONE G, 1963, Pathologica, V55, P371; STAMATOYANNOPOULOS G, 1971, J CLIN INVEST, V50, P1253, DOI 10.1172/JCI106603	18	32	32	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	2					307	313						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LH910	7211845				2022-12-18	WOS:A1981LH91000017
J	FERRELL, RE; BERTIN, T; BARTON, SA; ROTHHAMMER, F; SCHULL, WJ				FERRELL, RE; BERTIN, T; BARTON, SA; ROTHHAMMER, F; SCHULL, WJ			MULTINATIONAL ANDEAN GENETIC AND HEALTH-PROGRAM .9. GENE-FREQUENCIES AND RARE VARIANTS OF 20 SERUM-PROTEINS AND ERYTHROCYTE ENZYMES IN THE AYMARA OF CHILE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CHILE,DEPT CELLULAR BIOL & GENET,SANTIAGO 7,CHILE	Universidad de Chile	FERRELL, RE (corresponding author), UNIV TEXAS,HLTH SCI CTR,CTR DEMOG & POPULAT GENET,HOUSTON,TX 77025, USA.			Barton, Sara Ann/0000-0002-6196-3324				ARIASSTELLA J, 1963, CIRCULATION, V28, P915, DOI 10.1161/01.CIR.28.5.915; CHAKRABORTY R, 1978, AM J HUM GENET, V30, P550; Diaz B, 1978, Bull Pan Am Health Organ, V12, P219; FERRELL RE, 1978, AM J PHYS ANTHROPOL, V48, P269, DOI 10.1002/ajpa.1330480302; FERRELL RE, 1978, AM J HUM GENET, V30, P539; Forbes David, 1870, J ETHNOLOGICAL SOC L, V2, P193; FRISANCHO AR, 1975, SCIENCE, V187, P313, DOI 10.1126/science.1089311; Harris, 1976, HDB ENZYME ELECTROPH; Hurtado A., 1971, HIGH ALTITUDE PHYSL, P3; HURTADO A, 1964, PHYSIOLOGICAL EFFECT, P1; KIRK RL, 1974, AM J PHYS ANTHROPOL, V41, P301, DOI 10.1002/ajpa.1330410213; LENFANT C, 1968, J CLIN INVEST, V47, P2652, DOI 10.1172/JCI105948; MACNEISH RS, 1970, SCIENCE, V168, P975, DOI 10.1126/science.168.3934.975; MERINO CF, 1950, BLOOD, V5, P1; MONGE C, 1966, HIGH ALTITUDE DISEAS; MORPUGO G, 1970, NATURE, V227, P386; NEEL JV, 1978, ANN HUM GENET, V41, P429, DOI 10.1111/j.1469-1809.1978.tb00913.x; NEEL JV, 1978, AM J HUM GENET, V30, P465; NEEL JV, 1977, HUM GENET, V36, P81, DOI 10.1007/BF00390440; PENALOZA D, 1963, AM J CARDIOL, V11, P150, DOI 10.1016/0002-9149(63)90055-9; PENALOZA D, 1961, AM HEART J, V61, P101, DOI 10.1016/0002-8703(61)90522-1; REYNAFAR.C, 1966, FED PROC, V25, P1240; REYNAFARJE B, 1969, AM J PHYSIOL, V216, P1542, DOI 10.1152/ajplegacy.1969.216.6.1542; REYNAFARJE B, 1961, AM J PHYSIOL, V200, P351, DOI 10.1152/ajplegacy.1961.200.2.351; REYNAFARJE C, 1959, BLOOD, V14, P433, DOI 10.1182/blood.V14.4.433.433; SCHULL WJ, 1977, GENETIC NONGENETIC C, V17, P139; TANIS RJ, 1973, AM J HUM GENET, V25, P655; TCHEN P, 1978, HUM GENET, V45, P317, DOI 10.1007/BF00278729; TILLS D, 1970, HUM HERED, V20, P523, DOI 10.1159/000152354; VANDERDOES JA, 1978, HUM GENET, V34, P327	30	32	32	1	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	1					92	102						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JH296	7361767				2022-12-18	WOS:A1980JH29600012
J	MAGENIS, RE; BREG, WR; CLARK, KA; HOOK, EB; PALMER, CG; PASZTOR, LM; SUMMITT, RL; VANDYKE, D				MAGENIS, RE; BREG, WR; CLARK, KA; HOOK, EB; PALMER, CG; PASZTOR, LM; SUMMITT, RL; VANDYKE, D			DISTRIBUTION OF SEX-CHROMOSOME COMPLEMENTS IN 651 PATIENTS WITH TURNERS SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									UNIV OREGON,HLTH SCI CTR,PORTLAND,OR 97201	University of Oregon									0	32	32	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	6					A79	A79						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KT964					2022-12-18	WOS:A1980KT96400175
J	RAO, DC; LALOUEL, JM; MORTON, NE; GERRARD, JW				RAO, DC; LALOUEL, JM; MORTON, NE; GERRARD, JW			IMMUNOGLOBULIN-E REVISITED	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note											RAO, DC (corresponding author), UNIV HAWAII,POPULAT GENET LAB,HONOLULU,HI 96822, USA.							ELSTON RC, 1979, AM J HUM GENET, V31, P655; ELSTON RC, 1980, ADV HUMAN GENETICS, V11; GERRARD JW, 1978, AM J HUM GENET, V30, P46; LALOUEL JM, 1980, 3 U HAW POP GEN LAB; LALOUEL JM, 1979, 14 U UT DEP MED BIOP; LALOUEL JM, UNPUBLISHED; MACLEAN CJ, 1975, AM J HUM GENET, V27, P365; MACLEAN CJ, 1976, BIOMETRICS, V32, P695, DOI 10.2307/2529760; MORTON NE, 1974, AM J HUM GENET, V26, P489; OTT J, 1979, AM J HUM GENET, V31, P161	10	32	32	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	4					620	625						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KB522	7395873				2022-12-18	WOS:A1980KB52200016
J	LOWDEN, JA; IVES, EJ; KEENE, DL; BURTON, AL; SKOMOROWSKI, MA; HOWARD, F				LOWDEN, JA; IVES, EJ; KEENE, DL; BURTON, AL; SKOMOROWSKI, MA; HOWARD, F			CARRIER DETECTION IN SANDHOFF DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV SASKATCHEWAN,DEPT PEDIAT,SASKATOON S7N 0W0,SASKATCHEWAN,CANADA; UNIV SASKATCHEWAN,DEPT GENET,SASKATOON S7N 0W0,SASKATCHEWAN,CANADA	University of Saskatchewan; University of Saskatchewan	LOWDEN, JA (corresponding author), HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ONTARIO,CANADA.							ANDERMANN F, 1974, AM J HUM GENET, V26, pA10; GALJAARD H, 1974, EXP CELL RES, V87, P444, DOI 10.1016/0014-4827(74)90515-1; GEIGER B, 1976, BIOCHEMISTRY-US, V15, P3484, DOI 10.1021/bi00661a014; GORDON BA, 1974, CLIN RES, V22, pA740; JACKSON LG, 1974, CLIN PEDIATR, V13, P303; Kaback M. M., 1972, SPHINGOLIPIDS SPHING, P613; LOWDEN JA, 1974, CAN MED ASSOC J, V111, P900; LOWDEN JA, 1973, CLIN CHEM, V19, P1345; LOWDEN JA, 1972, SPHINGOLIPIDS SPHING, P257; MOLZER B, 1976, CLIN CHIM ACTA, V73, P163, DOI 10.1016/0009-8981(76)90318-1; NAVON R, 1973, AM J HUM GENET, V25, P287; OKADA S, 1969, SCIENCE, V165, P698, DOI 10.1126/science.165.3894.698; PENTON E, 1975, BIOCHIM BIOPHYS ACTA, V391, P162, DOI 10.1016/0005-2744(75)90162-X; POENARU L, 1973, BIOMED EXPRESS, V19, P538; PRICE RG, 1972, BIOCHIM BIOPHYS ACTA, V271, P145, DOI 10.1016/0005-2795(72)90142-0; RATTAZZI MC, 1974, AM J HUM GENET, V26, pA71; SAIFER A, 1975, CLIN CHEM, V21, P334; SANDHOFF K, 1971, J NEUROCHEM, V18, P2469, DOI 10.1111/j.1471-4159.1971.tb00204.x; SANDHOFF K, 1968, LIFE SCI PT 1 PHYSI, V7, P283, DOI 10.1016/0024-3205(68)90024-6; SCRIVER CR, 1974, CAN MED ASSOC J, V111, P899; SPENCE MW, 1974, PEDIATR RES, V8, P628, DOI 10.1203/00006450-197406000-00003; SRIVASTA.SK, 1974, J BIOL CHEM, V249, P2054; SUZUKI Y, 1973, CLIN CHIM ACTA, V48, P153, DOI 10.1016/0009-8981(73)90360-4; SUZUKI Y, 1970, NEUROLOGY, V20, P848, DOI 10.1212/WNL.20.9.848; SWALLOW DM, 1974, ANN HUM GENET, V37, P287, DOI 10.1111/j.1469-1809.1974.tb01836.x; TUCKER SM, 1977, BIOCHEM SOC T, V5, P241, DOI 10.1042/bst0050241; VIDGOFF J, 1973, AM J HUM GENET, V25, P372; WOOD S, 1976, AM J HUM GENET, V28, P489	28	32	34	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	1					38	45						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EL575	414620				2022-12-18	WOS:A1978EL57500005
J	CHAMPION, MJ; SHOWS, TB				CHAMPION, MJ; SHOWS, TB			ELECTROPHORETIC ABNORMALITIES OF LYSOSOMAL ENZYMES IN MUCOLIPIDOSIS FIBROBLAST LINES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,BIOCHEM GENET SECT,BUFFALO,NY 14263	Roswell Park Cancer Institute								BARTHOLOMEW EM, 1969, J IMMUNOL, V103, P787; BERMAN ER, 1974, CLIN CHIM ACTA, V52, P115; CARROLL M, 1972, BIOCHEM BIOPH RES CO, V49, P579, DOI 10.1016/0006-291X(72)90450-0; CHAMPION MJ, 1976, EXCERPTA MEDIA, V397, P27; CHEN SH, 1975, AM J HUM GENET, V27, P46; DENTANDT WR, 1974, J LAB CLIN MED, V83, P403; EDWARDS YH, 1971, ANN HUM GENET, V35, P207, DOI 10.1111/j.1469-1809.1956.tb01393.x; GIBLETT ER, 1972, LANCET, V2, P1067; GILBERT EF, 1973, Z KINDERHEILKD, V114, P259, DOI 10.1007/BF00569920; GLASER JH, 1974, J PEDIATR-US, V85, P192, DOI 10.1016/S0022-3476(74)80391-4; GOLDSTON.A, 1971, FEBS LETT, V13, P68, DOI 10.1016/0014-5793(71)80667-1; HICKMAN S, 1972, BIOCHEM BIOPH RES CO, V49, P992, DOI 10.1016/0006-291X(72)90310-5; HIRSCHHORN R, 1973, NATURE-NEW BIOL, V246, P200, DOI 10.1038/newbio246200a0; KELLY TE, 1975, JOHNS HOPKINS MED J, V137, P156; KELLY TE, 1976, CLIN ORTHOP RELAT R, V114, P116; KOMMA DJ, 1963, J HISTOCHEM CYTOCHEM, V11, P619, DOI 10.1177/11.5.619; LALLEY PA, 1974, P NATL ACAD SCI USA, V71, P1569, DOI 10.1073/pnas.71.4.1569; LEROY JG, 1972, PEDIATR RES, V6, P752, DOI 10.1203/00006450-197210000-00002; LEROY JG, 1971, J PEDIATR-US, V79, P360, DOI 10.1016/S0022-3476(71)80142-7; LIE KK, 1973, CLIN CHIM ACTA, V45, P243, DOI 10.1016/0009-8981(73)90433-6; MCKUSICK VA, 1972, HERITABLE DISORDERS, P521; MELHEM R, 1973, RADIOLOGY, V106, P153, DOI 10.1148/106.1.153; NEUFELD EF, 1975, ANNU REV BIOCHEM, V44, P357, DOI 10.1146/annurev.bi.44.070175.002041; NEUFELD EF, 1974, PROG MED GENET, V10, P81; NISHIHARA H, 1973, BIOCHIM BIOPHYS ACTA, V302, P429, DOI 10.1016/0005-2744(73)90172-1; POENARU L, 1973, BIOCHIM BIOPHYS ACTA, V303, P171, DOI 10.1016/0005-2795(73)90158-X; RATTAZZI MC, 1976, AM J HUM GENET, V28, P143; SENSENBRENNER JA, 1972, BIRTH DEFECTS OAS, V19; SHOWS T B, 1975, P251; Shows T B, 1975, Birth Defects Orig Artic Ser, V11, P29; SHOWS TB, 1975, P NATL ACAD SCI USA, V72, P2125, DOI 10.1073/pnas.72.6.2125; SHOWS TB, 1974, BIOCHEM GENET, V11, P121, DOI 10.1007/BF00485769; SHOWS TB, 1972, P NATL ACAD SCI USA, V69, P348, DOI 10.1073/pnas.69.2.348; SHOWS TB, 1969, BIOCHEM GENET, V4, P297; SHOWS TB, 1975, ISOZYMES, V3, P619; SLY WS, 1976, P NATL ACAD SCI USA, V73, P2443, DOI 10.1073/pnas.73.7.2443; SWALLOW DM, 1972, ANN HUM GENET, V36, P141, DOI 10.1111/j.1469-1809.1972.tb00765.x; TAYLOR HA, 1975, CLIN CHIM ACTA, V59, P93, DOI 10.1016/0009-8981(75)90223-5; THOMAS GH, 1976, BIOCHEM BIOPH RES CO, V71, P188, DOI 10.1016/0006-291X(76)90267-9; THOMAS GH, 1973, PEDIATR RES, V7, P751, DOI 10.1203/00006450-197309000-00004; TURNER BM, 1974, CLIN CHIM ACTA, V57, P29, DOI 10.1016/0009-8981(74)90174-0; VLADUTIU GD, 1975, BIOCHEM BIOPH RES CO, V67, P956, DOI 10.1016/0006-291X(75)90768-8; VLADUTIU GD, 1974, J CELL BIOL, V62, P560, DOI 10.1083/jcb.62.2.560; WIESMANN UN, 1974, PEDIATR RES, V8, P865, DOI 10.1203/00006450-197411000-00002	44	32	32	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1977	29	2					149	163						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DB507	848490				2022-12-18	WOS:A1977DB50700004
J	NEI, M				NEI, M			ESTIMATION OF MUTATION-RATE FROM RARE PROTEIN VARIANTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TEXAS, CTR DEMOGRAPH & POPULATION STUDIES, HOUSTON, TX 77030 USA	University of Texas System								EWENS WJ, 1974, THEOR POPUL BIOL, V6, P143, DOI 10.1016/0040-5809(74)90020-3; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Kamei T, 1969, MONKEY, V106, P5; KIMURA M, 1971, GENET RES, V18, P125, DOI 10.1017/S0016672300012520; KIMURA M, 1969, GENETICS, V63, P701; KIMURA M, 1964, GENETICS, V49, P725; KIMURA M, 1971, Theoretical Population Biology, V2, P174; KIMURA M, 1975, P NATL ACAD SCI USA, V72, P2761, DOI 10.1073/pnas.72.7.2761; LI WH, 1976, GENETICS, V83, P423; NEEL JV, 1973, P NATL ACAD SCI USA, V70, P3311, DOI 10.1073/pnas.70.12.3311; NEI M, 1968, P NATL ACAD SCI USA, V60, P517, DOI 10.1073/pnas.60.2.517; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; NEI M, IN PRESS; NOZAWA K, 1972, Primates, V13, P381, DOI 10.1007/BF01793658; NOZAWA K, TO BE PUBLISHED; NOZAWA K, 1975, CONT PRIMATOLOGY, P75; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; SPIELMAN RS, 1974, SCIENCE, V184, P637, DOI 10.1126/science.184.4137.637; TANIS R, 1974, ANN HUM GENET, V38, P179, DOI 10.1111/j.1469-1809.1974.tb01949.x; WARD RH, 1975, AM J HUM GENET, V27, P1; WEITKAMP LR, 1973, ANN HUM GENET, V37, P219, DOI 10.1111/j.1469-1809.1973.tb01829.x; Wright S., 1942, Bull Amer Math Soc, V48, P223, DOI 10.1090/S0002-9904-1942-07641-5; Wright S, 1938, P NATL ACAD SCI USA, V24, P253, DOI 10.1073/pnas.24.7.253	23	32	32	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1977	29	3					225	232						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DG794	405863				2022-12-18	WOS:A1977DG79400001
J	VANDYKE, DL; PALMER, CG; NANCE, WE; YU, PL				VANDYKE, DL; PALMER, CG; NANCE, WE; YU, PL			CHROMOSOME POLYMORPHISM AND TWIN ZYGOSITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HENRY FORD HOSP,DETROIT,MI 48202; INDIANA UNIV,SCH MED,DEPT MED GENET,INDIANAPOLIS,IN 46204; MED COLL VIRGINIA,DEPT MED GENET,RICHMOND,VA 23219	Henry Ford Health System; Henry Ford Hospital; Indiana University System; Indiana University-Purdue University Indianapolis; Virginia Commonwealth University								ALLEN G, 1960, Acta Genet Med Gemellol (Roma), V9, P240; Boyden S.V., 1970, IMPACT CIVILIZATION; CASPERSSON T, 1970, EXP CELL RES, V63, P240, DOI 10.1016/0014-4827(70)90363-0; CASPERSSON T, 1971, HEREDITAS-GENETISK A, V67, P89; CHRISTENSEN KR, 1974, CLIN GENET, V5, P205; Cotterman C. W., 1947, CONTR LAB VERTEBRATE BIOL MICHIGAN UNIV, V33, P1; CRAIGHOLMES AP, 1975, AM J HUM GENET, V27, P178; CRAIGHOLMES AP, 1973, AM J HUM GENET, V25, P181; GAINES RE, 1969, AM J HUM GENET, V21, P457; GARONER IC, 1943, HEREDITY, V34, P27; GERAEDTS JP, 1974, CLIN GENET, V6, P247; HAUGE M, 1975, HUMANGENETIK, V26, P187; HECHT F, 1971, NEW ENGL J MED, V285, P1482, DOI 10.1056/NEJM197112232852610; HOEHN H, 1972, EXP CELL RES, V75, P275, DOI 10.1016/0014-4827(72)90548-4; HOLZER S, 1972, HUMANGENETIK, V16, P341; KUNZE J, 1975, LANCET, V1, P273; LIN CC, 1973, TISSUE CULTURE METHO, P778; LUBS H, 1973, AM J HUM GENET, V25, pA47; Lubs H A, 1973, Methods Cell Biol, V6, P345, DOI 10.1016/S0091-679X(08)60057-6; LUBS HA, 1970, HUMAN POPULATION CYT, P119; MADAN K, 1974, ANN GENET-PARIS, V17, P81; MCKENZIE WH, 1975, CYTOGENET CELL GENET, V14, P97, DOI 10.1159/000130330; MIGEON BR, 1965, B JOHNS HOPKINS HOSP, V116, P396; MIKELSAAR AV, 1974, HUMANGENETIK, V23, P59, DOI 10.1007/BF00295683; MIKELSAAR AVN, 1975, HUMANGENETIK, V26, P1, DOI 10.1007/BF00280281; MILLER OJ, 1962, T NEW YORK ACAD SCI, V24, P372, DOI 10.1111/j.2164-0947.1962.tb01413.x; MOSCETTI G, 1971, HUMANGENETIK, V12, P56, DOI 10.1007/BF00291033; MULLER H, 1975, CYTOGENET CELL GENET, V15, P239, DOI 10.1159/000130522; MULLER HJ, 1975, CHROMOSOMES TODAY, V5, P249; NIELSEN J, 1974, HUMANGENETIK, V21, P211, DOI 10.1007/BF00279014; NIIKAWA N, 1975, HUMANGENETIK, V30, P83, DOI 10.1007/BF00273636; PALMER CG, 1975, MAMMAL CHROM NEWLS, V16, P93; PARK J, 1974, AM J HUM GENET, V26, pA65; PARK J, 1976, THESIS INDIANA U, P155; Rivas M L, 1975, Birth Defects Orig Artic Ser, V11, P239; SCHNEDL W, 1971, HUMANGENETIK, V12, P59, DOI 10.1007/BF00291034; SEKHON GS, 1975, AM J HUM GENET, V27, pA79; SOKAL RR, 1969, BIOMETRY PRINCIPLES, P156; SUMNER AT, 1971, NATURE-NEW BIOL, V232, P31, DOI 10.1038/newbio232031a0; VERMA RS, 1975, AM J HUM GENET, V27, P110; VERMA RS, 1975, HUMANGENETIK, V30, P225, DOI 10.1007/BF00279188; WAHLSTROM J, 1971, HUMANGENETIK, V12, P77, DOI 10.1007/BF00291038; 1975, BIRTH DEFECTS OAS  S; 1972, BIRTH DEFECTS OAS	44	32	33	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1977	29	5					431	447						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DV673	331942				2022-12-18	WOS:A1977DV67300002
J	CHERN, CJ; CROCE, CM				CHERN, CJ; CROCE, CM			ASSIGNMENT OF STRUCTURAL GENE FOR HUMAN BETA-GLUCURONIDASE TO CHROMOSOME-7 AND TETRAMERIC ASSOCIATION OF SUBUNITS IN ENZYME MOLECULE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV PENN, WISTAR INST ANAT & BIOL,PHILADELPHIA,PA 19104	The Wistar Institute; University of Pennsylvania			Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647				BANNISTER DL, 1975, J PEDIATR-US, V86, P916, DOI 10.1016/S0022-3476(75)80228-9; CHERN CJ, 1975, CYTOGENET CELL GENET, V15, P299, DOI 10.1159/000130527; CHERN CJ, IN PRESS; CRISTOFALO VJ, 1975, MECH AGEING DEV, V4, P19, DOI 10.1016/0047-6374(75)90004-4; CROCE CM, 1973, P NATL ACAD SCI USA, V70, P3617, DOI 10.1073/pnas.70.12.3617; CROCE CM, 1974, J EXP MED, V140, P1221, DOI 10.1084/jem.140.5.1221; CROCE CM, 1973, EXP CELL RES, V82, P457, DOI 10.1016/0014-4827(73)90366-2; CROCE CM, 1975, SCIENCE, V190, P1200, DOI 10.1126/science.173020; DELVIN E, 1970, BIOCHIM BIOPHYS ACTA, V220, P93, DOI 10.1016/0005-2744(70)90232-9; GRZESCHIK KH, 1976, 3RD BALT C INT WORKS; KHOURY G, 1975, CELL, V6, P535, DOI 10.1016/0092-8674(75)90043-4; LAGUNOFF D, 1973, LAB INVEST, V29, P449; LALLEY PA, 1974, SCIENCE, V185, P442, DOI 10.1126/science.185.4149.442; LALLEY PA, 1976, 3RD BALT C INT WORKS; LIN CW, 1975, J BIOL CHEM, V250, P4737; LIN CW, 1975, ISOZYMES, V1, P637; MURNANE MJ, 1975, AM J HUM GENET, V27, pA68; MUSA BU, 1965, J BIOL CHEM, V240, P2811; PAIGEN K, 1961, EXP CELL RES, V25, P286, DOI 10.1016/0014-4827(61)90280-4; PAIGEN K, 1975, J CELL PHYSIOL, V85, P379, DOI 10.1002/jcp.1040850406; PLAPP BV, 1966, ARCH BIOCHEM BIOPHYS, V116, P193, DOI 10.1016/0003-9861(66)90027-0; PLAPP BV, 1967, BIOCHEMISTRY-US, V6, P3676, DOI 10.1021/bi00864a009; SEABRIGH.M, 1971, LANCET, V2, P971; SLY WS, 1973, J PEDIATR-US, V82, P249, DOI 10.1016/S0022-3476(73)80162-3; STAHL PD, 1971, J BIOL CHEM, V246, P5398; TOMINO S, 1975, J BIOL CHEM, V250, P8503; TULSIANI DRP, 1975, J BIOL CHEM, V250, P4770; Wakabayashi M., 1970, METAB CONJUGATION, V2, P519; WEISS MC, 1968, P NATL ACAD SCI USA, V59, P1132, DOI 10.1073/pnas.59.4.1132	29	32	32	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	4					350	356						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	BX345	941902				2022-12-18	WOS:A1976BX34500004
J	FRANCKE, U				FRANCKE, U			HUMAN GENE FOR BETA-GLUCURONIDASE IS ON CHROMOSOME-7	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF SAN DIEGO,SCH MED,DEPT PEDIAT,LA JOLLA,CA 92093	University of California System; University of California San Diego								BEAUDET AL, 1975, J PEDIATR-US, V86, P388, DOI 10.1016/S0022-3476(75)80968-1; Danes B S, 1974, Birth Defects Orig Artic Ser, V10, P251; FRANCKE U, 1976, SOMAT CELL GENET, V2, P27, DOI 10.1007/BF01539240; GEHLER J, 1974, HUMANGENETIK, V23, P149; GRZESCHIK KH, 1976, 3RD BALT C INT WORKS; HALL CW, 1973, ARCH BIOCHEM BIOPHYS, V155, P32, DOI 10.1016/S0003-9861(73)80006-2; KARL TR, 1974, BIOCHEM GENET, V11, P367, DOI 10.1007/BF00486410; LALLEY PA, 1974, SCIENCE, V185, P442, DOI 10.1126/science.185.4149.442; LALLEY PA, 1976, 3RD BALT C INT WORKS; McKusick V. A, 1975, MENDELIAN INHERITANC; MURNANE MJ, 1975, AM J HUM GENET, V27, pA68; PAIGEN K, 1975, J CELL PHYSIOL, V85, P379, DOI 10.1002/jcp.1040850406; SLY WS, 1973, J PEDIATR-US, V82, P249, DOI 10.1016/S0022-3476(73)80162-3; SWANK RT, 1973, J MOL BIOL, V81, P225, DOI 10.1016/0022-2836(73)90191-5	14	32	32	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	4					357	362						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	BX345	941903				2022-12-18	WOS:A1976BX34500005
J	FRASER, FC; BIDDLE, CJ				FRASER, FC; BIDDLE, CJ			ESTIMATING RISKS FOR OFFSPRING OF FIRST-COUSIN MATINGS - APPROACH	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note									MONTREAL CHILDRENS HOSP,DEPT MED GENET,MONTREAL H3H 1P3,QUEBEC,CANADA; MCGILL UNIV,DEPT BIOL,MONTREAL 101,QUEBEC,CANADA; MCGILL UNIV,DEPT PEDIAT,MONTREAL 101,QUEBEC,CANADA	McGill University; McGill University; McGill University								Blishen B.R., 1968, CANADIAN SOC SOCIOLO; BOOK JA, 1957, ANN HUM GENET, V21, P191; DRONAMRAJU KR, 1968, GENETICS MIGRANT ISO, P154; FRIED K, 1974, AM J HUM GENET, V26, P65; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; ROBERTS DF, 1974, PRACTITIONER, V213, P675; SCHULL WJ, 1970, AM J HUM GENET, V22, P239; Schull WJ, 1965, EFFECTS INBREEDING J; SLATIS HM, 1958, AM J HUM GENET, V10, P446; Sutter J, 1958, Biol Med (Paris), V47, P563; YAMAGUCHI M, 1970, AM J HUM GENET, V22, P145	11	32	32	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	5					522	526						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CH661	988748				2022-12-18	WOS:A1976CH66100011
J	WOOD, S; MACDOUGALL, BG				WOOD, S; MACDOUGALL, BG			JUVENILE SANDHOFF DISEASE - SOME PROPERTIES OF RESIDUAL HEXOSAMINIDASE IN CULTURED FIBROBLASTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV BRITISH COLUMBIA,DEPT MED GENET,VANCOUVER V6T 1W5,BRITISH COLUMBI,CANADA	University of British Columbia								BEUTLER E, 1975, NATURE, V258, P262, DOI 10.1038/258262a0; BEUTLER E, 1975, AM J HUM GENET, V27, P628; DESNICK RJ, 1972, SPHINGOLIPIDS SPHING, P351; GILBERT F, 1975, P NATL ACAD SCI USA, V72, P263, DOI 10.1073/pnas.72.1.263; IKONNE JU, 1975, AM J HUM GENET, V27, P639; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACLEOD PM, IN PRESS; OBRIEN JS, 1969, LANCET, V2, P805; OKADA S, 1972, PEDIATR RES, V6, P606; OKADA S, 1969, SCIENCE, V165, P698, DOI 10.1126/science.165.3894.698; OKADA S, 1971, AM J HUM GENET, V23, P55; ROBINSON D, 1968, BIOCHEM J, V107, P321, DOI 10.1042/bj1070321; ROPERS HH, 1973, HUMANGENETIK, V20, P167, DOI 10.1007/BF00284854; SANDHOFF K, 1971, J NEUROCHEM, V18, P2469, DOI 10.1111/j.1471-4159.1971.tb00204.x; SRIVASTAVA SK, 1973, NATURE, V241, P463, DOI 10.1038/241463a0; TALLMAN JF, 1974, J BIOL CHEM, V249, P3489; WOOD S, 1975, AM J HUM GENET, V27, pA95	17	32	32	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	5					489	495						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CH661	10724				2022-12-18	WOS:A1976CH66100007
J	BOLTON, WE; BARRANCO, SC				BOLTON, WE; BARRANCO, SC			CHARACTERIZATION OF CELL-KINETICS AND GROWTH PROPERTIES OF CYSTIC-FIBROSIS DIPLOID FIBROBLASTS INVITRO	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TEXAS,MED BRANCH,DEPT HUMAN BIOL CHEM & GENET,DIV CELL BIOL,GALVESTON,TX 77550	University of Texas System; University of Texas Medical Branch Galveston					NIADDK NIH HHS [1P01 AM 17040(01)] Funding Source: Medline	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANTONOWICZ I, 1972, PEDIATR RES, V6, P803, DOI 10.1203/00006450-197211000-00001; BARNETT DR, 1973, TEX REP BIOL MED, V31, P691; BARRANCO SC, 1973, CANCER RES, V33, P691; BARTMAN J, 1970, Journal of Pediatrics, V76, P430, DOI 10.1016/S0022-3476(70)80484-X; BESLEY ETN, 1969, J MED GENET, V6, P278; BOWMAN BH, 1973, P NATL ACAD SCI USA, V70, P548, DOI 10.1073/pnas.70.2.548; CRISTOFALO VJ, 1973, EXP CELL RES, V76, P419, DOI 10.1016/0014-4827(73)90394-7; DANES BS, 1969, J EXP MED, V129, P775, DOI 10.1084/jem.129.4.775; DANES BS, 1972, J EXP MED, V136, P1313, DOI 10.1084/jem.136.5.1313; GOLDSTEIN S, 1969, LANCET, V1, P424; HAM RG, 1963, EXP CELL RES, V29, P515, DOI 10.1016/S0014-4827(63)80014-2; HAYFLICK L, 1965, TEX REP BIOL MED, VS 23, P285; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; HAYFLICK L, 1974, J AM GERIATR SOC, V22, P1; HAYFLICK L, 1970, EXP GERONTOL, V5, P291, DOI 10.1016/0531-5565(70)90012-4; HOUCK JC, 1974, 15TH ANN M CYST FIBR, P51; Howard A, 1953, HEREDITY           S, V6, P261; JACOBSON CB, 1974, 15TH ANN M CYST FIBR, P23; MACIEIRACOELHO A, 1966, EXP CELL RES, V43, P20, DOI 10.1016/0014-4827(66)90373-9; MATALON R, 1968, BIOCHEM BIOPH RES CO, V33, P954, DOI 10.1016/0006-291X(68)90405-1; MENDELSOHN ML, 1962, SCIENCE, V135, P213, DOI 10.1126/science.135.3499.213; MENDELSOHN ML, 1962, J NATL CANCER I, V28, P1015; MERZ GS, 1969, J CELL PHYSIOL, V74, P219, DOI 10.1002/jcp.1040740302; PUCK TT, 1957, J EXP MED, V106, P145, DOI 10.1084/jem.106.1.145; RENNERT OM, 1972, CLIN PEDIATR, V11, P351, DOI 10.1177/000992287201100609; SEGAL DJ, 1974, J CELL PHYSIOL, V83, P85, DOI 10.1002/jcp.1040830112; SPOCK A, 1967, PEDIATR RES, V1, P173, DOI 10.1203/00006450-196705000-00003	28	32	32	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1975	27	3					394	409						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AD236	803019				2022-12-18	WOS:A1975AD23600013
J	CHRISTIAN, JC; FEINLEIB, M; NORTON, JA				CHRISTIAN, JC; FEINLEIB, M; NORTON, JA			STATISTICAL-ANALYSIS OF GENETIC VARIANCE IN TWINS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									INDIANA UNIV,SCH MED,DEPT MED GENET,1100 W MICHIGAN ST,INDIANAPOLIS,IN 46202; INDIANA UNIV,SCH MED,DEPT PSYCHIAT,INDIANAPOLIS,IN 46202; NHLI,EPIDEMIOL BRANCH,BETHESDA,MD 20014	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)								CHRISTIAN JC, 1974, AM J HUM GENET, V26, P154	1	32	32	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1975	27	6					807	807						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AX924	1239192				2022-12-18	WOS:A1975AX92400013
J	MARIMUTHU, KM; SELLES, WD; NEURATH, PW				MARIMUTHU, KM; SELLES, WD; NEURATH, PW			COMPUTER-ANALYSIS OF GIEMSA-BANDING PATTERNS AND AUTOMATIC CLASSIFICATION OF HUMAN CHROMOSOMES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									TUFTS NEW ENGLAND MED CTR, 171 HARRISON AVE, BOSTON, MA 02111 USA	Tufts Medical Center								CASPERSS.T, 1971, EXP CELL RES, V67, P233, DOI 10.1016/0014-4827(71)90645-8; CASPERSSON T, 1970, EXP CELL RES, V62, P490, DOI 10.1016/0014-4827(70)90586-0; CASPERSSON T, 1970, CHROMOSOMA, V30, P215; CASPERSSON T, 1971, HEREDITAS-GENETISK A, V67, P89; GALLUS G, 1970, PHYS MED BIOL, V15, P435, DOI 10.1088/0031-9155/15/3/004; GRANLUND G, IN PRESS; MOLLER A, 1972, EXP CELL RES, V70, P475, DOI 10.1016/0014-4827(72)90171-1; NEURATH PW, 1972, CYTOGENETICS, V11, P457, DOI 10.1159/000130213; NEURATH PW, 1970, CYTOGENETICS, V9, P424, DOI 10.1159/000130112; PATIL SR, 1971, SCIENCE, V173, P821, DOI 10.1126/science.173.3999.821; SUMNER AT, 1971, NATURE-NEW BIOL, V232, P31, DOI 10.1038/newbio232031a0; WANG HC, 1972, NATURE-NEW BIOL, V235, P52, DOI 10.1038/newbio235052a0	12	32	32	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1974	26	3					369	377						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T0991	4133275				2022-12-18	WOS:A1974T099100006
J	ERIKSSON, AW; FELLMAN, J				ERIKSSON, AW; FELLMAN, J			DIFFERENCES IN TWINNING TRENDS BETWEEN FINNS AND SWEDES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									FOLKHALSAN INST GENET, POPULATION GENET UNIT, HELSINGFORS 00101, FINLAND									AALEN G, 1971, SOC BIOL, V18, P18, DOI 10.1080/19485565.1971.9987896; ALLEN G, 1970, ACTA GENET MED GEMEL, V19, P30, DOI 10.1017/S1120962300024938; ANDERSON WJR, 1956, J OBSTET GYNAECOL, V63, P205; BERTILLON J, 1898, J SOC STAT PARIS, V39, P146; Bonnevie K, 1926, J GENET, V16, P125, DOI 10.1007/BF02982996; Brewer JI, 1941, AM J OBSTET GYNECOL, V41, P733, DOI 10.1016/S0002-9378(41)90861-X; BULMER MG, 1959, ANN HUM GENET, V23, P454, DOI 10.1111/j.1469-1809.1959.tb01486.x; BULMER MG, 1960, ANN HUM GENET, V24, P121; Crew FAE, 1949, BR J SOC MED, V3, P1; DAHLBERG G, 1926, THESIS U UPPSALA; ENDERS T, 1948, GENETICS, V33, P263; ERIKSSON A, 1962, ACTA GENET STAT MED, V12, P242; ERIKSSON AW, 1964, LANCET, V2, P1298; ERIKSSON AW, 1967, ACTA GENET STAT MED, V17, P385; ERIKSSON AW, 1967, HEREDITAS-GENETISK A, V57, P395; ERIKSSON AW, IN PRESS; GEDDA L, 1961, TWINS HISTORY SCIENC; GITTELSOHN AM, 1965, BRIT J PREV SOC MED, V19, P8; HERTIG AT, 1959, PEDIATRICS, V23, P202; HILL AB, 1961, PRINCIPLES MEDICAL S; JEANNERET O, 1962, AM J HUM GENET, V14, P410; KAJANOJA P, 1971, THESIS U HELSINKI; Komai T, 1936, AM J PHYS ANTHROPOL, V21, P433, DOI 10.1002/ajpa.1330210325; LAMY M, 1955, Acta Genet Stat Med, V5, P403; MACGILLIVRAY I, 1970, ACTA GENET MED GEMEL, V19, P26, DOI 10.1017/S1120962300024926; MEITTINEN M, 1954, ACTA PAEDIATR, P99; MILHAM S, 1964, LANCET, V2, P566; MORTON NE, 1967, GENETICS INTERRACIAL, V3; MYRIANTHOPOULOS N C, 1970, American Journal of Human Genetics, V22, P611; NYLANDER PP, 1970, ACTA GENET MED GEMEL, V19, P36, DOI 10.1017/S1120962300024951; NYLANDER PPS, 1967, WORLD MED J, V14, P178; PRINZING F, 1907, Z GEBURTSH GYNAKOL, V60, P420; RAIHA CE, 1967, AM J EPIDEMIOL, V85, P147; SCRAGG RFR, 1970, HUM BIOL, V42, P442; SKERLJ B, 1961, TWINS HISTORY SCIENC; STEVENSON C, 1971, EXCERPTA MEDICA INT, P172; SUNDBARG G, 1923, BEVOLKERUNGSSTATISTI; Tanner JM, 1962, GROWTH ADOLESCENCE G; Waterhouse JAH, 1950, BR J SOC MED, V4, P197; Weinberg W, 1901, ARCH GESAMTE PHYSIOL, V88, P346, DOI 10.1007/BF01657695; WHITE C, 1964, NEW ENGL J MED, V271, P1003, DOI 10.1056/NEJM196411052711908; YERUSHALMY J., 1940, HUMAN BIOL, V12, P95	42	32	32	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1973	25	2					141	151						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	P0622	4689036				2022-12-18	WOS:A1973P062200003
J	LIEBERMA.J; MITTMAN, C				LIEBERMA.J; MITTMAN, C			DYNAMIC-RESPONSE OF ALPHA-ANTITRYPSIN VARIANTS TO DIETHYLSTILBESTROL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CITY HOPE NATL MED CTR, DEPT RESP DIS, DUARTE, CA 91010 USA	City of Hope								AAGENAES O, 1972, ACTA PAEDIATR SCAND, V61, P632, DOI 10.1111/j.1651-2227.1972.tb15960.x; CLIFFTON EE, 1950, J NATL CANCER I, V11, P33; DELELLIS RA, 1972, ARCH PATHOL, V94, P308; ERIKSSON S, 1965, ACTA MED SCAND, VS177, P5; FAARVANG HJ, 1963, NATURE, V199, P290, DOI 10.1038/199290b0; FAGERHOL MAGNE K., 1968, SER HAEMATOL, V1, P153; FAGERHOL MK, 1969, ACTA ALLERGOL, V24, P107, DOI 10.1111/j.1398-9995.1969.tb03760.x; GANROT PO, 1967, ACTA OBSTET GYN SCAN, V46, P126; GLASGOW JFT, 1973, AM J MED, V54, P181, DOI 10.1016/0002-9343(73)90222-2; GORDON HW, 1972, HUM PATHOL, V3, P361, DOI 10.1016/S0046-8177(72)80037-6; HOMER GM, 1963, CLIN CHEM, V9, P428; ISHAK KG, 1972, ARCH PATHOL, V94, P445; JACOBSSON K, 1955, SCAND J CLIN LAB S14, V7, P66; KUEPPERS F, 1968, HUMANGENETIK, V6, P207, DOI 10.1007/BF00291864; LAURELL CB, 1968, SCAND J CLIN LAB INV, V21, P337, DOI 10.3109/00365516809077003; LIEBERMA.J, 1969, NEW ENGL J MED, V281, P279, DOI 10.1056/NEJM196908072810601; LIEBERMAN J, 1971, J AMER MED ASSOC, V217, P1198, DOI 10.1001/jama.217.9.1198; LIEBERMAN J, 1972, Chest, V62, P557; LIEBERMAN J, 1972, SCIENCE, V175, P63, DOI 10.1126/science.175.4017.63; LIEBERMAN J, 1973, AM REV RESPIR DIS, V108, P248; LIEBERMAN J, IN PRESS; MATSUDA T, 1963, ACTA HAEMATOL JAPON, V26, P590; MITTMAN C, 1972, J OCCUP MED, V15, P33; PEACOCK AC, 1952, J NATL CANCER I, V12, P861; SHARP H L, 1971, Hospital Practice, V6, P83; SHARP HL, 1969, J LAB CLIN MED, V73, P934; TALAMO RC, 1973, SCIENCE, V181, P70, DOI 10.1126/science.181.4094.70; YOSHIDA A, 1973, SCIENCE, V179, P532, DOI 10.1126/science.179.4073.532	28	32	33	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1973	25	6					610	617						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R7135	4543998				2022-12-18	WOS:A1973R713500005
J	CHAN, TK; TODD, D				CHAN, TK; TODD, D			CHARACTERISTICS AND DISTRIBUTION OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE-DEFICIENT VARIANTS IN SOUTH CHINA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		AZEVEDO E, 1968, ANN HUM GENET, V31, P373, DOI 10.1111/j.1469-1809.1968.tb00569.x; BEUTLER E, 1969, PHARMACOL REV, V21, P73; BUXTON LHD, 1925, PEOPLES ASIA, P126; CHAN TK, 1972, BIOCHEM GENET, V6, P119, DOI 10.1007/BF00486396; CHAN TK, 1971, J MED GENET, V8, P149, DOI 10.1136/jmg.8.2.149; CHAN TK, 1965, J LAB CLIN MED, V66, P937; CHAN TK, 1964, BRIT MED J, V2, P102, DOI 10.1136/bmj.2.5401.102; FERNANDEZ MN, 1968, MAYO CLIN PROC, V43, P645; HSU PPS, 1967, S HISTORICAL ARCHAEO, P115; KIRKMAN HN, 1963, AM J HUM GENET, V15, P241; KIRKMAN HN, 1968, HERED DISORD, P126; LEE TC, 1963, AM J HUM GENET, V15, P126; LO HL, 1967, S HIST ARCHAELOGICAL, P139; LO HL, 1965, HISTORICAL SOURCES S; MATHAI CK, 1966, NATURE, V210, P115, DOI 10.1038/210115a0; MCCURDY PR, 1970, J LAB CLIN MED, V75, P788; MCCURDY PR, 1966, J LAB CLIN MED, V67, P374; MCFADZEAN A J, 1964, Trans R Soc Trop Med Hyg, V58, P490, DOI 10.1016/0035-9203(64)90103-8; STAMATOYANNOPOU.G, 1970, J CLIN INVEST, V49, P92; WONG PWK, 1965, NATURE, V208, P1323, DOI 10.1038/2081323a0; YOSHIDA A, 1967, P NATL ACAD SCI USA, V57, P835, DOI 10.1073/pnas.57.3.835; 1967, 366WHO TECH REP	22	32	33	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1972	24	4					475	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M8063	5031985				2022-12-18	WOS:A1972M806300009
J	LI, WH; NEI, M				LI, WH; NEI, M			TOTAL NUMBER OF INDIVIDUALS AFFECTED BY A SINGLE DELETERIOUS MUTATION IN A FINITE POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article														Li, Wen-Hsiung/0000-0003-1086-1456				ABRAMOWITZ M, 1964, HDB MATHEMATICAL FUN; KIMURA M, 1969, GENETICS, V63, P701; KIMURA M, 1969, GENETICS, V61, P763; KIMURA M, 1957, ANN MATH STAT, V28, P882, DOI 10.1214/aoms/1177706791; Kimura Motoo, 1964, DIFFUSION MODELS POP; Livingstone FB, 1967, ABNORMAL HEMOGLOBINS; Motulsky A G, 1971, Birth Defects Orig Artic Ser, V7, P22; NEI M, 1971, Theoretical Population Biology, V2, P426, DOI 10.1016/0040-5809(71)90031-1; NEI M, 1968, P NATL ACAD SCI USA, V60, P517, DOI 10.1073/pnas.60.2.517; NEI M, 1971, Theoretical Population Biology, V2, P419, DOI 10.1016/0040-5809(71)90030-X	10	32	32	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1972	24	6					667	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	O0504	5082917				2022-12-18	WOS:A1972O050400005
J	SAUK, JJ; WITKOP, CJ; LYON, HW				SAUK, JJ; WITKOP, CJ; LYON, HW			ELECTRON OPTIC MICROANALYSIS OF 2 GENE PRODUCTS IN ENAMEL OF FEMALES HETEROZYGOUS FOR X-LINKED HYPOMATURATION AMELOGENESIS IMPERFECTA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article														Sauk, John/0000-0002-9208-5739				BESIC FC, 1969, J DENT RES, V48, P131, DOI 10.1177/00220345690480010501; BOYDE A, 1967, P ROY SOC MED, V60, P923, DOI 10.1177/003591576706000965; HOFFMAN S, 1969, J DENT RES, V48, P1234, DOI 10.1177/00220345690480062501; HOFFMAN S, 1969, J DENT RES, V48, P242, DOI 10.1177/00220345690480021301; HOFFMAN S, 1968, NDRI6801 NAV DENT RE; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; POOLE DFG, 1967, ARCH ORAL BIOL, V12, P1621, DOI 10.1016/0003-9969(67)90196-3; RUSHTON MA, 1964, P ROY SOC MED, V57, P53, DOI 10.1177/003591576405700112; SCHULZE C, 1957, Acta Genet Stat Med, V7, P231; WEYERS H, 1957, STOMA, V10, P177; WITKOP C J, 1957, Acta Genet Stat Med, V7, P236; WITKOP CJ, 1958, EUGEN QUART, V5, P15, DOI 10.1080/19485565.1958.9987342; WITKOP CJ, 1967, ORAL SURG ORAL MED O, V23, P174, DOI 10.1016/0030-4220(67)90092-8; WITKOP CJ, 1965, TEXTBOOK ORAL PATHOL, P801	14	32	32	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1972	24	3					267	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M6948	4623931				2022-12-18	WOS:A1972M694800004
J	SHREFFLER, DC; SING, CF; NEEL, JV; GERSHOWITZ, H; NAPIER, JA				SHREFFLER, DC; SING, CF; NEEL, JV; GERSHOWITZ, H; NAPIER, JA			STUDIES ON GENETIC SELECTION IN A COMPLETELY ASCERTAINED CAUCASIAN POPULATION .1. FREQUENCIES, AGE AND SEX EFFECTS, AND PHENOTYPE ASSOCIATIONS FOR 12 BLOOD GROUP SYSTEMS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article														Sing, Charles/0000-0001-5872-7956				CEPPELLINI R, 1955, 5 P INT C BLOOD TRAN, P207; CHAPLIN H, 1953, LANCET, V264, P215; EPSTEIN FH, 1965, ANN INTERN MED, V62, P1170, DOI 10.7326/0003-4819-62-6-1170; FRANCIS T, 1965, MILBANK FUND Q, V43, P333, DOI 10.2307/3348903; GERSHOWITZ H, 1967, AM J HUM GENET, V19, P502; GERSHOWITZ H, 1966, AM J HUM GENET, V18, P264; GERSHOWITZ H, 1965, ACTA GENET STATIST M, V5, P261; Giblett ER., 1969, GENETIC MARKERS HUMA; Hart EW, 1943, ANN EUGENIC, V12, P89, DOI 10.1111/j.1469-1809.1943.tb02312.x; JORGENSE, 1967, HUMANGENETIK, V3, P264; JORGENSEN G, 1968, HUMANGENETIK, V5, P254; MACCLUER JW, 1967, AM J HUM GENET, V19, P189; MI MP, 1966, VOX SANG, V11, P434, DOI 10.1111/j.1423-0410.1966.tb04240.x; MOHR J, 1966, ACTA GENET STAT MED, V16, P1; NAPIER JA, 1962, AM J PUBLIC HEALTH N, V52, P208, DOI 10.2105/AJPH.52.2.208; NAPIER JA, 1971, CASE BOOK COMMUNITY; NEEL JV, 1968, PERSPECT BIOL MED, V11, P565; NEEL JV, 1954, HUM HERED, P204; RACE RR, 1962, BLOOD GROUPS MAN; REED TE, 1968, AM J HUM GENET, V20, P142; REED TE, 1968, AM J HUM GENET, V20, P579; REED TE, 1961, P C GENETIC POLYMORP, P80; ROBERTS JAF, 1948, ANN EUGENIC, V14, P109; SHAW MW, 1962, AM J HUM GENET, V14, P317; SHOKEIR MHK, 1969, THESIS U MICHIGAN, P74; SHREFFLER DC, 1967, AM J HUM GENET, V19, P514; SING CF, 1971, AM J HUM GENET, V23, P164; Thompsen O, 1927, CR SOC BIOL, V97, P198	28	32	32	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1971	23	2					150	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	J1653	4997203				2022-12-18	WOS:A1971J165300005
J	REED, TE				REED, TE			CRITICAL TESTS OF HYPOTHESES FOR RACE MIXTURE USING GM DATA ON AMERICAN CAUCASIANS AND NEGROES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BLUMBERG BS, 1964, NATURE, V202, P561, DOI 10.1038/202561a0; BOYER SH, 1961, NATURE, V190, P456, DOI 10.1038/190456a0; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; GESSAIN R, 1965, B MEM SOC ANTHRO PAR, V8, P5; GESSAIN R, 1965, B MEM SOC ANTHRO PAR, V8, P19; GLASS B, 1955, AM J HUM GENET, V7, P368; GLASS B, 1953, AM J HUM GENET, V5, P1; GREENWALT TJ, 1967, S IMMUNOGENETICS  ED, pCH3; HERSKOVITS MJ, 1941, MYTH NEGOR PAST; KANE Y, 1963, B MEM SOC ANTHRO PAR, V4, P545, DOI 10.3406/bmsap.1963.1269; LIVINGSTONE FB, 1960, AM J PHYS ANTHROPOL, V18, P161, DOI 10.1002/ajpa.1330180302; PLATT JR, 1964, SCIENCE, V146, P347, DOI 10.1126/science.146.3642.347; POLLITZER WS, 1958, AM J PHYS ANTHROPOL, V16, P241, DOI 10.1002/ajpa.1330160208; Rao C.R., 1952, ADV STAT METHODS BIO; REED TE, 1968, AM J HUM GENET, V20, P129; REED TE, 1968, AM J HUM GENET, V20, P579; ROPARTZ C, 1960, REV FR ETUD CLIN BIO, V5, P814; ROPARTZ C, 1963, REV FR ETUD CLIN BIO, V8, P465; ROPARTZ C, 1965, HUMANGENETIK, V1, P483, DOI 10.1007/BF00338339; STEINBERG A, 1961, AM J HUM GENET, V13, P205; STEINBERG AG, 1960, NATURE, V188, P169, DOI 10.1038/188169a0; STEINBERG AG, 1967, S IMMUNOGENETICS, pCH3; WORKMAN PL, 1963, AM J HUM GENET, V15, P429; WORKMAN PL, 1968, HUM BIOL, V40, P260	24	32	32	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1969	21	1					71	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D0848	5763608				2022-12-18	WOS:A1969D084800006
J	COHEN, BH; SAYRE, JE				COHEN, BH; SAYRE, JE			FURTHER OBSERVATIONS ON RELATIONSHIP OF MATERNAL ABO AND RH TYPES TO FETAL DEATH	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Allan TM, 1953, BRIT J PREV SOC MED, V7, P220; ALLEN CM, 1964, J CHRON DIS, V17, P619, DOI 10.1016/0021-9681(64)90085-2; ANDERSEN J, 1961, VOX SANG, V6, P3, DOI 10.1111/j.1423-0410.1961.tb03132.x; BARRAI I, 1965, AM J HUM GENET, V17, P221; BEHRMAN SJ, 1960, AM J OBSTET GYNECOL, V79, P847, DOI 10.1016/0002-9378(60)90677-3; BENNETT JH, 1956, ANN HUM GENET, V20, P299; BENNETT JH, 1954, ANN EUGENIC, V18, P302; BOETTCHER B, 1965, J REPROD FERTIL, V9, P267; BOORMAN KE, 1961, INTRODUCTION BLOOD G; BRAMBELL FWR, 1951, ANTIBODIES EMBRYOS; BRENDEMOEN O J, 1952, Acta Pathol Microbiol Scand, V31, P579; BRESLER JB, 1964, HUM BIOL, V36, P354; BURDETTE WJ, 1962, METHODOLOGY HUMAN ED, P17; CHUNG CS, 1961, AM J HUM GENET, V13, P9; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; COHEN BH, 1959, AM J HUM GENET, V11, P414; COHEN BH, 1960, AM J HUM GENET, V12, P180; Cooke B R, 1965, Med J Aust, V2, P437; DAVIDSOHN I, 1956, BIBL HAEMAT BASEL, P1; DEWEY WJ, 1965, AM J HUM GENET, V17, P237; DONOHUE WL, 1964, CAN MED ASSOC J, V90, P1; EDWARDS RG, 1964, J REPROD FERTIL, V7, P153; GITTELSOHN AM, 1960, AM J HUM GENET, V12, P425; GLASS B, 1949, AM J OBSTET GYNECOL, V57, P323; GRUBB R., 1955, ANN HUMAN GENETICS, V19, P183, DOI 10.1111/j.1469-1809.1955.tb01343.x; GULLBRING B, 1957, ACTA MED SCAND, V159, P169; HALDANE JBS, 1956, ANN HUM GENET, V20, P309; HEISTO HELGE, 1955, ACTA PATHOL ET MICROBIOL SCAND, V36, P257; HERTZOG KP, 1968, HUM BIOL, V40, P86; HIRAIZUM.Y, 1964, COLD SPRING HARB SYM, V29, P51, DOI 10.1101/SQB.1964.029.01.010; KELLY WL, 1963, OBSTET GYNECOL, V21, P587; Kirk RL, 1955, BRIT J PREV SOC MED, V9, P104; Kirk RL, 1953, BRIT J PREV SOC MED, V7, P1; Kiser CV, 1944, MILBANK MEML FUND Q, V22, P72, DOI 10.2307/3348215; KNOX EG, 1965, BIBL HAEMATOL, P940; KNOX EG, 1965, ACTA GENET STAT MED, V15, P224; KOJIMA KI, 1962, AM NAT, V96, P329, DOI 10.1086/282242; Landsteiner K, 1926, J IMMUNOL, V12, P415; LEVENE HOWARD, 1961, PROGR MED GENET, V1, P120; LEVINE P, 1959, J MED EDUC, V34, P418; Levine P, 1941, SCIENCE, V94, P371, DOI 10.1126/science.94.2442.371; LEVINE P, 1958, AM ANTHROPOL, V60, P14; Levine P, 1941, J AMER MED ASSOC, V116, P825, DOI 10.1001/jama.1941.02820090025006; Levine P, 1941, AM J OBSTET GYNECOL, V42, P925, DOI 10.1016/S0002-9378(41)90260-0; Levine P, 1943, J HERED, V34, P71, DOI 10.1093/oxfordjournals.jhered.a105249; Malone RH, 1949, BR J SOC MED, V3, P228; MATSUNAGA E, 1955, AM J HUM GENET, V7, P66; MATSUNAGA E, 1962, SCIENCE, V135, P432, DOI 10.1126/science.135.3502.432-a; MATSUNAGA E, 1957, ANN HUM GENET, V22, P111, DOI 10.1111/j.1469-1809.1957.tb01926.x; MATSUNAGA E, 1962, EUGEN QUART, V9, P36, DOI 10.1080/19485565.1962.9987499; MATSUNAGA E, 1956, Blut, V2, P188, DOI 10.1007/BF01630045; MCNEIL C, 1954, AM J CLIN PATHOL, V24, P767; MI MP, 1965, ACTA GENET STAT MED, V15, P177; MI MP, IN PRESS; MOLLISON PL, 1952, 27 MED RES COUNC MEM, P1; MOLLISON PL, 1952, 27 MED RES COUNC MEM; MOLTHAN L, 1963, J Pediatr, V62, P474, DOI 10.1016/S0022-3476(63)80003-7; MORTON NE, 1959, AM J HUM GENET, V11, P1; MORTON NE, 1966, AM J HUM GENET, V18, P153; MORTON NE, 1964, 11 P INT C GEN HAG, P935; MORTON NE, 1967, GENETICS INTERRACIAL; MORTON NE, 1962, METHODOLOGY HUMAN GE, P17; MUNK-ANDERSEN GEORG, 1958, ACTA PATH ET MICROBIOL SCAND, V42, P43; MURRAY S, 1967, VOX SANG, V12, P81, DOI 10.1111/j.1423-0410.1967.tb03072.x; MURRAY S, 1965, VOX SANG, V10, P6, DOI 10.1111/j.1423-0410.1965.tb04316.x; NEVANLINNA H R, 1953, Ann Med Exp Biol Fenn, V31, P1; NEVANLINNA HR, 1952, ACTA PATH MICROB S93, P402; NEWCOMBE HB, 1965, AM J HUM GENET, V17, P97; NEWCOMBE HB, 1963, AM J HUM GENET, V15, P449; OSBORNE RH, 1957, AM J HUM GENET, V9, P321; OVERSTREET EW, 1947, AM J OBSTET GYNECOL, V54, P235; PERITZ E, 1967, ANN HUM GENET, V30, P259, DOI 10.1111/j.1469-1809.1967.tb00026.x; Philip L., 1939, JAMA-J AM MED ASSOC, V113, P126; RACE RR, 1952, 27 MED RES COUNC MEM; RACE RR, 1962, BLOOD GROUPS MAN; REED TE, 1964, AM J HUM GENET, V16, P161; REED TE, 1959, NATURE, V184, P611, DOI 10.1038/184611a0; REEPMAKER J, 1954, VOX SANG, V4, P117; REEPMAKER J, 1955, ABO ANTAGONISME MORB; ROBERTS J A F, 1957, Br J Prev Soc Med, V11, P107; ROBINSON G C, 1960, Acta Paediatr Suppl, V48(Suppl 120), P1; SHAHANI S, 1962, Am J Obstet Gynecol, V84, P660; Sinnott E.W., 1958, PRINCIPLES GENETICS; STERN K, 1965, FED PROC, V24, P179; VONLOGHEM JJ, 1948, REV HEMATOL, V3, P276; VOS GH, 1966, VOX SANG, V11, P460, DOI 10.1111/j.1423-0410.1966.tb04242.x; Waterhouse JAH, 1947, BR J SOC MED, V1, P1; WEIL AJ, 1960, P SOC EXP BIOL MED, V105, P43; WEINER W, 1962, VOX SANG, V7, P228, DOI 10.1111/j.1423-0410.1962.tb03245.x; WIENER AS, 1945, P SOC EXP BIOL MED, V58, P133; WIENER AS, 1943, BLOOD GROUPS TRANSFU; WIENER AS, 1958, HEREDITY BLOOD GROUP; WITEBSKY E, 1948, BLOOD, V2, P66; WOOLF B, 1956, Acta Genet Stat Med, V6, P519; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; WOOLF B, 1956, ACTA GENET STAT MED, V6, P509; WOOLF B, 1956, ACTA GENET STAT MED, V6, P514; WORLLEDGE SM, 1966, LANCET, V1, P1095; WREN BG, 1961, J OBSTET GYN BR COMM, V68, P637	99	32	32	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1968	20	4					310	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	B8694	4969415				2022-12-18	WOS:A1968B869400004
J	STARKMAN, MN; SHAW, MW				STARKMAN, MN; SHAW, MW			ATYPICAL ACROCENTRIC CHROMOSOMES IN NEGRO AND CAUCASIAN MONGOLS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		CHANDRA H. S., 1963, CYTOGENETICS [BASEL], V2, P34, DOI 10.1159/000129763; COHEN MM, 1966, CYTOGENETICS, V5, P120, DOI 10.1159/000129890; COHEN MM, 1966, CYTOGENETICS, V5, P34, DOI 10.1159/000129883; COOPER HL, 1962, AM J HUM GENET, V14, P107; COURTBROWN WM, 1965, LANCET, V2, P561; DEKABAN A. S., 1963, CYTOGENETICS [BASEL], V2, P61, DOI 10.1159/000129768; EDGREN J, 1966, J MENT DEFIC RES, V10, P47; FERGUSON-SMITH M. A., 1964, CYTOGENETICS, V3, P124, DOI 10.1159/000129803; FERGUSONSMITH MA, 1963, ANN HUM GENET, V27, P143, DOI 10.1111/j.1469-1809.1963.tb00207.x; HAMERTON JL, 1965, CYTOGENETICS, V4, P171, DOI 10.1159/000129853; HAMERTON JL, 1962, CHROMOSOMES MEDICINE, P140; HAYASHI T, 1962, PERSONAL COMMUNICATI; MATTHEY R, 1965, VITRO, V1, P1; MERCER ROBERT D., 1963, CLEVELAND CLIN QUART, V30, P215; MIGEON BR, 1962, B JOHNS HOPKINS HOSP, V111, P221; MIGEON BR, 1965, PERSONAL COMMUNICATI; MILLER OJ, 1962, T NEW YORK ACAD SCI, V24, P372, DOI 10.1111/j.2164-0947.1962.tb01413.x; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; OHNO S., 1962, CYTOGENETICS, V1, P42, DOI 10.1159/000129712; OHNO S, 1961, LANCET, V2, P123; POLANI PE, 1965, CYTOGENETICS, V4, P193, DOI 10.1159/000129855; SERGOVICH FR, 1964, PERSONAL COMMUNICATI; SHERZ RG, 1962, LANCET, V2, P882; TOMPKINS A B, 1964, J Med Genet, V1, P115, DOI 10.1136/jmg.1.2.115; WALKER NF, 1963, J MENT DEFIC RES, V7, P150; WEINSTEIN ED, 1965, AM J HUM GENET, V17, P443; WILTON E, 1964, MED P, V10, P171; YOSIDA TH, 1965, CHROMOSOMA, V16, P658, DOI 10.1007/BF00285115	28	32	32	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1967	19	2					162	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	91653	4225661				2022-12-18	WOS:A19679165300008
J	SANGHVI, LD				SANGHVI, LD			GENETIC LOAD - 3 VIEWS .1. CONCEPT OF GENETIC LOAD - A CRITIQUE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		CROW JAMES F., 1958, HUMAN BIOL, V30, P1; CROW JF, 1960, MOLECULAR GENETICS H; DOBZHANSKY T, 1957, SCIENCE, V126, P191, DOI 10.1126/science.126.3266.191; Fisher R., 1930, GENETICAL THEORY NAT; Ford E. B., 1940, NEW SYSTEMATICS; FRASER GR, 1962, ANN HUM GENET, V25, P387, DOI 10.1111/j.1469-1809.1962.tb01774.x; Haldane J. B. S., 1932, CAUSES EVOLUTION LON; HALDANE JBS, 1949, ANN EUGENIC, V14, P288; LI CC, 1955, AM NAT, V89, P281, DOI 10.1086/281893; MORTON NE, 1960, AM J HUM GENET, V12, P348; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; MULLER HJ, 1950, AM J HUM GENET, V2, P111; NEEL JV, 1962, P NATL ACAD SCI USA, V48, P573, DOI 10.1073/pnas.48.4.573; PENROSE LS, 1949, ANN EUGENIC, V14, P301; WALLACE B, 1959, RADIATION GENES MAN; Wright S, 1931, GENETICS, V16, P0097; WRIGHT S, 1960, BIOLOGICAL EFFECTS A	17	32	33	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1963	15	3					298	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2967A	13976297				2022-12-18	WOS:A19632967A00008
J	TONDO, CV; SALZANO, FM				TONDO, CV; SALZANO, FM			ABNORMAL HEMOGLOBINS IN A BRAZILIAN NEGRO POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article													Salzano, Francisco M/L-7916-2015					ARENDS T, 1956, 6 MEM C VEN CIENC ME, V2, P777; COLLET A, 1958, ARCH I PASTEUR MARTI, V11, P16; Emmel VE, 1917, ARCH INTERN MED, V20, P586; FIRSCHEIN I, 1961, AM J HUM GENET, V13, P233; FRANCO SDC, 1952, SINOPSE ESTATISTICA; ITANO HA, 1953, ARCH BIOCHEM BIOPHYS, V47, P148, DOI 10.1016/0003-9861(53)90444-5; JONXIS JHP, 1959, ABNORMAL HAEMOGLOBIN; LAYTANO D, 1945, CONGADAS MUNICIPIO O; MENENDEZ CORRADA R, 1957, Bol Asoc Med P R, V49, P262; MONTESTRUC ETIENNE, 1959, BULL SOC PATHOL EXOT, V52, P156; POLLITZER WS, 1958, AM J PHYS ANTHROPOL, V16, P241, DOI 10.1002/ajpa.1330160208; RUCKNAGEL DL, 1961, PROGRESS MEDICAL GEN; SINGER K, 1951, BLOOD, V6, P413, DOI 10.1182/blood.V6.5.413.413; SUAREZ RM, 1959, BLOOD, V14, P255, DOI 10.1182/blood.V14.3.255.255; TONDO CV, 1960, SCIENCE, V132, P1893, DOI 10.1126/science.132.3443.1893; VANDERSAR A, 1959, THESIS U GRONINGEN; WENT LN, 1961, BLOOD, V17, P166, DOI 10.1182/blood.V17.2.166.166; WENT LN, 1957, NATURE, V180, P1131, DOI 10.1038/1801131a0; ZUELZER WW, 1956, PROGRESS HEMATOLOGY, V1	19	32	37	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1962	14	4					401	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2965A	13985475				2022-12-18	WOS:A19622965A00008
J	ALLEN, G				ALLEN, G			A DIFFERENTIAL METHOD FOR ESTIMATION OF TYPE FREQUENCIES IN TRIPLETS AND QUADRUPLETS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALLEN G, 1957, AM J HUM GENET, V9, P181; ALLEN G, ACTA GENET MED GEMEL; BERTILLON LA, 1874, B SOC ANTHROPOL PAR, V9, P267; BULMER MG, 1958, ANN HUM GENET, V23, P31, DOI 10.1111/j.1469-1809.1958.tb01439.x; BULMER MG, 1958, ANN HUM GENET, V22, P158; DAS S. R., 1953, METRON [ROVIGO], V17, P65; DAS SR, 1953, METRON, V17, P67; Jenkins RL, 1940, J HERED, V31, P243, DOI 10.1093/oxfordjournals.jhered.a104896; Jenkins RL, 1929, J HERED, V20, P485, DOI 10.1093/oxfordjournals.jhered.a103111; MACARTHUR JW, 1937, COLLECTED STUDIES DI; Newman HH, 1942, J HERED, V33, P311, DOI 10.1093/oxfordjournals.jhered.a105202; NEWMAN HH, 1940, MULTIPLE HUMAN BIRTH; NICHOLS JB, 1952, AM J OBSTET GYNECOL, V64, P376, DOI 10.1016/0002-9378(52)90311-6; PATTERSON JT, 1913, J MORPH, P24; Peller S, 1946, AM J PHYS ANTHROP-NE, V4, P99, DOI 10.1002/ajpa.1330040110; STRANDSKOV HH, 1946, GENETICS, V31, P438; Weinberg W, 1901, ARCH GESAMTE PHYSL M, V88, P346	17	32	32	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1960	12	2					210	224						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF078	13792733				2022-12-18	WOS:A1960WF07800006
J	BRUES, AM				BRUES, AM			LINKAGE OF BODY BUILD WITH SEX, EYE COLOR, AND FRECKLING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Brues AM, 1946, AM J PHYS ANTHROP-NE, V4, P1, DOI 10.1002/ajpa.1330040107; Penrose LS, 1938, ANN EUGENIC, V8, P233, DOI 10.1111/j.1469-1809.1938.tb02176.x; PENROSE LS, 1935, ANN EUGEN, V6, P133; YULE GU, 1932, INTRO THEORY STAT, P434	4	32	33	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1950	2	3					215	239						25	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XS390	14810688				2022-12-18	WOS:A1950XS39000001
J	Radio, FC; Pang, KF; Ciolfi, A; Levy, MA; Hernandez-Garcia, A; Pedace, L; Pantaleoni, F; Liu, ZD; de Boer, E; Jackson, A; Bruselles, A; McConkey, H; Stellacci, E; Lo Cicero, S; Motta, M; Carrozzo, R; Dentici, ML; McWalter, K; Desai, M; Monaghan, KG; Telegrafi, A; Philippe, C; Vitobello, A; Au, M; Grand, K; Sanchez-Lara, PA; Baez, J; Lindstrom, K; Kulch, P; Sebastian, J; Madan-Khetarpal, S; Roadhouse, C; MacKenzie, JJ; Monteleone, B; Saunders, CJ; Cuevas, JKJ; Cross, L; Zhou, DH; Hartley, T; Sawyer, SL; Monteiro, FP; Secches, TV; Kok, F; Schultz-Rogers, LE; Macke, EL; Morava, E; Klee, EW; Kemppainen, J; Iascone, M; Selicorni, A; Tenconi, R; Amor, DJ; Pais, L; Gallacher, L; Turnpenny, PD; Stals, K; Ellard, S; Cabet, S; Lesca, G; Pascal, J; Steindl, K; Ravid, S; Weiss, K; Castle, AMR; Carter, MT; Kalsner, L; de Vries, BBA; van Bon, BW; Wevers, MR; Pfundt, R; Stegmann, APA; Kerr, B; Kingston, HM; Chandler, KE; Sheehan, W; Elias, AF; Shinde, DN; Towne, MC; Robin, NH; Goodloe, D; Vanderver, A; Sherbini, O; Bluske, K; Hagelstrom, RT; Zanus, C; Faletra, F; Musante, L; Kurtz-Nelson, EC; Earl, RK; Anderlid, BM; Morin, G; van Slegtenhorst, M; Diderich, KEM; Brooks, AS; Gribnau, J; Boers, RG; Finestra, TR; Carter, LB; Rauch, A; Gasparini, P; Boycott, KM; Barakat, TS; Graham, JM; Faivre, L; Banka, S; Wang, TY; Eichler, EE; Priolo, M; Dallapiccola, B; Vissers, LELM; Sadikovic, B; Scott, DA; Holder, JL; Tartaglia, M				Radio, Francesca Clementina; Pang, Kaifang; Ciolfi, Andrea; Levy, Michael A.; Hernandez-Garcia, Andres; Pedace, Lucia; Pantaleoni, Francesca; Liu, Zhandong; de Boer, Elke; Jackson, Adam; Bruselles, Alessandro; McConkey, Haley; Stellacci, Emilia; Lo Cicero, Stefania; Motta, Marialetizia; Carrozzo, Rosalba; Dentici, Maria Lisa; McWalter, Kirsty; Desai, Megha; Monaghan, Kristin G.; Telegrafi, Aida; Philippe, Christophe; Vitobello, Antonio; Au, Margaret; Grand, Katheryn; Sanchez-Lara, Pedro A.; Baez, Joanne; Lindstrom, Kristin; Kulch, Peggy; Sebastian, Jessica; Madan-Khetarpal, Suneeta; Roadhouse, Chelsea; MacKenzie, Jennifer J.; Monteleone, Berrin; Saunders, Carol J.; Cuevas, July K. Jean; Cross, Laura; Zhou, Dihong; Hartley, Taila; Sawyer, Sarah L.; Monteiro, Fabiola Paoli; Secches, Tania Vertemati; Kok, Fernando; Schultz-Rogers, Laura E.; Macke, Erica L.; Morava, Eva; Klee, Eric W.; Kemppainen, Jennifer; Iascone, Maria; Selicorni, Angelo; Tenconi, Romano; Amor, David J.; Pais, Lynn; Gallacher, Lyndon; Turnpenny, Peter D.; Stals, Karen; Ellard, Sian; Cabet, Sara; Lesca, Gaetan; Pascal, Joset; Steindl, Katharina; Ravid, Sarit; Weiss, Karin; Castle, Alison M. R.; Carter, Melissa T.; Kalsner, Louisa; de Vries, Bert B. A.; van Bon, Bregje W.; Wevers, Marijke R.; Pfundt, Rolph; Stegmann, Alexander P. A.; Kerr, Bronwyn; Kingston, Helen M.; Chandler, Kate E.; Sheehan, Willow; Elias, Abdallah F.; Shinde, Deepali N.; Towne, Meghan C.; Robin, Nathaniel H.; Goodloe, Dana; Vanderver, Adeline; Sherbini, Omar; Bluske, Krista; Hagelstrom, R. Tanner; Zanus, Caterina; Faletra, Flavio; Musante, Luciana; Kurtz-Nelson, Evangeline C.; Earl, Rachel K.; Anderlid, Britt-Marie; Morin, Gilles; van Slegtenhorst, Marjon; Diderich, Karin E. M.; Brooks, Alice S.; Gribnau, Joost; Boers, Ruben G.; Finestra, Teresa Robert; Carter, Lauren B.; Rauch, Anita; Gasparini, Paolo; Boycott, Kym M.; Barakat, Tahsin Stefan; Graham, John M., Jr.; Faivre, Laurence; Banka, Siddharth; Wang, Tianyun; Eichler, Evan E.; Priolo, Manuela; Dallapiccola, Bruno; Vissers, Lisenka E. L. M.; Sadikovic, Bekim; Scott, Daryl A.; Holder, Jimmy Lloyd, Jr.; Tartaglia, Marco			SPEN haploinsufficiency causes a neurodevelopmental disorder overlapping proximal 1p36 deletion syndrome with an episignature of X chromosomes in females	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPLIT-ENDS; MONOSOMY 1P36; MOLECULAR CHARACTERIZATION; PHENOTYPE CORRELATIONS; REVEALS; SHARP; MUTATIONS; PROTEIN; GENE; IDENTIFICATION	Deletion 1p36 (del1p36) syndrome is the most common human disorder resulting from a terminal autosomal deletion. This condition is molecularly and clinically heterogeneous. Deletions involving two non-overlapping regions, known as the distal (telomeric) and proximal (centromeric) critical regions, are sufficient to cause the majority of the recurrent clinical features, although with different facial features and dysmorphisms. SPEN encodes a transcriptional repressor commonly deleted in proximal del1p36 syndrome and is located centromeric to the proximal 1p36 critical region. Here, we used clinical data from 34 individuals with truncating variants in SPEN to define a neurodevelopmental disorder presenting with features that overlap considerably with those of proximal del1p36 syndrome. The clinical profile of this disease includes developmental delay/intellectual disability, autism spectrum disorder, anxiety, aggressive behavior, attention deficit disorder, hypotonia, brain and spine anomalies, congenital heart defects, high/narrow palate, facial dysmorphisms, and obesity/increased BMI, especially in females. SPEN also emerges as a relevant gene for del1p36 syndrome by co-expression analyses. Finally, we show that haploinsufficiency of SPEN is associated with a distinctive DNA methylation episignature of the X chromosome in affected females, providing further evidence of a specific contribution of the protein to the epigenetic control of this chromosome, and a paradigm of an X chromosome-specific episignature that classifies syndromic traits. We conclude that SPEN is required for multiple developmental processes and SPEN haploinsufficiency is a major contributor to a disorder associated with deletions centromeric to the previously established 1p36 critical regions.	[Radio, Francesca Clementina; Ciolfi, Andrea; Pantaleoni, Francesca; Carrozzo, Rosalba; Dentici, Maria Lisa; Dallapiccola, Bruno; Tartaglia, Marco] Osped Pediat Bambino Gesu, IRCCS, Genet & Rare Dis Res Div, I-00146 Rome, Italy; [Pang, Kaifang; Liu, Zhandong; Holder, Jimmy Lloyd, Jr.] Baylor Coll Med, Div Neurol & Dev Neurosci, Houston, TX 77030 USA; [Levy, Michael A.; McConkey, Haley; Sadikovic, Bekim] London Hlth Sci Ctr, Mol Diagnost Div, Mol Genet Lab, London, ON N6A 5W9, Canada; [Hernandez-Garcia, Andres; Scott, Daryl A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Pedace, Lucia; Motta, Marialetizia] Osped Pediatr Bambino Gesu, IRCCS, Oncohaematol Res Div, I-00146 Rome, Italy; [de Boer, Elke; de Vries, Bert B. A.; van Bon, Bregje W.; Wevers, Marijke R.; Pfundt, Rolph; Stegmann, Alexander P. A.; Vissers, Lisenka E. L. M.] Radboudumc, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [de Boer, Elke; de Vries, Bert B. A.; Vissers, Lisenka E. L. M.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 GA Nijmegen, Netherlands; [Jackson, Adam; Banka, Siddharth] Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Div Evolut & Genom Sci, Manchester M13 9WL, Lancs, England; [Jackson, Adam; Kerr, Bronwyn; Kingston, Helen M.; Chandler, Kate E.; Banka, Siddharth] Manchester Univ NHS Fdn Trust, Manchester Ctr Genom Med, St Marys Hosp, Manchester M13 9WL, Lancs, England; [Bruselles, Alessandro; Stellacci, Emilia; Lo Cicero, Stefania] Ist Super Sanita, Dept Oncol & Mol Med, I-00161 Rome, Italy; [McWalter, Kirsty; Desai, Megha; Monaghan, Kristin G.; Telegrafi, Aida] GeneDx, Gaithersburg, MD 20877 USA; [Philippe, Christophe; Vitobello, Antonio] Univ Bourgogne, Inserm UMR 1231 GAD Genet Anomalies Dev, F-21070 Dijon, France; [Philippe, Christophe; Vitobello, Antonio] CHU, UF Innovat Diagnost Genom Malad Rares, F-21079 Dijon, France; [Au, Margaret; Grand, Katheryn; Sanchez-Lara, Pedro A.; Baez, Joanne; Graham, John M., Jr.] UCL Med Sch, David Geffen Sch Med, Dept Pediat, Div Med Genet,Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Lindstrom, Kristin; Kulch, Peggy] Phoenix Childrens Hosp, Phoenix, AZ 85016 USA; [Sebastian, Jessica; Madan-Khetarpal, Suneeta] UPMC Childrens Hosp Pittsburgh, Dept Pediat, Div Med Genet, Pittsburgh, PA 15224 USA; [Roadhouse, Chelsea; MacKenzie, Jennifer J.] McMaster Childrens Hosp, Hamilton, ON L8N 3Z5, Canada; [Monteleone, Berrin] NYU Langone Long Isl Sch Med, Clin Genet, Mineola, NY 11501 USA; [Saunders, Carol J.; Cuevas, July K. Jean; Cross, Laura; Zhou, Dihong] Childrens Mercy Hosp, Ctr Pediat Genom Med, Kansas City, MO 64108 USA; [Hartley, Taila; Sawyer, Sarah L.; Boycott, Kym M.] Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada; [Monteiro, Fabiola Paoli; Secches, Tania Vertemati; Kok, Fernando] Mendelics Genom Anal, BR-04013000 Sao Paulo, Brazil; [Schultz-Rogers, Laura E.; Macke, Erica L.; Morava, Eva; Klee, Eric W.; Kemppainen, Jennifer] Mayo Clin, Ctr Individualized Med, Rochester, MN 55905 USA; [Morava, Eva] Mayo Clin, Dept Clin Genom, Rochester, MN 55905 USA; [Iascone, Maria] Osped Papa Giovanni XXIII, I-24127 Bergamo, Italy; [Selicorni, Angelo] Azienda Socio Sanitaria Terr Lariana, I-22100 Como, Italy; [Tenconi, Romano] Univ Padua, Dipartimento Pediat, I-35137 Padua, Italy; [Amor, David J.; Gallacher, Lyndon] Murdoch Childrens Res Inst, Victorian Clin Genet Serv, Melbourne, Vic 3052, Australia; [Amor, David J.; Gallacher, Lyndon] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Melbourne, Vic 3052, Australia; [Pais, Lynn] Broad Inst MIT & Harvard, Med & Populat Genet Program, Cambridge, MA 02142 USA; [Turnpenny, Peter D.; Stals, Karen; Ellard, Sian] Royal Devon & Exeter NHS Fdn Trust, Exeter EX2 5DW, Devon, England; [Cabet, Sara; Lesca, Gaetan] Claude Bernard Lyon 1 Univ, Hosp Civils Lyon, Grp Hosp Est, Dept Genet, F-69002 Lyon, France; [Pascal, Joset; Steindl, Katharina; Rauch, Anita] Univ Zurich, Inst Med Genet, CH-8952 Schlieren, Switzerland; [Ravid, Sarit] Rambam Hlth Care Campus, Pediat Neurol Unit, Ruth Childrens Hosp, IL-3109601 Haifa, Israel; [Weiss, Karin] Israel Inst Technol, Genet Inst, Rappaport Fac Med, Rambam Hlth Care Campus, IL-3109601 Haifa, Israel; [Castle, Alison M. R.; Carter, Melissa T.] Univ Ottawa, Dept Genet, CHEO, Ottawa, ON K1N 6N5, Canada; [Kalsner, Louisa] Univ Connecticut, Connecticut Childrens Med Ctr, Sch Med, Farmington, CT 06032 USA; [Stegmann, Alexander P. A.] Maastricht Univ Med Ctr, Dept Clin Genet, NL-6229 HX Maastricht, Netherlands; [Sheehan, Willow; Elias, Abdallah F.] Shodair Childrens Hosp, Dept Med Genet, Helena, MT 59601 USA; [Shinde, Deepali N.; Towne, Meghan C.] Ambry Genet, Aliso Viejo, CA 92656 USA; [Robin, Nathaniel H.; Goodloe, Dana; Sherbini, Omar] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Vanderver, Adeline] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA; [Vanderver, Adeline] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Bluske, Krista; Hagelstrom, R. Tanner] Illumina Clin Serv Lab, San Diego, CA 92122 USA; [Zanus, Caterina; Faletra, Flavio; Musante, Luciana; Gasparini, Paolo] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, I-34137 Trieste, Italy; [Kurtz-Nelson, Evangeline C.; Earl, Rachel K.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Anderlid, Britt-Marie] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Anderlid, Britt-Marie] Karolinska Univ Hosp, Dept Clin Genet, S-17176 Stockholm, Sweden; [Morin, Gilles] CHU Amiens Picardie, CA Genet Clin & Oncogenet, F-80054 Amiens, France; [van Slegtenhorst, Marjon; Diderich, Karin E. M.; Brooks, Alice S.; Barakat, Tahsin Stefan] Erasmus MC Univ Med Ctr, Dept Clin Genet, NL-3015 GD Rotterdam, Netherlands; [Gribnau, Joost; Boers, Ruben G.; Finestra, Teresa Robert] Univ Med Ctr, Oncode Inst, Dept Dev Biol, Erasmus MC, NL-3015 GD Rotterdam, Netherlands; [Carter, Lauren B.] Levine Childrens Hosp, Dept Pediat, Div Med Genet, Atrium Hlth, Charlotte, NC 28203 USA; [Gasparini, Paolo] Univ Trieste, Dept Med Surg & Hlth Sci, I-34143 Trieste, Italy; [Faivre, Laurence] FHU TRANSLAD, Ctr Genet, Ctr Reference Malad Rares Anomalies Dev & Syndrom, F-77908 Dijon, France; [Faivre, Laurence] Inst GIMI, F-77908 Dijon, France; [Faivre, Laurence] Univ Bourgogne Franche Comte, INSERM, UMR 1231 GAD, F-77908 Dijon, France; [Wang, Tianyun; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Sch Med, Seattle, WA 98195 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Priolo, Manuela] Grande Osped Metropolitano Bianchi Melacrino More, UOSD Genet Med, I-89124 Reggio Di Calabria, Italy; [Scott, Daryl A.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA	IRCCS Bambino Gesu; Baylor College of Medicine; London Health Sciences Centre; Baylor College of Medicine; IRCCS Bambino Gesu; Radboud University Nijmegen; Radboud University Nijmegen; University of Manchester; University of Manchester; Istituto Superiore di Sanita (ISS); Institut Agro; AgroSup Dijon; Universite de Bourgogne; CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Phoenix Children's Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; McMaster University; Children's Mercy Hospital; University of Ottawa; Children's Hospital of Eastern Ontario; Mayo Clinic; Mayo Clinic; ASST Papa Giovanni XXIII; University of Padua; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Exeter; Assistance Publique Hopitaux Paris (APHP); CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Rambam Health Care Campus; Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Ottawa; Children's Hospital of Eastern Ontario; Connecticut Children's Medical Center; University of Connecticut; Maastricht University; Maastricht University Medical Centre (MUMC); University of Alabama System; University of Alabama Birmingham; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Illumina; IRCCS Burlo Garofolo; University of Washington; University of Washington Seattle; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Trieste; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Baylor College of Medicine	Tartaglia, M (corresponding author), Osped Pediat Bambino Gesu, IRCCS, Genet & Rare Dis Res Div, I-00146 Rome, Italy.	marco.tartaglia@opbg.net	Amor, David J/A-6478-2018; HERNANDEZ-GARCIA, ANDRES/B-9051-2014; Musante, Luciana/AAA-5726-2021; Holder, J. Lloyd/AFT-0389-2022; Sanchez, Pedro/HHM-5713-2022; Sanchez-Lara, Pedro A./AAP-5644-2021; Dentici, Maria Lisa/AAC-7654-2022; van Bon, Bregje/Q-2445-2015; Pedace, Lucia/ABF-1102-2021; stellacci, emilia/J-2747-2014; Iascone, Maria/AAA-4599-2019; Boers, Ruben/AAF-8181-2020; Vanderver, Adeline/CAG-5072-2022; Bruselles, Alessandro/M-6012-2019; Barakat, Stefan/X-8234-2019; Ciolfi, Andrea/J-4954-2018; Vitobello, Antonio/ABC-2970-2021; Lesca, Gaetan/C-6111-2019; CICERO, STEFANIA LO/AAC-4095-2021; Carrozzo, Rosalba/A-2808-2014; de Boer, Elke/S-7121-2018	Amor, David J/0000-0001-7191-8511; HERNANDEZ-GARCIA, ANDRES/0000-0002-5343-5513; Musante, Luciana/0000-0002-2742-1484; Sanchez, Pedro/0000-0003-1181-7828; Sanchez-Lara, Pedro A./0000-0003-1181-7828; Dentici, Maria Lisa/0000-0002-9505-5906; van Bon, Bregje/0000-0003-2234-0105; stellacci, emilia/0000-0003-0415-3285; Iascone, Maria/0000-0002-4707-212X; Boers, Ruben/0000-0002-3377-2897; Bruselles, Alessandro/0000-0002-1556-4998; Barakat, Stefan/0000-0003-1231-1562; Ciolfi, Andrea/0000-0002-6191-0978; Vitobello, Antonio/0000-0003-3717-8374; CICERO, STEFANIA LO/0000-0001-5794-1483; Stegmann, Alexander/0000-0002-9736-7137; Carrozzo, Rosalba/0000-0002-3327-4054; Faivre, Laurence/0000-0001-9770-444X; de Boer, Elke/0000-0002-7022-577X; Castle, Alison/0000-0002-1138-5044; Banka, Siddharth/0000-0002-8527-2210; PHILIPPE, Christophe/0000-0001-7098-6520; Diderich, Karin/0000-0003-2637-9998; McWalter, Kirsty/0000-0002-1654-9036; Lesca, Gaetan/0000-0001-7691-9492; Jackson, Adam/0000-0002-3674-3960	Fondazione BambinoGesu (Vite Coraggiose); Italian Ministry of Health [CCR-2017-23669081, RCR-2020-23670068_001, RF-2018-12366931]; Institute for Maternal and Child Health IRCCS Burlo Garofolo [RC11/16, RCR-2019-23669117_001]; Netherlands Organisation for Scientific Research (ZonMW Veni) [91617021]; Brain AMP; Behavior Research Foundation (NARSAD Young Investigator Grant); NIH [R01HD098458, R01MH101221]; Genome Canada; National Human Genome Research Institute; National Eye Institute; National Heart, Lung, and Blood Institute [UM1 HG008900]; National Human Genome Research Institute [R01 HG009141]; Simons Foundation (SFARI) [608045]; Health Innovation Challenge Fund [HICF-1009-003]; Wellcome	Fondazione BambinoGesu (Vite Coraggiose); Italian Ministry of Health(Ministry of Health, Italy); Institute for Maternal and Child Health IRCCS Burlo Garofolo; Netherlands Organisation for Scientific Research (ZonMW Veni); Brain AMP; Behavior Research Foundation (NARSAD Young Investigator Grant); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genome Canada(Genome Canada); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Simons Foundation (SFARI); Health Innovation Challenge Fund; Wellcome	The authors thank the participating families and Claudia Nardini (Ospedale Pediatrico Bambino Gesu, Rome) and Serenella Venanzi (Istituto Superiore di Sanita, Rome) for technical assistance. This workwas supported, inpart, by Fondazione BambinoGesu` (Vite Coraggiose toM.T.), Italian Ministry of Health(CCR-2017-23669081 and RCR-2020-23670068_001 to M.T.; RF-2018-12366931 to F.C.R. and B.D.; RC11/16-Institute for Maternal and Child Health IRCCS Burlo Garofolo and RCR-2019-23669117_001 to F.F., L.M., and P.G.), Netherlands Organisation for Scientific Research (ZonMW Veni) (grant 91617021 to T.S.B.), Brain & Behavior Research Foundation (NARSAD Young Investigator Grant to T.S.B.), NIH (R01HD098458 to D.A.S.), andGenome Canada (Genomic Applications Partnership Program grant to B.S.). Sequencing and data analysis of subject 14 were provided by the Broad Institute of MIT and Harvard Center for Mendelian Genomics and was funded by the National Human Genome Research Institute, National Eye Institute, and National Heart, Lung, and Blood Institute (UM1 HG008900) and by the National Human Genome Research Institute (R01 HG009141). Sequencing and data analyses of subjects 33 and 34 were supported bytheNIH(R01MH101221toE.E.E.) andSimons Foundation (SFARI #608045 to E.E.E.). The Deciphering Developmental Disorders (DDD) study presents independent research commissioned by the Health Innovation Challenge Fund (grant HICF-1009-003). This study makes use of DECIPHER, which is funded by the Wellcome. This work has been carried out in the frame of the ERN-ITHACA research activities.	Aref-Eshghi E, 2020, AM J HUM GENET, V106, P356, DOI 10.1016/j.ajhg.2020.01.019; Aref-Eshghi E, 2019, AM J HUM GENET, V104, P685, DOI 10.1016/j.ajhg.2019.03.008; Ariyoshi M, 2003, GENE DEV, V17, P1909, DOI 10.1101/gad.266203; Arndt AK, 2013, AM J HUM GENET, V93, P67, DOI 10.1016/j.ajhg.2013.05.015; Battaglia A, 2008, PEDIATRICS, V121, P404, DOI 10.1542/peds.2007-0929; Boonsawat P, 2019, GENET MED, V21, P2043, DOI 10.1038/s41436-019-0464-7; Braun KVN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124120; Carter AC, 2020, ELIFE, V9, DOI 10.7554/eLife.54508; Chatron N, 2019, BRAIN, V142, P3367, DOI 10.1093/brain/awz272; Chen FL, 2000, CURR BIOL, V10, P943, DOI 10.1016/S0960-9822(00)00625-4; D'Angelo CS, 2010, AM J MED GENET A, V152A, P102, DOI 10.1002/ajmg.a.33160; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Dibbens LM, 2004, HUM MOL GENET, V13, P1315, DOI 10.1093/hmg/ddh146; Doroquez DB, 2007, MECH DEVELOP, V124, P792, DOI 10.1016/j.mod.2007.05.002; Dossin F, 2020, NATURE, V578, P455, DOI 10.1038/s41586-020-1974-9; Farwell KD, 2015, GENET MED, V17, P578, DOI 10.1038/gim.2014.154; Feng Y, 2007, CANCER RES, V67, P482, DOI 10.1158/0008-5472.CAN-06-2314; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Fregeau B, 2016, AM J HUM GENET, V98, P963, DOI 10.1016/j.ajhg.2016.03.002; Gajecka M, 2007, AM J MED GENET C, V145C, P346, DOI 10.1002/ajmg.c.30154; Gillette CM, 2020, GENETICS, V215, P887; Hazegh KE, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006859; Heilstedt HA, 2003, CLIN GENET, V64, P310, DOI 10.1034/j.1399-0004.2003.00126.x; Heilstedt HA, 2003, AM J HUM GENET, V72, P1200, DOI 10.1086/375179; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Hormozdiari F, 2015, GENOME RES, V25, P142, DOI 10.1101/gr.178855.114; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Jain P, 2020, BLOOD ADV, V4, P1038, DOI 10.1182/bloodadvances.2019001396; Jordan VK, 2015, APPL CLIN GENET, V8, P189, DOI 10.2147/TACG.S65698; Jordan VK, 2018, HUM MUTAT, V39, P666, DOI 10.1002/humu.23400; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kang SHL, 2007, CLIN GENET, V72, P329, DOI 10.1111/j.1399-0004.2007.00876.x; Kaplanis J, 2020, NATURE, V586, P757, DOI 10.1038/s41586-020-2832-5; Krumm N, 2015, NAT GENET, V47, P582, DOI 10.1038/ng.3303; Kuang B, 2000, DEVELOPMENT, V127, P1517; Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3; Lane ME, 2000, GENETICS, V155, P233; Legare S, 2016, MOL ENDOCRINOL, V30, P965, DOI 10.1210/me.2016-1072; Legare S, 2015, CANCER RES, V75, P4351, DOI 10.1158/0008-5472.CAN-14-3475; Liu DJ, 2020, ONCOTARGETS THER, V13, P351, DOI 10.2147/OTT.S200317; Maulik PK, 2011, RES DEV DISABIL, V32, P419, DOI 10.1016/j.ridd.2010.12.018; McCormack K, 2002, J BIOL CHEM, V277, P13219, DOI 10.1074/jbc.M111465200; McHugh CA, 2015, NATURE, V521, P232, DOI 10.1038/nature14443; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; Monfort A, 2015, CELL REP, V12, P554, DOI 10.1016/j.celrep.2015.06.067; Motta M, 2020, AM J HUM GENET, V107, P499, DOI 10.1016/j.ajhg.2020.06.018; Oswald F, 2005, MOL CELL BIOL, V25, P10379, DOI 10.1128/MCB.25.23.10379-10390.2005; Oswald F, 2002, EMBO J, V21, P5417, DOI 10.1093/emboj/cdf549; Pang KF, 2020, GENOME RES, V30, P835, DOI 10.1101/gr.254987.119; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Rebay I, 2000, GENETICS, V154, P695; Retterer K, 2016, GENET MED, V18, P696, DOI 10.1038/gim.2015.148; Rosenfeld JA, 2010, AM J MED GENET A, V152A, P1951, DOI 10.1002/ajmg.a.33516; Rudnik-Schoneborn S, 2008, AM J MED GENET A, V146A, P2018, DOI 10.1002/ajmg.a.32405; Shaffer LG, 2000, ANNU REV GENET, V34, P297, DOI 10.1146/annurev.genet.34.1.297; Shapria SK, 1997, AM J HUM GENET, V61, P642, DOI 10.1086/515520; Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201; Shimada S, 2015, BRAIN DEV-JPN, V37, P515, DOI 10.1016/j.braindev.2014.08.002; Sierra OL, 2004, J BIOL CHEM, V279, P32913, DOI 10.1074/jbc.M314098200; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Thevenon J, 2016, CLIN GENET, V89, P700, DOI 10.1111/cge.12732; Thiffault I, 2018, HUM MUTAT, V39, P1505, DOI 10.1002/humu.23646; Vissers LELM, 2016, NAT REV GENET, V17, P9, DOI 10.1038/nrg3999; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Wagner M, 2020, GENET MED, V22, P1061, DOI 10.1038/s41436-020-0768-7; Wang T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18723-y; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; Windpassinger C, 2002, GENE, V292, P25, DOI 10.1016/S0378-1119(02)00649-2; Wright CF, 2015, LANCET, V385, P1305, DOI 10.1016/S0140-6736(14)61705-0; Wu YQ, 1999, HUM MOL GENET, V8, P313, DOI 10.1093/hmg/8.2.313; Yabe D, 2007, GENESIS, V45, P300, DOI 10.1002/dvg.20296; Yuen RKC, 2016, NPJ GENOM MED, V1, DOI 10.1038/npjgenmed.2016.27; Zanus C, 2020, EPILEPTIC DISORD, V22, P659, DOI 10.1684/epd.2020.1204; Zaveri HP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085600; Zhong SJ, 2018, NATURE, V555, P524, DOI 10.1038/nature25980; Zoltewicz JS, 2004, DEVELOPMENT, V131, P3, DOI 10.1242/dev.00908	76	31	31	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 4	2021	108	3					502	516		10.1016/j.ajhg.2021.01.015	http://dx.doi.org/10.1016/j.ajhg.2021.01.015		MAR 2021	15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QX1XX	33596411	Green Published, Bronze			2022-12-18	WOS:000629143200015
J	Romano, MT; Tafazzoli, A; Mattern, M; Sivalingam, S; Wolf, S; Rupp, A; Thiele, H; Altmuller, J; Nurnberg, P; Ellwanger, J; Gambon, R; Baumer, A; Kohlschmidt, N; Metze, D; Holdenrieder, S; Paus, R; Lutjohann, D; Frank, J; Geyer, M; Bertolini, M; Kokordelis, P; Betz, RC				Romano, Maria-Teresa; Tafazzoli, Aylar; Mattern, Maximilian; Sivalingam, Sugirthan; Wolf, Sabrina; Rupp, Alexander; Thiele, Holger; Altmueller, Janine; Nuernberg, Peter; Ellwanger, Juergen; Gambon, Reto; Baumer, Alessandra; Kohlschmidt, Nicolai; Metze, Dieter; Holdenrieder, Stefan; Paus, Ralf; Luetjohann, Dieter; Frank, Jorge; Geyer, Matthias; Bertolini, Marta; Kokordelis, Pavlos; Betz, Regina C.			Bi-allelic Mutations in LSS, Encoding Lanosterol Synthase, Cause Autosomal-Recessive Hypotrichosis Simplex	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GLAND TUMOR STEROLS; OXIDOSQUALENE CYCLASE; HAIR; CHOLESTEROL; PROTEIN; INHIBITORS; LIPIDS; DHCR7	Hypotrichosis simplex (HS) is a rare form of hereditary alopecia characterized by childhood onset of diffuse and progressive scalp and body hair loss. Although research has identified a number of causal genes, genetic etiology in about 50% of HS cases remains unknown. The present report describes the identification via whole-exome sequencing of five different mutations in the gene LSS in three unrelated families with unexplained, potentially autosomal-recessive HS. Affected individuals showed sparse to absent lanugo-like scalp hair, sparse and brittle eyebrows, and sparse eyelashes and body hair. LSS encodes lanosterol synthase (LSS), which is a key enzyme in the cholesterol biosynthetic pathway. This pathway plays an important role in hair follicle biology. After localizing LSS protein expression in the hair shaft and bulb of the hair follicle, the impact of the mutations on keratinocytes was analyzed using immunoblotting and immunofluorescence. Interestingly, wild-type LSS was localized in the endoplasmic reticulum (ER), whereas mutant LSS proteins were localized in part outside of the ER. A plausible hypothesis is that this mislocalization has potential deleterious implications for hair follicle cells. Immunoblotting revealed no differences in the overall level of wild-type and mutant protein. Analyses of blood cholesterol levels revealed no decrease in cholesterol or cholesterol intermediates, thus supporting the previously proposed hypothesis of an alternative cholesterol pathway. The identification of LSS as causal gene for autosomal-recessive HS highlights the importance of the cholesterol pathway in hair follicle biology and may facilitate novel therapeutic approaches for hair loss disorders in general.	[Romano, Maria-Teresa; Tafazzoli, Aylar; Mattern, Maximilian; Sivalingam, Sugirthan; Wolf, Sabrina; Kokordelis, Pavlos; Betz, Regina C.] Univ Bonn, Inst Human Genet, Sch Med, D-53127 Bonn, Germany; [Romano, Maria-Teresa; Tafazzoli, Aylar; Mattern, Maximilian; Sivalingam, Sugirthan; Wolf, Sabrina; Kokordelis, Pavlos; Betz, Regina C.] Univ Hosp Bonn, D-53127 Bonn, Germany; [Rupp, Alexander; Holdenrieder, Stefan] Tech Univ Munich, Inst Lab Med, German Heart Ctr, D-80636 Munich, Germany; [Thiele, Holger; Altmueller, Janine; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Altmueller, Janine; Nuernberg, Peter] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Gambon, Reto] Feldstr, CH-7430 Thusis, Switzerland; [Baumer, Alessandra] Univ Zurich, Inst Med Genet, CH-8092 Schlieren, Switzerland; [Kohlschmidt, Nicolai] Inst Clin Genet, D-53111 Bonn, Germany; [Metze, Dieter; Bertolini, Marta] Univ Munster, Dept Dermatol, D-48149 Munster, Germany; [Paus, Ralf] Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA; [Paus, Ralf] Univ Manchester, Ctr Dermatol Res, Manchester, Lancs, England; [Luetjohann, Dieter] Univ Bonn, Inst Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany; [Frank, Jorge] Univ Med Ctr Gottingen, Dept Dermatol Venereol & Allergol, D-37075 Gottingen, Germany; [Geyer, Matthias] Univ Bonn, Inst Innate Immun, D-53175 Bonn, Germany; [Bertolini, Marta] Skin & Hair Res Solut GmbH, Monasterium Lab, D-48149 Munster, Germany	University of Bonn; University of Bonn; German Heart Centre Munich; Technical University of Munich; University of Cologne; University of Cologne; University of Cologne; University of Munster; University of Miami; University of Manchester; University of Bonn; University of Gottingen; University of Bonn	Betz, RC (corresponding author), Univ Bonn, Inst Human Genet, Sch Med, D-53127 Bonn, Germany.; Betz, RC (corresponding author), Univ Hosp Bonn, D-53127 Bonn, Germany.	regina.betz@uni-bonn.de	Thiele, Holger/ABE-6792-2020	Thiele, Holger/0000-0002-0169-998X; Altmuller, Janine/0000-0003-4372-1521; Geyer, Matthias/0000-0002-7718-5002; Rupp, Alexander/0000-0002-2131-4581; Bertolini, Marta/0000-0002-5927-6998	BONFOR program; German Research Foundation (DFG); DFG [BE 2346/4-2]	BONFOR program; German Research Foundation (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	We thank the patients and their families for participating in this study. R.C.B. received local funding from the BONFOR program. R.C.B. and M.G. are members of the German Research Foundation (DFG)-funded excellence cluster ImmunoSensation. R.C.B. is a past recipient of a Heisenberg Professorship of the DFG (BE 2346/4-2).	Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; Basmanav FBU, 2016, AM J HUM GENET, V99, P1292, DOI 10.1016/j.ajhg.2016.10.004; Betz RC, 2012, J INVEST DERMATOL, V132, P906, DOI 10.1038/jid.2011.408; BLOCH K, 1965, SCIENCE, V150, P19, DOI 10.1126/science.150.3692.19; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Charlton-Menys V, 2007, DRUGS, V67, P11, DOI 10.2165/00003495-200767010-00002; Chen XD, 2017, J PEDIATR ENDOCR MET, V30, P1231, DOI 10.1515/jpem-2017-0101; Cichon S, 1998, HUM MOL GENET, V7, P1671, DOI 10.1093/hmg/7.11.1671; DeStefano GM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004333; Frank J, 1999, NATURE, V398, P473, DOI 10.1038/18997; Ikegawa S, 2000, AM J MED GENET, V94, P300, DOI 10.1002/1096-8628(20001002)94:4<300::AID-AJMG7>3.0.CO;2-3; KANDUTSCH AA, 1960, J BIOL CHEM, V235, P2253; KANDUTSCH AA, 1960, J BIOL CHEM, V235, P2256; Karnik P, 2009, J INVEST DERMATOL, V129, P1243, DOI 10.1038/jid.2008.369; Karunagaran S, 2017, CURR COMPUT-AID DRUG, V13, P275, DOI 10.2174/1573409913666170426153509; Kazantseva A, 2006, SCIENCE, V314, P982, DOI 10.1126/science.1133276; Kljuic A, 2003, CELL, V113, P249, DOI 10.1016/S0092-8674(03)00273-3; Lee WS, 2011, J DERMATOL SCI, V64, P153, DOI 10.1016/j.jdermsci.2011.08.004; Levy-Nissenbaum E, 2003, NAT GENET, V34, P151, DOI 10.1038/ng1163; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Masukawa Y, 2005, J COSMET SCI, V56, P1; MERCER EI, 1993, PROG LIPID RES, V32, P357, DOI 10.1016/0163-7827(93)90016-P; Mitsche MA, 2015, ELIFE, V4, DOI 10.7554/eLife.07999; Moebius FF, 2000, TRENDS ENDOCRIN MET, V11, P106, DOI 10.1016/S1043-2760(00)00235-6; Murphy S, 2009, BBA-MOL CELL BIOL L, V1791, P441, DOI 10.1016/j.bbalip.2008.07.004; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Pasternack SM, 2013, AM J HUM GENET, V92, P81, DOI 10.1016/j.ajhg.2012.10.022; Prabhu AV, 2016, PROG LIPID RES, V64, P138, DOI 10.1016/j.plipres.2016.09.003; Pyrah IT, 2001, TOXICOL PATHOL, V29, P174, DOI 10.1080/019262301317052440; Rabelo VWH, 2017, J STEROID BIOCHEM, V171, P305, DOI 10.1016/j.jsbmb.2017.05.002; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ruf A, 2004, BIOCHEM BIOPH RES CO, V315, P247, DOI 10.1016/j.bbrc.2004.01.052; Serra M, 2010, J STEROID BIOCHEM, V122, P318, DOI 10.1016/j.jsbmb.2010.08.006; Shimomura Y, 2010, NATURE, V464, P1043, DOI 10.1038/nature08875; Stenn KS, 2010, J INVEST DERMATOL, V130, P1205, DOI 10.1038/jid.2010.52; Thoma R, 2004, NATURE, V432, P118, DOI 10.1038/nature02993; Trapani L, 2011, IUBMB LIFE, V63, P964, DOI 10.1002/iub.522; WERTZ PW, 1989, COMP BIOCHEM PHYS B, V92, P759, DOI 10.1016/0305-0491(89)90264-2; Ye D, 2010, BIOCHEM BIOPH RES CO, V395, P387, DOI 10.1016/j.bbrc.2010.04.027; Zhao L, 2015, NATURE, V523, P607, DOI 10.1038/nature14650; Zheng Y, 1999, NAT GENET, V23, P268, DOI 10.1038/15446	41	31	31	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 1	2018	103	5					777	785		10.1016/j.ajhg.2018.09.011	http://dx.doi.org/10.1016/j.ajhg.2018.09.011			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GY9EO	30401459	Green Published, Bronze			2022-12-18	WOS:000448942100012
J	Alston, CL; Heidler, J; Dibley, MG; Kremer, LS; Taylor, LS; Fratter, C; French, CE; Glasgow, RIC; Feichtinger, RG; Delon, I; Pagnamenta, AT; Dolling, H; Lemonde, H; Aiton, N; Bjornstad, A; Henneke, L; Gartner, J; Thiele, H; Tauchmannova, K; Quaghebeur, G; Houstek, J; Sperl, W; Raymond, FL; Prokisch, H; Mayr, JA; McFarland, R; Poulton, J; Ryan, MT; Wittig, I; Henneke, M; Taylor, RW				Alston, Charlotte L.; Heidler, Juliana; Dibley, Marris G.; Kremer, Laura S.; Taylor, Lucie S.; Fratter, Carl; French, Courtney E.; Glasgow, Ruth I. C.; Feichtinger, Rene G.; Delon, Isabelle; Pagnamenta, Alistair T.; Dolling, Helen; Lemonde, Hugh; Aiton, Neil; Bjornstad, Alf; Henneke, Lisa; Gaertner, Jutta; Thiele, Holger; Tauchmannova, Katerina; Quaghebeur, Gerardine; Houstek, Josef; Sperl, Wolfgang; Raymond, F. Lucy; Prokisch, Holger; Mayr, Johannes A.; McFarland, Robert; Poulton, Joanna; Ryan, Michael T.; Wittig, Ilka; Henneke, Marco; Taylor, Robert W.			Bi-allelic Mutations in NDUFA6 Establish Its Role in Early-Onset Isolated Mitochondrial Complex I Deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASSEMBLY FACTOR TMEM126B; HYPERTROPHIC CARDIOMYOPATHY; BIALLELIC MUTATIONS; POLYACRYLAMIDE-GELS; MOLECULAR PATHOLOGY; CLINICAL PHENOTYPE; VARIANTS; DISEASE; DIAGNOSIS; PROTEINS	Isolated complex I deficiency is a common biochemical phenotype observed in pediatric mitochondrial disease and often arises as a consequence of pathogenic variants affecting one of the similar to 65 genes encoding the complex I structural subunits or assembly factors. Such genetic heterogeneity means that application of next-generation sequencing technologies to undiagnosed cohorts has been a catalyst for genetic diagnosis and gene-disease associations. We describe the clinical and molecular genetic investigations of four unrelated children who presented with neuroradiological findings and/or elevated lactate levels, highly suggestive of an underlying mitochondrial diagnosis. Next-generation sequencing identified bi-allelic variants in NDUFA6, encoding a 15 kDa LYR-motif-containing complex I subunit that forms part of the Q-module. Functional investigations using subjects' fibroblast cell lines demonstrated complex I assembly defects, which were characterized in detail by mass-spectrometry-based complexome profiling. This confirmed a marked reduction in incorporated NDUFA6 and a concomitant reduction in other Q-module subunits, including NDUFAB1, NDUFA7, and NDUFA12. Lentiviral transduction of subjects' fibroblasts showed normalization of complex I. These data also support supercomplex formation, whereby the similar to 830 kDa complex I intermediate (consisting of the P- and Q-modules) is in complex with assembled complex III and IV holoenzymes despite lacking the N-module. Interestingly, RNA-sequencing data provided evidence that the consensus RefSeq accession number does not correspond to the predominant transcript in clinically relevant tissues, prompting revision of the NDUFA6 RefSeq transcript and highlighting not only the importance of thorough variant interpretation but also the assessment of appropriate transcripts for analysis.	[Alston, Charlotte L.; Taylor, Lucie S.; Glasgow, Ruth I. C.; McFarland, Robert; Taylor, Robert W.] Newcastle Univ, Inst Neurosci, Med Sch, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Heidler, Juliana; Wittig, Ilka] Goethe Univ, Fac Med, SFB Core Unit 815, Funct Prote, D-60590 Frankfurt, Germany; [Dibley, Marris G.; Ryan, Michael T.] Monash Univ, Monash Biomed Discovery Inst, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia; [Kremer, Laura S.; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Kremer, Laura S.; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Fratter, Carl] Churchill Hosp, Oxford Univ Hosp NHS Fdn Trust, Oxford Med Genet Labs, Oxford OX3 7LE, England; [French, Courtney E.; Dolling, Helen; Raymond, F. Lucy] Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England; [Feichtinger, Rene G.; Sperl, Wolfgang; Mayr, Johannes A.] Salzburger Landeskliniken & Paracelsus Med Univ, Dept Pediat, A-5020 Salzburg, Austria; [Delon, Isabelle; Raymond, F. Lucy] Cambridge Univ Hosp NHS Fdn Trust, Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Pagnamenta, Alistair T.] Univ Oxford, Wellcome Ctr Human Genet, Oxford Biomed Res Ctr, Natl Inst Hlth Res, Oxford OX3 7BN, England; [Dolling, Helen; Raymond, F. Lucy] Cambridge Univ Hosp NHS Fdn Trust, NIHR BioResource Rare Dis, Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Lemonde, Hugh] Evelina London Childrens Hosp, Guys & St Thomas NHS Fdn Trusts, Dept Inherited Metab Dis, London SE1 7EH, England; [Aiton, Neil] Brighton & Sussex Univ Hosp NHS Trust, Trevor Mann Baby Unit, Brighton BN2 5BE, E Sussex, England; [Bjornstad, Alf] Drammen Sykehus, Dept Pediat, N-3004 Drammen, Norway; [Henneke, Lisa; Gaertner, Jutta; Henneke, Marco] Univ Med Ctr Gottingen, Dept Pediat & Adolescent Med, Div Pediat Neurol, D-37075 Gottingen, Germany; [Thiele, Holger] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Tauchmannova, Katerina; Houstek, Josef] Czech Acad Sci, Inst Physiol, Prague 14220, Czech Republic; [Quaghebeur, Gerardine] Oxford Univ Hosp NHS Fdn Trust, Dept Neuroradiol, Oxford OX3 9DU, England; [Poulton, Joanna] Univ Oxford, Nuffield Dept Womens & Reprod Hlth, Oxford OX3 9DU, England; [Wittig, Ilka] German Ctr Cardiovasc Res, Partner Site Rhein Main, D-60590 Frankfurt, Germany; [Wittig, Ilka] Goethe Univ, Cluster Excellence Macromol Complexes, D-60590 Frankfurt, Germany	Newcastle University - UK; Goethe University Frankfurt; Monash University; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Cambridge; Paracelsus Private Medical University; University of Cambridge; University of Oxford; Wellcome Centre for Human Genetics; University of Cambridge; Brighton and Sussex University Hospitals NHS Trust; University of Brighton; University of Gottingen; University of Cologne; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Oxford University Hospitals NHS Foundation Trust; University of Oxford; German Centre for Cardiovascular Research; Goethe University Frankfurt	Taylor, RW (corresponding author), Newcastle Univ, Inst Neurosci, Med Sch, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	robert.taylor@ncl.ac.uk	Poulton, Joanna/AAB-4828-2021; Tauchmannova, Katerina/G-1023-2014; Houstek, Josef/C-5019-2012; Thiele, Holger/ABE-6792-2020; Ryan, Michael/X-2152-2019; Alston, Charlotte/ABG-9602-2020	Tauchmannova, Katerina/0000-0002-3745-8790; Houstek, Josef/0000-0002-8413-4772; Thiele, Holger/0000-0002-0169-998X; Ryan, Michael/0000-0003-2586-8829; Alston, Charlotte/0000-0003-2095-5464; Glasgow, Ruth/0000-0002-9522-2735; Poulton, Joanna/0000-0002-2460-5587; McFarland, Robert/0000-0002-8833-2688; Aiton, Neil/0000-0001-9762-1169; Kremer, Laura/0000-0002-1647-7538	Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; MRC Centre for Neuromuscular Diseases [G0601943]; NIHR Biomedical Research Centre in Age and Age Related Diseases award; Newcastle Molecular Pathology Node; NHS Highly Specialised Service for Rare Mitochondrial Disorders; Lily Foundation; Georg August University Gottingen Faculty of Medicine research program; Deutsche Forschungsgemeinschaft [SFB 815, GA354/14-1]; Centre of Mitochondrial Biology and Pathology (Czech Science Foundation) [14-36804G]; German Bundesministerium fur Bildung und Forschung through the German Network for Mitochondrial Disorders (mitoNET) [01GM1113]; E-Rare project GENOMIT [01GM1603, I 2741-B26]; EU Horizon2020 Collaborative Research Project SOUND [633974]; Wellcome Trust [090532/Z/09/Z, 0948685/Z/10/Z]; NIHR Biomedical Research Centre Oxford; NIHR doctoral fellowship [NIHR-HCS-D12-03-04]; MRC [MR/J010448/1]; Australian National Health and Medical Research Council [1125390]; Australian Mitochondrial Disease Foundation; Austrian Science Fonds; Rosetrees Trust; Cambridge Biomedical Research Centre; NIHR BioResource [RG65966]; MRC [G0800674, MR/K000608/1, G0601943] Funding Source: UKRI	Wellcome Centre for Mitochondrial Research; MRC Centre for Neuromuscular Diseases(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Biomedical Research Centre in Age and Age Related Diseases award; Newcastle Molecular Pathology Node; NHS Highly Specialised Service for Rare Mitochondrial Disorders; Lily Foundation; Georg August University Gottingen Faculty of Medicine research program; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Centre of Mitochondrial Biology and Pathology (Czech Science Foundation); German Bundesministerium fur Bildung und Forschung through the German Network for Mitochondrial Disorders (mitoNET)(Federal Ministry of Education & Research (BMBF)); E-Rare project GENOMIT; EU Horizon2020 Collaborative Research Project SOUND; Wellcome Trust(Wellcome TrustEuropean Commission); NIHR Biomedical Research Centre Oxford(National Institute for Health Research (NIHR)); NIHR doctoral fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Mitochondrial Disease Foundation; Austrian Science Fonds(Austrian Science Fund (FWF)); Rosetrees Trust(Rosetrees Trust); Cambridge Biomedical Research Centre(General Electric); NIHR BioResource; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Work in our laboratories is supported by the Wellcome Centre for Mitochondrial Research (203105/Z/16/Z), the MRC Centre for Neuromuscular Diseases (G0601943), the NIHR Biomedical Research Centre in Age and Age Related Diseases award to the Newcastle upon Tyne Hospitals NHS Foundation, the Newcastle Molecular Pathology Node, the NHS Highly Specialised Service for Rare Mitochondrial Disorders, the Lily Foundation, the Georg August University Gottingen Faculty of Medicine research program (to M.H.), the Deutsche Forschungsgemeinschaft (SFB 815, project Z1 to I.W. and GA354/14-1 to J.G.), the Centre of Mitochondrial Biology and Pathology (Czech Science Foundation grant 14-36804G), the German Bundesministerium fur Bildung und Forschung through the German Network for Mitochondrial Disorders (mitoNET, 01GM1113), the E-Rare project GENOMIT (01GM1603), the EU Horizon2020 Collaborative Research Project SOUND (633974), the Wellcome Trust (090532/Z/09/Z), and the NIHR Biomedical Research Centre Oxford. C.L.A. received a NIHR doctoral fellowship (NIHR-HCS-D12-03-04). J.P. is supported by the MRC (MR/J010448/1) and the Wellcome Trust (0948685/Z/10/Z). M.T.R. is supported by Australian National Health and Medical Research Council grant 1125390. M.G.D. is supported by the Australian Mitochondrial Disease Foundation. J.A.M. is supported by the E-Rare project GENOMIT (I 2741-B26) and Austrian Science Fonds. F.L.R., C.F., and H.D. are supported by the Rosetrees Trust, Cambridge Biomedical Research Centre, and NIHR BioResource (RG65966). We thank Jana Meisterknecht for technical assistance, Christian Mertes for helping to create Figure S2, and Anne Lombes for the MTND1 antibody. The views expressed are those of the authors and not necessarily of the NHS, NIHR, or Department of Health.	Alston CL, 2016, J MED GENET, V53, P634, DOI 10.1136/jmedgenet-2015-103576; Alston CL, 2016, AM J HUM GENET, V99, P217, DOI 10.1016/j.ajhg.2016.05.021; Angerer H, 2014, P NATL ACAD SCI USA, V111, P5207, DOI 10.1073/pnas.1322438111; Calabrese C, 2014, BIOINFORMATICS, V30, P3115, DOI 10.1093/bioinformatics/btu483; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Carss KJ, 2017, AM J HUM GENET, V100, P75, DOI 10.1016/j.ajhg.2016.12.003; Formosa LE, 2018, SEMIN CELL DEV BIOL, V76, P154, DOI 10.1016/j.semcdb.2017.08.011; Frazier AE, 2019, J BIOL CHEM, V294, P5386, DOI 10.1074/jbc.R117.809194; Freisinger P., 2013, NEUROPEDIATRICS, V44; Fuhrmann DC, 2018, CELL MOL LIFE SCI, V75, P3051, DOI 10.1007/s00018-018-2779-y; Haack TB, 2013, AM J HUM GENET, V93, P211, DOI 10.1016/j.ajhg.2013.06.006; Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846; Heide H, 2012, CELL METAB, V16, P538, DOI 10.1016/j.cmet.2012.08.009; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kremer LS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15824; Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07; Lee C, 2014, BBA-GEN SUBJECTS, V1840, P993, DOI 10.1016/j.bbagen.2013.10.042; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Mckenzie M, 2010, IUBMB LIFE, V62, P497, DOI 10.1002/iub.335; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020; Ohtake A, 2014, BBA-GEN SUBJECTS, V1840, P1355, DOI 10.1016/j.bbagen.2014.01.025; Olahova M, 2015, BRAIN, V138, P3503, DOI 10.1093/brain/awv291; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Piekutowska-Abramczuk D, 2018, AM J HUM GENET, V102, P460, DOI 10.1016/j.ajhg.2018.01.008; Ploski R, 2014, CIRC RES, V114, pE2, DOI 10.1161/CIRCRESAHA.114.302662; Punzi G, 2018, HUM MOL GENET, V27, P499, DOI 10.1093/hmg/ddx419; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036; Sanchez-Caballero L, 2016, AM J HUM GENET, V99, P208, DOI 10.1016/j.ajhg.2016.05.022; Scholimann G, 2017, MITOCHONDRION, V37, P46, DOI 10.1016/j.mito.2017.06.007; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Stroud DA, 2016, NATURE, V538, P123, DOI 10.1038/nature19754; Stroud DA, 2015, HUM MOL GENET, V24, P5404, DOI 10.1093/hmg/ddv265; Swalwell H, 2011, EUR J HUM GENET, V19, P769, DOI 10.1038/ejhg.2011.18; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; Wirth C, 2016, BBA-BIOENERGETICS, V1857, P902, DOI 10.1016/j.bbabio.2016.02.013; Wu M, 2016, CELL, V167, P1598, DOI 10.1016/j.cell.2016.11.012; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131	39	31	31	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 4	2018	103	4					592	601		10.1016/j.ajhg.2018.08.013	http://dx.doi.org/10.1016/j.ajhg.2018.08.013			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GV7MS	30245030	Green Published, hybrid			2022-12-18	WOS:000446312200011
J	Reidy, KJ; Hjorten, RC; Simpson, CL; Rosenberg, AZ; Rosenblum, SD; Kovesdy, CP; Tylavsky, FA; Myrie, J; Ruiz, BL; Haque, S; Mozhui, K; Nelson, GW; David, VA; Yang, XP; Suzuki, M; Jacob, J; Reznik, SE; Kaskel, FJ; Kopp, JB; Winkler, CA; Davis, RL				Reidy, Kimberly J.; Hjorten, Rebecca C.; Simpson, Claire L.; Rosenberg, Avi Z.; Rosenblum, Stacy D.; Kovesdy, Csaba P.; Tylavsky, Frances A.; Myrie, Joseph; Ruiz, Bianca L.; Haque, Soulin; Mozhui, Khyobeni; Nelson, George W.; David, Victor A.; Yang, Xiaoping; Suzuki, Masako; Jacob, Jack; Reznik, Sandra E.; Kaskel, Frederick J.; Kopp, Jeffrey B.; Winkler, Cheryl A.; Davis, Robert L.			Fetal-Not Maternal-APOL1 Genotype Associated with Risk for Preeclampsia in Those with African Ancestry	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							L GENE-CLUSTER; APOLIPOPROTEIN-L; SOLUBLE ENDOGLIN; KIDNEY-DISEASE; VARIANTS; POLYMORPHISMS; CYTOTOXICITY; PREGNANCY; AMERICAN; GENOME	Black Americans are at increased risk for preeclampsia. Genetic variants in apolipoprotein L1 (APOL1) account for much of the increased risk for kidney disease in blacks. APOL1 is expressed in human placenta and transgenic mice expressing APOL1 develop preeclampsia. We evaluated the role of APOL1 variants in human preeclampsia. We determined maternal and fetal APOL1 genotypes in black women with preeclampsia in two populations. At Einstein Montefiore Center (EMC) Affiliated Hospitals, we studied 121 pregnancies in black women with preeclampsia. At University of Tennessee Health Science Center (UTHSC), we studied 93 pregnancies in black women with preeclampsia and 793 pregnancies without preeclampsia. We measured serum markers of preeclampsia soluble fmslike tyrosine kinase 1 (sFlt-1), placental growth factor (PlGF), and soluble endoglin (sEng). Fetal APOL1 high-risk (HR) genotype was associated with preeclampsia, with odds ratios at EMC and UTHSC of 1.84 (95% CI 1.11, 2.93) and 1.92 (95% CI 1.05, 3.49), respectively. Maternal APOL1 HR genotype was not associated with preeclampsia. Mothers with the fetal APOL1 HR genotype had more cerebral or visual disturbances (63% versus 37%, p = 0.04). In addition, fetal APOL1 HR genotype was associated with a higher sFLT-1/PlGF ratio at birth (p = 0.04). Fetal APOL1 high-risk genotype increases the risk for preeclampsia, likely by adversely affecting placental function. Further research is needed to assess whether APOL1 genetic testing can predict preeclampsia and improve pregnancy outcomes.	[Reidy, Kimberly J.; Hjorten, Rebecca C.; Myrie, Joseph; Ruiz, Bianca L.; Haque, Soulin; Kaskel, Frederick J.] Childrens Hosp Montefiore, Albert Einstein Coll Med, Dept Pediat, Div Pediat Nephrol, Bronx, NY 10461 USA; [Hjorten, Rebecca C.] Cincinnati Childrens Hosp, Dept Pediat, Div Nephrol & Hypertens, Cincinnati, OH 45229 USA; [Simpson, Claire L.; Mozhui, Khyobeni] Univ Tennessee, Ctr Hlth Sci, Dept Genet Genom & Informat, Memphis, TN 38163 USA; [Rosenberg, Avi Z.; Yang, Xiaoping] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA; [Rosenblum, Stacy D.] Childrens Hosp Montefiore, Albert Einstein Coll Med, Dept Pediat, Div Neonatol, Bronx, NY 10461 USA; [Kovesdy, Csaba P.] Univ Tennessee, Ctr Hlth Sci, Dept Med, Div Nephrol, Memphis, TN 38163 USA; [Tylavsky, Frances A.; Mozhui, Khyobeni] Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, Memphis, TN 38163 USA; [Nelson, George W.] NCI, Adv Biomed Computat Sci Biomed Informat & Data Sc, Frederick Natl Lab Canc Res, Frederick, MD 21701 USA; [David, Victor A.] NCI, Basic Res Lab, Ctr Canc Res, Frederick, MD 21702 USA; [Suzuki, Masako] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Jacob, Jack] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; [Reznik, Sandra E.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; [Reznik, Sandra E.] Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10461 USA; [Reznik, Sandra E.] St Johns Univ, Dept Pharmaceut Sci, Queens, NY 11439 USA; [Kopp, Jeffrey B.] NIDDK, Kidney Dis Sect, NIH, Bethesda, MD 20814 USA; [Winkler, Cheryl A.] NCI, Basic Res Lab, Mol Genet Epidemiol Sect, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Davis, Robert L.] Univ Tennessee, Hlth Sci Ctr, Dept Pediat, Ctr Biomed Informat, Memphis, TN 38103 USA	Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore; Cincinnati Children's Hospital Medical Center; University of Tennessee System; University of Tennessee Health Science Center; Johns Hopkins University; Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Saint John's University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Tennessee System; University of Tennessee Health Science Center	Winkler, CA (corresponding author), NCI, Basic Res Lab, Mol Genet Epidemiol Sect, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA.; Davis, RL (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Pediat, Ctr Biomed Informat, Memphis, TN 38103 USA.	winklerc@mail.nih.gov; rdavis88@uthsc.edu	Kopp, Jeffrey B/O-2681-2015; Suzuki, Masako/ABF-6497-2020; David, Victor A/I-9330-2012	Kopp, Jeffrey B/0000-0001-9052-186X; Suzuki, Masako/0000-0003-0605-9225; Rosenberg, Avi/0000-0003-2356-950X	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Intramural Research Program [HHSN26120080001E]; National Institutes of Health, National Cancer Institute Intramural Research Program [HHSN26120080001E]; Pediatric Young Investigator Award from the Children's Hospital at Montefiore; Albert Einstein College of Medicine; NIH [K08 DK091507, T32 DK007110, T32 DK007695-16]; NIH CTSA Grant [1 UL1 TR001073]; University of Tennessee Health Science Center's Clinical Translational Science Institute; Urban Child Institute, Memphis, TN; NATIONAL CANCER INSTITUTE [ZIABC010022] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073, UL1TR002556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK043308, T32DK007695, K08DK091507, ZIADK043412, T32DK007110] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health, National Cancer Institute Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pediatric Young Investigator Award from the Children's Hospital at Montefiore; Albert Einstein College of Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH CTSA Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); University of Tennessee Health Science Center's Clinical Translational Science Institute; Urban Child Institute, Memphis, TN; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors acknowledge the assistance of Dr. Ellen J. Silver for assistance with statistical analysis of the EMC population data. The project has been supported in part the National Institutes of Health, including the National Institute of Diabetes and Digestive and Kidney Diseases Intramural Research Program (J.B.K.) and the National Cancer Institute Intramural Research Program (C.A.W.) and under contract HHSN26120080001E (C.A.W.). K.J.R. receives support by a Pediatric Young Investigator Award from the Children's Hospital at Montefiore & Albert Einstein College of Medicine and was supported by NIH K08 DK091507 and with a catalytic seed grant from the NIH CTSA Grant Number 1 UL1 TR001073. R.C.H. was supported by NIH T32 DK007110 and is currently supported by NIH T32 DK007695-16. The CANDLE study was supported by the University of Tennessee Health Science Center's Clinical Translational Science Institute and by grants from the Urban Child Institute, Memphis, TN. The content of this publication does not necessarily reflect the view or policy of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the government. A portion of this work was presented at the American Society of Nephrology Kidney Week (2016), Pediatric Academic Societies annual meeting (2017), and the ISSHP European Congress (2017).	Baak-Pablo R, 2010, J MOL DIAGN, V12, P746, DOI 10.2353/jmoldx.2010.100047; Bruggeman LA, 2016, J AM SOC NEPHROL, V27, P3600, DOI 10.1681/ASN.2015111220; Capewell P, 2015, PARASITOLOGY, V142, pS108, DOI 10.1017/S0031182014000602; Chappell S, 2006, CLIN SCI, V110, P443, DOI 10.1042/CS20050323; Cheng DM, 2015, J LIPID RES, V56, P1583, DOI 10.1194/jlr.M059733; Cooper A, 2017, ELIFE, V6, DOI [10.7554/eLife.25461, 10.7554/elife.25461]; De Vivo A, 2008, ACTA OBSTET GYN SCAN, V87, P837, DOI 10.1080/00016340802253759; Dezso Z, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-49; Duchateau PN, 1997, J BIOL CHEM, V272, P25576, DOI 10.1074/jbc.272.41.25576; Dummer PD, 2015, SEMIN NEPHROL, V35, P222, DOI 10.1016/j.semnephrol.2015.04.008; Elliott SE, 2014, HYPERTENSION, V63, P1086, DOI 10.1161/HYPERTENSIONAHA.113.02362; Engels WR, 2009, GENETICS, V183, P1431, DOI 10.1534/genetics.109.108977; Fong FM, 2014, AM J EPIDEMIOL, V180, P335, DOI 10.1093/aje/kwu151; Freedman BI, 2009, KIDNEY INT, V75, P736, DOI 10.1038/ki.2008.701; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Goodwin AA, 2005, AM J OBSTET GYNECOL, V193, P973, DOI 10.1016/j.ajog.2005.05.047; Harmon QE, 2014, AM J REPROD IMMUNOL, V71, P472, DOI 10.1111/aji.12241; Helfrich BB, 2017, PLACENTA, V52, P106, DOI 10.1016/j.placenta.2017.02.016; Hill LD, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-64; Jenkins LD, 2008, REPROD SCI, V15, P696, DOI 10.1177/1933719108316984; Johnson MP, 2009, HUM GENET, V126, P655, DOI 10.1007/s00439-009-0714-x; Kasembeli AN, 2015, J AM SOC NEPHROL, V26, P2882, DOI 10.1681/ASN.2014050469; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Khatua AK, 2015, AM J PHYSIOL-CELL PH, V309, pC22, DOI 10.1152/ajpcell.00384.2014; Kopp JB, 2011, J AM SOC NEPHROL, V22, P2129, DOI 10.1681/ASN.2011040388; Kruzel-Davila E, 2016, NEPHROL DIAL TRANSPL, V31, P349, DOI 10.1093/ndt/gfu391; Lan XQ, 2014, AM J PHYSIOL-RENAL, V307, pF326, DOI 10.1152/ajprenal.00647.2013; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Limou S, 2015, KIDNEY INT, V88, P28, DOI 10.1038/ki.2015.109; Limou S, 2014, ADV CHRONIC KIDNEY D, V21, P426, DOI 10.1053/j.ackd.2014.06.005; Loisel DA, 2013, MOL HUM REPROD, V19, P144, DOI 10.1093/molehr/gas041; Majander KK, 2013, EUR J HUM GENET, V21, P1024, DOI 10.1038/ejhg.2013.6; McGinnis R, 2017, NAT GENET, V49, P1255, DOI 10.1038/ng.3895; Monajemi H, 2002, GENOMICS, V79, P539, DOI 10.1006/geno.2002.6729; Nakimuli A, 2014, AM J OBSTET GYNECOL, V210, P510, DOI 10.1016/j.ajog.2013.10.879; Olabisi OA, 2016, P NATL ACAD SCI USA, V113, P830, DOI 10.1073/pnas.1522913113; Page NM, 2001, GENOMICS, V74, P71, DOI 10.1006/geno.2001.6534; Phipps E, 2016, CLIN J AM SOC NEPHRO, V11, P1102, DOI 10.2215/CJN.12081115; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Redline RW, 2015, AM J OBSTET GYNECOL, V213, pS21, DOI 10.1016/j.ajog.2015.05.056; Redline RW, 2015, SEMIN PERINATOL, V39, P2, DOI 10.1053/j.semperi.2014.10.002; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Robertson CC, 2017, NEPHROL DIAL TRANSPL, V32, P2051, DOI 10.1093/ndt/gfw317; Rothman K.J., 1998, MODERN EPIDEMIOLOGY; She XW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-269; Sontag-Padilla L., 2015, URBAN CHILD I CANDLE; Unal ER, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.05.022; Urquia ML, 2012, J OBSTET GYNAECOL CA, V34, P348, DOI 10.1016/S1701-2163(16)35215-X; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Verlohren S, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.09.016; Wen Q, 2013, PLOS ONE, V8; Zeisler H, 2016, NEW ENGL J MED, V374, P13, DOI 10.1056/NEJMoa1414838	53	31	31	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 6	2018	103	3					367	376		10.1016/j.ajhg.2018.08.002	http://dx.doi.org/10.1016/j.ajhg.2018.08.002			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GS6PJ	30173819	Green Published, hybrid			2022-12-18	WOS:000443819500006
J	Martin, S; Chamberlin, A; Shinde, DN; Hempel, M; Strom, TM; Schreiber, A; Johannsen, J; Ousager, LB; Larsen, MJ; Hansen, LK; Fatemi, A; Cohen, JS; Lemke, J; Sorensen, KP; Helbig, KL; Lessel, D; Abou Jamra, R				Martin, Sonja; Chamberlin, Adam; Shinde, Deepali N.; Hempel, Maja; Strom, Tim M.; Schreiber, Allison; Johannsen, Jessika; Ousager, Lilian Bomme; Larsen, Martin J.; Hansen, Lars Kjaersgaard; Fatemi, Ali; Cohen, Julie S.; Lemke, Johannes; Sorensen, Kristina P.; Helbig, Katherine L.; Lessel, Davor; Abou Jamra, Rami			De Novo Variants in GRIA4 Lead to Intellectual Disability with or without Seizures and Gait Abnormalities	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMPA RECEPTOR CHANNELS; NMDA RECEPTOR; GLUTAMATE-RECEPTOR; EPILEPTIC ENCEPHALOPATHIES; MOVEMENT-DISORDERS; CEREBELLAR-ATAXIA; GENETIC-VARIATION; GRIN1 MUTATIONS; FOCAL EPILEPSY; DOMAINS	Using trio whole-exome sequencing, we have identified de novo heterozygous pathogenic variants in GRIA4 in five unrelated individuals with intellectual disability and other symptoms. GRIA4 encodes an AMPA receptor subunit known as GluR4, which is found on excitatory glutamatergic synapses and is important for learning and memory. Four of the variants are located in the highly conserved SYTANLAAF motif in the transmembrane protein M3, and the fifth is in an extra-cellular domain. Molecular modeling of the altered protein showed that three of the variants in the SYTANLAAF motif orient toward the center of the pore region and most likely lead to disturbance of the gating mechanism. The fourth variant in the SYTANLAAF motif most likely results in reduced permeability. The variant in the extracellular domain potentially interferes with the binding between the monomers. On the basis of clinical information and genetic results, and the fact that other subunits of the AMPA receptor have already been associated with neurodevelopmental disorders, we suggest that pathogenic de novo variants in GRIA4 lead to intellectual disability with or without seizures, gait abnormalities, problems of social behavior, and other variable features.	[Martin, Sonja; Lemke, Johannes; Abou Jamra, Rami] Univ Med Ctr Leipzig, Inst Human Genet, D-04103 Leipzig, Germany; [Chamberlin, Adam; Shinde, Deepali N.; Helbig, Katherine L.] Ambry Genet, Div Clin Genom, Aliso Viejo, CA 92565 USA; [Hempel, Maja; Lessel, Davor] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, D-20246 Hamburg, Germany; [Strom, Tim M.] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Strom, Tim M.] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Schreiber, Allison] Cleveland Clin, Genom Med Inst, Cleveland, OH 44195 USA; [Johannsen, Jessika] Univ Med Ctr Hamburg Eppendorf, Dept Pediat, D-20246 Hamburg, Germany; [Ousager, Lilian Bomme; Larsen, Martin J.; Sorensen, Kristina P.] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Hansen, Lars Kjaersgaard] Odense Univ Hosp, Dept Paediat, DK-5000 Odense, Denmark; [Fatemi, Ali; Cohen, Julie S.] Kennedy Krieger Inst, Div Neurogenet, Baltimore, MD 21205 USA; [Fatemi, Ali; Cohen, Julie S.] Kennedy Krieger Inst, Hugo W Moser Res Inst, Baltimore, MD 21205 USA; [Fatemi, Ali] Johns Hopkins Med Inst, Dept Neurol, Baltimore, MD 21205 USA; [Fatemi, Ali] Johns Hopkins Med Inst, Dept Pediat, Baltimore, MD 21205 USA	Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Cleveland Clinic Foundation; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; Kennedy Krieger Institute; Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Abou Jamra, R (corresponding author), Univ Med Ctr Leipzig, Inst Human Genet, D-04103 Leipzig, Germany.	rami.aboujamra@medizin.uni-leipzig.de	Abou Jamra, Rami/AAC-8192-2019; Lessel, Davor/ABD-6088-2021; Larsen, Martin Jakob/L-5794-2019; Ousager, Lilian Bomme/F-7119-2015; Helbig, Katherine/B-7454-2012	Abou Jamra, Rami/0000-0002-1542-1399; Helbig, Katherine/0000-0001-8249-0549; Larsen, Martin Jakob/0000-0003-4107-8771; Ousager, Lilian Bomme/0000-0001-9936-2201; Lessel, Davor/0000-0003-4496-244X	Ambry Genetics	Ambry Genetics	A.C., D.N.S., and K.L.H. are employed by and receive a salary from Ambry Genetics. A.F. is a consultant to Ambry Genetics. J.S.C. is a consultant to Invitae. Exome sequencing is a commercially available test.	Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Allen NM, 2016, EPILEPSIA, V57, pE12, DOI 10.1111/epi.13250; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; [Anonymous], ALIGNING SEQUENCE RE, DOI DOI 10.48550/ARXIV.1303.3997; Barad Z, 2012, NEUROSCIENCE, V217, P19, DOI 10.1016/j.neuroscience.2012.05.011; Bettler B, 2017, CURR OPIN NEUROBIOL, V45, P16, DOI 10.1016/j.conb.2017.02.011; Beyer B, 2008, HUM MOL GENET, V17, P1738, DOI 10.1093/hmg/ddn064; Blanke ML, 2009, FRONT NEUROSCI, P283; Catuara-Solarz S., 2016, ENEURO; Chang HR, 2008, J NEUROSCI, V28, P1546, DOI 10.1523/JNEUROSCI.3485-07.2008; Coutelier M, 2015, NEUROLOGY, V84, P1751, DOI 10.1212/WNL.0000000000001524; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Dingledine R, 1999, PHARMACOL REV, V51, P7; Durr KL, 2014, CELL, V158, P778, DOI 10.1016/j.cell.2014.07.023; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; Erb I, 2016, THEOR BIOSCI, V135, P21, DOI 10.1007/s12064-015-0220-8; Farwell KD, 2015, GENET MED, V17, P578, DOI 10.1038/gim.2014.154; Fogel BL, 2014, JAMA NEUROL, V71, P1237, DOI 10.1001/jamaneurol.2014.1944; Gao K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170818; Geisheker MR, 2017, NAT NEUROSCI, V20, P1043, DOI 10.1038/nn.4589; Hackmann K, 2013, EUR J HUM GENET, V21, P112, DOI 10.1038/ejhg.2012.97; Hempel M, 2015, AM J HUM GENET, V97, P493, DOI 10.1016/j.ajhg.2015.08.003; Hu H, 2016, MOL PSYCHIATR, V21, P133, DOI 10.1038/mp.2014.193; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Jatzke C, 2003, J PHYSIOL-LONDON, V549, P439, DOI 10.1113/jphysiol.2002.034413; Jones KS, 2002, J NEUROSCI, V22, P2044, DOI 10.1523/JNEUROSCI.22-06-02044.2002; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kobayashi Y, 2016, BRAIN DEV-JPN, V38, P285, DOI 10.1016/j.braindev.2015.09.011; Kuner T, 2001, J NEUROSCI, V21, P4162, DOI 10.1523/JNEUROSCI.21-12-04162.2001; Lee JH, 2016, BRAIN STRUCT FUNCT, V221, P3259, DOI 10.1007/s00429-015-1099-3; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lemke JR, 2016, NEUROLOGY, V86, P2171, DOI 10.1212/WNL.0000000000002740; Lemke JR, 2014, ANN NEUROL, V75, P147, DOI 10.1002/ana.24073; Lemke JR, 2013, NAT GENET, V45, P1067, DOI 10.1038/ng.2728; Lesca G, 2013, NAT GENET, V45, P1061, DOI 10.1038/ng.2726; Li D, 2016, AM J HUM GENET, V99, P802, DOI 10.1016/j.ajhg.2016.07.013; Malinow R, 2003, PHILOS T ROY SOC B, V358, P707, DOI 10.1098/rstb.2002.1233; Maulik PK, 2011, RES DEV DISABIL, V32, P419, DOI 10.1016/j.ridd.2010.12.018; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; Ohba C, 2015, EPILEPSIA, V56, P841, DOI 10.1111/epi.12987; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Perrais D, 2009, J NEUROSCI, V29, P15499, DOI 10.1523/JNEUROSCI.2724-09.2009; Philips AK, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-49; Platzer K, 2017, J MED GENET, V54, P460, DOI 10.1136/jmedgenet-2016-104509; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sagata N, 2010, GENES BRAIN BEHAV, V9, P899, DOI 10.1111/j.1601-183X.2010.00629.x; Schwarz MK, 2001, EUR J NEUROSCI, V14, P861, DOI 10.1046/j.0953-816x.2001.01705.x; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sobolevsky AI, 2005, BIOPHYS J, V88, P235, DOI 10.1529/biophysj.104.049411; Sobolevsky AI, 2003, J NEUROSCI, V23, P7559; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Swanger SA, 2016, AM J HUM GENET, V99, P1261, DOI 10.1016/j.ajhg.2016.10.002; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Trujillano D, 2017, EUR J HUM GENET, V25, P176, DOI 10.1038/ejhg.2016.146; Wollmuth LP, 2004, TRENDS NEUROSCI, V27, P321, DOI 10.1016/j.tins.2004.04.005; Wu Y, 2007, P NATL ACAD SCI USA, V104, P18163, DOI 10.1073/pnas.0708699104; Yuan HJ, 2005, J BIOL CHEM, V280, P29708, DOI 10.1074/jbc.M414215200; Yuan HJ, 2015, MOL PHARMACOL, V88, P203, DOI 10.1124/mol.115.097998; Zehavi Y, 2017, EUR J MED GENET, V60, P317, DOI 10.1016/j.ejmg.2017.04.001; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	64	31	31	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 7	2017	101	6					1013	1020		10.1016/j.ajhg.2017.11.004	http://dx.doi.org/10.1016/j.ajhg.2017.11.004			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FP5FD	29220673	Green Published, Bronze			2022-12-18	WOS:000417644500012
J	Mattioli, F; Schaefer, E; Magee, A; Mark, P; Mancini, GM; Dieterich, K; Von Allmen, G; Alders, M; Coutton, C; van Slegtenhorst, M; Vieville, G; Engelen, M; Cobben, JM; Juusola, J; Pujol, A; Mandel, JL; Piton, A				Mattioli, Francesca; Schaefer, Elise; Magee, Alex; Mark, Paul; Mancini, Grazia M.; Dieterich, Klaus; Von Allmen, Gretchen; Alders, Marielle; Coutton, Charles; van Slegtenhorst, Marjon; Vieville, Gaelle; Engelen, Mark; Cobben, Jan Maarten; Juusola, Jane; Pujol, Aurora; Mandel, Jean-Louis; Piton, Amelie			Mutations in Histone Acetylase Modifier BRPF1 Cause an Autosomal-Dominant Form of Intellectual Disability with Associated Ptosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PHENOTYPE; FEATURES; MICRODELETION; GENE; DEFICIENCY; EXPRESSION; REGULATORS; DISORDERS; VARIANTS; HUMANS	Intellectual disability (ID) is a common neurodevelopmental disorder exhibiting extreme genetic heterogeneity, and more than 500 genes have been implicated in Mendelian forms of ID. We performed exome sequencing in a large family affected by an autosomal-dominant form of mild syndromic ID with ptosis, growth retardation, and hypotonia, and we identified an inherited 2 bp deletion causing a frameshift in BRPF1 (c.1052_1053del) in five affected family members. BRPF1 encodes a protein modifier of two histone acetyltransferases associated with ID: KAT6A (also known as MOZ or MYST3) and KAT6B (MORF or MYST4). The mRNA transcript was not significantly reduced in affected fibroblasts and most likely produces a truncated protein (p.Val351Glyfs*8). The protein variant shows an aberrant cellular location, loss of certain protein interactions, and decreased histone H3K23 acetylation. We identified BRPF1 deletions or point mutations in six additional individuals with a similar phenotype. Deletions of the 3p25 region, containing BRPF1 and SETD5, cause a defined ID syndrome where most of the clinical features are attributed to SETDS deficiency. We compared the clinical symptoms of individuals carrying mutations or small deletions of BRPF1 alone or SETDS alone with those of individuals with deletions encompassing both BRPF1 and SETDS. We conclude that both genes contribute to the phenotypic severity of 3p25 deletion syndrome but that some specific features, such as ptosis and blepharophimosis, are mostly driven by BRPF1 haploinsufficiency.	[Mattioli, Francesca; Mandel, Jean-Louis; Piton, Amelie] Inst Genet & Biol Mol & Cellulaire, F-67400 Illkirch Graffenstaden, France; [Mattioli, Francesca; Mandel, Jean-Louis; Piton, Amelie] INSERM, U964, F-67400 Illkirch Graffenstaden, France; [Mattioli, Francesca; Mandel, Jean-Louis; Piton, Amelie] CNRS, UMR 7104, F-67400 Illkirch Graffenstaden, France; [Mattioli, Francesca; Mandel, Jean-Louis; Piton, Amelie] Univ Strasbourg, F-67400 Illkirch Graffenstaden, France; [Mattioli, Francesca; Mandel, Jean-Louis] Coll France, Chaire Genet Humaine, F-67400 Illkirch Graffenstaden, France; [Schaefer, Elise] Hop Univ Strasbourg, Inst Genet Med Alsace, Serv Genet Med, F-67000 Strasbourg, France; [Magee, Alex] Belfast City Hosp, Genet Med, Belfast BT9 7AB, Antrim, North Ireland; [Mark, Paul] Spectrum Hlth Med Grp, Grand Rapids, MI 49544 USA; [Mancini, Grazia M.; van Slegtenhorst, Marjon] Erasmus MC, Dept Clin Genet, NL-3015 Rotterdam, Netherlands; [Dieterich, Klaus] Hop Couple Enfant, Ctr Hosp Univ Grenoble Site Nord, Serv Genet Clin, F-38700 Grenoble, France; [Von Allmen, Gretchen] Univ Texas Houston, McGovern Med Sch, Dept Pediat, Houston, TX 77030 USA; [Alders, Marielle; Engelen, Mark; Cobben, Jan Maarten] Acad Med Ctr, Dept Clin Genet, NL-1100 Amsterdam, Netherlands; [Coutton, Charles; Vieville, Gaelle] Univ Grenoble Alpes, Inst Albert Bonniot, Ctr Hosp Univ Grenoble Alpes, Lab Genet Chromosom,CNRS UMR 5309,INSERM 1209, F-38706 Grenoble, France; [Juusola, Jane] GeneDx, Gaithersburg, MD 20877 USA; [Pujol, Aurora] Inst Invest Biomed Bellvitge, Inst Neuropathol, Neurometab Dis Lab, Barcelona 08908, Spain; [Pujol, Aurora] Ctr Biomed Res Rare Dis U759, Barcelona 08908, Spain; [Pujol, Aurora] Catalan Inst Res & Adv Studies, Barcelona 08010, Spain; [Mandel, Jean-Louis; Piton, Amelie] Hop Univ Strasbourg, Inst Genet Med Alsace, Lab Diagnost Genet, F-67000 Strasbourg, France; [Mandel, Jean-Louis] Univ Strasbourg, Inst Adv Studies, F-67000 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; College de France; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Belfast City Hospital; Spectrum Health Medical Group; Erasmus University Rotterdam; Erasmus MC; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); University of Texas System; University of Texas Health Science Center Houston; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Grenoble Alpes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; ICREA; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Mandel, JL; Piton, A (corresponding author), Inst Genet & Biol Mol & Cellulaire, F-67400 Illkirch Graffenstaden, France.; Mandel, JL; Piton, A (corresponding author), INSERM, U964, F-67400 Illkirch Graffenstaden, France.; Mandel, JL; Piton, A (corresponding author), CNRS, UMR 7104, F-67400 Illkirch Graffenstaden, France.; Mandel, JL; Piton, A (corresponding author), Univ Strasbourg, F-67400 Illkirch Graffenstaden, France.; Mandel, JL (corresponding author), Coll France, Chaire Genet Humaine, F-67400 Illkirch Graffenstaden, France.; Mandel, JL; Piton, A (corresponding author), Hop Univ Strasbourg, Inst Genet Med Alsace, Lab Diagnost Genet, F-67000 Strasbourg, France.; Mandel, JL (corresponding author), Univ Strasbourg, Inst Adv Studies, F-67000 Strasbourg, France.	jlmandel@igbmc.fr; piton@igbmc.fr	piton, amelie/F-1201-2013; Mark, Paul/AAK-2153-2020; COUTTON, Charles/G-2859-2014; dieterich, klaus/R-8418-2019; Pujol, Aurora/N-4990-2014	piton, amelie/0000-0003-0408-7468; dieterich, klaus/0000-0002-4362-4062; Pujol, Aurora/0000-0002-9606-0600; Mark, Paul R./0000-0002-1020-888X; Coutton, Charles/0000-0002-8873-8098; Engelen, Marc/0000-0002-5346-8497; schaefer, elise/0000-0003-1004-6814; Mattioli, Francesca/0000-0002-1595-4320	Fondation Jerome Lejeune; Fondation Maladies Rares; Association APLM; French state fund [ANR-10-LABX-0030-I NRT]; Agence Nationale de la Recherche [ANR-10-IDEX-0002-02]; ICREA Funding Source: Custom	Fondation Jerome Lejeune; Fondation Maladies Rares; Association APLM; French state fund; Agence Nationale de la Recherche(French National Research Agency (ANR)); ICREA(ICREA)	The authors thank the families for their participation in this study. The authors also thank Fondation Jerome Lejeune, Fondation Maladies Rares, and Association APLM for financial support. This study was also supported by grant ANR-10-LABX-0030-I NRT, a French state fund managed by the Agence Nationale de la Recherche under the frame program Investissements d'Avenir ANR-10-IDEX-0002-02. The authors also thank all members of the Strasbourg Hospital molecular diagnostic lab, the Clinical Genetics Service of Prof. Helene Dollfus, the Institut Genetique Biologie Moleculaire Cellulaire sequencing platform, and UMR_S 1112 (Bernard Jost, Stephanie Le Gras, Mathieu Jung, Jean Muller, and Veronique Geoffroy) for their technical and bioinformatics support. We also thank Sylvain Daujat, Robert Schneider, Federica Evangelista, Tiago Baptista, and Lazlo Tora for histone H3 antibodies and technical advice; and Xiang-Jiao Yang for the cDNA of BRPF1, KAT6A, ING5, and MEAF6 expression plasmids and technical help. J.J. is an employee of GeneDx, and A. Pujol is a consultant for GeneDx.	Arboleda VA, 2015, AM J HUM GENET, V96, P498, DOI 10.1016/j.ajhg.2015.01.017; Campeau PM, 2012, HUM MUTAT, V33, P1520, DOI 10.1002/humu.22141; Clayton-Smith J, 2011, AM J HUM GENET, V89, P675, DOI 10.1016/j.ajhg.2011.10.008; Dikow N, 2014, AM J MED GENET A, V164, P3061, DOI 10.1002/ajmg.a.36761; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Ellery PM, 2014, CLIN DYSMORPHOL, V23, P29, DOI 10.1097/MCD.0000000000000017; Geoffroy V, 2015, PEERJ, V3, DOI 10.7717/peerj.796; Grozeva D, 2014, AM J HUM GENET, V94, P618, DOI 10.1016/j.ajhg.2014.03.006; Hibiya K, 2009, DEV BIOL, V329, P176, DOI 10.1016/j.ydbio.2009.02.021; Huether R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4630; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Kraft M, 2011, J CLIN INVEST, V121, P3479, DOI 10.1172/JCI43428; Kuechler A, 2015, EUR J HUM GENET, V23, P753, DOI 10.1038/ejhg.2014.165; Laue K, 2008, DEVELOPMENT, V135, P1935, DOI 10.1242/dev.017160; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; McRae J. F., 2016, BIORXIV; NARAHARA K, 1990, AM J MED GENET, V35, P269, DOI 10.1002/ajmg.1320350225; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Redin C, 2014, J MED GENET, V51, P724, DOI 10.1136/jmedgenet-2014-102554; Tham E, 2015, AM J HUM GENET, V96, P507, DOI 10.1016/j.ajhg.2015.01.016; Ullah M, 2008, MOL CELL BIOL, V28, P6828, DOI 10.1128/MCB.01297-08; Voss AK, 2009, DEV CELL, V17, P674, DOI 10.1016/j.devcel.2009.10.006; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902; You LY, 2015, J BIOL CHEM, V290, P11349, DOI 10.1074/jbc.M115.643189; You LY, 2015, J BIOL CHEM, V290, P7114, DOI 10.1074/jbc.M114.635250; You LY, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005034; Yu HC, 2014, AM J MED GENET A, V164, P950, DOI 10.1002/ajmg.a.36379	29	31	34	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 5	2017	100	1					105	116		10.1016/j.ajhg.2016.11.010	http://dx.doi.org/10.1016/j.ajhg.2016.11.010			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EH6UX	27939639	Green Published, Bronze			2022-12-18	WOS:000391910500009
J	Assoum, M; Philippe, C; Isidor, B; Perrin, L; Makrythanasis, P; Sondheimer, N; Paris, C; Douglas, J; Lesca, G; Antonarakis, S; Hamamy, H; Jouan, T; Duffourd, Y; Auvin, S; Saunier, A; Begtrup, A; Nowak, C; Chatron, N; Ville, D; Mireskandari, K; Milani, P; Jonveaux, P; Lemeur, G; Milh, M; Amamoto, M; Kato, M; Nakashima, M; Miyake, N; Matsumoto, N; Masri, A; Thauvin-Robinet, C; Riviere, JB; Faivre, L; Thevenon, J				Assoum, Mirna; Philippe, Christophe; Isidor, Bertrand; Perrin, Laurence; Makrythanasis, Periklis; Sondheimer, Neal; Paris, Caroline; Douglas, Jessica; Lesca, Gaetan; Antonarakis, Stylianos; Hamamy, Hanan; Jouan, Thibaud; Duffourd, Yannis; Auvin, Stephane; Saunier, Aline; Begtrup, Amber; Nowak, Catherine; Chatron, Nicolas; Ville, Dorothee; Mireskandari, Kamiar; Milani, Paolo; Jonveaux, Philippe; Lemeur, Guylene; Milh, Mathieu; Amamoto, Masano; Kato, Mitsuhiro; Nakashima, Mitsuko; Miyake, Noriko; Matsumoto, Naomichi; Masri, Amira; Thauvin-Robinet, Christel; Riviere, Jean-Baptiste; Faivre, Laurence; Thevenon, Julien			Autosomal-Recessive Mutations in AP3B2, Adaptor-Related Protein Complex 3 Beta 2 Subunit, Cause an Early-Onset Epileptic Encephalopathy with Optic Atrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTELLECTUAL DISABILITY; MEDNIK SYNDROME; AP-3; SEIZURES; DEFICIENCY; DISEASE; DEFECT; PEARL	Early-onset epileptic encephalopathy (EOEE) represents a heterogeneous group of severe disorders characterized by seizures, interictal epileptiform activity with a disorganized electroencephalography background, developmental regression or retardation, and onset before 1 year of age. Among a cohort of 57 individuals with epileptic encephalopathy, we ascertained two unrelated affected individuals with EOEE associated with developmental impairment and autosomal-recessive variants in AP3B2 by means of whole-exome sequencing. The targeted sequencing of AP3B2 in 86 unrelated individuals with EOEE led to the identification of an additional family. We gathered five additional families with eight affected individuals through the Matchmaker Exchange initiative by matching autosomal- recessive mutations in AP3B2. Reverse phenotyping of 12 affected individuals from eight families revealed a homogeneous EOEE phenotype characterized by severe developmental delay, poor visual contact with optic atrophy, and postnatal microcephaly. No spasticity, albinism, or hematological symptoms were reported. AP3B2 encodes the neuron-specific subunit of the AP-3 complex. Autosomal-recessive variations of AP3B1, the ubiquitous isoform, cause Hermansky-Pudlak syndrome type 2. The only isoform for the delta subunit of the AP-3 complex is encoded by AP3D1. Autosomal-recessive mutations in AP3D1 cause a severe disorder cumulating the symptoms of the AP3B1 and AP3B2 defects.	[Assoum, Mirna; Jouan, Thibaud; Duffourd, Yannis; Thauvin-Robinet, Christel; Riviere, Jean-Baptiste; Faivre, Laurence; Thevenon, Julien] Univ Bourgogne, Equipe Accueil 4271, Genet Anomalies Dev, F-21079 Dijon, France; [Philippe, Christophe; Saunier, Aline; Jonveaux, Philippe] Ctr Hosp Univ Hop Brabois, Nutr Genet Environm Risk Exposure, INSERM, U954,Lab Genet Med, F-54511 Vandoeuvre Les Nancy, France; [Isidor, Bertrand] Ctr Hosp Univ Nantes, Serv Genet Med, F-44093 Nantes, France; [Isidor, Bertrand] INSERM, UMR S957, F-44093 Nantes, France; [Perrin, Laurence] Hop Robert Debre, Ctr Hosp Univ Paris, AP HP, Dept Genet, F-75019 Paris, France; [Makrythanasis, Periklis; Antonarakis, Stylianos; Hamamy, Hanan] Univ Geneva, Dept Genet Med & Dev, Rue Michel Servet 1, CH-1211 Geneva 4, Switzerland; [Makrythanasis, Periklis; Antonarakis, Stylianos] Univ Hosp Geneva, Serv Genet Med, CH-1211 Geneva 4, Switzerland; [Sondheimer, Neal] Hosp Sick Children, Div Clin & Metab Genet, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Paris, Caroline] Hop Jean Minjoz, Ctr Hosp Reg Univ, F-25030 Besancon, France; [Douglas, Jessica; Nowak, Catherine] Boston Childrens Hosp, Feingold Ctr, Boston, MA 02115 USA; [Lesca, Gaetan; Chatron, Nicolas] Hosp Civils Lyon, Grp Hosp Est, Dept Med Genet, F-69677 Bron, France; [Lesca, Gaetan; Chatron, Nicolas] Univ Lyon, F-69100 Villeurbanne, France; [Lesca, Gaetan; Chatron, Nicolas] Ctr Rech Neurosci Lyon, INSERM, U1028, CNRS,UMR 5292, Batiment Inst Multidisciplinaire Biochim Lipides, F-69621 Villeurbanne, France; [Antonarakis, Stylianos] Univ Geneva, Inst Genet & Genom Geneva, CH-1211 Geneva 4, Switzerland; [Duffourd, Yannis] Ctr Hosp Univ Dijon, Federat Hosp Univ Med Translat & Anomalies Dev, F-21079 Dijon, France; [Auvin, Stephane; Thauvin-Robinet, Christel; Riviere, Jean-Baptiste; Faivre, Laurence; Thevenon, Julien] Hop Robert Debre, INSERM 1141, Serv Neurol Pediat, F-75019 Paris, France; [Begtrup, Amber] GeneDx, 207 Perry Pkwy, Gaithersburg, MD 20877 USA; [Ville, Dorothee] Hosp Civils Lyon, Grp Hosp Est, Dept Pediat Neurol, F-69677 Bron, France; [Mireskandari, Kamiar] Hosp Sick Children, Dept Ophthalmol & Vis Sci, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Milani, Paolo] Hop Lariboisiere, AP HP, Serv Physiol Clin & Explorat Fonct, F-75475 Paris, France; [Lemeur, Guylene] Ctr Hosp Univ Nantes, Serv Ophtalmol, F-44093 Nantes, France; [Milh, Mathieu] Hop La Timone, Assistance Publ Hop Marseille, Serv Neurol Pediat, F-13005 Marseille, France; [Milh, Mathieu] Aix Marseille Univ, INSERM, UMR S910, F-13005 Marseille, France; [Amamoto, Masano] Kitakyushu Municipal Yahata Hosp, Pediat Emergency Ctr, Kitakyushu, Fukuoka 8038501, Japan; [Kato, Mitsuhiro] Showa Univ, Sch Med, Dept Pediat, Tokyo 1428555, Japan; [Nakashima, Mitsuko; Miyake, Noriko; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan; [Masri, Amira] Univ Jordan, Fac Med, Dept Paediat, Amman 11942, Jordan; [Thauvin-Robinet, Christel; Faivre, Laurence; Thevenon, Julien] Ctr Hosp Univ Dijon, Ctr Genet, F-21079 Dijon, France; [Thauvin-Robinet, Christel; Faivre, Laurence; Thevenon, Julien] Ctr Hosp Univ Dijon, Ctr Reference Anomalies Dev & Syndromes Malformat, F-21079 Dijon, France	Institut Agro; AgroSup Dijon; Universite de Bourgogne; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Geneva; University of Geneva; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Universite de Franche-Comte; CHU Besancon; Harvard University; Boston Children's Hospital; Assistance Publique Hopitaux Paris (APHP); CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; University of Geneva; CHU Dijon Bourgogne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); CHU Lyon; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Nantes Universite; CHU de Nantes; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Showa University; Yokohama City University; University of Jordan; CHU Dijon Bourgogne; CHU Dijon Bourgogne	Thevenon, J (corresponding author), Univ Bourgogne, Equipe Accueil 4271, Genet Anomalies Dev, F-21079 Dijon, France.; Thevenon, J (corresponding author), Hop Robert Debre, INSERM 1141, Serv Neurol Pediat, F-75019 Paris, France.; Thevenon, J (corresponding author), Ctr Hosp Univ Dijon, Ctr Genet, F-21079 Dijon, France.; Thevenon, J (corresponding author), Ctr Hosp Univ Dijon, Ctr Reference Anomalies Dev & Syndromes Malformat, F-21079 Dijon, France.	jthevenon@chu-grenoble.fr	masri, amira/C-4570-2015; Antonarakis, Stylianos E/N-8866-2014; Makrythanasis, Periklis/AAD-7180-2019; Lesca, Gaetan/C-6111-2019; Sondheimer, Neal/X-7846-2019; Auvin, Stéphane/AAB-7824-2021; Isidor, Bertrand/AAJ-3456-2021; CHATRON, Nicolas/J-2770-2019	masri, amira/0000-0001-6103-8713; Antonarakis, Stylianos E/0000-0001-8907-5823; Auvin, Stéphane/0000-0003-3874-9749; Isidor, Bertrand/0000-0001-6480-126X; CHATRON, Nicolas/0000-0003-0538-0981; Sondheimer, Neal/0000-0001-9982-5712; Kato, Mitsuhiro/0000-0003-1485-8553; PHILIPPE, Christophe/0000-0001-7098-6520; Lesca, Gaetan/0000-0001-7691-9492; Faivre, Laurence/0000-0001-9770-444X	Regional Council of Burgundy; Dijon University Hospital; Association Francaise du Syndrome de Rett; Grants-in-Aid for Scientific Research [16H05357] Funding Source: KAKEN	Regional Council of Burgundy(Region Bourgogne-Franche-Comte); Dijon University Hospital; Association Francaise du Syndrome de Rett; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We wish to thank the individuals and families involved in this study, IntegraGen for the exome sequencing experiments, the Centre de Calcul de l'Universite de Bourgogne for technical support and management of the informatics platform, and the Centre for Genetic Medicine at the Hospital for Sick Children. This work was supported by the Regional Council of Burgundy, Dijon University Hospital, and the Association Francaise du Syndrome de Rett.	Abdollahpour H, 2015, EUR J HUM GENET, V23, P256, DOI 10.1038/ejhg.2014.73; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Allen NM, 2016, EPILEPSIA, V57, pE12, DOI 10.1111/epi.13250; Allou L, 2016, CLIN GENET; Ammann S, 2016, BLOOD, V127, P997, DOI 10.1182/blood-2015-09-671636; BALKEMA GW, 1983, SCIENCE, V219, P1085, DOI 10.1126/science.6600521; Blumstein J, 2001, J NEUROSCI, V21, P8034, DOI 10.1523/JNEUROSCI.21-20-08034.2001; Boehm M, 2001, MOL BIOL CELL, V12, P2907, DOI 10.1091/mbc.12.10.2907; Cacciagli P, 2014, EUR J HUM GENET, V22, P363, DOI 10.1038/ejhg.2013.135; DellAngelica EC, 1997, EMBO J, V16, P917, DOI 10.1093/emboj/16.5.917; EpiPM Consortium, 2016, LANCET NEUROL, V15, P241, DOI 10.1016/S1474-4422(15)00199-4; Fairfield H, 2015, GENOME RES, V25, P948, DOI 10.1101/gr.186882.114; Feng LJ, 1999, HUM MOL GENET, V8, P323, DOI 10.1093/hmg/8.2.323; Hardies K, 2015, HUM MOL GENET, V24, P2218, DOI 10.1093/hmg/ddu740; Jameel M, 2014, BMC MED GENET, V15, DOI 10.1186/s12881-014-0133-2; Kantheti P, 1998, NEURON, V21, P111, DOI 10.1016/S0896-6273(00)80519-X; Kong XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058286; Martinelli D, 2014, ANN NY ACAD SCI, V1314, P55, DOI 10.1111/nyas.12426; Martinelli D, 2013, BRAIN, V136, P872, DOI 10.1093/brain/awt012; McTague A, 2016, LANCET NEUROL, V15, P304, DOI 10.1016/S1474-4422(15)00250-1; Nahorski MS, 2016, BRAIN, V139, P1036, DOI 10.1093/brain/aww014; NEWMAN LS, 1995, CELL, V82, P773, DOI 10.1016/0092-8674(95)90474-3; Philippakis AA, 2015, HUM MUTAT, V36, P915, DOI 10.1002/humu.22858; Seong E, 2005, MOL BIOL CELL, V16, P128, DOI 10.1091/mbc.E04-10-0892; Simpson F, 1996, J CELL BIOL, V133, P749, DOI 10.1083/jcb.133.4.749; Thevenon J, 2016, CLIN GENET, V89, P700, DOI 10.1111/cge.12732; Thevenon J, 2014, AM J HUM GENET, V95, P113, DOI 10.1016/j.ajhg.2014.06.006	27	31	32	2	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 1	2016	99	6					1368	1376		10.1016/j.ajhg.2016.10.009	http://dx.doi.org/10.1016/j.ajhg.2016.10.009			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED8VI	27889060	Green Published, Bronze			2022-12-18	WOS:000389148600012
J	Lenk, GM; Szymanska, K; Debska-Vielhaber, G; Rydzanicz, M; Walczak, A; Bekiesinska-Figatowska, M; Vielhaber, S; Hallmann, K; Stawinski, P; Buehring, S; Hsu, DA; Kunz, WS; Meisler, MH; Ploski, R				Lenk, Guy M.; Szymanska, Krystyna; Debska-Vielhaber, Grazyna; Rydzanicz, Malgorzata; Walczak, Anna; Bekiesinska-Figatowska, Monika; Vielhaber, Stefan; Hallmann, Kerstin; Stawinski, Piotr; Buehring, Sonja; Hsu, David A.; Kunz, Wolfram S.; Meisler, Miriam H.; Ploski, Rafal			Biallelic Mutations of VAC14 in Pediatric-Onset Neurological Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PHOSPHATIDYLINOSITOL 3,5-BISPHOSPHATE; PHOSPHOINOSITIDE PHOSPHATASE; LYSOSOME FUNCTION; FIG4 CAUSES; PIKFYVE; PI(3,5)P-2; NEURODEGENERATION; MOUSE; COMPLEX; METABOLISM	In the PI(3,5)P-2 biosynthetic complex, the lipid kinase PIKFYVE and the phosphatase FIG4 are bound to the dimeric scaffold protein VAC14, which is composed of multiple heat-repeat domains. Mutations of FIG4 result in the inherited disorders Charcot-Marie-Tooth disease type 4J, Yunis-Varon syndrome, and polymicrogyria with seizures. We here describe inherited variants of VAC14 in two unrelated children with sudden onset of a progressive neurological disorder and regression of developmental milestones. Both children developed impaired movement with dystonia, became nonambulatory and nonverbal, and exhibited striatal abnormalities on MRI. A diagnosis of Leigh syndrome was rejected due to normal lactate profiles. Exome sequencing identified biallelic variants of VAC14 that were inherited from unaffected heterozygous parents in both families. Proband 1 inherited a splice-site variant that results in skipping of exon 13, p.Ile459Profs*4 (not reported in public databases), and the missense variant p.Trp424Leu (reported in the ExAC database in a single heterozygote). Proband 2 inherited two missense variants in the dimerization domain of VAC14, p.Ala582Ser and p.Ser583Leu, that have not been previously reported. Cultured skin fibroblasts exhibited the accumulation of vacuoles that is characteristic of PI(3,5)P-2 deficiency. Vacuolization of fibroblasts was rescued by transfection of wild-type VAC14 cDNA. The similar age of onset and neurological decline in the two unrelated children define a recessive disorder resulting from compound heterozygosity for deleterious variants of VAC14.	[Lenk, Guy M.; Meisler, Miriam H.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Szymanska, Krystyna] Med Univ Warsaw, Dept Child Psychiat, Warsaw, Poland; [Szymanska, Krystyna] Polish Acad Sci, Dept Expt & Clin Neuropathol, Med Res Ctr, PL-02106 Warsaw, Poland; [Debska-Vielhaber, Grazyna; Vielhaber, Stefan] Univ Klinikum Magdeburg, Neurol Klin, D-39120 Magdeburg, Germany; [Rydzanicz, Malgorzata; Walczak, Anna; Stawinski, Piotr; Ploski, Rafal] Med Univ Warsaw, Dept Med Genet, PL-02106 Warsaw, Poland; [Stawinski, Piotr] Inst Physiol & Pathol Hearing, PL-05830 Nadarzyn, Poland; [Bekiesinska-Figatowska, Monika] Inst Mother & Child Hlth, Dept Diagnost Imaging, PL-01211 Warsaw, Poland; [Hallmann, Kerstin; Kunz, Wolfram S.] Univ Klinikum Bonn, Klin Epileptol, D-53105 Bonn, Germany; [Hallmann, Kerstin; Kunz, Wolfram S.] Univ Klinikum Bonn, Life & Brain Ctr, D-53105 Bonn, Germany; [Hsu, David A.] Univ Wisconsin, Dept Neurol, Madison, WI 53705 USA	University of Michigan System; University of Michigan; Medical University of Warsaw; Polish Academy of Sciences; University Hospital Magdeburg; Medical University of Warsaw; Institute of Physiology & Hearing Pathology; University of Bonn; University of Bonn; University of Wisconsin System; University of Wisconsin Madison	Meisler, MH (corresponding author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.; Ploski, R (corresponding author), Med Univ Warsaw, Dept Med Genet, PL-02106 Warsaw, Poland.	meislerm@umich.edu; rploski@wp.pl	Kunz, Wolfram/K-1232-2019; Bekiesinska-Figatowska, Monika/U-7498-2019; Lenk, Guy M./Q-1226-2016	Kunz, Wolfram/0000-0003-1113-3493; Lenk, Guy M./0000-0001-8092-1405; Rydzanicz, Malgorzata/0000-0002-6969-0535; Bekiesinska-Figatowska, Monika/0000-0003-1787-3425; Ploski, Rafal/0000-0001-6286-5526; Walczak, Anna/0000-0003-2011-5334	NIH [R01 GM24872]; National Science Centre [2013/11/B/NZ7/04944]; Deutsche Forschungsgemeinschaft [KU 911/21-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024872] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Centre(National Science Centre, Poland); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Rachel Hollander for technical assistance. This work was supported in part by NIH research grant R01 GM24872 (M.H.M.), National Science Centre grant 2013/11/B/NZ7/04944 (R.P.), and Deutsche Forschungsgemeinschaft grant KU 911/21-1 (W.S.K.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alghamdi TA, 2013, J BIOL CHEM, V288, P9363, DOI 10.1074/jbc.M113.453712; Baulac S, 2014, NEUROLOGY, V82, P1068, DOI 10.1212/WNL.0000000000000241; Botelho RJ, 2008, MOL BIOL CELL, V19, P4273, DOI 10.1091/mbc.E08-04-0405; Cai XM, 2013, CHEM BIOL, V20, P912, DOI 10.1016/j.chembiol.2013.05.010; Campeau PM, 2013, AM J HUM GENET, V92, P781, DOI 10.1016/j.ajhg.2013.03.020; Chow CY, 2007, NATURE, V448, P68, DOI 10.1038/nature05876; Cooke FT, 2002, ARCH BIOCHEM BIOPHYS, V407, P143, DOI 10.1016/S0003-9861(02)00487-3; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Dove SK, 2009, BIOCHEM J, V419, P1, DOI 10.1042/BJ20081950; Ferguson CJ, 2012, HUM MOL GENET, V21, P3525, DOI 10.1093/hmg/dds179; Gee JA, 2015, MOL VIS, V21, P1093; Ho CY, 2012, TRAFFIC, V13, P1, DOI 10.1111/j.1600-0854.2011.01246.x; Ikonomov OC, 2011, J BIOL CHEM, V286, P13404, DOI 10.1074/jbc.M111.222364; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Jin N, 2008, EMBO J, V27, P3221, DOI 10.1038/emboj.2008.248; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lenk GM, 2016, HUM MOL GENET, V25, P340, DOI 10.1093/hmg/ddv480; Lenk GM, 2014, METHOD ENZYMOL, V534, P245, DOI 10.1016/B978-0-12-397926-1.00014-7; Lenk GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002104; McCartney AJ, 2014, P NATL ACAD SCI USA, V111, pE4896, DOI 10.1073/pnas.1411117111; McCartney AJ, 2014, BIOESSAYS, V36, P52, DOI 10.1002/bies.201300012; Michell RH, 2013, FEBS J, V280, P6281, DOI 10.1111/febs.12452; Min SH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5691; Nicholson G, 2011, BRAIN, V134, P1959, DOI 10.1093/brain/awr148; Sbrissa D, 2008, J MOL BIOL, V384, P766, DOI 10.1016/j.jmb.2008.10.009; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Takasuga S, 2013, J BIOCHEM, V154, P211, DOI 10.1093/jb/mvt064; Wang X, 2012, CELL, V151, P372, DOI 10.1016/j.cell.2012.08.036; Zhang XB, 2008, BRAIN, V131, P1990, DOI 10.1093/brain/awn114; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P17518, DOI 10.1073/pnas.0702275104; Zolov SN, 2012, P NATL ACAD SCI USA, V109, P17472, DOI 10.1073/pnas.1203106109; Zou JL, 2015, J NEUROSCI, V35, P6801, DOI 10.1523/JNEUROSCI.4442-14.2015	33	31	32	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 7	2016	99	1					188	194		10.1016/j.ajhg.2016.05.008	http://dx.doi.org/10.1016/j.ajhg.2016.05.008			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TI	27292112	Bronze, Green Published			2022-12-18	WOS:000381616600015
J	Madeo, M; Stewart, M; Sun, YY; Sahir, N; Wiethoff, S; Chandrasekar, I; Yarrow, A; Rosenfeld, JA; Yang, YP; Cordeiro, D; McCormick, EM; Muraresku, CC; Jepperson, TN; McBeth, LJ; Seidahmed, MZ; El Khashab, HY; Hamad, M; Azzedine, H; Clark, K; Corrochano, S; Wells, S; Elting, MW; Weiss, MM; Burn, S; Myers, A; Landsverk, M; Crotwell, PL; Waisfisz, Q; Wolf, NI; Nolan, PM; Padilla-Lopez, S; Houlden, H; Lifton, R; Mane, S; Singh, BB; Falk, MJ; Mercimek-Mahmutoglu, S; Bilguvar, K; Salih, MA; Acevedo-Arozena, A; Kruer, MC				Madeo, Marianna; Stewart, Michelle; Sun, Yuyang; Sahir, Nadia; Wiethoff, Sarah; Chandrasekar, Indra; Yarrow, Anna; Rosenfeld, Jill A.; Yang, Yaping; Cordeiro, Dawn; McCormick, Elizabeth M.; Muraresku, Colleen C.; Jepperson, Tyler N.; McBeth, Lauren J.; Seidahmed, Mohammed Zain; El Khashab, Heba Y.; Hamad, Muddathir; Azzedine, Hamid; Clark, Karl; Corrochano, Silvia; Wells, Sara; Elting, Mariet W.; Weiss, Marjan M.; Burn, Sabrina; Myers, Angela; Landsverk, Megan; Crotwell, Patricia L.; Waisfisz, Quinten; Wolf, Nicole I.; Nolan, Patrick M.; Padilla-Lopez, Sergio; Houlden, Henry; Lifton, Richard; Mane, Shrikant; Singh, Brij B.; Falk, Marni J.; Mercimek-Mahmutoglu, Saadet; Bilguvar, Kaya; Salih, Mustafa A.; Acevedo-Arozena, Abraham; Kruer, Michael C.			Loss-of-Function Mutations in FRRS1L Lead to an Epileptic-Dyskinetic Encephalopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMPA; RECEPTORS; SPECTRUM; ACID	Glutamatergic neurotransmission governs excitatory signaling in the mammalian brain, and abnormalities of glutamate signaling have been shown to contribute to both epilepsy and hyperkinetic movement disorders. The etiology of many severe childhood movement disorders and epilepsies remains uncharacterized. We describe a neurological disorder with epilepsy and prominent choreoathetosis caused by biallelic pathogenic variants in FRRS1L, which encodes an AMPA receptor outer-core protein. Loss of FRRS1L function attenuates AMPA-mediated currents, implicating chronic abnormalities of glutamatergic neurotransmission in this monogenic neurological disease of childhood.	[Madeo, Marianna; Sahir, Nadia; Chandrasekar, Indra; Yarrow, Anna; Jepperson, Tyler N.; McBeth, Lauren J.; Burn, Sabrina; Myers, Angela; Landsverk, Megan; Crotwell, Patricia L.; Kruer, Michael C.] Sanford Res, Childrens Hlth Res Ctr, Sioux Falls, SD 57104 USA; [Stewart, Michelle; Corrochano, Silvia; Wells, Sara; Nolan, Patrick M.; Acevedo-Arozena, Abraham] Med Res Council Harwell, Mammalian Genet Unit, Dicot, Oxon, England; [Sun, Yuyang; Singh, Brij B.] Univ N Dakota, Dept Basic Sci, Grand Forks, ND 58202 USA; [Wiethoff, Sarah; Houlden, Henry] UCL Inst Neurol, Dept Mol Neurosci, Queen Sq, London WC1N 3BG, England; [Rosenfeld, Jill A.; Yang, Yaping] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Cordeiro, Dawn; Mercimek-Mahmutoglu, Saadet] Univ Toronto, Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Cordeiro, Dawn; Mercimek-Mahmutoglu, Saadet] Univ Toronto, Hosp Sick Children, Dept Pediat, Genet & Genome Biol Program, Toronto, ON M5G 1X8, Canada; [McCormick, Elizabeth M.; Muraresku, Colleen C.; Falk, Marni J.] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [McCormick, Elizabeth M.; Muraresku, Colleen C.; Falk, Marni J.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Seidahmed, Mohammed Zain] Secur Forces Hosp, Dept Pediat, Riyadh 12625, Saudi Arabia; [El Khashab, Heba Y.; Hamad, Muddathir; Salih, Mustafa A.] King Saud Univ, Coll Med, Dept Pediat, Div Pediat Neurol, Riyadh 12372, Saudi Arabia; [El Khashab, Heba Y.] Ain Shams Univ, Childrens Hosp, Dept Pediat, Cairo 11355, Egypt; [Azzedine, Hamid] Uniklin RWTH Aachen, Inst Neuropathol, D-52074 Aachen, Germany; [Clark, Karl] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Elting, Mariet W.; Weiss, Marjan M.; Waisfisz, Quinten] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, NL-1007 Amsterdam, Netherlands; [Wolf, Nicole I.] Vrije Univ Amsterdam, Med Ctr, Dept Child Neurol & Neurosci, Campus Amsterdam, NL-1007 Amsterdam, Netherlands; [Padilla-Lopez, Sergio; Kruer, Michael C.] Univ Arizona, Coll Med, Dept Child Hlth, Phoenix, AZ 85004 USA; [Padilla-Lopez, Sergio; Kruer, Michael C.] Phoenix Childrens Hosp, Barrow Neurol Inst, Neurogenet Res Program, Phoenix, AZ 85016 USA; [Lifton, Richard; Mane, Shrikant] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06516 USA; [Lifton, Richard; Mane, Shrikant] Yale Univ, Sch Med, Yale Ctr Genome Anal, New Haven, CT 06516 USA; [Kruer, Michael C.] Arizona State Univ, Program Neurosci, Tempe, AZ 85287 USA; [Kruer, Michael C.] Phoenix Childrens Hosp, Barrow Neurol Inst, Pediat Movement Disorders Ctr, Phoenix, AZ 85016 USA	Sanford Health; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of North Dakota Grand Forks; University of London; University College London; Baylor College of Medicine; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Security Forces Hospital - Saudi Arabia; King Saud University; Egyptian Knowledge Bank (EKB); Ain Shams University; RWTH Aachen University; RWTH Aachen University Hospital; Mayo Clinic; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Arizona; Barrow Neurological Institute; Phoenix Children's Hospital; Yale University; Yale University; Arizona State University; Arizona State University-Tempe; Barrow Neurological Institute; Phoenix Children's Hospital	Kruer, MC (corresponding author), Sanford Res, Childrens Hlth Res Ctr, Sioux Falls, SD 57104 USA.; Kruer, MC (corresponding author), Univ Arizona, Coll Med, Dept Child Hlth, Phoenix, AZ 85004 USA.; Kruer, MC (corresponding author), Phoenix Childrens Hosp, Barrow Neurol Inst, Neurogenet Res Program, Phoenix, AZ 85016 USA.; Kruer, MC (corresponding author), Arizona State Univ, Program Neurosci, Tempe, AZ 85287 USA.; Kruer, MC (corresponding author), Phoenix Childrens Hosp, Barrow Neurol Inst, Pediat Movement Disorders Ctr, Phoenix, AZ 85016 USA.	mkruer@phoenixchildrens.com	Houlden, Henry J/C-1532-2008; Weiss, Marjan M/AAN-4979-2020; Arozena, Abraham Acevedo/L-6584-2018; Wolf, Nicole I/H-3943-2014; Wang, Guilin/G-8794-2018; Nolan, Patrick/W-3918-2019; Corrochano, Silvia/L-2687-2015	Houlden, Henry J/0000-0002-2866-7777; Weiss, Marjan M/0000-0002-0936-1406; Arozena, Abraham Acevedo/0000-0001-6127-7116; Wolf, Nicole I/0000-0003-1721-0728; Nolan, Patrick/0000-0001-5550-0334; Corrochano, Silvia/0000-0003-0958-0083; Waisfisz, Quinten/0000-0002-7384-9182; Falk, Marni/0000-0002-1723-6728; Clark, Karl/0000-0002-9637-0967; Singh, Brij/0000-0003-0535-5997	Retrophin Inc.; NIH [U42OD011174, U54HG006348]; Deanship of Scientific Research at King Saud University [RGP-VPP-301]; Sanford Seed Grant; NIH Centers for Mendelian Genomics [5U54HG006504]; NIH National Institute of Neurological Disorders and Stroke [NS083739]; National Institute of Dental and Craniofacial Research [DE017102]; Doris Duke Charitable Foundation Clinical Scientist Development Award [CSDA2014112]; Medical Research Council [MC_UP_A390_1106, G108/638, G0802760, MC_UP_1502/3, G1001253, MC_U142684173, MR/J004758/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10082] Funding Source: researchfish; MRC [MC_U142684173, G0802760, MR/J004758/1, G108/638, G1001253, MC_UP_A390_1106, MC_UP_1502/3] Funding Source: UKRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006504, U54HG006348, UM1HG006504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE024300, R01DE017102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS083739] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U42OD011174] Funding Source: NIH RePORTER	Retrophin Inc.; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deanship of Scientific Research at King Saud University(King Saud University); Sanford Seed Grant; NIH Centers for Mendelian Genomics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Doris Duke Charitable Foundation Clinical Scientist Development Award(American Heart AssociationDoris Duke Charitable Foundation (DDCF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the families for their gracious participation in these studies. M.C.K. has served as a grant reviewer for the Department of Defense and an advisory committee member for Lundbeck Inc. and receives grant support from Retrophin Inc. Medical Research Council Harwell is a member of the International Mouse Phenotyping Consortium and has received funding from the NIH for generating (U42OD011174) and/or phenotyping (U54HG006348) the Frrs1l-tm1b(EUCOMM)Hmgu mice. The research reported in this publication is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. These studies were also supported by the Deanship of Scientific Research at King Saud University (RGP-VPP-301 to M.A.S.), by a Sanford Seed Grant (to A.M., P.L.C., and M.C.K.), by the NIH Centers for Mendelian Genomics (5U54HG006504 to R.L., K.B., and S.M.), by the NIH National Institute of Neurological Disorders and Stroke (NS083739 to M.C.K.), by the National Institute of Dental and Craniofacial Research (DE017102 to B.B.S.), and by a Doris Duke Charitable Foundation Clinical Scientist Development Award (CSDA2014112 to M.C.K.).	Aoto J, 2013, CELL, V154, P75, DOI 10.1016/j.cell.2013.05.060; Cellini E, 2016, DEV MED CHILD NEUROL, V58, P93, DOI 10.1111/dmcn.12894; CHRISTNACHER A, 1995, FEBS LETT, V373, P93, DOI 10.1016/0014-5793(95)01016-8; Delcourt M, 2015, J NEUROL NEUROSUR PS, V86, P782, DOI 10.1136/jnnp-2014-309025; DEMEMES D, 1995, BRAIN RES, V671, P83, DOI 10.1016/0006-8993(94)01322-9; Deprez L, 2010, NEUROLOGY, V75, P1159, DOI 10.1212/WNL.0b013e3181f4d7bf; Gardella E, 2016, ANN NEUROL, V79, P428, DOI 10.1002/ana.24580; Guerrini R, 2007, NEUROLOGY, V69, P427, DOI 10.1212/01.wnl.0000266594.16202.c1; Heron SE, 2012, AM J HUM GENET, V90, P152, DOI 10.1016/j.ajhg.2011.12.003; Kruer MC, 2015, PEDIATR REV, V36, P104, DOI 10.1542/pir.36-3-104; McKinney RA, 2010, J PHYSIOL-LONDON, V588, P107, DOI 10.1113/jphysiol.2009.178905; Mink JW, 2003, ARCH NEUROL-CHICAGO, V60, P1365, DOI 10.1001/archneur.60.10.1365; Patzke C, 2015, J CLIN INVEST, V125, P3560, DOI 10.1172/JCI78612; Schwenk J, 2012, NEURON, V74, P621, DOI 10.1016/j.neuron.2012.03.034; Soto D, 2009, NAT NEUROSCI, V12, P277, DOI 10.1038/nn.2266; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; von Engelhardt J, 2010, SCIENCE, V327, P1518, DOI 10.1126/science.1184178; WAGSTER MV, 1994, EXP NEUROL, V127, P70, DOI 10.1006/exnr.1994.1081; YOUNG AB, 1988, SCIENCE, V241, P981, DOI 10.1126/science.2841762	19	31	33	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 2	2016	98	6					1249	1255		10.1016/j.ajhg.2016.04.008	http://dx.doi.org/10.1016/j.ajhg.2016.04.008			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN7US	27236917	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000377286000019
J	Molloy, AM; Pangilinan, F; Mills, JL; Shane, B; O'Neill, MB; McGaughey, DM; Velkova, A; Abaan, HO; Ueland, PM; McNulty, H; Ward, M; Strain, JJ; Cunningham, C; Casey, M; Cropp, CD; Kim, Y; Bailey-Wilson, JE; Wilson, AF; Brody, LC				Molloy, Anne M.; Pangilinan, Faith; Mills, James L.; Shane, Barry; O'Neill, Mary B.; McGaughey, David M.; Velkova, Aneliya; Abaan, Hatice Ozel; Ueland, Per M.; McNulty, Helene; Ward, Mary; Strain, J. J.; Cunningham, Conal; Casey, Miriam; Cropp, Cheryl D.; Kim, Yoonhee; Bailey-Wilson, Joan E.; Wilson, Alexander F.; Brody, Lawrence C.			A Common Polymorphism in HIBCH Influences Methylmalonic Acid Concentrations in Blood Independently of Cobalamin	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; TOTAL HOMOCYSTEINE; VITAMIN-B-12 DEFICIENCY; VALINE METABOLISM; AUTOMATED-ASSAY; SERUM; PLASMA; FOLATE; HOLOTRANSCOBALAMIN; MUTATIONS	Methylmalonic acid (MMA) is a by-product of propionic acid metabolism through the vitamin B-12 (cobalamin)-dependent enzyme methylmalonyl CoA mutase. Elevated MMA concentrations are a hallmark of several inborn errors of metabolism and indicators of cobalamin deficiency in older persons. In a genome-wide analysis of 2,210 healthy young Irish adults (median age 22 years) we identified a strong association of plasma MMA with SNPs in 3-hydroxyisobutyryl-CoA hydrolase (HIBCH, p = 8.42 x 10(-89)) and acyl-CoA synthetase family member 3 (ACSF3, p = 3.48x10(-19)). These loci accounted for 12% of the variance in MMA concentration. The most strongly associated SNP (HIBCH rs291466; c:2T>C) causes a missense change of the initiator methionine codon (minor-allele frequency = 0.43) to threonine. Surprisingly, the resulting variant, p.Met1?, is associated with increased expression of HIBCH mRNA and encoded protein. These homozygotes had, on average, 46% higher MMA concentrations than methionine-encoding homozygotes in young adults with generally low MMA concentrations (0.17 [0.14-0.21] mu mol/L; median [25th-75th quartile]). The association between MMA levels and HIBCH rs291466 was highly significant in a replication cohort of 1,481 older individuals (median age 79 years) with elevated plasma MMA concentrations (0.34 [0.24-0.51] mu mol/L; p = 4.0 x 10(-26)). In a longitudinal study of 185 pregnant women and their newborns, the association of this SNP remained significant across the gestational trimesters and in newborns. HIBCH is unique to valine catabolism. Studies evaluating flux through the valine catabolic pathway in humans should account for these variants. Furthermore, this SNP could help resolve equivocal clinical tests where plasma MMA values have been used to diagnose cobalamin deficiency.	[Molloy, Anne M.] Univ Dublin, Trinity Coll Dublin, Sch Med, Dept Clin Med, Dublin 2, Ireland; [Pangilinan, Faith; O'Neill, Mary B.; McGaughey, David M.; Velkova, Aneliya; Abaan, Hatice Ozel; Brody, Lawrence C.] NHGRI, Med Genom & Metab Genet Branch, Bethesda, MD 20892 USA; [Mills, James L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Intramural Populat Hlth Res, Bethesda, MD 20892 USA; [Shane, Barry] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Ueland, Per M.] Univ Bergen, Inst Med, Pharmacol Sect, N-5021 Bergen, Norway; [Ueland, Per M.] Haukeland Hosp, N-5021 Bergen, Norway; [McNulty, Helene; Ward, Mary; Strain, J. J.] Univ Ulster, Northern Ireland Ctr Food & Hlth, Coleraine BT52 1SA, Londonderry, North Ireland; [Cunningham, Conal; Casey, Miriam] St James Hosp, Dublin 8, Ireland; [Cropp, Cheryl D.; Kim, Yoonhee; Bailey-Wilson, Joan E.; Wilson, Alexander F.] NHGRI, Computat & Stat Genom Branch, Bethesda, MD 20892 USA; [Cropp, Cheryl D.] Translat Genom Res Inst TGen, Phoenix, AZ 85004 USA; [Kim, Yoonhee] Macrogen, Rockville, MD 20850 USA	Trinity College Dublin; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California Berkeley; University of Bergen; Ulster University; Trinity College Dublin; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Translational Genomics Research Institute	Molloy, AM (corresponding author), Univ Dublin, Trinity Coll Dublin, Sch Med, Dept Clin Med, Dublin 2, Ireland.; Brody, LC (corresponding author), NHGRI, Med Genom & Metab Genet Branch, Bethesda, MD 20892 USA.	amolloy@tcd.ie; lbrody@mail.nih.gov	Wilson, Alexander F./Q-6910-2019; Ueland, Per M/C-7340-2013	McNulty, Helene/0000-0002-4366-6457; Ueland, Per Magne/0000-0002-1903-0571; Mills, James/0000-0003-4496-332X; Bailey-Wilson, Joan/0000-0002-9153-2920; Cropp, Cheryl/0000-0001-7662-9567; McGaughey, David/0000-0002-9224-2888	National Human Genome Research Institute (NHGRI); Eunice Kennedy Shriver National Institute of Child Health and Human Development of the NIH; Health Research Board, Dublin; NHGRI; Irish Department of Agriculture, Food and the Marine's Food Institutional Research Measure initiative; Northern Ireland Department for Employment and Learning under the Cross-Border Research and Development Programme "Strengthening the all-Island Research Base"; Axis-Shield Diagnostics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD002502] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000200, ZIAHG000167, ZIAHG200327] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Eunice Kennedy Shriver National Institute of Child Health and Human Development of the NIH; Health Research Board, Dublin; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Irish Department of Agriculture, Food and the Marine's Food Institutional Research Measure initiative; Northern Ireland Department for Employment and Learning under the Cross-Border Research and Development Programme "Strengthening the all-Island Research Base"; Axis-Shield Diagnostics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors acknowledge the contributions made by the participants in the Trinity Student Study, the Trinity Ulster Department of Agriculture study, and the longitudinal pregnancy study. The TSS GWAS work was supported in part by the Intramural Research Programs of the National Human Genome Research Institute (NHGRI), the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the NIH, and the Health Research Board, Dublin. This study utilized the high-performance computational capabilities of the Biowulf Linux cluster at the NIH (https://hpc.nih.gov/systems). C.D.C. is the recipient of an NHGRI Health Disparities Research Fellowship. The TUDA study was funded by the Irish Department of Agriculture, Food and the Marine's Food Institutional Research Measure initiative and the Northern Ireland Department for Employment and Learning under the Cross-Border Research and Development Programme "Strengthening the all-Island Research Base." Holotranscobalamin and methylmalonic acid measurements in the TUDA cohort were sponsored by Axis-Shield Diagnostics.	Akizu N, 2013, AM J HUM GENET, V92, P392, DOI 10.1016/j.ajhg.2013.02.004; Alfares A, 2011, J MED GENET, V48, P602, DOI 10.1136/jmedgenet-2011-100230; Allen LH, 2009, AM J CLIN NUTR, V89, p693S, DOI 10.3945/ajcn.2008.26947A; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Baik HW, 1999, ANNU REV NUTR, V19, P357, DOI 10.1146/annurev.nutr.19.1.357; Bailey RL, 2013, AM J CLIN NUTR, V98, P460, DOI 10.3945/ajcn.113.061234; Bailey RL, 2011, AM J CLIN NUTR, V94, P552, DOI 10.3945/ajcn.111.015222; Banerjee R., 1999, Chemistry and biochemistry of B12., P707; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Brady J, 2008, CLIN CHEM, V54, P567, DOI 10.1373/clinchem.2007.096784; BROWN GK, 1982, PEDIATRICS, V70, P532; Carmel R, 2011, AM J CLIN NUTR, V94, DOI 10.3945/ajcn.111.013441; Carter TC, 2015, J NUTR, V145, P1386, DOI 10.3945/jn.114.208769; Clarke R, 2003, AM J CLIN NUTR, V77, P1241, DOI 10.1093/ajcn/77.5.1241; Desch KC, 2013, P NATL ACAD SCI USA, V110, P588, DOI 10.1073/pnas.1219885110; Ferdinandusse S, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-188; Gradinger Abigail B, 2007, Hum Mutat, V28, P1045, DOI 10.1002/humu.9507; Grarup N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003530; Hazra A, 2008, NAT GENET, V40, P1160, DOI 10.1038/ng.210; Herrmann W, 2005, CURR DRUG METAB, V6, P47, DOI 10.2174/1389200052997384; Holleland G, 1999, CLIN CHEM, V45, P189; Johnson MA, 2003, AM J CLIN NUTR, V77, P211, DOI 10.1093/ajcn/77.1.211; KELLEHER BP, 1987, CLIN CHEM, V33, P52; Laird E, 2014, J CLIN ENDOCR METAB, V99, P1807, DOI 10.1210/jc.2013-3507; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; LETTO J, 1986, BIOCHEM J, V240, P909, DOI 10.1042/bj2400909; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lin XL, 2012, HUM MOL GENET, V21, P2610, DOI 10.1093/hmg/dds062; LINDENBAUM J, 1994, AM J CLIN NUTR, V60, P2, DOI 10.1093/ajcn/60.1.2; Lonati S, 2004, CLIN CHEM LAB MED, V42, P228, DOI 10.1515/CCLM.2004.041; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Loupatty FJ, 2007, AM J HUM GENET, V80, P195, DOI 10.1086/510725; Ludwig ML, 1997, ANNU REV BIOCHEM, V66, P269, DOI 10.1146/annurev.biochem.66.1.269; Marcadier JL, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-98; Mills JL, 2011, AM J CLIN NUTR, V94, P495, DOI 10.3945/ajcn.111.014621; Monsen ALB, 2003, AM J CLIN NUTR, V78, P7, DOI 10.1093/ajcn/78.1.7; Monsen ALB, 2001, PEDIATRICS, V108, P624, DOI 10.1542/peds.108.3.624; MONTGOMERY JA, 1983, J CLIN INVEST, V72, P1937, DOI 10.1172/JCI111158; Morris MS, 2002, J NUTR, V132, P2799, DOI 10.1093/jn/132.9.2799; Murphy MM, 2007, J NUTR, V137, P1863, DOI 10.1093/jn/137.8.1863; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; PENNYPACKER LC, 1992, J AM GERIATR SOC, V40, P1197, DOI 10.1111/j.1532-5415.1992.tb03641.x; Peters H, 2015, MOL GENET METAB, V115, P168, DOI 10.1016/j.ymgme.2015.06.008; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raffler J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005487; Ramalho AS, 2009, CELL PHYSIOL BIOCHEM, V24, P335, DOI 10.1159/000257426; RASMUSSEN K, 1990, CLIN CHEM, V36, P1295; Reynolds E, 2006, LANCET NEUROL, V5, P949, DOI 10.1016/S1474-4422(06)70598-1; SAVAGE DG, 1994, AM J MED, V96, P239, DOI 10.1016/0002-9343(94)90149-X; SHIMOMURA Y, 1994, J BIOL CHEM, V269, P14248; Sloan JL, 2011, NAT GENET, V43, P883, DOI 10.1038/ng.908; Sobczynska-Malefora A, 2014, CLIN BIOCHEM, V47, P82, DOI 10.1016/j.clinbiochem.2013.08.006; Stabler SP, 1996, J NUTR, V126, pS1266, DOI 10.1093/jn/126.suppl_4.1266S; Tanaka T, 2009, AM J HUM GENET, V84, P477, DOI 10.1016/j.ajhg.2009.02.011; Taniguchi K, 1996, HEPATOLOGY, V24, P1395, DOI 10.1053/jhep.1996.v24.pm0008938168; Valayannopoulos V, 2010, MITOCHONDRION, V10, P335, DOI 10.1016/j.mito.2010.02.006; Valente E, 2011, CLIN CHEM, V57, P856, DOI 10.1373/clinchem.2010.158154; Van Hove JLK, 2010, PEDIATR RES, V68, P159, DOI 10.1203/00006450-201011001-00310; Villalpando S, 2008, FOOD NUTR BULL, V29, pS112, DOI 10.1177/15648265080292S114; Vogiatzoglou A, 2009, CLIN CHEM, V55, P2198, DOI 10.1373/clinchem.2009.128678; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Windelberg A, 2005, CLIN CHEM, V51, P2103, DOI 10.1373/clinchem.2005.053835	63	31	32	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 5	2016	98	5					869	882		10.1016/j.ajhg.2016.03.005	http://dx.doi.org/10.1016/j.ajhg.2016.03.005			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DL8DF	27132595	Green Published, Bronze			2022-12-18	WOS:000375869300006
J	Kuschal, C; Botta, E; Orioli, D; Digiovanna, JJ; Seneca, S; Keymolen, K; Tamura, D; Heller, E; Khan, SG; Caligiuri, G; Lanzafame, M; Nardo, T; Ricotti, R; Peverali, FA; Stephens, R; Zhao, YM; Lehmann, AR; Baranello, L; Levens, D; Kraemer, KH; Stefanini, M				Kuschal, Christiane; Botta, Elena; Orioli, Donata; Digiovanna, John J.; Seneca, Sara; Keymolen, Kathelijn; Tamura, Deborah; Heller, Elizabeth; Khan, Sikandar G.; Caligiuri, Giuseppina; Lanzafame, Manuela; Nardo, Tiziana; Ricotti, Roberta; Peverali, Fiorenzo A.; Stephens, Robert; Zhao, Yongmei; Lehmann, Alan R.; Baranello, Laura; Levens, David; Kraemer, Kenneth H.; Stefanini, Miria			GTF2E2 Mutations Destabilize the General Transcription Factor Complex TFIIE in Individuals with DNA Repair-Proficient Trichothiodystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							C7ORF11 TTDN1 GENE; XERODERMA-PIGMENTOSUM; BASAL TRANSCRIPTION; EXCISION-REPAIR; TERMINAL DOMAIN; XPD MUTATIONS; BETA-SUBUNIT; HELICASE; ELONGATION; INITIATION	The general transcription factor IIE (TFIIE) is essential for transcription initiation by RNA polymerase II (RNA pol II) via direct interaction with the basal transcription/DNA repair factor IIH (TFIIH). TFIIH harbors mutations in two rare genetic disorders, the cancer-prone xeroderma pigmentosum (XP) and the cancer-free, multisystem developmental disorder trichothiodystrophy (TTD). The phenotypic complexity resulting from mutations affecting TFIIH has been attributed to the nucleotide excision repair (NER) defect as well as to impaired transcription. Here, we report two unrelated children showing clinical features typical of TTD who harbor different homozygous missense mutations in GTF2E2 (c.448G>C [p.A1a150Pro] and c.559G>T [p.Asp187Tyr]) encoding the beta subunit of transcription factor IIE (TFIIE beta). Repair of ultraviolet-induced DNA damage was normal in the GTF2E2 mutated cells, indicating that TFIIE was not involved in NER. We found decreased protein levels of the two TFIIE subunits (TFIIE alpha and TFIIE beta) as well as decreased phosphorylation of TFIIE alpha in cells from both children. Interestingly, decreased phosphorylation of TFIIE alpha was also seen in TTD cells with mutations in ERCC2, which encodes the XPD subunit of TFIIH, but not in XP cells with ERCC2 mutations. Our findings support the theory that TTD is caused by transcriptional impairments that are distinct from the NER disorder XP.	[Kuschal, Christiane; Digiovanna, John J.; Tamura, Deborah; Heller, Elizabeth; Khan, Sikandar G.; Kraemer, Kenneth H.] NCI, Dermatol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA; [Botta, Elena; Orioli, Donata; Caligiuri, Giuseppina; Lanzafame, Manuela; Nardo, Tiziana; Ricotti, Roberta; Peverali, Fiorenzo A.; Stefanini, Miria] CNR, Ist Genet Mol, Via Abbiategrasso 207, I-27100 Pavia, Italy; [Seneca, Sara; Keymolen, Kathelijn] Vrije Univ Brussel, UZ Brussel, Res Grp Reprod & Genet, Ctr Med Genet, Laarbeeklaan 101, B-1090 Brussels, Belgium; [Stephens, Robert] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Cancer Res Technol Program, Frederick, MD 21702 USA; [Stephens, Robert; Zhao, Yongmei] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Adv Biomed Comp Ctr, Frederick, MD 21702 USA; [Lehmann, Alan R.] Univ Sussex, Sch Life Sci, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; [Baranello, Laura; Levens, David] NCI, Pathol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA; [Kuschal, Christiane] Natl Univ Singapore, Canc Sci Inst, 14 Med Dr, Singapore 117599, Singapore	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University Hospital Brussels; Vrije Universiteit Brussel; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Sussex; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National University of Singapore	Kraemer, KH (corresponding author), NCI, Dermatol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.; Stefanini, M (corresponding author), CNR, Ist Genet Mol, Via Abbiategrasso 207, I-27100 Pavia, Italy.	kraemerk@nih.gov; stefanini@igm.cnr.it	Levens, David/C-9216-2009; Botta, Elena/B-9065-2015; Lanzafame, Manuela/Q-2353-2018; BOTTA, ELENA/O-3892-2019	Levens, David/0000-0002-7616-922X; Lanzafame, Manuela/0000-0002-0456-1134; BOTTA, ELENA/0000-0003-2060-0110; Caligiuri, Giuseppina/0000-0001-8798-8418; KHAN, SIKANDAR/0000-0001-9957-4132; Seneca, Sara/0000-0002-0853-9890; DiGiovanna, John J./0000-0002-2750-2313; Keymolen, Kathelijn/0000-0002-7349-641X; Kuschal, Christiane/0000-0001-6113-3585; Baranello, Laura/0000-0001-6039-1849; Kraemer, Kenneth/0000-0002-2689-3316	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; Associazione Italiana per la Ricerca sul Cancro Grant [IG 13537, IG 17710]; Telethon Grant [GEP13022]; NATIONAL CANCER INSTITUTE [ZIABC004517] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Associazione Italiana per la Ricerca sul Cancro Grant(Fondazione AIRC per la ricerca sul cancro); Telethon Grant(Fondazione Telethon); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research (C.K., K.H.K., J.J.D., S.G.K., D.T., D.L., L.B., R.S.), the Associazione Italiana per la Ricerca sul Cancro Grant IG 13537 (M.S.), and IG 17710 (D.O.) and Telethon Grant GEP13022 (E.B.). We thank Dr. Wei Yang (NIDDK, NIH) for the schematic image of TFIIE mutations, Russell Bandle (NCI) for helpful suggestions in the procedure of nuclear protein isolation, and Heather Fawcett (Sussex University) for technical assistance. We would also like to thank the Genomics Laboratory and CCR Sequencing Facility at Frederick National Laboratory for Cancer Research including Dan Soppett and Kristen Pike for DNA target preparation, Bao Tran for performing the sequencing, Ming Yi for help perfecting the GATK workflow, and Shashi Ratanayke and Keyur Talsania for assistance running the analysis.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arseni L, 2015, P NATL ACAD SCI USA, V112, P1499, DOI 10.1073/pnas.1416181112; Assfalg R, 2012, NUCLEIC ACIDS RES, V40, P650, DOI 10.1093/nar/gkr746; Backendorf C, 2005, DNA REPAIR, V4, P1325, DOI 10.1016/j.dnarep.2005.07.011; Botta E, 2002, HUM MOL GENET, V11, P2919, DOI 10.1093/hmg/11.23.2919; Botta E, 2007, HUM MUTAT, V28, P92, DOI 10.1002/humu.20419; Botta E, 2009, HUM MUTAT, V30, P438, DOI 10.1002/humu.20912; Boyle J, 2008, HUM MUTAT, V29, P1194, DOI 10.1002/humu.20768; Compe E, 2005, MOL CELL BIOL, V25, P6065, DOI 10.1128/MCB.25.14.6065-6076.2005; Compe E, 2007, NAT NEUROSCI, V10, P1414, DOI 10.1038/nn1990; Compe E, 2012, NAT REV MOL CELL BIO, V13, P343, DOI 10.1038/nrm3350; Corbett MA, 2015, J MED GENET, V52, P269, DOI 10.1136/jmedgenet-2014-102418; de Boer J, 1998, MOL CELL, V1, P981, DOI 10.1016/S1097-2765(00)80098-2; DiGiovanna JJ, 2012, J INVEST DERMATOL, V132, P785, DOI 10.1038/jid.2011.426; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; Dubaele S, 2003, MOL CELL, V11, P1635, DOI 10.1016/S1097-2765(03)00182-5; Egly JM, 2011, DNA REPAIR, V10, P714, DOI 10.1016/j.dnarep.2011.04.021; Faghri S, 2008, J MED GENET, V45, P609, DOI 10.1136/jmg.2008.058743; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Giglia-Mari G, 2004, NAT GENET, V36, P714, DOI 10.1038/ng1387; Grunberg S, 2012, NAT STRUCT MOL BIOL, V19, P788, DOI 10.1038/nsmb.2334; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Heller ER, 2015, J INVEST DERMATOL, V135, P734, DOI 10.1038/jid.2014.440; Imoto K, 2002, J INVEST DERMATOL, V119, P1177, DOI 10.1046/j.1523-1747.2002.19514.x; Khan SG, 2002, NUCLEIC ACIDS RES, V30, P3624, DOI 10.1093/nar/gkf469; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kuschal C, 2013, P NATL ACAD SCI USA, V110, P19483, DOI 10.1073/pnas.1312088110; Larochelle S, 2012, NAT STRUCT MOL BIOL, V19, P1108, DOI 10.1038/nsmb.2399; Lehmann AR, 2008, DNA REPAIR, V7, P1912, DOI 10.1016/j.dnarep.2008.07.008; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang C, 2005, J AM ACAD DERMATOL, V52, P224, DOI 10.1016/j.jaad.2004.09.013; Lin YC, 2005, NUCLEIC ACIDS RES, V33, P3072, DOI 10.1093/nar/gki623; Liu H, 2008, CELL, V133, P801, DOI 10.1016/j.cell.2008.04.029; LU H, 1992, NATURE, V358, P641, DOI 10.1038/358641a0; Nakabayashi K, 2005, AM J HUM GENET, V76, P510, DOI 10.1086/428141; Nonnekens J, 2013, HUM MOL GENET, V22, P2881, DOI 10.1093/hmg/ddt143; Oh KS, 2006, HUM MUTAT, V27, P1092, DOI 10.1002/humu.20392; OHKUMA Y, 1994, NATURE, V368, P160, DOI 10.1038/368160a0; OHKUMA Y, 1995, MOL CELL BIOL, V15, P4856; Okamoto T, 1998, J BIOL CHEM, V273, P19866, DOI 10.1074/jbc.273.31.19866; Okuda M, 2004, J BIOL CHEM, V279, P51395, DOI 10.1074/jbc.M404722200; Okuda M, 2000, EMBO J, V19, P1346, DOI 10.1093/emboj/19.6.1346; Orioli D, 2006, MOL BIOL CELL, V17, P2391, DOI 10.1091/mbc.E05-08-0753; Orioli D, 2013, HUM MOL GENET, V22, P1061, DOI 10.1093/hmg/dds508; Park JY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002346; Racioppi L, 2001, CLIN EXP IMMUNOL, V126, P511, DOI 10.1046/j.1365-2249.2001.01625.x; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; STEFANINI M, 1986, HUM GENET, V73, P189, DOI 10.1007/BF00401225; STEFANINI M, 1986, HUM GENET, V74, P107, DOI 10.1007/BF00282072; STEFANINI M, 1992, MUTAT RES, V273, P119, DOI 10.1016/0921-8777(92)90073-C; Stefanini M, 1996, HUM GENET, V97, P418; STEFANINI M, 1993, AM J HUM GENET, V53, P817; Stefanini M, 2010, DNA REPAIR, V9, P2, DOI 10.1016/j.dnarep.2009.10.005; Tamura D, 2011, PRENATAL DIAG, V31, P1046, DOI 10.1002/pd.2829; Tanaka A, 2015, GENES CELLS, V20, P203, DOI 10.1111/gtc.12212; Traboulsi H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004732; Ueda T, 2009, J EXP MED, V206, P3031, DOI 10.1084/jem.20091892; Vermeulen W, 2001, NAT GENET, V27, P299, DOI 10.1038/85864; Viprakasit V, 2001, HUM MOL GENET, V10, P2797, DOI 10.1093/hmg/10.24.2797; Watanabe T, 2003, MOL CELL BIOL, V23, P2914, DOI 10.1128/MCB.23.8.2914-2926.2003; Zhang Y, 2007, CELL MOL LIFE SCI, V64, P632, DOI 10.1007/s00018-007-6501-8; Zhou XL, 2013, EUR J HUM GENET, V21, P831, DOI 10.1038/ejhg.2012.246	62	31	32	2	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 7	2016	98	4					627	642		10.1016/j.ajhg.2016.02.008	http://dx.doi.org/10.1016/j.ajhg.2016.02.008			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DJ4UO	26996949	Green Published, Bronze			2022-12-18	WOS:000374203800003
J	Brand, H; Collins, RL; Hanscom, C; Rosenfeld, JA; Pillalamarri, V; Stone, MR; Kelley, F; Mason, T; Margolin, L; Eggert, S; Mitchell, E; Hodge, JC; Gusella, JF; Sanders, SJ; Talkowski, ME				Brand, Harrison; Collins, Ryan L.; Hanscom, Carrie; Rosenfeld, Jill A.; Pillalamarri, Vamsee; Stone, Matthew R.; Kelley, Fontina; Mason, Tamara; Margolin, Lauren; Eggert, Stacey; Mitchell, Elyse; Hodge, Jennelle C.; Gusella, James F.; Sanders, Stephan J.; Talkowski, Michael E.			Paired-Duplication Signatures Mark Cryptic Inversions and Other Complex Structural Variation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPY NUMBER VARIATION; CHROMOSOMAL MICROARRAY; REVEALS; REARRANGEMENTS; IDENTIFICATION; POPULATION; GENES; RISK; CNVS	Copy-number variants (CNVs) have been the predominant focus of genetic studies of structural variation, and chromosomal microarray (CMA) for genome-wide CNV detection is the recommended first-tier genetic diagnostic screen in neurodevelopmental disorders. We compared CNVs observed by CMA to the structural variation detected by whole-genome large-insert sequencing in 259 individuals diagnosed with autism spectrum disorder (ASD) from the Simons Simplex Collection. These analyses revealed a diverse landscape of complex duplications in the human genome. One remarkably common class of complex rearrangement, which we term dupINVdup, involves two closely located duplications ("paired duplications") that flank the breakpoints of an inversion. This complex variant class is cryptic to CMA, but we observed it in 8.1% of all subjects. We also detected other paired-duplication signatures and duplication-mediated complex rearrangements in 15.8% of all ASD subjects. Breakpoint analysis showed that the predominant mechanism of formation of these complex duplication-associated variants was microhomology-mediated repair. On the basis of the striking prevalence of dupINVdups in this cohort, we explored the landscape of all inversion variation among the 235 highest-quality libraries and found abundant complexity among these variants: only 39.3% of inversions were canonical, or simple, inversions without additional rearrangement. Collectively, these findings indicate that dupINVdups, as well as other complex duplication-associated rearrangements, represent relatively common sources of genomic variation that is cryptic to population-based microarray and low-depth whole-genome sequencing. They also suggest that paired-duplication signatures detected by CMA warrant further scrutiny in genetic diagnostic testing given that they might mark complex rearrangements of potential clinical relevance.	[Brand, Harrison; Collins, Ryan L.; Hanscom, Carrie; Pillalamarri, Vamsee; Stone, Matthew R.; Eggert, Stacey; Gusella, James F.; Talkowski, Michael E.] Massachusetts Gen Hosp, Mol Neurogenet Unit, Ctr Human Genet Res, Boston, MA 02114 USA; [Brand, Harrison; Collins, Ryan L.; Hanscom, Carrie; Pillalamarri, Vamsee; Stone, Matthew R.; Eggert, Stacey; Gusella, James F.; Talkowski, Michael E.] Massachusetts Gen Hosp, Ctr Human Genet Res, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Brand, Harrison; Talkowski, Michael E.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02114 USA; [Rosenfeld, Jill A.] PerkinElmer Inc, Signature Genom Labs, Spokane, WA 99207 USA; [Kelley, Fontina; Mason, Tamara; Margolin, Lauren; Gusella, James F.; Talkowski, Michael E.] Broad Inst Harvard & MIT, Program Med & Populat Genet & Genom Platform, Cambridge, MA 02141 USA; [Mitchell, Elyse; Hodge, Jennelle C.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Hodge, Jennelle C.] Cedars Sinai Med Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90048 USA; [Gusella, James F.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Sanders, Stephan J.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94103 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Mayo Clinic; Cedars Sinai Medical Center; Harvard University; Harvard Medical School; University of California System; University of California San Francisco	Talkowski, ME (corresponding author), Massachusetts Gen Hosp, Mol Neurogenet Unit, Ctr Human Genet Res, Boston, MA 02114 USA.	talkowski@chgr.mgh.harvard.edu	Sanders, Stephan/S-8645-2019; Hodge, Jennelle/AAW-5082-2020	Collins, Ryan/0000-0003-1268-9995; Sanders, Stephan/0000-0001-9112-5148; Talkowski, Michael/0000-0003-2889-0992	Simons Foundation for Autism Research [SFARI 238504]; Nancy Lurie Marks Family Foundation; March of Dimes; Charles Hood Foundation; Brain & Behavioral Research Foundation; National Institute of Mental Health [R00MH095867, GM061354]; National Institute of Child Health and Human Development [HD007396]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH095867] Funding Source: NIH RePORTER	Simons Foundation for Autism Research; Nancy Lurie Marks Family Foundation; March of Dimes(March of Dimes); Charles Hood Foundation; Brain & Behavioral Research Foundation; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to all of the families at the participating Simons Simplex Collection sites, as well as the principal investigators (A. Beaudet, R. Bernier, J. Constantino, E. Cook, E. Fombonne, D. Geschwind, R. Goin-Kochel, E. Hanson, D. Grice, A. Kiln, D. Ledbetter, C. Lord, C. Martin, D. Martin, R. Maxim, J. Miles, O. Ousley, K. Pelphrey, B. Peterson, J. Piggot, C. Saulnier, M. State, W. Stone, J. Sutcliffe, C. Walsh, Z. Warren, and E. Wijsman). We also thank Matthew State, Bernie Devlin, and Kathryn Roeder for contributing to the generation and analysis of the microarray copy-number-variant data and Patricia Greipp for coordinating efforts at the Mayo Clinic. We thank Dr. Lisa Shaffer, formerly of Signature Genomics, and Dr. Yiping Shen of Boston Children's Hospital for making the clinical diagnostic chromosomal-microarray data available to us. This work was supported by funding from the Simons Foundation for Autism Research (SFARI 238504), the Nancy Lurie Marks Family Foundation, the March of Dimes, the Charles Hood Foundation, the Brain & Behavioral Research Foundation, and the National Institute of Mental Health (R00MH095867 and GM061354) to M.E.T. H.B. is supported by a T32 fellowship from the National Institute of Child Health and Human Development (HD007396).	American College of Obstetricians and Gynecologists Committee on Genetics, 2013, Obstet Gynecol, V122, P1374, DOI 10.1097/01.AOG.0000438962.16108.d1; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Beunders G, 2013, AM J HUM GENET, V92, P210, DOI 10.1016/j.ajhg.2012.12.011; Brand H, 2014, AM J HUM GENET, V95, P454, DOI 10.1016/j.ajhg.2014.09.005; Chiang C, 2012, NAT GENET, V44, P390, DOI 10.1038/ng.2202; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Drabova J, 2014, MOL CYTOGENET, V7, DOI 10.1186/1755-8166-7-51; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Girirajan S, 2013, HUM MOL GENET, V22, P2870, DOI 10.1093/hmg/ddt136; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Hanscom C., 2014, CURR PROTOC HUM GENE, V80, P1; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Klambauer G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks003; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Layer RM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r84; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Newman S, 2015, AM J HUM GENET, V96, P208, DOI 10.1016/j.ajhg.2014.12.017; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; SCHROTH GP, 1995, NUCLEIC ACIDS RES, V23, P1977, DOI 10.1093/nar/23.11.1977; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sultana R, 2002, GENOMICS, V80, P129, DOI 10.1006/geno.2002.6810; Talkowski ME, 2012, NEW ENGL J MED, V367, P2226, DOI 10.1056/NEJMoa1208594; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Talkowski ME, 2011, AM J HUM GENET, V88, P469, DOI 10.1016/j.ajhg.2011.03.013; Wapner RJ, 2012, NEW ENGL J MED, V367, P2175, DOI 10.1056/NEJMoa1203382; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399	31	31	33	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 2	2015	97	1					170	176		10.1016/j.ajhg.2015.05.012	http://dx.doi.org/10.1016/j.ajhg.2015.05.012			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN1OO	26094575	Bronze, Green Published			2022-12-18	WOS:000358189500015
J	Carvalho, CMB; Vasanth, S; Shinawi, M; Russell, C; Ramocki, MB; Brown, CW; Graakjaer, J; Skytte, AB; Vianna-Morgante, AM; Krepischi, ACV; Patel, GS; Immken, L; Aleck, K; Lim, C; Cheung, SW; Rosenberg, C; Katsanis, N; Lupski, JR				Carvalho, Claudia M. B.; Vasanth, Shivakumar; Shinawi, Marwan; Russell, Chad; Ramocki, Melissa B.; Brown, Chester W.; Graakjaer, Jesper; Skytte, Anne-Bine; Vianna-Morgante, Angela M.; Krepischi, Ana C. V.; Patel, Gayle S.; Immken, LaDonna; Aleck, Kyrieckos; Lim, Cynthia; Cheung, Sau Wai; Rosenberg, Carla; Katsanis, Nicholas; Lupski, James R.			Dosage Changes of a Segment at 17p13.1 Lead to Intellectual Disability and Microcephaly as a Result of Complex Genetic Interaction of Multiple Genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACYL-COA DEHYDROGENASE; RECEPTOR; MUTATIONS; DELETIONS; MICRODELETION; MECHANISMS; FEATURES; GABARAP; HAPLOINSUFFICIENCY; MICRODUPLICATION	The 17p13.1 microdeletion syndrome is a recently described genomic disorder with a core clinical phenotype of intellectual disability, poor to absent speech, dysmorphic features, and a constellation of more variable clinical features, most prominently microcephaly. We identified five subjects with copy-number variants (CNVs) on 17p13.1 for whom we performed detailed clinical and molecular studies. Breakpoint mapping and retrospective analysis of published cases refined the smallest region of overlap (SRO) for microcephaly to a. genomic interval containing nine genes. Dissection of this phenotype in zebrafish embryos revealed a complex genetic architecture: dosage perturbation of four genes (ASGR1, ACADVL, DVL2, and GABARAP) impeded neurodevelopment and decreased dosage of the same loci caused a reduced mitotic index in vitro. Moreover, epistatic analyses in vivo showed that dosage perturbations of discrete gene pairings induce microcephaly. Taken together, these studies support a model in which concomitant dosage perturbation of multiple genes within the CNV drive the microcephaly and possibly other neurodevelopmental phenotypes associated with rearrangements in the 17p13.1 SRO.	[Carvalho, Claudia M. B.; Brown, Chester W.; Cheung, Sau Wai; Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Carvalho, Claudia M. B.] Ctr Pesquisas Rene Rachou FIOCRUZ, BR-30190002 Belo Horizonte, MG, Brazil; [Vasanth, Shivakumar; Russell, Chad; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Shinawi, Marwan] Washington Univ, Div Genet & Genom Med, Dept Pediat, St Louis, MO 63110 USA; [Ramocki, Melissa B.; Brown, Chester W.; Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Ramocki, Melissa B.; Brown, Chester W.; Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA; [Graakjaer, Jesper; Skytte, Anne-Bine] Vejle Hosp, Clin Genet Dept, DK-7100 Vejle, Denmark; [Vianna-Morgante, Angela M.; Krepischi, Ana C. V.; Rosenberg, Carla] Univ Sao Paulo, Biosci Inst, Dept Genet & Evolutionary Biol, BR-05508090 Sao Paulo, Brazil; [Patel, Gayle S.] Texas Oncol, Austin, TX 78731 USA; [Immken, LaDonna] Specially Children, Austin, TX 78723 USA; [Aleck, Kyrieckos; Lim, Cynthia] Phoenix Childrens Hosp, Phoenix, AZ 85006 USA	Baylor College of Medicine; Fundacao Oswaldo Cruz; Duke University; Washington University (WUSTL); Baylor College of Medicine; Baylor College of Medicine; University of Southern Denmark; Lillebaelt Hospital; Universidade de Sao Paulo; Texas Oncology; Phoenix Children's Hospital	Katsanis, N (corresponding author), Duke Univ, Ctr Human Dis Modeling, Durham, NC 27710 USA.	nicholas.katsanis@dm.duke.edu; jlupski@bcm.edu	rosenberg, carla/N-4148-2015; Krepischi, Ana C V/E-4976-2012	rosenberg, carla/0000-0003-3253-4448; Krepischi, Ana C V/0000-0003-2931-8605; Skytte, Anne-Bine/0000-0002-0067-9557; shinawi, Marwan/0000-0003-1329-4100; Katsanis, Nicholas/0000-0002-2480-0171	US National Institute of Neurological Disorders and Stroke (NINDS) [R01 NS058529, 5K08NS062711]; US National Human Genome Research Institute/National Heart Blood and Lung Institute (NHGRI/NHBLI) [U54HG006542]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), a Young Investigator fellowship from the Science without Borders Program [402520/2012-2]; Simons Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058529, K08NS062711] Funding Source: NIH RePORTER	US National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Human Genome Research Institute/National Heart Blood and Lung Institute (NHGRI/NHBLI); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), a Young Investigator fellowship from the Science without Borders Program; Simons Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the families for their participation in the study. This work was supported in part by US National Institute of Neurological Disorders and Stroke (NINDS) grants R01 NS058529 to J.R.L. and 5K08NS062711 to M.B.R.; US National Human Genome Research Institute/National Heart Blood and Lung Institute (NHGRI/NHBLI) grant U54HG006542 to J.R.L.; by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), a Young Investigator fellowship from the Science without Borders Program grant 402520/2012-2 to C.M.B.C.; and a grant from the Simons Foundation to N.K. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NINDS, NHGRI, NIH, or CNPq. J.R.L. holds stock ownership in 23andMe, Inc., and is a coinventor on multiple United States and European patents related to molecular diagnostics. The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from molecular genetic testing offered in the Medical Genetics Laboratories.	Adam MP, 2009, J PEDIATR, V154, P143, DOI 10.1016/j.jpeds.2008.07.045; Alcantara D, 2014, AM J MED GENET C, V166, P124, DOI 10.1002/ajmg.c.31397; AOYAMA T, 1994, J BIOL CHEM, V269, P19088; Belligni EF, 2012, EUR J MED GENET, V55, P222, DOI 10.1016/j.ejmg.2012.01.016; Beunders G, 2013, AM J HUM GENET, V92, P210, DOI 10.1016/j.ajhg.2012.12.011; Bi WM, 2009, NAT GENET, V41, P168, DOI 10.1038/ng.302; Boone PM, 2014, AM J HUM GENET, V95, P143, DOI 10.1016/j.ajhg.2014.06.014; Boone PM, 2010, HUM MUTAT, V31, P1326, DOI 10.1002/humu.21360; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Carvalho CMB, 2013, NAT GENET, V45, P1319, DOI 10.1038/ng.2768; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Chen L, 2000, P NATL ACAD SCI USA, V97, P11557, DOI 10.1073/pnas.190133497; Chen ZW, 2007, J NEUROCHEM, V100, P279, DOI 10.1111/j.1471-4159.2006.04206.x; Coutton C, 2012, AM J MED GENET A, V158A, P2564, DOI 10.1002/ajmg.a.35553; Dauber A, 2013, AM J HUM GENET, V93, P798, DOI 10.1016/j.ajhg.2013.09.010; Deem A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000594; Everitt AB, 2004, J BIOL CHEM, V279, P21701, DOI 10.1074/jbc.M312806200; Fritschy JM, 2003, PHARMACOL THERAPEUT, V98, P299, DOI 10.1016/S0163-7258(03)00037-8; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Hicks WM, 2010, SCIENCE, V329, P82, DOI 10.1126/science.1191125; Kabuyama Y, 2010, AM J PHYSIOL-CELL PH, V298, pC107, DOI 10.1152/ajpcell.00231.2009; Kamp C, 2000, HUM MOL GENET, V9, P2563, DOI 10.1093/hmg/9.17.2563; Karaca E, 2014, CELL, V157, P636, DOI 10.1016/j.cell.2014.02.058; Kikuchi K, 2010, EMBO J, V29, P3470, DOI 10.1038/emboj.2010.221; Kleefstra T, 2006, AM J HUM GENET, V79, P370, DOI 10.1086/505693; Komoike Y, 2010, J HUM GENET, V55, P155, DOI 10.1038/jhg.2010.1; Krepischi-Santos ACV, 2009, CYTOGENET GENOME RES, V125, P1, DOI 10.1159/000218743; Kurotaki N, 2002, NAT GENET, V30, P365, DOI 10.1038/ng863; Lainhart JE, 2006, AM J MED GENET A, V140A, P2257, DOI 10.1002/ajmg.a.31465; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Legido A, 2013, SEMIN PEDIATR NEUROL, V20, P163, DOI 10.1016/j.spen.2013.10.008; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Ma PX, 2013, J BIOL CHEM, V288, P37204, DOI 10.1074/jbc.M113.528067; McDonell LM, 2013, NAT GENET, V45, P556, DOI 10.1038/ng.2602; Niederriter AR, 2013, JOVE-J VIS EXP, DOI 10.3791/50338; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Potocki L, 2007, AM J HUM GENET, V80, P633, DOI 10.1086/512864; Pulvirenti T, 2011, CANCER RES, V71, P7280, DOI 10.1158/0008-5472.CAN-11-1531; Schluth-Bolard C, 2010, AM J MED GENET A, V152A, P1278, DOI 10.1002/ajmg.a.33316; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; Schwarzbraun T, 2009, J MED GENET, V46, P341, DOI 10.1136/jmg.2008.064972; Sereda M, 1996, NEURON, V16, P1049, DOI 10.1016/S0896-6273(00)80128-2; Shinawi M, 2010, J MED GENET, V47, P332, DOI 10.1136/jmg.2009.073015; Shlien A, 2010, AM J HUM GENET, V87, P631, DOI 10.1016/j.ajhg.2010.10.007; Shuvarikov A, 2013, HUM MUTAT, V34, P1415, DOI 10.1002/humu.22384; STOCKERT RJ, 1995, PHYSIOL REV, V75, P591, DOI 10.1152/physrev.1995.75.3.591; STRAUSS AW, 1995, P NATL ACAD SCI USA, V92, P10496, DOI 10.1073/pnas.92.23.10496; Sun C, 2000, HUM MOL GENET, V9, P2291, DOI 10.1093/oxfordjournals.hmg.a018920; Tremblay RG, 2010, J NEUROSCI METH, V186, P60, DOI 10.1016/j.jneumeth.2009.11.004; VANTUINEN P, 1988, AM J HUM GENET, V43, P587; Verdin H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003358; Vissers LELM, 2009, HUM MOL GENET, V18, P3579, DOI 10.1093/hmg/ddp306; Wang HB, 1999, NATURE, V397, P69, DOI 10.1038/16264; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6; Yamamoto S, 2014, CELL, V159, P200, DOI 10.1016/j.cell.2014.09.002; Zankl A, 2003, AM J MED GENET A, V121A, P146, DOI 10.1002/ajmg.a.20185; Zeesman S, 2012, AM J MED GENET A, V158A, P1832, DOI 10.1002/ajmg.a.35508	60	31	31	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 6	2014	95	5					565	578		10.1016/j.ajhg.2014.10.006	http://dx.doi.org/10.1016/j.ajhg.2014.10.006			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AT3OY	25439725	Green Published, Bronze			2022-12-18	WOS:000344845000007
J	Guo, Y; Wei, XM; Das, J; Grimson, A; Lipkin, SM; Clark, AG; Yu, HY				Guo, Yu; Wei, Xiaomu; Das, Jishnu; Grimson, Andrew; Lipkin, Steven M.; Clark, Andrew G.; Yu, Haiyuan			Dissecting Disease Inheritance Modes in a Three-Dimensional Protein Network Challenges the "Guilt-by-Association" Principle	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FIT BACKBONE REFINEMENT; MISSENSE MUTATIONS; INACTIVATING MUTATIONS; TRUNCATING MUTATIONS; INTERACTOME NETWORK; SOMATIC MUTATIONS; MOLECULAR DOCKING; BREAST-CANCER; GENES; DISORDERS	To better understand different molecular mechanisms by which mutations lead to various human diseases, we classified 82,833 disease-associated mutations according to their inheritance modes (recessive versus dominant) and molecular types (in-frame [missense point mutations and in-frame indels] versus truncating [nonsense mutations and frameshift indels]) and systematically examined the effects of different classes of disease mutations in a three-dimensional protein interactome network with the atomic-resolution interface resolved for each interaction. We found that although recessive mutations affecting the interaction interface of two interacting proteins tend to cause the same disease, this widely accepted "guilt-by-association" principle does not apply to dominant mutations. Furthermore, recessive truncating mutations in regions encoding the same interface are much more likely to cause the same disease, even for interfaces close to the N terminus of the protein. Conversely, dominant truncating mutations tend to be enriched in regions encoding areas between interfaces. These results suggest that a significant fraction of truncating mutations can generate functional protein products. For example, TRIM27, a known cancer-associated protein, interacts with three proteins (MID2, TRIM42, and SIRPA) through two different interfaces. A dominant truncating mutation (c.1024delT [p.Tyr342Thrfs*30]) associated with ovarian carcinoma is located between the regions encoding the two interfaces; the altered protein retains its interaction with MID2 and TRIM42 through the first interface but loses its interaction with SIRPA through the second interface. Our findings will help clarify the molecular mechanisms of thousands of disease-associated genes and their tens of thousands of mutations, especially for those carrying truncating mutations, often erroneously considered "knockout" alleles.	[Guo, Yu; Grimson, Andrew; Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Guo, Yu; Wei, Xiaomu; Das, Jishnu; Yu, Haiyuan] Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY 14853 USA; [Das, Jishnu; Clark, Andrew G.; Yu, Haiyuan] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Wei, Xiaomu; Lipkin, Steven M.] Cornell Univ, Dept Med, Weill Cornell Coll Med, New York, NY 10021 USA	Cornell University; Cornell University; Cornell University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Yu, HY (corresponding author), Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY 14853 USA.	haiyuan.yu@cornell.edu	Das, Jishnu/C-6924-2015; Das, Jishnu/AAK-4950-2020	Das, Jishnu/0000-0002-5747-064X; Das, Jishnu/0000-0002-5747-064X; Clark, Andrew/0000-0001-7159-8511	National Institutes of Health [R01 GM104424, R01 CA167824, R01 HG003229]; Weill Cornell Medical College Clinical and Translational Science Center Pilot Award; Cornell University Seed Grant; Cornell Presidential Life Sciences Fellowship; Tata Graduate Fellowship; NATIONAL CANCER INSTITUTE [R01CA167824] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104424] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Weill Cornell Medical College Clinical and Translational Science Center Pilot Award; Cornell University Seed Grant; Cornell Presidential Life Sciences Fellowship; Tata Graduate Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors wish to thank Nicolas A. Cordero for critical reading of the manuscript. This work was supported by National Institutes of Health grants R01 GM104424 (to H.Y. and S.M.L.), R01 CA167824 (to H.Y. and S.M.L.), and R01 HG003229 (to A.G.C.); by the Weill Cornell Medical College Clinical and Translational Science Center Pilot Award (to H.Y. and S.M.L.); by the Cornell University Seed Grant for Collaborations between Cornell University-Ithaca and Weill Cornell Medical College Faculty (to H.Y. and S.M.L.); by a donation from Matthew Bell (to S.M.L.); by the Cornell Presidential Life Sciences Fellowship (to Y.G.); and by the Tata Graduate Fellowship (to J.D.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Duhovny D, 2002, LECT NOTES COMPUT SC, V2452, P185; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Fan SJ, 2001, ONCOGENE, V20, P8215, DOI 10.1038/sj.onc.1205033; Feldman I, 2008, P NATL ACAD SCI USA, V105, P4323, DOI 10.1073/pnas.0701722105; Finn RD, 2005, BIOINFORMATICS, V21, P410, DOI 10.1093/bioinformatics/bti011; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Hatherley D, 2009, J BIOL CHEM, V284, P26613, DOI 10.1074/jbc.M109.017566; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Inoue K, 2004, NAT GENET, V36, P361, DOI 10.1038/ng1322; Jimenez-Sanchez G, 2001, NATURE, V409, P853, DOI 10.1038/35057050; Kaminker JS, 2007, NUCLEIC ACIDS RES, V35, pW595, DOI 10.1093/nar/gkm405; Kaminker JS, 2007, CANCER RES, V67, P465, DOI 10.1158/0008-5472.CAN-06-1736; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Lodish H., 2013, MOL CELL BIOL; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Mashiach E, 2010, NUCLEIC ACIDS RES, V38, pW457, DOI 10.1093/nar/gkq373; Mashiach E, 2010, PROTEINS, V78, P1503, DOI 10.1002/prot.22668; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Meyer M. J., 2013, BIOINFORMATICS; MORRIS JA, 1988, BRIT MED J, V296, P1313, DOI 10.1136/bmj.296.6632.1313; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Oliver S, 2000, NATURE, V403, P601, DOI 10.1038/35001165; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Pajkos M, 2012, MOL BIOSYST, V8, P296, DOI 10.1039/c1mb05246b; Petsalaki E, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000335; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schuster-Bockler B, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r9; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Stein A, 2009, NUCLEIC ACIDS RES, V37, pD300, DOI 10.1093/nar/gkn690; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Suzuki Y, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni103; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; Tuncbag N, 2011, NAT PROTOC, V6, P1341, DOI 10.1038/nprot.2011.367; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Veitia RA, 2007, PLANT CELL, V19, P3843, DOI 10.1105/tpc.107.055053; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wang M, 1996, AM J HUM GENET, V59, P1027; Wang XJ, 2012, NAT BIOTECHNOL, V30, P159, DOI 10.1038/nbt.2106; Wang XJ, 2011, BRIEF FUNCT GENOMICS, V10, P280, DOI 10.1093/bfgp/elr024; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Wu XB, 2009, BIOINFORMATICS, V25, P98, DOI 10.1093/bioinformatics/btn593; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Yu HY, 2007, BIOINFORMATICS, V23, P2163, DOI 10.1093/bioinformatics/btm291; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80; Zlotogora J, 2003, GENET MED, V5, P347, DOI 10.1097/01.GIM.0000086478.87623.69	65	31	32	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 11	2013	93	1					78	89		10.1016/j.ajhg.2013.05.022	http://dx.doi.org/10.1016/j.ajhg.2013.05.022			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	183HG	23791107	Green Published, Bronze			2022-12-18	WOS:000321804500007
J	Abu-Safieh, L; Abboud, EB; Alkuraya, H; Shamseldin, H; Al-Enzi, S; Al-Abdi, L; Hashem, M; Colak, D; Jarallah, A; Ahmad, H; Bobis, S; Nemer, G; Bitar, F; Alkuraya, FS				Abu-Safieh, Leen; Abboud, Emad B.; Alkuraya, Hisham; Shamseldin, Hanan; Al-Enzi, Shamsa; Al-Abdi, Lama; Hashem, Mais; Colak, Dilek; Jarallah, Abdullah; Ahmad, Hala; Bobis, Steve; Nemer, Georges; Bitar, Fadi; Alkuraya, Fowzan S.			Mutation of IGFBP7 Causes Upregulation of BRAF/MEK/ERK Pathway and Familial Retinal Arterial Macroaneurysms	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GROWTH; IDENTIFICATION; SENESCENCE; APOPTOSIS; PROTEIN; CELLS; BRAF	Insulin-like growth factor binding proteins (IGFBPs) play important physiological functions through the modulation of IGF signaling as well as IGF-independent mechanisms. Despite the established role of IGFs in development, a similar role for the seven known IGFBPs has not been established in humans. Here, we show that an autosomal-recessive syndrome that consists of progressive retinal arterial macroaneurysms and supravalvular pulmonic stenosis is caused by mutation of IGFBP7. Consistent with the recently established inhibitory role of IGFBP7 on BRAF signaling, the BRAF/MEK/ERK pathway is upregulated in these patients, which may explain why the cardiac phenotype overlaps with other disorders characterized by germline mutations in this pathway. The retinal phenotype appears to be mediated by a role in vascular endothelium, where IGFBP7 is highly expressed.	[Abu-Safieh, Leen; Alkuraya, Hisham; Shamseldin, Hanan; Al-Enzi, Shamsa; Al-Abdi, Lama; Hashem, Mais; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Abboud, Emad B.; Alkuraya, Hisham] King Khalid Eye Specialist Hosp, Vitreoretinal Div, Riyadh 11462, Saudi Arabia; [Colak, Dilek] King Faisal Specialist Hosp & Res Ctr, Dept Biostat Epidemiol & Comp, Riyadh 11211, Saudi Arabia; [Jarallah, Abdullah] King Khalid Univ Hosp & Coll Med, Dept Cardiac Sci, Riyadh 11462, Saudi Arabia; [Ahmad, Hala; Bobis, Steve] King Faisal Specialist Hosp & Res Ctr, Dept Comparat Med, Riyadh 11211, Saudi Arabia; [Nemer, Georges] Amer Univ Beirut, Dept Biochem & Mol Genet, Beirut 11072020, Lebanon; [Bitar, Fadi] Amer Univ Beirut, Dept Pediat, Beirut 11072020, Lebanon; [Alkuraya, Fowzan S.] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh 11533, Saudi Arabia; [Alkuraya, Fowzan S.] King Khalid Univ Hosp & Coll Med, Dept Pediat, Riyadh 11462, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Khaled Eye Specialist Hospital; King Faisal Specialist Hospital & Research Center; King Saud University; King Khalid University Hospital; King Faisal Specialist Hospital & Research Center; American University of Beirut; American University of Beirut; Alfaisal University; King Saud University; King Khalid University Hospital	Alkuraya, FS (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.	falkuraya@kfshrc.edu.sa	Nemer, Georges/ABB-5117-2020; Nemer, Georges/H-7801-2014; Alkuraya, Fowzan S./A-1542-2009	Nemer, Georges/0000-0003-2157-5279; Alkuraya, Fowzan S./0000-0003-4158-341X; AlJarallah, Abdullah/0000-0002-2817-6687; Colak, Dilek/0000-0001-6485-8768	King Abdulaziz City for Science and Technology [08-MED497-20]; Dubai Harvard Foundation for Medical Research	King Abdulaziz City for Science and Technology; Dubai Harvard Foundation for Medical Research	We thank the patients and their families for their enthusiastic participation and the sequencing and genomic core facilities at King Faisal Specialist Hospital and Research Center for their technical help. We also thank Angela Lin for a helpful discussion on the cardiac phenotype. This study was funded in part by a King Abdulaziz City for Science and Technology grant 08-MED497-20 and a Collaborative Research Grant from the Dubai Harvard Foundation for Medical Research to F.S.A.	Abu Safieh L, 2010, J MED GENET, V47, P236, DOI 10.1136/jmg.2009.070755; Clemmons D, 2010, IGFS LOCAL REPAIR SU; Dhindsa HS, 2002, RETINA-J RET VIT DIS, V22, P607, DOI 10.1097/00006982-200210000-00012; Durai R, 2006, INT J ONCOL, V28, P1317; Fang Peng, 2004, Novartis Found Symp, V262, P215; Hooper AT, 2009, CIRC RES, V105, P201, DOI 10.1161/CIRCRESAHA.109.196790; Jogie-Brahim S, 2009, ENDOCR REV, V30, P417, DOI 10.1210/er.2008-0028; Leu JIJ, 2007, GENE DEV, V21, P3095, DOI 10.1101/gad.1567107; MURPHY M, 1993, CELL GROWTH DIFFER, V4, P715; Nakamura T, 2009, P NATL ACAD SCI USA, V106, P15436, DOI 10.1073/pnas.0903302106; ONO Y, 1994, BIOCHEM BIOPH RES CO, V202, P1490, DOI 10.1006/bbrc.1994.2099; Popovici RM, 2001, J CLIN ENDOCR METAB, V86, P2653, DOI 10.1210/jc.86.6.2653; Ruan WJ, 2007, CANCER BIOL THER, V6, P354, DOI 10.4161/cbt.6.3.3702; Salih DAM, 2004, P NATL ACAD SCI USA, V101, P4314, DOI 10.1073/pnas.0400230101; Silha JV, 2005, ADV EXP MED BIOL, V567, P55; Spagnoli A, 2002, J BIOL CHEM, V277, P18860, DOI 10.1074/jbc.M200218200; Tamura K, 2009, EUR J PHARMACOL, V610, P61, DOI 10.1016/j.ejphar.2009.01.045; Tartaglia M, 2010, MOL SYNDROMOL, V1, P2, DOI 10.1159/000276766; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Wajapeyee N, 2010, CELL, V141, P746, DOI 10.1016/j.cell.2010.05.014; ZENKER M, 2008, NOONAN SYNDROME RELA; Zhu WD, 2008, NATURE, V454, P345, DOI 10.1038/nature07027	22	31	33	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG 12	2011	89	2					313	319		10.1016/j.ajhg.2011.07.010	http://dx.doi.org/10.1016/j.ajhg.2011.07.010			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	810TA	21835307	Green Published, Bronze			2022-12-18	WOS:000294148800012
J	Wonnapinij, P; Chinnery, PF; Samuels, DC				Wonnapinij, Passorn; Chinnery, Patrick F.; Samuels, David C.			Previous Estimates of Mitochondrial DNA Mutation Level Variance Did Not Account for Sampling Error: Comparing the mtDNA Genetic Bottleneck in Mice and Humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY OPTIC NEUROPATHY; RAGGED-RED FIBERS; TISSUE DISTRIBUTION; MYOCLONUS EPILEPSY; RAPID SEGREGATION; LEIGH-SYNDROME; T->G MUTATION; MUTANT MTDNA; LHON FAMILY; HETEROPLASMY	In cases of inherited pathogenic mitochondrial DNA (mtDNA) mutations, a mother and her offspring generally have large and seemingly random differences in the amount of mutated mtDNA that they carry. Comparisons of measured mtDNA mutation level variance values have become an important issue in determining the mechanisms that cause these large random shifts in mutation level. These variance measurements have been made with samples of quite modest size, which should be a source of concern because higher-order statistics, such as variance, are poorly estimated from small sample sizes. We have developed an analysis of the standard error of variance from a sample of size n, and we have defined error bars for variance measurements based on this standard error. We calculate variance error bars for several published sets of measurements of mtDNA mutation level variance and show how the addition of the error bars alters the interpretation of these experimental results. We compare variance measurements from human clinical data and from mouse models and show that the mutation level variance is clearly higher in the human data than it is in the mouse models at both the primary oocyte and offspring stages of inheritance. We discuss how the standard error of variance can be used in the design of experiments measuring mtDNA mutation level variance. Our results show that variance measurements based on fewer than 20 measurements are generally unreliable and ideally more than 50 measurements are required to reliably compare variances with less than a 2-fold difference.	[Wonnapinij, Passorn; Samuels, David C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Med Ctr, Nashville, TN 37232 USA; [Wonnapinij, Passorn] Virginia Polytech Inst & State Univ, Interdisciplinary Program Genet Bioinformat & Com, Blacksburg, VA 24060 USA; [Chinnery, Patrick F.] Newcastle Univ, Mitochondrial Res Grp, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Chinnery, Patrick F.] Newcastle Univ, Inst Human Genet, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Vanderbilt University; Virginia Polytechnic Institute & State University; Newcastle University - UK; Newcastle University - UK	Samuels, DC (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Med Ctr, Nashville, TN 37232 USA.	david.samuels@chgr.mc.vanderbilt.edu	Samuels, David/C-1365-2012; Samuels, David C/A-5393-2008; Samuels, David/AHC-8381-2022	Samuels, David C/0000-0003-3529-7791; Samuels, David/0000-0003-3529-7791; Chinnery, Patrick/0000-0002-7065-6617	Thailand's Commission on Higher Education, Royal Thai Government; Medical Research Council (UK); UK Parkinson's Disease Society; UK NIHR Biomedical Research Centre for Ageing; National Institute for Health Research [NF-SI-0509-10011] Funding Source: researchfish	Thailand's Commission on Higher Education, Royal Thai Government(Office of Higher Education Commission (OHEC)); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Parkinson's Disease Society(Parkinson's UK); UK NIHR Biomedical Research Centre for Ageing(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	P.W. is supported by Thailand's Commission on Higher Education, Royal Thai Government under the program "Strategic Scholarship for Frontier Research Network." P.F.C. is a Wellcome Trust Senior Fellow in Clinical Science who also receives funding from the Medical Research Council (UK), the UK Parkinson's Disease Society, and the UK NIHR Biomedical Research Centre for Ageing and Age-related disease award to the Newcastle upon Tyne Foundation Hospitals NHS Trust.	Black GCM, 1996, BRIT J OPHTHALMOL, V80, P915, DOI 10.1136/bjo.80.10.915; Bredenoord AL, 2010, CLIN GENET, V77, P10, DOI 10.1111/j.1399-0004.2009.01312.x; Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190; Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970; Cao LQ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000756; Carelli V, 1997, NEUROLOGY, V48, P1623, DOI 10.1212/WNL.48.6.1623; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Chinnery PF, 1999, AM J MED GENET, V85, P498; Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; Dodge Y, 1999, AM STAT, V53, P267, DOI 10.2307/2686108; Durham SE, 2005, NEUROLOGY, V65, P453, DOI 10.1212/01.wnl.0000171861.30277.88; Enns GM, 2006, MOL GENET METAB, V88, P364, DOI 10.1016/j.ymgme.2006.02.001; Frederiksen AL, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039339; HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617; HARDING AE, 1995, AM J HUM GENET, V57, P77; HOUSTEK J, 1995, BBA-MOL BASIS DIS, V1271, P349, DOI 10.1016/0925-4439(95)00063-A; HOWELL N, 1994, AM J HUM GENET, V55, P203; Hurvitz H, 2002, AM J MED GENET, V111, P446, DOI 10.1002/ajmg.10613; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; Kaplanova V, 2004, J NEUROL SCI, V223, P149, DOI 10.1016/j.jns.2004.05.001; KIMURA M, 1955, P NATL ACAD SCI USA, V41, P144, DOI 10.1073/pnas.41.3.144; LARSSON NG, 1992, AM J HUM GENET, V51, P1201; LOTT MT, 1990, AM J OPHTHALMOL, V109, P625, DOI 10.1016/S0002-9394(14)72429-8; Mak SC, 1996, PEDIATR NEUROL, V15, P72, DOI 10.1016/0887-8994(96)00126-9; MAKELABENGS P, 1995, PEDIATR RES, V37, P634; Phasukkijwatana N, 2006, J HUM GENET, V51, P1110, DOI 10.1007/s10038-006-0073-6; PICCOLO G, 1993, ACTA NEUROL SCAND, V88, P406, DOI 10.1111/j.1600-0404.1993.tb05368.x; Porto FBO, 2001, AM J OPHTHALMOL, V132, P935, DOI 10.1016/S0002-9394(01)01187-4; Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007; SANTORELLI FM, 1994, NEUROLOGY, V44, P972, DOI 10.1212/WNL.44.5.972; Sheskin D., 2007, HDB PARAMETRIC NONPA; SHOUBRIDGE EA, 1994, J BIOENERG BIOMEMBR, V26, P301, DOI 10.1007/BF00763101; SOLIGNAC M, 1984, MOL GEN GENET, V197, P183, DOI 10.1007/BF00330961; Tanaka A, 1998, J NEURO-OPHTHALMOL, V18, P81; TATUCH Y, 1992, AM J HUM GENET, V50, P852; Thorburn DR, 2001, AM J MED GENET, V106, P102, DOI 10.1002/ajmg.1380; Uziel G, 1997, J NEUROL NEUROSUR PS, V63, P16, DOI 10.1136/jnnp.63.1.16; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; White SL, 1999, J INHERIT METAB DIS, V22, P899, DOI 10.1023/A:1005639407166; Wilks S., 1962, MATH STAT; Wong LJC, 2002, GENET MED, V4, P78, DOI 10.1097/00125817-200203000-00005; Wonnapinij P, 2008, AM J HUM GENET, V83, P582, DOI 10.1016/j.ajhg.2008.10.007; WRIGHT S, 1990, B MATH BIOL, V52, P241, DOI 10.1007/BF02459575; Wright S., 1942, Bull Amer Math Soc, V48, P223, DOI 10.1090/S0002-9904-1942-07641-5; ZHU DP, 1992, AM J MED GENET, V42, P173, DOI 10.1002/ajmg.1320420208	46	31	31	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 9	2010	86	4					540	550		10.1016/j.ajhg.2010.02.023	http://dx.doi.org/10.1016/j.ajhg.2010.02.023			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	583YP	20362273	Green Published, Bronze			2022-12-18	WOS:000276716800004
J	Vieland, VJ; Huang, Y; Bartlett, C; Davies, TF; Tomers, Y				Vieland, Veronica J.; Huang, Yungui; Bartlett, Christopher; Davies, Terry F.; Tomers, Yaron			A multilocus model of the genetic architecture of Autoimmune Thyroid Disorder, with clinical implications	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POSTERIOR PROBABILITY; LINKAGE; ASCERTAINMENT; THYROGLOBULIN; DISEASE; GRAVES; CTLA-4; LOCI; MAPS	We report here a preliminary model of the genetic architecture of Autoimmune Thyroid Disorder (AITD). Using a flexible class of mathematical modeling techniques, applied to an established set of data and supplemented with information both from candidate-gene and genome-wide-association studies and from basic bioinformatics, we find strong statistical support for a model in which AITD is the result of "hits" along three distinct genetic pathways: affected individuals have (1) a genetic susceptibility to clinical AITD, along with (2) a separate predisposition to develop the autoantibodies characteristic of AITD, and they also have (3) a predisposition to develop high levels of autoantibodies once they occur. Genes underlying each of these factors then appear to interact with one another to cause clinical AITD. We also find that a genetic variant in CTLA4 that increases risk for AITD in some people might actually protect against AITD in others, depending on which additional risk variants an individual carries. Our data show that the use of statistical methods for the incorporation of information from multiple sources, combined with careful modeling of distinct intermediate phenotypes, can provide insights into the genetic architecture of complex diseases. This model has several clinical implications, which we believe will prove relevant to other complex diseases as well.	[Vieland, Veronica J.; Huang, Yungui; Bartlett, Christopher] Nationwide Childrens Hosp, Res Inst, Battelle Ctr Math Med, Columbus, OH 43205 USA; [Vieland, Veronica J.; Bartlett, Christopher] Ohio State Univ, Dept Pediat, Columbus, OH 43205 USA; [Vieland, Veronica J.] Ohio State Univ, Dept Stat, Columbus, OH 43205 USA; [Davies, Terry F.] James J Peters Vet Affairs Med Ctr, New York, NY 10029 USA; [Davies, Terry F.] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Tomers, Yaron] Univ Cincinnati, Dept Internal Med, Div Endocrinol Diabet & Metab, Cincinnati, OH 45267 USA; [Tomers, Yaron] Cincinnati Vet Affairs Med Ctr, Cincinnati, OH 45267 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Icahn School of Medicine at Mount Sinai; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Vieland, VJ (corresponding author), Nationwide Childrens Hosp, Res Inst, Battelle Ctr Math Med, 700 Childrens Dr, Columbus, OH 43205 USA.	veronica.vieland@nationwidechildrens.org	Bartlett, Christopher/AAD-8813-2022; Bartlett, Christopher/B-4958-2009	Bartlett, Christopher/0000-0001-7837-6348; Bartlett, Christopher/0000-0001-7837-6348	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067555, R01DK061659, R01DK069713, R01DK052464, R01DK073681] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK061659, DK052464, R01 DK052464, DK069713, R01 DK069713, DK61659, R01 DK067555, DK067555, R01 DK073681, DK073681] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Bartlett CW, 2007, GENET EPIDEMIOL, V31, P91, DOI 10.1002/gepi.20193; Bartlett CW, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S121; Bartlett CW, 2004, HUM HERED, V57, P10, DOI 10.1159/000077385; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Edwards AWF, 1992, LIKELIHOOD; ELSTON RC, 1989, AM J MED GENET, V34, P487, DOI 10.1002/ajmg.1320340407; ELSTON RC, 1975, CYTOGENET CELL GENET, V14, P290, DOI 10.1159/000130366; EWENS WJ, 1986, THEOR POPUL BIOL, V30, P388, DOI 10.1016/0040-5809(86)90042-0; GREENBERG DA, 1989, AM J MED GENET, V34, P480, DOI 10.1002/ajmg.1320340406; Greenberg DA, 1998, AM J HUM GENET, V62, P202, DOI 10.1086/301690; Hodge SE, 2006, THYROID, V16, P351, DOI 10.1089/thy.2006.16.351; Huang Yungui, 2007, BMC Proc, V1 Suppl 1, pS64; Jacobson EM, 2007, J AUTOIMMUN, V28, P85, DOI 10.1016/j.jaut.2007.02.006; Kavvoura FK, 2007, J CLIN ENDOCR METAB, V92, P3162, DOI 10.1210/jc.2007-0147; Kong X, 2005, BIOINFORMATICS, V21, P557, DOI 10.1093/bioinformatics/bti024; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Logue MW, 2006, HUM HERED, V62, P47, DOI 10.1159/000096035; Logue MW, 2003, AM J MED GENET B, V121B, P95, DOI 10.1002/ajmg.b.20072; Maier LM, 2007, P NATL ACAD SCI USA, V104, P18607, DOI 10.1073/pnas.0706409104; Matise TC, 1999, AM J HUM GENET, V65, pA435; Mead KI, 2005, J IMMUNOL, V174, P4803, DOI 10.4049/jimmunol.174.8.4803; Royall R.M., 1997, STAT EVIDENCE LIKELI; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; Taper M. L., 2004, NATURE SCI EVIDENCE; Taylor AL, 2005, AM J CARDIOL, V96, p44I, DOI 10.1016/j.amjcard.2005.07.033; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tomer Y, 2003, ENDOCR REV, V24, P694, DOI 10.1210/er.2002-0030; Tomer Y, 2003, AM J HUM GENET, V73, P736, DOI 10.1086/378588; Vieland VJ, 2006, HUM HERED, V61, P144, DOI 10.1159/000093775; Vieland VJ, 2002, HUM HERED, V53, P23, DOI 10.1159/000048601; Vieland VJ, 1998, AM J HUM GENET, V63, P947, DOI 10.1086/302076; Vieland VJ, 1996, AM J HUM GENET, V58, P1072	33	31	31	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2008	82	6					1349	1356		10.1016/j.ajhg.2008.04.017	http://dx.doi.org/10.1016/j.ajhg.2008.04.017			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	312CP	18485327	Green Published, Bronze			2022-12-18	WOS:000256647000012
J	Anttila, V; Nyholt, DR; Kallela, M; Artto, V; Vepsalainen, S; Jakkula, E; Wennerstrom, A; Tikka-Kleemola, P; Kaunisto, MA; Hamalainen, E; Widen, E; Terwilliger, J; Merikangas, K; Montgomery, GW; Martin, NG; Daly, M; Kaprio, J; Peltonen, L; Farkkila, M; Wessman, M; Palotie, A				Anttila, Verneri; Nyholt, Dale R.; Kallela, Mikko; Artto, Ville; Vepsalainen, Salli; Jakkula, Eveliina; Wennerstrom, Annika; Tikka-Kleemola, Paeivi; Kaunisto, Mari A.; Hamalainen, Eija; Widen, Elisabeth; Terwilliger, Joseph; Merikangas, Kathleen; Montgomery, Grant W.; Martin, Nicholas G.; Daly, Mark; Kaprio, Jaakko; Peltonen, Leena; Farkkila, Markus; Wessman, Maija; Palotie, Aarno			Consistently replicating locus linked to migraine on 10q22-q23	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; FAMILIAL HEMIPLEGIC MIGRAINE; SUSCEPTIBILITY LOCUS; SIGNIFICANT LINKAGE; GENETIC DISSECTION; PROSTATE-CANCER; INFLUENCES RISK; COMPLEX TRAITS; AURA; POPULATION	Here, we present the results of two genome-wide scans in two diverse populations in which a consistent use of recently introduced migraine-phenotyping methods detects and replicates a locus on 10q22-q23, with an additional independent replication. No genetic variants have been convincingly established in migraine, and although several loci have been reported, none of them has been consistently replicated. We employed the three known migraine-phenotyping methods (clinical end diagnosis, latent-class analysis, and trait-component analysis) with robust multiple testing correction in a large sample set of 1675 individuals from 210 migraine families from Finland and Australia. Genome-wide multipoint linkage analysis that used the Kong and Cox exponential model in Finns detected a locus on 10q22-q23 with highly significant evidence of linkage (LOD 7.68 at 103 cM in female-specific analysis). The Australian sample showed a LOD score of 3.50 at the same locus (100 cM), as did the independent Finnish replication study (LOD score 2.41, at 102 cM). In addition, four previously reported loci on 8q21, 14q21, 18q12, and Xp21 were also replicated. A shared-segment analysis of 10q22-q23 linked Finnish families identified a 1.6-9.5 cM segment, centered on 101 cM, which shows in-family homology in 95% of affected Finns. This region was further studied with 1323 SNPs. Although no significant association was observed, four regions warranting follow-up studies were identified. These results support the use of symptomology-based phenotyping in migraine and suggest that the 10q22-q23 locus probably contains one or more migraine susceptibility variants.	[Anttila, Verneri; Jakkula, Eveliina; Wennerstrom, Annika; Tikka-Kleemola, Paeivi; Kaunisto, Mari A.; Hamalainen, Eija; Terwilliger, Joseph; Peltonen, Leena; Wessman, Maija; Palotie, Aarno] Univ Helsinki, Res Program Mol Med, FIN-00290 Helsinki, Finland; [Anttila, Verneri; Jakkula, Eveliina; Wennerstrom, Annika; Tikka-Kleemola, Paeivi; Kaunisto, Mari A.; Hamalainen, Eija; Widen, Elisabeth; Wessman, Maija; Palotie, Aarno] Univ Helsinki, Finnish Genome Ctr, FIN-00290 Helsinki, Finland; [Anttila, Verneri; Wessman, Maija; Palotie, Aarno] Univ Helsinki, Cent Hosp, Dept Clin Chem, Helsinki 00029, Finland; [Nyholt, Dale R.; Montgomery, Grant W.; Martin, Nicholas G.] Queensland Inst Med Res, Genet Epidemiol Lab, Brisbane, Qld 4029, Australia; [Kallela, Mikko; Artto, Ville; Vepsalainen, Salli; Farkkila, Markus] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki 00029, Finland; [Kaunisto, Mari A.; Wessman, Maija] Folkhalsan Res Ctr, Helsinki 00290, Finland; [Terwilliger, Joseph] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Terwilliger, Joseph] Columbia Univ, Columbia Genome Ctr, New York, NY 10032 USA; [Merikangas, Kathleen] NIMH, NIH, Sect Dev Genet Epidemiol, New York, NY 10032 USA; [Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, FIN-00014 Helsinki, Finland; [Kaprio, Jaakko] Natl Publ Hlth Inst, Dept Mental Hlth & Alcohol Res, SF-00300 Helsinki, Finland; [Jakkula, Eveliina; Peltonen, Leena] Natl Publ Hlth Inst, Dept Mol Med, Helsinki 00290, Finland; [Jakkula, Eveliina; Daly, Mark; Peltonen, Leena; Palotie, Aarno] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Anttila, Verneri; Peltonen, Leena; Palotie, Aarno] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; QIMR Berghofer Medical Research Institute; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; Columbia University; Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Helsinki; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Wellcome Trust Sanger Institute	Palotie, A (corresponding author), Univ Helsinki, Res Program Mol Med, FIN-00290 Helsinki, Finland.	aarno@sanger.ac.uk	Montgomery, Grant W/B-7148-2008; Nyholt, Dale Robert/J-3174-2017; Daly, Mark J/B-2453-2017; Kaprio, Jaakko/A-1820-2008	Montgomery, Grant W/0000-0002-4140-8139; Nyholt, Dale Robert/0000-0001-7159-3040; Daly, Mark J/0000-0002-0949-8752; Kaprio, Jaakko/0000-0002-3716-2455; Merikangas, Kathkeen/0000-0002-4667-2414; Kaunisto, Mari/0000-0002-6946-9195; Palotie, Aarno/0000-0002-2527-5874; Martin, Nicholas/0000-0003-4069-8020; Anttila, Verneri/0000-0002-0073-4675	NCRR NIH HHS [U54 RR020278] Funding Source: Medline; NIAAA NIH HHS [AA014041, P50 AA011998, R01 AA007728, AA013320, R01 AA010249, R01 AA013326, R01 AA013320, R37 AA007728, R01 AA014041, AA07728, AA11998, R01 AA007535, AA013326] Funding Source: Medline; NINDS NIH HHS [R01 NS37675, R01 NS037675] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA007728, R01AA014041, R01AA013326, R01AA010249, R01AA013320, P60AA011998, P50AA011998, R37AA007728, R01AA007535] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Abecasis GR, 2004, AM J HUM GENET, V74, P403, DOI 10.1086/381713; Abecasis GR, 2004, AM J HUM GENET, V74, P482, DOI 10.1086/382786; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Andlin-Sobocki P, 2005, EUR J NEUROL, V12, P1, DOI 10.1111/j.1468-1331.2005.01202.x; Anttila V, 2006, AM J HUM GENET, V79, P85, DOI 10.1086/504814; Bjornsson A, 2003, AM J HUM GENET, V73, P986, DOI 10.1086/378417; BLAU J, 1995, CEPHALALGIA, V15, P186, DOI 10.1046/j.1468-2982.1995.015003186.x; Cader ZM, 2003, HUM MOL GENET, V12, P2511, DOI 10.1093/hmg/ddg252; Carlsson A, 2002, NEUROLOGY, V59, P1804, DOI 10.1212/01.WNL.0000036617.04943.96; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; Dichgans M, 2005, LANCET, V366, P371, DOI 10.1016/S0140-6736(05)66786-4; Elston RC, 2005, AM J HUM GENET, V76, P152, DOI 10.1086/426872; FEINGOLD E, 1993, AM J HUM GENET, V53, P234; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Heath A C, 2001, Twin Res, V4, P73, DOI 10.1375/1369052012182; Heath AC, 1997, PSYCHOL MED, V27, P1381, DOI 10.1017/S0033291797005643; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; HONKASALO ML, 1995, HEADACHE, V35, P70, DOI 10.1111/j.1526-4610.1995.hed3502070.x; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Kallela M, 2001, EUR J NEUROL, V8, P61, DOI 10.1046/j.1468-1331.2001.00165.x; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LARSSON B, 1995, HEADACHE, V35, P513, DOI 10.1111/j.1526-4610.1995.hed3509513.x; Launer LJ, 1999, NEUROLOGY, V53, P537, DOI 10.1212/WNL.53.3.537; Lea RA, 2005, NEUROGENETICS, V6, P67, DOI 10.1007/s10048-005-0215-6; Ligthart L, 2006, TWIN RES HUM GENET, V9, P54, DOI 10.1375/183242706776403019; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; MERIKANGAS KR, 1994, NEUROLOGY, V44, P11; Mulder EJ, 2003, TWIN RES, V6, P422, DOI 10.1375/twin.6.5.422; Nyholt DR, 2005, AM J HUM GENET, V77, P500, DOI 10.1086/444510; Nyholt DR, 2004, GENET EPIDEMIOL, V26, P231, DOI 10.1002/gepi.10311; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rao DC, 2000, HUM HERED, V50, P34, DOI 10.1159/000022889; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; RUSSELL MB, 1995, BRIT MED J, V311, P541, DOI 10.1136/bmj.311.7004.541; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Soragna D, 2003, AM J HUM GENET, V72, P161, DOI 10.1086/345298; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; Stewart WF, 1997, ANN NEUROL, V41, P166, DOI 10.1002/ana.410410207; Stovner LJ, 2006, EUR J NEUROL, V13, P333, DOI 10.1111/j.1468-1331.2006.01184.x; Suarez BK, 2006, AM J HUM GENET, V78, P315, DOI 10.1086/500272; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; WEEKS DE, 1988, AM J HUM GENET, V42, P315; Wessman M, 2002, AM J HUM GENET, V70, P652, DOI 10.1086/339078; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Wiltshire S, 2001, AM J HUM GENET, V69, P553, DOI 10.1086/323249; Wiltshire S, 2002, AM J HUM GENET, V71, P1175, DOI 10.1086/342976	59	31	31	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2008	82	5					1051	1063		10.1016/j.ajhg.2008.03.003	http://dx.doi.org/10.1016/j.ajhg.2008.03.003			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	301VJ	18423523	Green Published, Bronze			2022-12-18	WOS:000255923600005
J	Spirin, V; Schmidt, S; Pertsemlidis, A; Cooper, RS; Cohen, JC; Sunyaev, SR				Spirin, Victor; Schmidt, Steffen; Pertsemlidis, Alexander; Cooper, Richard S.; Cohen, Jonathan C.; Sunyaev, Shamil R.			Common single-nucleotide polymorphisms act in concert to affect plasma levels of high-density lipoprotein cholesterol	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HDL METABOLISM; HEART-DISEASE; POPULATION; RISK	The identification of DNA sequence variants underlying human complex phenotypes remains a significant challenge for several reasons: individual variants can have small phenotypic effects or low population frequencies, and multiple allelic variants may act in concert to affect a trait. We evaluated the combined effect of allelic variants in seven genes involved in high-density lipoprotein (HDL) metabolism, using forward stepwise regression. Analysis of all known common single-nucleotide polymorphisms (SNPs) in the seven candidate genes revealed four variants that were associated with incremental changes in HDL cholesterol levels in three independent samples. Conversely, analysis of 660 polymorphisms in eight genes that do not appear to be involved in HDL metabolism did not identify any associations with plasma HDL-cholesterol levels. These data indicate that several common SNPs act in concert to influence plasma levels of HDL cholesterol.	Brigham & Womens Hosp, Harvard Med Sch, Genet Div, Boston, MA 02115 USA; MIT, Div Hlth Sci & Technol, Boston, MA USA; Uni Texas Southwestern Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX USA; Uni Texas Southwestern Med Ctr, Ctr Huamn Nutr, Dallas, TX USA; Uni Texas Southwestern Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX USA; Uni Texas Southwestern Med Ctr, Dept Internal Med, Dallas, TX USA; Loyola Univ, Stritch Sch Med, Dept Prevent Med & Epidemiol, Maywood, IL 60153 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Loyola University Chicago	Sunyaev, SR (corresponding author), Brigham & Womens Hosp, Harvard Med Sch, Genet Div, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	ssunyaev@rics.bwh.harvard.edu	Pertsemlidis, Alexander/Q-7899-2017	Pertsemlidis, Alexander/0000-0003-1624-9372; Spirin, Victor/0000-0003-4523-1972; Schmidt, Steffen/0000-0001-9077-6010	NLM NIH HHS [U54 LM008748, U54LM008748] Funding Source: Medline; NATIONAL LIBRARY OF MEDICINE [U54LM008748] Funding Source: NIH RePORTER	NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Andersen RV, 2003, J AM COLL CARDIOL, V41, P1972, DOI 10.1016/S0735-1097(03)00407-8; Boekholdt SM, 2005, CIRCULATION, V111, P278, DOI 10.1161/01.CIR.0000153341.46271.40; Brousseau ME, 2004, REV ENDOCR METAB DIS, V5, P343, DOI 10.1023/B:REMD.0000045106.90301.26; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Frikke-Schmidt R, 2004, J CLIN INVEST, V114, P1343, DOI 10.1172/JCI200420361; GOTTO AM, 1990, AM J CARDIOL, V66, P20; Guerra R, 1997, P NATL ACAD SCI USA, V94, P4532, DOI 10.1073/pnas.94.9.4532; Hovingh GK, 2005, CURR OPIN LIPIDOL, V16, P139, DOI 10.1097/01.mol.0000162318.47172.ef; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; SCHORK NJ, 1995, GENOME RES, V5, P164, DOI 10.1101/gr.5.2.164; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; VEGA GL, 1991, J INTERN MED, V230, P341, DOI 10.1111/j.1365-2796.1991.tb00454.x; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058	13	31	32	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2007	81	6					1298	1303		10.1086/522497	http://dx.doi.org/10.1086/522497			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233NY	17952847	Green Published, Bronze			2022-12-18	WOS:000251098800016
J	Ashley, T; Gaeth, AP; Inagaki, H; Seftel, A; Cohen, MM; Anderson, LK; Kurahashi, H; Emanuel, BS				Ashley, Terry; Gaeth, Ann P.; Inagaki, Hidehito; Seftel, Allen; Cohen, Maimon M.; Anderson, Lorinda K.; Kurahashi, Hiroki; Emanuel, Beverly S.			Meiotic recombination and spatial proximity in the etiology of the recurrent t(11;22)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							REPLICATION PROTEIN-A; V(D)J RECOMBINATION; 22Q11 BREAKPOINTS; ESCHERICHIA-COLI; RICH PALINDROMES; CLUSTERED 11Q23; DNA-REPLICATION; SOMATIC-CELLS; MOUSE; TRANSLOCATION	Although balanced translocations are among the most common human chromosomal aberrations, the constitutional t(11; 22)(q23;q11) is the only known recurrent non-Robertsonian translocation. Evidence indicates that de novo formation of the t( 11; 22) occurs during meiosis. To test the hypothesis that spatial proximity of chromosomes 11 and 22 in meiotic prophase oocytes and spermatocytes plays a role in the rearrangement, the positions of the 11q23 and 22q11 translocation breakpoints were examined. Fluorescence in situ hybridization with use of DNA probes for these sites demonstrates that 11q23 is closer to 22q11 in meiosis than to a control at 6q26. Although chromosome 21p11, another control, often lies as close to 11q23 as does 22q11 during meiosis, chromosome 21 rarely rearranges with 11q23, and the DNA sequence of chromosome 21 appears to be less susceptible than 22q11 to double-strand breaks (DSBs). It has been suggested that the rearrangement recurs as a result of the palindromic AT-rich repeats at both 11q23 and 22q11, which extrude hairpin structures that are susceptible to DSBs. To determine whether the DSBs at these sites coincide with normal hotspots of meiotic recombination, immunocytochemical mapping of MLH1, a protein involved in crossing over, was employed. The results indicate that the translocation breakpoints do not coincide with recombination hotspots and therefore are unlikely to be the result of meiotic programmed DSBs, although MRE11 is likely to be involved. Previous analysis indicated that the DSBs appear to be repaired by a mechanism similar to nonhomologous end joining (NHEJ), although NHEJ is normally suppressed during meiosis. Taken together, these studies support the hypothesis that physical proximity between 11q23 and 22q11 - but not typical meiotic recombinational activity in meiotic prophase - plays an important role in the generation of the constitutional t( 11; 22) rearrangement.	Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Fujita Hlth Univ, Inst Comprehens Med Sci, Div Mol Genet, Aichi, Japan; Univ Hosp Cleveland, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Urol, Cleveland, OH 44106 USA; Cleveland VA Med Ctr, Cleveland, OH USA; Greater Baltimore Med Ctr, Harvey Inst Human Genet, Baltimore, MD USA; Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Yale University; Fujita Health University; University Hospitals of Cleveland; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Greater Baltimore Medical Center; Colorado State University	Emanuel, BS (corresponding author), Childrens Hosp Philadelphia, Div Human Genet, 3615 Civic Ctr Blvd,1002 Abramson Res Ctr, Philadelphia, PA 19104 USA.	beverly@mail.med.upenn.edu			NATIONAL CANCER INSTITUTE [R01CA039926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067846] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA039926, CA39926] Funding Source: Medline; NIGMS NIH HHS [R01 GM067846, GM67846] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson LK, 1999, GENETICS, V151, P1569; ASHLEY T, 1995, CHROMOSOMA, V104, P19, DOI 10.1007/BF00352222; Assenmacher N, 2004, CHROMOSOMA, V113, P157, DOI 10.1007/s00412-004-0306-4; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Bandyopadhyay R, 2002, AM J HUM GENET, V71, P1456, DOI 10.1086/344662; Barlow AL, 1997, EMBO J, V16, P5207, DOI 10.1093/emboj/16.17.5207; Borde V, 2004, MOL CELL, V13, P389, DOI 10.1016/S1097-2765(04)00034-6; Boyle S, 2001, HUM MOL GENET, V10, P211, DOI 10.1093/hmg/10.3.211; Cheng EY, 2004, AM J OBSTET GYNECOL, V190, P1781, DOI 10.1016/j.ajog.2004.02.062; Cheng EY, 1999, HUM GENET, V105, P191, DOI 10.1007/s004399900120; Connelly JC, 1996, GENES CELLS, V1, P285, DOI 10.1046/j.1365-2443.1996.23024.x; Connelly JC, 1998, P NATL ACAD SCI USA, V95, P7969, DOI 10.1073/pnas.95.14.7969; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Cunningham LA, 2003, MOL CELL BIOL, V23, P8740, DOI 10.1128/MCB.23.23.8740-8750.2003; Debeer P, 2002, CLIN GENET, V62, P410, DOI 10.1034/j.1399-0004.2002.620510.x; Dodson GE, 2004, J BIOL CHEM, V279, P34010, DOI 10.1074/jbc.C400242200; Dresser ME, 1997, GENETICS, V147, P533; Edelmann L, 2001, AM J HUM GENET, V68, P1, DOI 10.1086/316952; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; EVANS EP, 1964, CYTOGENETICS, V3, P289, DOI 10.1159/000129818; FRACCARO M, 1980, HUM GENET, V56, P21, DOI 10.1007/BF00281567; Froenicke L, 2002, AM J HUM GENET, V71, P1353, DOI 10.1086/344714; Funke B, 1999, AM J HUM GENET, V64, P747, DOI 10.1086/302284; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Goedecke W, 1999, NAT GENET, V23, P194, DOI 10.1038/13821; Gotter AL, 2004, HUM MOL GENET, V13, P103, DOI 10.1093/hmg/ddh004; Hamer G, 2003, BIOL REPROD, V68, P717, DOI 10.1095/biolreprod.102.008920; Kato T, 2006, SCIENCE, V311, P971, DOI 10.1126/science.1121452; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; KehrerSawatzki H, 1997, HUM GENET, V99, P237, DOI 10.1007/s004390050346; Kozubek S, 1999, CHROMOSOMA, V108, P426, DOI 10.1007/s004120050394; Kurahashi H, 2000, AM J HUM GENET, V67, P763, DOI 10.1086/303054; Kurahashi H, 2000, HUM MOL GENET, V9, P1665, DOI 10.1093/hmg/9.11.1665; Kurahashi H, 2004, J BIOL CHEM, V279, P35377, DOI 10.1074/jbc.M400354200; Kurahashi H, 2001, HUM MOL GENET, V10, P2605, DOI 10.1093/hmg/10.23.2605; Kurahashi H, 2001, NAT GENET, V29, P139, DOI 10.1038/ng1001-139; Lewis SM, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni189; Li M., 1995, American Journal of Human Genetics, V57, pA119; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; Lin TY, 1996, DEVELOPMENT, V122, P1331; Lynn A, 2002, SCIENCE, V296, P2222, DOI 10.1126/science.1071220; LYNN A, 2004, ANNU REV GENOM HUM G, P317; Majewski J, 2000, GENOME RES, V10, P1108, DOI 10.1101/gr.10.8.1108; Maser RS, 2001, MOL CELL BIOL, V21, P6006, DOI 10.1128/MCB.21.17.6006-6016.2001; Mirzoeva OK, 2003, MOL CANCER RES, V1, P207; Misteli T, 2004, CELL, V119, P153, DOI 10.1016/j.cell.2004.09.035; Nagele RG, 1998, CHROMOSOMA, V107, P330, DOI 10.1007/s004120050315; NIELSEN J, 1975, HUMANGENETIK, V30, P1, DOI 10.1007/BF00273626; Nikiforova MN, 2000, SCIENCE, V290, P138, DOI 10.1126/science.290.5489.138; Nimmakayalu MA, 2003, HUM MOL GENET, V12, P2817, DOI 10.1093/hmg/ddg301; Nishant KT, 2006, NUCLEIC ACIDS RES, V34, pD25, DOI 10.1093/nar/gkj009; Parada LA, 2004, EXP CELL RES, V296, P64, DOI 10.1016/j.yexcr.2004.03.013; Parada LA, 2002, CURR BIOL, V12, P1692, DOI 10.1016/S0960-9822(02)01166-1; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 2000, P NATL ACAD SCI USA, V97, P6409, DOI 10.1073/pnas.110144297; Plug AW, 1998, J CELL SCI, V111, P413; Reeves A, 2001, GENOME, V44, P439, DOI 10.1139/gen-44-3-439; Rhodes CH, 1997, CYTOGENET CELL GENET, V78, P247, DOI 10.1159/000134667; ROTH DB, 1992, CELL, V70, P983, DOI 10.1016/0092-8674(92)90248-B; Saitta SC, 2004, HUM MOL GENET, V13, P417, DOI 10.1093/hmg/ddh041; Scherthan H, 1996, J CELL BIOL, V134, P1109, DOI 10.1083/jcb.134.5.1109; Shaikh TH, 1999, AM J HUM GENET, V65, P1595, DOI 10.1086/302666; Spiteri E, 2003, HUM MOL GENET, V12, P1823, DOI 10.1093/hmg/ddg203; STAHL A, 1983, P NATL ACAD SCI-BIOL, V80, P5946, DOI 10.1073/pnas.80.19.5946; Sun F, 2005, HUM GENET, V116, P172, DOI 10.1007/s00439-004-1215-6; Tapia-Paez I, 2000, HUM GENET, V106, P506, DOI 10.1007/s004390000287; Tease C, 2002, AM J HUM GENET, V70, P1469, DOI 10.1086/340734; VOURCH C, 1993, EXP CELL RES, V205, P142, DOI 10.1006/excr.1993.1068; Walpita D, 1999, P NATL ACAD SCI USA, V96, P5622, DOI 10.1073/pnas.96.10.5622; ZACKAI EH, 1980, AM J MED GENET, V7, P507, DOI 10.1002/ajmg.1320070412; Zhou ZH, 2001, P NATL ACAD SCI USA, V98, P8326, DOI 10.1073/pnas.151008498; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	72	31	36	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2006	79	3					524	538		10.1086/507652	http://dx.doi.org/10.1086/507652			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	074RY	16909390	Green Published, Bronze			2022-12-18	WOS:000239830700014
J	Thomas, A; Camp, NJ				Thomas, A; Camp, NJ			Graphical modeling of the joint distribution of alleles at associated loci	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HAPLOTYPE; SELECTION; GENE	Pairwise linkage disequilibrium, haplotype blocks, and recombination hotspots provide only a partial description of the patterns of dependences and independences between the allelic states at proximal loci. On the gross scale, where recombination and spatial relationships dominate, the associations can be reasonably described in these terms. However, on the fine scale of current high-density maps, the mutation process is also important and creates associations between loci that are independent of the physical ordering and that can not be summarized with pairwise measures of association. Graphical modeling provides a standard statistical framework for characterizing precisely these sorts of complex stochastic data. Although graphical models are often used in situations in which assumptions lead naturally to specific models, it is less well known that estimation of graphical models is also a developed field. We show how decomposable graphical models can be fitted to dense genetic data. The objective function is the maximized log likelihood for the model penalized by a multiple of the model's degrees of freedom. We also describe how this can be modified to incorporate prior information of locus position. Simulated annealing is used to find good solutions. Part of the appeal of this approach is that categorical phenotypes can be included in the same analysis and association with polymorphisms can be assessed jointly with the interlocus associations. We illustrate our method with genotypic data from 25 loci in the ELAC2 gene. The results contain third- and fourth-order locus interactions and show that, at this density of markers, linkage disequilibrium is not a simple function of physical distance. Graphical models provide more flexibility to express these features of the joint distribution of alleles than do monotonic functions connecting physical and genetic maps.	Univ Utah, Dept Med Informat, Salt Lake City, UT 84112 USA; Univ Utah, Ctr High Performance Comp, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Thomas, A (corresponding author), 391 Chipeta Way,Suite D, Salt Lake City, UT 84108 USA.	alun@genepi.med.utah.edu		Thomas, Alun/0000-0001-5650-7044	DIVISION OF CANCER CONTROL &POPULATION SCIENCE [N01PC067000] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R03CA099844, R01CA090752] Funding Source: NIH RePORTER	DIVISION OF CANCER CONTROL &POPULATION SCIENCE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Control & Population Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Camp NJ, 2002, AM J HUM GENET, V71, P1475, DOI 10.1086/344516; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Dawson E, 2002, NATURE, V418, P544, DOI 10.1038/nature00864; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; GEORGE AW, IN PRESS STAT SCI; GEYER CJ, 1995, J AM STAT ASSOC, V90, P909, DOI 10.1080/01621459.1995.10476590; GEYER CJ, 1991, COMPUTING SCIENCE AND STATISTICS, P156; Golumbic M.C., 1980, ALGORITHMIC GRAPH TH, DOI [10.1007/BF00390110, DOI 10.1007/BF00390110]; Hampe J, 2003, HUM GENET, V114, P36, DOI 10.1007/s00439-003-1017-2; HOJSGAARD S, 1995, COMPUT STAT DATA AN, V19, P155, DOI 10.1016/0167-9473(93)E0054-8; Horne BD, 2004, GENET EPIDEMIOL, V26, P11, DOI 10.1002/gepi.10292; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Jolliffe I, 2002, PRINCIPAL COMPONENT; Ke XY, 2003, BIOINFORMATICS, V19, P287, DOI 10.1093/bioinformatics/19.2.287; KIRKPATRICK S, 1982, 9353 RC IBM; KONG A, 1993, GENET EPIDEMIOL, V10, P483, DOI 10.1002/gepi.1370100626; LAURITZEN SL, 1988, J ROY STAT SOC B MET, V50, P157; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shannon C.E., 1948, BELL SYSTEMS TECHNIC; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stevens J., 1992, APPL MULTIVARIATE ST; Stram DO, 2003, HUM HERED, V55, P27, DOI 10.1159/000071807; TARJAN RE, 1984, SIAM J COMPUT, V13, P566, DOI 10.1137/0213035; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Thomas A, 2003, BIOINFORMATICS, V19, P2002, DOI 10.1093/bioinformatics/btg254; Thomas A, 2000, STAT COMPUT, V10, P259, DOI 10.1023/A:1008947712763; Thompson EA, 1978, ANN HUM GENET, V32, P445; Zhang K, 2003, BIOINFORMATICS, V19, P1300, DOI 10.1093/bioinformatics/btg142	30	31	32	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2004	74	6					1088	1101		10.1086/421249	http://dx.doi.org/10.1086/421249			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	823ZB	15114533	Green Published, Bronze			2022-12-18	WOS:000221651900002
J	Kang, HS; Qin, ZHS; Niu, TH; Liu, JS				Kang, HS; Qin, ZHS; Niu, TH; Liu, JS			Incorporating genotyping uncertainty in haplotype inference for single-nucleotide polymorphisms	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAXIMUM-LIKELIHOOD; LINKAGE; ERRORS; LOCUS; RECONSTRUCTION; FREQUENCIES; MUTATIONS; ALGORITHM; TEMPLATE; IMPACT	The accuracy of the vast amount of genotypic information generated by high-throughput genotyping technologies is crucial in haplotype analyses and linkage-disequilibrium mapping for complex diseases. To date, most automated programs lack quality measures for the allele calls; therefore, human interventions, which are both labor intensive and error prone, have to be performed. Here, we propose a novel genotype clustering algorithm, GeneScore, based on a bivariate t-mixture model, which assigns a set of probabilities for each data point belonging to the candidate genotype clusters. Furthermore, we describe an expectation-maximization ( EM) algorithm for haplotype phasing, GenoSpectrum (GS)-EM, which can use probabilistic multilocus genotype matrices ( called "GenoSpectrum") as inputs. Combining these two model-based algorithms, we can perform haplotype inference directly on raw readouts from a genotyping machine, such as the TaqMan assay. By using both simulated and real data sets, we demonstrate the advantages of our probabilistic approach over the current genotype scoring methods, in terms of both the accuracy of haplotype inference and the statistical power of haplotype-based association analyses.	Harvard Univ, Dept Stat, Cambridge, MA 02138 USA; Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Prevent Med, Boston, MA 02115 USA	Harvard University; University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Liu, JS (corresponding author), Harvard Univ, Dept Stat, 1 Oxford St, Cambridge, MA 02138 USA.	jliu@stat.harvard.edu	Qin, Zhaohui/Q-3133-2019; Qin, Zhaohui S/E-8196-2011	Qin, Zhaohui/0000-0002-1583-146X; Qin, Zhaohui S/0000-0002-1583-146X	NHGRI NIH HHS [R01 HG002518, R01 HG002518-01] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002518] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Abecasis GR, 2001, EUR J HUM GENET, V9, P130, DOI 10.1038/sj.ejhg.5200594; Akey JM, 2001, AM J HUM GENET, V68, P1447, DOI 10.1086/320607; Akula N, 2002, BIOTECHNIQUES, V32, P1072, DOI 10.2144/02325rr02; BUETOW KH, 1991, AM J HUM GENET, V49, P985; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Douglas JA, 2000, AM J HUM GENET, V66, P1287, DOI 10.1086/302861; Douglas JA, 2001, NAT GENET, V28, P361, DOI 10.1038/ng582; Douglas JA, 2002, AM J HUM GENET, V70, P487, DOI 10.1086/338919; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Fallin D, 2001, GENOME RES, V11, P143, DOI 10.1101/gr.148401; Goldstein DR, 1997, HUM HERED, V47, P86, DOI 10.1159/000154396; Grant SFA, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf125; Han JL, 2003, CANCER RES, V63, P8536; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; Kirk KM, 2002, EUR J HUM GENET, V10, P616, DOI 10.1038/sj.ejhg.5200855; LEWONTIN RC, 1964, GENETICS, V49, P49; Li H, 2001, ANN HUM GENET, V65, P189, DOI 10.1017/S0003480001008491; Lin S, 2002, AM J HUM GENET, V71, P1129, DOI 10.1086/344347; Liu JS, 1999, J AM STAT ASSOC, V94, P1264, DOI 10.2307/2669940; LIVAK KJ, 1995, NAT GENET, V9, P341, DOI 10.1038/ng0495-341; LONG JC, 1995, AM J HUM GENET, V56, P799; Luo XG, 2003, AM J MED GENET B, V120B, P97, DOI 10.1002/ajmg.b.20034; MichalatosBeloin S, 1996, NUCLEIC ACIDS RES, V24, P4841, DOI 10.1093/nar/24.23.4841; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; North BV, 2003, ANN HUM GENET, V67, P348, DOI 10.1046/j.1469-1809.2003.00030.x; Olivier M, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf052; Qin ZHS, 2002, AM J HUM GENET, V71, P1242, DOI 10.1086/344207; Ranade K, 2001, GENOME RES, V11, P1262; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Sobel E, 2002, AM J HUM GENET, V70, P496, DOI 10.1086/338920; Stephens M, 2000, J ROY STAT SOC B, V62, P795, DOI 10.1111/1467-9868.00265; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tsai CT, 2003, HYPERTENSION, V41, P9, DOI 10.1161/01.HYP.0000045080.28739.12; van den Oord EJCG, 2003, BIOTECHNIQUES, V34, P610, DOI 10.2144/03343dd04; van Dyk DA, 2001, J COMPUT GRAPH STAT, V10, P1, DOI 10.1198/10618600152418584; Yan H, 2000, NATURE, V403, P723, DOI 10.1038/35001659	38	31	36	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2004	74	3					495	510		10.1086/382284	http://dx.doi.org/10.1086/382284			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	801TP	14966673	Green Published, Bronze			2022-12-18	WOS:000220118500016
J	Rahman, N; Dunstan, M; Teare, MD; Hanks, S; Douglas, J; Coleman, K; Bottomly, WE; Campbell, ME; Berglund, B; Nordenskjold, M; Forssell, B; Burrows, N; Lunt, P; Young, I; Williams, N; Bignell, GR; Futreal, PA; Pope, FM				Rahman, N; Dunstan, M; Teare, MD; Hanks, S; Douglas, J; Coleman, K; Bottomly, WE; Campbell, ME; Berglund, B; Nordenskjold, M; Forssell, B; Burrows, N; Lunt, P; Young, I; Williams, N; Bignell, GR; Futreal, PA; Pope, FM			Ehlers-Danlos syndrome with severe early-onset periodontal disease (EDS-VIII) is a distinct, heterogeneous disorder with one predisposition gene at chromosome 12p13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; SYNDROME TYPE-IV; TENASCIN-X; INTEGRIN; COLLAGEN	Ehlers-Danlos VIII (EDS-VIII) is an autosomal dominant disorder characterized by severe early-onset periodontal disease in conjunction with the features of Ehlers-Danlos syndrome (EDS). We performed a genomewide linkage search in a large Swedish pedigree with EDS-VIII and established linkage to a 7-cM interval on chromosome 12p13, generating a maximum multipoint LOD score of 5.17. Analysis of four further pedigrees with EDS-VIII revealed two consistent with linkage to 12p13 and two in which linkage could be excluded, indicating that EDS-VIII is a genetically heterogeneous disorder. Chromosome 12p13 has not previously been implicated in either EDS or periodontal disease and contains no known collagen genes or collagen-processing enzymes. Mutational screening of the microfibril-associated glycoprotein-2 gene, a strong candidate within the minimal interval, did not reveal any likely pathogenic mutations.	Inst Canc Res, Sect Canc Genet, Surrey SM2 5NG, England; Univ Wales Coll Med, Dept Med Psychol, Cardiff CF4 4XN, S Glam, Wales; Univ Sheffield, Math Modelling & Genet Epidemiol Grp, Sheffield, S Yorkshire, England; Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, Cambs, England; Univ London Kings Coll, Div Life Sci, Connect Tissue Matrix Genet Grp, London WC2R 2LS, England; Karolinska Inst, Dept Nursing, Stockholm, Sweden; Karolinska Inst, Dept Mol Med, Stockholm, Sweden; Sodermalmstandlakarna, Stockholm, Sweden; Addenbrookes Hosp, Dept Dermatol, Cambridge, England; Inst Child Hlth, Dept Clin Genet, Bristol, Avon, England; Leicester Royal Infirm, Dept Clin Genet, Leicester, Leics, England	University of London; Institute of Cancer Research - UK; Cardiff University; University of Sheffield; Wellcome Trust Sanger Institute; University of London; King's College London; Karolinska Institutet; Karolinska Institutet; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Bristol; University of Leicester	Rahman, N (corresponding author), Inst Canc Res, Sect Canc Genet, Brookes Lawler Bldg,15 Cotswold Rd, Surrey SM2 5NG, England.	nazneen@icr.ac.uk	Rahman, Nazneen/B-8890-2012; Lunt, Peter/AAF-8265-2020; Rahman, Nazneen/D-2802-2013	Nordenskjold, Magnus/0000-0002-4974-425X; Newton-Bishop, Julia/0000-0001-9147-6802; Rahman, Nazneen/0000-0003-4376-0440; Teare, Marion Dawn/0000-0003-3994-0051				Barabas G M, 1967, Br Dent J, V123, P473; Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; BIESECKER LG, 1991, AM J MED GENET, V41, P284, DOI 10.1002/ajmg.1320410305; Bond Priscilla Johns, 1993, Pediatric Dentistry, V15, P212; BYERS PH, 1995, METABOLIC MOL BASES, P4029; Cunniff C, 1995, Clin Dysmorphol, V4, P145; DYNE KM, 1993, BRIT J DERMATOL, V128, P458, DOI 10.1111/j.1365-2133.1993.tb00211.x; Elefteriou F, 1999, EUR J BIOCHEM, V263, P840, DOI 10.1046/j.1432-1327.1999.00563.x; FLACHOWSKY S, 1990, ZBL GYNAKOL, V112, P1369; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; Gibson MA, 1999, J BIOL CHEM, V274, P13060, DOI 10.1074/jbc.274.19.13060; Gibson MA, 1996, J BIOL CHEM, V271, P1096, DOI 10.1074/jbc.271.2.1096; HARTSFIELD JK, 1990, AM J MED GENET, V37, P465, DOI 10.1002/ajmg.1320370408; HOFFMAN GS, 1991, ARTHRITIS RHEUM, V34, P1466; Karrer S, 2000, ACTA DERM-VENEREOL, V80, P56; LAPIERE CM, 1981, J INVEST DERMATOL, V76, P422; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LINCH DC, 1979, BRIT DENT J, V147, P95, DOI 10.1038/sj.bdj.4804291; MCKUSICK VA, 1972, HERITABLE DISORDERS, P292; NELSON DL, 1981, J AM ACAD DERMATOL, V5, P297, DOI 10.1016/S0190-9622(81)70095-1; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Olesen B H, 1987, Tandlaegebladet, V91, P313; Papapanou P N, 1996, Ann Periodontol, V1, P1, DOI 10.1902/annals.1996.1.1.1; Pepin M, 2000, NEW ENGL J MED, V342, P673, DOI 10.1056/NEJM200003093421001; Piette E, 1980, Acta Stomatol Belg, V77, P217; Pope FM, 1997, J MED GENET, V34, P400, DOI 10.1136/jmg.34.5.400; RIEDL M, 1989, DEUT ZAHNAERZTL Z, V44, P289; Schalkwijk J, 2001, NEW ENGL J MED, V345, P1167, DOI 10.1056/NEJMoa002939; Spranger S, 1996, AM J MED GENET, V66, P239, DOI 10.1002/(SICI)1096-8628(19961211)66:2<239::AID-AJMG23>3.3.CO;2-U; Stewart R E, 1977, Birth Defects Orig Artic Ser, V13, P85	30	31	31	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2003	73	1					198	204		10.1086/376416	http://dx.doi.org/10.1086/376416			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	696UA	12776252	Bronze, Green Published			2022-12-18	WOS:000183904900017
J	Saito-Ohara, F; Fukuda, Y; Ito, M; Agarwala, KL; Hayashi, M; Matsuo, M; Imoto, I; Yamakawa, K; Nakamura, Y; Inazawa, J				Saito-Ohara, F; Fukuda, Y; Ito, M; Agarwala, KL; Hayashi, M; Matsuo, M; Imoto, I; Yamakawa, K; Nakamura, Y; Inazawa, J			The Xq22 inversion breakpoint interrupted a novel Ras-like GTPase gene in a patient with Duchenne muscular dystrophy and profound mental retardation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PELIZAEUS-MERZBACHER-DISEASE; NUCLEOTIDE EXCHANGE FACTOR; PROTEOLIPID PROTEIN GENE; INTELLECTUAL IMPAIRMENT; MUTATIONS; KINASE; CELLS; IDENTIFICATION; FAMILIES	A male patient with profound mental retardation, athetosis, nystagmus, and severe congenital hypotonia (Duchenne muscular dystrophy [DMD]) was previously shown to carry a pericentric inversion of the X chromosome, 46, Y, inv(X)(p21.2q22.2). His mother carried this inversion on one X allele. The patient's condition was originally misdiagnosed as cerebral palsy, and only later was it diagnosed as DMD. Because the DMD gene is located at Xp21.2, which is one breakpoint of the inv( X), and because its defects are rarely associated with severe mental retardation, the other clinical features of this patient were deemed likely to be associated with the opposite breakpoint at Xq22. Our precise molecular-cytogenetic characterization of both breakpoints revealed three catastrophic genetic events that had probably influenced neuromuscular and cognitive development: deletion of part of the DMD gene at Xp21.2, duplication of the human proteolipid protein gene (PLP) at Xq22.2, and disruption of a novel gene. The latter sequence, showing a high degree of homology to the Sec4 gene of yeast, encoded a putative small guanine-protein, Ras-like GTPase that we have termed "RLGP." Immunocytochemistry located RLGP at mitochondria. We speculate that disruption of RLGP was responsible for the patient's profound mental retardation.	Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Bunkyo Ku, Tokyo 1138519, Japan; Tokyo Metropolitan Bokutoh Hosp, Dept Pediat, Tokyo, Japan; Tokyo Metropolitan Inst Neurosci, Dept Clin Pathol, Tokyo, Japan; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan; RIKEN, Brain Sci Inst, Neurogenet Lab, Wako, Saitama, Japan; Kobe Univ, Sch Med, Int Ctr Med Res, Div Genet, Kobe, Hyogo 650, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; University of Tokyo; RIKEN; Kobe University	Inazawa, J (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.		imoto, Issei/D-8065-2012; Imoto, Issei/AAD-5799-2020; Yamakawa, Kazuhiro/N-5050-2015	Yamakawa, Kazuhiro/0000-0002-1478-4390; Imoto, Issei/0000-0002-4150-7938				Alimsardjono H., 1995, American Journal of Human Genetics, V57, pA335; ARIYAMA T, 1995, CANCER GENET CYTOGEN, V81, P20, DOI 10.1016/0165-4608(94)00197-9; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; Bandoh T, 1987, Rinsho Shinkeigaku, V27, P692; Bardoni A, 2000, NEUROMUSCULAR DISORD, V10, P194, DOI 10.1016/S0960-8966(99)00108-X; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; BUSHBY KMD, 1995, DEV MED CHILD NEUROL, V37, P260; Chelly J, 2001, NAT REV GENET, V2, P669, DOI 10.1038/35088558; Chinnery PF, 1999, J MED GENET, V36, P425; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; DENSLOW ND, 1991, J BIOL CHEM, V266, P9586; DUBOWITZ V, 1965, ARCH DIS CHILD, V40, P296, DOI 10.1136/adc.40.211.296; Felisari G, 2000, NEUROLOGY, V55, P559, DOI 10.1212/WNL.55.4.559; HERBST DS, 1980, AM J MED GENET, V7, P461, DOI 10.1002/ajmg.1320070407; Imoto I, 2001, CANCER RES, V61, P6629; INAZAWA J, 1993, GENOMICS, V17, P153, DOI 10.1006/geno.1993.1297; Inoue K, 1999, ANN NEUROL, V45, P624, DOI 10.1002/1531-8249(199905)45:5<624::AID-ANA11>3.3.CO;2-T; Jin H, 1996, NAT GENET, V14, P177, DOI 10.1038/ng1096-177; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; NATARAJA R, 1998, GENE, V215, P259; RENIER WO, 1981, ACTA NEUROPATHOL, V54, P11, DOI 10.1007/BF00691328; SAITO F, 1995, CYTOGENET CELL GENET, V68, P45, DOI 10.1159/000133885; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Sistermans EA, 1998, NEUROLOGY, V50, P1749, DOI 10.1212/WNL.50.6.1749; Sleer LS, 2000, BBA-BIOMEMBRANES, V1463, P99, DOI 10.1016/S0005-2736(99)00185-6; Stevenson RE, 2000, AM J MED GENET, V97, P174, DOI 10.1002/1096-8628(200023)97:3<174::AID-AJMG1034>3.0.CO;2-4; Thomson M, 1998, PLACENTA, V19, P209, DOI 10.1016/S0143-4004(98)90010-8; Toniolo D, 2000, AM J MED GENET, V97, P221, DOI 10.1002/1096-8628(200023)97:3<221::AID-AJMG1040>3.0.CO;2-Q; Trivier E, 1996, NATURE, V384, P567, DOI 10.1038/384567a0; Wibawa T, 2000, BRAIN DEV-JPN, V22, P107, DOI 10.1016/S0387-7604(99)00126-6; WORDEN DK, 1962, PEDIATRICS, V29, P968; Zemni R, 2000, NAT GENET, V24, P167, DOI 10.1038/72829; Zheng Y, 1996, J BIOL CHEM, V271, P33169, DOI 10.1074/jbc.271.52.33169	33	31	34	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2002	71	3					637	645		10.1086/342208	http://dx.doi.org/10.1086/342208			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	584VN	12145744	Green Published, Bronze			2022-12-18	WOS:000177489600018
J	Krebsova, A; Kuster, W; Lestringant, GG; Schulze, B; Hinz, B; Frossard, PM; Reis, A; Hennies, HC				Krebsova, A; Kuster, W; Lestringant, GG; Schulze, B; Hinz, B; Frossard, PM; Reis, A; Hennies, HC			Identification, by homozygosity mapping, of a novel locus for autosomal recessive congenital ichthyosis on chromosome 17p, and evidence for further genetic heterogeneity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LAMELLAR ICHTHYOSIS; KERATINOCYTE TRANSGLUTAMINASE; EPIDERMAL-KERATINOCYTES; I GENE; MUTATIONS; TRANSCRIPTION; EXPRESSION; ENVELOPE; ELEMENTS; MAP	Autosomal recessive congenital ichthyosis (ARCI) comprises a group of severe disorders of keratinization, characterized by variable erythema and skin scaling. It is known for its high degree of genetic and clinical heterogeneity. Mutations in the gene for keratinocyte transglutaminase (TGM1) on chromosome 14q11 were shown in patients with ARCI, and a second locus was described, on chromosome 2q, in families from northern Africa. Three other loci for ARCI, on chromosomes 3p and 19p, were identified recently. We have embarked on a whole-genome scan for further loci for ARCI in four families from Germany, Turkey, and the United Arab Emirates. A novel ARCI locus was identified on chromosome 17p, between the markers at D17S938 and D17S1856, with a maximum LOD score of 3.38, at maximum recombination fraction 0.00, at D17S945, under heterogeneity. This locus is linked to the disease in the Turkish family and in the German family. Extensive genealogical studies revealed that the parents of the German patients with ARCI were eighth cousins. By homozygosity mapping, the localization of the gene could then be refined to the 8.4-cM interval between D17S938 and D17S1879. It could be shown, however, that ARCI in the two Arab families is linked neither to the new locus on chromosome 17p nor to one of the five loci known previously. Our findings give evidence of further genetic heterogeneity that is not linked to distinctive phenotypes.	Max Delbruck Ctr Mol Med, Dept Mol Genet, D-13125 Berlin, Germany; Max Delbruck Ctr Mol Med, Gene Mapping Ctr, D-13125 Berlin, Germany; Humboldt Univ, Charite, Inst Human Genet, Berlin, Germany; TOMESA Clin, Bad Salzschlirf, Germany; Tawam Hosp, Dept Dermatol, Al Ain, U Arab Emirates; Fac Med & Hlth Sci, Dept Pathol, Al Ain, U Arab Emirates; Praxis Humangenet, Hannover, Germany; Univ Erlangen Nurnberg, Inst Human Genet, Nurnberg, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; United Arab Emirates University; University of Erlangen Nuremberg	Hennies, HC (corresponding author), Max Delbruck Ctr Mol Med, Dept Mol Genet, Robert Rossle Str 10, D-13125 Berlin, Germany.		Hennies, Hans C/G-9424-2014; Reis, André/D-2309-2009	Hennies, Hans C/0000-0001-7210-2389; Reis, André/0000-0002-6301-6363				AESCHLIMANN D, 1994, THROMB HAEMOSTASIS, V71, P402; Bale SJ, 1996, J INVEST DERMATOL, V107, P808, DOI 10.1111/1523-1747.ep12330566; Bhat A, 1999, HUM HERED, V49, P229, DOI 10.1159/000022879; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Eckert RL, 1997, J INVEST DERMATOL, V109, P501, DOI 10.1111/1523-1747.ep12336477; Fischer J, 2000, AM J HUM GENET, V66, P904, DOI 10.1086/302814; Hennies HC, 1998, HUM GENET, V102, P314, DOI 10.1007/s004390050697; Hennies HC, 1998, AM J HUM GENET, V62, P1052, DOI 10.1086/301818; Hohl D, 1998, J INVEST DERMATOL, V110, P268, DOI 10.1046/j.1523-1747.1998.00132.x; HUBER M, 1995, J INVEST DERMATOL, V105, P653, DOI 10.1111/1523-1747.ep12324122; HUBER M, 1995, SCIENCE, V267, P525, DOI 10.1126/science.7824952; Kanekura T, 1998, J INVEST DERMATOL, V111, P634, DOI 10.1046/j.1523-1747.1998.00340.x; Kawabe S, 1998, J INVEST DERMATOL, V111, P1098, DOI 10.1046/j.1523-1747.1998.00441.x; Kim SY, 1998, EXP MOL MED, V30, P257, DOI 10.1038/emm.1998.38; KUBILUS J, 1984, MOL CELL BIOCHEM, V58, P129, DOI 10.1007/BF00240612; Laiho E, 1999, EUR J HUM GENET, V7, P625, DOI 10.1038/sj.ejhg.5200353; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LORAND L, 1984, MOL CELL BIOCHEM, V58, P9, DOI 10.1007/BF00240602; Medvedev A, 1999, J BIOL CHEM, V274, P3887, DOI 10.1074/jbc.274.6.3887; Ott J., 1991, ANAL HUMAN GENETIC L; Parmentier L, 1999, EUR J HUM GENET, V7, P77, DOI 10.1038/sj.ejhg.5200271; PARMENTIER L, 1995, HUM MOL GENET, V4, P1391, DOI 10.1093/hmg/4.8.1391; PARMENTIER L, 1996, HUM MOL GENET, V5, P55; PETERSON LL, 1983, J INVEST DERMATOL, V81, pS95, DOI 10.1111/1523-1747.ep12540777; Polakowska RR, 1999, J CELL BIOCHEM, V73, P355; Raghunath M, 1998, ARCH DERMATOL RES, V290, P621, DOI 10.1007/s004030050362; Robinson NA, 1997, J BIOL CHEM, V272, P12035, DOI 10.1074/jbc.272.18.12035; RUSSELL LJ, 1995, NAT GENET, V9, P279, DOI 10.1038/ng0395-279; Sandler B, 1998, J CUTAN PATHOL, V25, P116, DOI 10.1111/j.1600-0560.1998.tb01699.x; TRAUPE H, 1979, ICHTHYOSES GUIDE CLI; Virolainen E, 2000, AM J HUM GENET, V66, P1132, DOI 10.1086/302813	33	31	33	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2001	69	1					216	222		10.1086/321284	http://dx.doi.org/10.1086/321284			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XM	11398099	Green Published, Bronze			2022-12-18	WOS:000170108100022
J	Lee, N; Daly, MJ; Delmonte, T; Lander, ES; Xu, FH; Hudson, TJ; Mitchell, GA; Morin, CC; Robinson, BH; Rioux, JD				Lee, N; Daly, MJ; Delmonte, T; Lander, ES; Xu, FH; Hudson, TJ; Mitchell, GA; Morin, CC; Robinson, BH; Rioux, JD			A genomewide linkage-disequilibrium scan localizes the Saguenay-Lac-Saint-Jean cytochrome oxidase deficiency to 2p16	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY; MITOCHONDRIAL RESPIRATORY-CHAIN; RECESSIVE SPASTIC ATAXIA; C-OXIDASE; CHARLEVOIX-SAGUENAY; SEQUENCE-ANALYSIS; FRENCH-CANADIANS; COX DEFICIENCY; LEIGH-SYNDROME; QUEBEC	Leigh syndrome (LS) affects 1/40,000 newborn infants in the worldwide population and is characterized by the presence of developmental delay and lactic acidosis and by a mean life expectancy variously estimated at 3-5 years. Saguenay-Lac-Saint-Jean (SLSJ) cytochrome oxidase (COX) deficiency (LS French-Canadian type [LSFC] [MIM 220111]), an autosomal recessive form of congenital lactic acidosis, presents with developmental delay and hypotonia. It is an LS variant that is found in a geographically isolated region of Quebec and that occurs in 1/2,178 live births. Patients with LSFC show a phenotype similar to that of patients with LS, but the two groups differ in clinical presentation. We studied DNA samples from 14 patients with LSFC and from their parents, representing a total of 13 families. Because of founder effects in the SLSJ region, considerable linkage disequilibrium (LD) was expected to surround the LSFC mutation. We therefore performed a genomewide screen for LD, using 290 autosomal microsatellite markers. A single marker, D2S1356, located on 2p16, showed significant (P < 10(-5)) genomewide LD. Using high-resolution genetic mapping with additional markers and four additional families with LSFC, we were able to identify a common ancestral haplotype and to limit the critical region to <similar to>2 cM between D2S119 and D2S2174. COX7AR, a gene encoding a COX7a-related protein, had previously been mapped to this region. We determined the genomic structure and resequenced this gene in patients with LSFC and in controls but found no functional mutations. Although the LSFC gene remains to be elucidated, the present study demonstrates the feasibility of using a genomewide LD strategy to localize the critical region for a rare genetic disease in a founder population.	Hosp Sick Children, Res Inst, Metab Res Programme, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Biochem, Toronto, ON, Canada; Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada; MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; McGill Univ, Hlth Ctr Res Inst, Montreal Genome Ctr, Montreal, PQ, Canada; Hop St Justine, Serv Genet Med, Montreal, PQ H3T 1C5, Canada; Chicoutimi Hosp, Dept Pediat, Chicoutimi, PQ, Canada; Chicoutimi Hosp, Res Clin Unit, Chicoutimi, PQ, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); McGill University; Universite de Montreal	Robinson, BH (corresponding author), Hosp Sick Children, Res Inst, Metab Res Programme, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	bhr@sickkids.on.ca	Daly, Mark J/B-2453-2017; Rioux, John D/A-9599-2015	Daly, Mark J/0000-0002-0949-8752; Rioux, John D/0000-0001-7560-8326; Hudson, Thomas/0000-0002-1376-4849; Lee, Nana/0000-0002-3315-6744				BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Brinkmann B, 1998, AM J HUM GENET, V62, P1408, DOI 10.1086/301869; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Couture P, 1999, ATHEROSCLEROSIS, V143, P145, DOI 10.1016/S0021-9150(98)00267-6; Dahl HHM, 1998, AM J HUM GENET, V63, P1594, DOI 10.1086/302169; De Braekeleer M, 1998, CLIN GENET, V53, P44, DOI 10.1034/j.1399-0004.1998.531530108.x; DEBRAEKELEER M, 1991, HUM HERED, V41, P141, DOI 10.1159/000153992; DEBRAEKELEER M, 1993, GENET EPIDEMIOL, V10, P17, DOI 10.1002/gepi.1370100103; GAVREAU D, 1988, REV HIST AM FR, V42, P167; Glerum DM, 1999, METALS AND GENETICS, P237; GROMPE M, 1994, NEW ENGL J MED, V331, P353, DOI 10.1056/NEJM199408113310603; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HAWKINS TL, 1994, NUCLEIC ACIDS RES, V22, P4543, DOI 10.1093/nar/22.21.4543; HEYER E, 1995, AM J HUM GENET, V56, P970; Heyer E, 1999, HUM BIOL, V71, P99; Jette R., 1991, HIST GENOME POPULATI, P75; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Labuda M, 1996, AM J HUM GENET, V59, P633; Lee N, 1998, BBA-MOL BASIS DIS, V1406, P1, DOI 10.1016/S0925-4439(98)00003-9; McEachern G, 2000, BIOCHEM BIOPH RES CO, V273, P359, DOI 10.1006/bbrc.2000.2933; MERANTE F, 1993, AM J HUM GENET, V53, P481; MONTPETIT VJ, 1971, BRAIN, V94, P1, DOI 10.1093/brain/94.1.1; MORIN C, 1993, AM J HUM GENET, V53, P488; Morin C, 1999, ANN NEUROL, V45, P389, DOI 10.1002/1531-8249(199903)45:3<389::AID-ANA16>3.0.CO;2-B; Papadopoulou LC, 1999, NAT GENET, V23, P333; Petruzzella V, 1998, GENOMICS, V54, P494, DOI 10.1006/geno.1998.5580; PINCUS JH, 1972, DEV MED CHILD NEUROL, V14, P87; Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798; Richter A, 1999, AM J HUM GENET, V64, P768, DOI 10.1086/302274; Rioux JD, 1998, AM J HUM GENET, V63, P1086, DOI 10.1086/302053; ROBINSON BH, 1993, BIOCHIM BIOPHYS ACTA, V1182, P231, DOI 10.1016/0925-4439(93)90064-8; Segade F, 1996, J BIOL CHEM, V271, P12343, DOI 10.1074/jbc.271.21.12343; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150; Valnot I, 2000, AM J HUM GENET, V67, P1104; Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245; Watanabe T, 1998, MOL CELL BIOL, V18, P442, DOI 10.1128/MCB.18.1.442; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804	38	31	32	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2001	68	2					397	409		10.1086/318197	http://dx.doi.org/10.1086/318197			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	394LD	11156535	Green Published, Bronze			2022-12-18	WOS:000166524800010
J	McMullan, TFW; Collins, AR; Tyers, AG; Robinson, DO				McMullan, TFW; Collins, AR; Tyers, AG; Robinson, DO			A novel X-linked dominant condition: X-linked congenital isolated ptosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE MAP; GENE	We present a large family with a previously undescribed condition: X-linked dominant congenital bilateral isolated ptosis. Linkage analysis defined a critical region between Xq24 and Xq27.1, with a maximum single-point LOD score of 2.88 at DXS1047 and DXS984. Male and female family members are equally affected, providing an example of an X-linked, truly dominant condition.	Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury SP2 8BJ, Wilts, England; Salisbury Dist Hosp, Dept Ophthalmol, Salisbury SP2 8BJ, Wilts, England; Univ Southampton, Southampton Gen Hosp, Dept Human Genet, Southampton, Hants, England	Salisbury District Hospital; Salisbury District Hospital; University of Southampton	McMullan, TFW (corresponding author), Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury SP2 8BJ, Wilts, England.		Collins, Andrew/S-2196-2019; Collins, Andrew/A-6595-2010	Collins, Andrew/0000-0001-7108-0771; Collins, Andrew/0000-0001-7108-0771				COHEN MA, 1972, ARCH OPHTHALMOL-CHIC, V87, P161; Collins A, 1996, GENOMICS, V36, P157, DOI 10.1006/geno.1996.0436; Engle EC, 1997, AM J HUM GENET, V60, P1150; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; PEGORARO E, 1994, AM J HUM GENET, V54, P989; RAO DC, 1977, HUM HERED, V27, P99, DOI 10.1159/000152856; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; SHIELDS DC, 1991, P NATL ACAD SCI USA, V88, P6501, DOI 10.1073/pnas.88.15.6501; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI	9	31	34	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2000	66	4					1455	1460		10.1086/302860	http://dx.doi.org/10.1086/302860			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QP	10739771	Bronze, Green Published			2022-12-18	WOS:000088373400031
J	Lee, YA; Stevens, HP; Delaporte, E; Wahn, U; Reis, A				Lee, YA; Stevens, HP; Delaporte, E; Wahn, U; Reis, A			A gene for an autosomal dominant scleroatrophic syndrome predisposing to skin cancer (Huriez syndrome) maps to chromosome 4q23	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							SQUAMOUS-CELL CARCINOMA; EPIDERMAL GROWTH-FACTOR; FACTOR RECEPTOR; HUMAN GENOME; KERATODERMA; LINKAGE; TRENDS		Humboldt Univ, Charite, Inst Human Genet, D-13353 Berlin, Germany; Max Delbruck Ctr Mol Med, Gene Mapping Ctr, Berlin, Germany; Humboldt Univ, Charite, Dept Pediat Pneumol & Immunol, D-13353 Berlin, Germany; St Bartholomews & Royal London Sch Med & Dent, Acad Dept Dermatol, London, England; Barnet Gen Hosp, Dept Dermatol, Barnet, Herts, England; Hop Claude Huriez, Serv Dermatol A, Lille, France	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of London; Queen Mary University London; Universite de Lille - ISITE; CHU Lille	Reis, A (corresponding author), Humboldt Univ, Charite, Inst Human Genet, Campus Virchow,Augustenburger Pl 1, D-13353 Berlin, Germany.	andre.reis@charite.de	Reis, André/D-2309-2009	Reis, André/0000-0002-6301-6363				BRISSENDEN JE, 1984, NATURE, V310, P781, DOI 10.1038/310781a0; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; CARPENTER G, 1979, ANNU REV BIOCHEM, V48, P193, DOI 10.1146/annurev.bi.48.070179.001205; DELAPORTE E, 1995, BRIT J DERMATOL, V133, P409, DOI 10.1111/j.1365-2133.1995.tb02669.x; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FISCHER S, 1978, ANN DERMATOL VENER, V105, P1079; FLEMING M D, 1990, Journal of Burn Care and Rehabilitation, V11, P460, DOI 10.1097/00004630-199009000-00016; Gray DT, 1997, ARCH DERMATOL, V133, P735, DOI 10.1001/archderm.133.6.735; Grossman D, 1997, ARCH DERMATOL, V133, P1263, DOI 10.1001/archderm.133.10.1263; Hagiwara Keisuke, 1996, Journal of Dermatology (Tokyo), V23, P883; Hamm H, 1996, BRIT J DERMATOL, V134, P512; HURIEZ C, 1968, SEM HOP [PARIS], V44, P481; JACKSON R, 1975, CAN MED ASSOC J, V113, P396; Kavanagh GM, 1997, BRIT J DERMATOL, V137, P114, DOI 10.1046/j.1365-2133.1997.17791866.x; Kim JW, 1996, GYNECOL ONCOL, V60, P283, DOI 10.1006/gyno.1996.0039; LAMBERT D, 1977, ANN DERMATOL VENER, V104, P654; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Lee CS, 1997, PATHOLOGY, V29, P251, DOI 10.1080/00313029700169005; LEVI F, 1995, BRIT J CANCER, V72, P1047, DOI 10.1038/bjc.1995.460; MITRA AB, 1994, CANCER RES, V54, P4481; NACHBAR F, 1993, ACTA DERM-VENEREOL, V73, P217; Ozturk MA, 1998, DERMATOL SURG, V24, P777; Pershouse MA, 1997, ONCOGENE, V14, P369, DOI 10.1038/sj.onc.1200836; Pfeiffer P, 1998, BRIT J CANCER, V78, P96, DOI 10.1038/bjc.1998.448; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Shaw M, 1978, Med Cutan Ibero Lat Am, V6, P291; SPRINGER EA, 1991, J DERMATOL SURG ONC, V17, P20, DOI 10.1111/j.1524-4725.1991.tb01588.x; Stevens HP, 1996, ARCH DERMATOL, V132, P640, DOI 10.1001/archderm.132.6.640; Stewart EA, 1997, GENOME RES, V7, P422, DOI 10.1101/gr.7.5.422; YANO H, 1991, CANCER, V67, P91, DOI 10.1002/1097-0142(19910101)67:1<91::AID-CNCR2820670118>3.0.CO;2-A	30	31	31	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2000	66	1					326	330		10.1086/302718	http://dx.doi.org/10.1086/302718			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279FK	10631162	Bronze, Green Published			2022-12-18	WOS:000085033600033
J	Young, TL; Woods, MO; Parfrey, PS; Green, JS; Hefferton, D; Davidson, WS				Young, TL; Woods, MO; Parfrey, PS; Green, JS; Hefferton, D; Davidson, WS			A founder effect in the Newfoundland population reduces the Bardet-Biedl syndrome I (BBS1) interval to 1 cM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM ANALYSIS; TYPE-1 MEN1 REGION; SYNDROME LOCUS; GENE; DNA; FAMILIES; MARKERS; 11Q13	Bardet-Biedl syndrome (BBS) is a rare, autosomal recessive disorder; major phenotypic findings include dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal anomalies. In the majority of northern European families with BBS, the syndrome is linked to a 26-cM region on chromosome 11q13. However, the finding, so far, of five distinct BBS loci (BBS1, 1q; BBS2, 16q; BBS3, 3p; BBS4, 15q; BBS5, 2q) has hampered the positional cloning of these genes. We use linkage disequilibrium (LD) mapping in an isolated founder population in Newfoundland to significantly reduce the BBS1 critical region. Extensive haplotyping in several unrelated BBS families of English descent revealed that the affected members were homozygous for overlapping portions of a rare, disease-associated ancestral haplotype on chromosome 11q13. The LD data suggest that the BBS1 gene lies in a 1-Mb, sequence-ready region on chromosome 11q13, which should enable its identification.	Mem Univ Newfoundland, Fac Med, St Johns, NF A1B 3V9, Canada; Simon Fraser Univ, Inst Biochem & Mol Biol, Burnaby, BC V5A 1S6, Canada	Memorial University Newfoundland; Simon Fraser University	Young, TL (corresponding author), Mem Univ Newfoundland, Fac Med, St Johns, NF A1B 3V9, Canada.			Young, Terry-Lynn/0000-0003-4673-6470				Beales PL, 1997, J MED GENET, V34, P92, DOI 10.1136/jmg.34.2.92; BEAR JC, 1988, AM J MED GENET, V29, P649, DOI 10.1002/ajmg.1320290324; Bruford EA, 1997, GENOMICS, V41, P93, DOI 10.1006/geno.1997.4613; CARMI R, 1995, HUM MOL GENET, V4, P9, DOI 10.1093/hmg/4.1.9; Cooper PR, 1997, GENOMICS, V41, P185, DOI 10.1006/geno.1997.4660; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Froggatt NJ, 1999, J MED GENET, V36, P97; GREEN JS, 1989, NEW ENGL J MED, V321, P1002, DOI 10.1056/NEJM198910123211503; Groenewald JZ, 1998, AM J HUM GENET, V62, P1254, DOI 10.1086/301833; Guru SC, 1997, GENOMICS, V42, P436, DOI 10.1006/geno.1997.4783; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; JORDE LB, 1995, AM J HUM GENET, V56, P11; KWITEKBLACK AE, 1993, NAT GENET, V5, P392, DOI 10.1038/ng1293-392; Labuda M, 1996, AM J HUM GENET, V59, P633; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LEPPERT M, 1994, NAT GENET, V7, P108, DOI 10.1038/ng0594-108; LITT M, 1993, BIOTECHNIQUES, V15, P280; Manickam P, 1997, HUM GENET, V101, P102, DOI 10.1007/s004390050595; MANION JJ, 1977, PEOPLING NEWFOUNDLAN; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; ODea D, 1996, AM J KIDNEY DIS, V27, P776, DOI 10.1016/S0272-6386(96)90513-2; Olufemi SE, 1998, HUM MUTAT, V11, P264, DOI 10.1002/(SICI)1098-1004(1998)11:4<264::AID-HUMU2>3.3.CO;2-M; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SHEFFIELD VC, 1994, HUM MOL GENET, V3, P1331, DOI 10.1093/hmg/3.8.1331; Woods MO, 1999, GENOMICS, V55, P2, DOI 10.1006/geno.1998.5626; Xiong MM, 1997, AM J HUM GENET, V60, P1513, DOI 10.1086/515475; Young TL, 1999, AM J HUM GENET, V64, P900, DOI 10.1086/302301	27	31	32	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1680	1687		10.1086/302686	http://dx.doi.org/10.1086/302686			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577922	Green Published, Bronze			2022-12-18	WOS:000084282500023
J	Winick, JD; Blundell, ML; Galke, BL; Salam, AA; Leal, SM; Karayiorgou, M				Winick, JD; Blundell, ML; Galke, BL; Salam, AA; Leal, SM; Karayiorgou, M			Homozygosity mapping of the achromatopsia locus in the pingelapese	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BLUE CONE MONOCHROMACY; LINKAGE-DISEQUILIBRIUM; 1-CM INTERVAL; DNA; GENE	Achromatopsia, or total color blindness (also referred to as "rod monochromacy"), is a severe retinal disorder characterized clinically by an inability to distinguish colors, impaired visual acuity in daylight, photophobia, and nystagmus. Inherited as an autosomal recessive trait, achromatopsia is rare in the general population (1:20,000-1:50,000). Among the Pingelapese people of the Eastern Caroline Islands, however, the disorder occurs at an extremely high frequency, as recounted in Oliver Sacks's popular book The Island of the Colorblind: 4%-10% of this island population have the disorder and similar to 30% carry the gene. This extraordinary enrichment of the disease allele most likely resulted from a sharp reduction in population in the late 18th century, in the aftermath of a typhoon and subsequent geographic and cultural isolation. To obtain insights into the genetic basis of achromatopsia, as well as into the genetic history of this region of Micronesia, a genome-wide search for linkage was performed in three Pingelapese kindreds with achromatopsia. A two-step search was used with a DNA pooling strategy, followed by genotyping of individual family members. Genetic markers that displayed a shift toward homozygosity in the affected DNA pool were used to genotype individual members of the kindreds, and an achromatopsia locus was identified on 8q21-q22. A maximal multipoint LOD score of 9.5 was observed with marker D8S1707. Homozygosity was seen for three adjacent markers (D8S275, D8S1119, and D8S1707), whereas recombination was observed with the flanking markers D8S1757 and D8S270, defining the outer boundaries of the disease-gene locus that spans a distance of <6.5 cM.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Karayiorgou, M (corresponding author), Rockefeller Univ, 1230 York Ave,Box 313, New York, NY 10021 USA.							Arbour NC, 1997, HUM MOL GENET, V6, P689, DOI 10.1093/hmg/6.5.689; Brennan TMH, 1998, AM J HUM GENET, V62, P355, DOI 10.1086/301708; BRODY JA, 1970, LANCET, V1, P1253; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; CARR RE, 1971, AM J OPHTHALMOL, V72, P746, DOI 10.1016/0002-9394(71)90013-4; FRANCOIS J, 1961, HEREDITY OPHTHALMOLO, P198; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390; HUSSELS IE, 1972, AM J HUM GENET, V24, P304; JAGER W, 1972, HDB SENSORY PHYSL, P625; Kohl S, 1998, NAT GENET, V19, P257, DOI 10.1038/935; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEWIS RA, 1987, ARCH OPHTHALMOL-CHIC, V105, P1055, DOI 10.1001/archopht.1987.01060080057028; MILUNSKY A, 1998, AM J HUM GENET S, V63, pA301; NATHANS J, 1989, SCIENCE, V245, P831, DOI 10.1126/science.2788922; Nystuen A, 1996, HUM MOL GENET, V5, P525, DOI 10.1093/hmg/5.4.525; Parvari R, 1998, AM J HUM GENET, V63, P163, DOI 10.1086/301915; Sacks O., 1998, ISLAND COLORBLIND; Scott DA, 1996, AM J HUM GENET, V59, P385; SHARPE LT, 1990, NIGHT VISION BASIC C; SHEFFIELD VC, 1995, CURR OPIN GENET DEV, V5, P335, DOI 10.1016/0959-437X(95)80048-4; SHEFFIELD VC, 1994, HUM MOL GENET, V3, P1331, DOI 10.1093/hmg/3.8.1331; Stockton DW, 1998, HUM GENET, V103, P328, DOI 10.1007/s004390050825; Wang CY, 1997, AM J HUM GENET, V60, P1461, DOI 10.1086/515469; WEEKS DE, 1995, AM J HUM GENET, V56, P1506; Wissinger B, 1998, AM J HUM GENET, V63, P1257, DOI 10.1086/302127; Wissinger B, 1998, GENOMICS, V51, P325, DOI 10.1006/geno.1998.5390	26	31	32	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1999	64	6					1679	1685		10.1086/302423	http://dx.doi.org/10.1086/302423			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	203FA	10330355	Bronze, Green Published			2022-12-18	WOS:000080696200020
J	McHale, DP; Mitchell, S; Bundey, S; Moynihan, L; Campbell, DA; Woods, CG; Lench, NJ; Mueller, RF; Markham, AF				McHale, DP; Mitchell, S; Bundey, S; Moynihan, L; Campbell, DA; Woods, CG; Lench, NJ; Mueller, RF; Markham, AF			A gene for autosomal recessive symmetrical spastic cerebral palsy maps to chromosome 2q24-25	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; FAMILIES; CHILDREN	Cerebral palsy has an incidence of similar to 1/500 births, although this varies between different ethnic groups. Genetic forms of the disease account for similar to 1%-2% of cases in most countries but contribute a larger proportion in populations with extensive inbreeding. We have clinically characterized consanguineous families with multiple children affected by symmetrical spastic cerebral palsy, to locate recessive genes responsible for this condition. The eight families studied were identified from databases of patients in different regions of the United Kingdom. After ascertainment and clinical assessment, we performed a genomewide search for linkage, using 290 polymorphic DNA markers. In three families, a region of homozygosity at chromosome 2q24-q25 was identified between the markers D2S124 and D2S148. The largest family gave a maximum LOD score of 3.0, by multipoint analysis (HOMOZ). The maximum combined multipoint LOD score for the three families was 5.75. The minimum region of homozygosity is similar to 5 cM between the markers D2S124 and D2S2284. We have shown that a proportion of autosomal recessive symmetrical spastic cerebral palsy maps to chromosome 2q24-25. The identification of genes involved in the etiology of cerebral palsy may lead to improved management of this clinically intractable condition.	Univ Leeds, St James Univ Hosp, Mol Med Unit, Leeds LS9 7TF, W Yorkshire, England; St James Univ Hosp, Yorkshire Reg Genet Serv, Leeds LS9 7TF, W Yorkshire, England; Univ Birmingham, Birmingham Womens Hosp, Clin Genet Unit, Birmingham, W Midlands, England	Saint James's University Hospital; University of Leeds; Saint James's University Hospital; Birmingham Women's Hospital; University of Birmingham	McHale, DP (corresponding author), Univ Leeds, St James Univ Hosp, Mol Med Unit, Clin Sci Bldg, Leeds LS9 7TF, W Yorkshire, England.	mrpdpm@leeds.ac.uk	woods, christopher g/A-1361-2010; Lench, Nicholas/AAB-1791-2021	Lench, Nicholas/0000-0002-6108-0759	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BLAIR E, 1988, J PEDIATR-US, V112, P515, DOI 10.1016/S0022-3476(88)80161-6; BUNDEY S, 1977, DEV MED CHILD NEUROL, V19, P179; BUNDEY S, 1978, DEV MED CHILD NEUROL, V20, P390; Bundey Sarah, 1993, European Journal of Human Genetics, V1, P206; GUSTAVSON KH, 1969, ACTA PAEDIATR SCAND, V58, P330, DOI 10.1111/j.1651-2227.1969.tb04729.x; HAGBERG B, 1972, ACTA PAEDIATR SCAND, P1; Hagberg B, 1993, RECENT ADV PAEDIATRI, P67; HUGHES I, 1992, DEV MED CHILD NEUROL, V34, P80; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; Mitchell S, 1997, CLIN GENET, V51, P7; OTT J, 1976, AM J HUM GENET, V28, P528; PHAROAH POD, 1987, ARCH DIS CHILD, V62, P379, DOI 10.1136/adc.62.4.379; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; STANLEY FJ, 1994, EARLY HUM DEV, V36, P81, DOI 10.1016/0378-3782(94)90035-3	14	31	31	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					526	532		10.1086/302237	http://dx.doi.org/10.1086/302237			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973289	Bronze, Green Published			2022-12-18	WOS:000078740600021
J	Huntriss, J; Daniels, R; Bolton, V; Monk, M				Huntriss, J; Daniels, R; Bolton, V; Monk, M			Imprinted expression of SNRPN in human preimplantation embryos	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRADER-WILLI-SYNDROME; GENE; HUMAN-CHROMOSOME-15; MECHANISMS; ANGELMAN; REGION	Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are two clinically distinct neurogenetic disorders arising from a loss of expression of imprinted genes within the human chromosome region 15q11-q13. Recent evidence suggests that the SNRPN gene, which is defective in PWS, plays a central role in the imprinting-center regulation of the PWS/AS region. To increase our understanding of the regulation of expression of this imprinted gene, we have develop ed single-cell-sensitive procedures for the analysis of expression of the SNRPN gene during early human development. Transcripts of SNRPN were detected in human oocytes and at all stages of preimplantation development analyzed. Using embryos heterozygous for a polymorphism within the SNRPN gene, we showed that monoallelic expression from the paternal allele occurs by the 4-cell stage. Thus, the imprinting epigenetic information inherited in the gametes is recognized already in the preimplantation embryo. The demonstration of monoallelic expression in embryos means that efficient preimplantation diagnosis of PWS may be made by analysis for the presence or absence of SNRPN mRNA.	Inst Child Hlth, Mol Embryol Unit, London WC1N 1EH, England; Univ London Kings Coll, Dept Obstet & Gynaecol, Kings Assisted Concept Unit, London WC2R 2LS, England	University of London; University College London; University of London; King's College London	Huntriss, J (corresponding author), Inst Child Hlth, Mol Embryol Unit, 30 Guilford St, London WC1N 1EH, England.							BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; CATTANACH BM, 1992, NAT GENET, V2, P270, DOI 10.1038/ng1292-270; Dittrich B, 1996, NAT GENET, V14, P163, DOI 10.1038/ng1096-163; GIACALONE J, 1994, HUM MOL GENET, V3, P379, DOI 10.1093/hmg/3.2.379; Glenn CC, 1997, MOL HUM REPROD, V3, P321, DOI 10.1093/molehr/3.4.321; Huq AHMM, 1997, GENOME RES, V7, P642, DOI 10.1101/gr.7.6.642; LATHAM KE, 1995, DEV BIOL, V168, P670, DOI 10.1006/dbio.1995.1111; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; Lerchner W, 1997, MECH DEVELOP, V61, P141, DOI 10.1016/S0925-4773(96)00630-2; Lighten AD, 1997, NAT GENET, V15, P122, DOI 10.1038/ng0297-122; MCALLISTER G, 1988, P NATL ACAD SCI USA, V85, P5296, DOI 10.1073/pnas.85.14.5296; REED ML, 1994, NAT GENET, V6, P163, DOI 10.1038/ng0294-163; Shemer R, 1997, P NATL ACAD SCI USA, V94, P10267, DOI 10.1073/pnas.94.19.10267; Szabo PE, 1995, GENE DEV, V9, P3097, DOI 10.1101/gad.9.24.3097; Wevrick R, 1996, LANCET, V348, P1068, DOI 10.1016/S0140-6736(96)04342-5	15	31	35	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					1009	1014		10.1086/302039	http://dx.doi.org/10.1086/302039			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9758597	Bronze, Green Published			2022-12-18	WOS:000076577800013
J	Brown, GM; Leversha, M; Hulten, M; Ferguson-Smith, MA; Affara, NA; Furlong, RA				Brown, GM; Leversha, M; Hulten, M; Ferguson-Smith, MA; Affara, NA; Furlong, RA			Genetic analysis of meiotic recombination in humans by use of sperm typing: Reduced recombination within a heterozygous paracentric inversion of chromosome 9q32-q34.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MALE CARRIER; CHIASMA FREQUENCY; SINGLE-SPERM; PERICENTRIC-INVERSION; TRANSLOCATION HETEROZYGOTE; SYNAPTONEMAL COMPLEXES; LINKAGE MAP; SEGREGATION; REGION; CONSTRUCTION	To investigate patterns of genetic recombination within a heterozygous paracentric inversion of chromosome 9 (46XY inv[9] [q32q34.3]), we performed sperm typing using a series of polymorphic microsatellite markers spanning the inversion region. For comparison, two donors with cytogenetically normal chromosomes 9, one of whom was heterozygous for a pericentric chromosome 2 inversion (46XY inv[2] [p11q13]), were also tested. Linkage analysis was performed by use of the multilocus linkage-analysis program SPERM, and also CRI-MAP, which was adapted for sperm-typing data, Analysis of the controls generated a marker order in agreement with previously published data and revealed no significant interchromosomal effects of the inv(2) on recombination on chromosome 9. FISH employing cosmids containing appropriate chromosome 9 markers was used to localize the inversion breakpoint of inv(9). Analysis of inv(9) sperm was performed by use of a set of microsatellite markers that mapped centromeric to, telomeric to, and within the inversion breakpoints. Three distinct patterns of recombination across the region were observed. Proximal to the centromeric breakpoint, recombination was similar to normal levels. Distal to the telomeric breakpoint, there was an increase in recombination found in the inversion patient. Finally, within the inversion, recombination was dramatically reduced, but several apparent double recombinants were found. A putative model explaining these data is proposed.	Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; Sanger Ctr, Cambridge, England; Birmingham Heartlands Hosp, NHS Trust, Reg Genet Lab, Birmingham B9 5ST, W Midlands, England	University of Cambridge; Wellcome Trust Sanger Institute; Heart of England NHS Foundation Trust; University of Birmingham	Furlong, RA (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	raf17@mole.bio.cam.ac.uk			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ATTWOOD J, 1994, GENOMICS, V19, P203, DOI 10.1006/geno.1994.1049; BATANIAN J, 1987, HUM GENET, V76, P81; CHADOV BF, 1994, GENETIKA+, V30, P1633; Colls P, 1997, CHROMOSOME RES, V5, P457, DOI 10.1023/A:1018464929628; CUI XF, 1989, P NATL ACAD SCI USA, V86, P9389, DOI 10.1073/pnas.86.23.9389; FURLONG RA, 1993, AM J HUM GENET, V52, P1191; GOLDMAN ASH, 1993, CYTOGENET CELL GENET, V63, P16, DOI 10.1159/000133493; GOLDMAN ASH, 1993, CHROMOSOMA, V102, P102, DOI 10.1007/BF00356027; HARRIS RM, 1993, GENOMICS, V15, P265, DOI 10.1006/geno.1993.1056; He L, 1996, PSYCHIATR GENET, V6, P201, DOI 10.1097/00041444-199624000-00006; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LAURIE DA, 1985, ANN HUM GENET, V49, P189, DOI 10.1111/j.1469-1809.1985.tb01693.x; LAURIE DA, 1985, ANN HUM GENET, V49, P203, DOI 10.1111/j.1469-1809.1985.tb01694.x; LAURIE DA, 1984, HUM GENET, V68, P235, DOI 10.1007/BF00418394; LAURIE DA, 1981, CYTOGENET CELL GENET, V31, P153, DOI 10.1159/000131641; LAZZERONI LC, 1994, AM J HUM GENET, V55, P431; Leeflang E. P., 1995, American Journal of Human Genetics, V57, pA29; Leeflang EP, 1996, AM J HUM GENET, V59, P896; LEVERSHA MA, 1997, GENOME MAPPING PRACT, P199; LI HH, 1988, NATURE, V335, P414, DOI 10.1038/335414a0; LUCHESSI JC, 1976, GENET BIOL DROSOPHIL, P315; MADAN K, 1995, HUM GENET, V96, P503; MARTIN RH, 1986, HUM GENET, V73, P97, DOI 10.1007/BF00291594; PARK C, 1995, GENOMICS, V27, P113, DOI 10.1006/geno.1995.1012; Povey S, 1997, ANN HUM GENET, V61, P183, DOI 10.1017/S0003480097006106; SAADALLAH N, 1986, ANN HUM GENET, V50, P369, DOI 10.1111/j.1469-1809.1986.tb01758.x; SCHMITT K, 1994, AM J HUM GENET, V55, P423; Takiyama Y, 1997, HUM MOL GENET, V6, P1063, DOI 10.1093/hmg/6.7.1063; WINSOR EJT, 1978, CYTOGENET CELL GENET, V20, P169, DOI 10.1159/000130849; Yu J, 1996, AM J HUM GENET, V59, P1186; ZAHN LM, 1995, GENOMICS, V28, P140, DOI 10.1006/geno.1995.1124; ZETKA MC, 1992, GENETICS, V131, P321; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847; ZHANG L, 1995, HUM MOL GENET, V4, P303, DOI 10.1093/hmg/4.2.303; ZHOU CY, 1995, GENOMICS, V25, P304, DOI 10.1016/0888-7543(95)80143-A	37	31	35	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1484	1492		10.1086/301863	http://dx.doi.org/10.1086/301863			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585591	Green Published, Bronze			2022-12-18	WOS:000074174700026
J	Dushay, MS; Eldon, ED				Dushay, MS; Eldon, ED			Drosophila immune responses as models for human immunity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							KAPPA-B; DIFFERENTIAL DISPLAY; GENE; IDENTIFICATION; SYSTEM		Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame	Eldon, ED (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.		Dushay, Mitchell/B-1029-2009					ASLING B, 1995, INSECT BIOCHEM MOLEC, V25, P511, DOI 10.1016/0965-1748(94)00091-C; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Braun A, 1997, GENETICS, V147, P623; COCIANCICH S, 1994, PARASITOL TODAY, V10, P132, DOI 10.1016/0169-4758(94)90260-7; Dushay MS, 1996, P NATL ACAD SCI USA, V93, P10343, DOI 10.1073/pnas.93.19.10343; ENGSTROM Y, 1993, J MOL BIOL, V232, P327, DOI 10.1006/jmbi.1993.1392; Ezekowitz RAB, 1998, AM J HUM GENET, V62, P6, DOI 10.1086/301696; Faye Ingrid, 1993, P25; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; Fearon DT, 1977, NATURE, V388, P323, DOI DOI 10.1038/40967; FERRANDON D, 1997, ANN DROS RES C, V38, P15; Hoffmann JA, 1997, TRENDS CELL BIOL, V7, P309, DOI 10.1016/S0962-8924(97)01087-8; IP YT, 1993, CELL, V75, P753, DOI 10.1016/0092-8674(93)90495-C; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Rodriguez A, 1996, GENETICS, V143, P929; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; SUN SC, 1992, EUR J BIOCHEM, V204, P885, DOI 10.1111/j.1432-1033.1992.tb16708.x; SWINGLER S, 1994, BIOCHEM BIOPH RES CO, V203, P623, DOI 10.1006/bbrc.1994.2228; Williams MJ, 1997, EMBO J, V16, P6120, DOI 10.1093/emboj/16.20.6120; Yang YO, 1997, GENE DEV, V11, P1621, DOI 10.1101/gad.11.13.1621	24	31	33	0	6	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1998	62	1					10	14		10.1086/301694	http://dx.doi.org/10.1086/301694			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YY246	9443887	hybrid, Green Published			2022-12-18	WOS:000072127900003
J	Alcais, A; Abel, L; David, C; Torrez, ME; Flandre, P; Dedet, JP				Alcais, A; Abel, L; David, C; Torrez, ME; Flandre, P; Dedet, JP			Evidence for a major gene controlling susceptibility to tegumentary leishmaniasis in a recently exposed Bolivian population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMERICAN CUTANEOUS LEISHMANIASIS; REGRESSIVE LOGISTIC-MODELS; MUCOCUTANEOUS LEISHMANIASIS; NATURAL-RESISTANCE; MUCOSAL LEISHMANIASIS; FAMILIAL DISEASES; UNIFIED MODEL; PEDIGREE DATA; INFECTION; MICE	Tegumentary leishmaniasis due to Leishmania braziliensis is a parasitic disease that occurs in two stages after the infected sandfly bite: (1) a primary cutaneous lesion followed by (2) a secondary mucosal involvement generally resulting in severe facial deformities. In order to investigate the genetic and environmental factors involved in the development of the cutaneous lesion, a familial study was performed in a region of Bolivia in which the disease is endemic. Complete selection of 118 nuclear families (703 subjects, with 241 patients), each with at least one cutaneous affected subject, was achieved; 41 families were of native origin, and 77 (herein designated ''migrant'') recently had settled in the area. For the analysis, the trait under study was the time to onset of the primary cutaneous lesion. The start of the follow-up was birth, for native population, or date of arrival in the endemic area, for migrant population. Segregation analysis was performed by use of a model based on survival analysis methods that allows joint estimation of genetic and environmental effects and accounts for gene x covariate interactions. A significant effect of gender, home-forest distance, and forest-related activity was found. in the 77 migrant families there was evidence for a recessive major gene controlling the onset of the primary cutaneous lesion, with residual familial dependences and age x genotype interaction. Penetrance estimations show that young subjects are genetically more susceptible than older subjects, suggesting that this genetic component could concern mechanisms involved in the development of individual protection during childhood. There was also a significant genetic heterogeneity of the sample according to the native/migrant origin of the families, and no major-gene effect was found in the native subsample.	CHU PITIE SALPETRIERE, INSERM, U436, PARIS, FRANCE; IBBA, LA PAZ, BOLIVIA; INSERM, SC10, VILLEJUIF, FRANCE; UNIV MONTPELLIER 1, LAB ECOL MED & PATHOL PARASITAIRE, F-34006 MONTPELLIER, FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universidad Mayor de San Andres; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier			Abel, Laurent/H-8888-2017; Alcais, Alexandre/J-5882-2017; Flandre, Philippe/N-6314-2017	Abel, Laurent/0000-0001-7016-6493; Alcais, Alexandre/0000-0002-1012-2226; Flandre, Philippe/0000-0002-2612-3522	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NCRR NIH HHS [1 P41 RR03655] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ABEL L, 1990, GENET EPIDEMIOL, V7, P391, DOI 10.1002/gepi.1370070602; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alcais A, 1997, AM J TROP MED HYG, V57, P79, DOI 10.4269/ajtmh.1997.57.79; ANTOINE JC, 1995, PATHOL BIOL, V43, P215; BARBIER D, 1987, TISSUE ANTIGENS, V30, P63, DOI 10.1111/j.1399-0039.1987.tb01598.x; BLACKWELL J, 1980, NATURE, V283, P72, DOI 10.1038/283072a0; BLACKWELL JM, 1985, CURR TOP MICROBIOL I, V122, P227; BONNEY GE, 1986, BIOMETRICS, V42, P611, DOI 10.2307/2531211; BRADLEY DJ, 1979, CLIN EXP IMMUNOL, V37, P7; BRADLEY DJ, 1974, NATURE, V250, P353, DOI 10.1038/250353a0; CABELLO PH, 1995, AM J TROP MED HYG, V52, P364, DOI 10.4269/ajtmh.1995.52.364; CABRERA M, 1995, J EXP MED, V182, P1259, DOI 10.1084/jem.182.5.1259; CELLIER M, 1994, J EXP MED, V180, P1741, DOI 10.1084/jem.180.5.1741; CHANG KP, 1978, J EXP MED, V147, P515, DOI 10.1084/jem.147.2.515; CRONIN T M, 1987, Paleontological Society Memoir, P1; DAVID C, 1993, T ROY SOC TROP MED H, V87, P7, DOI 10.1016/0035-9203(93)90398-A; DAVIES CR, 1995, EPIDEMIOL INFECT, V114, P297, DOI 10.1017/S0950268800057964; DEDET JP, 1995, B WORLD HEALTH ORGAN, V73, P339; DEMENAIS F, 1986, AM J HUM GENET, V38, P228; DEMENAIS F, 1989, GENET EPIDEMIOL, V6, P229, DOI 10.1002/gepi.1370060140; DEMENAIS FM, 1991, AM J HUM GENET, V49, P773; DEMENAIS FM, 1992, GENET EPIDEMIOL, V9, P419, DOI 10.1002/gepi.1370090605; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; ELSTON RC, 1979, AM J HUM GENET, V31, P62; ELSTON RC, 1986, 7 INT C HUM GEN BERL; FINE PEM, 1981, INT J LEPROSY, V49, P437; Guler ML, 1996, SCIENCE, V271, P984, DOI 10.1126/science.271.5251.984; HOWARD JG, 1980, PARASITE IMMUNOL, V2, P303, DOI 10.1111/j.1365-3024.1980.tb00061.x; JONES TC, 1987, J INFECT DIS, V156, P73, DOI 10.1093/infdis/156.1.73; LARA ML, 1991, HUM IMMUNOL, V30, P129, DOI 10.1016/0198-8859(91)90081-J; Llanos-Cuentas E. A., 1984, Revista da Sociedade Brasileira de Medicina Tropical, V17, P169, DOI 10.1590/S0037-86821984000400003; Marquet S, 1996, NAT GENET, V14, P181, DOI 10.1038/ng1096-181; MARSDEN PD, 1986, T ROY SOC TROP MED H, V80, P859, DOI 10.1016/0035-9203(86)90243-9; PETZLERLER ML, 1991, HUM IMMUNOL, V32, P254, DOI 10.1016/0198-8859(91)90088-Q; PIRMEZ C, 1993, J CLIN INVEST, V91, P1390, DOI 10.1172/JCI116341; REVELLO S, 1992, T R SOC TROP MED HYG, V86, P388; RIOUX JA, 1990, ANN PARASIT HUM COMP, V65, P111, DOI 10.1051/parasite/1990653111; ROBERTS M, 1993, EUR J IMMUNOGENET, V20, P349, DOI 10.1111/j.1744-313X.1993.tb00154.x; ROBERTS M, 1989, INFECT IMMUN, V57, P875, DOI 10.1128/IAI.57.3.875-881.1989; SCHURR E, 1989, J IMMUNOL, V142, P4507; SHAW MA, 1995, AM J HUM GENET, V57, P1159; SKAMENE E, 1982, NATURE, V297, P506, DOI 10.1038/297506a0; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; WALTON BC, 1979, ANN TROP MED PARASIT, V73, P23, DOI 10.1080/00034983.1979.11687222	45	31	34	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1997	61	4					968	979		10.1086/514882	http://dx.doi.org/10.1086/514882			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YA591	9382111	Green Published, Bronze			2022-12-18	WOS:A1997YA59100027
J	Jarman, PR; Wood, NW; Davis, MT; Davis, PV; Bhatia, KP; Marsden, CD; Davis, MB				Jarman, PR; Wood, NW; Davis, MT; Davis, PV; Bhatia, KP; Marsden, CD; Davis, MB			Hereditary geniospasm: Linkage to chromosome 9q13-q21 and evidence for genetic heterogeneity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IDIOPATHIC TORSION DYSTONIA; POTASSIUM CHANNEL GENE; PERIODIC PARALYSIS; ESSENTIAL TREMOR; TREMBLING CHIN; CHOREOATHETOSIS; MUTATIONS; FAMILY; TOXIN; ONSET	Hereditary geniospasm is an unusual movement disorder causing episodes of involuntary tremor of the chin and the lower lip. Episodes typically start in early childhood and may be precipitated by stress, concentration, and emotion. Hereditary geniospasm is inherited as an autosomal dominant trait, and its cause is not known. We report the results of a genomewide genetic linkage study in a four-generation British family with hereditary geniospasm. Positive two-point LOD scores were obtained for 15 microsatellite markers on the peri-centromeric region of chromosome 9. A maximum two-point LOD score of 5.24 at theta = .00 was obtained for the marker D9S1837. Construction of haplotypes defined an interval of 2.1 cM between the nanking markers D9S1806 and D9S175, thus assigning one locus for hereditary geniospasm to the proximal long arm of chromosome 9q13-q21. Hereditary geniospasm in a second British family is not linked to this region, indicating genetic heterogeneity. These findings may have implications for other inherited focal movement disorders that as yet remain unmapped.	UNIV LONDON,INST NEUROL,DEPT CLIN NEUROL,LONDON WC1N 3BG,ENGLAND; UNIV ALBERTA,DEPT FAMILY MED,EDMONTON,AB T6G 2M7,CANADA	University of London; University College London; University of Alberta			Wood, Nicholas W/C-2505-2009	Wood, Nicholas W/0000-0002-9500-3348	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALSAGER DE, 1991, CLIN GENET, V40, P186; Auburger G, 1996, GENOMICS, V31, P90, DOI 10.1006/geno.1996.0013; BAIN PG, 1994, BRAIN, V117, P805, DOI 10.1093/brain/117.4.805; BECKER H, 1982, ARCH PSYCHIAT NERVEN, V231, P509, DOI 10.1007/BF00343994; Biary N, 1987, Mov Disord, V2, P25, DOI 10.1002/mds.870020103; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DANEK A, 1993, MOVEMENT DISORD, V8, P335, DOI 10.1002/mds.870080314; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Fink JK, 1996, AM J HUM GENET, V59, P140; Fouad GT, 1996, AM J HUM GENET, V59, P135; GANNER H., 1935, ARCH RASS U GES BIOL, V29, P121; Goldsmith JB, 1927, J HERED, V18, P185, DOI 10.1093/oxfordjournals.jhered.a102839; GORDON K, 1993, J CHILD NEUROL, V8, P154, DOI 10.1177/088307389300800208; GROSSMAN BJ, 1957, PEDIATRICS, V19, P453; JARMAN PR, IN PRESS BRAIN; JEDYNAK CP, 1991, MOVEMENT DISORD, V6, P230, DOI 10.1002/mds.870060307; JOHNSON LF, 1971, DEV MED CHILD NEUROL, V13, P726; KRAMER PL, 1994, AM J HUM GENET, V55, P468; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LAURANCE BM, 1968, ARCH DIS CHILD, V43, P249, DOI 10.1136/adc.43.228.249; Leube B, 1996, HUM MOL GENET, V5, P1673, DOI 10.1093/hmg/5.10.1673; MASSARO D, 1894, PISANI PALERMO, V1, P47; OZELIUS L, 1989, NEURON, V2, P1427, DOI 10.1016/0896-6273(89)90188-8; Povey S, 1997, ANN HUM GENET, V61, P183, DOI 10.1017/S0003480097006106; PTACEK LJ, 1991, CELL, V67, P1021; PTACEK LJ, 1994, CELL, V77, P863; RAPOPORT A, 1991, MOVEMENT DISORD, V6, P276; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; Soland VL, 1996, MOVEMENT DISORD, V11, P744, DOI 10.1002/mds.870110626; Stocks P, 1922, BIOMETRIKA, V14, P311; WADLINGTON WB, 1958, J PEDIATR-US, V53, P316, DOI 10.1016/S0022-3476(58)80218-8; WELT C, 1990, J COMP NEUROL, V291, P621, DOI 10.1002/cne.902910409	33	31	31	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1997	61	4					928	933		10.1086/514883	http://dx.doi.org/10.1086/514883			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YA591	9382105	Green Published, Bronze			2022-12-18	WOS:A1997YA59100021
J	Mignot, E				Mignot, E			Genetics of narcolepsy and other sleep disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							RESTLESS LEGS SYNDROME; RECOMBINANT INBRED STRAINS; FATAL FAMILIAL INSOMNIA; TWINS LIVING APART; BRED LONG-SLEEP; PARADOXICAL SLEEP; APNEA SYNDROME; LOCOMOTOR-ACTIVITY; CIRCADIAN CLOCK; THALAMIC NUCLEI				Mignot, E (corresponding author), STANFORD UNIV, DEPT PSYCHIAT & BEHAV SCI,CTR NARCOLEPSY, MSLS BLDG,1201 WELCH RD, ROOM P112, STANFORD, CA 94305 USA.		Tafti, Mehdi/A-8887-2017	Tafti, Mehdi/0000-0002-6997-3914	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS023724, P01NS023724] Funding Source: NIH RePORTER; NINDS NIH HHS [NS23724] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABE K, 1966, ACTA PAEDOPSYCHIATR, V33, P339; ABE K, 1984, AM J PSYCHIAT, V141, P800; ADICKES ED, 1986, HUM GENET, V73, P39; ALDRICH MS, 1992, NEUROLOGY, V42, P34; Ambrosetto C, 1965, Riv Patol Nerv Ment, V86, P244; ANGST J, 1989, EUR ARCH PSY CLIN N, V238, P285, DOI 10.1007/BF00449810; ANOKHIN A, 1992, HUM GENET, V90, P99; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Baker TL, 1985, BRAIN MECH SLEEP, P199; BAKWIN H, 1970, LANCET, V2, P466; BELL CC, 1986, J NATL MED ASSOC, V78, P649; BENCA RM, 1991, PHYSIOL BEHAV, V49, P83, DOI 10.1016/0031-9384(91)90235-G; BILLIARD M, 1994, SLEEP, V17, pS54, DOI 10.1093/sleep/17.suppl_8.S54; BORNSTEIN B, 1961, PSYCHIAT NEUROL, V141, P165; BROUGHTON RJ, 1968, SCIENCE, V159, P1070, DOI 10.1126/science.159.3819.1070; BYRNE E, 1991, J NEUROL NEUROSUR PS, V54, P1090, DOI 10.1136/jnnp.54.12.1090; Carlander B., 1993, Neurophysiologie Clinique, V23, P15, DOI 10.1016/S0987-7053(05)80279-5; CARSKADON M A, 1990, Pediatrician, V17, P5; CARSKADON MA, 1993, CHILD NERV SYST, V9, P452, DOI 10.1007/BF00393547; CHALLAMEL MJ, 1994, SLEEP, V17, pS17, DOI 10.1093/sleep/17.suppl_8.S17; Chapman J, 1996, NEUROLOGY, V46, P758, DOI 10.1212/WNL.46.3.758; CHILSHLOM RC, 1985, SLEEP RES, V15, P113; CRABBE JC, 1994, SCIENCE, V264, P1715, DOI 10.1126/science.8209252; DALHITZ M, 1992, J SLEEP RES S1, V1, P52; DALY DD, 1959, P STAFF M MAYO CLIN, V34, P313; DEBRAY C, 1973, ANN MED INTERNE, V124, P927; DEFIEBRE CM, 1992, J PHARMACOL EXP THER, V261, P173; DEFIEBRE CM, 1992, ALCOHOL CLIN EXP RES, V16, P511; DEFRIES JC, 1989, ALCOHOL CLIN EXP RES, V13, P196, DOI 10.1111/j.1530-0277.1989.tb00310.x; DEMENT WC, 1973, SLEEP RES, V2, P147; Drennan M, 1992, SOC NEUR ABSTR, V8, P196; DUDEK BC, 1984, BEHAV GENET, V14, P1, DOI 10.1007/BF01066065; DUDEK BC, 1995, ALCOHOL CLIN EXP RES, V19, P802, DOI 10.1111/j.1530-0277.1995.tb00950.x; Dunlap JC, 1996, ANNU REV GENET, V30, P579, DOI 10.1146/annurev.genet.30.1.579; DUNLAP JC, 1993, ANNU REV PHYSIOL, V55, P583; EDGAR DM, 1991, NEUROSCI LETT, V125, P125, DOI 10.1016/0304-3940(91)90007-G; Ekbom KA, 1960, NEUROLOGY, V10, P868, DOI 10.1212/WNL.10.9.868; ELBAYADI S, 1990, CHEST, V98, P554, DOI 10.1378/chest.98.3.554; ERWIN VG, 1990, ALCOHOL CLIN EXP RES, V14, P200, DOI 10.1111/j.1530-0277.1990.tb00472.x; ERWIN VG, 1988, J PHARMACOL EXP THER, V247, P857; FERINISTRAMBI L, 1995, RESP MED, V89, P337, DOI 10.1016/0954-6111(95)90004-7; FISCHER H, 1993, KLIN PADIATR, V205, P166, DOI 10.1055/s-2007-1025220; FREDRIKSON S, 1990, ACTA NEUROL SCAND, V81, P253; FRIEDMAN.JK, 1974, PHYSIOL BEHAV, V12, P169, DOI 10.1016/0031-9384(74)90169-3; GASTAUT H, 1965, REV NEUROL, V112, P573; GEDDA L, 1983, ACTA GENET MED GEMEL, V32, P17, DOI 10.1017/S0001566000008114; GELARDI JAM, 1967, J NEUROL NEUROSUR PS, V30, P455, DOI 10.1136/jnnp.30.5.455; Gelineau J, 1880, GAZ HOPITAUX, V53, P735; Gelineau JBE, 1880, GAZ HOP PARIS, V54, P635; GEORGE CFP, 1991, SLEEP, V14, P267; GOLDBERG R, 1980, AM J MED GENET, V5, P73, DOI 10.1002/ajmg.1320050110; GOLDFARB LG, 1992, SCIENCE, V258, P806, DOI 10.1126/science.1439789; GOODE G B, 1962, Arch Neurol, V6, P228; GREENBERG F, 1991, AM J HUM GENET, V49, P1207; GUILLEMINAULT C, 1995, CHEST, V107, P1545, DOI 10.1378/chest.107.6.1545; GUILLEMINAULT C, 1989, LANCET, V2, P1376; GUILLEMINAULT C, 1975, WESTERN J MED, V123, P7; HALL JC, 1995, TRENDS NEUROSCI, V18, P230, DOI 10.1016/0166-2236(95)93908-G; Hall JC, 1996, NEURON, V17, P799, DOI 10.1016/S0896-6273(00)80211-1; Hall M J, 1995, Curr Opin Pulm Med, V1, P512, DOI 10.1097/00063198-199511000-00014; HALLSTROM T, 1972, ACTA PSYCHIAT SCAND, V48, P350, DOI 10.1111/j.1600-0447.1972.tb04375.x; HARTMANN E, 1989, PRINCIPLES PRACTICE, P385; HARTSE K M, 1988, Henry Ford Hospital Medical Journal, V36, P24; HAURI P, 1989, PRINCIPLES PRACTICE, P442; HEATH AC, 1990, SLEEP, V13, P318, DOI 10.1093/sleep/13.4.318; Higurashi M, 1986, Birth Defects Orig Artic Ser, V22, P251; HOFSTETTER JR, 1995, BEHAV GENET, V25, P545, DOI 10.1007/BF02327578; HONDA Y, 1983, SLEEP RES, V12, P254; Honda Y., 1990, HDB SLEEP DISORDERS, P217; Honda Y., 1979, SLEEP RES, V8, P191; HORI A, 1986, JPN J PSYCHIAT NEUR, V40, P35; HORI A, 1995, SLEEP RES A, V24, P324; HRUBEC Z, 1984, NEW ENGL J MED, V310, P435, DOI 10.1056/NEJM198402163100706; Hublin C, 1997, NEUROLOGY, V48, P177, DOI 10.1212/WNL.48.1.177; ISHIKAWA A, 1995, MOVEMENT DISORD, V10, P482, DOI 10.1002/mds.870100413; JACOBSEN JH, 1986, SLEEP, V9, P54, DOI 10.1093/sleep/9.1.54; JOHNSON W, 1992, SLEEP RES, V21, P214; JULIEN J, 1990, REV NEUROL, V146, P173; KALES A, 1980, BRIT J PSYCHIAT, V137, P111, DOI 10.1192/bjp.137.2.111; KAPLAN J, 1991, MAYO CLIN PROC, V66, P1124, DOI 10.1016/S0025-6196(12)65792-9; KAWAKAMI Y, 1984, AM REV RESPIR DIS, V129, P703, DOI 10.1164/arrd.1984.129.5.703; Keefauver SP., 1994, PRINC PRACT SLEEP ME, P567; KENDLER KS, 1987, ARCH GEN PSYCHIAT, V44, P451; KESSLER S, 1974, ACTA NEUROL SCAND, V50, P503; KHANNA JM, 1991, PHARMACOL BIOCHEM BE, V39, P705, DOI 10.1016/0091-3057(91)90151-Q; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; KITAHAMA K, 1980, NEUROPHARMACOLOGY, V19, P529, DOI 10.1016/0028-3908(80)90022-2; Klein D.C., 1991, SUPRACHIASMATIC NUCL; KORPI ER, 1993, NATURE, V361, P356, DOI 10.1038/361356a0; KOSKENVUO M, 1985, LANCET, V1, P893; Kronholm E, 1996, J APPL PHYSIOL, V80, P14, DOI 10.1152/jappl.1996.80.1.14; KUSHIDA CA, 1989, SLEEP, V12, P22, DOI 10.1093/sleep/12.1.22; KUSHIDA CA, 1996, SLEEP RES, V25, P275; LABUDA MC, 1997, RLS FDN C WASH FEB 2; LAVIE P, 1987, SLEEP, V10, P608; LAVIGNE GJ, 1994, SLEEP, V17, P739; LE AD, 1992, J PHARMACOL EXP THER, V263, P480; LEUNG C, 1992, PHYSIOL BEHAV, V52, P127, DOI 10.1016/0031-9384(92)90441-4; LINKOWSKI P, 1993, AM J PHYSIOL, V264, pE173, DOI 10.1152/ajpendo.1993.264.2.E173; LINKOWSKI P, 1991, ELECTROEN CLIN NEURO, V79, P114, DOI 10.1016/0013-4694(91)90048-9; Linkowski P, 1992, Clin Neuropharmacol, V15 Suppl 1 Pt A, p42A; LINKOWSKI P, 1989, ELECTROEN CLIN NEURO, V73, P279, DOI 10.1016/0013-4694(89)90106-5; LUGARESI E, 1992, NEUROLOGY, V42, P28; LUGARESI E, 1986, NEW ENGL J MED, V315, P997, DOI 10.1056/NEJM198610163151605; Mahowald MW, 1994, PRINCIPLES PRACTICE, P574; MANETTO V, 1992, NEUROLOGY, V42, P312, DOI 10.1212/WNL.42.2.312; MANNI R, 1991, ACTA NEUROL SCAND, V84, P498, DOI 10.1111/j.1600-0404.1991.tb05002.x; MANONESPAILLAT R, 1988, NEUROLOGY, V38, P190, DOI 10.1212/WNL.38.2.190; MARINI G, 1988, NEUROSCI LETT, V85, P223, DOI 10.1016/0304-3940(88)90355-2; Markel PD, 1996, BEHAV GENET, V26, P447, DOI 10.1007/BF02359489; MARLEY RJ, 1988, PHARMACOL BIOCHEM BE, V31, P453, DOI 10.1016/0091-3057(88)90373-5; MATHUR R, 1995, ANN INTERN MED, V122, P174, DOI 10.7326/0003-4819-122-3-199502010-00003; MATSUKI K, 1992, LANCET, V339, P1052, DOI 10.1016/0140-6736(92)90571-J; MATSUKI K, 1988, IMMUNOLOGICAL FEATUR, P58; Mayeda AR, 1996, BEHAV GENET, V26, P505, DOI 10.1007/BF02359755; MCCLEARN GE, 1973, BEHAV GENET, V3, P409; MELBERG A, 1995, J NEUROL SCI, V134, P119, DOI 10.1016/0022-510X(95)00228-0; Mestel R, 1996, SCIENCE, V273, P184, DOI 10.1126/science.273.5272.184; MIGNOT E, 1995, ADV NEUROIMMUNOL, V5, P23, DOI 10.1016/0960-5428(94)00043-N; MIGNOT E, 1993, J NEUROSCI, V13, P1057; MIGNOT E, 1991, P NATL ACAD SCI USA, V88, P3475, DOI 10.1073/pnas.88.8.3475; Mignot E, 1997, TISSUE ANTIGENS, V49, P329, DOI 10.1111/j.1399-0039.1997.tb02761.x; MIGNOT E, 1992, GENETICALLY DETERMIN, P90; MIGNOT E, IN PRESS SLEEP RES; MIGNOT E, IN PRESS NEUROLOGY; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; Montagna P, 1983, SLEEP WAKE DISORDERS, P231; MONTPLAISIR J, 1985, NEUROLOGY, V35, P130, DOI 10.1212/WNL.35.1.130; MONTPLAISIR J, 1994, PRINCIPLES PRACTICE, P589; MORZORATI S, 1988, BRAIN RES BULL, V21, P101, DOI 10.1016/0361-9230(88)90124-4; *NAT I MENT HLTH, 1988, JAMA-J AM MED ASSOC, V251, P2410; NEVSIMALOVABRUH, 1973, ACTA U CAROL MED, V18, P109; NOLAN PM, 1995, GENETICS, V140, P245; OHARE JP, 1986, CLIN ENDOCRINOL, V24, P327, DOI 10.1111/j.1365-2265.1986.tb03274.x; Ohayon MM, 1996, BRIT J PSYCHIAT, V169, P459, DOI 10.1192/bjp.169.4.459; OREN J, 1987, PEDIATRICS, V80, P355; OVERSTREET DH, 1990, ALCOHOL ALCOHOLISM, V25, P59; PARTINEN M, 1983, SLEEP, V6, P179, DOI 10.1093/sleep/6.3.179; Petersen RB, 1996, J BIOL CHEM, V271, P12661, DOI 10.1074/jbc.271.21.12661; PHILLIPS TJ, 1991, ALCOHOL CLIN EXP RES, V15, P255, DOI 10.1111/j.1530-0277.1991.tb01866.x; PHILLIPS TJ, 1989, EXPERIENTIA, V45, P805, DOI 10.1007/BF01954056; PILLAR G, 1995, AM J RESP CRIT CARE, V151, P688; POIRIER G, 1986, SLEEP, V9, P153, DOI 10.1093/sleep/9.1.153; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; RALPH MR, 1988, SCIENCE, V241, P1225, DOI 10.1126/science.3413487; RECHTSCHAFFEN A, 1983, SCIENCE, V221, P182, DOI 10.1126/science.6857280; REDLINE S, 1995, AM J RESP CRIT CARE, V151, P682; Redline S, 1997, AM J RESP CRIT CARE, V155, P186, DOI 10.1164/ajrccm.155.1.9001310; ROEHRS T, 1989, PHARMACOL BIOCHEM BE, V34, P321, DOI 10.1016/0091-3057(89)90319-5; ROEMER K, 1991, NEW BIOL, V3, P331; Rogers AE, 1997, NEUROLOGY, V48, P1550, DOI 10.1212/WNL.48.6.1550; ROSENBERG RS, 1987, SLEEP, V10, P537; ROTH B, 1968, ARCH SUISSE NEUROL N, V102, P321; RUBIN RL, 1988, CLIN IMMUNOL IMMUNOP, V49, P149, DOI 10.1016/0090-1229(88)90104-3; Schenck CH, 1996, ANN NEUROL, V39, P261, DOI 10.1002/ana.410390216; SCHWARTZ WJ, 1990, J NEUROSCI, V10, P3685; Sehgal A, 1996, MOL CELL NEUROSCI, V7, P165, DOI 10.1006/mcne.1996.0013; SHIROMANI PJ, 1991, SLEEP, V14, P116; SINGH SM, 1990, LANCET, V335, P726, DOI 10.1016/0140-6736(90)90842-S; Solomon P, 1945, DIS NERV SYST, V6, P179; STALEYGANE MS, 1996, AM J HUM GENET S, V59, pA105; STEINLEIN O, 1992, GENOMICS, V12, P69, DOI 10.1016/0888-7543(92)90408-K; STERIADE M, 1992, NEUROLOGY, V42, P9; STINO FKR, 1992, PHARMACOLOGY, V44, P257, DOI 10.1159/000138927; Strang R R, 1967, Med J Aust, V1, P1211; STROHL KP, 1978, NEW ENGL J MED, V299, P969, DOI 10.1056/NEJM197811022991801; SUMMERS JA, 1992, J DEV BEHAV PEDIATR, V13, P284; Tafti M, 1996, J NEUROSCI, V16, P4588; TAKAHASHI JS, 1994, SCIENCE, V264, P1724, DOI 10.1126/science.8209253; TAKAHASHI JS, 1995, ANNU REV NEUROSCI, V18, P531, DOI 10.1146/annurev.neuro.18.1.531; THOMAS DA, 1993, AM REV RESPIR DIS, V148, P1605, DOI 10.1164/ajrccm/148.6_Pt_1.1605; THORPY MJ, 1994, PRINCIPLES PRACTICE, P426; Thorpy MJ, 1989, PRINCIPLES PRACTICE, P648; Tishler PV, 1996, AM J RESP CRIT CARE, V153, P1857, DOI 10.1164/ajrccm.153.6.8665046; Tobler I, 1996, NATURE, V380, P639, DOI 10.1038/380639a0; TODD JA, 1991, NATURE, V351, P542, DOI 10.1038/351542a0; TRAVIS J, 1992, SCIENCE, V256, P1392, DOI 10.1126/science.1351316; Trenkwalder C, 1996, MOVEMENT DISORD, V11, P389, DOI 10.1002/mds.870110407; VALATX JL, 1974, BRAIN RES, V69, P315, DOI 10.1016/0006-8993(74)90009-2; VALATX JL, 1972, NATURE, V238, P226, DOI 10.1038/238226a0; VALATX JL, 1984, EXP BRAIN RES S, V8, P135; vanBeijsterveldt CEM, 1996, AM J HUM GENET, V58, P562; VANTWYVER H, 1973, BEHAV BIOL, V9, P105, DOI 10.1016/S0091-6773(73)80173-7; VELABUENO A, 1978, WAKING SLEEPING, V2, P125; Vgontzas AN, 1996, AM J MED GENET, V67, P478; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Vogel F, 1986, HUM GENET, P590; Vossler DG, 1996, NEUROLOGY, V46, P1258, DOI 10.1212/WNL.46.5.1258; WALTERS AS, 1994, PEDIATR NEUROL, V11, P241, DOI 10.1016/0887-8994(94)90110-4; WALTERS AS, 1990, ARCH NEUROL-CHICAGO, V47, P1219, DOI 10.1001/archneur.1990.00530110079020; WALTERS AS, 1995, MOVEMENT DISORD, V10, P634, DOI 10.1002/mds.870100517; WEBB WB, 1971, PHYSIOL BEHAV, V6, P459, DOI 10.1016/0031-9384(71)90183-1; WEBB WB, 1983, ARCH GEN PSYCHIAT, V40, P1093; WEHNER JM, 1992, ALCOHOL CLIN EXP RES, V16, P522, DOI 10.1111/j.1530-0277.1992.tb01410.x; WEHNER JM, 1991, BEHAVIORAL BIOCH ISS, P80; WEISSMANN C, 1991, NATURE, V352, P679, DOI 10.1038/352679a0; WITTIG R M, 1988, Henry Ford Hospital Medical Journal, V36, P13; YOSHIZAWA T, 1993, INTERNAL MED, V32, P94, DOI 10.2169/internalmedicine.32.94; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; ZWYGHUIZENDOORENBOS A, 1990, ALCOHOL CLIN EXP RES, V14, P400, DOI 10.1111/j.1530-0277.1990.tb00494.x	200	31	32	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1997	60	6					1289	1302		10.1086/515487	http://dx.doi.org/10.1086/515487			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XE294	9199548	Green Published, Bronze			2022-12-18	WOS:A1997XE29400005
J	Adeokun, AM; West, SP; Ellis, FR; Halsall, PJ; Hopkins, PM; Foroughmand, AM; Iles, DE; Robinson, RL; Stewart, AD; Curran, JL				Adeokun, AM; West, SP; Ellis, FR; Halsall, PJ; Hopkins, PM; Foroughmand, AM; Iles, DE; Robinson, RL; Stewart, AD; Curran, JL			The G1021A substitution in the RYR1 gene does not cosegregate with malignant hyperthermia susceptibility in a British pedigree	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; HYPERKALEMIC PERIODIC PARALYSIS; DEPENDENT CALCIUM-CHANNEL; RYANODINE RECEPTOR GENE; CENTRAL CORE DISEASE; PARAMYOTONIA-CONGENITA; CHROMOSOME 19Q12-13.2; LOCUS; LOCALIZATION; CANDIDATE	A single base change in the RYR1 gene encoding the skeletal muscle ryanodine receptor (calcium-sensitive calcium-release channel of the sarcoplasmic reticulum), resulting in the substitution of G1021 by A, has been proposed to underlie malignant-hyperthermia (MH) susceptibility in as many as 10% of cases in the European population. As part of our mutation-screening program in MH-susceptible (MHS) individuals, we have investigated this substitution in individuals from 151 unrelated British MHS families and have detected G1021A heterozygotes in 7 families. This mutation was not found in 156 unrelated MH-negative (MHN) individuals. We also examined eight families with central core disease (CCD): the mutation did not occur in any family members of any disease status (affected or unaffected for CCD, MHS, or MHN). In one large family, the G1021A mutation was found but did not show complete cosegregation with MH susceptibility: it occurred in only 7/12 MHS individuals in the kinship, and susceptibility was inherited from parents who were G1021 homozygotes, as well as from parents who were heterozygotes. On the basis of these findings, it is clearly unreliable at present to offer presymptomatic DNA testing for MH status, even in families in which a mutation has been detected.	NO GENET SERV,NEWCASTLE TYNE NE2 4AA,TYNE & WEAR,ENGLAND; UNIV NEWCASTLE UPON TYNE,DEPT HUMAN GENET,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND; ST JAMES UNIV HOSP,ACAD UNIT ANAESTHESIA,LEEDS,W YORKSHIRE,ENGLAND; UNIV LEEDS,DEPT GENET,LEEDS LS2 9JT,W YORKSHIRE,ENGLAND; UNIV NIJMEGEN,DEPT CELL BIOL & HISTOL,NIJMEGEN,NETHERLANDS	Newcastle University - UK; Newcastle University - UK; Saint James's University Hospital; University of Leeds; Radboud University Nijmegen			Hopkins, Philip/ABE-5970-2020	Hopkins, Philip/0000-0002-8127-1739				BALL SP, 1993, J MED GENET, V30, P89, DOI 10.1136/jmg.30.2.89; BALL SP, 1993, BRIT J ANAESTH, V70, P70, DOI 10.1093/bja/70.1.70; COUCH FJ, 1991, NUCLEIC ACIDS RES, V19, P5094, DOI 10.1093/nar/19.18.5094; DEINARD AS, 1992, NUCLEIC ACIDS RES, V20, P1171, DOI 10.1093/nar/20.5.1171-a; DEUFEL T, 1995, AM J HUM GENET, V56, P1334; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; ELLIS FR, 1972, BMJ-BRIT MED J, V3, P559, DOI 10.1136/bmj.3.5826.559; *EMHG, 1984, BRIT J ANAESTH, V56, P1267; *EMHG, 1985, BRIT J ANAESTH, V57, P1038; GILLARD EF, 1992, GENOMICS, V13, P1247, DOI 10.1016/0888-7543(92)90042-Q; Hall-Curran Julie L., 1993, Human Mutation, V2, P330, DOI 10.1002/humu.1380020418; HARBITZ I, 1990, GENOMICS, V8, P243, DOI 10.1016/0888-7543(90)90278-3; HOPKINS PM, IN PRESS ANESTH ANAL; HOPKINS PM, 1995, PRACTICE ANAESTHESIA, P938; IAIZZO PA, 1995, ANESTHESIOLOGY, V82, P1093, DOI 10.1097/00000542-199505000-00001; ILES DE, 1993, HUM MOL GENET, V2, P863; ILES DE, 1994, HUM MOL GENET, V3, P969, DOI 10.1093/hmg/3.6.969; ILES DE, 1992, NUCLEIC ACIDS RES, V20, P1170; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; KALOW W, 1970, LANCET, V2, P895, DOI 10.1016/S0140-6736(70)92069-6; KAUSCH K, 1991, GENOMICS, V10, P765, DOI 10.1016/0888-7543(91)90461-M; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LEVITT RC, 1992, GENOMICS, V14, P562, DOI 10.1016/S0888-7543(05)80152-1; MACLENNAN DH, 1990, NATURE, V343, P559, DOI 10.1038/343559a0; MCCARTHY TV, 1990, NATURE, V343, P562, DOI 10.1038/343562a0; MCCLATCHEY AI, 1992, AM J HUM GENET, V50, P896; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MULLEY JC, 1993, AM J HUM GENET, V52, P398; *NIH CEPH COLL MAP, 1992, SCIENCE, V258, P67; OBRIEN RO, 1995, J MED GENET, V32, P913, DOI 10.1136/jmg.32.11.913; OPPENHEIM A, 1990, HUM GENET, V86, P175; Plassart Emmanuelle, 1994, European Journal of Human Genetics, V2, P110; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P689, DOI 10.1093/nar/19.3.689; QUANE KA, 1994, HUM MOL GENET, V3, P471, DOI 10.1093/hmg/3.3.471; Serfas KD, 1996, ANESTHESIOLOGY, V84, P322, DOI 10.1097/00000542-199602000-00009; SUDBRAK R, 1995, AM J HUM GENET, V56, P684; VITA GM, 1995, ANESTHESIOLOGY, V82, P1097, DOI 10.1097/00000542-199505000-00002; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P1927, DOI 10.1093/nar/18.7.1927; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WEST SP, 1996, HYPERTHERMIC HYPERME, P184	41	31	32	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1997	60	4					833	841						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WT614	9106529				2022-12-18	WOS:A1997WT61400012
J	Strathdee, G; Sutherland, R; Jonsson, JJ; Sataloff, R; KohonenCorish, M; Grady, D; Overhauser, J				Strathdee, G; Sutherland, R; Jonsson, JJ; Sataloff, R; KohonenCorish, M; Grady, D; Overhauser, J			Molecular characterization of patients with 18q23 deletions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC-LINKAGE MAP; HUMAN CHROMOSOME-18; DNA; DEFICIENCY; EXPRESSION; LIBRARIES; VECTORS; MUTANT; REGION; YEAST	The 18q(-) syndrome is a deletion syndrome that is characterized by mental retardation, hearing loss, midfacial hypoplasia, growth deficiency, and limb anomalies. Most patients with this syndrome have deletions from 18q21-qter. We report: on three patients with deletions of 18q23. A mother and daughter with identical deletions of 18q23 have many of the typical features of the 18q(-) syndrome, including midfacial hypoplasia and hearing loss. In contrast, the third patient has few of the symptoms of the 18q(-) syndrome. A contig of the 18q23 region was generated to aid in the mapping of the breakpoints. FISH was used to map both breakpoints to the same YAC clone. Furthermore, somatic-cell hybrids from the daughter and the third patient were isolated. The mapping results of sequence-tagged sites relative to the two breakpoints were identical, suggesting that the two deletion breakpoints map very close to one another. The analyses of these patients demonstrate that the critical region for the 18q(-) syndrome maps to 18q23 but that a deletion of 18q23 does not always lead to the clinical features associated with the syndrome. These patients demonstrate the wide phenotypic variability associated with deletions of 18q.	THOMAS JEFFERSON UNIV,DEPT BIOCHEM & MOL BIOL,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,DEPT OTOLARYNGOL,PHILADELPHIA,PA 19107; LOS ALAMOS NATL LAB,CTR HUMAN GENOME STUDIES,LOS ALAMOS,NM 87545; LOS ALAMOS NATL LAB,DIV LIFE SCI,LOS ALAMOS,NM 87545; YALE UNIV,DEPT GENET,NEW HAVEN,CT; AUSTRALIAN NATL UNIV,JOHN CURTIN SCH MED RES,DIV MOL MED,CANBERRA,ACT 2601,AUSTRALIA	Jefferson University; Jefferson University; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; Yale University; Australian National University; John Curtin School of Medical Research			Kohonen-Corish, Maija/Q-9763-2019	Kohonen-Corish, Maija/0000-0002-4073-1479; Strathdee, Gordon/0000-0001-9681-8429				BARBARESE E, 1983, J NEUROCHEM, V40, P160; BREUKEL C, 1990, NUCLEIC ACIDS RES, V18, P3097, DOI 10.1093/nar/18.10.3097; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; CHERNOFF GF, 1981, J HERED, V72, P128, DOI 10.1093/oxfordjournals.jhered.a109442; DE GROUCHY J, 1964, Pathol Biol, V12, P579; ESTABROOKS LL, 1995, AM J MED GENET, V55, P453, DOI 10.1002/ajmg.1320550412; FEINGOLD M, 1969, AM J DIS CHILD, V117, P129, DOI 10.1001/archpedi.1969.02100030131001; FELDING I, 1987, CLIN GENET, V31, P206; FRANCKE U, 1994, CYTOGENET CELL GENET, V66, P196, DOI 10.1159/000133697; GAMES J, 1994, CYTOGENET CELL GENET, V65, P160; GERKEN S, 1994, GENOMICS, V24, P612, DOI 10.1006/geno.1994.1679; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; KLINE AD, 1993, AM J HUM GENET, V52, P895; KLINE AD, 1992, GENOMICS, V13, P1, DOI 10.1016/0888-7543(92)90193-V; KohonenCorish M, 1996, J MED GENET, V33, P240, DOI 10.1136/jmg.33.3.240; LEDBETTER DH, 1989, P NATL ACAD SCI USA, V86, P5136, DOI 10.1073/pnas.86.13.5136; LEWKONIA RM, 1980, J MED GENET, V17, P453, DOI 10.1136/jmg.17.6.453; LIU P, 1993, CANCER GENET CYTOGEN, V65, P93, DOI 10.1016/0165-4608(93)90213-6; LONGMIRE JL, 1993, GENET ANAL-BIOMOL E, V10, P69, DOI 10.1016/1050-3862(93)90037-J; MEWAR R, 1992, AM J MED GENET, V44, P477, DOI 10.1002/ajmg.1320440418; OVERHAUSER J, 1994, HUM MOL GENET, V3, P247, DOI 10.1093/hmg/3.2.247; OVERHAUSER J, 1993, GENOMICS, V15, P387, DOI 10.1006/geno.1993.1072; QAZI QH, 1980, ANN GENET-PARIS, V23, P60; ROCH JM, 1987, MOL BRAIN RES, V3, P61, DOI 10.1016/0169-328X(87)90045-3; Sataloff RT, 1991, EMBRYOLOGY ANOMALIES; SHEPHARD EA, 1991, GENOMICS, V11, P302, DOI 10.1016/0888-7543(91)90136-3; SHINE HD, 1992, J NEUROCHEM, V58, P342, DOI 10.1111/j.1471-4159.1992.tb09316.x; SILVERMAN GA, 1993, PCR METH APPL, V3, P141; SILVERMAN GA, 1995, AM J HUM GENET, V56, P926; STRATHDEE G, 1994, AM J HUM GENET, V54, P1085; STRATHDEE G, 1995, AM J MED GENET, V59, P476, DOI 10.1002/ajmg.1320590414; STRAUB RE, 1993, GENOMICS, V15, P48, DOI 10.1006/geno.1993.1008; STRICKER RB, 1982, JAMA-J AM MED ASSOC, V248, P1359, DOI 10.1001/jama.248.11.1359; SUBRT I, 1970, HUMANGENETIK, V10, P181, DOI 10.1007/BF00295518; VANKESSEL AG, 1994, CYTOGENET CELL GENET, V65, P141; WEISS BJ, 1991, ANN NEUROL, V30, P419, DOI 10.1002/ana.410300316; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WERTELECKI W, 1971, J PEDIATR-US, V78, P44, DOI 10.1016/S0022-3476(71)80262-7; WILSON MG, 1979, AM J MED GENET, V3, P155, DOI 10.1002/ajmg.1320030207	39	31	32	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1997	60	4					860	868						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WT614	9106532				2022-12-18	WOS:A1997WT61400015
J	Tayebi, N; Cushner, S; Sidransky, E				Tayebi, N; Cushner, S; Sidransky, E			Differentiation of the glucocerebrosidase gene from pseudogene by long-template PCR: Implications for Gaucher disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							MUTATIONS		NIMH,CLIN NEUROSCI BRANCH,NIH,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)								BEUTLER E, 1992, GENOMICS, V12, P795, DOI 10.1016/0888-7543(92)90311-F; BEUTLER E, 1993, GENOMICS, V15, P203, DOI 10.1006/geno.1993.1035; Beutler E., 1995, METABOLIC MOL BASES, P2641; CHOUDARY PV, 1986, COLD SPRING HARB SYM, V51, P1047, DOI 10.1101/SQB.1986.051.01.121; HOROWITZ M, 1989, GENOMICS, V4, P87, DOI 10.1016/0888-7543(89)90319-4; IDA H, 1995, HUM GENET, V95, P717; Long GL, 1996, GENOMICS, V33, P177, DOI 10.1006/geno.1996.0181; SIDRANSKY E, 1993, JAMA-J AM MED ASSOC, V269, P1154, DOI 10.1001/jama.269.9.1154; ZIMRAN A, 1990, J CLIN INVEST, V85, P219, DOI 10.1172/JCI114415	9	31	32	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1996	59	3					740	741						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN625	8751878				2022-12-18	WOS:A1996VN62500031
J	Aronovich, EL; Pan, D; Whitley, CB				Aronovich, EL; Pan, D; Whitley, CB			Molecular genetic defect underlying alpha-L-iduronidase pseudodeficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUCOPOLYSACCHARIDOSIS TYPE-II; HURLER-SYNDROME; NONSENSE MUTATIONS; PRENATAL-DIAGNOSIS; HUNTER SYNDROME; ENZYME-ACTIVITY; IDUA GENE; EXPRESSION; DEFICIENCY; DISEASE	Mucopolysaccharidosis type I (i.e., Hurler, Hurler-Scheie, and Scheie syndromes) and type II: (i.e., Hunter syndrome) are lysosomal storage disorders resulting from alpha-L-iduronidase (IDUA) deficiency and iduronate-2-sulfatase (TDS) deficiency, respectively. The a priori probability that both disorders would occur in a single individual is similar to 1 in 5 billion. Nevertheless, such a proband was referred for whom clinical findings (i.e., a male with characteristic facies, dysostosis multiplex, and mental retardation) and biochemical tests indicated these concomitant diagnoses. In repeated studies, leukocyte 4-methylumbelliferyl-alpha-L-iduronidase activities in this kindred were as follows: <1.0 nmol/mg protein/h in the proband and proband's clinically normal sister; 45.3 in mother; and 45.7 in father (normal range 65.0-140). Leukocyte L-O-(alpha-iduronate-2-sulfate)-(1-->4)-D-0-2,5-anhydro[1-H-3]mannitol-6-sulfate activities were as follows: 0.0 U/mg protein/h in the proband; 5.7 in his sister; 4.9 in mother; and 15.0 in father (normal range 11.0-18.4). Multiple techniques, including automated sequencing of the entire IDS and IDUA coding regions, were employed to unravel the molecular genetic basis of these intriguing observations. The common IDS mutation R468W was identified in the proband, his mother, and his sister, thus explaining their biochemical phenotypes. Additionally, the proband, his sister, and his father were found to be heterozygous for a common IDUA mutation, W402X. Notably, a new IDUA mutation A300T was also identified in the proband, his sister, and his mother, accounting for reduced IDUA activity in these individuals; the asymptomatic sister, whose cells demonstrated normal glycosaminoglycan metabolism, is thus a compound heterozygote for W402X and the new allele. This A300T mutation is the first IDUA pseudodeficiency gene to be elucidated at the molecular level.	UNIV MINNESOTA,INST HUMAN GENET,GENE THERAPY PROGRAM,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,DEPT PEDIAT,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,MOLEC CELLULAR DEV BIOL & GENET PROGRAM,MINNEAPOLIS,MN 55455	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities				Aronovich, Elena/0000-0002-9713-8502				BACH G, 1993, AM J HUM GENET, V53, P330; BACH G, 1993, INT S MUCOPOLYSACCHA; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUNGE S, 1995, HUM MUTAT, V6, P91, DOI 10.1002/humu.1380060119; BUNGE S, 1994, HUM MOL GENET, V3, P861, DOI 10.1093/hmg/3.6.861; CLARKE JTR, 1990, CLIN GENET, V37, P355; CLARKE LA, 1994, GENOMICS, V24, P311, DOI 10.1006/geno.1994.1621; CLARKE LA, 1993, HUM MOL GENET, V2, P1311, DOI 10.1093/hmg/2.8.1311; CLARKE LA, 1994, HUM MUTAT, V3, P275, DOI 10.1002/humu.1380030316; Crotty Paul L., 1992, Human Molecular Genetics, V1, P755, DOI 10.1093/hmg/1.9.755; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; GATTI R, 1985, PRENATAL DIAG, V5, P149, DOI 10.1002/pd.1970050209; GORLIN RJ, 1990, SYNDROMES HEAD NECK, P99; HALL CW, 1973, ARCH BIOCHEM BIOPHYS, V155, P32, DOI 10.1016/S0003-9861(73)80006-2; HOFFMEYER S, 1994, NAT GENET, V6, P331, DOI 10.1038/ng0494-331; HOPWOOD JJ, 1990, MOL BIOL MED, V7, P381; JONSSON JJ, 1995, AM J HUM GENET, V56, P597; LEGUERN E, 1990, GENOMICS, V7, P358, DOI 10.1016/0888-7543(90)90169-U; LICHTMAN MA, 1990, HEMATOLOGY, P1742; LOWRY RB, 1990, HUM GENET, V85, P389; MARSH J, 1985, CLIN GENET, V27, P258; MOSKOWITZ SM, 1993, HUM MUTAT, V2, P71, DOI 10.1002/humu.1380020113; Neufeld EF, 1989, METABOLIC BASIS INHE, P1565; Scott Hamish S., 1992, Human Mutation, V1, P333, DOI 10.1002/humu.1380010412; SCOTT HS, 1991, P NATL ACAD SCI USA, V88, P9695, DOI 10.1073/pnas.88.21.9695; SCOTT HS, 1993, AM J HUM GENET, V53, P973; STOLTZFUS LJ, 1992, J BIOL CHEM, V267, P6570; TAYLOR HA, 1993, J INHERIT METAB DIS, V16, P1058, DOI 10.1007/BF00711533; THOMAS GH, 1994, AM J HUM GENET, V54, P934; TIEU PT, 1995, HUM MUTAT, V6, P55, DOI 10.1002/humu.1380060111; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868; WASTESON A, 1982, METHOD ENZYMOL, V83, P573; Whitley C. B., 1994, American Journal of Human Genetics, V55, pA249; Whitley C.B, 1993, MCKUSICKS HERITABLE, P367; WHITLEY CB, 1987, AM J MED GENET, V28, P233, DOI 10.1002/ajmg.1320280136; WHITLEY CB, 1986, IW ALLELE SOC INHERI; ZHANG ZX, 1994, HUM MOL GENET, V3, P139, DOI 10.1093/hmg/3.1.139	37	31	35	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1996	58	1					75	85						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TL697	8554071				2022-12-18	WOS:A1996TL69700011
J	CHENG, LSC; CARMELLI, D; HUNT, SC; WILLIAMS, RR				CHENG, LSC; CARMELLI, D; HUNT, SC; WILLIAMS, RR			EVIDENCE FOR A MAJOR GENE INFLUENCING 7-YEAR INCREASES IN DIASTOLIC BLOOD-PRESSURE WITH AGE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRENCH-CANADIAN POPULATION; SEGREGATION ANALYSIS; MODEL; PEDIGREES	The contribution of genetic factors to blood pressure levels is well established. The contribution of genes to the longitudinal change in blood pressure has been less well studied, because of the lack of longitudinal family data. The present study investigated a possible major-gene effect on the observed increase with age in diastolic blood pressure (DBP) levels. Subjects included 965 unmedicated adults (age greater than or equal to 18 years) in 73 pedigrees collected in Utah as part of a longitudinal cardiovascular family study. Segregation analysis of DBP change over 7.2 years of follow-up identified a recessive major-gene effect with a gene frequency of p = .23. There was also a significant age effect on the genotypic means, which decreased expression of the major gene at older ages. For those inferred to have the genotype responsible for large DBP increases, DBP increased 32.3%, compared with a 1.5% increase in the nonsusceptible group (P < .0001). The relative risk of developing hypertension between the susceptible and nonsusceptible groups after 7.2 years was 2.4 (P = .006). Baseline DBP reactivities to mental arithmetic (P < .0001), and isometric handgrip (P < .0001) stress tests were greatest in those assigned to the susceptible genotype. We conclude that age-related changes in DBP are influenced by a major gene. Characteristics of this major-gene effect for greater age-related blood pressure increases include greater reactivity to mental and physical stressors. The present study thus provides evidence for genetic control of changes in blood pressure, in addition to the previously suggested genetic control of absolute blood pressure level.	UNIV UTAH,SALT LAKE CITY,UT	Utah System of Higher Education; University of Utah	CHENG, LSC (corresponding author), SRI INT,HLTH SCI PROGRAM,BN134,333 RAVENSWOOD AVE,MENLO PK,CA 94025, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021088, R01HL024855] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL21088, HL24855, HL50679] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BORECKI IB, 1995, AM J HUM GENET, V56, P319; CANNINGS C, 1978, ADV APPL PROBAB, V10, P26, DOI 10.2307/1426718; COLLETTO GMDD, 1993, GENET EPIDEMIOL, V10, P533, DOI 10.1002/gepi.1370100634; DYSART JN, 1994, AM J HYPERTENS, V7, P15, DOI 10.1093/ajh/7.1.15; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; HARRAP SB, 1990, HYPERTENSION, V16, P603, DOI 10.1161/01.HYP.16.6.603; HASSTEDT SJ, 1993, PAP PEDIGREE ANAL PA; HUNT SC, 1989, AM J EPIDEMIOL, V129, P625, DOI 10.1093/oxfordjournals.aje.a115175; HUNT SC, 1994, TXB HYPERTENSION, P519; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; Lalouel JM, 1979, GEMINI COMPUTER PROG; LEW EA, 1990, HYPERTENSION PATHOPH, V1, P175; MANATUNGA AK, 1993, HYPERTENSION, V22, P84, DOI 10.1161/01.HYP.22.1.84; PERUSSE L, 1989, AM J HUM GENET, V45, P240; PERUSSE L, 1991, AM J HUM GENET, V49, P94; PROVINCE M A, 1985, Genetic Epidemiology, V2, P363, DOI 10.1002/gepi.1370020405; PROVINCE MA, 1989, GENET EPIDEMIOL, V6, P333, DOI 10.1002/gepi.1370060204; RICE T, 1990, AM J HUM GENET, V46, P37; RICE T, 1994, AM J HUM GENET, V55, P1019; TAMBS K, 1993, HYPERTENSION, V22, P789, DOI 10.1161/01.HYP.22.5.789; TROISI RJ, 1990, INT J OBESITY, V14, P515; UNGER T, 1990, HYPERTENSION, V16, P615, DOI 10.1161/01.HYP.16.6.615; VANHOOFT IM, 1988, J HYPERTENS, V6, pS594, DOI 10.1097/00004872-198812040-00186; WEISSBECKER KA, 1993, GENET EPIDEMIOL, V10, P659, DOI 10.1002/gepi.1370100655; Whelton P.K, 1994, TXB HYPERTENSION, P11; WILLIAMS RR, 1987, CONTROL CLIN TRIALS, V8, pS105; YUSUF S, 1993, J HYPERTENS, V11, pS61; 1989, J HUM HYPERTENS, V3, P279	28	31	31	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1995	57	5					1169	1177						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TA449	7485169				2022-12-18	WOS:A1995TA44900025
J	WEI, S; CHARMLEY, P; BIRCHFIELD, RI; CONCANNON, P				WEI, S; CHARMLEY, P; BIRCHFIELD, RI; CONCANNON, P			HUMAN T-CELL RECEPTOR V-BETA GENE POLYMORPHISM AND MULTIPLE-SCLEROSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHAIN GENES; GERMLINE REPERTOIRE; SUSCEPTIBILITY; ORGANIZATION; REGION; LOCUS	Population-based genetic associations have been reported between RFLPs detected with probes corresponding to the genes encoding the beta chain of the T-cell receptor for antigen (TCRB) and a variety of autoimmune disorders. In the case of multiple sclerosis (MS), these studies have localized a putative disease-associated gene to a region of similar to 110 kb in length, located within the TCRB locus. In the current study, ah 14 known TCRBV (variable region) genes within the region of localization were mapped and identified. The nucleotide sequences of these genes were determined in a panel of six MS patients and six healthy controls, who were human-leukocyte antigen and TCRB-RFLP haplotype matched. Nine of the 14 TCRBV genes studied showed evidence of polymorphism. PCR-based assays for each of these polymorphic genes were developed, and allele and genotype frequencies were determined in a panel of DNA samples from 48 MS patients and 60 control individuals. No significant differences in allele, genotype, or phenotype frequencies were observed between the MS patients and controls for any of the 14 TCRBV-gene polymorphisms studied. In light of the extensive linkage disequilibrium across the region studied, the saturating numbers of polymorphisms examined, and the direct sequence analysis of all BV genes in the region, these results suggest that it is unlikely that germ-line polymorphism in the TCRBV locus makes a major contribution to MS susceptibility. The TCRBV coding region-specific markers generated in these studies, as well as the approach of testing for associations with specific functionally relevant polymorphic sites within individual BV genes, should be useful in the evaluation of the many reported disease associations involving the human TCRB region.	VIRGINIA MASON MED CTR,VIRGINIA MASON RES CTR,SEATTLE,WA 98101; VIRGINIA MASON MED CTR,VIRGINIA MASON CLIN,SEATTLE,WA 98101; UNIV WASHINGTON,SCH MED,DEPT IMMUNOL,SEATTLE,WA	Virginia Mason Medical Center; Virginia Mason Medical Center; University of Washington; University of Washington Seattle				Concannon, Patrick/0000-0002-5801-1859	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK041347] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK41347] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BEALL SS, 1993, J NEUROIMMUNOL, V45, P53, DOI 10.1016/0165-5728(93)90163-S; BEALL SS, 1989, J NEUROIMMUNOL, V21, P59, DOI 10.1016/0165-5728(89)90159-8; CHARMLEY P, 1991, J NEUROIMMUNOL, V32, P231, DOI 10.1016/0165-5728(91)90193-B; CHARMLEY P, 1993, IMMUNOGENETICS, V38, P283; CHOTHIA C, 1988, EMBO J, V12, P3745; CONCANNON P, 1992, MANUAL CLIN LABORATO, P885; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; FUGGER L, 1990, IMMUNOGENETICS, V31, P278; HANSEN T, 1992, SCAND J IMMUNOL, V36, P285, DOI 10.1111/j.1365-3083.1992.tb03101.x; HILLERT J, 1991, J NEUROIMMUNOL, V31, P141; KRETZ KA, 1989, NUCLEIC ACIDS RES, V17, P5864, DOI 10.1093/nar/17.14.5864; LYNCH SG, 1991, ANN NEUROL, V30, P402, DOI 10.1002/ana.410300313; MARTINEZNAVES E, 1993, J NEUROIMMUNOL, V47, P9, DOI 10.1016/0165-5728(93)90279-8; NEPOM GT, 1992, AUTOIMMUNE DISEASES, P127; POSNETT DN, 1994, J EXP MED, V179, P1707, DOI 10.1084/jem.179.5.1707; ROBINSON MA, 1993, P NATL ACAD SCI USA, V90, P2433, DOI 10.1073/pnas.90.6.2433; SEBOUN E, 1989, CELL, V57, P1095, DOI 10.1016/0092-8674(89)90046-9; SLIGHTOM JL, 1994, GENOMICS, V20, P1149; VANDEVYVER C, 1994, J NEUROIMMUNOL, V52, P25, DOI 10.1016/0165-5728(94)90158-9; WEI S, 1994, HUM IMMUNOL, V41, P201, DOI 10.1016/0198-8859(94)90037-X; WEI S, 1994, IMMUNOGENETICS, V40, P27, DOI 10.1007/BF00163961; WILSON RK, 1988, IMMUNOL REV, V101, P149, DOI 10.1111/j.1600-065X.1988.tb00736.x	22	31	31	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1995	56	4					963	969						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QP663	7717407				2022-12-18	WOS:A1995QP66300018
J	VANDENBERG, IET; VANBEURDEN, EACM; MALINGRE, HEM; VANAMSTEL, HKP; POLLTHE, BT; SMEITINK, JAM; LAMERS, WH; BERGER, R				VANDENBERG, IET; VANBEURDEN, EACM; MALINGRE, HEM; VANAMSTEL, HKP; POLLTHE, BT; SMEITINK, JAM; LAMERS, WH; BERGER, R			X-LINKED LIVER PHOSPHORYLASE-KINASE DEFICIENCY IS ASSOCIATED WITH MUTATIONS IN THE HUMAN LIVER PHOSPHORYLASE-KINASE ALPHA-SUBUNIT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GLYCOGEN-STORAGE DISEASE; SKELETAL-MUSCLE; MOLECULAR-BASIS; BETA-SUBUNITS; CDNA CLONING; ISOFORM; GENE; LOCALIZATION	Two Dutch patients with liver phosphorylase kinase (PhK) deficiency were studied for abnormalities in the PhK liver alpha (alpha L) subunit mRNA by reversed-transcribed-PCR (RT-PCR) and RNase protection assays. One patient, belonging to a large Dutch family that expresses X-linked liver PhK deficiency, had a C3614T mutation in the PhK alpha(L) coding sequence. The C3614T mutation leads to replacement of proline 1205 with leucine, which changes the composition of an amino acid region, containing amino acids 1195-1214 of the PhK alpha(L) subunit, that is highly conserved in different species. The patient showed normal levels of PhK alpha(L) mRNA. The second patient, from an unrelated family, was found to have a TCT (bp 419-421) deletion in the PhK alpha(L) coding sequence, resulting in a phenylalanine 141 deletion. The same deletion was found in the PhK alpha(L) coding sequence from lymphocytes of the patient's mother, together with a normal PhK alpha(L) coding sequence. The phenylalanine that is absent in the PhK alpha(L) coding sequence of the second patient is a highly conserved amino acid between species. Both the C3614T mutation and the TCT (bp 419-421) deletion were not found in a panel of 80 control X chromosomes. On the basis of these results, it is postulated that the mutations found are responsible for liver PhK deficiency in the two patients investigated.	CLIN GENET CTR,3501 CA UTRECHT,NETHERLANDS; UNIV AMSTERDAM,ACAD MED CTR,DEPT ANAT & EMBRYOL,1105 AZ AMSTERDAM,NETHERLANDS	University of Amsterdam; Academic Medical Center Amsterdam	VANDENBERG, IET (corresponding author), WILHELMINA CHILDRENS HOSP,DEPT METAB DIS,METAB DIS LAB,NIEUWE GRACHT 137,3512 LK UTRECHT,NETHERLANDS.		Smeitink, Jan A.M./D-6064-2011; Smeitink, Jan/C-1351-2013; Lamers, Wouter H./D-2965-2012					ABARBANEL JM, 1986, NEUROLOGY, V36, P560, DOI 10.1212/WNL.36.4.560; ALVARADO LJF, 1988, J PEDIATR-US, V113, P865, DOI 10.1016/S0022-3476(88)80020-9; BAKKER HD, 1991, J INHERIT METAB DIS, V14, P269, DOI 10.1007/BF01800604; BASHAN N, 1981, PEDIATR RES, V15, P299, DOI 10.1203/00006450-198104000-00002; CALALB MB, 1992, J BIOL CHEM, V267, P1455; COHEN PTW, 1976, EUR J BIOCHEM, V66, P347, DOI 10.1111/j.1432-1033.1976.tb10524.x; COOPER RH, 1980, J BIOL CHEM, V255, P1794; DAVIDSON JJ, 1992, P NATL ACAD SCI USA, V89, P2096, DOI 10.1073/pnas.89.6.2096; FRANCKE U, 1989, AM J HUM GENET, V45, P276; HARMANN B, 1991, J BIOL CHEM, V266, P15631; HEILMEYER LMG, 1991, BIOCHIM BIOPHYS ACTA, V1094, P168, DOI 10.1016/0167-4889(91)90005-I; HENDRICKX J, 1993, HUM MOL GENET, V2, P583, DOI 10.1093/hmg/2.5.583; HUIJING F, 1969, AM J HUM GENET, V21, P275; JENNISSEN HP, 1974, FEBS LETT, V42, P77, DOI 10.1016/0014-5793(74)80283-8; JONES TA, 1990, BIOCHIM BIOPHYS ACTA, V1048, P24, DOI 10.1016/0167-4781(90)90017-V; KILIMANN MW, 1988, P NATL ACAD SCI USA, V85, P9381, DOI 10.1073/pnas.85.24.9381; LEDERER B, 1980, BIOCHEM BIOPH RES CO, V92, P169, DOI 10.1016/0006-291X(80)91535-1; LEDERER B, 1975, BIOCHEM J, V147, P23, DOI 10.1042/bj1470023; LYON JB, 1963, J BIOL CHEM, V238, P1; MALTHUS R, 1980, BIOCHEM J, V188, P99, DOI 10.1042/bj1880099; MIZUTA K, 1984, BIOCHEM BIOPH RES CO, V119, P582, DOI 10.1016/S0006-291X(84)80288-0; OHTANI Y, 1982, NEUROLOGY, V32, P833, DOI 10.1212/WNL.32.8.833; PICKETTGIES CA, 1986, ENZYMES, V17, P396; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHIMKE RN, 1973, J PEDIATR-US, V83, P1031, DOI 10.1016/S0022-3476(73)80544-X; SCHNEIDER A, 1993, NAT GENET, V5, P381, DOI 10.1038/ng1293-381; SERVIDEI S, 1988, J PEDIATR-US, V113, P82, DOI 10.1016/S0022-3476(88)80535-3; VANDENBERG IET, 1990, J INHERIT METAB DIS, V13, P442, DOI 10.1007/BF01799501; VARSANYI M, 1980, BIOCHEM GENET, V18, P247, DOI 10.1007/BF00484240; WILLEMS PJ, 1990, EUR J PEDIATR, V149, P268, DOI 10.1007/BF02106291; WILLEMS PJ, 1991, GENOMICS, V9, P565, DOI 10.1016/0888-7543(91)90347-H; WULLRICH A, 1993, J BIOL CHEM, V268, P23208; ZANDER NF, 1988, P NATL ACAD SCI USA, V85, P2929, DOI 10.1073/pnas.85.9.2929	33	31	33	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1995	56	2					381	387						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QF423	7847371				2022-12-18	WOS:A1995QF42300004
J	ELPELEG, ON; ANIKSTER, Y; BARASH, V; BRANSKI, D; SHAAG, A				ELPELEG, ON; ANIKSTER, Y; BARASH, V; BRANSKI, D; SHAAG, A			THE FREQUENCY OF THE C854 MUTATION IN THE ASPARTOACYLASE GENE IN ASHKENAZI JEWS IN ISRAEL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							N-ACETYLASPARTIC ACIDURIA; CANAVAN DISEASE; POPULATION	Canavan disease (CD) is an infantile neurodegenerative disease that is transmitted in an autosomal recessive manner and has mainly been reported in Ashkenazi Jewish families. The primary enzymatic defect is aspartoacylase deficiency, and an A-to-C transition at nucleotide 854 of the cDNA has recently been reported. We screened 18 patients with CD and 879 healthy individuals, all Israeli Ashkenazi Jews, for the mutation. Al 18 patients were homozygotes for the mutation, and 15 heterozygotes were found among the healthy individuals. The results disclose a carrier rate of 1:59 and suggest that a screening for the mutation is warranted among Ashkenazi Jewish couples.	SHAARE ZEDEK MED CTR,DEPT PEDIAT,JERUSALEM,ISRAEL; HADASSAH MED CTR,DEPT CLIN BIOCHEM,IL-91120 JERUSALEM,ISRAEL	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	ELPELEG, ON (corresponding author), SHAARE ZEDEK MED CTR,METABOL UNIT,IL-91031 JERUSALEM,ISRAEL.							ABELIOVICH D, 1992, AM J HUM GENET, V51, P951; BEUTLER E, 1993, AM J HUM GENET, V52, P85; DIVRY P, 1988, J INHERIT METAB DIS, V11, P307, DOI 10.1007/BF01800378; KAUL R, 1993, NAT GENET, V5, P118, DOI 10.1038/ng1093-118; MATALON R, 1988, AM J MED GENET, V29, P463, DOI 10.1002/ajmg.1320290234; MATALON R, IN PRESS AM J HUM GE; UNGAR M, 1983, CLIN GENET, V23, P23; VANBOGAERT L, 1970, HDB CLIN NEUROLOGY, V10, P203; ZELNIK N, 1993, DEV MED CHILD NEUROL, V35, P346	9	31	31	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1994	55	2					287	288						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NZ336	8037206				2022-12-18	WOS:A1994NZ33600008
J	YU, CE; OSHIMA, J; GODDARD, KAB; MIKI, T; NAKURA, J; OGIHARA, T; POOT, M; HOEHN, H; FRACCARO, M; PIUSSAN, C; MARTIN, GM; SCHELLENBERG, GD; WIJSMAN, EM				YU, CE; OSHIMA, J; GODDARD, KAB; MIKI, T; NAKURA, J; OGIHARA, T; POOT, M; HOEHN, H; FRACCARO, M; PIUSSAN, C; MARTIN, GM; SCHELLENBERG, GD; WIJSMAN, EM			LINKAGE DISEQUILIBRIUM AND HAPLOTYPE STUDIES OF CHROMOSOME-8P-11.1-21.1 MARKERS AND WERNER-SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WILSON DISEASE GENE; DNA; LOCUS; POLYMORPHISMS; REGION; MAP; ATPASE; REPEAT	Werner syndrome (WS) is an autosomal recessive disorder, characterized as a progeroid syndrome, previously mapped to the 8p 11.1-21.1 region. Because WS is so rare, and because many patients are from consanguineous marriages, fine localization of the gene by traditional meiotic mapping methods is unlikely to succeed. Here we present the results of a search for a region that exhibits linkage disequilibrium with the disorder, under the assumption that identification of such a region may provide an alternative method of narrowing down the location of WRN, the gene responsible for WS. We present allele frequencies in Japanese and Caucasian cases and controls for D8S137, D8S131, D8S87, D8S278, D8S259, D8S283, fibroblast growth factor receptor 1, ankyrin 1, D8S339, and two polymorphisms in glutathione reductase (GSR), covering similar to 16.5 cM in total. We show that three of the markers examined--D8S339 and both polymorphisms in the GSR locus-show strong statistically significant evidence of disequilibrium with WRN in the Japanese population but not in the Caucasian population. In addition, we show that a limited number of haplotypes are associated with the disease in both populations and that these haplotypes define clusters of apparently related haplotypes that may identify as many as eight or nine independent WRN mutations in these two populations.	UNIV WASHINGTON,DEPT MED,DIV MED GENET,SEATTLE,WA 98185; UNIV WASHINGTON,DEPT PATHOL,DIV NEUROL,SEATTLE,WA; UNIV WASHINGTON,DEPT BIOSTAT,SEATTLE,WA 98195; OSAKA UNIV,SCH MED,DEPT GERIATR MED,OSAKA 553,JAPAN; UNIV WURZBURG,DEPT HUMAN GENET,W-8700 WURZBURG,GERMANY; UNIV PAVIA,I-27100 PAVIA,ITALY; UNIV AMIENS,AMIENS,FRANCE	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Osaka University; University of Wurzburg; University of Pavia; Picardie Universites; Universite de Picardie Jules Verne (UPJV)			Poot, Martin/F-9427-2010		NATIONAL INSTITUTE ON AGING [R37AG008303] Funding Source: NIH RePORTER; NIA NIH HHS [AG08303] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AKSENTIJEVICH I, 1993, AM J HUM GENET, V53, P644; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; CEPELLINI R, 1955, ANN HUM GENET, V20, P97; CHAKRABORTY R, 1987, HUM GENET, V76, P40; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001; FUJITA R, 1990, P NATL ACAD SCI USA, V87, P1796, DOI 10.1073/pnas.87.5.1796; GOTO M, 1985, ADV EXP MED BIOL, V190, P245; GOTO M, 1992, NATURE, V355, P735, DOI 10.1038/355735a0; HARLEY HG, 1991, AM J HUM GENET, V49, P68; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; Martin G M, 1978, Birth Defects Orig Artic Ser, V14, P5; MARTIN GM, 1970, LAB INVEST, V23, P86; MITCHISON HM, 1993, GENOMICS, V16, P455, DOI 10.1006/geno.1993.1210; NAKURA J, IN PRESS GENOMICS; OSHIMA J, IN PRESS GENOMICS; PETRUKHIN K, 1993, NAT GENET, V5, P338, DOI 10.1038/ng1293-338; Sambrook J., 1989, MOL CLONING LAB MANU; SCHELLENBERG GD, 1992, LANCET, V339, P1002, DOI 10.1016/0140-6736(92)91590-5; SMITH CAB, 1953, J R STAT SOC B, V15, P153; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; THOMAS W, 1993, HUM MOL GENET, V2, P828, DOI 10.1093/hmg/2.6.828; THOMAS W, 1993, GENOMICS, V16, P685, DOI 10.1006/geno.1993.1248; TOMFOHRDE J, 1992, GENOMICS, V14, P144, DOI 10.1016/S0888-7543(05)80297-6; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WIJSMAN EM, IN PRESS HDB PSYCHON; YU CE, 1994, HUM MOL GENET, V3, P212, DOI 10.1093/hmg/3.1.212; YU CE, 1994, HUM MOL GENET, V3, P211; 1993, CELL, V72, P971	35	31	32	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1994	55	2					356	364						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NZ336	8037212				2022-12-18	WOS:A1994NZ33600018
J	GUO, SW				GUO, SW			COMPUTATION OF IDENTITY-BY-DESCENT PROPORTIONS SHARED BY 2 SIBLINGS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE TRAITS; LINKAGE	I provide a novel approach to computing the mean and variance of the proportion of genetic material shared identical by descent (IBD) by sibling pairs in a specified chromosomal region, conditional on observed marker data. I first show that each chromosome in an offspring can be represented by a two-state Markov chain, with the time parameter being the map distance along the chromosome. On this basis, I show that IBD proportion can be written as a stochastic integral and that the computation of its mean and variance can be reduced to evaluation of an integral of some elementary functions. In addition, I show how Goldgar's model can be extended to include dominance effects. Several examples are provided to illustrate the calculation.	UNIV MICHIGAN,CTR HUMAN GENOME,ANN ARBOR,MI	University of Michigan System; University of Michigan	GUO, SW (corresponding author), UNIV MICHIGAN,SCH PUBL HLTH,DEPT BIOSTAT,1420 WASHINGTON HTS,ANN ARBOR,MI 48109, USA.				NHGRI NIH HHS [HG00209, HG00376] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000376, R29HG000376] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Fisher R.A., 1965, THEORY INBREEDING, V2nd ed.; GEO SW, UNPUB GENOMIC SIMILI; GOLDGAR DE, 1990, AM J HUM GENET, V47, P957; GOLDGAR DE, 1993, GENET EPIDEMIOL, V10, P383, DOI 10.1002/gepi.1370100609; GOLDGAR DE, 1992, AM J HUM GENET, V50, P598; GOLDGAR DE, 1993, DOCUMENTATION MIM SO; GUO SW, UNPUB IDENTITY BY DE; Haldane JBS, 1919, J GENET, V8, P299; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Malecot G, 1948, MATH HEREDITE; SCHORK NJ, 1993, AM J HUM GENET, V53, P1306; THOMPSON EA, 1993, POPULATION MANAGEMEN; [No title captured]	13	31	33	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1994	54	6					1104	1109						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NP053	8198133				2022-12-18	WOS:A1994NP05300020
J	HU, PY; ERNST, AR; SLY, WS; VENTA, PJ; SKAGGS, LA; TASHIAN, RE				HU, PY; ERNST, AR; SLY, WS; VENTA, PJ; SKAGGS, LA; TASHIAN, RE			CARBONIC-ANHYDRASE-II DEFICIENCY - SINGLE-BASE DELETION IN EXON-7 IS THE PREDOMINANT MUTATION IN CARIBBEAN HISPANIC PATIENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RENAL TUBULAR-ACIDOSIS; CEREBRAL CALCIFICATION; DNA TRANSFECTION; GENE; OSTEOPETROSIS; PURIFICATION; EXPRESSION; LUNG	To date, three different structural gene mutations have been identified in patients with carbonic anhydrase II deficiency (osteopetrosis with renal tubular acidosis and cerebral calcification). These include a missense mutation (H107Y) in two families, a splice junction mutation in intron 5 in one of these families, and a splice junction mutation in intron 2 for which many Arabic patients are homozygous. We report here a novel mutation for which carbonic anhydrase II-deficient patients from seven unrelated Hispanic families were found to be homozygous. The proband was a 2(1)/2-year-old Hispanic girl of Puerto Rican ancestry who was unique clinically, in that she had no evidence of renal tubular acidosis, even though she did have osteopetrosis, developmental delay, and cerebral calcification. She proved to be homozygous for a single-base deletion in the coding region of exon 7 that produces a frameshift that changes the next 12 amino acids before leading to chain termination and that also introduces a new MaeIII restriction site. The 27-kD truncated enzyme produced when the mutant cDNA was expressed in COS cells was enzymatically inactive, present mainly in insoluble aggregates, and detectable immunologically at only 5% the level of the 29-kD normal carbonic anhydrase II expressed from the wild-type cDNA. Metabolic labeling revealed that this 27-kD mutant protein has an accelerated rate of degradation. Six subsequent Hispanic patients of Caribbean ancestry, all of whom had osteopetrosis and renal tubular acidosis but who varied widely in clinical severity, were found to be homozygous for the same mutation. These findings identify a novel mutation common to Hispanic patients from the Caribbean islands and provide a ready means for PCR-based diagnosis of the ''Hispanic mutation.'' The basis for their phenotypic variability is not yet clear.	ST LOUIS UNIV,SCH MED,EDWARD A DOISY DEPT BIOCHEM & MOLEC BIOL,ST LOUIS,MO 63104; MICHIGAN STATE UNIV,COLL VET MED,E LANSING,MI; UNIV MICHIGAN,DEPT HUMAN GENET,ANN ARBOR,MI	Saint Louis University; Michigan State University; University of Michigan System; University of Michigan					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024681, R37GM034182, R01GM034182] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK40163] Funding Source: Medline; NIGMS NIH HHS [GM24681, GM34182] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Hu Peiyi Y., 1992, Human Mutation, V1, P288, DOI 10.1002/humu.1380010404; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOPATA MA, 1984, NUCLEIC ACIDS RES, V12, P5707, DOI 10.1093/nar/12.14.5707; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUTHMAN H, 1983, NUCLEIC ACIDS RES, V11, P1295, DOI 10.1093/nar/11.5.1295; MIYAZAKI J, 1989, GENE, V79, P269; ROTH DE, 1992, P NATL ACAD SCI USA, V89, P1804, DOI 10.1073/pnas.89.5.1804; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWARTZ GJ, 1991, SKELETAL RADIOL, V20, P447; SLY WS, 1985, NEW ENGL J MED, V313, P139, DOI 10.1056/NEJM198507183130302; SUNDARAM V, 1986, AM J HUM GENET, V38, P125; VENTA PJ, 1991, AM J HUM GENET, V49, P1082; WAHEED A, 1992, J BIOL CHEM, V267, P3308; YOSHIDA K, 1991, AM J HUM GENET, V49, P435; ZHU XL, 1990, J BIOL CHEM, V265, P8795	15	31	32	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1994	54	4					602	608						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NC836	8128957				2022-12-18	WOS:A1994NC83600004
J	VANHERWERDEN, L; ROSE, CSP; REARDON, W; BRUETON, LA; WEISSENBACH, J; MALCOLM, S; WINTER, RM				VANHERWERDEN, L; ROSE, CSP; REARDON, W; BRUETON, LA; WEISSENBACH, J; MALCOLM, S; WINTER, RM			EVIDENCE FOR LOCUS HETEROGENEITY IN ACROCEPHALOSYNDACTYLY - A REFINED LOCALIZATION FOR THE SAETHRE-CHOTZEN SYNDROME LOCUS ON DISTAL CHROMOSOME 7P - AND EXCLUSION OF JACKSON-WEISS SYNDROME FROM CRANIOSYNOSTOSIS LOCI ON 7P AND 5Q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE; GENE	Craniosynostosis (premature fusion of the skull sutures) occurs as a clinically heterogeneous group of disorders, frequently involving digital abnormalities. We have previously provisionally assigned the gene for one such condition, Saethre-Chotzen syndrome (ACS III), to chromosome 7p. Linkage analysis is now reported between ACS III and dinucleotide repeat loci on distal 7p. The maximum lod scores, Z(max), were 5.57 at a recombination fraction of .05, with D7S488, and 4.74 at a recombination fraction of .05, with D7S493. Only weak linkage, not reaching significance, was found with distal markers (D7S513 and afm281vc9) and a proximal marker (D7S516). Multipoint analysis shows that the disease locus lies between D7S513 and D7S516. Analysis of individual recombinants shows that the most likely position is between D7S493 and D7S516. Linkage data in regard of Jackson-Weiss syndrome demonstrate that this autosomal dominant form of acrocephalosyndactyly does not map to the ACS III region on 7p or to the acrocephalosyndactyly locus on 5q (Boston type). These findings underline the genetic heterogeneity among the different clinical conditions manifesting with acrocephalosyndactyly.	INST CHILD HLTH,DEPT CLIN GENET & FETAL MED,MOLEC GENET UNIT,LONDON WC1 1EH,ENGLAND; INST CHILD HLTH,CLIN GENET UNIT,LONDON,ENGLAND; NORTHWICK PK HOSP & CLIN RES CTR,KENNEDY GALTON CTR,HARROW,MIDDX,ENGLAND; GENETHON,HUMAN GENOME RES CTR,EVRY,FRANCE	University of London; University College London; University of London; University College London; Imperial College London			van Herwerden, Lynne/I-1087-2012	van Herwerden, Lynne/0000-0001-6717-8995; Reardon, Willie/0000-0001-7329-9179				ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; BARAITSER M, 1980, J MED GENET, V17, P250, DOI 10.1136/jmg.17.4.250; BLANK CE, 1960, ANN HUM GENET, V24, P151; BRUETON L, 1988, AM J MED GENET, V31, P799, DOI 10.1002/ajmg.1320310412; BRUETON LA, 1992, J MED GENET, V29, P681, DOI 10.1136/jmg.29.10.681; COHEN M M JR, 1986, P413; Gorlin RJ, 1990, PLAST RECONSTR SURG; JACKSON CE, 1976, J PEDIATR-US, V88, P963, DOI 10.1016/S0022-3476(76)81050-5; KIKKAWA K, 1993, AM J MED GENET, V45, P108, DOI 10.1002/ajmg.1320450127; LATHROP GM, 1985, AM J HUM GENET, V37, P482; McKusick V.A., 1992, MENDELIAN INHERITANC; MULLER U, 1993, HUM MOL GENET, V2, P119, DOI 10.1093/hmg/2.2.119; REARDON W, 1993, AM J MED GENET, V47, P633, DOI 10.1002/ajmg.1320470510; REARDON W, IN PRESS J MED GENET; REDI CS, 1993, AM J MED GENET, V47, P637; TSUI LC, 1991, CYTOGENET CELL GENET, V58, P337, DOI 10.1159/000133167; WARMAN ML, 1993, AM J MED GENET, V46, P444, DOI 10.1002/ajmg.1320460420; WEBER JL, 1991, GENOMICS, V11, P695, DOI 10.1016/0888-7543(91)90077-R; WEISSENBACH J, 1992, GENETHON MICROSATELL; WINTER RM, 1993, LONDON DYSMORPHOLOGY	20	31	32	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1994	54	4					669	674						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NC836	8128964				2022-12-18	WOS:A1994NC83600011
J	AKSENTIJEVICH, I; PRAS, E; GRUBERG, L; SHEN, Y; HOLMAN, K; HELLING, S; PROSEN, L; SUTHERLAND, GR; RICHARDS, RI; DEAN, M; PRAS, M; KASTNER, DL				AKSENTIJEVICH, I; PRAS, E; GRUBERG, L; SHEN, Y; HOLMAN, K; HELLING, S; PROSEN, L; SUTHERLAND, GR; RICHARDS, RI; DEAN, M; PRAS, M; KASTNER, DL			FAMILIAL MEDITERRANEAN FEVER (FMF) IN MOROCCAN JEWS - DEMONSTRATION OF A FOUNDER EFFECT BY EXTENDED HAPLOTYPE ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MARKER LOCI D9S5; LINKAGE DISEQUILIBRIUM; FRIEDREICH ATAXIA; HUMAN CHROMOSOME-16; GENETIC-ANALYSIS; ASHKENAZI JEWS; SHORT ARM; DISEASE; HOMOGENEITY; MAP	Familial Mediterranean fever (FMF) is an autosomal recessive disease causing attacks of fever and serositis. The FMF gene (designated ''MEF'') is on 16p, with the gene order 16cen-D16S80-MEF-D16S94-D16S283-D16S291-16pter. Here we report the association of FMF susceptibility with alleles at D16S94, D16S283, and D16S291 among 31 non-Ashkenazi Jewish families (14 Moroccan, 17 non-Moroccan). We observed highly significant associations at D16S283 and D16S291 among the Moroccan families. For the non-Moroccans, only the allelic association at D16S94 approached statistical significance. Haplotype analysis showed that 18/25 Moroccan FMF chromosomes, versus 0/21 noncarrier chromosomes, bore a specific haplotype for D16S94-D16S283-D16S291. Among non-Moroccans this haplotype was present in 6/26 FMF chromosomes versus 1/28 controls. Both groups of families are largely descended from Jews who fled the Spanish Inquisition. The strong haplotype association seen among the Moroccans is most likely a founder effect, given the recent origin and genetic isolation of the Moroccan Jewish community. The lower haplotype frequency among non-Moroccan carriers may reflect differences both in history and in population genetics.	NIAMSO,ARTHRITIS & RHEUMATISM BRANCH,BLDG 6,ROOM 112,BETHESDA,MD 20892; CHAIM SHEBA MED CTR,DEPT MED F,IL-52621 TEL HASHOMER,ISRAEL; CHAIM SHEBA MED CTR,HELLER INST MED RES,IL-52621 TEL HASHOMER,ISRAEL; ADELAIDE CHILDRENS HOSP INC,DEPT CYTOGENET & MOLEC GENET,ADELAIDE,SA 5006,AUSTRALIA; NCI,FREDERICK CANC RES & DEV CTR,VIRAL CARCINOGENESIS LAB,FREDERICK,MD 21701	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Chaim Sheba Medical Center; Chaim Sheba Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick			Dean, Michael/R-7501-2019; Aksentijevich, Ivona/AAF-1335-2019; Sutherland, Grant Robert/D-2606-2012; Richards, Robert/ABE-6423-2020; Dean, Michael C/G-8172-2012	Dean, Michael C/0000-0003-2234-0631; Richards, Robert Ian/0000-0002-5978-6453				AKSENTIJEVICH I, IN PRESS AM J HUM GE, V53; Bishop YM., 2007, DISCRETE MULTIVARIAT; BREUNING MH, 1990, J MED GENET, V27, P603, DOI 10.1136/jmg.27.10.603; CALLEN DF, 1992, GENOMICS, V13, P1178, DOI 10.1016/0888-7543(92)90035-Q; FUJITA R, 1990, P NATL ACAD SCI USA, V87, P1796, DOI 10.1073/pnas.87.5.1796; FUJIWARA TM, 1989, AM J HUM GENET, V44, P327; GERMINO GG, 1992, GENOMICS, V13, P144, DOI 10.1016/0888-7543(92)90214-D; HARLEY HG, 1991, AM J HUM GENET, V49, P68; HARRIS PC, 1991, LANCET, V338, P1484, DOI 10.1016/0140-6736(91)92300-Q; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; HILL WG, 1975, THEOR POPUL BIOL, V8, P117, DOI 10.1016/0040-5809(75)90028-3; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; MCALPINE PJ, 1991, CYTOGENET CELL GENET, V58, P5, DOI 10.1159/000133160; NAVON R, 1991, AM J HUM GENET, V48, P412; OZELIUS LJ, 1992, AM J HUM GENET, V50, P619; PANDOLFO M, 1990, AM J HUM GENET, V47, P228; PRAS E, 1992, NEW ENGL J MED, V326, P1509, DOI 10.1056/NEJM199206043262301; REEDERS ST, 1991, CYTOGENET CELL GENET, V58, P643, DOI 10.1159/000133176; ROTH C, 1987, CLIN GENET, V31, P315; SHOHAT M, 1992, AM J HUM GENET, V51, P1349; SIRUGO G, 1992, AM J HUM GENET, V50, P559; SOHAR E, 1967, AM J MED, V43, P227, DOI 10.1016/0002-9343(67)90167-2; SOHAR E, 1961, ARCH INTERN MED, V107, P529, DOI 10.1001/archinte.1961.03620040055006; THOMPSON AD, 1992, GENOMICS, V13, P402, DOI 10.1016/0888-7543(92)90260-Y; THOMPSON EA, 1988, AM J HUM GENET, V42, P113; WEIR BS, 1978, GENETICS, V88, P633; 1993, CELL, V72, P971	27	31	32	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1993	53	3					644	651						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LU559	8102507				2022-12-18	WOS:A1993LU55900008
J	KREYSING, J; BOHNE, W; BOSENBERG, C; MARCHESINI, S; TURPIN, JC; BAUMANN, N; VONFIGURA, K; GIESELMANN, V				KREYSING, J; BOHNE, W; BOSENBERG, C; MARCHESINI, S; TURPIN, JC; BAUMANN, N; VONFIGURA, K; GIESELMANN, V			HIGH RESIDUAL ARYLSULFATASE-A (ARSA) ACTIVITY IN A PATIENT WITH LATE-INFANTILE METACHROMATIC LEUKODYSTROPHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SKIN FIBROBLASTS; PSEUDODEFICIENCY; DEFICIENCY; CELLS; GLYCOSYLATION; MUTAGENESIS; EXPRESSION; MUTATIONS; DISEASE; PROTEIN	We identified a patient suffering from late-infantile metachromatic leukodystrophy (MLD) who has a residual arylsulfatase A (ARSA) activity of about 10%. Fibroblasts of the patient show significant sulfatide degradation activity exceeding that of adult MLD patients. Analysis of the ARSA gene in this patient revealed heterozygosity for two new mutant alleles: in one allele, deletion of C 447 in exon 2 leads to a frameshift and to a premature stop codon at amino acid position 105; in the second allele, a G-->A transition in exon 5 causes a Gly309-->Ser substitution. Transient expression of the mutant Ser309-ARSA resulted in only 13% enzyme activity of that observed in cells expressing normal ARSA. The mutant ARSA is correctly targeted to the lysosomes but is unstable. These findings are in contrast to previous results showing that the late-infantile type of MLD is always associated with the complete absence of ARSA activity. The expression of the mutant ARSA protein may be influenced by particular features of oligodendrocytes, such that the level of mutant enzyme is lower in these cells than in others.	UNIV GOTTINGEN,DEPT BIOCHEM 2,GOSSLERSTR 12D,W-3400 GOTTINGEN,GERMANY; UNIV BRESCIA,DEPT BIOMED SCI & BIOTECHNOL,BRESCIA,ITALY; CTR HOSP REG UNIV REIMS,REIMS,FRANCE; HOP LA PITIE SALPETRIERE,INSERM,U134,F-75651 PARIS 13,FRANCE	University of Gottingen; University of Brescia; CHU de Reims; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite				Bohne, Wolfgang/0000-0002-5554-131X				ARTELT P, 1988, GENE, V68, P213, DOI 10.1016/0378-1119(88)90023-6; BHNE W, 1991, HUM GENET, V87, P155; FLUHARTY AL, 1991, AM J HUM GENET, V49, P1340; GIESELMANN V, 1991, AM J HUM GENET, V49, P407; GIESELMANN V, 1989, P NATL ACAD SCI USA, V86, P9436, DOI 10.1073/pnas.86.23.9436; GIESELMANN V, 1992, J BIOL CHEM, V267, P13262; GIESELMANN V, 1991, Brain Dysfunction, V4, P235; HERZ B, 1984, HUM GENET, V66, P147, DOI 10.1007/BF00286589; HOHENSCHUTZ C, 1989, HUM GENET, V82, P45, DOI 10.1007/BF00288270; KAPPLER J, 1991, HUM GENET, V86, P463; KOLODNY EH, 1989, METABOLIC BASIS INHE, V2, P1721; LEINEKUGEL P, 1992, HUM GENET, V88, P513, DOI 10.1007/BF00219337; MONTI E, 1992, BIOCHIM BIOPHYS ACTA, V1124, P80, DOI 10.1016/0005-2760(92)90129-J; NAKAMAYE KL, 1986, NUCLEIC ACIDS RES, V14, P9679, DOI 10.1093/nar/14.24.9679; POLTEN A, 1991, NEW ENGL J MED, V324, P18, DOI 10.1056/NEJM199101033240104; SHAPIRO LJ, 1979, PEDIATR RES, V13, P1179, DOI 10.1203/00006450-197910000-00021; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; STEIN C, 1989, J BIOL CHEM, V264, P1252; VIANI P, 1989, BIOCHIM BIOPHYS ACTA, V1002, P20, DOI 10.1016/0005-2760(89)90059-3; WAHEED A, 1982, H-S Z PHYSIOL CHEM, V363, P425, DOI 10.1515/bchm2.1982.363.1.425; WAHEED A, 1988, EMBO J, V7, P2351, DOI 10.1002/j.1460-2075.1988.tb03079.x; WENGER DA, 1989, AM J MED GENET, V33, P255, DOI 10.1002/ajmg.1320330223; WILSON PJ, 1990, P NATL ACAD SCI USA, V87, P8531, DOI 10.1073/pnas.87.21.8531	23	31	33	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1993	53	2					339	346						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LN820	8101038				2022-12-18	WOS:A1993LN82000006
J	SWEETMAN, WA; RASH, B; SYKES, B; BEIGHTON, P; HECHT, JT; ZABEL, B; THOMAS, JT; BOOTHANDFORD, R; GRANT, ME; WALLIS, GA				SWEETMAN, WA; RASH, B; SYKES, B; BEIGHTON, P; HECHT, JT; ZABEL, B; THOMAS, JT; BOOTHANDFORD, R; GRANT, ME; WALLIS, GA			SSCP AND SEGREGATION ANALYSIS OF THE HUMAN TYPE-X COLLAGEN GENE (COL10A1) IN HERITABLE FORMS OF CHONDRODYSPLASIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							II COLLAGEN; GROWTH-PLATE; ACHONDROPLASIA; CARTILAGE; DNA; LOCALIZATION; STRAND; LOCUS; HYPOCHONDROPLASIA; POLYMORPHISMS	Type X collagen is a homotrimeric, short chain, nonfibrillar collagen that is expressed exclusively by hypertrophic chondrocytes at the sites of endochondral ossification. The distribution and pattern of expression of the type X collagen gene (COL10A1) suggests that mutations altering the structure and synthesis of the protein may be responsible for causing heritable forms of chondrodysplasia. We investigated whether mutations within the human COL10A1 gene were responsible for causing the disorders achondroplasia, hypochondroplasia, pseudoachondroplasia, and thanatophoric dysplasia, by analyzing the coding regions of the gene by using PCR and the single-stranded conformational polymorphism technique. By this approach, seven sequence changes were identified within and flanking the coding regions of the gene of the affected persons. We demonstrated that six of these sequence changes were not responsible for causing these forms of chondrodysplasia but were polymorphic in nature. The sequence changes were used to demonstrate discordant segregation between the COL10A1 locus and achondroplasia and pseudoachondroplasia, in nuclear families. This lack of segregation suggests that mutations within or near the COL10A1 locus are not responsible for these disorders. The seventh sequence change resulted in a valine-to-methionine substitution in the carboxyl-terminal domain of the molecule and was identified in only two hypochondroplasic individuals from a single family. Segregation analysis in this family was inconclusive, and the significance of this substitution remains uncertain.	UNIV MANCHESTER,DEPT BIOCHEM & MOLEC BIOL,MANCHESTER M13 9PL,LANCS,ENGLAND; UNIV OXFORD,INST MOLEC MED,OXFORD,ENGLAND; UNIV TEXAS,DEPT PEDIAT,HOUSTON,TX 77025; UNIV CAPE TOWN,DEPT HUMAN GENET,CAPE TOWN,SOUTH AFRICA; UNIV MAINZ,DEPT PEDIAT,W-6500 MAINZ,GERMANY	University of Manchester; University of Oxford; University of Texas System; University of Cape Town; Johannes Gutenberg University of Mainz				Boot-Handford, Raymond/0000-0002-6167-8419				APTE S, 1991, FEBS LETT, V282, P393, DOI 10.1016/0014-5793(91)80521-4; BYERS PH, 1989, METABOLIC BASIS INHE, P2805; EYRE DR, 1987, J RHEUMATOL, V14, P25; FINKELSTEIN JE, 1991, AM J HUM GENET, V48, P97; FRANCOMANO CA, 1988, AM J MED GENET, V29, P955, DOI 10.1002/ajmg.1320290433; Gordon MK, 1990, CURR OPIN CELL BIOL, V2, P833, DOI 10.1016/0955-0674(90)90080-X; GRANT WT, 1987, J BIOL CHEM, V262, P9844; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; Hayashi K, 1991, PCR Methods Appl, V1, P34; HECHT JT, IN PRESS AM J MED GE; HORTON WA, 1989, AM J MED GENET, V34, P579, DOI 10.1002/ajmg.1320340425; KASHTAN CE, 1990, PEDIATR NEPHROL, V4, P523, DOI 10.1007/BF00869840; KIRSCH T, 1990, BIOCHEM J, V265, P453, DOI 10.1042/bj2650453; KUIVANIEMI H, 1991, FASEB J, V5, P2052, DOI 10.1096/fasebj.5.7.2010058; KWAN APL, 1986, BIOSCIENCE REP, V6, P155, DOI 10.1007/BF01115001; KWAN APL, 1989, J CELL BIOL, V109, P1849, DOI 10.1083/jcb.109.4.1849; KWAN APL, 1991, J CELL BIOL, V114, P597, DOI 10.1083/jcb.114.3.597; LEE B, 1991, EUKARYOTIC GENE EXPR, V1, P173; MARRIOTT A, 1991, J CELL SCI, V99, P641; MAYNARD JA, 1981, J BONE JOINT SURG AM, V63, P969, DOI 10.2106/00004623-198163060-00015; MAYNE R, 1989, ARTHRITIS RHEUM, V32, P241, DOI 10.1002/anr.1780320302; MCKUSICK VA, 1973, J MED GENET, V10, P11, DOI 10.1136/jmg.10.1.11; MESSING J, 1982, GENE, V19, P269, DOI 10.1016/0378-1119(82)90016-6; MESSING J, 1981, NUCLEIC ACIDS RES, V9, P309, DOI 10.1093/nar/9.2.309; MULLIS PE, 1991, CLIN ENDOCRINOL, V34, P265, DOI 10.1111/j.1365-2265.1991.tb03765.x; OBERKLAID F, 1979, J MED GENET, V16, P140, DOI 10.1136/jmg.16.2.140; OGILVIE D, 1986, J MED GENET, V23, P19, DOI 10.1136/jmg.23.1.19; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PERIAM N, IN PRESS NUCLEIC ACI; PODUSLO SE, 1991, AM J HUM GENET, V49, P106; PONSETI IV, 1970, J BONE JOINT SURG AM, VA 52, P701, DOI 10.2106/00004623-197052040-00004; POOLE AR, 1988, J CLIN INVEST, V81, P579, DOI 10.1172/JCI113356; PULST SM, 1990, HUM GENET, V85, P12; REDDI AH, 1981, COLLAGEN REL RES, V1, P209; RIMOIN DL, 1983, PRINCIPLES PRACTICE, P703; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAWADA H, 1990, J CELL BIOL, V110, P219, DOI 10.1083/jcb.110.1.219; SCHMID TM, 1985, J CELL BIOL, V100, P598, DOI 10.1083/jcb.100.2.598; SCHMID TM, 1983, J BIOL CHEM, V258, P9504; SILLENCE DO, 1979, AM J PATHOL, V96, P811; SPRANGER J, 1974, ADV HUM GENET, V19, P1; STANESCU R, 1990, AM J MED GENET, V37, P412, DOI 10.1002/ajmg.1320370323; STANESCU V, 1984, J BONE JOINT SURG AM, V66A, P817, DOI 10.2106/00004623-198466060-00002; THOMAS JT, 1990, J CELL SCI, V95, P639; THOMAS JT, 1991, BIOCHEM J, V280, P617, DOI 10.1042/bj2800617; WORDSWORTH P, 1988, J MED GENET, V25, P521, DOI 10.1136/jmg.25.8.521; WYNNEDAVIS R, 1985, ATLAS SKELETAL DYSPL	47	31	31	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1992	51	4					841	849						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JQ667	1329505				2022-12-18	WOS:A1992JQ66700018
J	KAPLAN, N; WEIR, BS				KAPLAN, N; WEIR, BS			EXPECTED BEHAVIOR OF CONDITIONAL LINKAGE DISEQUILIBRIUM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NON-RANDOM ASSOCIATION; GLOBIN GENE-CLUSTER; HUNTINGTONS-DISEASE; FINITE POPULATIONS; COALESCENT PROCESS; SELECTION; RECOMBINATION; MODELS	The ubiquitousness of RFLPs in the human genome has greatly helped the mapping of human disease genes, and it has been suggested that population measures of association between disease and marker loci could help with this mapping. For rare diseases, random samples are taken from within disease genotypes in order to obtain reasonable sample sizes, but this sampling strategy requires a modification of the usual measures of association. We present theoretical predictions for the mean and variance of such a modified measure, under the assumption that the disease gene is maintained at a constant low frequency in the population. The coefficient of variation of this modified measure is large enough that caution is needed in using the measure to locate disease genes, and, furthermore, the coefficient of variation cannot be made arbitrarily small by increasing sample size. The modified association measure is calculated for recently published data on cystic fibrosis.	N CAROLINA STATE UNIV, DEPT STAT, PROGRAM STAT GENET, RALEIGH, NC 27695 USA	University of North Carolina; North Carolina State University	KAPLAN, N (corresponding author), NIEHS, DIV BIOMETRY & RISK ASSESSMENT, POB 12233, RES TRIANGLE PK, NC 27709 USA.				NIGMS NIH HHS [GM45344] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM045344] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; CHAKRABORTY R, 1986, GENET EPIDEMIOL, V3, P323, DOI 10.1002/gepi.1370030505; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P177; EIBERG H, 1985, CLIN GENET, V28, P265; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; Ewens W.J., 1979, MATH POPULATION GENE; Gusella J F, 1991, Adv Hum Genet, V20, P125; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HILL WG, 1988, THEOR POPUL BIOL, V33, P54, DOI 10.1016/0040-5809(88)90004-4; HUDSON RR, 1988, GENETICS, V120, P831; HUDSON RR, 1985, GENETICS, V109, P611; KAPLAN NL, 1988, GENETICS, V120, P819; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KIMURA M, 1969, GENETICS, V61, P893; KIMURA M, 1971, Theoretical Population Biology, V2, P174; KUPKE KG, 1991, AM J HUM GENET, V49, P347; MACDONALD ME, 1991, AM J HUM GENET, V49, P723; MAISTE PJ, 1992, AM J HUM GENET, V50, P1138; NEI M, 1980, GENET RES, V35, P65, DOI 10.1017/S001667230001394X; PRESS WH, 1986, NUMERICAL RECIPES AR; PRITCHARD C, 1991, AM J HUM GENET, V49, P1; SNELL RG, 1989, J MED GENET, V26, P673, DOI 10.1136/jmg.26.11.673; THEILMANN J, 1989, J MED GENET, V26, P676, DOI 10.1136/jmg.26.11.676; Tsui L C, 1991, Adv Hum Genet, V20, P153; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WEIR BS, 1989, PROG CLIN BIOL RES, V329, P81; WEIR BS, 1986, AM J HUM GENET, V38, P776; WEIR BS, 1980, GENETICS, V95, P477; Weir BS, 1990, GENETIC DATA ANAL	29	31	35	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1992	51	2					333	343						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JF776	1353663				2022-12-18	WOS:A1992JF77600013
J	MACLEAN, CJ; PLOUGHMAN, LM; DIEHL, SR; KENDLER, KS				MACLEAN, CJ; PLOUGHMAN, LM; DIEHL, SR; KENDLER, KS			A NEW TEST FOR LINKAGE IN THE PRESENCE OF LOCUS HETEROGENEITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOD SCORE; POWER	The detection of linkage in complex traits, although potentially of the greatest value, has proved very difficult. One reason may be the drastic effect that locus heterogeneity has on statistical power. We propose a new test for linkage in the presence of heterogeneity, based upon the sum of individual pedigree maximum lod scores, combined with a bootstrap method for estimating the null-hypothesis distribution. The technique is designed to exploit modern computer capability and to avoid reliance on asymptotic-distribution theory. Numerical comparisons indicate that for small pedigrees this new test can detect linkage with 30%-50% less data than are required by standard methods. A computer program for simulating the distribution and for performing the test of linkage is available from the authors.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT HUMAN GENET,RICHMOND,VA 23298	Virginia Commonwealth University	MACLEAN, CJ (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PSYCHIAT,MCV BOX 710,RICHMOND,VA 23298, USA.		Kendler, Kenneth/AAF-2876-2019		NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045390, R01MH041953] Funding Source: NIH RePORTER; NIMH NIH HHS [MH41953, MH45390] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		CAVALLISFORZA LL, 1986, AM J HUM GENET, V38, P599; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; EDWARDS JH, 1976, CYTOGENET CELL GENET, V16, P289, DOI 10.1159/000130612; Efron B, 1982, JACKKNIFE BOOTSTRAP; Finney DJ, 1940, ANN EUGENIC, V10, P171, DOI 10.1111/j.1469-1809.1940.tb02246.x; GOLDIN LR, 1988, GENET EPIDEMIOL, V5, P35, DOI 10.1002/gepi.1370050104; HODGE SE, 1983, AM J HUM GENET, V35, P1139; KENDALL MG, 1961, ADV THEORY STATISTIC, V2; KENDLER KS, 1988, GENET EPIDEMIOL, V5, P407, DOI 10.1002/gepi.1370050605; KIDD KK, 1984, CYTOGENET CELL GENET, V37, P510; MARTINEZ M, 1990, GENET EPIDEMIOL, V7, P219, DOI 10.1002/gepi.1370070306; MORTON NE, 1956, AM J HUM GENET, V8, P80; MORTON NE, 1955, AM J HUM GENET, V7, P277; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; Ott J., 1991, ANAL HUMAN GENETIC L; Papoulis A., 2002, PROBABILITY RANDOM V; PLOUGHMAN LM, 1992, C GEN USERS MANUAL; RISCH N, 1988, AM J HUM GENET, V42, P353; RISCH N, 1989, GENET EPIDEMIOL, V6, P473, DOI 10.1002/gepi.1370060402; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; TERWILLIGER JD, 1992, CYTOGENET CELL GENET, V59, P142, DOI 10.1159/000133228; WEEKS DE, 1990, GENET EPIDEMIOL, V7, P237, DOI 10.1002/gepi.1370070402	23	31	31	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1992	50	6					1259	1266						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HY654	1598905				2022-12-18	WOS:A1992HY65400014
J	CORESH, J; BEATY, TH; KWITEROVICH, PO; ANTONARAKIS, SE				CORESH, J; BEATY, TH; KWITEROVICH, PO; ANTONARAKIS, SE			PEDIGREE AND SIB-PAIR LINKAGE ANALYSIS SUGGEST THE APOLIPOPROTEIN-B GENE IS NOT THE MAJOR GENE INFLUENCING PLASMA APOLIPOPROTEIN-B LEVELS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORONARY-ARTERY DISEASE; MYOCARDIAL-INFARCTION; DNA POLYMORPHISM; HEART-DISEASE; CHOLESTEROL LEVELS; RISK-FACTORS; LIPID-LEVELS; LIPOPROTEIN; ATHEROSCLEROSIS; ASSOCIATION	Previous studies suggest that plasma apolipoprotein B-100 (apoB) level is strongly influenced by genetic factors. Characterizing alleles that influence plasma apoB level would help define genetic risk factors for coronary artery disease. This study examined the role of variability in the apolipoprotein B gene (APOB) in determining plasma apoB level. Twenty-three informative families from the Johns Hopkins Coronary Artery Disease Family Study were studied. Linkage analysis between three polymorphisms in the APOB gene (XbaI at codon 2488, MspI at codon 3611, and EcoRI at codon 4154) and a putative major gene with a codominant allele for elevated apoB levels gave evidence against linkage (LOD score of - 7.9 at a recombination fraction of .001). None of the families had a LOD score greater than 0.5, while five families had a LOD score less than - 0.5. Sib-pair analysis also showed no relationship between the proportion of genes identical by descent at the APOB locus and either crude or adjusted plasma apoB levels. Thus, in 23 informative families, there was no evidence for the presence, in APOB, of common alleles that influence plasma apoB levels. These results suggest that APOB is not the major locus influencing plasma apoB levels.	JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,CTR HUMAN GENET,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	CORESH, J (corresponding author), JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT EPIDEMIOL,615 N WOLFE ST,BALTIMORE,MD 21205, USA.		Antonarakis, Stylianos E/N-8866-2014	Antonarakis, Stylianos E/0000-0001-8907-5823	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031497] Funding Source: NIH RePORTER; NCRR NIH HHS [RR03655] Funding Source: Medline; NHLBI NIH HHS [HL31497] Funding Source: Medline; NIGMS NIH HHS [GM07309] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABURATANI H, 1988, ATHEROSCLEROSIS, V72, P71, DOI 10.1016/0021-9150(88)90064-0; ALMUHTASEB N, 1989, ATHEROSCLEROSIS, V77, P131, DOI 10.1016/0021-9150(89)90074-9; AMOS CI, 1987, GENET EPIDEMIOL, V4, P115, DOI 10.1002/gepi.1370040206; AVOGARO P, 1978, ARTERY, V4, P385; BACHORIK PS, 1988, CLIN CHIM ACTA, V178, P1, DOI 10.1016/0009-8981(88)90265-3; BEATY TH, 1986, AM J HUM GENET, V38, P492; BERG K, 1986, CLIN GENET, V30, P515; BERG K, 1984, ACTA GENET MED GEMEL, V33, P349, DOI 10.1017/S0001566000005808; CAMPEAU L, 1984, NEW ENGL J MED, V311, P1329, DOI 10.1056/NEJM198411223112101; CHEN SH, 1987, SCIENCE, V238, P363, DOI 10.1126/science.3659919; CORESH J, 1992, THESIS J HOPKINS U B; DARNFORS C, 1989, ATHEROSCLEROSIS, V75, P183, DOI 10.1016/0021-9150(89)90175-5; ELSTON RC, 1986, 7TH INT C HUM GEN BE; FORD ES, 1990, J CLIN EPIDEMIOL, V43, P425, DOI 10.1016/0895-4356(90)90130-H; FRIEDL W, 1990, J LIPID RES, V31, P659; GENEST JJ, 1990, ATHEROSCLEROSIS, V82, P7, DOI 10.1016/0021-9150(90)90138-9; GREENBERG DA, 1990, GENET EPIDEMIOL, V7, P467, DOI 10.1002/gepi.1370070608; HAMSTEN A, 1986, ATHEROSCLEROSIS, V60, P199, DOI 10.1016/0021-9150(86)90166-8; HASSTEDT SJ, 1982, COMPUT BIOMED RES, V15, P295, DOI 10.1016/0010-4809(82)90064-7; HASSTEDT SJ, 1987, GENET EPIDEMIOL, V4, P67, DOI 10.1002/gepi.1370040202; Hasstedt SJ, 1981, 13 U UT DEP MED BIOP; HEARN JA, 1990, AM J CARDIOL, V66, P1176, DOI 10.1016/0002-9149(90)91094-M; HEGELE RA, 1986, NEW ENGL J MED, V315, P1509, DOI 10.1056/NEJM198612113152403; HIGUCHI K, 1988, P NATL ACAD SCI USA, V85, P1772, DOI 10.1073/pnas.85.6.1772; KLADETZKY RG, 1980, ARTERY, V7, P191; KWITEROVICH PO, 1992, AM J CARDIOL, V69, P1015, DOI 10.1016/0002-9149(92)90856-T; KWITEROVICH PO, 1987, ARTERIOSCLEROSIS, V7, P211, DOI 10.1161/01.ATV.7.3.211; LATHROP GM, 1988, AM J HUM GENET, V42, P498; LAW A, 1986, LANCET, V1, P1301; Maniatis T., 1982, MOL CLONING; MYANT NB, 1989, ATHEROSCLEROSIS, V77, P193, DOI 10.1016/0021-9150(89)90081-6; NEUMAN RJ, 1990, GENET EPIDEMIOL, V7, P349, DOI 10.1002/gepi.1370070505; PAIRITZ G, 1988, AM J HUM GENET, V43, P311; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANDKAMP M, 1990, CLIN CHEM, V36, P20; SCOTT J, 1990, J ROY COLL PHYS LOND, V24, P101; SNIDERMAN A, 1980, P NATL ACAD SCI-BIOL, V77, P604, DOI 10.1073/pnas.77.1.604; SNIDERMAN AD, 1982, ANN INTERN MED, V97, P833, DOI 10.7326/0003-4819-97-6-833; SORIA LF, 1989, P NATL ACAD SCI USA, V86, P587, DOI 10.1073/pnas.86.2.587; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TIKKANEN MJ, 1990, CLIN GENET, V37, P327, DOI 10.1111/j.1399-0004.1990.tb03514.x; TIKKANEN MJ, 1988, BRIT MED J, V296, P169, DOI 10.1136/bmj.296.6616.169; TIRET L, 1990, GENET EPIDEMIOL, V7, P187, DOI 10.1002/gepi.1370070303; WILLIAMSON JA, 1990, GENET EPIDEMIOL, V7, P309, DOI 10.1002/gepi.1370070502	45	31	31	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1992	50	5					1038	1045						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HR473	1570833				2022-12-18	WOS:A1992HR47300020
J	CHOO, KHA; EARLE, E; VISSEL, B; KALITSIS, P				CHOO, KHA; EARLE, E; VISSEL, B; KALITSIS, P			A CHROMOSOME-14-SPECIFIC HUMAN SATELLITE-III DNA SUBFAMILY THAT SHOWS VARIABLE PRESENCE ON DIFFERENT CHROMOSOMES-14	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SAU3A FAMILY; GENES; NONDISJUNCTION; IDENTIFICATION; HYBRIDIZATION; ORGANIZATION; SEQUENCES; REPEATS	We describe a new subfamily of satellite III DNA (pTRS-63), which, by a combination of in situ hybridization to human metaphase chromosomes and analysis of a panel of somatic cell hybrids, is shown to be specific for human chromosome 14. This DNA has a basic 5-bp repeating unit of diverged GGAAT which is tandemly repeated and organized into either one of two distinct higher-order structures of 5 kb (designated the "L" form) or 4.8 kb (designated the "S" form). In addition, a third (Z) form, representing no detectable levels of this satellite III subfamily, is found. Results from five somatic cell hybrid lines and from a number of informative human individuals suggest that, on any one chromosome 14, only one of the three forms may exist. Subchromosomally, this sequence has been mapped to the p11 region and is distal to the domain occupied by another previously described satellite III subfamily (pTRS-47) found on chromosome 14. The pTRS-63 sequence described adds to the understanding of the structural organization of the short arm of human chromosome 14 and should be useful for the investigation of the molecular etiology of the frequently occurring t(13q14q) and t(14q21q) Robertsonian translocations.			CHOO, KHA (corresponding author), ROYAL CHILDRENS HOSP,MURDOCH INST RES BIRTH DEFECTS,FLEMINGTON RD,PARKVILLE,VIC 3052,AUSTRALIA.		Kalitsis, Paul/C-1916-2015	Kalitsis, Paul/0000-0001-5569-0609; Vissel, Bryce/0000-0001-8860-8050				AGRESTI A, 1987, HUM GENET, V75, P326, DOI 10.1007/BF00284102; CHOO KH, 1990, GENOMICS, V7, P143, DOI 10.1016/0888-7543(90)90534-2; CHOO KH, 1991, NUCLEIC ACIDS RES, V19, P1179, DOI 10.1093/nar/19.6.1179; CHOO KH, 1990, MOL BIOL MED, V7, P437; CHOO KH, 1991, METHOD MOL BIOL, V9, P233; CHOO KH, 1990, NUCLEIC ACIDS RES, V18, pS641; EARLE E, 1992, AM J HUM GENET, V50, P717; HEISTERKAMP N, 1982, NATURE, V299, P747, DOI 10.1038/299747a0; HIGGINS MJ, 1985, CHROMOSOMA, V93, P77, DOI 10.1007/BF01259449; HILLS L, 1991, HUM GENET, V87, P173, DOI 10.1007/BF00204176; HOBART MJ, 1981, ANN HUM GENET, V45, P331, DOI 10.1111/j.1469-1809.1981.tb00346.x; KRYSTAL M, 1981, P NATL ACAD SCI USA, V78, pS744; KURNIT DM, 1986, CYTOGENET CELL GENET, V43, P109, DOI 10.1159/000132305; LAI EC, 1983, AM J HUM GENET, V35, P385; MENEVERI R, 1985, J MOL BIOL, V186, P483, DOI 10.1016/0022-2836(85)90123-8; MOHANDAS T, 1980, CYTOGENET CELL GENET, V28, P116, DOI 10.1159/000131519; SCHMICKEL RD, 1985, ANN NY ACAD SCI, V450, P121, DOI 10.1111/j.1749-6632.1985.tb21488.x; SLATE DL, 1978, J VIROL, V25, P319, DOI 10.1128/JVI.25.1.319-325.1978; SMITH GP, 1976, SCIENCE, V191, P528, DOI 10.1126/science.1251186; VANKESSEL AHMG, 1981, SOMAT CELL GENET, V7, P645, DOI 10.1007/BF01538754; VISSEL B, 1991, NUCLEIC ACIDS RES, V19, P271, DOI 10.1093/nar/19.2.271; WAYE JS, 1989, P NATL ACAD SCI USA, V86, P6250, DOI 10.1073/pnas.86.16.6250; WORTON RG, 1988, SCIENCE, V239, P64, DOI 10.1126/science.3336775	24	31	41	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1992	50	4					706	716						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HL848	1550116				2022-12-18	WOS:A1992HL84800006
J	STOLL, C; QIAN, JF; FEINGOLD, J; SAUVAGE, P; MAY, E				STOLL, C; QIAN, JF; FEINGOLD, J; SAUVAGE, P; MAY, E			GENETIC-VARIATION IN TRANSFORMING GROWTH FACTOR-ALPHA - POSSIBLE ASSOCIATION OF BAMHI POLYMORPHISM WITH BILATERAL SPORADIC CLEFT-LIP AND PALATE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									INST RECH SCI CANC,CNRS,F-94802 VILLEJUIF,FRANCE; INSERM,U155,F-75005 PARIS,FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	STOLL, C (corresponding author), CHU STRASBOURG,INST PUERICULTURE,F-67091 STRASBOURG,FRANCE.							ARDINGER HH, 1989, AM J HUM GENET, V45, P348; CHENEVIXTRENCH G, 1991, AM J HUM GENET, V48, P1012; HECHT JT, 1991, AM J HUM GENET, V49, P682; QIAN JF, IN PRESS NUCLEIC ACI	4	31	31	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1992	50	4					870	871						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HL848	1347971				2022-12-18	WOS:A1992HL84800025
J	CASALS, T; VAZQUEZ, C; LAZARO, C; GIRBAU, E; GIMENEZ, FJ; ESTIVILL, X				CASALS, T; VAZQUEZ, C; LAZARO, C; GIRBAU, E; GIMENEZ, FJ; ESTIVILL, X			CYSTIC-FIBROSIS IN THE BASQUE COUNTRY - HIGH-FREQUENCY OF MUTATION DELTA-F508 IN PATIENTS OF BASQUE ORIGIN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CF FAMILIES; GENE; DNA; IDENTIFICATION; AMPLIFICATION; POLYMERASE; HAPLOTYPES; DELETION; SAMPLE; RFLP	The Basque population is one of the oldest populations of Europe. It has been suggested that the Basques arose from a population established in western Europe during the late Paleolithic Age. The Basque language (Euskera) is a supposedly pre-Indo-European language that originates from the first settlers of Europe. The variable distribution of the major cystic fibrosis (CF) mutation (DELTA-F508 deletion) in Europe, with higher frequencies of the mutation in northern Europe and lower frequencies in southern Europe, has suggested that the DELTA-F508 mutation was spread by early farmers migrating from the Middle East during the Neolithic period. We have studied 45 CF families from the Basque Country, where the incidence of CF is approximately 1/4,500. The birthplaces of the parents and grandparents have been traced and are distributed according to their origin as Basque or Mixed Basque. The frequency of the DELTA-F508 mutation in the chromosomes of Basque origin is 87%, compared with 58% in those of Mixed Basque origin. The analysis of haplotypes, both with markers closely linked to the CF gene and with intragenic markers, suggests that the DELTA-F508 mutation was not spread by the Indo-European invasions but was already present in Europe more than 10,000 years ago, during the Paleolithic period.	HOSP DURAN & REYNALS,CANC RES INST,DEPT MOLEC GENET,CTRA CASTELLDEFELS,KM 2-7,LHOSP LLOBREGAT,E-08907 BARCELONA,SPAIN; HOSP CRUCES,SERV PEDIAT,VIZCAYA,SPAIN	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; Hospital Universitario Cruces			Estivill, Xavier/A-3125-2013; GARCIA, CONXI LAZARO/Q-2410-2016	Estivill, Xavier/0000-0002-0723-2256; GARCIA, CONXI LAZARO/0000-0002-7198-5906				Aguirre A I, 1989, Gene Geogr, V3, P41; Ammerman A.J., 1984, NEOLITHIC TRANSITION; ANWAR R, 1990, HUM GENET, V85, P319; BAL J, 1991, HUM GENET, V86, P329; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; CASALS T, IN PRESS J MED GENET; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; CHILLON M, 1990, HUM GENET, V85, P396, DOI 10.1007/BF02428272; CREMONESI L, 1990, HUM GENET, V85, P400, DOI 10.1007/BF02428276; ESTIVILL X, 1989, LANCET, V2, P1404; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; GOTI-ITURRIAGA J. L., 1966, REV CLIN ESPAN, V101, P30; HUNDRIESER J, 1990, HUM GENET, V85, P409, DOI 10.1007/BF02428283; HUTH A, 1989, NUCLEIC ACIDS RES, V17, P7118, DOI 10.1093/nar/17.17.7118; KERE J, 1990, HUM GENET, V85, P413, DOI 10.1007/BF02428286; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; LEMNA WK, 1990, NEW ENGL J MED, V322, P291, DOI 10.1056/NEJM199002013220503; Mallory JP., 1989, SEARCH INDO EUROPEAN, DOI DOI 10.1038/nature11698; MCINTOSH I, 1990, HUM GENET, V85, P419, DOI 10.1007/BF02428290; MORRAL N, 1991, GENOMICS, V10, P692, DOI 10.1016/0888-7543(91)90454-M; Mourant AE, 1976, DISTRIBUTION HUMAN B; MOURANT AE, 1983, BLOOD RELATIONS; NOVELLI G, 1990, HUM GENET, V85, P420, DOI 10.1007/BF02428291; NUNES V, 1990, NUCLEIC ACIDS RES, V18, P4957, DOI 10.1093/nar/18.16.4957; PANCORBO M, 1989, ANN HUM BIOL, V16, P147; PANCORBO MM, 1986, ANN HUM BIOL, V13, P297; PANCORBO MM, 1983, HUM GENET, V64, P395; PIAZZA A, 1981, BIOMETRICS, V37, P635, DOI 10.2307/2530147; Piazza A, 1988, MUNIBE S, V6, P169; RENFREW AC, 1988, ARCHAEOLOGY LANGUAGE; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; ROSENBLOOM CL, 1989, NUCLEIC ACIDS RES, V17, P7117, DOI 10.1093/nar/17.17.7117; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANTIS G, 1990, HUM GENET, V85, P424, DOI 10.1007/BF02428295; SCHWARTZ M, 1990, HUM GENET, V85, P427, DOI 10.1007/BF02428297; SCHWARZ MJ, 1990, HUM GENET, V85, P428, DOI 10.1007/BF02428298; WATSON EK, 1990, HUM GENET, V85, P435, DOI 10.1007/BF02428303; 1990, HUM GENET, V85, P436	39	31	31	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1992	50	2					404	410						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HD001	1370875				2022-12-18	WOS:A1992HD00100017
J	LEBO, RV; LYNCH, ED; BIRD, TD; GOLBUS, MS; BARKER, DF; OCONNELL, P; CHANCE, PF				LEBO, RV; LYNCH, ED; BIRD, TD; GOLBUS, MS; BARKER, DF; OCONNELL, P; CHANCE, PF			MULTICOLOR INSITU HYBRIDIZATION AND LINKAGE ANALYSIS ORDER CHARCOT-MARIE-TOOTH TYPE-1 (CMT1A) GENE-REGION MARKERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEUROPATHY TYPE-I; NUCLEIC-ACID SEQUENCES; SENSORY NEUROPATHY; HEREDITARY MOTOR; HUMAN-CHROMOSOMES; DNA-SEQUENCES; DUFFY LOCUS; LOCALIZATION; DISEASE; HETEROGENEITY	This study demonstrates a clear and current role for multicolor in situ hybridization in expediting positional cloning studies of unknown disease genes. Nine polymorphic DNA cosmids have been mapped to eight ordered locations spanning the Charcot-Marie-Tooth type 1 (CMT1A) disease gene region in distal band 17p11.2, by multicolor in situ hybridization. When used with linkage analysis, these methods have generated a fine physical map and have firmly assigned the CMT1A gene to distal band 17p11.2. Linkage analysis with four CMT1A pedigrees mapped the CMT1A gene with respect to two flanking markers (8B10-5 cM[LOD 5.2]-CMT1A-3.5 cM[LOD 5.3]-10E4). Additional loci were physically mapped and ordered by in situ hybridization and analysis of phase-known recombinants in CMT1A pedigrees. The order determined by multicolor in situ hybridization was 17cen-LEW301-8B10-5H5/6A9-VAW409-5G7-6G1-4A11-VAW412-10E4-pter. Two ordered probes, 4A11 and 6G1, reside on the same 440-kb partial SfiI restriction fragment. These data demonstrate the ability of in situ hybridization to resolve loci within 0.5 Mb on early-metaphase chromosomes. Multicolor in situ hybridization also excluded the possibility of pericentric inversions in two unrelated patients with CMT1 and neurofibromatosis type 1. When used with pulsed-field gel electrophoresis, multicolor in situ hybridization can establish physical location, order, and distance in closely spaced chromosome loci.	UNIV WASHINGTON,SCH MED,DIV MED GENET,SEATTLE,WA 98195; UNIV UTAH,MED CTR,DIV MED GENET,SALT LAKE CITY,UT 84112; UNIV WASHINGTON,SCH MED,DIV NEUROL,SEATTLE,WA 98195; HOWARD HUGHES MED INST,DEPT MED INFORMAT,SALT LAKE CITY,UT	University of Washington; University of Washington Seattle; Utah System of Higher Education; University of Utah; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute	LEBO, RV (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT OBSTET,ROOM U262,SAN FRANCISCO,CA 94143, USA.		Chance, Phillip/AAX-5826-2020	Barker, David/0000-0002-1438-4100	NINDS NIH HHS [NS01341, R01 NS25541] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001341, R01NS025541] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBERTSON DG, 1985, EMBO J, V4, P2493, DOI 10.1002/j.1460-2075.1985.tb03961.x; BECKER PE, 1978, HUMANGENETIK EIN K 1, V5; BECKETT J, 1986, J NEUROGENET, V3, P225, DOI 10.3109/01677068609106852; BIRD TD, 1978, CLIN GENET, V14, P43; BIRD TD, 1980, AM J HUM GENET, V32, pA99; BIRD TD, 1982, AM J HUM GENET, V34, P388; BIRD TD, 1983, ANN NEUROL, V14, P679, DOI 10.1002/ana.410140612; BONIFAS JM, UNPUB REGIONAL ASSIG; CHANCE PF, 1990, AM J HUM GENET, V47, P915; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; DEFSCHE JC, 1990, NEUROLOGY, V40, P1450; DYCK PJ, 1968, ARCH NEUROL-CHICAGO, V18, P619, DOI 10.1001/archneur.1968.00470360041003; DYCK PJ, 1968, ARCH NEUROL-CHICAGO, V18, P603, DOI 10.1001/archneur.1968.00470360025002; DYCK PJ, 1983, MAYO CLIN PROC, V58, P430; DYCK PJ, 1984, DISEASES PERIPHERAL, P1609; FISCHBECK KH, 1986, ANN NEUROL, V20, P527, DOI 10.1002/ana.410200414; FOUNTAIN JW, 1989, SCIENCE, V244, P1085, DOI 10.1126/science.2543076; GAL A, 1985, HUM GENET, V70, P38, DOI 10.1007/BF00389456; GUILOFF RJ, 1982, ANN HUM GENET, V46, P25, DOI 10.1111/j.1469-1809.1982.tb00691.x; HARDING AE, 1980, J MED GENET, V17, P329, DOI 10.1136/jmg.17.5.329; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; IONASESCU VV, 1991, AM J HUM GENET, V48, P1075; LANDEGENT JE, 1984, EXP CELL RES, V153, P61, DOI 10.1016/0014-4827(84)90448-8; LANDEGENT JE, 1985, NATURE, V317, P175, DOI 10.1038/317175a0; LANGERSAFER PR, 1982, P NATL ACAD SCI-BIOL, V79, P4381, DOI 10.1073/pnas.79.14.4381; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LAWRENCE JB, 1990, SCIENCE, V249, P928, DOI 10.1126/science.2203143; LEBO RV, IN PRESS HUM GENET; LEBO RV, IN PRSS HUM GENET; LEBO RV, 1990, AM J HUM GENET S, V47, pA188; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; LOVELACE RE, 1990, CHARCOT MARIE TOOTH; MENDELSOHN ML, 1973, SCIENCE, V179, P1126, DOI 10.1126/science.179.4078.1126; MIDDLETONPRICE HR, 1990, AM J HUM GENET, V46, P92; MONACO AP, 1987, HUM GENET, V75, P221, DOI 10.1007/BF00281063; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NEDERLOF PM, 1989, CYTOMETRY, V10, P20, DOI 10.1002/cyto.990100105; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; OCONNELL P, 1989, SCIENCE, V244, P1087, DOI 10.1126/science.2543077; OCONNELL P, IN PRESS GENOMICS; OLSON MV, 1986, P NATL ACAD SCI USA, V83, P7826, DOI 10.1073/pnas.83.20.7826; PATEL PI, 1990, AM J HUM GENET, V46, P801; RAEYMAEKERS P, 1989, AM J HUM GENET, V45, P953; RAEYMAEKERS P, IN PRESS J MED GENET; RIORDAN JR, 1989, SCIENCE, V245, P1066; SHROYER KR, 1983, J CELL BIOL, V97, pA377; SKRE H, 1974, CLIN GENET, V6, P98; SMITH ACM, 1986, AM J MED GENET, V24, P393, DOI 10.1002/ajmg.1320240303; STEBBINS NB, 1982, AM J HUM GENET, V34, pA195; STRICKBERGER MW, 1990, AM J HUM GENET, V47, P680; TRASK B, 1989, GENOMICS, V5, P710, DOI 10.1016/0888-7543(89)90112-2; TRASK BJ, 1991, AM J HUM GENET, V48, P1; VANASSE M, 1981, MUSCLE NERVE, V4, P26, DOI 10.1002/mus.880040106; VANCE JM, 1989, EXP NEUROL, V104, P186, DOI 10.1016/S0014-4886(89)80013-5; 1985, CYTOGENET CELL GENET, V6, P48; 1988, OTABA373 US C OFF TE; 1989, CYTOGENET CELL GENET, V51, P322	57	31	33	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1992	50	1					42	55						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HA040	1729894				2022-12-18	WOS:A1992HA04000005
J	COLLINGE, J; POULTER, M; DAVIS, MB; BARAITSER, M; OWEN, F; CROW, TJ; HARDING, AE				COLLINGE, J; POULTER, M; DAVIS, MB; BARAITSER, M; OWEN, F; CROW, TJ; HARDING, AE			PRESYMPTOMATIC DETECTION OR EXCLUSION OF PRION PROTEIN GENE DEFECTS IN FAMILIES WITH INHERITED PRION DISEASES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CREUTZFELDT-JAKOB DISEASE; GERSTMANN-STRAUSSLER SYNDROME; MUTATION; DNA	The identification of defects in the prion protein (PrP) gene in families with inherited Creutzfeldt-Jakob disease or Gerstmann-Straussler syndrome allows presymptomatic diagnosis or exclusion of these disorders in subjects at risk. After counseling, PrP gene analysis was performed in three such individuals: two from families with a 144-bp insert and one with a point mutation at codon 102 in the PrP gene. The presence of a PrP gene defect was confirmed in one and excluded in two. Despite the potential problems of using PrP gene analysis in genetic prediction-specifically, uncertainty about penetrance and, generally, problems of presymptomatic testing in any inherited late-onset neurodegenerative disorder-we conclude that it has a role to play in improved genetic counseling for families with inherited prion diseases.	UNIV LONDON,INST NEUROL,DEPT CLIN NEUROL,QUEEN SQ,LONDON WC1N 3BG,ENGLAND; CLIN RES CTR,DIV PSYCHIAT,HARROW HA1 3UJ,MIDDX,ENGLAND; NATL HOSP,LONDON WC1N 3BG,ENGLAND	University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	HARDING, AE (corresponding author), UNIV LONDON,INST NEUROL,DEPT CLIN NEUROL,QUEEN SQ,LONDON WC1N 3BG,ENGLAND.							COLLINGE J, 1989, LANCET, V2, P15, DOI 10.1016/S0140-6736(89)90256-0; COLLINGE J, 1990, LANCET, V336, P7, DOI 10.1016/0140-6736(90)91518-F; CRAUFURD D, 1989, LANCET, V2, P603; CRAUFURD DIO, 1986, BRIT MED J, V293, P307; DOHURA K, 1989, BIOCHEM BIOPH RES CO, V163, P974, DOI 10.1016/0006-291X(89)92317-6; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GOLDFARB LG, 1990, LANCET, V336, P514, DOI 10.1016/0140-6736(90)92073-Q; GOLDFARB LG, 1990, LANCET, V336, P174, DOI 10.1016/0140-6736(90)91693-5; GOLDGABER D, 1989, EXP NEUROL, V106, P204, DOI 10.1016/0014-4886(89)90095-2; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; HSIAO KK, 1990, SCIENCE, V250, P1587, DOI 10.1126/science.1980379; KRETZSCHMAR HA, 1986, DNA-J MOLEC CELL BIO, V5, P315, DOI 10.1089/dna.1986.5.315; MASTERS CL, 1981, BRAIN, V104, P559, DOI 10.1093/brain/104.3.559; NIETO A, 1991, LANCET, V337, P622, DOI 10.1016/0140-6736(91)91696-R; OWEN F, 1989, LANCET, V1, P51; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; WESTAWAY D, 1989, TRENDS NEUROSCI, V12, P221, DOI 10.1016/0166-2236(89)90126-4; World Federation of Neurology, 1989, J NEUROL SCI, V94, P327	18	31	32	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1991	49	6					1351	1354						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GU672	1684089				2022-12-18	WOS:A1991GU67200022
J	OETTING, WS; MENTINK, MM; SUMMERS, CG; LEWIS, RA; WHITE, JG; KING, RA				OETTING, WS; MENTINK, MM; SUMMERS, CG; LEWIS, RA; WHITE, JG; KING, RA			3 DIFFERENT FRAMESHIFT MUTATIONS OF THE TYROSINASE GENE IN TYPE-IA OCULOCUTANEOUS ALBINISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MOLECULAR-BASIS; MELANOMA-CELLS; DNA; GLYCOSYLATION; MELANOGENESIS; INHIBITORS; PATIENT	Mutations in the gene for the pigment-producing enzyme tyrosinase are responsible for type IA (tyrosinase-negative) oculocutaneous albinism (OCA). Most reported mutations have been single base substitutions. We now report three different frameshift mutations in three unrelated individuals with type IA OCA. The first individual has a single base deletion within a series of five guanidines, resulting in a premature stop codon in exon I on one allele and a missense mutation at codon 382 in exon III on the homologous allele. The second individual is a genetic compound of two separate frameshift mutations, including both the same exon I single base deletion found in the first individual and a deletion of a thymidine-guanidine pair, within the sequence GTGTG, forming a termination codon (TAG) in exon I on the homologous allele. The third individual has a single base insertion in exon I on one allele and a missense mutation at codon 373 in exon III on the homologous allele. The two missense mutations occur within the copper Bbinding region and may interfere with either copper binding to the enzyme or oxygen binding to the copper. These five different mutations disrupt tyrosinase function and are associated with a total lack of melanin biosynthesis.	UNIV MINNESOTA,DEPT MED,BOX 485 UMHC,420 DELAWARE ST SE,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,DEPT OPHTHALMOL,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,DEPT LAB MED & PATHOL,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,DEPT PEDIAT,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,INST HUMAN GENET,MINNEAPOLIS,MN 55455; BAYLOR UNIV,DEPT OPHTHALMOL,HOUSTON,TX 77030; BAYLOR UNIV,DEPT MED,HOUSTON,TX 77030; BAYLOR UNIV,DEPT PEDIAT,HOUSTON,TX 77030; BAYLOR UNIV,INST MOLEC GENET,HOUSTON,TX 77030; BAYLOR UNIV,CULLEN EYE INST,HOUSTON,TX 77030	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Baylor University; Baylor University; Baylor University; Baylor College of Medicine; Baylor University; Baylor College of Medicine; Baylor University					NIAMS NIH HHS [AR40001] Funding Source: Medline; NIGMS NIH HHS [GM22167] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR040001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM022167] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABADIE V, 1989, GENOMICS, V5, P936, DOI 10.1016/0888-7543(89)90137-7; BARTON D E, 1988, Genomics, V3, P17, DOI 10.1016/0888-7543(88)90153-X; COOPER DN, 1990, HUM GENET, V85, P55; FUCHS RPP, 1988, MECHANISMS CONSEQUEN, P33; GIEBEL LB, 1990, NUCLEIC ACIDS RES, V18, P3103, DOI 10.1093/nar/18.10.3103-a; GIEBEL LB, 1991, J CLIN INVEST, V87, P1119, DOI 10.1172/JCI115075; GIEBEL LB, 1991, AM J HUM GENET, V48, P1159; GIEBEL LB, 1990, P NATL ACAD SCI USA, V87, P3255, DOI 10.1073/pnas.87.9.3255; GIEBEL LB, IN PRESS GENOMICS; GIEBEL LB, IN PRESS J MED GENET; HANDOKO HY, 1990, 14TH INT PIGM CELL C; HEARING VJ, 1989, PIGM CELL RES, V2, P75, DOI 10.1111/j.1600-0749.1989.tb00166.x; IMOKAWA G, 1982, CANCER RES, V42, P1994; IMOKAWA G, 1986, J INVEST DERMATOL, V87, P319, DOI 10.1111/1523-1747.ep12524388; KIKUCHI H, 1990, HUM GENET, V85, P123; KING RA, 1985, AM J MED GENET, V20, P49, DOI 10.1002/ajmg.1320200108; KING RA, 1991, J CLIN INVEST, V87, P1046, DOI 10.1172/JCI115064; KING RA, 1988, DERMATOL CLIN, V6, P217, DOI 10.1016/S0733-8635(18)30668-5; KING RA, 1986, CLIN GENET, V29, P42; KUNKEL TA, 1985, J BIOL CHEM, V260, P2866; LERNER AB, 1950, PHYSIOL REV, V30, P91, DOI 10.1152/physrev.1950.30.1.91; LITZ CE, 1988, AM J MED GENET, V30, P821, DOI 10.1002/ajmg.1320300316; NANCE WE, 1970, AM J HUM GENET, V22, P579; OETTING WS, IN PRESS J INVEST DE; PROTA G, 1980, J INVEST DERMATOL, V75, P122, DOI 10.1111/1523-1747.ep12521344; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEIJI M, 1967, ADV BIOLOGY SKIN VII, P189; SEIJI M, 1972, PIGMENTATION ITS GEN, P525; SHIBAHARA S, 1988, TOHOKU J EXP MED, V156, P403, DOI 10.1620/tjem.156.403; SPRITZ RA, 1991, AM J HUM GENET, V48, P318; SPRITZ RA, 1990, NEW ENGL J MED, V322, P1724, DOI 10.1056/NEJM199006143222407; STREISINGER G, 1985, GENETICS, V109, P633; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; TAKEDA A, 1990, J BIOL CHEM, V265, P17792; TOMITA Y, 1989, BIOCHEM BIOPH RES CO, V164, P990, DOI 10.1016/0006-291X(89)91767-1; [No title captured]	37	31	31	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1991	49	1					199	206						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FW511	1905879				2022-12-18	WOS:A1991FW51100023
J	SARAIVA, MJM; ALMEIDA, MD; ALVES, IL; MOREIRA, P; GAWINOWICZ, MA; COSTA, PP; RAUH, S; BANHZOFF, A; ALTLAND, K				SARAIVA, MJM; ALMEIDA, MD; ALVES, IL; MOREIRA, P; GAWINOWICZ, MA; COSTA, PP; RAUH, S; BANHZOFF, A; ALTLAND, K			MOLECULAR ANALYSES OF AN ACIDIC TRANSTHYRETIN ASN-90 VARIANT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL AMYLOIDOTIC POLYNEUROPATHY; PREALBUMIN	A mutation in transthyretin (TTR Asn 90) has been identified in the Portuguese and German populations. This variant has a lower pI and was found by screening analyses in 2/4,000 German subjects and in 4/1,200 Portuguese by using either double one-dimensional (D1-D) electrophoresis with isoelectric focusing (IEF) or hybrid isoelectric focusing in immobilized pH gradients (HIEF) as the final separation step. The Portuguese population sample was from the area where TTR Met 30-associated familial amyloidotic polyneuropathy (FAP) prevails, and it was divided into (a) group of 500 individuals belonging to FAP kindreds and (b) a group of 700 collected at random. HIEF showed two particular situations: (1) one case, from an FAP kindred, was simultaneously carrier of the Met 30 substitution and the acidic variant, and (2) one individual, from the randomly selected Portuguese sample, had only the acidic monomer. Comparative peptide mapping, by HPLC, of the acidic variant carriers and of normal TTR showed the presence of an abnormal tryptic peptide, not present in the normal TTR digests, with an asparagine-for-histidine substitution at position 90 explained by a single base change of adenine for cytosine in the histidine codon. This was confirmed at the DNA level by RFLP analyses of PCR-amplified material after digestion with SphI and BsmI. In all carriers of the Asn 90 substitution, no indicators were found for an association with traits characteristic for FAP.	UNIV PORTO, INST CIENCIAS BIOMED, OPORTO, PORTUGAL; COLUMBIA UNIV COLL PHYS & SURG, DEPT MED, NEW YORK, NY 10032 USA; UNIV GIESSEN, INST HUMAN GENET, W-6300 GIESSEN, GERMANY	Universidade do Porto; Columbia University; Justus Liebig University Giessen	SARAIVA, MJM (corresponding author), HOSP SANTO ANTONIO, CTR ESTUDOS PARAMILOIDOSE, P-4000 OPORTO, PORTUGAL.		Saraiva, Maria João/K-3907-2013; Almeida, Maria Rosario/K-3938-2013	Saraiva, Maria João/0000-0002-3360-6899; Almeida, Maria Rosario/0000-0001-9289-3835	NINDS NIH HHS [R01NS25190] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025190] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALMEIDA MR, 1990, HUM GENET, V85, P623; ALTLAND K, 1981, ELECTROPHORESIS, V2, P148, DOI 10.1002/elps.1150020305; ALTLAND K, 1987, ELECTROPHORESIS, V8, P293, DOI 10.1002/elps.1150080606; ALTLAND K, 1986, ELECTROPHORESIS, V7, P529, DOI 10.1002/elps.1150071110; SARAIVA MJM, 1990, SCAND J IMMUNOL, V32, P341, DOI 10.1111/j.1365-3083.1990.tb02928.x; SKARE JC, 1989, BIOCHEM BIOPH RES CO, V164, P1240, DOI 10.1016/0006-291X(89)91802-0	6	31	31	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1991	48	5					1004	1008						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK897	1850190				2022-12-18	WOS:A1991FK89700021
J	BARBUJANI, G; JACQUEZ, GM; LIGI, L				BARBUJANI, G; JACQUEZ, GM; LIGI, L			DIVERSITY OF SOME GENE-FREQUENCIES IN EUROPEAN AND ASIAN POPULATIONS .5. STEEP MULTILOCUS CLINES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									SUNY STONY BROOK, DEPT ECOL & EVOLUT, STONY BROOK, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	BARBUJANI, G (corresponding author), UNIV PADUA, DIPARTIMENTO BIOL, VIA TRIESTE 75, I-35121 PADUA, ITALY.		Barbujani, Guido/ABE-9998-2020	Barbujani, Guido/0000-0001-7854-6669				BARBUJANI G, 1986, J HUM EVOL, V15, P61, DOI 10.1016/S0047-2484(86)80066-5; BARBUJANI G, 1987, GENETICS, V117, P777; BARBUJANI G, 1988, ANN HUM GENET, V52, P215, DOI 10.1111/j.1469-1809.1988.tb01099.x; BARBUJANI G, 1988, J GENET, V67, P129, DOI 10.1007/BF02927793; BARBUJANI G, 1987, ANN HUM GENET, V51, P345, DOI 10.1111/j.1469-1809.1987.tb01069.x; BARBUJANI G, 1989, SYST ZOOL, V38, P376, DOI 10.2307/2992403; BARBUJANI G, 1990, P NATL ACAD SCI USA, V87, P1816, DOI 10.1073/pnas.87.5.1816; BARRANTES R, 1990, AM J HUM GENET, V46, P63; Batschelet E, 1981, CIRCULAR STAT BIOL; BERETTA M, 1986, HUM HERED, V36, P379, DOI 10.1159/000153662; CAVALLIS.LL, 1966, PROC R SOC SER B-BIO, V164, P362, DOI 10.1098/rspb.1966.0038; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; CAVALLISFORZA LL, 1984, HUMAN POPULATION GEN, P229; CHAKRABORTY R, 1976, SOC BIOL, V23, P73, DOI 10.1080/19485565.1976.9988205; COOK PJL, 1974, ANN HUM GENET, V37, P261, DOI 10.1111/j.1469-1809.1974.tb01834.x; Endler J.A., 1977, Monographs in Population Biology, pi; FARABEGOLI A, IN PRESS HUM HERED; GREEN PJ, 1977, COMPUT J, V21, P68; HARDING RM, 1988, P NATL ACAD SCI USA, V85, P9370, DOI 10.1073/pnas.85.23.9370; HEDRICK PW, 1986, EVOLUTIONARY PROCESS, P583; Jorde L., 1980, CURRENT DEV ANTHR GE, V1, P135, DOI DOI 10.1007/978-1-4613-3084-4_7; KIMURA M, 1964, GENETICS, V49, P561; Malecot G, 1948, MATH HEREDITE; Matheron G, 1970, CAHIERS CMM FASCICUL; MCKUSICK VA, 1988, MENDELIAN INHERITANC; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; MONMONIER MS, 1973, GEOGR ANAL, V5, P245; MORTON N E, 1971, Theoretical Population Biology, V2, P507, DOI 10.1016/0040-5809(71)90038-4; MORTON NE, 1982, CURRENT DEV ANTHR GE, P449; NAGYLAKI T, 1988, THEOR POPUL BIOL, V33, P291, DOI 10.1016/0040-5809(88)90017-2; NAGYLAKI T, 1988, THEOR POPUL BIOL, V33, P311, DOI 10.1016/0040-5809(88)90018-4; PIAZZA A, 1981, BIOMETRICS, V37, P635, DOI 10.2307/2530147; PIAZZA A, 1981, P NATL ACAD SCI-BIOL, V78, P2638, DOI 10.1073/pnas.78.4.2638; SLATKIN M, 1989, GENOME, V31, P196, DOI 10.1139/g89-034; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; SLATKIN M, 1989, EVOLUTION, V43, P1349, DOI [10.2307/2409452, 10.1111/j.1558-5646.1989.tb02587.x]; SLATKIN M, 1975, GENETICS, V81, P787; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; SLATKIN M, 1973, GENETICS, V75, P733; SMOUSE PE, 1988, 2ND P INT C QUANT GE, P32; SOKAL RR, 1990, AM NAT, V135, P157, DOI 10.1086/285037; SOKAL RR, 1989, AM J PHYS ANTHROPOL, V79, P489, DOI 10.1002/ajpa.1330790406; SOKAL RR, 1988, AM J PHYS ANTHROPOL, V76, P337, DOI 10.1002/ajpa.1330760308; SOKAL RR, 1982, AM NAT, V119, P1, DOI 10.1086/283886; SOKAL RR, 1989, AM J PHYS ANTHROPOL, V80, P267, DOI 10.1002/ajpa.1330800302; SOKAL RR, 1988, P NATL ACAD SCI USA, V85, P1722, DOI 10.1073/pnas.85.5.1722; WIJSMAN EM, 1984, ANNU REV ECOL SYST, V15, P279; WOMBLE WH, 1951, SCIENCE, V114, P315, DOI 10.1126/science.114.2961.315; WOOD JW, 1987, AM NAT, V129, P165, DOI 10.1086/284628; Wright S, 1931, GENETICS, V16, P0097; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Wright S, 1943, GENETICS, V28, P114	53	31	31	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1990	47	5					867	875						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EE940	2220827				2022-12-18	WOS:A1990EE94000015
J	DAZZO, C; TOLAN, DR				DAZZO, C; TOLAN, DR			MOLECULAR EVIDENCE FOR COMPOUND HETEROZYGOSITY IN HEREDITARY FRUCTOSE INTOLERANCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BOSTON UNIV,DEPT BIOL,5 CUMMINGTON ST,BOSTON,MA 02215	Boston University				Tolan, Dean/0000-0002-0598-7241	NIDDK NIH HHS [DK-38821] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK038821] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANAI M, 1973, ARCH BIOCHEM BIOPHYS, V156, P712, DOI 10.1016/0003-9861(73)90324-X; ANGELINI G, 1986, P NATL ACAD SCI USA, V83, P4489, DOI 10.1073/pnas.83.12.4489; CHAMBERS RA, 1956, LANCET, V2, P340; Cox T M, 1983, Mol Biol Med, V1, P393; CROSS NCP, 1988, CELL, V53, P881, DOI 10.1016/S0092-8674(88)90349-2; CROSS NCP, 1990, LANCET, P306; KELLEY PM, 1986, PLANT PHYSIOL, V82, P1076, DOI 10.1104/pp.82.4.1076; KOBASHI K, 1967, ARCH BIOCHEM BIOPHYS, V121, P178, DOI 10.1016/0003-9861(67)90022-7; KUNKEL TA, 1986, J BIOL CHEM, V261, P3581; LAMEIRE N, 1978, AM J MED, V65, P416, DOI 10.1016/0002-9343(78)90767-2; LEBO RV, 1985, CYTOMETRY, V6, P478, DOI 10.1002/cyto.990060513; LENCH N, 1988, LANCET, V1, P787; Maniatis T., 1982, MOL CLONING; ODIEVRE M, 1978, AM J DIS CHILD, V132, P605, DOI 10.1001/archpedi.1978.02120310069014; ORKIN SH, 1978, NEW ENGL J MED, V299, P166, DOI 10.1056/NEJM197807272990403; ROTTMANN WH, 1984, P NATL ACAD SCI-BIOL, V81, P2738, DOI 10.1073/pnas.81.9.2738; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; TOLAN DR, 1986, MOL BIOL MED, V3, P245	22	31	33	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1990	46	6					1194	1199						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DF202	2339710				2022-12-18	WOS:A1990DF20200021
J	GREGER, V; PASSARGE, E; HORSTHEMKE, B				GREGER, V; PASSARGE, E; HORSTHEMKE, B			SOMATIC MOSAICISM IN A PATIENT WITH BILATERAL RETINOBLASTOMA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV ESSEN KLINIKUM,INST HUMANGENET,HUFELANDSTR 55,W-4300 ESSEN,GERMANY	University of Duisburg Essen				Greger, Valerie/0000-0001-7716-3973				ALBERTINI AM, 1982, CELL, V29, P319, DOI 10.1016/0092-8674(82)90148-9; BOOKSTEIN R, 1988, P NATL ACAD SCI USA, V85, P2210, DOI 10.1073/pnas.85.7.2210; BRUNIER D, 1988, CELL, V52, P883, DOI 10.1016/0092-8674(88)90430-8; CANNING S, 1989, P NATL ACAD SCI USA, V86, P5044, DOI 10.1073/pnas.86.13.5044; DRYJA TP, 1986, P NATL ACAD SCI USA, V83, P7391, DOI 10.1073/pnas.83.19.7391; DUNN JM, 1988, SCIENCE, V241, P1797, DOI 10.1126/science.3175621; DUNN JM, 1989, MOL CELL BIOL, V9, P4594; EFSTRATIADIS A, 1980, CELL, V21, P653, DOI 10.1016/0092-8674(80)90429-8; FRIEND SH, 1987, P NATL ACAD SCI USA, V84, P9059, DOI 10.1073/pnas.84.24.9059; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; GARDNER RL, 1983, BIOL BASIS REPRODUCT, P31; GODDARD AD, 1990, CLIN GENET, V37, P117; GODDARD AD, 1988, MOL CELL BIOL, V8, P2082, DOI 10.1128/MCB.8.5.2082; HALL JG, 1988, AM J HUM GENET, V43, P355; HARBOUR JW, 1988, SCIENCE, V241, P353, DOI 10.1126/science.2838909; HOROWITZ JM, 1989, SCIENCE, V243, P937, DOI 10.1126/science.2521957; HORSTHEMKE B, 1987, EUR J BIOCHEM, V164, P77, DOI 10.1111/j.1432-1033.1987.tb10995.x; HORSTHEMKE B, 1987, HUM GENET, V76, P257; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LALANDE M, 1984, CANCER GENET CYTOGEN, V13, P283, DOI 10.1016/0165-4608(84)90073-6; LEE EYHP, 1988, SCIENCE, V241, P218, DOI 10.1126/science.3388033; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; LEHRMAN MA, 1986, P NATL ACAD SCI USA, V83, P3679, DOI 10.1073/pnas.83.11.3679; LEHRMAN MA, 1985, SCIENCE, V227, P140, DOI 10.1126/science.3155573; LUCKETT WP, 1978, AM J ANAT, V152, P59, DOI 10.1002/aja.1001520106; Maniatis T., 1982, MOL CLONING; MCGEE TL, 1989, GENE, V80, P119, DOI 10.1016/0378-1119(89)90256-4; RIBEIRO MCM, 1988, CANCER GENET CYTOGEN, V32, P168; SORIANO P, 1986, CELL, V46, P19, DOI 10.1016/0092-8674(86)90856-1; VOGEL F, 1979, HUM GENET, V52, P1; WIGGS J, 1988, NEW ENGL J MED, V318, P151, DOI 10.1056/NEJM198801213180305; YANDELL DW, 1989, NEW ENGL J MED, V321, P1689, DOI 10.1056/NEJM198912213212501	34	31	31	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1990	46	6					1187	1193						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DF202	1971154				2022-12-18	WOS:A1990DF20200020
J	REISS, AL; FREUND, L; VINOGRADOV, S; HAGERMAN, R; CRONISTER, A				REISS, AL; FREUND, L; VINOGRADOV, S; HAGERMAN, R; CRONISTER, A			PARENTAL INHERITANCE AND PSYCHOLOGICAL DISABILITY IN FRAGILE-X FEMALES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT,DIV CHILD PSYCHIAT,BEHAV GENET RES UNIT,BALTIMORE,MD 21205; STANFORD UNIV,MED CTR,SCH MED,DEPT PSYCHIAT & BEHAV SCI,STANFORD,CA 94305; UNIV COLORADO,HLTH SCI CTR,DEPT PEDIAT,DENVER,CO 80262; CHILDRENS HOSP,CHILD DEV UNIT,DENVER,CO 80218	Johns Hopkins University; Stanford University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Children's Hospital Colorado	REISS, AL (corresponding author), KENNEDY INST,BEHAV GENET UNIT,ROOM 106,707 N BROADWAY,BALTIMORE,MD 21205, USA.		Freund, Lisa/ABD-8855-2020	Freund, Lisa/0000-0003-2095-4023	NIMH NIH HHS [MH16744] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH016744] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDREASEN NC, 1981, ARCH GEN PSYCHIAT, V38, P400; BROWN WT, 1986, AM J MED GENET, V23, P341, DOI 10.1002/ajmg.1320230126; COHEN IL, 1988, AM J MENT RETARD, V92, P436; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; FREUND LS, UNPUB CHROMOSOME FRA; GILL CE, 1985, BRIT J EDUC PSYCHOL, V55, P240, DOI 10.1111/j.2044-8279.1985.tb02629.x; HAGERMAN RJ, 1986, AM J MED GENET, V23, P359, DOI 10.1002/ajmg.1320230128; HANSON DM, 1986, AM J MED GENET, V23, P195, DOI 10.1002/ajmg.1320230114; Hollingshead A., 2011, 4 FACTOR INDEX SOCIA, V8; KNOLL JH, 1984, AM J HUM GENET, V36, P640; LAIRD CD, 1987, GENETICS, V117, P587; Overall JE, 1974, MOD PROBL PHARMACOPS, V7, P67; PAUL J, 1984, HUM GENET, V66, P344, DOI 10.1007/BF00287638; REISS AL, 1986, AM J MED GENET, V23, P393, DOI 10.1002/ajmg.1320230131; REISS AL, 1988, ARCH GEN PSYCHIAT, V45, P25; REISS AL, 1986, SCHIZOPHRENIA BULL, V12, P724, DOI 10.1093/schbul/12.4.724; REISS AL, 1989, 1989 INT FRAG X C DE; RUSHTON JP, 1986, P NATL ACAD SCI USA, V83, P7340, DOI 10.1073/pnas.83.19.7340; SHERMAN SL, 1985, HUM GENET, V69, P289, DOI 10.1007/BF00291644; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; WENT LN, 1984, LANCET, V1, P1100; WILHELM D, 1988, AM J MED GENET, V30, P407, DOI 10.1002/ajmg.1320300141; ZERBINRUDIN E, 1987, J PSYCHIAT RES, V21, P377, DOI 10.1016/0022-3956(87)90084-7; 1987, DIAGNOSTIC STATISTIC	24	31	31	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1989	45	5					697	705						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	AZ049	2816940				2022-12-18	WOS:A1989AZ04900006
J	CHEN, JD; HALLIDAY, F; KEITH, G; SHEFFIELD, L; DICKINSON, P; GRAY, R; CONSTABLE, I; DENTON, M				CHEN, JD; HALLIDAY, F; KEITH, G; SHEFFIELD, L; DICKINSON, P; GRAY, R; CONSTABLE, I; DENTON, M			LINKAGE HETEROGENEITY BETWEEN X-LINKED RETINITIS PIGMENTOSA AND A MAP OF 10-RFLP LOCI	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									PRINCE WALES HOSP, DEPT CLIN CHEM, DIV PATHOL, RANDWICK, NSW 2031, AUSTRALIA; PRINCE WALES HOSP, RETINAL DYSTROPHY SERV, RANDWICK, NSW 2031, AUSTRALIA; ROYAL CHILDRENS HOSP, PARKVILLE, VIC 3052, AUSTRALIA; ROYAL VICTORIAN EYE & EAR HOSP, MELBOURNE, AUSTRALIA; LIONS EYE INST, PERTH, AUSTRALIA	Royal Children's Hospital Melbourne; Royal Victorian Eye & Ear Hospital; Lions Eye Institute; University of Western Australia								BHATTACHARYA SS, 1984, NATURE, V309, P253, DOI 10.1038/309253a0; BIRD AC, 1975, BRIT J OPHTHALMOL, V59, P177, DOI 10.1136/bjo.59.4.177; CHEN JD, 1989, GENOMICS, V4, P105, DOI 10.1016/0888-7543(89)90322-4; CHEN JD, 1988, OPHTHALMIC PAED GEN, V9, P143, DOI 10.3109/13816818809031490; DENTON MJ, 1988, HUM GENET, V78, P60, DOI 10.1007/BF00291236; DESTBASILE G, 1988, HUM GENET, V80, P85, DOI 10.1007/BF00451463; DRAYNA D, 1985, SCIENCE, V230, P753, DOI 10.1126/science.4059909; FRANCKE U, 1985, AM J HUM GENET, V37, P250; FRANCKE U, 1987, AM J HUM GENET, V40, P212; FRIEDRICH U, 1985, HUM GENET, V71, P93; GOODFELLOW PN, 1985, CYTOGENET CELL GENET, V40, P296, DOI 10.1159/000132178; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; McKusick V. A., 1986, MENDELIAN INHERITANC; MUSARELLA MA, 1988, AM J HUM GENET, V43, P484; NUSSBAUM RL, 1985, HUM GENET, V70, P45, DOI 10.1007/BF00389458; OTT J, 1986, HUM GENET, V74, P280; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; VANOMMEN GJB, 1986, CELL, V47, P499, DOI 10.1016/0092-8674(86)90614-8; WIRTH B, 1988, Genomics, V2, P263, DOI 10.1016/0888-7543(88)90011-0; WRIGHT AF, 1983, T OPHTHAL SOC UK, V103, P467; WRIGHT AF, 1987, AM J HUM GENET, V41, P635	21	31	33	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1989	45	3					401	411						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AN879	2570529				2022-12-18	WOS:A1989AN87900009
J	IANNUZZI, MC; DEAN, M; DRUMM, ML; HIDAKA, N; COLE, JL; PERRY, A; STEWART, C; GERRARD, B; COLLINS, FS				IANNUZZI, MC; DEAN, M; DRUMM, ML; HIDAKA, N; COLE, JL; PERRY, A; STEWART, C; GERRARD, B; COLLINS, FS			ISOLATION OF ADDITIONAL POLYMORPHIC CLONES FROM THE CYSTIC-FIBROSIS REGION, USING CHROMOSOME JUMPING FROM D7S8	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MICHIGAN,HOWARD HUGHES MED INST,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT HUMAN GENET,ANN ARBOR,MI 48109; FREDERICK CANC RES FACIL,PROGRAM RESOURCES INC,BIOL CARCINOGENESIS DEV PROGRAM,FREDERICK,MD 21701	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	IANNUZZI, MC (corresponding author), UNIV MICHIGAN,DEPT INTERNAL MED,MSRB I,ROOM 5520 B,1150 W MED CTR DR,ANN ARBOR,MI 48109, USA.		Dean, Michael/R-7501-2019; Dean, Michael C/G-8172-2012	Dean, Michael C/0000-0003-2234-0631	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039690] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD011087] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NCI [N01CO074102] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-74102] Funding Source: Medline; NIDDK NIH HHS [DK39690-01] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARFIN SM, 1983, SOMAT CELL GENET, V9, P517, DOI 10.1007/BF01574256; BARTELS I, 1986, AM J HUM GENET, V38, P280; BEAUDET A, 1986, AM J HUM GENET, V39, P681; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BERGER W, 1987, HUM GENET, V77, P197, DOI 10.1007/BF00272392; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; CARLE GF, 1986, SCIENCE, V232, P65, DOI 10.1126/science.3952500; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; Collins F. S., 1988, Genome analysis: a practical approach., P73; COLLINS FS, 1984, P NATL ACAD SCI-BIOL, V81, P6812, DOI 10.1073/pnas.81.21.6812; COLLINS FS, 1987, SCIENCE, V235, P1046, DOI 10.1126/science.2950591; DEAN M, 1985, NATURE, V318, P385, DOI 10.1038/318385a0; DEAN M, 1987, J PEDIATR-US, V111, P490, DOI 10.1016/S0022-3476(87)80106-3; Drumm ML, 1988, GENOMICS, V2, P346, DOI 10.1016/0888-7543(88)90024-9; ESTIVILL X, 1987, Genomics, V1, P257, DOI 10.1016/0888-7543(87)90052-8; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; FARRALL M, 1988, IN PRESS AM J HUM GE; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FRISCHAUF AM, 1983, J MOL BIOL, V170, P827, DOI 10.1016/S0022-2836(83)80190-9; FRIZZELL RA, 1986, SCIENCE, V233, P558, DOI 10.1126/science.2425436; KENWRICK SJ, 1988, NUCLEIC ACIDS RES, V16, P1305, DOI 10.1093/nar/16.4.1305; KNOWLES M, 1983, J CLIN INVEST, V71, P1410, DOI 10.1172/JCI110894; LATHROP GM, 1988, AM J HUM GENET, V42, P38; LLOYDSTILL JD, 1983, TXB CYSTIC FIBROSIS; MICHIELS F, 1987, SCIENCE, V236, P1305, DOI 10.1126/science.3035716; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; PATTERSON TA, 1987, NUCLEIC ACIDS RES, V15, P6298, DOI 10.1093/nar/15.15.6298; POUSTKA A, 1986, TRENDS GENET, V2, P174, DOI 10.1016/0168-9525(86)90219-2; Poustka A, 1988, GENOMICS, V2, P337, DOI 10.1016/0888-7543(88)90023-7; QUINTON PM, 1983, NEW ENGL J MED, V308, P1185, DOI 10.1056/NEJM198305193082002; RICHARDS JE, 1988, P NATL ACAD SCI USA, V85, P6437, DOI 10.1073/pnas.85.17.6437; ROMMENS JM, 1988, AM J HUM GENET, V43, P4; ROYERPOKORA B, 1986, NATURE, V322, P32, DOI 10.1038/322032a0; SCHMIDTKE J, 1987, HUM GENET, V76, P337, DOI 10.1007/BF00272441; SCHOUMACHER RA, 1987, NATURE, V330, P7552; TSUI LC, 1985, SCIENCE, V230, P1054, DOI 10.1126/science.2997931; WAINWRIGHT BJ, 1985, NATURE, V318, P384, DOI 10.1038/318384a0; WALSH MJ, 1986, NATURE, V322, P467; WHITE R, 1986, AM J HUM GENET, V39, P694; WHITE R, 1985, NATURE, V318, P382, DOI 10.1038/318382a0; WHITE R, 1985, NATURE, V313, P101, DOI 10.1038/313101a0; ZABAROVSKY ER, 1986, GENE, V42, P119, DOI 10.1016/0378-1119(86)90158-7	43	31	33	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1989	44	5					695	703						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	U3338	2565081				2022-12-18	WOS:A1989U333800010
J	OLSHAN, AF; BAIRD, PA; TESCHKE, K				OLSHAN, AF; BAIRD, PA; TESCHKE, K			PATERNAL OCCUPATIONAL EXPOSURES AND THE RISK OF DOWNS-SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV BRITISH COLUMBIA,DEPT HLTH CARE,VANCOUVER V6T 1W5,BC,CANADA; UNIV BRITISH COLUMBIA,DEPT EPIDEMIOL,VANCOUVER V6T 1W5,BC,CANADA; BRITISH COLUMBIA MINIST HLTH,DIV VITAL STAT,HLTH SURVEILLANCE REGISTRY,VANCOUVER,BC,CANADA	University of British Columbia; University of British Columbia	OLSHAN, AF (corresponding author), UNIV BRITISH COLUMBIA,DEPT MED GENET,226-6174 UNIV BLVD,VANCOUVER V6T 1W5,BC,CANADA.							ALLEN JW, 1986, MUTAT RES, V167, P123, DOI 10.1016/0165-1110(86)90013-8; BAIRD PA, 1987, CAN MED ASSOC J, V136, P109; Bond D, 1983, OXFORD MONOGRAPHS ME, P198; BRESLOW NE, 1980, IARC SCI PUBLICAT 32, V1; BRISSON C, 1987, J EPIDEMIOL COMMUN H, V41, P290, DOI 10.1136/jech.41.4.290; Cohen BH, 1977, POPULATION CYTOGENET, P301; ERICKSON JD, 1984, JAMA-J AM MED ASSOC, V252, P903, DOI 10.1001/jama.252.7.903; HALES BF, 1986, TOXICOL APPL PHARM, V27, P602; HASSOLD T, 1984, ANN HUM GENET, V48, P129, DOI 10.1111/j.1469-1809.1984.tb01008.x; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; JANERICH DT, 1986, J CHRON DIS, V39, P1079, DOI 10.1016/0021-9681(86)90141-4; KNISHKOWY B, 1986, AM J IND MED, V9, P543, DOI 10.1002/ajim.4700090606; LOWRY RB, 1975, CAN J PUBLIC HEALTH, V66, P322; POLEDNAK AP, 1983, AM J IND MED, V4, P329, DOI 10.1002/ajim.4700040124; Rothman K, 1986, MODERN EPIDEMIOLOGY; THOMAS DC, 1985, AM J EPIDEMIOL, V122, P1080, DOI 10.1093/oxfordjournals.aje.a114189; 1982, MB3821 OFF POP CENS	17	31	33	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1989	44	5					646	651						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	U3338	2523192				2022-12-18	WOS:A1989U333800004
J	SULLIVAN, SE; MOORE, SD; CONNOR, JM; KING, M; COCKBURN, F; STEINMANN, B; GITZELMANN, R; DAIGER, SP; WOO, SLC				SULLIVAN, SE; MOORE, SD; CONNOR, JM; KING, M; COCKBURN, F; STEINMANN, B; GITZELMANN, R; DAIGER, SP; WOO, SLC			HAPLOTYPE DISTRIBUTION OF THE HUMAN PHENYLALANINE-HYDROXYLASE LOCUS IN SCOTLAND AND SWITZERLAND	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030; KINDERSPITAL,DEPT PEDIAT,CH-8032 ZURICH,SWITZERLAND; UNIV TEXAS,HLTH SCI CTR,GRAD SCH BIOL SCI,HOUSTON,TX 77225; ROYAL HOSP SICK CHILDREN,DUNCAN GUTHRIE INST MED GENET,GLASGOW G3 8SJ,SCOTLAND; ROYAL HOSP SICK CHILDREN,DEPT CHILD HLTH,GLASGOW G3 8SJ,SCOTLAND	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Glasgow; University of Glasgow	WOO, SLC (corresponding author), BAYLOR COLL MED,HOWARD HUGHES MED INST,DEPT CELL BIOL,1 BAYLOR PLAZA,T-721,HOUSTON,TX 77030, USA.				NICHD NIH HHS [HD-17711] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD017711, R01HD017711] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AULEHLASCHOLZ C, 1988, HUM GENET, V78, P353, DOI 10.1007/BF00291734; CHAKRABORTY R, 1987, HUM GENET, V76, P40; DAIGER SP, 1986, LANCET, V1, P229; DILELLA AG, 1987, NATURE, V327, P333, DOI 10.1038/327333a0; DILELLA AG, 1986, NATURE, V322, P799, DOI 10.1038/322799a0; DILELLA AG, 1986, BIOCHEMISTRY-US, V25, P743, DOI 10.1021/bi00352a001; Folling A, 1934, H-S Z PHYSIOL CHEM, V227, P169, DOI 10.1515/bchm2.1934.227.1-4.169; GUTTLER F, 1980, ACTA PAEDIATR SC   S, V280, P7; KWOK SCM, 1985, BIOCHEMISTRY-US, V24, P556, DOI 10.1021/bi00324a002; LEDLEY FD, 1985, SCIENCE, V228, P77, DOI 10.1126/science.3856322; LICHTERKONECKI U, 1988, HUM GENET, V78, P347, DOI 10.1007/BF00291733; LIDSKY AS, 1985, P NATL ACAD SCI USA, V82, P6221, DOI 10.1073/pnas.82.18.6221; LIDSKY AS, 1985, AM J HUM GENET, V37, P619; LIDSKY AS, 1984, AM J HUM GENET, V36, P527; MORTON NE, 1988, AM J HUM GENET, V42, P173; ORKIN SH, 1984, ANNU REV GENET, V18, P131; RIESS O, 1988, HUM GENET, V78, P343, DOI 10.1007/BF00291732; SCRIVER CR, 1980, ANNU REV GENET, V14, P179, DOI 10.1146/annurev.ge.14.120180.001143; SPEER A, 1986, CLIN GENET, V29, P491; WOO SLC, 1988, AM J HUM GENET, V43, P781; WOO SLC, 1983, NATURE, V306, P151, DOI 10.1038/306151a0	21	31	31	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1989	44	5					652	659						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	U3338	2565077				2022-12-18	WOS:A1989U333800005
J	MACKENZIE, AE; MACLEOD, HL; HUNTER, AGW; KORNELUK, RG				MACKENZIE, AE; MACLEOD, HL; HUNTER, AGW; KORNELUK, RG			LINKAGE ANALYSIS OF THE APOLIPOPROTEIN-C2 GENE AND MYOTONIC-DYSTROPHY ON HUMAN CHROMOSOME-19 REVEALS LINKAGE DISEQUILIBRIUM IN A FRENCH-CANADIAN POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CHILDRENS HOSP EASTERN ONTARIO,DIV GENET,OTTAWA K1H 8L1,ONTARIO,CANADA	University of Ottawa; Children's Hospital of Eastern Ontario								APPLEBY V L, 1986, American Journal of Human Genetics, V39, pA145; BIRD TD, 1987, ARCH NEUROL-CHICAGO, V44, P273, DOI 10.1001/archneur.1987.00520150029015; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BRUNNER H, 1987, CYTOGENET CELL GENET, V46, P587; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; FARALL M, 1987, LANCET, V2, P156; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FROSSARD P, 1985, American Journal of Human Genetics, V37, pA153; FROSSARD PM, 1986, NUCLEIC ACIDS RES, V14, P5120, DOI 10.1093/nar/14.12.5120; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; HULSEBOS T, 1985, CYTOGENET CELL GENET, V40, P658; Humphries S E, 1983, Mol Biol Med, V1, P463; KORNELUK RG, 1987, NUCLEIC ACIDS RES, V15, P6769, DOI 10.1093/nar/15.16.6769; KORNELUK RG, IN PRESS GENOMICS; LABERGE C, 1985, CYTOGENET CELL GENET, V40, P675; LAPIN L, 1980, STATISTICS MEANING M; LUNT PW, 1986, LANCET, V2, P350; LUNT PW, 1987, J MED GENET, V24, P239; LUSIS AJ, 1985, CYTOGENET CELL GENET, V40, P683; MACLEOD H L, 1987, American Journal of Human Genetics, V41, pA175; MADISEN L, 1987, AM J MED GENET, V27, P379, DOI 10.1002/ajmg.1320270216; Myotonic Dystrophy Foundation, 2017, VOIC PAT REP MYOT DY; NAYLOR S, 1985, CYTOGENET CELL GENET, V40, P242, DOI 10.1159/000132176; OTT J, 1974, AM J HUM GENET, V26, P588; RAO CR, 1965, LINEAR STATISTICAL I; SARFARAZI M, 1987, CYTOGENET CELL GENET, V46, P687; SHARPE CR, 1984, NUCLEIC ACIDS RES, V12, P3917, DOI 10.1093/nar/12.9.3917; SHAW DJ, 1985, HUM GENET, V70, P271; SMIT M, 1988, HUM GENET, V78, P90, DOI 10.1007/BF00291243; TODOROV A, 1970, J GENET HUM, V18, P387; VEILLETTE S, 1986, CEGEP JONQUIERE JONQ; WALLIS SC, 1984, HUM GENET, V68, P286, DOI 10.1007/BF00292585; WILLIAMS LG, 1985, HUM GENET, V71, P227, DOI 10.1007/BF00284580	33	31	31	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1989	44	1					140	147						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R5596	2562820				2022-12-18	WOS:A1989R559600020
J	ADAMS, P; FALEK, A; ARNOLD, J				ADAMS, P; FALEK, A; ARNOLD, J			HUNTINGTON DISEASE IN GEORGIA - AGE AT ONSET	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV GEORGIA, DEPT GENET, ATHENS, GA 30602 USA; COLUMBIA UNIV, DEPT PSYCHIAT, NEW YORK, NY 10027 USA; EMORY UNIV, SCH MED, DEPT PSYCHIAT, ATLANTA, GA 30322 USA; GEORGIA MENTAL HLTH INST, HUMAN & BEHAV GENET RES LAB, ATLANTA, GA 30306 USA	University System of Georgia; University of Georgia; Columbia University; Emory University	ADAMS, P (corresponding author), NEW YORK STATE PSYCHIAT INST, DIV CLIN GENET EPIDEMIOL, 722 W 168TH ST-BOX 14, NEW YORK, NY 10032 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH028274, R01MH028274, R01MH036197] Funding Source: NIH RePORTER; NIMH NIH HHS [MH 28274, MH 36197] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDREASEN NC, 1986, ARCH GEN PSYCHIAT, V43, P421; ARNOLD J, 1982, THESIS YALE U NEW HA; BARON M, 1983, J PSYCHIAT RES, V17, P5, DOI 10.1016/0022-3956(82)90030-9; Bell J, 1941, ANN EUGENIC, V11, P272, DOI 10.1111/j.1469-1809.1941.tb02290.x; BOEHNKE M, 1983, AM J HUM GENET, V35, P845; BRACKENRIDGE CJ, 1972, J MED GENET, V9, P23, DOI 10.1136/jmg.9.1.23; BRACKENRIDGE CJ, 1974, J NEUROL NEUROSUR PS, V37, P297, DOI 10.1136/jnnp.37.3.297; BRUYN GW, 1968, HDB CLIN NEUROLOGY, P268; BRUYN GW, 1979, ADV NEUROL, V23, P83; CAINE ED, 1978, ARCH GEN PSYCHIAT, V35, P377; CHASE GA, 1986, J NEUROGENET, V3, P215, DOI 10.3109/01677068609106851; Di Maio L, 1984, Acta Neurol (Napoli), V6, P447; FARRER LA, 1985, AM J HUM GENET, V37, P350; FARRER LA, 1987, ARCH NEUROL-CHICAGO, V44, P109, DOI 10.1001/archneur.1987.00520130083023; FOLSTEIN SE, 1979, ADV NEUROL, V23, P281; GROPPI C, 1986, ACTA NEUROL SCAND, V74, P266; HARRIS EL, 1986, GENET EPIDEMIOL, P229; HAYDEN MR, 1985, CLIN GENET, V28, P100; HAYDEN MR, 1982, J MED GENET, V19, P94, DOI 10.1136/jmg.19.2.94; Hayden MR., 1981, HUNTINGTONS CHOREA, P45; HEIMBUCH RC, 1980, AM J HUM GENET, V32, P564; HODGE SE, 1980, AM J MED GENET, V5, P247, DOI 10.1002/ajmg.1320050305; Huntington G., 1872, MED SURG REP, V26, P320; HUSQUINET H, 1973, HUNTINGTONS CHOREA 1, P161; JONES M B, 1970, Journal of Medical Genetics, V7, P20, DOI 10.1136/jmg.7.1.20; KALBFLEISCH JD, 1980, STATISTICAL ANAL FAI; KLERMAN GL, 1985, ARCH GEN PSYCHIAT, V42, P689; LECKMAN JF, 1982, ARCH GEN PSYCHIAT, V39, P879; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; MATTSSON B, 1974, ACTA PSYCHIAT SCAND, P221; MERRITT AD, 1969, PROGR NEUROGENETICS, V1, P645; MYERS RH, 1983, LANCET, V1, P208; MYERS RH, 1982, AM J HUM GENET, V34, P481; MYERS RH, 1985, AM J HUM GENET, V37, P511; MYRIANTHOPOULOS NTINOS C., 1966, J MED GENET, V3, P298, DOI 10.1136/jmg.3.4.298; NAUS JI, 1975, DATA QUALITY CONTROL; NEWCOMBE RG, 1981, ANN HUM GENET, V45, P375, DOI 10.1111/j.1469-1809.1981.tb00351.x; PENROSE LS, 1948, ANN EUGENIC, V14, P125; PERICAKVANCE MA, 1983, AM J MED GENET, V14, P49, DOI 10.1002/ajmg.1320140109; STEVENS DL, 1976, THESIS U LONDON LOND; THOMPSON WD, 1982, ARCH GEN PSYCHIAT, V39, P53; VANDIJK JG, 1986, HUM GENET, V73, P235, DOI 10.1007/BF00401235; VEGTERVANDERVLIS M, 1976, ANN HUM GENET, V39, P329; WALKER DA, 1981, CLIN GENET, V19, P213; WALLACE DC, 1979, ADV NEUROL, V23, P73; WENDT G G, 1959, Acta Genet Stat Med, V9, P18; WENT LN, 1983, ANN HUM GENET, V47, P205, DOI 10.1111/j.1469-1809.1983.tb00989.x; WENT LN, 1984, LANCET, V1, P1100	48	31	31	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1988	43	5					695	704						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q9336	2973230				2022-12-18	WOS:A1988Q933600016
J	YUZBASIYANGURKAN, V; BREWER, GJ; BOERWINKLE, E; VENTA, PJ				YUZBASIYANGURKAN, V; BREWER, GJ; BOERWINKLE, E; VENTA, PJ			LINKAGE OF THE WILSON DISEASE GENE TO CHROMOSOME-13 IN NORTH-AMERICAN PEDIGREES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MICHIGAN,SCH MED,DEPT INTERNAL MED,ANN ARBOR,MI 48109; UNIV TEXAS,HLTH SCI CTR,CTR DEMOG & POPULAT GENET,HOUSTON,TX 77225	University of Michigan System; University of Michigan; University of Texas System; University of Texas Health Science Center Houston	YUZBASIYANGURKAN, V (corresponding author), UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,4708 MED SCI 2,BOX 0618,ANN ARBOR,MI 48109, USA.		Yuzbasiyan-Gurkan, Vilma/AAF-8459-2020		NCRR NIH HHS [RR05383] Funding Source: Medline; NIADDK NIH HHS [R01-AM26050] Funding Source: Medline; FDA HHS [FD-R-00179] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM026050] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S07RR005383] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); FDA HHS; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BEARN AG, 1960, ANN HUM GENET, V24, P33; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BONNETAMIR B, 1986, GENET EPIDEMIOL, V3, P201, DOI 10.1002/gepi.1370030307; BOWCOCK AM, 1987, AM J HUM GENET, V41, P27; BREWER GJ, 1987, P SOC EXP BIOL MED, V184, P446; BREWER GJ, 1983, ANN INTERN MED, V99, P314, DOI 10.7326/0003-4819-99-3-314; BREWER GJ, 1987, J LAB CLIN MED, V109, P526; BREWER GJ, 1987, SEMIN NEUROL, V7, P209, DOI 10.1055/s-2008-1041420; CAVENEE W, 1984, AM J HUM GENET, V36, P10; COX DW, 1972, AM J HUM GENET, V24, P646; DRYJA TP, 1984, HUM GENET, V65, P320, DOI 10.1007/BF00291555; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRYDMAN M, 1985, P NATL ACAD SCI USA, V82, P1819, DOI 10.1073/pnas.82.6.1819; HILL GM, 1987, HEPATOLOGY, V7, P522, DOI 10.1002/hep.1840070318; HILL GM, 1986, AM J MED SCI, V29, P344; HOPKINSON DA, 1973, ANN HUM GENET, V37, P119, DOI 10.1111/j.1469-1809.1973.tb01820.x; LEPPERT M, 1986, AM J HUM GENET, V39, P425; MANIATIS T, 1975, P NATL ACAD SCI USA, V72, P1184, DOI 10.1073/pnas.72.3.1184; OTT J, 1974, AM J HUM GENET, V26, P773; PASSWELL J, 1977, ISRAEL J MED SCI, V13, P15; SASSKORTSAK A, 1978, METABOLIC BASIS INHE, P1098; Scheinberg, 1984, MAJOR PROBLEMS INTER, V23, P9; [No title captured]	24	31	32	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1988	42	6					825	829						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N5197	3163469				2022-12-18	WOS:A1988N519700004
J	HAYDEN, MR; HEWITT, J; WASMUTH, JJ; KASTELEIN, JJ; LANGLOIS, S; CONNEALLY, M; HAINES, J; SMITH, B; HILBERT, C; ALLARD, D				HAYDEN, MR; HEWITT, J; WASMUTH, JJ; KASTELEIN, JJ; LANGLOIS, S; CONNEALLY, M; HAINES, J; SMITH, B; HILBERT, C; ALLARD, D			A POLYMORPHIC DNA MARKER THAT REPRESENTS A CONSERVED EXPRESSED SEQUENCE IN THE REGION OF THE HUNTINGTON DISEASE GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF IRVINE,DEPT BIOL CHEM,IRVINE,CA 92717; INDIANA UNIV,DEPT MED GENET,BLOOMINGTON,IN 47401	University of California System; University of California Irvine; Indiana University System; Indiana University Bloomington	HAYDEN, MR (corresponding author), UNIV BRITISH COLUMBIA,DEPT MED GENET,F168-2211 WESBROOK MALL,VANCOUVER V6T 2B5,BC,CANADA.		Haines, Jonathan/C-3374-2012; Hayden, Michael R/D-8581-2011; Kastelein, John/AAF-7950-2020	Haines, Jonathan/0000-0002-4351-4728; Hayden, Michael R/0000-0001-5159-1419; 				CARLOCK L, 1986, SOMAT CELL MOLEC GEN, V11, P163; CARPENTER N J, 1985, American Journal of Human Genetics, V37, pA48; CONNEALLY P M, 1984, Genetic Epidemiology, V1, P81, DOI 10.1002/gepi.1370010110; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GILLIAM TC, 1987, CELL, V50, P565, DOI 10.1016/0092-8674(87)90029-8; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HAINES J, 1986, American Journal of Human Genetics, V39, pA156; HAYDEN MR, 1987, NUCLEIC ACIDS RES, V15, P3938, DOI 10.1093/nar/15.9.3938; HAYDEN MR, 1987, AM J HUM GENET, V40, P421; HAYDEN MR, 1987, LANCET, V1, P1284; HAYDEN MR, 1981, HUNTINGTON CHOREA; HEWITT J, 1986, American Journal of Human Genetics, V39, pA94; MAGENIS RE, 1986, AM J HUM GENET, V39, P383; MCGINNIS W, 1984, CELL, V37, P403, DOI 10.1016/0092-8674(84)90370-2; SHILO BZ, 1981, P NATL ACAD SCI-BIOL, V78, P6789, DOI 10.1073/pnas.78.11.6789; SUTCLIFFE JG, 1984, NATURE, V308, P237, DOI 10.1038/308237a0; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; THAYER RE, IN PRESS CYTOGENET C; WANG HS, 1986, AM J HUM GENET, V39, P392; WASMUTH JJ, 1986, AM J HUM GENET, V39, P397	20	31	31	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1988	42	1					125	131						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L8697	2892395				2022-12-18	WOS:A1988L869700017
J	SABATINI, LM; CARLOCK, LR; JOHNSON, GW; AZEN, EA				SABATINI, LM; CARLOCK, LR; JOHNSON, GW; AZEN, EA			CDNA CLONING AND CHROMOSOMAL LOCALIZATION (4Q11-13) OF A GENE FOR STATHERIN, A REGULATOR OF CALCIUM IN SALIVA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WISCONSIN,DEPT MED GENET,MADISON,WI 53706; UNIV WISCONSIN,DEPT MED,MADISON,WI 53706; UNIV CALIF IRVINE,DEPT PEDIAT,IRVINE,CA 92717	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Irvine					NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [F32DE005443, R01DE003658, R37DE003658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007131] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE05443-01, DE03658-22] Funding Source: Medline; NIGMS NIH HHS [GM07131-10] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AZEN EA, 1985, AM J HUM GENET, V37, P418; BENNICK A, 1982, MOL CELL BIOCHEM, V45, P83; BEUBE FE, 1978, DIAGNOSIS DISEASES M, P104; CARLOCK LR, 1986, SOMAT CELL MOLEC GEN, V12, P163, DOI 10.1007/BF01560663; CLARK RA, 1977, INFECT IMMUN, V18, P694, DOI 10.1128/IAI.18.3.694-700.1977; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FITZGERALD M, 1981, CELL, V24, P251, DOI 10.1016/0092-8674(81)90521-3; GRUNSTEIN M, 1975, P NATL ACAD SCI USA, V72, P3961, DOI 10.1073/pnas.72.10.3961; HAY DI, 1984, J DENT RES, V63, P857, DOI 10.1177/00220345840630060901; KIDD KK, 1985, CYTOGENET CELL GENET, V40, P107, DOI 10.1159/000132171; KOZAK M, 1978, CELL, V15, P1109, DOI 10.1016/0092-8674(78)90039-9; MAEDA N, 1985, J BIOL CHEM, V260, P1123; MAMULA PW, 1985, CYTOGENET CELL GENET, V39, P279, DOI 10.1159/000132158; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; McKusick V. A., 1986, MENDELIAN INHERITANC; MCMASTER GK, 1977, P NATL ACAD SCI USA, V74, P4835, DOI 10.1073/pnas.74.11.4835; PONCZ M, 1982, HEMOGLOBIN, V6, P27, DOI 10.3109/03630268208996930; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHLESINGER DH, 1977, J BIOL CHEM, V252, P1689; SINGERSAM J, 1983, P NATL ACAD SCI-BIOL, V80, P802, DOI 10.1073/pnas.80.3.802; SINGH L, 1984, NUCLEIC ACIDS RES, V12, P5627, DOI 10.1093/nar/12.14.5627; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Suggs S. V., 1981, ICN UCLA S DEV BIOL, V23, P683; VANIN EF, 1983, CELL, V35, P701, DOI 10.1016/0092-8674(83)90103-4; WASMUTH JJ, 1986, AM J HUM GENET, V39, P397; WATSON MEE, 1984, NUCLEIC ACIDS RES, V12, P5145, DOI 10.1093/nar/12.13.5145; WITKOP CJ, 1977, BIRTH DEFECTS, V7, P153; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	28	31	33	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1987	41	6					1048	1060						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L2984	3502720				2022-12-18	WOS:A1987L298400008
J	GAHL, WA; FINKELSTEIN, JD; MULLEN, KD; BERNARDINI, I; MARTIN, JJ; BACKLUND, P; ISHAK, KG; HOOFNAGLE, JH; MUDD, SH				GAHL, WA; FINKELSTEIN, JD; MULLEN, KD; BERNARDINI, I; MARTIN, JJ; BACKLUND, P; ISHAK, KG; HOOFNAGLE, JH; MUDD, SH			HEPATIC METHIONINE ADENOSYLTRANSFERASE DEFICIENCY IN A 31-YEAR-OLD MAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									VET ADM MED CTR,WASHINGTON,DC 20422; NIDDKD,DIGEST DIS BRANCH,LIVER DIS SECT,BETHESDA,MD 20892; NIMH,GEN & COMPARAT BIOCHEM LAB,BETHESDA,MD 20892; ARMED FORCES INST PATHOL,HEPAT PATHOL BRANCH,WASHINGTON,DC 20306	US Department of Veterans Affairs; Veterans Health Administration (VHA); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); United States Department of Defense	GAHL, WA (corresponding author), NICHD,HUMAN GENET BRANCH,HUMAN BIOCHEM GENET SECT,BLDG 10,ROOM 10N-318,BETHESDA,MD 20892, USA.							Baldessarini R J, 1975, Int Rev Neurobiol, V18, P41, DOI 10.1016/S0074-7742(08)60033-1; BERNARDINI I, 1985, J CLIN INVEST, V75, P1124, DOI 10.1172/JCI111806; FINKELSTEIN JD, 1967, J BIOL CHEM, V242, P873; FINKELSTEIN JD, 1975, BIOCHEM BIOPH RES CO, V66, P1491, DOI 10.1016/0006-291X(75)90527-6; GAULL GE, 1981, J PEDIATR-US, V98, P734, DOI 10.1016/S0022-3476(81)80833-5; GAULL GE, 1974, SCIENCE, V186, P59, DOI 10.1126/science.186.4158.59; GAULL GE, 1980, ANN NEUROL, V9, P423; HOFFMAN J, 1975, ANAL BIOCHEM, V68, P522, DOI 10.1016/0003-2697(75)90647-8; HOFFMAN JL, 1977, BIOCHEM BIOPH RES CO, V77, P1231, DOI 10.1016/S0006-291X(77)80111-3; KUNZ GL, 1980, ARCH BIOCHEM BIOPHYS, V202, P565, DOI 10.1016/0003-9861(80)90463-4; LEVY HL, 1970, AM J MED, V48, P390, DOI 10.1016/0002-9343(70)90070-7; LIAU MC, 1979, CANCER RES, V39, P162; MUDD SH, 1965, J BIOL CHEM, V240, P4382; MUDD SH, 1980, METABOLISM, V29, P707, DOI 10.1016/0026-0495(80)90192-4; MUDD SH, 1983, METABOLIC BASIS INHE, P522; Rosenberg, 1973, AMINO ACID METABOLIS; TALLAN HH, 1979, BIOCHEM MED METAB B, V21, P129, DOI 10.1016/0006-2944(79)90064-4	17	31	32	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1987	40	1					39	49						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	G0618	3812486				2022-12-18	WOS:A1987G061800004
J	TSUI, LC; BUETOW, K; BUCHWALD, M				TSUI, LC; BUETOW, K; BUCHWALD, M			GENETIC-ANALYSIS OF CYSTIC-FIBROSIS USING LINKED DNA MARKERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									FOX CHASE CANC CTR,INST CANC RES,PHILADELPHIA,PA 19111	Fox Chase Cancer Center	TSUI, LC (corresponding author), HOSP SICK CHILDREN,RES INST,DEPT GENET,TORONTO M5G 1X8,ONTARIO,CANADA.		Tsui, Lap-chee/A-1081-2010					BARTELS I, 1986, AM J HUM GENET, V38, P280; BEAUDET A, 1986, AM J HUM GENET, V39, P681; BUCHWALD M, 1986, CYTOGENET CELL GENET, V41, P234, DOI 10.1159/000132235; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; DEAN M, 1985, NATURE, V318, P385, DOI 10.1038/318385a0; EIBERG H, 1985, CLIN GENET, V28, P265; EIBERG H, 1985, CYTOGENET CELL GENET, V40, P623; HEDRICK PW, 1986, GENETICS, V112, P135; KNOWLTON RG, 1985, NATURE, V318, P380, DOI 10.1038/318380a0; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MEYERS JC, 1981, P NATL ACAD SCI USA, V78, P3516; MORTON NE, 1955, AM J HUM GENET, V7, P277; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; OTT J, 1974, AM J HUM GENET, V26, P588; SCAMBLER PJ, 1985, LANCET, V2, P1241; SCAMBLER PJ, 1986, NUCLEIC ACIDS RES, V14, P1951, DOI 10.1093/nar/14.5.1951; SCHMIEGELOW K, 1986, CLIN GENET, V29, P374; SING CF, 1982, AM J MED GENET, V13, P179, DOI 10.1002/ajmg.1320130209; THOMPSON MW, 1980, PERSPECTIVES CYSTIC, P281; TSIPOURAS P, 1984, AM J HUM GENET, V36, P1172; TSUI LC, 1985, SCIENCE, V230, P1054, DOI 10.1126/science.2997931; TSUI LC, 1986, COLD SPRING HARBOR S; WAINWRIGHT BJ, 1985, NATURE, V318, P384, DOI 10.1038/318384a0; WHITE R, 1985, NATURE, V318, P382, DOI 10.1038/318382a0; YANAGI Y, 1984, NATURE, V308, P145, DOI 10.1038/308145a0	25	31	34	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1986	39	6					720	728						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	F5414	3467587				2022-12-18	WOS:A1986F541400006
J	HAAF, T; STEINLEIN, K; SCHMID, M				HAAF, T; STEINLEIN, K; SCHMID, M			PREFERENTIAL SOMATIC PAIRING BETWEEN HOMOLOGOUS HETEROCHROMATIC REGIONS OF HUMAN-CHROMOSOMES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											HAAF, T (corresponding author), UNIV WURZBURG,DEPT HUMAN GENET,KOELLIKERSTR 2,D-8700 WURZBURG,FED REP GER.							BARR HJ, 1972, CHROMOSOMA, V39, P53, DOI 10.1007/BF00320590; CHANDRA HS, 1972, J GENET, V61, P78, DOI 10.1007/BF02984102; COMINGS DE, 1980, HUM GENET, V53, P131, DOI 10.1007/BF00273484; DUTRILLAUX B, 1981, HUM GENET, V59, P208; GOSDEN JR, 1975, EXP CELL RES, V92, P148, DOI 10.1016/0014-4827(75)90648-5; GROPP A, 1963, EXP CELL RES, V30, P577, DOI 10.1016/0014-4827(63)90333-1; Heitz E., 1934, Biologisches Zentralblatt Leipzig, V54, P588; HENS L, 1975, HUMANGENETIK, V28, P303; HOEHN H, 1973, CYTOGENET CELL GENET, V12, P443, DOI 10.1159/000130487; HSU TC, 1971, CHROMOSOMA, V34, P73, DOI 10.1007/BF00285517; KIRSCHVOLDERS M, 1980, HUM GENET, V54, P69, DOI 10.1007/BF00279051; MICHIE D, 1953, NATURE, V171, P26, DOI 10.1038/171026a0; MIKLOS GLG, 1979, AM J HUM GENET, V31, P264; MORAD M, 1973, HEREDITAS, V74, P273; NATARAJAN AT, 1972, EXP CELL RES, V74, P245, DOI 10.1016/0014-4827(72)90502-2; NATARAJAN AT, 1973, S MEDICA HOECHST, V6, P215; Pfeiffer R.A., 1974, METHODS HUMAN CYTOGE, P1; SCHMID M, 1983, CYTOGENET CELL GENET, V36, P554, DOI 10.1159/000131972; SCHMID M, 1981, CYTOGENET CELL GENET, V29, P203, DOI 10.1159/000131571; SCHMID M, 1975, CYTOGENET CELL GENET, V15, P66, DOI 10.1159/000130503; SCHMID M, 1984, HUM GENET, V67, P257, DOI 10.1007/BF00291352; SCHWEIZER D, 1978, EXP CELL RES, V111, P327, DOI 10.1016/0014-4827(78)90177-5; SELE B, 1977, HUM GENET, V39, P39, DOI 10.1007/BF00273152; SPAETER M, 1975, HUMANGENETIK, V27, P111; VOGEL F, 1974, HUMANGENETIK, V25, P265, DOI 10.1007/BF00336904; WARBURTON D, 1973, HUMANGENETIK, V18, P297, DOI 10.1007/BF00291126	26	31	32	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1986	38	3					319	329						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	A5781	2420175				2022-12-18	WOS:A1986A578100006
J	PACKMAN, S; CASWELL, N; GONZALEZRIOS, MD; KADLECEK, T; CANN, H; RASSIN, D; MCKAY, C				PACKMAN, S; CASWELL, N; GONZALEZRIOS, MD; KADLECEK, T; CANN, H; RASSIN, D; MCKAY, C			ACETYL COA CARBOXYLASE IN CULTURED FIBROBLASTS - DIFFERENTIAL BIOTIN DEPENDENCE IN THE 2 TYPES OF BIOTIN-RESPONSIVE MULTIPLE CARBOXYLASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									STANFORD UNIV,DEPT PEDIAT,DIV GENET,STANFORD,CA 94305; UNIV TEXAS,MED BRANCH,DEPT PEDIAT,DIV DEV NUTR & METAB,GALVESTON,TX 77550	Stanford University; University of Texas System; University of Texas Medical Branch Galveston	PACKMAN, S (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT PEDIAT,DIV GENET,SAN FRANCISCO,CA 94143, USA.			Kadlecek, Theresa/0000-0002-1020-8169	NIADDK NIH HHS [AM25884] Funding Source: Medline	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARTLETT K, 1980, CLIN CHIM ACTA, V100, P183, DOI 10.1016/0009-8981(80)90081-9; BARTLETT K, 1976, LANCET, V2, P804; BARTLETT K, 1978, CLIN CHIM ACTA, V84, P399, DOI 10.1016/0009-8981(78)90255-3; BURRI BJ, 1981, J CLIN INVEST, V68, P1491, DOI 10.1172/JCI110402; CHARLES BM, 1979, LANCET, V2, P118; COWAN MJ, 1979, LANCET, V2, P115; DAVIES DR, 1982, BIOCHEM J, V202, P559, DOI 10.1042/bj2020559; FELDMAN GL, 1981, AM J HUM GENET, V33, P692; FELDMAN GL, 1981, CLIN CHIM ACTA, V111, P147, DOI 10.1016/0009-8981(81)90181-9; FREYTAG SO, 1980, P NATL ACAD SCI-BIOL, V77, P1321, DOI 10.1073/pnas.77.3.1321; GIORGIO AJ, 1967, BIOCHIM BIOPHYS ACTA, V139, P487, DOI 10.1016/0005-2744(67)90052-6; GOMPERTZ D, 1972, CLIN CHIM ACTA, V37, P405, DOI 10.1016/0009-8981(72)90462-7; GOMPERTZ D, 1971, LANCET, V2, P22; GREENSPAN MD, 1968, J BIOL CHEM, V243, P6273; GREGOLIN C, 1968, J BIOL CHEM, V243, P4227; JACOBS RA, 1973, J BIOL CHEM, V248, P1268; KIM KH, 1979, MOL CELL BIOCHEM, V28, P27; KOSOW DP, 1962, J BIOL CHEM, V237, P3633; LYNEN F, 1979, CRC CR REV BIOCH MOL, V7, P103, DOI 10.3109/10409237909105428; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MARTIN DB, 1962, J BIOL CHEM, V237, P1787; MOCK DM, 1981, NEW ENGL J MED, V304, P820, DOI 10.1056/NEJM198104023041405; MUNNICH A, 1980, LANCET, V1, P1080; MURTHY PNA, 1974, P SOC EXP BIOL MED, V147, P114; PACKMAN S, 1981, J PEDIATR-US, V99, P418, DOI 10.1016/S0022-3476(81)80333-2; PACKMAN S, 1981, J PEDIATR-US, V99, P421, DOI 10.1016/S0022-3476(81)80334-4; PACKMAN S, 1982, BIOCHEM GENET, V20, P17, DOI 10.1007/BF00484932; PACKMAN S, 1982, LANCET, V1, P1435; ROTH K, 1976, J PEDIATR-US, V88, P229, DOI 10.1016/S0022-3476(76)80987-0; ROTH KS, 1980, J PEDIATR-US, V96, P845, DOI 10.1016/S0022-3476(80)80554-3; SAUNDERS M, 1979, J CLIN INVEST, V64, P1695, DOI 10.1172/JCI109632; SAUNDERS ME, 1982, AM J HUM GENET, V34, P590; SHAFRIR E, 1981, BIOCHIM BIOPHYS ACTA, V663, P432, DOI 10.1016/0005-2760(81)90172-7; SHERWOOD WG, 1982, J PEDIATR-US, V101, P546, DOI 10.1016/S0022-3476(82)80697-5; SIEGEL L, 1965, J BIOL CHEM, V240, P1025; SNEDECOR GW, 1980, STATISTICAL METHODS, P135; THOENE J, 1981, NEW ENGL J MED, V304, P817, DOI 10.1056/NEJM198104023041404; VOLPE J, 1975, J NEUROCHEM, V26, P333; WEYLER W, 1977, CLIN CHIM ACTA, V76, P321, DOI 10.1016/0009-8981(77)90158-9; WILLIAMS ML, 1983, J AM ACAD DERMATOL, V9, P97, DOI 10.1016/S0190-9622(83)70113-1; WOLF B, 1983, NEW ENGL J MED, V308, P161	41	31	31	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	1					80	92						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SC430	6141728				2022-12-18	WOS:A1984SC43000007
J	RICH, SS; WEITKAMP, LR; BARBOSA, J				RICH, SS; WEITKAMP, LR; BARBOSA, J			GENETIC-HETEROGENEITY OF INSULIN-DEPENDENT (TYPE-I) DIABETES-MELLITUS - EVIDENCE FROM A STUDY OF EXTENDED HAPLOTYPES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MINNESOTA,DEPT MED,MINNEAPOLIS,MN 55455; UNIV ROCHESTER,DEPT PSYCHIAT,DIV GENET,ROCHESTER,NY 14642; UNIV ROCHESTER,DEPT PEDIAT,ROCHESTER,NY 14642	University of Minnesota System; University of Minnesota Twin Cities; University of Rochester; University of Rochester	RICH, SS (corresponding author), UNIV MINNESOTA,DEPT LAB MED & PATHOL,MINNEAPOLIS,MN 55455, USA.			Rich, Stephen/0000-0003-3872-7793	NCRR NIH HHS [RR-400] Funding Source: Medline; NIADDK NIH HHS [AM-20729] Funding Source: Medline; NICHD NIH HHS [N01-HD-8-2846] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALPER CA, 1972, J EXP MED, V135, P68, DOI 10.1084/jem.135.1.68; BACH FH, 1982, TISSUE ANTIGENS, V20, P28; BARBOSA J, 1982, CLIN GENET, V21, P25; BAUR MP, 1980, HISTOCOMPATIBILITY T, P1063; BENGTSSON BO, 1981, TISSUE ANTIGENS, V18, P356, DOI 10.1111/j.1399-0039.1981.tb01404.x; BERTRAMS J, 1981, DIABETOLOGIA, V21, P47, DOI 10.1007/BF03216223; CAHILL GF, 1981, NEW ENGL J MED, V304, P1454, DOI 10.1056/NEJM198106113042403; CLERGETDARPOUX F, 1981, ANN HUM GENET, V45, P199, DOI 10.1111/j.1469-1809.1981.tb00321.x; CUDWORTH AG, 1975, BRIT MED J, V3, P133, DOI 10.1136/bmj.3.5976.133; CURIECOHEN M, 1981, TISSUE ANTIGENS, V17, P136; Danilovs J., 1980, HISTOCOMPATIBILITY T, P287; DAUSSET J, 1978, TISSUE ANTIGENS, V12, P297, DOI 10.1111/j.1399-0039.1978.tb01337.x; DAWKINS RL, 1983, IMMUNOL REV, V70, P5, DOI 10.1111/j.1600-065X.1983.tb00707.x; DUNSWORTH TS, 1982, CLIN GENET, V21, P233; DUNSWORTH TS, 1982, DIABETES, V31, P991, DOI 10.2337/diabetes.31.11.991; FALK CT, 1983, ANN HUM GENET, V47, P161, DOI 10.1111/j.1469-1809.1983.tb00983.x; GREENBERG DA, 1983, AM J MED GENET, V14, P487, DOI 10.1002/ajmg.1320140313; HODGE SE, 1981, LANCET, V2, P893; HODGE SE, 1983, AM J HUM GENET, V35, P1139; HODGE SE, 1980, ANN HUM GENET, V43, P399, DOI 10.1111/j.1469-1809.1980.tb01573.x; KIRK RL, 1979, DIABETES, V28, P949, DOI 10.2337/diabetes.28.10.949; LILLIENFELD AM, 1980, F EPIDEMIOLOGY, P209; MORTON NE, 1983, AM J HUM GENET, V35, P201; NERUP J, 1974, DIABETES, V24, P345; RAUM D, 1979, LANCET, V1, P1208; ROTTER JI, 1983, DIABETES, V32, P169, DOI 10.2337/diabetes.32.2.169; ROTTER JI, 1981, AM J HUM GENET, V33, P835; RUBINSTEIN P, 1981, AM J HUM GENET, V33, P865; SCHERNTHANER G, 1979, J CLIN ENDOCR METAB, V48, P403, DOI 10.1210/jcem-48-3-403; SCHERNTHANER G, 1976, NEW ENGL J MED, V295, P622; SCHERNTHANER G, 1982, GENETICS DIABETES ME, P99; SINGAL DP, 1973, DIABETES, V22, P429, DOI 10.2337/diab.22.6.429; SKLENAR I, 1982, BRIT MED J, V285, P1451, DOI 10.1136/bmj.285.6353.1451; SPIELMAN RS, 1980, ANN HUM GENET, V44, P135, DOI 10.1111/j.1469-1809.1980.tb00954.x; THOMSON G, 1980, ANN HUM GENET, V43, P383, DOI 10.1111/j.1469-1809.1980.tb01572.x; THOMSON G, 1983, TISSUE ANTIGENS, V21, P320; WEITKAMP LR, 1979, LANCET, V2, P369; WEITKAMP LR, UNPUB SEX HLA GENETI; WILLIAMS RC, 1983, DIABETES, V32, P774, DOI 10.2337/diabetes.32.8.774; WOLF E, 1983, DIABETOLOGIA, V24, P224	40	31	31	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	5					1015	1023						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TS302	6594040				2022-12-18	WOS:A1984TS30200008
J	HOOK, EB; SCHREINEMACHERS, DM; WILLEY, AM; CROSS, PK				HOOK, EB; SCHREINEMACHERS, DM; WILLEY, AM; CROSS, PK			RATES OF MUTANT STRUCTURAL CHROMOSOME REARRANGEMENTS IN HUMAN FETUSES - DATA FROM PRENATAL CYTOGENETIC STUDIES AND ASSOCIATIONS WITH MATERNAL AGE AND PARENTAL MUTAGEN EXPOSURE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NEW YORK STATE DEPT HLTH,DIV LABS & RES,INST BIRTH DEFECTS,ALBANY,NY 12237; UNION UNIV ALBANY MED COLL,DEPT PEDIAT,ALBANY,NY 12208	State University of New York (SUNY) System; Albany Medical College	HOOK, EB (corresponding author), NEW YORK STATE DEPT HLTH,BUR MATERNAL & CHILD HLTH,ALBANY,NY 12237, USA.							HAMERTON JL, 1972, BIRTH DEFECTS ORIG A, V8, P1; HOOK EB, 1983, AM J HUM GENET, V35, P110; HOOK EB, 1978, NEW ENGL J MED, V299, P1036, DOI 10.1056/NEJM197811092991903; HOOK EB, 1981, HUM GENET, V59, P235; HOOK EB, 1981, POPULATION BIOL ASPE, P389; JACOBS PA, 1981, AM J HUM GENET, V33, P44; Prescott G H, 1978, Birth Defects Orig Artic Ser, V14, P269; Warburton D, 1982, CLIN GENETICS PROBLE, P63	8	31	31	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	1					96	109						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB703	6823977				2022-12-18	WOS:A1983QB70300011
J	CLEAVER, JE				CLEAVER, JE			NORMAL RECONSTRUCTION OF DNA SUPERCOILING AND CHROMATIN STRUCTURE IN COCKAYNE SYNDROME CELLS DURING REPAIR OF DAMAGE FROM ULTRAVIOLET-LIGHT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											CLEAVER, JE (corresponding author), UNIV CALIF SAN FRANCISCO,RADIOBIOL & ENVIRONM HLTH LAB,SAN FRANCISCO,CA 94143, USA.							AHMED FE, 1978, BIOCHIM BIOPHYS ACTA, V521, P805, DOI 10.1016/0005-2787(78)90319-2; BODELL WJ, 1981, NUCLEIC ACIDS RES, V9, P203, DOI 10.1093/nar/9.1.203; CIARROCCHI G, 1979, NUCLEIC ACIDS RES, V7, P1205, DOI 10.1093/nar/7.5.1205; Cleaver J.E., 1974, ADV RADIAT BIOL, V4, P1; CLEAVER JE, 1977, NATURE, V270, P451, DOI 10.1038/270451a0; CLEAVER JE, 1979, BIOCHIM BIOPHYS ACTA, V564, P122, DOI 10.1016/0005-2787(79)90193-X; CLEAVER JE, 1968, NATURE, V218, P652, DOI 10.1038/218652a0; CLEAVER JE, 1981, J CELL PHYSIOL, V108, P163, DOI 10.1002/jcp.1041080207; CLEAVER JE, 1980, J ENVIRON PATHOL TOX, V3, P53; CLEAVER JE, 1972, EXP CELL RES, V74, P67, DOI 10.1016/0014-4827(72)90482-X; CLEAVER JE, 1978, BIOCHIM BIOPHYS ACTA, V516, P489, DOI 10.1016/0304-419X(78)90020-3; CLEAVER JE, 1969, P NATL ACAD SCI USA, V63, P428, DOI 10.1073/pnas.63.2.428; CLEAVER JE, 1975, ANNU REV GENET, V9, P19, DOI 10.1146/annurev.ge.09.120175.000315; CLEAVER JE, 1982, CHROMOSOME BREAKAGE; Cockayne E A, 1936, Arch Dis Child, V11, P1; COOK PR, 1976, J CELL SCI, V22, P303; DINGMAN CW, 1976, INT J RADIAT BIOL, V30, P55, DOI 10.1080/09553007614550801; GRUENERT DC, 1981, CHEM-BIOL INTERACT, V33, P163, DOI 10.1016/0009-2797(81)90038-7; HASHEM N, 1980, CANCER RES, V40, P13; HISS EA, 1977, BIOCHIM BIOPHYS ACTA, V478, P1, DOI 10.1016/0005-2787(77)90238-6; HOAR DI, 1978, AM J HUM GENET, V30, P590; IKENAGA M, 1981, MUTAT RES, V91, P87, DOI 10.1016/0165-7992(81)90077-4; KAUFMANN WK, 1981, J MOL BIOL, V149, P171, DOI 10.1016/0022-2836(81)90297-7; LEHMANN AR, 1979, CANCER RES, V39, P4237; PAINTER RB, 1980, P NATL ACAD SCI-BIOL, V77, P7315, DOI 10.1073/pnas.77.12.7315; PARK SD, 1979, NUCLEIC ACIDS RES, V6, P1151, DOI 10.1093/nar/6.3.1151; PATERSON MC, 1979, CANCER RES, V39, P3725; PATERSON MC, 1979, ANNU REV GENET, V13, P291, DOI 10.1146/annurev.ge.13.120179.001451; SCHMICKEL RD, 1977, PEDIATRICS, V60, P135; SMERDON MJ, 1978, BIOCHEMISTRY-US, V17, P2377, DOI 10.1021/bi00605a020; SMERDON MJ, 1978, P NATL ACAD SCI USA, V75, P4238, DOI 10.1073/pnas.75.9.4238; SNYDER RD, 1981, BIOCHEM BIOPH RES CO, V99, P1088, DOI 10.1016/0006-291X(81)90730-0; SUGARMAN GI, 1977, CLIN PEDIATR, V16, P225, DOI 10.1177/000992287701600304; WADE MH, 1979, MUTAT RES, V59, P49, DOI 10.1016/0027-5107(79)90194-5; WATERS R, 1981, CARCINOGENESIS, V2, P795, DOI 10.1093/carcin/2.8.795	35	31	32	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	4					566	575						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NY863	7102674				2022-12-18	WOS:A1982NY86300004
J	SUTHERLAND, GR				SUTHERLAND, GR			HERITABLE FRAGILE SITES ON HUMAN-CHROMOSOMES .7. CHILDREN HOMOZYGOUS FOR THE BRDU-REQUIRING FRA(10)(Q25) ARE PHENOTYPICALLY NORMAL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											SUTHERLAND, GR (corresponding author), ADELAIDE CHILDRENS HOSP,DEPT HISTOPATHOL,CYTOGENET UNIT,N ADELAIDE,SA 5006,AUSTRALIA.		Sutherland, Grant Robert/D-2606-2012					BERG JM, 1969, LANCET, V1, P531; SCHERES JMJC, 1980, AM J HUM GENET, V32, P628; SCHMID M, 1980, CYTOGENET CELL GENET, V28, P87, DOI 10.1159/000131516; SUTHERLAND GR, 1979, AM J HUM GENET, V31, P136; SUTHERLAND GR, 1980, AM J HUM GENET, V32, P542; TURNER G, 1980, NEW ENGL J MED, V303, P662, DOI 10.1056/NEJM198009183031202	6	31	31	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	6					946	949						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MV199	7325157				2022-12-18	WOS:A1981MV19900012
J	BIRD, TD; OTT, J; GIBLETT, ER				BIRD, TD; OTT, J; GIBLETT, ER			LINKAGE OF CHARCOT-MARIE-TOOTH NEUROPATHY TO THE DUFFY LOCUS ON CHROMOSOME-1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									UNIV WASHINGTON,SEATTLE,WA 98195; VET ADM HOSP,SEATTLE,WA 98108	University of Washington; University of Washington Seattle									0	31	31	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	6					A99	A99						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KT964					2022-12-18	WOS:A1980KT96400235
J	ANGELL, RR; JACOBS, PA				ANGELL, RR; JACOBS, PA			LATERAL ASYMMETRY IN HUMAN CONSTITUTIVE HETEROCHROMATIN - FREQUENCY AND INHERITANCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											ANGELL, RR (corresponding author), UNIV HAWAII,SCH MED,DEPT ANAT & REPROD BIOL,HONOLULU,HI 96822, USA.							ANGELL RR, 1975, CHROMOSOMA, V51, P301, DOI 10.1007/BF00326317; ARRIGHI FE, 1971, CYTOGENETICS, V10, P81, DOI 10.1159/000130130; GALLOWAY SM, 1975, EXP CELL RES, V94, P454, DOI 10.1016/0014-4827(75)90517-0; JONES KW, 1973, CHROMOSOMA, V42, P445, DOI 10.1007/BF00399411; KIM MA, 1975, HUMANGENETIK, V28, P57, DOI 10.1007/BF00272483; LATT SA, 1973, P NATL ACAD SCI USA, V70, P3395, DOI 10.1073/pnas.70.12.3395; LATT SA, 1974, EXP CELL RES, V87, P427; LIN MS, 1974, EXP CELL RES, V86, P392, DOI 10.1016/0014-4827(74)90727-7	9	31	31	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	2					144	152						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV595	566032				2022-12-18	WOS:A1978EV59500005
J	CALLIS, J; HOEHN, H				CALLIS, J; HOEHN, H			FLOW-FLUOROMETRIC DIAGNOSIS OF EUPLOID AND ANEUPLOID HUMAN LYMPHOCYTES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WASHINGTON,MED SCH,DEPT PATHOL,SEATTLE,WA 98195; UNIV WASHINGTON,MED SCH,CTR INHERITED DIS,SEATTLE,WA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle								CRAM LS, 1976, J HISTOCHEM CYTOCHEM, V24, P383, DOI 10.1177/24.1.768372; Crissman H A, 1975, Methods Cell Biol, V9, P179, DOI 10.1016/S0091-679X(08)60076-X; CROSLANDTAYLOR PJ, 1953, NATURE, V171, P37, DOI 10.1038/171037b0; GLEDHILL BL, 1976, J CELL PHYSIOL, V87, P367, DOI 10.1002/jcp.1040870312; GRAY JW, 1975, P NATL ACAD SCI USA, V72, P1231, DOI 10.1073/pnas.72.4.1231; HARRIS R, 1970, BRIT J HAEMATOL, V18, P229, DOI 10.1111/j.1365-2141.1970.tb01436.x; KNOTT GD, 1972, P ONLINE 72 INT C, V1, P497; KRAEMER PM, 1973, COLD SPRING HARB SYM, V38, P133, DOI 10.1101/SQB.1974.038.01.017; KRISHAN A, 1975, J CELL BIOL, V66, P188, DOI 10.1083/jcb.66.1.188; MELAMED MR, 1975, INT REV EXPT PATHOLO, V14, P206; MENDELSOHN ML, 1973, SCIENCE, V179, P1126, DOI 10.1126/science.179.4078.1126; SMITH LB, 1970, COMMUN ACM, V13, P625, DOI 10.1145/355598.362789; SOKAL RR, 1969, PRINCIPLES PRACTICE, P155; STOLLA R, 1974, J REPROD FERTIL, V38, P335, DOI 10.1530/jrf.0.0380335	14	31	31	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	6					577	584						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CQ152	795296				2022-12-18	WOS:A1976CQ15200005
J	SPIELMAN, RS; SMOUSE, PE				SPIELMAN, RS; SMOUSE, PE			MULTIVARIATE CLASSIFICATION OF HUMAN-POPULATIONS .1. ALLOCATION OF YANOMAMA INDIANS TO VILLAGES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,ANN ARBOR,MI 48109; UNIV PENN,SCH MED,DEPT HUMAN GENET,PHILADELPHIA,PA 19174	University of Michigan System; University of Michigan; University of Pennsylvania								CHAGNON NA, 1968, YANAMAMO FIERCE PEOP, P142; FELSENSTEIN J, 1973, AM J HUM GENET, V25, P471; HILLS M, 1966, J ROY STAT SOC B, V28, P1; LACHENBRUCH PA, 1967, BIOMETRICS, V23, P639, DOI 10.2307/2528418; Lewontin R.C., 1972, J EVOLUTION BIOL, V14, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; MCHENRY H, 1971, AM J PHYS ANTHROPOL, V35, P241, DOI 10.1002/ajpa.1330350211; NEEL JAMES V., 1967, JAP J HUM GENET, V12, P1; NEEL JV, 1970, SCIENCE, V170, P815, DOI 10.1126/science.170.3960.815; NEEL JV, 1972, GENETICS, V72, P639; NEEL JV, 1975, AM J PHYS ANTHROPOL, V42, P25, DOI 10.1002/ajpa.1330420105; NEI M, 1974, AM J HUM GENET, V26, P421; Osborne RH, 1959, GENETIC BASIS MORPHO; ROTHHAMMER F, 1972, AM J HUM GENET, V24, P371; SMOUSE PE, IN PRESS; SPIELMAN RS, 1973, AM NAT, V107, P694, DOI 10.1086/282868; SPIELMAN RS, 1972, AM J PHYS ANTHROPOL, V37, P345, DOI 10.1002/ajpa.1330370304; SPIELMAN RS, 1974, SCIENCE, V184, P637, DOI 10.1126/science.184.4137.637; TANIS R, 1974, ANN HUM GENET, V38, P179, DOI 10.1111/j.1469-1809.1974.tb01949.x; WARD RH, 1975, AM J HUM GENET, V27, P1; WEISS KM, 1976, AM J PHYS ANTHROPOL, V44, P31, DOI 10.1002/ajpa.1330440106	20	31	32	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	4					317	331						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	BX345	821344				2022-12-18	WOS:A1976BX34500001
J	KURISU, K; NISWANDER, JD; JOHNSTON, MC; MAZAHERI, M				KURISU, K; NISWANDER, JD; JOHNSTON, MC; MAZAHERI, M			FACIAL MORPHOLOGY AS AN INDICATOR OF GENETIC PREDISPOSITION TO CLEFT-LIP AND PALATE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									LANCASTER CLEFT PALATE CLIN,LANCASTER,PA 17602; NIDR,HUMAN GENET BRANCH,BETHESDA,MD 20014	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)								ADUSS H, 1971, TERATOLOGY, V4, P171, DOI 10.1002/tera.1420040208; BHATIA SN, 1972, BRIT DENT J, V132, P95, DOI 10.1038/sj.bdj.4802808; CARTER C. O., 1965, PROGR MED GENET, V4, P59; CARTER CO, 1961, BRIT MED BULL, V17, P251, DOI 10.1093/oxfordjournals.bmb.a069918; CHUNG CS, 1974, AM J HUM GENET, V26, P177; Coccaro P J, 1972, Cleft Palate J, V9, P28; CORRUCCINI RS, 1973, AM J PHYS ANTHROPOL, V38, P743, DOI 10.1002/ajpa.1330380313; Dahl E, 1970, ACTA ODONTOL SCA S57, V28, P1; Dixon D. A., 1966, CAUSES NATURAL HIST, P178; Falconer D.S., 1960, INTRO QUANTITATIVE G; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Fogh-Andersen, 1942, INHERITANCE HARELIP; FRASER F C, 1970, Journal of Medical Genetics, V7, P112, DOI 10.1136/jmg.7.2.112; FRASER FC, 1970, AM J HUM GENET, V22, P336; FRASER FC, 1963, 2 P INT C HUM GEN, V3, P1852; FUJINO HIROSHI, 1967, JAP J HUM GENET, V12, P62; JENNRICH RI, 1966, PSYCHOMETRIKA, V31, P313, DOI 10.1007/BF02289465; MICHENER CD, 1957, EVOLUTION, V11, P130, DOI 10.1111/j.1558-5646.1957.tb02884.x; MORISHIMA H, 1960, EVOLUTION, V14, P153, DOI 10.2307/2405822; MOSS ML, 1965, ACTA ANAT, V61, P547; NISWANDER JD, 1971, MAR M INT ASS DENT R; PENROSE LS, 1954, ANN EUGENIC, V18, P337; PSAUME J, 1957, SEM HOP ANN CHIR PLA, V2, P3; RAO CR, 1952, ADV STATISTICAL METH; ROHLF F. JAMES, 1965, UNIV KANS SCI BULL, V45, P3; ROHLF FJ, 1967, SYST ZOOL, V16, P109, DOI 10.2307/2411403; Sokal R, 1963, PRINCIPLES NUMERICAL; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; TRASLER DG, 1968, TERATOLOGY, V1, P33, DOI 10.1002/tera.1420010106; WOOLF CM, 1971, J MED GENET, V8, P65, DOI 10.1136/jmg.8.1.65; WOOLF CM, 1963, AM J HUM GENET, V15, P209	31	31	31	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1974	26	6					702	714						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V0911	4440679				2022-12-18	WOS:A1974V091100005
J	LENZERINI, L; KHAN, PM; FILIPPI, G; RATTAZZI, MC; RAY, AK; SINISCALCO, M				LENZERINI, L; KHAN, PM; FILIPPI, G; RATTAZZI, MC; RAY, AK; SINISCALCO, M			CHARACTERIZATION OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE VARIANTS .I. OCCURRENCE OF A G6PD SEATTLE-LIKE VARIANT IN SARDINIA AND ITS INTERACTION WITH G6PD MEDITERRANEAN VARIANT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BEUTLER E, 1966, BLOOD-J HEMATOL, V28, P553, DOI 10.1182/blood.V28.4.553.553; BLUMBERG BS, 1961, P C GENETIC POLYM ED, P159; DOWD JE, 1965, J BIOL CHEM, V240, P863; GALL GC, 1965, AM J HUM GENET, V17, P359; KIRKMAN HN, 1965, J LAB CLIN MED, V66, P834; KIRKMAN HN, 1964, J LAB CLIN MED, V63, P715; MCCURDY PR, 1966, J LAB CLIN MED, V67, P374; MOTULSKY AG, 1966, AM J HUM GENET, V18, P514; MOTULSKY AG, 1964, COLD SPRING HARB SYM, V29, P391; Motulsky AG, 1961, P C GENETIC POLYMORP, P159; PIOMELLI S, IN PRESS; PORTER IH, 1964, LANCET, V1, P895; RATTAZZI MC, 1969, AM J HUM GENET, V21, P154; RATTAZZI MC, 1967, NATURE, V213, P79, DOI 10.1038/213079b0; SINISCALCO M., 1966, WORLD HEALTH ORGAN BULL, V34, P379; SMITH SM, 1961, MATHEMATICAL TABLES; YOSHIDA A, 1967, P NATL ACAD SCI USA, V57, P835, DOI 10.1073/pnas.57.3.835; YOSHIDA A, 1966, J BIOL CHEM, V241, P4966; 1967, WHO366 TECHN REP SER	19	31	31	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1969	21	2					142	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D3696	5305539				2022-12-18	WOS:A1969D369600004
J	OSBORNE, RH; DEGEORGE, FV				OSBORNE, RH; DEGEORGE, FV			ABO BLOOD GROUPS IN PAROTID AND SUBMAXILLARY GLAND TUMORS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article													Osborne, Richard H/A-9447-2010	Osborne, Richard H/0000-0002-9081-2699				AIRD I, 1953, BRIT MED J, V1, P799, DOI 10.1136/bmj.1.4814.799; BHOSKAR SN, 1957, TUMORS ORAL REGIONS, P9; BILLINGTON BP, 1956, LANCET, V2, P859; Boyd WC., 1950, GENETICS RACES MAN; CAMERON JM, 1958, LANCET, V1, P238; CHUNG CS, 1961, AM J HUM GENET, V13, P9; CLARKE CA, 1959, J MED EDUC, V34, P400; CLARKE CA, 1956, BRIT MED J, V2, P725, DOI 10.1136/bmj.2.4995.725; EVANS WR, 1956, HISTOLOGICAL APPEARA; Fisher R., 1930, GENETICAL THEORY NAT; FORD EB, 1942, GENETICS MEDICAL STU; FRAZELL EL, 1954, CANCER, V7, P637, DOI 10.1002/1097-0142(195407)7:4<637::AID-CNCR2820070403>3.0.CO;2-#; GILLMAN J, 1947, S Afr J Med Sci, V12, P99; GLYNN LE, 1959, BRIT MED BULL, V15, P150, DOI 10.1093/oxfordjournals.bmb.a069740; HADDOCK DR, 1956, LANCET, V2, P146; HELMBOLD W, 1961, ACTA GENET STAT MED, V11, P29; JENNINGS D, 1956, LANCET, V2, P11; Kabat EA, 1956, BLOOD GROUP SUBSTANC; MARSDEN ATH, 1951, BRIT J CANCER, V5, P375, DOI 10.1038/bjc.1951.42; MATSUNAGA E, 1959, J MED EDUC, V34, P405; MCCONNELL RB, 1957, 1 P INT C HUM GEN CO, P574; Moore RE, 1955, AM J PHYS ANTHROP-NE, V13, P121, DOI 10.1002/ajpa.1330130109; Mourant A. E., 1958, ABO BLOOD GROUPS COM; ROBERTS J A F, 1957, Br J Prev Soc Med, V11, P107; ROBERTS JAF, 1959, BRIT MED BULL, V15, P129, DOI 10.1093/oxfordjournals.bmb.a069736; SHEPPARD PM, 1959, BRIT MED BULL, V15, P134, DOI 10.1093/oxfordjournals.bmb.a069737; STEWART FW, 1945, ANN SURG, V122, P820, DOI 10.1097/00000658-194511000-00005; Willis R. A., 1953, PATHOLOGY TUMORS; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x	29	31	31	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1962	14	2					199	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2963A	14482468				2022-12-18	WOS:A19622963A00008
J	BOYD, WC				BOYD, WC			MAXIMUM LIKELIHOOD METHOD FOR ESTIMATION OF GENE FREQUENCIES FROM MNS DATA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BOYD WC, 1954, SCIENCE, V118, P756; BOYD WC, 1954, IN PRESS AM J PHYS A; Fisher R. A., 1950, STATISTICAL METHODS; FISHER RA, 1947, ANN EUGENIC, V13, P223; FISHER RA, 1946, ANN EUGENIC, V13, P150, DOI 10.1111/j.1469-1809.1946.tb02352.x; FISHER RA, 1947, ANN EUGEN, V13, P224; KELLEY TL, 1947, FUNDAMENTALS STATIST; Mather K., 1951, MEASUREMENT LINKAGE; MOURANT AE, 1954, IN PRESS DISTRIBUTIO; Race R.R., 1950, BLOOD GROUPS MAN; Stevens WL, 1938, ANN EUGENIC, V8, P362, DOI 10.1111/j.1469-1809.1938.tb02188.x	11	31	31	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1954	6	1					1	10						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YB732	13138564				2022-12-18	WOS:A1954YB73200001
J	Zheng, W; Zhou, Z; Sha, QQ; Niu, XL; Sun, XX; Shi, JZ; Zhao, L; Zhang, SP; Dai, J; Cai, SF; Meng, F; Hu, L; Gong, F; Li, XR; Fu, J; Shi, R; Lu, GX; Chen, BB; Fan, HY; Wang, L; Lin, G; Sang, Q				Zheng, Wei; Zhou, Zhou; Sha, Qianqian; Niu, Xiangli; Sun, Xiaoxi; Shi, Juanzi; Zhao, Lei; Zhang, Shuoping; Dai, Jing; Cai, Sufen; Meng, Fei; Hu, Liang; Gong, Fei; Li, Xiaoran; Fu, Jing; Shi, Rong; Lu, Guangxiu; Chen, Biaobang; Fan, Hengyu; Wang, Lei; Lin, Ge; Sang, Qing			Homozygous Mutations in BTG4 Cause Zygotic Cleavage Failure and Female Infertility	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PADI6	Zygotic cleavage failure (ZCF) is a unique early embryonic phenotype resulting in female infertility and recurrent failure of in vitro fertilization (IVF) and/or intracytoplasmic sperm injection (ICSI). With this phenotype, morphologically normal oocytes can be retrieved and successfully fertilized, but they fail to undergo cleavage. Until now, whether this phenotype has a Mendelian inheritance pattern and which underlying genetic factors play a role in its development remained to be elucidated. B cell translocation gene 4 (BTG4) is a key adaptor of the CCR4-NOT deadenylase complex, which is involved in maternal mRNA decay in mice, but no human diseases caused by mutations in BTG4 have previously been reported. Here, we identified four homozygous mutations in BTG4 (GenBank: NM_017589.4) that are responsible for the phenotype of ZCF, and we found they followed a recessive inheritance pattern. Three of them-c.73C>T (p.Gln25Ter), c.1A>G (p.?), and c.475_478del (p.Ile159LeufsTer15)-resulted in complete loss of full-length BTG4 protein. For c.166G>A (p.Ala56Thr), although the protein level and distribution of mutant BTG4 was not altered in zygotes from affected individuals or in HeLa cells, the interaction between BTG4 and CNOT7 was abolished. In vivo studies further demonstrated that the process of maternal mRNA decay was disrupted in the zygotes of the affected individuals, which provides a mechanistic explanation for the phenotype of ZCF. Thus, we provide evidence that ZCF is a Mendelian phenotype resulting from mutations in BTG4. These findings contribute to our understanding of the role of BTG4 in human early embryonic development and provide a genetic marker for female infertility.	[Zheng, Wei; Zhao, Lei; Zhang, Shuoping; Dai, Jing; Cai, Sufen; Meng, Fei; Hu, Liang; Gong, Fei; Lu, Guangxiu; Lin, Ge] Reprod & Genet Hosp CITIC Xiangya, Clin Res Ctr Reprod & Genet Hunan Prov, Changsha 410078, Peoples R China; [Zhou, Zhou; Wang, Lei; Sang, Qing] Fudan Univ, Childrens Hosp, Inst Pediat, Shanghai 200032, Peoples R China; [Zhou, Zhou; Wang, Lei; Sang, Qing] Fudan Univ, Shanghai Key Lab Med Epigenet, Int Colab Med Epigenet & Metab, Minist Sci & Technol, Shanghai 200032, Peoples R China; [Zhou, Zhou; Wang, Lei; Sang, Qing] Fudan Univ, Inst Biomed Sci, State Key Lab Genet Engn, Shanghai 200032, Peoples R China; [Sha, Qianqian] Guangdong Second Prov Gen Hosp, Reprod Med Ctr, Fertil Preservat Lab, Guangzhou 510317, Peoples R China; [Niu, Xiangli; Li, Xiaoran] Reprod Hosp Guangxi Zhuang Autonomous Reg, Nanning 530021, Peoples R China; [Sun, Xiaoxi; Fu, Jing] Fudan Univ, Obstet & Gynecol Hosp, Shanghai Ji Ai Genet & IVF Inst, Shanghai 200011, Peoples R China; [Shi, Juanzi; Shi, Rong] Shaanxi Maternal & Child Care Serv Ctr, Reprod Med Ctr, Xian 710069, Shaanxi, Peoples R China; [Hu, Liang; Gong, Fei; Lu, Guangxiu; Lin, Ge] Cent South Univ, Sch Basic Med Sci, Inst Reprod & Stem Cell Engn, Changsha 410078, Peoples R China; [Hu, Liang; Gong, Fei; Lu, Guangxiu; Lin, Ge] Natl Hlth & Family Planning Commiss, Lab Reprod & Stem Cell Engn, Changsha 410078, Peoples R China; [Chen, Biaobang] Shanghai Inst Planned Parenthood Res, NHC Key Lab Reprod Regulat, Shanghai 200032, Peoples R China; [Fan, Hengyu] Zhejiang Univ, Life Sci Inst, Hangzhou 310058, Peoples R China; [Wang, Lei] Shanghai Ctr Women & Childrens Hlth, Shanghai 200062, Peoples R China	Central South University; Fudan University; Fudan University; Fudan University; Fudan University; Central South University; Zhejiang University	Lin, G (corresponding author), Reprod & Genet Hosp CITIC Xiangya, Clin Res Ctr Reprod & Genet Hunan Prov, Changsha 410078, Peoples R China.; Sang, Q (corresponding author), Fudan Univ, Childrens Hosp, Inst Pediat, Shanghai 200032, Peoples R China.; Lin, G (corresponding author), Cent South Univ, Sch Basic Med Sci, Inst Reprod & Stem Cell Engn, Changsha 410078, Peoples R China.; Lin, G (corresponding author), Natl Hlth & Family Planning Commiss, Lab Reprod & Stem Cell Engn, Changsha 410078, Peoples R China.	linggf@hotmail.com; sangqing@fudan.edu.cn		Chen, Biaobang/0000-0002-9921-2155; Shi, Juanzi/0000-0002-9040-7829; Niu, Xiangli/0000-0003-3803-6378	National Key Research and Development Program of China [2017YFC1001500, 2016YFC1000600, 2016YFC1000200, 2018YFC1003100, 2018YFC1003800]; National Natural Science Foundation of China [81725006, 81822019, 81771581, 81971450, 81971382]; Natural Science Foundation of Hunan Province [2018JJ3893]; Scientific Research Foundation of Reproductive and Genetic Hospital of China International Trust Investment Corporation (CITIC) Xiangya [YNXM-201913]; Shanghai Municipal Science and Technology Major Project [2017SHZDZX01]; Project of Shanghai Municipal Science and Technology Commission [19JC1411001]; Shanghai Rising-Star Program [17QA 1400200]; Natural Science Foundation of Shanghai [19ZR1444500, 17ZR1401900]; Shuguang Program of Shanghai Education Development Foundation; Shanghai Municipal Education Commission [18SG03]; Strategic Collaborative Research Program of the Ferring Institute of Reproductive Medicine, Ferring Pharmaceuticals and Chinese Academy of Sciences [FIRMC200507]; Capacity Building Planning Program for Shanghai Women and Children's Health Service; Collaborative Innovation Center Project Construction for Shanghai Women and Children's Health; Guangdong Second Provincial General Hospital [YY2019-001]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); Scientific Research Foundation of Reproductive and Genetic Hospital of China International Trust Investment Corporation (CITIC) Xiangya; Shanghai Municipal Science and Technology Major Project; Project of Shanghai Municipal Science and Technology Commission; Shanghai Rising-Star Program; Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Shuguang Program of Shanghai Education Development Foundation; Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Strategic Collaborative Research Program of the Ferring Institute of Reproductive Medicine, Ferring Pharmaceuticals and Chinese Academy of Sciences(Ferring Pharmaceuticals); Capacity Building Planning Program for Shanghai Women and Children's Health Service; Collaborative Innovation Center Project Construction for Shanghai Women and Children's Health; Guangdong Second Provincial General Hospital	This work was supported by the National Key Research and Development Program of China (2017YFC1001500, 2016YFC1000600, 2016YFC1000200, 2018YFC1003100, and 2018YFC1003800), the National Natural Science Foundation of China (81725006, 81822019, 81771581, 81971450, and 81971382), the Natural Science Foundation of Hunan Province (2018JJ3893), the Scientific Research Foundation of Reproductive and Genetic Hospital of China International Trust Investment Corporation (CITIC) Xiangya (YNXM-201913), the Shanghai Municipal Science and Technology Major Project (2017SHZDZX01), the Project of Shanghai Municipal Science and Technology Commission (19JC1411001), the Shanghai Rising-Star Program (17QA 1400200), the Natural Science Foundation of Shanghai (19ZR1444500 and 17ZR1401900), Shuguang Program of Shanghai Education Development Foundation and Shanghai Municipal Education Commission (18SG03), the Strategic Collaborative Research Program of the Ferring Institute of Reproductive Medicine, Ferring Pharmaceuticals and Chinese Academy of Sciences (FIRMC200507), the Capacity Building Planning Program for Shanghai Women and Children's Health Service, the Collaborative Innovation Center Project Construction for Shanghai Women and Children's Health, and Start-up Funding of Guangdong Second Provincial General Hospital (YY2019-001).	Alazami AM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0792-0; Audouard C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017109; Chen BB, 2017, AM J HUM GENET, V101, P609, DOI 10.1016/j.ajhg.2017.08.018; Clift D, 2013, NAT REV MOL CELL BIO, V14, P549, DOI 10.1038/nrm3643; Cui C, 2014, BMC DEV BIOL, V14, DOI 10.1186/s12861-014-0033-x; Feng RZ, 2016, NEW ENGL J MED, V374, P223, DOI 10.1056/NEJMoa1510791; Hart RJ, 2016, PHYSIOL REV, V96, P873, DOI 10.1152/physrev.00023.2015; Horiuchi M, 2009, J BIOL CHEM, V284, P13244, DOI 10.1074/jbc.M809250200; Huang L, 2019, CELL DEATH DIFFER, V26, P969, DOI 10.1038/s41418-018-0181-9; Leng LZ, 2019, CELL STEM CELL, V25, P697, DOI 10.1016/j.stem.2019.09.004; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Li L, 2017, CELL STEM CELL, V20, P858, DOI 10.1016/j.stem.2017.03.007; Lu XK, 2017, TRENDS MOL MED, V23, P1014, DOI 10.1016/j.molmed.2017.09.004; Mascarenhas MN, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001356; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Sang Q, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav8731; Sang Q, 2018, AM J HUM GENET, V102, P649, DOI 10.1016/j.ajhg.2018.02.015; Sha QQ, 2019, BIOL REPROD, V101, P579, DOI 10.1093/biolre/ioz012; Sha QQ, 2018, EMBO J, V37, DOI 10.15252/embj.201899333; Wu JY, 2018, NATURE, V557, P256, DOI 10.1038/s41586-018-0080-8; Xu Y, 2016, AM J HUM GENET, V99, P744, DOI 10.1016/j.ajhg.2016.06.024; Yatsenko SA, 2019, BIOL REPROD, V101, P549, DOI 10.1093/biolre/ioz084; Yu C, 2016, NAT STRUCT MOL BIOL, V23, P387, DOI 10.1038/nsmb.3204; Yurttas P, 2008, DEVELOPMENT, V135, P2627, DOI 10.1242/dev.016329; Zhang ZX, 2017, J ASSIST REPROD GEN, V34, P399, DOI 10.1007/s10815-016-0864-4; Zheng W, 2020, J ASSIST REPROD GEN, V37, P205, DOI 10.1007/s10815-019-01606-7; Zhou F, 2019, NATURE, V572, P660, DOI 10.1038/s41586-019-1500-0	27	30	30	6	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 2	2020	107	1					24	33		10.1016/j.ajhg.2020.05.010	http://dx.doi.org/10.1016/j.ajhg.2020.05.010			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MH4EU	32502391	Green Published, Bronze			2022-12-18	WOS:000546685300003
J	Zhou, Y; Browning, SR; Browning, BL				Zhou, Ying; Browning, Sharon R.; Browning, Brian L.			A Fast and Simple Method for Detecting Identity-by-Descent Segments in Large-Scale Data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WHOLE-GENOME ASSOCIATION; HUMAN MUTATION; WIDE DATA; INFERENCE; RELATEDNESS; GENE; HERITABILITY; SELECTION; REGIONS; RATES	Segments of identity by descent (IBD) are used in many genetic analyses. We present a method for detecting identical-by-descent haplotype segments in phased genotype data. Our method, called hap-IBD, combines a compressed representation of haplotype data, the positional Burrows-Wheeler transform, and multi-threaded execution to produce very fast analysis times. An attractive feature of hap-IBD is its simplicity: the input parameters clearly and precisely define the IBD segments that are reported, so that program correctness can be confirmed by users. We evaluate hap-IBD and four state-of-the-art IBD segment detection methods (GERMLINE, iLASH, RaPID, and TRUFFLE) using UK Biobank chromosome 20 data and simulated sequence data. We show that hap-IBD detects IBD segments faster and more accurately than competing methods, and that hap-IBD is the only method that can rapidly and accurately detect short 2-4 centiMorgan (cM) IBD segments in the full UK Biobank data. Analysis of 485,346 UK Biobank samples through the use of hap-IBD with 12 computational threads detects 231.5 billion autosomal IBD segments with length >= 2 cM in 24.4 h.	[Zhou, Ying; Browning, Sharon R.; Browning, Brian L.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Browning, Brian L.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Browning, BL (corresponding author), Univ Washington, Dept Biostat, Seattle, WA 98195 USA.; Browning, BL (corresponding author), Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA.	browning@uw.edu	Browning, Sharon/B-1530-2008; Browning, Brian/ABC-4543-2021; Zhou, Ying/AAT-2949-2020	Browning, Sharon/0000-0001-7251-9715; Zhou, Ying/0000-0002-8107-3927	National Human Genome Research Institute of the National Institutes of Health [HG008359, HG005701, GM075091]; National Institute of General Medical Sciences of the National Institutes of Health [HG008359, HG005701, GM075091]	National Human Genome Research Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Human Genome Research Institute and National Institute of General Medical Sciences of the National Institutes of Health under award numbers HG008359, HG005701, and GM075091. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This research has been conducted using the UK Biobank Resource under Application Number 19934.	Albrechtsen A, 2010, GENETICS, V186, P295, DOI 10.1534/genetics.110.113977; Albrechtsen A, 2009, GENET EPIDEMIOL, V33, P266, DOI 10.1002/gepi.20378; Brown MD, 2012, GENETICS, V190, P1447, DOI 10.1534/genetics.111.137570; Browning BL, 2018, AM J HUM GENET, V103, P338, DOI 10.1016/j.ajhg.2018.07.015; Browning BL, 2013, AM J HUM GENET, V93, P840, DOI 10.1016/j.ajhg.2013.09.014; Browning BL, 2013, GENETICS, V194, P459, DOI 10.1534/genetics.113.150029; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Browning SR, 2008, GENETICS, V178, P2123, DOI 10.1534/genetics.107.084624; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Browning SR, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007385; Browning SR, 2015, AM J HUM GENET, V97, P404, DOI 10.1016/j.ajhg.2015.07.012; Browning SR, 2013, HUM GENET, V132, P129, DOI 10.1007/s00439-012-1230-y; Browning SR, 2012, GENETICS, V190, P1521, DOI 10.1534/genetics.111.136937; Browning SR, 2010, AM J HUM GENET, V86, P526, DOI 10.1016/j.ajhg.2010.02.021; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Cai Z, 2011, EUR J HUM GENET, V19, P667, DOI 10.1038/ejhg.2010.257; Campbell CD, 2012, NAT GENET, V44, P1277, DOI 10.1038/ng.2418; Chiang CWK, 2016, G3-GENES GENOM GENET, V6, P1287, DOI 10.1534/g3.116.027581; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Delaneau O, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13225-y; Dimitromanolakis A, 2019, AM J HUM GENET, V105, P78, DOI 10.1016/j.ajhg.2019.05.007; Durbin R, 2014, BIOINFORMATICS, V30, P1266, DOI 10.1093/bioinformatics/btu014; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fu WQ, 2016, AM J HUM GENET, V99, P1106, DOI 10.1016/j.ajhg.2016.09.011; Gusev A, 2012, MOL BIOL EVOL, V29, P473, DOI 10.1093/molbev/msr133; Gusev A, 2011, AM J HUM GENET, V88, P706, DOI 10.1016/j.ajhg.2011.04.023; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Haller BC, 2019, MOL ECOL RESOUR, V19, P552, DOI 10.1111/1755-0998.12968; Haller BC, 2019, MOL BIOL EVOL, V36, P632, DOI 10.1093/molbev/msy228; Haller BC, 2017, MOL BIOL EVOL, V34, P230, DOI 10.1093/molbev/msw211; Han EJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14238; Han LD, 2013, EUR J HUM GENET, V21, P205, DOI 10.1038/ejhg.2012.148; Han L, 2011, GENET EPIDEMIOL, V35, P557, DOI 10.1002/gepi.20606; Henden L, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007279; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Huff CD, 2011, GENOME RES, V21, P768, DOI 10.1101/gr.115972.110; Jeffreys AJ, 2004, NAT GENET, V36, P151, DOI 10.1038/ng1287; Kelleher J, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004842; Kenny EE, 2009, P NATL ACAD SCI USA, V106, P13886, DOI 10.1073/pnas.0907336106; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Lappalainen I, 2015, NAT GENET, V47, P692, DOI 10.1038/ng.3312; Leutenegger AL, 2003, AM J HUM GENET, V73, P516, DOI 10.1086/378207; Li H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004144; Loh PR, 2016, NAT GENET, V48, P1443, DOI 10.1038/ng.3679; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Maples BK, 2013, AM J HUM GENET, V93, P278, DOI 10.1016/j.ajhg.2013.06.020; Moltke I, 2011, GENOME RES, V21, P1168, DOI 10.1101/gr.115360.110; Narasimhan VM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00323-y; Naseri A, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1754-8; Palamara PF, 2018, NAT GENET, V50, P1311, DOI 10.1038/s41588-018-0177-x; Palamara PF, 2015, AM J HUM GENET, V97, P775, DOI 10.1016/j.ajhg.2015.10.006; Palamara PF, 2013, BIOINFORMATICS, V29, P180, DOI 10.1093/bioinformatics/btt239; Palamara PF, 2012, AM J HUM GENET, V91, P809, DOI 10.1016/j.ajhg.2012.08.030; Price AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001317; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qiao Y., 2019, BIORXIV, DOI [10.1101/753343, DOI 10.1101/753343]; Ralph P, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001555; Ramstetter MD, 2017, GENETICS, V207, P75, DOI 10.1534/genetics.117.1122; Rodriguez JM, 2015, GENOME RES, V25, P280, DOI 10.1101/gr.173641.114; Shemirani R., 2019, BIORXIV, DOI [10.1101/749507, DOI 10.1101/749507]; Taliun D., 2019, GENOMICS, DOI [10.1101/563866, DOI 10.1101/563866., DOI 10.1101/563866]; Taylor AR, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007065; Thompson EA, 2008, THEOR POPUL BIOL, V73, P369, DOI 10.1016/j.tpb.2007.11.011; Tian XW, 2019, AM J HUM GENET, V105, P883, DOI 10.1016/j.ajhg.2019.09.012; Weedon MN, 2019, VERY RARE PATHOGENIC, DOI [10.1101/696799, DOI 10.1101/696799]; Williams AL, 2015, ELIFE, V4, DOI 10.7554/eLife.04637; Zhou Y., 2019, BIORXIV, DOI [10.1101/868091, DOI 10.1101/868091]; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	70	30	30	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 2	2020	106	4					426	437		10.1016/j.ajhg.2020.02.010	http://dx.doi.org/10.1016/j.ajhg.2020.02.010			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KZ5MJ	32169169	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000523306000002
J	Beck, DB; Petracovici, A; He, CS; Moore, HW; Louie, RJ; Ansar, M; Douzgou, S; Sithambaram, S; Cottrell, T; Santos-Cortez, RLP; Prijoles, EJ; Bend, R; Keren, B; Mignot, C; Nougues, MC; Ounap, K; Reimand, T; Pajusalu, S; Zahid, M; Saqib, MAN; Buratti, J; Seaby, EG; McWalter, K; Telegrafi, A; Baldridge, D; Shinawi, M; Leal, SM; Schaefer, GB; Stevenson, RE; Banka, S; Bonasio, R; Fahrner, JA				Beck, David B.; Petracovici, Ana; He, Chongsheng; Moore, Hannah W.; Louie, Raymond J.; Ansar, Muhammad; Douzgou, Sofia; Sithambaram, Sivagamy; Cottrell, Trudie; Santos-Cortez, Regie Lyn P.; Prijoles, Eloise J.; Bend, Renee; Keren, Boris; Mignot, Cyril; Nougues, Marie-Christine; Ounap, Katrin; Reimand, Tiia; Pajusalu, Sander; Zahid, Muhammad; Saqib, Muhammad Arif Nadeem; Buratti, Julien; Seaby, Eleanor G.; McWalter, Kirsty; Telegrafi, Aida; Baldridge, Dustin; Shinawi, Marwan; Leal, Suzanne M.; Schaefer, G. Bradley; Stevenson, Roger E.; Banka, Siddharth; Bonasio, Roberto; Fahrner, Jill A.			Delineation of a Human Mendelian Disorder of the DNA Demethylation Machinery: TET3 Deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUTATIONS; 5-METHYLCYTOSINE; OVERGROWTH; OXIDATION; GENES; 5-HYDROXYMETHYLCYTOSINE; CONVERSION; PROTEINS; 5MC	Germline pathogenic variants in chromatin-modifying enzymes are a common cause of pediatric developmental disorders. These enzymes catalyze reactions that regulate epigenetic inheritance via histone post-translational modifications and DNA methylation. Cytosine methylation (5-methylcytosine [5mC]) of DNA is the quintessential epigenetic mark, yet no human Mendelian disorder of DNA demethylation has yet been delineated. Here, we describe in detail a Mendelian disorder caused by the disruption of DNA demethylation. TET3 is a methylcytosine dioxygenase that initiates DNA demethylation during early zygote formation, embryogenesis, and neuronal differentiation and is intolerant to haploinsufficiency in mice and humans. We identify and characterize 11 cases of human TET3 deficiency in eight families with the common phenotypic features of intellectual disability and/or global developmental delay; hypotonia; autistic traits; movement disorders; growth abnormalities; and facial dysmorphism. Mono-allelic frameshift and nonsense variants in TET3 occur throughout the coding region. Mono-allelic and bi-allelic missense variants localize to conserved residues; all but one such variant occur within the catalytic domain, and most display hypomorphic function in an assay of catalytic activity. TET3 deficiency and other Mendelian disorders of the epigenetic machinery show substantial phenotypic overlap, including features of intellectual disability and abnormal growth, underscoring shared disease mechanisms.	[Beck, David B.] NHGRI, NIH, Bethesda, MD 20892 USA; [Petracovici, Ana] Univ Penn, Grad Grp Genet & Epigenet, Perelman Sch Med, Philadelphia, PA 19104 USA; [Petracovici, Ana; He, Chongsheng; Bonasio, Roberto] Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Petracovici, Ana; He, Chongsheng; Bonasio, Roberto] Univ Penn, Epigenet Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [He, Chongsheng] Hunan Univ, Hunan Key Lab Plant Funct Genom & Dev Regulat, Changsha 410082, Hunan, Peoples R China; [Moore, Hannah W.; Louie, Raymond J.; Prijoles, Eloise J.; Bend, Renee; Stevenson, Roger E.] Greenwood Genet Ctr, Greenwood, SC 29646 USA; [Ansar, Muhammad; Zahid, Muhammad] Quaid I Azam Univ, Fac Biol Sci, Dept Biochem, Islamabad 45320, Pakistan; [Douzgou, Sofia; Banka, Siddharth] Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Div Evolut & Genom Sci, Manchester M13 9PL, Lancs, England; [Douzgou, Sofia; Sithambaram, Sivagamy; Cottrell, Trudie; Banka, Siddharth] Manchester Univ NHS Fdn Trust, St Marys Hosp, Manchester Ctr Genom Med, Hlth Innovat Manchester, Manchester M13 9WL, Lancs, England; [Santos-Cortez, Regie Lyn P.] Univ Colorado, Dept Otolaryngol, Sch Med, Aurora, CO 80045 USA; [Keren, Boris; Mignot, Cyril; Buratti, Julien] Grp Hosp Pitie Salpetriere, AP HP, Dept Genet, F-75013 Paris, France; [Mignot, Cyril] Ctr Reference Deficiences Intellectuelles Causes, F-75013 Paris, France; [Nougues, Marie-Christine] Armand Trousseau Hosp, AP HP, Dept Neuropediat, F-75012 Paris, France; [Ounap, Katrin; Reimand, Tiia; Pajusalu, Sander] Tartu Univ Hosp, Dept Clin Genet, United Labs, EE-50406 Tartu, Estonia; [Ounap, Katrin; Reimand, Tiia; Pajusalu, Sander] Univ Tartu, Inst Clin Med, Dept Clin Genet, EE-50406 Tartu, Estonia; [Reimand, Tiia] Univ Tartu, Inst Biomed & Translat Med, Chair Human Genet, EE-50406 Tartu, Estonia; [Pajusalu, Sander] Yale Univ, Dept Genet, Sch Med, New Haven, CT 06510 USA; [Saqib, Muhammad Arif Nadeem] Pakistan Hlth Res Council, Islamabad 45320, Pakistan; [Seaby, Eleanor G.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Seaby, Eleanor G.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [McWalter, Kirsty; Telegrafi, Aida] GeneDx, Gaithersburg, MD 20877 USA; [Baldridge, Dustin; Shinawi, Marwan] Washington Univ, Dept Pediat, Div Genet & Genom Med, Sch Med, St Louis, MO 63110 USA; [Leal, Suzanne M.] Columbia Univ, Ctr Stat Genet, Gertrude H Sergievsky Ctr,Med Ctr, Dept Neurol,Taub Inst Alzheimers Dis & Aging Brai, 630 W 168th St, New York, NY 10032 USA; [Schaefer, G. Bradley] Univ Arkansas Med Sci, Lowell, AK USA; [Fahrner, Jill A.] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Dept Pediat, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Hunan University; Greenwood Genetic Center; Quaid I Azam University; University of Manchester; University of Manchester; University of Colorado System; University of Colorado Anschutz Medical Campus; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Tartu; University of Tartu; Yale University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Washington University (WUSTL); Columbia University; Johns Hopkins University	Fahrner, JA (corresponding author), Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Dept Pediat, Baltimore, MD 21205 USA.	jfahrne1@jhmi.edu	Seaby, Eleanor G/AAM-7744-2020; Ansar, Muhammad/H-5967-2011; Pajusalu, Sander/U-1739-2019; Houge, Sofia Douzgou/I-2049-2019; He, Cshe1985!/AAV-1903-2021; Pajusalu, Sander/HDO-6793-2022; OUNAP, KATRIN/Q-1103-2016	Seaby, Eleanor G/0000-0002-6814-8648; Ansar, Muhammad/0000-0001-5891-7063; Pajusalu, Sander/0000-0002-5435-0781; Houge, Sofia Douzgou/0000-0001-8890-7544; Saqib, Muhammad Arif/0000-0001-6365-5520; He, Chongsheng/0000-0003-1719-6794; shinawi, Marwan/0000-0003-1329-4100; OUNAP, KATRIN/0000-0002-4594-6364; Banka, Siddharth/0000-0002-8527-2210	NIH [DP2MH107055, R01GM127408, T32 HD083185, K08HD086250]; Hartwell Foundation (individual biomedical research award Individual Biomedical Research Award); National Human Genome Research Institute (NHGRI) [5UM1HG006542]; National Heart, Lung, and Blood Institute (NHLBI) [5UM1HG006542]; Estonian Research Council [PUT355, PRG471, PUTJD827]; NHGRI [UM1HG008900]; NHBLI under the TransOmics for Precision Medicine (TOPMed) program; National Eye Institute; Higher Education Commission of Pakistan [NRPU-7099]; Health Innovation Challenge Fund [HICF-1009-003]; Wellcome Trust	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hartwell Foundation (individual biomedical research award Individual Biomedical Research Award); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Estonian Research Council(Estonian Research Council); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHBLI under the TransOmics for Precision Medicine (TOPMed) program; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Health Innovation Challenge Fund; Wellcome Trust(Wellcome TrustEuropean Commission)	We would like to thank all of the participating families. R.B. acknowledges support from the NIH (DP2MH107055, R01GM127408). A.P. was supported in part by an NIH training grant (T32 HD083185). J.A.F. acknowledges support from The Hartwell Foundation (individual biomedical research award Individual Biomedical Research Award) and the NIH(K08HD086250). We thank the Baylor-Hopkins Center for Mendelian Genomics for exome sequencing andbioinformatics analysis on family 1; this work was supported by grant 5UM1HG006542 from the National Human Genome Research Institute (NHGRI) and National Heart, Lung, and Blood Institute (NHLBI). Work on family 6 was supported by the Estonian Research Council grants PUT355, PRG471, and PUTJD827. The Broad Center for Mendelian Genomics (UM1HG008900) is funded by the NHGRI, and supplemental funding was provided by NHBLI under the TransOmics for Precision Medicine (TOPMed) program and the National Eye Institute. Work on family 3 was supported by Higher Education Commission of Pakistan grant number NRPU-7099 to M.A. The DDD study presents independent research commissioned by the Health Innovation Challenge Fund (grant number HICF-1009-003). This study makes use of DECIPHER, which is funded by the Wellcome Trust. See Nature<SUP>44</SUP> or the Web Resources.	Bend EG, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0658-5; Bjornsson HT, 2015, GENOME RES, V25, P1473, DOI 10.1101/gr.190629.115; Boukas L, 2019, GENOME RES, V29, P532, DOI 10.1101/gr.239442.118; Chong JX, 2015, AM J HUM GENET, V96, P462, DOI 10.1016/j.ajhg.2015.01.003; Choufani S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10207; Ehrlich M, 2001, HUM MOL GENET, V10, P2917, DOI 10.1093/hmg/10.25.2917; Fahrner JA, 2014, ANNU REV GENOM HUM G, V15, P269, DOI 10.1146/annurev-genom-090613-094245; Faundes V, 2018, AM J HUM GENET, V102, P175, DOI 10.1016/j.ajhg.2017.11.013; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hu LL, 2015, NATURE, V527, P118, DOI 10.1038/nature15713; Imagawa E, 2017, HUM MUTAT, V38, P637, DOI 10.1002/humu.23200; Inoue A, 2015, CELL REP, V10, P463, DOI 10.1016/j.celrep.2014.12.049; Inoue A, 2012, CELL RES, V22, P1640, DOI 10.1038/cr.2012.160; Inoue A, 2011, CELL RES, V21, P1670, DOI 10.1038/cr.2011.189; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kaasinen E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09198-7; Kernohan KD, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0254-x; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Larizza L, 2019, CLIN GENET, V95, P231, DOI 10.1111/cge.13365; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li X, 2014, P NATL ACAD SCI USA, V111, P7120, DOI 10.1073/pnas.1318906111; Luscan A, 2014, J MED GENET, V51, P512, DOI 10.1136/jmedgenet-2014-102402; Martin HC, 2018, SCIENCE, V362, P1161, DOI 10.1126/science.aar6731; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Mnatzakanian GN, 2004, NAT GENET, V36, P339, DOI 10.1038/ng1327; Olsenetal, 2010 GROWTH CALCULTO; Perera A, 2015, CELL REP, V11, P283, DOI 10.1016/j.celrep.2015.03.020; Rainger J, 2014, AM J HUM GENET, V94, P915, DOI 10.1016/j.ajhg.2014.05.005; Sadikovic B, 2019, EPIGENOMICS-UK, V11, P563, DOI 10.2217/epi-2018-0192; Santos-Cortez RLP, 2018, HUM GENET, V137, P735, DOI 10.1007/s00439-018-1928-6; Schenkel LC, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0453-8; Sobreira N, 2015, HUM MUTAT, V36, P425, DOI 10.1002/humu.22769; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tatton-Brown K, 2017, AM J HUM GENET, V100, P725, DOI 10.1016/j.ajhg.2017.03.010; Tatton-Brown K, 2014, NAT GENET, V46, P385, DOI 10.1038/ng.2917; Tsukada Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep15876; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wu XJ, 2017, NAT REV GENET, V18, P517, DOI 10.1038/nrg.2017.33; Yu HM, 2015, NAT NEUROSCI, V18, P836, DOI 10.1038/nn.4008; Zhu XD, 2016, NEURON, V89, P100, DOI 10.1016/j.neuron.2015.11.030	45	30	30	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 6	2020	106	2					234	245		10.1016/j.ajhg.2019.12.007	http://dx.doi.org/10.1016/j.ajhg.2019.12.007			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KK7IW	31928709	Green Submitted, Bronze, Green Published			2022-12-18	WOS:000512913300008
J	Thomas, L; Bouhouche, K; Whitfield, M; Thouvenin, G; Coste, A; Louis, B; Szymanski, C; Bequignon, E; Papon, JF; Castelli, M; Lemullois, M; Dhalluin, X; Drouin-Garraud, V; Montantin, G; Tissier, S; Duquesnoy, P; Copin, B; Dastot, F; Couvet, S; Barbotin, AL; Faucon, C; Honore, I; Maitre, B; Beydon, N; Tamalet, A; Rives, N; Koll, F; Escudier, E; Tassin, AM; Toure, A; Mitchell, V; Amselem, S; Legendre, M				Thomas, Lucie; Bouhouche, Khaled; Whitfield, Marjorie; Thouvenin, Guillaume; Coste, Andre; Louis, Bruno; Szymanski, Claire; Bequignon, Emilie; Papon, Jean-Francois; Castelli, Manon; Lemullois, Michel; Dhalluin, Xavier; Drouin-Garraud, Valerie; Montantin, Guy; Tissier, Sylvie; Duquesnoy, Philippe; Copin, Bruno; Dastot, Florence; Couvet, Sandrine; Barbotin, Anne-Laure; Faucon, Catherine; Honore, Isabelle; Maitre, Bernard; Beydon, Nicole; Tamalet, Aline; Rives, Nathalie; Koll, France; Escudier, Estelle; Tassin, Anne-Marie; Toure, Aminata; Mitchell, Valerie; Amselem, Serge; Legendre, Marie			TTC12 Loss-of-Function Mutations Cause Primary Ciliary Dyskinesia and Unveil Distinct Dynein Assembly Mechanisms in Motile Cilia Versus Flagella	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TETRATRICOPEPTIDE REPEAT; PROTEOMIC ANALYSIS; PROTEINS; INNER; OUTER; RANDOMIZATION; INTERFERENCE; INHIBITION; ASYMMETRY; MEMBRANE	Cilia and flagella are evolutionarily conserved organelles whose motility relies on the outer and inner dynein arm complexes (ODAs and IDAs). Defects in ODAs and IDAs result in primary ciliary dyskinesia (PCD), a disease characterized by recurrent airway infections and male infertility. PCD mutations in assembly factors have been shown to cause a combined ODA-IDA defect, affecting both cilia and flagella. We identified four loss-of-function mutations in TTC12, which encodes a cytoplasmic protein, in four independent families in which affected individuals displayed a peculiar PCD phenotype characterized by the absence of ODAs and IDAs in sperm flagella, contrasting with the absence of only IDAs in respiratory cilia. Analyses of both primary cells from individuals carrying TTC12 mutations and human differentiated airway cells invalidated for TTC12 by a CRISPR-Cas9 approach revealed an IDA defect restricted to a subset of single-headed IDAs that are different in flagella and cilia, whereas TTC12 depletion in the ciliate Paramecium tetraurelia recapitulated the sperm phenotype. Overall, our study, which identifies TTC12 as a gene involved in PCD, unveils distinct dynein assembly mechanisms in human motile cilia versus flagella.	[Thomas, Lucie; Duquesnoy, Philippe; Couvet, Sandrine; Escudier, Estelle; Amselem, Serge; Legendre, Marie] Sorbonne Univ, INSERM, Hop Armand Trousseau, U933, F-75012 Paris, France; [Bouhouche, Khaled; Castelli, Manon; Lemullois, Michel; Koll, France; Tassin, Anne-Marie] Univ Paris Sud, Univ Paris Saclay, Ctr Energie Atom & Energies Alternat, I2BC,CNRS, F-91198 Gif Sur Yvette, France; [Whitfield, Marjorie; Toure, Aminata] Univ Paris 05, CNRS, Inst Cochin, U1016,INSERM,UMR8104, F-75014 Paris, France; [Thouvenin, Guillaume; Beydon, Nicole; Tamalet, Aline] Hop Armand Trousseau, AP HP, Serv Physiol & Explorat Fonct, Unite Fonct Explorat Fonct Resp Somnol,Ctr Natl R, F-75012 Paris, France; [Thouvenin, Guillaume] Sorbonne Univ, Ctr Rech St Antoine, F-75012 Paris, France; [Coste, Andre; Bequignon, Emilie] Hop Henri Mondor, F-94010 Creteil, France; [Coste, Andre; Bequignon, Emilie] Ctr Hosp Intercommunal Creteil, AP HP, Serv Otorhinolaryngol & Chirurg Cerv Faciale, F-94010 Creteil, France; [Coste, Andre; Louis, Bruno; Bequignon, Emilie; Papon, Jean-Francois] Univ Paris Est, Fac Med, CNRS, U955,INSERM,ERL7240, F-94010 Creteil, France; [Szymanski, Claire] Hop Huriez, Serv Otorhinolaryngol & Chirurg Cerv Faciale, Ctr Hosp Univ Lille, F-59000 Lille, France; [Papon, Jean-Francois] Hop Bicetre, AP HP, Serv Otorhinolaryngol & Chirurg Cerv Faciale, F-94275 Le Kremlin Bicetre, France; [Dhalluin, Xavier] Hop Calmette, Serv Pneumol & Oncol Thorac & Endoscopie Resp, CHU Lille, F-59000 Lille, France; [Drouin-Garraud, Valerie] Hop Charles Nicolle, Serv Genet Med, Ctr Hosp Univ Hop Rouen, F-76000 Rouen, France; [Montantin, Guy; Tissier, Sylvie; Copin, Bruno; Dastot, Florence; Escudier, Estelle; Amselem, Serge; Legendre, Marie] Hop Armand Trousseau, AP HP, Dept Genet Med, F-75012 Paris, France; [Barbotin, Anne-Laure; Mitchell, Valerie] Hop Jeanne Flandre, Inst Biol Reprod Spermiol Cecos, CHU Lille, F-59000 Lille, France; [Barbotin, Anne-Laure; Mitchell, Valerie] Univ Lille, EA4308 Gametogenesis & Gamete Qual, F-59000 Lille, France; [Faucon, Catherine] Ctr Hosp Intercommunal Creteil, Serv Anatomopathol, Lab Microscopie Electron, F-94010 Creteil, France; [Honore, Isabelle] Hop Cochin, AP HP, Serv Pneumol & Oncol Thorac, F-75014 Paris, France; [Maitre, Bernard] Hop Henri Mondor, Serv Pneumol, F-94010 Creteil, France; [Maitre, Bernard] Ctr Hosp Intercommunal Creteil, AP HP, F-94010 Creteil, France; [Rives, Nathalie] Normandie Univ, Rouen Univ Hosp, Dept Reprod Biol, Ctr Etud & Conservat Sperme,UNIROUEN,EA Gametogen, EA 4308 Gametogenesis & Gamete Quality, F-76000 Rouen, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHI Creteil; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Universite de Lille - ISITE; CHU Lille; CHU de Rouen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHI Creteil; CHU de Rouen	Amselem, S (corresponding author), Sorbonne Univ, INSERM, Hop Armand Trousseau, U933, F-75012 Paris, France.; Toure, A (corresponding author), Univ Paris 05, CNRS, Inst Cochin, U1016,INSERM,UMR8104, F-75014 Paris, France.; Amselem, S (corresponding author), Hop Armand Trousseau, AP HP, Dept Genet Med, F-75012 Paris, France.	aminata.toure@inserm.fr; serge.amselem@inserm.fr	WHITFIELD, Marjorie/ABH-3433-2021; BEQUIGNON, Emilie/AAO-3221-2020; Bouhouche, khaled/AGR-4456-2022; Louis, Bruno/AGB-7050-2022; Louis, Bruno C/R-1862-2018; Legendre, Marie/AAD-7018-2021; TOURE, Aminata/B-3236-2018	WHITFIELD, Marjorie/0000-0001-7956-3436; Louis, Bruno/0000-0001-9587-9932; Louis, Bruno C/0000-0001-9587-9932; Legendre, Marie/0000-0003-2178-0846; TOURE, Aminata/0000-0001-5629-849X	French National Research Agency [ANR-10-COHO-0003]; Chancellerie des Universites de Paris (Legs Poix grant)	French National Research Agency(French National Research Agency (ANR)); Chancellerie des Universites de Paris (Legs Poix grant)	We are grateful to the affected persons and their families, whose cooperation made this study possible. We acknowledge the contributions of the CELPHEDIA Infrastructure, especially the center AniRA in Lyon and Gisele Froment, Didier Negre, and Caroline Costa from the lentivectors production facility (UMS3444/US8, SFR Biosciences Gerland-Lyon Sud) and RaDiCo, funded by the French National Research Agency under the specific program "Investments for the Future,'' (Cohort grant agreement ANR-10-COHO-0003) and the Chancellerie des Universites de Paris (Legs Poix grant). We thank Lucas Fares-Taie and Araksya Izmiryan at IMAGINE Institute for their advice in setting up the CRISPR-Cas9 technology. We thank Anne Loyens from INSERM U1172 at Lille University for TEM technical assistance and Feng Zhang from the Massachusetts Institute of Technology for the gift of the plentiCRISPRv2 plasmid.	ADOUTTE A, 1980, J CELL BIOL, V84, P717, DOI 10.1083/jcb.84.3.717; Amaral A, 2013, MOL CELL PROTEOMICS, V12, P330, DOI 10.1074/mcp.M112.020552; Arnaiz Olivier, 2014, Cilia, V3, P9, DOI 10.1186/2046-2530-3-9; Arnaiz O, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap022; Assimon VA, 2015, BIOCHEMISTRY-US, V54, P7120, DOI 10.1021/acs.biochem.5b00801; Auger J, 2016, HUM REPROD, V31, P10, DOI 10.1093/humrep/dev251; Austin-Tse C, 2013, AM J HUM GENET, V93, P672, DOI 10.1016/j.ajhg.2013.08.015; Blackburn K, 2017, J PROTEOME RES, V16, P1579, DOI 10.1021/acs.jproteome.6b00972; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.3.CO;2-E; Bui KH, 2012, J CELL BIOL, V198, P913, DOI 10.1083/jcb.201201120; Cho KJ, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007316; Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048; Coste A, 2000, EUR RESPIR J, V15, P367, DOI 10.1034/j.1399-3003.2000.15b24.x; Dasgupta A., 2016, PHILOS T R SOC LON B, V371, P2; Desai PB, 2018, DYNEINS BIOL DYNEIN, V1, P141, DOI DOI 10.1016/B978-0-12-809471-6.00004-8; Diggle CP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004577; Duquesnoy P, 2009, AM J HUM GENET, V85, P890, DOI 10.1016/j.ajhg.2009.11.008; Eisa NH, 2019, J BIOL CHEM, V294, P5246, DOI 10.1074/jbc.RA118.006597; Fassad MR, 2018, AM J HUM GENET, V103, P984, DOI 10.1016/j.ajhg.2018.10.016; Fassad MR, 2018, AM J HUM GENET, V102, P956, DOI 10.1016/j.ajhg.2018.03.024; Galvani A, 2002, TRENDS GENET, V18, P11, DOI 10.1016/S0168-9525(01)02548-3; Hauser K, 2000, EUR J CELL BIOL, V79, P144, DOI 10.1078/S0171-9335(04)70016-3; Hjeij R, 2013, AM J HUM GENET, V93, P357, DOI 10.1016/j.ajhg.2013.06.009; Hoben IM, 2018, AM J HUM GENET, V102, P973, DOI 10.1016/j.ajhg.2018.03.025; Hoh RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052166; Hom EFY, 2011, CYTOSKELETON, V68, P555, DOI 10.1002/cm.20533; Horani A, 2013, AM J RESP CELL MOL, V49, P341, DOI 10.1165/rcmb.2013-0046TE; Horani A, 2012, AM J HUM GENET, V91, P685, DOI 10.1016/j.ajhg.2012.08.022; Huizar RL, 2018, ELIFE, V7, DOI 10.7554/eLife.38497; Jaffe KM, 2016, CELL REP, V14, P1841, DOI 10.1016/j.celrep.2016.01.069; Jaganathan K, 2019, CELL, V176, P535, DOI 10.1016/j.cell.2018.12.015; Knowles MR, 2013, AM J HUM GENET, V93, P711, DOI 10.1016/j.ajhg.2013.07.025; Kobayashi D, 2012, DIFFERENTIATION, V83, pS23, DOI 10.1016/j.diff.2011.11.009; Kollmar M, 2016, MOL BIOL EVOL, V33, P3249, DOI 10.1093/molbev/msw213; Kott E, 2012, AM J HUM GENET, V91, P958, DOI 10.1016/j.ajhg.2012.10.003; Lin JF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6727; Lucas JS, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01090-2016; Lucas JS, 2014, ARCH DIS CHILD, V99, P850, DOI 10.1136/archdischild-2013-304831; Mitchison HM, 2012, NAT GENET, V44, P381, DOI 10.1038/ng.1106; Mooneyham A, 2019, MOL CANCER RES, V17, P370, DOI 10.1158/1541-7786.MCR-18-0670; Nicholls P, 2014, FEBS LETT, V588, P3977, DOI 10.1016/j.febslet.2014.09.013; Olcese C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14279; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Osinka A, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070730; Paff T, 2017, AM J HUM GENET, V100, P160, DOI 10.1016/j.ajhg.2016.11.019; Pal M, 2014, STRUCTURE, V22, P805, DOI 10.1016/j.str.2014.04.001; Panizzi JR, 2012, NAT GENET, V44, P714, DOI 10.1038/ng.2277; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Rudiger AH, 1999, EUR J CELL BIOL, V78, P15; Skouri F, 1997, MOL BIOL CELL, V8, P1063; Sonneborn T.M., 1970, CHAPTER 12 METHODS P, P241; Tarkar A, 2013, NAT GENET, V45, P995, DOI 10.1038/ng.2707; Taschner M, 2012, DIFFERENTIATION, V83, pS12, DOI 10.1016/j.diff.2011.11.001; Tewari R, 2010, TRENDS CELL BIOL, V20, P470, DOI 10.1016/j.tcb.2010.05.003; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Vandenbrouck Y, 2016, J PROTEOME RES, V15, P3998, DOI 10.1021/acs.jproteome.6b00400; VERRA F, 1993, AM REV RESPIR DIS, V147, P908, DOI 10.1164/ajrccm/147.4.908; Viswanadha R, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a018325; Wang GG, 2013, J PROTEOMICS, V79, P114, DOI 10.1016/j.jprot.2012.12.008; Whitfield M, 2019, AM J HUM GENET, V105, P198, DOI 10.1016/j.ajhg.2019.04.015; Xu YA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124378; Zariwala MA, 2013, AM J HUM GENET, V93, P336, DOI 10.1016/j.ajhg.2013.06.007	63	30	30	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 6	2020	106	2					153	169		10.1016/j.ajhg.2019.12.010	http://dx.doi.org/10.1016/j.ajhg.2019.12.010			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KK7IW	31978331	Green Published, Bronze			2022-12-18	WOS:000512913300003
J	Dong, ZR; Yan, JH; Xu, FP; Yuan, JY; Jiang, H; Wang, HL; Chen, HX; Zhang, L; Ye, LF; Xu, JJ; Shi, YH; Yang, ZJ; Cao, Y; Chen, LY; Li, QL; Zhao, X; Li, JG; Chen, A; Zhang, WW; Wong, HG; Qin, YY; Zhao, H; Chen, Y; Li, P; Ma, T; Wang, WJ; Kwok, YK; Jiang, Y; Pursley, AN; Chung, JPW; Hong, Y; Kristiansen, K; Yang, HM; Pina-Aguilar, RE; Leung, TY; Cheung, SW; Morton, CC; Choy, KW; Chen, ZJ				Dong, Zirui; Yan, Junhao; Xu, Fengping; Yuan, Jianying; Jiang, Hui; Wang, Huilin; Chen, Haixiao; Zhang, Lei; Ye, Lingfei; Xu, Jinjin; Shi, Yuhua; Yang, Zhenjun; Cao, Ye; Chen, Lingyun; Li, Qiaoling; Zhao, Xia; Li, Jiguang; Chen, Ao; Zhang, Wenwei; Wong, Hoi Gin; Qin, Yingying; Zhao, Han; Chen, Yuan; Li, Pei; Ma, Tao; Wang, Wen-Jing; Kwok, Yvonne K.; Jiang, Yuan; Pursley, Amber N.; Chung, Jacqueline P. W.; Hong, Yan; Kristiansen, Karsten; Yang, Huanming; Pina-Aguilar, Raul E.; Leung, Tak Yeung; Cheung, Sau Wai; Morton, Cynthia C.; Choy, Kwong Wai; Chen, Zi-Jiang			Genome Sequencing Explores Complexity of Chromosomal Abnormalities in Recurrent Miscarriage	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COUPLES; TRANSLOCATIONS; REARRANGEMENTS; SEGREGATION; GUIDELINES; MECHANISM; STANDARDS; PRODUCTS; REGION; WOMEN	Recurrent miscarriage (RM) affects millions of couples globally, and half of them have no demonstrated etiology. Genome sequencing (GS) is an enhanced and novel cytogenetic tool to define the contribution of chromosomal abnormalities in human diseases. In this study we evaluated its utility in RM-affected couples. We performed low-pass GS retrospectively for 1,090 RM-affected couples, all of whom had routine chromosome analysis. A customized sequencing and interpretation pipeline was developed to identify chromosomal rearrangements and deletions/duplications with confirmation by fluorescence in situ hybridization, chromosomal microarray analysis, and PCR studies. Low-pass GS yielded results in 1,077 of 1,090 couples (98.8%) and detected 127 chromosomal abnormalities in 11.7% (126/1,077) of couples; both members of one couple were identified with inversions. Of the 126 couples, 39.7% (50/126) had received former diagnostic results by karyotyping characteristic of normal human male or female karyotypes. Low-pass GS revealed additional chromosomal abnormalities in 50 (4.0%) couples, including eight with balanced translocations and 42 inversions. Follow-up studies of these couples showed a higher miscarriage/fetal-anomaly rate of 5/10 (50%) compared to 21/93 (22.6%) in couples with normal GS, resulting in a relative risk of 2.2 (95% confidence interval, 1.1 to 4.6). In these couples, this protocol significantly increased the diagnostic yield of chromosomal abnormalities per couple (11.7%) in comparison to chromosome analysis (8.0%, chi-square test p = 0.000751). In summary, low-pass GS identified underlying chromosomal aberrations in 1 in 9 RM-affected couples, enabling identification of a subgroup of couples with increased risk of subsequent miscarriage who would benefit from a personalized intervention.	[Dong, Zirui; Yan, Junhao; Zhang, Lei; Shi, Yuhua; Qin, Yingying; Zhao, Han; Chen, Zi-Jiang] Shandong Univ, Ctr Reprod Med, Jinan 250021, Shandong, Peoples R China; [Dong, Zirui; Xu, Fengping; Yuan, Jianying; Jiang, Hui; Chen, Haixiao; Ye, Lingfei; Xu, Jinjin; Yang, Zhenjun; Chen, Lingyun; Li, Qiaoling; Zhao, Xia; Li, Jiguang; Chen, Ao; Zhang, Wenwei; Chen, Yuan; Li, Pei; Ma, Tao; Wang, Wen-Jing; Jiang, Yuan; Kristiansen, Karsten; Yang, Huanming] BGI Shenzhen, Shenzhen 518083, Guangdong, Peoples R China; [Dong, Zirui; Wang, Huilin; Yang, Zhenjun; Cao, Ye; Wong, Hoi Gin; Kwok, Yvonne K.; Chung, Jacqueline P. W.; Leung, Tak Yeung; Choy, Kwong Wai] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Peoples R China; [Dong, Zirui; Jiang, Hui; Cao, Ye; Wong, Hoi Gin; Kwok, Yvonne K.; Leung, Tak Yeung; Choy, Kwong Wai] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen 518057, Guangdong, Peoples R China; [Yan, Junhao; Zhang, Lei; Shi, Yuhua; Qin, Yingying; Zhao, Han; Chen, Zi-Jiang] Shandong Univ, Minist Educ, Key Lab Reprod Endocrinol, Jinan 250021, Shandong, Peoples R China; [Yan, Junhao; Zhang, Lei; Shi, Yuhua; Qin, Yingying; Zhao, Han; Chen, Zi-Jiang] Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan 250021, Shandong, Peoples R China; [Xu, Fengping; Yuan, Jianying; Jiang, Hui; Chen, Haixiao; Ye, Lingfei; Xu, Jinjin; Yang, Zhenjun; Chen, Lingyun; Li, Qiaoling; Zhao, Xia; Li, Jiguang; Chen, Ao; Zhang, Wenwei; Chen, Yuan; Ma, Tao; Wang, Wen-Jing; Yang, Huanming] BGI Shenzhen, China Natl Genebank, Shenzhen 518120, Guangdong, Peoples R China; [Xu, Fengping; Kristiansen, Karsten] Univ Copenhagen, Dept Biol, Lab Genom & Mol Biomed, DK-2100 Copenhagen, Denmark; [Wang, Huilin] Jinan Univ, Sch Med, Baoan Matern & Child Healthcare Hosp, Dept Cent Lab, Shenzhen 518133, Guangdong, Peoples R China; [Jiang, Yuan] Complete Genom, Mountain View, CA 95134 USA; [Pursley, Amber N.; Cheung, Sau Wai] Baylor Coll Med, Dept Mol & Cellar Biol, Houston, TX 77030 USA; [Yang, Huanming] James D Watson Inst Genome Sci, Hangzhou 310008, Zhejiang, Peoples R China; [Hong, Yan; Chen, Zi-Jiang] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Ctr Reprod Med, Shanghai 200135, Peoples R China; [Hong, Yan; Chen, Zi-Jiang] Shanghai Key Lab Assisted Reprod & Reprod Genet, Shanghai 200135, Peoples R China; [Pina-Aguilar, Raul E.; Morton, Cynthia C.] Brigham & Womens Hosp, Dept Obstet & Gynecol, 75 Francis St, Boston, MA 02115 USA; [Pina-Aguilar, Raul E.; Morton, Cynthia C.] Harvard Med Sch, Boston, MA 02115 USA; [Leung, Tak Yeung; Cheung, Sau Wai; Choy, Kwong Wai] Chinese Univ Hong Kong Baylor Coll Med Joint Ctr, Hong Kong, Peoples R China; [Leung, Tak Yeung; Choy, Kwong Wai; Chen, Zi-Jiang] Ctr Assisted Reprod Technol & Reprod Genet, Chinese Natl Engn Res Ctr, Hong Kong Branches, Hong Kong, Peoples R China; [Morton, Cynthia C.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Morton, Cynthia C.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Morton, Cynthia C.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester Ctr Audiol & Deafness, Sch Hlth Sci,Fac Biol Med & Hlth, Manchester M13 9NT, Lancs, England	Shandong University; Beijing Genomics Institute (BGI); Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen; Shandong University; Beijing Genomics Institute (BGI); University of Copenhagen; Jinan University; Baylor College of Medicine; Shanghai Jiao Tong University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; University of Manchester	Chen, ZJ (corresponding author), Shandong Univ, Ctr Reprod Med, Jinan 250021, Shandong, Peoples R China.; Choy, KW (corresponding author), Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Peoples R China.; Choy, KW (corresponding author), Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen 518057, Guangdong, Peoples R China.; Chen, ZJ (corresponding author), Shandong Univ, Minist Educ, Key Lab Reprod Endocrinol, Jinan 250021, Shandong, Peoples R China.; Chen, ZJ (corresponding author), Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan 250021, Shandong, Peoples R China.; Chen, ZJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Ctr Reprod Med, Shanghai 200135, Peoples R China.; Chen, ZJ (corresponding author), Shanghai Key Lab Assisted Reprod & Reprod Genet, Shanghai 200135, Peoples R China.; Choy, KW (corresponding author), Chinese Univ Hong Kong Baylor Coll Med Joint Ctr, Hong Kong, Peoples R China.; Choy, KW; Chen, ZJ (corresponding author), Ctr Assisted Reprod Technol & Reprod Genet, Chinese Natl Engn Res Ctr, Hong Kong Branches, Hong Kong, Peoples R China.	richardchoy@cuhk.edu.hk; chenzijiang@hotmail.com	Chen, Zi-Jiang/GOE-6119-2022; Li, Yuan/GXV-1310-2022; Chung, Jacqueline/U-5538-2019; Kristiansen, Karsten/J-5148-2014; Piña-Aguilar, Raul Eduardo/C-6639-2008; Cao, Ye/ABF-4282-2020; DONG, Elvis/AAM-9274-2020; Choy, Richard/AAW-8230-2020; Yan, Junhao/AAH-8310-2019	Chung, Jacqueline/0000-0002-9742-578X; Kristiansen, Karsten/0000-0002-6024-0917; Piña-Aguilar, Raul Eduardo/0000-0002-2043-4282; Cao, Ye/0000-0002-5712-1968; DONG, Elvis/0000-0002-3626-6500; Choy, Richard/0000-0002-3616-6200; Cheung, Sau W/0000-0002-3813-5256; Chen, Zi-Jiang/0000-0001-6637-6631	National Natural Science Foundation of China [81490743, 81370715, 81300075]; National Key Research and Development Program of China [2016YFC1000202]; Health and Medical Research Fund [04152666]; General Research Fund [14115418]; National Institute of General Medical Sciences [GM061354]; NIH/NIGMS [P01 GM061354]; NIHR Manchester Biomedical Research Centre; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Health and Medical Research Fund; General Research Fund; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIHR Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We especially thank Terence T. Lao, Fernando Scaglia, and Feng Zhang for their contributions during manuscript preparation. This project is supported by the National Natural Science Foundation of China (81490743, 81370715, and 81300075), the National Key Research and Development Program of China (2016YFC1000202), the Health and Medical Research Fund (04152666), the General Research Fund (14115418), and the National Institute of General Medical Sciences (GM061354). C.C.M. is supported by the NIH/NIGMS (P01 GM061354) and the NIHR Manchester Biomedical Research Centre.	Amer Soc Reprod Med, 2013, FERTIL STERIL, V99, P63, DOI 10.1016/j.fertnstert.2012.09.023; Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P1103, DOI 10.1016/j.fertnstert.2012.06.048; Barber JCK, 2010, BJOG-INT J OBSTET GY, V117, P885, DOI 10.1111/j.1471-0528.2010.02566.x; Bhatt SS, 2014, CYTOGENET GENOME RES, V142, P145, DOI 10.1159/000356142; Cai YN, 2019, REPROD BIOMED ONLINE, V38, P669, DOI 10.1016/j.rbmo.2018.12.043; Carnevali P, 2012, J COMPUT BIOL, V19, P279, DOI 10.1089/cmb.2011.0201; Chiang C, 2012, NAT GENET, V44, P390, DOI 10.1038/ng.2202; Choy KW, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00761; Coomarasamy A, 2015, NEW ENGL J MED, V373, P2141, DOI 10.1056/NEJMoa1504927; de Pagter MS, 2015, AM J HUM GENET, V96, P651, DOI 10.1016/j.ajhg.2015.02.005; DEBRAEKELEER M, 1990, HUM REPROD, V5, P519, DOI 10.1093/oxfordjournals.humrep.a137135; Dong ZR, 2018, GENET MED, V20, P697, DOI 10.1038/gim.2017.170; Dong ZR, 2016, GENET MED, V18, P940, DOI 10.1038/gim.2015.199; Dong ZR, 2014, HUM MUTAT, V35, P625, DOI 10.1002/humu.22541; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Ellard S, 2015, EUR J HUM GENET, V23, P401, DOI 10.1038/ejhg.2014.120; Ford Holly B, 2009, Rev Obstet Gynecol, V2, P76; Franssen MTM, 2011, HUM REPROD UPDATE, V17, P467, DOI 10.1093/humupd/dmr011; Fryns JP, 1998, EUR J OBSTET GYN R B, V81, P171, DOI 10.1016/S0301-2115(98)00185-7; Grati FR, 2018, REPROD BIOMED ONLINE, V36, P442, DOI 10.1016/j.rbmo.2018.01.005; Greco E, 2015, NEW ENGL J MED, V373, P2089, DOI 10.1056/NEJMc1500421; HAN JY, 1994, AM J HUM GENET, V55, P960; Jarmuz-Szymczak M, 2014, CHROMOSOME RES, V22, P517, DOI 10.1007/s10577-014-9439-3; Kaandorp SP, 2010, NEW ENGL J MED, V362, P1586, DOI 10.1056/NEJMoa1000641; Kearney HM, 2011, GENET MED, V13, P680, DOI 10.1097/GIM.0b013e3182217a3a; Keymolen K, 2011, AM J MED GENET A, V155A, P2381, DOI 10.1002/ajmg.a.33941; Kurahashi H, 2010, CLIN GENET, V78, P299, DOI 10.1111/j.1399-0004.2010.01445.x; Levy B, 2014, OBSTET GYNECOL, V124, P202, DOI 10.1097/AOG.0000000000000325; Lin SB, 2015, J CHIN MED ASSOC, V78, P408, DOI 10.1016/j.jcma.2015.03.010; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Liu Z, 2019, INT J UROL, V26, P195; McCoy RC, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005601; Morel F, 2004, INT J ANDROL, V27, P200, DOI 10.1111/j.1365-2605.2004.00490.x; Nilsson D, 2017, HUM MUTAT, V38, P180, DOI 10.1002/humu.23146; Petrovski S, 2019, LANCET, V393, P758, DOI 10.1016/S0140-6736(18)32042-7; Popescu F, 2018, HUM REPROD, V33, P579, DOI 10.1093/humrep/dey021; Pujol A, 2006, REPRODUCTION, V131, P1025, DOI 10.1530/rep.1.01063; Qiao Y, 2016, MOL HUM REPROD, V22, P364, DOI 10.1093/molehr/gaw008; Redin C, 2017, NAT GENET, V49, P36, DOI 10.1038/ng.3720; Shpiz A, 2015, MOL HUM REPROD, V21, P271, DOI 10.1093/molehr/gau104; South ST, 2013, GENET MED, V15, P901, DOI 10.1038/gim.2013.129; Stankewicz T, 2017, FERTIL STERIL, V107, pE14; Talkowski ME, 2012, NEW ENGL J MED, V367, P2226, DOI 10.1056/NEJMoa1208594; Victor AR, 2019, FERTIL STERIL, V111, P280, DOI 10.1016/j.fertnstert.2018.10.019; Weissman A, 2017, REPROD BIOMED ONLINE, V35, P693, DOI 10.1016/j.rbmo.2017.09.001; Zepeda-Mendoza CJ, 2019, AM J HUM GENET, V104, P565, DOI 10.1016/j.ajhg.2019.02.024; Zhang L, 2019, HUM REPROD, V34, P380, DOI 10.1093/humrep/dey367	47	30	36	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 5	2019	105	6					1102	1111		10.1016/j.ajhg.2019.10.003	http://dx.doi.org/10.1016/j.ajhg.2019.10.003			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JT4BB	31679651	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000500935400004
J	Zepeda-Mendoza, CJ; Morton, CC				Zepeda-Mendoza, Cinthya J.; Morton, Cynthia C.			The Iceberg under Water: Unexplored Complexity of Chromoanagenesis in Congenital Disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							NUCLEOTIDE-LEVEL RESOLUTION; STRUCTURAL VARIATION; CHROMOSOME REARRANGEMENTS; GERMLINE CHROMOTHRIPSIS; DNA-DAMAGE; GENOME; BREAKS; SCALE; MECHANISMS; DISCOVERY	Structural variation, composed of balanced and unbalanced genomic rearrangements, is an important contributor to human genetic diversity with prominent roles in somatic and congenital disease. At the nucleotide level, structural variants (SVs) have been shown to frequently harbor additional breakpoints and copy-number imbalances, a complexity predicted to emerge wholly as a single-cell division event. Chromothripsis, chromoplexy, and chromoanasynthesis, collectively referred to as chromoanagenesis, are three major mechanisms that explain the occurrence of complex germline and somatic SVs. While chromothripsis and chromoplexy have been shown to be key signatures of cancer, chromoanagenesis has been detected in numerous cases of developmental disease and phenotypically normal individuals. Such observations advocate for a deeper study of the polymorphic and pathogenic properties of complex germline SVs, many of which go undetected by traditional clinical molecular and cytogenetic methods. This review focuses on congenital chromoanagenesis, mechanisms leading to occurrence of these complex rearrangements, and their impact on chromosome organization and genome function. We highlight future applications of routine screening of complex and balanced SVs in the clinic, as these represent a potential and often neglected genetic disease source, a true "iceberg under water.''	[Zepeda-Mendoza, Cinthya J.] Mayo Clin, Div Lab Genet, Dept Lab Med & Pathol, Rochester, MN 55902 USA; [Morton, Cynthia C.] Brigham & Womens Hosp, Dept Obstet & Gynecol, 75 Francis St, Boston, MA 02115 USA; [Morton, Cynthia C.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Morton, Cynthia C.] Harvard Med Sch, Boston, MA 02115 USA; [Morton, Cynthia C.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Morton, Cynthia C.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Hlth Sci, Manchester Ctr Audiol & Deafness, Manchester M13 9NT, Lancs, England	Mayo Clinic; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Manchester	Morton, CC (corresponding author), Brigham & Womens Hosp, Dept Obstet & Gynecol, 75 Francis St, Boston, MA 02115 USA.; Morton, CC (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.; Morton, CC (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Morton, CC (corresponding author), Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA.; Morton, CC (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Hlth Sci, Manchester Ctr Audiol & Deafness, Manchester M13 9NT, Lancs, England.	cmorton@bwh.harvard.edu			National Institutes of Health [GM061354]; NIHR Manchester Biomedical Research Centre; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIHR Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by the National Institutes of Health (GM061354 to C.C.M.). C.C.M. is supported by the NIHR Manchester Biomedical Research Centre.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anderson ND, 2018, SCIENCE, V361, DOI 10.1126/science.aam8419; Andrey G, 2017, DEVELOPMENT, V144, P3646, DOI 10.1242/dev.148304; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Bertelsen B, 2016, GENET MED, V18, P494, DOI 10.1038/gim.2015.112; Bianco S, 2018, NAT GENET, V50, P662, DOI 10.1038/s41588-018-0098-8; Broustas CG, 2014, RADIAT RES, V181, P111, DOI 10.1667/RR13515.1; Cheng CX, 2016, AM J HUM GENET, V98, P256, DOI 10.1016/j.ajhg.2015.12.013; Chiang C, 2012, NAT GENET, V44, P390, DOI 10.1038/ng.2202; Collins RL, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1158-6; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; de Pagter MS, 2015, AM J HUM GENET, V96, P651, DOI 10.1016/j.ajhg.2015.02.005; DePinho RA, 2004, NAT GENET, V36, P932, DOI 10.1038/ng0904-932; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Feuk L, 2005, PLOS GENET, V1, P489, DOI 10.1371/journal.pgen.0010056; Gamba BF, 2015, MOL GENET GENOMICS, V290, P2213, DOI 10.1007/s00438-015-1072-0; Genesio R, 2015, MOL CYTOGENET, V8, DOI 10.1186/s13039-015-0199-3; Grochowski CM, 2018, HUM MUTAT, V39, P939, DOI 10.1002/humu.23537; Grossmann V, 2010, CLIN GENET, V78, P548, DOI 10.1111/j.1399-0004.2010.01419.x; Gu HG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081759; Haffner MC, 2010, NAT GENET, V42, P668, DOI 10.1038/ng.613; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Holland AJ, 2012, NAT MED, V18, P1630, DOI 10.1038/nm.2988; Huddleston J, 2017, GENOME RES, V27, P677, DOI 10.1101/gr.214007.116; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; KATO H, 1968, J NATL CANCER I, V40, P165; Kloosterman WP, 2012, CELL REP, V1, P648, DOI 10.1016/j.celrep.2012.05.009; Kloosterman WP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r103; Kloosterman WP, 2011, HUM MOL GENET, V20, P1916, DOI 10.1093/hmg/ddr073; Korbel JO, 2013, CELL, V152, P1226, DOI 10.1016/j.cell.2013.02.023; Krefting J, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0556-x; Krier JB, 2016, DIALOGUES CLIN NEURO, V18, P299; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Liu BA, 2015, ONCOTARGET, V6, P5477, DOI 10.18632/oncotarget.3491; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Lupski JR, 2007, NEW ENGL J MED, V356, P1169, DOI 10.1056/NEJMcibr067658; Lupski JR, 2015, ENVIRON MOL MUTAGEN, V56, P419, DOI 10.1002/em.21943; Ly P, 2017, TRENDS CELL BIOL, V27, P917, DOI 10.1016/j.tcb.2017.08.005; Ly P, 2017, NAT CELL BIOL, V19, P68, DOI 10.1038/ncb3450; Maciejowski J, 2015, CELL, V163, P1641, DOI 10.1016/j.cell.2015.11.054; Magrangeas F, 2011, BLOOD, V118, P675, DOI 10.1182/blood-2011-03-344069; Malhotra A, 2013, GENOME RES, V23, P762, DOI 10.1101/gr.143677.112; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Masset H, 2016, HUM MUTAT, V37, P661, DOI 10.1002/humu.22984; Mateos-Gomez PA, 2015, NATURE, V518, P254, DOI 10.1038/nature14157; McClintock B, 1938, GENETICS, V23, P315; McClintock B, 1941, GENETICS, V26, P234; McDermott DH, 2015, CELL, V160, P686, DOI 10.1016/j.cell.2015.01.014; Middelkamp S, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0399-z; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Morishita M, 2016, ONCOTARGET, V7, P10182, DOI 10.18632/oncotarget.7186; Nattestad M, 2018, GENOME RES, V28, P1126, DOI 10.1101/gr.231100.117; Nazaryan L, 2014, EUR J HUM GENET, V22, P338, DOI 10.1038/ejhg.2013.147; Nazaryan-Petersen L, 2016, HUM MUTAT, V37, P385, DOI 10.1002/humu.22953; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Ordulu Z, 2016, AM J HUM GENET, V99, P1015, DOI 10.1016/j.ajhg.2016.08.022; Ordulu Z, 2014, AM J HUM GENET, V94, P695, DOI 10.1016/j.ajhg.2014.03.020; Parker M, 2014, NATURE, V506, P451, DOI 10.1038/nature13109; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Pettersson M, 2018, MUTAT RES-FUND MOL M, V812, P1, DOI 10.1016/j.mrfmmm.2018.10.001; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Plaisancie J, 2014, EUR J MED GENET, V57, P567, DOI 10.1016/j.ejmg.2014.07.004; Prokop JW, 2018, PHYSIOL GENOMICS, V50, P563, DOI 10.1152/physiolgenomics.00046.2018; Qian YQ, 2018, MOL CYTOGENET, V11, DOI 10.1186/s13039-018-0362-8; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Redin C, 2017, NAT GENET, V49, P36, DOI 10.1038/ng.3720; Rode A, 2016, INT J CANCER, V138, P2322, DOI 10.1002/ijc.29888; Sabatini PJB, 2018, MOL CYTOGENET, V11, DOI 10.1186/s13039-018-0394-0; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Shendure J, 2017, NATURE, V550, P345, DOI 10.1038/nature24286; Shlien A, 2009, GENOME MED, V1, DOI 10.1186/gm62; Spielmann M, 2018, NAT REV GENET, V19, P453, DOI 10.1038/s41576-018-0007-0; Stancu MC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01343-4; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Symmons O, 2014, GENOME RES, V24, P390, DOI 10.1101/gr.163519.113; Talkowski ME, 2012, NEW ENGL J MED, V367, P2226, DOI 10.1056/NEJMoa1208594; Talkowski ME, 2011, AM J HUM GENET, V88, P469, DOI 10.1016/j.ajhg.2011.03.013; Tan LZ, 2018, SCIENCE, V361, P924, DOI 10.1126/science.aat5641; TOMMERUP N, 1993, J MED GENET, V30, P713, DOI 10.1136/jmg.30.9.713; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; van Binsbergen E, 2012, AM J MED GENET A, V158A, P2888, DOI 10.1002/ajmg.a.35580; Weckselblatt B, 2015, GENOME RES, V25, P937, DOI 10.1101/gr.191247.115; Weischenfeldt J, 2013, NAT REV GENET, V14, P125, DOI 10.1038/nrg3373; Zanardo EA, 2014, MOL GENET GENOMICS, V289, P1037, DOI 10.1007/s00438-014-0876-7; Zepeda-Mendoza CJ, 2018, EUR J HUM GENET, V26, P374, DOI 10.1038/s41431-017-0068-0; Zepeda-Mendoza CJ, 2017, AM J HUM GENET, V101, P206, DOI 10.1016/j.ajhg.2017.06.011; Zhan YX, 2017, GENOME RES, V27, P479, DOI 10.1101/gr.212803.116; Zhang CZ, 2015, NATURE, V522, P179, DOI 10.1038/nature14493; Zhang CZ, 2013, GENE DEV, V27, P2513, DOI 10.1101/gad.229559.113	97	30	30	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 4	2019	104	4					565	577		10.1016/j.ajhg.2019.02.024	http://dx.doi.org/10.1016/j.ajhg.2019.02.024			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HR9JE	30951674	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000463474700001
J	Harms, FL; Kloth, K; Bley, A; Denecke, J; Santer, R; Lessel, D; Hempel, M; Kutsche, K				Harms, Frederike L.; Kloth, Katja; Bley, Annette; Denecke, Jonas; Santer, Rene; Lessel, Davor; Hempel, Maja; Kutsche, Kerstin			Activating Mutations in PAK1, Encoding p21-Activated Kinase 1, Cause a Neurodevelopmental Disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							REGULATES SPINE MORPHOGENESIS; INTELLECTUAL DISABILITY; MENTAL-RETARDATION; PROTEIN-KINASE; PATHWAY; PHENOTYPES; CDC42; GENE; CONFORMATION; REVEALS	p21-activated kinases (PAKs) are serine/threonine protein kinases acting as effectors of CDC42 and RAC, which are members of the RHO family of small GTPases. PAK1's kinase activity is autoinhibited by homodimerization, whereas CDC42 or RAC1 binding causes PAK1 activation by dimer dissociation. Major functions of the PAKs include actin cytoskeleton reorganization, for example regulation of the cellular protruding activity during cell spreading. We report the de novo PAK1 mutations c.392A>G (p.Tyr131Cys) and c.1286A>G (p.Tyr429Cys) in two unrelated subjects with developmental delay, secondary macrocephaly, seizures, and ataxic gait. We identified enhanced phosphorylation of the PAK1 targets JNK and AKT in fibroblasts of one subject and of c-JUN in those of both subjects compared with control subjects. In fibroblasts of the two affected individuals, we observed a trend toward enhanced PAK1 kinase activity. By using co-immunoprecipitation and size-exclusion chromatography, we observed a significantly reduced dimerization for both PAK1 mutants compared with wild-type PAK1. These data demonstrate that the two PAK1 variants function as activating alleles. In a cell spreading assay, subject-derived fibroblasts showed significant enrichment in cells occupied by filopodia. Interestingly, application of the PAK1 inhibitor FRAX486 completely reversed this cellular phenotype. Together, our data reveal that dominantly acting, gain-of-function PAK1 mutations cause a neurodevelopmental phenotype with increased head circumference, possibly by a combined effect of defective homodimerization and enhanced kinase activity of PAK1. This condition, along with the developmental disorders associated with RAC1 and CDC42 missense mutations, highlight the importance of RHO GTPase members and effectors in neuronal development.	[Harms, Frederike L.; Kloth, Katja; Lessel, Davor; Hempel, Maja; Kutsche, Kerstin] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, D-20246 Hamburg, Germany; [Bley, Annette; Denecke, Jonas; Santer, Rene] Univ Med Ctr Hamburg Eppendorf, Dept Pediat, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Kutsche, K (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, D-20246 Hamburg, Germany.	kkutsche@uke.de	Lessel, Davor/ABD-6088-2021	Harms, Frederike Leonie/0000-0003-2610-0600; Lessel, Davor/0000-0003-4496-244X	Deutsche Forschungsgemeinschaft [KU 1240/10-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank all subjects and family members for their participation in this study; Sigrid Fuchs and Jennifer Kaiser for fibroblast cultures; Andre Friedrich for the immunoprecipitation protocol; Inka Jantke and Henrike Wilshusen for skillful technical assistance; Johannes Brand for help with size-exclusion chromatography; Yingzhou Edward Pan for help with the statistics; Hans-Jurgen Kreienkamp for technical advice and helpful discussion; and the Microscopy Imaging Facility at the University Medical Center Hamburg-Eppendorf (UMIF) for technical support. This work was supported by a grant from the Deutsche Forschungsgemeinschaft (KU 1240/10-1 to Kerstin Kutsche).	Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; [Anonymous], 2014, SMALL GTPASES; Asrar S, 2009, NEUROPHARMACOLOGY, V56, P73, DOI 10.1016/j.neuropharm.2008.06.055; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Brown JL, 1996, CURR BIOL, V6, P598, DOI 10.1016/S0960-9822(02)00546-8; Combeau G, 2012, J BIOL CHEM, V287, P30084, DOI 10.1074/jbc.M112.355073; Dolan BM, 2013, P NATL ACAD SCI USA, V110, P5671, DOI [10.1073/pnas.1219383110, 10.1073/pnas.1219353110]; Frost JA, 1996, MOL CELL BIOL, V16, P3707, DOI 10.1128/mcb.16.7.3707; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Goldsmith EJ, 2007, CHEM REV, V107, P5065, DOI 10.1021/cr068221w; Hayashi-Takagi A, 2014, P NATL ACAD SCI USA, V111, P6461, DOI 10.1073/pnas.1321109111; Hempel M, 2015, AM J HUM GENET, V97, P493, DOI 10.1016/j.ajhg.2015.08.003; Hertecant J, 2017, EUR J MED GENET, V60, P212, DOI 10.1016/j.ejmg.2017.01.004; Higuchi M, 2008, NAT CELL BIOL, V10, P1356, DOI 10.1038/ncb1795; Huang WN, 2011, MOL CELL BIOL, V31, P388, DOI 10.1128/MCB.00969-10; Kreis P, 2007, J BIOL CHEM, V282, P21497, DOI 10.1074/jbc.M703298200; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Lei M, 2005, STRUCTURE, V13, P769, DOI 10.1016/j.str.2005.03.007; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Magini P, 2014, HUM MOL GENET, V23, P3607, DOI 10.1093/hmg/ddu070; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Martinelli S, 2018, AM J HUM GENET, V102, P309, DOI 10.1016/j.ajhg.2017.12.015; Meng JS, 2005, J NEUROSCI, V25, P6641, DOI 10.1523/JNEUROSCI.0028-05.2005; Meng QH, 2011, PROTEIN CELL, V2, P889, DOI 10.1007/s13238-011-1113-3; Ng YW, 2010, STRUCTURE, V18, P879, DOI 10.1016/j.str.2010.04.011; Niemann S, 2008, NEUROLOGY, V70, P666, DOI 10.1212/01.wnl.0000271078.51280.17; Parrini MC, 2009, J BIOL CHEM, V284, P24133, DOI 10.1074/jbc.M109.015271; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Rane CK, 2019, SEMIN CANCER BIOL, V54, P40, DOI 10.1016/j.semcancer.2018.01.006; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Reijnders MRF, 2017, AM J HUM GENET, V101, P466, DOI 10.1016/j.ajhg.2017.08.007; Rosenberger G, 2003, HUM MOL GENET, V12, P155, DOI 10.1093/hmg/ddg019; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934; Zhou TJ, 2004, STRUCTURE, V12, P1891, DOI 10.1016/j.str.2004.07.021	36	30	31	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 4	2018	103	4					579	591		10.1016/j.ajhg.2018.09.005	http://dx.doi.org/10.1016/j.ajhg.2018.09.005			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GV7MS	30290153	Green Published, Bronze			2022-12-18	WOS:000446312200010
J	Martin, AR; Karczewski, KJ; Kerminen, S; Kurki, MI; Sarin, AP; Artomov, M; Eriksson, JG; Esko, T; Genovese, G; Havulinna, AS; Kaprio, J; Konradi, A; Koranyi, L; Kostareva, A; Mannikko, M; Metspalu, A; Perola, M; Prasad, RB; Raitakari, O; Rotar, O; Salomaa, V; Groop, L; Palotie, A; Neale, BM; Ripatti, S; Pirinen, M; Daly, MJ				Martin, Alicia R.; Karczewski, Konrad J.; Kerminen, Sini; Kurki, Mitja I.; Sarin, Antti-Pekka; Artomov, Mykyta; Eriksson, Johan G.; Esko, Tonu; Genovese, Giulio; Havulinna, Aki S.; Kaprio, Jaakko; Konradi, Alexandra; Koranyi, Laszlo; Kostareva, Anna; Mannikko, Minna; Metspalu, Andres; Perola, Markus; Prasad, Rashmi B.; Raitakari, Olli; Rotar, Oxana; Salomaa, Veikko; Groop, Leif; Palotie, Aarno; Neale, Benjamin M.; Ripatti, Samuli; Pirinen, Matti; Daly, Mark J.			Haplotype Sharing Provides Insights into Fine-Scale Population History and Disease in Finland	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE PATTERNS; CARDIOVASCULAR RISK; GENETIC-STRUCTURE; WHOLE-GENOME; IDENTITY; DESCENT; RARE; VARIANT; REVEALS; ORIGIN	Finland provides unique opportunities to investigate population and medical genomics because of its adoption of unified national electronic health records, detailed historical and birth records, and serial population bottlenecks. We assembled a comprehensive view of recent population history (<= 100 generations), the timespan during which most rare-disease-causing alleles arose, by comparing pairwise haplotype sharing from 43,254 Finns to that of 16,060 Swedes, Estonians, Russians, and Hungarians from geographically and linguistically adjacent countries with different population histories. We find much more extensive sharing in Finns, with at least one >= 5 cM tract on average between pairs of unrelated individuals. By coupling haplotype sharing with fine-scale birth records from more than 25,000 individuals, we find that although haplotype sharing broadly decays with geographical distance, there are pockets of excess haplotype sharing; individuals from northeast Finland typically share several-fold more of their genome in identity-by-descent segments than individuals from southwest regions. We estimate recent effective population-size changes through time across regions of Finland, and we find that there was more continuous gene flow as Finns migrated from southwest to northeast between the early- and late-settlement regions than was dichotomously described previously. Lastly, we show that haplotype sharing is locally enriched by an order of magnitude among pairs of individuals sharing rare alleles and especially among pairs sharing rare disease-causing variants. Our work provides a general framework for using haplotype sharing to reconstruct an integrative view of recent population history and gain insight into the evolutionary origins of rare variants contributing to disease.	[Martin, Alicia R.; Karczewski, Konrad J.; Kurki, Mitja I.; Artomov, Mykyta; Neale, Benjamin M.; Daly, Mark J.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Martin, Alicia R.; Karczewski, Konrad J.; Kurki, Mitja I.; Artomov, Mykyta; Esko, Tonu; Genovese, Giulio; Palotie, Aarno; Neale, Benjamin M.; Daly, Mark J.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Martin, Alicia R.; Kurki, Mitja I.; Artomov, Mykyta; Genovese, Giulio; Palotie, Aarno; Neale, Benjamin M.; Daly, Mark J.] Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Kerminen, Sini; Kurki, Mitja I.; Sarin, Antti-Pekka; Havulinna, Aki S.; Kaprio, Jaakko; Perola, Markus; Groop, Leif; Palotie, Aarno; Ripatti, Samuli; Pirinen, Matti; Daly, Mark J.] Univ Helsinki, Inst Mol Med Finland FIMM, FIN-00014 Helsinki, Finland; [Kurki, Mitja I.; Palotie, Aarno] Massachusetts Gen Hosp, Dept Psychiat, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Sarin, Antti-Pekka; Eriksson, Johan G.; Havulinna, Aki S.; Salomaa, Veikko] Natl Inst Hlth & Welf Finland, Helsinki 00271, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki 00290, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, FIN-00014 Helsinki, Finland; [Eriksson, Johan G.] Helsinki Univ Hosp, Helsinki 00014, Finland; [Esko, Tonu; Metspalu, Andres; Perola, Markus] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Kaprio, Jaakko; Ripatti, Samuli; Pirinen, Matti] Univ Helsinki, Dept Publ Hlth, FIN-00014 Helsinki, Finland; [Konradi, Alexandra; Kostareva, Anna; Rotar, Oxana] Almazov Natl Med Res Ctr, St Petersburg 197341, Russia; [Konradi, Alexandra; Kostareva, Anna] Natl Res Univ Informat Technol Mech & Opt, St Petersburg 197101, Russia; [Koranyi, Laszlo] Drug Res Ctr, Heart Ctr Fdn, H-8230 Balatonfured, Hungary; [Mannikko, Minna] Univ Oulu, Fac Med, Ctr Life Course Hlth Res, Oulu 90014, Finland; [Perola, Markus; Raitakari, Olli] Univ Turku, Turku Univ Hosp, Res Ctr Appl & Prevent Cardiovasc Med, FIN-20520 Turku, Finland; [Raitakari, Olli] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, FIN-20520 Turku, Finland; [Prasad, Rashmi B.; Groop, Leif] Lund Univ, Skane Univ Hosp Malmo, Lund Univ CRC, Diabet Ctr,Dept Clin Sci, SE-20502 Malmo, Sweden; [Pirinen, Matti] Univ Helsinki, Helsinki Inst Informat Technol, FIN-00014 Helsinki, Finland; [Pirinen, Matti] Univ Helsinki, Dept Math & Stat, FIN-00014 Helsinki, Finland	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Helsinki; Harvard University; Massachusetts General Hospital; Folkhalsan Research Center; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Tartu; University of Helsinki; Almazov National Medical Research Centre; ITMO University; University of Oulu; University of Turku; University of Turku; Lund University; Skane University Hospital; University of Helsinki; University of Helsinki	Martin, AR; Daly, MJ (corresponding author), Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA.; Martin, AR; Daly, MJ (corresponding author), Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA.; Martin, AR; Daly, MJ (corresponding author), Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA.; Daly, MJ (corresponding author), Univ Helsinki, Inst Mol Med Finland FIMM, FIN-00014 Helsinki, Finland.	armartin@broadinstitute.org; mjdaly@broadinstitute.org	Kurki, Mitja/GWM-5671-2022; Prasad, Rashmi/Y-4276-2019; Prasad, Rashmi B/D-7067-2017; Kaprio, Jaakko/A-1820-2008; Raitakari, Olli/AAQ-7389-2021; Konradi, Alexandra/AAN-6815-2021; Havulinna, Aki/AAM-4769-2021; Rotar, Oxana/AAZ-6232-2020; Daly, Mark J/B-2453-2017; Artomov, Mykyta/K-7768-2019; Kostareva, Anna/AAO-5429-2020; Prasad, Rashmi B/GRJ-5491-2022	Prasad, Rashmi B/0000-0002-4400-6741; Kaprio, Jaakko/0000-0002-3716-2455; Konradi, Alexandra/0000-0001-8169-7812; Daly, Mark J/0000-0002-0949-8752; Artomov, Mykyta/0000-0001-5282-8764; Prasad, Rashmi B/0000-0002-4400-6741; Pirinen, Matti/0000-0002-1664-1350; Kerminen, Sini/0000-0001-6361-6759; Palotie, Aarno/0000-0002-2527-5874; Koranyi, Laszlo/0000-0002-5733-9350	NIMH [R01 MH077139]; Estonian Research Council [PUT1660]; Russian Science Foundation [17-15-01177]; National Human Genome Research Institute [5U54HG003079]; European Foundation for the Study of Diabetes (EFSD) New Horizons Programme; EFSD/Novo Nordisk; Academy of Finland Center of Excellence in Complex Disease Genetics [312063, 312074, 312062]; Academy of Finland [263401, 267 882, 286500, 265240, 263278, 285380]; Sigrid Juselius Foundation; Finnish Foundation for Cardiovascular Research; Nordic Information for Action eScience Center [62721]; 7th Research and Innovation Framework Programme [602633]; Horizon Research and Innovation Programme [667301, 692145]; Biocentrum Helsinki; University of Helsinki HiLIFE Fellow grant; National Institutes of Health [R01HL113315-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113315] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, R01DK075787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH109528, R01MH077139] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Estonian Research Council(Estonian Research Council); Russian Science Foundation(Russian Science Foundation (RSF)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); European Foundation for the Study of Diabetes (EFSD) New Horizons Programme; EFSD/Novo Nordisk(Novo Nordisk); Academy of Finland Center of Excellence in Complex Disease Genetics(Academy of Finland); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Foundation for Cardiovascular Research; Nordic Information for Action eScience Center; 7th Research and Innovation Framework Programme; Horizon Research and Innovation Programme; Biocentrum Helsinki; University of Helsinki HiLIFE Fellow grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Thanks to the participants in the Finnish cohort studies. Thanks to the sequencing centers at Washington University, the Broad Institute, and the UK10K project for generation and deposition of exome sequencing data from FINRISK and other Finnish cohorts. We thank Eimear Kenny and Gillian Belbin for helpful discussions and Cotton Seed and Tim Poterba for helping to scale computational analyses. The Sweden Schizophrenia Study was supported by NIMH grant R01 MH077139. The Estonian Biobank was funded by an Estonian Research Council personal research grant (PUT1660). This research was supported by the Russian Science Foundation (17-15-01177); the National Human Genome Research Institute (5U54HG003079); the European Foundation for the Study of Diabetes (EFSD) New Horizons Programme (L.G. and L.K.); an EFSD/Novo Nordisk grant to R.B.P.; the Academy of Finland Center of Excellence in Complex Disease Genetics (grant 312063 to L.G., 312074 to A.P., and 312062 to S.R.); the Academy of Finland (grants 263401 and 267 882 to L.G.; 286500 to A.P.; 265240 and 263278 to J.K.; and 285380 to S.R.); the Sigrid Juselius Foundation (A.P., L.G., and S.R.); the Finnish Foundation for Cardiovascular Research (A.P. and S.R.); the Nordic Information for Action eScience Center (62721 to A.P.); the 7th Research and Innovation Framework Programme (602633 to A.P.) (EUROHEADPAIN); and the Horizon 2020 Research and Innovation Programme (667301 to A.P. [COSYN] and 692145 to S.R. [ePerMed]); Biocentrum Helsinki (S.R.); University of Helsinki HiLIFE Fellow grant (S.R.); and the National Institutes of Health (R01HL113315-01 to A.P. and S.R.). M.J.D. is on the scientific advisory board of Ancestry DNA.	Abraham G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093766; Atzmon G, 2010, AM J HUM GENET, V86, P850, DOI 10.1016/j.ajhg.2010.04.015; Baharian S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006059; Behar DM, 2013, HUM BIOL, V85, P859, DOI 10.3378/027.085.0604; Belbin GM, 2017, ELIFE, V6, DOI 10.7554/eLife.25060; Bonnen PE, 2006, NAT GENET, V38, P214, DOI 10.1038/ng1712; Borodulin K, 2015, EUR J PUBLIC HEALTH, V25, P539, DOI 10.1093/eurpub/cku174; Botigue LR, 2013, P NATL ACAD SCI USA, V110, P11791, DOI 10.1073/pnas.1306223110; Browning BL, 2013, AM J HUM GENET, V93, P840, DOI 10.1016/j.ajhg.2013.09.014; Browning SR, 2015, AM J HUM GENET, V97, P404, DOI 10.1016/j.ajhg.2015.07.012; Browning SR, 2013, HUM GENET, V132, P129, DOI 10.1007/s00439-012-1230-y; Browning SR, 2012, GENETICS, V190, P1521, DOI 10.1534/genetics.111.136937; Campbell CL, 2012, P NATL ACAD SCI USA, V109, P13865, DOI 10.1073/pnas.1204840109; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Evans L., 2017, BIORXIV, DOI DOI 10.1101/164848; Fiorito G, 2016, EUR J HUM GENET, V24, P1056, DOI 10.1038/ejhg.2015.233; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gamsiz ED, 2013, AM J HUM GENET, V93, P103, DOI 10.1016/j.ajhg.2013.06.004; Gauvin H, 2014, EUR J HUM GENET, V22, P814, DOI 10.1038/ejhg.2013.227; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gilbert E, 2017, SCI REP-UK, V7, DOI 10.1038/srep42187; Glodzik D, 2013, EUR J HUM GENET, V21, P1140, DOI 10.1038/ejhg.2012.307; Gravel S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004023; Gunther T, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003703; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Haller T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170325; Han EJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14238; Henn BM, 2016, P NATL ACAD SCI USA, V113, pE440, DOI 10.1073/pnas.1510805112; Homburger JR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005602; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; Joshi PK, 2015, NATURE, V523, P459, DOI 10.1038/nature14618; Kerminen S, 2017, G3-GENES GENOM GENET, V7, P3459, DOI 10.1534/g3.117.300217; Kiezun A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003301; Kittles RA, 1998, AM J HUM GENET, V62, P1171, DOI 10.1086/301831; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Lahtinen AM, 2015, ATHEROSCLEROSIS, V238, P64, DOI 10.1016/j.atherosclerosis.2014.11.015; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Leslie S, 2015, NATURE, V519, P309, DOI 10.1038/nature14230; Lim ET, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004494; Loh PR, 2016, NAT GENET, V48, P811, DOI 10.1038/ng.3571; Lohmueller KE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004379; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Mathias RA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12522; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; Moorjani P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058633; Moreno-Estrada A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003925; Nakatsuka N, 2017, NAT GENET, V49, P1403, DOI 10.1038/ng.3917; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Palamara PF, 2012, AM J HUM GENET, V91, P809, DOI 10.1016/j.ajhg.2012.08.030; Palo JU, 2009, EUR J HUM GENET, V17, P1336, DOI 10.1038/ejhg.2009.53; Panoutsopoulou K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6345; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913; Petkova D, 2016, NAT GENET, V48, P94, DOI 10.1038/ng.3464; Poznik GD, 2016, NAT GENET, V48, P593, DOI 10.1038/ng.3559; Prasad RB, 2016, DIABETOLOGIA, V59, P1702, DOI 10.1007/s00125-016-3973-9; Ralph P, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001555; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Rasmussen MD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004342; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Rivas MA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12342; Rotar O, 2015, J HYPERTENS, V33, P1772, DOI 10.1097/HJH.0000000000000640; Sajantila A, 1996, P NATL ACAD SCI USA, V93, P12035, DOI 10.1073/pnas.93.21.12035; Salmela E, 2012, THESIS; Salmela E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003519; Sousa V, 2013, NAT REV GENET, V14, P404, DOI 10.1038/nrg3446; Stoll G, 2013, NAT NEUROSCI, V16, P1228, DOI 10.1038/nn.3484; Surakka I, 2015, NAT GENET, V47, P589, DOI 10.1038/ng.3300; Szpiech ZA, 2013, AM J HUM GENET, V93, P90, DOI 10.1016/j.ajhg.2013.05.003; Tallavaara M, 2010, J ARCHAEOL SCI, V37, P251, DOI 10.1016/j.jas.2009.09.035; Tremblay M, 2000, AM J HUM GENET, V66, P651, DOI 10.1086/302770; Vacic V, 2014, HUM MOL GENET, V23, P4693, DOI 10.1093/hmg/ddu158; Wang SR, 2014, AM J HUM GENET, V94, P710, DOI 10.1016/j.ajhg.2014.03.019; Zaitlen N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003520; Zhang QS, 2015, EUR J HUM GENET, V23, P672, DOI 10.1038/ejhg.2014.105; Zidan J, 2015, EUR J HUM GENET, V23, P1093, DOI 10.1038/ejhg.2014.218; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	81	30	30	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 3	2018	102	5					760	775		10.1016/j.ajhg.2018.03.003	http://dx.doi.org/10.1016/j.ajhg.2018.03.003			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG1IH	29706349	Green Submitted, Bronze, Green Published			2022-12-18	WOS:000432440100004
J	Olson, HE; Jean-Marcais, N; Yang, E; Heron, D; Tatton-Brown, K; van der Zwaag, PA; Bijlsma, EK; Krock, BL; Backer, E; Kamsteeg, EJ; Sinnema, M; Reijnders, MRF; Bearden, D; Begtrup, A; Telegrafi, A; Lunsing, RJ; Burglen, L; Lesca, G; Cho, MT; Smith, LA; Sheidley, BR; El Achkar, CM; Pearl, PL; Poduri, A; Skraban, CM; Tarpinian, J; Nesbitt, AI; van de Putte, DEF; Ruivenkamp, CAL; Rump, P; Chatron, N; Sabatier, I; De Bellescize, J; Guibaud, L; Sweetser, DA; Waxler, JL; Wierenga, KJ; Donadieu, J; Narayanan, V; Ramsey, KM; Nava, C; Riviere, JB; Vitobello, A; Mau-Them, FT; Philippe, C; Bruel, AL; Duffourd, Y; Thomas, L; Lelieveld, SH; Schuurs-Hoeijmakers, J; Brunner, HG; Keren, B; Thevenon, J; Faivre, L; Thomas, G; Thauvin-Robinet, C				Olson, Heather E.; Jean-Marcais, Nolwenn; Yang, Edward; Heron, Delphine; Tatton-Brown, Katrina; van der Zwaag, Paul A.; Bijlsma, Emilia K.; Krock, Bryan L.; Backer, E.; Kamsteeg, Erik-Jan; Sinnema, Margje; Reijnders, Margot R. F.; Bearden, David; Begtrup, Amber; Telegrafi, Aida; Lunsing, Roelineke J.; Burglen, Lydie; Lesca, Gaetan; Cho, Megan T.; Smith, Lacey A.; Sheidley, Beth R.; El Achkar, Christelle Moufawad; Pearl, Phillip L.; Poduri, Annapurna; Skraban, Cara M.; Tarpinian, Jennifer; Nesbitt, Addie I.; van de Putte, Dietje E. Fransen; Ruivenkamp, Claudia A. L.; Rump, Patrick; Chatron, Nicolas; Sabatier, Isabelle; De Bellescize, Julitta; Guibaud, Laurent; Sweetser, David A.; Waxler, Jessica L.; Wierenga, Klaas J.; Donadieu, Jean; Narayanan, Vinodh; Ramsey, Keri M.; Nava, Caroline; Riviere, Jean-Baptiste; Vitobello, Antonio; Mau-Them, Frederic Tran; Philippe, Christophe; Bruel, Ange-Line; Duffourd, Yannis; Thomas, Laurel; Lelieveld, Stefan H.; Schuurs-Hoeijmakers, Janneke; Brunner, Han G.; Keren, Boris; Thevenon, Julien; Faivre, Laurence; Thomas, Gary; Thauvin-Robinet, Christel		DDD Study; C4RCD Res Grp	A Recurrent De Novo PACS2 Heterozygous Missense Variant Causes Neonatal-Onset Developmental Epileptic Encephalopathy, Facial Dysmorphism, and Cerebellar Dysgenesis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTELLECTUAL DISABILITY; MENDELIAN DISORDERS; CLINICAL EPILEPSY; MUTATIONS; DISEASE; APOPTOSIS; PHENOTYPE; DIAGNOSIS; PROTEINS; GENETICS	Developmental and epileptic encephalopathies (DEEs) represent a large clinical and genetic heterogeneous group of neurodevelopmental diseases. The identification of pathogenic genetic variants in DEEs remains crucial for deciphering this complex group and for accurately caring for affected individuals (clinical diagnosis, genetic counseling, impacting medical, precision therapy, clinical trials, etc.). Whole-exome sequencing and intensive data sharing identified a recurrent de novo PACS2 heterozygous missense variant in 14 unrelated individuals. Their phenotype was characterized by epilepsy, global developmental delay with or without autism, common cerebellar dysgenesis, and facial dysmorphism. Mixed focal and generalized epilepsy occurred in the neonatal period, controlled with difficulty in the first year, but many improved in early childhood. PACS2 is an important PACS1 paralog and encodes a multifunctional sorting protein involved in nuclear gene expression and pathway traffic regulation. Both proteins harbor cargo(furin)-binding regions (FBRs) that bind cargo proteins, sorting adaptors, and cellular kinase. Compared to the defined PACS1 recurrent variant series, individuals with PACS2 variant have more consistently neonatal/early-infantile-onset epilepsy that can be challenging to control. Cerebellar abnormalities may be similar but PACS2 individuals exhibit a pattern of clear dysgenesis ranging from mild to severe. Functional studies demonstrated that the PACS2 recurrent variant reduces the ability of the predicted autoregulatory domain to modulate the interaction between the PACS2 FBR and client proteins, which may disturb cellular function. These findings support the causality of this recurrent de novo PACS2 heterozygous missense in DEE5 with facial dysmorphim and cerebellar dysgenesis.	[Olson, Heather E.; Smith, Lacey A.; Sheidley, Beth R.; El Achkar, Christelle Moufawad; Pearl, Phillip L.; Poduri, Annapurna] Boston Childrens Hosp, Epilepsy Genet Program, Dept Neurol, Div Epilepsy & Clin Neurophysiol, Boston, MA 02115 USA; [Jean-Marcais, Nolwenn; Thevenon, Julien; Faivre, Laurence; Thauvin-Robinet, Christel] CHU Dijon Bourgogne, Ctr Reference Deficiences Intellectuelles Causes, Ctr Genet Med, F-21079 Dijon, France; [Jean-Marcais, Nolwenn; Riviere, Jean-Baptiste; Vitobello, Antonio; Mau-Them, Frederic Tran; Philippe, Christophe; Bruel, Ange-Line; Duffourd, Yannis; Thevenon, Julien; Faivre, Laurence; Thauvin-Robinet, Christel] CHU Dijon Bourgogne, Fed Hosp Univ, Med Translat & Anomalies Dev TRANSLAD, F-21079 Dijon, France; [Yang, Edward] Boston Childrens Hosp, Dept Radiol, Boston, MA 02115 USA; [Heron, Delphine] Hop La Pitie Salpetriere, AP HP, Dept Genet, F-75013 Paris, France; [Heron, Delphine] Ctr Reference Deficiences Intellectuelles Causes, F-75013 Paris, France; [Heron, Delphine] UPMC, Grp Rech Clin GRC Deficience Intellectuelle & Aut, F-75013 Paris, France; [Tatton-Brown, Katrina] St Georges Univ London, London, England; [Tatton-Brown, Katrina] St Georges Univ NHS Fdn Trust, South West Thames Reg Genet Serv, London SW17 0RE, England; [van der Zwaag, Paul A.; Rump, Patrick] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Bijlsma, Emilia K.; van de Putte, Dietje E. Fransen; Ruivenkamp, Claudia A. L.] Leiden Univ, Med Ctr, Dept Clin Genet, NL-2333 ZA Leiden, Netherlands; [Krock, Bryan L.; Telegrafi, Aida; Nesbitt, Addie I.] Childrens Hosp Philadelphia, Dept Pathol, Philadelphia, PA 19104 USA; [Krock, Bryan L.; Telegrafi, Aida; Nesbitt, Addie I.] Childrens Hosp Philadelphia, Div Genom Diagnost, Lab Med, Philadelphia, PA 19104 USA; [Krock, Bryan L.; Telegrafi, Aida; Nesbitt, Addie I.] Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA; [Krock, Bryan L.; Telegrafi, Aida; Nesbitt, Addie I.] Univ Penn, Perelman Sch Med, Lab Med, Philadelphia, PA 19104 USA; [Backer, E.] St Marys Hosp, Cent Manchester Univ Hosp, NHS Fdn Trust, Manchester Ctr Genom Med,Genom Diagnost Lab, Manchester M13 9WL, Lancs, England; [Kamsteeg, Erik-Jan; Reijnders, Margot R. F.; Lelieveld, Stefan H.; Schuurs-Hoeijmakers, Janneke; Brunner, Han G.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Kamsteeg, Erik-Jan; Reijnders, Margot R. F.; Brunner, Han G.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands; [Sinnema, Margje; Brunner, Han G.] Maastricht Univ, Med Ctr, Dept Clin Genet, NL-6229 ER Maastricht, Netherlands; [Sinnema, Margje; Brunner, Han G.] Maastricht Univ, Med Ctr, Sch Oncol & Dev Biol GROW, NL-6229 ER Maastricht, Netherlands; [Bearden, David] Univ Rochester, Sch Med, Dept Neurol, Div Child Neurol, Rochester, NY 14642 USA; [Begtrup, Amber; Telegrafi, Aida; Cho, Megan T.] GeneDx program, Gaithersburg, MD 20877 USA; [Lunsing, Roelineke J.] Univ Groningen, Univ Med Ctr Groningen, Dept Child Neurol, NL-9713 GZ Groningen, Netherlands; [Burglen, Lydie] Hop Trousseau, AP HP, Ctr Reference Maladies Rares Malformat & Maladies, Dept Genet Med,GHUEP, F-75012 Paris, France; [Burglen, Lydie] UPMC Univ 06, Sorbonne Univ, GRC ConCer LD, F-75019 Paris, France; [Burglen, Lydie] Univ Paris Diderot, INSERM, U1141, F-75019 Paris, France; [Lesca, Gaetan; Chatron, Nicolas] Lyon Univ Hosp, Dept Med Genet, F-69677 Lyon, France; [Lesca, Gaetan; Chatron, Nicolas] CNRS, INSERM, UMR 5292, U1028 CNRL, F-69500 Lyon, France; [Lesca, Gaetan; Chatron, Nicolas] Univ Claude Bernard Lyon 1, GHE, F-69100 Lyon, France; [Skraban, Cara M.; Tarpinian, Jennifer] Childrens Hosp Philadelphia, Div Genet, Philadelphia, PA 19104 USA; [Skraban, Cara M.; Tarpinian, Jennifer] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Sabatier, Isabelle] Lyon Univ Hosp, Dept Pediat Neurol, F-69677 Lyon, France; [De Bellescize, Julitta] Lyon Univ Hosp, Dept Clin Epileptol Sleep & Funct Neurol Children, F-69677 Lyon, France; [Guibaud, Laurent] Univ Claude Bernard Lyon 1, CHU Lyon, F-69677 Lyon, France; [Guibaud, Laurent] Hosp Civils Lyon, Hop Femme Mere Enfant, Serv Radiol, F-69677 Lyon, France; [Sweetser, David A.; Waxler, Jessica L.] MassGeneral Hosp Children, Dept Pediat & Metab, Div Med Genet, Boston, MA 02114 USA; [Wierenga, Klaas J.] OUHSC, Dept Pediat, Oklahoma City, OK 73104 USA; [Donadieu, Jean] Hop Trousseau, AP HP, Serv Hemato Oncol Pediatr, F-75012 Paris, France; [Narayanan, Vinodh; Ramsey, Keri M.] Translat Genom Res Inst TGen, Ctr Rare Childhood Disorders, Phoenix, AZ 85004 USA; [Nava, Caroline; Keren, Boris] Hop La Pitie Salpetriere, AP HP, Dept Genet, F-75013 Paris, France; [Nava, Caroline; Keren, Boris] CNRS, INSERM, UPMC, UM 75,U 1127,UMR 7225,ICM, F-75013 Paris, France; [Riviere, Jean-Baptiste; Vitobello, Antonio; Mau-Them, Frederic Tran; Philippe, Christophe; Bruel, Ange-Line; Duffourd, Yannis; Thevenon, Julien; Faivre, Laurence; Thauvin-Robinet, Christel] Univ Bourgogne, INSERM, UMR1231 GAD, Genet Anomalies Dev, F-21079 Dijon, France; [Thomas, Laurel; Thomas, Gary] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA; [Thomas, Laurel; Thomas, Gary] Univ Pittsburgh, Canc Inst, Sch Med, Pittsburgh, PA 15219 USA; [Lelieveld, Stefan H.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, NL-6500 HB Nijmegen, Netherlands	Harvard University; Boston Children's Hospital; CHU Dijon Bourgogne; CHU Dijon Bourgogne; Harvard University; Boston Children's Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; St Georges University London; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Oxford University Hospitals NHS Foundation Trust; University of Manchester; Radboud University Nijmegen; Radboud University Nijmegen; Maastricht University; Maastricht University; University of Rochester; University of Groningen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; CHU Lyon; CHU Lyon; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; University of Oklahoma System; University of Oklahoma Health Sciences Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Translational Genomics Research Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Radboud University Nijmegen	Thauvin-Robinet, C (corresponding author), CHU Dijon Bourgogne, Ctr Reference Deficiences Intellectuelles Causes, Ctr Genet Med, F-21079 Dijon, France.; Thauvin-Robinet, C (corresponding author), CHU Dijon Bourgogne, Fed Hosp Univ, Med Translat & Anomalies Dev TRANSLAD, F-21079 Dijon, France.; Thauvin-Robinet, C (corresponding author), Univ Bourgogne, INSERM, UMR1231 GAD, Genet Anomalies Dev, F-21079 Dijon, France.	christel.thauvin@chu-dijon.fr	Lesca, Gaetan/C-6111-2019; Vitobello, Antonio/ABC-2970-2021; CHATRON, Nicolas/J-2770-2019; Sweetser, David/ABB-9347-2021; Yang, Edward/Q-8175-2019	Vitobello, Antonio/0000-0003-3717-8374; CHATRON, Nicolas/0000-0003-0538-0981; Sweetser, David/0000-0002-1621-3284; Lesca, Gaetan/0000-0001-7691-9492; Faivre, Laurence/0000-0001-9770-444X; Tran Mau Them, Frederic/0000-0002-3795-9456; PHILIPPE, Christophe/0000-0001-7098-6520; Nava, Caroline/0000-0003-1272-0518	Regional Council of Burgundy / Dijon University hospital (PARI); French Ministry of Health (PHRC) [2013-A00103-42]; NIH [R01 CA151564, DK112844, DK114855]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA151564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK112844, R01DK114855] Funding Source: NIH RePORTER	Regional Council of Burgundy / Dijon University hospital (PARI); French Ministry of Health (PHRC); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the affected individuals and their families involved in the study and the University of Burgundy Centre de Calcul (CCuB, see Web Resources) for technical support and management of the informatics platform. The authors also thank the Genome Aggregation Database (gnomAD) and the groups that provided exome and genome variant data to this resource. A full list of contributing groups can be found at http://gnomad.broadinstitute.org/about. We thank the Integragen society and CNG for exome analysis. pTRPV1/f was a gift from D. Julius and pHDAC1/f was a gift from E. Verdin (Addgene #13820). We also thank P. Narvakar and S. Luan for assistance. The authors acknowledge the contributions of all members (current and past) of The C4RCD Research Group. This work was funded by the Regional Council of Burgundy / Dijon University hospital (PARI 2013), the French Ministry of Health (PHRC No 2013-A00103-42), and NIH (grants R01 CA151564, DK112844, and DK114855).	Allen NM, 2016, EPILEPSIA, V57, pE12, DOI 10.1111/epi.13250; Asher YJT, 2012, EUR J MED GENET, V55, P299, DOI 10.1016/j.ejmg.2012.04.002; Aslan JE, 2009, MOL CELL, V34, P497, DOI 10.1016/j.molcel.2009.04.011; Assoum M, 2016, AM J HUM GENET, V99, P1368, DOI 10.1016/j.ajhg.2016.10.009; Atkins KM, 2014, CELL REP, V8, P1545, DOI 10.1016/j.celrep.2014.07.049; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Barthelery NJ, 2016, TRENDS MOL MED, V22, P404, DOI 10.1016/j.molmed.2016.03.006; Berg AT, 2017, JAMA PEDIATR, V171, P863, DOI 10.1001/jamapediatrics.2017.1743; Biesecker LG, 2010, NAT GENET, V42, P13, DOI 10.1038/ng0110-13; Catterall WA, 2008, J NEUROSCI, V28, P11768, DOI 10.1523/JNEUROSCI.3901-08.2008; Eltze CM, 2013, EPILEPSIA, V54, P437, DOI 10.1111/epi.12046; EpiPM Consortium, 2016, LANCET NEUROL, V15, P241, DOI 10.1016/S1474-4422(15)00199-4; Gadzicki D, 2015, CLIN GENET, V88, P300, DOI 10.1111/cge.12544; Hardies K, 2016, EUR J HUM GENET, V24, P961, DOI 10.1038/ejhg.2015.251; Henshall DC, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a022731; Hoischen A, 2014, NAT NEUROSCI, V17, P764, DOI 10.1038/nn.3703; Holder JL, 2012, AM J MED GENET A, V158A, P1962, DOI 10.1002/ajmg.a.35289; Kambouris M, 2017, ANN CLIN TRANSL NEUR, V4, P26, DOI 10.1002/acn3.372; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; Lelieveld SH, 2017, AM J HUM GENET, V101, P478, DOI 10.1016/j.ajhg.2017.08.004; Lemke JR, 2012, EPILEPSIA, V53, P1387, DOI 10.1111/j.1528-1167.2012.03516.x; Marzban H, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00450; McTague A, 2016, LANCET NEUROL, V15, P304, DOI 10.1016/S1474-4422(15)00250-1; Mei D, 2017, MOL DIAGN THER, V21, P357, DOI 10.1007/s40291-017-0257-0; Mercimek-Mahmutoglu S, 2015, EPILEPSIA, V56, P707, DOI 10.1111/epi.12954; Moller RS, 2015, EXPERT REV MOL DIAGN, V15, P1531, DOI 10.1586/14737159.2015.1113132; Molloy SS, 1998, J CELL BIOL, V142, P1399, DOI 10.1083/jcb.142.6.1399; Myers CT, 2016, PROG BRAIN RES, V226, P35, DOI 10.1016/bs.pbr.2016.04.006; Olson H, 2014, ANN NEUROL, V75, P943, DOI 10.1002/ana.24178; Olson HE, 2017, ANN NEUROL, V81, P419, DOI 10.1002/ana.24883; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Schermer B, 2005, EMBO J, V24, P4415, DOI 10.1038/sj.emboj.7600885; Schuurs-Hoeijmakers JHM, 2016, AM J MED GENET A, V170, P670, DOI 10.1002/ajmg.a.37476; Schuurs-Hoeijmakers JHM, 2012, AM J HUM GENET, V91, P1122, DOI 10.1016/j.ajhg.2012.10.013; Scott GK, 2003, EMBO J, V22, P6234, DOI 10.1093/emboj/cdg596; Sheidley BR, 2012, J PEDIATR EPILEPSY, V1, P135, DOI 10.3233/PEP-2012-023; Simmen T, 2005, EMBO J, V24, P717, DOI 10.1038/sj.emboj.7600559; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Thauvin-Robinet C, 2014, NAT GENET, V46, P905, DOI 10.1038/ng.3031; Thevenon J, 2016, CLIN GENET, V89, P700, DOI 10.1111/cge.12732; Thomas G, 2017, J CELL SCI, V130, P1865, DOI 10.1242/jcs.199463; Toyo-oka K, 2014, J NEUROSCI, V34, P12168, DOI 10.1523/JNEUROSCI.2513-13.2014; Trump N, 2016, J MED GENET, V53, P310, DOI 10.1136/jmedgenet-2015-103263; Urbanska M, 2012, J BIOL CHEM, V287, P30240, DOI 10.1074/jbc.M112.374405; Veeramah KR, 2013, EPILEPSIA, V54, P1270, DOI 10.1111/epi.12201; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; von Deimling M, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0720-7; Wan L, 1998, CELL, V94, P205, DOI 10.1016/S0092-8674(00)81420-8; Wang J, 2017, SEIZURE-EUR J EPILEP, V44, P11, DOI 10.1016/j.seizure.2016.11.030; Werneburg NW, 2012, J BIOL CHEM, V287, P24427, DOI 10.1074/jbc.M112.342238; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Youker RT, 2009, BIOCHEM J, V421, P1, DOI 10.1042/BJ20081016; Zollino M, 2009, AM J MED GENET A, V149A, P1116, DOI 10.1002/ajmg.a.32831	53	30	34	2	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 3	2018	102	5					995	1007		10.1016/j.ajhg.2018.03.005	http://dx.doi.org/10.1016/j.ajhg.2018.03.005			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG1IH	29656858	Bronze, Green Published			2022-12-18	WOS:000432440100020
J	Ng, BG; Xu, GG; Chandy, N; Steyermark, J; Shinde, DN; Radtke, K; Raymond, K; Lebrilla, CB; AlAsmari, A; Suchy, SF; Powis, Z; Faqeih, EA; Berry, SA; Kronn, DF; Freeze, HH				Ng, Bobby G.; Xu, Gege; Chandy, Nandini; Steyermark, Joan; Shinde, Deepali N.; Radtke, Kelly; Raymond, Kimiyo; Lebrilla, Carlito B.; AlAsmari, Ali; Suchy, Sharon F.; Powis, Zoe; Faqeih, Eissa Ali; Berry, Susan A.; Kronn, David F.; Freeze, Hudson H.			Biallelic Mutations in FUT8 Cause a Congenital Disorder of Glycosylation with Defective Fucosylation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GDP-FUCOSE TRANSPORTER; ALPHA-1,6-FUCOSYL-TRANSFERASE FUT8; CORE FUCOSYLATION; CELL-RECEPTOR; DEFICIENCY; MICE; EXPRESSION; ACTIVATION; PHENOTYPE; MECHANISM	Fucosyltransferase 8 (FUT8) encodes a Golgi-localized alpha 1,6 fucosyltransferase that is essential for transferring the monosaccharide fucose into N-linked glycoproteins, a process known as "core fucosylation.'' Here we describe three unrelated individuals, who presented with intrauterine growth retardation, severe developmental and growth delays with shortened limbs, neurological impairments, and respiratory complications. Each underwent whole-exome sequencing and was found to carry pathogenic variants in FUT8. The first individual (consanguineous family) was homozygous for c.715C>T(p.Arg239*), while the second (non-consanguineous family) was compound heterozygous for c.1009C> G(p.Arg337Gly) and a splice site variant c.1259thorn5G>T. The third individual (consanguineous family) was homozygous for a c.943C>T (p.Arg315*). Splicing analysis confirmed the c.1259thorn5G>T resulted in expression of an abnormal FUT8 transcript lacking exon 9. Functional studies using primary fibroblasts from two affected individuals revealed a complete lack of FUT8 protein expression that ultimately resulted in substantial deficiencies in total core fucosylated N-glycans. Furthermore, serum samples from all three individuals showed a complete loss of core fucosylation. Here, we show that loss of function mutations in FUT8 cause a congenital disorder of glycosylation (FUT8-CDG)characterized by defective core fucosylation that phenotypically parallels some aspects of the Fut8(-/-) knockout mouse. Importantly, identification of additional affected individuals can be easily achieved through analysis of core fucosylation of N-glycans.	[Ng, Bobby G.; Freeze, Hudson H.] Sanford Burnham Prebys Med Discovery Inst, Human Genet Program, La Jolla, CA 92037 USA; [Xu, Gege; Lebrilla, Carlito B.] Univ Calif Davis, Coll Letters & Sci, Dept Chem, Davis, CA 95616 USA; [Chandy, Nandini; Kronn, David F.] New York Med Coll, Dept Pediat, Valhalla, NY 10595 USA; [Steyermark, Joan; Berry, Susan A.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Steyermark, Joan; Berry, Susan A.] Univ Minnesota, Dept Genet, Minneapolis, MN 55455 USA; [Steyermark, Joan; Berry, Susan A.] Univ Minnesota, Dept Cell Biol & Dev, Minneapolis, MN 55455 USA; [Shinde, Deepali N.; Radtke, Kelly; Powis, Zoe] Ambry Genet, Aliso Viejo, CA 92656 USA; [Raymond, Kimiyo] Mayo Clin, Coll Med, Biochem Genet Lab, Rochester, MN 55905 USA; [AlAsmari, Ali; Faqeih, Eissa Ali] Childrens Hosp, King Fahad Med City, Dept Pediat Subspecialties, Sect Med Genet, Riyadh, Saudi Arabia; [Suchy, Sharon F.] GeneDx, Gaithersburg, MD 20877 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California Davis; New York Medical College; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; King Fahad Medical City	Freeze, HH (corresponding author), Sanford Burnham Prebys Med Discovery Inst, Human Genet Program, La Jolla, CA 92037 USA.	hudson@sbpdiscovery.org	Xu, Gege/AAC-5097-2019; Lebrilla, Carlito Bangeles/ABE-6369-2020	Xu, Gege/0000-0002-0792-2636; Berry, Susan/0000-0001-7970-688X	National Institutes of Health (NIH) [R01DK099551]; Rocket Fund; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049077] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rocket Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank the families for their participation in this study. The SBP Medical Discovery Institute FACS core. 12G10 anti-alpha-tubulin was deposited to the DSHB by J. Frankel and E.M. Nelsen (DSHB Hybridoma Product 12G10 anti-alpha-tubulin). Deepali N. Shinde, Kelly Radtke, and Zoe Powis are employed by Ambry Genetics. Sharon F. Suchy is employed by GeneDx, Inc., a wholly-owned subsidiary of OPKO Health, Inc. The Rocket Fund and National Institutes of Health (NIH) grant R01DK099551 supported this work.	Agrawal P, 2017, CANCER CELL, V31, P804, DOI 10.1016/j.ccell.2017.05.007; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Freeze HH, 2015, ANNU REV NEUROSCI, V38, P105, DOI 10.1146/annurev-neuro-071714-034019; Fujii H, 2016, GASTROENTEROLOGY, V150, P1620, DOI 10.1053/j.gastro.2016.03.002; Ihara H, 2007, GLYCOBIOLOGY, V17, P455, DOI 10.1093/glycob/cwl079; Ito Y, 2003, CANCER LETT, V200, P167, DOI 10.1016/S0304-3835(03)00383-5; Jaeken J, 2017, J INHERIT METAB DIS, V40, P569, DOI 10.1007/s10545-017-0050-6; Kotzler MP, 2012, BBA-GEN SUBJECTS, V1820, P1915, DOI 10.1016/j.bbagen.2012.08.018; Li M, 2013, AM J HUM GENET, V92, P895, DOI 10.1016/j.ajhg.2013.04.022; Li WZ, 2015, J IMMUNOL, V194, P2596, DOI 10.4049/jimmunol.1402678; Lubke T, 2001, NAT GENET, V28, P73, DOI 10.1038/88299; Luhn K, 2001, NAT GENET, V28, P69, DOI 10.1038/88289; Marquardt T, 1999, BLOOD, V94, P3976, DOI 10.1182/blood.V94.12.3976.424k06_3976_3985; OVERTON K, 1981, BIOCHIM BIOPHYS ACTA, V675, P281, DOI 10.1016/0304-4165(81)90238-5; Park DY, 2017, GLYCOBIOLOGY, V27, P847, DOI 10.1093/glycob/cwx041; Puglielli L, 1999, J BIOL CHEM, V274, P35596, DOI 10.1074/jbc.274.50.35596; Rombouts Y, 2016, GLYCOCONJUGATE J, V33, P457, DOI 10.1007/s10719-015-9648-9; Schneider M, 2017, GLYCOBIOLOGY, V27, P601, DOI 10.1093/glycob/cwx034; Smith PL, 2002, J CELL BIOL, V158, P801, DOI 10.1083/jcb.200203125; Song T, 2015, ANAL CHEM, V87, P7754, DOI 10.1021/acs.analchem.5b01340; Sparrow DB, 2006, AM J HUM GENET, V78, P28, DOI 10.1086/498879; Tateno H, 2009, GLYCOBIOLOGY, V19, P527, DOI 10.1093/glycob/cwp016; Ueda M, 2016, PANCREATOLOGY, V16, P238, DOI 10.1016/j.pan.2016.01.004; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang XC, 2009, J BIOCHEM, V145, P643, DOI 10.1093/jb/mvp022; Yakubenia S, 2008, BLOOD, V112, P1472, DOI 10.1182/blood-2008-01-132035; Yamane-Ohnuki N, 2004, BIOTECHNOL BIOENG, V87, P614, DOI 10.1002/bit.20151; YURCHENCO PD, 1975, BIOCHEMISTRY-US, V14, P3107, DOI 10.1021/bi00685a011; ZIELKE K, 1972, J EXP MED, V136, P197, DOI 10.1084/jem.136.1.197	29	30	30	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 4	2018	102	1					188	195		10.1016/j.ajhg.2017.12.009	http://dx.doi.org/10.1016/j.ajhg.2017.12.009			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FR8DU	29304374	Green Published, Bronze			2022-12-18	WOS:000419305500014
J	Marin-Valencia, I; Gerondopoulos, A; Zaki, MS; Ben-Omran, T; Almureikhi, M; Demir, E; Guemez-Gamboa, A; Gregor, A; Issa, MY; Appelhof, B; Roosing, S; Musaev, D; Rosti, B; Wirth, S; Stanley, V; Baas, F; Barr, FA; Gleeson, JG				Marin-Valencia, Isaac; Gerondopoulos, Andreas; Zaki, Maha S.; Ben-Omran, Tawfeg; Almureikhi, Mariam; Demir, Ercan; Guemez-Gamboa, Alicia; Gregor, Anne; Issa, Mahmoud Y.; Appelhof, Bart; Roosing, Susanne; Musaev, Damir; Rosti, Basak; Wirth, Sara; Stanley, Valentina; Baas, Frank; Barr, Francis A.; Gleeson, Joseph G.			Homozygous Mutations in TBC1D23 Lead to a Non-degenerative Form of Pontocerebellar Hypoplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GTPASE-ACTIVATING PROTEIN; CEREBELLAR DEVELOPMENT; BIALLELIC MUTATIONS; STRUCTURAL BASIS; RAB GTPASES; RECEPTOR; ARL1; GAPS; TRAFFICKING; MATURATION	Pontocerebellar hypoplasia (PCH) represents a group of recessive developmental disorders characterized by impaired growth of the pons and cerebellum, which frequently follows a degenerative course. Currently, there are 10 partially overlapping clinical subtypes and 13 genes known mutated in PCH. Here, we report biallelic TBC1D23 mutations in six individuals from four unrelated families manifesting a non-degenerative form of PCH. In addition to reduced volume of pons and cerebellum, affected individuals had microcephaly, psychomotor delay, and ataxia. In zebrafish, tbc1d23 morphants replicated the human phenotype showing hindbrain volume loss. TBC1D23 localized at the trans-Golgi and was regulated by the small GTPases Arl1 and Arl8, suggesting a role in trans-Golgi membrane trafficking. Altogether, this study provides a causative link between TBC1D23 mutations and PCH and suggests a less severe clinical course than other PCH subtypes.	[Marin-Valencia, Isaac; Guemez-Gamboa, Alicia; Gregor, Anne; Roosing, Susanne; Rosti, Basak; Gleeson, Joseph G.] Rockefeller Univ, Howard Hughes Med Inst, Lab Pediat Brain Dis, New York, NY 10065 USA; [Gerondopoulos, Andreas; Barr, Francis A.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Zaki, Maha S.; Issa, Mahmoud Y.] Natl Res Ctr, Human Genet & Genome Res Div, Clin Genet Dept, Cairo 12311, Egypt; [Ben-Omran, Tawfeg; Almureikhi, Mariam] Hamad Med Corp, Dept Pediat, Clin & Metab Genet, Doha 3050, Qatar; [Demir, Ercan] Gazi Univ, Dept Pediat Neurol, TR-06500 Ankara, Turkey; [Appelhof, Bart; Baas, Frank] Leiden Univ, Med Ctr, Dept Clin Genet, NL-2333 ZA Leiden, Netherlands; [Musaev, Damir; Rosti, Basak; Wirth, Sara; Stanley, Valentina; Gleeson, Joseph G.] Univ Calif San Diego, Rady Childrens Inst Genom Med, Howard Hughes Med Inst, Lab Pediat Brain Dis, San Diego, CA 92093 USA	Howard Hughes Medical Institute; Rockefeller University; University of Oxford; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Hamad Medical Corporation; Gazi University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Howard Hughes Medical Institute; University of California System; University of California San Diego	Gleeson, JG (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Pediat Brain Dis, New York, NY 10065 USA.; Gleeson, JG (corresponding author), Univ Calif San Diego, Rady Childrens Inst Genom Med, Howard Hughes Med Inst, Lab Pediat Brain Dis, San Diego, CA 92093 USA.	jogleeson@ucsd.edu	Baas, Frank/F-9574-2010; Zaki, Maha S/B-9361-2013; Roosing, Susanne/F-1616-2018; Roosing, Susanne/ABF-9604-2021; Demir, Ercan/CAA-1553-2022; Roosing, Susanne/AAK-3454-2020; Issa, Mahmoud/AAL-5118-2020	Baas, Frank/0000-0003-3912-5428; Roosing, Susanne/0000-0001-9038-0067; Roosing, Susanne/0000-0001-9038-0067; Roosing, Susanne/0000-0001-9038-0067; Issa, Mahmoud/0000-0002-3899-2821; Zaki, Maha/0000-0001-7840-0002; Guemez-Gamboa, Alicia/0000-0001-6890-4661	Center for Basic and Translational Research on Disorders of the Digestive System at The Rockefeller University through Leona M. and Harry B. Helmsley Charitable Trust; Broad Institute [U54HG003067, UM1HG008900]; Yale Center for Mendelian Disorders [U54HG006504]; NIH from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program [P01HD070494, 1R01NS098004, R01NS048453, R01NS052455, UL1TR001866]; Simons Foundation Autism Research Initiative [275275]; Howard Hughes Medical Institute; Qatar National Research Foundation NPRP [6-1463-3-351]; NIH [K99NS089943]; American Academy of Neurology Clinical Research Training Scholarship [2017-205]; Joshua Deeth Foundation; Wellcome Trust [097769/Z/11/Z]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070494] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001866] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006504, U54HG003067, UM1HG008900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS098004, R01NS048453, R01NS052455, K99NS089943, P30NS047101, R00NS089943] Funding Source: NIH RePORTER	Center for Basic and Translational Research on Disorders of the Digestive System at The Rockefeller University through Leona M. and Harry B. Helmsley Charitable Trust; Broad Institute; Yale Center for Mendelian Disorders; NIH from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program; Simons Foundation Autism Research Initiative; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Qatar National Research Foundation NPRP; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Academy of Neurology Clinical Research Training Scholarship; Joshua Deeth Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank all families for participation in this study. We thank Tessa van Dijk for coordinating data gathering from family 4572. Thanks to the Rockefeller and UCSD Microscopy Cores (P30 NS047101) for imaging support. I. M.-V. was sponsored by Pilot Grant awarded by the Center for Basic and Translational Research on Disorders of the Digestive System at The Rockefeller University through the generosity of the Leona M. and Harry B. Helmsley Charitable Trust. We thank the Broad Institute (U54HG003067 to E. Lander and UM1HG008900 to D. MacArthur) and the Yale Center for Mendelian Disorders (U54HG006504 to R. Lifton and M. Gunel). This work was supported by NIH grants P01HD070494, 1R01NS098004, R01NS048453, R01NS052455, and UL1TR001866 from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program, the Simons Foundation Autism Research Initiative (275275), Howard Hughes Medical Institute (to J.G.G.), Qatar National Research Foundation NPRP 6-1463-3-351 (to T.B.-O. and J.G.G.), NIH grant K99NS089943 (to A. G.-G.), American Academy of Neurology Clinical Research Training Scholarship 2017-205 (to I. M.-V.), Joshua Deeth Foundation (to F.B.), and a Wellcome Trust Senior Investigator Award 097769/Z/11/Z (to F.A.B.).	Akizu N, 2015, NAT GENET, V47, P528, DOI 10.1038/ng.3256; Akizu N, 2013, CELL, V154, P505, DOI 10.1016/j.cell.2013.07.005; [Anonymous], TITLE ERROR, DOI 10.1016/j.bbi.2019.12.019; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Bhoj EJ, 2016, AM J HUM GENET, V98, P782, DOI 10.1016/j.ajhg.2016.03.016; Brun R, 1917, SCHWEIZ ARCH NEUROL, V1, P61; Budde BS, 2008, NAT GENET, V40, P1113, DOI 10.1038/ng.204; Chong JX, 2016, AM J HUM GENET, V98, P772, DOI 10.1016/j.ajhg.2016.01.016; Corbett MA, 2010, AM J HUM GENET, V87, P371, DOI 10.1016/j.ajhg.2010.08.001; De Arras L, 2012, J IMMUNOL, V188, P2905, DOI 10.4049/jimmunol.1102595; Dixon-Salazar TJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003544; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; Falace A, 2014, P NATL ACAD SCI USA, V111, P2337, DOI 10.1073/pnas.1316294111; Falace A, 2010, AM J HUM GENET, V87, P365, DOI 10.1016/j.ajhg.2010.07.020; Frasa MAM, 2012, NAT REV MOL CELL BIO, V13, P67, DOI 10.1038/nrm3267; Fukuda M, 2011, BIOSCIENCE REP, V31, P159, DOI 10.1042/BSR20100112; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; Harripaul R., 2017, MOL PSYCHIAT; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Howard TL, 2001, J CELL SCI, V114, P2395; Hu Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149277; Lardelli RM, 2017, NAT GENET, V49, P457, DOI 10.1038/ng.3762; Liu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071349; Lu L, 2004, MOL BIOL CELL, V15, P4426, DOI 10.1091/mbc.E03-12-0872; Lu L, 2001, J CELL SCI, V114, P4543; Mochida GH, 2012, NAT GENET, V44, P1260, DOI 10.1038/ng.2425; Nakae I, 2010, MOL BIOL CELL, V21, P2434, DOI 10.1091/mbc.E09-12-1010; Namavar Y, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-50; Namavar Y, 2011, BRAIN, V134, P143, DOI 10.1093/brain/awq287; Ozcelik T, 2008, P NATL ACAD SCI USA, V105, P4232, DOI 10.1073/pnas.0804078105; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Panic B, 2003, MOL CELL, V12, P863, DOI 10.1016/S1097-2765(03)00356-3; Pu J, 2015, DEV CELL, V33, P176, DOI 10.1016/j.devcel.2015.02.011; Renbaum P, 2009, AM J HUM GENET, V85, P281, DOI 10.1016/j.ajhg.2009.07.006; Rudnik-Schoneborn S, 2014, AM J MED GENET C, V166, P173, DOI 10.1002/ajmg.c.31403; Schaffer AE, 2014, CELL, V157, P651, DOI 10.1016/j.cell.2014.03.049; Sonmez FM, 2013, J CHILD NEUROL, V28, P379, DOI 10.1177/0883073812441065; Stauffer DR, 2001, J CELL SCI, V114, P2383; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Wu MS, 2004, NAT STRUCT MOL BIOL, V11, P86, DOI 10.1038/nsmb714	41	30	31	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 7	2017	101	3					441	450		10.1016/j.ajhg.2017.07.015	http://dx.doi.org/10.1016/j.ajhg.2017.07.015			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FG1CS	28823706	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000409530900010
J	Nakajima, M; Kou, I; Ohashi, H; Ikegawa, S				Nakajima, Masahiro; Kou, Ikuyo; Ohashi, Hirofumi; Ikegawa, Shiro		Invest Comm Ossification Spinal Li	Identification and Functional Characterization of RSPO2 as a Susceptibility Gene for Ossification of the Posterior Longitudinal Ligament of the Spine	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CERVICAL-SPINE; CELL-LINE; R-SPONDIN2; EXPRESSION; DIFFERENTIATION; FAMILY	Ossification of the posterior longitudinal ligament of the spine (OPLL) is a common spinal disorder that results from ectopic ossification of the posterior longitudinal ligament and causes intractable myelopathy and radiculopathy. In a previous genome-wide association study (GWAS), we found six loci associated with OPLL; however, susceptibility genes in these loci have not been identified yet. Here, we examined one of the GWAS loci and identified RSPO2 (encoding R-spondin 2) as a susceptibility gene for OPLL. R-spondin 2 is a secreted agonist of canonical Wnt-beta-catenin signaling. RSPO2 was decreased in the early stage of chondrocyte differentiation. R-spondin 2 inhibited expression of genes encoding early chondrocyte differentiation markers by activating Wnt-b-catenin signaling. rs374810, the most significantly associated SNP in the GWAS locus in chromosomal region 8q23.1 was located in the chondrocyte promoter region of RSPO2. A transcription factor, CCAAT-enhancer-binding protein beta (C/EBP beta), specifically bound to the RSPO2 core promoter region containing rs374810 and increased RSPO2 expression. The risk allele of rs374810 affected the binding of the promoter with C/EBP beta and decreased the RSPO2 transcription in vitro and in vivo. Our genetic and functional data indicate that RSPO2 is a susceptibility gene for OPLL.	[Nakajima, Masahiro; Kou, Ikuyo; Ikegawa, Shiro] RIKEN, Ctr Integrat Med Sci, Lab Bone & Joint Dis, Tokyo 1088639, Japan; [Ohashi, Hirofumi] Saitama Childrens Med Ctr, Div Med Genet, Saitama 3398551, Japan	RIKEN; Saitama Children's Medical Center	Ikegawa, S (corresponding author), RIKEN, Ctr Integrat Med Sci, Lab Bone & Joint Dis, Tokyo 1088639, Japan.	sikegawa@ims.u-tokyo.ac.jp	Ikegawa, Shiro/N-6895-2015	Ikegawa, Shiro/0000-0003-0316-2147	Japan Agency for Medical Research and Development [M15318]	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	We thank T. Oguma and Y. Takahashi for technical assistance. We also thank N. Atsumi for assistance in preparing the manuscript and Zen-Sekichu-Ren (president: Y. Masuda) for collecting the subjects. This study was supported by research grants from the Japan Agency for Medical Research and Development (contract no. M15318).	Abed E, 2011, ARTHRITIS RHEUM-US, V63, P3865, DOI 10.1002/art.30625; Aoki M, 2008, DEV GROWTH DIFFER, V50, P85, DOI 10.1111/j.1440-169x.2007.00978.x; Bell SM, 2008, DEVELOPMENT, V135, P1049, DOI 10.1242/dev.013359; Blasi A, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-5; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; de Lau WBM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-242; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Epstein Nancy, 2002, Neurosurg Focus, V13, pECP1; Han XH, 2011, J BIOL CHEM, V286, P10649, DOI 10.1074/jbc.M110.169391; Ikegawa S, 2014, P JPN ACAD B-PHYS, V90, P405, DOI 10.2183/pjab.90.405; Kashii M, 2016, J BONE MINER METAB, V34, P315, DOI 10.1007/s00774-015-0671-5; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Matsunaga S, 2012, SPINE, V37, pE309, DOI 10.1097/BRS.0b013e318241ad33; Nakajima M, 2014, NAT GENET, V46, P1012, DOI 10.1038/ng.3045; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Reinhold MI, 2006, J BIOL CHEM, V281, P1381, DOI 10.1074/jbc.M504875200; Sato R, 2007, J NEUROSURG-SPINE, V7, P174, DOI 10.3171/SPI-07/08/174; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; TAKIGAWA M, 1989, CANCER RES, V49, P3996; Ushijima T, 2014, J BIOL CHEM, V289, P2852, DOI 10.1074/jbc.M113.492843; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Yamada W, 2009, BIOCHEM BIOPH RES CO, V381, P453, DOI 10.1016/j.bbrc.2009.02.066	25	30	32	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 7	2016	99	1					202	207		10.1016/j.ajhg.2016.05.018	http://dx.doi.org/10.1016/j.ajhg.2016.05.018			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TI	27374772	Green Published, Bronze			2022-12-18	WOS:000381616600017
J	Ayturk, UM; Couto, JA; Hann, S; Mulliken, JB; Williams, KL; Huang, AY; Fishman, SJ; Boyd, TK; Kozakewich, HPW; Bischoff, J; Greene, AK; Warman, ML				Ayturk, Ugur M.; Couto, Javier A.; Hann, Steven; Mulliken, John B.; Williams, Kaitlin L.; Huang, August Yue; Fishman, Steven J.; Boyd, Theonia K.; Kozakewich, Harry P. W.; Bischoff, Joyce; Greene, Arin K.; Warman, Matthew L.			Somatic Activating Mutations in GNAQ and GNA11 Are Associated with Congenital Hemangioma (vol 98, pg 789, 2016)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Correction												matthew.warman@childrens.harvard.edu	BISCHOFF, JOYCE/K-3354-2019	BISCHOFF, JOYCE/0000-0002-6367-1974; Williams, Kaitlin/0000-0002-8768-0488	NHLBI NIH HHS [R01 HL096384] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ayturk UM, 2016, AM J HUM GENET, V98, P789, DOI 10.1016/j.ajhg.2016.03.009	1	30	30	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 2	2016	98	6					1271	1271		10.1016/j.ajhg.2016.05.010	http://dx.doi.org/10.1016/j.ajhg.2016.05.010			1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN7US	27259057	Green Published, Bronze			2022-12-18	WOS:000377286000023
J	Rautanen, A; Pirinen, M; Mills, TC; Rockett, KA; Strange, A; Ndungu, AW; Naranbhai, V; Gilchrist, JJ; Bellenguez, C; Freeman, C; Band, G; Bumpstead, SJ; Edkins, S; Giannoulatou, E; Gray, E; Dronov, S; Hunt, SE; Langford, C; Pearson, RD; Su, Z; Vukcevic, D; Macharia, AW; Uyoga, S; Ndila, C; Mturi, N; Njuguna, P; Mohammed, S; Berkley, JA; Mwangi, I; Mwarumba, S; Kitsao, BS; Lowe, BS; Morpeth, SC; Khandwalla, I; Blackwell, JM; Bramon, E; Brown, MA; Casas, JP; Corvin, A; Duncanson, A; Jankowski, J; Markus, HS; Mathew, CG; Palmer, CNA; Plomin, R; Sawcer, SJ; Trembath, RC; Viswanathan, AC; Wood, NW; Deloukas, P; Peltonen, L; Williams, TN; Scott, JAG; Chapman, SJ; Donnelly, P; Hill, AVS; Spencer, CCA				Rautanen, Anna; Pirinen, Matti; Mills, Tara C.; Rockett, Kirk A.; Strange, Amy; Ndungu, Anne W.; Naranbhai, Vivek; Gilchrist, James J.; Bellenguez, Celine; Freeman, Colin; Band, Gavin; Bumpstead, Suzannah J.; Edkins, Sarah; Giannoulatou, Eleni; Gray, Emma; Dronov, Serge; Hunt, Sarah E.; Langford, Cordelia; Pearson, Richard D.; Su, Zhan; Vukcevic, Damjan; Macharia, Alex W.; Uyoga, Sophie; Ndila, Carolyne; Mturi, Neema; Njuguna, Patricia; Mohammed, Shebe; Berkley, James A.; Mwangi, Isaiah; Mwarumba, Salim; Kitsao, Barnes S.; Lowe, Brett S.; Morpeth, Susan C.; Khandwalla, Iqbal; Blackwell, Jenefer M.; Bramon, Elvira; Brown, Matthew A.; Casas, Juan P.; Corvin, Aiden; Duncanson, Audrey; Jankowski, Janusz; Markus, Hugh S.; Mathew, Christopher G.; Palmer, Colin N. A.; Plomin, Robert; Sawcer, Stephen J.; Trembath, Richard C.; Viswanathan, Ananth C.; Wood, Nicholas W.; Deloukas, Panos; Peltonen, Leena; Williams, Thomas N.; Scott, J. Anthony G.; Chapman, Stephen J.; Donnelly, Peter; Hill, Adrian V. S.; Spencer, Chris C. A.		Kilifi Bacteraemia Surveillance Gr; Kenyan Bacteraemia Study Grp; WTCCC2	Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LONG NONCODING RNAS; GENE-EXPRESSION; SUSCEPTIBILITY; NEUTROPHILS; ACTIVATION; MORTALITY; INFECTION; DISEASE; COHORT	Bacteremia (bacterial bloodstream infection) is a major cause of illness and death in sub-Saharan Africa but little is known about the role of human genetics in susceptibility. We conducted a genome-wide association study of bacteremia susceptibility in more than 5,000 Kenyan children as part of the Wellcome Trust Case Control Consortium 2 (WTCCC2). Both the blood-culture-proven bacteremia case subjects and healthy infants as controls were recruited from Kilifi, on the east coast of Kenya. Streptococcus pneumoniae is the most common cause of bacteremia in Kilifi and was thus the focus of this study. We identified an association between polymorphisms in a long intergenic non-coding RNA (lincRNA) gene (AC011288.2) and pneumococcal bacteremia and replicated the results in the same population (p combined = 1.69 x 10(-9); OR = 2.47, 95% CI = 1.84-3.31). The susceptibility allele is African specific, derived rather than ancestral, and occurs at low frequency (2.7% in control subjects and 6.4% in case subjects). Our further studies showed AC011288.2 expression only in neutrophils, a cell type that is known to play a major role in pneumococcal clearance. Identification of this novel association will further focus research on the role of lincRNAs in human infectious disease.	[Rautanen, Anna; Pirinen, Matti; Mills, Tara C.; Rockett, Kirk A.; Strange, Amy; Ndungu, Anne W.; Naranbhai, Vivek; Gilchrist, James J.; Bellenguez, Celine; Freeman, Colin; Band, Gavin; Giannoulatou, Eleni; Pearson, Richard D.; Su, Zhan; Vukcevic, Damjan; Chapman, Stephen J.; Donnelly, Peter; Hill, Adrian V. S.; Spencer, Chris C. A.] Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England; [Rockett, Kirk A.; Bumpstead, Suzannah J.; Edkins, Sarah; Gray, Emma; Dronov, Serge; Hunt, Sarah E.; Langford, Cordelia; Deloukas, Panos; Peltonen, Leena] Wellcome Trust Genome Campus, Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Gilchrist, James J.] Univ Oxford, Dept Paediat, Oxford OX3 9DU, England; [Macharia, Alex W.; Uyoga, Sophie; Ndila, Carolyne; Mturi, Neema; Njuguna, Patricia; Mohammed, Shebe; Berkley, James A.; Mwangi, Isaiah; Mwarumba, Salim; Kitsao, Barnes S.; Lowe, Brett S.; Morpeth, Susan C.; Khandwalla, Iqbal; Williams, Thomas N.; Scott, J. Anthony G.] KEMRI Wellcome Trust Res Programme, Kilifi 80108, Kenya; [Morpeth, Susan C.; Williams, Thomas N.; Scott, J. Anthony G.] Univ Oxford, Nuffield Dept Clin Med, Oxford OX3 9DU, England; [Morpeth, Susan C.; Scott, J. Anthony G.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England; [Blackwell, Jenefer M.] Univ Cambridge, Cambridge Inst Med Res, Tennis Court Rd, Cambridge CB2 1QP, England; [Blackwell, Jenefer M.] Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England; [Blackwell, Jenefer M.] Univ Western Australia, Telethon Kids Inst, Subiaco, WA 6008, Australia; [Bramon, Elvira] Kings Coll London, Natl Inst Hlth Res, Biomed Res Ctr Mental Hlth, South London & Maudsley Natl Hlth Serv NHS Fdn Tr, Denmark Hill, London SE5 8AF, England; [Bramon, Elvira] Kings Coll London, Inst Psychiat, Denmark Hill, London SE5 8AF, England; [Brown, Matthew A.] Queensland Univ Technol, Princess Alexandra Hosp, Translat Res Inst, Inst Hlth & Biomed Innovat, Brisbane, Qld 4102, Australia; [Casas, Juan P.] UCL, Farr Inst Hlth Informat, London NW1 2DA, England; [Corvin, Aiden] Univ Dublin Trinity Coll, Inst Mol Med, Neuropsychiat Genet Res Grp, Dublin 2, Ireland; [Duncanson, Audrey] Wellcome Trust Res Labs, Mol & Physiol Sci, London NW1 2BE, England; [Jankowski, Janusz] Peninsula Sch Med & Dent, Associate Deans Off, John Bull Bldg, Plymouth PL6 8BU, Devon, England; [Markus, Hugh S.] Univ Cambridge, Dept Neurol, Cambridge CB2 0QQ, England; [Mathew, Christopher G.] Kings Coll London, Div Genet & Mol Med, London SE1 9RT, England; [Mathew, Christopher G.] Univ Witwatersrand, Sydney Brenner Inst Mol Biosci, ZA-2193 Johannesburg, South Africa; [Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Dundee DD1 9SY, Scotland; [Plomin, Robert] Kings Coll London, Inst Psychiat, MRC Social Genet & Dev Psychiat Ctr, Crespigny Pk, London SE5 8AF, England; [Sawcer, Stephen J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Hills Rd, Cambridge CB2 0QQ, England; [Trembath, Richard C.] Queen Mary Univ London, London Sch Med & Dent, London E1 2AT, England; [Viswanathan, Ananth C.] Moorfields Eye Hosp NHSFT, NIHR Biomed Res Ctr, London EC1V 2PD, England; [Viswanathan, Ananth C.] UCL Inst Ophthalmol, London EC1V 2PD, England; [Wood, Nicholas W.] Inst Neurol, Dept Mol Neurosci, Queen Sq, London WC1N 3BG, England; [Williams, Thomas N.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London W2 1NY, England; [Williams, Thomas N.] INDEPTH Network, Accra, Ghana; [Chapman, Stephen J.] Oxford Univ Hosp, Churchill Hosp Site, Oxford Ctr Resp Med, Oxford OX3 7LE, England; [Donnelly, Peter; Spencer, Chris C. A.] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Hill, Adrian V. S.] Univ Oxford, Jenner Inst, Old Rd Campus Res Bldg, Oxford OX3 7DQ, England	University of Oxford; Wellcome Centre for Human Genetics; Wellcome Trust Sanger Institute; University of Oxford; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge; University of Cambridge; Telethon Kids Institute; University of Western Australia; University of London; King's College London; University of London; King's College London; Queensland University of Technology (QUT); University of London; University College London; Trinity College Dublin; University of Plymouth; University of Cambridge; University of London; King's College London; University of Witwatersrand; University of Dundee; University of London; King's College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; Queen Mary University London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of London; University College London; Imperial College London; INDEPTH Network; University of Oxford; University of Oxford; Jenner Institute	Rautanen, A (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	anna.rautanen@well.ox.ac.uk	Wood, Nicholas W/C-2505-2009; Belllenguez, Céline/Y-3183-2018; Bramon, Elvira/A-9463-2011; Bellenguez, Céline/X-4004-2019; Brown, Matthew A/E-5749-2010; Deloukas, Panos/B-2922-2013; Palmer, Colin NA/C-7053-2008; Bramon, Elvira/HHC-3809-2022; Jankowski, Janusz/H-2706-2012	Wood, Nicholas W/0000-0002-9500-3348; Belllenguez, Céline/0000-0002-1240-7874; Bellenguez, Céline/0000-0002-1240-7874; Brown, Matthew A/0000-0003-0538-8211; Deloukas, Panos/0000-0001-9251-070X; Palmer, Colin NA/0000-0002-6415-6560; Bramon, Elvira/0000-0003-1369-5983; Pirinen, Matti/0000-0002-1664-1350; Donnelly, Peter/0000-0001-9495-3408; Berkley, James/0000-0002-1236-849X; Uyoga, Sophie/0000-0003-1746-7873; Walters, James/0000-0002-6980-4053; Sawcer, Stephen/0000-0001-7685-0974; Trembath, Richard/0000-0003-0550-3400; Giannoulatou, Eleni/0000-0002-7084-6736; Hunt, Sarah/0000-0002-8350-1235; Jankowski, Janusz/0000-0003-2130-9181; Vukcevic, Damjan/0000-0001-7780-9586	Wellcome Trust as part of the Wellcome Trust Case Control Consortium 2 project [084716/Z/08/Z, 085475/B/08/Z, 085475/Z/08/Z]; Wellcome Trust Centre for Human Genetics [090532/Z/09/Z]; Wellcome Trust Sanger Institute Core Award [98051]; Kenya Medical Research Institute (KEMRI); Wellcome Trust of Great Britain; Wellcome Trust [084716/Z/08/Z, 090770/2/09/2, 091758, 098532, HCUZZ0]; European Research Council; Academy of Finland [257654]; NIHR Biomedical Research Centre in Oxford; Wolfson-Royal Society Merit Award; ERC [294557]; Wellcome Trust Career Development Fellowship [097364/Z/11/Z]; NIHR Biomedical Research Centre in Guy's St Thomas'; Medical Research Council [G1001712] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10158, NF-SI-0512-10019] Funding Source: researchfish; Wellcome Trust [098532/B/12/Z] Funding Source: researchfish; MRC [G1001712, G0901310] Funding Source: UKRI	Wellcome Trust as part of the Wellcome Trust Case Control Consortium 2 project; Wellcome Trust Centre for Human Genetics(Wellcome Trust); Wellcome Trust Sanger Institute Core Award; Kenya Medical Research Institute (KEMRI); Wellcome Trust of Great Britain(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Academy of Finland(Academy of Finland); NIHR Biomedical Research Centre in Oxford; Wolfson-Royal Society Merit Award(Royal Society of London); ERC(European Research Council (ERC)European Commission); Wellcome Trust Career Development Fellowship(Wellcome Trust); NIHR Biomedical Research Centre in Guy's St Thomas'; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all the study participants and Kilifi District Hospital clinical team and laboratory staff for their involvement in data and sample collection. The principal funding for this study was provided by the Wellcome Trust, as part of the Wellcome Trust Case Control Consortium 2 project (grants 084716/Z/08/Z, 085475/B/08/Z, and 085475/Z/08/Z). This work was partially supported by Wellcome Trust Centre for Human Genetics core grant 090532/Z/09/Z and the Wellcome Trust Sanger Institute Core Award (98051). The fieldwork and phenotyping for this study was supported by the Kenya Medical Research Institute (KEMRI) and the Wellcome Trust of Great Britain. A.R. was supported by the Wellcome Trust (084716/Z/08/Z) and by the European Research Council, M.P. is supported by the Academy of Finland (257654), K.A.R. is supported by the Wellcome Trust (090770/2/09/2), T.N.W. and J.A.G.S. were supported by Senior Research Fellowships from the Wellcome Trust (091758 and 098532, respectively), S.J.C. and C.G.M. were supported by the NIHR Biomedical Research Centres in Oxford and Guy's & St Thomas', respectively, P. Donnelly was supported in part by a Wolfson-Royal Society Merit Award, A.V.S.H. is supported by a Wellcome Trust Senior Investigator Award (HCUZZ0) and an ERC Advanced Grant (294557), and C.C.A.S. was supported by a Wellcome Trust Career Development Fellowship (097364/Z/11/Z). This paper was published with the permission of the Director of KEMRI.	Band G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003509; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Bellenguez C, 2012, NAT GENET, V44, P328, DOI 10.1038/ng.1081; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Cederlund A, 2010, J INNATE IMMUN, V2, P508, DOI 10.1159/000317665; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Davila S, 2010, NAT GENET, V42, P772, DOI 10.1038/ng.640; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Gingles NA, 2001, INFECT IMMUN, V69, P426, DOI 10.1128/IAI.69.1.426-434.2001; Gomez JA, 2013, CELL, V152, P743, DOI 10.1016/j.cell.2013.01.015; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; INGRAM VM, 1957, NATURE, V180, P326, DOI 10.1038/180326a0; Kitagawa M, 2012, J BIOL CHEM, V287, P27983, DOI 10.1074/jbc.M112.350074; Kuppermann N, 1998, ANN EMERG MED, V31, P679, DOI 10.1016/S0196-0644(98)70225-2; Laupland KB, 2011, INFECTION, V39, P405, DOI 10.1007/s15010-011-0149-x; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Lillie PJ, 2013, CLIN MICROBIOL INFEC, V19, P955, DOI 10.1111/1469-0691.12101; Magi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-288; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Morris JA, 2010, BIOINFORMATICS, V26, P1786, DOI 10.1093/bioinformatics/btq280; Naranbhai V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8545; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pirinen M, 2013, ANN APPL STAT, V7, P369, DOI 10.1214/12-AOAS586; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Nguyen QT, 2013, INFECT IMMUN, V81, P2168, DOI 10.1128/IAI.00115-13; Rautanen A, 2015, LANCET RESP MED, V3, P53, DOI 10.1016/S2213-2600(14)70290-5; Scott JAG, 2011, LANCET, V378, P1316, DOI 10.1016/S0140-6736(11)60888-X; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; Williams TN, 2009, LANCET, V374, P1364, DOI 10.1016/S0140-6736(09)61374-X; Wyllie DH, 2006, BRIT MED J, V333, P281, DOI 10.1136/bmj.38834.421713.2F	38	30	30	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 2	2016	98	6					1092	1100		10.1016/j.ajhg.2016.03.025	http://dx.doi.org/10.1016/j.ajhg.2016.03.025			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN7US	27236921	Green Published, hybrid, Green Accepted			2022-12-18	WOS:000377286000005
J	El-Asrag, ME; Sergouniotis, PI; McKibbin, M; Plagnol, V; Sheridan, E; Waseem, N; Abdelhamed, Z; McKeefry, D; Van Schil, K; Poulter, JA; Johnson, CA; Carr, IM; Leroy, BP; De Baere, E; Inglehearn, CF; Webster, AR; Toomes, C; Ali, M				El-Asrag, Mohammed E.; Sergouniotis, Panagiotis I.; McKibbin, Martin; Plagnol, Vincent; Sheridan, Eamonn; Waseem, Naushin; Abdelhamed, Zakia; McKeefry, Declan; Van Schil, Kristof; Poulter, James A.; Johnson, Colin A.; Carr, Ian M.; Leroy, Bart P.; De Baere, Elfride; Inglehearn, Chris F.; Webster, Andrew R.; Toomes, Carmel; Ali, Manir		UK Inherited Retinal Dis	Biallelic Mutations in the Autophagy Regulator DRAM2 Cause Retinal Dystrophy with Early Macular Involvement	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PIGMENT EPITHELIUM; CELL-DEATH; PHOTORECEPTORS; CILIOGENESIS; MECHANISMS; EXPRESSION; VARIANTS; RENEWAL	Retinal dystrophies are an overlapping group of genetically heterogeneous conditions resulting from mutations in more than 250 genes. Here we describe five families affected by an adult-onset retinal dystrophy with early macular involvement and associated central visual loss in the third or fourth decade of life. Affected individuals were found to harbor disease-causing variants in DRAM2 (DNA-damage regulated autophagy modulator protein 2). Homozygosity mapping and exome sequencing in a large, consanguineous British family of Pakistani origin revealed a homozygous frameshift variant (c.140delG [p.Gly47Valfs*3]) in nine affected family members. Sanger sequencing of DRAM2 in 322 unrelated probands with retinal dystrophy revealed one European subject with compound heterozygous DRAM2 changes (c.494G>A [p.Trp165*] and c.131G>A [p.Ser44Asn]). Inspection of previously generated exome sequencing data in unsolved retinal dystrophy cases identified a homozygous variant in an individual of Indian origin (c.64_66del [p.Ala22del]). Independently, a gene-based case-control association study was conducted via an exome sequencing dataset of 18 phenotypically similar case subjects and 1,917 control subjects. Using a recessive model and a binomial test for rare, presumed biallelic, variants, we found DRAM2 to be the most statistically enriched gene; one subject was a homozygote (c.362A>T [p.His121Leu]) and another a compound heterozygote (c.79T>C [p.Tyr27His] and c.217_225del [p.Val73_Tyr75del]). DRAM2 encodes a transmembrane lysosomal protein thought to play a role in the initiation of autophagy. Immunohistochemical analysis showed DRAM2 localization to photoreceptor inner segments and to the apical surface of retinal pigment epithelial cells where it might be involved in the process of photoreceptor renewal and recycling to preserve visual function.	[El-Asrag, Mohammed E.; Abdelhamed, Zakia; Poulter, James A.; Johnson, Colin A.; Carr, Ian M.; Inglehearn, Chris F.; Toomes, Carmel; Ali, Manir] Univ Leeds, Sect Ophthalmol & Neurosci, Leeds Inst Biomed & Clin Sci, Leeds LS9 7TF, W Yorkshire, England; [El-Asrag, Mohammed E.] Benha Univ, Dept Zool, Fac Sci, Banha 13511, Egypt; [Sergouniotis, Panagiotis I.; Waseem, Naushin; Webster, Andrew R.] UCL, Inst Ophthalmol, London EC1V 9EL, England; [Sergouniotis, Panagiotis I.] Univ Manchester, Inst Human Dev, Fac Med & Human Sci, Manchester M13 9WL, Lancs, England; [McKibbin, Martin] St James Univ Hosp, Dept Ophthalmol, Leeds LS9 7TF, W Yorkshire, England; [Plagnol, Vincent] UCL, Genet Inst, London WC1E 6BT, England; [Sheridan, Eamonn] St James Univ Hosp, Yorkshire Reg Genet Serv, Leeds LS9 7TF, W Yorkshire, England; [McKeefry, Declan] Univ Bradford, Bradford Sch Optometry & Visual Sci, Bradford BD7 1DP, W Yorkshire, England; [Van Schil, Kristof; Leroy, Bart P.; De Baere, Elfride] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Leroy, Bart P.] Ghent Univ Hosp, Dept Ophthalmol, B-9000 Ghent, Belgium; [Leroy, Bart P.] Childrens Hosp Philadelphia, Div Ophthalmol, Philadelphia, PA 19104 USA; [Webster, Andrew R.] Moorfields Eye Hosp, London EC1V 2PD, England	University of Leeds; Egyptian Knowledge Bank (EKB); Benha University; University of London; University College London; University of Manchester; Saint James's University Hospital; University of London; University College London; Saint James's University Hospital; University of Bradford; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Toomes, C (corresponding author), Univ Leeds, Sect Ophthalmol & Neurosci, Leeds Inst Biomed & Clin Sci, Leeds LS9 7TF, W Yorkshire, England.	c.toomes@leeds.ac.uk; m.ali@leeds.ac.uk	Ali, Manir/ABE-5251-2020; De Baere, Elfride/E-7405-2017; Poulter, James A/A-8190-2013; Elasrag, Mohammed/ABF-5702-2020; Inglehearn, Chris/GYD-9783-2022; Black, Graeme/K-7374-2015; Manson, Forbes/G-2222-2015	Ali, Manir/0000-0003-3204-3788; De Baere, Elfride/0000-0002-5609-6895; Poulter, James A/0000-0003-2048-5693; Elasrag, Mohammed/0000-0003-3750-7414; Cheetham, Michael/0000-0001-6429-654X; Fiorentino, Alessia/0000-0002-1403-4581; Lise, Stefano/0000-0003-4472-6893; Taylor, Rachel/0000-0002-1235-4303; Plagnol, Vincent/0000-0002-5597-9215; Black, Graeme/0000-0001-8727-6592; Johnson, Colin/0000-0002-2979-8234; Lord, Emma/0000-0001-9216-7382; Sergouniotis, Panos/0000-0003-0986-4123; Toomes, Carmel/0000-0001-8373-9545; Manson, Forbes/0000-0002-8342-660X	NERC (Yorkshire branch); Macular Society UK; UK National Institute for Health Research (Biomedical Research Centre, Moorfields Eye Hospital and Institute of Ophthalmology); RP Fighting Blindness and Fight For Sight (RP Genome Project) [GR586]; Belspo IAP project [P7/43]; Belgium Medical Genomics Initiative (BeMGI); Ghent University Special Research Fund [BOF15/GOA/011]; Funds for Research in Ophthalmology (FRO); Jules Thorn Charitable Trust; Egyptian Government; MRC [MR/L01629X/1] Funding Source: UKRI; Medical Research Council [MR/L01629X/1] Funding Source: researchfish; National Institute for Health Research [ACF-2013-06-009] Funding Source: researchfish	NERC (Yorkshire branch)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Macular Society UK; UK National Institute for Health Research (Biomedical Research Centre, Moorfields Eye Hospital and Institute of Ophthalmology); RP Fighting Blindness and Fight For Sight (RP Genome Project); Belspo IAP project; Belgium Medical Genomics Initiative (BeMGI); Ghent University Special Research Fund(Ghent University); Funds for Research in Ophthalmology (FRO); Jules Thorn Charitable Trust; Egyptian Government; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We would like to thank the subjects and their families who participated in this study. We thank our colleagues at University College London (UK) for kindly contributing to the UCL-exomes control panel. This work was supported by grants from NERC (Yorkshire branch), Macular Society UK, the UK National Institute for Health Research (Biomedical Research Centre, Moorfields Eye Hospital and Institute of Ophthalmology), RP Fighting Blindness and Fight For Sight (RP Genome Project GR586), the Belspo IAP project P7/43, the Belgium Medical Genomics Initiative (BeMGI), the Ghent University Special Research Fund (BOF15/GOA/011), and the Funds for Research in Ophthalmology (FRO). C.A.J. and C.F.I. were supported by a grant from the Jules Thorn Charitable Trust. M.E.E. is funded by an Egyptian Government Scholarship and K.V.S. is a doctoral fellow from the Institute for Innovation by Science and Technology (IWT). E.D.B. and B.P.L. are senior clinical investigators of the Research Foundation Flanders (FWO).	Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Metrailler S, 2012, EXP EYE RES, V96, P70, DOI 10.1016/j.exer.2011.12.019; Nguyen-Legros J, 2000, INT REV CYTOL, V196, P245; O'Prey J, 2009, CELL CYCLE, V8, P2260, DOI 10.4161/cc.8.14.9050; Pampliega O, 2013, NATURE, V502, P194, DOI 10.1038/nature12639; Park SM, 2009, BIOCHEM BIOPH RES CO, V390, P1340, DOI 10.1016/j.bbrc.2009.10.149; Pearson RD, 2011, NAT GENET, V43, P392, DOI 10.1038/ng.816; Rodriguez-Muela N, 2013, AGING CELL, V12, P478, DOI 10.1111/acel.12072; Sergouniotis PI, 2014, AM J HUM GENET, V94, P760, DOI 10.1016/j.ajhg.2014.04.003; Silberstein M, 2006, AM J HUM GENET, V78, P922, DOI 10.1086/504158; Tang ZM, 2013, NATURE, V502, P254, DOI 10.1038/nature12606; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717; Yao JY, 2014, INVEST OPHTH VIS SCI, V55, P3237, DOI 10.1167/iovs.13-13336; Yoon JH, 2012, MOL BIOL REP, V39, P1087, DOI 10.1007/s11033-011-0835-x; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; Yuan J, 2003, NEURON, V40, P401, DOI 10.1016/S0896-6273(03)00601-9	18	30	32	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 4	2015	96	6					948	954		10.1016/j.ajhg.2015.04.006	http://dx.doi.org/10.1016/j.ajhg.2015.04.006			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CK0YH	25983245	Green Published, Bronze, Green Accepted			2022-12-18	WOS:000355931200008
J	Gordon, CT; Weaver, KN; Zechi-Ceide, RM; Madsen, EC; Tavares, ALP; Oufadem, M; Kurihara, Y; Adameyko, I; Picard, A; Breton, S; Pierrot, S; Biosse-Duplan, M; Voisin, N; Masson, C; Bole-Feysot, C; Nitschke, P; Delrue, MA; Lacombe, D; Guion-Almeida, ML; Moura, PP; Garib, DG; Munnich, A; Ernfors, P; Hufnagel, RB; Hopkin, RJ; Kurihara, H; Saal, HM; Weaver, DD; Katsanis, N; Lyonnet, S; Golzio, C; Clouthier, DE; Amiel, J				Gordon, Christopher T.; Weaver, K. Nicole; Zechi-Ceide, Roseli Maria; Madsen, Erik C.; Tavares, Andre L. P.; Oufadem, Myriam; Kurihara, Yukiko; Adameyko, Igor; Picard, Arnaud; Breton, Sylvain; Pierrot, Sebastien; Biosse-Duplan, Martin; Voisin, Norine; Masson, Cecile; Bole-Feysot, Christine; Nitschke, Patrick; Delrue, Marie-Ange; Lacombe, Didier; Guion-Almeida, Maria Leine; Moura, Priscila Padilha; Garib, Daniela Gamba; Munnich, Arnold; Ernfors, Patrik; Hufnagel, Robert B.; Hopkin, Robert J.; Kurihara, Hiroki; Saal, Howard M.; Weaver, David D.; Katsanis, Nicholas; Lyonnet, Stanislas; Golzio, Christelle; Clouthier, David E.; Amiel, Jeanne			Mutations in the Endothelin Receptor Type A Cause Mandibulofacial Dysostosis with Alopecia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							JOHNSON-MCMILLIN-SYNDROME; AURICULOCONDYLAR SYNDROME; NEUROECTODERMAL SYNDROME; EXPRESSION; TRANSFORMATION; HYPOGONADISM; MECHANISMS; DEFICIENT; EVOLUTION; DEAFNESS	The endothelin receptor type A (EDNRA) signaling pathway is essential for the establishment of mandibular identity during development of the first pharyngeal arch. We report four unrelated individuals with the syndrome mandibulofacial dysostosis with alopecia (MFDA) who have de novo missense variants in EDNRA. Three of the four individuals have the same substitution, p.Tyr129Phe. Tyr129 is known to determine the selective affinity of EDNRA for endothelin 1 (EDN1), its major physiological ligand, and the p.Tyr129Phe variant increases the affinity of the receptor for EDN3, its non-preferred ligand, by two orders of magnitude. The fourth individual has a somatic mosaic substitution, p.Glu303Lys, and was previously described as having Johnson-McMillin syndrome. The zygomatic arch of individuals with MFDA resembles that of mice in which EDNRA is ectopically activated in the maxillary prominence, resulting in a maxillary to mandibular transformation, suggesting that the p.Tyr129Phe variant causes an EDNRA gain of function in the developing upper jaw. Our in vitro and in vivo assays suggested complex, context-dependent effects of the EDNRA variants on downstream signaling. Our findings highlight the importance of finely tuned regulation of EDNRA signaling during human craniofacial development and suggest that modification of endothelin receptor-ligand specificity was a key step in the evolution of vertebrate jaws.	[Gordon, Christopher T.; Oufadem, Myriam; Biosse-Duplan, Martin; Voisin, Norine; Masson, Cecile; Bole-Feysot, Christine; Nitschke, Patrick; Munnich, Arnold; Lyonnet, Stanislas; Amiel, Jeanne] INSERM, Inst Imagine, UMR 1163, F-75015 Paris, France; [Gordon, Christopher T.; Oufadem, Myriam; Biosse-Duplan, Martin; Voisin, Norine; Masson, Cecile; Bole-Feysot, Christine; Nitschke, Patrick; Munnich, Arnold; Lyonnet, Stanislas; Amiel, Jeanne] Univ Paris 05, Sorbonne Paris Cite, Inst Imagine, F-75015 Paris, France; [Weaver, K. Nicole; Hufnagel, Robert B.; Hopkin, Robert J.; Saal, Howard M.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Zechi-Ceide, Roseli Maria; Guion-Almeida, Maria Leine; Moura, Priscila Padilha] Univ Sao Paulo, Hosp Rehabil Craniofacial Anomalies, Dept Clin Genet, BR-17012900 Bauru, Brazil; [Madsen, Erik C.; Katsanis, Nicholas; Golzio, Christelle] Duke Univ, Med Ctr, Ctr Human Dis Modeling, Durham, NC 27701 USA; [Tavares, Andre L. P.; Clouthier, David E.] Univ Colorado Denver, Dept Craniofacial Biol, Aurora, CO 80045 USA; [Kurihara, Yukiko; Kurihara, Hiroki] Univ Tokyo, Grad Sch Med, Dept Physiol Chem & Metab, Tokyo 1130033, Japan; [Adameyko, Igor; Ernfors, Patrik] Karolinska Inst, Dept Med Biochem & Biophys, Unit Mol Neurobiol, S-17177 Stockholm, Sweden; [Picard, Arnaud] Hop Necker Enfants Malad, Ctr Reference Malformat Face & Cavite Buccale, Serv Chirurg Maxillofaciale & Plast, F-75015 Paris, France; [Picard, Arnaud] Univ Paris 06, F-75015 Paris, France; [Breton, Sylvain] Hop Necker Enfants Malad, AP HP, Serv Imagerie Pediat, F-75015 Paris, France; [Breton, Sylvain] Univ Paris 05, Lab Anat, F-75015 Paris, France; [Pierrot, Sebastien] Hop Necker Enfants Malad, AP HP, Serv ORL Pediat, F-75015 Paris, France; [Pierrot, Sebastien] Univ Paris 05, F-75015 Paris, France; [Biosse-Duplan, Martin] Hop Bretonneau, AP HP, HUPNVS, Serv Odontol, F-75018 Paris, France; [Delrue, Marie-Ange; Lacombe, Didier] CHU Bordeaux, Unite Genet Med, F-33076 Bordeaux, France; [Garib, Daniela Gamba] Univ Sao Paulo, Bauru Dent Sch, Dept Orthodont, BR-17012901 Bauru, Brazil; [Munnich, Arnold; Lyonnet, Stanislas; Amiel, Jeanne] Hop Necker Enfants Malad, AP HP, Serv Genet, F-75015 Paris, France; [Weaver, David D.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Cincinnati Children's Hospital Medical Center; Universidade de Sao Paulo; Duke University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Tokyo; Karolinska Institutet; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Hopital Universitaire Bretonneau - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Bordeaux; Universidade de Sao Paulo; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Indiana University System; Indiana University Bloomington	Gordon, CT (corresponding author), INSERM, Inst Imagine, UMR 1163, F-75015 Paris, France.	chris.gordon@inserm.fr; jeanne.amiel@inserm.fr	Lyonnet, Stanislas/H-5483-2017; Zechi-Ceide, Roseli/I-8178-2013; Garib, Daniela G/E-7044-2012; Biosse Duplan, Martin/H-7491-2017; amiel, jeanne/H-3501-2017; Gordon, Chris/F-1267-2017; amiel, jeanne/AGX-1124-2022; Soueidan, Assem/P-1781-2014; Tavares, Andre/Q-1213-2015	Lyonnet, Stanislas/0000-0001-5426-9417; Zechi-Ceide, Roseli/0000-0002-4526-3336; Garib, Daniela G/0000-0002-2449-1620; Biosse Duplan, Martin/0000-0001-9417-3970; amiel, jeanne/0000-0001-5973-4728; Gordon, Chris/0000-0002-9300-8399; Soueidan, Assem/0000-0001-8759-2165; Tavares, Andre/0000-0001-9893-2305; Hufnagel, Robert/0000-0003-3015-3545; Lacombe, Didier/0000-0002-8956-2207; Voisin, Norine/0000-0001-9479-4179; Golzio, Christelle/0000-0002-4420-3921; Saal, Howard/0000-0002-0277-4777; Adameyko, Igor/0000-0001-5471-0356; Kurihara, Hiroki/0000-0002-6476-5593; Katsanis, Nicholas/0000-0002-2480-0171	Universite Sorbonne Paris-Cite Pole de recherche et d'enseignement superieur (PRES) grant [SPC/JFG/2013-031]; NIH [DE014181, DE018899, DE023050, 5T32HD060558-04]; ANR E-Rare grant CRANIRARE; ANR grant EvoDevoMut; ANR [ANR-10-IAHU-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018899, R01DE023050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014181] Funding Source: NIH RePORTER	Universite Sorbonne Paris-Cite Pole de recherche et d'enseignement superieur (PRES) grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ANR E-Rare grant CRANIRARE(French National Research Agency (ANR)); ANR grant EvoDevoMut(French National Research Agency (ANR)); ANR(French National Research Agency (ANR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a Universite Sorbonne Paris-Cite Pole de recherche et d'enseignement superieur (PRES) grant, project number SPC/JFG/2013-031 (to J.A.) and from NIH grants DE014181, DE018899, and DE023050 (to D.E.C.). J.A. and S.L. are supported by funding from the ANR E-Rare grant CRANIRARE. S.L. is supported by the ANR grant EvoDevoMut. N.K. is a Distinguished Brumley Professor. E.C.M. is supported by NIH Training Grant 5T32HD060558-04. The Institut Imagine is supported by an ANR grant ANR-10-IAHU-01. We thank Pierre Corvol, Gerard Couly, and Giovanni Levi for discussions and Holly Buttermore for technical support.	Braasch I, 2014, GEN COMP ENDOCR, V209, P21, DOI 10.1016/j.ygcen.2014.06.028; Brand M, 1998, J CLIN INVEST, V101, P549, DOI 10.1172/JCI524; BREU V, 1995, EUR J BIOCHEM, V231, P266, DOI 10.1111/j.1432-1033.1995.0266f.x; Brunskill EW, 2014, DEV BIOL, V391, P133, DOI 10.1016/j.ydbio.2014.04.016; Cerny R, 2010, P NATL ACAD SCI USA, V107, P17262, DOI 10.1073/pnas.1009304107; Chang CY, 2013, NATURE, V495, P98, DOI 10.1038/nature11847; Clouthier DE, 2013, AM J MED GENET C, V163, P306, DOI 10.1002/ajmg.c.31376; Clouthier DE, 1998, DEVELOPMENT, V125, P813; Cushman LJ, 2005, BIRTH DEFECTS RES A, V73, P638, DOI 10.1002/bdra.20178; De Metsenaere F, 2004, AM J OBSTET GYNECOL, V191, P1728, DOI 10.1016/j.ajog.2004.06.040; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Gordon CT, 2014, AM J MED GENET A, V164, P1850, DOI 10.1002/ajmg.a.36505; Gordon CT, 2013, AM J HUM GENET, V93, P1118, DOI 10.1016/j.ajhg.2013.10.023; Gordon CT, 2013, J MED GENET, V50, P174, DOI 10.1136/jmedgenet-2012-101331; HENNEKAM RCM, 1993, AM J MED GENET, V47, P714, DOI 10.1002/ajmg.1320470526; Hwang J, 2008, DEVELOPMENT, V135, P3149, DOI 10.1242/dev.022202; Javidan Y, 2004, METHOD CELL BIOL, V76, P415; JOHNSON VP, 1983, AM J MED GENET, V15, P497, DOI 10.1002/ajmg.1320150316; JOHNSTON K, 1987, AM J MED GENET, V26, P925, DOI 10.1002/ajmg.1320260422; Kimmel CB, 2007, J EXP ZOOL PART B, V308B, P609, DOI 10.1002/jez.b.21155; KRYSTEK SR, 1994, J BIOL CHEM, V269, P12383; Kuraku S, 2010, DEV BIOL, V341, P315, DOI 10.1016/j.ydbio.2010.02.013; KURIHARA Y, 1994, NATURE, V368, P703, DOI 10.1038/368703a0; Le Douarin NM, 1999, NEURAL CREST; LEE JA, 1994, P NATL ACAD SCI USA, V91, P7164, DOI 10.1073/pnas.91.15.7164; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu B, 2003, J BIOL CHEM, V278, P2384, DOI 10.1074/jbc.M208683200; Maemura K, 1996, GENOMICS, V31, P177, DOI 10.1006/geno.1996.0029; Miller CT, 2000, DEVELOPMENT, V127, P3815; Morimoto H, 2001, J MED CHEM, V44, P3355, DOI 10.1021/jm0102304; Nair S, 2007, DEVELOPMENT, V134, P335, DOI 10.1242/dev.02704; Nataf V, 1998, MECH DEVELOP, V73, P217, DOI 10.1016/S0925-4773(98)00048-3; Niederriter AR, 2013, JOVE-J VIS EXP, DOI 10.3791/50338; Ohyama M, 2012, J CELL SCI, V125, P4114, DOI 10.1242/jcs.105700; Rieder MJ, 2012, AM J HUM GENET, V90, P907, DOI 10.1016/j.ajhg.2012.04.002; Romanelli Tavares V.L., 2014, EUR J HUM GENET; Ruest LB, 2004, DEVELOPMENT, V131, P4413, DOI 10.1242/dev.01291; Sato T, 2008, DEVELOPMENT, V135, P755, DOI 10.1242/dev.012708; Sato T, 2008, P NATL ACAD SCI USA, V105, P18806, DOI 10.1073/pnas.0807345105; Schon MP, 1999, J IMMUNOL, V162, P6641; Schweitzer DN, 2003, AM J MED GENET A, V120A, P400, DOI 10.1002/ajmg.a.20085; Webb ML, 1996, BIOCHEMISTRY-US, V35, P2548, DOI 10.1021/bi951836v; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE, P385; Wieczorek D, 2013, CLIN GENET, V83, P499, DOI 10.1111/cge.12123; Zechi-Ceide RM, 2010, AM J MED GENET A, V152A, P1838, DOI 10.1002/ajmg.a.33477	45	30	32	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 2	2015	96	4					519	531		10.1016/j.ajhg.2015.01.015	http://dx.doi.org/10.1016/j.ajhg.2015.01.015			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CF0DJ	25772936	Green Published, Bronze			2022-12-18	WOS:000352212600001
J	Golan, D; Rosset, S				Golan, David; Rosset, Saharon			Effective Genetic-Risk Prediction Using Mixed Models	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; HERITABILITY; STRATIFICATION; TRAITS; LASSO; SNPS	For predicting genetic risk, we propose a statistical approach that is specifically adapted to dealing with the challenges imposed by disease phenotypes and case-control sampling. Our approach (termed Genetic Risk Scores Inference [GeRSI]), combines the power of fixed-effects models (which estimate and aggregate the effects of single SNPs) and random-effects models (which rely primarily on whole-genome similarities between individuals) within the framework of the widely used liability-threshold model. We demonstrate in extensive simulation that GeRSI produces predictions that are consistently superior to current state-of-the-art approaches. When applying GeRSI to seven phenotypes from the Wellcome Trust Case Control Consortium (WTCCC) study, we confirm that the use of random effects is most beneficial for diseases that are known to be highly polygenic: hypertension (HT) and bipolar disorder (BD). For HT, there are no significant associations in the WTCCC data. The fixed-effects model yields an area under the ROC curve (AUC) of 54%, whereas GeRSI improves it to 59%. For BD, using GeRSI improves the AUC from 55% to 62%. For individuals ranked at the top 10% of BD risk predictions, using GeRSI substantially increases the BD relative risk from 1.4 to 2.5.	[Golan, David; Rosset, Saharon] Tel Aviv Univ, Dept Stat, IL-69978 Tel Aviv, Israel	Tel Aviv University	Golan, D (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	golandavid@gmail.com; saharon@post.tau.ac.il			Wellcome Trust [076113]; Edmond J. Safra Center for Bioinformatics at Tel Aviv University; Colton Family Foundation; Israeli Science Foundation [1487/12]	Wellcome Trust(Wellcome TrustEuropean Commission); Edmond J. Safra Center for Bioinformatics at Tel Aviv University; Colton Family Foundation; Israeli Science Foundation(Israel Science Foundation)	This study made use of data generated by the Wellcome Trust Case Control Consortium (WTCCC). A full list of the investigators who contributed to the generation of the data is available at www.wtccc.org.uk. Funding for the WTCCC project was provided by the Wellcome Trust under award 076113. D.G. was partially supported by a fellowship from the Edmond J. Safra Center for Bioinformatics at Tel Aviv University and by a fellowship from the Colton Family Foundation. This research was partially supported by Israeli Science Foundation grant 1487/12.	Abraham G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004137; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell DD, 2010, GENET EPIDEMIOL, V34, P159, DOI 10.1002/gepi.20446; CASELLA G, 1992, AM STAT, V46, P167, DOI 10.2307/2685208; Chatterjee N, 2013, NAT GENET, V45, P400, DOI 10.1038/ng.2579; Clark Samuel A, 2013, Methods Mol Biol, V1019, P321, DOI 10.1007/978-1-62703-447-0_13; Crossett A, 2013, ANN APPL STAT, V7, P669, DOI 10.1214/12-AOAS598; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Efron B, 1993, INTRO BOOTSTRAP, DOI DOI 10.1007/978-1-4899-4541-9; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Golan D, 2011, BIOINFORMATICS, V27, pI317, DOI 10.1093/bioinformatics/btr219; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Gray A, 2012, BIOINFORMATICS, V28, P3134, DOI 10.1093/bioinformatics/bts571; Gusev A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003993; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kooperberg C, 2010, GENET EPIDEMIOL, V34, P643, DOI 10.1002/gepi.20509; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Li JH, 2011, BIOINFORMATICS, V27, P516, DOI 10.1093/bioinformatics/btq688; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/NMETH.1681, 10.1038/nmeth.1681]; Meuwissen THE, 2001, GENETICS, V157, P1819; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rakitsch B, 2013, BIOINFORMATICS, V29, P206, DOI 10.1093/bioinformatics/bts669; Speed D, 2014, GENOME RES, V24, P1550, DOI 10.1101/gr.169375.113; Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zaitlen N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003032; Zaitlen N, 2012, BIOINFORMATICS, V28, P1729, DOI 10.1093/bioinformatics/bts259; Zhou X, 2014, NAT METHODS, V11, P407, DOI [10.1038/NMETH.2848, 10.1038/nmeth.2848]; Zhou X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003264; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	35	30	32	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 2	2014	95	4					383	393		10.1016/j.ajhg.2014.09.007	http://dx.doi.org/10.1016/j.ajhg.2014.09.007			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AQ2XW	25279982	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000342654300004
J	Smith, JD; Hing, AV; Clarke, CM; Johnson, NM; Perez, FA; Park, SS; Horst, JA; Mecham, B; Maves, L; Nickerson, DA; Cunningham, ML				Smith, Joshua D.; Hing, Anne V.; Clarke, Christine M.; Johnson, Nathan M.; Perez, Francisco A.; Park, Sarah S.; Horst, Jeremy A.; Mecham, Brig; Maves, Lisa; Nickerson, Deborah A.; Cunningham, Michael L.		Univ Washington	Exome Sequencing Identifies a Recurrent De Novo ZSWIM6 Mutation Associated with Acromelic Frontonasal Dysostosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE-EXPRESSION; INDIAN-HEDGEHOG; MOUSE MUTANT; PROTEIN; DOUBLEFOOT; DATABASE; PREDICTION; REGIONS	Acromelic frontonasal dysostosis (AFND) is a rare disorder characterized by distinct craniofacial, brain, and limb malformations, including frontonasal dysplasia, interhemispheric lipoma, agenesis of the corpus callosum, tibial hemimelia, preaxial polydactyly of the feet, and intellectual disability. Exome sequencing of one trio and two unrelated probands revealed the same heterozygous 'variant (c.3487C>T [p. Arg1163Trp]) in a highly conserved protein domain of ZSWIM6; this variant has not been seen in the 1000 Genomes data, dbSNP, or the Exome Sequencing Project. Sanger validation of the three trios confirmed that the variant was de novo and was also present in a fourth isolated proband. In situ hybridization of early zebrafish embryos at 24 hr postfertilization (hpf) demonstrated telencephalic expression of zswim6 and onset of midbrain, hindbrain, and retinal expression at 48 hpf. Immunohistochemistry of later-stage mouse embryos demonstrated tissue-specific expression in the derivatives of all three germ layers. gRT-PCR expression analysis of osteoblast and fibroblast cell lines available from two probands was suggestive of Hedgehog pathway activation, indicating that the ZSWIM6 mutation associated with AFND may lead to the craniofacial, brain and limb malformations through the disruption of Hedgehog signaling.	[Smith, Joshua D.; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Hing, Anne V.; Johnson, Nathan M.; Maves, Lisa; Cunningham, Michael L.] Seattle Childrens Res Inst, Ctr Dev Biol & Regenerat Med, Seattle, WA 98101 USA; [Hing, Anne V.; Maves, Lisa; Cunningham, Michael L.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Hing, Anne V.; Clarke, Christine M.; Park, Sarah S.; Cunningham, Michael L.] Seattle Childrens Hosp, Craniofacial Ctr, Seattle, WA 98105 USA; [Horst, Jeremy A.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Mecham, Brig] Trialomics, Seattle, WA 98101 USA; [Perez, Francisco A.] UW Med, Dept Radiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of California System; University of California San Francisco	Cunningham, ML (corresponding author), Seattle Childrens Res Inst, Ctr Dev Biol & Regenerat Med, Seattle, WA 98101 USA.	michael.cunningham@seattlechildrens.org			National Human Genome Research Institute; National Heart, Lung and Blood Institute of the National Institutes of Health [1U54HG006493, 1RC2HG005608, 5R000HG004316]; Jean Renny Endowment for Craniofacial Medicine; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006493, R00HG004316, U54HG006493, K99HG004316, RC2HG005608] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Jean Renny Endowment for Craniofacial Medicine; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We would like to thank the participating families and the following people for their participation and support in developing the manuscript: Colleen Davis, Stephanie Krauter, and Jason Underwood for editorial assistance. Our work is supported in part by grants from National Human Genome Research Institute and National Heart, Lung and Blood Institute of the National Institutes of Health (1U54HG006493 to M.B., D.N., and J.S.; 1RC2HG005608 to M.B., D.N., and J.S.; and 5R000HG004316 to H.K.T.) and the Jean Renny Endowment for Craniofacial Medicine (M.L.C.). Brigham Mecham is founder and CEO of Trialomics.	Babbs C, 2008, MECH DEVELOP, V125, P517, DOI 10.1016/j.mod.2008.01.001; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bradford Y, 2011, NUCLEIC ACIDS RES, V39, pD822, DOI 10.1093/nar/gkq1077; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; Cheng JL, 2006, DATA MIN KNOWL DISC, V13, P1, DOI 10.1007/s10618-005-0023-5; Cheng JL, 2005, DATA MIN KNOWL DISC, V11, P213, DOI 10.1007/s10618-005-0001-y; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Hayes C, 1998, J ANAT, V193, P81, DOI 10.1046/j.1469-7580.1998.19310081.x; Hing AV, 2004, AM J MED GENET A, V128A, P374, DOI 10.1002/ajmg.a.30091; Horst JA, 2010, CURR PROTEIN PEPT SC, V11, P573; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MacDonald WA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-105; Makarova KS, 2002, TRENDS BIOCHEM SCI, V27, P384, DOI 10.1016/S0968-0004(02)02140-0; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Slaney SF, 1999, AM J MED GENET, V83, P109, DOI 10.1002/(SICI)1096-8628(19990312)83:2<109::AID-AJMG6>3.3.CO;2-#; Smith CM, 2014, NUCLEIC ACIDS RES, V42, pD818, DOI 10.1093/nar/gkt954; Toriello H V, 1986, Am J Med Genet Suppl, V2, P89; Vargas FR, 1998, HUM GENET, V102, P387, DOI 10.1007/s004390050709; Wang CB, 2007, DEV BIOL, V305, P460, DOI 10.1016/j.ydbio.2007.02.029; Wang K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-385; Wang K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000181; Yang Y, 1998, DEVELOPMENT, V125, P3123; Yao ZZ, 2013, BIOL OPEN, V2, P546, DOI 10.1242/bio.20133921	27	30	32	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 7	2014	95	2					235	240		10.1016/j.ajhg.2014.07.008	http://dx.doi.org/10.1016/j.ajhg.2014.07.008			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM7VE	25105228	Green Published, Bronze			2022-12-18	WOS:000340076000010
J	Eytan, O; Morice-Picard, F; Sarig, O; Ezzedine, K; Isakov, O; Li, QL; Ishida-Yamamoto, A; Shomron, N; Goldsmith, T; Fuchs-Telem, D; Adir, N; Uitto, J; Orlow, SJ; Taieb, A; Sprecher, E				Eytan, Ori; Morice-Picard, Fanny; Sarig, Ofer; Ezzedine, Khaled; Isakov, Ofer; Li, Qiaoli; Ishida-Yamamoto, Akemi; Shomron, Noam; Goldsmith, Tomer; Fuchs-Telem, Dana; Adir, Noam; Uitto, Jouni; Orlow, Seth J.; Taieb, Alain; Sprecher, Eli			Cole Disease Results from Mutations in ENPP1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ARTERIAL CALCIFICATION; PUNCTATE KERATOSIS; HYPOPIGMENTATION; PALMS	The coexistence of abnormal keratinization and aberrant pigmentation in a number of comification disorders has long suggested a mechanistic link between these two processes. Here, we deciphered the genetic basis of Cole disease, a rare autosomal-dominant genodermatosis featuring punctate keratoderma, patchy hypopigmentation, and uncommonly, cutaneous calcifications. Using a combination of exome and direct sequencing, we showed complete cosegregation of the disease phenotype with three heterozygous ENPP1 mutations in three unrelated families. All mutations were found to affect cysteine residues in the somatomedin-B-like 2 (SMB2) domain in the encoded protein, which has been implicated in insulin signaling. ENPP1 encodes ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1), which is responsible for the generation of inorganic pyrophosphate, a natural inhibitor of mineralization. Previously, biallelic mutations in ENPP1 were shown to underlie a number of recessive conditions characterized by ectopic calcification, thus providing evidence of profound phenotypic heterogeneity in ENPP1-associated genetic diseases.	[Eytan, Ori; Sarig, Ofer; Goldsmith, Tomer; Fuchs-Telem, Dana; Sprecher, Eli] Tel Aviv Sourasky Med Ctr, Dept Dermatol, IL-642395 Tel Aviv, Israel; [Eytan, Ori; Fuchs-Telem, Dana; Sprecher, Eli] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Ramat Aviv, Israel; [Morice-Picard, Fanny; Ezzedine, Khaled; Taieb, Alain] St Andre Hosp, Dept Dermatol & Pediat Dermatol, Natl Ctr Rare Skin Disorders, F-33075 Bordeaux, France; [Morice-Picard, Fanny; Ezzedine, Khaled; Taieb, Alain] Univ Bordeaux, Inst Natl Sante & Rech Med 1035, F-33075 Bordeaux, France; [Isakov, Ofer; Shomron, Noam] Tel Aviv Univ, Dept Cell & Dev Biol, Fac Med, IL-69978 Ramat Aviv, Israel; [Li, Qiaoli; Uitto, Jouni] Thomas Jefferson Univ, Jefferson Med Coll, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; [Li, Qiaoli; Uitto, Jouni] Thomas Jefferson Univ, Jefferson Med Coll, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Li, Qiaoli; Uitto, Jouni] Thomas Jefferson Univ, Jefferson Inst Mol Med, Philadelphia, PA 19107 USA; [Ishida-Yamamoto, Akemi] Asahikawa Med Univ, Dept Dermatol, Asahikawa, Hokkaido 0788510, Japan; [Adir, Noam] Technion Israel Inst Technol, Schulich Fac Chem, IL-32000 Haifa, Israel; [Orlow, Seth J.] NYU, Sch Med, Ronald O Perelman Dept Dermatol, New York, NY 10016 USA	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Tel Aviv University; Jefferson University; Jefferson University; Jefferson University; Asahikawa Medical College; Technion Israel Institute of Technology; New York University	Taieb, A (corresponding author), St Andre Hosp, Dept Dermatol & Pediat Dermatol, Natl Ctr Rare Skin Disorders, F-33075 Bordeaux, France.	alain.taieb@chu-bordeaux.fr; elisp@tasmc.health.gov.il	Adir, Noam/ABE-6990-2020; TAIEB, ALAIN/AAB-1085-2021	Li, Qiaoli/0000-0002-8495-7103; Orlow, Seth/0000-0003-2548-7380; Ezzedine, Khaled/0000-0002-5468-4589	Ram family; National Institutes of Health; National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR28450, R21 AR063781]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR063781, R01AR028450] Funding Source: NIH RePORTER	Ram family; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We would like to acknowledge the participation of all family members in this study. This study was supported by a generous donation from the Ram family, National Institutes of Health and National Institute of Arthritis and Musculoskeletal and Skin Diseases grants R01 AR28450 and R21 AR063781, and a gift from the Bohnert Foundation.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Boissy RE, 2003, EXP DERMATOL, V12, P5, DOI 10.1034/j.1600-0625.12.s2.1.x; COLE LA, 1976, ARCH DERMATOL, V112, P998, DOI 10.1001/archderm.112.7.998; Edmondson SR, 1999, J CELL PHYSIOL, V179, P201, DOI 10.1002/(SICI)1097-4652(199905)179:2<201::AID-JCP10>3.0.CO;2-9; Giehl KA, 2012, AM J HUM GENET, V91, P754, DOI 10.1016/j.ajhg.2012.08.024; Goding JW, 2003, BBA-MOL BASIS DIS, V1638, P1, DOI 10.1016/S0925-4439(03)00058-9; Goldfine ID, 2008, ENDOCR REV, V29, P62, DOI 10.1210/er.2007-0004; Hyun E, 2010, J IMMUNOL, V184, P2702, DOI 10.4049/jimmunol.0902171; Jansen S, 2012, STRUCTURE, V20, P1948, DOI 10.1016/j.str.2012.09.001; Kato K, 2012, P NATL ACAD SCI USA, V109, P16876, DOI 10.1073/pnas.1208017109; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lorenz-Depiereux B, 2010, AM J HUM GENET, V86, P267, DOI 10.1016/j.ajhg.2010.01.006; Maddux BA, 2000, DIABETES, V49, P13, DOI 10.2337/diabetes.49.1.13; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moore MM, 2009, ARCH DERMATOL, V145, P395; Nitschke Y, 2012, TRENDS CARDIOVAS MED, V22, P145, DOI 10.1016/j.tcm.2012.07.011; Nitschke Y, 2012, AM J HUM GENET, V90, P25, DOI 10.1016/j.ajhg.2011.11.020; Pohler E, 2012, NAT GENET, V44, P1272, DOI 10.1038/ng.2444; Rutsch F, 2003, NAT GENET, V34, P379, DOI 10.1038/ng1221; Schmieder A, 2011, ACTA DERM-VENEREOL, V91, P737, DOI 10.2340/00015555-1122; Stachelscheid H, 2008, EMBO J, V27, P2091, DOI 10.1038/emboj.2008.141; Stefan C, 2005, TRENDS BIOCHEM SCI, V30, P542, DOI 10.1016/j.tibs.2005.08.005; Vignale R, 2002, PEDIATR DERMATOL, V19, P302, DOI 10.1046/j.1525-1470.2002.00084.x	25	30	33	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 3	2013	93	4					752	757		10.1016/j.ajhg.2013.08.007	http://dx.doi.org/10.1016/j.ajhg.2013.08.007			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	243GT	24075184	Bronze, Green Published			2022-12-18	WOS:000326305600017
J	Niemczyk, M; Ito, Y; Huddleston, J; Git, A; Abu-Amero, S; Caldas, C; Moore, GE; Stojic, L; Murre, A				Niemczyk, Malwina; Ito, Yoko; Huddleston, Joanna; Git, Anna; Abu-Amero, Sayeda; Caldas, Carlos; Moore, Gudrun E.; Stojic, Lovorka; Murre, Adele			Imprinted Chromatin around DIRAS3 Regulates Alternative Splicing of GNG12-AS1, a Long Noncoding RNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TUMOR-SUPPRESSOR GENE; CANCER CELL-MIGRATION; ARHI DIRAS3; DNA METHYLATION; BREAST; TRANSCRIPTION; EXPRESSION; OVARIAN; REVEALS; GENOME	Imprinted gene clusters are regulated by long noncoding RNAs (lncRNAs), CCCTC binding factor (CTCF)-mediated boundaries, and DNA methylation. DIRAS3 (also known as ARH1 or NOEY1) is an imprinted gene encoding a protein belonging to the RAS superfamily of GTPases and is located within an intron of a lncRNA called GNG12-AS1. In this study, we investigated whether GNG12-AS1 is imprinted and coregulated with DIRAS3. We report that GNG12-AS1 is coexpressed with DIRAS3 in several tissues and coordinately downregulated with DIRAS3 in breast cancers. GNG12-AS1 has several splice variants, all of which initiate from a single transcription start site. In placenta tissue and normal cell lines, GNG12-AS1 is biallelically expressed but some isoforms are allele-specifically spliced. Cohesin plays a role in allele-specific splicing of GNG12-AS1. In breast cancer cell lines with loss of DIRAS3 imprinting, DIRAS3 and GNG12-AS1 are silenced in cis and the remaining GNG12-AS1 transcripts are predominantly monoallelic. The GNG12-AS1 locus, which includes D1RAS3, provides an example of imprinted cotranscriptional splicing and a potential model system for studying the long-range effects of CTCF-cohesin binding on splicing and transcriptional interference.	[Niemczyk, Malwina; Ito, Yoko; Huddleston, Joanna; Git, Anna; Caldas, Carlos; Stojic, Lovorka; Murre, Adele] Canc Res UK, Cambridge CB2 ORE, England; [Abu-Amero, Sayeda; Moore, Gudrun E.] UCL, Inst Child Hlth, London WC1N 1EH, England	Cancer Research UK; University of London; University College London	Murre, A (corresponding author), Canc Res UK, Robinson Way, Cambridge CB2 ORE, England.	adele.murrell@cruk.cam.ac.uk	Moore, Gudrun/A-2092-2009; Caldas, Carlos/U-7250-2019; Stojic, Lovorka/C-8598-2016	Caldas, Carlos/0000-0003-3547-1489; Stojic, Lovorka/0000-0001-6691-3396; Murrell, adele/0000-0003-2647-3511; Prater, Malwina/0000-0002-8202-5345	University of Cambridge; Cancer Research UK; Hutchison Whampoa Limited	University of Cambridge(University of Cambridge); Cancer Research UK(Cancer Research UK); Hutchison Whampoa Limited	The authors wish to thank G.E.M. and S.A.-A. at the Institute of Child Health at University College London for the placenta tissue and DNA. We would like to acknowledge the support of The University of Cambridge, Cancer Research UK, and Hutchison Whampoa Limited.	Badgwell DB, 2012, ONCOGENE, V31, P68, DOI 10.1038/onc.2011.213; Barletta JM, 1997, CANCER RES, V57, P48; Barlow DP, 2011, ANNU REV GENET, V45, P379, DOI 10.1146/annurev-genet-110410-132459; Bertani S, 2011, MOL CELL, V43, P1040, DOI 10.1016/j.molcel.2011.08.019; Chen HS, 2012, J VIROL, V86, P9454, DOI 10.1128/JVI.00787-12; Chen Y, 2011, CANCER PREV RES, V4, P76, DOI 10.1158/1940-6207.CAPR-10-0167; Coolen MW, 2010, NAT CELL BIOL, V12, P235, DOI 10.1038/ncb2023; Cowley M, 2012, NUCLEIC ACIDS RES, V40, P8917, DOI 10.1093/nar/gks654; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dalai I, 2007, NEOPLASIA, V9, P181, DOI 10.1593/neo.06838; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hon G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000566; Huang J, 2009, MOL CARCINOGEN, V48, P130, DOI 10.1002/mc.20461; Huang SY, 2010, BIOSCIENCE REP, V30, P159, DOI 10.1042/BSR20090008; Klingauf M, 2013, BIOL CELL, V105, P91, DOI 10.1111/boc.201200030; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Latos PA, 2012, SCIENCE, V338, P1469, DOI 10.1126/science.1228110; Li Y, 2012, TUMOR BIOL, V33, P1403, DOI 10.1007/s13277-012-0388-1; Lu Z, 2013, CELL ADHES MIGR, V7, P232, DOI 10.4161/cam.23648; Mokry M, 2012, NUCLEIC ACIDS RES, V40, P148, DOI 10.1093/nar/gkr720; Murrell A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001849; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Nishimoto A, 2005, CANCER RES, V65, P6701, DOI 10.1158/0008-5472.CAN-05-0130; Palmer AC, 2011, TRANSCR-AUSTIN, V2, P9, DOI 10.4161/trns.2.1.13511; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Pauler FM, 2012, CURR OPIN GENET DEV, V22, P283, DOI 10.1016/j.gde.2012.02.005; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Seidl CIM, 2006, EMBO J, V25, P3565, DOI 10.1038/sj.emboj.7601245; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Stojic L, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-16; Tilgner H, 2012, GENOME RES, V22, P1616, DOI 10.1101/gr.134445.111; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang L, 2003, CLIN CANCER RES, V9, P3660; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Wood AJ, 2008, GENE DEV, V22, P1141, DOI 10.1101/gad.473408; Wood AJ, 2007, PLOS GENET, V3, P192, DOI 10.1371/journal.pgen.0030020; Woodfine K, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-1; Yu YH, 1999, P NATL ACAD SCI USA, V96, P214, DOI 10.1073/pnas.96.1.214; Yu YH, 2006, METHOD ENZYMOL, V407, P455, DOI 10.1016/S0076-6879(05)07037-0; Yuan JH, 2003, CANCER RES, V63, P4174; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zou CF, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-22	46	30	30	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 8	2013	93	2					224	235		10.1016/j.ajhg.2013.06.010	http://dx.doi.org/10.1016/j.ajhg.2013.06.010			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202AP	23871723	Green Published, hybrid			2022-12-18	WOS:000323186200003
J	Vasseur, E; Boniotto, M; Patin, E; Laval, G; Quach, H; Manry, J; Crouau-Roy, B; Quintana-Murci, L				Vasseur, Estelle; Boniotto, Michele; Patin, Etienne; Laval, Guillaume; Quach, Helene; Manry, Jeremy; Crouau-Roy, Brigitte; Quintana-Murci, Lluis			The Evolutionary Landscape of Cytosolic Microbial Sensors in Humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CROHNS-DISEASE; HUMAN GENOME; POSITIVE SELECTION; NATURAL-SELECTION; HUMAN-POPULATIONS; GENE; SUSCEPTIBILITY; POLYMORPHISM; RECOGNITION; ASSOCIATION	Host-pathogen interactions are generally initiated by host recognition of microbial components or danger signals triggered by microbial invasion. This recognition involves germline-encoded microbial sensors or pattern-recognition receptors (PRRs). By studying the way in which natural selection has driven the evolution of these microbial sensors in humans, we can identify genes playing an essential role and distinguish them from other, more redundant genes. We characterized the sequence diversity of the NOD-like receptor family, including the NALP and NOD/IPAF subfamilies, in various populations worldwide and compared this diversity with that of other PRR families, such as Toll-like receptors (TLRs) and RIG-I-like receptors (RLRs). We found that most NALPs had evolved under strong selective constraints, suggesting that their functions are essential and possibly much broader than previously thought. Conversely, most NOD/IPAF subfamily members were subject to more relaxed selective constraints, suggesting greater redundancy. Furthermore, some NALP genes, including NLRP1, NLRP14, and CIITA, were found to have evolved adaptively. We identified those variants conferring a selective advantage on some human populations as the most likely targets of positive selection. More generally, the strength of selection differed considerably between the major families of microbial sensors. Endosomal TLRs and most NALPs were found to evolve under stronger purifying selection than most NOD/IPAF subfamily members and cell-surface TLRs and RLRs, suggesting some degree of redundancy in the signaling pathways triggered by these molecules. This study provides novel perspectives and experimentally testable hypotheses concerning the relative biological relevance of the various families of microbial sensors in humans.	[Vasseur, Estelle; Boniotto, Michele; Patin, Etienne; Laval, Guillaume; Quach, Helene; Manry, Jeremy; Quintana-Murci, Lluis] Inst Pasteur, Unit Human Evolutionary Genet, F-75015 Paris, France; [Vasseur, Estelle; Boniotto, Michele; Patin, Etienne; Laval, Guillaume; Quach, Helene; Manry, Jeremy; Quintana-Murci, Lluis] CNRS, URA 3012, F-75015 Paris, France; [Vasseur, Estelle; Crouau-Roy, Brigitte] Univ Toulouse, CNRS, UMR 5174, F-31062 Toulouse, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA)	Quintana-Murci, L (corresponding author), Inst Pasteur, Unit Human Evolutionary Genet, 25-28 Rue Dr Roux, F-75015 Paris, France.	quintana@pasteur.fr	Quintana-Murci, Lluis/AAB-7468-2022; Boniotto, Michele/F-1857-2010; Patin, Etienne/G-6768-2012; Boniotto, Michele/AAB-4302-2020	Boniotto, Michele/0000-0002-9548-2254; Boniotto, Michele/0000-0002-9548-2254; Patin, Etienne/0000-0002-9911-4459; Quach, Helene/0000-0002-3493-0973; Manry, Jeremy/0000-0001-5998-2051; Quintana-Murci, Lluis/0000-0003-2429-6320	Institut Pasteur; Agence Nationale de la Recherche [ANR-08-MIEN-009-01]; Fondation pour la Recherche Medicale; Centre National de la Recherche Scientifique; Merck-Serono; Ecole Polytechnique Federale de Lausanne-Debiopharm Life Sciences Award	Institut Pasteur(European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Merck-Serono(Merck & Company); Ecole Polytechnique Federale de Lausanne-Debiopharm Life Sciences Award	We would like to thank Luis B. Barreiro, Jean-Laurent Casanova, and Philippe Sansonetti for critical reading of the manuscript. This work was supported by Institut Pasteur, the Agence Nationale de la Recherche (ANR-08-MIEN-009-01), the Fondation pour la Recherche Medicale, the Centre National de la Recherche Scientifique, Merck-Serono, and an Ecole Polytechnique Federale de Lausanne-Debiopharm Life Sciences Award to L.Q.-M.	Aganna E, 2002, ARTHRITIS RHEUM-US, V46, P2445, DOI 10.1002/art.10509; Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boniotto M, 2012, HUM IMMUNOL, V73, P196, DOI 10.1016/j.humimm.2011.10.014; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Cann HM, 2002, SCIENCE, V296, P261; Casanova JL, 2011, ANNU REV IMMUNOL, V29, P447, DOI 10.1146/annurev-immunol-030409-101335; EXCOFFIER L, 1992, GENETICS, V131, P479; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gerard N, 2004, J ENDOCRINOL, V180, P203, DOI 10.1677/joe.0.1800203; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kufer TA, 2011, NAT IMMUNOL, V12, P121, DOI 10.1038/ni.1985; Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006; Laval G, 2004, BIOINFORMATICS, V20, P2485, DOI 10.1093/bioinformatics/bth264; Laval G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010284; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Magitta NF, 2009, GENES IMMUN, V10, P120, DOI 10.1038/gene.2008.85; Manry J, 2011, J EXP MED, V208, P2747, DOI 10.1084/jem.20111680; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Murdoch S, 2006, NAT GENET, V38, P300, DOI 10.1038/ng1740; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ohno S., 1970, EVOLUTION GENE DUPLI; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Quintana-Murci L, 2007, NAT IMMUNOL, V8, P1165, DOI 10.1038/ni1535; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; SAWYER SA, 1992, GENETICS, V132, P1161; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sironi M, 2010, MICROBES INFECT, V12, P421, DOI 10.1016/j.micinf.2010.02.002; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Swanberg M, 2005, NAT GENET, V37, P486, DOI 10.1038/ng1544; Takahashi Masazumi, 2003, J Bioinform Comput Biol, V1, P253, DOI 10.1142/S021972000300006X; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Vasseur E, 2011, HUM MOL GENET, V20, P4462, DOI 10.1093/hmg/ddr377; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zhang P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002755	55	30	30	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 13	2012	91	1					27	37		10.1016/j.ajhg.2012.05.008	http://dx.doi.org/10.1016/j.ajhg.2012.05.008			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	974OE	22748209	Green Published, Bronze			2022-12-18	WOS:000306445000003
J	Fu, WQ; Zhang, F; Wang, Y; Gu, X; Jin, L				Fu, Wenqing; Zhang, Feng; Wang, Yi; Gu, Xun; Jin, Li			Identification of Copy Number Variation Hotspots in Human Populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENOME; DNA; REARRANGEMENTS; RECOMBINATION; DIVERSITY; DUPLICATIONS; DISEASE; RATES; MAP; POLYMORPHISMS	Copy number variants (CNVs) in the human genome contribute to both Mendelian and complex traits as well as to genomic plasticity in evolution The investigation of mutational rates of CNVs is critical to understanding genomic instability and the etiology of the copy number variation (CNV)-related traits However, the evaluation of the CNV mutation rate at the genome level poses an insurmountable practical challenge that requires large samples and accurate typing. In this study, we show that an approximate estimation of the CNV mutation rate could be achieved by using the phylogeny information of flanking SNPs This allows a genome-wide comparison of mutation rates between CNVs with the use of vast, readily available data of SNP genotyping. A total of 4187 CNV regions (CNVRs) previously identified in HapMap populations were investigated in this study We showed that the mutation rates for the majority of these CNVRs are at the order of 10(-5) per generation, consistent with experimental observations at individual loci Notably, the mutation rates of 104 (2 5%) CNVRs were estimated at the order of 10(-3) per generation, therefore, they were identified as potential hotspots. Additional analyses revealed that genome architecture at CNV loci has a potential role in inciting mutational hotspots in the human genome. Interestingly, 49 (47%) CNV hotspots include human genes, some of which are known to be functional CNV loci (e g, CNVs of C4 and beta-defensin causing autoimmune diseases and CNVs of HYDIN with implication in control of cerebral cortex size), implicating the important role of CNV in human health and evolution, especially in common and complex diseases	[Fu, Wenqing; Zhang, Feng; Wang, Yi; Gu, Xun; Jin, Li] Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Fu, Wenqing; Zhang, Feng; Wang, Yi; Gu, Xun; Jin, Li] Fudan Univ, MOE Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai 200433, Peoples R China; [Fu, Wenqing; Zhang, Feng; Wang, Yi; Gu, Xun; Jin, Li] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Gu, Xun] Iowa State Univ, Dept Genet Dev & Cell Biol Genet, Ctr Bioinformat & Biol Stat, Ames, IA 50011 USA; [Jin, Li] Chinese Acad Sci, Dept Computat Genom, CAS MPG Partner Inst Computat Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Fudan University; Fudan University; Fudan University; Iowa State University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Jin, L (corresponding author), Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.		Jin, Li/C-1468-2009; Zhang, Feng/C-7735-2009; Jin, Li/M-5063-2019	Jin, Li/0000-0002-4546-2415; Zhang, Feng/0000-0003-4556-8276; 	National Natural Science Foundation of China (NSFC) [30890034, 31000552]; NSFC for the Young Distinguished Scholar [30625016]; Program of Shanghai Subject Chief Scientist [09XD1400200]; Shanghai Pujiang Program [10PJ1400300]; Ministry of Education of China [NCET-09-0322]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC for the Young Distinguished Scholar; Program of Shanghai Subject Chief Scientist; Shanghai Pujiang Program(Shanghai Pujiang Program); Ministry of Education of China(Ministry of Education, China)	We are grateful to M E. Hurles and D F Conrad for their kind providing of the data for CNV formation mechanisms The project was supported by the National Natural Science Foundation of China (NSFC) (30890034 and 31000552), NSFC for the Young Distinguished Scholar (30625016), and the Program of Shanghai Subject Chief Scientist (09XD1400200) FZ is supported by the Shanghai Pujiang Program (10PJ1400300) and a Ministry of Education of China grant (NCET-09-0322).	Abu Bakar S, 2009, P NATL ACAD SCI USA, V106, P853, DOI 10.1073/pnas.0809073106; Argueso JL, 2008, P NATL ACAD SCI USA, V105, P11845, DOI 10.1073/pnas.0804529105; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; COLIN Y, 1991, BLOOD, V78, P2747; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cusco I, 2009, HUM MOL GENET, V18, P1795, DOI 10.1093/hmg/ddp092; Egan CM, 2007, NAT GENET, V39, P1384, DOI 10.1038/ng.2007.19; Ester WA, 2009, J CLIN ENDOCR METAB, V94, P4717, DOI 10.1210/jc.2008-1502; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Huang RS, 2009, HUM MOL GENET, V18, P366, DOI 10.1093/hmg/ddn345; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Kato M, 2008, AM J HUM GENET, V83, P157, DOI 10.1016/j.ajhg.2008.06.021; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lam KWG, 2007, P NATL ACAD SCI USA, V104, P10950, DOI 10.1073/pnas.0703856104; Lam KWG, 2006, P NATL ACAD SCI USA, V103, P8921, DOI 10.1073/pnas.0602690103; Laval G, 2004, BIOINFORMATICS, V20, P2485, DOI 10.1093/bioinformatics/bth264; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Minichiello MJ, 2006, AM J HUM GENET, V79, P910, DOI 10.1086/508901; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Park H, 2010, NAT GENET, V42, P400, DOI 10.1038/ng.555; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Repping S, 2006, NAT GENET, V38, P463, DOI 10.1038/ng1754; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Turner DJ, 2008, NAT GENET, V40, P90, DOI 10.1038/ng.2007.40; van Ommen GJB, 2005, NAT GENET, V37, P333, DOI 10.1038/ng0405-333; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257; Zhang F, 2009, TRENDS GENET, V25, P298, DOI 10.1016/j.tig.2009.05.005; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399	41	30	32	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 8	2010	87	4					494	504		10.1016/j.ajhg.2010.09.006	http://dx.doi.org/10.1016/j.ajhg.2010.09.006			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	665LU	20920665	Green Published, Bronze			2022-12-18	WOS:000283037600005
J	Li, H; Cho, K; Kidd, JR; Kidd, KK				Li, Hui; Cho, Kelly; Kidd, Judith R.; Kidd, Kenneth K.			Genetic Landscape of Eurasia and "Admixture" in Uyghurs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							POPULATION; INFERENCE; DIVERSITY		[Li, Hui; Cho, Kelly; Kidd, Judith R.; Kidd, Kenneth K.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA	Yale University	Kidd, KK (corresponding author), Yale Univ, Sch Med, Dept Genet, 333 Cedar St, New Haven, CT 06520 USA.	kenneth.kidd@yale.edu	Li, Hui/A-2014-2010		NIGMS NIH HHS [P01 GM057672] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM057672] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Du R, 1997, B BIOL FR BELG, V32, P9; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Li DN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002168; Li H, 2007, AM J PHYS ANTHROPOL, V134, P481, DOI 10.1002/ajpa.20690; Li H, 2007, HUM GENET, V122, P383, DOI 10.1007/s00439-007-0407-2; Li H, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-146; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Mackerras Colin, 1972, UIGHUR EMPIRE ACCORD; Mallory J.P., 2000, TARIM MUMMIES ANCIEN; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; SAMPSON JN, 2008, ANN M AM SOC HUM GEN; Xiao FX, 2002, HUM BIOL, V74, P555, DOI 10.1353/hub.2002.0050; Xu SH, 2008, AM J HUM GENET, V83, P322, DOI 10.1016/j.ajhg.2008.08.001; Xu SH, 2008, AM J HUM GENET, V82, P883, DOI 10.1016/j.ajhg.2008.01.017	15	30	33	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 11	2009	85	6					934	937		10.1016/j.ajhg.2009.10.024	http://dx.doi.org/10.1016/j.ajhg.2009.10.024			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	533BN	20004770	Bronze, Green Published			2022-12-18	WOS:000272797100020
J	Marchini, J; Howie, B				Marchini, Jonathan; Howie, Bryan			Comparing Algorithms for Genotype Imputation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							GENOME-WIDE ASSOCIATION		[Marchini, Jonathan; Howie, Bryan] Univ Oxford, Dept Stat, Oxford OX1 3TG, England	University of Oxford	Marchini, J (corresponding author), Univ Oxford, Dept Stat, Oxford OX1 3TG, England.	marchini@stats.ox.ac.uk	Marchini, Jonathan/ABE-9024-2020	Marchini, Jonathan/0000-0003-0610-8322	Wellcome Trust [076113] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Lin DY, 2008, AM J HUM GENET, V82, P444, DOI 10.1016/j.ajhg.2007.11.004; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Nicolae DL, 2006, GENET EPIDEMIOL, V30, P718, DOI 10.1002/gepi.20182; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	9	30	31	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT 10	2008	83	4					535	539		10.1016/j.ajhg.2008.09.007	http://dx.doi.org/10.1016/j.ajhg.2008.09.007			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	363AV	18940314	Bronze, Green Published			2022-12-18	WOS:000260239200012
J	Arnos, KS; Welch, KO; Tekin, M; Norris, VW; Blanton, SH; Pandya, A; Nance, WE				Arnos, Kathleen S.; Welch, Katherine O.; Tekin, Mustafa; Norris, Virginia W.; Blanton, Susan H.; Pandya, Arti; Nance, Walter E.			A comparative analysis of the genetic epidemiology of deafness in the United States in two sets of pedigrees collected more than a century apart	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL RECESSIVE DEAFNESS; GJB2 MUTATIONS; CHILDHOOD DEAFNESS; DFNB1 LOCUS; CONNEXIN-26; POPULATION; PREVALENCE; FREQUENCY; FOUNDER; FORM	In 1898, E.A. Fay published an analysis of nearly 5000 marriages among deaf individuals in America collected during the 19(th) century. Each pedigree included three-generation data on marriage partners that included at least one deaf proband, who were ascertained by complete selection. We recently proposed that the intense phenotypic assortative mating among the deaf might have greatly accelerated the normally slow response to relaxed genetic selection against deafness that began in many Western countries with the introduction of sign language and the establishment of residential schools. Simulation studies suggest that this mechanism might have doubled the frequency of the commonest forms of recessive deafness (DFNB1) in this country during the past 200 years. To test this prediction, we collected pedigree data on 311 contemporary marriages among deaf individuals that were comparable to those collected by Fay. Segregation analysis of the resulting data revealed that the estimated proportion of noncomplementary matings that can produce only deaf children has increased by a factor of more than five in the past 100 years. Additional analysis within our sample of contemporary pedigrees showed that there was a statistically significant linear increase in the prevalence of pathologic GJB2 mutations when the data on 441 probands were partitioned into three 20-year birth cohorts (1920 through 1980). These data are consistent with the increase in the frequency of DFNB1 predicted by our previous simulation studies and provide convincing evidence for the important influence that assortative mating can have on the frequency of common genes for deafness.	[Arnos, Kathleen S.; Welch, Katherine O.; Norris, Virginia W.] Gallaudet Univ, Dept Biol, Washington, DC 20002 USA; [Tekin, Mustafa] Ankara Univ, Sch Med, Dept Pediat, Div Clin Mol Pathol & Genet, TR-06100 Ankara, Turkey; [Blanton, Susan H.] Univ Miami, Miami Inst Human Genom, Miami, FL 33136 USA; [Pandya, Arti; Nance, Walter E.] Virginia Commonwealth Univ, Dept Human Genet, Richmond, VA 23298 USA	Ankara University; University of Miami; Virginia Commonwealth University	Arnos, KS (corresponding author), Gallaudet Univ, Dept Biol, Washington, DC 20002 USA.	kathleen.arnos@gallaudet.edu	Tekin, Mustafa/ABG-7627-2020; Blanton, Susan Halloran/ABF-1323-2021	Tekin, Mustafa/0000-0002-3525-7960	National Institutes of Health [OR01DC006707]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006707] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank all participating Gallaudet University alumni and their families for their cooperation. We also thank Samuel Sonnen-strahl, Director, Office of Alumni Relations at Gallaudet University for his assistance with subject recruitment. The authors also acknowledge Amber Bart for assistance with the statistical analysis and Chana Esther Fogel for assistance with data collection and preparation of the figure. This study was supported by National Institutes of Health grant OR01DC006707 awarded to K.S.A.	Abe S, 2000, J MED GENET, V37, P41, DOI 10.1136/jmg.37.1.41; Adato A, 1999, AM J HUM GENET, V65, P261, DOI 10.1086/302438; BELL AG, 1883, NAT ACAD SCI MEM, V2, P177; BRADEN JP, 1987, AM ANN DEAF, V132, P263, DOI 10.1353/aad.2012.0723; Braden JP, 1994, DEAFNESS DEPRIVATION; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; del Castillo FJ, 2005, J MED GENET, V42, P588, DOI 10.1136/jmg.2004.028324; del Castillo I, 2003, AM J HUM GENET, V73, P1452, DOI 10.1086/380205; Denoyelle F, 1997, HUM MOL GENET, V6, P2173, DOI 10.1093/hmg/6.12.2173; Denoyelle F, 1999, LANCET, V353, P1298, DOI 10.1016/S0140-6736(98)11071-1; EMERY AEH, 1986, METHODOLOGY CLIN GEN, P37; Fay E.A., 1898, MARRIAGES DEAF AM; FRIEDMAN TB, 1995, NAT GENET, V9, P86, DOI 10.1038/ng0195-86; Kudo T, 2000, AM J MED GENET, V90, P141, DOI 10.1002/(SICI)1096-8628(20000117)90:2<141::AID-AJMG10>3.0.CO;2-G; MARAZITA ML, 1993, AM J MED GENET, V46, P486, DOI 10.1002/ajmg.1320460504; Morell R, 1997, HUM MOL GENET, V6, P659, DOI 10.1093/hmg/6.5.659; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; MORTON NE, 1969, COMPUTER APPLICATION, P129; Nance WE, 2000, LANCET, V356, P500, DOI 10.1016/S0140-6736(00)02565-4; Nance WE, 2004, AM J HUM GENET, V74, P1081, DOI 10.1086/420979; Orzan E, 1999, BRIT J AUDIOL, V33, P291, DOI 10.3109/03005369909090112; Pandya A, 2003, GENET MED, V5, P295, DOI 10.1097/01.GIM.0000078026.01140.68; PAQUIN MM, 1992, THESIS CALIFORNIA SC; RamShankar M, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.5.e68; Riazuddin S, 2000, NAT GENET, V26, P431, DOI 10.1038/82558; Rose S. P., 1975, THESIS INDIANA U; ROSE SP, 1977, CHILDHOOD DEAFNESS, P9; RUBEN RJ, 1991, ANN NY ACAD SCI, V630, P6, DOI 10.1111/j.1749-6632.1991.tb19571.x; SCHEIN JD, 1974, DEAF POPULATION US, P1; Schlingmann KP, 2004, PEDIATR NEPHROL, V19, P13, DOI 10.1007/s00467-003-1293-z; SCOTT DA, 1995, AM J HUM GENET, V57, P965; SOYSAL Y, 2001, 4 INT K HETH WURZB 4, P652; Tekin M, 2001, HUM GENET, V108, P385, DOI 10.1007/s004390100507; Tekin M, 2007, AM J MED GENET A, V143A, P1583, DOI 10.1002/ajmg.a.31702; Van Laer L, 2001, J MED GENET, V38, P515, DOI 10.1136/jmg.38.8.515; VANCLEVE JV, 1987, GALLAUDET ENCY DEAF, V1, P426; Wilch E, 2006, AM J HUM GENET, V79, P174, DOI 10.1086/505333; Zelante L, 1997, HUM MOL GENET, V6, P1605, DOI 10.1093/hmg/6.9.1605	39	30	33	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 8	2008	83	2					200	207		10.1016/j.ajhg.2008.07.001	http://dx.doi.org/10.1016/j.ajhg.2008.07.001			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337EL	18656178	Bronze, Green Published			2022-12-18	WOS:000258418200005
J	Choudhury, K; McQuillin, A; Puri, V; Pimm, J; Datta, S; Thirumalai, S; Krasucki, R; Lawrence, J; Bass, NJ; Quested, D; Crombie, C; Fraser, G; Walker, N; Nadeem, H; Johnson, S; Curtis, D; St Clair, D; Gurling, HMD				Choudhury, Khalid; McQuillin, Andrew; Puri, Vinay; Pimm, Jonathan; Datta, Susmita; Thirumalai, Srinivasa; Krasucki, Robert; Lawrence, Jacob; Bass, Nicholas J.; Quested, Digby; Crombie, Caroline; Fraser, Gillian; Walker, Nicholas; Nadeem, Haitham; Johnson, Sophie; Curtis, David; St Clair, David; Gurling, Hugh M. D.			A genetic association study of chromosome 11q22-24 in two different samples implicates the FXYD6 gene, encoding phosphohippolin, in susceptibility to schizophrenia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ION-TRANSPORT; NA,K-ATPASE; REGULATOR; LINKAGE; MARKERS; EXPRESSION; PEDIGREES; FAILURE; SUPPORT; TESTS	Previous linkage analyses of families with multiple cases of schizophrenia by us and others have confirmed the involvement of the chromosome 11q22-24 region in the etiology of schizophrenia, with LOD scores of 3.4 and 3.1. We now report fine mapping of a susceptibility gene in the 11q22-24 region, determined on the basis of a University College London (UCL) sample of 496 cases and 488 supernormal controls. Confirmation was then performed by the study of an Aberdeen sample consisting of 858 cases and 591 controls (for a total of 2,433 individuals: 1,354 with schizophrenia and 1,079 controls). Seven microsatellite or single-nucleotide polymorphism (SNP) markers localized within or near the FXYD6 gene showed empirically significant allelic associations with schizophrenia in the UCL sample (for D11S1998, for P = .021; for rs3168238, P = .009; for TTTC20.2, P = .048; for rs1815774, P = .049; for rs4938445, P = .010; for rs4938446, P = .025; for rs497768, P = .023). Several haplotypes were also found to be associated with schizophrenia; for example, haplotype Hap-F21 comprising markers rs10790212-rs4938445-rs497768 was found to be associated with schizophrenia, by a global permutation test (P = .002). Positive markers in the UCL sample were then genotyped in the Aberdeen sample. Two of these SNPs were found to be associated with schizophrenia in the Scottish sample (for rs4938445, P = .044; for rs497768, P = .037). The Hap- F21 haplotype also showed significant association with schizophrenia in the P p.044 P p.037 Aberdeen sample, with the same alleles being associated (P = .013). The FXYD6 gene encodes a protein called "phos phohippolin" that is highly expressed in regions of the brain thought to be involved in schizophrenia. The protein functions by modulating the kinetic properties of Na, K-ATPase to the specific physiological requirements of the tissue. Etiological base-pair changes in FXYD6 or in associated promoter/control regions are likely to cause abnormal function or expression of phosphohippolin and to increase genetic susceptibility to schizophrenia.	UCL, Sch Med, Windeyer Inst Med Sci, Dept Mental Hlth Sci,Mol Psychiat Lab, London W1T 4JF, England; W London Mental Hlth Trust, Hammersmith & Fulham Mental Hlth Unit, London, England; St Bernard Hosp, London, England; Univ London, Queen Mary Coll, London WC1E 7HU, England; Royal London Hosp, E London & City Mental Hlth Trust, London E1 1BB, England; W Berkshire Natl Hlth Serv Trust, Reading, Berks, England; Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX1 2JD, England; Univ Aberdeen, Inst Med Sci, Dept Mental Hlth, Aberdeen AB9 1FX, Scotland; Ravenscraig Hosp, Greenock, Scotland; Buckinghamshire Mental Hlth Natl Hlth Serv Trust, Aylesbury, Bucks, England	University of London; University College London; UCL Medical School; University of London; Queen Mary University London; Barts Health NHS Trust; Royal London Hospital; University of Oxford; University of Aberdeen	Gurling, HMD (corresponding author), UCL, Sch Med, Windeyer Inst Med Sci, Dept Mental Hlth Sci,Mol Psychiat Lab, 46 Cleveland St, London W1T 4JF, England.	h.gurling@ucl.ac.uk	Gurling, Hugh M/A-5029-2010; St Clair, David/AAN-2412-2021; McQuillin, Andrew/C-1623-2008; Curtis, David/HGB-3921-2022	McQuillin, Andrew/0000-0003-1567-2240; Curtis, David/0000-0002-4089-9183; Quested, Digby/0000-0001-6155-3336				ANDREASEN NC, 1995, LANCET, V346, P477, DOI 10.1016/S0140-6736(95)91325-4; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beguin P, 2002, EMBO J, V21, P3264, DOI 10.1093/emboj/cdf330; Crambert G, 2002, P NATL ACAD SCI USA, V99, P11476, DOI 10.1073/pnas.182267299; Crambert G, 2005, MOL BIOL CELL, V16, P2363, DOI 10.1091/mbc.E04-10-0878; CRAMBERT G, 2003, SCI STKE, pRE1; Curtis D, 2006, ANN HUM GENET, V70, P277, DOI 10.1111/j.1529-8817.2005.00225.x; Curtis D, 2002, ANN HUM GENET, V66, P235, DOI 10.1017/S0003480002001094; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Gurling HMD, 2001, AM J HUM GENET, V68, P661, DOI 10.1086/318788; Gurling HMD, 2006, ARCH GEN PSYCHIAT, V63, P844, DOI 10.1001/archpsyc.63.8.844; Kadowaki K, 2004, MOL BRAIN RES, V125, P105, DOI 10.1016/j.molbrainres.2004.03.021; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Maziade M, 1995, AM J MED GENET, V60, P522, DOI 10.1002/ajmg.1320600607; NANKO S, 1992, JPN J PSYCHIAT NEUR, V46, P155; Pimm J, 2005, AM J HUM GENET, V76, P902, DOI 10.1086/430095; Puri V, 2006, BIOL PSYCHIAT, V59, P195, DOI 10.1016/j.biopsych.2005.08.015; PURI V, 2006, BIOL PSYCHIAT   0913; Rizig MA, 2006, AM J MED GENET B, V141B, P296, DOI 10.1002/ajmg.b.30288; Rozen S, 2000, Methods Mol Biol, V132, P365; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; SPITZER REJ, 1977, SCHEDULE AFFECTIVE D; Spitzer RL, 1978, RES DIAGNOSTIC CRITE; Stefansson H, 2003, AM J HUM GENET, V72, P83, DOI 10.1086/345442; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Yamaguchi F, 2001, MOL BRAIN RES, V86, P189, DOI 10.1016/S0169-328X(00)00213-8; Zhao JH, 2002, BIOINFORMATICS, V18, P1694, DOI 10.1093/bioinformatics/18.12.1694; Zhao JH, 2000, HUM HERED, V50, P133, DOI 10.1159/000022901	30	30	33	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2007	80	4					664	672		10.1086/513475	http://dx.doi.org/10.1086/513475			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	153VV	17357072	Green Published, Bronze			2022-12-18	WOS:000245465200007
J	Chan, TL; Chan, YW; Ho, JWC; Chan, C; Chan, ASY; Chan, E; Lam, PWY; Tse, CW; Lee, KC; Lau, CW; Gwi, E; Leung, SY; Yuen, ST				Chan, TL; Chan, YW; Ho, JWC; Chan, C; Chan, ASY; Chan, E; Lam, PWY; Tse, CW; Lee, KC; Lau, CW; Gwi, E; Leung, SY; Yuen, ST			MSH2 c. 1452-1455delAATG is a founder mutation and an important cause of hereditary nonpolyposis colorectal cancer in the southern Chinese population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA MISMATCH REPAIR; MICROSATELLITE INSTABILITY; COLON-CANCER; ASHKENAZI; GERMLINE; ORIGIN; FAMILIES; DELETION; GENE; AGE	Hereditary nonpolyposis colorectal cancer (HNPCC) accounts for similar to2% of all colorectal cancer (CRC) cases and is the most common hereditary CRC syndrome. We have previously reported a high incidence of microsatellite instability (MSI) and germline mismatch repair (MMR) gene mutations in young Hong Kong Chinese with CRC. Ongoing studies at the Hereditary Gastrointestinal Cancer Registry in Hong Kong have revealed a unique germline MSH2 c. 1452-1455delAATG mutation that has not been reported in other ethnic groups. Detailed analysis showed that this specific MSH2 mutation constituted 21% of all germline MMR gene mutations and 36% of all MSH2 germline mutations identified. We designed a specific PCR-based diagnostic test on paraffin-embedded tissues and identified this germline mutation in 2 (1.5%) of 138 consecutive patients with early-onset CRC (< 46 years of age at diagnosis). Haplotype analysis was performed using 11 microsatellite markers located between D2S391 and D2S123. All 10 families had the same disease haplotype, suggesting a founder effect. These 10 families all originated from the Chinese province of Guangdong, which historically included Hong Kong. It is the most populous of the Chinese provinces, with a population of >93 million. Further analysis suggested that this founder mutation may date back to between 22 and 103 generations ago. The identification of this MSH2 founder mutation has important implications for the design of mutation-detection strategies for the southern Chinese population. Since there were major emigrations from Hong Kong and Guangdong province during the 19th and 20th centuries, this finding is also significant for Chinese communities worldwide.	Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Queen Mary Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Queen Mary Hosp, Hereditary Gastrointestinal Canc Registry, Hong Kong, Hong Kong, Peoples R China; Queen Elizabeth Hosp, Dept Pathol, Kowloon, Hong Kong, Peoples R China; Queen Elizabeth Hosp, Dept Surg, Kowloon, Hong Kong, Peoples R China; Princess Margaret Hosp, Dept Pathol, Kowloon, Hong Kong, Peoples R China; Princess Margaret Hosp, Dept Surg, Kowloon, Hong Kong, Peoples R China; Kwong Wah Hosp, Dept Pathol, Kowloon, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; Kwong Wah Hospital	Yuen, ST (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China.	suetyi@hkucc.hku.hk	Yuen, Siu/K-6311-2014; Leung, Suet Yi/C-4340-2009; Leung, Suet Yi/T-9620-2019	Leung, Suet Yi/0000-0001-8614-4619				Aaltonen LA, 1998, NEW ENGL J MED, V338, P1481, DOI 10.1056/NEJM199805213382101; BENGTSSON BO, 1981, TISSUE ANTIGENS, V18, P356, DOI 10.1111/j.1399-0039.1981.tb01404.x; Chan TL, 1999, JNCI-J NATL CANCER I, V91, P1221, DOI 10.1093/jnci/91.14.1221; Chan TL, 2001, ONCOGENE, V20, P2976, DOI 10.1038/sj.onc.1204376; CHINN TW, 1969, HIST CHINESE CALIFOR; Colombo R, 2000, HUM GENET, V107, P559, DOI 10.1007/s004390000421; Desai DC, 2000, J MED GENET, V37, P646, DOI 10.1136/jmg.37.9.646; Foulkes WD, 2002, AM J HUM GENET, V71, P1395, DOI 10.1086/345075; Froggatt NJ, 1999, J MED GENET, V36, P97; Ho JWC, 2000, INT J CANCER, V89, P356, DOI 10.1002/1097-0215(20000720)89:4<356::AID-IJC7>3.0.CO;2-J; HOEXTER CK, 1976, CANTON CALIFORNIA; Hutter P, 1996, J MED GENET, V33, P636, DOI 10.1136/jmg.33.8.636; Leung SY, 1998, AM J PATHOL, V153, P1181, DOI 10.1016/S0002-9440(10)65662-3; Moisio AL, 1996, AM J HUM GENET, V59, P1243; NYSTROMLAHTI M, 1995, NAT MED, V1, P1203, DOI 10.1038/nm1195-1203; Peltomaki P, 2001, HUM MOL GENET, V10, P735, DOI 10.1093/hmg/10.7.735; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; RodriguezBigas MA, 1997, J NATL CANCER I, V89, P1758, DOI 10.1093/jnci/89.23.1758; Shiri-Sverdlov R, 2000, HUM MUTAT, V16, P491, DOI 10.1002/1098-1004(200012)16:6<491::AID-HUMU6>3.3.CO;2-A; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Wagner A, 2003, AM J HUM GENET, V72, P1088, DOI 10.1086/373963; Yuen ST, 1997, BRIT J CANCER, V76, P1610, DOI 10.1038/bjc.1997.605; Yuen ST, 2002, ONCOGENE, V21, P7585, DOI 10.1038/sj.onc.1205968	23	30	32	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2004	74	5					1035	1042		10.1086/383591	http://dx.doi.org/10.1086/383591			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	813SF	15042510	Green Published, Bronze			2022-12-18	WOS:000220926100021
J	Sulek, A; Hoffman-Zacharska, D; Zdzienicka, E; Zaremba, J				Sulek, A; Hoffman-Zacharska, D; Zdzienicka, E; Zaremba, J			SCA8 repeat expansion coexists with SCA1 - Not only with SCA6	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							CAG REPEAT		Inst Psychiat & Neurol, Dept Genet, PL-02957 Warsaw, Poland	Institute of Psychiatry & Neurology	Zaremba, J (corresponding author), Inst Psychiat & Neurol, Dept Genet, Sobieskiego 9, PL-02957 Warsaw, Poland.			Sulek, Anna/0000-0003-2975-4888; Zaremba, Jacek/0000-0002-9546-7767				CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; Izumi Y, 2003, AM J HUM GENET, V72, P704, DOI 10.1086/367775; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221	3	30	31	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2003	73	4					972	974		10.1086/378524	http://dx.doi.org/10.1086/378524			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	727TL	14508711	Bronze, Green Published			2022-12-18	WOS:000185676100023
J	Sun, FZ; Cui, J; Gavras, H; Schwartz, F				Sun, FZ; Cui, J; Gavras, H; Schwartz, F			A novel class of tests for the detection of mitochondrial DNA-mutation involvement in diseases	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY OPTIC NEUROPATHY; PEDIGREE-MEMBER METHOD; DIABETES-MELLITUS; MATERNAL TRANSMISSION; LINKAGE ANALYSIS; HUMAN-EVOLUTION; LEBERS DISEASE; TRAITS; HYPERTENSION; INHERITANCE	We develop a novel class of tests to detect mitochondrial DNA (mtDNA)-mutation involvement in complex diseases by the study of affected pedigree members. For a pedigree, affected individuals are first considered and are then connected through their relatives. We construct a reduced pedigree from an original pedigree. Each configuration of a reduced pedigree is given a score, with high scores given to configurations that are consistent with mtDNA-mutation involvement and low scores given to configurations that are not consistent with mtDNA-mutation involvement. For many pedigrees, the weighted sum of scores of the pedigrees is calculated. The tests are formed by comparing the observed score with the expected score under the null hypothesis that only nuclear autosomal mutations are involved. We study the optimality of score functions and weights under the heterogeneity model without phenocopies. We also develop a method to estimate the contribution that mtDNA mutations make if they are involved under a heterogeneity model. Finally, we apply our methods to three data sets: Leber hereditary optic neuropathy, a disease that has been proved to be caused by mtDNA mutations; non-insulin-dependent diabetes mellitus (NIDDM); and hypertension (HTN). We find evidence of mtDNA-mutation involvement in all three diseases. The estimated fraction of patients with NIDDM due to mtDNA-mutation involvement is 22% (95% confidence interval [CI] 6%-38%). The fraction of patients with HTN potentially due to mtDNA-mutation involvement is estimated at 55% (95% CI 45%-65%).	Univ So Calif, Dept Biol Sci, Mol & Computat Biol Program, Los Angeles, CA 90089 USA; Boston Univ, Sch Med, Dept Med, Hypertens Sect, Boston, MA 02118 USA	University of Southern California; Boston University	Sun, FZ (corresponding author), Univ So Calif, Dept Biol Sci, Mol & Computat Biol Program, Los Angeles, CA 90089 USA.		Sun, Fengzhu/G-4373-2010	Sun, Fengzhu/0000-0002-8552-043X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK053392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018412] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG18412, R01 AG018412] Funding Source: Medline; NIDDK NIH HHS [R29 DK53392] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADAMS JH, 1966, BRAIN, V89, P15, DOI 10.1093/brain/89.1.15; Alcolado JC, 2002, DIABETIC MED, V19, P89, DOI 10.1046/j.1464-5491.2002.00675.x; BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11; Bickel P.J., 2001, MATH STAT BASIC IDEA; Cotticelli L, 1984, Metab Ophthalmol, V8, P31; Davis RE, 1997, P NATL ACAD SCI USA, V94, P4526, DOI 10.1073/pnas.94.9.4526; DeStefano AL, 2001, CLIN GENET, V60, P13, DOI 10.1034/j.1399-0004.2001.600103.x; Feingold E, 1997, AM J HUM GENET, V60, P965; Haghighi F, 2002, AM J HUM GENET, V70, P142, DOI 10.1086/324709; JOHNSTON PB, 1979, AM J OPHTHALMOL, V88, P868, DOI 10.1016/0002-9394(79)90565-8; KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403; KHOURYMJ, 1993, FUNDAMENTALS GENETIC, P77; KWITTKEN J, 1958, AM J PATHOL, V34, P185; MCLEOD JG, 1978, NEUROLOGY, V28, P179, DOI 10.1212/WNL.28.2.179; MCMAHON FJ, 1995, AM J HUM GENET, V56, P1277; Mili F, 1996, GENET EPIDEMIOL, V13, P605, DOI 10.1002/(SICI)1098-2272(1996)13:6<605::AID-GEPI6>3.3.CO;2-N; MULLERJENSEN A, 1978, KLIN MONATSBL AUGENH, V172, P831; NIKOSKELAINEN E, 1977, ARCH OPHTHALMOL-CHIC, V95, P969; NIKOSKELAINEN EK, 1987, ARCH OPHTHALMOL-CHIC, V105, P665, DOI 10.1001/archopht.1987.01060050083043; NOVOTNY EJ, 1986, NEUROLOGY, V36, P1053, DOI 10.1212/WNL.36.8.1053; OTTMAN R, 1988, AM J HUM GENET, V43, P257; Raffel LJ, 1996, DIABETES CARE, V19, P864, DOI 10.2337/diacare.19.8.864; REARDON W, 1992, LANCET, V340, P1376, DOI 10.1016/0140-6736(92)92560-3; SCHORK NJ, 1993, AM J HUM GENET, V53, P1320; SINGH G, 1989, NEW ENGL J MED, V320, P1300, DOI 10.1056/NEJM198905183202002; Sleutels F, 2000, CURR OPIN GENET DEV, V10, P229, DOI 10.1016/S0959-437X(00)00062-9; Sun FZ, 1998, GENET EPIDEMIOL, V15, P451, DOI 10.1002/(SICI)1098-2272(1998)15:5<451::AID-GEPI2>3.3.CO;2-J; Teng J, 1997, AM J HUM GENET, V60, P979; VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368; WALLACE DC, 1995, AM J HUM GENET, V57, P201; WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739; WALLACE DC, 1970, BRAIN, V93, P121, DOI 10.1093/brain/93.1.121; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; Watson B, 2001, AM J KIDNEY DIS, V38, P529, DOI 10.1053/ajkd.2001.26848; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WEEKS DE, 1992, AM J HUM GENET, V50, P859; WENT LN, 1964, ACTA GENET STAT MED, V14, P220; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Whittemore AS, 2001, AM J HUM GENET, V68, P457, DOI 10.1086/318186; WILSON J, 1963, BRAIN, V86, P347, DOI 10.1093/brain/86.2.347; WILSON J, 1965, Ann Phys Med, V8, P91	42	30	32	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2003	72	6					1515	1526		10.1086/375656	http://dx.doi.org/10.1086/375656			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	685QV	12730827	Bronze, Green Published			2022-12-18	WOS:000183275500014
J	Epstein, MP; Lin, XH; Boehnke, M				Epstein, MP; Lin, XH; Boehnke, M			Ascertainment-adjusted parameter estimates revisited	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PEDIGREE DATA; MODELS; INFERENCE	Ascertainment-adjusted parameter estimates from a genetic analysis are typically assumed to reflect the parameter values in the original population from which the ascertained data were collected. Burton et al. (2000) recently showed that, given unmodeled parameter heterogeneity, the standard ascertainment adjustment leads to biased parameter estimates of the population-based values. This finding has important implications in complex genetic studies, because of the potential existence of unmodeled genetic parameter heterogeneity. The authors further stated the important point that, given unmodeled heterogeneity, the ascertainment-adjusted parameter estimates reflect the true parameter values in the ascertained subpopulation. They illustrated these statements with two examples. By revisiting these examples, we demonstrate that if the ascertainment scheme and the nature of the data can be correctly modeled, then an ascertainment-adjusted analysis returns population-based parameter estimates. We further demonstrate that if the ascertainment scheme and data cannot be modeled properly, then the resulting ascertainment-adjusted analysis produces parameter estimates that generally do not reflect the true values in either the original population or the ascertained subpopulation.	Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Boehnke, M (corresponding author), Univ Michigan, Dept Biostat, 1420 Washington Hts, Ann Arbor, MI 48109 USA.				NCI NIH HHS [R29 CA076404, R29 CA 76404] Funding Source: Medline; NHGRI NIH HHS [R01 HG 00376, T32 HG000040, T32 HG 00040, R01 HG000376] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA076404] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000040, R01HG000376] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Apert E., 1914, J HERED, V5, P492; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Burton PR, 2000, AM J HUM GENET, V67, P1505, DOI 10.1086/316899; CANNINGS C, 1977, CLIN GENET, V12, P208; de Andrade M, 2000, GENET EPIDEMIOL, V19, P333, DOI 10.1002/1098-2272(200012)19:4<333::AID-GEPI5>3.3.CO;2-R; ELSTON RC, 1979, AM J HUM GENET, V31, P62; EWENS WJ, 1986, THEOR POPUL BIOL, V30, P388, DOI 10.1016/0040-5809(86)90042-0; EWENS WJ, 1986, ANN HUM GENET, V50, P399, DOI 10.1111/j.1469-1809.1986.tb01760.x; Fisher RA, 1934, ANN EUGENIC, V6, P13, DOI 10.1111/j.1469-1809.1934.tb02105.x; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; Haldane JBS, 1938, ANN EUGENIC, V8, P255, DOI 10.1111/j.1469-1809.1938.tb02179.x; LI CC, 1968, AM J HUM GENET, V20, P61; MORTON NE, 1959, AM J HUM GENET, V11, P1; Olson JM, 2000, GENET EPIDEMIOL, V18, P217, DOI 10.1002/(SICI)1098-2272(200003)18:3<217::AID-GEPI3>3.0.CO;2-8; Pinheiro J. C., 1995, J COMPUTATIONAL GRAP, V4, P12, DOI [DOI 10.2307/1390625, 10.1080/10618600.1995.10474663, DOI 10.1080/10618600.1995.10474663]; Pritchard JK, 2000, GENETICS, V155, P945; Roeder K, 1999, J AM STAT ASSOC, V94, P766, DOI 10.2307/2669989; Spiegelhalter D. J., 2000, WINBUGS VERSION 1 3; VIELAND VJ, 1995, AM J HUM GENET, V56, P33; Weinberg W., 1912, Archiv Rassenbiol Leipzig, V9; ZEGER SL, 1991, J AM STAT ASSOC, V86, P79, DOI 10.2307/2289717	21	30	30	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2002	70	4					886	895		10.1086/339517	http://dx.doi.org/10.1086/339517			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	528PL	11880949	Bronze, Green Published			2022-12-18	WOS:000174252100006
J	Scholz, M; Bachmann, L; Nicholson, GJ; Bachmann, J; Giddings, I; Ruschoff-Thale, B; Czarnetzki, A; Pusch, CM				Scholz, M; Bachmann, L; Nicholson, GJ; Bachmann, J; Giddings, I; Ruschoff-Thale, B; Czarnetzki, A; Pusch, CM			Genomic differentiation of neanderthals and anatomically modern man allows a fossil-DNA-based classification of morphologically indistinguishable hominid bones	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIGHER PRIMATES; MODERN HUMANS; ANCIENT DNA; PHYLOGENY; HYBRIDIZATION; SEQUENCES; REGION	Southern blot hybridizations of genomic DNA were introduced as a relatively simple fossil-DNA-based approach to classify remains of Neanderthals. When hybridized with genomic DNA of either human or Neanderthal origin, DNA extracted from two Neanderthal finds-the Os parietale, from Warendorf-Neuwarendorf, Germany, and a clavicula, from Krapina, Croatia-was shown to yield hybridization signals that differ by at least a factor of two compared to the signals obtained with the use of fossil DNA of an early Homo sapiens from the Vogelherd cave (Stetten I), Germany. When labeled chimpanzee DNA was used as a probe, Neanderthal and human DNA, however, revealed hybridization signals of similar intensity. Thus, the genome of Neanderthals is expected to differ significantly from the genome of anatomically modern man, because of the contrasting composition of repetitive DNA. These data support the hypothesis that Neanderthals were not ancestors of anatomically modern man.	Field Museum Nat Hist, Pritzker Lab Mol Systemat & Evolut, Chicago, IL 60605 USA; Univ Tubingen, Osteol Collect, Tubingen, Germany; Univ Tubingen, Inst Organ Chem, Tubingen, Germany; Univ Tubingen, Inst Cell Biol, Tubingen, Germany; Univ Tubingen, Eye Hosp 2, Genet Mol Lab, Tubingen, Germany; Westfalian Museum Archeol, Munster, Germany; Haddow Labs, Canc Res Inst, Sutton, Surrey, England	Field Museum of Natural History (Chicago); Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; University of London; Institute of Cancer Research - UK	Bachmann, L (corresponding author), Field Museum Nat Hist, Pritzker Lab Mol Systemat & Evolut, 1400 S Lake Shore Dr, Chicago, IL 60605 USA.			Giddings, Ian/0000-0003-1078-5780; Scholz, Michael/0000-0001-8440-6785				Abbate E, 1998, NATURE, V393, P458, DOI 10.1038/30954; BILSBOROUGH A, 1992, HUMAN EVOLUTION; Campbell B.G., 1964, CLASSIFICATION HUMAN, P50; Cooper A, 1997, SCIENCE, V277, P1021; Gieseler W., 1974, FOSSILGESCHICHTE MEN; Henke Winfried Rothe, 1994, PALAOANTHROPOLOGIE; Hoss M, 1996, P NATL ACAD SCI USA, V93, P181, DOI 10.1073/pnas.93.1.181; HOUDE P, 1995, J MOL EVOL, V40, P678, DOI 10.1007/BF00160517; KING W, 1864, Q J SCI, V1, P273; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Krings M, 1999, P NATL ACAD SCI USA, V96, P5581, DOI 10.1073/pnas.96.10.5581; Lindahl T, 1997, CELL, V90, P1, DOI 10.1016/S0092-8674(00)80306-2; MIYAMOTO MM, 1988, P NATL ACAD SCI USA, V85, P7627, DOI 10.1073/pnas.85.20.7627; Poinar HN, 1996, SCIENCE, V272, P864, DOI 10.1126/science.272.5263.864; PUSCH C., 1997, TRENDS GENET, V13, P417; Pusch CM, 1998, NUCLEIC ACIDS RES, V26, P857, DOI 10.1093/nar/26.3.857; ROYLE NJ, 1994, NAT GENET, V6, P52, DOI 10.1038/ng0194-52; Saban R., 1986, ANTHROPUS BRNO, V23, P15; Saban R., 1984, B M MOIRES SOCI T DA, V3, P60; SCHOLZ M, 1997, TRENDS GENET, V13, P249; Schwartz JH, 1996, P NATL ACAD SCI USA, V93, P10852, DOI 10.1073/pnas.93.20.10852; SHREEVE J, 1995, NEANDERTHAL ENIGMA; SIBLEY CG, 1984, J MOL EVOL, V20, P2, DOI 10.1007/BF02101980; Stringer, 1997, CONCEPTUAL ISSUES MO, P191; TAKAHATA N, 1995, THEOR POPUL BIOL, V48, P198, DOI 10.1006/tpbi.1995.1026; Trinkaus E, 1993, NEANDERTHALS CHANGIN; WAYE JS, 1989, CHROMOSOMA, V98, P273, DOI 10.1007/BF00327313	27	30	31	0	10	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2000	66	6					1927	1932		10.1086/302949	http://dx.doi.org/10.1086/302949			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QU	10788336	Green Published, Bronze			2022-12-18	WOS:000088373800020
J	Green, PM; Saad, S; Lewis, CM; Giannelli, F				Green, PM; Saad, S; Lewis, CM; Giannelli, F			Mutation rates in humans. I. Overall and sex-specific rates obtained from a population study of hemophilia B	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HAEMOPHILIA-B; GERMLINE MOSAICISM; POINT MUTATIONS; GENE; DEFICIENCY; RATIO; DNA; DINUCLEOTIDES; INVERSIONS; SEQUENCE	A population-based study of hemophilia B mutations was conducted in the United Kingdom in order to construct a national confidential database of mutations and pedigrees to be used for the provision of carrier and prenatal diagnoses based on mutation detection. This allowed the direct estimate of overall (mu), male (v), and female (u) mutation rates for hemophilia B. The values obtained per gamete per generation and the 95% confidence intervals are mu = 7.73 (6.29-9.12) x 10(-6); v = 18.8 (14.5-22.9) x 10(-6); and u = 2.18 (1.44-3.16) x 10(-6). The ratio of male-to-female mutation rates is 8.64, with a 95% confidence interval of 5.46-14.5. The higher male rate was not caused by a much higher rate of transition at CpG sites in the male. Attempts to detect evidence of gonadal mosaicism for hemophilia B mutation in suitable families did not detect any instances of ovarian mosaicism in any of 47 available opportunities. This suggests that the risk of a noncarrier mother manifesting as a gonadal mosaic by transmitting the mutation to a second child should be <0.062.	Guys Kings & St Thomas Sch Med, Div Med & Mol Genet, London SE1 9RT, England	University of London; King's College London	Giannelli, F (corresponding author), Guys Kings & St Thomas Sch Med, Div Med & Mol Genet, 8th Floor,Guys Hosp Tower,London Bridge, London SE1 9RT, England.		Lewis, Cathryn/M-8766-2019; Lewis, Cathryn M/A-5225-2010; Peng, Bo/A-6920-2009	Lewis, Cathryn/0000-0002-8249-8476; Lewis, Cathryn M/0000-0002-8249-8476; Peng, Bo/0000-0001-8225-2284				ANSON DS, 1984, EMBO J, V3, P1053, DOI 10.1002/j.1460-2075.1984.tb01926.x; Becker J, 1996, AM J HUM GENET, V58, P657; Chen JX, 1998, CANCER RES, V58, P2070; Giannelli F, 1996, BAILLIERE CLIN HAEM, V9, P211, DOI 10.1016/S0950-3536(96)80059-X; Giannelli F, 1999, AM J HUM GENET, V65, P1580, DOI 10.1086/302652; GREEN PM, 1992, THROMB HAEMOSTASIS, V67, P66; GREEN PM, 1989, EMBO J, V8, P1067, DOI 10.1002/j.1460-2075.1989.tb03474.x; GREEN PM, 1991, BRIT J HAEMATOL, V78, P390, DOI 10.1111/j.1365-2141.1991.tb04453.x; KETTERLING RP, 1993, AM J HUM GENET, V52, P152; KETTERLING RP, 1994, AM J HUM GENET, V54, P831; KLING S, 1992, EUR J HAEMATOL, V48, P142; LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236; LARSSON SA, 1985, BRIT J HAEMATOL, V59, P593, DOI 10.1111/j.1365-2141.1985.tb07353.x; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MONTANDON AJ, 1989, NUCLEIC ACIDS RES, V17, P3347, DOI 10.1093/nar/17.9.3347; MONTANDON AJ, 1992, HUM GENET, V89, P319; NAYLOR J, 1993, HUM MOL GENET, V2, P1773, DOI 10.1093/hmg/2.11.1773; *OFF NAT STAT, 1997, POPUL TRENDS, V89, P67; *OFF NAT STAT, 1997, SER FM1, V24; RIZZA CR, 1983, BRIT MED J, V286, P929, DOI 10.1136/bmj.286.6369.929; RIZZA CR, 1997, HAEMOPHILIA OTHER IN, P87; Rowley G, 1995, GENOMICS, V30, P574, DOI 10.1006/geno.1995.1279; SAAD S, 1994, THROMB HAEMOSTASIS, V71, P563; SOMMER SS, 1995, HUM MOL GENET, V4, P2181, DOI 10.1093/hmg/4.11.2181; TAYLOR SAM, 1991, P NATL ACAD SCI USA, V88, P39, DOI 10.1073/pnas.88.1.39; TUCHMAN M, 1995, AM J MED GENET, V55, P67, DOI 10.1002/ajmg.1320550118; VANESSEN AJ, 1992, HUM GENET, V88, P249, DOI 10.1007/BF00197255; VERPY E, 1994, P NATL ACAD SCI USA, V91, P1873, DOI 10.1073/pnas.91.5.1873; WINSHIP PR, 1989, NUCLEIC ACIDS RES, V17, P1266, DOI 10.1093/nar/17.3.1266; WINSHIP PR, 1989, LANCET, V1, P631; YOSHITAKE S, 1985, BIOCHEMISTRY-US, V24, P3736, DOI 10.1021/bi00335a049	31	30	32	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1572	1579		10.1086/302651	http://dx.doi.org/10.1086/302651			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577910	Green Published, Bronze			2022-12-18	WOS:000084282500011
J	Toren, A; Amariglio, N; Rozenfeld-Granot, G; Simon, AJ; Brok-Simoni, F; Pras, E; Rechavi, G				Toren, A; Amariglio, N; Rozenfeld-Granot, G; Simon, AJ; Brok-Simoni, F; Pras, E; Rechavi, G			Genetic linkage of autosomal-dominant Alport syndrome with leukocyte inclusions and macrothrombocytopenia (Fechtner syndrome) to chromosome 22q11-13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALPHA-6(IV) COLLAGEN GENES; SMOOTH-MUSCLE TUMORS; ALPHA-5(IV) COLLAGEN; IV COLLAGEN; HEREDITARY NEPHRITIS; X-CHROMOSOME; IDENTIFICATION; DEAFNESS; THROMBOCYTOPENIA; DELETIONS	Fechtner syndrome is an autosomal-dominant variant of Alport syndrome, manifested by nephritis, sensorineural hearing loss, cataract formation, macrothrombocytopenia, and polymorphonuclear inclusion bodies. As opposed to autosomal-recessive and X-linked Alport syndromes, which have been genetically well studied, the genetic basis of Fechtner syndrome remains elusive. We have mapped the disease-causing gene to the long arm of chromosome 22 in an extended Israeli family with Fechtner syndrome plus impaired liver functions and hypercholesterolemia in some individuals. Six markers from chromosome 22q yielded a LOD score >3.00. A maximum two-point LOD score of 7.02 was obtained with the marker D22S283 at a recombination fraction of 0. Recombination analysis placed the disease-causing gene in a 5.5-Mb interval between the markers D22S284 and D22S1167. No collagen genes or genes comprising the basement membrane have been mapped to this region.	Tel Aviv Univ, Sackler Sch Med, Chaim Sheba Med Ctr, Pediat Hematooncol Dept, IL-52621 Tel Hashomer, Israel; Tel Aviv Univ, Sackler Sch Med, Chaim Sheba Med Ctr, Inst Hematol, IL-52621 Tel Hashomer, Israel; Tel Aviv Univ, Sackler Sch Med, Chaim Sheba Med Ctr, Dept Internal Med C, IL-52621 Tel Hashomer, Israel; Tel Aviv Univ, Sackler Sch Med, Chaim Sheba Med Ctr, Inst Human Genet, IL-52621 Tel Hashomer, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Toren, A (corresponding author), Tel Aviv Univ, Sackler Sch Med, Chaim Sheba Med Ctr, Pediat Hematooncol Dept, IL-52621 Tel Hashomer, Israel.	drt@inter.net.il						Alport AC, 1927, BMJ-BRIT MED J, V1927, P504, DOI 10.1136/bmj.1.3454.504; ANTIGNAC C, 1992, KIDNEY INT, V42, P1178, DOI 10.1038/ki.1992.402; Barrat FJ, 1996, AM J HUM GENET, V59, P625; BERNHEIM J, 1976, AM J MED, V61, P145, DOI 10.1016/0002-9343(76)90058-9; BOYD CD, 1988, AM J HUM GENET, V42, P309; BOYE E, 1991, GENOMICS, V11, P1125, DOI 10.1016/0888-7543(91)90040-L; BUDARF ML, 1995, HUM MOL GENET, V4, P763, DOI 10.1093/hmg/4.4.763; CHURG J, 1973, ARCH PATHOL, V95, P374; CLARE NM, 1979, AM J CLIN PATHOL, V72, P111; ECKSTEIN JD, 1975, ANN INTERN MED, V82, P639, DOI 10.7326/0003-4819-82-5-639; EPSTEIN CJ, 1972, AM J MED, V52, P299, DOI 10.1016/0002-9343(72)90017-4; GERSHONIBARUCH R, 1988, AM J MED GENET, V31, P357, DOI 10.1002/ajmg.1320310213; GREINACHER A, 1990, BLUT, V61, P282, DOI 10.1007/BF01732878; HEGGLIN R, 1945, Helv Med Acta, V12, P439; HEIDET L, 1995, HUM MOL GENET, V4, P99, DOI 10.1093/hmg/4.1.99; HOSTIKKA SL, 1990, P NATL ACAD SCI USA, V87, P1606, DOI 10.1073/pnas.87.4.1606; Jefferson JA, 1997, NEPHROL DIAL TRANSPL, V12, P1595, DOI 10.1093/ndt/12.8.1595; Kawai S, 1996, KIDNEY INT, V49, P814, DOI 10.1038/ki.1996.113; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEMMINK HH, 1994, HUM MOL GENET, V3, P1269, DOI 10.1093/hmg/3.8.1269; MARIYAMA M, 1992, GENOMICS, V13, P809, DOI 10.1016/0888-7543(92)90157-N; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOCHIZUKI T, 1994, NAT GENET, V8, P77, DOI 10.1038/ng0994-77; MYERS JC, 1990, AM J HUM GENET, V46, P1024; NAKAZATO H, 1993, KIDNEY INT, V44, P1091, DOI 10.1038/ki.1993.353; NETZER KO, 1992, KIDNEY INT, V42, P1336, DOI 10.1038/ki.1992.425; NOMURA S, 1993, KIDNEY INT, V43, P1116, DOI 10.1038/ki.1993.157; PARSA KP, 1976, AM J MED, V60, P665, DOI 10.1016/0002-9343(76)90501-5; PETERSON LC, 1985, BLOOD, V65, P397; ROCCA B, 1993, BRIT J HAEMATOL, V85, P423, DOI 10.1111/j.1365-2141.1993.tb03193.x; Spear G S, 1973, Clin Nephrol, V1, P336; SPEAR GS, 1972, AM J PATHOL, V69, P213; TRYGGVASON K, 1993, KIDNEY INT, V43, P38, DOI 10.1038/ki.1993.8; ZHOU J, 1993, SCIENCE, V261, P1167, DOI 10.1126/science.8356449	34	30	32	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1711	1717		10.1086/302654	http://dx.doi.org/10.1086/302654			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577925	Green Published, Bronze			2022-12-18	WOS:000084282500026
J	Rugarli, EI				Rugarli, EI			Kallmann syndrome and the link between olfactory and reproductive development	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PUTATIVE PHEROMONE RECEPTORS; ADHESION MOLECULES; SYNDROME GENE; X-CHROMOSOME; EXTRACELLULAR-MATRIX; NERVOUS-SYSTEM; CELL-ADHESION; LHRH NEURONS; KAL GENE; EXPRESSION		Telethon Inst Genet & Med, I-20132 Milan, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM)	Rugarli, EI (corresponding author), Telethon Inst Genet & Med, Via Olgettina 58, I-20132 Milan, Italy.			Rugarli, Elena/0000-0002-5782-1067	Telethon [TGM00P08, TGM06S01] Funding Source: Medline	Telethon(Fondazione Telethon)		BALLABIO A, 1995, METABOLIC MOL BASES, V2, P4549; BALLABIO A, IN PRESS METABOLIC M; Ballabio Andrea, 1992, Human Molecular Genetics, V1, P221, DOI 10.1093/hmg/1.4.221; Berliner DL, 1996, J STEROID BIOCHEM, V58, P259, DOI 10.1016/0960-0760(96)00062-3; BICK DP, 1993, AM J NEURORADIOL, V14, P852; De Morster G, 1954, SCHWEIZ ARCH NEUROL, V74, P309; Drapkin PT, 1999, DEV DYNAM, V214, P349, DOI 10.1002/(SICI)1097-0177(199904)214:4<349::AID-AJA7>3.3.CO;2-5; DRENTH J, 1980, J BIOL CHEM, V255, P2652; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; FARBMAN AI, 1992, CELL BIOL OLFACTION; FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0; HARDELIN JP, 1993, HUM MOL GENET, V2, P373, DOI 10.1093/hmg/2.4.373; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; Kallmann FJ, 1944, AM J MENT DEF, V48, P203; Kamiguchi H, 1998, ANNU REV NEUROSCI, V21, P97, DOI 10.1146/annurev.neuro.21.1.97; LEGOUIS R, 1991, CELL, V67, P423, DOI 10.1016/0092-8674(91)90193-3; LEGOUIS R, 1994, ANAT EMBRYOL, V190, P549; LEGOUIS R, 1993, P NATL ACAD SCI USA, V90, P2461, DOI 10.1073/pnas.90.6.2461; Letourneau PC, 1992, CURR OPIN GENET DEV, V2, P625, DOI 10.1016/S0959-437X(05)80183-2; Lin DM, 1999, CURR OPIN NEUROBIOL, V9, P74, DOI 10.1016/S0959-4388(99)80009-9; LUTZ B, 1994, HUM MOL GENET, V3, P1717, DOI 10.1093/hmg/3.10.1717; MCGUIRE PG, 1990, NEURON, V4, P633, DOI 10.1016/0896-6273(90)90121-U; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; NORGREN RB, 1993, DEV BIOL, V160, P377, DOI 10.1006/dbio.1993.1314; Osterwalder T, 1996, EMBO J, V15, P2944, DOI 10.1002/j.1460-2075.1996.tb00657.x; RUGARLI EI, 1993, JAMA-J AM MED ASSOC, V270, P2713, DOI 10.1001/jama.270.22.2713; RUGARLI EI, 1993, NAT GENET, V4, P19, DOI 10.1038/ng0593-19; Rugarli EI, 1996, HUM MOL GENET, V5, P1109, DOI 10.1093/hmg/5.8.1109; SCHWANZELFUKUDA M, 1990, EXPERIENTIA, V46, P956, DOI 10.1007/BF01939389; SCHWANZELFUKUDA M, 1989, MOL BRAIN RES, V6, P311, DOI 10.1016/0169-328X(89)90076-4; SCHWANZELFUKUDA M, 1989, NATURE, V338, P161, DOI 10.1038/338161a0; Soussi-Yanicostas N, 1998, J CELL SCI, V111, P2953; SoussiYanicostas N, 1996, J CELL SCI, V109, P1749; Stern K, 1998, NATURE, V392, P177, DOI 10.1038/32408; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; WRAY S, 1989, P NATL ACAD SCI USA, V86, P8132, DOI 10.1073/pnas.86.20.8132; Yoshida K, 1999, J NEUROSCI, V19, P794	38	30	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1999	65	4					943	948		10.1086/302600	http://dx.doi.org/10.1086/302600			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	241XW	10486312	Green Published, Bronze			2022-12-18	WOS:000082910000002
J	Jensen, CS; Kong, A				Jensen, CS; Kong, A			Blocking Gibbs sampling for linkage analysis in large pedigrees with many loops	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NORMALIZING CONSTANTS; SEQUENTIAL IMPUTATION; COMPLEX PEDIGREES; EXPERT-SYSTEMS; PROBABILITIES; COMPUTATIONS; PROPAGATION; MODELS	We apply the method of "blocking Gibbs" sampling to a problem of great importance and complexity-linkage analysis. Blocking Gibbs sampling combines exact local computations with Gibbs sampling, in a way that complements the strengths of both. The method is able to handle problems with very high complexity, such as linkage analysis in large pedigrees with many loops, a task that no other known method is able to handle. New developments of the method are outlined, and it is applied to a highly complex linkage problem in a human pedigree.	Univ Aalborg, Inst Elect Syst, Dept Math & Comp Sci, DK-9220 Aalborg, Denmark; Univ Chicago, Dept Stat, Chicago, IL 60637 USA	Aalborg University; University of Chicago	Jensen, CS (corresponding author), Univ Aalborg, Inst Elect Syst, Dept Math & Comp Sci, Fredrik Bajers Vej 7E, DK-9220 Aalborg, Denmark.			Kong, Augustine/0000-0001-8193-5438				Andersen S.K., 1989, P 11 INT JOINT C ART, P1080; BENNETT CH, 1976, J COMPUT PHYS, V22, P245, DOI 10.1016/0021-9991(76)90078-4; CANNINGS C, 1978, ADV APPL PROBAB, V10, P26, DOI 10.2307/1426718; CANNINGS C, 1976, ADV APPL PROBAB, V8, P622, DOI 10.2307/1425918; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dawid A. P., 1992, Statistics and Computing, V2, P25, DOI 10.1007/BF01890546; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; Gelman A, 1998, STAT SCI, V13, P163; Gelman A., 1994, 376 U CHIC DEP STAT; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; GEYER CJ, 1991, COMPUTING SCIENCE AND STATISTICS, P156; GEYER CJ, 1993, 589 U MINN SCH STAT; Geyer CJ., 1992, STAT SCI, V7, P473, DOI [10.1214/ss/1177011137, DOI 10.1214/SS/1177011137]; IRWIN M, 1994, P NATL ACAD SCI USA, V91, P11684, DOI 10.1073/pnas.91.24.11684; Jensen CS, 1998, BIOMETRICS, V54, P416, DOI 10.2307/3109752; JENSEN CS, 1995, INT J HUM-COMPUT ST, V42, P647, DOI 10.1006/ijhc.1995.1029; JENSEN CS, 1996, R962046 AALB U DEP C; JENSEN CS, 1997, THESIS AALBORG U AAL; Jensen F. V., 1990, Computational Statistics Quarterly, V5, P269; Jensen F.V., 1996, INTRO BAYESIAN NETWO; KJAERULFF U, 1993, IR932007 AALB U DEP; KONG A, 1991, GENET EPIDEMIOL, V8, P81, DOI 10.1002/gepi.1370080203; KONG A, 1993, GENET EPIDEMIOL, V10, P483, DOI 10.1002/gepi.1370100626; LANGE K, 1975, HUM HERED, V25, P95, DOI 10.1159/000152714; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LAURITZEN SL, 1992, J AM STAT ASSOC, V87, P1098, DOI 10.2307/2290647; LAURITZEN SL, 1988, J ROY STAT SOC B MET, V50, P157; LIN SL, 1994, AM J HUM GENET, V54, P695; Meng XL, 1996, STAT SINICA, V6, P831; Meng XL, 1996, J AM STAT ASSOC, V91, P1254, DOI 10.2307/2291744; PEARL J, 1986, ARTIF INTELL, V29, P241, DOI 10.1016/0004-3702(86)90072-X; Pearl J., 1991, PROBABILISTIC REASON; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SHEEHAN N, 1993, BIOMETRICS, V49, P163, DOI 10.2307/2532611; Shenoy P.P., 1990, UNCERTAIN ARTIF INTE, V9, P169, DOI DOI 10.1016/B978-0-444-88650-7.50019-6; SMITH WD, 1993, RES VET SCI, V55, P1, DOI 10.1016/0034-5288(93)90025-B; Thomas A, 1992, BAYESIAN STATISTICS, P837; THOMAS DC, 1992, HUM HERED, V42, P63, DOI 10.1159/000154046; [No title captured]	42	30	32	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					885	901		10.1086/302524	http://dx.doi.org/10.1086/302524			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441593	Green Published, Bronze			2022-12-18	WOS:000082426400032
J	Nolin, SL; Houck, GE; Gargano, AD; Blumstein, H; Dobkin, CS; Brown, WT				Nolin, SL; Houck, GE; Gargano, AD; Blumstein, H; Dobkin, CS; Brown, WT			FMR1 CCG-repeat instability by single sperm and lymphocytes of fragile-X premutation males	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL MYOTONIC-DYSTROPHY; POLYMERASE CHAIN-REACTION; CGG REPEAT; TRINUCLEOTIDE REPEAT; LENGTH VARIATION; HUMAN MINISATELLITES; MUTATION FREQUENCY; TRANSGENIC MICE; FULL MUTATION; CTG REPEATS	To determine the meiotic instability of the CGG-triplet repeat in the fragile-X gene, FMR1, we examined the size of the repeat in single sperm from four premutation males. The males had CGG-repeat sizes of 68, 75, 78, and 100, as determined in peripheral blood samples. All samples showed a broad range of variations, with expansions more common than contractions. Examination of single lymphocytes indicated that somatic cells were relatively more stable than sperm. Surprisingly, the repeats in sperm from the 75- and 78-repeat males had very different size ranges and distribution patterns despite the similarity of the repeat size and AGG interruption in their somatic cells. These results suggest that cis or trans factors may have a role in male germline repeat instability.	New York State Inst Basic Res Dev Disabil, Dept Human Genet, Staten Isl, NY 10314 USA	Institute for Basic Research in Developmental Disabilities	Nolin, SL (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Human Genet, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA.		Brown, William/GXN-2777-2022	Nolin, Sarah/0000-0001-5209-289X				ASHIZAWA T, 1994, NEUROLOGY, V44, P120, DOI 10.1212/WNL.44.1.120; Ashley-Koch AE, 1998, AM J HUM GENET, V63, P776, DOI 10.1086/302018; BAKKER CE, 1994, CELL, V78, P23; BOYUM A, 1968, SCAND J CLIN LAB INV, V21, P97; Brown W. Ted, 1992, Current Opinion in Pediatrics, V4, P960, DOI 10.1097/00008480-199212000-00009; BROWN WT, 1993, JAMA-J AM MED ASSOC, V270, P1569, DOI 10.1001/jama.270.13.1569; Carbonell P, 1996, AM J MED GENET, V64, P434, DOI 10.1002/(SICI)1096-8628(19960809)64:2<434::AID-AJMG40>3.0.CO;2-D; Chong SS, 1997, HUM MOL GENET, V6, P301, DOI 10.1093/hmg/6.2.301; EICHLER EE, 1994, NAT GENET, V8, P88, DOI 10.1038/ng0994-88; FISCH GS, 1995, AM J HUM GENET, V56, P1147; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Gordenin DA, 1997, NAT GENET, V16, P116, DOI 10.1038/ng0697-116; Gourdon G, 1997, NAT GENET, V15, P190, DOI 10.1038/ng0297-190; HEITZ D, 1992, J MED GENET, V29, P794, DOI 10.1136/jmg.29.11.794; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; JEFFREYS AJ, 1988, NUCLEIC ACIDS RES, V16, P10953, DOI 10.1093/nar/16.23.10953; JENSEN G, 1994, AM J HUM GENET, V54, P575; Kunst CB, 1997, J MED GENET, V34, P627, DOI 10.1136/jmg.34.8.627; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; LAVEDAN C, 1993, LANCET, V341, P237, DOI 10.1016/0140-6736(93)90097-Z; LEEFLANG EP, 1995, HUM MOL GENET, V4, P1519; LEEFLANG EP, 1994, CURRENT PROTOCOLS HU; LEVINSON G, 1994, AM J MED GENET, V51, P527, DOI 10.1002/ajmg.1320510448; Malter HE, 1997, NAT GENET, V15, P165, DOI 10.1038/ng0297-165; Mangiarini L, 1997, NAT GENET, V15, P197, DOI 10.1038/ng0297-197; Monckton DG, 1997, NAT GENET, V15, P193, DOI 10.1038/ng0297-193; MONCKTON DG, 1995, HUM MOL GENET, V4, P1; MORICPETROVIC S, 1983, J MED GENET, V20, P476, DOI 10.1136/jmg.20.6.476; Mornet E, 1996, HUM MOL GENET, V5, P821, DOI 10.1093/hmg/5.6.821; MULLEY JC, 1993, LANCET, V341, P236, DOI 10.1016/0140-6736(93)90096-Y; Murray A, 1997, HUM MOL GENET, V6, P173, DOI 10.1093/hmg/6.2.173; Nolin SL, 1996, AM J HUM GENET, V59, P1252; NOLIN SL, 1994, AM J MED GENET, V51, P509, DOI 10.1002/ajmg.1320510444; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Pianese L, 1997, AM J HUM GENET, V60, P460; REYNIERS E, 1993, NAT GENET, V4, P143, DOI 10.1038/ng0693-143; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; Schweitzer JK, 1998, HUM MOL GENET, V7, P69, DOI 10.1093/hmg/7.1.69; SNOW K, 1993, AM J HUM GENET, V53, P1217; SNOW K, 1994, HUM MOL GENET, V3, P1543, DOI 10.1093/hmg/3.9.1543; TSILFIDIS C, 1992, NAT GENET, V1, P192, DOI 10.1038/ng0692-192; VANROY BC, 1983, J MED GENET, V20, P286, DOI 10.1136/jmg.20.4.286; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VOELCKEL MA, 1988, HUM GENET, V80, P375, DOI 10.1007/BF00273654; VOGEL F, 1975, ADV HUM GENET, V5, P259; WILLEMS PJ, 1992, HUM MOL GENET, V1, P511, DOI 10.1093/hmg/1.7.511; WOHRLE D, 1993, NAT GENET, V4, P140, DOI 10.1038/ng0693-140; YU S, 1992, AM J HUM GENET, V50, P968; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179; ZHANG L, 1995, HUM MOL GENET, V4, P303, DOI 10.1093/hmg/4.2.303; ZHONG N, 1995, AM J HUM GENET, V57, P351	52	30	31	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					680	688		10.1086/302543	http://dx.doi.org/10.1086/302543			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441574	Bronze, Green Published			2022-12-18	WOS:000082426400012
J	Wadey, R; McKie, J; Papapetrou, C; Sutherland, H; Lohman, F; Osinga, J; Frohn, I; Hofstra, R; Meijers, C; Amati, F; Conti, E; Pizzuti, A; Dallapiccola, B; Novelli, G; Scambler, P				Wadey, R; McKie, J; Papapetrou, C; Sutherland, H; Lohman, F; Osinga, J; Frohn, I; Hofstra, R; Meijers, C; Amati, F; Conti, E; Pizzuti, A; Dallapiccola, B; Novelli, G; Scambler, P			Mutations of UFD1L are not responsible for the majority of cases of DiGeorge syndrome - Velocardiofacial syndrome without deletions within chromosome 22q11	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							CRITICAL REGION; GENE; IDENTIFICATION; EXPRESSION; PROTEIN		Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; Erasmus Univ, Dept Cell Biol & Genet Pediat Surg, NL-3000 DR Rotterdam, Netherlands; Sophia Childrens Univ Hosp, Dept Pediat, Div Cardiol, Rotterdam, Netherlands; Univ Groningen, Dept Med Genet, Groningen, Netherlands; Univ Roma Tor Vergata, Dept Biopathol & Diagnost Imaging, Rome, Italy; CSS Mendel Inst, Rome, Italy	University of London; University College London; Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC - Sophia Children's Hospital; University of Groningen; University of Rome Tor Vergata; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel	Wadey, R (corresponding author), Inst Child Hlth, Mol Med Unit, Rome 211, London WC1N 1EH, England.		Novelli, Giuseppe/A-5195-2013; Novelli, Giuseppe/GQB-3329-2022; Novelli, Giuseppe/T-8822-2019; Scambler, Peter/AAZ-6026-2020; Pillay, Nischalan/F-9536-2012; Amati, Francesca/J-8439-2012; Scambler, Peter J/C-4998-2008; Dallapiccola, Bruno/K-8692-2016	Novelli, Giuseppe/0000-0002-7781-602X; Novelli, Giuseppe/0000-0002-7781-602X; Scambler, Peter/0000-0002-1487-4628; Amati, Francesca/0000-0003-2209-2156; Scambler, Peter J/0000-0002-1487-4628; Hofstra, Robert/0000-0001-7498-3829; Dallapiccola, Bruno/0000-0002-5031-1013; PIZZUTI, Antonio/0000-0003-3245-1925	Telethon [E.0723] Funding Source: Medline	Telethon(Fondazione Telethon)		AUGUSSEAU S, 1986, HUM GENET, V74, P206, DOI 10.1007/BF00282098; Baldini A, 1999, NAT GENET, V21, P246, DOI 10.1038/6750; Carlson C, 1997, AM J HUM GENET, V61, P620, DOI 10.1086/515508; Dallapiccola B, 1996, AM J HUM GENET, V59, P7; Daw SCM, 1996, NAT GENET, V13, P458, DOI 10.1038/ng0896-458; EMANUEL BS, 1998, HEART DEV, P463; Farrell MJ, 1999, CIRC RES, V84, P127, DOI 10.1161/01.RES.84.2.127; Gong WK, 1996, HUM MOL GENET, V5, P789, DOI 10.1093/hmg/5.6.789; Gong WL, 1997, HUM MOL GENET, V6, P267, DOI 10.1093/hmg/6.2.267; Gottlieb S, 1997, AM J HUM GENET, V60, P1194; Hagmann M, 1999, SCIENCE, V283, P1091; HELLER JL, 1996, CLOSING TIME; Heller Joseph, 1955, CATCH 22; Kurahashi H, 1996, AM J HUM GENET, V58, P1377; Lindsay EA, 1998, HUM MOL GENET, V7, P629, DOI 10.1093/hmg/7.4.629; Lindsay EA, 1998, MOL MED TODAY, V4, P350, DOI 10.1016/S1357-4310(98)01302-1; Magnaghi P, 1998, NAT GENET, V20, P74, DOI 10.1038/1739; McKie JM, 1998, GENOME RES, V8, P834, DOI 10.1101/gr.8.8.834; Novelli G, 1998, BBA-GENE STRUCT EXPR, V1396, P158, DOI 10.1016/S0167-4781(97)00211-X; Rauch A, 1999, AM J HUM GENET, V64, P659, DOI 10.1086/302235; Ryan AK, 1997, J MED GENET, V34, P798, DOI 10.1136/jmg.34.10.798; Sutherland HF, 1996, AM J HUM GENET, V59, P23; WADEY R, 1995, HUM MOL GENET, V4, P1027, DOI 10.1093/hmg/4.6.1027; Yamagishi H, 1999, SCIENCE, V283, P1158, DOI 10.1126/science.283.5405.1158	24	30	30	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1999	65	1					247	249		10.1086/302468	http://dx.doi.org/10.1086/302468			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	212NZ	10364538	Bronze, Green Published			2022-12-18	WOS:000081224300030
J	Klein, C; Ozelius, LJ; Hagenah, J; Breakefield, XO; Risch, NJ; Vieregge, P				Klein, C; Ozelius, LJ; Hagenah, J; Breakefield, XO; Risch, NJ; Vieregge, P			Search for a founder mutation in idiopathic focal dystonia from northern Germany	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TORSION DYSTONIA; LINKAGE DISEQUILIBRIUM; PARKINSONS-DISEASE; GENETIC COMPLEXITY; ASHKENAZI JEWS; CHROMOSOME 18P; ADULT-ONSET; FAMILY; TORTICOLLIS; INHERITANCE	Both the discovery of the DYT1 gene on chromosome 9q34 in autosomal dominant early-onset torsion dystonia and the detection of linkage for one form of adult-onset focal dystonia to chromosome 18p (DYT7) in a family from northern Germany provide the opportunity to further investigate genetic factors in the focal dystonias. Additionally, reports of linkage disequilibrium between several chromosome 18 markers and focal dystonia, both in sporadic patients from northern Germany and in members of affected families from central Europe suggest the existence of a founder mutation underlying focal dystonia in this population. To evaluate the role of these loci in focal dystonia, we tested 85 patients from northern Germany who had primary focal dystonia, both for the GAG deletion in the DYT1 gene on chromosome 9q34 and for linkage disequilibrium at the chromosome 18p markers D18S1105, D18S1098, D18S481, and D18S54. None of these patients had the GAG deletion in the DYT1 gene. Furthermore, Hardy-Weinberg analysis of markers on 18p in our patient population and in 85 control subjects from the same region did not support linkage disequilibrium. Taken together, these results suggest that most cases of focal dystonia in patients of northern German or central European origin are due neither to the GAC deletion in DYT1 nos to a proposed founder mutation on chromosome 18p but must be caused by other genetic or environmental factors.	Massachusetts Gen Hosp, Mol Neurogenet Unit, Boston, MA USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA USA; Univ Lubeck, Dept Neurol, Lubeck, Germany; Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Lubeck; Stanford University	Ozelius, LJ (corresponding author), Massachusetts Gen Hosp E, Bldg 149,13th St, Charlestown, MA 02129 USA.	Ozelius@helix.mgh.harvard.edu	Klein, Christine/AGK-8003-2022		NHGRI NIH HHS [HG00348] Funding Source: Medline; ONDIEH CDC HHS [ND38485] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000348] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); ONDIEH CDC HHS; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BENGTSSON BO, 1981, TISSUE ANTIGENS, V18, P356, DOI 10.1111/j.1399-0039.1981.tb01404.x; BRESSMAN SB, 1994, NEUROLOGY, V44, P283, DOI 10.1212/WNL.44.2.283; Bressman SB, 1996, ANN NEUROL, V40, P681, DOI 10.1002/ana.410400421; BRESSMAN SB, 1994, ANN NEUROL, V36, P771, DOI 10.1002/ana.410360514; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; FAHN S, 1987, MOVEMENT DISORD, V2, P332; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; FRIEDMAN A, 1986, NEUROLOGY, V36, P398, DOI 10.1212/WNL.36.3.398; Gasser T, 1997, SCIENCE, V277, P388; Gasser T, 1997, CURR OPIN NEUROL, V10, P357, DOI 10.1097/00019052-199708000-00013; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HOLMGREN G, 1995, J NEUROL NEUROSUR PS, V59, P178, DOI 10.1136/jnnp.59.2.178; Kakinuma S, 1994, Rinsho Shinkeigaku, V34, P474; Leube B, 1997, AM J MED GENET, V74, P529, DOI 10.1002/(SICI)1096-8628(19970919)74:5<529::AID-AJMG15>3.0.CO;2-E; Leube B, 1996, HUM MOL GENET, V5, P1673, DOI 10.1093/hmg/5.10.1673; Leube B, 1997, ANN NEUROL, V42, P111, DOI 10.1002/ana.410420117; Leube B, 1997, MOVEMENT DISORD, V12, P1000, DOI 10.1002/mds.870120625; MACDONALD ME, 1991, AM J HUM GENET, V49, P723; Muller U, 1998, NEUROGENETICS, V1, P165, DOI 10.1007/s100480050025; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; OZELIUS LJ, 1992, AM J HUM GENET, V50, P619; Page CE, 1998, NEUROLOGY, V50, pA427; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Scott WK, 1997, SCIENCE, V277, P387, DOI 10.1126/science.277.5324.387; Sheehy M P, 1988, Adv Neurol, V50, P457; Soland VL, 1996, J NEUROL NEUROSUR PS, V60, P204, DOI 10.1136/jnnp.60.2.204; VONDEIMLING A, 1993, NEUROPATH APPL NEURO, V19, P524; WADDY HM, 1991, ANN NEUROL, V29, P320, DOI 10.1002/ana.410290315	28	30	35	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1777	1782		10.1086/302143	http://dx.doi.org/10.1086/302143			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EL	9837831	Green Published, Bronze			2022-12-18	WOS:000077707700024
J	Borecki, IB; Blangero, J; Rice, T; Perusse, L; Bouchard, C; Rao, DC				Borecki, IB; Blangero, J; Rice, T; Perusse, L; Bouchard, C; Rao, DC			Evidence for at least two major loci influencing human fatness	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ABDOMINAL VISCERAL FAT; BODY-MASS INDEX; SEGREGATION ANALYSIS; QUEBEC FAMILY; RECESSIVE INHERITANCE; HERITAGE FAMILY; GENE; OBESITY; LINKAGE; TRUNK	The genetics of human fatness has been the subject of many recent studies, motivated by the increased morbidity and mortality associated with obesity, as well as the increasing prevalence of overweight and obesity. The body-mass index (BMI) and fat mass (FM), measured by underwater weighing, were assessed for 1,630 individuals from similar to 300 families from phase 1 of the Quebec Family Study. The two phenotypes are highly correlated (similar to.8) in adults, and previous segregation analysis revealed evidence for a recessive major gene for each trait. In our study we utilized bivariate segregation analysis to determine the source(s) of phenotypic correlation-namely, a pleiotropic major gene, shared familial factors/polygenes, or shared nontransmitted environmental factors. Analysis was performed by use of the Pedigree Analysis Package, with extensions to the bivariate case. Tests of hypotheses provided evidence for two pleiotropic recessive loci, together accounting for 64% and 47% of the variance in BMI and FM, respectively. Under the model, all sources of phenotypic correlation were significant: 73% of the covariance was attributed to the pleiotropic major loci, 8% to residual familial effects, and 19% to nontransmitted environmental factors. The high degree of genetic identity between the two traits is not surprising, since the BMI often is used as a surrogate for FM; however, simultaneous analysis of both phenotypes enabled the detection of a second major locus, which apparently does not affect extreme overweight (as does the primary major locus) but which affects variation in the "normal" range.	Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; SW Fdn Biomed Res, Dept Genet, San Antonio, TX USA; Univ Laval, Phys Act Sci Lab, St Foy, PQ G1K 7P4, Canada	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Texas Biomedical Research Institute; Laval University	Borecki, IB (corresponding author), Washington Univ, Sch Med, Div Biostat, 660 S Euclid Ave,Box 8067, St Louis, MO 63110 USA.		Rice, Treva K/D-1385-2009; Perusse, Louis/A-3444-2012; Blangero, John/ABA-7175-2021; Bouchard, Claude/AAE-2035-2019; Bouchard, Claude/A-7637-2009	Perusse, Louis/0000-0001-6440-9698; Bouchard, Claude/0000-0002-0048-491X; Rice, Treva/0000-0001-7452-2600	NICHD NIH HHS [HD18281] Funding Source: Medline; NIGMS NIH HHS [GM28719] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028719] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; BLANGERO J, 1991, GENET EPIDEMIOL, V8, P299, DOI 10.1002/gepi.1370080503; BLANGERO J, 1990, AM J HUM GENET, V47, P414; Borecki IB, 1998, OBES RES, V6, P107, DOI 10.1002/j.1550-8528.1998.tb00323.x; BORECKI IB, 1991, INT J OBESITY, V15, P763; BORECKI IB, 1993, AM J HUM GENET, V53, P676; BORECKI IB, 1995, OBES RES, V3, P1; Bouchard C, 1996, INT J OBESITY, V20, P420; BOUCHARD C, 1988, ANNU REV NUTR, V8, P259, DOI 10.1146/annurev.nu.08.070188.001355; Chagnon YC, 1998, OBES RES, V6, P76, DOI 10.1002/j.1550-8528.1998.tb00318.x; COMUZZIE AG, 1995, GENET EPIDEMIOL, V12, P475, DOI 10.1002/gepi.1370120505; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; Garrison RJ, 1996, CURR OPIN LIPIDOL, V7, P199, DOI 10.1097/00041433-199608000-00005; Hasstedt SJ, 1997, AM J HUM GENET, V61, P668, DOI 10.1086/515509; HASSTEDT SJ, 1989, AM J HUM GENET, V45, P917; HASSTEDT SJ, 1989, PEDIGREE ANAL PACKAG; Lecomte E, 1997, GENET EPIDEMIOL, V14, P51, DOI 10.1002/(SICI)1098-2272(1997)14:1<51::AID-GEPI4>3.0.CO;2-8; MOLL PP, 1991, AM J HUM GENET, V49, P1243; Norman RA, 1997, AM J HUM GENET, V60, P166; PERUSSE L, 1989, AM J HUM GENET, V45, P240; POPKIN BM, 1995, OBES RES, V3, pS145, DOI 10.1002/j.1550-8528.1995.tb00457.x; Price R. Arlen, 1992, Behavior Genetics, V22, P746; PRICE RA, 1990, HUM BIOL, V62, P747; PROVINCE MA, 1990, AM J HUM GENET S, V47, pA143; Rice T, 1997, INT J OBESITY, V21, P1024, DOI 10.1038/sj.ijo.0800511; Rice T, 1993, Obes Res, V1, P288; RICE T, 1993, AM J HUM GENET, V52, P967; Rice T, 1997, OBES RES, V5, P417, DOI 10.1002/j.1550-8528.1997.tb00664.x; RICE T, 1995, INT J OBESITY, V19, P902	29	30	31	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1998	63	3					831	838		10.1086/302006	http://dx.doi.org/10.1086/302006			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	119VN	9718336	Green Published, Bronze			2022-12-18	WOS:000075919000022
J	Dork, T; El-Harith, EHA; Stuhrmann, M; Macek, M; Egan, M; Cutting, GR; Tzetis, M; Kanavakis, E; Carles, S; Claustres, M; Padoa, C; Ramsay, M; Schmidtke, J				Dork, T; El-Harith, EHA; Stuhrmann, M; Macek, M; Egan, M; Cutting, GR; Tzetis, M; Kanavakis, E; Carles, S; Claustres, M; Padoa, C; Ramsay, M; Schmidtke, J			Evidence for a common ethnic origin of cystic fibrosis mutation 3120+1G -> A in diverse populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							CFTR MUTATIONS; HAPLOTYPE ANALYSIS; DNA MARKERS; GENE; MICROSATELLITES; AMPLIFICATION; FAMILIES		Hannover Med Sch, Inst Human Genet, D-30625 Hannover, Germany; Coll Hlth Sci, Dammam, Saudi Arabia; Univ Hosp Prague Motol, Dept Med Genet 2, Prague, Czech Republic; Johns Hopkins Hosp, Ctr Genet Med, Baltimore, MD 21287 USA; Univ Athens, Dept Pediat 1, Athens, Greece; CHU Montpellier, Inst Biol, Biochim Genet Lab, Montpellier, France; Univ Witwatersrand, Sch Pathol, Johannesburg, South Africa; S African Inst Med Res, Dept Human Genet, Johannesburg, South Africa	Hannover Medical School; Imam Abdulrahman Bin Faisal University; Johns Hopkins University; Johns Hopkins Medicine; National & Kapodistrian University of Athens; Universite de Montpellier; CHU de Montpellier; University of Witwatersrand	Dork, T (corresponding author), Hannover Med Sch, Inst Human Genet, D-30625 Hannover, Germany.		Dörk, Thilo/J-8620-2012; Tzetis, Maria/K-5220-2012	Dörk, Thilo/0000-0002-9458-0282; Tzetis, Maria/0000-0002-6810-2922; Ramsay, Michele/0000-0002-4156-4801				Carles S, 1996, J MED GENET, V33, P802, DOI 10.1136/jmg.33.9.802; Claustres M, 1996, HUM GENET, V98, P336, DOI 10.1007/s004390050219; CUPPENS H, 1994, HUM MOL GENET, V3, P607, DOI 10.1093/hmg/3.4.607; DORK T, 1994, HUM GENET, V94, P533; DORK T, 1992, HUM GENET, V88, P417, DOI 10.1007/BF00215676; El-Harith EA, 1997, J MED GENET, V34, P996, DOI 10.1136/jmg.34.12.996; ESTIVILL X, 1987, Genomics, V1, P257, DOI 10.1016/0888-7543(87)90052-8; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; Hughes D, 1996, HUM MUTAT, V8, P229, DOI 10.1002/(SICI)1098-1004(1996)8:3<229::AID-HUMU6>3.3.CO;2-M; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Macek M, 1997, AM J HUM GENET, V60, P1122; Macek M, 1997, HUM GENET, V99, P565, DOI 10.1007/s004390050407; MORRAL N, 1992, GENOMICS, V13, P1362, DOI 10.1016/0888-7543(92)90071-Y; Morral N, 1996, HUM MUTAT, V8, P149, DOI 10.1002/(SICI)1098-1004(1996)8:2<149::AID-HUMU7>3.0.CO;2-6; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; MORRAL N, 1993, HUM MOL GENET, V2, P1015, DOI 10.1093/hmg/2.7.1015; RAMSAY M, 1993, HUM MOL GENET, V2, P1007, DOI 10.1093/hmg/2.7.1007; ROMEO G, 1989, HUM GENET, V84, P1, DOI 10.1007/BF00210660; RUSSO MP, 1995, HUM MUTAT, V5, P23, DOI 10.1002/humu.1380050103; SERETH H, 1993, HUM GENET, V92, P289; TRAEGERSYNODINOS J, 1993, AM J HEMATOL, V44, P162, DOI 10.1002/ajh.2830440305; Tzetis M, 1997, HUM GENET, V99, P121; Welsh MJ, 1995, METABOLIC MOL BASES, V3, P3799; WILLIAMS C, 1988, LANCET, V2, P102; ZIELENSKI J, 1991, AM J HUM GENET, V49, P1256	25	30	30	0	6	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					656	662		10.1086/301950	http://dx.doi.org/10.1086/301950			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683582	Green Published, Bronze			2022-12-18	WOS:000075360800043
J	Hauser, ER; Boehnke, M				Hauser, ER; Boehnke, M			Confirmation of linkage results in affected-sib-pair linkage analysis for complex genetic traits.	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan									0	30	30	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1997	61	4		S		1621	A278	A278						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YQ995					2022-12-18	WOS:000071446001624
J	Hebebrand, J; Nothen, MM; Ziegler, A; Klug, B; Neidt, H; Eggermann, K; Lehmkuhl, G; Poustka, F; Schmidt, MH; Propping, P; Remschmidt, H				Hebebrand, J; Nothen, MM; Ziegler, A; Klug, B; Neidt, H; Eggermann, K; Lehmkuhl, G; Poustka, F; Schmidt, MH; Propping, P; Remschmidt, H			Nonreplication of linkage disequilibrium between the dopamine D4 receptor locus and Tourette syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							GENE; HOMOZYGOSITY				Hebebrand, J (corresponding author), UNIV MARBURG,DEPT CHILD & ADOLESCENT PSYCHIAT,CLIN RES GRP,D-35033 MARBURG,GERMANY.		Ziegler, Alban/AGY-4798-2022; Nöthen, Markus/B-2027-2009; Ziegler, Andreas/G-4246-2012	Nöthen, Markus/0000-0002-8770-2464; Ziegler, Andreas/0000-0002-8386-5397				CATALANO M, 1993, BIOL PSYCHIAT, V34, P459, DOI 10.1016/0006-3223(93)90236-7; Cichon S, 1995, PSYCHIATR GENET, V5, P97, DOI 10.1097/00041444-199505030-00001; Grice DE, 1996, AM J HUM GENET, V59, P644; HEBEBRAND J, 1993, LANCET, V341, P1483, DOI 10.1016/0140-6736(93)90931-6; LICHTER JB, 1993, HUM MOL GENET, V2, P767, DOI 10.1093/hmg/2.6.767; NOTHEN MM, 1994, HUM MOL GENET, V3, P2207, DOI 10.1093/hmg/3.12.2207; NOTHEN MM, 1994, AM J MED GENET, V54, P249, DOI 10.1002/ajmg.1320540311; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; VANTOL HHM, 1992, NATURE, V358, P149	9	30	32	1	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1997	61	1					238	239		10.1016/S0002-9297(07)64298-0	http://dx.doi.org/10.1016/S0002-9297(07)64298-0			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM728	9246007	Bronze, Green Published			2022-12-18	WOS:A1997XM72800034
J	Ronce, N; Moizard, MP; Robb, L; Toutain, A; Villard, L; Moraine, C				Ronce, N; Moizard, MP; Robb, L; Toutain, A; Villard, L; Moraine, C			A C2055T transition in exon 8 of the ATP7A gene is associated with exon skipping in an occipital horn syndrome family	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							COPPER-TRANSPORTING ATPASE; MENKES DISEASE; CANDIDATE GENE; MUTATIONS; ENCODES; LOCUS		CHILDRENS HOSP,DIV MED GENET,MONTREAL,PQ,CANADA; INSERM,U406,F-13258 MARSEILLE,FRANCE	McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm)	Ronce, N (corresponding author), CHU BRETONNEAU,UNITE GENET,2 BD TONNELLE,F-37044 TOURS,FRANCE.		Villard, Laurent/E-3941-2016	Villard, Laurent/0000-0001-6657-5008; Toutain, Annick/0000-0002-5999-5300				CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; DAS S, 1994, AM J HUM GENET, V55, P883; DAS S, 1995, AM J HUM GENET, V56, P570; DIERICK HA, 1995, GENOMICS, V28, P462, DOI 10.1006/geno.1995.1175; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; FISHER CW, 1993, AM J HUM GENET, V52, P414; Kaler SG, 1995, ANN NEUROL, V38, P921, DOI 10.1002/ana.410380613; Kaler SG, 1996, BIOCHEM MOL MED, V57, P37, DOI 10.1006/bmme.1996.0007; KALER SG, 1994, NAT GENET, V8, P195, DOI 10.1038/ng1094-195; KRAWCZAK M, 1992, HUM GENET, V90, P41; Lazoff S G, 1975, Birth Defects Orig Artic Ser, V11, P71; Levinson B, 1996, HUM MOL GENET, V5, P1737, DOI 10.1093/hmg/5.11.1737; LIGTENBERG MJL, 1990, NUCLEIC ACIDS RES, V19, P297; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; PETRUKHIN K, 1994, HUM MOL GENET, V3, P1647, DOI 10.1093/hmg/3.9.1647; STEINGRIMSDOTTIR H, 1992, NUCLEIC ACIDS RES, V20, P1201, DOI 10.1093/nar/20.6.1201; TONNESEN T, 1989, J INHERIT METAB DIS, V1, P207; TSUKAHARA M, 1994, CLIN GENET, V45, P32; TUMER Z, 1995, GENOMICS, V26, P437, DOI 10.1016/0888-7543(95)80160-N; Tumer Z, 1997, AM J HUM GENET, V60, P63; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; WAKAMATSU N, 1992, J BIOL CHEM, V267, P2406	22	30	31	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1997	61	1					233	238						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM728	9246006				2022-12-18	WOS:A1997XM72800033
J	Matsumoto, N; Ohashi, H; Tsukahara, M; Kim, KC; Soeda, E; Niikawa, N				Matsumoto, N; Ohashi, H; Tsukahara, M; Kim, KC; Soeda, E; Niikawa, N			Possible narrowed assignment of the loci of monosomy 21-associated microcephaly and intrauterine growth retardation to a 1.2-Mb segment at 21q22.2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							MINDED GENE ENCODES; DOWN-SYNDROME; DROSOPHILA; PROTEIN; CHROMOSOME-21; REGION		SAITAMA CHILDRENS MED CTR,DEPT PEDIAT,IWATSUKI,SAITAMA,JAPAN; YAMAGUCHI UNIV,SCH ALLIED HLTH SCI,UBE,YAMAGUCHI 755,JAPAN; RIKEN,INST PHYS & CHEM RES,GENE BANK,TSUKUBA,IBARAKI,JAPAN	Saitama Children's Medical Center; Yamaguchi University; RIKEN	Matsumoto, N (corresponding author), NAGASAKI UNIV,SCH MED,DEPT HUMAN GENET,SAKAMOTO 1-12-4,NAGASAKI 852,JAPAN.							CHEN H, 1995, NAT GENET, V10, P9, DOI 10.1038/ng0595-9; CHETTOUH Z, 1995, AM J HUM GENET, V57, P62; CREWS ST, 1988, CELL, V52, P143, DOI 10.1016/0092-8674(88)90538-7; DAHMANE N, 1995, P NATL ACAD SCI USA, V92, P9191, DOI 10.1073/pnas.92.20.9191; Egashira M, 1996, CYTOGENET CELL GENET, V72, P175, DOI 10.1159/000134179; Fan CM, 1996, MOL CELL NEUROSCI, V7, P1, DOI 10.1006/mcne.1996.0001; Guimera J, 1996, HUM MOL GENET, V5, P1305, DOI 10.1093/hmg/5.9.1305; MCGINNISS MJ, 1992, AM J HUM GENET, V50, P15; NAMBU JR, 1991, CELL, V67, P1157, DOI 10.1016/0092-8674(91)90292-7; Osoegawa K, 1996, GENOMICS, V32, P375, DOI 10.1006/geno.1996.0132; PANGALOS C, 1992, AM J HUM GENET, V51, P1240; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; YAMAMOTO Y, 1979, HUM GENET, V48, P321, DOI 10.1007/BF00272832	13	30	30	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1997	60	4					997	999						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WT614	9106547				2022-12-18	WOS:A1997WT61400030
J	Ledoux, P; Scriver, CR; Hechtman, P				Ledoux, P; Scriver, CR; Hechtman, P			Expression and molecular analysis of mutations in prolidase deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IMINODIPEPTIDURIA; AMINOPEPTIDASE; FIBROBLASTS; ALLELES; PROLINE; PATIENT; DEFECT; CELLS; GENE	Prolidase (E.C.3.4.13.3) cleaves iminodipeptides. Prolidase deficiency (PD; McKusick 170100) is an autosomal recessive disorder with highly variable penetrance. We have identified two novel alleles in the prolidase gene (PEPD) by direct sequencing of PCR-amplified cDNA from a PD individual asymptomatic at age 11 years: a 551G-->A transition in exon 8 (R184Q) and a 833G-->A transition in exon 12 (G278D). To assess the biochemical phenotypes of these and two previously identified PEPD mutations (G448R and delE452), we have designed a transient-expression system for prolidase in COS-1 cells. The enzyme was expressed as a fusion protein carrying an N-terminal tag, the HA1 epitope of influenza hemagglutinin, allowing its immunological discrimination from the endogenous enzyme with a monoclonal antibody. Expression of the R184Q mutation produced 7.4% of control enzymatic activity whereas the expression of the G278D, G448R, and delE452 mutations produced inactive enzymes. Western analysis of the R184Q, G278D, and G448R prolidases revealed stable immunoreactive material whereas the delE452 prolidase was not detectable. Pulse-chase metabolic labeling of cells followed by immunoprecipitation revealed that the delE452 mutant protein was synthesized but had an increased rate of degradation.	MONTREAL CHILDRENS HOSP,RES INST,DEBELLE LAB,DIV MED GENET,MONTREAL,PQ H3H 1P3,CANADA; MCGILL UNIV,DEPT BIOL,MONTREAL,PQ,CANADA; MCGILL UNIV,DEPT HUMAN GENET,MONTREAL,PQ,CANADA	McGill University; McGill University; McGill University								BAZAN JF, 1994, P NATL ACAD SCI USA, V91, P2473, DOI 10.1073/pnas.91.7.2473; BORIGHT AP, 1989, AM J HUM GENET, V44, P731; BUTTERWORTH J, 1985, J INHERIT METAB DIS, V8, P193, DOI 10.1007/BF01805434; DAVIS NC, 1957, J BIOL CHEM, V224, P261; ENDO F, 1989, J BIOL CHEM, V264, P4476; GRAY RGF, 1983, J INHERIT METAB DIS, V6, P143; ISEMURA M, 1979, CLIN CHIM ACTA, V93, P401, DOI 10.1016/0009-8981(79)90291-2; JACKSON SH, 1975, CAN MED ASSOC J, V113, P759; LEDOUX P, 1994, AM J HUM GENET, V54, P1014; LEMIEUX B, 1984, J INHERIT METAB DIS, V7, P145; MOCK WL, 1995, J BIOL CHEM, V270, P18437, DOI 10.1074/jbc.270.31.18437; MYARA I, 1982, CLIN CHIM ACTA, V125, P193, DOI 10.1016/0009-8981(82)90196-6; NAUGHTEN ER, 1984, PEDIATR RES, V18, P259, DOI 10.1203/00006450-198403000-00008; POWELL GF, 1976, METABOLISM, V25, P503, DOI 10.1016/0026-0495(76)90003-2; PROIA RL, 1984, J BIOL CHEM, V259, P3350; Sambrook J, 1989, MOL CLONING LAB MANU; SJOSTROM H, 1973, BIOCHIM BIOPHYS ACTA, V327, P457, DOI 10.1016/0005-2744(73)90429-4; TANOUE A, 1990, J BIOL CHEM, V265, P11306; UMEMURA S, 1978, PHYSIOL CHEM PHYS M, V10, P279; Valle, 1995, METABOLIC MOL BASES, P1125	20	30	33	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1996	59	5					1035	1039						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN900	8900231				2022-12-18	WOS:A1996VN90000010
J	Wang, SB; DeteraWadleigh, SD; Coon, H; Sun, CE; Goldin, LR; Duffy, DL; Byerley, WF; Gershon, ES; Diehl, SR				Wang, SB; DeteraWadleigh, SD; Coon, H; Sun, CE; Goldin, LR; Duffy, DL; Byerley, WF; Gershon, ES; Diehl, SR			Evidence of linkage disequilibrium between schizophrenia and the SCA1 CAG repeat on chromosome 6p23	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							SCHIZOAFFECTIVE DISORDER; MICROSATELLITE LOCI; GENETIC DISSECTION; COMPLEX TRAITS; SUSCEPTIBILITY; ASSOCIATION; WORKSHOP; DISEASE; TYPE-1; FAMILY		NIDR,MOL EPIDEMIOL & DIS INDICATORS BRANCH,DEODP,NIH,BETHESDA,MD 20892; NIMH,CLIN NEUROGENET BRANCH,NIH,BETHESDA,MD 20892; UNIV UTAH,SCH MED,DEPT PSYCHIAT,SALT LAKE CITY,UT 84112; JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,BALTIMORE,MD	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Utah System of Higher Education; University of Utah; Johns Hopkins University			Duffy, David L/B-7392-2013	Duffy, David L/0000-0001-7227-632X				ANTONARAKIS SE, 1995, NAT GENET, V11, P235, DOI 10.1038/ng1195-235; Barinaga M, 1996, SCIENCE, V271, P1233, DOI 10.1126/science.271.5253.1233; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; Bickeboller H, 1995, GENET EPIDEMIOL, V12, P865, DOI 10.1002/gepi.1370120656; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; CLONINGER CR, 1994, AM J MED GENET, V54, P83, DOI 10.1002/ajmg.1320540202; COON H, 1994, AM J MED GENET, V54, P59, DOI 10.1002/ajmg.1320540111; CURTIS D, 1994, ANN HUM GENET, V58, P151, DOI 10.1111/j.1469-1809.1994.tb01884.x; DELISI LE, 1987, ARCH GEN PSYCHIAT, V44, P891; Devlin B., 1995, American Journal of Human Genetics, V57, pA15; DIEHL SR, 1989, SCHIZOPHRENIA BULL, V15, P403, DOI 10.1093/schbul/15.3.403; EWENS WJ, 1995, AM J HUM GENET, V57, P445; FENG HS, 1994, AM J HUM GENET, V55, P932; GERSHON ES, 1988, ARCH GEN PSYCHIAT, V45, P328; GOTTESMAN II, 1991, SCHIZOPHRENIA GENETI; JODICE C, 1993, HUM MOL GENET, V2, P1383, DOI 10.1093/hmg/2.9.1383; JORDE LB, 1995, AM J HUM GENET, V56, P11; KENDLER KS, 1993, SCHIZOPHRENIA BULL, V19, P261, DOI 10.1093/schbul/19.2.261; Kendler KS, 1996, AM J MED GENET, V67, P179, DOI 10.1002/(SICI)1096-8628(19960409)67:2<179::AID-AJMG8>3.0.CO;2-N; Kendler KS, 1995, COMPREHENSIVE TXB PS, P942; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lennon D. J., 1995, American Journal of Human Genetics, V57, pA196; McGinnis R. E., 1995, American Journal of Human Genetics, V57, pA12; MOISES HW, 1995, NAT GENET, V11, P321, DOI 10.1038/ng1195-321; Mullan M., 1995, American Journal of Human Genetics, V57, pA198; ODONOVAN MC, 1995, NAT GENET, V10, P380, DOI 10.1038/ng0895-380; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PETRONIS A, 1995, AM J PSYCHIAT, V152, P164; *SAGE, 1994, STAT AN GEN EP REL 2; SCHAID DJ, 1994, AM J HUM GENET, V55, P402; SCHWAB SG, 1995, NAT GENET, V11, P325, DOI 10.1038/ng1195-325; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; SU Y, 1993, ARCH GEN PSYCHIAT, V50, P205; SUTHERLAND GR, 1995, P NATL ACAD SCI USA, V92, P3636, DOI 10.1073/pnas.92.9.3636; THOMSON G, 1995, AM J HUM GENET, V57, P487; Virtaneva K. I., 1995, American Journal of Human Genetics, V57, pA273; VOLZ A, 1994, GENOMICS, V21, P464, DOI 10.1006/geno.1994.1302; WANG SB, 1995, NAT GENET, V10, P41, DOI 10.1038/ng0595-41; WEEKS DE, 1990, SCHIZOPHRENIA BULL, V16, P673, DOI 10.1093/schbul/16.4.673; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; ZIEGLE JS, 1992, GENOMICS, V14, P1026, DOI 10.1016/S0888-7543(05)80126-0	43	30	31	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1996	59	3					731	736						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	VN625	8751875				2022-12-18	WOS:A1996VN62500028
J	Purandare, SM; Cawthon, R; Nelson, LM; Sawada, S; Watkins, WS; Ward, K; Jorde, LB; Viskochil, DH				Purandare, SM; Cawthon, R; Nelson, LM; Sawada, S; Watkins, WS; Ward, K; Jorde, LB; Viskochil, DH			Genotyping of PCR-based polymorphisms and linkage-disequilibrium analysis at the NF1 locus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEUROFIBROMATOSIS TYPE-1 NF1; ALU-REPEAT; GENE; MICROSATELLITES; INSTABILITY; REGION; IDENTIFICATION; DIAGNOSIS; ALLELES; INTRON	Six polymorphisms across the NF1 gene have been adapted for genotyping through application of PCR-based assays. Three exon-based polymorphisms--at positions 702, 2034, and 10647 in the NF1 cDNA--were genotyped by mutagenically separated PCR (MS-PCR). A fourth polymorphism, DV1.9, is an L1 insertion element in intron 30, and the other two polymorphisms, GXAlu and EVI-20, are short tandem repeats in intron 27b. All the polymorphisms were evaluated in a cohort of 110 CEPH individuals who previously had been analyzed by use of eight RFLPs at the NF1 locus. Pairwise linkage-disequilibrium analyses with the six PCR-based polymorphisms and their flanking markers demonstrated disequilibrium between all tested loci. Genotypes of the four diallelic polymorphisms (702, 2034, 10647, and DV1.9) were also evaluated in cohorts from the CEPH, African, and Japanese populations. The CEPH and Japanese cohorts showed similar heterozygosities and linkage-disequilibrium coefficients. The African cohort showed a higher degree of heterozygosity and lower linkage-disequilibrium values, compared with the CEPH and Japanese cohorts.	UNIV UTAH, DEPT PEDIAT, MREB, SALT LAKE CITY, UT 84112 USA; UNIV UTAH, DEPT HUMAN GENET, SALT LAKE CITY, UT 84112 USA; UNIV UTAH, DEPT OBSTET & GYNECOL, SALT LAKE CITY, UT 84112 USA; JIKEI UNIV, TOKYO, JAPAN	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Jikei University					NCI NIH HHS [CA 57511-01] Funding Source: Medline; NHGRI NIH HHS [HG 00347] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R55CA057511] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000347] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ANDERSEN LB, 1993, HUM MOL GENET, V2, P1083, DOI 10.1093/hmg/2.7.1083-a; [Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BLEYL S, 1994, HUM MOL GENET, V3, P517, DOI 10.1093/hmg/3.3.517; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; DAMS E, 1995, CANCER RES, V55, P1547; DEKA R, 1995, AM J HUM GENET, V56, P461; ELBEIN SC, 1992, AM J HUM GENET, V51, P1103; HEIM RA, 1995, HUM MOL GENET, V4, P975, DOI 10.1093/hmg/4.6.975; HOFFMEYER S, 1994, HUM GENET, V93, P481; HOFFMEYER S, 1995, HUM MOL GENET, V4, P1267, DOI 10.1093/hmg/4.8.1267; HOFMAN KJ, 1992, J PEDIATR-US, V120, P394, DOI 10.1016/S0022-3476(05)80903-5; HONCHEL R, 1995, SEMIN CELL BIOL, V6, P45, DOI 10.1016/1043-4682(95)90014-4; JORDE LB, 1993, AM J HUM GENET, V53, P1038; JORDE LB, 1995, AM J HUM GENET, V57, P523; LAZARO C, 1993, HUM GENET, V92, P429, DOI 10.1007/BF01247353; LAZARO C, 1994, HUM GENET, V93, P351, DOI 10.1007/BF00212039; LAZARO C, 1993, HUM MOL GENET, V2, P725, DOI 10.1093/hmg/2.6.725; Leppig KA, 1996, CYTOGENET CELL GENET, V72, P95, DOI 10.1159/000134171; LI Y, 1995, GENOMICS, V25, P9, DOI 10.1016/0888-7543(95)80104-T; MARCHUK DA, 1992, GENOMICS, V13, P672, DOI 10.1016/0888-7543(92)90140-N; MARCHUK DA, 1991, GENOMICS, V11, P931, DOI 10.1016/0888-7543(91)90017-9; OTTINI L, 1995, CANCER RES, V55, P5677; Purandare SM, 1995, GENOMICS, V30, P476, DOI 10.1006/geno.1995.1268; PYKETT MJ, 1994, CANCER RES, V54, P6340; REGNIER V, 1995, HUM GENET, V96, P131, DOI 10.1007/BF00214202; RODENHISER DI, 1993, J MED GENET, V30, P363, DOI 10.1136/jmg.30.5.363; RUST S, 1993, NUCLEIC ACIDS RES, V21, P3623, DOI 10.1093/nar/21.16.3623; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; WARD K, 1990, AM J HUM GENET, V46, P943; WEIR BS, 1979, BIOMETRICS, V35, P235, DOI 10.2307/2529947; WEIR BS, 1990, GENETIC DATA ANAL, P102; XU GF, 1991, NUCLEIC ACIDS RES, V19, P3764, DOI 10.1093/nar/19.13.3764; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9; XU W, 1991, NUCLEIC ACIDS RES, V19, P4570, DOI 10.1093/nar/19.16.4570; [No title captured]	36	30	31	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1996	59	1					159	166						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL455	8659521				2022-12-18	WOS:A1996VL45500023
J	Feussner, G; Dobmeyer, J; Grone, HJ; Lohmer, S; Wohlfeil, S				Feussner, G; Dobmeyer, J; Grone, HJ; Lohmer, S; Wohlfeil, S			A 10-bp deletion in the apolipoprotein epsilon gene causing apolipoprotein E deficiency and severe type III hyperlipoproteinemia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PLASMA-LIPOPROTEINS; FAMILIAL DYSBETALIPOPROTEINEMIA; GEL-ELECTROPHORESIS; ATHEROSCLEROSIS; DIAGNOSIS; PROTEIN; CELLS; HYPERCHOLESTEROLEMIA; POLYMORPHISM; SEQUENCE	Type III hyperlipoproteinemia (HLP) is usually associated with homozygosity for apolipoprotein (ape) E2. We identified a 30-year-old male German of Hungarian ancestry with severe type III HLP and apo E deficiency. The disease was expressed in an extreme phenotype with multiple cutaneous xanthomas. Apo E was detectable only in trace amounts in plasma but not in the different lipoprotein fractions. Direct sequencing of PCR-amplified segments of the apo epsilon gene identified a 10-bp deletion in exon 4 (bp 4037-4046 coding for amino acids 209-212 of the mature protein). The mutation is predictive for a reading frameshift introducing a premature stop codon (TGA) at amino acid 229. By western blot analysis, we found small amounts of a truncated apo E in the patient's plasma. Family analysis revealed that the proband was homozygous - and 10 of 24 relatives were heterozygous - for the mutation. Heterozygotes had, as compared to unaffected family members, significantly higher triglycerides (TG), very low-density lipoprotein (VLDL) cholesterol and a significantly higher VLDL cholesterol-to-serum TG ratio, which is indicative of a delayed remnant catabolism. We propose that the absence of a functionally active apo E is the cause of the severe type III HLP in the patient and that the mutation, even in a single dose in heterozygotes, predisposes in variable severity to the phenotypic expression of the disease.	MED ZENTRUM PATHOL,MARBURG,GERMANY; BAYER AG,PHARMA FORSCH,HERZKREISLAUFFORSCH 3,W-5600 WUPPERTAL,GERMANY	Bayer AG	Feussner, G (corresponding author), UNIV HEIDELBERG,DEPT INTERNAL MED 1,MED KLIN,BERGHEIMER STR 58,D-69115 HEIDELBERG,GERMANY.							ANAKSHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133; BREWER HB, 1983, ANN INTERN MED, V98, P623, DOI 10.7326/0003-4819-98-5-623; CLADARAS C, 1987, J BIOL CHEM, V262, P2310; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; EHNHOLM C, 1984, P NATL ACAD SCI-BIOL, V81, P5566, DOI 10.1073/pnas.81.17.5566; FEUSSNER G, 1993, CLIN INVESTIGATOR, V71, P362; FEUSSNER G, 1993, HUM GENET, V92, P122; GHISELLI G, 1981, SCIENCE, V214, P1239, DOI 10.1126/science.6795720; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HAVEL RJ, 1982, MED CLIN N AM, V66, P441, DOI 10.1016/S0025-7125(16)31429-8; ISHIBASHI S, 1994, P NATL ACAD SCI USA, V91, P4431, DOI 10.1073/pnas.91.10.4431; JI ZS, 1993, J BIOL CHEM, V268, P10160; KUROSAKA D, 1991, ATHEROSCLEROSIS, V88, P15, DOI 10.1016/0021-9150(91)90252-X; LOHSE P, 1992, J LIPID RES, V33, P1583; LULEY C, 1991, J LIPID RES, V32, P880; MABUCHI H, 1989, METABOLISM, V38, P115, DOI 10.1016/0026-0495(89)90249-7; Mahley Jr RWRS, 1989, METABOLIC BASIS INHE, P1195; MAHLEY RW, 1989, J CLIN INVEST, V83, P2125, DOI 10.1172/JCI114126; MAHLEY RW, 1984, ADV INTERNAL MED, V29, P385; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NEVILLE DM, 1971, J BIOL CHEM, V246, P6328; PAIK YK, 1985, P NATL ACAD SCI USA, V82, P3445, DOI 10.1073/pnas.82.10.3445; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; RALL SC, 1982, J BIOL CHEM, V257, P4171; REDDICK RL, 1994, ARTERIOSCLER THROMB, V14, P141, DOI 10.1161/01.ATV.14.1.141; REDGRAVE TG, 1975, ANAL BIOCHEM, V65, P42, DOI 10.1016/0003-2697(75)90488-1; RUZICKA V, 1993, ELECTROPHORESIS, V14, P1032, DOI 10.1002/elps.11501401164; SCHAEFER EJ, 1986, J CLIN INVEST, V78, P1206, DOI 10.1172/JCI112704; VANMELSEN A, 1974, CLIN CHIM ACTA, V55, P225, DOI 10.1016/0009-8981(74)90299-X; VANREE JH, 1995, ATHEROSCLEROSIS, V112, P237, DOI 10.1016/0021-9150(94)05419-J; WARNICK GR, 1979, CLIN CHEM, V25, P279; WEISGRABER KH, 1990, J LIPID RES, V31, P1503; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; WESTERLUND JA, 1993, J BIOL CHEM, V268, P15745; ZANNIS VI, 1981, BIOCHEMISTRY-US, V20, P1033, DOI 10.1021/bi00507a059; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	37	30	31	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1996	58	2					281	291						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TR791	8571954				2022-12-18	WOS:A1996TR79100004
J	STUMM, M; GATTI, RA; REIS, A; UDAR, N; CHRZANOWSKA, K; SEEMANOVA, E; SPERLING, K; WEGNER, RD				STUMM, M; GATTI, RA; REIS, A; UDAR, N; CHRZANOWSKA, K; SEEMANOVA, E; SPERLING, K; WEGNER, RD			THE ATAXIA-TELANGIECTASIA-VARIANT GENE-1 AND GENE-2 ARE DISTINCT FROM THE ATAXIA-TELANGIECTASIA GENE ON CHROMOSOME-11Q23.1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							COMPLEMENTATION		HUMBOLDT UNIV BERLIN,VIRCHOW KLINIKUM,INST HUMANGENET,D-14059 BERLIN,GERMANY; UNIV CALIF LOS ANGELES,SCH MED,DEPT PATHOL,LOS ANGELES,CA 90024; MEM HOSP WARSAW,CTR CHILD HLTH,DEPT HUMAN GENET,WARSAW,POLAND; UNIV HOSP,DEPT CLIN GENET,PRAGUE,CZECH REPUBLIC	Humboldt University of Berlin; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Children's Memorial Health Institute; General University Hospital Prague			Reis, André/D-2309-2009	Reis, André/0000-0002-6301-6363; Chrzanowska, Krystyna/0000-0003-3888-0624; Udar, Nitin/0000-0001-8533-9190				AMBROSE HJ, 1994, GENOMICS, V21, P612, DOI 10.1006/geno.1994.1321; CHRZANOWSKA KH, 1995, AM J MED GENET, V57, P462, DOI 10.1002/ajmg.1320570321; GATTI RA, 1988, NATURE, V336, P577, DOI 10.1038/336577a0; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; JASPERS NGJ, 1988, CYTOGENET CELL GENET, V49, P259, DOI 10.1159/000132673; KOMATSU K, 1994, CANCER RES, V54, P6007; LANGE E, 1995, AM J HUM GENET, V57, P112; ROTMAN G, 1994, HUM MOL GENET, V3, P2079; ROTMAN G, 1994, GENOMICS, V24, P234, DOI 10.1006/geno.1994.1611; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; UHRHAMMER N, 1994, GENOMICS, V20, P278, DOI 10.1006/geno.1994.1165; UHRHAMMER N, 1995, AM J HUM GENET, V57, P103; VANAGAITE L, 1995, HUM GENET, V95, P451; VANAGAITE L, 1994, GENOMICS, V22, P231, DOI 10.1006/geno.1994.1370; WEGNER RD, 1988, CLIN GENET, V33, P20	15	30	30	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1995	57	4					960	962						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RV793	7573059				2022-12-18	WOS:A1995RV79300029
J	BUGAWAN, TL; CHANG, JD; KLITZ, W; ERLICH, HA				BUGAWAN, TL; CHANG, JD; KLITZ, W; ERLICH, HA			PCR/OLIGONUCLEOTIDE PROBE TYPING OF HLA CLASS-II ALLELES IN A FILIPINO POPULATION REVEALS AN UNUSUAL DISTRIBUTION OF HLA HAPLOTYPES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NONRADIOACTIVE OLIGONUCLEOTIDE PROBES; POLYMERASE CHAIN-REACTION; AMPLIFIED DNA; POLYMORPHISM; LOCI; AMPLIFICATION; EVOLUTIONARY; COMPLEX; BETA	We have analyzed the distribution of HLA class II alleles and haplotypes in a Filipino population by PCR amplification of the DRB1, DQB1, and DPB1 second-exon sequences from buccal swabs obtained from 124 family members and 53 unrelated individuals. The amplified DNA was typed by using nonradioactive sequence-specific oligonucleotide probes. Twenty-two different DRB1 alleles, including the novel Filipino *1105, and 46 different DRB1/DQB1 haplotypes, including the unusual DRB1*0405-DQB1*0503, were identified. An unusually high frequency (f = .383) of DPB1*0101, a rare allele in other Asian populations, was also observed. In addition, an unusual distribution of DRB1 alleles and haplotypes was seen in this population, with DR2 (f = .415) and DRB1*1502-DQB1*0502 (f = .233) present at high frequencies. This distribution of DRB1 alleles differs from the typical HLA population distribution, in which the allele frequencies are more evenly balanced. The distribution of HLA class II alleles and haplotypes in this Filipino population is different from that of other Asian and Pacific groups: of those populations studied to date; the Indonesian population is the most similar, DRB1*1502-DQB1*0502 was in strong linkage disequilibrium (D' = .41) with DPB1*0101 (f = .126, for the extended haplotype), which is consistent with selection for this DR, DQ, DP haplotype being responsible for the high frequency of these three class II alleles in this population.	ROCHE MOLEC SYST,DEPT HUMAN GENET,ALAMEDA,CA 94501; UNIV CALIF BERKELEY,DEPT INTEGRAT BIOL,BERKELEY,CA 94720	Roche Holding; University of California System; University of California Berkeley					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035326] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL47170] Funding Source: Medline; NIAID NIH HHS [AI29042] Funding Source: Medline; NIGMS NIH HHS [GM35326] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSSON R, 1979, THESIS MONASH U CLAY; APPLE RJ, 1993, TISSUE ANTIGENS, V41, P51, DOI 10.1111/j.1399-0039.1993.tb01978.x; Baur M.P., 1980, HISTOCOMPATIBILITY T, P955; BEGOVICH AB, 1990, HUM IMMUNOL, V28, P365, DOI 10.1016/0198-8859(90)90031-J; BEGOVICH AB, 1992, J IMMUNOL, V148, P249; BUGAWAN TL, 1991, IMMUNOGENETICS, V33, P163, DOI 10.1007/BF01719235; BUGAWAN TL, 1990, IMMUNOGENETICS, V32, P231; COMEY CT, 1991, J FORENSIC SCI, V36, P1633; ERLICH H, 1991, EUR J IMMUNOGENET, V18, P33, DOI 10.1111/j.1744-313X.1991.tb00005.x; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; FERNANDEZVINA MA, 1991, IMMUNOGENETICS, V34, P299, DOI 10.1007/BF00211994; GAO XJ, 1992, HUM IMMUNOL, V34, P153, DOI 10.1016/0198-8859(92)90107-X; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; HEDRICK PW, 1991, P NATL ACAD SCI USA, V88, P5897, DOI 10.1073/pnas.88.13.5897; HELMUTH R, 1990, AM J HUM GENET, V47, P515; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; HUGHES AL, 1989, P NATL ACAD SCI USA, V86, P958, DOI 10.1073/pnas.86.3.958; IMANISHI T, 1991, HLA 1991, V1, P1065; KLITZ W, 1986, AM J HUM GENET, V39, P340; KLITZ W, 1992, EVOL BIOL, V26, P35; LEWONTIN RC, 1964, GENETICS, V49, P49; NEPOM GT, 1991, ANNU REV IMMUNOL, V9, P493; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SAIKI RK, 1989, P NATL ACAD SCI USA, V86, P6230, DOI 10.1073/pnas.86.16.6230; SCHARF SJ, 1991, HUM IMMUNOL, V30, P190, DOI 10.1016/0198-8859(91)90034-7; SMITH CAB, 1957, ANN HUM GENET, V21, P254, DOI 10.1111/j.1469-1809.1972.tb00287.x; TIERCY JM, 1992, AM J HUM GENET, V51, P592; TIWARI JL, 1985, HLA DISEASE ASS; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WATTERSON GA, 1978, GENETICS, V88, P405	30	30	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1994	54	2					331	340						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU315	8304349				2022-12-18	WOS:A1994MU31500017
J	DIZIER, MH; BONAITIPELLIE, C; CLERGETDARPOUX, F				DIZIER, MH; BONAITIPELLIE, C; CLERGETDARPOUX, F			CONCLUSIONS OF SEGREGATION ANALYSIS FOR FAMILY DATA GENERATED UNDER 2-LOCUS MODELS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							UNIFIED MODEL; COMPLEX SEGREGATION; TRAITS; ROBUSTNESS	Susceptibility to a disease may involve the interactive effect of two genes. What conclusions will be drawn by segregation analysis in such a case? To answer this question, we considered a set of two-locus models and the corresponding exact distribution for 300 families. We investigated the conclusions and parameter estimations obtained for this sample, by comparing the likelihood expectations of the unified model and of more restricted models. In many cases, segregation analysis leads to the conclusion of a major gene effect, with or without a polygenic component-usually without a polygenic component in multiplicative models (i.e., where two genes have a multiplicative effect) and with such a component in nonmultiplicative models. For all the models considered, existence of a major gene effect is supported by transmission probability tests; there is evidence for transmission and agreement with the hypothesis of Mendelian transmission. Accordingly, there is no means of detecting that the effect of a major gene, with or without a polygenic component, does not correspond to the correct model. In addition, the parameter estimates for the major gene do not correspond to the characteristics of either of the two genes of the true model. This may substantially affect further linkage analysis.			DIZIER, MH (corresponding author), INSERM,U155,UNITE RECH EPIDEMIOL GENET,CHATEAU LONGCHAMP,F-75016 PARIS,FRANCE.		Dizier, Marie-Hélène/K-8463-2018; Clerget-Darpoux, Francoise/I-4825-2017	Dizier, Marie-Hélène/0000-0001-8460-7667; Clerget-Darpoux, Francoise/0000-0003-4816-6619				CLERGETDARPOUX F, 1990, GENET EPIDEMIOL, V7, P245, DOI 10.1002/gepi.1370070403; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; DEMENAIS F, 1986, AM J HUM GENET, V38, P228; DEMENAIS F, 1989, GENET EPIDEMIOL, V6, P229, DOI 10.1002/gepi.1370060140; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; GREENBERG DA, 1984, AM J HUM GENET, V36, P167; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LALOUEL JM, 1980, POINTER COMPUTER PRO; MORTON NE, 1955, AM J HUM GENET, V7, P277; MORTON NE, 1974, AM J HUM GENET, V26, P489; VIELAND VJ, 1992, GENET EPIDEMIOL, V9, P45, DOI 10.1002/gepi.1370090106	12	30	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1993	53	6					1338	1346						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MJ818	8250049				2022-12-18	WOS:A1993MJ81800020
J	STELLA, A; RESTA, N; GENTILE, M; SUSCA, F; MARENI, C; MONTERA, MP; GUANTI, G				STELLA, A; RESTA, N; GENTILE, M; SUSCA, F; MARENI, C; MONTERA, MP; GUANTI, G			EXCLUSION OF THE APC GENE AS THE CAUSE OF A VARIANT FORM OF FAMILIAL ADENOMATOUS POLYPOSIS (FAP)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; HUMAN SARCOMAS; COLI APC; LOCUS; IDENTIFICATION; MUTATIONS; DNA; CHROMOSOME-5Q21; AMPLIFICATION; POLYMORPHISM	Familial adenomatous polyposis (FAP) is a premalignant disease inherited as an autosomal dominant trait, characterized by hundreds to thousands of polyps in the colorectal tract. Recently, the syndrome has been shown to be caused by mutations in the APC (adenomatous polyposis coli) gene located on chromosome 5q21. We studied two families that both presented a phenotype different than that of the classical form of FAP. The most important findings observed in these two kindreds are (a) low and variable number of colonic polyps (from 5 to 100) and (b) a slower evolution of the disease, with colon cancer occurring at a more advanced age than in FAP in spite of the early onset of intestinal manifestations. To determine whether mutations of the APC gene are also responsible for this variant syndrome, linkage studies were performed by using a series of markers both intragenic and tightly linked to the APC gene. The results provide evidence for exclusion of the APC gene as the cause of the variant form of polyposis present in the two families described.	UNIV BARI,IST GENET,CATTEDRA GENET MED,VIA AMENDOLA 165A,I-70126 BARI,ITALY; UNIV GENOA,DIPARTIMENTO MED INTERNA,I-16126 GENOA,ITALY; IST RICOVERO & CURA CARATTERE SCI DE BELLIS,CASTELLANZA,ITALY	Universita degli Studi di Bari Aldo Moro; University of Genoa			Stella, Alessandro/I-8832-2012; Resta, Nicoletta/I-8424-2018; Gentile, Mattia/AEQ-3183-2022	Stella, Alessandro/0000-0002-9035-6267; Resta, Nicoletta/0000-0001-8640-5532; Gentile, Mattia/0000-0002-5299-6036; Susca, Francesco Claudio/0000-0002-9899-8301				ATTWOOD J, 1988, ANN HUM GENET, V52, P259, DOI 10.1111/j.1469-1809.1988.tb01103.x; BLAIR NP, 1980, AM J OPHTHALMOL, V90, P661, DOI 10.1016/S0002-9394(14)75133-5; BUDOWLE B, 1991, AM J HUM GENET, V48, P137; COTTRELL S, 1992, LANCET, V340, P626, DOI 10.1016/0140-6736(92)92169-G; DELEON MP, 1989, AM J GASTROENTEROL, V84, P906; FEINMESSER R, 1992, NEW ENGL J MED, V326, P17, DOI 10.1056/NEJM199201023260103; GARDNER EJ, 1951, AM J HUM GENET, V3, P167; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; HEIGHWAY J, 1991, NUCLEIC ACIDS RES, V19, P6966, DOI 10.1093/nar/19.24.6966; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEPPERT M, 1990, NEW ENGL J MED, V322, P904, DOI 10.1056/NEJM199003293221306; MARENI C, 1993, HUM GENET, V90, P545, DOI 10.1007/BF00217456; MIYOSHI Y, 1992, P NATL ACAD SCI USA, V89, P4452, DOI 10.1073/pnas.89.10.4452; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; MULLIGAN LM, 1990, P NATL ACAD SCI USA, V87, P5863, DOI 10.1073/pnas.87.15.5863; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P5707, DOI 10.1093/nar/16.12.5707; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; OLSCHWANG S, 1992, HUM GENET, V88, P658, DOI 10.1007/BF02265293; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PELTOMAKI P, 1992, CANCER RES, V52, P4530; POWLL SM, 1992, NATURE, V359, P235; Sambrook J., 1989, MOL CLONING LAB MANU; SPIRIO L, 1992, AM J HUM GENET, V51, P92; SPIRIO L, 1991, NUCLEIC ACIDS RES, V19, P643; STELLA A, 1992, BIOCHEM BIOPH RES CO, V184, P1357, DOI 10.1016/S0006-291X(05)80032-4; TOPS CMJ, 1992, AM J MED GENET, V43, P888, DOI 10.1002/ajmg.1320430528; WIJNEN J, 1991, NUCLEIC ACIDS RES, V19, P6965, DOI 10.1093/nar/19.24.6965-a	30	30	31	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1993	53	5					1031	1037						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MC333	8213830				2022-12-18	WOS:A1993MC33300007
J	HOWE, JR; LAIRMORE, TC; MISHRA, SK; DOU, S; VEILE, R; WELLS, SA; DONISKELLER, H				HOWE, JR; LAIRMORE, TC; MISHRA, SK; DOU, S; VEILE, R; WELLS, SA; DONISKELLER, H			IMPROVED PREDICTIVE TEST FOR MEN2, USING FLANKING DINUCLEOTIDE REPEATS AND RFLPS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPLE ENDOCRINE NEOPLASIA; GENETIC-LINKAGE MAP; MEDULLARY-THYROID CARCINOMA; POLYMERASE CHAIN-REACTION; HUMAN CHROMOSOME-10; DNA POLYMORPHISMS; TYPE-2A; MARKERS; CELLS; IDENTIFICATION	Gene(s) for the autosomal dominant endocrine cancer syndromes, multiple endocrine neoplasia type 2A (MEN2A), multiple endocrine neoplasia type 2B (MEN2B), and familial medullary thyroid carcinoma (MTC1) all map to the pericentromeric region of chromosome 10. Predictive testing for the inheritance of mutant alleles in individuals at risk for these disorders has been limited by the availability of highly informative and closely linked flanking markers. We describe the development of eight new markers, including two PCR-based dinucleotide repeat polymorphisms and six RFLPs that flank the disease loci. One of the dinucleotide repeat markers (sJRH-1) derives from the RBP3 locus on 10q11.2 and has a PIC of .88. The other dinucleotide repeat (sTCL-1) defines a new locus, D10S176, that maps by in situ hybridization to 10p11.2 and has a PIC of .68. We have constructed a new genetic linkage map of the pericentromeric region of chromosome 10, on the basis of 13 polymorphisms at six loci, which places the MEN2A locus between the dinucleotide repeat markers, with odds of 5,750:1 over the next most likely position. Using this set of markers, predictive genetic testing of 130 at-risk individuals from six families segregating MEN2A revealed that 95% were jointly informative with flanking markers, representing a significant improvement in genetic testing capabilities.	WASHINGTON UNIV,SCH MED,DEPT SURG,DIV HUMAN MOLEC GENET,BOX 8109,ST LOUIS,MO 63110	Washington University (WUSTL)	DONISKELLER, H (corresponding author), WASHINGTON UNIV,SCH MED,DEPT SURG,DIV HUMAN MOLEC GENET,BOX 8109,ST LOUIS,MO 63110, USA.			Howe, James/0000-0001-5312-5972	NATIONAL CANCER INSTITUTE [T32CA009621] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000304] Funding Source: NIH RePORTER; NCI NIH HHS [CA09621] Funding Source: Medline; NHGRI NIH HHS [HG00304] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ARGRAVES WS, 1987, J CELL BIOL, V105, P1183, DOI 10.1083/jcb.105.3.1183; BOWDEN DW, 1989, GENOMICS, V5, P718, DOI 10.1016/0888-7543(89)90113-4; CARLE GF, 1984, NUCLEIC ACIDS RES, V12, P5647, DOI 10.1093/nar/12.14.5647; CARTER C, 1987, CYTOGENET CELL GENET, V45, P33, DOI 10.1159/000132422; CHIN KS, 1988, NUCLEIC ACIDS RES, V16, P1645, DOI 10.1093/nar/16.4.1645; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; EASTON DF, 1989, AM J HUM GENET, V44, P208; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FONG SL, 1988, J BIOL CHEM, V263, P15330; GARDNER E, 1991, CYTOGENET CELL GENET, V58, P1949; GIANCOTTI FG, 1990, CELL, V60, P849, DOI 10.1016/0092-8674(90)90098-Y; GOODFELLOW PJ, 1990, AM J HUM GENET, V47, P952; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; HOWE J R, 1991, Surgical Forum (Chicago), V42, P432; HOWE JR, 1992, SURGERY, V112, P219; HOWE JR, 1990, AM J HUM GENET, V47, pA184; ISHIZAKA Y, 1989, ONCOGENE, V4, P1519; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; KIDD KK, 1989, CYTOGENET CELL GENET, V51, P622, DOI 10.1159/000132810; LAIRMORE TC, 1991, GENOMICS, V9, P181, DOI 10.1016/0888-7543(91)90237-9; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; MATHEW CGP, 1991, LANCET, V337, P7, DOI 10.1016/0140-6736(91)93329-8; MATHEW CGP, 1987, NATURE, V328, P527, DOI 10.1038/328527a0; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NAKAMURA Y, 1988, GENOMICS, V3, P389, DOI 10.1016/0888-7543(88)90133-4; NAKAMURA Y, 1989, GENOMICS, V5, P199, DOI 10.1016/0888-7543(89)90046-3; NORUM RA, 1990, GENOMICS, V8, P313, DOI 10.1016/0888-7543(90)90287-5; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHUMM JW, 1988, AM J HUM GENET, V42, P143; SIMPSON NE, 1987, NATURE, V328, P528, DOI 10.1038/328528a0; SOBOL H, 1989, NEW ENGL J MED, V321, P996, DOI 10.1056/NEJM198910123211502; WEAVER R, 1992, AM J HUM GENET, V50, P1267; WEBER JL, 1989, AM J HUM GENET, V44, P388; WELLS SA, 1978, ANN SURG, V188, P139, DOI 10.1097/00000658-197808000-00002; WELLS SA, 1982, ANN SURG, V195, P595, DOI 10.1097/00000658-198205000-00008; WU JS, 1990, GENOMICS, V8, P461, DOI 10.1016/0888-7543(90)90032-P; WU JS, 1990, AM J HUM GENET, V46, P624; WU JS, 1990, NUCLEIC ACIDS RES, V18, P1316; YAMAMOTO M, 1989, HUM GENET, V82, P287, DOI 10.1007/BF00291173	42	30	31	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1992	51	6					1430	1442						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KC995	1361102				2022-12-18	WOS:A1992KC99500026
J	ESTABROOKS, LL; LAMB, AN; KIRKMAN, HN; CALLANAN, NP; RAO, KW				ESTABROOKS, LL; LAMB, AN; KIRKMAN, HN; CALLANAN, NP; RAO, KW			A MOLECULAR DELETION OF DISTAL CHROMOSOME 4P IN 2 FAMILIES WITH A SATELLITED CHROMOSOME-4 LACKING THE WOLF-HIRSCHHORN SYNDROME PHENOTYPE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NUCLEOLUS ORGANIZER REGIONS; HUNTINGTON DISEASE GENE; X-CHROMOSOME; TRANSLOCATION; CELLS; ACTIVATION; TELOMERE	We report two families with a satellited chromosome 4 short arm (4ps). Satellites and stalks normally occur on the short arms of acrocentric chromosomes; however, the literature cites several reports of satellited nonacrocentric chromosomes, which presumably result from a translocation with an acrocentric chromosome. This is the first report of 4ps chromosomes. Our families are remarkable in that both unaffected and affected individuals carry the 4ps chromosome. The phenotypes observed in affected individuals, although dissimilar, were sufficient to encourage a search for a deletion of chromosome 4p. By Southern blot analysis and fluorescence in situ hybridization, a deletion of material mapping approximately 150 kb from chromosome 4pter was discovered. This deletion is notable because it does not result in the Wolf-Hirschhorn syndrome and can result in an apparently normal phenotype. We speculate that homology between subterminal repeat sequences on 4p and sequences on the acrocentric short arms may explain the origin of the rearrangement and that position effect may play a role in the expression of the abnormal phenotype.	UNIV N CAROLINA,DEPT PEDIAT,DIV GENET & METAB,CHAPEL HILL,NC 27514; UNIV N CAROLINA,DEPT PATHOL,CHAPEL HILL,NC 27514; UNIV N CAROLINA,BRAIN & DEV RES CTR,CHAPEL HILL,NC 27514	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill								ALTHERR MR, 1991, AM J HUM GENET, V49, P1235; ALTHERR MR, 1989, GENOMICS, V5, P581, DOI 10.1016/0888-7543(89)90026-8; Ausubel F., 1988, SHORT PROTOCOLS MOL; BABU V R, 1987, American Journal of Human Genetics, V41, pA113; BARCH J, 1991, ACT CYTOGENETIC LABO; BATES GP, 1990, AM J HUM GENET, V46, P762; BAULD R, 1984, J MED GENET, V21, P54; Berger S. L., 1987, GUIDE MOL CLONING TE; COX DR, 1989, CYTOGENET CELL GENET, V51, P121, DOI 10.1159/000132788; DEV VG, 1979, HUM GENET, V51, P277; DOGGETT NA, 1989, P NATL ACAD SCI USA, V86, P10011, DOI 10.1073/pnas.86.24.10011; Elliot J, 1992, J MED GENET, V29, P203; FERRARO M, 1983, EXP CELL RES, V145, P452, DOI 10.1016/0014-4827(83)90024-1; FERRARO M, 1981, CHROMOSOMA, V84, P345, DOI 10.1007/BF00286024; GANDELMAN K, 1991, AM J HUM GENET S, V49, pA310; HAAF T, 1991, EXP CELL RES, V193, P78, DOI 10.1016/0014-4827(91)90540-B; HANSMANN I, 1977, HUM GENET, V38, P1, DOI 10.1007/BF00295801; Harnden DG, 1985, INT SYSTEM HUMAN CYT; LUCAS M, 1972, J OBSTET GYN BR COMM, V79, P1119; MIHELICK K, 1984, American Journal of Human Genetics, V36, p105S; MIKKELSEN M, 1980, CYTOGENET CELL GENET, V26, P14, DOI 10.1159/000131416; MURRAY JC, 1990, CYTOGENET CELL GENET, V55, P97, DOI 10.1159/000133000; PARSLOW M, 1979, HUM GENET, V47, P253, DOI 10.1007/BF00321017; PRIETO F, 1989, HUM GENET, V81, P289; REEVES BR, 1984, CANCER GENET CYTOGEN, V13, P159, DOI 10.1016/0165-4608(84)90057-8; ROULSTON D, 1991, AM J HUM GENET S, V49, pA274; Sambrook J., 1989, MOL CLONING LAB MANU; SCHMID M, 1984, HUM GENET, V67, P72, DOI 10.1007/BF00270562; SMETANA K, 1984, CELL TISSUE RES, V237, P367, DOI 10.1007/BF00217159; STETTEN G, 1986, AM J HUM GENET, V39, P245; TAKAHASHI R, 1986, P NATL ACAD SCI USA, V83, P1079, DOI 10.1073/pnas.83.4.1079; VANTUINEN P, 1983, HUM GENET, V65, P82, DOI 10.1007/BF00285036; VARLEY JM, 1981, HUM GENET, V59, P422, DOI 10.1007/BF00295484; VERELLENDUMOULIN C, 1984, HUM GENET, V67, P115, DOI 10.1007/BF00270570; WATT JL, 1984, J MED GENET, V21, P379, DOI 10.1136/jmg.21.5.379; WILSON MG, 1981, HUM GENET, V59, P297, DOI 10.1007/BF00295461	36	30	30	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1992	51	5					971	978						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JU840	1384329				2022-12-18	WOS:A1992JU84000006
J	AUST, MR; ANDREWS, LG; BARRETT, MJ; NORBYSLYCORD, CJ; MARKERT, ML				AUST, MR; ANDREWS, LG; BARRETT, MJ; NORBYSLYCORD, CJ; MARKERT, ML			MOLECULAR ANALYSIS OF MUTATIONS IN A PATIENT WITH PURINE NUCLEOSIDE PHOSPHORYLASE-DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENETIC-DISEASE; ACTIN MESSENGER-RNAS; T-CELL-IMMUNITY; ADENOSINE-DEAMINASE; BETA-ACTIN; 2 FAMILIES; DNA; IMMUNODEFICIENCY; SEQUENCE; CHILD	Purine nucleoside phosphorylase (PNP) deficiency is an inherited autosomal recessive disorder resulting in severe combined immunodeficiency. The purpose of this study was to determine the molecular defects responsible for PNP deficiency in one such patient. The patient's PNP cDNA was amplified by PCR and sequenced. Point mutations leading to amino acid substitutions were found in both alleles. One point mutation led to a Ser-to-Gly substitution at amino acid 51 and was common to both alleles. In addition, a Asp-to-Gly substitution at amino acid 128 and an Arg-to-Pro substitution at amino acid 234 were found in the maternal and paternal alleles, respectively. In order to prove that these mutations were responsible for the disease state, each of the three mutations was constructed separately by site-directed mutagenesis of th normal PNP cDNA, and each was transiently expressed in COS cells. Lysates from cells transfected with the allele carrying the substitution at amino acid 51 retained both function and immunoreactivity. Lysates fro cel s transfected with PNP alleles carrying a substitution at either amino acid 128 or am no acid 234 contain immunoreactive material but had no detectable human PNP activity. In summary, molecular analysis of this patient identified point mutations within the PNP gene which are responsible for the enzyme deficiency.	DUKE UNIV,MED CTR,DEPT PEDIAT,BOX 3068,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT MICROBIOL & IMMUNOL,DURHAM,NC 27710; SUNNYSIDE HOSP,DEPT ALLERGY & IMMUNOL,CLACKAMAS,OR	Duke University; Duke University					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R23AI023791, R29AI023791, T32AI007062, R01AI023791] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR-30] Funding Source: Medline; NIAID NIH HHS [AI-23791, 5T32-AI07062] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AGARWAL RP, 1969, J BIOL CHEM, V244, P644; AMMANN AJ, 1978, CLIN IMMUNOL IMMUNOP, V10, P262, DOI 10.1016/0090-1229(78)90180-0; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; AVIS H, 1972, P NATL ACAD SCI USA, V69, P1408; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARAPELLADELUCA E, 1978, J PEDIATR-US, V93, P1000; CARSON DA, 1977, P NATL ACAD SCI USA, V74, P5677, DOI 10.1073/pnas.74.12.5677; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COOPER DN, 1990, HUM GENET, V85, P55; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; CORRALES FB, 1983, AN ESP PEDIATR, V18, P248; DIDSBURY J, 1989, J BIOL CHEM, V264, P16378; EALICK SE, 1990, J BIOL CHEM, V265, P1812; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FOX IH, 1977, SCIENCE, V197, P1084, DOI 10.1126/science.407651; GIBLETT ER, 1975, LANCET, V1, P1010, DOI 10.1016/S0140-6736(75)91950-9; GREENBERG ML, 1989, J BIOL CHEM, V264, P795; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; GUDAS LJ, 1978, J BIOL CHEM, V253, P8916; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; GUSTAFSON S, 1987, ANAL BIOCHEM, V165, P294, DOI 10.1016/0003-2697(87)90272-7; JONSSON JJ, 1991, NUCLEIC ACIDS RES, V19, P5015, DOI 10.1093/nar/19.18.5015; KATSUKI T, 1975, INT J CANCER, V15, P203, DOI 10.1002/ijc.2910150205; KREDICH NM, 1989, METABOLIC BASIS INHE, P1045; MARKERT M L, 1991, Immunodeficiency Reviews, V3, P45; MARKERT ML, 1987, J IMMUNOL, V138, P3203; MARKERT ML, 1987, J CLIN IMMUNOL, V7, P389, DOI 10.1007/BF00917017; MCCUTCHAN JH, 1968, JNCI-J NATL CANCER I, V41, P351; MCGINNISS MH, 1985, TRANSFUSION, V25, P131, DOI 10.1046/j.1537-2995.1985.25285169204.x; MCROBERTS JA, 1980, J BIOL CHEM, V255, P5605; MITCHELL BS, 1978, P NATL ACAD SCI USA, V75, P5011, DOI 10.1073/pnas.75.10.5011; OSBORNE WRA, 1977, J CLIN INVEST, V60, P741, DOI 10.1172/JCI108826; PONTE P, 1984, NUCLEIC ACIDS RES, V12, P1687, DOI 10.1093/nar/12.3.1687; RICCIUTI F, 1973, NATURE-NEW BIOL, V241, P180, DOI 10.1038/newbio241180a0; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STOOP JW, 1977, NEW ENGL J MED, V296, P651, DOI 10.1056/NEJM197703242961203; STROBEL S, 1989, EUR J PEDIATR, V148, P312, DOI 10.1007/BF00444121; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8765; THOMAS PS, 1983, METHOD ENZYMOL, V100, P255; ULLMAN B, 1979, P NATL ACAD SCI USA, V76, P1074, DOI 10.1073/pnas.76.3.1074; VANHEUKELOM LHS, 1976, CLIN CHIM ACTA, V72, P117, DOI 10.1016/0009-8981(76)90042-5; VIRELIZIER JL, 1978, J PEDIATR-US, V92, P358, DOI 10.1016/S0022-3476(78)80419-3; WANG LM, 1988, BIOTECHNIQUES, V6, P839; WATSON AR, 1981, ARCH DIS CHILD, V56, P563, DOI 10.1136/adc.56.7.563; WIGINTON DA, 1986, BIOCHEMISTRY-US, V25, P8234, DOI 10.1021/bi00373a017; WILLIAMS SR, 1987, J BIOL CHEM, V262, P2332; WILLIAMS SR, 1984, NUCLEIC ACIDS RES, V12, P5779, DOI 10.1093/nar/12.14.5779; WORTMANN RL, 1979, ARTHRITIS RHEUM, V22, P524, DOI 10.1002/art.1780220513; ZANNIS V, 1978, J BIOL CHEM, V253, P504	52	30	31	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1992	51	4					763	772						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JQ667	1384322				2022-12-18	WOS:A1992JQ66700010
J	GILBERT, JR; STAJICH, JM; SPEER, MC; VANCE, JM; STEWART, CS; YAMAOKA, LH; SAMSON, F; FARDEAU, M; POTTER, TG; ROSES, AD; PERICAKVANCE, MA				GILBERT, JR; STAJICH, JM; SPEER, MC; VANCE, JM; STEWART, CS; YAMAOKA, LH; SAMSON, F; FARDEAU, M; POTTER, TG; ROSES, AD; PERICAKVANCE, MA			LINKAGE STUDIES IN FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY (FSHD)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA MARKER; DISEASE; GENE	Facioscapulohumeral muscular dystrophy (FSHD) has been localized to the 4q35-qter region of chromosome 4. Linkage analyses of two polymorphic markers from the region, D4S139 and D4S163, have been carried out using four large multigenerational FSHD families. The results indicate that both markers are closely linked to FSHD, with D4S139 being the closest proximal marker to FSHD.	INSERM,U153,F-75005 PARIS,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm)	GILBERT, JR (corresponding author), DUKE UNIV,MED CTR,DEPT MED,DIV NEUROL,BOX 2900,DURHAM,NC 27710, USA.			Vance, Jeffery/0000-0003-3815-8199	NIA NIH HHS [AGO7922] Funding Source: Medline; NINDS NIH HHS [P01-NS-26630, NS19999] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019999, P01NS026630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R35AG007922] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		DUBOWITZ V, 1985, MUSCLE BIOPSY MODERN; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LUNT PW, 1988, J NEUROL SCI, V88, P287, DOI 10.1016/0022-510X(88)90225-0; MORTON NE, 1959, AM J HUM GENET, V11, P360; MOSER H, 1966, SCHWEIZ MED WSCHR, V96, P169; NEUWEILER J, 1990, NUCLEIC ACIDS RES, V18, P691, DOI 10.1093/nar/18.3.691; OTT J, 1974, AM J HUM GENET, V26, P588; OTT J, 1991, ANAL HUMAN GENETIC L, P66; PERICAKVANCE MA, 1988, EXP NEUROL, V102, P271, DOI 10.1016/0014-4886(88)90220-8; SARFARAZI M, 1992, AM J HUM GENET, V51, P396; UPADHYAYA M, 1990, LANCET, V336, P1320, DOI 10.1016/0140-6736(90)93005-A; UPADHYAYA M, 1991, J MED GENET, V28, P665, DOI 10.1136/jmg.28.10.665; WALTON JN, 1981, DISORDERS VOLUNTARY, P502; Wijmenga C, 1990, LANCET, V336, P651, DOI 10.1016/0140-6736(90)92148-B; WIJMENGA C, 1991, GENOMICS, V9, P570, DOI 10.1016/0888-7543(91)90348-I	15	30	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1992	51	2					424	427						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JF776	1642241				2022-12-18	WOS:A1992JF77600024
J	MATHEWS, KD; MILLS, KA; BOSCH, EP; IONASESCU, VV; WILES, KR; BUETOW, KH; MURRAY, JC				MATHEWS, KD; MILLS, KA; BOSCH, EP; IONASESCU, VV; WILES, KR; BUETOW, KH; MURRAY, JC			LINKAGE LOCALIZATION OF FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY (FSHD) IN 4Q35	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LONG ARM; CHROMOSOME-4; DISEASE; GENE	Fasioscapulohumeral muscular dystrophy (FSHD) has recently been localized to 4q35. We have studied four families with FSHD. Linkage to the 4q35 probes D4S163, D4S139, and D4S171 was confirmed. We found no recombinants helpful in detailed localization of the FSHD gene. Two of our families include males with a rapidly progressive muscle disease that had been diagnosed, on the basis of clinical features, as Duchenne muscular dystrophy. One of these males is available for linkage study and shares the haplotype of his FSHD-affected aunt and cousin.	UNIV IOWA, COLL MED, DEPT PEDIAT, IOWA CITY, IA 52242 USA; UNIV IOWA, COLL MED, DEPT NEUROL, IOWA CITY, IA 52242 USA; FOX CHASE CANC INST, DIV CLIN RES, PHILADELPHIA, PA 19111 USA	University of Iowa; University of Iowa; Fox Chase Cancer Center				mathews, katherine/0000-0003-4160-0435	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000355, P50HG000206] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01HG00355, P50HG00206] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ALTHERR MR, 1991, NUCLEIC ACIDS RES, V19, P1168, DOI 10.1093/nar/19.5.1168; BAILEY RO, 1986, ACTA NEUROL SCAND, V74, P51, DOI 10.1111/j.1600-0404.1986.tb04625.x; BODRUG SE, 1990, J MED GENET, V27, P426, DOI 10.1136/jmg.27.7.426; KATO A, 1989, CYTOGENET CELL GENET, V52, P77, DOI 10.1159/000132844; LATHROP GM, 1988, AM J HUM GENET, V42, P498; LETH A, 1985, ACTA PAEDIATR SCAND, V74, P881, DOI 10.1111/j.1651-2227.1985.tb10052.x; LUNT PW, 1989, J MED GENET, V26, P755, DOI 10.1136/jmg.26.12.755; LUNT PW, 1991, J MED GENET, V28, P655, DOI 10.1136/jmg.28.10.655; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MILLS KA, 1992, AM J HUM GENET, V51, P432; MILNER ECB, 1989, NUCLEIC ACIDS RES, V17, P4002, DOI 10.1093/nar/17.10.4002; NEUWEILER J, 1990, NUCLEIC ACIDS RES, V18, P691, DOI 10.1093/nar/18.3.691; REARDON W, 1991, CLIN GENET, V39, P172; Sambrook J., 1989, MOL CLONING LAB MANU; SARFARAZI M, 1992, AM J HUM GENET, V51, P396; UPADHYAYA M, 1989, J MED GENET, V26, P490, DOI 10.1136/jmg.26.8.490; UPADHYAYA M, 1990, LANCET, V336, P1320, DOI 10.1016/0140-6736(90)93005-A; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P2022; Wijmenga C, 1990, LANCET, V336, P651, DOI 10.1016/0140-6736(90)92148-B; WIJMENGA C, 1991, GENOMICS, V9, P570, DOI 10.1016/0888-7543(91)90348-I	20	30	31	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1992	51	2					428	431						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JF776	1642242				2022-12-18	WOS:A1992JF77600025
J	YU, JW; HARTZ, J; XU, YS; GEMMILL, RM; KORENBERG, JR; PATTERSON, D; KAO, FT				YU, JW; HARTZ, J; XU, YS; GEMMILL, RM; KORENBERG, JR; PATTERSON, D; KAO, FT			ISOLATION, CHARACTERIZATION, AND REGIONAL MAPPING OF MICROCLONES FROM A HUMAN CHROMOSOME-21 MICRODISSECTION LIBRARY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA-SEQUENCES; HUMAN GENOME; MOLECULAR DEFINITION; DOWN-SYNDROME; GENE; CLONES; CLONING; MAPS; AMPLIFICATION; LOCALIZATION	Thirty-four unique-sequence microclones were isolated from a previously described microdissection library of human chromosome 21 and were regionally mapped using a cell hybrid mapping panel which consists of six cell hybrids and divides chromosome 21 into eight regions. The mapping results showed that the microclones were unevenly distributed along chromosome 21, with the majority of microclones located in the distal half portion of the long arm, between 21q21.3 and 21qter. The number of unique-sequence clones began to decrease significantly from 21q21.2 to centromere and extending to the short arm. This finding is consistent with those reported in other chromosome 21 libraries. Thus, it may be inferred that the proximal portion of the long arm of chromosome 21 contains higher proportions of repetitive sequences, rather than unique sequences or genes. The microclones were also characterized for insert size and were used to identify the corresponding genomic fragments generated by HindIII. In addition, we demonstrated that the microclones with short inserts can be efficiently used to identify YAC (yeast artificial chromosome) clones with large inserts, for increased genomic coverage for high-resolution physical mapping. We also used 200 unique-sequence microclones to screen a human liver cDNA library and identified two cDNA clones which were regionally assigned to the 21q21.3-q22.1 region. Thus, generation of unique-sequence microclones from chromosome 21 appears to be useful to isolate and regionally map many cDNA clones, among which will be candidate genes for important diseases on chromosome 21, including Down syndrome, Alzheimer disease, amyotrophic lateral sclerosis, and one form of epilepsy.	ELEANOR ROOSEVELT INST CANC RES,1899 GAYLORD ST,DENVER,CO 80206; UNIV COLORADO,HLTH SCI CTR,DEPT BIOCHEM BIOPHYS & GENET,DENVER,CO 80262; UNIV COLORADO,HLTH SCI CTR,CTR CANC,DENVER,CO 80262; UNIV CALIF LOS ANGELES,CEDARS SINAI MED CTR,AHMANSON DEPT PEDIAT,LOS ANGELES,CA 90048	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Cedars Sinai Medical Center; University of California System; University of California Los Angeles					NATIONAL CANCER INSTITUTE [P01CA041183] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000353] Funding Source: NIH RePORTER; NCI NIH HHS [CA41183] Funding Source: Medline; NHGRI NIH HHS [HG00353] Funding Source: Medline; NICHD NIH HHS [HD17749] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BROWNSTEIN BH, 1989, SCIENCE, V244, P1348, DOI 10.1126/science.2544027; BUITING K, 1990, GENOMICS, V6, P521, DOI 10.1016/0888-7543(90)90481-9; EPSTEIN CJ, 1991, AM J HUM GENET, V49, P207; FIEDLER W, 1991, GENOMICS, V10, P786, DOI 10.1016/0888-7543(91)90464-P; GAO JZ, 1991, GENOMICS, V10, P166, DOI 10.1016/0888-7543(91)90497-3; GARDINER K, 1988, SOMAT CELL MOLEC GEN, V14, P623, DOI 10.1007/BF01535316; GARDINER K, 1990, EMBO J, V9, P25, DOI 10.1002/j.1460-2075.1990.tb08076.x; HAMPTON G, 1991, GENOMICS, V11, P247, DOI 10.1016/0888-7543(91)90130-7; KAO FT, 1991, P NATL ACAD SCI USA, V88, P1844, DOI 10.1073/pnas.88.5.1844; KORENBERG JR, 1987, AM J HUM GENET, V41, P963; KORENBERG JR, 1990, AM J HUM GENET, V47, P236; KORENBERG JR, 1992, AM J HUM GENET, V50, P294; LEHESJOKI AE, 1991, P NATL ACAD SCI USA, V88, P3696, DOI 10.1073/pnas.88.9.3696; LUDECKE HJ, 1989, NATURE, V338, P348, DOI 10.1038/338348a0; LUDECKE HJ, 1991, AM J HUM GENET, V49, P1197; MACKINNON RN, 1990, AM J HUM GENET, V47, P181; MENDEZ MJ, 1991, GENOMICS, V10, P661, DOI 10.1016/0888-7543(91)90449-O; MUNKE M, 1988, AM J HUM GENET, V42, P550; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; PATTERSON D, 1988, P NATL ACAD SCI USA, V85, P8266, DOI 10.1073/pnas.85.21.8266; ROHME D, 1984, CELL, V36, P783, DOI 10.1016/0092-8674(84)90358-1; ROWLEY JD, 1981, LANCET, V2, P1020; SAUNDERS RDC, 1989, NUCLEIC ACIDS RES, V17, P9027, DOI 10.1093/nar/17.22.9027; SCALENGHE F, 1981, CHROMOSOMA, V82, P205, DOI 10.1007/BF00286105; SIDDIQUE T, 1991, NEW ENGL J MED, V324, P1381, DOI 10.1056/NEJM199105163242001; SOLOMON E, 1991, CYTOGENET CELL GENET, V58, P1, DOI 10.1159/000133157; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; TANTRAVAHI U, 1988, HUM GENET, V79, P196, DOI 10.1007/BF00366237; VANKEUREN ML, 1986, AM J HUM GENET, V38, P793	29	30	30	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1992	51	2					263	272						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JF776	1642227				2022-12-18	WOS:A1992JF77600005
J	SUTHERLAND, GR; RICHARDS, RI				SUTHERLAND, GR; RICHARDS, RI			ANTICIPATION LEGITIMIZED - UNSTABLE DNA TO THE RESCUE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							X SYNDROME				SUTHERLAND, GR (corresponding author), ADELAIDE CHILDRENS HOSP INC,DEPT CYTOGENET & MOLEC GENET,KING WILLIAM RD,ADELAIDE,SA 5006,AUSTRALIA.		Richards, Robert/ABE-6423-2020; Sutherland, Grant Robert/D-2606-2012	Richards, Robert Ian/0000-0002-5978-6453				ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1991, CELL, V67, P1; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; HARPER PS, 1992, AM J HUM GENET, V50, P10; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; NAKAHORI Y, 1991, NUCLEIC ACIDS RES, V19, P4355, DOI 10.1093/nar/19.16.4355; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; PENROSE LS, 1948, ANN EUGENIC, V14, P125; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Pirsig Robert M., 1991, LILA INQUIRY MORALS; RICHARDS RI, 1992, NAT GENET, V1, P7, DOI 10.1038/ng0492-7; SHERMAN SL, 1985, HUM GENET, V69, P289, DOI 10.1007/BF00291644; SHERMAN SL, 1984, ANN HUM GENET, V48, P21, DOI 10.1111/j.1469-1809.1984.tb00830.x; SUTHERLAND GR, 1991, LANCET, V338, P289, DOI 10.1016/0140-6736(91)90426-P; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; YU S, 1992, AM J HUM GENET, V50, P968; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	22	30	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1992	51	1					7	9						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JA467	1609807				2022-12-18	WOS:A1992JA46700002
J	SARAIVA, MJM; ALMEIDA, MR; SHERMAN, W; GAWINOWICZ, M; COSTA, P; COSTA, PP; GOODMAN, DS				SARAIVA, MJM; ALMEIDA, MR; SHERMAN, W; GAWINOWICZ, M; COSTA, P; COSTA, PP; GOODMAN, DS			A NEW TRANSTHYRETIN MUTATION ASSOCIATED WITH AMYLOID CARDIOMYOPATHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VARIANT	In transthyretin (TTR) a new mutation (TTR-Thr45) has been identified in a patient with familial amyloidosis characterized clinically by prominent cardiomyopathy and the absence of peripheral neuropathy. Comparative peptide mapping by high-performance liquid chromatography of the patient's plasma TTR together with normal TTR showed the presence of an abnormal tryptic peptide in the patient's TTR. The sequence of this peptide (peptide 6, residues 36-48) demonstrated the presence of a threonine-for-alanine substitution at position 45. This change can be explained by a single base change of adenine for guanine in the Ala-45 codon and was demonstrated directly by DNA sequence analysis of PCR-amplified exon 2 of the TTR gene; allele-specific oligonucleotide hybridization both in the patient and in fixed heart tissue from his aunt confirmed the base change. The TTR-Thr45 mutation is a new variant TTR found associated with cardiomyopathy.	COLUMBIA UNIV COLL PHYS & SURG, DEPT MED, NEW YORK, NY 10032 USA; UNIV PORTO, INST CIENCIAS BIOMED, OPORTO, PORTUGAL	Columbia University; Universidade do Porto	SARAIVA, MJM (corresponding author), HOSP SANTO ANTONIO, CTR ESTUDOS PARAMILOIDOS, P-4000 OPORTO, PORTUGAL.		Saraiva, Maria João/K-3907-2013; Costa, Paulo Pinho/B-4392-2008; Almeida, Maria Rosario/K-3938-2013	Saraiva, Maria João/0000-0002-3360-6899; Costa, Paulo Pinho/0000-0001-6125-7000; Almeida, Maria Rosario/0000-0001-9289-3835	NHLBI NIH HHS [HL21006] Funding Source: Medline; NIDDK NIH HHS [DK05968] Funding Source: Medline; NINDS NIH HHS [R01 NS25190] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL021006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK005968, R37DK005968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025190] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALMEIDA MR, 1991, BASIC RES CARDIOL, V86, P567, DOI 10.1007/BF02190707; ALMEIDA MR, 1990, HUM GENET, V85, P623; NORDLIE M, 1988, SCAND J IMMUNOL, V27, P119, DOI 10.1111/j.1365-3083.1988.tb02329.x; SARAIVA MJM, 1990, SCAND J IMMUNOL, V32, P341, DOI 10.1111/j.1365-3083.1990.tb02928.x; SARAIVA MJM, IN PRESS MOL GENETIC; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843	6	30	31	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1992	50	5					1027	1030						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HR473	1570831				2022-12-18	WOS:A1992HR47300018
J	EARLE, E; SHAFFER, LG; KALITSIS, P; MCQUILLAN, C; DALE, S; CHOO, KHA				EARLE, E; SHAFFER, LG; KALITSIS, P; MCQUILLAN, C; DALE, S; CHOO, KHA			IDENTIFICATION OF DNA-SEQUENCES FLANKING THE BREAKPOINT OF HUMAN T(14Q21Q) ROBERTSONIAN TRANSLOCATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN ACROCENTRIC CHROMOSOMES; NON-HOMOLOGOUS CHROMOSOMES; NONDISJUNCTION; RECOMBINATION; GENES	We have employed molecular probes and in situ hybridization to investigate the DNA sequences flanking the breakpoint of a group of t(14q21q) Robertsonian translocations. In all the families studied, the probands were patients with Down syndrome who carried a de novo t(14q21q) translocation. The DNA probes used were two alphoid sequences, alphaRI and alphaXT, which are specific for the centromeres of chromosomes 13 and 21 and of chromosomes 14 and 22, respectively; a satellite III sequence, pTRS-47, which is specific for the proximal p11 region of chromosomes 14 and 22; and a newly defined satellite III DNA, pTRS-63, which is specific for the distal p11 region of chromosome 14. The two alphoid probes detected approximately the same amount of autoradiographic signal on the translocated chromosomes as was expected for chromosomes 14 and 21 of the originating parent, suggesting that there has been no loss of these centromeric sequences during the translocation events. Results with the two satellite III probes indicated that the domain corresponding to pTRS-47 was retained in the translocated chromosomes, whereas the domain for pTRS-63 was lost. These results have allowed us to place the translocation breakpoint between the pTRS-47 and pTRS-63 domains within the p11 region of chromosome 14.	ROYAL CHILDRENS HOSP,MURDOCH INST RES BIRTH DEFECTS,FLEMINGTON RD,PARKVILLE,VIC 3052,AUSTRALIA; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT HUMAN GENET,RICHMOND,VA 23298	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Virginia Commonwealth University			Kalitsis, Paul/C-1916-2015	Kalitsis, Paul/0000-0001-5569-0609				CHEUNG SW, 1990, CYTOGENET CELL GENET, V54, P97, DOI 10.1159/000132970; CHOO KH, 1988, NUCLEIC ACIDS RES, V16, P1273, DOI 10.1093/nar/16.4.1273; CHOO KH, 1991, NUCLEIC ACIDS RES, V19, P1179, DOI 10.1093/nar/19.6.1179; CHOO KH, 1990, MOL BIOL MED, V7, P437; CHOO KH, 1990, NUCLEIC ACIDS RES, V18, P5641, DOI 10.1093/nar/18.19.5641; CHOO KH, 1991, METHOD MOL BIOL, V9, P233; CHOO KHA, 1992, AM J HUM GENET, V50, P706; FERGUSONSMITH MA, 1967, LANCET, V1, P1156; GUICHAOUA MR, 1986, CYTOGENET CELL GENET, V42, P191, DOI 10.1159/000132277; HAMERTON JL, 1981, TRISOMY 21 DOWN SYND, P99; HILLS L, 1991, HUM GENET, V87, P173, DOI 10.1007/BF00204176; Hook EB, 1977, POPULATION CYTOGENET, P63; JACOBS PA, 1974, ANN HUM GENET, V37, P359, DOI 10.1111/j.1469-1809.1974.tb01843.x; JORGENSEN A L, 1988, Genomics, V3, P100, DOI 10.1016/0888-7543(88)90139-5; JORGENSEN AL, 1987, P NATL ACAD SCI USA, V84, P1075, DOI 10.1073/pnas.84.4.1075; KRYSTAL M, 1981, P NATL ACAD SCI-BIOL, V78, P5744, DOI 10.1073/pnas.78.9.5744; MIKKELSEN M, 1980, CYTOGENET CELL GENET, V24, P122; SCHMICKEL RD, 1985, ANN NY ACAD SCI, V450, P121, DOI 10.1111/j.1749-6632.1985.tb21488.x; SHAFFER LG, IN PRESS AM J MED GE; THERMAN E, 1989, ANN HUM GENET, V53, P49, DOI 10.1111/j.1469-1809.1989.tb01121.x; Therman E., 1986, HUMAN CHROMOSOMES ST; VISSEL B, 1991, NUCLEIC ACIDS RES, V19, P271, DOI 10.1093/nar/19.2.271	23	30	41	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1992	50	4					717	724						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HL848	1550117				2022-12-18	WOS:A1992HL84800007
J	BOWDEN, DW; AKOTS, G; ROTHSCHILD, CB; FALLS, KF; SHEEHY, MJ; HAYWARD, C; MACKIE, A; BAIRD, J; BROCK, D; ANTONARAKIS, SE; FAJANS, SS				BOWDEN, DW; AKOTS, G; ROTHSCHILD, CB; FALLS, KF; SHEEHY, MJ; HAYWARD, C; MACKIE, A; BAIRD, J; BROCK, D; ANTONARAKIS, SE; FAJANS, SS			LINKAGE ANALYSIS OF MATURITY-ONSET DIABETES OF THE YOUNG (MODY) - GENETIC-HETEROGENEITY AND NONPENETRANCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENOME; MAP	We have analyzed the inheritance of maturity-onset diabetes of the young (MODY) on chromosome 20 in a large multigeneration family, the R.-W. family, and in two other MODY families. Of the four branches of the R.-W. pedigree which have been studied, two have documented early onset of non-insulin-dependent diabetes mellitus (NIDDM), while there is no evidence of early onset in the other two branches. The early-onset branches have apparently inherited the same D20S16 allele from the affected parent, while another D20S16 allele was inherited in the two branches without evidence of early onset. A test for homogeneity, the M-test, using the results of two-point linkage analysis with D20S16 indicates heterogeneity between early- and late-onset branches of the R.-W. family (P less-than-or-equal-to .014). In addition, analysis strongly suggests that MODY as expressed in the EDI and WIS families is unlinked to loci on chromosome 20 (P less-than-or-equal-to .018-.004). Comparable results are seen when the data are analyzed by the HOMOG program. Three polymorphic loci-D20S16, D20S17, and ADA-show no recombination with the MODY locus when two-point linkage analysis is used in the early-onset branches of the family. The multipoint lod score in the early-onset branches of the R.-W. family is 10.16, with the most likely location being between D20S4 and D20S17. Multipoint linkage analysis using the CHROMPICS option of the program CRI-MAP has been used to follow inheritance of the MODY disease locus. This analysis has identified two cases of possible nonpenetrance in the early-onset branches of the family (odds of at least 156:1), as determined by the appearance of apparent isolated double crossovers at the MODY locus in these unaffected individuals.	COLLABORAT RES INC,WALTHAM,MA; AMER RED CROSS BLOOD SERV,MADISON,WI; WESTERN GEN HOSP,HUMAN GENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND; WESTERN GEN HOSP,METAB UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND; JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,DEPT PEDIAT,BALTIMORE,MD 21205; UNIV MICHIGAN,MED CTR,DEPT INTERNAL MED,ANN ARBOR,MI 48109	American Red Cross; University of Edinburgh; University of Edinburgh; Johns Hopkins University; University of Michigan System; University of Michigan	BOWDEN, DW (corresponding author), WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT BIOCHEM,300 S HAWTHORNE RD,WINSTON SALEM,NC 27103, USA.		Antonarakis, Stylianos E/N-8866-2014; Hayward, Caroline/M-8818-2016	Antonarakis, Stylianos E/0000-0001-8907-5823; Hayward, Caroline/0000-0002-9405-9550	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038209, R01DK041269, R23DK038209] Funding Source: NIH RePORTER; NIADDK NIH HHS [AM-20572] Funding Source: Medline; NIDDK NIH HHS [R01 DK41269, DK 38209] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARNETT AH, 1981, DIABETOLOGIA, V20, P87, DOI 10.1007/BF00262007; BELL GI, 1991, P NATL ACAD SCI USA, V88, P1484, DOI 10.1073/pnas.88.4.1484; BOWDEN DW, 1989, GENOMICS, V5, P718, DOI 10.1016/0888-7543(89)90113-4; BOWDEN DW, 1992, DIABETES, V41, P88, DOI 10.2337/diabetes.41.1.88; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; ECONOMOU EP, 1990, P NATL ACAD SCI USA, V87, P2951, DOI 10.1073/pnas.87.8.2951; FAJANS SS, 1987, HORM METAB RES, V19, P591, DOI 10.1055/s-2007-1011888; FAJANS SS, IN PRESS J LAB CLIN; GOODFELLOW PJ, 1987, CYTOGENET CELL GENET, V44, P112, DOI 10.1159/000132354; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MORTON NE, 1956, AM J HUM GENET, V8, P80; OTT J, 1985, ANAL HUMAN GENETIC L; ROTTER JI, 1980, HDB DIABETES MELLITU, P3; SCHUMM JW, 1988, AM J HUM GENET, V42, P143	14	30	32	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1992	50	3					607	618						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HH974	1539597				2022-12-18	WOS:A1992HH97400021
J	LANDSBERGER, D; MEINER, V; RESHEF, A; LEVY, Y; VANDERWESTHUYZEN, DR; COETZEE, GA; LEITERSDORF, E				LANDSBERGER, D; MEINER, V; RESHEF, A; LEVY, Y; VANDERWESTHUYZEN, DR; COETZEE, GA; LEITERSDORF, E			A NONSENSE MUTATION IN THE LDL RECEPTOR GENE LEADS TO FAMILIAL HYPERCHOLESTEROLEMIA IN THE DRUZE SECT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOW-DENSITY-LIPOPROTEIN; MEDIATED ENDOCYTOSIS; DNA; CHOLESTEROL; DELETION; DISEASE; ISRAEL; CELLS; LOCUS	Familial hypercholesterolemia (FH) is an autosomal dominant disease caused by mutations in the LDL receptor gene. Here we characterize an LDL receptor mutation that is associated with a distinct haplotype and causes FH in the Druze, a small Middle Eastern Islamic sect with a high degree of inbreeding. The mutation was found in FH families from two distinct Druze villages from the Golan Heights (northern Israel). It was not found neither in another Druze FH family residing in a different geographical area nor in eight Arab and four Jewish FH heterozygote index cases whose hypercholesterolemia cosegregates with an identical LDL receptor gene haplotype. The mutation, a single-base substitution, results in a termination codon in exon 4 of the LDL receptor gene that encodes for the fourth repeat of the binding domain of the mature receptor. It can be diagnosed by allele-specific oligonucleotide hybridization of PCR-amplified DNA from FH patients.	HADASSAH UNIV HOSP,DEPT MED,IL-91120 JERUSALEM,ISRAEL; HADASSAH UNIV HOSP,LIPID RES LAB,IL-91120 JERUSALEM,ISRAEL; TECHNION ISRAEL INST TECHNOL,RAMBAM MED CTR,LIPID RES UNIT,HAIFA,ISRAEL; TECHNION ISRAEL INST TECHNOL,FAC MED,HAIFA,ISRAEL; UNIV CAPE TOWN,SCH MED,DEPT MED BIOCHEM,MRC,CELL BIOL ATHEROSCLEROSIS UNIT,CAPE TOWN,SOUTH AFRICA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Cape Town			coetzee, Gerhard/AAT-6203-2020; Coetzee, Gerhard/AAG-8439-2019	Coetzee, Gerhard/0000-0001-8820-8364				AALTOSETALA K, 1989, J CLIN INVEST, V84, P499, DOI 10.1172/JCI114192; AULINSKAS TH, 1983, ATHEROSCLEROSIS, V47, P159, DOI 10.1016/0021-9150(83)90152-1; BEISIEGEL U, 1981, J BIOL CHEM, V256, P1923; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COOPER DN, 1990, HUM GENET, V85, P55; FREUNDLICH E, 1984, ISRAEL J MED SCI, V20, P1035; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GOETZ PW, 1986, NEW ENCY BRITANNICA, V4, P237; Goldstein J.L., 1989, METABOLIC BASIS INHE, P1215; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GRANT KI, 1990, J BIOL CHEM, V256, P4041; HOBBS HH, 1986, J BIOL CHEM, V261, P3114; HOBBS HH, 1988, J CLIN INVEST, V81, P909, DOI 10.1172/JCI113402; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; HOBBS HH, 1987, NEW ENGL J MED, V317, P734, DOI 10.1056/NEJM198709173171204; LEHRMAN MA, 1987, J BIOL CHEM, V262, P401; LEITERSDORF E, 1989, J CLIN INVEST, V84, P954, DOI 10.1172/JCI114258; LEITERSDORF E, 1990, J CLIN INVEST, V85, P1014, DOI 10.1172/JCI114531; LEITERSDORF E, 1989, AM J HUM GENET, V44, P409; MEINER V, 1991, AM J HUM GENET, V49, P443; NEVO S, 1988, AM J PHYS ANTHROPOL, V77, P183, DOI 10.1002/ajpa.1330770206; OPPENHEIM A, IN PRESS HUM GENET; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TOLLESHAUG H, 1982, CELL, V30, P715, DOI 10.1016/0092-8674(82)90276-8; ZLOTOGORA J, 1985, AM J MED GENET, V21, P765, DOI 10.1002/ajmg.1320210420; 1990, ISRAELI GENERAL ENCY, V1, P469	28	30	30	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1992	50	2					427	433						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HD001	1734722				2022-12-18	WOS:A1992HD00100020
J	MAESTRINI, E; RIVELLA, S; TRIBIOLI, C; ROCCHI, M; CAMERINO, G; SANTACHIARABENERECETTI, S; PAROLINI, O; NOTARANGELO, LD; TONIOLO, D				MAESTRINI, E; RIVELLA, S; TRIBIOLI, C; ROCCHI, M; CAMERINO, G; SANTACHIARABENERECETTI, S; PAROLINI, O; NOTARANGELO, LD; TONIOLO, D			IDENTIFICATION OF NOVEL RFLPS IN THE VICINITY OF CPG ISLANDS IN XQ28 - APPLICATION TO THE ANALYSIS OF THE PATTERN OF X-CHROMOSOME INACTIVATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WISKOTT-ALDRICH SYNDROME; SEVERE COMBINED IMMUNODEFICIENCY; LINKED AGAMMAGLOBULINEMIA; CARRIER DETECTION; GENE; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; METHYLATION; MUTATION; LINKAGE; PROBES	Probes for CpG islands were cloned from the distal long arm of the human X chromosome; three of them were found to be polymorphic. A HindIII RFLP was identified by the probe 2-25 (DXS606), and it was mapped to the Xq27-Xq28 boundary. Probes 2-19 (DXS605) and 2-55 (DXS707), which identify EcoRI and MspI polymorphisms, respectively, have been mapped to the distal part of Xq28, in the G6PD-RCP/GCP gene region. Probe 2-19 has been further localized about 16 kb from the 3' end of the G6PD gene. The new RFLPs may be useful for the precise mapping of the many disease genes localized in this part of the human X chromosome. Probe 2-19 is highly informative, and it has been studied in greater detail. Using the methylation-sensitive rare-cutter enzyme EagI in conjunction with the polymorphic EcoRI site, we were able to demonstrate that the RFLP may be used both to study randomness of X chromosome inactivation and for carrier detection in X-linked syndromes where nonrandom X inactivation occurs. It is conceivable that the combined use of 2-19 and of the probes described so far (pSPT-PGK and M27-beta) will make analysis of X inactivation feasible in virtually every female.	UNIV PAVIA,DIPARTIMENTO PATOL UMANA & EREDITARIA,I-27100 PAVIA,ITALY; UNIV PAVIA,DIPARTIMENTO GENET & MICROBIOL,I-27100 PAVIA,ITALY; UNIV BARI,IST GENET,I-70124 BARI,ITALY; UNIV BRESCIA,DIPARTMENTO PEDIAT,BRESCIA,ITALY	University of Pavia; University of Pavia; Universita degli Studi di Bari Aldo Moro; University of Brescia	TONIOLO, D (corresponding author), CNR,IST GENET BIOCHIM & EVOLUZ,VIA ABBIATEGRASSO 207,I-27100 PAVIA,ITALY.		Rivella, Stefano/A-1597-2010; Toniolo, Daniela/AAE-2969-2019; PAROLINI, ORNELLA/ABI-7862-2020; Notarangelo, Luigi D/F-9718-2016; Maestrini, Elena/K-7508-2012	Toniolo, Daniela/0000-0001-9545-6032; PAROLINI, ORNELLA/0000-0002-5211-6430; Notarangelo, Luigi D/0000-0002-8335-0262; Maestrini, Elena/0000-0001-5924-3179; TRIBIOLI, CARLA/0000-0003-2544-476X; Rivella, Stefano/0000-0002-0938-6558	Telethon [8] Funding Source: Medline	Telethon(Fondazione Telethon)		ALCALAY M, 1988, NUCLEIC ACIDS RES, V16, P9527, DOI 10.1093/nar/16.20.9527; BEUTLER E, 1991, NEW ENGL J MED, V324, P169; BIRD AP, 1987, TRENDS GENET, V3, P342, DOI 10.1016/0168-9525(87)90294-0; BOYD Y, 1990, HGENOMICS, V7, P215; BOYD Y, IN PRESS GENOMICS; CONLEY ME, 1988, P NATL ACAD SCI USA, V85, P3090, DOI 10.1073/pnas.85.9.3090; CONLEY ME, 1988, IMMUNOL INVEST, V17, P425, DOI 10.3109/08820138809049847; DESAINTBASILE G, UNPUB AM J HUM GENET; DURSO M, 1988, AM J HUM GENET, V42, P735; DURSO M, 1983, SOMAT CELL GENET, V9, P429, DOI 10.1007/BF01543044; FEARON ER, 1987, NEW ENGL J MED, V316, P427, DOI 10.1056/NEJM198702193160802; FEARON ER, 1988, BLOOD, V72, P1735; FRASER NJ, 1989, GENOMICS, V5, P144, DOI 10.1016/0888-7543(89)90099-2; GEALY WJ, 1980, LANCET, V1, P63; GOODSHIP J, 1988, LANCET, V1, P729; GREER WL, 1989, GENOMICS, V4, P60, DOI 10.1016/0888-7543(89)90315-7; GUIOLI S, 1989, HUM GENET, V84, P19, DOI 10.1007/BF00210664; KEITH DH, 1986, MOL CELL BIOL, V6, P4122, DOI 10.1128/MCB.6.11.4122; LYON MF, 1972, BIOL REV, V47, P1; MAESTRINI E, 1990, GENOMICS, V8, P664, DOI 10.1016/0888-7543(90)90253-Q; MANONI M, 1991, GENOMICS, V9, P551, DOI 10.1016/0888-7543(91)90424-D; MARTINI G, 1986, EMBO J, V5, P1849, DOI 10.1002/j.1460-2075.1986.tb04436.x; POUSTKA AM, IN PRESS P NATL ACAD; ROSENSTRAUS M, 1975, P NATL ACAD SCI USA, V72, P493, DOI 10.1073/pnas.72.2.493; SUTHERS GK, 1990, AM J HUM GENET, V47, P187; TONIOLO D, 1984, EMBO J, V3, P1987, DOI 10.1002/j.1460-2075.1984.tb02080.x; WOLF SF, 1984, P NATL ACAD SCI-BIOL, V81, P2806, DOI 10.1073/pnas.81.9.2806	27	30	30	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1992	50	1					156	163						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HA040	1346076				2022-12-18	WOS:A1992HA04000016
J	GRAHAM, JB; KUNKEL, GR; EGILMEZ, NK; WALLMARK, A; FOWLKES, DM; LORD, ST				GRAHAM, JB; KUNKEL, GR; EGILMEZ, NK; WALLMARK, A; FOWLKES, DM; LORD, ST			THE VARYING FREQUENCIES OF 5 DNA POLYMORPHISMS OF X-LINKED COAGULANT FACTOR-IX IN 8 ETHNIC-GROUPS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEMOPHILIA-B; NUCLEOTIDE-SEQUENCE; MALMO POLYMORPHISM; BAMHI POLYMORPHISM; GENE; ANTIBODIES; DIAGNOSIS	Five RFLPS of X-linked coagulation factor IX were evaluated in more than 500 normal persons (723-804 X chromosomes) of both sexes who belonged to eight ethnic groups: Anglo-Americans, Basques, Swedes, African-Americans, East Africans, East Indians, Chinese, and Malays. The polymorphisms, 5' to 3', were BamHI, XmnI, TaqI, MnlI, and HhaI. A PCR procedure was developed for three previously described RFLPs-XmnI, TaqI, and MnlI; a PCRP procedure was developed for BamHI, and a PCRP which had been described by others was used for HhaI. Europeans were the most polymorphic, African-Americans and East Africans were intermediate, and Orientals were the least polymorphic. Extragenic 3' HhaI was highly polymorphic in most groups, and extragenic 5' BamHI was polymorphic only in persons with African ancestry. Two major haplotypes predominated among 247 men, and the expected and observed heterozygosities were concordant among women. Allelic association was very strong between the three intragenic PCRPs; it was present but weak between 5' extragenic BamHI and XmnI. No association was found between 3' extragenic HhaI and MnlI.	UNIV N CAROLINA,CURRICULUM GENET,CHAPEL HILL,NC 27599; UNIV ARKANSAS,MED CTR,LITTLE ROCK,AR 72204; MALMO GEN HOSP,S-21401 MALMO,SWEDEN	University of North Carolina; University of North Carolina Chapel Hill; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock	GRAHAM, JB (corresponding author), UNIV N CAROLINA,DEPT PATHOL,CHAPEL HILL,NC 27599, USA.			Egilmez, Nejat/0000-0002-2544-2767	NHLBI NIH HHS [HL 35152, HL 07225, HL 06350] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035152] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		CAMERINO G, 1984, P NATL ACAD SCI-BIOL, V81, P498, DOI 10.1073/pnas.81.2.498; GIANNELLI F, 1983, NATURE, V303, P181, DOI 10.1038/303181a0; GRAHAM JB, 1989, BLOOD, V73, P2104; GRAHAM JB, 1988, AM J HUM GENET, V42, P573; GRAHAM JB, 1990, BRIT J HAEMATOL, V76, P1; HAY CW, 1986, BLOOD, V67, P1508; KOGAN SC, 1987, NEW ENGL J MED, V317, P985, DOI 10.1056/NEJM198710153171603; KUNKEL GR, 1990, NUCLEIC ACIDS RES, V18, P4961, DOI 10.1093/nar/18.16.4961-a; LITT M, 1986, AM J HUM GENET, V39, P166; LUBAHN DB, 1987, AM J HUM GENET, V40, P527; SMITH KJ, 1985, AM J HUM GENET, V37, P668; WALLMARK A, 1985, P NATL ACAD SCI USA, V82, P3839, DOI 10.1073/pnas.82.11.3839; WINSHIP PR, 1984, NUCLEIC ACIDS RES, V12, P8861, DOI 10.1093/nar/12.23.8861; WINSHIP PR, 1989, LANCET, V1, P631; YOSHITAKE S, 1985, BIOCHEMISTRY-US, V24, P3736, DOI 10.1021/bi00335a049; ZHANG M, 1989, HUM GENET, V82, P283, DOI 10.1007/BF00291171	16	30	30	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1991	49	3					537	544						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	GE367	1679290				2022-12-18	WOS:A1991GE36700006
J	COTE, GB; GYFTODIMOU, J				COTE, GB; GYFTODIMOU, J			TWINNING AND MITOTIC CROSSING-OVER - SOME POSSIBILITIES AND THEIR IMPLICATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; MONOZYGOTIC TWINS DISCORDANT; GENETIC-ASPECTS; X-CHROMOSOME; WILMS TUMOR; SEX-RATIO; ZYGOSITY DETERMINATION; HEMIFACIAL MICROSOMIA; UNIPARENTAL DISOMY; GOLDENHAR SYNDROME	Mitotic crossing-over does occur in man and is much more frequent and important than generally assumed. Its postzygotic occurrence before an embryo differentiates into MZ twins is theoretically predicted to have disrupting effects on genomic imprinting and cis-acting sequences, with consequences ranging from early lethality to MZ twin discordance. Some predictions are at odds with classical views on twinning and include a high discordance rate of MZ twins for some genetic diseases. A review of MZ twin discordance and an attempt at explaining some of the data lead one to hypothesize both the existence of a sex difference in the rate of mitotic crossing-over and the impossibility for crossed X chromosomes to undergo inactivation. The close interrelationship of twinning and midline malformations further suggests a major role of mitotic crossing-over in the induction of the twinning process itself. The model can be tested with molecular methods and provides a new approach for the gene mapping of so-called multifactorial diseases and of rarer disorders with apparently irregular inheritance.	INST CHILD HLTH, DIV GENET, ATHENS, GREECE									BENIRSCHKE K, 1972, Clinical Obstetrics and Gynecology, V15, P220, DOI 10.1097/00003081-197203000-00008; Boklage C E, 1981, Prog Clin Biol Res, V69A, P155; BOKLAGE CE, 1987, AM J MED GENET, V28, P67, DOI 10.1002/ajmg.1320280111; BOKLAGE CE, 1990, INT J FERTIL, V35, P75; BOLES DJ, 1987, AM J MED GENET, V28, P103, DOI 10.1002/ajmg.1320280115; BRILLIANT MH, 1990, AM J HUM GENET, V47, pA210; BURCK U, 1983, HUM GENET, V64, P291, DOI 10.1007/BF00279415; BURN J, 1986, J MED GENET, V23, P494, DOI 10.1136/jmg.23.6.494; CAMPANELLA G, 1984, NEUROLOGY, V34, P1398, DOI 10.1212/WNL.34.10.1398-b; CAMPBELL JA, 1975, BIRTH DEFECTS, V51, P326; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; CHANDLEY AC, 1989, J MED GENET, V26, P546, DOI 10.1136/jmg.26.9.546; CHUTKOW JG, 1987, NEUROLOGY, V37, P1147, DOI 10.1212/WNL.37.7.1147; CONNOR JM, 1984, HUM GENET, V68, P349, DOI 10.1007/BF00292601; COTE GB, 1989, ANN GENET-PARIS, V32, P132; COTE GB, 1990, CLIN GENET, V37, P470; COTE GB, 1989, ANN GENET-PARIS, V32, P69; CRAIGHOLMES AP, 1975, AM J HUM GENET, V27, P178; DAIGER SP, 1990, AM J HUM GENET S, V47, pA176; DAO DD, 1987, AM J HUM GENET, V41, P202; DAVIES KE, 1985, HUM GENET, V70, P249; DEROM C, 1985, J MED GENET, V22, P279, DOI 10.1136/jmg.22.4.279; EDWARDS J. H., 1966, J MED GEMET, V3, P117, DOI 10.1136/jmg.3.2.117; ELDRIDGE R, 1984, NEUROLOGY, V34, P1399, DOI 10.1212/WNL.34.10.1399; ELDRIDGE R, 1983, AM J HUM GENET, V35, pA88; GARDNER RL, 1990, RECHERCHE, V21, P1476; GOMEZ MR, 1977, NEUROLOGY, V27, P537, DOI 10.1212/WNL.27.6.537; GORLIN R, 1990, 1990 S EUR SOC HUM G; GRODEN J, 1988, American Journal of Human Genetics, V43, pA24; HALL JG, 1983, AM J MED GENET, V15, P591, DOI 10.1002/ajmg.1320150408; HENRY I, 1989, CYTOGENET CELL GENET, V51, P1012; HENRY I, 1987, CYTOGENET CELL GENET, V46, P629; HENRY I, 1987, CYTOGENET CELL GENET, V46, P628; HILL AVS, 1985, LANCET, V2, P1394; HU XY, 1989, AM J HUM GENET, V44, P855; HU XY, 1990, AM J HUM GENET, V46, P682; JAMES WH, 1980, ANN HUM BIOL, V7, P273, DOI 10.1080/03014468000004321; JAMES WH, 1979, J MED GENET, V16, P129, DOI 10.1136/jmg.16.2.129; JAMES WH, 1975, ANN HUM BIOL, V2, P365, DOI 10.1080/03014467500000981; JAMES WH, 1988, J MED GENET, V25, P213; JAMES WH, 1980, J MED GENET, V17, P93, DOI 10.1136/jmg.17.2.93; JAMES WH, 1976, ANN HUM BIOL, V3, P401, DOI 10.1080/03014467600001661; JAMES WH, 1979, J MED GENET, V16, P384, DOI 10.1136/jmg.16.5.384; JONGBLOET PH, 1988, J MED GENET, V25, P214, DOI 10.1136/jmg.25.3.214; JONGBLOET PH, 1987, J MED GENET, V24, P616, DOI 10.1136/jmg.24.10.616; JONGBLOET PH, 1980, J PEDIATR-US, V97, P868, DOI 10.1016/S0022-3476(80)80293-9; JONGBLOET PH, 1971, MAANDSCHR KINDERGENE, V39, P251; JONGBLOET PH, 1968, MAANDSCHR KINDERGENE, V36, P352; KALLEN B, 1986, ACTA GENET MED GEMEL, V35, P167; KIPPS TJ, 1986, EMBO J, V5, P263, DOI 10.1002/j.1460-2075.1986.tb04208.x; KITCHENS CS, 1987, AM J HEMATOL, V24, P225, DOI 10.1002/ajh.2830240215; KOULISCHER L, 1968, 1 CR C INT NEUR GEN, P242; KURNIT DM, 1979, HUM GENET, V47, P169, DOI 10.1007/BF00273199; LAIRD C, 1987, TRENDS GENET, V3, P274, DOI 10.1016/0168-9525(87)90268-X; LANDY HJ, 1986, AM J OBSTET GYNECOL, V155, P14, DOI 10.1016/0002-9378(86)90068-2; LANDY HJ, 1982, ACTA GENET MED GEMEL, V31, P179, DOI 10.1017/S0001566000008278; LAYDE PM, 1980, AM J HUM GENET, V32, P69; LITTLE J, 1988, TWINNING TWINS, P207; MALCOLM S, 1990, AM J HUM GENET S, V47, pA227; MANNENS M, 1988, HUM GENET, V81, P41, DOI 10.1007/BF00283727; MORLEY AA, 1990, CANCER RES, V50, P4584; MOTOMURA K, 1987, JPN J HUM GENET, V32, P9, DOI 10.1007/BF01876522; Nance W E, 1981, Prog Clin Biol Res, V69A, P123; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; NIELSEN J, 1967, LANCET, V2, P717; ORNOY A, 1980, TERATOLOGY, V22, P145, DOI 10.1002/tera.1420220203; Passarge E, 1976, Birth Defects Orig Artic Ser, V12, P177; PENA SDJ, 1987, J NEUROL SCI, V79, P337, DOI 10.1016/0022-510X(87)90240-1; PENA SDJ, 1982, NEUROLOGY, V32, pA83; PHELAN MC, 1980, AM J HUM GENET, V32, pA123; PHILIP J, 1969, ANN HUM GENET, V33, P185, DOI 10.1111/j.1469-1809.1969.tb01644.x; PONTECORVO G, 1958, ADV GENET, V9, P71, DOI 10.1016/S0065-2660(08)60160-1; POZZAN GB, 1990, AM J MED GENET, P57; PRIMROSE DA, 1975, J MENT DEFIC RES, V19, P195; PURRELLO M, 1985, EMBO J, V4, P725, DOI 10.1002/j.1460-2075.1985.tb03689.x; RAIZIS AM, 1985, HUM GENET, V70, P344, DOI 10.1007/BF00295375; REID COMV, 1986, AM J MED GENET, V24, P701, DOI 10.1002/ajmg.1320240415; REIK W, 1987, NATURE, V328, P248, DOI 10.1038/328248a0; REVESZ T, 1972, J MED GENET, V9, P396, DOI 10.1136/jmg.9.4.396; RICHARDS CS, 1990, AM J HUM GENET, V46, P672; RICHARDS CS, 1990, AM J HUM GENET S, V47, pA105; RYAN CA, 1988, AM J MED GENET, V29, P755, DOI 10.1002/ajmg.1320290404; SAMN M, 1990, AM J MED GENET, V37, P543, DOI 10.1002/ajmg.1320370424; SAMPSON JR, 1989, J MED GENET, V26, P28, DOI 10.1136/jmg.26.1.28; SARRI C, 1988, J MED GENET, V25, P247, DOI 10.1136/jmg.25.4.247; SARTO GE, 1987, CYTOGENET CELL GENET, V45, P191, DOI 10.1159/000132453; SCHINZEL A, 1990, AM J HUM GENET S, V47, pA235; SCHINZEL AAGL, 1979, J PEDIATR-US, V95, P921, DOI 10.1016/S0022-3476(79)80278-4; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; SCHWARTZ CE, 1989, CYTOGENET CELL GENET, V51, P1075; SCHWARTZ CE, 1990, AM J HUM GENET, V47, pA235; SEARLE AG, 1989, ANN HUM GENET, V53, P89, DOI 10.1111/j.1469-1809.1989.tb01777.x; SPENCE JE, 1988, AM J HUM GENET, V42, P217; Stern C, 1936, GENETICS, V21, P625; STORRS EE, 1968, P NATL ACAD SCI USA, V60, P910, DOI 10.1073/pnas.60.3.910; SURANI MAH, 1987, NATURE, V326, P395, DOI 10.1038/326395a0; TAKAGI N, 1990, DEVELOPMENT, V109, P189; THERMAN E, 1976, CYTOGENET CELL GENET, V17, P254, DOI 10.1159/000130721; THERMAN E, 1981, HUM GENET, V59, P93, DOI 10.1007/BF00293053; TUCKERMAN E, 1985, J MED GENET, V22, P85, DOI 10.1136/jmg.22.2.85; UCHIDA IA, 1983, AM J HUM GENET, V35, P987; VANDYKE DL, 1977, AM J HUM GENET, V29, P431; VOSS R, 1989, AM J HUM GENET, V45, P373; WESTON PJ, 1990, AM J MED GENET, V37, P558, DOI 10.1002/ajmg.1320370428; WITSCHI E, 1963, DEV BIOL, V7, P605, DOI 10.1016/0012-1606(63)90145-3; WITSCHI E, 1952, CANCER RES, V12, P763; YOVICH J, 1987, J MED GENET, V24, P644, DOI 10.1136/jmg.24.10.644; YOVICH J L, 1985, Journal of In Vitro Fertilization and Embryo Transfer, V2, P27	108	30	31	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1991	49	1					120	130						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FW511	2063864				2022-12-18	WOS:A1991FW51100015
J	SLIPETZ, DM; APRILLE, JR; GOODYER, PR; ROZEN, R				SLIPETZ, DM; APRILLE, JR; GOODYER, PR; ROZEN, R			DEFICIENCY OF COMPLEX-III OF THE MITOCHONDRIAL RESPIRATORY-CHAIN IN A PATIENT WITH FACIOSCAPULOHUMERAL DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; CYTOCHROME-C REDUCTASE; LACTIC-ACIDOSIS; OXIDATIVE-PHOSPHORYLATION; MUSCLE MITOCHONDRIA; SKELETAL-MUSCLE; MYOPATHY; DNA; DEFECT; FIBROBLASTS	Facioscapulohumeral disease (FSHD), an inherited neuromuscular disorder, is characterized by progressive wasting of specific muscle groups, particularly the proximal musculature of the upper limbs; the primary defect in this disorder is unknown. We studied a patient with FSHD to determine whether the mitochondrial respiratory chain was functionally abnormal. Muscle biopsy revealed fiber atrophy with patchy staining for oxidative enzymes. Electron microscopy of a liver section showed many enlarged mitochondria with paracrystalline inclusions. Decreased oxidation of the respiratory substrates-alanine and succinate-in skin fibroblasts suggested a deficiency of complex III of the electron-transport chain; cytochrome c oxidase activity (complex IV) was in the normal range. Biochemical analysis of liver supported the fibroblast data, since succinate oxidase activity (electron-transport activity through complexes II-IV) was reduced, whereas complex IV activity was normal. Furthermore, analysis of the cytochrome spectrum in liver revealed typical peaks for cytochromes cc1 and aa3, whereas cytochrome b (a component of complex III) was undetectable. Southern blot analysis of fibroblast mtDNA revealed no major deletions or rearrangements. Our study provides the first documentation of a specific enzyme-complex deficiency associated with FSHD.	MCGILL UNIV,MONTREAL CHILDRENS HOSP,RES INST,DEPT PEDIAT,2300 TUPPER ST,MONTREAL H3H 1P3,QUEBEC,CANADA; MCGILL UNIV,MONTREAL CHILDRENS HOSP,RES INST,DEPT BIOL,MONTREAL H3H 1P3,QUEBEC,CANADA; TUFTS UNIV,DEPT BIOL,MEDFORD,MA 02155	McGill University; McGill University; Tufts University			Rozen, Rima/AAE-9294-2020					APRILLE JR, 1989, PEDIATR RES, V25, pA353; APRILLE JR, 1985, ACHIEVEMENTS PERSPEC, V2, P464; BIRCHMACHIN MA, 1989, PEDIATR RES, V25, P553, DOI 10.1203/00006450-198905000-00025; BOOKELMAN H, 1978, BIOCHEM MED METAB B, V19, P366, DOI 10.1016/0006-2944(78)90037-6; BOUSTANY RN, 1983, ANN NEUROL, V14, P462, DOI 10.1002/ana.410140411; BROWN WM, 1980, P NATL ACAD SCI-BIOL, V77, P3605, DOI 10.1073/pnas.77.6.3605; CAPALDI RA, 1982, BIOCHIM BIOPHYS ACTA, V694, P291, DOI 10.1016/0304-4157(82)90009-0; DARLEYUSMAR VM, 1983, P NATL ACAD SCI-BIOL, V80, P5103, DOI 10.1073/pnas.80.16.5103; DARLEYUSMAR VM, 1986, CLIN CHIM ACTA, V158, P253, DOI 10.1016/0009-8981(86)90289-5; GOODYER PR, 1984, PEDIATR RES, V18, P1144, DOI 10.1203/00006450-198411000-00018; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.bi.54.070185.005055; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; KENNAWAY NG, 1984, PEDIATR RES, V18, P991; Landouzy L, 1885, REV MED, V5, P253; MITSUMOTO H, 1983, NEUROLOGY, V33, P452, DOI 10.1212/WNL.33.4.452; MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001; MORGANHUGHES JA, 1982, BRAIN, V105, P553, DOI 10.1093/brain/105.3.553; MORGANHUGHES JA, 1977, BRAIN, V100, P617, DOI 10.1093/brain/100.4.617; PAPADIMITRIOU A, 1984, PEDIATR RES, V18, P1023, DOI 10.1203/00006450-198418100-00023; ROBINSON BH, 1985, AM J HUM GENET, V37, P938; ROZEN R, 1985, NATURE, V313, P815, DOI 10.1038/313815a0; SCHOLTE HR, 1987, J INHERIT METAB DIS, V10, P81, DOI 10.1007/BF01812849; SENGERS RCA, 1984, EUR J PEDIATR, V141, P192, DOI 10.1007/BF00572761; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPIRO AJ, 1970, ARCH NEUROL-CHICAGO, V23, P103, DOI 10.1001/archneur.1970.00480260009002; UPADHYAYA M, 1989, J MED GENET, V26, P490, DOI 10.1136/jmg.26.8.490; WORSFOLD M, 1973, J NEUROL SCI, V19, P261, DOI 10.1016/0022-510X(73)90090-7	27	30	31	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1991	48	3					502	510						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK470	1847791				2022-12-18	WOS:A1991FK47000010
J	OLSON, JM; BOEHNKE, M				OLSON, JM; BOEHNKE, M			MONTE-CARLO COMPARISON OF PRELIMINARY METHODS FOR ORDERING MULTIPLE GENETIC-LOCI	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MICHIGAN,SCH PUBL HLTH,DEPT BIOSTAT,109 S OBSERV,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan					NIGMS NIH HHS [GM41440] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM041440] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BUETOW KH, 1987, AM J HUM GENET, V41, P180; BUETOW KH, 1987, AM J HUM GENET, V41, P189; DIACONIS P, 1988, I MATH STATISTICS LE, V11; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; EDWARDS JH, 1971, ANN HUM GENET, V34, P229, DOI 10.1111/j.1469-1809.1971.tb00237.x; FALK CT, 1989, GENETIC WORKSHOP, V6, P17; HALDANE JSB, 1919, J GENET, V8, P229; Johnson R. A., 1988, APPL MULTIVARIATE ST, V2nd, P9607; KAMMERER CM, 1988, AM J HUM GENET, V43, P964; KNAPP M, 1989, GENETIC ANAL WORKSHO, V6, P41; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; RAO CR, 1973, LINEAR STATISTICAL I; REZA FM, 1961, INTRO INFORMATION TH; ROSS SM, 1970, APPLIED PROBABILITY; THOMAS A, 1986, IMA Journal of Mathematics Applied in Medicine and Biology, V3, P167; WEEKS D E, 1987, Genomics, V1, P236, DOI 10.1016/0888-7543(87)90050-4; WEEKS DE, 1988, THESIS U CALIFORNIA; WILSON SR, 1988, GENET EPIDEMIOL, V5, P75, DOI 10.1002/gepi.1370050203	20	30	31	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1990	47	3					470	482						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX223	2393021				2022-12-18	WOS:A1990DX22300012
J	FEIL, R; PALMIERI, G; DURSO, M; HEILIG, R; OBERLE, I; MANDEL, JL				FEIL, R; PALMIERI, G; DURSO, M; HEILIG, R; OBERLE, I; MANDEL, JL			PHYSICAL AND GENETIC-MAPPING OF POLYMORPHIC LOCI IN XQ28 (DXS15, DXS52, AND DXS134) - ANALYSIS OF A COSMID CLONE AND A YEAST ARTIFICIAL CHROMOSOME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									FAC MED STRASBOURG,INST CHIM BIOL,CNRS,GENET MOLEC EUCARYOTES LAB,INSERM,U184,F-67085 STRASBOURG,FRANCE; INT INST GENET & BIOPHYS,NAPLES,ITALY	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR)			Palmieri, Giuseppe/AAX-2627-2021; Feil, Robert P/D-2087-2013; Palmieri, Giuseppe/K-6095-2016	Feil, Robert P/0000-0002-5671-5860; Palmieri, Giuseppe/0000-0002-4350-2276				ARVEILER B, 1989, GENOMICS, V4, P460, DOI 10.1016/0888-7543(89)90269-3; BALLABIO A, 1989, CYTOGENET CELL GENET, V51, P957; BARDONI B, 1988, Genomics, V3, P32, DOI 10.1016/0888-7543(88)90155-3; BELL MV, 1989, HUM GENET, V82, P27, DOI 10.1007/BF00288266; BROWN WT, 1988, HUM GENET, V78, P201, DOI 10.1007/BF00291662; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; DAVIES KE, 1981, NATURE, V293, P374, DOI 10.1038/293374a0; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; DRAYNA D, 1984, P NATL ACAD SCI-BIOL, V81, P2836, DOI 10.1073/pnas.81.9.2836; DRAYNA D, 1985, SCIENCE, V230, P753, DOI 10.1126/science.4059909; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GARDINER K, 1988, SOMAT CELL MOLEC GEN, V14, P623, DOI 10.1007/BF01535316; HEILIG R, 1987, NUCLEIC ACIDS RES, V15, P9129, DOI 10.1093/nar/15.22.9129; HOFKER MH, 1987, AM J HUM GENET, V40, P312; HOLM C, 1986, GENE, V42, P169, DOI 10.1016/0378-1119(86)90293-3; KRETZ PL, 1989, NUCLEIC ACIDS RES, V17, P5409, DOI 10.1093/nar/17.13.5409; LAFRENIERE RG, 1989, CYTOGENET CELL GENET, V51, P1028; LEHESJOKI AE, 1989, CYTOGENET CELL GENET, V51, P1031; LINDSAY S, 1987, NATURE, V327, P336, DOI 10.1038/327336a0; LITTLE RD, 1989, P NATL ACAD SCI USA, V86, P1598, DOI 10.1073/pnas.86.5.1598; MANDEL JL, 1986, COLD SPRING HARB SYM, V51, P195, DOI 10.1101/SQB.1986.051.01.024; MANDEL JL, 1989, CYTOGENET CELL GENET, V51, P384, DOI 10.1159/000132801; OBERLE I, 1985, P NATL ACAD SCI USA, V82, P2824, DOI 10.1073/pnas.82.9.2824; OBERLE I, 1986, P NATL ACAD SCI USA, V83, P1016, DOI 10.1073/pnas.83.4.1016; OBERLE I, 1986, HUM GENET, V72, P43, DOI 10.1007/BF00278816; PATTERSON M, 1987, NUCLEIC ACIDS RES, V15, P2639, DOI 10.1093/nar/15.6.2639; PATTERSON M, 1988, AM J MED GENET, V30, P581, DOI 10.1002/ajmg.1320300159; VEENEMA H, 1987, J MED GENET, V24, P413, DOI 10.1136/jmg.24.7.413; WADA M, 1990, AM J HUM GENET, V46, P95	29	30	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1990	46	4					720	728						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CW549	1969226				2022-12-18	WOS:A1990CW54900009
J	BREGUET, G; BUTLER, R; BUTLERBRUNNER, E; SANCHEZMAZAS, A				BREGUET, G; BUTLER, R; BUTLERBRUNNER, E; SANCHEZMAZAS, A			A WORLDWIDE POPULATION STUDY OF THE AG-SYSTEM HAPLOTYPES, A GENETIC-POLYMORPHISM OF HUMAN LOW-DENSITY-LIPOPROTEIN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV GENEVA,DEPT ANTHROPOL,GENET & BIOFAETRIE LAB,12 RUE GUSTAVE REVILLIOD,CH-1227 GENEVA,SWITZERLAND; SWISS RED CROSS,CENT LAB BLOOD TRANSFUS,CH-3000 BERN 22,SWITZERLAND	University of Geneva				SANCHEZ-MAZAS, Alicia/0000-0002-7714-2432				ALLISON AC, 1961, LANCET, V1, P634; BERG K, 1976, P NATL ACAD SCI USA, V73, P937, DOI 10.1073/pnas.73.3.937; BERG K, 1986, P NATL ACAD SCI USA, V83, P7367, DOI 10.1073/pnas.83.19.7367; BLACKHART BD, 1986, J BIOL CHEM, V261, P15634; BREGUET G, 1982, TISSUE ANTIGENS, V20, P229; BUTLER R, 1974, VOX SANG, V27, P550; BUTLER R, 1973, VOX SANG, V24, P267; Butler R, 1970, Vox Sang, V18, P90; Butler R, 1970, Vox Sang, V18, P85; BUTLER R, 1967, VOX SANG, V13, P508; BUTLER R, 1974, VOX SANG, V26, P485; BUTLER R, 1966, VOX SANG, V11, P738; BUTLER R, 1978, PROTIDES BIOL FLUIDS, P255; BUTLER R, IN PRESS ADV FORENSI, V3; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CAVALLISFORZA LL, 1964, GENETICS TODAY, V2, P932; CLADARAS C, 1986, EMBO J, V5, P3495, DOI 10.1002/j.1460-2075.1986.tb04675.x; CONTU L, 1966, NOUV REV FR HEMATOL, V6, P671; DEEB SS, 1985, P NATL ACAD SCI USA, V82, P4983, DOI 10.1073/pnas.82.15.4983; DUNNING AM, 1988, HUM GENET, V78, P325, DOI 10.1007/BF00291728; EXCOFFIER L, 1989, AM J HUM GENET, V44, P73; EXCOFFIER L, 1987, YEARB PHYS ANTHROPOL, V30, P151; EXCOFFIER L, 1988, THESIS U GENEVA GENE; FISHER R A, 1947, Am Sci, V35, P95; HEIKEN A, 1974, HEREDITAS, V76, P117; HIRSCHFE.J, 1969, VOX SANG, V16, P146, DOI 10.1111/j.1423-0410.1969.tb04727.x; HIRSCHFE.J, 1967, VOX SANG, V13, P1, DOI 10.1111/j.1423-0410.1967.tb03378.x; HIRSCHFE J, 1964, NATURE, V201, P1337, DOI 10.1038/2011337a0; HIRSCHFELD J, 1968, Series Haematologica, V1, P38; HIRSCHFELD J, 1966, NATURE, V212, P206, DOI 10.1038/212206b0; HIRSCHFELD J, 1964, NATURE, V202, P706, DOI 10.1038/202706a0; HIRSCHFELD J, 1973, HUM HERED, V23, P298, DOI 10.1159/000152589; HIRSCHFELD J, 1973, HUM HERED, V23, P154, DOI 10.1159/000152567; HITZEROTH HW, 1980, HUM HERED, V30, P94, DOI 10.1159/000153109; HUANG LS, 1985, P NATL ACAD SCI USA, V82, P6825, DOI 10.1073/pnas.82.20.6825; HUANG LS, 1988, J LIPID RES, V29, P63; HUNG NV, 1967, Z ARZTL FORTBILD JEN, V61, P252; JOHNSTON FE, 1969, AM J HUM GENET, V21, P376; KNOTT TJ, 1986, NATURE, V323, P734, DOI 10.1038/323734a0; KNOTT TJ, 1985, SCIENCE, V230, P37, DOI 10.1126/science.2994225; LANGANEY A, 1988, MAY ISI M LANG CHANG; LAW SW, 1985, P NATL ACAD SCI USA, V82, P8340, DOI 10.1073/pnas.82.24.8340; LAW SW, 1986, P NATL ACAD SCI USA, V82, P4597; LUSIS AJ, 1985, P NATL ACAD SCI USA, V82, P4597, DOI 10.1073/pnas.82.14.4597; MA YH, 1987, ARTERIOSCLEROSIS, V7, P301, DOI 10.1161/01.ATV.7.3.301; MISAWA S, 1971, JPN J HUM GENET, V16, P30; MORGANTI G, 1968, HUMANGENETIK, V5, P98, DOI 10.1007/BF00278670; MORGANTI G, 1967, HUMANGENETIK, V4, P262, DOI 10.1007/BF00292198; Mourant AE, 1976, DISTRIBUTION HUMAN B; MULLER U, 1974, HUM HERED, V24, P458, DOI 10.1159/000152683; NEI M, 1982, EVOL BIOL, V14, P1; NEI M, 1974, AM J HUM GENET, V26, P421; Nei M., 1987, MOL EVOLUTIONARY GEN; OKOCHI K, 1967, VOX SANG, V13, P319, DOI 10.1111/j.1423-0410.1967.tb03115.x; ROBINSON MT, 1986, ARTERIOSCLEROSIS, V6, P341, DOI 10.1161/01.ATV.6.3.341; SALZANO FM, 1981, HUM HERED, V31, P61, DOI 10.1159/000153178; SANCHEZMAZAS A, 1988, HUM GENET, V78, P161, DOI 10.1007/BF00278189; SANCHEZMAZAS A, IN PRESS 2EME P C DE; SANCHEZMAZAS A, 1986, THEORIA-SPAIN, V4, P143; SCHERZ R, 1988, AM J PHYS ANTHROPOL, V76, P489, DOI 10.1002/ajpa.1330760408; SCHLAPFER P, 1987, HYBRIDOMA, V6, P575, DOI 10.1089/hyb.1987.6.575; SCHUMAKER VN, 1984, J BIOL CHEM, V259, P6423; STRINGER C, 1988, NATURE, V331, P565, DOI 10.1038/331565a0; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; TIKKANEN MJ, 1986, FEBS LETT, V202, P54, DOI 10.1016/0014-5793(86)80648-2; VALLADAS H, 1988, NATURE, V331, P614, DOI 10.1038/331614a0; VIERUCCI A, 1967, NATURE, V216, P1231, DOI 10.1038/2161231a0; WAINSCOAT JS, 1986, NATURE, V319, P491, DOI 10.1038/319491a0; WANG X, 1988, ARTERIOSCLEROSIS, V8, P429, DOI 10.1161/01.ATV.8.4.429; XU C, 1989, HUM GENET, V82, P322	70	30	31	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1990	46	3					502	517						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CT668	1689953				2022-12-18	WOS:A1990CT66800013
J	TRASK, B; VANDENENGH, G; GRAY, JW				TRASK, B; VANDENENGH, G; GRAY, JW			INHERITANCE OF CHROMOSOME HETEROMORPHISMS ANALYZED BY HIGH-RESOLUTION BIVARIATE FLOW KARYOTYPING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											TRASK, B (corresponding author), UNIV CALIF LAWRENCE LIVERMORE NATL LAB,DIV BIOMED SCI,POB 5507,L-452,LIVERMORE,CA 94550, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017665] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-17665] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alberts B., 2012, MOL BIOL CELL CLASSI; CARTER NP, IN PRESS CYTOMETRY; COOKE A, 1988, HUM GENET, V79, P49, DOI 10.1007/BF00291709; CRAIGHOLMES AP, 1975, AM J HUM GENET, V27, P178; FITZGERALD PH, 1973, CYTOGENET CELL GENET, V12, P404, DOI 10.1159/000130483; GERAEDTS JP, 1974, CLIN GENET, V6, P247; GREEN DK, 1984, HUM GENET, V66, P143, DOI 10.1007/BF00286588; HARRIS P, 1986, CYTOGENET CELL GENET, V41, P14, DOI 10.1159/000132190; HARRIS P, 1987, HUM GENET, V76, P129, DOI 10.1007/BF00284908; Jacobs P A, 1977, Prog Med Genet, V2, P251; KURNIT DM, 1979, HUM GENET, V47, P169, DOI 10.1007/BF00273199; MAGENIS E, 1977, POPULATION CYTOGENET, P179; MAYALL BH, 1984, CYTOMETRY, V5, P376, DOI 10.1002/cyto.990050414; MCKENZIE WH, 1975, CYTOGENET CELL GENET, V14, P97, DOI 10.1159/000130330; MCKENZIE WH, 1972, AM J HUM GENET, V24, P686; OLSON SB, 1986, AM J HUM GENET, V38, P235; PATTERSON M, 1987, Genomics, V1, P297, DOI 10.1016/0888-7543(87)90028-0; PODUGOLNIKOVA OA, 1979, HUM GENET, V49, P251, DOI 10.1007/BF00569344; ROBINSON JA, 1976, ANN HUM GENET, V40, P113, DOI 10.1111/j.1469-1809.1976.tb00169.x; STACK SM, 1984, J CELL SCI, V71, P159; TRASK B, 1989, AM J HUM GENET, V45, P739; TRASK B, IN PRESS CYTOMETRY; VANDENENGH G, 1984, CYTOMETRY, V5, P108; VANDENENGH G, 1988, CYTOMETRY, V9, P266; VANDENENGH GJ, 1985, CYTOMETRY, V6, P92, DOI 10.1002/cyto.990060203; VANDENENGH GJ, IN PRESS CYTOMETRY; VANDILLA MA, 1986, BIO-TECHNOL, V4, P537, DOI 10.1038/nbt0686-537; VERMA RS, 1976, HUM HERED, V26, P315, DOI 10.1159/000152820; WILCOX DE, 1986, HUM GENET, V73, P175, DOI 10.1007/BF00291610	29	30	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1989	45	5					753	760						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AZ049	2816941				2022-12-18	WOS:A1989AZ04900011
J	SIMS, KB; OZELIUS, L; COREY, T; RINEHART, WB; LIBERFARB, R; HAINES, J; CHEN, WJ; NORIO, R; SANKILA, E; DELACHAPELLE, A; MURPHY, DL; GUSELLA, J; BREAKEFIELD, XO				SIMS, KB; OZELIUS, L; COREY, T; RINEHART, WB; LIBERFARB, R; HAINES, J; CHEN, WJ; NORIO, R; SANKILA, E; DELACHAPELLE, A; MURPHY, DL; GUSELLA, J; BREAKEFIELD, XO			NORRIE DISEASE GENE IS DISTINCT FROM THE MONOAMINE-OXIDASE GENES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV HELSINKI, DEPT MED GENET, SF-00100 HELSINKI 10, FINLAND; NIMH, CTR CLIN, BETHESDA, MD 20205 USA; MASSACHUSETTS GEN HOSP, NEUROGENET LAB NEUROL, BOSTON, MA 02114 USA; HARVARD UNIV, SCH MED, DEPT EPIDEMIOL & PUBL HLTH, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, NEUROSCI PROGRAM, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT NEUROL, BOSTON, MA 02115 USA; MASSACHUSETTS EYE & EAR HOSP, RETINA ASSOCIATES & EYE RES INST, BOSTON, MA 02114 USA	University of Helsinki; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Institute of Mental Health (NIMH); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	SIMS, KB (corresponding author), EK SHRIVER CTR, DIV MOLEC NEUROGENET, 200 TRAPELO RD, WALTHAM, MA 02254 USA.		Haines, Jonathan/C-3374-2012	Haines, Jonathan/0000-0002-4351-4728; Chen, Wei Jen/0000-0001-5899-5870	NICHD NIH HHS [HD00824] Funding Source: Medline; NINDS NIH HHS [NS21921] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K11HD000824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021921] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; BACH AWJ, 1988, P NATL ACAD SCI USA, V85, P4934, DOI 10.1073/pnas.85.13.4934; BAKKER E, 1985, LANCET, V1, P655; BATES PF, 1983, GENE, V26, P137, DOI 10.1016/0378-1119(83)90183-X; BLEEKERWAGEMAKERS LM, 1985, HUM GENET, V71, P211, DOI 10.1007/BF00284575; BOND PA, 1977, CLIN CHIM ACTA, V80, P317, DOI 10.1016/0009-8981(77)90039-0; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREAKEFIELD XO, 1986, MOL BIOL MED, V3, P483; BREAKEFIELD XO, 1980, PSYCHIAT RES, V2, P307, DOI 10.1016/0165-1781(80)90022-0; BREAKEFIELD XO, 1981, GENETIC RES STRATEGI, P129; CAWTHON RM, 1981, J NEUROCHEM, V37, P363, DOI 10.1111/j.1471-4159.1981.tb00464.x; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COSTA M R C, 1980, Biochemical Genetics, V18, P577, DOI 10.1007/BF00484403; DAVIS LG, 1986, BASIC METHODS MOL BI, P143; DELACHAPELLE A, 1985, CLIN GENET, V28, P317; DENNEY RM, 1982, MOL PHARMACOL, V22, P500; DONNAI D, 1988, J MED GENET, V25, P73, DOI 10.1136/jmg.25.2.73; EDELSTEIN SB, 1986, CELL MOL NEUROBIOL, V6, P121, DOI 10.1007/BF00711066; EMANUEL BS, 1988, AM J HUM GENET, V43, P575; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FRADKIN AH, 1971, AM J OPHTHALMOL, V72, P947, DOI 10.1016/0002-9394(71)91694-1; FREDERICK JM, 1982, J COMP NEUROL, V210, P65, DOI 10.1002/cne.902100108; FUNG SC, 1982, J NEUROSCI, V2, P1623; GAL A, 1985, CYTOGENET CELL GENET, V40, P633; GAL A, 1986, CYTOGENET CELL GENET, V42, P219, DOI 10.1159/000132282; GLOVER V, 1986, CELL BIOCHEM FUNCT, V4, P89, DOI 10.1002/cbf.290040203; GOODFELLOW PN, 1985, CYTOGENET CELL GENET, V40, P296, DOI 10.1159/000132178; GUSELLA J, 1979, P NATL ACAD SCI USA, V76, P5239, DOI 10.1073/pnas.76.10.5239; HADJICONSTANTINOU M, 1983, J NEUROCHEM, V41, P1440, DOI 10.1111/j.1471-4159.1983.tb00843.x; HARPER RA, 1979, SCIENCE, V204, P526, DOI 10.1126/science.432659; HOLMES LB, 1971, J PEDIATR-US, V79, P89, DOI 10.1016/S0022-3476(71)80063-X; HSU YPP, 1988, J NEUROCHEM, V51, P1321, DOI 10.1111/j.1471-4159.1988.tb03105.x; JOHNSTON JP, 1968, BIOCHEM PHARMACOL, V17, P1285, DOI 10.1016/0006-2952(68)90066-X; JOHNSTON SS, 1982, BIRTH DEFECTS-ORIG, V18, P729; KIVLIN JD, 1987, AM J MED GENET, V26, P733, DOI 10.1002/ajmg.1320260329; Knoll J, 1972, Adv Biochem Psychopharmacol, V5, P393; KUNKEL LM, 1982, NUCLEIC ACIDS RES, V10, P1557, DOI 10.1093/nar/10.5.1557; LAM DMK, 1981, J NEUROSCI, V1, P1117; Lauder J M, 1985, Prog Clin Biol Res, V163C, P375; LEVITT P, 1982, P NATL ACAD SCI-BIOL, V79, P6385, DOI 10.1073/pnas.79.20.6385; LEVY ER, IN PRESS GENOMICS; LIBERFARB RM, 1985, OPHTHALMOLOGY, V92, P1445; MAJOR LF, 1979, J NEUROCHEM, V32, P229, DOI 10.1111/j.1471-4159.1979.tb04533.x; MOREIRAFILHO CA, 1979, J MED GENET, V16, P125, DOI 10.1136/jmg.16.2.125; MURPHY DL, 1976, BIOCHEM MED METAB B, V16, P254, DOI 10.1016/0006-2944(76)90031-4; MURPHY DL, 1977, J NERV MENT DIS, V164, P129, DOI 10.1097/00005053-197702000-00008; MURPHY DL, 1978, BIOCHEM PHARMACOL, V27, P1889, DOI 10.1016/0006-2952(78)90001-1; MURPHY DL, IN PRESS J NEUROCHEM; NANCE WE, 1969, AM J HUM GENET, V21, P423; NGO JT, 1988, CLIN GENET, V34, P43; NORRIE GORDON, 1927, ACTA OPHTHALMOLOGICA, V5, P357; OSBORNE NN, 1981, J NEUROCHEM, V36, P17, DOI 10.1111/j.1471-4159.1981.tb02372.x; OTT J, 1976, AM J HUM GENET, V28, P528; OZELIUS L, 1988, Genomics, V3, P53, DOI 10.1016/0888-7543(88)90159-0; PARVING A, 1977, AUDIOLOGY, V16, P124; PINTAR JE, 1987, DEV BIOL, V120, P305, DOI 10.1016/0012-1606(87)90128-X; POWELL JF, 1989, BIOCHEM J, V259, P407, DOI 10.1042/bj2590407; POWELL JF, 1977, BIOCHEM SOC T, V5, P180, DOI 10.1042/bst0050180; ROBINSON DS, 1968, BIOCHEM PHARMACOL, V17, P109, DOI 10.1016/0006-2952(68)90163-9; SIMS KB, 1989, NEURON, V2, P1069, DOI 10.1016/0896-6273(89)90231-6; SUZUKI O, 1977, BRAIN RES, V135, P305, DOI 10.1016/0006-8993(77)91033-2; Thorpe LW, 1987, J HISTOCHEM CYTOCHEM, V35, P23, DOI 10.1177/35.1.3025289; TROFATTER JA, 1986, AM J HUM GENET, V39, P147; WARBURG M, 1979, T OPHTHAL SOC UK, V99, P272; Warburg M., 1966, ACTA OPHTHALMOL SCAN, V89, P1; WEYLER W, IN PRESS J PHARM THE; WIEACKER P, 1984, CYTOGENET CELL GENET, V37, P606; WURTMAN RJ, 1963, BIOCHEM PHARMACOL, V12, P1439, DOI 10.1016/0006-2952(63)90215-6; ZHU D, 1988, American Journal of Human Genetics, V43, pA209	70	30	30	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1989	45	3					424	434						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AN879	2773935				2022-12-18	WOS:A1989AN87900011
J	BROWN, BI; BROWN, DH				BROWN, BI; BROWN, DH			BRANCHING ENZYME-ACTIVITY OF CULTURED AMNIOCYTES AND CHORIONIC VILLI - PRENATAL TESTING FOR TYPE-IV GLYCOGEN-STORAGE DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											BROWN, BI (corresponding author), WASHINGTON UNIV,SCH MED,DEPT BIOL CHEM,BOX 8094,4566 SCOTT AVE,ST LOUIS,MO 63110, USA.							ANDERSEN DH, 1956, LAB INVEST, V5, P11; BROWN BI, 1966, P NATL ACAD SCI USA, V56, P725, DOI 10.1073/pnas.56.2.725; BROWN BI, 1985, CONGENITAL METABOLIC, P227; BROWN DH, 1983, BIOCHEM BIOPH RES CO, V111, P636, DOI 10.1016/0006-291X(83)90354-6; HOWELL RR, 1971, J PEDIATR-US, V78, P638, DOI 10.1016/S0022-3476(71)80466-3; HOWELL RR, 1983, METABOLIC BASIS INHE, P141; ILLINGWORTH B, 1952, J BIOL CHEM, V199, P653; LEGUM CP, 1969, J PEDIATR, V74, P84, DOI 10.1016/S0022-3476(69)80011-9; SHIN YS, 1988, J INHERIT METAB DIS, V11, P252, DOI 10.1007/BF01804250; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9	10	30	30	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1989	44	3					378	381						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T3535	2521770				2022-12-18	WOS:A1989T353500010
J	FUJIWARA, TM; MORGAN, K; SCHWARTZ, RH; DOHERTY, RA; MILLER, SR; KLINGER, K; STANISLOVITIS, P; STUART, N; WATKINS, PC				FUJIWARA, TM; MORGAN, K; SCHWARTZ, RH; DOHERTY, RA; MILLER, SR; KLINGER, K; STANISLOVITIS, P; STUART, N; WATKINS, PC			GENEALOGICAL ANALYSIS OF CYSTIC-FIBROSIS FAMILIES AND CHROMOSOME 7Q RFLP HAPLOTYPES IN THE HUTTERITE BRETHREN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MCGILL UNIV,DEPT EPIDEMIOL & BIOSTAT,1020 PINE AVE W,MONTREAL H3A 1A2,QUEBEC,CANADA; MCGILL UNIV,CTR HUMAN GENET,MONTREAL H3A 2T5,QUEBEC,CANADA; MCGILL UNIV,DEPT PEDIAT,MONTREAL H3A 2T5,QUEBEC,CANADA; UNIV ROCHESTER,DEPT PEDIAT,ROCHESTER,NY 14627; INTEGRATED GENET,FRAMINGHAM,MA	McGill University; McGill University; McGill University; University of Rochester					NHLBI NIH HHS [HL31916] Funding Source: Medline; NIADDK NIH HHS [AM34948, AM34917] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM034917] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R44HL031916] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BEAUDET A, 1986, AM J HUM GENET, V39, P681; BEAUDET AL, 1988, NEW ENGL J MED, V318, P50; BERGER W, 1987, HUM GENET, V77, P197, DOI 10.1007/BF00272392; BOIS E, 1978, CLIN GENET, V14, P73; BOWEN P, 1985, AM J MED GENET, V22, P449, DOI 10.1002/ajmg.1320220302; EATON JOSEPH W., 1953, HUMAN BIOL, V25, P206; ESTIVILL X, 1987, Genomics, V1, P257, DOI 10.1016/0888-7543(87)90052-8; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; FARRALL M, 1987, LANCET, V2, P156; HOFER AM, 1974, HIST HUTTERITE MENNO, P64; Hofer John, 1982, HIST HUTTERITES; Hostetler J, 1974, HUTTERITE SOC; HOSTETLER JA, 1985, AM J MED GENET, V22, P453, DOI 10.1002/ajmg.1320220303; KARIGL G, 1981, ANN HUM GENET, V45, P299, DOI 10.1111/j.1469-1809.1981.tb00341.x; KLINGER K, 1986, NUCLEIC ACIDS RES, V14, P8681, DOI 10.1093/nar/14.21.8681; KLINGER KW, 1983, HUM GENET, V65, P94; LAING LM, 1980, HUM BIOL, V52, P289; LANGE K, 1975, HUM HERED, V25, P95, DOI 10.1159/000152714; LATHROP GM, 1988, AM J HUM GENET, V42, P38; LEWIS M, 1985, AM J MED GENET, V22, P477, DOI 10.1002/ajmg.1320220305; LOWRY RB, 1985, AM J MED GENET, V22, P531, DOI 10.1002/ajmg.1320220311; MARTIN AO, 1973, GENETIC STRUCTURE PO, P195; MATHY L, 1987, HUM GENET, V75, P359, DOI 10.1007/BF00284108; MORGAN K, 1980, AM J HUM GENET, V32, P246; MORGAN K, 1982, CURRENT DEV ANTHR GE, V2, P429; OBER C, 1987, AM J HUM GENET, V41, P1145; OBRIEN E, 1987, MAMMALIAN DISPERSAL, P193; PEARCE WG, 1986, OPHTHALMIC PAEDIATR, V8, P119; PETER KA, 1980, CANADIAN ETHNIC STUD, V12, P97; SCAMBLER PJ, 1986, NUCLEIC ACIDS RES, V14, P1951, DOI 10.1093/nar/14.5.1951; SCHMIDTKE J, 1987, HUM GENET, V76, P337, DOI 10.1007/BF00272441; SMITH CAB, 1986, ANN HUM GENET, V50, P163, DOI 10.1111/j.1469-1809.1986.tb01035.x; SPENCE JE, 1986, AM J HUM GENET, V39, P729; STEINBERG AG, 1967, 3RD P INT C HUM GEN, P267; THOMAS A, 1987, 99 U WASH DEP STAT T; THOMAS A, 1987, 100 U WASH DEP STAT; THOMPSON EA, UNPUB RECURSIVE DESC; Thompson EA, 1986, PEDIGREE ANAL HUMAN; WAINWRIGHT BJ, 1985, NATURE, V318, P384, DOI 10.1038/318384a0; WARWICK WJ, 1978, HELV PAEDIATR ACTA, V33, P117; WATKINS PC, 1986, AM J HUM GENET, V39, P735; WEBSTER HL, 1981, CLIN CHEM, V27, P385; WHITE R, 1986, AM J HUM GENET, V39, P694; WHITE R, 1985, NATURE, V318, P382, DOI 10.1038/318382a0	44	30	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1989	44	3					327	337						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T3535	2563632				2022-12-18	WOS:A1989T353500004
J	WARD, PA; HEJTMANCIK, JF; WITKOWSKI, JA; BAUMBACH, LL; GUNNELL, S; SPEER, J; HAWLEY, P; TANTRAVAHI, U; CASKEY, CT				WARD, PA; HEJTMANCIK, JF; WITKOWSKI, JA; BAUMBACH, LL; GUNNELL, S; SPEER, J; HAWLEY, P; TANTRAVAHI, U; CASKEY, CT			PRENATAL-DIAGNOSIS OF DUCHENNE MUSCULAR-DYSTROPHY - PROSPECTIVE LINKAGE ANALYSIS AND RETROSPECTIVE DYSTROPHIN CDNA ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030; HARVARD UNIV,CHILDRENS HOSP,INST MED,DIV GENET,CAMBRIDGE,MA 02138; HARVARD UNIV,INST MED,DEPT PEDIAT,CAMBRIDGE,MA 02138; HOWARD HUGHES MED INST,COCONUT GROVE,FL 33133	Baylor College of Medicine; Harvard University; Harvard University; Howard Hughes Medical Institute			Witkowski, Jan/FHJ-8549-2022	Witkowski, Jan/0000-0002-8159-2874				ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; BAKKER E, 1985, LANCET, V1, P655; BAKKER E, 1987, NATURE, V329, P554, DOI 10.1038/329554a0; BAUMBACH L L, 1988, American Journal of Human Genetics, V43, pA176; BURGHES AHM, 1987, NATURE, V328, P434, DOI 10.1038/328434a0; BURMEISTER M, 1986, NATURE, V324, P582, DOI 10.1038/324582a0; CAMARINO G, 1984, CYTOGENET CELL GENET, V37, P431; Caskey C T, 1988, Adv Neurol, V48, P83; CASKEY CT, 1980, CLIN GENET, V18, P329; CHAMBERLAIN JS, 1988, SCIENCE, V239, P1416, DOI 10.1126/science.3347839; CHAMBERLAIN JS, IN PRESS NUCLEIC ACI; COLE CG, 1988, LANCET, V1, P262; DAIGER S P, 1986, American Journal of Human Genetics, V39, pA152; DARRAS BT, 1987, NEW ENGL J MED, V316, P985, DOI 10.1056/NEJM198704163161604; DARRAS BT, 1988, AM J MED GENET, V29, P713, DOI 10.1002/ajmg.1320290341; DARRAS BT, 1987, NATURE, V329, P556, DOI 10.1038/329556a0; DENDUNNEN JT, 1987, NATURE, V329, P640, DOI 10.1038/329640a0; EMERY AEH, 1977, NATURE, V266, P472, DOI 10.1038/266472a0; FISCHBECK KH, 1986, LANCET, V2, P104; FORREST SM, 1987, NATURE, V329, P638, DOI 10.1038/329638a0; GOLBUS MS, 1979, NEW ENGL J MED, V300, P860; HEJTMANCIK JF, 1986, NEUROLOGY, V36, P1553, DOI 10.1212/WNL.36.12.1553; HEJTMANCIK JF, IN PRESS MOL GENETIC; HOFKER MH, 1985, HUM GENET, V70, P148, DOI 10.1007/BF00273073; KENRICK S, 1987, CELL, V48, P351; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KUNKEL LM, 1986, NATURE, V322, P73, DOI 10.1038/322073a0; KUNKEL LM, 1985, P NATL ACAD SCI USA, V82, P4778, DOI 10.1073/pnas.82.14.4778; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; OTT J, 1974, AM J HUM GENET, V26, P588; PERRY TB, 1973, NEUROLOGY, V23, P1316, DOI 10.1212/WNL.23.12.1316; RAY PN, 1985, NATURE, V318, P672, DOI 10.1038/318672a0; SPEER MC, 1988, PRENATAL DIAG, V8, P427, DOI 10.1002/pd.1970080607; VANOMMEN GJB, 1986, CELL, V47, P499, DOI 10.1016/0092-8674(86)90614-8; WOOD S, 1988, AM J MED GENET, V29, P419, DOI 10.1002/ajmg.1320290225	36	30	31	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1989	44	2					270	281						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R9705	2643315				2022-12-18	WOS:A1989R970500013
J	RAO, DC; WETTE, R; EWENS, WJ				RAO, DC; WETTE, R; EWENS, WJ			MULTIFACTORIAL ANALYSIS OF FAMILY DATA ASCERTAINED THROUGH TRUNCATION - A COMPARATIVE-EVALUATION OF 2 METHODS OF STATISTICAL-INFERENCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WASHINGTON UNIV, SCH MED, DEPT PSYCHIAT, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT GENET, ST LOUIS, MO 63110 USA; MONASH UNIV, DEPT MATH, CLAYTON, VIC 3168, AUSTRALIA; UNIV PENN, DEPT BIOL, PHILADELPHIA, PA 19104 USA	Washington University (WUSTL); Washington University (WUSTL); Monash University; University of Pennsylvania	RAO, DC (corresponding author), WASHINGTON UNIV, SCH MED, DIV BIOSTAT, BOX 8067, 660 S EUCLID, ST LOUIS, MO 63110 USA.				NHLBI NIH HHS [HL 33973] Funding Source: Medline; NIGMS NIH HHS [GM 28719] Funding Source: Medline; NIMH NIH HHS [MH 31302] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH031302, P50MH031302] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BEATY TH, 1987, GENET EPIDEMIOL, V4, P203, DOI 10.1002/gepi.1370040305; BOEHNKE M, 1984, GENETIC EPIDEMIOLOGY, P173; CANNINGS C, 1977, CLIN GENET, V12, P208; DADONE MM, 1984, AM J MED GENET, V17, P565, DOI 10.1002/ajmg.1320170304; GLUECK CJ, 1975, METABOLISM, V24, P1243, DOI 10.1016/0026-0495(75)90063-3; GULBRANDSEN CL, 1977, SOC BIOL, V24, P289, DOI 10.1080/19485565.1977.9988299; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; JANUS ED, 1985, LANCET, V1, P152; MCGUE M, 1987, GENET EPIDEMIOL, V4, P129, DOI 10.1002/gepi.1370040207; RAO CR, 1973, LINEAR STATISTICAL I; RAO DC, 1987, GENET EPIDEMIOL, V4, P357, DOI 10.1002/gepi.1370040505; RAO DC, 1984, HUMAN POPULATION GEN, P35; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P365; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351; RIFKIND BM, 1984, AM J EPIDEMIOL, V119, P931; SIMPSON JM, 1981, AM J HUM GENET, V33, P293; THIRD JLHC, 1984, METABOLISM, V33, P136, DOI 10.1016/0026-0495(84)90126-4	17	30	30	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1988	42	3					506	515						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M6206	3348215				2022-12-18	WOS:A1988M620600014
J	LYONS, LA; LEWIS, RA; STRONG, LC; ZUCKERBROD, S; FERRELL, RE				LYONS, LA; LEWIS, RA; STRONG, LC; ZUCKERBROD, S; FERRELL, RE			A GENETIC-STUDY OF GARDNER SYNDROME AND CONGENITAL HYPERTROPHY OF THE RETINAL-PIGMENT EPITHELIUM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV PITTSBURGH,GRAD SCH PUBL HLTH,DEPT BIOSTAT,DIV HUMAN GENET,A315 CRABTREE HALL,130 DESOTO ST,PITTSBURGH,PA 15261; UNIV PITTSBURGH,PITTSBURGH CANC INST,PITTSBURGH,PA 15261; BAYLOR COLL MED,CULLEN EYE INST,DEPT OPHTHALMOL,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT MED,HOUSTON,TX 77030; BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030; UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT PEDIAT,HOUSTON,TX 77030	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center				Lyons, Leslie/0000-0002-1628-7726	NATIONAL CANCER INSTITUTE [R01CA027925] Funding Source: NIH RePORTER; NCI NIH HHS [CA 27925] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BLAIR NP, 1980, AM J OPHTHALMOL, V90, P661, DOI 10.1016/S0002-9394(14)75133-5; BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; CHASE GA, 1983, AM J EPIDEMIOL, V117, P590, DOI 10.1093/oxfordjournals.aje.a113581; FADER M, 1962, Oral Surg Oral Med Oral Pathol, V15, P153, DOI 10.1016/0030-4220(62)90004-X; FINEMAN RM, 1984, CANCER, V53, P317, DOI 10.1002/1097-0142(19840115)53:2<317::AID-CNCR2820530223>3.0.CO;2-C; GARDNER EJ, 1980, WESTERN J MED, V132, P488; GARDNER EJ, 1982, CANCER, V49, P1413, DOI 10.1002/1097-0142(19820401)49:7<1413::AID-CNCR2820490718>3.0.CO;2-1; GARDNER EJ, 1953, AM J HUM GENET, V5, P139; GARDNER EJ, 1950, AM J HUM GENET, V2, P41; GARDNER EJ, 1951, AM J HUM GENET, V3, P167; GARDNER EJ, 1952, AM J HUM GENET, V4, P31; GARDNER EJ, 1955, MENDELIAN PATTERN DO; Harris, 1976, HDB ENZYME ELECTROPH; HERRERA L, 1986, AM J MED GENET, V25, P473, DOI 10.1002/ajmg.1320250309; Kamboh M I, 1984, Acta Anthropogenet, V8, P159; KAMBOH MI, 1986, BIOCHEM GENET, V24, P273, DOI 10.1007/BF00502794; LEWIS RA, 1984, OPHTHALMOLOGY, V91, P916; NAYLOR EW, 1980, DIGEST DIS SCI, V25, P945, DOI 10.1007/BF01308046; NAYLOR EW, 1979, PEDIATRICS, V63, P222; OTT J, 1974, AM J HUM GENET, V26, P588; PIERCE E R, 1970, Clinical Genetics, V1, P65; SMITH W G, 1958, Dis Colon Rectum, V1, P323, DOI 10.1007/BF02616659; TRABOULSI EI, 1987, NEW ENGL J MED, V316, P661, DOI 10.1056/NEJM198703123161104	23	30	32	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1988	42	2					290	296						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M3133	3422541				2022-12-18	WOS:A1988M313300011
J	RAO, DC; VOGLER, GP; MCGUE, M; RUSSELL, JM				RAO, DC; VOGLER, GP; MCGUE, M; RUSSELL, JM			MAXIMUM-LIKELIHOOD-ESTIMATION OF FAMILIAL CORRELATIONS FROM MULTIVARIATE QUANTITATIVE DATA ON PEDIGREES - A GENERAL-METHOD AND EXAMPLES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WASHINGTON UNIV,SCH MED,DEPT PSYCHIAT,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT GENET,ST LOUIS,MO 63110; UNIV MINNESOTA,DEPT PSYCHOL,MINNEAPOLIS,MN 55455	Washington University (WUSTL); Washington University (WUSTL); University of Minnesota System; University of Minnesota Twin Cities	RAO, DC (corresponding author), WASHINGTON UNIV,SCH MED,DIV BIOSTAT,660 S EUCLID,BOX 8067,ST LOUIS,MO 63110, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH017104] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL33973] Funding Source: Medline; NIGMS NIH HHS [GM28719] Funding Source: Medline; NIMH NIH HHS [MH17104] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Blom G., 1958, STAT ESTIMATES TRANS; CRUMPACKER DW, 1979, ACTA GENET MED GEMEL, V28, P173, DOI 10.1017/S0001566000009041; DAHLEN G, 1983, INT J EPIDEMIOL, V12, P32, DOI 10.1093/ije/12.1.32; DONNER A, 1980, BIOMETRICS, V36, P19, DOI 10.2307/2530491; Fisher R.A., 1921, METRON, V1, P3, DOI DOI 10.1093/BIOMET/9.1-2.22; KAPLAN EB, 1972, I STAT MIMEO SER, P823; KARLIN S, 1981, P NATL ACAD SCI USA, V78, P2664, DOI 10.1073/pnas.78.5.2664; LALOUEL JM, 1979, 14 U UT TECH REP; MCGUE M, 1985, AM J HUM GENET, V37, P998; MORTON NE, 1974, AM J HUM GENET, V26, P489; NANCE WE, 1978, GENETIC EPIDEMIOLOGY, P87; RAO DC, 1979, ANN HUM GENET, V42, P467, DOI 10.1111/j.1469-1809.1979.tb00680.x; RAO DC, 1982, AM J HUM GENET, V34, P888; RAO DC, 1984, HUMAN POPULATION GEN, P35; RAO DC, IN PRESS GENET EPIDE; RAO DC, 1979, PGL2 U HAW TECH REP; ROSNER B, 1979, BIOMETRIKA, V66, P533; ROSNER B, 1982, AM J EPIDEMIOL, V116, P722, DOI 10.1093/oxfordjournals.aje.a113455; VOGLER GP, 1987, AM J EPIDEMIOL, V125, P706, DOI 10.1093/oxfordjournals.aje.a114583; WETTE R, UNPUB BIOMETRICS; WILLIAMS JS, 1981, ACTA GENET MED GEMEL, V30, P9, DOI 10.1017/S0001566000006590; 1978, NUMERICAL ALGORITHMS; 1977, MINUIT SYSTEM FUNCTI	23	30	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1987	41	6					1104	1116						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L2984	3687943				2022-12-18	WOS:A1987L298400012
J	HARDS, RG; BENKOVIC, SJ; VANKEUREN, ML; GRAW, SL; DRABKIN, HA; PATTERSON, D				HARDS, RG; BENKOVIC, SJ; VANKEUREN, ML; GRAW, SL; DRABKIN, HA; PATTERSON, D			ASSIGNMENT OF A 3RD PURINE BIOSYNTHETIC GENE (GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE) TO HUMAN CHROMOSOME-21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									PENN STATE UNIV,DEPT CHEM,UNIVERSITY PK,PA 16802; UNIV COLORADO,HLTH SCI CTR,DEPT ONCOL,DENVER,CO 80262; UNIV COLORADO,HLTH SCI CTR,DEPT MED,DEPT BIOPHYS BIOCHEM GENET,DENVER,CO 80262	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	HARDS, RG (corresponding author), ELEANOR ROOSEVELT INST CANC RES,4200 E 9TH AVE,B129,DENVER,CO 80262, USA.				NICHD NIH HHS [HD17449] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD017449] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BARTLEY JA, 1980, BIOCHEM BIOPH RES CO, V93, P1286, DOI 10.1016/0006-291X(80)90629-4; CHADEFAUX B, 1984, HUM GENET, V66, P190, DOI 10.1007/BF00286599; COBURN SP, 1968, METABOLISM, V17, P560, DOI 10.1016/0026-0495(68)90049-8; COBURN SP, 1967, J APPL PHYSIOL, V23, P579, DOI 10.1152/jappl.1967.23.4.579; COX DW, 1984, CYTOGENET CELL GENET, V37, P441; DAUBNER SC, 1986, BIOCHEMISTRY; DRABKIN HA, 1985, P NATL ACAD SCI USA, V82, P464, DOI 10.1073/pnas.82.2.464; DRABKIN HA, 1985, P NATL ACAD SCI USA, V82, P6980, DOI 10.1073/pnas.82.20.6980; FULLER RW, 1962, SCIENCE, V137, P868, DOI 10.1126/science.137.3533.868; GOODMAN HO, 1966, AM J MENT DEF, V71, P437; HARDS RG, 1986, PURINE METABOLISM MA, V5; HENIKOFF S, 1986, P NATL ACAD SCI US; JONES C, 1981, SOMAT CELL GENET, V7, P399, DOI 10.1007/BF01542985; MOORE EE, 1977, AM J HUM GENET, V29, P389; OATES DC, 1977, SOMAT CELL GENET, V3, P561, DOI 10.1007/BF01539066; PANT SS, 1968, J CLIN ENDOCR METAB, V28, P472, DOI 10.1210/jcem-28-4-472; PATTERSON D, 1975, SOMAT CELL GENET, V1, P91, DOI 10.1007/BF01538734; PATTERSON D, 1981, P NATL ACAD SCI-BIOL, V78, P405, DOI 10.1073/pnas.78.1.405; PATTERSON D, 1983, SOMAT CELL GENET, V9, P259; PATTERSON D, 1985, MOL CELL GENETICS, P268; PATTERSON D, 1986, NATIONAL DOWN SYNDRO; SACCHI N, 1986, SCIENCE, V231, P379, DOI 10.1126/science.3941901; SCOGGIN CH, 1980, CLIN RES, V28, P31; SMITH GK, 1981, BIOCHEMISTRY-US, V20, P4034, DOI 10.1021/bi00517a013; VANKEUREN ML, 1986, AM J HUM GENET, V38, P794	25	30	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1986	39	2					179	185						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	E1459	3529945				2022-12-18	WOS:A1986E145900003
J	TAGGART, RT; SAMLOFF, IM; RAFFEL, LJ; GRAHAM, A; CASS, C; PETERSEN, GM; ROTTER, JI; SKOLNICK, MH; SCHWARTZ, CE; BELL, GI				TAGGART, RT; SAMLOFF, IM; RAFFEL, LJ; GRAHAM, A; CASS, C; PETERSEN, GM; ROTTER, JI; SKOLNICK, MH; SCHWARTZ, CE; BELL, GI			RELATIONSHIPS BETWEEN THE HUMAN PEPSINOGEN DNA AND PROTEIN POLYMORPHISMS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF LOS ANGELES,DEPT MED,LOS ANGELES,CA 90073; UNIV CALIF LOS ANGELES,HARBOR GEN HOSP,DIV MED GENET,TORRANCE,CA 90509; UNIV MARYLAND,SCH MED,DIV MED GENET,BALTIMORE,MD 21201; UNIV UTAH,CTR MED,DEPT HUMAN GENET,SALT LAKE CITY,UT 84132; GREENWOOD GENET CTR,GREENWOOD,SC 29646; CHIRON CORP,EMERYVILLE,CA 94608	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University System of Maryland; University of Maryland Baltimore; Utah System of Higher Education; University of Utah; Greenwood Genetic Center; Novartis	TAGGART, RT (corresponding author), VET ADM MED CTR,SEPULVEDA,CA 91343, USA.				NIADDK NIH HHS [AM32015, AM3329] Funding Source: Medline	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FRANTS RR, 1984, HUM GENET, V65, P385, DOI 10.1007/BF00291564; KORNELUK RG, 1984, J BIOL CHEM, V259, P3819; KORSNES L, 1980, ANN HUM GENET, V43, P199, DOI 10.1111/j.1469-1809.1980.tb01554.x; OTT J, 1974, AM J HUM GENET, V26, P588; SAMLOFF IM, 1973, AM J HUM GENET, V25, P178; SAMLOFF IM, 1970, SCIENCE, V168, P144, DOI 10.1126/science.168.3927.144; SAMLOFF IM, 1985, ASPARTIC PROTEINASES, P79; SOGAWA K, 1983, J BIOL CHEM, V258, P5306; TAGGART RT, 1979, HUM GENET, V52, P227; TAGGART RT, 1985, P NATL ACAD SCI USA, V82, P6240, DOI 10.1073/pnas.82.18.6240; TAGGART RT, 1986, GASTROENTEROLOGY; TAGGART RT, 1978, ELECTROPHORESIS 78, P231; WILSON JT, 1978, NUCLEIC ACIDS RES, V5, P563, DOI 10.1093/nar/5.2.563; ZELLE B, 1985, HUM GENET, V70, P337, DOI 10.1007/BF00295373	17	30	31	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1986	38	6					848	854						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D3922	3014868				2022-12-18	WOS:A1986D392200007
J	GOODFELLOW, PJ; WHITE, BN; HOLDEN, JJA; DUNCAN, AMV; SEARS, EVP; WANG, HS; BERLIN, L; KIDD, KK; SIMPSON, NE				GOODFELLOW, PJ; WHITE, BN; HOLDEN, JJA; DUNCAN, AMV; SEARS, EVP; WANG, HS; BERLIN, L; KIDD, KK; SIMPSON, NE			LINKAGE ANALYSIS OF A DNA MARKER LOCALIZED TO 20P12 AND MULTIPLE ENDOCRINE NEOPLASIA TYPE-2A	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									QUEENS UNIV,DEPT PAEDIAT,DIV MED GENET,KINGSTON K7L 3N6,ONTARIO,CANADA; QUEENS UNIV,DEPT BIOL,KINGSTON K7L 3N6,ONTARIO,CANADA; UNIV MANITOBA,DEPT PAEDIAT,DIV MED GENET,WINNIPEG R3E 0W3,MANITOBA,CANADA; YALE UNIV,SCH MED,DEPT MED GENET,NEW HAVEN,CT 06510	Queens University - Canada; Queens University - Canada; University of Manitoba; Yale University					NCI NIH HHS [CA32066] Funding Source: Medline; NIMH NIH HHS [MH39239] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA032066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH039239, R37MH039239] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BABU VR, 1984, P NATL ACAD SCI-BIOL, V81, P2525, DOI 10.1073/pnas.81.8.2525; BALABAN G, 1982, CANCER GENET CYTOGEN, V6, P213, DOI 10.1016/0165-4608(82)90058-9; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; DARBY JK, 1985, CYTOGENET CELL GENET; DAVIES KE, 1984, CYTOGENET CELL GENET, V37, P448; EMMERTSEN K, 1983, CANCER GENET CYTOGEN, V9, P251, DOI 10.1016/0165-4608(83)90009-2; FEARON ER, 1984, NATURE, V309, P176, DOI 10.1038/309176a0; FRANCKE U, 1979, CYTOGENET CELL GENET, V24, P185, DOI 10.1159/000131375; GAGEL RF, 1982, J PEDIATR-US, V101, P941, DOI 10.1016/S0022-3476(82)80014-0; GERHARD DS, 1984, P NATL ACAD SCI-BIOL, V81, P7875, DOI 10.1073/pnas.81.24.7875; GUSTAVSON KH, 1983, CLIN GENET, V23, P143; HAMILTON BP, 1978, AM J MED, V65, P1027, DOI 10.1016/0002-9343(78)90757-X; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; Hodge SE, 1979, AM J HUM GENET, V31, P761; HSU TC, 1981, JAMA-J AM MED ASSOC, V246, P2046, DOI 10.1001/jama.246.18.2046; KIDD KK, 1985, H FORD HOSP MED J, V32, P262; KNUDSON AG, 1976, NEW ENGL J MED, V295, P1120, DOI 10.1056/NEJM197611112952007; KOUFOS A, 1984, NATURE, V309, P170, DOI 10.1038/309170a0; KRUGER SD, 1985, HUM HERED; MULLIGAN LM, 1985, AM J HUM GENET, V37, P463; ORKIN SH, 1984, NATURE, V309, P172, DOI 10.1038/309172a0; OTT J, 1974, AM J HUM GENET, V26, P588; PARTINGTON MW, 1981, CAN MED ASSOC J, V124, P403; REEVE AE, 1984, NATURE, V309, P174, DOI 10.1038/309174a0; RICCARDI VM, 1980, CANCER GENET CYTOGEN, V2, P131, DOI 10.1016/0165-4608(80)90056-4; RICCARDI VM, 1978, PEDIATRICS, V61, P604; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SIMPSON NE, 1982, HUM GENET, V60, P157, DOI 10.1007/BF00569703; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; VANDERLAND J, 1982, NETH J ZOOL, V32, P324; VANDYKE DL, 1981, CLIN RES, V29, pA37; VANDYKE DL, 1981, AM J HUM GENET, V33, pA69; YUNIS JJ, 1980, J PEDIATR-US, V96, P1027, DOI 10.1016/S0022-3476(80)80630-5; YUNIS JJ, 1978, AM J DIS CHILD, V132, P161, DOI 10.1001/archpedi.1978.02120270059012; ZATTERALE A, 1984, J MED GENET, V121, P108	36	30	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	5					890	897						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ASD55	2864854				2022-12-18	WOS:A1985ASD5500006
J	DEMARTINVILLE, B; BLAKEMORE, KJ; MAHONEY, MJ; FRANCKE, U				DEMARTINVILLE, B; BLAKEMORE, KJ; MAHONEY, MJ; FRANCKE, U			DNA ANALYSIS OF 1ST-TRIMESTER CHORIONIC VILLOUS BIOPSIES - TEST FOR MATERNAL CONTAMINATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510	Yale University								BLAKEMORE KJ, 1984, AM J HUM GENET, V36, P1386; BRAMBATI B, 1983, LANCET, V1, P586; COHENSOLAL MM, 1982, DNA-J MOLEC CELL BIO, V1, P355, DOI 10.1089/dna.1982.1.355; DEMARTINVILLE B, 1982, AM J HUM GENET, V34, P216; ELLES RG, 1983, NEW ENGL J MED, V308, P1433, DOI 10.1056/NEJM198306163082401; FORD JH, 1983, LANCET, V2, P1491; GOOSSENS M, 1983, NEW ENGL J MED, V309, P831, DOI 10.1056/NEJM198310063091405; GOSDEN JR, 1982, LANCET, V2, P1416; GREBNER EE, 1983, LANCET, V2, P286; GREGSON NM, 1983, LANCET, V2, P1491; HIGGS DR, 1981, NUCLEIC ACIDS RES, V9, P4213, DOI 10.1093/nar/9.17.4213; KAPUSCINSKI J, 1977, ANAL BIOCHEM, V83, P252, DOI 10.1016/0003-2697(77)90533-4; KAZI Z, 1982, PRENATAL DIAG, V2, P39; LILFORD R, 1983, LANCET, V2, P1491; MACKENZIE IZ, 1983, LANCET, V2, P1426; MELLON P, 1981, CELL, V27, P279, DOI 10.1016/0092-8674(81)90411-6; NIAZI M, 1981, BRIT J OBSTET GYNAEC, V88, P1081, DOI 10.1111/j.1471-0528.1981.tb01756.x; OLD JM, 1982, LANCET, V2, P1413; PAGE D, 1982, P NATL ACAD SCI-BIOL, V79, P5352, DOI 10.1073/pnas.79.17.5352; PERGAMENT E, 1983, LANCET, V2, P286; PRESSLEY L, 1980, P NATL ACAD SCI-BIOL, V77, P3586, DOI 10.1073/pnas.77.6.3586; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; RODECK CH, 1983, BRIT MED BULL, V39, P338, DOI 10.1093/oxfordjournals.bmb.a071845; RODECK CH, 1983, LANCET, V2, P1340; SACHS ES, 1983, LANCET, V2, P1426; SIMONI G, 1983, HUM GENET, V63, P349, DOI 10.1007/BF00274761; WARD RHT, 1983, BRIT MED J, V286, P1542, DOI 10.1136/bmj.286.6377.1542; WILLIAMSON R, 1981, LANCET, V2, P1125; WYMAN AR, 1980, P NATL ACAD SCI-BIOL, V77, P6754, DOI 10.1073/pnas.77.11.6754	29	30	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	6					1357	1368						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TZ590	6517057				2022-12-18	WOS:A1984TZ59000017
J	DANCIS, J; HUTZLER, J; AMPOLA, MG; SHIH, VE; VANGELDEREN, HH; KIRBY, LT; WOODY, NC				DANCIS, J; HUTZLER, J; AMPOLA, MG; SHIH, VE; VANGELDEREN, HH; KIRBY, LT; WOODY, NC			THE PROGNOSIS OF HYPERLYSINEMIA - AN INTERIM-REPORT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									TUFTS UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02111; MASSACHUSETTS GEN HOSP,NEUROL & PEDIAT SERV,BOSTON,MA 02114; LEIDEN STATE UNIV HOSP,DEPT PEDIAT,2333 AA LEIDEN,NETHERLANDS; UNIV BRITISH COLUMBIA,FAC MED,DEPT PATHOL,VANCOUVER V6T 1W5,BC,CANADA; TULANE UNIV,SCH MED,DEPT PEDIAT,NEW ORLEANS,LA 70112	Tufts University; Harvard University; Massachusetts General Hospital; Leiden University; Leiden University Medical Center (LUMC); University of British Columbia; Tulane University	DANCIS, J (corresponding author), NYU,SCH MED,DEPT PEDIAT,NEW YORK,NY 10016, USA.				NICHD NIH HHS [HD04526] Funding Source: Medline; NINDS NIH HHS [NS-05096] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD004526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS005096] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARMSTRONG MD, 1967, PEDIATRICS, V39, P546; DANCIS J, 1969, J CLIN INVEST, V48, P1447, DOI 10.1172/JCI106110; DANCIS J, 1979, AM J HUM GENET, V31, P290; DANCIS J, 1976, PEDIATR RES, V10, P686, DOI 10.1203/00006450-197610070-00011; GHADIMI H, 1965, NEW ENGL J MED, V273, P723, DOI 10.1056/NEJM196509302731401; LEVY HL, 1974, NEW ENGL J MED, V291, P1214, DOI 10.1056/NEJM197412052912303; OZALP I, 1981, ACTA PAEDIATR SCAND, V70, P951, DOI 10.1111/j.1651-2227.1981.tb06259.x; SCHNEIDER H, 1979, PEDIATR RES, V13, P236, DOI 10.1203/00006450-197904000-00005; VANDERHEIDEN C, 1978, J INHERIT METAB DIS, V1, P89; VANGELDEREN HH, 1973, ARCH DIS CHILD, V48, P892, DOI 10.1136/adc.48.11.892; VELAZQUEZ A, 1976, BIOL NEONATE, V29, P28; WOODY NC, 1966, AM J DIS CHILD, V112, P577, DOI 10.1001/archpedi.1966.02090150121014	12	30	30	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	3					438	442						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QS160	6407303				2022-12-18	WOS:A1983QS16000009
J	UCHIDA, IA; FREEMAN, VCP; GEDEON, M; GOLDMAKER, J				UCHIDA, IA; FREEMAN, VCP; GEDEON, M; GOLDMAKER, J			TWINNING RATE IN SPONTANEOUS-ABORTIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MCMASTER UNIV,HLTH SCI CTR,DEPT PATHOL,HAMILTON L8N 3Z5,ONTARIO,CANADA	McMaster University; University of Manitoba; Children's Hospital Research Institute of Manitoba	UCHIDA, IA (corresponding author), MCMASTER UNIV,HLTH SCI CTR,DEPT PEDIAT,HAMILTON L8N 3Z5,ONTARIO,CANADA.							BOUE J, 1975, TERATOLOGY, V12, P11, DOI 10.1002/tera.1420120103; Bulmer M. G., 1970, BIOL TWINNING MAN; CARR DH, 1978, CAN J GENET CYTOL, V20, P415, DOI 10.1139/g78-048; CREASY MR, 1976, HUM GENET, V31, P177, DOI 10.1007/BF00296145; ELWOOD JM, 1973, BRIT J PREV SOC MED, V27, P236; HASSOLD T, 1980, ANN HUM GENET, V44, P151, DOI 10.1111/j.1469-1809.1980.tb00955.x; HUNTER A, 1982, PRENATAL DIAG, V2, P127, DOI 10.1002/pd.1970020209; KAJII T, 1973, AM J HUM GENET, V25, P539; KAJII T, 1980, HUM GENET, V55, P87, DOI 10.1007/BF00329132; LAURITSEN JG, 1978, ACTA OBSTET GYNECO S, V52, P1; LEVI S, 1976, Journal of Clinical Ultrasound, V4, P3, DOI 10.1002/jcu.1870040104; TAKAHARA H, 1977, HIROSHIMA J MED SCI, V26, P291; WARBURTON D, 1978, AM J HUM GENET, V30, P609; WARBURTON D, 1980, REPRODUCTIVE LOSS, P261; Weinberg W, 1901, ARCH GESAMTE PHYSIOL, V88, P346, DOI 10.1007/BF01657695; WORTON RG, UNPUB CANADIAN COLLA; 1980, 1978 STAT CAN VIT ST; 1981, 1979 STAT CAN VIT ST; 1982, 1980 STAT CAN VIT ST	19	30	30	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	5					987	993						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RK604	6614011				2022-12-18	WOS:A1983RK60400018
J	SHAPIRO, BL; LAM, LFH; FEIGAL, RJ				SHAPIRO, BL; LAM, LFH; FEIGAL, RJ			MITOCHONDRIAL NADH DEHYDROGENASE IN CYSTIC-FIBROSIS - ENZYME-KINETICS IN CULTURED FIBROBLASTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											SHAPIRO, BL (corresponding author), UNIV MINNESOTA,DEPT ORAL BIOL,HLTH SCI UNIT A,MINNEAPOLIS,MN 55455, USA.				NIA NIH HHS [1-R01-AG02114] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		DAVIS PB, 1980, PEDIATR RES, V14, P83, DOI 10.1203/00006450-198002000-00002; Di Sant'Agnese P A, 1976, N Engl J Med, V295, P481, DOI 10.1056/NEJM197608262950905; DISANTAGNESE PA, 1976, NEW ENGL J MED, V295, P534, DOI 10.1056/NEJM197609022951005; DISANTAGNESE PA, 1976, NEW ENGL J MED, V295, P597, DOI 10.1056/NEJM197609092951105; FEIGAL RJ, 1979, NATURE, V278, P276, DOI 10.1038/278276a0; FEIGAL RJ, 1979, PEDIATR RES, V13, P764, DOI 10.1203/00006450-197906000-00009; FEIGAL RJ, 1979, THESIS U MINNESOTA; HARRIS H, 1975, PRINCIPLES HUMAN BIO; Hatefi Y, 1978, Methods Enzymol, V53, P11; HUBSCHER G, 1965, NATURE, V205, P799, DOI 10.1038/205799a0; King T.E., 1967, METHOD ENZYMOL, V10, P322, DOI DOI 10.1016/0076-6879(67)10061-X; King T.E., 1967, METHOD ENZYMOL, V10, P275, DOI DOI 10.1016/0076-6879(67)10055-4; LAM LFH, 1979, LIFE SCI, V24, P2483, DOI 10.1016/0024-3205(79)90459-4; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MINIKAMI S, 1962, J BIOL CHEM, V237, P569; SHAPIRO BL, 1980, AM J HUM GENET, V32, pA54; SHAPIRO BL, 1979, P NATL ACAD SCI USA, V76, P2979, DOI 10.1073/pnas.76.6.2979; SHAPIRO BL, 1978, CLIN CHIM ACTA, V82, P125, DOI 10.1016/0009-8981(78)90035-9; SHAPIRO BL, 1979, SCIENCE, V203, P1251, DOI 10.1126/science.424752; SHAPIRO BL, 1980, PERSPECTIVES CYSTIC, P15; SHAPIRO BL, 1978, 1977 GAP C REP LAK P; STANBURY JB, 1978, METABOLIC BASIS INHE, P2	22	30	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	6					846	852						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PU211	7180843				2022-12-18	WOS:A1982PU21100003
J	COMINGS, DE; PEKKALA, A; SCHUH, JR; KUO, PC; CHAN, SI				COMINGS, DE; PEKKALA, A; SCHUH, JR; KUO, PC; CHAN, SI			HUNTINGTON DISEASE AND TOURETTE SYNDROME .1. ELECTRON-SPIN RESONANCE OF RED-BLOOD-CELL GHOSTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CALTECH,DIV CHEM & CHEM ENGN,PASADENA,CA 91125	California Institute of Technology	COMINGS, DE (corresponding author), CITY HOPE NATL MED CTR,DEPT MED GENET,DUARTE,CA 91010, USA.				NINDS NIH HHS [NS-14861] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABOOD ME, 1979, J NEUROSCI RES, V4, P183, DOI 10.1002/jnr.490040305; AMINOFF MJ, 1974, LANCET, V2, P1115; ARLETT CF, 1979, HEREDITY, V42, P276; ARLETT CF, 1980, LANCET, V1, P540; BARCHI RL, 1980, MUSCLE NERVE, V3, P82, DOI 10.1002/mus.880030109; BARKLEY DS, 1977, ANN NEUROL, V1, P426, DOI 10.1002/ana.410010505; Berliner Lj, 1976, SEELING SPIN LABELLI; BUTTERFIELD DA, 1974, BIOCHEMISTRY-US, V13, P5078, DOI 10.1021/bi00722a003; BUTTERFIELD DA, 1977, NATURE, V267, P453, DOI 10.1038/267453a0; BUTTERFIELD DA, 1978, ANN NEUROL, V4, P60, DOI 10.1002/ana.410040111; BUTTERFIELD DA, 1978, J SUPRAMOL STR CELL, V9, P125, DOI 10.1002/jss.400090112; BUTTERFIELD DA, 1974, P NATL ACAD SCI USA, V71, P909, DOI 10.1073/pnas.71.3.909; BUTTERFIELD DA, 1979, ADV NEUROL, V23, P397; CASSIMAN JJ, 1979, HUM GENET, V53, P75, DOI 10.1007/BF00289454; COMINGS DE, 1979, ADV NEUROL, V23, P335; GAFFNEY BJ, 1980, NEUROLOGY, V30, P272, DOI 10.1212/WNL.30.3.272; GOETZ I, 1975, NEW ENGL J MED, V293, P1225, DOI 10.1056/NEJM197512112932403; GOETZ I, 1979, ADV NEUROL, V23, P351; GRAY PN, 1979, J NEUROCHEM, V33, P985, DOI 10.1111/j.1471-4159.1979.tb05234.x; KIRK D, 1977, HUM GENET, V36, P143, DOI 10.1007/BF00273252; LEONARDI A, 1978, NEW ENGL J MED, V298, P632; MARKESBERY WR, 1977, BIOCHEM BIOPH RES CO, V78, P560, DOI 10.1016/0006-291X(77)90215-7; MCLEAN DR, 1977, LANCET, V1, P249; MENKES JH, 1977, ANN NEUROL, V1, P423, DOI 10.1002/ana.410010504; MENKES JH, 1973, NEW ENGL J MED, V288, P856; MOSHELL AN, 1980, LANCET, V1, P9; NORONHA ABC, 1979, ANN NEUROL, V6, P447, DOI 10.1002/ana.410060512; OMENN GS, 1978, NEUROLOGY, V28, P300, DOI 10.1212/WNL.28.3.300; PETTEGREW JW, 1979, NEW ENGL J MED, V300, P678; TOURIAN A, 1977, BIOCHEM BIOPH RES CO, V76, P345, DOI 10.1016/0006-291X(77)90731-8; WHERRETT JR, 1969, NEUROLOGY, V19, P489, DOI 10.1212/WNL.19.5.489; [No title captured]	32	30	30	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	2					166	174						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LH910	6259936				2022-12-18	WOS:A1981LH91000002
J	GOETZ, IE; ROBERTS, E; WARREN, J				GOETZ, IE; ROBERTS, E; WARREN, J			SKIN FIBROBLASTS IN HUNTINGTON DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											GOETZ, IE (corresponding author), CITY HOPE NATL MED CTR,DIV NEUROSCI,DUARTE,CA 91010, USA.				NINDS NIH HHS [NS12116, NS01615] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARKLEY DS, 1977, ANN NEUROL, V1, P426, DOI 10.1002/ana.410010505; CASSIMAN JJ, 1979, HUM GENET, V53, P75, DOI 10.1007/BF00289454; GOETZ I, 1975, NEW ENGL J MED, V293, P1225, DOI 10.1056/NEJM197512112932403; GOETZ I, 1979, ADV NEUROL, V23, P351; GRAY PN, 1979, J NEUROCHEM, V33, P985, DOI 10.1111/j.1471-4159.1979.tb05234.x; HARPER RA, 1979, SCIENCE, V204, P526, DOI 10.1126/science.432659; HOLLIDAY R, 1972, NATURE, V238, P26, DOI 10.1038/238026a0; HOUBEN A, 1978, NATURE, V275, P59, DOI 10.1038/275059a0; KELLEY RO, 1977, J ULTRA MOL STRUCT R, V59, P113, DOI 10.1016/S0022-5320(77)80033-6; KIRK D, 1977, HUM GENET, V36, P143, DOI 10.1007/BF00273252; LEONARDI A, 1978, NEW ENGL J MED, V298, P632; MENKES JH, 1977, ANN NEUROL, V1, P423, DOI 10.1002/ana.410010504; MENKES JH, 1973, NEW ENGL J MED, V288, P856; MILNE JA, 1972, INTRO DIAGNOSTIC HIS, P40; STANBRIDGE EJ, 1976, TISSUE CULTURE ASSOC, V2, P371; WILLMER EN, 1965, CELLS TISSUES CUL ED, V1, P147	16	30	30	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	2					187	196						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LH910	6452059				2022-12-18	WOS:A1981LH91000004
J	GREENBERG, DA				GREENBERG, DA			A SIMPLE METHOD FOR TESTING 2-LOCUS MODELS OF INHERITANCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											GREENBERG, DA (corresponding author), UNIV CALIF LOS ANGELES,HARBOR MED CTR,DEPT PEDIAT,DIV MED GENET,TORRANCE,CA 90509, USA.				NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [P01AM017328] Funding Source: NIH RePORTER; NIADDK NIH HHS [AM-17328] Funding Source: Medline	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CAHILL GF, GENETIC ANAL COMMON, P113; CARTWRIGHT GE, 1979, NEW ENGL J MED, V301, P175, DOI 10.1056/NEJM197907263010402; DEFRISEG.E, 1962, ACTA GENET STAT MED, V12, P65; ELSTON RC, 1978, ANNU REV BIOPHYS BIO, V7, P253, DOI 10.1146/annurev.bb.07.060178.001345; FRAZIER TM, 1960, AM J OBSTET GYNECOL, V80, P184; GOTTLIEB MS, 1968, DIABETES, V17, P693, DOI 10.2337/diab.17.11.693; GREENBERG DA, 1981, AM J MED GENET, V8, P205, DOI 10.1002/ajmg.1320080211; KRAVITZ K, 1979, AM J HUM GENET, V31, P601; MERRY A, 1979, ANN HUM GENET, V43, P71, DOI 10.1111/j.1469-1809.1979.tb01550.x; PENA AS, 1978, GASTROENTEROLOGY, V75, P230; ROTTER JI, 1978, GENETIC EPIDEMIOLOGY, P381; SCOTTEMUAKPOR AB, 1976, HUM HERED, V26, P198, DOI 10.1159/000152803; SIMON M, 1977, CLIN GENET, V11, P327; THOMSON G, 1980, ANN HUM GENET, V43, P383, DOI 10.1111/j.1469-1809.1980.tb01572.x; UTERMANN G, 1979, CLIN GENET, V15, P37; WALKER JT, 1961, ANN HUM GENET, V25, P65, DOI 10.1111/j.1469-1809.1961.tb01498.x	16	30	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	4					519	530						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LZ348	7258186				2022-12-18	WOS:A1981LZ34800003
J	HOOK, EB; CROSS, PK; LAMSON, SH; REGAL, RR; BAIRD, PA; UH, SH				HOOK, EB; CROSS, PK; LAMSON, SH; REGAL, RR; BAIRD, PA; UH, SH			PATERNAL AGE AND DOWN SYNDROME IN BRITISH-COLUMBIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNION UNIV ALBANY MED COLL,DEPT PEDIAT,ALBANY,NY 12208; SUNY ALBANY,DEPT MATH & STAT,ALBANY,NY 12222; UNIV BRITISH COLUMBIA,DEPT MED GENET,RECORD LINKAGE PROJECT,VANCOUVER V6T 1W5,BC,CANADA	Albany Medical College; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of British Columbia	HOOK, EB (corresponding author), NEW YORK STATE DEPT HLTH,INST BIRTH DEFECTS,DIV THEATRE ARTS,ALBANY,NY 12237, USA.							Bishop YMM, 1975, DISCRETE MULTIVARIAT, P125; Cohen BH, 1977, POPULATION CYTOGENET, P301; ERICKSON JD, 1979, AM J HUM GENET, V31, P489; ERICKSON JD, 1978, ANN HUM GENET, V41, P289, DOI 10.1111/j.1469-1809.1978.tb01896.x; HANSSON A, 1978, CYTOGENET CELL GENET, V20, P194, DOI 10.1159/000130851; HOOK EB, 1978, TERATOLOGY, V17, P223, DOI 10.1002/tera.1420170303; HOOK EB, 1978, AM J HUM GENET, V30, P19; HOOK EB, 1980, TRISOMY 21 DOWN SYND; Jenkins RL, 1933, AM J DIS CHILD, V45, P506; LILIENFELD A M, 1969, P145; LOWRY RB, 1975, CAN J PUBLIC HEALTH, V66, P322; LOWRY RB, 1976, TERATOLOGY, V14, P29, DOI 10.1002/tera.1420140105; MANTEL N, 1966, AM J MENT DEFIC, V71, P1025; MATSUNAGA E, 1978, HUM GENET, V40, P259, DOI 10.1007/BF00272186; Penrose LS, 1933, J GENET, V27, P219, DOI 10.1007/BF02984413; REGAL R, AM J EPIDEMIOL; SIGLER AT, 1967, J PEDIATR-US, V70, P608, DOI 10.1016/S0022-3476(67)80046-5; STENE J, 1977, ANN HUM GENET, V40, P299, DOI 10.1111/j.1469-1809.1977.tb00194.x	18	30	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	1					123	128						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LA930	6451171				2022-12-18	WOS:A1981LA93000014
J	MATSUMOTO, H; MIYAZAKI, T; OMOTO, K; MISAWA, S; HARADA, S; HIRAI, M; SUMPAICO, JS; MEDADO, PM; OGONUKI, H				MATSUMOTO, H; MIYAZAKI, T; OMOTO, K; MISAWA, S; HARADA, S; HIRAI, M; SUMPAICO, JS; MEDADO, PM; OGONUKI, H			POPULATION GENETIC-STUDIES OF THE PHILIPPINE NEGRITOS .2. GM AND KM ALLOTYPES OF 3 POPULATION GROUPS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TOKYO,FAC SCI,DEPT ANTHROPOL,TOKYO 113,JAPAN; UNIV TSUKUBA,INST COMMUNITY MED,DEPT LEGAL MED,TSUKUBA,JAPAN; NATL INST RADIOL SCI,DIV GENET,CHIBA 280,JAPAN; DEPT HLTH,BUR RES & LABS,MANILA,PHILIPPINES; JAPAN INT COOPERAT AGCY,MANILA,PHILIPPINES	University of Tokyo; University of Tsukuba; National Institutes for Quantum Science & Technology; Philippine Department Health	MATSUMOTO, H (corresponding author), OSAKA MED SCH,DEPT LEGAL MED,TAKATSUKI,OSAKA,JAPAN.							CURTAIN CC, 1971, AM J PHYS ANTHROPOL, V34, P257, DOI 10.1002/ajpa.1330340209; CURTAIN CC, 1972, AM J HUM GENET, V24, P145; FRASER GR, 1974, HUM HERED, V24, P435, DOI 10.1159/000152680; Howells, 1973, PACIFIC ISLANDERS; KURCZYNSKI TW, 1967, AM J HUM GENET, V19, P178; MARTENSS.L, 1966, VOX SANG, V11, P393, DOI 10.1111/j.1423-0410.1966.tb04237.x; MATSUMOTO H, 1972, JPN J HUM GENET, V17, P27; MATSUMOTO H, 1975, JPN J HUM GENET, V20, P201; MATSUMOTO H, 1977, J ANTHROPOL SOC NIP, V85, P265; MATSUMOTO H, 1975, JPN J HUM GENET, V20, P169; MATSUMOTO H, 1968, Japanese Journal of Human Genetics, V13, P10; OMOTO K, 1978, AM J HUM GENET, V30, P190; PIAZZA A, 1976, AM J HUM GENET, V28, P77; SCHANFIELD MS, 1973, AM J HUM GENET, V25, P567; SCHANFIELD MS, 1977, J HUM EVOL, V6, P341, DOI 10.1016/S0047-2484(77)80003-1; SNEDECOR GW, 1956, STATISTICAL METHODS; STEINBERG AG, 1975, AM J HUM GENET, V27, P528; STEINBERG AG, 1972, HUM HERED, V22, P254, DOI 10.1159/000152495; STEINBERG AG, 1972, AM J PHYS ANTHROPOL, V36, P77, DOI 10.1002/ajpa.1330360109; STEINBERG AG, 1969, ANNU REV GENET, V3, P25, DOI 10.1146/annurev.ge.03.120169.000325; STEINBERG AG, 1973, AM J PHYS ANTHROPOL, V39, P403, DOI 10.1002/ajpa.1330390308; STEINBERG AG, 1973, AM J PHYS ANTHROPOL, V38, P699, DOI 10.1002/ajpa.1330380307; VANLOGHEM E, 1971, ANN NY ACAD SCI, V190, P136	23	30	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	1					70	76						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	GR115	433923				2022-12-18	WOS:A1979GR11500009
J	MORTON, NE; LALOUEL, JM				MORTON, NE; LALOUEL, JM			GENETIC EPIDEMIOLOGY OF LESCH-NYHAN DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									UNIV HAWAII,POPULATION GENET LAB,HONOLULU,HI 96822	University of Hawaii System								BARRAI I, 1968, AM J HUM GENET, V20, P175; BIGGS R, 1976, LANCET, V2, P431; CRAWHALL JC, 1972, PEDIATR RES, V6, P504, DOI 10.1203/00006450-197205000-00004; FRANCKE V, 1976, AM J HUM GENET, V28, P123; HALDANE JBS, 1947, ANN EUGENIC, V13, P262; KELLEY WN, 1972, METABOLIC BASIS INHE, P969; KOSOWER D, 1962, AM J HUM GENET, V14, P159; MORTON NE, 1958, SCIENCE, V127, P79, DOI 10.1126/science.127.3289.79; MORTON NE, 1959, AM J HUM GENET, V11, P360; MORTON NE, 1969, COMPUTER APPLICATION, P129; ROSES AD, 1976, NEW ENGL J MED, V294, P193, DOI 10.1056/NEJM197601222940404; SCHAPIRA G, 1963, MUSCULAR DYSTROPHY M, P48; Seegmiller J E, 1976, Adv Hum Genet, V6, P75; THOMPSON MW, 1976, 5 INT C HUM GEN, P195; VOGEL F, 1975, ADV HUM GENET, V5, P223	15	30	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1977	29	3					304	307						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DG794	868879				2022-12-18	WOS:A1977DG79400012
J	CHILDS, B; GORDIS, L; KABACK, M; KAZAZIAN, HH				CHILDS, B; GORDIS, L; KABACK, M; KAZAZIAN, HH			TAY-SACHS SCREENING - MOTIVES FOR PARTICIPATING AND KNOWLEDGE OF GENETICS AND PROBABILITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHNS HOPKINS UNIV, SCH MED, DEPT PEDIAT, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH HYG & PUBL HLTH, DEPT EPIDEMIOL, BALTIMORE, MD 21205 USA; HARBOR GEN HOSP, DEPT PEDIAT, TORRANCE, CA 90509 USA	Johns Hopkins University; Johns Hopkins University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center								BECK E, 1974, NEW ENGL J MED, V291, P1166, DOI 10.1056/NEJM197411282912206; Becker M H, 1975, J Community Health, V1, P3, DOI 10.1007/BF01318939; CARTER CO, 1971, LANCET, V1, P281, DOI 10.1016/S0140-6736(71)91016-6; DAVIES CM, 1965, CHILD DEV, V36, P779, DOI 10.1111/j.1467-8624.1965.tb05338.x; KABACK MM, 1974, PROG MED GENET, V10, P103; KABACK MM, 1974, DIMENSIONS SCREENING; Murphy EA, 1975, PRINCIPLES GENETIC C; PEARN JH, 1973, J MED GENET, V10, P129, DOI 10.1136/jmg.10.2.129; ROSENSTOCK IM, 1966, MILBANK FUND Q, V44, P94, DOI 10.2307/3348967; ROSENSTOCK IM, 1975, GENETIC SCREENING ST	10	30	30	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1976	28	6					537	549						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	CQ152	1008060				2022-12-18	WOS:A1976CQ15200001
J	SCOTTEMUAKPOR, AB				SCOTTEMUAKPOR, AB			MUTATION LOAD IN AN AFRICAN POPULATION .1. ANALYSIS OF CONSANGUINEOUS MARRIAGES IN NIGERIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV IBADAN,DEPT ZOOL,IBADAN,NIGERIA; UNIV IBADAN,DEPT CHEM PATHOL,IBADAN,NIGERIA	University of Ibadan; University of Ibadan								BEMISS SM, 1858, T AM MED ASS, V11, P319; BOOK JA, 1957, ANN HUM GENET, V21, P191; FREIREMAIA N, 1963, ACTA GENET STAT MED, V13, P199; FREIREMAIA N, 1971, AM J HUM GENET, V23, P1; FREIREMAIA N, 1963, HUM HERED, V13, P185; Mitchell Arthur, 1865, Edinb Med J, V10, P894; Mitchell Arthur, 1865, Edinb Med J, V10, P781; Mitchell Arthur, 1865, Edinb Med J, V10, P1074; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; PENROSE LS, 1957, ANN HUM GENET, V21, P222, DOI 10.1111/j.1469-1809.1972.tb00283.x; Schull WJ, 1965, EFFECTS INBREEDING J; SLATIS HM, 1958, AM J HUM GENET, V10, P446; SLATIS HM, 1954, AM J HUM GENET, V6, P412; Sutter J, 1952, POPULATION, V7, P249, DOI 10.2307/1524207	14	30	30	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1974	26	6					674	682						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V0911	4474815				2022-12-18	WOS:A1974V091100002
J	NUTE, PE; PATARYAS, HA; STAMATOY.G				NUTE, PE; PATARYAS, HA; STAMATOY.G			GGAMMA AND AGAMMA HEMOGLOBIN CHAINS DURING HUMAN FETAL DEVELOPMENT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WASHINGTON,DEPT MED,DIV MED GENET,SEATTLE,WA 98195; UNIV WASHINGTON,REG PRIMATE RES CTR,SEATTLE,WA 98195	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle								HUISMAN THJ, 1971, NEW ENGL J MED, V285, P711, DOI 10.1056/NEJM197109232851303; HUISMAN THJ, 1969, ANN NY ACAD SCI, V165, P320, DOI 10.1111/j.1749-6632.1969.tb27802.x; KABAT D, 1972, SCIENCE, V175, P134, DOI 10.1126/science.175.4018.134; Patten B M, 1953, HUMAN EMBRYOLOGY, V2; Rossi-Fanelli A., 1958, BIOCHIM BIOPHYS ACTA, V30, P608; SCHROEDER W A, 1970, P249; SCHROEDER WA, 1963, BIOCHEMISTRY-US, V2, P992, DOI 10.1021/bi00905a016; SCHROEDER WA, 1972, NATURE-NEW BIOL, V240, P273, DOI 10.1038/newbio240273a0; SCHROEDER WA, 1970, AM J HUM GENET, V22, P505; SCHROEDER WA, 1968, P NATL ACAD SCI USA, V60, P537, DOI 10.1073/pnas.60.2.537; STAMATOYANNOPOULOS G, 1971, BRIT J HAEMATOL, V21, P633, DOI 10.1111/j.1365-2141.1971.tb02726.x	11	30	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1973	25	3					271	276						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	P9182	4735813				2022-12-18	WOS:A1973P918200006
J	CHEN, SH; GIBLETT, ER				CHEN, SH; GIBLETT, ER			PHOSPHOGLYCERATE KINASE - ADDITIONAL VARIANTS AND THEIR GEOGRAPHIC DISTRIBUTION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter																		CHEN SH, 1971, AM J HUM GENET, V23, P87	1	30	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1972	24	2					229	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M2541	5016513				2022-12-18	WOS:A1972M254100011
J	CROW, JF; KIMURA, M				CROW, JF; KIMURA, M			EFFECTIVE NUMBER OF A POPULATION WITH OVERLAPPING GENERATIONS - CORRECTION AND FURTHER DISCUSSION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		COCKERHAM CC, 1969, EVOLUTION, V23, P72, DOI 10.1111/j.1558-5646.1969.tb03496.x; Crow J.F., 1954, STAT MATH BIOL, P543; CROW JF, 1955, EVOLUTION, V9, P202, DOI 10.2307/2405589; Ewens W.J., 1969, POPULATION GENETICS; FELSENSTEIN J, 1971, GENETICS, V68, P581; FELSENSTEIN J, 1969, GENETICS           S, V61, P18; Fisher R., 1930, GENETICAL THEORY NAT; KIMURA M, 1963, EVOLUTION, V17, P279, DOI 10.2307/2406157; MACCLUER JW, 1970, AM J HUM GENET, V22, P176; MORAN PAP, 1962, STATISTICAL PROCESSE; NEI M, 1966, GENET RES, V8, P257, DOI 10.1017/S0016672300010119; NEI M, 1966, HEREDITY, V21, P183, DOI 10.1038/hdy.1966.17; NEI M, 1970, American Journal of Human Genetics, V22, P694; NEI M, 1966, HEREDITY, V21, P344; WATTERSON G. A., 1964, J. appl. Prob., V1, P233, DOI 10.2307/3211857; Wright S, 1931, GENETICS, V16, P0097; WRIGHT S, 1939, ACTUAL SCI IND, V13, P5	17	30	30	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1972	24	1					1	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	L6958	5012689				2022-12-18	WOS:A1972L695800001
J	MYRIANTHOPOULOS, NC; ARONSON, SM; NAYLOR, AF				MYRIANTHOPOULOS, NC; ARONSON, SM; NAYLOR, AF			FOUNDER EFFECT IN TAY-SACHS DISEASE UNLIKELY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		CHASE GA, 1972, AM J HUM GENET, V24, P339; LI CC, 1955, POPULATION GENETICS, P252; MYRIANTHOPOULOS NC, 1966, AM J HUM GENET, V18, P313; MYRIANTHOPOULOS NC, 1972, 4 P INT S SPHING NEW	4	30	30	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1972	24	3					341	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M6948	5028972				2022-12-18	WOS:A1972M694800015
J	YAMAGUCHI, M; YANASE, T; NAGANO, H; NAKAMOTO, N				YAMAGUCHI, M; YANASE, T; NAGANO, H; NAKAMOTO, N			EFFECTS OF INBREEDING ON MORTALITY IN FUKUOKA POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		CROW JF, 1958, AM ANTHROPOL, V60, P1; CROW JF, 1963, AM J HUM GENET, V15, P310; ITOH K, 1966, ACADEMIA, V54, P25; KUDO A, 1964, B MATH STAT, V11, P63; LI CC, 1963, AM J HUM GENET, V15, P316; MORTON NE, 1960, AM J HUM GENET, V12, P348; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; SANGHVI LD, 1963, AM J HUM GENET, V15, P298; YANASE T, 1962, P UN WHO SEMINAR USE, P119; YANASE TOSHIYUKI, 1965, JAP J HUM GENET, V10, P60	10	30	30	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1970	22	2					145	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	F9213	5461628				2022-12-18	WOS:A1970F921300003
J	SHAW, MW; CRAIG, AP; RICCIUTI, FC				SHAW, MW; CRAIG, AP; RICCIUTI, FC			RANDOM ASSOCIATION OF HUMAN ACROCENTRIC CHROMOSOMES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BACK F, 1967, LANCET, V1, P1228; BLOOM GE, 1967, 1967 ANN M AM SOC HU; COHEN MM, 1967, ANN HUM GENET, V31, P129, DOI 10.1111/j.1469-1809.1967.tb00544.x; HECHT F, 1968, SCIENCE, V161, P371, DOI 10.1126/science.161.3839.371; OHNO S, 1961, LANCET, V2, P123; 1966, CHICAGO C STANDARD 2, P10	6	30	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1969	21	5					513	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	E7549	5822292				2022-12-18	WOS:A1969E754900009
J	BOYER, SH; CROSBY, EF; FULLER, GF; ULENURM, L; BUCK, AA				BOYER, SH; CROSBY, EF; FULLER, GF; ULENURM, L; BUCK, AA			A SURVEY OF HEMOGLOBINS IN REPUBLIC OF CHAD AND CHARACTERIZATION OF HEMOGLOBIN CHAD-ALPHA23-2GLU-]LYS BETA2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BOYER SH, 1967, J BIOL CHEM, V242, P2211; BOYER SH, 1963, AM J HUM GENET, V15, P438; BUCK AA, 1968, COMPREHENSIVE EPIDEM; CLEGG JB, 1966, J MOL BIOL, V19, P91, DOI 10.1016/S0022-2836(66)80052-9; HILL RJ, 1962, J BIOL CHEM, V237, P3151; HUISMAN THJ, 1965, J CHROMATOGR, V19, P160, DOI 10.1016/S0021-9673(01)99434-8; MARDER VJ, 1959, B JOHNS HOPKINS HOSP, V105, P77; WEATHERALL DJ, 1962, B JOHNS HOPKINS HOSP, V110, P8	8	30	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1968	20	6					570	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	C8180	5714528				2022-12-18	WOS:A1968C818000008
J	SALZANO, FM; SUTTON, HE				SALZANO, FM; SUTTON, HE			HAPTOGLOBIN AND TRANSFERRIN TYPES OF INDIANS FROM SANTA CATARINA BRAZIL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article													Salzano, Francisco M/L-7916-2015					ARENDS T, 1962, 8 P C INT SOC BLOOD, P379; ARENDS T, 1964, 9 P C INT SOC BLOOD, P463; BLUMBERG BS, 1959, ANN HUM GENET, V23, P349, DOI 10.1111/j.1469-1809.1959.tb01478.x; CEPPELLINI R, 1955, ANN HUM GENET, V20, P97; FLORY LL, 1963, NATURE, V107, P577; GIBLETT E. R., 1962, PROGR MED GENET, V2, P34; GIBLETT ER, 1961, NATURE, V192, P1300, DOI 10.1038/1921300a0; GUERIOS RFM, 1945, ARQ MUSEU PARANAENSE, V4, P321; KIRK RL, 1964, WENNERGREN S BIOLOGY; MATSON GA, 1963, HUM BIOL, V35, P474; MATSON GA, IN PRESS; Mayr E., 1963, ANIMAL SPECIES EVOLU; NAGEL R, 1963, NATURE, V197, P187, DOI 10.1038/197187a0; NEEL JV, 1964, AM J HUM GENET, V16, P52; PARKER WC, 1961, ANN HUM GENET, V25, P227; PARKER WC, 1961, SCIENCE, V134, P106, DOI 10.1126/science.134.3472.106; PERSSON I, 1962, ACTA GENET STAT MED, V12, P292; PERSSON I, 1962, ACTA GENET STAT MED, V12, P41; SALZANO FM, 1964, ACTA GENET MED GEMEL, V13, P278, DOI 10.1017/S1120962300015596; SALZANO FM, 1964, AM J PHYS ANTHROPOL, V22, P91, DOI 10.1002/ajpa.1330220120; SALZANO FM, 1964, AM J HUM GENET, V16, P301; SALZANO FM, 1963, ACTA GENET STAT MED, V13, P1; SALZANO FM, 1964, ACTA GENET STAT MED, V14, P212; SALZANO FM, 1965, AM J HUM GENET, V17, P273; SUTTON H E, 1959, Ann Hum Genet, V23, P175; SUTTON HE, 1960, AM J HUM GENET, V12, P338; TONDO CV, 1963, ANN HUM GENET, V26, P325, DOI 10.1111/j.1469-1809.1963.tb01329.x; [No title captured]	28	30	31	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1965	17	3					280	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	65219	14295496				2022-12-18	WOS:A19656521900008
J	LYNCH, HT; HARLAN, WL				LYNCH, HT; HARLAN, WL			HEREDITARY FACTORS IN ADIPOSIS DOLOROSA (DERCUMS DISEASE)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		DERCUM FX, 1892, AM J MED SCI, V104, P521; Gates Reginald Ruggles, 1946, HUMAN GENETICS; KEUSCH M, 1936, CLUJ MED, V17, P155; McNUTT WALLACE, 1960, TEXAS REPT BIOL AND MED, V18, P222; STEIGER WA, 1952, NEW ENGL J MED, V247, P393, DOI 10.1056/NEJM195209112471104; Winkelman NW, 1925, J AMER MED ASSOC, V85, P1935, DOI 10.1001/jama.1925.02670250009003	6	30	31	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1963	15	2					184	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2970A	17948485				2022-12-18	WOS:A19632970A00005
J	KUDO, A				KUDO, A			A METHOD FOR CALCULATING INBREEDING COEFFICIENT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Malecot G, 1948, MATH HEREDITE; Neel JV, 1954, HUMAN HEREDITY; WRIGHT S, 1951, ANN EUGENIC, V15, P323	3	30	30	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1962	14	4					426	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2965A	13927306				2022-12-18	WOS:A19622965A00004
J	COTTERMAN, CW				COTTERMAN, CW			REGULAR 2-ALLELE AND 3-ALLELE PHENOTYPE SYSTEMS .1.	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Boye CL, 1941, J GENET, V42, P191, DOI 10.1007/BF02982516; COTTERMAN CW, 1951, AM J HUM GENET, V3, P362; Crow J. F., 1952, Heterosis., P282; DAVIS RL, 1953, P AM MATH SOC, V4, P486, DOI 10.2307/2032159; FELLER W, 1950, INTRO PROBABILITY TH, P419; FISHER RA, 1943, STAT TABLES BIOL AGR, P98; GREEN MM, 1952, P NATL ACAD SCI USA, V38, P300, DOI 10.1073/pnas.38.4.300; Haldane JBS, 1942, ANN EUGEN, V11, P333; ITANO HA, 1953, AM J HUM GENET, V5, P34; LANDAU H. G., 1951, BULL MATH BIOPHYS, V13, P1, DOI 10.1007/BF02478336; LEDERMANN W, 1949, INTRO THEORY FINITE, P152; PENROSE LS, 1946, ANN EUGENIC, V13, P141, DOI 10.1111/j.1469-1809.1946.tb02350.x; RACE RR, 1950, BLOOD GROUPS MAN, P250; SRB AM, 1952, GENERAL GENETICS, P561; Stern C, 1943, P NATL ACAD SCI USA, V29, P361, DOI 10.1073/pnas.29.11.361; Whiting PW, 1940, J MORPHOL, V66, P323, DOI 10.1002/jmor.1050660208; WOODGER JH, 1937, AXIOMATIC METHOD BIO, P174	17	30	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1953	5	3					193	235						43	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XW631	13080248				2022-12-18	WOS:A1953XW63100001
J	UCHIDA, IA				UCHIDA, IA			POSSIBLE GENETIC FACTORS IN THE ETIOLOGY OF RHEUMATIC FEVER	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BEERS CV, 1948, HEREDITAS LUND, V35, P534; DRAPER G, 1923, EUGEN NEWS, V8, P63; Faulkner JM, 1924, J AMER MED ASSOC, V83, P425, DOI 10.1001/jama.1924.02660060029010; FINNEY DJ, 1949, ANN EUGENIC, V14, P319; GARDINER JH, 1951, PEDIATRICS, V7, P713; GRIFFITH GC, 1948, AM HEART J, V35, P438, DOI 10.1016/0002-8703(48)90119-7; Haldane JBS, 1932, J GENET, V25, P251, DOI 10.1007/BF02983257; Haldane JBS, 1938, ANN EUGENIC, V8, P255, DOI 10.1111/j.1469-1809.1938.tb02179.x; Hedley OF, 1940, PUBLIC HEALTH REP, V55, P1647, DOI 10.2307/4583440; Hedley OF, 1940, PUBLIC HEALTH REP, V55, P1707, DOI 10.2307/4583446; Pickles W., 1943, LANCET, V2, P241; PRIBRAM A, 1899, AKUTE GELENKRHEUMATI; WEITZ W, 1936, VERERBUNG INNERER KR; WILSON M, 1940, RHEUMATIC FEVER; Wilson MG, 1943, J PEDIATR-US, V22, P581, DOI 10.1016/S0022-3476(43)80027-5; Wilson MG, 1937, J CLIN INVEST, V16, P555, DOI 10.1172/JCI100882; Wilson MG, 1943, J PEDIATR-US, V22, P468, DOI 10.1016/S0022-3476(43)80097-4; 1934, P R SOC M LOND, V27, P953; 1949, GUIDE FAMILY SPENDIN	19	30	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1953	5	1					61	69						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XW629	13050610				2022-12-18	WOS:A1953XW62900005
J	RICHTER, RB				RICHTER, RB			LATE CORTICAL CEREBELLAR ATROPHY - A FORM OF HEREDITARY CEREBELLAR ATAXIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Akelaitis AJ, 1938, AM J PSYCHIAT, V94, P1115, DOI 10.1176/ajp.94.5.1115; Archambault L, 1918, J NERV MENT DIS, V48, P273, DOI 10.1097/00005053-191810000-00001; BELL J, 1939, TREASURY HUMAN INHER, V4; Brodal A, 1940, Z GESAMTE NEUROL PSY, V169, P1, DOI 10.1007/BF02871362; Brun R, 1917, SCHWEIZ ARCH NEUROL, V1, P61; Brun R, 1918, SCHWEIZ ARCH NEUROL, V2, P48; BUCHANAN AR, 1947, J NEUROPATH EXP NEUR, V6, P152, DOI 10.1097/00005072-194704000-00004; COURVILLE CB, 1940, B LOS ANGELES NEUROL, V5, P171; DEHAENE A., 1937, JOUR BELGE DE NEUROLOGIE ET PSYCHIATRIE, V37, P427; Demole V., 1927, Schweizer Archiv fuer Neurologie und Psychiatrie Zurich, V20, P271; DEMOLE V, 1927, SCHWEIZ ARCH NEUROL, V21, P73; Dow RS, 1942, BIOL REV CAMB PHILOS, V17, P179, DOI 10.1111/j.1469-185X.1942.tb00437.x; GUILLAIN J, 1931, REV NEUR PAR, V50, P565; Hall B, 1941, BRAIN, V64, P178, DOI 10.1093/brain/64.2-3.178; Hanel H, 1915, J PSYCHOL NEUROL, V21, P385; Hassin GB, 1934, ARCH NEURO PSYCHIATR, V31, P1205, DOI 10.1001/archneurpsyc.1934.02250060091006; Holmes G, 1908, BRAIN, V31, P125, DOI 10.1093/brain/31.1.125; Ingvar S, 1928, B JOHNS HOPKINS HOSP, V43, P315; KEILLER W, 1926, SOUTH MED J, V19, P518; KIRSCHBAUM W, 1932, DTSCH Z NERVENH, V125, P21; Larsell O, 1937, ARCH NEURO PSYCHIATR, V38, P580, DOI 10.1001/archneurpsyc.1937.02260210146011; LEY RA, 1925, J BELG NEUROL PSYCH, V25, P92; LICHTENSTEIN BW, 1946, J NEUROPATH EXP NEUR, V5, P29, DOI 10.1097/00005072-194601000-00003; Marie P., 1922, REV NEUROL-FRANCE, V38, P1082; Marie P, 1922, REV NEUROL, V38, P849; Parker HL, 1933, BRAIN, V56, P191, DOI 10.1093/brain/56.2.191; Richter R, 1940, J NERV MENT DIS, V91, P37, DOI 10.1097/00005053-194001000-00004; ROSSI I, 1907, NOUV ICONOGR SALPET, V20, P66; Scherer HJ, 1933, Z GESAMTE NEUROL PSY, V145, P406, DOI 10.1007/BF02865876; Scherer HJ, 1933, Z GESAMTE NEUROL PSY, V145, P335, DOI 10.1007/BF02865875; STENDER A, 1931, DTSCH Z NERVENH, V119, P604; THOMAS A, 1905, REV NEUROL PARIS, V13, P917; Thorpe FT, 1935, BRAIN, V58, P97, DOI 10.1093/brain/58.1.97; VAN BOGAERT L, 1947, J Belge Neurol Psychiatr, V47, P268; VONSTAUFFENBERG, 1918, Z GES NEUR PSYCHIAT, V39, P1; Weber FP, 1942, BRAIN, V65, P220, DOI 10.1093/brain/65.2.220; Zulch KJ, 1936, Z GESAMTE NEUROL PSY, V156, P493, DOI 10.1007/BF02870813	37	30	30	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1950	2	1					1	29						29	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XS388	15425502				2022-12-18	WOS:A1950XS38800001
J	Roman, TS; Crowley, SB; Roche, MI; Foreman, AKM; O'Daniel, JM; Seifert, BA; Lee, K; Brandt, A; Gustafson, C; DeCristo, DM; Strande, NT; Ramkissoon, L; Milko, LV; Owen, P; Roy, S; Xiong, M; Paquin, RS; Butterfield, RM; Lewis, MA; Souris, KJ; Bailey, DB; Rini, C; Booker, JK; Powell, BC; Weck, KE; Powell, CM; Berg, JS				Roman, Tamara S.; Crowley, Stephanie B.; Roche, Myra, I; Foreman, Ann Katherine M.; O'Daniel, Julianne M.; Seifert, Bryce A.; Lee, Kristy; Brandt, Alicia; Gustafson, Chelsea; DeCristo, Daniela M.; Strande, Natasha T.; Ramkissoon, Lori; Milko, Laura, V; Owen, Phillips; Roy, Sayanty; Xiong, Mai; Paquin, Ryan S.; Butterfield, Rita M.; Lewis, Megan A.; Souris, Katherine J.; Bailey, Donald B., Jr.; Rini, Christine; Booker, Jessica K.; Powell, Bradford C.; Weck, Karen E.; Powell, Cynthia M.; Berg, Jonathan S.			Genomic Sequencing for Newborn Screening: Results of the NC NEXUS Project	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYRUP-URINE-DISEASE; GENOTYPE-PHENOTYPE CORRELATION; PRIMARY CARNITINE DEFICIENCY; MALONYL-COA DECARBOXYLASE; RECEPTOR GENE-MUTATIONS; BREAST-CANCER PATIENTS; SYNDROMIC HEARING-LOSS; GERMLINE MUTATIONS; MISSENSE MUTATIONS; CYSTIC-FIBROSIS	Newborn screening (NBS) was established as a public health program in the 1960s and is crucial for facilitating detection of certain medical conditions in which early intervention can prevent serious, life-threatening health problems. Genomic sequencing can potentially expand the screening for rare hereditary disorders, but many questions surround its possible use for this purpose. We examined the use of exome sequencing (ES) for NBS in the North Carolina Newborn Exome Sequencing for Universal Screening (NC NEXUS) project, comparing the yield from ES used in a screening versus a diagnostic context. We enrolled healthy newborns and children with metabolic diseases or hearing loss (106 participants total). ES confirmed the participant's underlying diagnosis in 15 out of 17 (88%) children with metabolic disorders and in 5 out of 28 (similar to 18%) children with hearing loss. We discovered actionable findings in four participants that would not have been detected by standard NBS. A subset of parents was eligible to receive additional information for their child about childhood-onset conditions with low or no clinical actionability, clinically actionable adult-onset conditions, and carrier status for autosomal-recessive conditions. We found pathogenic variants associated with hereditary breast and/or ovarian cancer in two children, a likely pathogenic variant in the gene associated with Lowe syndrome in one child, and an average of 1.8 reportable variants per child for carrier results. These results highlight the benefits and limitations of using genomic sequencing for NBS and the challenges of using such technology in future precision medicine approaches.	[Roman, Tamara S.; Crowley, Stephanie B.; Roche, Myra, I; Foreman, Ann Katherine M.; O'Daniel, Julianne M.; Seifert, Bryce A.; Lee, Kristy; Brandt, Alicia; Gustafson, Chelsea; DeCristo, Daniela M.; Milko, Laura, V; Booker, Jessica K.; Powell, Bradford C.; Weck, Karen E.; Powell, Cynthia M.; Berg, Jonathan S.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Roche, Myra, I; Powell, Cynthia M.] Univ N Carolina, Dept Pediat, Sch Med, Chapel Hill, NC 27599 USA; [Strande, Natasha T.; Ramkissoon, Lori; Roy, Sayanty; Xiong, Mai; Booker, Jessica K.; Weck, Karen E.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Owen, Phillips] Renaissance Comp Inst, Chapel Hill, NC 27517 USA; [Paquin, Ryan S.; Lewis, Megan A.] RTI Int, Ctr Commun Sci, Res Triangle Pk, NC 27709 USA; [Butterfield, Rita M.] Duke Univ, Dept Family Med & Community Hlth, Sch Med, Durham, NC 27705 USA; [Souris, Katherine J.] Univ N Carolina, Dept Hlth Behav, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA; [Bailey, Donald B., Jr.] RTI Int, Genom Bioinformat & Translat Res Ctr, Res Triangle Pk, NC 27709 USA; [Rini, Christine] Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, Chicago, IL 60611 USA; [Rini, Christine] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Research Triangle Institute; Duke University; University of North Carolina; University of North Carolina Chapel Hill; Research Triangle Institute; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Berg, JS (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA.	jonathan_berg@med.unc.edu	Facility, Biospecimen Processing/AAC-7837-2022; Seifert, Bryce/R-6071-2019; Souris, Katherine/ABI-7531-2020; Souris, Katherine/ABI-7526-2020	Seifert, Bryce/0000-0001-7970-3611; Souris, Katherine/0000-0003-3936-7339; Rini, Christine/0000-0002-3169-3626; Strande, Natasha/0000-0001-5148-9772; Roman, Tamara/0000-0003-1056-5294; Lewis, Megan/0000-0002-1670-9298; Bailey, Donald/0000-0002-0513-9330	National Human Genome Research Institute; Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health [U19 HD077632]	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank the families who participated in the study. This work was funded by the National Human Genome Research Institute and the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health as part of the Newborn Sequencing in Genomic Medicine and Public Health (NSIGHT) Program, U19 HD077632. We gratefully acknowledge the UNC BioSpecimen Processing Facility and the UNC High-Throughput Sequencing Facility for their work in DNA extraction, sample preparation and exome sequencing, and Manyu Li and the UNC Hospitals Clinical Molecular Genetics Laboratory. We also thank Jason Reilly, Ian Wilhelmsen, Kirk Wilhelmsen, Dylan Young, and the Renaissance Computing Institute (RENCI) at UNC for bioinformatics analysis and expertise; Alexandra Arreola and Claire Edgerly for contributions to molecular analysis; and Lonna Mollison and Kathleen Wallace for their contributions to curating the NGS-NBS and additional findings gene lists.	Ahn SH, 2007, CANCER LETT, V245, P90, DOI 10.1016/j.canlet.2005.12.031; Albers CA, 2012, NAT GENET, V44, P435, DOI 10.1038/ng.1083; Alford RL, 2014, GENET MED, V16, P347, DOI 10.1038/gim.2014.2; Andresen BS, 2001, AM J HUM GENET, V68, P1408, DOI 10.1086/320602; Bassaganyas L, 2018, HUM MUTAT, V39, P167, DOI 10.1002/humu.23356; Berg JS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2252; Bonnet C, 2016, EUR J HUM GENET, V24, P1730, DOI 10.1038/ejhg.2016.99; Bottillo Irene, 2013, BMC Res Notes, V6, P376, DOI 10.1186/1756-0500-6-376; Burwinkel B, 1999, BIOCHEM BIOPH RES CO, V261, P484, DOI 10.1006/bbrc.1999.1060; Carney AE, 2009, HUM MOL GENET, V18, P1624, DOI 10.1093/hmg/ddp080; Carrasquillo MM, 1997, HUM MOL GENET, V6, P2163, DOI 10.1093/hmg/6.12.2163; Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P1012; Ceyhan-Birsoy O, 2019, AM J HUM GENET, V104, P76, DOI 10.1016/j.ajhg.2018.11.016; Chaoui A, 2011, HUM MUTAT, V32, P1436, DOI 10.1002/humu.21583; Chapel-Crespo C, 2019, MOL GENET METAB, V128, P113, DOI 10.1016/j.ymgme.2019.07.015; Chattaraj P, 2017, J MED GENET, V54, P665, DOI 10.1136/jmedgenet-2017-104721; Choi BY, 2009, HUM MUTAT, V30, P599, DOI 10.1002/humu.20884; Choi DH, 2004, J CLIN ONCOL, V22, P1638, DOI 10.1200/JCO.2004.04.179; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Civeira F, 2008, J AM COLL CARDIOL, V52, P1546, DOI 10.1016/j.jacc.2008.06.050; Coyle B, 1998, HUM MOL GENET, V7, P1105, DOI 10.1093/hmg/7.7.1105; D'Andrea P, 2002, BIOCHEM BIOPH RES CO, V296, P685, DOI 10.1016/S0006-291X(02)00891-4; Day INM, 1997, HUM MUTAT, V10, P116; DiStefano MT, 2019, GENET MED, V21, P2239, DOI 10.1038/s41436-019-0487-0; Duman D, 2011, GENET TEST MOL BIOMA, V15, P29, DOI 10.1089/gtmb.2010.0120; Esteban J, 2017, HAEMOPHILIA, V23, pE488, DOI 10.1111/hae.13356; Etxebarria A, 2015, ATHEROSCLEROSIS, V238, P304, DOI 10.1016/j.atherosclerosis.2014.12.026; FISHER CR, 1991, J CLIN INVEST, V88, P1034, DOI 10.1172/JCI115363; FitzPatrick DR, 1999, AM J HUM GENET, V65, P318, DOI 10.1086/302492; Frazier DM, 2006, J INHERIT METAB DIS, V29, P76, DOI 10.1007/s10545-006-0228-9; FRIDOVICHKEIL JL, 1995, AM J HUM GENET, V56, P640; Froese DS, 2013, STRUCTURE, V21, P1182, DOI 10.1016/j.str.2013.05.001; Gao JM, 1999, J LIPID RES, V40, P178; Garrison E., 2012, ARXIV12073907QBIO; GREGERSEN N, 1991, HUM GENET, V86, P545; GUTHRIE R, 1963, PEDIATRICS, V32, P338; Hammett-Stabler C.A., 2010, CLIN APPL MASS SPECT; Han SH, 2006, CLIN GENET, V70, P496, DOI 10.1111/j.1399-0004.2006.00717.x; Heuser A, 2006, AM J HUM GENET, V79, P1081, DOI 10.1086/509044; Hichri H, 2011, HUM MUTAT, V32, P379, DOI 10.1002/humu.21391; Hildebrand MS, 2011, HUM MUTAT, V32, P825, DOI 10.1002/humu.21512; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; Kim H, 2012, BREAST CANCER RES TR, V134, P1315, DOI 10.1007/s10549-012-2159-5; Kim Hyun-Kyung, 2014, Korean J Pediatr, V57, P140, DOI 10.3345/kjp.2014.57.3.140; Kingsmore SF, 2019, AM J HUM GENET, V105, P719, DOI 10.1016/j.ajhg.2019.08.009; Korver AMH, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2016.94; Kozak L, 1999, J MED GENET, V36, P576; Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153; Laurie AD, 2004, ATHEROSCLEROSIS SUPP, V5, P13, DOI 10.1016/j.atherosclerosissup.2004.09.001; Lee NC, 2010, MOL GENET METAB, V100, P46, DOI 10.1016/j.ymgme.2009.12.015; Lee WK, 1998, J MED GENET, V35, P573, DOI 10.1136/jmg.35.7.573; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lewis MA, 2018, GENET MED, V20, P181, DOI 10.1038/gim.2017.93; Lewis MA, 2016, PEDIATRICS, V137, pS16, DOI 10.1542/peds.2015-3731E; Lhota F, 2016, CLIN GENET, V90, P324, DOI 10.1111/cge.12748; Li FY, 2010, HUM MUTAT, V31, pE1632, DOI 10.1002/humu.21311; Li H., 2013, ARXIV, DOI DOI 10.48550/ARXIV.1303.3997; Lim MC, 2009, J CANCER RES CLIN, V135, P1593, DOI 10.1007/s00432-009-0607-3; Love-Gregory LD, 2002, MOL GENET METAB, V75, P79, DOI 10.1006/mgme.2001.3264; Machini K, 2019, AM J HUM GENET, V105, P177, DOI 10.1016/j.ajhg.2019.05.017; Maier EM, 2005, HUM MUTAT, V25, P443, DOI 10.1002/humu.20163; MATSUDA I, 1990, BIOCHEM BIOPH RES CO, V172, P646, DOI 10.1016/0006-291X(90)90723-Z; Milko LV, 2019, J PEDIATR-US, V209, P68, DOI 10.1016/j.jpeds.2018.12.027; Milko LV, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2686-4; Mitchell M, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9439; Morell RJ, 1998, NEW ENGL J MED, V339, P1500, DOI 10.1056/NEJM199811193392103; Moteki H, 2012, J HUM GENET, V57, P587, DOI 10.1038/jhg.2012.73; Myers JH, 1996, AM J EMERG MED, V14, P553, DOI 10.1016/S0735-6757(96)90097-2; NELSON PV, 1991, HUM GENET, V86, P391; OROZCO L, 1994, AM J MED GENET, V51, P137, DOI 10.1002/ajmg.1320510210; Oza AM, 2018, HUM MUTAT, V39, P1593, DOI 10.1002/humu.23630; Paquin RS, 2021, SOC SCI MED, V271, DOI 10.1016/j.socscimed.2018.11.017; Pedersen P, 2009, ANN HEMATOL, V88, P775, DOI 10.1007/s00277-008-0679-1; Petersen MB, 2002, CLIN GENET, V62, P1, DOI 10.1034/j.1399-0004.2002.620101.x; Petit C, 2001, ANNU REV GENET, V35, P589, DOI 10.1146/annurev.genet.35.102401.091224; Pike GN, 2016, HAEMOPHILIA, V22, P403, DOI 10.1111/hae.12846; Porter KM, 2018, MOL GENET GENOM MED, V6, P898, DOI 10.1002/mgg3.453; Punj S, 2018, AM J HUM GENET, V102, P1078, DOI 10.1016/j.ajhg.2018.04.004; Pyhtila BM, 2015, JIMD REP, V15, P79, DOI 10.1007/8904_2014_302; Rehm HL, 1999, GENET MED, V1, P295; REICHARDT JKV, 1991, AM J HUM GENET, V49, P860; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rose EC, 2012, HUM MUTAT, V33, P118, DOI 10.1002/humu.21607; Sacksteder KA, 1999, J BIOL CHEM, V274, P24461, DOI 10.1074/jbc.274.35.24461; Sagong B, 2010, ANN CLIN LAB SCI, V40, P380; Scott DA, 2000, HUM MOL GENET, V9, P1709, DOI 10.1093/hmg/9.11.1709; Seong MW, 2009, CLIN GENET, V76, P152, DOI 10.1111/j.1399-0004.2009.01202.x; Shearer AE, 2014, GENOME MED, V6, DOI 10.1186/gm554; Shieh JTC, 2019, PEDIATRICS, V143, pS22, DOI 10.1542/peds.2018-1099E; Song HL, 2015, J CLIN ONCOL, V33, P2901, DOI 10.1200/JCO.2015.61.2408; Stojiljkovic M, 2016, CLIN GENET, V90, P252, DOI 10.1111/cge.12751; Sun J, 2017, CLIN CANCER RES, V23, P6113, DOI 10.1158/1078-0432.CCR-16-3227; Sundstrom RA, 1999, AM J MED GENET, V89, P123, DOI 10.1002/(SICI)1096-8628(19990924)89:3<123::AID-AJMG2>3.0.CO;2-P; Sweetman L, 2006, PEDIATRICS, V117, pS308, DOI 10.1542/peds.2005-2633J; Syrjakoski K, 2004, NEOPLASIA, V6, P541, DOI 10.1593/neo.04193; Thormaehlen AS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004855; Umstead KL, 2020, TRANSL BEHAV MED, V10, P441, DOI 10.1093/tbm/ibz111; van der Lelij P, 2010, AM J HUM GENET, V86, P262, DOI 10.1016/j.ajhg.2010.01.008; Van Hauwe P, 1998, HUM MOL GENET, V7, P1099, DOI 10.1093/hmg/7.7.1099; Villeger L, 2002, HUM MUTAT, V20, P81, DOI 10.1002/humu.10102; Watson M.S., 2006, PEDIATRICS, V117, pS296, DOI DOI 10.1542/PEDS.2005-26331; Watson MS, 2006, GENET MED, V8, p1S, DOI 10.1097/01.gim.0000223891.82390.ad; Yamaguchi S, 2006, HUM MUTAT, V27, P626, DOI 10.1002/humu.20339; YOKOTA I, 1991, AM J HUM GENET, V49, P1280; Yoon YA, 2012, ANN CLIN LAB SCI, V42, P424; Zelante L, 1997, HUM MOL GENET, V6, P1605, DOI 10.1093/hmg/6.9.1605; ZHANG B, 1989, J CLIN INVEST, V83, P1425, DOI 10.1172/JCI114033	109	29	32	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 1	2020	107	4					596	611		10.1016/j.ajhg.2020.08.001	http://dx.doi.org/10.1016/j.ajhg.2020.08.001			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NZ5IY	32853555	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000577135400003
J	Choufani, S; Gibson, WT; Turinsky, AL; Chung, BHY; Wang, TR; Garg, K; Vitriolo, A; Cohen, ASA; Cyrus, S; Goodman, S; Chater-Diehl, E; Brzezinski, J; Brudno, M; Ming, LH; White, SM; Lynch, SA; Clericuzio, C; Temple, IK; Flinter, F; McConnell, V; Cushing, T; Bird, LM; Splitt, M; Kerr, B; Scherer, SW; Machado, J; Imagawa, E; Okamoto, N; Matsumoto, N; Testa, G; Iascone, M; Tenconi, R; Caluseriu, O; Mendoza-Londono, R; Chitayat, D; Cytrynbaum, C; Tatton-Brown, K; Weksberg, R				Choufani, Sanaa; Gibson, William T.; Turinsky, Andrei L.; Chung, Brian H. Y.; Wang, Tianren; Garg, Kopal; Vitriolo, Alessandro; Cohen, Ana S. A.; Cyrus, Sharri; Goodman, Sarah; Chater-Diehl, Eric; Brzezinski, Jack; Brudno, Michael; Ming, Luk Ho; White, Susan M.; Lynch, Sally Ann; Clericuzio, Carol; Temple, I. Karen; Flinter, Frances; McConnell, Vivienne; Cushing, Tom; Bird, Lynne M.; Splitt, Miranda; Kerr, Bronwyn; Scherer, Stephen W.; Machado, Jerry; Imagawa, Eri; Okamoto, Nobuhiko; Matsumoto, Naomichi; Testa, Guiseppe; Iascone, Maria; Tenconi, Romano; Caluseriu, Oana; Mendoza-Londono, Roberto; Chitayat, David; Cytrynbaum, Cheryl; Tatton-Brown, Katrina; Weksberg, Rosanna			DNA Methylation Signature for EZH2 Functionally Classifies Sequence Variants in Three PRC2 Complex Genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WEAVER SYNDROME; MUTATIONS; POLYCOMB; OVERGROWTH; ARRAY	Weaver syndrome (WS), an overgrowth/intellectual disability syndrome (OGID), is caused by pathogenic variants in the histone methyl-transferase EZH2, which encodes a core component of the Polycomb repressive complex-2 (PRC2). Using genome-wide DNA methylation (DNAm) data for 187 individuals with OGID and 969 control subjects, we show that pathogenic variants in EZH2 generate a highly specific and sensitive DNAm signature reflecting the phenotype of WS. This signature can be used to distinguish loss-of-function from gain-of-function missense variants and to detect somatic mosaicism. We also show that the signature can accurately classify sequence variants in EED and SUZ12, which encode two other core components of PRC2, and predict the presence of pathogenic variants in undiagnosed individuals with OGID. The discovery of a functionally relevant signature with utility for diagnostic classification of sequence variants in EZH2, EED, and SUZ12 supports the emerging paradigm shift for implementation of DNAm signatures into diagnostics and translational research.	[Choufani, Sanaa; Turinsky, Andrei L.; Wang, Tianren; Garg, Kopal; Goodman, Sarah; Chater-Diehl, Eric; Brzezinski, Jack; Brudno, Michael; Scherer, Stephen W.; Cytrynbaum, Cheryl; Weksberg, Rosanna] Hosp Sick Children, Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Gibson, William T.; Cohen, Ana S. A.; Cyrus, Sharri] British Columbia Childrens Hosp, Res Inst, Vancouver, BC V5Z 4H4, Canada; [Gibson, William T.; Cohen, Ana S. A.; Cyrus, Sharri] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; [Turinsky, Andrei L.; Brudno, Michael] Hosp Sick Children, Ctr Computat Med, Toronto, ON M5G 1X8, Canada; [Chung, Brian H. Y.] Univ Hong Kong, Pediat & Adolescent Med, Queen Mary Hosp, Hong Kong 999077, Peoples R China; [Chung, Brian H. Y.] Univ Hong Kong, Hong Kong Childrens Hosp, Hong Kong 999077, Peoples R China; [Vitriolo, Alessandro; Testa, Guiseppe] Univ Milan, Dept Oncol & Hematooncol, Milan 20122, Italy; [Vitriolo, Alessandro; Testa, Guiseppe] IRCCS, Lab Stem Cell Epigenet, European Inst Oncol, IEO, Milan 20139, Italy; [Cohen, Ana S. A.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Brzezinski, Jack] Hosp Sick Children, Div Haematol & Oncol, Toronto, ON M5G 1X8, Canada; [Brudno, Michael] Univ Toronto, Dept Comp Sci, Toronto, ON M5S 3H5, Canada; [Ming, Luk Ho] Dept Hlth, Clin Genet Serv, Hong Kong 999077, Peoples R China; [White, Susan M.] Murdoch Childrens Res Inst, Victorian Clin Genet Serv, Melbourne, Vic 3052, Australia; [White, Susan M.] Univ Melbourne, Dept Paediat, Melbourne, Vic 3052, Australia; [Lynch, Sally Ann] Childrens Univ Hosp, Dept Clin Genet, Temple St, Dublin D01 XD99, Ireland; [Clericuzio, Carol; Cushing, Tom] Univ New Mexico, Pediat Genet, Albuquerque, NM 87131 USA; [Temple, I. Karen] Univ Southampton, Fac Med, Southampton SO16 6YD, Hants, England; [Temple, I. Karen] Univ Hosp Southampton NHS Fdn Trust, Wessex Clin Genet Serv, Southampton SO16 6YD, Hants, England; [Flinter, Frances] Guys & St Thomas NHS Fdn Trust, Dept Clin Genet, London SE1 9RT, England; [McConnell, Vivienne] Belfast City Hosp, Northern Ireland Reg Genet Serv, Belfast BT9 7AB, Antrim, North Ireland; [Bird, Lynne M.] Univ Calif San Diego, Dept Pediat, San Diego, CA 92093 USA; [Bird, Lynne M.] Rady Childrens Hosp San Diego, Div Genet, San Diego, CA 92123 USA; [Splitt, Miranda] Inst Genet Med, Northern Genet Serv, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Kerr, Bronwyn] Univ Manchester, Sch Biol Sci, Div Evolut & Genom Sci, Manchester M13 9PL, Lancs, England; [Kerr, Bronwyn] Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester Ctr Genom Med, Manchester M13 9WL, Lancs, England; [Scherer, Stephen W.; Cytrynbaum, Cheryl; Weksberg, Rosanna] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada; [Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1X8, Canada; [Machado, Jerry] PreventionGenetics, Marshfield, WI 54449 USA; [Imagawa, Eri; Matsumoto, Naomichi] Yokohama City Univ, Dept Human Genet, Grad Sch Med, Kanazawa Ku, Fukuura 3-9, Yokohama, Kanagawa 2360004, Japan; [Okamoto, Nobuhiko] Osaka Med Ctr, Dept Med Genet, Osaka 5941101, Japan; [Okamoto, Nobuhiko] Res Inst Maternal & Child Hlth, Osaka 5941101, Japan; [Testa, Guiseppe] Ctr Neurogen, Human Technopole, Via Cristina Belgioioso 171, Milan 20157, Italy; [Iascone, Maria] ASST Papa Giovanni XXIII, Lab Genet Med, Piazza OMS 1, Bergamo 24127, Italy; [Tenconi, Romano] Univ Padua, Dipartimento Pediat, Via Giustiani 3, Padua 35128, Italy; [Caluseriu, Oana] Univ Alberta, Dept Med Genet, Edmonton, AB T6G 2H7, Canada; [Caluseriu, Oana] Stollery Pediat Hosp, Edmonton, AB T6G 2H7, Canada; [Mendoza-Londono, Roberto; Chitayat, David; Cytrynbaum, Cheryl; Weksberg, Rosanna] Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Mendoza-Londono, Roberto; Chitayat, David; Weksberg, Rosanna] Univ Toronto, Dept Pediat, Toronto, ON M5S 1A1, Canada; [Chitayat, David] Mt Sinai Hosp, Prenatal Diag & Med Genet Program, Toronto, ON M5G 1X5, Canada; [Tatton-Brown, Katrina] St Georges Univ Hosp NHS Fdn Trust, London SW17 0QT, England; [Tatton-Brown, Katrina] St Georges Univ London, London SW17 0RE, England; [Tatton-Brown, Katrina] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; [Weksberg, Rosanna] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); BC Childrens Hospital; University of British Columbia; University of British Columbia; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Hong Kong; University of Hong Kong; University of Milan; IRCCS European Institute of Oncology (IEO); Icahn School of Medicine at Mount Sinai; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Murdoch Children's Research Institute; University of Melbourne; Childrens University Hospital - Temple Street; University of New Mexico; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; Belfast City Hospital; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; Newcastle University - UK; University of Manchester; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Yokohama City University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Human Technopole; ASST Papa Giovanni XXIII; University of Padua; University of Alberta; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; St Georges University London; University of London; Institute of Cancer Research - UK; University of Toronto	Weksberg, R (corresponding author), Hosp Sick Children, Genet & Genome Biol, Toronto, ON M5G 1X8, Canada.; Weksberg, R (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada.; Weksberg, R (corresponding author), Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada.; Weksberg, R (corresponding author), Univ Toronto, Dept Pediat, Toronto, ON M5S 1A1, Canada.; Weksberg, R (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada.	rweksb@sickkids.ca	Scherer, Stephen W./B-3785-2013; Choufani, Sanaa/GWC-1820-2022; Bird, Lynne/AAG-9533-2021; Iascone, Maria/AAA-4599-2019; Vitriolo, Alessandro/S-8606-2019	Scherer, Stephen W./0000-0002-8326-1999; Choufani, Sanaa/0000-0002-5241-2213; Iascone, Maria/0000-0002-4707-212X; Vitriolo, Alessandro/0000-0002-1462-8064; Bird, Lynne/0000-0003-4833-3747; Lynch, Sally Ann/0000-0003-3540-1333; Testa, Giuseppe/0000-0002-9104-0918	Canadian Institutes of Health Research (CIHR) [IGH-155182, MOP-126054]; CIHR Project Grant [PJT-148830]; BCCHR intramural IGAP salary award; Canadian Centre for Computational Genomics (C3G); Genome Technology Platform (GTP) - Genome Canada through Genome Quebec and Ontario Genomics; Genome Canada through Ontario Genomics; Ontario Brain Institute (OBI); Ontario government; Telethon Foundation [GEP13105]; EPI GEN Flagship Project of the Italian National Research Council; European Research Council [616441-DISEASEAVATARS]; Italian Ministry of Health	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Project Grant(Canadian Institutes of Health Research (CIHR)); BCCHR intramural IGAP salary award; Canadian Centre for Computational Genomics (C3G); Genome Technology Platform (GTP) - Genome Canada through Genome Quebec and Ontario Genomics; Genome Canada through Ontario Genomics(Genome Canada); Ontario Brain Institute (OBI); Ontario government; Telethon Foundation(Fondazione Telethon); EPI GEN Flagship Project of the Italian National Research Council; European Research Council(European Research Council (ERC)European Commission); Italian Ministry of Health(Ministry of Health, Italy)	We are grateful to all the families with childhood overgrowth conditionswhoparticipated in this research and to themanyclinicians who recruited them into the study. We also acknowledge the technical assistance of Youliang Lou and Chunhua Zhao. This work was supported by Canadian Institutes of Health Research (CIHR) grants to R.W. (IGH-155182 and MOP-126054), by CIHR Project Grant PJT-148830 to W.T.G., and by a BCCHR intramural IGAP salary award to W.T.G. Bioinformatic analyses were supported in part by the Canadian Centre for Computational Genomics (C3G), part of the Genome Technology Platform (GTP), funded by Genome Canada through Genome Quebec and Ontario Genomics (A.L.T., M.B.), Genome Canada through Ontario Genomics (A.L.T., S. Choufani, M.B., and R.W.), and the Ontario Brain Institute (OBI). OBI is an independent non-profit corporation, funded partially by the Ontario government. Protein Modeling was supported by Telethon Foundation (grantnumberGEP13105 to G.T.), the EPI GEN Flagship Project of the Italian National Research Council (to G.T.), the European Research Council (grant number 616441-DISEASEAVATARS to G.T.), and Ricerca Corrente granted by the Italian Ministry of Health (to G.T.). The opinions, results, and conclusions are those of the authors, and no endorsement by the Ontario Brain Institute is intended or should be inferred.	Accomando WP, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r50; Alisch RS, 2012, GENOME RES, V22, P623, DOI 10.1101/gr.125187.111; Aref-Eshghi E, 2019, AM J HUM GENET, V104, P685, DOI 10.1016/j.ajhg.2019.03.008; Aref-Eshghi E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07193-y; Aref-Eshghi E, 2018, AM J HUM GENET, V102, P156, DOI 10.1016/j.ajhg.2017.12.008; Barbosa M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04540-x; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Butcher DT, 2017, AM J HUM GENET, V100, P773, DOI 10.1016/j.ajhg.2017.04.004; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Capper D, 2018, NATURE, V555, P469, DOI 10.1038/nature26000; Chater-Diehl E, 2019, BMC MED GENOMICS, V12, DOI 10.1186/s12920-019-0555-y; Choufani S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10207; Cohen ASA, 2016, J HUM GENET, V61, P831, DOI 10.1038/jhg.2016.51; Cohen ASA, 2015, J HUM GENET, V60, P339, DOI 10.1038/jhg.2015.26; Cyrus SS, 2019, AM J MED GENET C, V181, P532, DOI 10.1002/ajmg.c.31748; Dogan MV, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-151; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/cpps.20]; FAUST C, 1995, DEVELOPMENT, V121, P273; Friemel C, 2014, FERTIL STERIL, V101, P1097, DOI 10.1016/j.fertnstert.2013.12.054; Gibson WT, 2012, AM J HUM GENET, V90, P110, DOI 10.1016/j.ajhg.2011.11.018; Grafodatskaya D, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-1; Guglielmelli P, 2011, BLOOD, V118, P5227, DOI 10.1182/blood-2011-06-363424; Hanna GL, 2016, J AM ACAD CHILD PSY, V55, P906, DOI 10.1016/j.jaac.2016.06.012; Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016; Imagawa E, 2018, CLIN GENET, V94, P461, DOI 10.1111/cge.13415; Imagawa E, 2017, HUM MUTAT, V38, P637, DOI 10.1002/humu.23200; Jaffe AE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r31; Jaffe AE, 2012, INT J EPIDEMIOL, V41, P200, DOI 10.1093/ije/dyr238; Jeffries AR, 2019, GENOME RES, V29, P1057, DOI 10.1101/gr.243584.118; Kular L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04732-5; Li DM, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0641-x; Li HJ, 2017, NATURE, V549, P287, DOI 10.1038/nature23881; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lui JC, 2018, J CLIN ENDOCR METAB, V103, P1470, DOI 10.1210/jc.2017-01948; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Montoya-Williams D, 2018, J DEV ORIG HLTH DIS, V9, P215, DOI 10.1017/S2040174417000800; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Reimand J, 2019, NAT PROTOC, V14, P482, DOI 10.1038/s41596-018-0103-9; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Salas LA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1448-7; Schuettengruber B, 2017, CELL, V171, P34, DOI 10.1016/j.cell.2017.08.002; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Siu MT, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0684-3; Tatton-Brown K, 2013, AM J MED GENET A, V161, P2972, DOI 10.1002/ajmg.a.36229; Tatton-Brown K, 2011, ONCOTARGET, V2, P1127, DOI 10.18632/oncotarget.385; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083737; Xu F, 2016, ONCOTARGET, V7, P8119, DOI 10.18632/oncotarget.6992; Youmans DT, 2018, GENE DEV, V32, P794, DOI 10.1101/gad.311936.118	52	29	29	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 7	2020	106	5					596	610		10.1016/j.ajhg.2020.03.008	http://dx.doi.org/10.1016/j.ajhg.2020.03.008			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LK8FQ	32243864	Green Accepted, hybrid, Green Published			2022-12-18	WOS:000531096100002
J	Cochran, JN; Geier, EG; Bonham, LW; Newberry, JS; Amaral, MD; Thompson, ML; Lasseigne, BN; Karydas, AM; Roberson, ED; Cooper, GM; Rabinovici, GD; Miller, BL; Myers, RM; Yokoyama, JS				Cochran, J. Nicholas; Geier, Ethan G.; Bonham, Luke W.; Newberry, J. Scott; Amaral, Michelle D.; Thompson, Michelle L.; Lasseigne, Brittany N.; Karydas, Anna M.; Roberson, Erik D.; Cooper, Gregory M.; Rabinovici, Gil D.; Miller, Bruce L.; Myers, Richard M.; Yokoyama, Jennifer S.		Alzheimers Dis Neuroimaging Initia	Non-coding and Loss-of-Function Coding Variants in TET2 are Associated with Multiple Neurodegenerative Diseases	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; GENOME; TAU; FRAMEWORK; ALIGNMENT; GENETICS; SUBTYPES; OVERLAP; SINGLE	We conducted genome sequencing to search for rare variation contributing to early-onset Alzheimer's disease (EOAD) and frontotemporal dementia (FTD). Discovery analysis was conducted on 435 cases and 671 controls of European ancestry. Burden testing for rare variation associated with disease was conducted using filters based on variant rarity (less than one in 10,000 or private), computational prediction of deleteriousness (CADD) (10 or 15 thresholds), and molecular function (protein loss-of-function [LoF] only, coding alteration only, or coding plus non-coding variants in experimentally predicted regulatory regions). Replication analysis was conducted on 16,434 independent cases and 15,587 independent controls. Rare variants in TET2 were enriched in the discovery combined EOAD and FTD cohort (p = 4.6 x 10(-8), genome-wide corrected p = 0.0026). Most of these variants were canonical LoF or non-coding in predicted regulatory regions. This enrichment replicated across several cohorts of Alzheimer's disease (AD) and FTD (replication only p = 0.0029). The combined analysis odds ratio was 2.3 (95% confidence interval [CI] 1.6-3.4) for AD and FTD. The odds ratio for qualifying non-coding variants considered independently from coding variants was 3.7 (95% CI 1.7-9.4). For LoF variants, the combined odds ratio (for AD, FTD, and amyotrophic lateral sclerosis, which shares clinicopathological overlap with FTD) was 3.1 (95% CI 1.9-5.2). TET2 catalyzes DNA demethylation. Given well-defined changes in DNA methylation that occur during aging, rare variation in TET2 may confer risk for neurodegeneration by altering the homeostasis of key aging-related processes. Additionally, our study emphasizes the relevance of non-coding variation in genetic studies of complex disease.	[Cochran, J. Nicholas; Newberry, J. Scott; Amaral, Michelle D.; Thompson, Michelle L.; Lasseigne, Brittany N.; Cooper, Gregory M.; Myers, Richard M.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Geier, Ethan G.; Bonham, Luke W.; Karydas, Anna M.; Rabinovici, Gil D.; Miller, Bruce L.; Yokoyama, Jennifer S.] Univ Calif San Francisco, Memory & Aging Ctr, Dept Neurol, San Francisco, CA 94158 USA; [Lasseigne, Brittany N.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Roberson, Erik D.] Univ Alabama Birmingham, Ctr Neurodegenerat & Expt Therapeut, Alzheimers Dis Ctr, Dept Neurol & Neurobiol, Birmingham, AL 35294 USA; [Rabinovici, Gil D.; Yokoyama, Jennifer S.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94158 USA	HudsonAlpha Institute for Biotechnology; University of California System; University of California San Francisco; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Francisco	Yokoyama, JS (corresponding author), Univ Calif San Francisco, Memory & Aging Ctr, Dept Neurol, San Francisco, CA 94158 USA.; Yokoyama, JS (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94158 USA.	jennifer.yokoyama@ucsf.edu	; Roberson, Erik/A-5718-2009	Miller, Bruce/0000-0002-2152-4220; Roberson, Erik/0000-0002-1810-9763	UCSF; Rainwater Charitable Foundation; University of Alabama at Birmingham; National Institutes of Health (NIH) National Institute on Aging (NIA) [NIH-NIA K01 AG049152, NIH-NIA R01 AG062588]; Larry L. Hillblom Foundation [2016-A-005-SUP]; NIA [P01 AG1972403, P50 AG023501, P30 AG062422, R01 AG045611]	UCSF; Rainwater Charitable Foundation; University of Alabama at Birmingham; National Institutes of Health (NIH) National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Larry L. Hillblom Foundation; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding for genomes from UCSF-enrolled participants sequenced at HudsonAlpha was generously provided by donors to the HudsonAlpha Foundation Memory and Mobility Fund (R.M.M). Funding for genomes sequenced at the New York Genome Center was provided from grant support from the Rainwater Charitable Foundation (J.S.Y.). Funding for sequencing of genomes from the University of Alabama at Birmingham was provided by the Daniel Foundation of Alabama (R.M.M.). Additional support was provided by National Institutes of Health (NIH) National Institute on Aging (NIA) grants NIH-NIA K01 AG049152 (J.S.Y.), NIH-NIA R01 AG062588 (J.S.Y.), Larry L. Hillblom Foundation grant 2016-A-005-SUP (J.S.Y.), the Rainwater Charitable Foundation (J.S.Y.), NIA P01 AG1972403 (B.L.M.), NIA P50 AG023501 (B.L.M.), NIA P30 AG062422 (B.L.M.), and R01 AG045611 (G.D.R.).	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Allen M, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.89; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Antunes C, 2019, NEUROSCI BIOBEHAV R, V102, P337, DOI 10.1016/j.neubiorev.2019.05.006; Beck DB, 2020, AM J HUM GENET, V106, P234, DOI 10.1016/j.ajhg.2019.12.007; Bennett DA, 2018, J ALZHEIMERS DIS, V64, pS161, DOI 10.3233/JAD-179939; Bis JC, 2020, MOL PSYCHIATR, V25, P1859, DOI 10.1038/s41380-018-0112-7; Bowling KM, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0433-1; Broce I, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002487; Carrillo-Jimenez A, 2019, CELL REP, V29, P697, DOI 10.1016/j.celrep.2019.09.013; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; Cochran JN, 2019, CSH MOL CASE STUD, V5, DOI 10.1101/mcs.a003491; Cruts M, 2012, HUM MUTAT, V33, P1340, DOI 10.1002/humu.22117; Cuyvers E, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.09.009; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Desikan RS, 2015, MOL PSYCHIATR, V20, P1588, DOI 10.1038/mp.2015.6; Ewers M., 2019, SCI TRANSL MED, V11, P11; Ferrari R, 2017, J NEUROL NEUROSUR PS, V88, P152, DOI 10.1136/jnnp-2016-314411; Ferrari R, 2014, LANCET NEUROL, V13, P686, DOI 10.1016/S1474-4422(14)70065-1; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fransquet PD, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0656-7; Geier EG, 2019, ACTA NEUROPATHOL, V137, P71, DOI 10.1007/s00401-018-1925-9; Goldman JS, 2005, NEUROLOGY, V65, P1817, DOI 10.1212/01.wnl.0000187068.92184.63; Gontier G, 2018, CELL REP, V22, P1974, DOI 10.1016/j.celrep.2018.02.001; Heyward FD, 2015, NEUROSCIENTIST, V21, P475, DOI 10.1177/1073858415579635; Horvath S, 2018, NAT REV GENET, V19, P371, DOI 10.1038/s41576-018-0004-3; Nguyen HP, 2018, TRENDS GENET, V34, P404, DOI 10.1016/j.tig.2018.03.001; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jessop P, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00045; Karch CM, 2018, JAMA NEUROL, V75, P860, DOI 10.1001/jamaneurol.2018.0372; Karczewski KJ., 2019, BIORXIV, DOI [DOI 10.1101/531210, 10.1101/531210]; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kunkle BW, 2019, NAT GENET, V51, P414, DOI 10.1038/s41588-019-0358-2; Kwok JBJ, 2004, ANN NEUROL, V55, P329, DOI 10.1002/ana.10826; Lambert MA, 2014, EUR J NEUROL, V21, P563, DOI 10.1111/ene.12325; Lattante S, 2015, TRENDS GENET, V31, P263, DOI 10.1016/j.tig.2015.03.005; Lee S, 2016, BIOSTATISTICS, V17, P1, DOI 10.1093/biostatistics/kxv033; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li LP, 2020, HUM MOL GENET, V29, P1833, DOI 10.1093/hmg/ddz282; Li XK, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15903; Liu XM, 2016, J MED GENET, V53, P111, DOI 10.1136/jmedgenet-2015-103423; Loy CT, 2014, LANCET, V383, P828, DOI 10.1016/S0140-6736(13)60630-3; Lu QS, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006933; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mi YJ, 2015, INT J MOL SCI, V16, P21846, DOI 10.3390/ijms160921846; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; NHLBI; and University of Michigan, 2018, NHLBI TRANSOMICS PRE; Nicolas G, 2016, HUM HERED, V81, P129, DOI 10.1159/000452256; O'Bryant SE, 2010, ARCH NEUROL-CHICAGO, V67, P746, DOI 10.1001/archneurol.2010.115; Orme T, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0874-y; Paila U, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003153; Pedersen BS, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix090; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; Pottier C, 2019, ACTA NEUROPATHOL, V137, P879, DOI 10.1007/s00401-019-01962-9; Pottier C, 2013, J ALZHEIMERS DIS, V35, P45, DOI 10.3233/JAD-122311; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rademakers R, 2003, HUM MUTAT, V22, P409, DOI 10.1002/humu.10269; Reed LA, 1997, ANN NEUROL, V42, P564, DOI 10.1002/ana.410420406; Saykin AJ, 2010, ALZHEIMERS DEMENT, V6, P265, DOI 10.1016/j.jalz.2010.03.013; Schott JM, 2016, ALZHEIMERS DEMENT, V12, P862, DOI 10.1016/j.jalz.2016.01.010; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Tan A, 2015, BIOINFORMATICS, V31, P2202, DOI 10.1093/bioinformatics/btv112; Tarasov A, 2015, BIOINFORMATICS, V31, P2032, DOI 10.1093/bioinformatics/btv098; Turner SD, 2014, BIORXIV, DOI 10. 1101/005165 , 2014 .; van Blitterswijk M, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-38; Van Rheenen W, 2018, EUR J HUM GENET, V26, P1537, DOI 10.1038/s41431-018-0177-4; Weiner Michael W, 2015, Alzheimers Dement, V11, pe1, DOI 10.1016/j.jalz.2014.11.001; Williams MM, 2013, ALZHEIMERS DEMENT, V9, pS39, DOI 10.1016/j.jalz.2012.01.005; Wingo TS, 2012, ARCH NEUROL-CHICAGO, V69, P59, DOI 10.1001/archneurol.2011.221; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yokoyama JS, 2016, JAMA NEUROL, V73, P691, DOI 10.1001/jamaneurol.2016.0150; Zhao H, 2014, BIOINFORMATICS, V30, P1006, DOI 10.1093/bioinformatics/btt730	76	29	29	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 7	2020	106	5					632	645		10.1016/j.ajhg.2020.03.010	http://dx.doi.org/10.1016/j.ajhg.2020.03.010			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LK8FQ	32330418	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000531096100005
J	O'Donnell-Luria, AH; Pais, LS; Faundes, V; Wood, JC; Sveden, A; Luria, V; Abou Jamra, R; Accogli, A; Amburgey, K; Anderlid, BM; Azzarello-Burri, S; Basinger, AA; Bianchini, C; Bird, LM; Buchert, R; Carre, W; Ceulemans, S; Charles, P; Cox, H; Culliton, L; Curro, A; Demurger, F; Dowling, JJ; Duban-Bedu, B; Dubourg, C; Eiset, SE; Escobar, LF; Ferrarini, A; Haack, TB; Hashim, M; Heide, S; Helbig, KL; Helbig, I; Heredia, R; Heron, D; Isidor, B; Jonasson, AR; Joset, P; Keren, B; Kok, F; Kroes, HY; Lavillaureix, A; Lu, X; Maas, SM; Maegawa, GHB; Marcelis, CLM; Mark, PR; Masruha, MR; McLaughlin, HM; McWalter, K; Melchinger, EU; Mercimek-Andrews, S; Nava, C; Pendziwiat, M; Person, R; Ramelli, GP; Ramos, LLP; Rauch, A; Reavey, C; Renieri, A; Riess, A; Sanchez-Valle, A; Sattar, S; Saunders, C; Schwarz, N; Smol, T; Srour, M; Steindl, K; Syrbe, S; Taylor, JC; Telegrafi, A; Thiffault, I; Trauner, DA; van der Linden, H; van Koningsbruggen, S; Villard, L; Vogel, I; Vogt, J; Weber, YG; Wentzensen, IM; Widjaja, E; Zak, J; Baxter, S; Banka, S; Rodan, LH; Mcrae, JF; Clayton, S; Fitzgerald, TW; Kaplanis, J; Prigmore, E; Rajan, D; Sifrim, A; Aitken, S; Akawi, N; Alvi, M; Ambridge, K; Barrett, DM; Bayzetinova, T; Jones, P; Jones, WD; King, D; Krishnappa, N; Mason, LE; Singh, T; Tivey, AR; Ahmed, M; Anjum, U; Archer, H; Armstrong, R; Awada, J; Balasubramanian, M; Banka, S; Baralle, D; Barnicoat, A; Batstone, P; Baty, D; Bennett, C; Berg, J; Bernhard, B; Bevan, AP; Bitner-Glindzicz, M; Blair, E; Blyth, M; Bohanna, D; Bourdon, L; Bourn, D; Bradley, L; Brady, A; Brent, S; Brewer, C; Brunstrom, K; Bunyan, DJ; Burn, J; Canham, N; Castle, B; Chandler, K; Chatzimichali, E; Cilliers, D; Clarke, A; Clasper, S; Clayton-Smith, J; Clowes, V; Coates, A; Cole, T; Colgiu, I; Collins, A; Collinson, MN; Connell, F; Cooper, N; Cox, H; Cresswell, L; Cross, G; Crow, Y; D'Alessandro, M; Dabir, T; Davidson, R; Davies, S; de Vries, D; Dean, J; Deshpande, C; Devlin, G; Dixit, A; Dobbie, A; Donaldson, A; Donnai, D; Donnelly, D; Donnelly, C; Douglas, A; Douzgou, S; Duncan, A; Eason, J; Ellard, S; Ellis, I; Elmslie, F; Evans, K; Everest, S; Fendick, T; Fisher, R; Flinter, F; Foulds, N; Fry, A; Fryer, A; Gardiner, C; Gaunt, L; Ghali, N; Gibbons, R; Gill, H; Goodship, J; Goudie, D; Gray, E; Green, A; Greene, P; Greenhalgh, L; Gribble, S; Harrison, R; Harrison, L; Harrison, V; Hawkins, R; He, L; Hellens, S; Henderson, A; Hewitt, S; Hildyard, L; Hobson, E; Holden, S; Holder, M; Holder, S; Hollingsworth, G; Homfray, T; Humphreys, M; Hurst, J; Hutton, B; Ingram, S; Irving, M; Islam, L; Jackson, A; Jarvis, J; Jenkins, L; Johnson, D; Jones, E; Josifova, D; Joss, S; Kaemba, B; Kazembe, S; Kelsell, R; Kerr, B; Kingston, H; Kini, U; Kinning, E; Kirby, G; Kirk, C; Kivuva, E; Kraus, A; Kumar, D; Kumar, VKA; Lachlan, K; Lam, W; Lampe, A; Langman, C; Lees, M; Lim, D; Longman, C; Lowther, G; Lynch, SA; Magee, A; Maher, E; Male, A; Mansour, S; Marks, K; Martin, K; Maye, U; McCann, E; McConnell, V; McEntagart, M; McGowan, R; Mckay, K; Mckee, S; McMullan, DJ; McNerlan, S; McWilliam, C; Mehta, S; Metcalfe, K; Middleton, A; Miedzybrodzka, Z; Miles, E; Mohammed, S; Montgomery, T; Moore, D; Morgan, S; Morton, J; Mugalaasi, H; Murday, V; Murphy, H; Naik, S; Nemeth, A; Nevitt, L; Newbury-Ecob, R; Norman, A; O'Shea, R; Ogilvie, C; Ong, KR; Park, SM; Parker, MJ; Patel, C; Paterson, J; Payne, S; Perrett, D; Phipps, J; Pilz, DT; Pollard, M; Pottinger, C; Poulton, J; Pratt, N; Prescott, K; Price, S; Pridham, A; Procter, A; Purnell, H; Quarrell, O; Ragge, N; Rahbari, R; Randall, J; Rankin, J; Raymond, L; Rice, D; Robert, L; Roberts, E; Roberts, J; Roberts, P; Roberts, G; Ross, A; Rosser, E; Saggar, A; Samant, S; Sampson, J; Sandford, R; Sarkar, A; Schweiger, S; Scott, R; Scurr, I; Selby, A; Seller, A; Sequeira, C; Shannon, N; Sharif, S; Shaw-Smith, C; Shearing, E; Shears, D; Sheridan, E; Simonic, I; Singzon, R; Skitt, Z; Smith, A; Smith, K; Smithson, S; Sneddon, L; Splitt, M; Squires, M; Stewart, F; Stewart, H; Straub, V; Suri, M; Sutton, V; Swaminathan, GJ; Sweeney, E; Tatton-Brown, K; Taylor, C; Taylor, R; Tein, M; Temple, IK; Thomson, J; Tischkowitz, M; Tomkins, S; Torokwa, A; Treacy, B; Turner, C; Turnpenny, P; Tysoe, C; Vandersteen, A; Varghese, V; Vasudevan, P; Vijayarangakannan, P; Vogt, J; Wakeling, E; Wallwark, S; Waters, J; Weber, A; Wellesley, D; Whiteford, M; Widaa, S; Wilcox, S; Wilkinson, E; Williams, D; Williams, N; Wilson, L; Woods, G; Wragg, C; Wright, M; Yates, L; Yau, M; Nellaker, C; Parker, M; Firth, HV; Wright, CF; FitzPatrick, DR; Barrett, JC; Hurles, ME				O'Donnell-Luria, Anne H.; Pais, Lynn S.; Faundes, Victor; Wood, Jordan C.; Sveden, Abigail; Luria, Victor; Abou Jamra, Rami; Accogli, Andrea; Amburgey, Kimberly; Anderlid, Britt Marie; Azzarello-Burri, Silvia; Basinger, Alice A.; Bianchini, Claudia; Bird, Lynne M.; Buchert, Rebecca; Carre, Wilfrid; Ceulemans, Sophia; Charles, Perrine; Cox, Helen; Culliton, Lisa; Curro, Aurora; Demurger, Florence; Dowling, James J.; Duban-Bedu, Benedicte; Dubourg, Christele; Eiset, Saga Elise; Escobar, Luis F.; Ferrarini, Alessandra; Haack, Tobias B.; Hashim, Mona; Heide, Solveig; Helbig, Katherine L.; Helbig, Ingo; Heredia, Raul; Heron, Delphine; Isidor, Bertrand; Jonasson, Amy R.; Joset, Pascal; Keren, Boris; Kok, Fernando; Kroes, Hester Y.; Lavillaureix, Alinoe; Lu, Xin; Maas, Saskia M.; Maegawa, Gustavo H. B.; Marcelis, Carlo L. M.; Mark, Paul R.; Masruha, Marcelo R.; McLaughlin, Heather M.; McWalter, Kirsty; Melchinger, Esther U.; Mercimek-Andrews, Saadet; Nava, Caroline; Pendziwiat, Manuela; Person, Richard; Ramelli, Gian Paolo; Ramos, Luiza L. P.; Rauch, Anita; Reavey, Caitlin; Renieri, Alessandra; Riess, Angelika; Sanchez-Valle, Amarilis; Sattar, Shifteh; Saunders, Carol; Schwarz, Niklas; Smol, Thomas; Srour, Myriam; Steindl, Katharina; Syrbe, Steffen; Taylor, Jenny C.; Telegrafi, Aida; Thiffault, Isabelle; Trauner, Doris A.; van der Linden, Helio, Jr.; van Koningsbruggen, Silvana; Villard, Laurent; Vogel, Ida; Vogt, Julie; Weber, Yvonne G.; Wentzensen, Ingrid M.; Widjaja, Elysa; Zak, Jaroslav; Baxter, Samantha; Banka, Siddharth; Rodan, Lance H.; Mcrae, Jeremy F.; Clayton, Stephen; Fitzgerald, Tomas W.; Kaplanis, Joanna; Prigmore, Elena; Rajan, Diana; Sifrim, Alejandro; Aitken, Stuart; Akawi, Nadia; Alvi, Mohsan; Ambridge, Kirsty; Barrett, Daniel M.; Bayzetinova, Tanya; Jones, Philip; Jones, Wendy D.; King, Daniel; Krishnappa, Netravathi; Mason, Laura E.; Singh, Tarjinder; Tivey, Adrian R.; Ahmed, Munaza; Anjum, Uruj; Archer, Hayley; Armstrong, Ruth; Awada, Jana; Balasubramanian, Meena; Banka, Siddharth; Baralle, Diana; Barnicoat, Angela; Batstone, Paul; Baty, David; Bennett, Chris; Berg, Jonathan; Bernhard, Birgitta; Bevan, A. Paul; Bitner-Glindzicz, Maria; Blair, Edward; Blyth, Moira; Bohanna, David; Bourdon, Louise; Bourn, David; Bradley, Lisa; Brady, Angela; Brent, Simon; Brewer, Carole; Brunstrom, Kate; Bunyan, David J.; Burn, John; Canham, Natalie; Castle, Bruce; Chandler, Kate; Chatzimichali, Elena; Cilliers, Deirdre; Clarke, Angus; Clasper, Susan; Clayton-Smith, Jill; Clowes, Virginia; Coates, Andrea; Cole, Trevor; Colgiu, Irina; Collins, Amanda; Collinson, Morag N.; Connell, Fiona; Cooper, Nicola; Cox, Helen; Cresswell, Lara; Cross, Gareth; Crow, Yanick; D'Alessandro, Mariella; Dabir, Tabib; Davidson, Rosemarie; Davies, Sally; de Vries, Dylan; Dean, John; Deshpande, Charu; Devlin, Gemma; Dixit, Abhijit; Dobbie, Angus; Donaldson, Alan; Donnai, Dian; Donnelly, Deirdre; Donnelly, Carina; Douglas, Angela; Douzgou, Sofia; Duncan, Alexis; Eason, Jacqueline; Ellard, Sian; Ellis, Ian; Elmslie, Frances; Evans, Karenza; Everest, Sarah; Fendick, Tina; Fisher, Richard; Flinter, Frances; Foulds, Nicola; Fry, Andrew; Fryer, Alan; Gardiner, Carol; Gaunt, Lorraine; Ghali, Neeti; Gibbons, Richard; Gill, Harinder; Goodship, Judith; Goudie, David; Gray, Emma; Green, Andrew; Greene, Philip; Greenhalgh, Lynn; Gribble, Susan; Harrison, Rachel; Harrison, Lucy; Harrison, Victoria; Hawkins, Rose; He, Liu; Hellens, Stephen; Henderson, Alex; Hewitt, Sarah; Hildyard, Lucy; Hobson, Emma; Holden, Simon; Holder, Muriel; Holder, Susan; Hollingsworth, Georgina; Homfray, Tessa; Humphreys, Mervyn; Hurst, Jane; Hutton, Ben; Ingram, Stuart; Irving, Melita; Islam, Lily; Jackson, Andrew; Jarvis, Joanna; Jenkins, Lucy; Johnson, Diana; Jones, Elizabeth; Josifova, Dragana; Joss, Shelagh; Kaemba, Beckie; Kazembe, Sandra; Kelsell, Rosemary; Kerr, Bronwyn; Kingston, Helen; Kini, Usha; Kinning, Esther; Kirby, Gail; Kirk, Claire; Kivuva, Emma; Kraus, Alison; Kumar, Dhavendra; Kumar, V. K. Ajith; Lachlan, Katherine; Lam, Wayne; Lampe, Anne; Langman, Caroline; Lees, Melissa; Lim, Derek; Longman, Cheryl; Lowther, Gordon; Lynch, Sally A.; Magee, Alex; Maher, Eddy; Male, Alison; Mansour, Sahar; Marks, Karen; Martin, Katherine; Maye, Una; McCann, Emma; McConnell, Vivienne; McEntagart, Meriel; McGowan, Ruth; McKay, Kirsten; McKee, Shane; McMullan, Dominic J.; McNerlan, Susan; McWilliam, Catherine; Mehta, Sarju; Metcalfe, Kay; Middleton, Anna; Miedzybrodzka, Zosia; Miles, Emma; Mohammed, Shehla; Montgomery, Tara; Moore, David; Morgan, Sian; Morton, Jenny; Mugalaasi, Hood; Murday, Victoria; Murphy, Helen; Naik, Swati; Nemeth, Andrea; Nevitt, Louise; Newbury-Ecob, Ruth; Norman, Andrew; O'Shea, Rosie; Ogilvie, Caroline; Ong, Kai-Ren; Park, Soo-Mi; Parker, Michael J.; Patel, Chirag; Paterson, Joan; Payne, Stewart; Perrett, Daniel; Phipps, Julie; Pilz, Daniela T.; Pollard, Martin; Pottinger, Caroline; Poulton, Joanna; Pratt, Norman; Prescott, Katrina; Price, Sue; Pridham, Abigail; Procter, Annie; Purnell, Hellen; Quarrell, Oliver; Ragge, Nicola; Rahbari, Raheleh; Randall, Josh; Rankin, Julia; Raymond, Lucy; Rice, Debbie; Robert, Leema; Roberts, Eileen; Roberts, Jonathan; Roberts, Paul; Roberts, Gillian; Ross, Alison; Rosser, Elisabeth; Saggar, Anand; Samant, Shalaka; Sampson, Julian; Sandford, Richard; Sarkar, Ajoy; Schweiger, Susann; Scott, Richard; Scurr, Ingrid; Selby, Ann; Seller, Anneke; Sequeira, Cheryl; Shannon, Nora; Sharif, Saba; Shaw-Smith, Charles; Shearing, Emma; Shears, Debbie; Sheridan, Eamonn; Simonic, Ingrid; Singzon, Roldan; Skitt, Zara; Smith, Audrey; Smith, Kath; Smithson, Sarah; Sneddon, Linda; Splitt, Miranda; Squires, Miranda; Stewart, Fiona; Stewart, Helen; Straub, Volker; Suri, Mohnish; Sutton, Vivienne; Swaminathan, Ganesh Jawahar; Sweeney, Elizabeth; Tatton-Brown, Kate; Taylor, Cat; Taylor, Rohan; Tein, Mark; Temple, I. Karen; Thomson, Jenny; Tischkowitz, Marc; Tomkins, Susan; Torokwa, Audrey; Treacy, Becky; Turner, Claire; Turnpenny, Peter; Tysoe, Carolyn; Vandersteen, Anthony; Varghese, Vinod; Vasudevan, Pradeep; Vijayarangakannan, Parthiban; Vogt, Julie; Wakeling, Emma; Wallwark, Sarah; Waters, Jonathon; Weber, Astrid; Wellesley, Diana; Whiteford, Margo; Widaa, Sara; Wilcox, Sarah; Wilkinson, Emily; Williams, Denise; Williams, Nicola; Wilson, Louise; Woods, Geoff; Wragg, Christopher; Wright, Michael; Yates, Laura; Yau, Michael; Nellaker, Chris; Parker, Michael; Firth, Helen V.; Wright, Caroline F.; FitzPatrick, David R.; Barrett, Jeffrey C.; Hurles, Matthew E.		Deciphering Dev Disorders DDD	Heterozygous Variants in KMT2E Cause a Spectrum of Neurodevelopmental Disorders and Epilepsy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DE-NOVO MUTATIONS; INTELLECTUAL DISABILITY; PROTEIN; EPIDEMIOLOGY; PREDICTION; DEFECTS; KDM5C; ACTB	We delineate a KMT2E-related neurodevelopmental disorder on the basis of 38 individuals in 36 families. This study includes 31 distinct heterozygous variants in KMT2E (28 ascertained from Matchmaker Exchange and three previously reported), and four individuals with chromosome 7q22.2-22.23 microdeletions encompassing KMT2E (one previously reported). Almost all variants occurred de novo, and most were truncating. Most affected individuals with protein-truncating variants presented with mild intellectual disability. One-quarter of individuals met criteria for autism. Additional common features include macrocephaly, hypotonia, functional gastrointestinal abnormalities, and a subtle facial gestalt. Epilepsy was present in about one-fifth of individuals with truncating variants and was responsive to treatment with anti-epileptic medications in almost all. More than 70% of the individuals were male, and expressivity was variable by sex; epilepsy was more common in females and autism more common in males. The four individuals with microdeletions encompassing KMT2E generally presented similarly to those with truncating variants, but the degree of developmental delay was greater. The group of four individuals with missense variants in KMT2E presented with the most severe developmental delays. Epilepsy was present in all individuals with missense variants, often manifesting as treatment-resistant infantile epileptic encephalopathy. Microcephaly was also common in this group. Haploinsufficiency versus gain-of-function or dominant-negative effects specific to these missense variants in KMT2E might explain this divergence in phenotype, but requires independent validation. Disruptive variants in KMT2E are an under-recognized cause of neurodevelopmental abnormalities.	[Accogli, Andrea; Dixit, Abhijit; Duncan, Alexis; Fryer, Alan; Magee, Alex] Harvard Med Sch, Div Genet & Gen, Boston Childrens Hosp, Boston, MA 02115 USA; [Ferrarini, Alessandra; Renieri, Alessandra; Sanchez-Valle, Amarilis; Rodan, Lance H.; Sifrim, Alejandro; Donaldson, Alan; Fry, Andrew; Green, Andrew; Magee, Alex; Ross, Alison] Massachusetts Inst Technol & Harvard, Program Med & Populat Genet, Broad Ctr Mendelian Genom, Broad Inst, Cambridge, MA 02142 USA; [Jonasson, Amy R.; Sanchez-Valle, Amarilis; Collins, Amanda; Male, Alison; Ross, Alison; Saggar, Anand] Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Div Evolut & Genom Sci, Manchester M13 9PL, Lancs, England; [Renieri, Alessandra; Donaldson, Alan; Duncan, Alexis; Rice, Debbie; Saggar, Anand] Univ Chile, Inst Nutr & Tecnol Alimentos, Santiago, Chile; [Jonasson, Amy R.; Telegrafi, Aida; Coates, Andrea; Kraus, Alison; Lim, Derek; Male, Alison] Harvard Med Sch, Boston, MA 02115 USA; [Accogli, Andrea; Jonasson, Amy R.; Telegrafi, Aida; Duncan, Alexis; Henderson, Alex; Magee, Alex; Male, Alison; Nemeth, Andrea] Univ Leipzig, Med Ctr, Inst Human Genet, D-04103 Leipzig, Germany; [Accogli, Andrea; Basinger, Alice A.; Bunyan, David J.; Collins, Amanda; Kraus, Alison] McGill Univ, Dept Neurol & Neurosurg, Dept Pediat, Montreal, PQ H4A 3J1, Canada; [Sanchez-Valle, Amarilis; Kraus, Alison; Longman, Cheryl] Univ Genoa, Genet Sci Materno Infantili, Dipartimento Neurosci Riabilitaz, I-16126 Genoa, Italy; [Basinger, Alice A.; Jonasson, Amy R.; Lavillaureix, Alinoe; Sifrim, Alejandro; Coates, Andrea; Collins, Amanda] IRCCS Ist Giannina Gaslini, I-16147 Genoa, Italy; [Accogli, Andrea; Jonasson, Amy R.; Lavillaureix, Alinoe; Sanchez-Valle, Amarilis; Barnicoat, Angela; Bevan, A. Paul; Collins, Amanda; Dobbie, Angus; Douglas, Angela; Saggar, Anand] Univ Toronto, Hosp Sick Children, Div Neurol, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Sanchez-Valle, Amarilis; Collins, Amanda; Duncan, Alexis; Henderson, Alex; Magee, Alex; Maher, Eddy; Ross, Alison] Karolinska Inst, Dept Mol Med & Surg, Ctr Mol Med, S-17176 Stockholm, Sweden; [Accogli, Andrea; Basinger, Alice A.; Collins, Amanda; Magee, Alex; Ross, Alison] Karolinska Univ Hosp, Dept Clin Genet, S-17176 Stockholm, Sweden; [Accogli, Andrea; Sanchez-Valle, Amarilis; Coates, Andrea; Fry, Andrew; Green, Andrew; Jackson, Andrew; Nemeth, Andrea] Univ Zurich, Inst Med Genet, CH-8952 Zurich, Switzerland; [Sanchez-Valle, Amarilis; Fry, Andrew; Green, Andrew; Jackson, Andrew; Kraus, Alison; Nemeth, Andrea; Norman, Andrew; Saggar, Anand] Univ Zurich, Neurosci Ctr Zurich, CH-8057 Zurich, Switzerland; [Waters, Jonathon] Cook Childrens Phys Network, Genetics, Ft Worth, TX 76104 USA; [Ross, Alison] Univ Florence, Meyer Childrens Hosp, Neuroscience Dept, I-50139 Florence, Italy; [Sanchez-Valle, Amarilis] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; [Renieri, Alessandra] Rady Childrens Hosp San Diego, Div Genet, San Diego, CA 92123 USA; [Ross, Alison] Univ Tubingen, Inst Med Genet & Appl Genom, D-72076 Tubingen, Germany; [Collins, Amanda] Ctr Hosp Univ Rennes, F-35033 Rennes, France; [Collins, Amanda] Hop Paris, AP HP, F-75013 Paris, France; [Magee, Alex] Sorbonne Univ, F-75006 Paris, France; [Colgiu, Irina; Roberts, Eileen] Birmingham Womens & Chil drens Hosp, Natl Hlth Serv Fdn Trust, Birmingham B15 2TG, W Midlands, England; [Male, Alison; Firth, Helen V.] Natl Hlth Serv Fdn Trust, Birmingham B15 2TG, W Midlands, England; [Widjaja, Elysa; Male, Alison] Childrens Mercy Hosp & Clin, Dept Neurol, Kansas City, MO 64108 USA; [Helbig, Ingo; Kraus, Alison] Univ Siena, Med Genet, I-53100 Siena, Italy; [Vogt, Julie; Blyth, Moira] Azienda Osped Univ Senese, Genet Medica, I-53100 Siena, Italy; [Sanchez-Valle, Amarilis; Cross, Gareth] Wellcome Sanger Inst, Wellcome Genome Campus, Hinxton CB10 1SA, England; [Jonasson, Amy R.; Collins, Amanda; Magee, Alex] Ctr Hosp Univ Rennes, F-35033 Rennes, France; [Kraus, Alison; Male, Alison; Saggar, Anand] Groupement Hop, F-59020 Lille, France; [Awada, Jana; Temple, I. Karen; FitzPatrick, David R.] Aarhus Univ Hosp, Dept Clin Genet, DK-8200 Aarhus, Denmark; [Lavillaureix, Alinoe; Magee, Alex; Ross, Alison] Aarhus Univ Hosp, DK-8200 Aarhus, Denmark; [Jonasson, Amy R.; Renieri, Alessandra; Collins, Amanda; Fryer, Alan; Kraus, Alison; Magee, Alex; Male, Alison; Ross, Alison] St Vincents Childrens Hosp, Indianapolis, IN 46260 USA; [Accogli, Andrea; Basinger, Alice A.; Sanchez-Valle, Amarilis; Collins, Amanda; Duncan, Alexis; Gray, Emma; Male, Alison] Italian Hosp Lugano, Med Genet Unit, Lugano, Switzerland; [Ferrarini, Alessandra; Jonasson, Amy R.; Sanchez-Valle, Amarilis; Trauner, Doris A.; Elmslie, Frances; Goodship, Judith; Kraus, Alison; Magee, Alex; Male, Alison] Univ Oxford, Oxford Natl Inst Hlth Res Biomed Res Ctr, Oxford OX3 7BN, England; [Demurger, Florence; Widjaja, Elysa; Prigmore, Elena; Elmslie, Frances; Jones, Elizabeth] Childrens Hosp Philadelphia, Div Neurol & Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA; [Accogli, Andrea; Basinger, Alice A.; Bevan, A. Paul; Coates, Andrea; Fry, Andrew; Green, Andrew; Jackson, Andrew; McCann, Emma; Nemeth, Andrea; Saggar, Anand] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Renieri, Alessandra; Sanchez-Valle, Amarilis; Collins, Amanda; Duncan, Alexis; Henderson, Alex; Jackson, Andrew; Magee, Alex; Ross, Alison; Saggar, Anand; Nellaker, Chris] Christian Albrechts Univ Kiel, Univ Med Ctr, Dept Neuropediatr, D-24105 Kiel, Germany; [Accogli, Andrea; Jonasson, Amy R.; Sanchez-Valle, Amarilis; Collins, Amanda; Kivuva, Emma; Ross, Alison; Saggar, Anand] GeneDx, Gaithersburg, MD 20877 USA; [Demurger, Florence; de Vries, Dylan; Donnai, Dian; Flinter, Frances; Hollingsworth, Georgina; Irving, Melita; Marks, Karen; Patel, Chirag] Ctr Hosp Univ Nantes, F-44093 Nantes, France; [Demurger, Florence; Taylor, Jenny C.; Vogt, Julie; Devlin, Gemma; Elmslie, Frances; Marks, Karen; McEntagart, Meriel; Ong, Kai-Ren; Poulton, Joanna; Rice, Debbie; Tein, Mark; Thomson, Jenny; Hurles, Matthew E.] Univ Florida, Dept Pediat, Gainesville, FL 32610 USA; [Culliton, Lisa; McWalter, Kirsty; Steindl, Katharina; Wentzensen, Ingrid M.; Ghali, Neeti; Rankin, Julia; Wilkinson, Emily; Barrett, Jeffrey C.] Univ Med Ctr Utrecht, Dept Med Genet, NL-3584 CX Utrecht, Netherlands; [Abou Jamra, Rami; Escobar, Luis F.; Wentzensen, Ingrid M.; Alvi, Mohsan; Jones, Philip; Collinson, Morag N.; Roberts, Jonathan; Sharif, Saba; Taylor, Rohan; Whiteford, Margo; Yates, Laura] Univ Oxford, Ludwig Inst Canc Res, Nuffield Dept Clin Med, Oxford OX3 7DQ, England; [Masruha, Marcelo R.; Kaplanis, Joanna; Bourdon, Louise; McEntagart, Meriel; Raymond, Lucy; Wilson, Louise; Woods, Geoff] Amsterdam Univ Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [Bird, Lynne M.; Dowling, James J.; Ramos, Luiza L. P.; Blyth, Moira; Pratt, Norman; Raymond, Lucy; Wilson, Louise] Univ Amsterdam, Dept Clin Genet, Med Ctr, Amsterdam, Netherlands; [Helbig, Ingo; Sanchez-Valle, Amarilis; Collins, Amanda; Male, Alison; Raymond, Lucy; Ross, Alison] Radboud Univ Nijmegen, Dept Clin Genet, Med Ctr, NL-6525 GA Nijmegen, Netherlands; [Kaplanis, Joanna; Hollingsworth, Georgina; Hurst, Jane; Robert, Leema; Roberts, Gillian; Simonic, Ingrid] Spectrum Hlth, Div Med Genet & Genom, Grand Rapids, MI 49544 USA; [Steindl, Katharina; Vogel, Ida; Burn, John; Temple, I. Karen] Univ Fed Sao Paulo, Dept Neurol & Neurosurg, BR-04023 Sao Paulo, Brazil; [Dowling, James J.; Trauner, Doris A.; Gaunt, Lorraine; Hildyard, Lucy; Male, Alison; Sneddon, Linda; Firth, Helen V.] Univ Toronto, Hosp Sick Children, Div Clin & Metab Genet, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Lavillaureix, Alinoe; Collins, Amanda; Henderson, Alex; Kraus, Alison; Male, Alison; Ross, Alison] Pediat Dept So Switzerland, San Giovanni Hosp, Neuropediat Unit, CH-6500 Bellinzona, Switzerland; [Accogli, Andrea; Jonasson, Amy R.; Sanchez-Valle, Amarilis; Coates, Andrea; Collins, Amanda; Saggar, Anand] Univ Zurich, Clin Res Prior Program Rare Dis, Rare Dis Initiat Zurich, CH-8006 Zurich, Switzerland; [Accogli, Andrea; Jonasson, Amy R.; Sanchez-Valle, Amarilis; Collins, Amanda; Male, Alison; Ross, Alison; Saggar, Anand; Scurr, Ingrid] Univ S Florida, Div Genet & Metab, Dept Pediat, Tampa, FL 33606 USA; [Jonasson, Amy R.; Sanchez-Valle, Amarilis; Duncan, Alexis; Fryer, Alan; Kraus, Alison; Pilz, Daniela T.; Ross, Alison; Sarkar, Ajoy] Rady Childrens Hosp, Pediat Neurol, San Diego, CA 92123 USA; [Accogli, Andrea; Basinger, Alice A.; Jonasson, Amy R.; Sanchez-Valle, Amarilis; Chatzimichali, Elena; Collins, Amanda; Henderson, Alex; Ross, Alison] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Basinger, Alice A.; Heron, Delphine; Collins, Amanda; Fryer, Alan; Kraus, Alison; Magee, Alex; Male, Alison; Ross, Alison] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Sanchez-Valle, Amarilis; Sifrim, Alejandro; Collins, Amanda; Kraus, Alison; Magee, Alex; Male, Alison; Roberts, Eileen; Ross, Alison] Childrens Mercy Hosp & Clin, Ctr Pediat Genom Med, Kansas City, MO 64108 USA; [Sanchez-Valle, Amarilis; Duncan, Alexis; Kraus, Alison; Male, Alison; Ross, Alison; Saggar, Anand] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Basinger, Alice A.; Renieri, Alessandra; Sanchez-Valle, Amarilis; Bohanna, David; Duncan, Alexis; Male, Alison] Univ Tuspacing, Hertie Inst Clin Brain Res, Dept Neurol & Epileptol, D-72076 Tubingen, Germany; [Lavillaureix, Alinoe; Collins, Amanda; Duncan, Alexis; Kraus, Alison] Childrens Mercy Hosp & Clin, Dept Pathol & Lab Med, Kansas City, MO 64108 USA; [Lavillaureix, Alinoe; Kraus, Alison; Male, Alison; Ross, Alison; Tysoe, Carolyn] Childrens Mercy Hosp & Clin, Kansas City, MO 64108 USA; [Basinger, Alice A.; Lavillaureix, Alinoe; Cilliers, Deirdre; Collins, Amanda; Kraus, Alison; Male, Alison; Ross, Alison] Childrens Mercy Hosp & Clin, Neurol & Inherited, Kansas City, MO 64108 USA; [Accogli, Andrea; Jonasson, Amy R.; Sanchez-Valle, Amarilis; Collins, Amanda; Hobson, Emma; Kraus, Alison; Male, Alison; Ross, Alison; Saggar, Anand] Childrens Mercy Hosp & Clin, Dept Pathol & Lab Med, Kansas City, MO 64108 USA; [Accogli, Andrea; Basinger, Alice A.; Jonasson, Amy R.; Lavillaureix, Alinoe; Sanchez-Valle, Amarilis; Coates, Andrea; Collins, Amanda; Duncan, Alexis; Kraus, Alison; Magee, Alex; Male, Alison; Saggar, Anand] Aarhus Univ Hosp, Ctr Fetal Diagnost, DK-8200 Aarhus, Denmark; [Accogli, Andrea; Lavillaureix, Alinoe; Duncan, Alexis; Magee, Alex; Ross, Alison; FitzPatrick, David R.] Aarhus Univ Hosp, DK-8200 Aarhus, Denmark; [Accogli, Andrea; Blair, Edward; Coates, Andrea; Kraus, Alison; Male, Alison; Saggar, Anand] UnivToronto, Hosp Sick Children, Dept Diagnost Imaging, Toronto, ON M5G 1X8, Canada; [Sifrim, Alejandro; Collins, Amanda; Duncan, Alexis; Ross, Alison; Deciphering Dev Disorders DDD] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Accogli, Andrea; Basinger, Alice A.; Jonasson, Amy R.; Renieri, Alessandra; Sifrim, Alejandro; Collins, Amanda; Duncan, Alexis; Fryer, Alan; Kraus, Alison; Magee, Alex; Nemeth, Andrea; Norman, Andrew] Scripps Res Inst, La Jolla, CA 92037 USA; [Lavillaureix, Alinoe; Sanchez-Valle, Amarilis; Tivey, Adrian R.; Collins, Amanda; Henderson, Alex; Moore, David; Nemeth, Andrea] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Accogli, Andrea; Basinger, Alice A.; Lavillaureix, Alinoe; Sanchez-Valle, Amarilis; Collins, Amanda; Kraus, Alison; Male, Alison; Ross, Alison] Manchester Univ Natl Hlth Serv Fdn Trust, Hlth Innovat Manchester, St Marys Hosp, Manchester Ctr Genom Med, Manchester M13 9WL, Lancs, England; [Rodan, Lance H.] Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Manchester; Universidad de Chile; Harvard University; Harvard Medical School; Leipzig University; McGill University; University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Zurich; University of Zurich; Cook Children's Medical Center; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; Eberhard Karls University of Tubingen; CHU Rennes; Universite de Rennes 1; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Sorbonne Universite; Children's Mercy Hospital; University of Siena; University of Siena; University Hospital of Siena; Wellcome Trust Sanger Institute; CHU Rennes; Universite de Rennes 1; Aarhus University; Aarhus University; University of Oxford; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Kiel; Schleswig Holstein University Hospital; Nantes Universite; CHU de Nantes; State University System of Florida; University of Florida; Utrecht University; Utrecht University Medical Center; Ludwig Institute for Cancer Research; University of Oxford; University of Amsterdam; Radboud University Nijmegen; Michigan State University; Michigan State University College of Human Medicine; Universidade Federal de Sao Paulo (UNIFESP); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Regional Hospital of Bellinzona & Valleys, San Giovanni; University of Zurich; State University System of Florida; University of South Florida; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Children's Mercy Hospital; Children's Mercy Hospital; Children's Mercy Hospital; Children's Mercy Hospital; Aarhus University; Aarhus University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; University of Manchester; Harvard University; Boston Children's Hospital; Harvard Medical School	O'Donnell-Luria, AH; Rodan, LH (corresponding author), Harvard Med Sch, Div Genet & Gen, Boston Childrens Hosp, Boston, MA 02115 USA.; O'Donnell-Luria, AH; Rodan, LH (corresponding author), Massachusetts Inst Technol & Harvard, Program Med & Populat Genet, Broad Ctr Mendelian Genom, Broad Inst, Cambridge, MA 02142 USA.; O'Donnell-Luria, AH; Rodan, LH (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA.	Anne.ODonnell@childrens.harvard.edu; Lance.Rodan@childrens.harvard.edu	Sifrim, Alejandro/AAY-2019-2021; Ogilve, Caroline/AAW-3793-2021; Rauch, Anita/C-5568-2014; Smol, Thomas/AAR-8827-2020; lavillaureix, alinoe/ABG-3435-2021; Faundes, Víctor/A-2125-2011; Vogel, Ida/AAD-1087-2019; Fry, Andrew/AFK-7448-2022; Buchert, Rebecca/R-6386-2019; Akawi, Nadia/AAX-2650-2020; Bird, Lynne/AAG-9533-2021; LACHLAN, KATHERINE/ABH-6991-2020; Marcelis, C.L.M./L-4504-2015; Poulton, Joanna/AAB-4828-2021; Villard, Laurent/E-3941-2016; Balasubramanian, Meena/AGB-4083-2022; Fry, Andrew/AAN-2730-2020; Houge, Sofia Douzgou/I-2049-2019; Mark, Paul/AAK-2153-2020; Abou Jamra, Rami/AAC-8192-2019; KRISHNAPPA, NETRAVATHI/AAD-9576-2021; Helbig, Ingo/G-8467-2018; Syrbe, Steffen/ABE-8020-2020; Sanchez-Valle, Amarilis/AAS-7075-2021; Isidor, Bertrand/AAJ-3456-2021; Bianchini, Claudia/J-2840-2018; Helbig, Katherine/B-7454-2012; Renieri, Alessandra/K-5950-2016	Sifrim, Alejandro/0000-0001-8247-4020; Rauch, Anita/0000-0003-2930-3163; lavillaureix, alinoe/0000-0002-3727-9530; Faundes, Víctor/0000-0002-6746-0103; Vogel, Ida/0000-0002-1125-0393; Fry, Andrew/0000-0001-9778-6924; Buchert, Rebecca/0000-0001-7576-3326; Akawi, Nadia/0000-0001-6311-7028; LACHLAN, KATHERINE/0000-0002-3816-7346; Marcelis, C.L.M./0000-0001-7095-4641; Villard, Laurent/0000-0001-6657-5008; Balasubramanian, Meena/0000-0003-1488-3695; Fry, Andrew/0000-0001-9778-6924; Houge, Sofia Douzgou/0000-0001-8890-7544; Abou Jamra, Rami/0000-0002-1542-1399; Helbig, Ingo/0000-0001-8486-0558; Isidor, Bertrand/0000-0001-6480-126X; Bianchini, Claudia/0000-0002-7144-785X; de Vries, Dylan/0000-0002-0953-0257; Maegawa, Gustavo/0000-0001-6933-4138; McKee, Shane/0000-0002-1772-0106; Murphy, Helen/0000-0002-5489-0614; Ramos, Luiza/0000-0003-1668-1683; Bird, Lynne/0000-0003-4833-3747; Smol, Thomas/0000-0002-0119-5896; Lim, Derek/0000-0002-6915-1363; O'Donnell-Luria, Anne/0000-0001-6418-9592; Eiset, Saga Elise/0000-0001-5582-3870; Andrews, Saadet/0000-0001-8396-6764; Helbig, Katherine/0000-0001-8249-0549; Sveden, Abigail/0000-0003-2350-5995; Nava, Caroline/0000-0003-1272-0518; Renieri, Alessandra/0000-0002-0846-9220; Straub, Volker/0000-0001-9046-3540; Taylor, Jenny/0000-0003-3602-5704; Lu, Xin/0000-0002-6587-1152; Heide, Solveig/0000-0002-4673-9762; Banka, Siddharth/0000-0002-8527-2210; Wright, Caroline/0000-0003-2958-5076; Pais, Lynn/0000-0001-9673-4305; Burn, John/0000-0002-9823-2322; Mark, Paul R./0000-0002-1020-888X; Nemeth, Andrea/0000-0002-2941-7657; VAN DER LINDEN JUNIOR, HELIO/0000-0002-3123-2264; Accogli, Andrea/0000-0001-8724-6721; Luria, Victor/0000-0003-0558-0983; Green, Andrew/0000-0002-1077-7417; Lynch, Sally Ann/0000-0003-3540-1333	National Institutes of Health's National Institute of Child Health and Human Development (NICHD) [K12HD052896]; Boston Children's Hospital Faculty Development Fellowship; National Human Genome Research Institute [UM1HG008900]; NICHD [R01 HD073104, R01 HD091846]; Chile's National Commission for Scientific and Technological Research (CONICYT) [72160007]; German Research Society [DFG WE4896/3-1, WE4896/4-1, HE5415/3-1, HE5415/5-1, HE5415/6-1, HE5415/7-1]; Children's Hospital of Philadelphia; University of Kiel; Dietmar-Hopp-Stiftung [1DH1813319]; Health Innovation Challenge Fund [R6-388/WT 100127, HICF-1009-003]; National Institute for Health Research through the Comprehensive Clinical Research Network; Skaggs-Oxford Scholarship; Department of Health [WT098051]; Wellcome Sanger Institute [WT098051]; MRC [MC_PC_16018] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD073104, K12HD052896, R01HD091846] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG009141, UM1HG008900] Funding Source: NIH RePORTER	National Institutes of Health's National Institute of Child Health and Human Development (NICHD); Boston Children's Hospital Faculty Development Fellowship; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Chile's National Commission for Scientific and Technological Research (CONICYT); German Research Society(German Research Foundation (DFG)); Children's Hospital of Philadelphia; University of Kiel; Dietmar-Hopp-Stiftung; Health Innovation Challenge Fund; National Institute for Health Research through the Comprehensive Clinical Research Network(National Institute for Health Research (NIHR)); Skaggs-Oxford Scholarship; Department of Health; Wellcome Sanger Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Support was provided by the National Institutes of Health's National Institute of Child Health and Human Development (NICHD) (K12HD052896) and the Boston Children's Hospital Faculty Development Fellowship to A.H.O.L.; the National Human Genome Research Institute-funded Broad Center for Mendelian Genomics (UM1HG008900) to L.S.P., A.S., and S.B.; by NICHD (R01 HD073104 and R01 HD091846) to V.L.; by Chile's National Commission for Scientific and Technological Research (CONICYT) (72160007) to V.F.; by the German Research Society (DFG WE4896/3-1, WE4896/4-1, HE5415/3-1, HE5415/5-1, HE5415/6-1, HE5415/7-1) to Y.W. and I.H.; by intramural funds from the Children's Hospital of Philadelphia and the University of Kiel to I.H.; by Dietmar-Hopp-Stiftung (1DH1813319) to S.S.; by the Health Innovation Challenge Fund (R6-388/WT 100127) and the National Institute for Health Research through the Comprehensive Clinical Research Network to J.C.T.; and by a Skaggs-Oxford Scholarship to J.Z.. The DDD Study (Cambridge South REC approval 10/H0305/83 and the Republic of Ireland REC GEN/284/12) presents independent research commissioned by the Health Innovation Challenge Fund (HICF-1009-003), a parallel funding partnership between the Department of Health and the Wellcome Sanger Institute (WT098051). Views expressed here are those of the authors and not necessarily those of the Wellcome or the Department of Health.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Brookes E, 2015, HUM MOL GENET, V24, P2861, DOI 10.1093/hmg/ddv046; Cuvertino S, 2017, AM J HUM GENET, V101, P1021, DOI 10.1016/j.ajhg.2017.11.006; Dong S, 2014, CELL REP, V9, P16, DOI 10.1016/j.celrep.2014.08.068; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Faundes V, 2018, AM J HUM GENET, V102, P175, DOI 10.1016/j.ajhg.2017.11.013; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Heuser M, 2009, BLOOD, V113, P1432, DOI [10.1182/blood-2008-02-162263, 10.1182/blood-2008-06-162263]; Hong Y, 2012, J NEUROSCI, V32, P17262, DOI 10.1523/JNEUROSCI.3300-12.2012; Il'yasova D, 2012, CLIN CHIM ACTA, V413, P1446, DOI 10.1016/j.cca.2012.06.012; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Jones WD, 2012, AM J HUM GENET, V91, P358, DOI 10.1016/j.ajhg.2012.06.008; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Koemans TS, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006864; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Madan V, 2009, BLOOD, V113, P1444, DOI 10.1182/blood-2008-02-142638; Mas-y-Mas S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165139; McHugh JC, 2008, INT REV NEUROBIOL, V83, P11, DOI 10.1016/S0074-7742(08)00002-0; Nakagawa T, 2011, MOL CELL, V43, P381, DOI 10.1016/j.molcel.2011.05.033; Philippakis AA, 2015, HUM MUTAT, V36, P915, DOI 10.1002/humu.22858; Poeta L, 2013, AM J HUM GENET, V92, P114, DOI 10.1016/j.ajhg.2012.11.008; Rao RC, 2015, NAT REV CANCER, V15, P334, DOI 10.1038/nrc3929; Riviere J-B, 2012, NAT GENET, V44, pS1; Riviere JB, 2012, NAT GENET, V44, P440, DOI 10.1038/ng.1091; Shen E, 2014, PHILOS T R SOC LON B, P369; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Tasdogan A, 2016, CELL STEM CELL, V19, P752, DOI 10.1016/j.stem.2016.08.007; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Uliana V, 2010, EUR J MED GENET, V53, P168, DOI 10.1016/j.ejmg.2010.02.003; Van Laarhoven PM, 2015, HUM MOL GENET, V24, P4443, DOI 10.1093/hmg/ddv180; Wang TY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13316; Watkins AM, 2016, J AM CHEM SOC, V138, P10386, DOI 10.1021/jacs.6b04892; Yap DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027127; Zech M, 2016, AM J HUM GENET, V99, P1377, DOI 10.1016/j.ajhg.2016.10.010; Zhang XM, 2017, CELL MOL LIFE SCI, V74, P2333, DOI 10.1007/s00018-017-2470-8	38	29	29	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 6	2019	104	6					1210	1222		10.1016/j.ajhg.2019.03.021	http://dx.doi.org/10.1016/j.ajhg.2019.03.021			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IB4KJ	31079897	Bronze, Green Accepted, Green Published, Green Submitted			2022-12-18	WOS:000470240000015
J	Smith, IN; Thacker, S; Seyfi, M; Cheng, FX; Eng, C				Smith, Iris Nira; Thacker, Stetson; Seyfi, Marilyn; Cheng, Feixiong; Eng, Charis			Conformational Dynamics and Allosteric Regulation Landscapes of Germline PTEN Mutations Associated with Autism Compared to Those Associated with Cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEOME-SCALE MAP; TUMOR-SUPPRESSOR; WEB SERVER; STRUCTURAL COMMUNICATION; PHOSPHATASE-ACTIVITY; FUNCTIONAL-ANALYSIS; STRUCTURE NETWORK; COWDEN DISEASE; GENE; INSIGHTS	Individuals with germline PTEN tumor-suppressor variants have PTEN hamartoma tumor syndrome (PHTS). Clinically, PHTS has variable presentations; there are distinct subsets of PHTS-affected individuals, such as those diagnosed with autism spectrum disorder (ASD) or cancer. It remains unclear why mutations in one gene can lead to such seemingly disparate phenotypes. Therefore, we sought to determine whether it is possible to predict a given PHTS-affected individual's a priori risk of ASD, cancer, or the co-occurrence of both phenotypes. By integrating network proximity analysis performed on the human interactome, molecular simulations, and residue-interaction networks, we demonstrate the role of conformational dynamics in the structural communication and long-range allosteric regulation of germline PTEN variants associated with ASD or cancer. We show that the PTEN interactome shares significant overlap with the ASD and cancer interactomes, providing network-based evidence that PTEN is a crucial player in the biology of both disorders. Importantly, this finding suggests that a germline PTEN variant might perturb the ASD or cancer networks differently, thus favoring one disease outcome at any one time. Furthermore, protein-dynamic structural-network analysis reveals small-world structural communication mediated by highly conserved functional residues and potential allosteric regulation of PTEN. We identified a salient structural-communication pathway that extends across the inter-domain interface for cancer-only mutations. In contrast, the structural-communication pathway is predominantly restricted to the phosphatase domain for ASD-only mutations. Our integrative approach supports the prediction and potential modulation of the relevant conformational states that influence structural communication and long-range perturbations associated with mutational effects that lead to PTEN-ASD or PTEN-cancer phenotypes.	[Smith, Iris Nira; Thacker, Stetson; Seyfi, Marilyn; Cheng, Feixiong; Eng, Charis] Cleveland Clin, Genom Med Inst, Lerner Res Inst, Cleveland, OH 44195 USA; [Thacker, Stetson; Cheng, Feixiong; Eng, Charis] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Cleveland, OH 44195 USA; [Cheng, Feixiong; Eng, Charis] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Eng, Charis] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44195 USA; [Eng, Charis] Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University	Eng, C (corresponding author), Cleveland Clin, Genom Med Inst, Lerner Res Inst, Cleveland, OH 44195 USA.; Eng, C (corresponding author), Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Cleveland, OH 44195 USA.; Eng, C (corresponding author), Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.; Eng, C (corresponding author), Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44195 USA.; Eng, C (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH 44106 USA.	engc@ccf.org	Thacker, Stetson/AAB-8858-2022; Smith, Iris/AAK-2032-2020	Thacker, Stetson/0000-0001-6050-409X; Smith, Iris/0000-0001-5560-8871; Cheng, Feixiong/0000-0002-1736-2847	National Cancer Institute [P01CA124570]; National Institute of Neurological Disorders and Stroke (NINDS) [U54NS092090]; Ambrose Monell Foundation PTEN-Switch Grant; Ohio Supercomputing Center [PCCF0020]; Ambrose Monell Cancer Genomic Medicine Fellowship; National Institutes of Health (NIH) [T32 5T32CA59366-22]; NATIONAL CANCER INSTITUTE [P01CA124570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM088088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS092090] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Ambrose Monell Foundation PTEN-Switch Grant; Ohio Supercomputing Center; Ambrose Monell Cancer Genomic Medicine Fellowship; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all the individuals with PHTS and PTEN-ASD and their families, whose participation was crucial to making this study possible. We thank Dr. Lamis Yehia for critical review of the manuscript. This study was funded, in part, by the National Cancer Institute grant P01CA124570, the National Institute of Neurological Disorders and Stroke (NINDS) grant U54NS092090, the Ambrose Monell Foundation PTEN-Switch Grant, and a grant allocation of computing time from the Ohio Supercomputing Center (PCCF0020) [all to C.E.]. I. N.S. is funded, in part, by the Ambrose Monell Cancer Genomic Medicine Fellowship and the National Institutes of Health (NIH) T32 5T32CA59366-22. C.E. is an American Cancer Society Clinical Research Professor and the Sondra J. and Stephen R. Hardis Endowed Chair of Cancer Genomic Medicine at the Cleveland Clinic.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkv1290, 10.1093/nar/gkx1095]; Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; Anastasio NC, 2013, J NEUROSCI, V33, P1615, DOI 10.1523/JNEUROSCI.2656-12.2013; Atilgan AR, 2004, BIOPHYS J, V86, P85, DOI 10.1016/S0006-3495(04)74086-2; Baysal C, 2002, BIOPHYS J, V83, P699, DOI 10.1016/S0006-3495(02)75201-6; Bonchev D, 2007, J CHEM INF MODEL, V47, P909, DOI 10.1021/ci7000617; Borgatti SP, 2006, SOC NETWORKS, V28, P466, DOI 10.1016/j.socnet.2005.11.005; Brinda KV, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-296; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Campbell RB, 2003, J BIOL CHEM, V278, P33617, DOI 10.1074/jbc.C300296200; Chatr-aryamontri A, 2015, NUCLEIC ACIDS RES, V43, pD470, DOI 10.1093/nar/gku1204; Cheng FX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10744-6; Cheng FX, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05116-5; Cheng FX, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004497; Cheng FX, 2014, MOL BIOL EVOL, V31, P2156, DOI 10.1093/molbev/msu167; Daily MD, 2008, PROTEINS, V71, P455, DOI 10.1002/prot.21800; Daily MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000293; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.0.CO;2-M; Davidson L, 2010, ONCOGENE, V29, P687, DOI 10.1038/onc.2009.384; Davis AP, 2011, NUCLEIC ACIDS RES, V39, pD1067, DOI 10.1093/nar/gkq813; del Sol A, 2005, PROTEINS, V58, P672, DOI 10.1002/prot.20348; del Sol A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100063; Di Paola L, 2013, CHEM REV, V113, P1598, DOI 10.1021/cr3002356; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; Doshi U, 2016, P NATL ACAD SCI USA, V113, P4735, DOI 10.1073/pnas.1523573113; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Fanelli F, 2016, BIOCHEM SOC T, V44, P613, DOI 10.1042/BST20150283; Fang YP, 2010, CHEMOMETR INTELL LAB, V101, P123, DOI 10.1016/j.chemolab.2010.02.005; Fazekas D, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-7; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Gardino AK, 2009, CELL, V139, P1109, DOI 10.1016/j.cell.2009.11.022; Georgescu Maria-Magdalena, 2010, Genes Cancer, V1, P1170, DOI 10.1177/1947601911407325; Gu JG, 1998, J CELL BIOL, V143, P1375, DOI 10.1083/jcb.143.5.1375; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hernandez-Boussard T, 2008, NUCLEIC ACIDS RES, V36, pD913, DOI 10.1093/nar/gkm1009; Ho J., 2019, MOVING P VALUES EVER, DOI [10.1101/377978, DOI 10.1101/377978]; Hu G, 2013, CURR PROTEIN PEPT SC, V14, P121, DOI 10.2174/1389203711314020004; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Isogai S, 2016, NATURE, V530, P237, DOI 10.1038/nature16577; Kanna N, 1999, J MOL BIOL, V292, P441, DOI 10.1006/jmbi.1999.3058; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Leslie NR, 2011, TRENDS PHARMACOL SCI, V32, P131, DOI 10.1016/j.tips.2010.12.005; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Lobo GP, 2009, HUM MOL GENET, V18, P2851, DOI 10.1093/hmg/ddp220; Maehama T, 1999, TRENDS CELL BIOL, V9, P125, DOI 10.1016/S0962-8924(99)01519-6; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; Matreyek KA, 2018, NAT GENET, V50, P874, DOI 10.1038/s41588-018-0122-z; Meyer MJ, 2013, BIOINFORMATICS, V29, P1577, DOI 10.1093/bioinformatics/btt181; Moncalero VL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018857; Myers MP, 1997, P NATL ACAD SCI USA, V94, P9052, DOI 10.1073/pnas.94.17.9052; Nanda H, 2015, METHODS, V77-78, P136, DOI 10.1016/j.ymeth.2014.10.014; Nelen MR, 1996, NAT GENET, V13, P114, DOI 10.1038/ng0596-114; Nelen MR, 1997, HUM MOL GENET, V6, P1383, DOI 10.1093/hmg/6.8.1383; Nussinov R, 2013, ANNU REV BIOPHYS, V42, P169, DOI 10.1146/annurev-biophys-083012-130257; Nussinov R, 2013, CELL, V153, P293, DOI 10.1016/j.cell.2013.03.034; Nussinov R, 2011, TRENDS PHARMACOL SCI, V32, P686, DOI 10.1016/j.tips.2011.08.004; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Papa A, 2014, CELL, V157, P595, DOI 10.1016/j.cell.2014.03.027; Piovesan D, 2016, NUCLEIC ACIDS RES, V44, pW367, DOI 10.1093/nar/gkw315; Raimondi F, 2013, J CHEM THEORY COMPUT, V9, P2504, DOI 10.1021/ct400096f; Rajasekaran N, 2017, BIOCHEM J, V474, P2379, DOI 10.1042/BCJ20170304; Redfern RE, 2008, BIOCHEMISTRY-US, V47, P2162, DOI 10.1021/bi702114w; Rodriguez-Escudero I, 2011, HUM MOL GENET, V20, P4132, DOI 10.1093/hmg/ddr337; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Rose PW, 2017, NUCLEIC ACIDS RES, V45, pD271, DOI 10.1093/nar/gkw1000; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Seeber M, 2015, BIOINFORMATICS, V31, P779, DOI 10.1093/bioinformatics/btu718; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith IN, 2016, PROTEINS, V84, P1625, DOI 10.1002/prot.25105; Smith IN, 2019, J BIOMOL STRUCT DYN, V37, P1766, DOI 10.1080/07391102.2018.1465854; Spinelli L, 2015, J MED GENET, V52, P128, DOI 10.1136/jmedgenet-2014-102803; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stelzer G., 2016, CURR PROTOC BIOINFOR, V54, P1, DOI [10.1002/cpbi.5, DOI 10.1002/CPBI.5]; Tamguney T, 2007, J CELL SCI, V120, P4071, DOI 10.1242/jcs.015230; Tan KP, 2013, NUCLEIC ACIDS RES, V41, pW314, DOI 10.1093/nar/gkt503; Tan MH, 2012, CLIN CANCER RES, V18, P400, DOI 10.1158/1078-0432.CCR-11-2283; Tan MH, 2011, AM J HUM GENET, V88, P42, DOI 10.1016/j.ajhg.2010.11.013; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Verkhivker GM, 2019, BBA-GEN SUBJECTS, V1863, P210, DOI 10.1016/j.bbagen.2018.10.009; Vijayabaskar MS, 2010, BIOPHYS J, V99, P3704, DOI 10.1016/j.bpj.2010.08.079; Vishveshwara S, 2009, CURR PROTEIN PEPT SC, V10, P146, DOI 10.2174/138920309787847590; Wang L, 2006, BIOCHEMISTRY-US, V45, P1383, DOI 10.1021/bi0518242; Yu W, 2008, NAT GENET, V40, P124, DOI 10.1038/ng0208-124; Zhang XC, 2012, BIOCHEM J, V444, P457, DOI 10.1042/BJ20120098; Zhao JF, 2017, CANCER RES, V77, P2810, DOI 10.1158/0008-5472.CAN-16-2460; 2007, FEBS LETT, V581, P2776	88	29	30	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 2	2019	104	5					861	878		10.1016/j.ajhg.2019.03.009	http://dx.doi.org/10.1016/j.ajhg.2019.03.009			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	HW3QV	31006514	Green Published, Bronze			2022-12-18	WOS:000466608700007
J	Remacha, L; Pirman, D; Mahoney, CE; Coloma, J; Calsina, B; Curras-Freixes, M; Leton, R; Torres-Perez, R; Richter, S; Pita, G; Herraez, B; Cianchetta, G; Honrado, E; Maestre, L; Urioste, M; Aller, J; Garcia-Uriarte, O; Galvez, MA; Luque, RM; Lahera, M; Moreno-Rengel, C; Eisenhofer, G; Montero-Conde, C; Rodriguez-Antona, C; Llorca, O; Smolen, GA; Robledo, M; Cascon, A				Remacha, Laura; Pirman, David; Mahoney, Christopher E.; Coloma, Javier; Calsina, Bruna; Curras-Freixes, Maria; Leton, Rocio; Torres-Perez, Rafael; Richter, Susan; Pita, Guillermo; Herraez, Belen; Cianchetta, Giovanni; Honrado, Emiliano; Maestre, Lorena; Urioste, Miguel; Aller, Javier; Garcia-Uriarte, Oscar; Angeles Galvez, Maria; Luque, Raul M.; Lahera, Marcos; Moreno-Rengel, Cristina; Eisenhofer, Graeme; Montero-Conde, Cristina; Rodriguez-Antona, Cristina; Llorca, Oscar; Smolen, Gromoslaw A.; Robledo, Mercedes; Cascon, Alberto			Recurrent Germline DLST Mutations in Individuals with Multiple Pheochromocytomas and Paragangliomas	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPREHENSIVE MOLECULAR CHARACTERIZATION; ALPHA-KETOGLUTARATE DEHYDROGENASE; GENE-MUTATIONS; ENCEPHALOPATHY; COMPONENT; ESTABLISH; SUBUNIT; SDHB	Pheochromocytomas and paragangliomas (PPGLs) provide some of the clearest genetic evidence for the critical role of metabolism in the tumorigenesis process. Approximately 40% of PPGLs are caused by driver germline mutations in 16 known susceptibility genes, and approximately half of these genes encode members of the tricarboxylic acid (TCA) cycle. Taking as a starting point the involvement of the TCA cycle in PPGL development, we aimed to identify unreported mutations that occurred in genes involved in this key metabolic pathway and that could explain the phenotypes of additional individuals who lack mutations in known susceptibility genes. To accomplish this, we applied a targeted sequencing of 37 TCA-cycle-related genes to DNA from 104 PPGL-affected individuals with no mutations in the major known predisposing genes. We also performed omics-based analyses, TCA-related metabolite determination, and C-13(5)-glutamate labeling assays. We identified five germline variants affecting DLST in eight unrelated individuals (similar to 7%); all except one were diagnosed with multiple PPGLs. A recurrent variant, c.1121G>A (p.Gly374Glu), found in four of the eight individuals triggered accumulation of 2-hydroxyglutarate, both in tumors and in a heterologous cell-based assay designed to functionally evaluate DLST variants. p.Gly374Glu-DLST tumors exhibited loss of heterozygosity, and their methylation and expression profiles are similar to those of EPAS1-mutated PPGLs; this similarity suggests a link between DLST disruption and pseudohypoxia. Moreover, we found positive DLST immunostaining exclusively in tumors carrying TCA-cycle or EPAS1 mutations. In summary, this study reveals DLST as a PPGL-susceptibility gene and further strengthens the relevance of the TCA cycle in PPGL development.	[Remacha, Laura; Calsina, Bruna; Curras-Freixes, Maria; Leton, Rocio; Torres-Perez, Rafael; Montero-Conde, Cristina; Rodriguez-Antona, Cristina; Robledo, Mercedes; Cascon, Alberto] Spanish Natl Canc Res Ctr, Hereditary Endocrine Canc Grp, Madrid 28029, Spain; [Pirman, David; Mahoney, Christopher E.; Cianchetta, Giovanni; Smolen, Gromoslaw A.] Agios Pharmaceut, 88 Sidney St, Cambridge, MA 02139 USA; [Coloma, Javier; Llorca, Oscar] Spanish Natl Canc Res Ctr, Struct Biol Programme, Madrid 28029, Spain; [Richter, Susan; Eisenhofer, Graeme] Tech Univ Dresden, Inst Clin Chem & Lab Med, Univ Hosp Carl Gustav Carus, Med Fac Carl Gustav Carus, D-01069 Dresden, Freistaat Sachs, Germany; [Pita, Guillermo; Herraez, Belen] Spanish Natl Canc Res Ctr, Human Canc Genet Programme, Human Genotyping Unit CeGen, Madrid 28029, Spain; [Honrado, Emiliano] Hosp Leon, Serv Anat Pathol, Leon 24071, Castilla Y Leon, Spain; [Maestre, Lorena] Spanish Natl Canc Res Ctr, Biotechnol Programme, Monoclonal Antibodies Unit, Madrid 28029, Spain; [Urioste, Miguel] Spanish Natl Canc Res Ctr, Familial Canc Clin Unit, Madrid 28029, Spain; [Aller, Javier] Univ Hosp Puerta de Hierro, Dept Endocrinol, Madrid 28222, Spain; [Garcia-Uriarte, Oscar] Univ Hosp Araba, Dept Nephrol, Vitoria 01009, Pais Vasco, Spain; [Angeles Galvez, Maria] Univ Hosp Reina Sofia, Serv Endocrinol & Nutr, Cordoba 14004, Andalucia, Spain; [Angeles Galvez, Maria] Maimonides Inst Biomed Res Cordoba, Cordoba 14004, Andalucia, Spain; [Luque, Raul M.] Maimonides Inst Biomed Res Cordoba, Hormones & Canc Grp, Cordoba 14004, Andalucia, Spain; [Lahera, Marcos] La Princesa Univ Hosp, Endocrinol & Nutr Dept, Madrid 28006, Spain; [Moreno-Rengel, Cristina] Univ Hosp Basurto, Dept Endocrinol & Nutr, Bilbao 48013, Spain; [Rodriguez-Antona, Cristina; Robledo, Mercedes; Cascon, Alberto] Ctr Invest Biomed Red Enfermedades Raras, Madrid 28029, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Agios Pharmaceuticals; Centro Nacional de Investigaciones Oncologicas (CNIO); Technische Universitat Dresden; Carl Gustav Carus University Hospital; Centro Nacional de Investigaciones Oncologicas (CNIO); Universidad de Leon; Hospital de Leon; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Hospital Puerta de Hierro-Majadahonda; University Hospital of Araba; Basurto Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Cascon, A (corresponding author), Spanish Natl Canc Res Ctr, Hereditary Endocrine Canc Grp, Madrid 28029, Spain.; Cascon, A (corresponding author), Ctr Invest Biomed Red Enfermedades Raras, Madrid 28029, Spain.	acascon@cnio.es	Llorca, Oscar/P-2784-2019; Raul, Luque Huertas/M-6948-2018; Leton, Rocio/AAD-7896-2020; Richter, Susan/AAP-1767-2020; Rodriguez-Antona, Cristina/E-1073-2011; Llorca, Oscar/K-1144-2014; Eisenhofer, Graeme/AAU-9829-2021; Montero-Conde, Cristina/K-7349-2014; Robledo, Mercedes/O-2230-2013; Cascon, Alberto/G-3160-2014; Maestre, Lorena/L-1352-2014	Llorca, Oscar/0000-0001-5705-0699; Richter, Susan/0000-0002-3549-2477; Rodriguez-Antona, Cristina/0000-0001-8750-7338; Llorca, Oscar/0000-0001-5705-0699; Eisenhofer, Graeme/0000-0002-8601-9903; Montero-Conde, Cristina/0000-0002-4452-4469; Robledo, Mercedes/0000-0001-6256-5902; Cascon, Alberto/0000-0003-2119-891X; Maestre, Lorena/0000-0001-8743-0422; Pita, Guillermo/0000-0003-2393-0510; Torres-Perez, Rafael/0000-0002-3696-4720; Luque, Raul M./0000-0002-7585-1913	Instituto de Salud Carlos III (ISCIII), through the "Accion Estrategica en Salud'' (AES) [PI15/00783, PI18/00454, PI17/01796]; Deutsche Forschungsgemeinschaft [DFG RI2684/1-1]; PE IthornDthorni 2013-2016 - ISCIII [PT17/0019]; ERDF	Instituto de Salud Carlos III (ISCIII), through the "Accion Estrategica en Salud'' (AES); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); PE IthornDthorni 2013-2016 - ISCIII; ERDF(European Commission)	This work was supported by the Instituto de Salud Carlos III (ISCIII), through the "Accion Estrategica en Salud'' (AES) (projects PI15/00783 and PI18/00454 to A. C. and PI17/01796 to M.R.); co-founded by the European Regional Development Fund [ERDF]), and the Deutsche Forschungsgemeinschaft (DFG RI2684/1-1 to S.R.). The Human Genotyping Unit is a member of the Centro Nacional de Genotipado - Plataforma de Recursos Biomoleculares (CeGen-PRB3) and is supported by grant PT17/0019 of the PE IthornDthorni 2013-2016, funded by ISCIII and ERDF.	Allen EL, 2016, CELL REP, V17, P876, DOI 10.1016/j.celrep.2016.09.052; Amar L, 2007, J CLIN ENDOCR METAB, V92, P3822, DOI 10.1210/jc.2007-0709; [Anonymous], PYMOL MOL GRAPH SYST; Bendl J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003440; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI 10.2217/EPI.09.14; Bjorklund P, 2016, J INTERN MED, V280, P559, DOI 10.1111/joim.12507; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; BOURGERON T, 1994, J CLIN INVEST, V93, P2514, DOI 10.1172/JCI117261; Buffet A, 2018, CANCER RES, V78, P1914, DOI 10.1158/0008-5472.CAN-17-2463; Burnichon N, 2011, HUM MOL GENET, V20, P3974, DOI 10.1093/hmg/ddr324; Burr SP, 2016, CELL METAB, V24, P740, DOI 10.1016/j.cmet.2016.09.015; Cascon A, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv053; Comino-Mendez I, 2011, NAT GENET, V43, P663, DOI 10.1038/ng.861; Dahia PLM, 2014, NAT REV CANCER, V14, P108, DOI 10.1038/nrc3648; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Danhauser K, 2012, AM J HUM GENET, V91, P1082, DOI 10.1016/j.ajhg.2012.10.006; de Cubas AA, 2015, CLIN CANCER RES, V21, P3020, DOI 10.1158/1078-0432.CCR-14-2804; Denes J, 2015, J CLIN ENDOCR METAB, V100, pE531, DOI 10.1210/jc.2014-3399; Fattal-Valevski A, 2017, NEUROGENETICS, V18, P57, DOI 10.1007/s10048-016-0507-z; Fishbein L, 2017, CANCER CELL, V31, P181, DOI 10.1016/j.ccell.2017.01.001; Flynn A, 2015, J PATHOL, V236, P78, DOI 10.1002/path.4503; Gibson GE, 2013, MOL CELL NEUROSCI, V55, P17, DOI 10.1016/j.mcn.2012.09.001; Intlekofer AM, 2017, NAT CHEM BIOL, V13, P494, DOI [10.1038/NCHEMBIO.2307, 10.1038/nchembio.2307]; Kanamori T, 2003, EMBO J, V22, P2913, DOI 10.1093/emboj/cdg299; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Knapp JE, 1998, J MOL BIOL, V280, P655, DOI 10.1006/jmbi.1998.1924; Letouze E, 2013, CANCER CELL, V23, P739, DOI 10.1016/j.ccr.2013.04.018; Linehan WM, 2016, NEW ENGL J MED, V374, P135, DOI 10.1056/NEJMoa1505917; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Jimenez E, 2010, MOL ENDOCRINOL, V24, P2382, DOI 10.1210/me.2010-0256; Lussey-Lepoutre C, 2017, METABOLITES, V7, DOI 10.3390/metabo7020017; Menara M, 2015, J CLIN ENDOCR METAB, V100, pE287, DOI 10.1210/jc.2014-1870; Morrissey ER, 2009, NUCLEIC ACIDS RES, V37, pW581, DOI 10.1093/nar/gkp366; Odievre MH, 2005, HUM MUTAT, V25, DOI 10.1002/humu.9319; Oldham WM, 2015, CELL METAB, V22, P291, DOI 10.1016/j.cmet.2015.06.021; Punzi G, 2018, HUM MOL GENET, V27, P499, DOI 10.1093/hmg/ddx419; Raimundo N, 2011, TRENDS MOL MED, V17, P641, DOI 10.1016/j.molmed.2011.06.001; Ramachandran S, 2011, PROTEINS, V79, P261, DOI 10.1002/prot.22879; Reich M, 2004, BIOINFORMATICS, V20, P1797, DOI 10.1093/bioinformatics/bth138; Remacha L, 2017, CLIN CANCER RES, V23, P6315, DOI 10.1158/1078-0432.CCR-16-2250; Richter S., 2018, GENET MED, V27; Ruderfer DM, 2016, NAT GENET, V48, P1107, DOI 10.1038/ng.3638; Schiavi F, 2010, HUM MUTAT, V31, P761, DOI 10.1002/humu.21269; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; Spiegel K, 2012, AM J HUM GENET, V90, P518, DOI 10.1016/j.ajhg.2012.01.009; Suzuki J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05854-6; Toledo RA, 2017, NAT REV ENDOCRINOL, V13, P233, DOI 10.1038/nrendo.2016.185; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; van Nederveen FH, 2009, LANCET ONCOL, V10, P764, DOI 10.1016/S1470-2045(09)70164-0; Vatrinet R, 2017, CANCER METAB, V5, DOI 10.1186/s40170-017-0165-0; Wang JJ, 2014, J BIOL CHEM, V289, P15215, DOI 10.1074/jbc.M113.544080; Wang YG, 2017, NATURE, V552, P273, DOI 10.1038/nature25003; Yang LC, 2009, NEUROBIOL DIS, V36, P320, DOI 10.1016/j.nbd.2009.07.023; Yoon WH, 2017, NEURON, V93, P115, DOI 10.1016/j.neuron.2016.11.038; Zhou XF, 2018, MOL CANCER RES, V16, P124, DOI 10.1158/1541-7786.MCR-17-0256; Zhou ZH, 2001, P NATL ACAD SCI USA, V98, P14802, DOI 10.1073/pnas.011597698	57	29	29	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 4	2019	104	4					651	664		10.1016/j.ajhg.2019.02.017	http://dx.doi.org/10.1016/j.ajhg.2019.02.017			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HR9JE	30929736	Bronze, Green Published			2022-12-18	WOS:000463474700007
J	Bonnefoy, S; Watson, CM; Kernohan, KD; Lemos, M; Hutchinson, S; Poulter, JA; Crinnion, LA; Berry, I; Simmonds, J; Vasudevan, P; O'Callaghan, C; Hirst, RA; Rutman, A; Huang, LJ; Hartley, T; Grynspan, D; Moya, E; Li, CM; Carr, IM; Bonthron, DT; Leroux, M; Boycott, KM; Bastin, P; Sheridan, EG				Bonnefoy, Serge; Watson, Christopher M.; Kernohan, Kristin D.; Lemos, Moara; Hutchinson, Sebastian; Poulter, James A.; Crinnion, Laura A.; Berry, Ian; Simmonds, Jennifer; Vasudevan, Pradeep; O'Callaghan, Chris; Hirst, Robert A.; Rutman, Andrew; Huang, Lijia; Hartley, Taila; Grynspan, David; Moya, Eduardo; Li, Chunmei; Carr, Ian M.; Bonthron, David T.; Leroux, Michel; Boycott, Kym M.; Bastin, Philippe; Sheridan, Eamonn G.		Care4Rare Canada Consortium	Biallelic Mutations in LRRC56, Encoding a Protein Associated with Intraflagellar Transport, Cause Mucociliary Clearance and Laterality Defects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OUTER DYNEIN ARMS; CILIARY BEAT PATTERN; TRYPANOSOMA-BRUCEI; FUNCTIONAL-ANALYSIS; FLAGELLAR MOTILITY; READ ALIGNMENT; CYTOKINESIS; EXPRESSION; IFT; MORPHOGENESIS	Primary defects in motile cilia result in dysfunction of the apparatus responsible for generating fluid flows. Defects in these mechanisms underlie disorders characterized by poor mucus clearance, resulting in susceptibility to chronic recurrent respiratory infections, often associated with infertility; laterality defects occur in about 50% of such individuals. Here we report biallelic variants in LRRC56 (known as oda8 in Chlamydomonas) identified in three unrelated families. The phenotype comprises laterality defects and chronic pulmonary infections. High-speed video microscopy of cultured epithelial cells from an affected individual showed severely dyskinetic cilia but no obvious ultra-structural abnormalities on routine transmission electron microscopy (TEM). Further investigation revealed that LRRC56 interacts with the intraflagellar transport (IFT) protein IFT88. The link with IFT was interrogated in Trypanosoma brucei. In this protist, LRRC56 is recruited to the cilium during axoneme construction, where it co-localizes with IFT trains and is required for the addition of dynein arms to the distal end of the flagellum. In T. brucei carrying LRRC56-null mutations, or a variant resulting in the p. Leu259Pro substitution corresponding to the p. Leu140Pro variant seen in one of the affected families, we observed abnormal ciliary beat patterns and an absence of outer dynein arms restricted to the distal portion of the axoneme. Together, our findings confirm that deleterious variants in LRRC56 result in a human disease and suggest that this protein has a likely role in dynein transport during cilia assembly that is evolutionarily important for cilia motility.	[Bonnefoy, Serge; Lemos, Moara; Hutchinson, Sebastian; Bastin, Philippe] Inst Pasteur, Trypanosome Cell Biol Unit, 25 Rue Docteur Roux, F-75015 Paris, France; [Bonnefoy, Serge; Lemos, Moara; Hutchinson, Sebastian; Bastin, Philippe] Inst Pasteur, INSERM, U1201, 25 Rue Docteur Roux, F-75015 Paris, France; [Watson, Christopher M.; Crinnion, Laura A.; Berry, Ian; Simmonds, Jennifer; Bonthron, David T.; Sheridan, Eamonn G.] St James Univ Hosp, Yorkshire Reg Genet Serv, Leeds LS9 7TF, W Yorkshire, England; [Watson, Christopher M.; Poulter, James A.; Crinnion, Laura A.; Carr, Ian M.; Bonthron, David T.; Sheridan, Eamonn G.] Univ Leeds, St Jamess Univ Hosp, Sch Med, Leeds LS9 7TF, W Yorkshire, England; [Kernohan, Kristin D.; Huang, Lijia; Hartley, Taila; Boycott, Kym M.; Care4Rare Canada Consortium] Univ Ottawa, Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [Vasudevan, Pradeep; O'Callaghan, Chris; Hirst, Robert A.; Rutman, Andrew] Univ Leicester, Dept Infect Immun & Inflammat, Ctr PCD Diag & Res, RKCSB, Leicester LE2 7LX, Leics, England; [O'Callaghan, Chris] UCL, Resp Crit Care & Anaesthesia, Inst Child Hlth, 30 Guilford St, London WC1N 1EH, England; [O'Callaghan, Chris] Great Ormond St Childrens Hosp, 30 Guilford St, London WC1N 1EH, England; [Grynspan, David] Childrens Hosp Eastern Ontario, Dept Pathol, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada; [Moya, Eduardo] Bradford Royal Infirm, Bradford BD9 6R, W Yorkshire, England; [Li, Chunmei; Leroux, Michel] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC, Canada; [Li, Chunmei; Leroux, Michel] Simon Fraser Univ, Ctr Cell Biol Dev & Dis, Burnaby, BC, Canada	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Saint James's University Hospital; Saint James's University Hospital; University of Leeds; University of Ottawa; Children's Hospital of Eastern Ontario; University of Leicester; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Ottawa; Children's Hospital of Eastern Ontario; Bradford Royal Infirmary; Simon Fraser University; Simon Fraser University	Bastin, P (corresponding author), Inst Pasteur, Trypanosome Cell Biol Unit, 25 Rue Docteur Roux, F-75015 Paris, France.; Bastin, P (corresponding author), Inst Pasteur, INSERM, U1201, 25 Rue Docteur Roux, F-75015 Paris, France.; Sheridan, EG (corresponding author), St James Univ Hosp, Yorkshire Reg Genet Serv, Leeds LS9 7TF, W Yorkshire, England.; Sheridan, EG (corresponding author), Univ Leeds, St Jamess Univ Hosp, Sch Med, Leeds LS9 7TF, W Yorkshire, England.	philippe.bastin@pasteur.fr; e.sheridan@leeds.ac.uk	Bastin, Philippe/E-6688-2017; Hirst, Robert/AAD-1649-2022; Bonnefoy, Serge/B-2466-2014; Bastin, Philippe/O-4230-2019; Lemos, Moara/AAM-8898-2020; Poulter, James/A-8190-2013	Bonnefoy, Serge/0000-0001-9148-0123; Bastin, Philippe/0000-0002-3042-8679; Poulter, James/0000-0003-2048-5693	ANR grant [ANR-14-CE35-0009-01]; French Government Investissement d'Avenir programme, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases'' [ANR-10-LABX-62-IBEID]; La Fondation pour la Recherche Medicale [Equipe FRM DEQ20150734356]; Care4Rare Canada Consortium - Genome Canada; Canadian Institutes of Health Research (CIHR); Ontario Genomics Institute; Genome Quebec; Children's Hospital of Eastern Ontario Foundation; Genome Canada; UK Medical Research Council [MR/M009084/1, MR/L01629X/1]; Ontario Research Fund; Canadian Rare Diseases: Models and Mechanisms Network - CIHR; MRC [MR/M009084/1] Funding Source: UKRI	ANR grant(French National Research Agency (ANR)); French Government Investissement d'Avenir programme, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases''; La Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Care4Rare Canada Consortium - Genome Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; Genome Quebec; Children's Hospital of Eastern Ontario Foundation; Genome Canada(Genome Canada); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ontario Research Fund; Canadian Rare Diseases: Models and Mechanisms Network - CIHR; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We wish to thank the families reported here for their willingness to participate in these research efforts. We thank the Ultrastructural BioImaging Plateforme for providing access to the TEM equipment. We thank Bruno Louis and Jean-Francois Papon, Institut National de la Santeet de la Recherche Medicale, U955, Creteil, France, for help in video-microscopy. Research at the Institut Pasteur is funded by an ANR grant (ANR-14-CE35-0009-01), by a French Government Investissement d'Avenir programme, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases'' (ANR-10-LABX-62-IBEID), and by La Fondation pour la Recherche Medicale (Equipe FRM DEQ20150734356). This work was supported, in part, by the Care4Rare Canada Consortium funded by Genome Canada, the Canadian Institutes of Health Research (CIHR), the Ontario Genomics Institute, Ontario Research Fund, Genome Quebec, and Children's Hospital of Eastern Ontario Foundation and the Canadian Rare Diseases: Models and Mechanisms Network funded by CIHR and Genome Canada. The authors wish to acknowledge the contribution of the high-throughput sequencing platform of the McGill University and Genome Quebec Innovation Centre, Montreal, Canada. Research at the University of Leeds was supported by grants MR/M009084/1 and MR/L01629X/1 awarded by the UK Medical Research Council.	Absalon S, 2008, MOL BIOL CELL, V19, P929, DOI 10.1091/mbc.E07-08-0749; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahmed NT, 2008, J CELL BIOL, V183, P313, DOI 10.1083/jcb.200802025; Baron DM, 2007, J CELL SCI, V120, P1513, DOI 10.1242/jcs.004846; Bastin P, 1999, MOL CELL BIOL, V19, P8191; Beaulieu CL, 2014, AM J HUM GENET, V94, P809, DOI 10.1016/j.ajhg.2014.05.003; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bertiaux E, 2018, J CELL BIOL, V217, P4284, DOI 10.1083/jcb.201805030; Branche C, 2006, J CELL SCI, V119, P3443, DOI 10.1242/jcs.03078; Brasseur A, 2013, EUKARYOT CELL, V12, P168, DOI 10.1128/EC.00077-12; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; BRUN R, 1979, ACTA TROP, V36, P289; Burkard G, 2007, MOL BIOCHEM PARASIT, V153, P220, DOI 10.1016/j.molbiopara.2007.02.008; Chilvers MA, 2000, THORAX, V55, P314, DOI 10.1136/thorax.55.4.314; Chilvers MA, 2003, J ALLERGY CLIN IMMUN, V112, P518, DOI 10.1067/mai.2003.1701; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Craft JM, 2015, J CELL BIOL, V208, P223, DOI 10.1083/jcb.201409036; Dacheux D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031344; Dawe HR, 2005, J CELL SCI, V118, P5421, DOI 10.1242/jcs.02659; Desai PB, 2015, CYTOSKELETON, V72, P16, DOI 10.1002/cm.21206; Dougherty GW, 2016, AM J RESP CELL MOL, V55, P213, DOI 10.1165/rcmb.2015-0353OC; Duquesnoy P, 2009, AM J HUM GENET, V85, P890, DOI 10.1016/j.ajhg.2009.11.008; Fort C, 2016, J CELL SCI, V129, P3026, DOI 10.1242/jcs.188227; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Hartill VL, 2018, HUM MOL GENET, V27, P529, DOI 10.1093/hmg/ddx422; Hirst RA, 2002, INFECT IMMUN, V70, P1017, DOI 10.1128/IAI.70.2.1017-1022.2002; Hirst RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089675; Hirst RA, 2010, CHEST, V138, P1441, DOI 10.1378/chest.10-0175; Hou YQ, 2007, J CELL BIOL, V176, P653, DOI 10.1083/jcb.200608041; Hughes LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0025700; Ishikawa H, 2017, COLD SPRING HARB PER, V9, P9; Ishikawa T, 2017, COLD SPRING HARB PER, V9, P9; KAMIYA R, 1988, J CELL BIOL, V107, P2253, DOI 10.1083/jcb.107.6.2253; Kelly S, 2007, MOL BIOCHEM PARASIT, V154, P103, DOI 10.1016/j.molbiopara.2007.03.012; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kohl L, 2003, EMBO J, V22, P5336, DOI 10.1093/emboj/cdg518; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lacomble S, 2009, J CELL SCI, V122, P1081, DOI 10.1242/jcs.045740; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; LEFEBVRE PA, 1986, ANNU REV CELL BIOL, V2, P517, DOI 10.1146/annurev.cb.02.110186.002505; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lucas JS, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01090-2016; Mitchison HM, 2017, J PATHOL, V241, P294, DOI 10.1002/path.4843; Qin HM, 2004, J CELL BIOL, V164, P255, DOI 10.1083/jcb.200308132; Ralston KS, 2009, ANNU REV MICROBIOL, V63, P335, DOI 10.1146/annurev.micro.091208.073353; Ralston KS, 2006, EUKARYOT CELL, V5, P696, DOI 10.1128/EC.5.4.696-711.2006; Reiter JF, 2017, NAT REV MOL CELL BIO, V18, P533, DOI 10.1038/nrm.2017.60; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Shapiro AJ, 2017, ULTRASTRUCT PATHOL, V41, P373, DOI 10.1080/01913123.2017.1362088; SHERWIN T, 1989, PHILOS T R SOC B, V323, P573, DOI 10.1098/rstb.1989.0037; Stannard WA, 2010, AM J RESP CRIT CARE, V181, P307, DOI 10.1164/rccm.200903-0459OC; Taschner M, 2016, COLD SPRING HARB PER, V8, P8; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vincensini L, 2011, BIOL CELL, V103, P109, DOI 10.1042/BC20100104; Wallmeier J, 2014, NAT GENET, V46, P646, DOI 10.1038/ng.2961; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Watson CM, 2016, J MED GENET, V53, P264, DOI 10.1136/jmedgenet-2015-103620; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	60	29	31	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 1	2018	103	5					727	739		10.1016/j.ajhg.2018.10.003	http://dx.doi.org/10.1016/j.ajhg.2018.10.003			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GY9EO	30388400	Bronze, Green Submitted, Green Published, Green Accepted			2022-12-18	WOS:000448942100008
J	Gueneau, L; Fish, RJ; Shamseldin, HE; Voisin, N; Mau-Them, FT; Preiksaitiene, E; Monroe, GR; Lai, A; Putoux, A; Allias, F; Ambusaidi, Q; Ambrozaityte, L; Cimbalistien, L; Delafontaine, J; Guex, N; Hashem, M; Kurdi, W; Jamuar, SS; Ying, LJ; Bonnard, C; Pippucci, T; Pradervand, S; Roechert, B; van Hasselt, PM; Wiederkehr, M; Wright, CF; Xenarios, I; van Haaften, G; Shaw-Smith, C; Schindewolf, EM; Neerman-Arbez, M; Sanlaville, D; Lesca, G; Guibaud, L; Reversade, B; Chelly, J; Kucinskas, V; Alkuraya, FS; Reymond, A				Gueneau, Lucie; Fish, Richard J.; Shamseldin, Hanan E.; Voisin, Norine; Mau-Them, Frederic Tran; Preiksaitiene, Egle; Monroe, Glen R.; Lai, Angeline; Putoux, Audrey; Allias, Fabienne; Ambusaidi, Qamariya; Ambrozaityte, Laima; Cimbalistien, Loreta; Delafontaine, Julien; Guex, Nicolas; Hashem, Mais; Kurdi, Wesam; Jamuar, Saumya Shekhar; Ying, Lim J.; Bonnard, Carine; Pippucci, Tommaso; Pradervand, Sylvain; Roechert, Bernd; van Hasselt, Peter M.; Wiederkehr, Michael; Wright, Caroline F.; Xenarios, Ioannis; van Haaften, Gijs; Shaw-Smith, Charles; Schindewolf, Erica M.; Neerman-Arbez, Marguerite; Sanlaville, Damien; Lesca, Gaetan; Guibaud, Laurent; Reversade, Bruno; Chelly, Jamel; Kucinskas, Vaidutis; Alkuraya, Fowzan S.; Reymond, Alexandre		DDD Study	KIAA1109 Variants Are Associated with a Severe Disorder of Brain Development and Arthrogryposis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEURONAL MIGRATION DISORDERS; AMINO-ACID SUBSTITUTIONS; PROTEIN; MUTATIONS; MALFORMATIONS; PREDICTION; SERVER; TOOL	Whole-exome and targeted sequencing of 13 individuals from 10 unrelated families with overlapping clinical manifestations identified loss-of-function and missense variants in KIAA1109 allowing delineation of an autosomal-recessive multi-system syndrome, which we suggest to name Alkuraya-Kucinskas syndrome (MIM 617822). Shared phenotypic features representing the cardinal characteristics of this syndrome combine brain atrophy with clubfoot and arthrogryposis. Affected individuals present with cerebral parenchymal underdevelopment, ranging from major cerebral parenchymal thinning with lissencephalic aspect to moderate parenchymal rarefaction, severe to mild ventriculomegaly, cerebellar hypoplasia with brainstem dysgenesis, and cardiac and ophthalmologic anomalies, such as microphthalmia and cataract. Severe loss-of-function cases were incompatible with life, whereas those individuals with milder missense variants presented with severe global developmental delay, syndactyly of 2nd and 3rd toes, and severe muscle hypotonia resulting in incapacity to stand without support. Consistent with a causative role for KIAA1109 loss-of-function/hypomorphic variants in this syndrome, knockdowns of the zebrafish orthologous gene resulted in embryos with hydrocephaly and abnormally curved notochords and overall body shape, whereas published knockouts of the fruit fly and mouse orthologous genes resulted in lethality or severe neurological defects reminiscent of the probands' features.	[Gueneau, Lucie; Voisin, Norine; Pradervand, Sylvain; Wiederkehr, Michael; Xenarios, Ioannis; Reymond, Alexandre] Univ Lausanne, Ctr Integrat Gen, CH-1015 Lausanne, Switzerland; [Fish, Richard J.; Neerman-Arbez, Marguerite] Univ Geneva, Med Sch, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Shamseldin, Hanan E.; Hashem, Mais; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Mau-Them, Frederic Tran; Chelly, Jamel] INSERM Unite 964, CNRS UMR 7104, IGBMC, F-67404 Illkirch Graffenstaden, France; [Mau-Them, Frederic Tran; Chelly, Jamel] Hosp Univ Strasbourg, Lab Diagnost Genet, F-67000 Strasbourg, France; [Preiksaitiene, Egle; Ambrozaityte, Laima; Cimbalistien, Loreta; Kucinskas, Vaidutis] Vilnius Univ, Fac Med, Dept Human & Med Genet, LT-08661 Vilnius, Lithuania; [Monroe, Glen R.] Univ Med Ctr Utrecht, Dept Genet, NL-3584 CX Utrecht, Netherlands; [Monroe, Glen R.] Univ Med Ctr Utrecht, Ctr Mol Med, NL-3584 CX Utrecht, Netherlands; [Lai, Angeline; Jamuar, Saumya Shekhar; Ying, Lim J.] KK Womens & Childrens Hosp, Singapore 229899, Singapore; [Lai, Angeline] Nanyang Technol Univ, Imperial Coll London, Lee Kong Chian Sch Med, Singapore 639798, Singapore; [Putoux, Audrey; Sanlaville, Damien; Lesca, Gaetan] Hosp Civils Lyon, Serv Genet, F-69002 Lyon, France; [Putoux, Audrey; Sanlaville, Damien; Lesca, Gaetan; Guibaud, Laurent] Univ Claude Bernard Lyon 1, UMR CNRS 5292, INSERM U1028, Ctr Rech Neurosci Lyon, F-69675 Bron, France; [Allias, Fabienne] Hosp Civils Lyon, Dept Pathol, F-69002 Lyon, France; [Ambusaidi, Qamariya; Kurdi, Wesam] King Faisal Specialist Hosp & Res Ctr, Dept Obstet & Gynecol, Riyadh 11211, Saudi Arabia; [Delafontaine, Julien; Guex, Nicolas; Pradervand, Sylvain; Roechert, Bernd; Xenarios, Ioannis] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Jamuar, Saumya Shekhar] Duke NUS Med Sch, Singapore 169857, Singapore; [Bonnard, Carine; Reversade, Bruno] A* STAR, Inst Med Biol, Singapore 138648, Singapore; [Pippucci, Tommaso] St Orsola Malpighi Hosp, Med Genet Unit, Pavillon 11,2nd Floor,Via Massarenti 9, I-40138 Bologna, Italy; [Wright, Caroline F.] Wellcome Trust Sanger Inst, Deciphering Dev Disorders DDD Study, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England; [Shaw-Smith, Charles] Royal Devon & Exeter NHS Fdn Trust, Dept Clin Genet, Exeter EX1 2ED, Devon, England; [Schindewolf, Erica M.] Childrens Hosp Philadelphia, Ctr Fetal Diag & Treatment, Philadelphia, PA 19104 USA; [Guibaud, Laurent] Univ Claude Bernard Lyon 1, Hop Femme Mere Enfant, Ctr Pluridisciplinaire Diagnost Prenatal, Dept Imagerie Pediatr & Foetale, F-69677 Bron, France; [Reversade, Bruno] A* STAR Agcy Sci Technol & Res, IMCB, 61 Biopolis Dr, Singapore 138673, Singapore; [Reversade, Bruno] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore 119228, Singapore; [Reversade, Bruno] Acad Med Ctr, Amsterdam Reprod & Dev, NL-1105 AZ Amsterdam, Netherlands; [Reversade, Bruno] Vrije Univ Amsterdam Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Alkuraya, Fowzan S.] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh 11533, Saudi Arabia; [Alkuraya, Fowzan S.] King Abdulaziz City Sci & Technol, Saudi Human Genome Program, Riyadh 12371, Saudi Arabia	University of Lausanne; University of Geneva; King Faisal Specialist Hospital & Research Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Strasbourg; Vilnius University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; KK Women's & Children's Hospital; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; King Faisal Specialist Hospital & Research Center; Swiss Institute of Bioinformatics; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); IRCCS Azienda Ospedaliero-Universitaria di Bologna; Wellcome Trust Sanger Institute; University of Exeter; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Alfaisal University	Reymond, A (corresponding author), Univ Lausanne, Ctr Integrat Gen, CH-1015 Lausanne, Switzerland.; Alkuraya, FS (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.; Alkuraya, FS (corresponding author), Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh 11533, Saudi Arabia.; Alkuraya, FS (corresponding author), King Abdulaziz City Sci & Technol, Saudi Human Genome Program, Riyadh 12371, Saudi Arabia.	falkuraya@kfshrc.edu.sa; alexandre.reymond@unil.ch	van Haaften, Gijs/G-7832-2012; Putoux, Audrey/D-7265-2015; Pippucci, Tommaso/M-8124-2019; Lesca, Gaetan/C-6111-2019; Sanlaville, Damien/M-4716-2014; KUČINSKAS, Vaidutis/A-4798-2013; Xenarios, Ioannis/ABD-5045-2021	van Haaften, Gijs/0000-0003-3033-0329; Sanlaville, Damien/0000-0001-9939-2849; Xenarios, Ioannis/0000-0002-3413-6841; GUEX, Nicolas/0000-0001-6023-0519; Tran Mau Them, Frederic/0000-0002-3795-9456; Ambrozaityte, Laima/0000-0001-5631-7005; Lesca, Gaetan/0000-0001-7691-9492; Reymond, Alexandre/0000-0003-1030-8327; PUTOUX, Audrey/0000-0001-5496-4604; , Egle/0000-0003-0282-134X; Wright, Caroline/0000-0003-2958-5076; REVERSADE, Bruno/0000-0002-4070-7997; Voisin, Norine/0000-0001-9479-4179; Neerman-Arbez, Marguerite/0000-0002-9351-4195	Swiss National Science Foundation [31003A_160203]; Lithuanian Swiss cooperation program to reduce economic and social disparities within the enlarged European Union (Unigene project) [CH-3-SMM-0104]; King Abdulaziz City for Science and Technology grant [13BIO-1113-20]; Saudi Human Genome Program; Health Innovation Challenge Fund [HICF-1009-003]; Wellcome Trust; Department of Health; Wellcome Trust Sanger Institute [WT098051]; National Institute for Health Research, through the Comprehensive Clinical Research Network	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Lithuanian Swiss cooperation program to reduce economic and social disparities within the enlarged European Union (Unigene project); King Abdulaziz City for Science and Technology grant; Saudi Human Genome Program; Health Innovation Challenge Fund; Wellcome Trust(Wellcome Trust); Department of Health; Wellcome Trust Sanger Institute(Wellcome Trust); National Institute for Health Research, through the Comprehensive Clinical Research Network(National Institute for Health Research (NIHR))	We thank the affected individuals and their families for their contribution to this study. We are grateful to Keith Joung for reagents. This work was supported by grants from the Swiss National Science Foundation (31003A_160203) to A.R.,the Lithuanian Swiss cooperation program to reduce economic and social disparities within the enlarged European Union (CH-3-SMM-0104, Unigene project) to V.K. and A.R., and King Abdulaziz City for Science and Technology grant 13BIO-1113-20 to F.S.A. We also acknowledge the support of the Saudi Human Genome Program. The DDD Study presents independent research commissioned by the Health Innovation Challenge Fund (grant number HICF-1009-003), a parallel funding partnership between the Wellcome Trust and the Department of Health, and the Wellcome Trust Sanger Institute (grant number WT098051). The study has UK Research Ethics Committee approval (10/H0305/83, granted by the Cambridge South REC, and GEN/284/12 granted by the Republic of Ireland REC). The research team acknowledges the support of the National Institute for Health Research, through the Comprehensive Clinical Research Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASE JM, 1968, J PEDIATR-US, V73, P606, DOI 10.1016/S0022-3476(68)80278-1; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alazami AM, 2015, CELL REP, V10, P148, DOI 10.1016/j.celrep.2014.12.015; Anazi S, 2017, MOL PSYCHIATR, V22, P615, DOI 10.1038/mp.2016.113; Brown SDM, 2012, MAMM GENOME, V23, P632, DOI 10.1007/s00335-012-9427-x; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Graziano C, 2015, GENE, V559, P144, DOI 10.1016/j.gene.2015.01.026; Harel T, 2016, AM J HUM GENET, V99, P831, DOI 10.1016/j.ajhg.2016.08.007; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Itoh K, 2015, PATHOL INT, V65, P58, DOI 10.1111/pin.12245; Jordan DM, 2015, NATURE, V524, P225, DOI 10.1038/nature14497; Kato M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00181; Khuong TM, 2010, P NATL ACAD SCI USA, V107, P17379, DOI 10.1073/pnas.1001794107; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Mirzaa GM, 2014, AM J MED GENET C, V166, P117, DOI 10.1002/ajmg.c.31404; Miyamoto-Sato E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009289; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Parrini E, 2016, MOL SYNDROMOL, V7, P220, DOI 10.1159/000448639; PATTON MA, 1985, CLIN GENET, V28, P521; Salgado D, 2016, HUM MUTAT, V37, P439, DOI 10.1002/humu.22965; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Spalice A, 2009, ACTA PAEDIATR, V98, P421, DOI 10.1111/j.1651-2227.2008.01160.x; Toth-Petroczy A, 2016, CELL, V167, P158, DOI 10.1016/j.cell.2016.09.010; Verrotti A, 2010, EUR J PAEDIATR NEURO, V14, P1, DOI 10.1016/j.ejpn.2009.01.005; Verstreken P, 2009, NEURON, V63, P203, DOI 10.1016/j.neuron.2009.06.017; Vissers LELM, 2016, NAT REV GENET, V17, P9, DOI 10.1038/nrg3999; Xue SF, 2017, AM J HUM GENET, V100, P659, DOI 10.1016/j.ajhg.2017.02.006; Xue Y, 2015, GENET MED, V17, P444, DOI 10.1038/gim.2014.122; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555	37	29	30	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 4	2018	102	1					116	132		10.1016/j.ajhg.2017.12.002	http://dx.doi.org/10.1016/j.ajhg.2017.12.002			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FR8DU	29290337	Green Published, hybrid			2022-12-18	WOS:000419305500009
J	Falkenberg, KD; Braverman, NE; Moser, AB; Steinberg, SJ; Klouwer, FCC; Schluter, A; Ruiz, M; Pujol, A; Engvall, M; Naess, K; van Spronsen, F; Korver-Keularts, I; Rubio-Gozalbo, ME; Ferdinandusse, S; Wanders, RJA; Waterham, HR				Falkenberg, Kim D.; Braverman, Nancy E.; Moser, Ann B.; Steinberg, Steven J.; Klouwer, Femke C. C.; Schluter, Agatha; Ruiz, Montserrat; Pujol, Aurora; Engvall, Martin; Naess, Karin; van Spronsen, FrancJan; Korver-Keularts, Irene; Rubio-Gozalbo, M. Estela; Ferdinandusse, Sacha; Wanders, Ronald J. A.; Waterham, Hans R.			Allelic Expression Imbalance Promoting a Mutant PEX6 Allele Causes Zellweger Spectrum Disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PEROXISOME BIOGENESIS DISORDERS; ALTERNATIVE CLEAVAGE; GENE-EXPRESSION; MUTATIONS; AAA; POLYADENYLATION; TRANSCRIPTION; FIBROBLASTS; METABOLISM; VARIANTS	Zellweger spectrum disorders (ZSDs) are autosomal-recessive disorders that are caused by defects in peroxisome biogenesis due to bi-allelic mutations in any of 13 different PEX genes. Here, we identified seven unrelated individuals affected with an apparent dominant ZSD in whom a heterozygous mutant PEX6 allele (c.2578C>T [p.Arg860Trp]) was overrepresented due to allelic expression imbalance (AEI). We demonstrated that AEI of PEX6 is a common phenomenon and is correlated with heterozygosity for a frequent variant in the 3' untranslated region (UTR) of the mutant allele, which disrupts the most distal of two polyadenylation sites. Asymptomatic parents, who were heterozygous for PEX c.2578C>T, did not show AEI and were homozygous for the 3' UTR variant. Overexpression models confirmed that the overrepresentation of the pathogenic PEX6 c.2578T variant compared to wild-type PEX6 c.2578C results in a peroxisome biogenesis defect and thus constitutes the cause of disease in the affected individuals. AEI promoting the overrepresentation of a mutant allele might also play a role in other autosomal-recessive disorders, in which only one heterozygous pathogenic variant is identified.	[Falkenberg, Kim D.; Klouwer, Femke C. C.; Ferdinandusse, Sacha; Wanders, Ronald J. A.; Waterham, Hans R.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Braverman, Nancy E.] McGill Univ, Res Inst, Hlth Ctr, Dept Pediat & Human Genet, Montreal, PQ H4A 3J1, Canada; [Braverman, Nancy E.] McGill Univ, Montreal, PQ H4A 3J1, Canada; [Moser, Ann B.] Kennedy Krieger Inst, Baltimore, MD 21205 USA; [Steinberg, Steven J.] Johns Hopkins Univ, Sch Med, Inst Genet Med, Baltimore, MD 21205 USA; [Steinberg, Steven J.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Klouwer, Femke C. C.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat Neurol, NL-1105 AZ Amsterdam, Netherlands; [Schluter, Agatha; Ruiz, Montserrat; Pujol, Aurora] IDIBELL, Inst Neuropathol, Neurometab Dis Lab, Barcelona 08908, Spain; [Schluter, Agatha; Ruiz, Montserrat; Pujol, Aurora] Ctr Biomed Res Rare Dis, CIBERER U759, Valencia 46010, Spain; [Pujol, Aurora] Catalan Inst Res & Adv Studies ICREA, Barcelona 08010, Spain; [Engvall, Martin; Naess, Karin] Karolinska Univ Hosp, Ctr Inherited Metab Dis, S-17177 Stockholm, Sweden; [Engvall, Martin] Karolinska Inst, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Naess, Karin] Karolinska Inst, Div Mol Metab, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [van Spronsen, FrancJan] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Beatrix Childrens Hosp, NL-9700 RB Groningen, Netherlands; [Korver-Keularts, Irene; Rubio-Gozalbo, M. Estela] Maastricht Univ, Dept Pediat, Med Ctr, NL-6211 LK Maastricht, Netherlands; [Rubio-Gozalbo, M. Estela] Maastricht Univ, Lab Genet Metab Dis, Med Ctr, NL-6211 LK Maastricht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; McGill University; McGill University; Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins University; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; ICREA; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; University of Groningen; Maastricht University; Maastricht University	Waterham, HR (corresponding author), Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands.	h.r.waterham@amc.uva.nl	Schluter, Agatha/AAA-9665-2021; Ruiz, Montse/N-4085-2014; Rubio-Gozalbo, M Estela/H-1833-2011; Pujol, Aurora/N-4990-2014	Ruiz, Montse/0000-0003-0466-2653; Pujol, Aurora/0000-0002-9606-0600; Ferdinandusse, Sacha/0000-0002-7738-5709; Naess, Karin/0000-0003-4310-7927; Schluter, Agatha/0000-0001-6732-1528; Braverman, Nancy/0000-0003-1621-5164; Rubio-Gozalbo, M. Estela/0000-0001-7182-4056; Falkenberg, Kim/0000-0002-6882-5231; Engvall, Martin/0000-0002-8339-3545	Marie Curie Initial Training Networks action [FP7-2012-PERFUME-316723]; Autonomous Government of Catalonia [SGR 2014SGR1430]; Spanish Center for Biomedical Research on Rare Diseases (CIBERER) [ER15PR02ACCI14]; Foundation Marato de TV3 [2014-0830]; Hesperia Foundation; grant "Intellectual and Developmental Disabilities Research Centers" Type: NICHD [1 U54 HD079123-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD079123] Funding Source: NIH RePORTER	Marie Curie Initial Training Networks action; Autonomous Government of Catalonia(Generalitat de Catalunya); Spanish Center for Biomedical Research on Rare Diseases (CIBERER); Foundation Marato de TV3; Hesperia Foundation; grant "Intellectual and Developmental Disabilities Research Centers" Type: NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Work at the Laboratory Genetic Metabolic Diseases in Amsterdam was supported by Marie Curie Initial Training Networks action (FP7-2012-PERFUME-316723 to K.D.F. and H.R.W.), at Kennedy Krieger Institute by the grant "Intellectual and Developmental Disabilities Research Centers 2013'' Type: (1 U54 HD079123-01A1) NICHD, and at the Neurometabolic Diseases Laboratory by grants from the Autonomous Government of Catalonia (SGR 2014SGR1430), the Spanish Center for Biomedical Research on Rare Diseases (CIBERER, ER15PR02ACCI14), the Foundation Marato de TV3 (2014-0830), and the Hesperia Foundation.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Amin AS, 2012, EUR HEART J, V33, P714, DOI 10.1093/eurheartj/ehr473; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bhogal MS, 2016, J BIOL CHEM, V291, P2460, DOI 10.1074/jbc.M115.686501; Braverman NE, 2013, DEV DISABIL RES REV, V17, P187, DOI 10.1002/ddrr.1113; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Butt C, 2003, BLOOD, V101, P3037, DOI 10.1182/blood-2002-09-2888; Ciniawsky S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8331; Ebberink MS, 2011, HUM MUTAT, V32, P59, DOI 10.1002/humu.21388; Ebberink MS, 2010, HUM MUTAT, V31, pE1058, DOI 10.1002/humu.21153; Johnson AD, 2008, PHARMACOGENET GENOM, V18, P781, DOI 10.1097/FPC.0b013e3283050107; Kelley R. I., 1991, TECHNIQUES DIAGNOSTI; Klouwer FCC, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0368-9; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Levesque S, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-72; Li WC, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0229-6; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Moncini S, 2015, EUR J HUM GENET, V23, P1531, DOI 10.1038/ejhg.2015.20; MOSER AB, 1995, J PEDIATR-US, V127, P13, DOI 10.1016/S0022-3476(95)70250-4; MOSER HW, 1991, TECHNIQUES DIAGNOSTI, P193; Moser HW, 1991, TECHNIQUES DIAGNOSTI, P177; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Pastinen T, 2004, PHYSIOL GENOMICS, V16, P184, DOI 10.1152/physiolgenomics.00163.2003; Ratbi I, 2015, AM J HUM GENET, V97, P535, DOI 10.1016/j.ajhg.2015.08.011; Rhee JK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01966-z; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Steinberg SJ, 2009, J INHERIT METAB DIS, V32, P109, DOI 10.1007/s10545-008-0969-8; Tamura S, 2006, J BIOL CHEM, V281, P27693, DOI 10.1074/jbc.M605159200; Vreken P, 1998, J CHROMATOGR B, V713, P281, DOI 10.1016/S0378-4347(98)00186-8; Wanders RJA, 1995, J INHERIT METAB DIS, V18, P101, DOI 10.1007/BF00711433; Wang Q, 2005, J BIOL CHEM, V280, P40515, DOI 10.1074/jbc.M509636200; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Waterval WAH, 2009, CLIN CHIM ACTA, V407, P36, DOI 10.1016/j.cca.2009.06.023; Wendler P, 2012, BBA-MOL CELL RES, V1823, P2, DOI 10.1016/j.bbamcr.2011.06.014; Yik WY, 2009, HUM MUTAT, V30, pE467, DOI 10.1002/humu.20932; Zhao CX, 2010, J BIOL CHEM, V285, P761, DOI 10.1074/jbc.M109.056739	38	29	30	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 7	2017	101	6					965	976		10.1016/j.ajhg.2017.11.007	http://dx.doi.org/10.1016/j.ajhg.2017.11.007			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FP5FD	29220678	Green Published, Bronze			2022-12-18	WOS:000417644500007
J	Fortes-Lima, C; Gessain, A; Ruiz-Linares, A; Bortolini, MC; Migot-Nabias, F; Bellis, G; Moreno-Mayar, JV; Restrepo, BN; Rojas, W; Avendano-Tamayo, E; Bedoya, G; Orlando, L; Salas, A; Helgason, A; Gilbert, MTP; Sikora, M; Schroeder, H; Dugoujon, JM				Fortes-Lima, Cesar; Gessain, Antoine; Ruiz-Linares, Andres; Bortolini, Maria-Catira; Migot-Nabias, Florence; Bellis, Gil; Moreno-Mayar, J. Victor; Restrepo, Berta Nelly; Rojas, Winston; Avendano-Tamayo, Efren; Bedoya, Gabriel; Orlando, Ludovic; Salas, Antonio; Helgason, Agnar; Gilbert, M. Thomas P.; Sikora, Martin; Schroeder, Hannes; Dugoujon, Jean-Michel			Genome-wide Ancestry and Demographic History of African-Descendant Maroon Communities from French Guiana and Suriname	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOCAL-ANCESTRY; POPULATION-STRUCTURE; GENETIC ANCESTRY; INBREEDING COEFFICIENT; ADMIXTURE DYNAMICS; INFERENCE; AMERICANS; CREOLES; PATTERNS; GBE	The transatlantic slave trade was the largest forced migration in world history. However, the origins of the enslaved Africans and their admixture dynamics remain unclear. To investigate the demographic history of African-descendant Marron populations, we generated genome-wide data (4.3 million markers) from 107 individuals from three African-descendant populations in South America, as well as 124 individuals from six west African populations. Throughout the Americas, thousands of enslaved Africans managed to escape captivity and establish lasting communities, such as the Noir Marron. We find that this population has the highest proportion of African ancestry (similar to 98%) of any African-descendant population analyzed to date, presumably because of centuries of genetic isolation. By contrast, African-descendant populations in Brazil and Colombia harbor substantially more European and Native American ancestry as a result of their complex admixture histories. Using ancestry tract-length analysis, we detect different dates for the European admixture events in the African-Colombian (1749 CE; confidence interval [CI]: 1737-1764) and African-Brazilian (1796 CE; CI: 1789-1804) populations in our dataset, consistent with the historically attested earlier influx of Africans into Colombia. Furthermore, we find evidence for sex-specific admixture patterns, resulting from predominantly European paternal gene flow. Finally, we detect strong genetic links between the African-descendant populations and specific source populations in Africa on the basis of haplotype sharing patterns. Although the Noir Marron and African-Colombians show stronger affinities with African populations from the Bight of Benin and the Gold Coast, the African-Brazilian population from Rio de Janeiro has greater genetic affinity with Bantu-speaking populations from the Bight of Biafra and west central Africa.	[Fortes-Lima, Cesar; Orlando, Ludovic; Dugoujon, Jean-Michel] Univ Paul Sabatier Toulouse III, CNRS, AMIS UMR5288, Lab Anthropol Mol & Imagerie Synth, F-31000 Toulouse, France; [Fortes-Lima, Cesar] Univ Paris Diderot, Lab Ecoanthropol & Ethnobiol, UMR7206, Musee Homme,CNRS,MNHN, 17 Pl Trocadero, F-75016 Paris, France; [Gessain, Antoine] Pasteur Inst, Oncogen Virus Epidemiol & Pathophysiol Grp, CNRS, Dept Virol,UMR3569, F-75015 Paris, France; [Ruiz-Linares, Andres] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Ruiz-Linares, Andres] Fudan Univ, Minist Educ, Key Lab Contemporary Anthropol, Shanghai 200438, Peoples R China; [Ruiz-Linares, Andres] Fudan Univ, Collaborat Innovat Ctr Genet & Dev, Shanghai 200438, Peoples R China; [Ruiz-Linares, Andres] Aix Marseille Univ, Lab Biocultural Anthropol Law Eth & Hlth, CNRS EFS ADES UMR7268, F-13824 Marseille, France; [Bortolini, Maria-Catira] Univ Fed Rio Grande do Sul, Dept Genet, BR-91501970 Porto Alegre, RS, Brazil; [Migot-Nabias, Florence] Paris 5 Univ, Res Inst Dev, Mother & Child Facing Trop Infect MERIT, Sorbonne Paris Cite, F-75006 Paris, France; [Bellis, Gil] French Inst Demog Studies, F-75020 Paris, France; [Moreno-Mayar, J. Victor; Orlando, Ludovic; Gilbert, M. Thomas P.; Sikora, Martin; Schroeder, Hannes] Univ Copenhagen, Nat Hist Museum Denmark, DK-1350 Copenhagen, Denmark; [Restrepo, Berta Nelly] Univ CES, Inst Colombiano Med Trop, Sabaneta 055450, Antioquia, Colombia; [Rojas, Winston; Avendano-Tamayo, Efren; Bedoya, Gabriel] Univ Antioquia, Inst Biol, Lab Mol Genet, Medellin 050010, Colombia; [Avendano-Tamayo, Efren] Tecnol Antioquia Inst Univ, Grp Ciencias Basicas Aplicadas Tecnol Antioquia, Medellin 050034, Colombia; [Salas, Antonio] Univ Santiago de Compostela, Fac Med, Dept Anat Patol & Ciencias Forenses, Unidade Xenet,Inst Ciencias Forenses, Galicia 15782, Spain; [Salas, Antonio] Hosp Clin Univ Santiago, Inst Invest Sanitarias, GenPoB Res Grp, Galicia 15782, Spain; [Helgason, Agnar] DeCode Genet, IS-101 Reykjavik, Iceland; [Gilbert, M. Thomas P.] Norwegian Univ Sci & Technol, Univ Museum, N-7491 Trondheim, Norway; [Schroeder, Hannes] Leiden Univ, Fac Archaeol, NL-2333 Leiden, Netherlands	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; Fudan University; Fudan University; UDICE-French Research Universities; Aix-Marseille Universite; Universidade Federal do Rio Grande do Sul; UDICE-French Research Universities; Universite Paris Cite; University of Copenhagen; Universidad de Antioquia; Universidade de Santiago de Compostela; Norwegian University of Science & Technology (NTNU); Leiden University; Leiden University - Excl LUMC	Dugoujon, JM (corresponding author), Univ Paul Sabatier Toulouse III, CNRS, AMIS UMR5288, Lab Anthropol Mol & Imagerie Synth, F-31000 Toulouse, France.; Schroeder, H (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, DK-1350 Copenhagen, Denmark.; Schroeder, H (corresponding author), Leiden Univ, Fac Archaeol, NL-2333 Leiden, Netherlands.	hschroeder@snm.ku.dk; jean-michel.dugoujon@univ-tlse3.fr	Sikora, Martin/C-8609-2015; Helgason, Agnar/K-1522-2015; Orlando, Ludovic/A-8932-2013; Moreno-Mayar, J. Víctor/AAB-3732-2022; Salas, Antonio/U-2029-2019; Fortes-Lima, Cesar A./H-4827-2013; Schroeder, Hannes/B-9444-2015; Fortes-Lima, Cesar/ABE-4823-2021; Ruiz-Linares, Andres/AAR-1104-2021; Salas, Antonio/E-3977-2012; Lima, Cesar Augusto A Fortes/M-1007-2019; Gilbert, Marcus/A-8936-2013	Sikora, Martin/0000-0003-2818-8319; Orlando, Ludovic/0000-0003-3936-1850; Moreno-Mayar, J. Víctor/0000-0002-7712-4496; Salas, Antonio/0000-0002-2336-702X; Fortes-Lima, Cesar A./0000-0002-9310-5009; Schroeder, Hannes/0000-0002-6743-0270; Fortes-Lima, Cesar/0000-0002-9310-5009; Ruiz-Linares, Andres/0000-0001-8372-1011; Salas, Antonio/0000-0002-2336-702X; Lima, Cesar Augusto A Fortes/0000-0002-9310-5009; Gilbert, Marcus/0000-0002-5805-7195; Fortes-Lima, Cesar/0000-0002-8972-3357; Avendano, Efren/0000-0003-3062-7990; Helgason, Agnar/0000-0002-8545-3767; Migot-Nabias, Florence/0000-0001-9982-594X; Rojas Montoya, Winston/0000-0002-7654-3998	European Union through the Marie Curie Actions (FP7) [290344]; EUROTAST Marie Curie Initial Training Network (FP7) [290344]; ERC Synergy Grant [319209, NEXUS1492]; HERA; European Union [649307]	European Union through the Marie Curie Actions (FP7); EUROTAST Marie Curie Initial Training Network (FP7); ERC Synergy Grant; HERA; European Union(European Commission)	The authors would like to acknowledge the volunteers who donated DNA samples and whose genetic data are reported in this study for the first time. We thank Bernard Carme, Mathieu Nacher, Gabriel Carles, Nicolas Pouillot, and Nicolle Joly for the new sampling performed in the French Guiana; Loic Niel for the logistical organization at "Etablissement Francais du Sang'' (EFS) in French Guiana; and Jacques Chiaroni and Ste'phane Mazieres for the DNA extraction. We thank all the members of EUROTAST network for their helpful comments and feedback. We thank Nicolas Brucato, Hakon Jonsson, Petr Triska, Alicia Martin, Simon Gravel, Soheil Baharian, Nicolas Valdeyron, Francis Roubinet, Esteban Parra, and Paul Verdu for helpful discussions on the analyses. We thank Francis Dupuy for his comments regarding to the Noir Marron communities' histories. We thank Garrett Hellenthal for providing us with GLOBETROTTER v2. We are grateful to the Genotoul bioinformatics platform Toulouse Midi-Pyrenees (Bioinfo Genotoul) for providing help and computing resources. Genotyping was performed at the SNP&SEQ Technology Platform in Uppsala, Sweden (www.genotyping.se). The research leading to these results received funding from the European Union through the Marie Curie Actions (FP7/2007-2013, grant no. 290344, EUROTAST). C.F.-L. was supported by the EUROTAST Marie Curie Initial Training Network (FP7/2007-2013, grant no. 290344). H.S. was funded by an ERC Synergy Grant (grant no. 319209, NEXUS1492) and a grant from HERA and the European Union (grant no. 649307, CITIGEN). This work is dedicated to the memory of Professor Georges Larrouy.	Abraham G, 2017, BIOINFORMATICS, V33, P2776, DOI 10.1093/bioinformatics/btx299; Alexander DH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-246; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Baharian S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006059; Bedoya G, 2006, P NATL ACAD SCI USA, V103, P7234, DOI 10.1073/pnas.0508716103; Bhatia G, 2014, AM J HUM GENET, V95, P437, DOI 10.1016/j.ajhg.2014.08.011; Bilby K, 2001, LAT AM MUSIC REV, V22, P31, DOI 10.1353/lat.2001.0003; Browning SR, 2016, G3-GENES GENOM GENET, V6, P1525, DOI 10.1534/g3.116.028779; Brucato N, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-314; Brucato N, 2009, CR BIOL, V332, P917, DOI 10.1016/j.crvi.2009.07.005; Bryc K, 2015, AM J HUM GENET, V96, P37, DOI 10.1016/j.ajhg.2014.11.010; Bryc K, 2010, P NATL ACAD SCI USA, V107, P8954, DOI 10.1073/pnas.0914618107; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; Busby GBJ, 2016, ELIFE, V5, DOI 10.7554/eLife.15266; Cassidy LM, 2016, P NATL ACAD SCI USA, V113, P368, DOI 10.1073/pnas.1518445113; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Conomos MP, 2016, AM J HUM GENET, V98, P127, DOI 10.1016/j.ajhg.2015.11.022; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Daval-Markussen A, 2011, ENGL WORLD-WIDE, V32, P115, DOI 10.1075/eww.32.2.01dav; Delaneau O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4934; Delaneau O, 2013, AM J HUM GENET, V93, P687, DOI 10.1016/j.ajhg.2013.09.002; Eltis D., 2013, ROUTES SLAVERY DIREC; Essegbey J, 2013, LINGUA, V129, P67, DOI 10.1016/j.lingua.2012.03.009; Essegbey J, 2013, LINGUA, V129, P1, DOI 10.1016/j.lingua.2013.02.005; Gazal S, 2014, BIOINFORMATICS, V30, P1940, DOI 10.1093/bioinformatics/btu149; Goldberg A, 2015, GENETICS, V201, P263, DOI 10.1534/genetics.115.178509; Gomes F, 2012, HIST CIENC SAUDE-MAN, V19, P80; Gravel S, 2012, GENETICS, V191, P607, DOI 10.1534/genetics.112.139808; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Hellenthal G, 2014, SCIENCE, V343, P747, DOI 10.1126/science.1243518; Huttar GL, 2013, LINGUA, V129, P96, DOI 10.1016/j.lingua.2013.01.009; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jin WF, 2012, AM J HUM GENET, V91, P849, DOI 10.1016/j.ajhg.2012.09.008; Kehdy FSG, 2015, P NATL ACAD SCI USA, V112, P8696, DOI 10.1073/pnas.1504447112; Kidd JM, 2012, AM J HUM GENET, V91, P660, DOI 10.1016/j.ajhg.2012.08.025; Kirin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013996; Klein HS, 2007, AFRICAN SLAVERY LATI; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Leutenegger AL, 2003, AM J HUM GENET, V73, P516, DOI 10.1086/378207; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Maples BK, 2013, AM J HUM GENET, V93, P278, DOI 10.1016/j.ajhg.2013.06.020; Martin AR, 2017, AM J HUM GENET, V100, P635, DOI 10.1016/j.ajhg.2017.03.004; Mathias RA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12522; May A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-644; Migge B, 2013, LINGUA, V129, P9, DOI 10.1016/j.lingua.2012.03.006; Moreno-Estrada A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003925; Morgan P. D., 1997, SLAVERY ABOLIT, V18, P122; Muysken P, 2015, TRENDS LINGUIST-STUD, V275, P1, DOI 10.1515/9783110343977; Manta FSN, 2013, ANN HUM BIOL, V40, P94, DOI 10.3109/03014460.2012.742138; Pardo-Seco J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2520-x; Patin E, 2017, SCIENCE, V356, P543, DOI 10.1126/science.aal1988; Patin E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4163; Pemberton TJ, 2014, HUM HERED, V77, P37, DOI 10.1159/000362878; Pemberton TJ, 2012, AM J HUM GENET, V91, P275, DOI 10.1016/j.ajhg.2012.06.014; Price R., 2003, ART MARRONS; Price R., 2013, 1 TEMPS CONCEPTION H; Price R, 2013, MAROON SOC REBEL SLA; Price Richard, 2002, NWIG-NEW W INDIAN GU, V76, P81, DOI DOI 10.1163/13822373-90002544; Price Richard., 2010, TRAVELS TOOY HIST ME; RCore Team, 2014, R LANG ENV STAT COMP; Rishishwar L, 2015, SCI REP-UK, V5, DOI 10.1038/srep12376; Ruiz-Linares A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004572; Salas A, 2008, AM J HUM BIOL, V20, P584, DOI 10.1002/ajhb.20783; Sankararaman S, 2008, AM J HUM GENET, V82, P290, DOI 10.1016/j.ajhg.2007.09.022; Schlebusch CM, 2012, SCIENCE, V338, P374, DOI 10.1126/science.1227721; Schroeder H, 2015, P NATL ACAD SCI USA, V112, P3669, DOI 10.1073/pnas.1421784112; Shringarpure SS, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1082-x; Szpiech ZA, 2013, AM J HUM GENET, V93, P90, DOI 10.1016/j.ajhg.2013.05.003; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Triska P, 2015, GENOME BIOL EVOL, V7, P3484, DOI 10.1093/gbe/evv236; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	73	29	29	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2017	101	5					725	736		10.1016/j.ajhg.2017.09.021	http://dx.doi.org/10.1016/j.ajhg.2017.09.021			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FL5DL	29100086	Bronze, Green Published			2022-12-18	WOS:000414251600006
J	De Mori, R; Romani, M; D'Arrigo, S; Zaki, MS; Lorefice, E; Tardivo, S; Biagini, T; Stanley, V; Musaev, D; Fluss, J; Micalizzi, A; Nuovo, S; Illi, B; Chiapparini, L; Di Marcotullio, L; Issa, MY; Anello, D; Casella, A; Ginevrino, M; Leggins, AS; Roosing, S; Alfonsi, R; Rosati, J; Schot, R; Mancini, GMS; Bertini, E; Dobyns, WB; Mazza, T; Gleeson, JG; Valente, EM				De Mori, Roberta; Romani, Marta; D'Arrigo, Stefano; Zaki, Maha S.; Lorefice, Elisa; Tardivo, Silvia; Biagini, Tommaso; Stanley, Valentina; Musaev, Damir; Fluss, Joel; Micalizzi, Alessia; Nuovo, Sara; Illi, Barbara; Chiapparini, Luisa; Di Marcotullio, Lucia; Issa, Mahmoud Y.; Anello, Danila; Casella, Antonella; Ginevrino, Monia; Leggins, Autumn Sa'na; Roosing, Susanne; Alfonsi, Romina; Rosati, Jessica; Schot, Rachel; Mancini, Grazia Maria Simonetta; Bertini, Enrico; Dobyns, William B.; Mazza, Tommaso; Gleeson, Joseph G.; Valente, Enza Maria			Hypomorphic Recessive Variants in SUFU Impair the Sonic Hedgehog Pathway and Cause Joubert Syndrome with Cranio-facial and Skeletal Defects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PLANAR CELL POLARITY; CEREBELLAR DEVELOPMENT; SIGNALING PATHWAY; PRIMARY CILIA; GLI PROTEINS; PHENOTYPIC SPECTRUM; MUTATIONS; KIF7; SHH; MEDULLOBLASTOMA	The Sonic Hedgehog (SHH) pathway is a key signaling pathway orchestrating embryonic development, mainly of the CNS and limbs. In vertebrates, SHH signaling is mediated by the primary cilium, and genetic defects affecting either SHH pathway members or ciliary proteins cause a spectrum of developmental disorders. SUFU is the main negative regulator of the SHH pathway and is essential during development. Indeed, Sufu knock-out is lethal in mice, and recessive pathogenic variants of this gene have never been reported in humans. Through whole-exome sequencing in subjects with Joubert syndrome, we identified four children from two unrelated families carrying homozygous missense variants in SUFU. The children presented congenital ataxia and cerebellar vermis hypoplasia with elongated superior cerebellar peduncles (mild "molar tooth sign''), typical cranio-facial dysmorphisms (hypertelorism, depressed nasal bridge, frontal bossing), and postaxial polydactyly. Two siblings also showed polymicrogyria. Molecular dynamics simulation predicted random movements of the mutated residues, with loss of the native enveloping movement of the binding site around its ligand GLI3. Functional studies on cellular models and fibroblasts showed that both variants significantly reduced SUFU stability and its capacity to bind GLI3 and promote its cleavage into the repressor form GLI3R. In turn, this impaired SUFU-mediated repression of the SHH pathway, as shown by altered expression levels of several target genes. We demonstrate that germline hypomorphic variants of SUFU cause deregulation of SHH signaling, resulting in recessive developmental defects of the CNS and limbs which share features with both SHH-related disorders and ciliopathies.	[De Mori, Roberta; Lorefice, Elisa; Tardivo, Silvia; Micalizzi, Alessia; Nuovo, Sara; Anello, Danila; Casella, Antonella; Ginevrino, Monia; Valente, Enza Maria] IRCCS, Santa Lucia Fdn, Neurogenet Unit, I-00143 Rome, Italy; [De Mori, Roberta; Micalizzi, Alessia] Univ Messina, Dept Biol & Environm Sci, I-98125 Messina, Italy; [Romani, Marta] GENOMA Grp, Mol Genet Lab, I-00138 Rome, Italy; [D'Arrigo, Stefano] Fdn IRCCS, Neurol Inst Carlo Besta, Dev Neurol Div, I-20133 Milan, Italy; [Zaki, Maha S.; Issa, Mahmoud Y.] Natl Res Ctr, Human Genet & Genome Res Div, Clin Genet Dept, Cairo 12311, Egypt; [Biagini, Tommaso; Mazza, Tommaso] IRCCS Casa Sollievo Sofferenza, Lab Bioinformat, I-71013 San Giovanni Rotondo, FG, Italy; [Stanley, Valentina; Musaev, Damir; Leggins, Autumn Sa'na; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Rady Childrens Inst Genom Med, Lab Pediat Brain Dis, La Jolla, CA 92037 USA; [Fluss, Joel] Geneva Childrens Hosp, Pediat Neurol Unit, CH-1211 Geneva 4, Switzerland; [Nuovo, Sara] Univ Salerno, Dept Med & Surg, I-84081 Salerno, Italy; [Illi, Barbara] CNR, Inst Mol Biol & Pathol, I-00185 Rome, Italy; [Chiapparini, Luisa] Fdn IRCCS, Neurol Inst Carlo Besta, Neuroradiol Dept, I-20133 Milan, Italy; [Di Marcotullio, Lucia; Alfonsi, Romina] Sapienza Univ, Dept Mol Med, I-00161 Rome, Italy; [Di Marcotullio, Lucia; Alfonsi, Romina] Sapienza Univ, Fdn Cenci Bolognetti, Ist Pasteur, I-00161 Rome, Italy; [Ginevrino, Monia; Valente, Enza Maria] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy; [Roosing, Susanne] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Rosati, Jessica] IRCCS Casa Sollievo Sofferenza, Lab Cellular Reprogramming, I-71013 San Giovanni Rotondo, FG, Italy; [Schot, Rachel; Mancini, Grazia Maria Simonetta] Erasmus MC, Dept Clin Genet, NL-3015 CN Rotterdam, Netherlands; [Bertini, Enrico] IRCCS, Bambino Gesu Childrens Hosp, Dept Neurosci, Lab Mol Med,Unit Neuromuscular & NeuroDegenerat D, I-00146 Rome, Italy; [Dobyns, William B.] Univ Washington, Dept Pediat, Seattle, WA 98101 USA; [Dobyns, William B.] Univ Washington, Dept Neurol, Seattle, WA 98101 USA; [Dobyns, William B.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA 98101 USA	IRCCS Santa Lucia; University of Messina; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); IRCCS Istituto Neurologico Besta; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); IRCCS Casa Sollievo Della Sofferenza; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of Salerno; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); IRCCS Istituto Neurologico Besta; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; University of Pavia; Radboud University Nijmegen; IRCCS Casa Sollievo Della Sofferenza; Erasmus University Rotterdam; Erasmus MC; IRCCS Bambino Gesu; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital	Valente, EM (corresponding author), IRCCS, Santa Lucia Fdn, Neurogenet Unit, I-00143 Rome, Italy.; Valente, EM (corresponding author), Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy.	em.valente@hsantalucia.it	Issa, Mahmoud/AAL-5118-2020; Lorefice, Elisa/AAB-8639-2019; Mazza, Tommaso/I-4531-2019; Bertini, Enrico/A-2284-2014; d'arrigo, stefano/K-3640-2016; Mazza, Tommaso/H-6414-2016; Casella, Antonella/AAC-1230-2022; Chiapparini, Luisa/K-4019-2016; Tardivo, Silvia/K-2163-2018; Roosing, Susanne/ABF-9604-2021; Dobyns, William Brian/ABC-6525-2021; Zaki, Maha S/B-9361-2013; Alfonsi, Romina/C-2641-2017; Illi, Barbara/AAY-8650-2020; Rosati, Jessica Diana/H-2867-2016; Bertini, Enrico/ABG-1278-2020; Ginevrino, Monia/K-2171-2018; Micalizzi, Alessia/AAI-1816-2019; Valente, Enza Maria/G-2942-2017; Micalizzi, Alessia/H-6936-2018; Roosing, Susanne/F-1616-2018; Ginevrino, Monia/AAB-6826-2022; Dobyns, William/AAI-2768-2020; Roosing, Susanne/AAK-3454-2020; Rosati, Jessica Diana/AAK-6084-2020; Nuovo, Sara/AAC-2233-2019; de mori, roberta/H-2982-2018; Biagini, Tommaso/K-3044-2016	Issa, Mahmoud/0000-0002-3899-2821; Mazza, Tommaso/0000-0003-0434-8533; Bertini, Enrico/0000-0001-9276-4590; d'arrigo, stefano/0000-0001-5188-9418; Mazza, Tommaso/0000-0003-0434-8533; Casella, Antonella/0000-0002-1514-2824; Chiapparini, Luisa/0000-0001-8115-9897; Tardivo, Silvia/0000-0001-7623-3407; Roosing, Susanne/0000-0001-9038-0067; Alfonsi, Romina/0000-0001-5100-5491; Rosati, Jessica Diana/0000-0002-4483-386X; Ginevrino, Monia/0000-0002-2782-6369; Valente, Enza Maria/0000-0002-0600-6820; Micalizzi, Alessia/0000-0001-9927-5781; Roosing, Susanne/0000-0001-9038-0067; Ginevrino, Monia/0000-0002-2782-6369; Dobyns, William/0000-0002-7681-2844; Roosing, Susanne/0000-0001-9038-0067; Rosati, Jessica Diana/0000-0002-4483-386X; de mori, roberta/0000-0002-1197-4308; DI MARCOTULLIO, LUCIA/0000-0003-0274-7178; Nuovo, Sara/0000-0003-1359-5122; Zaki, Maha/0000-0001-7840-0002; Lorefice, Elisa/0000-0001-8198-6286; Biagini, Tommaso/0000-0002-4539-028X	European Research Council [ERC StG 260888]; Telethon Foundation Italy [GGP13146]; MinistryItalian of Health (Ricerca Finalizzata grant) [NET-2013-02356160]; Pierfranco and Luisa Mariani Foundation (PADAPORT project) [R01NS048453, P01HD070494]; SFARI award [275275]; Howard Hughes Medical Institute; ErasmusMC MRace project [104673]; National Institute of Neurological Disorders and Stroke of the National Institutes of Health [R01NS050375]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101, R01NS050375, R01NS048453] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Telethon Foundation Italy(Fondazione Telethon); MinistryItalian of Health (Ricerca Finalizzata grant); Pierfranco and Luisa Mariani Foundation (PADAPORT project); SFARI award; Howard Hughes Medical Institute(Howard Hughes Medical Institute); ErasmusMC MRace project; National Institute of Neurological Disorders and Stroke of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the families for their cooperation to the study. This work was supported by European Research Council (ERC StG 260888), Telethon Foundation Italy (grant GGP13146), MinistryItalian of Health (Ricerca Finalizzata grant NET-2013-02356160), and Pierfranco and Luisa Mariani Foundation (PADAPORT project) to E.M.V.; R01NS048453, P01HD070494, SFARI award 275275, and the Howard Hughes Medical Institute to J.G.G.; the ErasmusMC MRace project (104673) to G.M.S.M.; and the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (award R01NS050375) to W.B.D.	Aavikko M, 2012, AM J HUM GENET, V91, P520, DOI 10.1016/j.ajhg.2012.07.015; Aguilar A, 2012, P NATL ACAD SCI USA, V109, P16951, DOI 10.1073/pnas.1201408109; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Brugieres L, 2012, J CLIN ONCOL, V30, P2087, DOI 10.1200/JCO.2011.38.7258; Brugieres L, 2010, J MED GENET, V47, P142, DOI 10.1136/jmg.2009.067751; Cherry AL, 2013, ACTA CRYSTALLOGR D, V69, P2563, DOI 10.1107/S0907444913028473; D'Amico D, 2015, DEV CELL, V35, P21, DOI 10.1016/j.devcel.2015.09.008; Dafinger C, 2011, J CLIN INVEST, V121, P2662, DOI 10.1172/JCI43639; De Luca A, 2016, CELL MOL LIFE SCI, V73, P291, DOI 10.1007/s00018-015-2065-1; Demurger F, 2015, EUR J HUM GENET, V23, P92, DOI 10.1038/ejhg.2014.62; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985; Dubourg C, 2016, HUM MUTAT, V37, P1329, DOI 10.1002/humu.23038; Dunaeva M, 2003, J BIOL CHEM, V278, P5116, DOI 10.1074/jbc.M209492200; Field M, 2012, EUR J HUM GENET, V20, P806, DOI 10.1038/ejhg.2012.9; Giordano L, 2009, AM J MED GENET A, V149A, P1511, DOI 10.1002/ajmg.a.32936; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Gorojankina T, 2016, CELL MOL LIFE SCI, V73, P1317, DOI 10.1007/s00018-015-2127-4; Gupta S, 2016, DEV BIOL, V413, P145, DOI 10.1016/j.ydbio.2016.03.019; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; He M, 2014, NAT CELL BIOL, V16, P663, DOI 10.1038/ncb2988; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Johnston JJ, 2005, AM J HUM GENET, V76, P609, DOI 10.1086/429346; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Kia SK, 2012, AM J HUM GENET, V91, P533, DOI 10.1016/j.ajhg.2012.07.008; Kim JJ, 2011, J NEUROSCI, V31, P1825, DOI 10.1523/JNEUROSCI.2166-10.2011; Kiwilsza M, 2012, MED SCI MONITOR, V18, pRA145, DOI 10.12659/MSM.883341; Larkins CE, 2011, MOL BIOL CELL, V22, P4694, DOI 10.1091/mbc.E10-12-0994; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lopez-Rios J, 2016, SEMIN CELL DEV BIOL, V49, P116, DOI 10.1016/j.semcdb.2015.12.018; Makino S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119455; Mitchison HM, 2017, J PATHOL, V241, P294, DOI 10.1002/path.4843; Nozawa YI, 2013, CURR OPIN GENET DEV, V23, P429, DOI 10.1016/j.gde.2013.04.008; Pastorino L, 2009, AM J MED GENET A, V149A, P1539, DOI 10.1002/ajmg.a.32944; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poretti A, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-4; Putoux A, 2012, J MED GENET, V49, P713, DOI 10.1136/jmedgenet-2012-101016; Putoux A, 2011, NAT GENET, V43, P601, DOI 10.1038/ng.826; Romani M, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000061; Romani M, 2013, LANCET NEUROL, V12, P894, DOI 10.1016/S1474-4422(13)70136-4; Roosing S, 2016, J MED GENET, V53, P608, DOI 10.1136/jmedgenet-2016-103832; Ruat M, 2012, DIFFERENTIATION, V83, pS97, DOI 10.1016/j.diff.2011.11.011; Schell-Apacik CC, 2009, AM J MED GENET A, V149A, P1592, DOI 10.1002/ajmg.a.32940; Shafer B, 2011, DEV CELL, V20, P177, DOI 10.1016/j.devcel.2011.01.002; Spassky N, 2008, DEV BIOL, V317, P246, DOI 10.1016/j.ydbio.2008.02.026; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Tissir F, 2013, NAT REV NEUROSCI, V14, P525, DOI 10.1038/nrn3525; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; Twigg SRF, 2016, AM J HUM GENET, V98, P1256, DOI 10.1016/j.ajhg.2016.04.007; Wallingford JB, 2011, GENE DEV, V25, P201, DOI 10.1101/gad.2008011; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Yue S, 2009, ONCOGENE, V28, P492, DOI 10.1038/onc.2008.403; Zhulyn O, 2015, DEV DYNAM, V244, P468, DOI 10.1002/dvdy.24249; Zhulyn O, 2014, DEV CELL, V29, P241, DOI 10.1016/j.devcel.2014.03.002	56	29	31	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 5	2017	101	4					552	563		10.1016/j.ajhg.2017.08.017	http://dx.doi.org/10.1016/j.ajhg.2017.08.017			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FI8UJ	28965847	Bronze, Green Published			2022-12-18	WOS:000412277300006
J	Ivanova, EL; Mau-Them, FT; Riazuddin, S; Kahrizi, K; Laugel, V; Schaefer, E; Martin, AD; Runge, K; Iqbal, Z; Spitz, MA; Laura, M; Drouot, N; Gerard, B; Deleuze, JF; de Brouwer, APM; Razzaq, A; Dollfus, H; Assir, MZ; Nitchke, P; Hinckelmann, MV; Ropers, H; Riazuddin, S; Najmabadi, H; van Bokhoven, H; Chelly, J				Ivanova, Ekaterina L.; Mau-Them, Frederic Tran; Riazuddin, Saima; Kahrizi, Kimia; Laugel, Vincent; Schaefer, Elise; Martin, Anne de Saint; Runge, Karen; Iqbal, Zafar; Spitz, Marie-Aude; Laura, Mary; Drouot, Nathalie; Gerard, Benedicte; Deleuze, Jean-Francois; de Brouwer, Arjan P. M.; Razzaq, Attia; Dollfus, Helene; Assir, Muhammad Zaman; Nitchke, Patrick; Hinckelmann, Maria-Victoria; Ropers, Hilger; Riazuddin, Sheikh; Najmabadi, Hossein; van Bokhoven, Hans; Chelly, Jamel			Homozygous Truncating Variants in TBC1D23 Cause Pontocerebellar Hypoplasia and Alter Cortical Development	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GTPASE-ACTIVATING PROTEINS; NEURONAL MIGRATION; INNATE IMMUNITY; MUTATIONS; RAB; GAPS; VISUALIZATION; MECHANISM; SYSTEM; DOMAIN	Pontocerebellar hypoplasia (PCH) is a heterogeneous group of rare recessive disorders with prenatal onset, characterized by hypoplasia of pons and cerebellum. Mutations in a small number of genes have been reported to cause PCH, and the vast majority of PCH cases are explained by mutations in TSEN54, which encodes a subunit of the tRNA splicing endonuclease complex. Here we report three families with homozygous truncating mutations in TBC1D23 who display moderate to severe intellectual disability and microcephaly. MRI data from available affected subjects revealed PCH, small normally proportioned cerebellum, and corpus callosum anomalies. Furthermore, through in utero electroporation, we show that downregulation of TBC1D23 affects cortical neuron positioning. TBC1D23 is a member of the Tre2-Bub2-Cdc16 (TBC) domain-containing RAB-specific GTPase-activating proteins (TBC/RABGAPs). Members of this protein family negatively regulate RAB proteins and modulate the signaling between RABs and other small GTPases, some of which have a crucial role in the trafficking of intracellular vesicles and are involved in neurological disorders. Here, we demonstrate that dense core vesicles and lysosomal trafficking dynamics are affected in fibroblasts harboring TBC1D23 mutation. We propose that mutations in TBC1D23 are responsible for a form of PCH with small, normally proportioned cerebellum and should be screened in individuals with syndromic pontocereballar hypoplasia.	[Mau-Them, Frederic Tran; Laura, Mary; Gerard, Benedicte; Chelly, Jamel] Hop Univ Strasbourg, Lab Diagnost Genet, F-67000 Strasbourg, France; [Ivanova, Ekaterina L.; Runge, Karen; Drouot, Nathalie; Hinckelmann, Maria-Victoria; Chelly, Jamel] Inst Genet & Biol Mol & Cellulaire, F-67400 Illkirch Graffenstaden, France; [Ivanova, Ekaterina L.; Mau-Them, Frederic Tran; Runge, Karen; Drouot, Nathalie; Hinckelmann, Maria-Victoria; Chelly, Jamel] CNRS, UMR7104, F-67400 Illkirch Graffenstaden, France; [Ivanova, Ekaterina L.; Mau-Them, Frederic Tran; Runge, Karen; Drouot, Nathalie; Hinckelmann, Maria-Victoria; Chelly, Jamel] INSERM, U964, F-67400 Illkirch Graffenstaden, France; [Ivanova, Ekaterina L.; Mau-Them, Frederic Tran; Runge, Karen; Drouot, Nathalie; Hinckelmann, Maria-Victoria; Chelly, Jamel] Univ Strasbourg, F-67400 Illkirch Graffenstaden, France; [Riazuddin, Saima] Univ Maryland, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Baltimore, MD 21201 USA; [Riazuddin, Saima; Razzaq, Attia; Assir, Muhammad Zaman; Riazuddin, Sheikh] Shaheed Zulfiqar Ali Bhutto Med Univ, Pakistan Inst Med Sci, Islamabad 44000, Pakistan; [Kahrizi, Kimia; Najmabadi, Hossein] Univ Social Welf & Rehabil Sci, Genet Res Ctr, Tehran 1985713834, Iran; [Laugel, Vincent; Martin, Anne de Saint; Spitz, Marie-Aude] Strasbourg Univ Hosp, Dept Pediat, F-67000 Strasbourg, France; [Laugel, Vincent; Spitz, Marie-Aude; Chelly, Jamel] Univ Strasbourg, Federat Med Translat Strasbourg, F-67000 Strasbourg, France; [Schaefer, Elise; Dollfus, Helene] Hop Univ Strasbourg, Serv Genet Med, F-67000 Strasbourg, France; [Iqbal, Zafar; de Brouwer, Arjan P. M.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Deleuze, Jean-Francois] CNG, F-91000 Evry, France; [Assir, Muhammad Zaman; Riazuddin, Sheikh] Univ Hlth Sci, Allama Iqbal Med Coll, Lahore 54000, Pakistan; [Nitchke, Patrick] Univ Paris 05, Inst Imagine, Bioinformat Platform, F-75015 Paris, France; [Ropers, Hilger] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Iqbal, Zafar] Oslo Univ Hosp, Dept Neurol, N-0450 Oslo, Norway	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University System of Maryland; University of Maryland Baltimore; Pakistan Institute of Medical Sciences; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Radboud University Nijmegen; UDICE-French Research Universities; Universite Paris Saclay; University of Health Science - Pakistan; UDICE-French Research Universities; Universite Paris Cite; Max Planck Society; University of Oslo	Chelly, J (corresponding author), Hop Univ Strasbourg, Lab Diagnost Genet, F-67000 Strasbourg, France.; Chelly, J (corresponding author), Inst Genet & Biol Mol & Cellulaire, F-67400 Illkirch Graffenstaden, France.; Chelly, J (corresponding author), CNRS, UMR7104, F-67400 Illkirch Graffenstaden, France.; Chelly, J (corresponding author), INSERM, U964, F-67400 Illkirch Graffenstaden, France.; Chelly, J (corresponding author), Univ Strasbourg, F-67400 Illkirch Graffenstaden, France.; Chelly, J (corresponding author), Univ Strasbourg, Federat Med Translat Strasbourg, F-67000 Strasbourg, France.	chelly@igbmc.fr	Najmabadi, Hossein/P-8182-2017; Bokhoven, J.H.L.M. van van/H-8015-2014; Kahrizi, Kimia/D-7989-2017; de Brouwer, Arjan PM/P-5949-2015	Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Dollfus, Helene/0000-0002-2249-895X; Iqbal, Zafar/0000-0002-1334-6372; DE SAINT-MARTIN, ANNE/0000-0003-4666-5369; Mary, Laura/0000-0002-4981-3999; Iqbal, Zafar/0000-0002-6387-8019; laugel, vincent/0000-0002-5782-6538; schaefer, elise/0000-0003-1004-6814; Tran Mau Them, Frederic/0000-0002-3795-9456	Strasbourg University; Fondation pour la Recherche Medicale (Equipe FRM) [J.C-DEQ20130326477]; Fondation Maladies Rares; Agence Nationale de Recherche [E10107KP, ANR-13-BSV-0009-01]; EU [241995, 602531]; Iranian National Science Foundation;  [ANR-10-LABX-0030-INRT];  [ANR-10-IDEX-0002-02]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS107428] Funding Source: NIH RePORTER	Strasbourg University; Fondation pour la Recherche Medicale (Equipe FRM)(Fondation pour la Recherche Medicale); Fondation Maladies Rares; Agence Nationale de Recherche(French National Research Agency (ANR)); EU(European Commission); Iranian National Science Foundation(Iran National Science Foundation (INSF)); ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the individuals and their families for their participation. This work was supported by funding from Strasbourg University and the grant ANR-10-LABX-0030-INRT, a French State Fund managed by the Agence Nationale de la Recherche under the frame program Investissements d'Avenir ANR-10-IDEX-0002-02, the Fondation pour la Recherche Medicale (Equipe FRM; J.C-DEQ20130326477), the Fondation Maladies Rares, Agence Nationale de Recherche (ANR-ERare-012-01 project E10107KP; ANR-13-BSV-0009-01), the EU-FP7 project GENECODYS (grant number 241995), and DESIRE (grant agreement 602531). Part of this work was also supported by a grant from the Iranian National Science Foundation. We thank the Imaging Center of IGBMC (ici.igbmc.fr), in particular Basile Gurchenkov and Elvire Guiot for their assistance in the microscope imaging experiments.	Ahmed MY, 2015, NEUROLOGY, V84, P1745, DOI 10.1212/WNL.0000000000001523; Anderson C, 2011, AM J MED GENET A, V155A, P667, DOI 10.1002/ajmg.a.33897; Anttonen AK, 2015, NEUROLOGY, V85, P306, DOI 10.1212/WNL.0000000000001787; Balestrini S, 2016, NEUROLOGY, V87, P77, DOI 10.1212/WNL.0000000000002807; Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; De Arras L, 2012, J IMMUNOL, V188, P2905, DOI 10.4049/jimmunol.1102595; Edwards TJ, 2014, BRAIN, V137, P1579, DOI 10.1093/brain/awt358; Eggens VRC, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-23; Fame RM, 2011, TRENDS NEUROSCI, V34, P41, DOI 10.1016/j.tins.2010.10.002; Frasa MAM, 2012, NAT REV MOL CELL BIO, V13, P67, DOI 10.1038/nrm3267; Fukuda M, 2011, BIOSCIENCE REP, V31, P159, DOI 10.1042/BSR20100112; Gabernet-Castello C, 2013, MOL BIOL CELL, V24, P1574, DOI 10.1091/mbc.E12-07-0557; Harripaul R., 2017, MOL PSYCHIAT; Karaca E, 2014, CELL, V157, P636, DOI 10.1016/j.cell.2014.02.058; Kosfeld A, 2016, HUM GENET, V135, P69, DOI 10.1007/s00439-015-1610-1; Krepinsky K, 2007, FEBS J, V274, P2778, DOI 10.1111/j.1742-4658.2007.05811.x; Lax NZ, 2015, J NEUROPATH EXP NEUR, V74, P688, DOI 10.1097/NEN.0000000000000209; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; Lykke-Andersen S, 2015, NAT REV MOL CELL BIO, V16, P665, DOI 10.1038/nrm4063; Marin-Valencia I, 2017, AM J HUM GENET, V101, P441, DOI 10.1016/j.ajhg.2017.07.015; Marsh APL, 2015, NEUROL-GENET, V1, DOI 10.1212/NXG.0000000000000014; Mochida GH, 2012, NAT GENET, V44, P1260, DOI 10.1038/ng.2425; Namavar Y, 2011, EUR J HUM GENET, V19, P724, DOI 10.1038/ejhg.2011.8; Namavar Y, 2011, BRAIN, V134, P143, DOI 10.1093/brain/awq287; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Remelli W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045193; Riazuddin S., 2016, MOL PSYCHIAT; Rudnik-Schoneborn S, 2014, AM J MED GENET C, V166, P173, DOI 10.1002/ajmg.c.31403; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Valence S, 2016, CLIN GENET, V90, P545, DOI 10.1111/cge.12779; Victorino F, 2013, IMMUNOL RES, V55, P3, DOI 10.1007/s12026-012-8344-0; Vinograd-Byk H, 2015, J NEUROSCI, V35, P936, DOI 10.1523/JNEUROSCI.1998-14.2015	33	29	29	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 7	2017	101	3					428	440		10.1016/j.ajhg.2017.07.010	http://dx.doi.org/10.1016/j.ajhg.2017.07.010			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FG1CS	28823707	Green Published, Bronze			2022-12-18	WOS:000409530900009
J	Zepeda-Mendoza, CJ; Ibn-Salem, J; Kammin, T; Harris, DJ; Rita, D; Gripp, KW; MacKenzie, JJ; Gropman, A; Graham, B; Shaheen, R; Alkuraya, FS; Brasington, CK; Spence, EJ; Masser-Frye, D; Bird, LM; Spiegel, E; Sparkes, RL; Ordulu, Z; Talkowski, ME; Andrade-Navarro, MA; Robinson, PN; Morton, CC				Zepeda-Mendoza, Cinthya J.; Ibn-Salem, Jonas; Kammin, Tammy; Harris, David J.; Rita, Debra; Gripp, Karen W.; MacKenzie, Jennifer J.; Gropman, Andrea; Graham, Brett; Shaheen, Ranad; Alkuraya, Fowzan S.; Brasington, Campbell K.; Spence, Edward J.; Masser-Frye, Diane; Bird, Lynne M.; Spiegel, Erica; Sparkes, Rebecca L.; Ordulu, Zehra; Talkowski, Michael E.; Andrade-Navarro, Miguel A.; Robinson, Peter N.; Morton, Cynthia C.			Computational Prediction of Position Effects of Apparently Balanced Human Chromosomal Rearrangements	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENOME; STRUCTURAL VARIATION; GENE-EXPRESSION; KB UPSTREAM; ENHANCER; DISRUPTION; PHENOTYPE; VARIANTS; DISEASE; MAP	Interpretation of variants of uncertain significance, especially chromosomal rearrangements in non-coding regions of the human genome, remains one of the biggest challenges in modern molecular diagnosis. To improve our understanding and interpretation of such variants, we used high-resolution three-dimensional chromosomal structural data and transcriptional regulatory information to predict position effects and their association with pathogenic phenotypes in 17 subjects with apparently balanced chromosomal abnormalities. We found that the rearrangements predict disruption of long-range chromatin interactions between several enhancers and genes whose annotated clinical features are strongly associated with the subjects' phenotypes. We confirm gene-expression changes for a couple of candidate genes to exemplify the utility of our analysis of position effect. These results highlight the important interplay between chromosomal structure and disease and demonstrate the need to utilize chromatin conformational data for the prediction of position effects in the clinical interpretation of non-coding chromosomal rearrangements.	[Zepeda-Mendoza, Cinthya J.; Kammin, Tammy; Morton, Cynthia C.] Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, 75 Francis St, Boston, MA 02115 USA; [Zepeda-Mendoza, Cinthya J.; Harris, David J.] Harvard Med Sch, Boston, MA 02115 USA; [Ibn-Salem, Jonas; Andrade-Navarro, Miguel A.; Morton, Cynthia C.] Johannes Gutenberg Univ Mainz, D-55122 Mainz, Germany; [Harris, David J.] Boston Childrens Hosp, Boston, MA 02115 USA; [Rita, Debra] ACL Labs, Cytogenet Lab, Rosemont, IL 60018 USA; [Gripp, Karen W.] Nemours Alfred I DuPont Hosp Children, Wilmington, DE 19803 USA; [MacKenzie, Jennifer J.] McMaster Univ, Dept Pediat, Hamilton, ON L8S 4L8, Canada; [Gropman, Andrea] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Graham, Brett] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Shaheen, Ranad; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 12713, Saudi Arabia; [Alkuraya, Fowzan S.] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh 11533, Saudi Arabia; [Brasington, Campbell K.; Spence, Edward J.] Carolinas Med Ctr, Levine Childrens Hosp, Dept Pediat, Clin Genet Div, Charlotte, NC 28203 USA; [Masser-Frye, Diane; Bird, Lynne M.] Rady Childrens Hosp San Diego, Genet & Dysmorphol, San Diego, CA 92123 USA; [Bird, Lynne M.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Spiegel, Erica] Columbia Univ, Med Ctr, Maternal Fetal Med, New York, NY 10032 USA; [Sparkes, Rebecca L.] Univ Calgary, Cumming Sch Med, Dept Med Genet, Calgary, AB T2N 1N4, Canada; [Ordulu, Zehra; Talkowski, Michael E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Talkowski, Michael E.] Massachusetts Gen Hosp, Dept Neurol & Psychiat, Boston, MA 02114 USA; [Talkowski, Michael E.] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Talkowski, Michael E.] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [Talkowski, Michael E.; Morton, Cynthia C.] Broad Inst Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Talkowski, Michael E.; Morton, Cynthia C.] MIT, Cambridge, MA 02142 USA; [Talkowski, Michael E.] Broad Inst Harvard, Stanley Ctr Psychiat Genet, Cambridge, MA 02142 USA; [Talkowski, Michael E.] MIT, Cambridge, MA 02142 USA; [Robinson, Peter N.] Jackson Lab Genom Med, Farmington, CT 06032 USA; [Morton, Cynthia C.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Morton, Cynthia C.] Manchester Acad, Hlth Sci Ctr, Sch Biol Sci, Div Evolut & Genom Sci, Manchester M13 9NT, Lancs, England	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Johannes Gutenberg University of Mainz; Harvard University; Boston Children's Hospital; Nemours Alfred I. duPont Hospital for Children; McMaster University; Children's National Health System; Baylor College of Medicine; King Faisal Specialist Hospital & Research Center; Alfaisal University; Carolinas Medical Center; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; Columbia University; University of Calgary; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Jackson Laboratory; Harvard University; Brigham & Women's Hospital; University of Manchester	Morton, CC (corresponding author), Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, 75 Francis St, Boston, MA 02115 USA.; Morton, CC (corresponding author), Johannes Gutenberg Univ Mainz, D-55122 Mainz, Germany.; Morton, CC (corresponding author), Broad Inst Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA.; Morton, CC (corresponding author), MIT, Cambridge, MA 02142 USA.; Morton, CC (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.; Morton, CC (corresponding author), Manchester Acad, Hlth Sci Ctr, Sch Biol Sci, Div Evolut & Genom Sci, Manchester M13 9NT, Lancs, England.	cmorton@bwh.harvard.edu	Ordulu, Zehra/ABI-6638-2020; Graham, Brett/R-8685-2018; Ibn-Salem, Jonas/L-2605-2019; Bird, Lynne/AAG-9533-2021	Ordulu, Zehra/0000-0002-3218-1075; Graham, Brett/0000-0001-8451-8154; Ibn-Salem, Jonas/0000-0001-9886-113X; MacKenzie, Jennifer/0000-0002-3374-8619; SHAHEEN, RANAD/0000-0002-2590-1759; Bird, Lynne/0000-0003-4833-3747; Talkowski, Michael/0000-0003-2889-0992	National Institutes of Health [GM061354]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We offer heartfelt gratitude to all DGAP research participants and their families and to countless genetic counselors, clinical geneticists, cytogeneticists, and physicians for their ongoing support of our study and for referrals to our project. This study was funded by the National Institutes of Health (GM061354 to C.C.M. and M.E.T.).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Bonev B, 2016, NAT REV GENET, V17, P661, DOI 10.1038/nrg.2016.112; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cai JL, 2003, HUM GENET, V114, P68, DOI 10.1007/s00439-003-1012-7; Cardoso AR, 2016, HUM GENOMICS, V10, DOI 10.1186/s40246-016-0088-9; Carvalho CMB, 2016, NAT REV GENET, V17, P224, DOI 10.1038/nrg.2015.25; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; FANTES J, 1995, HUM MOL GENET, V4, P415, DOI 10.1093/hmg/4.3.415; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Flomen RH, 1998, GENOMICS, V47, P409, DOI 10.1006/geno.1997.5127; FORD CE, 1959, LANCET, V1, P711; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Giorgio E, 2015, HUM MOL GENET, V24, P3143, DOI 10.1093/hmg/ddv065; Groschel S, 2014, CELL, V157, P369, DOI 10.1016/j.cell.2014.02.019; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Heger A, 2013, BIOINFORMATICS, V29, P2046, DOI 10.1093/bioinformatics/btt343; Higgins AW, 2008, AM J HUM GENET, V82, P712, DOI 10.1016/j.ajhg.2008.01.011; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hnisz D, 2016, SCIENCE, V351, P1454, DOI 10.1126/science.aad9024; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1; JACOBS PA, 1959, NATURE, V183, P302, DOI 10.1038/183302a0; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kleinjan DA, 2001, HUM MOL GENET, V10, P2049, DOI 10.1093/hmg/10.19.2049; Kleinjan DJ, 1998, HUM MOL GENET, V7, P1611, DOI 10.1093/hmg/7.10.1611; Kohler S, 2014, NUCLEIC ACIDS RES, V42, pD966, DOI 10.1093/nar/gkt1026; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lappalainen I, 2013, NUCLEIC ACIDS RES, V41, pD936, DOI 10.1093/nar/gks1213; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P1721; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Ligon AH, 2005, AM J HUM GENET, V76, P340, DOI 10.1086/427565; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lu WN, 2007, PLOS GENET, V3, P830, DOI 10.1371/journal.pgen.0030080; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Mifsud B, 2015, NAT GENET, V47, P598, DOI 10.1038/ng.3286; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Muro EM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-338; Nambiar M, 2011, NUCLEIC ACIDS RES, V39, P5813, DOI 10.1093/nar/gkr223; Narendra V, 2015, SCIENCE, V347, P1017, DOI 10.1126/science.1262088; Oldridge DA, 2015, NATURE, V528, P418, DOI 10.1038/nature15540; Ordulu Z, 2016, AM J HUM GENET, V99, P1015, DOI 10.1016/j.ajhg.2016.08.022; Ordulu Z, 2014, AM J HUM GENET, V94, P695, DOI 10.1016/j.ajhg.2014.03.020; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Pink RC, 2011, RNA, V17, P792, DOI 10.1261/rna.2658311; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Quinn JJ, 2016, NAT REV GENET, V17, P47, DOI 10.1038/nrg.2015.10; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Redin C, 2017, NAT GENET, V49, P36, DOI 10.1038/ng.3720; Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261; Roussos P, 2014, CELL REP, V9, P1417, DOI 10.1016/j.celrep.2014.10.015; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schmid JP, 2012, J EXP MED, V209, P2323, DOI 10.1084/jem.20121303; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Spielmann M, 2016, HUM MOL GENET, V25, pR157, DOI 10.1093/hmg/ddw205; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Talkowski ME, 2011, AM J HUM GENET, V88, P469, DOI 10.1016/j.ajhg.2011.03.013; Theisen A, 2010, APPL CLIN GENET, V3, P159, DOI 10.2147/TACG.S8884; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Trembath DG, 2004, BIRTH DEFECTS RES A, V70, P82, DOI 10.1002/bdra.10154; Velagaleti GVN, 2005, AM J HUM GENET, V76, P652, DOI 10.1086/429252; Vetro A, 2015, EUR J HUM GENET, V23, P1025, DOI 10.1038/ejhg.2014.237; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visser M, 2012, GENOME RES, V22, P446, DOI 10.1101/gr.128652.111; Weiler KS, 1995, ANNU REV GENET, V29, P577, DOI 10.1146/annurev.ge.29.120195.003045; Zhang F, 2015, HUM MOL GENET, V24, pR102, DOI 10.1093/hmg/ddv259; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhou Xin, 2012, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1010s40	83	29	29	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 3	2017	101	2					206	217		10.1016/j.ajhg.2017.06.011	http://dx.doi.org/10.1016/j.ajhg.2017.06.011			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FC5BD	28735859	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000406854800005
J	Morrison, AC; Huang, ZY; Yu, B; Metcalf, G; Liu, XM; Ballantyne, C; Coresh, J; Yu, FL; Muzny, D; Feofanova, E; Rustagi, N; Gibbs, R; Boerwinkle, E				Morrison, Alanna C.; Huang, Zhuoyi; Yu, Bing; Metcalf, Ginger; Liu, Xiaoming; Ballantyne, Christie; Coresh, Josef; Yu, Fuli; Muzny, Donna; Feofanova, Elena; Rustagi, Navin; Gibbs, Richard; Boerwinkle, Eric			Practical Approaches for Whole-Genome Sequence Analysis of Heart- and Blood-Related Traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							C-REACTIVE PROTEIN; GENETIC-VARIANTS; RARE VARIANTS; ASSOCIATION; DISEASE; RISK; PREDICTION; ELEMENTS; HEALTH	Whole-genome sequencing (WGS) allows for a comprehensive view of the sequence of the human genome. We present and apply integrated methodologic steps for interrogating WGS data to characterize the genetic architecture of 10 heart- and blood-related traits in a sample of 1,860 African Americans. In order to evaluate the contribution of regulatory and non-protein coding regions of the genome, we conducted aggregate tests of rare variation across the entire genomic landscape using a sliding window, complemented by an annotation-based assessment of the genome using predefined regulatory elements and within the first intron of all genes. These tests were performed treating all variants equally as well as with individual variants weighted by a measure of predicted functional consequence. Significant findings were assessed in 1,705 individuals of European ancestry. After these steps, we identified and replicated components of the genomic landscape significantly associated with heart- and blood-related traits. For two traits, lipoprotein(a) levels and neutrophil count, aggregate tests of low-frequency and rare variation were significantly associated across multiple motifs. For a third trait, cardiac troponin T, investigation of regulatory domains identified a locus on chromosome 9. These practical approaches for WGS analysis led to the identification of informative genomic regions and also showed that defined non coding regions, such as first introns of genes and regulatory domains, are associated with important risk factor phenotypes. This study illustrates the tractable nature of WGS data and outlines an approach for characterizing the genetic architecture of complex traits.	[Morrison, Alanna C.; Yu, Bing; Liu, Xiaoming; Feofanova, Elena; Boerwinkle, Eric] Univ Texas Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA; [Huang, Zhuoyi; Metcalf, Ginger; Yu, Fuli; Muzny, Donna; Rustagi, Navin; Gibbs, Richard; Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Ballantyne, Christie] Baylor Coll Med, Sect Cardiovasc Res, Houston, TX 77030 USA; [Ballantyne, Christie] Houston Methodist Debakey Heart & Vasc Ctr, Houston, TX 77030 USA; [Coresh, Josef] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21287 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Baylor College of Medicine; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Morrison, AC; Boerwinkle, E (corresponding author), Univ Texas Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA.; Boerwinkle, E (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.	alanna.c.morrison@uth.tmc.edu; eric.boerwinkle@uth.tmc.edu	Feofanova, Elena/ABC-7895-2021; Liu, Xiaoming/C-2743-2008; Ballantyne, Christie/A-6599-2008	Liu, Xiaoming/0000-0001-8285-5528; Morrison, Alanna/0000-0001-6381-4296; Ballantyne, Christie/0000-0002-6432-1730	National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]; NIH [5RC2HL102419]; National Human Genome Research Institute [U54 HG003273, UM1 HG008898]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102419] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, UM1HG008898] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The Atherosclerosis Risk in Communities (ARIC) study is carried out as a collaborative study supported by the National Heart, Lung, and Blood Institute (NHLBI) contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C). The authors thank the staff and participants of the ARIC study for their important contributions. Funding support for "Building on GWAS for NHLBI-diseases: the U.S. CHARGE consortium" was provided by the NIH through the American Recovery and Reinvestment Act of 2009 (ARRA) (5RC2HL102419). Sequencing was carried out at the Baylor College of Medicine Human Genome Sequencing Center, also supported by the National Human Genome Research Institute grants U54 HG003273 and UM1 HG008898 to R.G.	Abul Y, 2014, CLIN APPL THROMB-HEM, V20, P838, DOI 10.1177/1076029613486540; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Corbett-Detig RB, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002112; Crosslin DR, 2012, HUM GENET, V131, P639, DOI 10.1007/s00439-011-1103-9; Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Graur D, 2013, GENOME BIOL EVOL, V5, P578, DOI 10.1093/gbe/evt028; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Ionita-Laza I, 2016, NAT GENET, V48, P214, DOI 10.1038/ng.3477; Kellis M, 2014, P NATL ACAD SCI USA, V111, P6131, DOI 10.1073/pnas.1318948111; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Kim Taebeom, 2016, BMC Proc, V10, P257; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; Li AH, 2015, NAT GENET, V47, P640, DOI 10.1038/ng.3270; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Liu XM, 2016, J MED GENET, V53, P111, DOI 10.1136/jmedgenet-2015-103423; Majewski J, 2002, GENOME RES, V12, P1827, DOI 10.1101/gr.606402; Morrison AC, 2013, NAT GENET, V45, P899, DOI 10.1038/ng.2671; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Ober C, 2009, J LIPID RES, V50, P798, DOI 10.1194/jlr.M800515-JLR200; Okada Y, 2011, HUM MOL GENET, V20, P1224, DOI 10.1093/hmg/ddq551; Park SG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-526; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Qi QB, 2012, EUR HEART J, V33, P325, DOI 10.1093/eurheartj/ehr350; Reiner AP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002108; Ridker PM, 2008, AM J HUM GENET, V82, P1185, DOI 10.1016/j.ajhg.2008.03.015; Schick UM, 2015, HUM MOL GENET, V24, P559, DOI 10.1093/hmg/ddu450; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu Y, 2013, J LIPID RES, V54, P3198, DOI 10.1194/jlr.P042077; Yu B, 2016, CIRC-CARDIOVASC GENE, V9, P64, DOI 10.1161/CIRCGENETICS.115.001215; Yu FL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121644	36	29	29	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 2	2017	100	2					205	215		10.1016/j.ajhg.2016.12.009	http://dx.doi.org/10.1016/j.ajhg.2016.12.009			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ6TP	28089252	Bronze, Green Published			2022-12-18	WOS:000393352000003
J	van Rooij, FJA; Qayyum, R; Smith, AV; Zhou, Y; Trompet, S; Tanaka, T; Keller, MF; Chang, LC; Schmidt, H; Yang, ML; Chen, MH; Hayes, J; Johnson, AD; Yanek, LR; Mueller, C; Lange, L; Floyd, JS; Ghanbari, M; Zonderman, AB; Jukema, JW; Hofman, A; van Duijn, CM; Desch, KC; Saba, Y; Ozel, AB; Snively, BM; Wu, JY; Schmidt, R; Fornage, M; Klein, RJ; Fox, CS; Matsuda, K; Kamatani, N; Wild, PS; Stott, DJ; Ford, I; Slagboom, PE; Yang, J; Chu, AY; Lambert, AJ; Uitterlinden, AG; Franco, OH; Hofer, E; Ginsburg, D; Hu, B; Keating, B; Schick, UM; Brody, JA; Li, JZ; Chen, Z; Zeller, T; Guralnik, JM; Chasman, DI; Peters, LL; Kubo, M; Becker, DM; Li, J; Eiriksdottir, G; Rotter, JI; Levy, D; Grossmann, V; Patel, KV; Chen, CH; Ridker, PM; Tang, H; Launer, LJ; Rice, KM; Li-Gao, R; Ferrucci, L; Evans, MK; Choudhuri, A; Trompouki, E; Abraham, BJ; Yang, S; Takahashi, A; Kamatani, Y; Kooperberg, C; Harris, TB; Jee, SH; Coresh, J; Tsai, FJ; Longo, DL; Chen, YT; Felix, JF; Yang, Q; Psaty, BM; Boerwinkle, E; Becker, LC; Mook-Kanamori, DO; Wilson, JG; Gudnason, V; O'Donnell, CJ; Dehghan, A; Cupples, LA; Nalls, MA; Morris, AP; Okada, Y; Reiner, AP; Zon, LI; Ganesh, SK				van Rooij, Frank J. A.; Qayyum, Rehan; Smith, Albert V.; Zhou, Yi; Trompet, Stella; Tanaka, Toshiko; Keller, Margaux F.; Chang, Li-Ching; Schmidt, Helena; Yang, Min-Lee; Chen, Ming-Huei; Hayes, James; Johnson, Andrew D.; Yanek, Lisa R.; Mueller, Christian; Lange, Leslie; Floyd, James S.; Ghanbari, Mohsen; Zonderman, Alan B.; Jukema, J. Wouter; Hofman, Albert; van Duijn, Cornelia M.; Desch, Karl C.; Saba, Yasaman; Ozel, Ayse B.; Snively, Beverly M.; Wu, Jer-Yuarn; Schmidt, Reinhold; Fornage, Myriam; Klein, Robert J.; Fox, Caroline S.; Matsuda, Koichi; Kamatani, Naoyuki; Wild, Philipp S.; Stott, David J.; Ford, Ian; Slagboom, P. Eline; Yang, Jaden; Chu, Audrey Y.; Lambert, Amy J.; Uitterlinden, Andre G.; Franco, Oscar H.; Hofer, Edith; Ginsburg, David; Hu, Bella; Keating, Brendan; Schick, Ursula M.; Brody, Jennifer A.; Li, Jun Z.; Chen, Zhao; Zeller, Tanja; Guralnik, Jack M.; Chasman, Daniel I.; Peters, Luanne L.; Kubo, Michiaki; Becker, Diane M.; Li, Jin; Eiriksdottir, Gudny; Rotter, Jerome I.; Levy, Daniel; Grossmann, Vera; Patel, Kushang V.; Chen, Chien-Hsiun; Ridker, Paul M.; Tang, Hua; Launer, Lenore J.; Rice, Kenneth M.; Li-Gao, Ruifang; Ferrucci, Luigi; Evans, Michelle K.; Choudhuri, Avik; Trompouki, Eirini; Abraham, Brian J.; Yang, Song; Takahashi, Atsushi; Kamatani, Yoichiro; Kooperberg, Charles; Harris, Tamara B.; Jee, Sun Ha; Coresh, Josef; Tsai, Fuu-Jen; Longo, Dan L.; Chen, Yuan-Tsong; Felix, Janine F.; Yang, Qiong; Psaty, Bruce M.; Boerwinkle, Eric; Becker, Lewis C.; Mook-Kanamori, Dennis O.; Wilson, James G.; Gudnason, Vilmundur; O'Donnell, Christopher J.; Dehghan, Abbas; Cupples, L. Adrienne; Nalls, Michael A.; Morris, Andrew P.; Okada, Yukinori; Reiner, Alexander P.; Zon, Leonard I.; Ganesh, Santhi K.		BioBank Japan Project	Genome-wide Trans-ethnic Meta-analysis Identifies Seven Genetic Loci Influencing Erythrocyte Traits and a Role for RBPMS in Erythropoiesis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RED-BLOOD-CELL; TRANSETHNIC METAANALYSIS; AFRICAN-AMERICANS; STEM-CELLS; ASSOCIATION; PROTEIN; HEMOGLOBIN; LINKAGE; DIFFERENTIATION; MICROARRAY	Genome-wide association studies (GWASs) have identified loci for erythrocyte traits in primarily European ancestry populations. We conducted GWAS meta-analyses of six erythrocyte traits in 71,638 individuals from European, East Asian, and African ancestries using a Bayesian approach to account for heterogeneity in allelic effects and variation in the structure of linkage disequilibrium between ethnicities. We identified seven loci for erythrocyte traits including a locus (RBPMS/GTF2E2) associated with mean corpuscular hemoglobin and mean corpuscular volume. Statistical fine-mapping at this locus pointed to RBPMS at this locus and excluded nearby GTF2E2. Using zebrafish morpholino to evaluate loss of function, we observed a strong in vivo erythropoietic effect for RBPMS but not for GTF2E2, supporting the statistical fine-mapping at this locus and demonstrating that RBPMS is a regulator of erythropoiesis. Our findings show the utility of trans-ethnic GWASs for discovery and characterization of genetic loci influencing hematologic traits.	[van Rooij, Frank J. A.; Ghanbari, Mohsen; Hofman, Albert; van Duijn, Cornelia M.; Uitterlinden, Andre G.; Franco, Oscar H.; Felix, Janine F.; Dehghan, Abbas] Erasmus MC, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands; [Qayyum, Rehan; Yanek, Lisa R.; Becker, Diane M.; Becker, Lewis C.] Johns Hopkins Univ, Sch Med, GeneSTAR Res Program, Baltimore, MD 21287 USA; [Smith, Albert V.; Gudnason, Vilmundur] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Smith, Albert V.; Eiriksdottir, Gudny; Gudnason, Vilmundur] Iceland Heart Assoc, IS-210 Kopavogur, Iceland; [Zhou, Yi; Hu, Bella; Choudhuri, Avik; Yang, Song; Zon, Leonard I.] Harvard Univ, Harvard Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Zhou, Yi; Hu, Bella; Choudhuri, Avik; Trompouki, Eirini; Yang, Song; Zon, Leonard I.] Harvard Med Sch, Harvard Stem Cell Inst, Childrens Hosp Boston, Pediat Hematol Oncol DFCI,Stem Cell Program, Boston, MA 02115 USA; [Zhou, Yi; Hu, Bella; Choudhuri, Avik; Trompouki, Eirini; Yang, Song; Zon, Leonard I.] Harvard Med Sch, Harvard Stem Cell Inst, Childrens Hosp Boston, Pediat Hematol Oncol DFCI,Div Hematol Oncol, Boston, MA 02115 USA; [Zhou, Yi; Hu, Bella; Choudhuri, Avik; Trompouki, Eirini; Yang, Song; Zon, Leonard I.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Trompet, Stella; Jukema, J. Wouter] Leiden Univ, Med Ctr, Dept Cardiol, NL-2300 AC Leiden, Netherlands; [Trompet, Stella] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, NL-2300 AC Leiden, Netherlands; [Tanaka, Toshiko; Ferrucci, Luigi] NIA, NIH, Baltimore, MD 21224 USA; [Keller, Margaux F.; Nalls, Michael A.] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Chang, Li-Ching; Wu, Jer-Yuarn; Chen, Chien-Hsiun; Chen, Yuan-Tsong] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Schmidt, Helena; Saba, Yasaman] Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, A-8010 Graz, Austria; [Yang, Min-Lee; Ganesh, Santhi K.] Univ Michigan, Dept Human Genet, Dept Internal Med, Div Cardiovasc Med, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA; [Chen, Ming-Huei] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Chen, Ming-Huei; Johnson, Andrew D.; Fox, Caroline S.; Levy, Daniel; Yang, Qiong; O'Donnell, Christopher J.; Cupples, L. Adrienne] NHLBI, Framingham Heart Study, Populat Sci Branch, Div Intramural Res,NIH, Framingham, MA 01702 USA; [Hayes, James; Klein, Robert J.; Zeller, Tanja] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, Icahn Inst Multiscale Biol, New York, NY 10029 USA; [Mueller, Christian; Zeller, Tanja] Univ Heart Ctr Hamburg Eppendorf, Dept Gen & Intervent Cardiol, D-20246 Hamburg, Germany; [Lange, Leslie] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Floyd, James S.; Brody, Jennifer A.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Ghanbari, Mohsen] Mashhad Univ Med Sci, Sch Med, Dept Genet, Mashhad 91375345, Iran; [Zonderman, Alan B.; Patel, Kushang V.] NIA, NIH, Bethesda, MD 20892 USA; [Hofman, Albert] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Desch, Karl C.; Ozel, Ayse B.; Ginsburg, David; Li, Jun Z.] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA; [Snively, Beverly M.] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC 27101 USA; [Wu, Jer-Yuarn; Chen, Chien-Hsiun; Tsai, Fuu-Jen] China Med Univ, Sch Chinese Med, Taichung 40402, Taiwan; [Schmidt, Reinhold; Hofer, Edith] Med Univ Graz, Dept Neurol, Clin Div Neurogeriatr, A-8010 Graz, Austria; [Fornage, Myriam; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Human Genet Ctr, Houston, TX 77030 USA; [Matsuda, Koichi] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Mol Med, Tokyo 1088639, Japan; [Kamatani, Naoyuki; Takahashi, Atsushi; Kamatani, Yoichiro; Okada, Yukinori] RIKEN Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa 2300045, Japan; [Wild, Philipp S.; Grossmann, Vera] Univ Med Ctr Mainz, CTH, D-55131 Mainz, Germany; [Wild, Philipp S.] German Ctr Cardiovasc Res DZHK, Partner Site RhineMain, Mainz, Germany; [Wild, Philipp S.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Cardiol, Prevent Cardiol & Prevent Med, D-55131 Mainz, Germany; [Stott, David J.] Univ Glasgow, Fac Med, Inst Cardiovasc & Med Sci, Glasgow G12 8QQ, Lanark, Scotland; [Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Glasgow G12 8QQ, Lanark, Scotland; [Slagboom, P. Eline] Leiden Univ, Med Ctr, Sect Mol Epidemiol, Dept Med Stat & Bioinformat, NL-2300 AC Leiden, Netherlands; [Yang, Jaden] Stanford Univ, Sch Med, Quantitat Sci Unit, Palo Alto, CA 94304 USA; [Chu, Audrey Y.; Chasman, Daniel I.; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; [Chu, Audrey Y.; Chasman, Daniel I.; Ridker, Paul M.] Harvard Med Sch, Boston, MA 02215 USA; [Lambert, Amy J.; Peters, Luanne L.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, NL-3000 CA Rotterdam, Netherlands; [Hofer, Edith] Med Univ Graz, Inst Med Informat Stat & Documentat, A-8010 Graz, Austria; [Keating, Brendan] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Keating, Brendan] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [Schick, Ursula M.; Reiner, Alexander P.] Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div, Seattle, WA 98109 USA; [Schick, Ursula M.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Chen, Zhao] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Dept Epidemiol & Biostat, Tucson, AZ 85724 USA; [Mueller, Christian] German Ctr Cardiovasc Res DZHK, Partner Site Hamburg, D-20246 Hamburg, Germany; [Guralnik, Jack M.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Chasman, Daniel I.] Brigham & Womens Hosp, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Chasman, Daniel I.; Ridker, Paul M.] Harvard Med Sch, Boston, MA 02115 USA; [Kubo, Michiaki] RIKEN Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa 2300045, Japan; [Li, Jin] Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Palo Alto, CA 94304 USA; [Rotter, Jerome I.] Harbor UCLA Med Ctr, LABioMed, Inst Translat Genom & Populat Sci, Dept Pediat, Torrance, CA 90502 USA; [Rotter, Jerome I.] Harbor UCLA Med Ctr, LABioMed, Inst Translat Genom & Populat Sci, Dept Med, Torrance, CA 90502 USA; [Ridker, Paul M.] Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Tang, Hua] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Launer, Lenore J.; Harris, Tamara B.] NIA, Lab Epidemiol Demog & Biometry, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Rice, Kenneth M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Li-Gao, Ruifang; Mook-Kanamori, Dennis O.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 AC Leiden, Netherlands; [Evans, Michelle K.] NIA, Hlth Dispar Res Sect, Clin Res Branch, NIH, Bethesda, MD 20892 USA; [Trompouki, Eirini] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany; [Abraham, Brian J.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Kooperberg, Charles] Fred Hutchinson Canc Res Ctr, Biostat & Biomath, Seattle, WA 98109 USA; [Jee, Sun Ha] Yonsei Univ, Grad Sch Publ Hlth, Inst Hlth Promot, Seoul 03722, South Korea; [Coresh, Josef] Johns Hopkins Bloomberg Sch Publ Hlth, George W Comstock Ctr Publ Hlth Res & Prevent, Comstock Ctr & Cardiovasc Epidemiol, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; [Longo, Dan L.] NIA, Lab Genet & Genom, NIH, Baltimore, MD 21225 USA; [Yang, Qiong; Cupples, L. Adrienne] Boston Univ Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA 98101 USA; [Mook-Kanamori, Dennis O.] King Faisal Specialist Hosp & Res Ctr, Epidemiol Sect, Dept BESC, Riyadh, Saudi Arabia; [Mook-Kanamori, Dennis O.] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, NL-2300 AC Leiden, Netherlands; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Dehghan, Abbas] Imperial Coll, Sch Publ Hlth, MRC PHE Ctr Environm & Hlth, Dept Biostat & Epidemiol, London W2 1PG, England; [Morris, Andrew P.] Univ Liverpool, Dept Biostat, Block F,Waterhouse Bldg,1-5 Brownlow St, Liverpool L69 3GL, Merseyside, England; [Morris, Andrew P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England; [Okada, Yukinori] Osaka Univ, Grad Sch Med, Dept Stat Genet, Suita, Osaka 5650871, Japan; [Reiner, Alexander P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	Erasmus University Rotterdam; Erasmus MC; Johns Hopkins University; University of Iceland; Icelandic Heart Association; Harvard University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Academia Sinica - Taiwan; Medical University of Graz; University of Michigan System; University of Michigan; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Icahn School of Medicine at Mount Sinai; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; Mashhad University Medical Science; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Harvard University; Harvard T.H. Chan School of Public Health; University of Michigan System; University of Michigan; Wake Forest University; China Medical University Taiwan; Medical University of Graz; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Tokyo; RIKEN; Johannes Gutenberg University of Mainz; German Centre for Cardiovascular Research; Johannes Gutenberg University of Mainz; University of Glasgow; University of Glasgow; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Stanford University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Jackson Laboratory; Erasmus University Rotterdam; Erasmus MC; Medical University of Graz; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Fred Hutchinson Cancer Center; Icahn School of Medicine at Mount Sinai; University of Arizona; German Centre for Cardiovascular Research; University System of Maryland; University of Maryland Baltimore; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; RIKEN; Stanford University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Harvard University; Brigham & Women's Hospital; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Washington; University of Washington Seattle; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Max Planck Society; Massachusetts Institute of Technology (MIT); Whitehead Institute; Fred Hutchinson Cancer Center; Yonsei University; Yonsei University Health System; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Boston University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; King Faisal Specialist Hospital & Research Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Mississippi; University of Mississippi Medical Center; Imperial College London; University of Liverpool; University of Oxford; Wellcome Centre for Human Genetics; Osaka University; University of Washington; University of Washington Seattle	Ganesh, SK (corresponding author), Univ Michigan, Dept Human Genet, Dept Internal Med, Div Cardiovasc Med, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	sganesh@umich.edu	Longo, Dan L./F-6022-2011; Klein, Robert/ABI-7857-2020; Trompouki, Eirini/AAX-9539-2020; Johnson, Andrew D/G-6520-2013; Evans, Michele Kim/AAE-4776-2019; Levy, Daniel/ABF-6873-2021; Wu, Jer-Yuarn/S-7010-2018; Dehghan, Abbas/ABE-7377-2020; Franco, Óscar H/ABE-2305-2020; van Rooij, Frank/AAI-3997-2020; Gudnason, Vilmundur/AAE-7126-2019; Li-Gao, Ruifang/B-7172-2018; Ghanbari, Mohsen/AAH-1340-2020; Chen, Chien Hsiun/Q-3826-2018; Levy, Daniel/ABB-2752-2021; Wild, Philipp S./M-2106-2019; Ford, Ian/ABE-6145-2020; Jukema, J. Wouter/ABD-6503-2021; Rotter, Jerome/AAY-6598-2021; Schmidt, Reinhold/E-1137-2014; Abraham, Brian/C-2230-2019; Floyd, James/G-7563-2015; Smith, Albert Vernon/AHC-3838-2022; Dehghan, Abbas/B-9896-2008	Klein, Robert/0000-0003-3539-5391; Trompouki, Eirini/0000-0002-7242-8810; Johnson, Andrew D/0000-0001-6369-5178; Levy, Daniel/0000-0003-1843-8724; Franco, Óscar H/0000-0002-4606-4929; van Rooij, Frank/0000-0002-8600-9852; Gudnason, Vilmundur/0000-0001-5696-0084; Li-Gao, Ruifang/0000-0003-0650-1351; Ghanbari, Mohsen/0000-0002-9476-7143; Jukema, J. Wouter/0000-0002-3246-8359; Abraham, Brian/0000-0001-8085-3027; Smith, Albert Vernon/0000-0003-1942-5845; Jee, Sun Ha/0000-0001-9519-3068; Dehghan, Abbas/0000-0001-6403-016X; Van Duijn, Cornelia/0000-0002-2374-9204; Saba, Yasaman/0000-0002-3549-2493; Muller, Christian/0000-0002-9449-6865; Cupples, L. Adrienne/0000-0003-0273-7965; Wild, Philipp/0000-0003-4413-9752; Ozel, Ayse Bilge/0000-0002-1112-4258; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Zeller, Tanja/0000-0003-3379-2641; Peters, Luanne/0000-0002-0784-0534; Chen, Ming-Huei/0000-0003-3551-8726; Ginsburg, David/0000-0002-6436-8942	manufacturer (Zoll LifeCor) and on the Steering Committee of the Yale Open Data Access project - Johnson Johnson; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006170, R01HL039693, R01HL112642, R01HL048801, R01HL122684, P01HL032262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK106829, P30DK063491, U54DK110805] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000513, ZIAAG006000] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018522] Funding Source: NIH RePORTER	manufacturer (Zoll LifeCor) and on the Steering Committee of the Yale Open Data Access project - Johnson Johnson; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	B.M.P. serves on the DSMB of a clinical trial funded by the manufacturer (Zoll LifeCor) and on the Steering Committee of the Yale Open Data Access project funded by Johnson & Johnson.	Ascano M, 2012, WIRES RNA, V3, P159, DOI 10.1002/wrna.1103; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Chambers JC, 2009, NAT GENET, V41, P1170, DOI 10.1038/ng.462; Chen P, 2014, DIABETES, V63, P2551, DOI 10.2337/db13-1815; Chen Z, 2013, HUM MOL GENET, V22, P2529, DOI 10.1093/hmg/ddt087; CHURCHILL GA, 1994, GENETICS, V138, P963; Comuzzie AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051954; Cox A, 2009, GENETICS, V182, P1335, DOI 10.1534/genetics.109.105486; Dastani Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002607; de Mutsert R, 2013, EUR J EPIDEMIOL, V28, P513, DOI 10.1007/s10654-013-9801-3; Desch KC, 2013, P NATL ACAD SCI USA, V110, P588, DOI 10.1073/pnas.1219885110; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Ding KY, 2013, G3-GENES GENOM GENET, V3, P1061, DOI 10.1534/g3.113.006452; Evans D M, 1999, Twin Res, V2, P250, DOI 10.1375/136905299320565735; Franceschini N, 2012, AM J HUM GENET, V91, P744, DOI 10.1016/j.ajhg.2012.08.021; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Georgantas RW, 2004, CANCER RES, V64, P4434, DOI 10.1158/0008-5472.CAN-03-3247; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; Han B, 2011, AM J HUM GENET, V88, P586, DOI 10.1016/j.ajhg.2011.04.014; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Huang HT, 2013, NAT CELL BIOL, V15, P1516, DOI 10.1038/ncb2870; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Keller MF, 2014, HUM MOL GENET, V23, P6944, DOI 10.1093/hmg/ddu401; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kingsley PD, 2013, BLOOD, V121, pE5, DOI 10.1182/blood-2012-04-422394; Koury MJ, 2014, BLOOD REV, V28, P49, DOI 10.1016/j.blre.2014.01.002; Kullo IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013011; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Li J, 2013, HUM MOL GENET, V22, P1457, DOI 10.1093/hmg/dds534; Lin JP, 2007, AM J HEMATOL, V82, P605, DOI 10.1002/ajh.20868; Liu CT, 2014, HUM MOL GENET, V23, P4738, DOI 10.1093/hmg/ddu183; Lo KS, 2011, HUM GENET, V129, P307, DOI 10.1007/s00439-010-0925-1; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Morris AP, 2011, GENET EPIDEMIOL, V35, P809, DOI 10.1002/gepi.20630; Nalls MA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002113; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Otsuki M, 1999, BIOCHEM BIOPH RES CO, V266, P97, DOI 10.1006/bbrc.1999.1784; Pankratz N, 2016, NAT GENET, V48, P867, DOI 10.1038/ng.3607; Peters LL, 2010, BLOOD, V116, pE139, DOI 10.1182/blood-2010-05-283879; Pistis G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069206; Qayyum R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002491; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Reiner AP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002108; Richardson K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017944; Ridker PM, 2003, CIRCULATION, V108, P2292, DOI 10.1161/01.CIR.0000100688.17280.E6; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sankaran VG, 2012, GENE DEV, V26, P2075, DOI 10.1101/gad.197020.112; Sen S, 2001, GENETICS, V159, P371; Shimamoto A, 1996, P NATL ACAD SCI USA, V93, P10913, DOI 10.1073/pnas.93.20.10913; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Sun Y, 2006, NUCLEIC ACIDS RES, V34, P6314, DOI 10.1093/nar/gkl914; The ENCODE Project Consortium, 2011, PLOS BIOL; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Trakarnsanga K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100874; Trompouki E, 2011, CELL, V147, P577, DOI 10.1016/j.cell.2011.09.044; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; Wagner W, 2004, BLOOD, V104, P675, DOI 10.1182/blood-2003-10-3423; Wang X, 2013, HUM MOL GENET, V22, P2303, DOI 10.1093/hmg/ddt064; WHITFIELD J B, 1985, Genetic Epidemiology, V2, P133, DOI 10.1002/gepi.1370020204; Wild PS, 2012, BUNDESGESUNDHEITSBLA, V55, P824, DOI 10.1007/s00103-012-1502-7; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Williams Z, 2013, P NATL ACAD SCI USA, V110, P4255, DOI 10.1073/pnas.1214046110; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	67	29	29	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 5	2017	100	1					51	63		10.1016/j.ajhg.2016.11.016	http://dx.doi.org/10.1016/j.ajhg.2016.11.016			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EH6UX	28017375	Green Published, Green Submitted, Bronze, Green Accepted			2022-12-18	WOS:000391910500005
J	Cheong, SS; Hentschel, L; Davidson, AE; Gerrelli, D; Davie, R; Rizzo, R; Pontikos, N; Plagnol, V; Moore, AT; Sowden, JC; Michaelides, M; Snead, M; Tuft, SJ; Hardcastle, AJ				Cheong, Sek-Shir; Hentschel, Lisa; Davidson, Alice E.; Gerrelli, Dianne; Davie, Rebecca; Rizzo, Roberta; Pontikos, Nikolas; Plagnol, Vincent; Moore, Anthony T.; Sowden, Jane C.; Michaelides, Michel; Snead, Martin; Tuft, Stephen J.; Hardcastle, Alison J.			Mutations in CPAMD8 Cause a Unique Form of Autosomal-Recessive Anterior Segment Dysgenesis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PREGNANCY ZONE PROTEIN; HUMAN ALPHA-2-MACROGLOBULIN; GENE; IDENTIFICATION; COMPLEMENT; RECEPTOR; BINDING; ANIRIDIA; GLAUCOMA; FAMILY	Anterior segment dysgeneses (ASDs) comprise a spectrum of developmental disorders affecting the anterior segment of the eye. Here, we describe three unrelated families affected by a previously unclassified form of ASD. Shared ocular manifestations include bilateral iris hypoplasia, ectopia lentis, corectopia, ectropion uveae, and cataracts. Whole-exome sequencing and targeted Sanger sequencing identified mutations in CPAMD8 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8) as the cause of recessive ASD in all three families. A homozygous missense mutation in the evolutionarily conserved alpha-2-macroglobulin (A2M) domain of CPAMD8, c.4351T>C (p.Ser1451Pro), was identified in family 1. In family 2, compound heterozygous frameshift, c.2352_2353insC (p.Arg785Glnfs*23), and splice-site, c.4549-1G>A, mutations were identified. Two affected siblings in the third family were compound heterozygous for splice-site mutations c.700_1G>T and c.4002_1G>A. CPAMD8 splice-site mutations caused aberrant pre-mRNA splicing in vivo or in vitro. Intriguingly, our phylogenetic analysis revealed rodent lineage-specific CPAMD8 deletion, precluding a developmental expression study in mice. We therefore investigated the spatiotemporal expression of CPAMD8 in the developing human eye. RT-PCR and in situ hybridization revealed CPAMD8 expression in the lens, iris, cornea, and retina early in development, including strong expression in the distal tips of the retinal neuroepithelium that form the iris and ciliary body, thus correlating CPAMD8 expression with the affected tissues. Our study delineates a unique form of recessive ASD and defines a role for CPAMD8, a protein of unknown function, in anterior segment development, implying another pathway for the pathogenicity of ASD.	[Cheong, Sek-Shir; Davidson, Alice E.; Moore, Anthony T.; Michaelides, Michel; Tuft, Stephen J.; Hardcastle, Alison J.] UCL, Inst Ophthalmol, London EC1V 9EL, England; [Hentschel, Lisa; Gerrelli, Dianne; Sowden, Jane C.] UCL, Great Ormond St Inst Child Hlth, London WC1N 1EH, England; [Davie, Rebecca; Snead, Martin] Cambridge Univ Natl Hlth Serv Fdn Trust, Vitreoretinal Res Grp, Cambridge CB2 0QQ, England; [Rizzo, Roberta; Moore, Anthony T.; Tuft, Stephen J.] Moorfields Eye Hosp, London EC1V 2PD, England; [Pontikos, Nikolas; Plagnol, Vincent; Michaelides, Michel] UCL, Genet Inst, London WC1E 6BT, England; [Moore, Anthony T.] Univ Calif San Francisco, Dept Ophthalmol, Sch Med, San Francisco, CA 94143 USA	University of London; University College London; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of California System; University of California San Francisco	Hardcastle, AJ (corresponding author), UCL, Inst Ophthalmol, London EC1V 9EL, England.	a.hardcastle@ucl.ac.uk	Pontikos, Nikolas/U-3642-2018	Pontikos, Nikolas/0000-0003-1782-4711; snead, martin/0000-0003-0042-8659; Cheong, Sek-Shir/0000-0002-2218-7852; Sowden, Jane/0000-0003-0937-2479; Hardcastle, Alison/0000-0002-0038-6770	National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; Rosetrees Trust; Moorfields Eye Charity; NIHR BRC at Great Ormond Street Hospital; Great Ormond Street Hospital Charity; joint MRC/Wellcome Trust Human Developmental Biology Resource [099175/Z/12/Z]; MRC [G0700089, MC_PC_15004] Funding Source: UKRI; Medical Research Council [G0700089, MC_PC_15004, 1125070] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10069] Funding Source: researchfish; Rosetrees Trust [M311-F1, M257] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V2816, W1113] Funding Source: researchfish; Fight for Sight [1588/89] Funding Source: researchfish	National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; Rosetrees Trust(Rosetrees Trust); Moorfields Eye Charity; NIHR BRC at Great Ormond Street Hospital; Great Ormond Street Hospital Charity; joint MRC/Wellcome Trust Human Developmental Biology Resource; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Rosetrees Trust(Rosetrees Trust); Great Ormond Street Hospital Childrens Charity; Fight for Sight	The authors thank all family members for their participation in this study. This work was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, Rosetrees Trust, and Moorfields Eye Charity. J.C.S. and L.H. are supported by the NIHR BRC at Great Ormond Street Hospital and the Great Ormond Street Hospital Charity. The human embryonic and fetal material was provided by the joint MRC/Wellcome Trust Human Developmental Biology Resource (grant no. 099175/Z/12/Z) (http://www.hdbr.org/), with research ethics approval and informed consent.	Baralle M, 2003, J MED GENET, V40, P220, DOI 10.1136/jmg.40.3.220; Bath C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064244; Beebe DC, 2000, DEV BIOL, V220, P424, DOI 10.1006/dbio.2000.9638; Chen YY, 2013, HUM MOL GENET, V22, P1271, DOI 10.1093/hmg/dds527; CROOKSTON KP, 1994, J BIOL CHEM, V269, P1533; Davidson AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104163; Doward W, 1999, J MED GENET, V36, P152; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Finnson KW, 2006, FASEB J, V20, P1525, DOI 10.1096/fj.05-5229fje; FONG KY, 1990, GENOMICS, V7, P579, DOI 10.1016/0888-7543(90)90202-6; GONIAS SL, 1994, ANN NY ACAD SCI, V737, P273, DOI 10.1111/j.1749-6632.1994.tb44318.x; GORSKI JP, 1981, J BIOL CHEM, V256, P2707; Gould DB, 2004, INT J DEV BIOL, V48, P1015, DOI 10.1387/ijdb.041865dg; Gould DB, 2002, HUM MOL GENET, V11, P1185, DOI 10.1093/hmg/11.10.1185; HARRINGTON L, 1991, DEV BIOL, V148, P508, DOI 10.1016/0012-1606(91)90269-9; Hingorani M, 2012, EUR J HUM GENET, V20, P1011, DOI 10.1038/ejhg.2012.100; Idrees F, 2006, SURV OPHTHALMOL, V51, P213, DOI 10.1016/j.survophthal.2006.02.006; Ito YA, 2014, CLIN EXP OPHTHALMOL, V42, P13, DOI 10.1111/ceo.12152; Janssen SF, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-2; JENSEN PEH, 1992, EUR J BIOCHEM, V210, P1071, DOI 10.1111/j.1432-1033.1992.tb17513.x; Jonsson F, 2015, HUM MUTAT, V36, P463, DOI 10.1002/humu.22764; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; KAN CC, 1985, P NATL ACAD SCI USA, V82, P2282, DOI 10.1073/pnas.82.8.2282; Kelberman D, 2014, HUM MOL GENET, V23, P2511, DOI 10.1093/hmg/ddt643; Khan AO, 2008, OPHTHALMIC GENET, V29, P67, DOI 10.1080/13816810801908152; Kleinjan DA, 2006, DEV BIOL, V299, P563, DOI 10.1016/j.ydbio.2006.08.060; LEVISTRAUSS M, 1985, P NATL ACAD SCI USA, V82, P1746, DOI 10.1073/pnas.82.6.1746; Li ZF, 2004, GENOMICS, V83, P1083, DOI 10.1016/j.ygeno.2003.12.005; Lin M, 2002, BLOOD, V99, P1683, DOI 10.1182/blood.V99.5.1683; LUNDWALL AB, 1985, J BIOL CHEM, V260, P2108; Mears AJ, 1998, AM J HUM GENET, V63, P1316, DOI 10.1086/302109; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; Nishimura DY, 2001, AM J HUM GENET, V68, P364, DOI 10.1086/318183; Phillips JC, 2002, OPHTHALMIC RES, V34, P324, DOI 10.1159/000065602; Plagnol V, 2012, BIOINFORMATICS, V28, P2747, DOI 10.1093/bioinformatics/bts526; Reis LM, 2011, CURR OPIN OPHTHALMOL, V22, P314, DOI 10.1097/ICU.0b013e328349412b; Samonte IE, 2002, SCAND J IMMUNOL, V56, P344, DOI 10.1046/j.1365-3083.2002.01154.x; Sidis Y, 2006, ENDOCRINOLOGY, V147, P3586, DOI 10.1210/en.2006-0089; SOTTRUPJENSEN L, 1986, FEBS LETT, V205, P20, DOI 10.1016/0014-5793(86)80857-2; Sousounis K, 2014, REGENERATION, V1, P47, DOI 10.1002/reg2.25; Sousounis K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061445; Sowden JC, 2007, EYE, V21, P1310, DOI 10.1038/sj.eye.6702852; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; STUDD J W W, 1970, Journal of Obstetrics and Gynaecology of the British Commonwealth, V77, P42, DOI 10.1111/j.1471-0528.1970.tb03406.x; Tsuchida K, 2000, J BIOL CHEM, V275, P40788, DOI 10.1074/jbc.M006114200; VANLEUVEN F, 1986, J BIOL CHEM, V261, P6622; Webb TR, 2012, AM J HUM GENET, V90, P247, DOI 10.1016/j.ajhg.2011.12.019	47	29	31	5	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 1	2016	99	6					1338	1352		10.1016/j.ajhg.2016.09.022	http://dx.doi.org/10.1016/j.ajhg.2016.09.022			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED8VI	27839872	hybrid, Green Published			2022-12-18	WOS:000389148600009
J	Polfus, LM; Khajuria, RK; Schick, UM; Pankratz, N; Pazoki, R; Brody, JA; Chen, MH; Auer, PL; Floyd, JS; Huang, J; Lange, L; van Rooij, FJA; Gibbs, RA; Metcalf, G; Muzny, D; Veeraraghavan, N; Walter, K; Chen, L; Yanek, L; Becker, LC; Peloso, GM; Wakabayashi, A; Kals, M; Metspalu, A; Esko, T; Fox, K; Wallace, R; Franceschini, N; Matijevic, N; Rice, KM; Bartz, TM; Lyytikainen, LP; Kahonen, M; Lehtimaki, T; Raitakari, OT; Li-Gao, R; Mook-Kanamori, DO; Lettre, G; van Duijn, CM; Franco, OH; Rich, SS; Rivadeneira, F; Hofman, A; Uitterlinden, AG; Wilson, JG; Psaty, BM; Soranzo, N; Dehghan, A; Boerwinkle, E; Zhang, XL; Johnson, AD; O'Donnell, CJ; Johnsen, JM; Reiner, AP; Ganesh, SK; Sankaran, VG				Polfus, Linda M.; Khajuria, Rajiv K.; Schick, Ursula M.; Pankratz, Nathan; Pazoki, Raha; Brody, Jennifer A.; Chen, Ming-Huei; Auer, Paul L.; Floyd, James S.; Huang, Jie; Lange, Leslie; van Rooij, Frank J. A.; Gibbs, Richard A.; Metcalf, Ginger; Muzny, Donna; Veeraraghavan, Narayanan; Walter, Klaudia; Chen, Lu; Yanek, Lisa; Becker, Lewis C.; Peloso, Gina M.; Wakabayashi, Aoi; Kals, Mart; Metspalu, Andres; Esko, Tonu; Fox, Keolu; Wallace, Robert; Franceschini, Nora; Matijevic, Nena; Rice, Kenneth M.; Bartz, Traci M.; Lyytikainen, Leo-Pekka; Kahonen, Mika; Lehtimaki, Terho; Raitakari, Olli T.; Li-Gao, Ruifang; Mook-Kanamori, Dennis O.; Lettre, Guillaume; van Duijn, Cornelia M.; Franco, Oscar H.; Rich, Stephen S.; Rivadeneira, Fernando; Hofman, Albert; Uitterlinden, Andre G.; Wilson, James G.; Psaty, Bruce M.; Soranzo, Nicole; Dehghan, Abbas; Boerwinkle, Eric; Zhang, Xiaoling; Johnson, Andrew D.; O'Donnell, Christopher J.; Johnsen, Jill M.; Reiner, Alexander P.; Ganesh, Santhi K.; Sankaran, Vijay G.			Whole-Exome Sequencing Identifies Loci Associated with Blood Cell Traits and Reveals a Role for Alternative GFI1B Splice Variants in Human Hematopoiesis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DIAMOND-BLACKFAN ANEMIA; GRAY PLATELET SYNDROME; HEMATOLOGICAL TRAITS; GENETIC-VARIATION; GFI-1B; DIFFERENTIATION; METAANALYSIS; CONSORTIUM; MUTATIONS; DISORDER	Circulating blood cell counts and indices are important indicators of hematopoietic function and a number of clinical parameters, such as blood oxygen-carrying capacity, inflammation, and hemostasis. By performing whole-exome sequence association analyses of hematologic quantitative traits in 15,459 community-dwelling individuals, followed by in silico replication in up to 52,024 independent samples, we identified two previously undescribed coding variants associated with lower platelet count: a common missense variant in CPS1 (rs1047891, MAF=0.33, discovery + replication p=6.38 x 10(-10)) and a rare synonymous variant in GFI1B (rs150813342, MAF=0.009, discovery + replication p=1.79 x 10(-27)). By performing CRISPR/Cas9 genome editing in hematopoietic cell lines and follow-up targeted knockdown experiments in primary human hematopoietic stem and progenitor cells, we demonstrate an alternative splicing mechanism by which the GFI1B rs150813342 variant suppresses formation of a GFI1B isoform that preferentially promotes megakaryocyte differentiation and platelet production. These results demonstrate how unbiased studies of natural variation in blood cell traits can provide insight into the regulation of human hematopoiesis.	[Polfus, Linda M.; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA; [Khajuria, Rajiv K.; Wakabayashi, Aoi; Sankaran, Vijay G.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Khajuria, Rajiv K.; Wakabayashi, Aoi; Sankaran, Vijay G.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Khajuria, Rajiv K.; Wakabayashi, Aoi; Sankaran, Vijay G.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Khajuria, Rajiv K.] Charite, Berlin Brandenburg Sch Regenerat Therapies, D-13353 Berlin, Germany; [Schick, Ursula M.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Pankratz, Nathan] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55454 USA; [Pazoki, Raha; van Rooij, Frank J. A.; Franco, Oscar H.; Dehghan, Abbas] Erasmus Univ, Med Ctr, Dept Epidemiol, NL-3000 DR Rotterdam, Netherlands; [Brody, Jennifer A.; Floyd, James S.; Rice, Kenneth M.; Bartz, Traci M.; Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Brody, Jennifer A.; Floyd, James S.; Rice, Kenneth M.; Bartz, Traci M.; Psaty, Bruce M.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Chen, Ming-Huei] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Auer, Paul L.] Univ Wisconsin Milwaukee, Sch Publ Hlth, Milwaukee, WI 53205 USA; [Huang, Jie; Walter, Klaudia; Chen, Lu; Soranzo, Nicole] Wellcome Trust Sanger Inst, Human Genet, Hinxton CB10 1HH, England; [Lange, Leslie] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Gibbs, Richard A.; Metcalf, Ginger; Muzny, Donna; Veeraraghavan, Narayanan] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Chen, Lu; Soranzo, Nicole] Univ Cambridge, Dept Haematol, Cambridge CB2 0AH, England; [Yanek, Lisa; Becker, Lewis C.] Johns Hopkins Univ, Sch Med, Dept Med, GeneSTAR Res Program,Div Gen Internal Med, Baltimore, MD 21205 USA; [Peloso, Gina M.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Kals, Mart; Metspalu, Andres; Esko, Tonu] Univ Tartu, Estonian Genome Ctr, EE-51010 Tartu, Estonia; [Fox, Keolu] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Wallace, Robert] Univ Iowa, Coll Publ Hlth, Iowa City, IA 52242 USA; [Franceschini, Nora] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA; [Matijevic, Nena] Univ Texas Hlth Sci Ctr Houston, Dept Surg, Houston, TX 77030 USA; [Lyytikainen, Leo-Pekka; Lehtimaki, Terho] Fimlab Labs, Dept Clin Chem, Tampere 33520, Finland; [Lyytikainen, Leo-Pekka; Lehtimaki, Terho] Univ Tampere, Sch Med, Tampere 33520, Finland; [Kahonen, Mika] Tampere Univ Hosp, Dept Clin Physiol, Tampere 33521, Finland; [Kahonen, Mika] Univ Tampere, Sch Med, Tampere 33521, Finland; [Raitakari, Olli T.] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, Turku 20520, Finland; [Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku 20520, Finland; [Li-Gao, Ruifang; Mook-Kanamori, Dennis O.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 RA Leiden, Netherlands; [Mook-Kanamori, Dennis O.] King Faisal Specialist Hosp & Res Ctr, Dept Biostat, Epidemiol, Epidemiol Sect, Riyadh 11211, Saudi Arabia; [Mook-Kanamori, Dennis O.] King Faisal Specialist Hosp & Res Ctr, Dept Comp Sci, Riyadh 11211, Saudi Arabia; [Lettre, Guillaume] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Lettre, Guillaume] Univ Montreal, Montreal, PQ H1T 1C8, Canada; [van Duijn, Cornelia M.; Rivadeneira, Fernando; Hofman, Albert; Uitterlinden, Andre G.] Erasmus Univ, Med Ctr, Dept Internal Med, NL-3000 DR Rotterdam, Netherlands; [Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA 98101 USA; [Zhang, Xiaoling] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Zhang, Xiaoling] Boston Univ, Sch Med, Dept Biostat, Boston, MA 02118 USA; [Zhang, Xiaoling] Boston Univ, Sch Publ Hlth, Dept Med, Boston, MA 02118 USA; [Zhang, Xiaoling] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Johnson, Andrew D.] NHLBI, Cardiovasc Epidemiol & Human Genom Branch, Framingham Heart Study, Framingham, MA 01702 USA; [O'Donnell, Christopher J.] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; [Johnsen, Jill M.] Bloodworks Northwest, Seattle, WA 98102 USA; [Reiner, Alexander P.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Womens Hlth Initiat Clin Coordinating Ctr, Seattle, WA 98109 USA; [Ganesh, Santhi K.] Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Ganesh, Santhi K.] Univ Michigan, Dept Human Genet, Div Cardiovasc Med, Ann Arbor, MI 48109 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Icahn School of Medicine at Mount Sinai; University of Minnesota System; University of Minnesota Twin Cities; Erasmus University Rotterdam; Erasmus MC; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Boston University; University of Wisconsin System; University of Wisconsin Milwaukee; Wellcome Trust Sanger Institute; University of North Carolina; University of North Carolina Chapel Hill; Baylor College of Medicine; University of Cambridge; Johns Hopkins University; Harvard University; Massachusetts General Hospital; University of Tartu; University of Washington; University of Washington Seattle; University of Iowa; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Texas System; University of Texas Health Science Center Houston; Tampere University; Tampere University; Tampere University Hospital; Tampere University; University of Turku; University of Turku; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; Universite de Montreal; Universite de Montreal; Erasmus University Rotterdam; Erasmus MC; University of Virginia; University of Mississippi; University of Mississippi Medical Center; Group Health Cooperative; Boston University; Boston University; Boston University; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Fred Hutchinson Cancer Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sankaran, VG (corresponding author), Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.; Sankaran, VG (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.; Sankaran, VG (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	sankaran@broadinstitute.org	Dehghan, Abbas/ABE-7377-2020; Floyd, James/G-7563-2015; Auer, Paul/AAC-5060-2019; Johnson, Andrew D/G-6520-2013; Franco, Óscar H/ABE-2305-2020; Rivadeneira, Fernando/O-5385-2015; Lehtimäki, Terho/AAD-1094-2022; Raitakari, Olli/AAQ-7389-2021; Li-Gao, Ruifang/B-7172-2018; Dehghan, Abbas/B-9896-2008	Johnson, Andrew D/0000-0001-6369-5178; Franco, Óscar H/0000-0002-4606-4929; Rivadeneira, Fernando/0000-0001-9435-9441; Lehtimäki, Terho/0000-0002-2555-4427; Li-Gao, Ruifang/0000-0003-0650-1351; Soranzo, Nicole/0000-0003-1095-3852; Chen, Ming-Huei/0000-0003-3551-8726; Pazoki, Raha/0000-0002-5142-2348; Rich, Stephen/0000-0003-3872-7793; Kahonen, Mika/0000-0002-4510-7341; Van Duijn, Cornelia/0000-0002-2374-9204; Dehghan, Abbas/0000-0001-6403-016X; Pankratz, Nathan/0000-0001-5958-693X	NIH [HL122684, DK103794, HL120791]; Wellcome Trust [WT098051, WT091310]; EU [257082, HEALTH-F5-2011-282510]; NIH Research (NIHR) Blood and Transplant Research Unit (BTRU) in Donor Health and Genomics at the University of Cambridge; NHS Blood and Transplant (NHSBT); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL120791, R01HL122684, ZIAHL006170, R33HL120791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103794] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); EU(European Commission); NIH Research (NIHR) Blood and Transplant Research Unit (BTRU) in Donor Health and Genomics at the University of Cambridge; NHS Blood and Transplant (NHSBT); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work described in this manuscript was supported in part by NIH grants HL122684 to S.K.G. and DK103794 and HL120791 to V.G.S. N.S. is supported by the Wellcome Trust (grant codes WT098051 and WT091310), the EU 7th Framework Programme (EPIGENESYS grant code 257082 and BLUEPRINT grant code HEALTH-F5-2011-282510) and the NIH Research (NIHR) Blood and Transplant Research Unit (BTRU) in Donor Health and Genomics at the University of Cambridge in partnership with NHS Blood and Transplant (NHSBT).	Albers CA, 2011, NAT GENET, V43, P735, DOI 10.1038/ng.885; Auer PL, 2014, NAT GENET, V46, P629, DOI 10.1038/ng.2962; Catellier DJ, 2008, CLIN CHEM, V54, P1363, DOI 10.1373/clinchem.2007.102202; Chen L, 2014, SCIENCE, V345, P1580, DOI 10.1126/science.1251033; Cho SY, 2011, P NATL ACAD SCI USA, V108, P8233, DOI 10.1073/pnas.1017700108; Foudi A, 2014, J EXP MED, V211, P909, DOI 10.1084/jem.20131065; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Giani FC, 2016, CELL STEM CELL, V18, P73, DOI 10.1016/j.stem.2015.09.015; Johnsen JM, 2013, BLOOD, V122, P3268, DOI 10.1182/blood-2013-07-460287; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Koldehoff M, 2013, CANCER GENE THER, V20, P421, DOI 10.1038/cgt.2013.31; Laurent B, 2012, J CELL SCI, V125, P993, DOI 10.1242/jcs.095877; Ludwig LS, 2014, NAT MED, V20, P748, DOI 10.1038/nm.3557; Minelli A, 2004, GENE CHROMOSOME CANC, V40, P165, DOI 10.1002/gcc.20030; Monteferrario D, 2014, NEW ENGL J MED, V370, P245, DOI 10.1056/NEJMoa1308130; Okada Y, 2012, J HUM GENET, V57, P161, DOI 10.1038/jhg.2012.2; Pare G, 2009, CIRC-CARDIOVASC GENE, V2, P142, DOI 10.1161/CIRCGENETICS.108.829804; Pearson DL, 2001, NEW ENGL J MED, V344, P1832, DOI 10.1056/NEJM200106143442404; Randrianarison-Huetz V, 2010, BLOOD, V115, P2784, DOI 10.1182/blood-2009-09-241752; Sabater-Lleal M, 2013, CIRCULATION, V128, P1310, DOI 10.1161/CIRCULATIONAHA.113.002251; Saleque S, 2002, GENE DEV, V16, P301, DOI 10.1101/gad.959102; Sankaran VG, 2013, BLOOD, V122, P3575, DOI 10.1182/blood-2013-07-460337; Sankaran VG, 2012, J CLIN INVEST, V122, P2439, DOI 10.1172/JCI63597; Shiohara M, 2009, J PEDIAT HEMATOL ONC, V31, P319, DOI 10.1097/MPH.0b013e3181984dbe; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Stevenson WS, 2013, J THROMB HAEMOST, V11, P2039, DOI 10.1111/jth.12368; Summar ML, 2004, MOL GENET METAB, V81, pS12, DOI 10.1016/j.ymgme.2003.11.014; Summar ML, 2004, HYPERTENSION, V43, P186, DOI 10.1161/01.HYP.0000112424.06921.52; Thon JN, 2015, J THROMB HAEMOST, V13, pS55, DOI 10.1111/jth.12942; Ulirsch JC, 2016, CELL, V165, P1530, DOI 10.1016/j.cell.2016.04.048; Vassen L, 2009, INT J HEMATOL, V89, P422, DOI 10.1007/s12185-009-0286-5; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806; Zhang XL, 2015, NAT GENET, V47, P345, DOI 10.1038/ng.3220	33	29	29	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 4	2016	99	2					481	488		10.1016/j.ajhg.2016.06.016	http://dx.doi.org/10.1016/j.ajhg.2016.06.016			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TO	27486782	Bronze, Green Published			2022-12-18	WOS:000381617200020
J	Chen, X; Kuja-Halkola, R; Rahman, I; Arpegard, J; Viktorin, A; Karlsson, R; Hagg, S; Svensson, P; Pedersen, NL; Magnusson, PKE				Chen, Xu; Kuja-Halkola, Ralf; Rahman, Iffat; Arpegard, Johannes; Viktorin, Alexander; Karlsson, Robert; Hagg, Sara; Svensson, Per; Pedersen, Nancy L.; Magnusson, Patrik K. E.			Dominant Genetic Variation and Missing Heritability for Human Complex Traits: Insights from Twin versus Genome-wide Common SNP Models	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								In order to further illuminate the potential role of dominant genetic variation in the "missing heritability" debate, we investigated the additive (narrow-sense heritability, h(2)) and dominant (delta(2)) genetic variance for 18 human complex traits. Within the same study base (10,682 Swedish twins), we calculated and compared the estimates from classic twin-based structural equation model with SNP-based genomic-relatedness-matrix restricted maximum likelihood [GREML(d)] method. Contributions of delta(2) were evident for 14 traits in twin models (average delta(2)(twin) = 0.25, range 0.14-0.49), two of which also displayed significant delta(2) in the GREMLd analyses (triglycerides delta(2)(SNP) = 0.28 and waist circumference delta(2)(SNP) = 0.19). On average, the proportion of h(SNP)(2)/h(twin)(2) was 70% for ADE-fitted traits (for which the best-fitting model included additive and dominant genetic and unique environmental components) and 31% for AE-fitted traits (for which the best-fitting model included additive genetic and unique environmental components). Independent evidence for contribution from shared environment, also in ADE-fitted traits, was obtained from self-reported within-pair contact frequency and age at separation. We conclude that despite the fact that additive genetics appear to constitute the bulk of genetic influences for most complex traits, dominant genetic variation might often be masked by shared environment in twin and family studies and might therefore have a more prominent role than what family-based estimates often suggest. The risk of erroneously attributing all inherited genetic influences (additive and dominant) to the h(2) in too-small twin studies might also lead to exaggerated "missing heritability" (the proportion of h(2) that remains unexplained by SNPs).	[Chen, Xu; Kuja-Halkola, Ralf; Viktorin, Alexander; Karlsson, Robert; Hagg, Sara; Pedersen, Nancy L.; Magnusson, Patrik K. E.] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Rahman, Iffat] Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden; [Arpegard, Johannes; Svensson, Per] Karolinska Inst, Dept Med Solna, S-17177 Stockholm, Sweden; [Arpegard, Johannes; Svensson, Per] Karolinska Univ Hosp, Dept Emergency Med, S-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Magnusson, PKE (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden.	patrik.magnusson@ki.se	Magnusson, Patrik KE/C-4458-2017; Svensson, Per/D-5666-2012; Chen, Xu/I-6829-2016; Kuja-Halkola, Ralf/ABA-5061-2020	Magnusson, Patrik KE/0000-0002-7315-7899; Svensson, Per/0000-0003-0372-6272; Chen, Xu/0000-0002-7299-3238; Kuja-Halkola, Ralf/0000-0002-3765-2067; Karlsson, Robert/0000-0002-8949-2587; Hagg, Sara/0000-0002-2452-1500; Viktorin, Alexander/0000-0003-2141-2816	Swedish Twin Registry; Swedish Research Council; Swedish Heart-Lung-Foundation; China Scholarship Council	Swedish Twin Registry; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung-Foundation(Swedish Heart-Lung Foundation); China Scholarship Council(China Scholarship Council)	Karolinska Institutet financially supports the Swedish Twin Registry. The study was supported by Swedish Research Council, Swedish Heart-Lung-Foundation, and China Scholarship Council.	Arpegard J, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001467; CLEMENT K, 2007, OBESITY GENOMICS POS, P19; Deleeuw J., 1992, INFORM THEORY EXTENS, P599, DOI DOI 10.1007/978-1-4612-0919-5_37; Golan D, 2014, P NATL ACAD SCI USA, V111, pE5272, DOI 10.1073/pnas.1419064111; Keller MC, 2010, BEHAV GENET, V40, P377, DOI 10.1007/s10519-009-9320-x; Keller MC, 2005, BEHAV GENET, V35, P707, DOI 10.1007/s10519-005-6041-7; Magnusson PKE, 2013, TWIN RES HUM GENET, V16, P317, DOI 10.1017/thg.2012.104; Magnusson PKE, 2002, INT J OBESITY, V26, P1225, DOI 10.1038/sj.ijo.0802041; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Maki-Tanila A, 2014, GENETICS, V198, P355, DOI 10.1534/genetics.114.165282; Neale M.C., 2004, METHODOLOGY GENETIC, P2; Neale MC, 2016, PSYCHOMETRIKA, V81, P535, DOI 10.1007/s11336-014-9435-8; Polderman TJC, 2015, NAT GENET, V47, P702, DOI 10.1038/ng.3285; Rettew DC, 2008, BEHAV GENET, V38, P223, DOI 10.1007/s10519-008-9192-5; Ritchie MD, 2015, METHODS MOL BIOL, V1253, P19, DOI 10.1007/978-1-4939-2155-3_2; Tenesa A, 2013, NAT REV GENET, V14, P139, DOI 10.1038/nrg3377; van Dongen J, 2013, J LIPID RES, V54, P2914, DOI 10.1194/jlr.P041673; van Dongen J, 2012, NAT REV GENET, V13, P640, DOI 10.1038/nrg3243; Visscher PM, 2006, PLOS GENET, V2, P316, DOI 10.1371/journal.pgen.0020041; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhu ZH, 2015, AM J HUM GENET, V96, P377, DOI 10.1016/j.ajhg.2015.01.001; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	24	29	30	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 5	2015	97	5					708	714		10.1016/j.ajhg.2015.10.004	http://dx.doi.org/10.1016/j.ajhg.2015.10.004			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CW2ED	26544805	Green Published, Bronze			2022-12-18	WOS:000364803000006
J	Soave, D; Corvol, H; Panjwani, N; Gong, JF; Li, WL; Boelle, PY; Durie, PR; Paterson, AD; Rommens, JM; Strug, LJ; Sun, L				Soave, David; Corvol, Harriet; Panjwani, Naim; Gong, Jiafen; Li, Weili; Boelle, Pierre-Yves; Durie, Peter R.; Paterson, Andrew D.; Rommens, Johanna M.; Strug, Lisa J.; Sun, Lei			A Joint Location-Scale Test Improves Power to Detect Associated SNPs, Gene Sets, and Pathways	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LUNG-DISEASE SEVERITY; CYSTIC-FIBROSIS; ENVIRONMENT INTERACTIONS; GENOTYPE DATA; FAMILY; SUSCEPTIBILITY; METAANALYSIS; HAPLOTYPES; VARIANTS	Gene-based, pathway, and other multivariate association methods are motivated by the possibility of GxG and GxE interactions; however, accounting for such interactions is limited by the challenges associated with adequate modeling information. Here we propose an easy-to-implement joint location-scale (JLS) association testing framework for single-variant and multivariate analysis that accounts for interactions without explicitly modeling them. We apply the JLS method to a gene-set analysis of cystic fibrosis (CF) lung disease, which is influenced by multiple environmental and genetic factors. We identify and replicate an association between the constituents of the apical plasma membrane and CF lung disease (p = 0.0099 and p = 0.0180, respectively) and highlight a role for the SLC9A3-SLC9A3R1/2-EZR complex in contributing to CF lung disease. Many association studies could benefit from re-analysis with the JLS method that leverages complex genetic architecture for SNP, gene, and pathway identification. Analytical verification, simulation, and additional proof-of-principle applications support our approach.	[Soave, David; Li, Weili; Strug, Lisa J.; Sun, Lei] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Biostat, Toronto, ON M5T 3M7, Canada; [Soave, David; Panjwani, Naim; Gong, Jiafen; Li, Weili; Paterson, Andrew D.; Rommens, Johanna M.; Strug, Lisa J.] Hosp Sick Children, Res Inst, Program Genet & Genome Biol, Toronto, ON M5G 0A4, Canada; [Corvol, Harriet] Trousseau Hosp, AP HP, Pediat Pulmonol Dept, INSERM,UMR S 938,CDR St Antoine, F-75012 Paris, France; [Corvol, Harriet; Boelle, Pierre-Yves] Univ Paris 06, Sorbonne Univ, F-75005 Paris, France; [Boelle, Pierre-Yves] St Antoine Hosp, AP HP, Dept Biostat, INSERM,UMR S 1136, F-75012 Paris, France; [Durie, Peter R.] Hosp Sick Children, Program Physiol & Expt Med, Toronto, ON M5G 0A4, Canada; [Durie, Peter R.] Univ Toronto, Dept Pediat, Toronto, ON M5S 1A1, Canada; [Paterson, Andrew D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON M5T 3M7, Canada; [Rommens, Johanna M.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Sun, Lei] Univ Toronto, Dept Stat Sci, Toronto, ON M5S 3G3, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University of Toronto	Strug, LJ (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Div Biostat, Toronto, ON M5T 3M7, Canada.	lisa.strug@utoronto.ca; sun@utstat.toronto.edu	Corvol, Harriet/N-5922-2018; Paterson, Andrew D/A-4088-2011; Paterson, Andrew/AAQ-7511-2020; Rommens, Johanna/AAT-7465-2021	Corvol, Harriet/0000-0002-7026-7523; Paterson, Andrew D/0000-0002-9169-118X; Paterson, Andrew/0000-0002-9169-118X; Strug, Lisa/0000-0003-0503-9740; Panjwani, Naim/0000-0001-7551-0759	Canadian Foundation; US CF Foundation; Canadian Institutes of Health Research (CIHR) [201309MOP-310732-G-CEAA-117978, MOP-258916]; Natural Sciences and Engineering Research Council of Canada (NSERC) [250053-2013, 371399-2009]; Cystic Fibrosis Canada [2626]; Training grant [GET-101831]; Universite Pierre et Marie Curie Paris; Agence Nationale de la Recherche [R09186DS]; Direction Generale de la Sante; Association Vaincre la Mucoviscidose, Chancellerie des Universites (Legs Poix); Association Agir Informer Contre la Mucoviscidose; Groupement d'Interet Scientifique (GIS)-Institut des Maladies Rares	Canadian Foundation; US CF Foundation; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Cystic Fibrosis Canada; Training grant; Universite Pierre et Marie Curie Paris; Agence Nationale de la Recherche(French National Research Agency (ANR)); Direction Generale de la Sante(General Electric); Association Vaincre la Mucoviscidose, Chancellerie des Universites (Legs Poix); Association Agir Informer Contre la Mucoviscidose; Groupement d'Interet Scientifique (GIS)-Institut des Maladies Rares	The authors are grateful to the subjects in the CGS, French CF, and DCCT studies for their participation. The authors also thank Drs. Hughes Aschard and Peter Kraft for providing their simulation results; the CF Gene Modifier Consortium and Drs. Michael Knowles, Garry Cutting, and Mitchell Drumm for helpful discussions; and the Canadian and US CF Foundations for their generous support of the genotyping. This data resource was also supported in part by Genome Canada, through the Ontario Genomics Institute per research agreement 2004-OGI-3-05 (to P.R.D.), with the Ontario Research Fund, Research Excellence Program. This work was funded by the Canadian Institutes of Health Research (CIHR; 201309MOP-310732-G-CEAA-117978 to L.S. and MOP-258916 to L.J.S.); the Natural Sciences and Engineering Research Council of Canada (NSERC; 250053-2013 to L.S. and 371399-2009 to L.J.S.); Cystic Fibrosis Canada #2626 (to L.J.S.); Training grant GET-101831; Universite Pierre et Marie Curie Paris; Agence Nationale de la Recherche (R09186DS to H.C.), Direction Generale de la Sante; Association Vaincre la Mucoviscidose, Chancellerie des Universites (Legs Poix); Association Agir Informer Contre la Mucoviscidose; and Groupement d'Interet Scientifique (GIS)-Institut des Maladies Rares. A.D.P. held a Canada Research Chair in the Genetics of Complex Diseases. D.S. is a trainee of CIHR STAGE (Strategic Training for Advanced Genetic Epidemiology) program at the University of Toronto.	Acar EF, 2013, BIOMETRICS, V69, P427, DOI 10.1111/biom.12006; [Anonymous], 1960, CONTRIBUTIONS PROBAB; Aschard H, 2013, GENET EPIDEMIOL, V37, P323, DOI 10.1002/gepi.21716; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Blackman SM, 2006, GASTROENTEROLOGY, V131, P1030, DOI 10.1053/j.gastro.2006.07.016; Cao Y, 2014, GENET EPIDEMIOL, V38, P51, DOI 10.1002/gepi.21778; Chuang LL, 2012, J STAT PLAN INFER, V142, P457, DOI 10.1016/j.jspi.2011.08.004; Collaco JM, 2008, JAMA-J AM MED ASSOC, V299, P417, DOI 10.1001/jama.299.4.417; Collaco JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027784; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Cornelis MC, 2012, AM J EPIDEMIOL, V175, P191, DOI 10.1093/aje/kwr368; Deng WQ, 2014, EUR J HUM GENET, V22, P427, DOI 10.1038/ejhg.2013.166; Derkach A, 2014, STAT SCI, V29, P302, DOI 10.1214/13-STS456; Derkach A, 2013, GENET EPIDEMIOL, V37, P110, DOI 10.1002/gepi.21689; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; Dorfman R, 2011, PEDIATR PULM, V46, P385, DOI 10.1002/ppul.21372; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Dudbridge F, 2014, AM J HUM GENET, V95, P301, DOI 10.1016/j.ajhg.2014.07.014; Goss CH, 2004, AM J RESP CRIT CARE, V169, P816, DOI 10.1164/rccm.200306-779OC; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Hou CD, 2005, STAT PROBABIL LETT, V73, P179, DOI 10.1016/j.spl.2004.11.028; Hutter CM, 2013, GENET EPIDEMIOL, V37, P643, DOI 10.1002/gepi.21756; Kato A, 2011, ANNU REV PHYSIOL, V73, P261, DOI 10.1146/annurev-physiol-012110-142244; Kost JT, 2002, STAT PROBABIL LETT, V60, P183, DOI 10.1016/S0167-7152(02)00310-3; Kutalik Z, 2011, BIOSTATISTICS, V12, P1, DOI 10.1093/biostatistics/kxq039; Lehmann E.L., 2005, SPRINGER TEXTS STAT, P784; Li WL, 2014, HUM GENET, V133, P151, DOI 10.1007/s00439-013-1363-7; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lou XY, 2008, AM J HUM GENET, V83, P457, DOI 10.1016/j.ajhg.2008.09.001; Luna A, 2007, BIOINFORMATICS, V23, P774, DOI 10.1093/bioinformatics/btl657; Maciejewski H, 2014, BRIEF BIOINFORM, V15, P504, DOI 10.1093/bib/bbt002; Marozzi M, 2013, COMMUN STAT-SIMUL C, V42, P1298, DOI 10.1080/03610918.2012.665546; Mukherjee B, 2012, AM J EPIDEMIOL, V175, P177, DOI 10.1093/aje/kwr367; Owen AB, 2009, ANN STAT, V37, P3867, DOI 10.1214/09-AOS697; Pare G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000981; Paterson AD, 2010, DIABETES, V59, P539, DOI 10.2337/db09-0653; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Seidler U, 2009, ANN NY ACAD SCI, V1165, P249, DOI 10.1111/j.1749-6632.2009.04046.x; Struchalin MV, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-92; Sun F, 2000, J BIOL CHEM, V275, P29539, DOI 10.1074/jbc.M004961200; Sun L, 2012, NAT GENET, V44, P562, DOI 10.1038/ng.2221; Sun XQ, 2013, AM J HUM GENET, V93, P390, DOI 10.1016/j.ajhg.2013.06.017; Taylor C, 2011, PEDIATR PULM, V46, P857, DOI 10.1002/ppul.21456; Vanscoy LL, 2007, AM J RESP CRIT CARE, V175, P1036, DOI 10.1164/rccm.200608-1164OC; Welsh MJ, 2001, METABOLIC MOL BASES, P5121; Wood AR, 2014, NATURE, V514, pE3, DOI 10.1038/nature13691; Wright FA, 2011, NAT GENET, V43, P539, DOI 10.1038/ng.838; Yu ZX, 2012, BIOSTATISTICS, V13, P228, DOI 10.1093/biostatistics/kxr045	51	29	29	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 2	2015	97	1					125	138		10.1016/j.ajhg.2015.05.015	http://dx.doi.org/10.1016/j.ajhg.2015.05.015			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN1OO	26140448	Green Published, hybrid			2022-12-18	WOS:000358189500011
J	Larson, NB; McDonnell, S; French, AJ; Fogarty, Z; Cheville, J; Middha, S; Riska, S; Baheti, S; Nair, AA; Wang, L; Schaid, DJ; Thibodeau, SN				Larson, Nicholas B.; McDonnell, Shannon; French, Amy J.; Fogarty, Zach; Cheville, John; Middha, Sumit; Riska, Shaun; Baheti, Saurabh; Nair, Asha A.; Wang, Liang; Schaid, Daniel J.; Thibodeau, Stephen N.			Comprehensively Evaluating cis-Regulatory Variation in the Human Prostate Transcriptome by Using Gene-Level Allele-Specific Expression	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; QUANTITATIVE TRAIT LOCI; SURROGATE VARIABLE ANALYSIS; SEMINAL CLOT LIQUEFACTION; RNA-SEQ EXPERIMENTS; CANCER PROGRESSION; EQTL; DATABASE; UPDATE; TOOL	The identification of cis-acting regulatory variation in primary tissues has the potential to elucidate the genetic basis of complex traits and further our understanding of transcriptomic diversity across cell types. Expression quantitative trait locus (eQTL) association analysis using RNA sequencing (RNA-seq) data can improve upon the detection of cis-acting regulatory variation by leveraging allele-specific expression (ASE) patterns in association analysis. Here, we present a comprehensive evaluation of cis-acting eQTLs by analyzing RNA-seq gene-expression data and genome-wide high-density genotypes from 471 samples of normal primary prostate tissue. Using statistical models that integrate ASE information, we identified extensive cis-eQTLs across the prostate transcriptome and found that approximately 70% of expressed genes corresponded to a significant eQTL at a gene-level false-discovery rate of 0.05. Overall, cis-eQTLs were heavily concentrated near the transcription start and stop sites of affected genes, and effects were negatively correlated with distance. We identified multiple instances of cis-acting co-regulation by using phased genotype data and discovered 233 SNPs as the most strongly associated eQTLs for more than one gene. We also noted significant enrichment (25/50, p = 2E-5) of previously reported prostate cancer risk SNPs in prostate eQTLs. Our results illustrate the benefit of assessing ASE data in cis-eQTL analyses by showing better reproducibility of prior eQTL findings than of eQTL mapping based on total expression alone. Altogether, our analysis provides extensive functional context of thousands of SNPs in prostate tissue, and these results will be of critical value in guiding studies examining disease of the human prostate.	[Larson, Nicholas B.; McDonnell, Shannon; Fogarty, Zach; Middha, Sumit; Riska, Shaun; Baheti, Saurabh; Nair, Asha A.; Schaid, Daniel J.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [French, Amy J.; Cheville, John; Thibodeau, Stephen N.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Wang, Liang] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA	Mayo Clinic; Mayo Clinic; Medical College of Wisconsin	Larson, NB (corresponding author), Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA.	larson.nicholas@mayo.edu		Fogarty, Zachary/0000-0001-5588-3216; McDonnell, Shannon/0000-0001-6201-369X; Middha, Sumit/0000-0003-4135-6268	Department of Defense [W81XWH-11-1-0261]; NIH [CA151254, R01CA157881]; NATIONAL CANCER INSTITUTE [P30CA015083, R01CA157881, R01CA151254] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Department of Defense (W81XWH-11-1-0261) and the NIH (CA151254 to S.N.T.). SNP genotyping and RNA sequencing were partially supported by the NIH (R01CA157881 to L.W.).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bainbridge MN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-246; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; Brown CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003649; Chai H, 2009, ANN CLIN LAB SCI, V39, P331; Chakraborty S, 2012, BIOINFORMATICS, V28, P799, DOI 10.1093/bioinformatics/bts022; Degner JF, 2009, BIOINFORMATICS, V25, P3207, DOI 10.1093/bioinformatics/btp579; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; Ellis SE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-892; Emami N, 2008, J BIOL CHEM, V283, P19561, DOI 10.1074/jbc.M801194200; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Fisher R., 1970, STAT METHODS RES WOR; Hazelett DJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004102; Helfand BT, 2012, J UROLOGY, V187, pE489, DOI 10.1016/j.juro.2012.02.1498; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Jiang JF, 2014, ONCOTARGET, V5, P6168, DOI 10.18632/oncotarget.2179; Kalari KR, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-224; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kaushal A, 2008, PROSTATE, V68, P381, DOI 10.1002/pros.20685; Landmark-Hoyvik H, 2013, GENOMICS, V102, P278, DOI 10.1016/j.ygeno.2013.07.006; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; Lu QL, 2000, J PATHOL, V190, P169, DOI 10.1002/(SICI)1096-9896(200002)190:2<169::AID-PATH517>3.0.CO;2-#; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McKenzie M, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-31; Michael IP, 2006, J BIOL CHEM, V281, P12743, DOI 10.1074/jbc.M600326200; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Olsburgh J, 2003, J PATHOL, V199, P41, DOI 10.1002/path.1252; Panousis NI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0467-2; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Strimmer K, 2008, BIOINFORMATICS, V24, P1461, DOI 10.1093/bioinformatics/btn209; Sun W, 2013, STAT BIOSCI, V5, P198, DOI 10.1007/s12561-012-9068-3; Sun W, 2012, BIOMETRICS, V68, P1, DOI 10.1111/j.1541-0420.2011.01654.x; Taberlay PC, 2014, GENOME RES, V24, P1421, DOI 10.1101/gr.163485.113; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trowsdale J, 2011, IMMUNOL LETT, V137, P1, DOI 10.1016/j.imlet.2011.01.002; Vaarala MH, 2012, MOL MED REP, V6, P466, DOI 10.3892/mmr.2012.956; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1198/TECH.2003.S33, 10.1007/978-0-387-21706-2]; Vijay N, 2013, MOL ECOL, V22, P620, DOI 10.1111/mec.12014; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Xu X, 2014, EUR J HUM GENET, V22, P558, DOI 10.1038/ejhg.2013.195; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	62	29	29	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 4	2015	96	6					869	882		10.1016/j.ajhg.2015.04.015	http://dx.doi.org/10.1016/j.ajhg.2015.04.015			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CK0YH	25983244	Green Published, Bronze			2022-12-18	WOS:000355931200002
J	Jin, GF; Zhu, M; Yin, R; Shen, W; Liu, J; Sun, J; Wang, C; Dai, JC; Ma, HX; Wu, C; Yin, ZH; Huang, JQ; Higgs, BW; Xu, L; Yao, YH; Christiani, DC; Amos, CI; Hu, ZB; Zhou, BS; Shi, YY; Lin, DX; Shen, HB				Jin, Guangfu; Zhu, Meng; Yin, Rong; Shen, Wei; Liu, Jia; Sun, Jie; Wang, Cheng; Dai, Juncheng; Ma, Hongxia; Wu, Chen; Yin, Zhihua; Huang, Jiaqi; Higgs, Brandon W.; Xu, Lin; Yao, Yihong; Christiani, David C.; Amos, Christopher I.; Hu, Zhibin; Zhou, Baosen; Shi, Yongyong; Lin, Dongxin; Shen, Hongbing			Low-Frequency Coding Variants at 6p21.33 and 20q11.21 Are Associated with Lung Cancer Risk in Chinese Populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; RARE VARIANTS; NASOPHARYNGEAL CARCINOMA; GERMLINE MUTATIONS; IDENTIFIES 2; GENES; MULTIPLE; SCAN; SMOKING	Genome-wide association studies have successfully identified a subset of common variants associated with lung cancer risk. However, these variants explain only a fraction of lung cancer heritability. It has been proposed that low-frequency or rare variants might have strong effects and contribute to the missing heritability. To assess the role of low-frequency or rare variants in lung cancer development, we analyzed exome chips representing 1,348 lung cancer subjects and 1,998 control subjects during the discovery stage and subsequently evaluated promising associations in an additional 4,699 affected subjects and 4,915 control subjects during the replication stages. Single-variant and gene-based analyses were carried out for coding variants with a minor allele frequency less than 0.05. We identified three low-frequency missense variants in BAT2 (rs9469031, c.1544C>T [p.Pro515Leu]; odds ratio [OR] = 0.55, p = 1.28 x 10(-10)), FKBPL (rs200847762, c.410C>T [p.Pro137Leu]; OR = 0.25, p = 9.79 x 10(-12)), and BPIFB1 (rs6141383, c.850G>A [p.Val284Met]; OR = 1.72, p = 1.79 x 10(-7)); these variants were associated with lung cancer risk. rs9469031 in BAT2 and rs6141383 in BPIFB1 were also associated with the age of onset of lung cancer (p = 0.001 and 0.006, respectively). BAT2 and FKBPL at 6p21.33 and BPIFB1 at 20q11.21 were differentially expressed in lung tumors and paired normal tissues. Gene-based analysis revealed that FKBPL, in which two independent variants were identified, might account for the association with lung cancer risk at 6p21.33. Our results highlight the important role low-frequency variants play in lung cancer susceptibility and indicate that candidate genes at 6p21.33 and 20q11.21 are potentially biologically relevant to lung carcinogenesis.	[Jin, Guangfu; Zhu, Meng; Shen, Wei; Liu, Jia; Sun, Jie; Wang, Cheng; Dai, Juncheng; Ma, Hongxia; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing 211166, Jiangsu, Peoples R China; [Jin, Guangfu; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Collaborat Innovat Ctr Canc Personalized Med, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing 211166, Jiangsu, Peoples R China; [Yin, Rong; Xu, Lin] Nanjing Med Univ, Collaborat Innovat Ctr Canc Personalized Med, Jiangsu Key Lab Mol & Translat Canc Res, Affiliated Canc Hosp, Nanjing 210009, Jiangsu, Peoples R China; [Wu, Chen] Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst & Hosp, Beijing 100021, Peoples R China; [Wu, Chen] Peking Union Med Coll, Beijing 100021, Peoples R China; [Yin, Zhihua] China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang 110001, Peoples R China; [Huang, Jiaqi; Higgs, Brandon W.; Yao, Yihong] Medimmune, Gaithersburg, MD 20878 USA; [Christiani, David C.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Amos, Christopher I.] Dartmouth Coll, Ctr Genom Med, Dept Community & Family Med, Geisel Sch Med, Hanover, NH 03755 USA; [Shi, Yongyong] Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200240, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; China Medical University; AstraZeneca; Medimmune; Harvard University; Harvard T.H. Chan School of Public Health; Dartmouth College; Shanghai Jiao Tong University	Shen, HB (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing 211166, Jiangsu, Peoples R China.	hbshen@njmu.edu.cn	Shi, Yongyong/GSO-1627-2022	Shi, Yongyong/0000-0003-1710-1505; Ma, Hongxia/0000-0002-9821-6955; Lin, Dongxin/0000-0002-8723-8868; Jin, Guangfu/0000-0003-0249-5337; Shen, Hongbing/0000-0002-2581-5906; Wu, Chen/0000-0003-4954-1011; Higgs, Brandon/0000-0002-2951-0245; Xu, Lin/0000-0002-2153-4840	National Key Basic Research Program [2011CB503805, 2013CB910304, 2013CB911400]; State Key Program of National Natural Science of China [81230067]; National Distinguished Youth Science Foundation of China [81225020]; National Outstanding Youth Science Foundation of China [81422042]; Science Foundation for Distinguished Young Scholars of Jiangsu [BK2012042, BK20130042]; National Natural Science Foundation of China [81270044]; Jiangsu Specially Appointed Professor Project; Natural Science Foundation of Jiangsu Province [BK20130060]; Natural Science Foundation of Jiangsu Higher Education Institutions [11KJA330001]; National Program for Support of Top-Notch Young Professionals from the Organization Department of the Communist Party of China Central Committee; Jiangsu Province Clinical Science and Technology Projects [BL2012008]; Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine); NATIONAL CANCER INSTITUTE [P30CA023108, R35CA197449] Funding Source: NIH RePORTER	National Key Basic Research Program(National Basic Research Program of China); State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); National Distinguished Youth Science Foundation of China; National Outstanding Youth Science Foundation of China; Science Foundation for Distinguished Young Scholars of Jiangsu(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Specially Appointed Professor Project; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Natural Science Foundation of Jiangsu Higher Education Institutions; National Program for Support of Top-Notch Young Professionals from the Organization Department of the Communist Party of China Central Committee; Jiangsu Province Clinical Science and Technology Projects; Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Key Basic Research Program (grants 2011CB503805, 2013CB910304, and 2013CB911400), the State Key Program of National Natural Science of China (grant 81230067), the National Distinguished Youth Science Foundation of China (grant 81225020), the National Outstanding Youth Science Foundation of China (grant 81422042), the Science Foundation for Distinguished Young Scholars of Jiangsu (grants BK2012042 and BK20130042), the National Natural Science Foundation of China (grant 81270044), the Jiangsu Specially Appointed Professor Project, the Natural Science Foundation of Jiangsu Province (grant BK20130060), the Key Grant of the Natural Science Foundation of Jiangsu Higher Education Institutions (11KJA330001), the National Program for Support of Top-Notch Young Professionals from the Organization Department of the Communist Party of China Central Committee, the Jiangsu Province Clinical Science and Technology Projects (grant BL2012008), and the Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine). The authors wish to thank all the study participants, research staff, and students who participated in this work.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Auer PL, 2014, NAT GENET, V46, P629, DOI 10.1038/ng.2962; Bingle L, 2012, HISTOCHEM CELL BIOL, V138, P749, DOI 10.1007/s00418-012-0990-8; Broderick P, 2009, CANCER RES, V69, P6633, DOI 10.1158/0008-5472.CAN-09-0680; Cerhan JR, 2014, NAT GENET, V46, P1233, DOI 10.1038/ng.3105; Chubb D, 2013, NAT GENET, V45, P1221, DOI 10.1038/ng.2733; Dong J, 2012, NAT GENET, V44, P895, DOI 10.1038/ng.2351; Ewing CM, 2012, NEW ENGL J MED, V366, P141, DOI 10.1056/NEJMoa1110000; Goldstein JI, 2012, BIOINFORMATICS, V28, P2543, DOI 10.1093/bioinformatics/bts479; Guo H, 2011, CANCER RES, V71, P7576, DOI 10.1158/0008-5472.CAN-11-1409; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hinds DA, 2013, NAT GENET, V45, P907, DOI 10.1038/ng.2686; Hu ZB, 2013, NAT GENET, V45, P1499, DOI 10.1038/ng.2809; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Huyghe JR, 2013, NAT GENET, V45, P197, DOI 10.1038/ng.2507; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Juyal G, 2015, GUT, V64, P571, DOI 10.1136/gutjnl-2013-306625; Lan Q, 2012, NAT GENET, V44, P1330, DOI 10.1038/ng.2456; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Liao Q, 2014, ONCOGENE, V33, P2098, DOI 10.1038/onc.2013.161; Lin DY, 2011, AM J HUM GENET, V89, P354, DOI [10.1016/j.ajhg.2011.07.015, 10.1016/j.ajhg.2011.07.015.]; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Loveday C, 2011, NAT GENET, V43, P879, DOI 10.1038/ng.893; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; McKeen HD, 2011, BIOCHEM SOC T, V39, P663, DOI 10.1042/BST0390663; Peloso GM, 2014, AM J HUM GENET, V94, P223, DOI 10.1016/j.ajhg.2014.01.009; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rafnar T, 2011, NAT GENET, V43, P1104, DOI 10.1038/ng.955; Robson T, 2012, DRUG DISCOV TODAY, V17, P544, DOI 10.1016/j.drudis.2012.01.002; Shin OS, 2011, J INFECT DIS, V204, P1349, DOI 10.1093/infdis/jir544; Shiraishi K, 2012, NAT GENET, V44, P900, DOI 10.1038/ng.2353; Shum AK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006998; Singh R, 2007, FRONT BIOSCI-LANDMRK, V12, P4504, DOI 10.2741/2405; SPIES T, 1989, SCIENCE, V243, P214, DOI 10.1126/science.2911734; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Truong T, 2010, JNCI-J NATL CANCER I, V102, P959, DOI 10.1093/jnci/djq178; Walsh KM, 2013, CANCER EPIDEM BIOMAR, V22, P251, DOI 10.1158/1055-9965.EPI-12-1007-T; Wang YF, 2014, NAT GENET, V46, P736, DOI 10.1038/ng.3002; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zhang BC, 2003, GENE CHROMOSOME CANC, V38, P80, DOI 10.1002/gcc.10247; Zhu J, 2014, FRONT GENET, V5, DOI [10.3389/fgene.2014.00149, 10.3389/fgene.2014.00187]	49	29	31	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 7	2015	96	5					832	840		10.1016/j.ajhg.2015.03.009	http://dx.doi.org/10.1016/j.ajhg.2015.03.009			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CH7AZ	25937444	Green Published, Bronze			2022-12-18	WOS:000354189300014
J	Ehmke, N; Caliebe, A; Koenig, R; Kant, SG; Stark, Z; Cormier-Daire, V; Wieczorek, D; Gillessen-Kaesbach, G; Hoff, K; Kawalia, A; Thiele, H; Altmuller, J; Fischer-Zirnsak, B; Knaus, A; Zhu, N; Heinrich, V; Huber, C; Harabula, I; Spielmann, M; Horn, D; Komak, U; Hecht, J; Krawitz, PM; Nurnberg, P; Siebert, R; Manzke, H; Mundlos, S				Ehmke, Nadja; Caliebe, Almuth; Koenig, Rainer; Kant, Sarina G.; Stark, Zornitza; Cormier-Daire, Valerie; Wieczorek, Dagmar; Gillessen-Kaesbach, Gabriele; Hoff, Kirstin; Kawalia, Amit; Thiele, Holger; Altmueller, Janine; Fischer-Zirnsak, Bjoern; Knaus, Alexej; Zhu, Na; Heinrich, Verena; Huber, Celine; Harabula, Izabela; Spielmann, Malte; Horn, Denise; Komak, Uwe; Hecht, Jochen; Krawitz, Peter M.; Nuernberg, Peter; Siebert, Reiner; Manzke, Hermann; Mundlos, Stefan			Homozygous and Compound-Heterozygous Mutations in TGDS Cause Catel-Manzke Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PIERRE-ROBIN SYNDROME; INDEX FINGER; PROTEOGLYCAN SYNTHESIS; CHONDROITIN SYNTHASE; ACCESSORY METACARPAL; SEQUENCING DATA; CLEFT-PALATE; HYPERPHALANGISM; PHENOTYPE; ANOMALIES	Catel-Manzke syndrome is characterized by Pierre Robin sequence and a unique form of bilateral hyperphalangy causing a clinodactyly of the index finger. We describe the identification of homozygous and compound heterozygous mutations in TGDS in seven unrelated individuals with typical Catel-Manzke syndrome by exome sequencing. Six different TGDS mutations were detected: c.892A>G (p.Asn298Asp), c.270_271del (p.Lys91Asnfs*22), c.298G>T (p.A1a100Ser), c.294T>G (p.Phe98Leu), c.269A>G (p.G1u90Gly), and c.700T>C (p.Tyr234His), all predicted to be disease causing. By using haplotype reconstruction we showed that the mutation c.298G>T is probably a founder mutation. Due to the spectrum of the amino acid changes, we suggest that loss of function in TGDS is the underlying mechanism of Catel-Manzke syndrome. TGDS (dTDP-D-glucose 4,6-dehydrogenase) is a conserved protein belonging to the SDR family and probably plays a role in nucleotide sugar metabolism.	[Ehmke, Nadja; Fischer-Zirnsak, Bjoern; Knaus, Alexej; Zhu, Na; Heinrich, Verena; Spielmann, Malte; Horn, Denise; Komak, Uwe; Hecht, Jochen; Krawitz, Peter M.; Mundlos, Stefan] Charite, Inst Med & Human Genet, D-13353 Berlin, Germany; [Ehmke, Nadja; Komak, Uwe; Hecht, Jochen; Krawitz, Peter M.; Mundlos, Stefan] Charite, Berlin Brandenburg Ctr Regenerat Therapies BCRT, D-13353 Berlin, Germany; [Caliebe, Almuth; Hoff, Kirstin; Siebert, Reiner] Univ Kiel, Inst Human Genet, D-24105 Kiel, Germany; [Caliebe, Almuth; Hoff, Kirstin; Siebert, Reiner] Univ Hosp Schleswig Holstein, D-24105 Kiel, Germany; [Koenig, Rainer] Goethe Univ Frankfurt, Inst Human Genet, D-60590 Frankfurt, Germany; [Kant, Sarina G.] Leiden Univ Med Ctr, Dept Clin Genet, NL-2300 RC Leiden, Netherlands; [Stark, Zornitza] Murdoch Childrens Res Inst, Victorian Clin Genet Serv, Parkville, Vic 3052, Australia; [Cormier-Daire, Valerie; Huber, Celine] Univ Paris 05, Sorbonne Paris Cite, Hop Necker Enfants Males, Dept Genet,INSERM,UMR 1163,Imagine Inst, F-75015 Paris, France; [Wieczorek, Dagmar] Univ Duisburg Essen, Univ Klinikum Essen, Inst Humangenet, D-45122 Essen, Germany; [Gillessen-Kaesbach, Gabriele] Med Univ Lubeck, Inst Humangenet, D-23538 Lubeck, Germany; [Hoff, Kirstin] Univ Kiel, Dept Congenital Heart Dis & Pediat Cardiol, D-24105 Kiel, Germany; [Hoff, Kirstin] DZHK German Ctr Cardiovasc Res, D-24105 Kiel, Germany; [Kawalia, Amit; Thiele, Holger; Altmueller, Janine; Nuernberg, Peter] Univ Cologne, CCG, D-50931 Cologne, Germany; [Altmueller, Janine] Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Fischer-Zirnsak, Bjoern; Knaus, Alexej; Harabula, Izabela; Spielmann, Malte; Horn, Denise; Komak, Uwe; Hecht, Jochen; Krawitz, Peter M.; Mundlos, Stefan] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Nuernberg, Peter] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; Goethe University Frankfurt; Leiden University; Leiden University Medical Center (LUMC); Murdoch Children's Research Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Duisburg Essen; University of Lubeck; German Centre for Cardiovascular Research; University of Cologne; University of Cologne; Max Planck Society; University of Cologne; University of Cologne	Ehmke, N (corresponding author), Charite, Inst Med & Human Genet, D-13353 Berlin, Germany.	nadja.ehmke@charite.de; stefan.mundlos@charite.de	Fischer-Zirnsak, Björn/D-7487-2013; Siebert, Reiner/A-8049-2010; Kant, Sarina/F-8596-2010; Wieczorek, Dagmar/AAU-6008-2021; Thiele, Holger/ABE-6792-2020; Mundlos, Stefan/ABH-9585-2020; Krawitz, Peter M/F-3142-2012; Caliebe, Almuth/G-1248-2018; Zhu, Na/L-3444-2019; Ehmke, Nadja/F-3341-2019; Spielmann, Malte/H-2230-2018; cormier-daire, valerie/H-6520-2017	Fischer-Zirnsak, Björn/0000-0002-1075-7571; Wieczorek, Dagmar/0000-0003-2812-6492; Thiele, Holger/0000-0002-0169-998X; Krawitz, Peter M/0000-0002-3194-8625; Caliebe, Almuth/0000-0003-2157-425X; Spielmann, Malte/0000-0002-0583-4683; Altmuller, Janine/0000-0003-4372-1521; Zhu, Na/0000-0001-6460-3087; cormier-daire, valerie/0000-0002-2839-9856; huber, celine/0000-0002-8601-9655; Mundlos, Stefan/0000-0002-9788-3166	EU (EURO-CDG); GIS [A11144KS]; Deutsche Forschungsgemeinschaft (DFG); DFG [KR3895/1-1]; Deutsche Forschungsgemeinschaft; Max Planck Foundation	EU (EURO-CDG); GIS; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Foundation(Foundation CELLEX)	We would like to thank the families for their collaboration and contribution to this project, David Genevieve for his support, as well as Randi Kroll, Fabienne Pritsch, Gundula Leschik, Catrin Janetzki, Christian Becker, and Elisabeth Kirst for their technical assistance. We are indebted to Ammi Grahn and Emile Van Schaftingen for performing biochemical assays. U.K. received funding from the EU (EURO-CDG). Exome sequencing analysis for individual 7 has been supported by a GIS maladies rares funding A11144KS. The major part of exome data was analyzed on a high-performance computer cluster of the Regional Computing Centre of Cologne (RRZK), grant-aided by the Deutsche Forschungsgemeinschaft (DFG). P.N. is a founder, CEO, and shareholder of ATLAS Biolabs GmbH, which is a service provider for genomic analyses. P.M.K. is a founder, CEO, and shareholder of GeneTalk and received a grant from the DFG (KR3895/1-1). S.M. was supported by grants from the Deutsche Forschungsgemeinschaft and the Max Planck Foundation.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; BERND L, 1990, Z ORTHOP GRENZGEB, V128, P463, DOI 10.1055/s-2008-1039597; Blake JA, 2014, NUCLEIC ACIDS RES, V42, pD810, DOI 10.1093/nar/gkt1225; BRUDE E, 1984, EUR J PEDIATR, V142, P222, DOI 10.1007/BF00442455; Buck-Gramcko D., 1998, CONGENTIAL MALFORMAT; Catel W., 1961, DIFFERENTIALDIAGNOSE; Clarkson JHW, 2004, CLIN DYSMORPHOL, V13, P237, DOI 10.1097/00019605-200410000-00007; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; DIGNAN PS, 1986, CLIN GENET, V29, P168; DUDIN A, 1995, AM J MED GENET, V56, P161, DOI 10.1002/ajmg.1320560209; FARNSWORTH PB, 1971, CLIN PEDIATR, V10, P600, DOI 10.1177/000992287101001029; GEWITZ M, 1978, J MED GENET, V15, P162, DOI 10.1136/jmg.15.2.162; Giraud MF, 2000, CURR OPIN STRUC BIOL, V10, P687, DOI 10.1016/S0959-440X(00)00145-7; GORLIN R J, 1971, Birth Defects Original Article Series, V7, P3; Gorlin R.J., 2001, SYNDROMES HEAD NECK, V4th ed., DOI 10.17245/jdapm.2019.19.5.261; Heinrich V, 2013, GENOME MED, V5, DOI 10.1186/gm473; HOLTHUSEN W, 1972, ANN RADIOL, V15, P253; Huber C, 2009, AM J HUM GENET, V85, P706, DOI 10.1016/j.ajhg.2009.10.001; Jager M, 2014, HUM MUTAT, V35, P548, DOI 10.1002/humu.22531; Kamphans T, 2012, BIOINFORMATICS, V28, P2515, DOI 10.1093/bioinformatics/bts462; Kant SG, 1998, GENET COUNSEL, V9, P187; Kapoor S, 2011, CLIN DYSMORPHOL, V20, P117, DOI 10.1097/MCD.0b013e3283458946; Karchin R, 2009, BRIEF BIOINFORM, V10, P35, DOI 10.1093/bib/bbn047; Kiper POS, 2011, AM J MED GENET A, V155A, P2288, DOI 10.1002/ajmg.a.34163; Kiraz A, 2013, CLIN DYSMORPHOL, V22, P169, DOI 10.1097/MCD.0000000000000010; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; KLUG MS, 1983, J HAND SURG-AM, V8, P599, DOI 10.1016/S0363-5023(83)80135-X; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li Y, 2010, AM J HUM GENET, V87, P757, DOI 10.1016/j.ajhg.2010.10.003; LIPSON A, 1984, J PEDIATR-US, V104, P216, DOI 10.1016/S0022-3476(84)80995-6; MANZKE H, 1966, FORTSCHR RONTG NEUEN, V105, P425; Manzke H, 2008, EUR J MED GENET, V51, P452, DOI 10.1016/j.ejmg.2008.03.005; Moriarity JL, 2002, J BIOL CHEM, V277, P16968, DOI 10.1074/jbc.M109316200; Nizon M, 2012, AM J MED GENET A, V158A, P2183, DOI 10.1002/ajmg.a.35504; Nizon M, 2012, HUM MUTAT, V33, P1261, DOI 10.1002/humu.22104; Oh S.H., 1999, J KOREAN PEDIAT SOC, V42, P1154; Persson B, 2013, CHEM-BIOL INTERACT, V202, P111, DOI 10.1016/j.cbi.2012.11.009; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; Puri RD, 2003, CLIN DYSMORPHOL, V12, P279, DOI 10.1097/00019605-200310000-00015; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; SHEFFIELD LJ, 1987, AM J MED GENET, V28, P25, DOI 10.1002/ajmg.1320280105; SILENGO MC, 1977, PEDIATR RADIOL, V6, P178, DOI 10.1007/BF00972113; Skinner Sr S.A., 1989, P GR GENET CTR, V8, P60; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; STEVENSON RE, 1980, J MED GENET, V17, P238, DOI 10.1136/jmg.17.3.238; SUNDARAM V, 1982, CLIN GENET, V21, P407; Temtamy SA, 1998, CLIN DYSMORPHOL, V7, P249, DOI 10.1097/00019605-199810000-00003; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; THOMPSON EM, 1986, J MED GENET, V23, P271, DOI 10.1136/jmg.23.3.271; Vissers LELM, 2011, AM J HUM GENET, V88, P608, DOI 10.1016/j.ajhg.2011.04.002; WILSON GN, 1993, AM J MED GENET, V46, P176, DOI 10.1002/ajmg.1320460215	55	29	31	1	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 4	2014	95	6					763	770		10.1016/j.ajhg.2014.11.004	http://dx.doi.org/10.1016/j.ajhg.2014.11.004			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AX0DH	25480037	Bronze, Green Published			2022-12-18	WOS:000346623100013
J	Hussain, MS; Battaglia, A; Szczepanski, S; Kaygusuz, E; Toliat, MR; Sakakibara, S; Altmuller, J; Thiele, H; Nurnberg, G; Moosa, S; Yigit, G; Beleggia, F; Tinschert, S; Clayton-Smith, J; Vasudevan, P; Urquhart, JE; Donnai, D; Fryer, A; Percin, F; Brancati, F; Dobbie, A; Smigiel, R; Gillessen-Kaesbach, G; Wollnik, B; Noegel, AA; Newman, WG; Nurnberg, P				Hussain, Muhammad Sajid; Battaglia, Agatino; Szczepanski, Sandra; Kaygusuz, Emrah; Toliat, Mohammad Reza; Sakakibara, Shin-ichi; Altmueller, Janine; Thiele, Holger; Nuernberg, Gudrun; Moosa, Shahida; Yigit, Goekhan; Beleggia, Filippo; Tinschert, Sigrid; Clayton-Smith, Jill; Vasudevan, Pradeep; Urquhart, Jill E.; Donnai, Dian; Fryer, Alan; Percin, Ferda; Brancati, Francesco; Dobbie, Angus; Smigiel, Robert; Gillessen-Kaesbach, Gabriele; Wollnik, Bernd; Noegel, Angelika Anna; Newman, William G.; Nuernberg, Peter			Mutations in CKAP2L, the Human Homo log of the Mouse Radmis Gene, Cause Filippi Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MENTAL-RETARDATION; PHENOTYPE; PATIENT	Filippi syndrome is a rare, presumably autosomal-recessive disorder characterized by microcephaly, pre- and postnatal growth failure, syndactyly, and distinctive facial features, including a broad nasal bridge and underdeveloped alae nasi. Some affected individuals have intellectual disability, seizures, undescended testicles in males, and teeth and hair abnormalities. We performed homozygosity mapping and whole-exome sequencing in a Sardinian family with two affected children and identified a homozygous frameshift mutation, c.571dupA (p.Ile191Asnfs*6), in CKAP2L, encoding the protein cytoskeleton-associated protein 2-like (CKAP2L). The function of this protein was unknown until it was rediscovered in mice as Radmis (radial fiber and mitotic spindle) and shown to play a pivotal role in cell division of neural progenitors. Sanger sequencing of CKAP2L in a further eight unrelated individuals with clinical features consistent with Filippi syndrome revealed biallelic mutations in four subjects. In contrast to wild-type lymphoblastoid cell lines (LCLs), dividing LCLs established from the individuals homozygous for the c.571dupA mutation did not show CKAP2L at the spindle poles. Furthermore, in cells from the affected individuals, we observed an increase in the number of disorganized spindle microtubules owing to multipolar configurations and defects in chromosome segregation. The observed cellular phenotypes are in keeping with data from in vitro and in vivo knockdown studies performed in human cells and mice, respectively. Our findings show that loss-of-function mutations in CKAP2L are a major cause of Filippi syndrome.	[Hussain, Muhammad Sajid; Szczepanski, Sandra; Toliat, Mohammad Reza; Altmueller, Janine; Thiele, Holger; Nuernberg, Gudrun; Noegel, Angelika Anna; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Hussain, Muhammad Sajid; Szczepanski, Sandra; Kaygusuz, Emrah; Noegel, Angelika Anna] Univ Cologne, Fac Med, Inst Biochem 1, D-50931 Cologne, Germany; [Battaglia, Agatino; Moosa, Shahida; Yigit, Goekhan; Beleggia, Filippo; Wollnik, Bernd; Noegel, Angelika Anna; Nuernberg, Peter] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Battaglia, Agatino] Stella Maris Clin Res Inst Child & Adolescent Neu, I-56128 Pisa, Italy; [Sakakibara, Shin-ichi] Waseda Univ, Grad Sch Human Sci, Mol Neurobiol Lab, Tokorozawa, Saitama 3591192, Japan; [Altmueller, Janine; Moosa, Shahida; Yigit, Goekhan; Beleggia, Filippo; Wollnik, Bernd] Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Moosa, Shahida; Yigit, Goekhan; Beleggia, Filippo; Wollnik, Bernd; Noegel, Angelika Anna; Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Tinschert, Sigrid] Med Univ Innsbruck, Div Human Genet, A-6020 Innsbruck, Austria; [Tinschert, Sigrid] Tech Univ Dresden, Fac Med Carl Gustav Carus, Inst Clin Genet, D-01307 Dresden, Germany; [Clayton-Smith, Jill; Urquhart, Jill E.; Donnai, Dian; Newman, William G.] Univ Manchester, Sch Biomed, Manchester Acad Hlth Sci Ctr, Manchester Ctr Genom Med,St Marys Hosp, Manchester M13 9WL, Lancs, England; [Vasudevan, Pradeep] Univ Hosp Leicester NHS Fdn Trust, Dept Clin Genet, Leicester LE1 5WW, Leics, England; [Fryer, Alan] Alder Hey Childrens Hosp, Dept Clin Genet, Liverpool L12 2AP, Merseyside, England; [Percin, Ferda] Gazi Univ, Fac Med, Dept Med Genet, TR-06500 Ankara, Turkey; [Brancati, Francesco] Gabriele DAnnunzio Univ Chieti Pescara, Dept Med Oral & Biotechnol Sci, I-66100 Chieti, Italy; [Brancati, Francesco] Policlin Tor Vergata Univ Hosp, Med Genet Unit, I-00133 Rome, Italy; [Dobbie, Angus] Chapel Allerton Hosp, Yorkshire Reg Genet Serv, Leeds LS7 4SA, W Yorkshire, England; [Smigiel, Robert] Wroclaw Med Univ, Dept Genet, PL-50368 Wroclaw, Poland; [Gillessen-Kaesbach, Gabriele] Med Univ Lubeck, Inst Humangenet Lubeck, D-23538 Lubeck, Germany	University of Cologne; University of Cologne; University of Cologne; IRCCS Fondazione Stella Maris; Waseda University; University of Cologne; University of Cologne; Medical University of Innsbruck; Technische Universitat Dresden; University of Manchester; University Hospitals of Leicester NHS Trust; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; Gazi University; G d'Annunzio University of Chieti-Pescara; University of Rome Tor Vergata; Policlin Tor Vergata; Chapel Allerton Hospital; Wroclaw Medical University; University of Lubeck	Nurnberg, P (corresponding author), Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany.	nuernberg@uni-koeln.de	Brancati, Francesco/AAC-3778-2022; Urquhart, Jill/G-2282-2015; Beleggia, Filippo/S-8481-2018; Wollnik, Bernd/GRY-6062-2022; Moosa, Shahida/I-9735-2019; Percin, Ferda E/H-6850-2016; Battaglia, Agatino/AAG-1406-2020; Thiele, Holger/ABE-6792-2020	Brancati, Francesco/0000-0003-3624-2354; Urquhart, Jill/0000-0002-5788-5511; Wollnik, Bernd/0000-0003-2589-0364; Moosa, Shahida/0000-0002-4463-3067; Percin, Ferda E/0000-0001-9317-8155; Battaglia, Agatino/0000-0002-7128-7606; Thiele, Holger/0000-0002-0169-998X; Beleggia, Filippo/0000-0003-0234-7094; Newman, William/0000-0002-6382-4678; Smigiel, Robert/0000-0003-2930-9549; Hussain, Muhammad Sajid/0000-0002-1353-8809; Sakakibara, Shin-ichi/0000-0001-8983-2249; Altmuller, Janine/0000-0003-4372-1521	Koln Fortune; Center for Molecular Medicine Cologne; Grants-in-Aid for Scientific Research [26430042] Funding Source: KAKEN	Koln Fortune; Center for Molecular Medicine Cologne; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We wish to thank all family members for their participation. We are also thankful to Ramona Casper, Nina Dalibor, Elisabeth Kirst, and Yumi Iwasaki for their technical support. P.N. is a founder, CEO, and shareholder of ATLAS Biolabs GmbH. ATLAS Biolabs GmbH is a Service provider for genomic analyses. This work was supported by grants from Koln Fortune (M.S.H.) and the Center for Molecular Medicine Cologne (P.N. and A.A.N.).	Basmanav FB, 2014, AM J HUM GENET, V94, P135, DOI 10.1016/j.ajhg.2013.12.003; Battaglia A, 2008, AM J MED GENET A, V146A, P1848, DOI 10.1002/ajmg.a.32400; Blomster HA, 2010, J BIOL CHEM, V285, P19324, DOI 10.1074/jbc.M110.106955; BOBER E, 1994, DEVELOPMENT, V120, P603; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Buckingham M, 2009, CURR OPIN GENET DEV, V19, P444, DOI 10.1016/j.gde.2009.08.001; Cabala M, 2013, CLIN DYSMORPHOL, V22, P146, DOI 10.1097/MCD.0b013e3283645a30; FILIPPI G, 1985, AM J MED GENET, V22, P821, DOI 10.1002/ajmg.1320220416; Franceschini P, 2002, GENET COUNSEL, V13, P343; Fryer A, 1996, CLIN DYSMORPHOL, V5, P35, DOI 10.1097/00019605-199601000-00005; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hussain MS, 2013, HUM MOL GENET, V22, P5199, DOI 10.1093/hmg/ddt374; Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63; Jordan D, 2012, Open Orthop J, V6, P14, DOI 10.2174/1874325001206010014; Kalay E, 2011, NAT GENET, V43, P23, DOI 10.1038/ng.725; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; Lazier J, 2014, AM J MED GENET A, V164, P2385, DOI 10.1002/ajmg.a.36636; McCoy JP., 2001, CURR PROTOC CYTOM, VChapter 5; Meinecke P., 1993, Genetic Counseling, V4, P147; Nicholas AK, 2010, NAT GENET, V42, P1010, DOI 10.1038/ng.682; Orrico A, 1997, CLIN GENET, V52, P177; Pfleger CM, 2000, GENE DEV, V14, P655; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Sandhu M, 2013, CASE REP DENT, V2013, DOI 10.1155/2013/845405; Schorderet DE, 2002, GENET COUNSEL, V13, P441; Sharif S, 2004, CLIN DYSMORPHOL, V13, P221, DOI 10.1097/00019605-200410000-00004; Walpole IR, 1999, CLIN DYSMORPHOL, V8, P235; Williams MS, 1999, AM J MED GENET, V87, P128, DOI 10.1002/(SICI)1096-8628(19991119)87:2<128::AID-AJMG3>3.3.CO;2-K; WOODS CG, 1992, J MED GENET, V29, P500; Yumoto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079895	31	29	32	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 6	2014	95	5					622	632		10.1016/j.ajhg.2014.10.008	http://dx.doi.org/10.1016/j.ajhg.2014.10.008			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AT3OY	25439729	Bronze, Green Published			2022-12-18	WOS:000344845000013
J	Chan, YL; Lim, ET; Sandholm, N; Wang, SR; McKnight, AJ; Ripke, S; Daly, MJ; Neale, BM; Salem, RM; Hirschhorn, JN				Chan, Yingleong; Lim, Elaine T.; Sandholm, Niina; Wang, Sophie R.; McKnight, Amy Jayne; Ripke, Stephan; Daly, Mark J.; Neale, Benjamin M.; Salem, Rany M.; Hirschhorn, Joel N.		DIAGRAM Consortium; GENIE Consortium; GIANT Consortium; IIBDGC Consortium; PGC Consortium	An Excess of Risk-Increasing Low-Frequency Variants Can Be a Signal of Polygenic Inheritance in Complex Diseases	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; INFLAMMATORY-BOWEL-DISEASE; GENETIC ARCHITECTURE; MISSING HERITABILITY; ULCERATIVE-COLITIS; PROVIDES INSIGHTS; COMMON SNPS; METAANALYSIS; LOCI; SUSCEPTIBILITY	In most complex diseases, much of the heritability remains unaccounted for by common variants. It has been postulated that lower-frequency variants contribute to the remaining heritability. Here, we describe a method to test for polygenic inheritance from lower-frequency variants by using GWAS summary association statistics. We explored scenarios with many causal low-frequency variants and showed that there is more power to detect risk variants than to detect protective variants, resulting in an increase in the ratio of detected risk to protective variants (R/P ratio). Such an excess can also occur if risk variants are present and kept at lower frequencies because of negative selection. The R/P ratio can be falsely elevated because of reasons unrelated to polygenic inheritance, such as uneven sample sizes or asymmetric population stratification, so precautions to correct for these confounders are essential. We tested our method on published GWAS results and observed a strong signal in some diseases (schizophrenia and type 2 diabetes) but not others. We also explored the shared genetic component in overlapping phenotypes related to inflammatory bowel disease (Crohn disease [CD] and ulcerative colitis [UC]) and diabetic nephropathy (macroalbuminuria and end-stage renal disease [ESRD]). Although the signal was still present when both CD and UC were jointly analyzed, the signal was lost when macroalbuminuria and ESRD were jointly analyzed, suggesting that these phenotypes should best be studied separately. Thus, our method may also help guide the design of future genetic studies of various traits and diseases.	[Chan, Yingleong; Lim, Elaine T.; Wang, Sophie R.; Daly, Mark J.; Salem, Rany M.; Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Chan, Yingleong; Lim, Elaine T.; Wang, Sophie R.; Ripke, Stephan; Daly, Mark J.; Neale, Benjamin M.; Salem, Rany M.; Hirschhorn, Joel N.] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Chan, Yingleong; Wang, Sophie R.; Salem, Rany M.; Hirschhorn, Joel N.] Boston Childrens Hosp, Dept Endocrinol, Boston, MA 02115 USA; [Lim, Elaine T.; Ripke, Stephan; Daly, Mark J.; Neale, Benjamin M.] MIT, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Sandholm, Niina] Biomedicum Helsinki, Folkhalsan Res Ctr, Folkhalsan Inst Genet, Helsinki 00290, Finland; [Sandholm, Niina] Univ Helsinki, Cent Hosp, Dept Med, Div Nephrol, FIN-00290 Helsinki, Finland; [Sandholm, Niina] Aalto Univ, Sch Sci, Dept Biomed Engn & Computat Sci, Helsinki 00076, Finland; [McKnight, Amy Jayne] Queens Univ Belfast, Ctr Publ Hlth, Belfast BT7 1NN, Antrim, North Ireland	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Massachusetts Institute of Technology (MIT); Folkhalsan Research Center; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Aalto University; Queens University Belfast	Hirschhorn, JN (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	joelh@broadinstitute.org	Lim, Elaine/H-9032-2016; Franke, Andre/B-2151-2010; Daly, Mark J/B-2453-2017; Ripke, Stephan/AAK-5486-2021; D'Amato, Mauro/B-5050-2019; D'Amato, Mauro/F-2450-2010; McKnight, Amy Jayne/ABF-4492-2020	Franke, Andre/0000-0003-1530-5811; Daly, Mark J/0000-0002-0949-8752; D'Amato, Mauro/0000-0003-2743-5197; D'Amato, Mauro/0000-0003-2743-5197; McKnight, Amy Jayne/0000-0002-7482-709X; ripke, stephan/0000-0003-3622-835X; Lim, Teng Ting/0000-0003-3651-0654; Salem, Rany/0000-0001-8816-6862; Wang, Sophie Ran/0000-0002-7897-8389; Harrison, Pille/0000-0003-4117-6910; Sandholm, Niina/0000-0003-4322-6942	NIH [R01DK075787, R01DK081923]; Juvenile Diabetes Research Foundation (JDRF) [3-2011-70]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081923, R01DK075787] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding for this work was provided by NIH grants R01DK075787 and R01DK081923. R.M.S. was supported by a Juvenile Diabetes Research Foundation postdoctoral fellowship (JDRF #3-2011-70).	Adams AM, 2004, GENETICS, V168, P1699, DOI 10.1534/genetics.104.030171; Agarwala V, 2013, NAT GENET, V45, P1418, DOI 10.1038/ng.2804; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Anderson CA, 2009, GASTROENTEROLOGY, V136, P523, DOI 10.1053/j.gastro.2008.10.032; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Chan YL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002439; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Eyre-Walker A, 2010, P NATL ACAD SCI USA, V107, P1752, DOI 10.1073/pnas.0906182107; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Heinzen EL, 2012, AM J HUM GENET, V91, P293, DOI 10.1016/j.ajhg.2012.06.016; Hirschhorn JN, 2011, ANNU REV MED, V62, P11, DOI 10.1146/annurev.med.091708.162036; Iyengar Sudha K, 2007, Methods Mol Biol, V376, P71; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kryukov GV, 2009, P NATL ACAD SCI USA, V106, P3871, DOI 10.1073/pnas.0812824106; Lambert BW, 2008, BIOINFORMATICS, V24, P1821, DOI 10.1093/bioinformatics/btn317; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Lim ET, 2013, NEURON, V77, P235, DOI 10.1016/j.neuron.2012.12.029; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Park JH, 2011, P NATL ACAD SCI USA, V108, P18026, DOI 10.1073/pnas.1114759108; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Sandholm N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002921; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Slatkin M, 2008, GENETICS, V179, P2253, DOI 10.1534/genetics.107.077719; Su Z, 2011, BIOINFORMATICS, V27, P2304, DOI 10.1093/bioinformatics/btr341; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Yang Jian, 2013, Methods Mol Biol, V1019, P215, DOI 10.1007/978-1-62703-447-0_9; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yu TW, 2013, NEURON, V77, P259, DOI 10.1016/j.neuron.2012.11.002	43	29	29	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 6	2014	94	3					437	452		10.1016/j.ajhg.2014.02.006	http://dx.doi.org/10.1016/j.ajhg.2014.02.006			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AC6DK	24607388	Green Published, Bronze			2022-12-18	WOS:000332611400017
J	Rippey, C; Walsh, T; Gulsuner, S; Brodsky, M; Nord, AS; Gasperini, M; Pierce, S; Spurrell, C; Coe, BP; Krumm, N; Lee, MK; Sebat, J; McClellan, JM; King, MC				Rippey, Caitlin; Walsh, Tom; Gulsuner, Suleyman; Brodsky, Matt; Nord, Alex S.; Gasperini, Molly; Pierce, Sarah; Spurrell, Cailyn; Coe, Bradley P.; Krumm, Niklas; Lee, Ming K.; Sebat, Jonathan; McClellan, Jon M.; King, Mary-Claire			Formation of Chimeric Genes by Copy-Number Variation as a Mutational Mechanism in Schizophrenia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNAPTIC PLASTICITY; PB1 DOMAIN; ERK5; TRANSCRIPTS; ACTIVATION; EXPRESSION; EVOLUTION; SEQUENCE; DELETION; VARIANTS	Chimeric genes can be caused by structural genomic rearrangements that fuse together portions of two different genes to create a novel gene. We hypothesize that brain-expressed chimeras may contribute to schizophrenia. Individuals with schizophrenia and control individuals were screened genome wide for copy-number variants (CNVs) that disrupted two genes on the same DNA strand. Candidate events were filtered for predicted brain expression and for frequency < 0.001 in an independent series of 20,000 controls. Four of 124 affected individuals and zero of 290 control individuals harbored such events (p = 0.002); a 47 kb duplication disrupted MATK and ZFR2, a 58 kb duplication disrupted PLEKHD1 and SLC39A9, a 121 kb duplication disrupted DNAJA2 and NETO2, and a 150 kb deletion disrupted M4P3K3 and DDX42. Each fusion produced a stable protein when exogenously expressed in cultured cells. We examined whether these chimeras differed from their parent genes in localization, regulation, or function. Subcellular localizations of DNAJA2-NETO2 and MAP3K3-DDX42 differed from their parent genes. On the basis of the expression profile of the MATK promoter, MATK-ZFR2 is likely to be far more highly expressed in the brain during development than the ZFR2 parent gene. MATK-ZFR2 includes a ZFR2-derived isoform that we demonstrate localizes preferentially to neuronal dendritic branch sites. These results suggest that the formation of chimeric genes is a mechanism by which CNVs contribute to schizophrenia and that, by interfering with parent gene function, chimeras may disrupt critical brain processes, including neurogenesis, neuronal differentiation, and dendritic arborization.	[Rippey, Caitlin; Walsh, Tom; Gulsuner, Suleyman; Nord, Alex S.; Gasperini, Molly; Pierce, Sarah; Spurrell, Cailyn; Coe, Bradley P.; Krumm, Niklas; Lee, Ming K.; King, Mary-Claire] Univ Washington, Dept Med & Genome Sci, Seattle, WA 98195 USA; [Brodsky, Matt; McClellan, Jon M.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Sebat, Jonathan] Univ Calif, Inst Genom Med, Dept Cellular & Mol Med, Dept Psychiat, La Jolla, CA 92093 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Diego	Rippey, C (corresponding author), Univ Washington, Dept Med & Genome Sci, Seattle, WA 98195 USA.	cfields@uw.edu	Gulsuner, Suleyman/AAF-2098-2020; Coe, Bradley/A-2878-2009	Gulsuner, Suleyman/0000-0002-3897-1238; King, Mary-Claire/0000-0001-9426-1743; Sebat, Jonathan/0000-0002-9087-526X; Nord, Alexander/0000-0003-4259-7514; Coe, Bradley/0000-0001-8471-4016; Pierce, Sarah/0000-0001-6739-7135; Walsh, Tom/0000-0002-8875-0310	National Institutes of Health [R01 MH083989, F30 MH085467-03, T32 GM07266]; Achievement Rewards for College Scientists Foundation; NATIONAL CANCER INSTITUTE [R01CA157744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH096844, F30MH085467, R01MH083989, U01MH094411] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Achievement Rewards for College Scientists Foundation(General Electric); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This project was supported by National Institutes of Health grants R01 MH083989, F30 MH085467-03, and T32 GM07266 and a fellowship from the Achievement Rewards for College Scientists Foundation. This study makes use of data generated by the Wellcome Trust Case Control Consortium.	Barbee SA, 2006, NEURON, V52, P997, DOI 10.1016/j.neuron.2006.10.028; Brandon NJ, 2011, NAT REV NEUROSCI, V12, P707, DOI 10.1038/nrn3120; Cavanaugh JE, 2006, J NEUROSCI RES, V84, P1367, DOI 10.1002/jnr.21024; Chao TH, 1999, J BIOL CHEM, V274, P36035, DOI 10.1074/jbc.274.51.36035; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Courseaux A, 2001, SCIENCE, V291, P1293, DOI 10.1126/science.1057284; DINGWALL C, 1988, J CELL BIOL, V107, P841, DOI 10.1083/jcb.107.3.841; Dwivedi Y, 2007, NEUROPSYCHOPHARMACOL, V32, P2338, DOI 10.1038/sj.npp.1301372; Elvira G, 2006, J NEUROCHEM, V96, P105, DOI 10.1111/j.1471-4159.2005.03523.x; Eykelenboom JE, 2012, HUM MOL GENET, V21, P3374, DOI 10.1093/hmg/dds169; Friedman JI, 2008, MOL PSYCHIATR, V13, P261, DOI 10.1038/sj.mp.4002049; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; HEISTERKAMP N, 1985, NATURE, V315, P758, DOI 10.1038/315758a0; Holt R, 2012, EUR J HUM GENET, V20, P1141, DOI 10.1038/ejhg.2012.73; Horne BE, 2010, J BIOL CHEM, V285, P21679, DOI 10.1074/jbc.M110.113118; Huang QJ, 2004, NAT IMMUNOL, V5, P98, DOI 10.1038/ni1014; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Jia J, 2013, CURR OPIN GENET DEV, V23, P29, DOI 10.1016/j.gde.2012.12.004; Kirov G, 2009, HUM MOL GENET, V18, P1497, DOI 10.1093/hmg/ddp043; Kleines M, 2001, GENE, V275, P157, DOI 10.1016/S0378-1119(01)00620-5; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Li T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061948; Lin CW, 2008, VIRUS RES, V137, P49, DOI 10.1016/j.virusres.2008.05.015; Meuillet EJ, 2011, CURR MED CHEM, V18, P2727; Michels AA, 1999, J BIOL CHEM, V274, P36757, DOI 10.1074/jbc.274.51.36757; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Mingorance-Le Meur A, 2006, J NEUROSCI, V26, P12104, DOI 10.1523/JNEUROSCI.4216-06.2006; Nakamura K, 2006, MOL CELL BIOL, V26, P2065, DOI 10.1128/MCB.26.6.2065-2079.2006; Nakamura K, 2003, J BIOL CHEM, V278, P36989, DOI 10.1074/jbc.C300313200; Nord AS, 2011, EUR J HUM GENET, V19, P727, DOI 10.1038/ejhg.2011.24; Orlova KA, 2010, J CLIN INVEST, V120, P1591, DOI 10.1172/JCI41592; Pan YW, 2012, J BIOL CHEM, V287, P23306, DOI 10.1074/jbc.M112.344762; Peisajovich SG, 2010, SCIENCE, V328, P368, DOI 10.1126/science.1182376; Perycz M, 2011, J NEUROSCI, V31, P5271, DOI 10.1523/JNEUROSCI.2387-10.2011; Raes J, 2005, TRENDS GENET, V21, P428, DOI 10.1016/j.tig.2005.05.013; Ranz JM, 2012, BIOESSAYS, V34, P477, DOI 10.1002/bies.201100177; Rogers RL, 2012, MOL BIOL EVOL, V29, P517, DOI 10.1093/molbev/msr184; Rogers RL, 2009, GENETICS, V181, P313, DOI 10.1534/genetics.108.091538; Rosales-Hernandez A, 2009, CELL STRESS CHAPERON, V14, P71, DOI 10.1007/s12192-008-0056-y; Schmitz C, 2007, P NATL ACAD SCI USA, V104, P834, DOI 10.1073/pnas.0510527104; Sottocornola R, 2010, DEV CELL, V19, P126, DOI 10.1016/j.devcel.2010.06.003; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stirling PC, 2006, NAT STRUCT MOL BIOL, V13, P865, DOI 10.1038/nsmb1153; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Tang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051433; Taniguchi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058022; Terada K, 2000, J BIOL CHEM, V275, P24728, DOI 10.1074/jbc.M002021200; Thomson TM, 2000, GENOME RES, V10, P1743, DOI 10.1101/gr.GR-1405R; Tong LQ, 2012, J NEUROSCI, V32, P17714, DOI 10.1523/JNEUROSCI.1253-12.2012; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Uhlmann-Schiffler H, 2009, ONCOGENE, V28, P2065, DOI 10.1038/onc.2009.75; Vacic V, 2011, NATURE, V471, P499, DOI 10.1038/nature09884; Walker VE, 2010, J BIOL CHEM, V285, P3319, DOI 10.1074/jbc.M109.024000; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang XF, 2011, J IMMUNOL, V186, P5791, DOI 10.4049/jimmunol.1002127; Williams HJ, 2013, AM J MED GENET B, V162B, P177, DOI 10.1002/ajmg.b.32129; Williams NM, 2011, SCHIZOPHRENIA BULL, V37, P882, DOI 10.1093/schbul/sbr095; Wu Q, 2013, GENE, V518, P223, DOI 10.1016/j.gene.2013.01.015; Xu BE, 2004, J BIOL CHEM, V279, P7826, DOI 10.1074/jbc.M313465200; Yang K, 2011, GENES BRAIN BEHAV, V10, P834, DOI 10.1111/j.1601-183X.2011.00723.x; Zheng WH, 2012, BRAIN RES, V1470, P145, DOI 10.1016/j.brainres.2012.06.032; Zhou X, 2010, MOL PSYCHIATR, V15, P670, DOI 10.1038/mp.2009.127	66	29	31	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 3	2013	93	4					697	710		10.1016/j.ajhg.2013.09.004	http://dx.doi.org/10.1016/j.ajhg.2013.09.004			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	243GT	24094746	Green Published, Bronze			2022-12-18	WOS:000326305600011
J	Pasternack, SM; Refke, M; Paknia, E; Hennies, HC; Franz, T; Schafer, N; Fryer, A; van Steensel, M; Sweeney, E; Just, M; Grimm, C; Kruse, R; Ferrandiz, C; Nothen, MM; Fischer, U; Betz, RC				Pasternack, Sandra M.; Refke, Melanie; Paknia, Elham; Hennies, Hans Christian; Franz, Thomas; Schaefer, Niklas; Fryer, Alan; van Steensel, Maurice; Sweeney, Elizabeth; Just, Miquel; Grimm, Clemens; Kruse, Roland; Ferrandiz, Carlos; Noethen, Markus M.; Fischer, Utz; Betz, Regina C.			Mutations in SNRPE, which Encodes a Core Protein of the Spliceosome, Cause Autosomal-Dominant Hypotrichosis Simplex	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN HAIR-GROWTH; RETINITIS-PIGMENTOSA; MESSENGER-RNA; GENE; TRANSLATION; DEFICIENCY; INITIATION	Hypotrichosis simplex (HS) comprises a group of hereditary isolated alopecias that are characterized by a diffuse and progressive loss of hair starting in childhood and shows a wide phenotypic variability. We mapped an autosomal-dominant form of HS to chromosome 1q31.3-1q41 in a Spanish family. By direct sequencing, we identified the heterozygous mutation c.1A>G (p.Met1?) in SNRPE that results in loss of the start codon of the transcript. We identified the same mutation in a simplex HS case from the UK and an additional mutation (c.133G>A [p.Gly45Ser]) in a simplex HS case originating from Tunisia. SNRPE encodes a core protein of U snRNPs, the key factors of the pre-mRNA processing spliceosome. The missense mutation c.133G>A leads to a glycine to senile substitution and is predicted to disrupt the structure of SNRPE. Western blot analyses of HEK293T cells expressing SNRPE c.1A>G revealed an N-terminally truncated protein, and therefore the mutation might result in use of an alternative in-frame downstream start codon. Subcellular localization of mutant SNRPE by immunofluorescence analyses as well as incorporation of mutant SNRPE proteins into U snRNPs was found to be normal, suggesting that the function of U snRNPs in splicing, rather than their biogenesis, is affected. In this report we link a core component of the spliceosome to hair loss, thus adding another specific factor in the complexity of hair growth. Furthermore, our findings extend the range of human phenotypes that are linked to the splicing machinery.	[Pasternack, Sandra M.; Refke, Melanie; Schaefer, Niklas; Noethen, Markus M.; Betz, Regina C.] Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany; [Paknia, Elham; Grimm, Clemens; Fischer, Utz] Univ Wurzburg, Theodor Boveri Inst, Dept Biochem, D-97074 Wurzburg, Germany; [Hennies, Hans Christian] Univ Cologne, CCG, D-50931 Cologne, Germany; [Hennies, Hans Christian] Med Univ Innsbruck, Div Human Genet, Ctr Dermatogenet, A-6020 Innsbruck, Austria; [Hennies, Hans Christian] Med Univ Innsbruck, Dept Dermatol, A-6020 Innsbruck, Austria; [Franz, Thomas] Univ Bonn, Dept Anat, D-53115 Bonn, Germany; [Fryer, Alan; Sweeney, Elizabeth] Alder Hey Hosp, Cheshire & Merseyside Genet Serv, Liverpool L12 2AP, Merseyside, England; [van Steensel, Maurice] Maastricht Univ, Med Ctr, Dept Dermatol, NL-6200 Maastricht, Netherlands; [van Steensel, Maurice] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, NL-6200 Maastricht, Netherlands; [Just, Miquel; Ferrandiz, Carlos] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Serv Dermatol, Badalona 08916, Spain; [Noethen, Markus M.] Univ Bonn, Dept Genom, Life & Brain Ctr, D-53127 Bonn, Germany	University of Bonn; University of Wurzburg; University of Cologne; Medical University of Innsbruck; Medical University of Innsbruck; University of Bonn; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; Maastricht University; Maastricht University; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; University of Bonn	Betz, RC (corresponding author), Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany.	regina.betz@uni-bonn.de	Betz, Regina C/E-8591-2011; Fischer, Utz/AAT-8422-2020; Fischer, Utz/A-4090-2016; van Steensel, Maurice A.M./V-3852-2019; Hennies, Hans C/G-9424-2014	Betz, Regina C/0000-0001-5024-3623; Fischer, Utz/0000-0002-1465-6591; Fischer, Utz/0000-0002-1465-6591; Hennies, Hans C/0000-0001-7210-2389; Nothen, Markus/0000-0002-8770-2464; van Steensel, Maurice/0000-0002-7507-2442	German Excellence Initiative; Alfried Krupp von Bohlen und Halbach-Stiftung; German Research Foundation (DFG) [FI 573/8-1, BE 2346/3, BE 2346/4-1]	German Excellence Initiative; Alfried Krupp von Bohlen und Halbach-Stiftung; German Research Foundation (DFG)(German Research Foundation (DFG))	We would like to thank the families for participating in this study. The technical support by J. Pforr, G. Eversloh, and M. Michels is gratefully acknowledged. The H20 antibody was a generous gift of R. Luhrmann. Constructs for analysis of differential splicing of various genes are a kind gift of Y. Fu and K. Ohno. E.P. was supported by a grant of the German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg. M.M.N. was supported by the Alfried Krupp von Bohlen und Halbach-Stiftung. The work presented here was supported by a DFG grant to U.F. (FI 573/8-1) and an Emmy Noether research grant of the German Research Foundation (DFG) to R.C.B. (BE 2346/3). R.C.B. is a recipient of a Heisenberg Professorship of the DFG (BE 2346/4-1).	Chakarova CF, 2002, HUM MOL GENET, V11, P87, DOI 10.1093/hmg/11.1.87; HERMANN H, 1995, EMBO J, V14, P2076, DOI 10.1002/j.1460-2075.1995.tb07199.x; Just M, 1998, DERMATOLOGY, V196, P339, DOI 10.1159/000017909; Kazantseva A, 2006, SCIENCE, V314, P982, DOI 10.1126/science.1133276; Keen TJ, 2002, EUR J HUM GENET, V10, P245, DOI 10.1038/sj.ejhg.5200797; Kljuic A, 2003, CELL, V113, P249, DOI 10.1016/S0092-8674(03)00273-3; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Levy-Nissenbaum E, 2003, NAT GENET, V34, P151, DOI 10.1038/ng1163; Linder B, 2011, HUM MOL GENET, V20, P368, DOI 10.1093/hmg/ddq473; McKie AB, 2001, HUM MOL GENET, V10, P1555, DOI 10.1093/hmg/10.15.1555; NEISWANGER K, 1990, GENOMICS, V7, P503, DOI 10.1016/0888-7543(90)90192-W; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; PATTEN JL, 1990, NEW ENGL J MED, V322, P1412, DOI 10.1056/NEJM199005173222002; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; Shimomura Y, 2010, NATURE, V464, P1043, DOI 10.1038/nature08875; Vithana EN, 2003, INVEST OPHTH VIS SCI, V44, P4204, DOI 10.1167/iovs.03-0253; Wang CP, 2012, ORAL ONCOL, V48, P125, DOI 10.1016/j.oraloncology.2011.08.025; Weiss J, 2012, MAMM GENOME, V23, P346, DOI 10.1007/s00335-011-9388-5; Zhao C, 2009, AM J HUM GENET, V85, P617, DOI 10.1016/j.ajhg.2009.09.020; Zhou C, 2011, HUM MUTAT, V32, P710, DOI 10.1002/humu.21503	21	29	33	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN 10	2013	92	1					81	87		10.1016/j.ajhg.2012.10.022	http://dx.doi.org/10.1016/j.ajhg.2012.10.022			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	073RA	23246290	Bronze, Green Published			2022-12-18	WOS:000313759000008
J	Kiuru, M; Kurban, M; Itoh, M; Petukhova, L; Shimomura, Y; Wajid, M; Christiano, AM				Kiuru, Maija; Kurban, Mazen; Itoh, Munenari; Petukhova, Lynn; Shimomura, Yutaka; Wajid, Muhammad; Christiano, Angela M.			Hereditary Leukonychia, or Porcelain Nails, Resulting from Mutations in PLCD1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EPIDERMOLYSIS-BULLOSA SIMPLEX; MULTIPLE SEBACEOUS CYSTS; KNUCKLE PADS; TOTALIS; EXPRESSION; DOMINANT; DEAFNESS; GENES; FOXN1	Hereditary leukonychia (porcelain nails or white nails) is a rare nail disorder with an unknown genetic basis. To identify variants in a gene underlying this phenotype, we identified four families of Pakistani origin showing features of hereditary leukonychia. All 20 nails of each affected individual were chalky and white in appearance, consistent with total leukonychia, with no other cutaneous, appendageal, or systemic findings. By using Affymetrix 10K chip, we established linkage to chromosome 3p21.3-p22 with a LOD score (Z) of 5.1. We identified pathogenic mutations in PLCD1 in all four families, which encodes phosphoinositide-specific phospholipase C delta 1 subunit, a key enzyme in phosphoinositide metabolism. We then identified localization of PLCD1 in the nail matrix. It was recently shown that PLCD1 is a component of the human nail plate by proteomic analysis and is localized in the matrix of human nails. Furthermore, mutations detected in PLCD1 resulted in reduced enzymatic activity in vitro. Our data show that mutations in PLCD1 underlie hereditary leukonychia, revealing a gene involved in molecular control of nail growth.	[Kiuru, Maija; Kurban, Mazen; Itoh, Munenari; Petukhova, Lynn; Shimomura, Yutaka; Wajid, Muhammad; Christiano, Angela M.] Columbia Univ, Dept Dermatol, New York, NY 10032 USA; [Christiano, Angela M.] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA	Columbia University; Columbia University	Christiano, AM (corresponding author), Columbia Univ, Dept Dermatol, New York, NY 10032 USA.	amc65@columbia.edu	Petukhova, Lynn/W-6858-2019; Wajid, Muhammad/F-5087-2015	Kiuru, Maija/0000-0002-7010-5516; Itoh, Munenari/0000-0003-3640-6355	USPHS/NIH from NIAMS [RO1AR44924]; skin Disease Research Center at Columbia University [P30AR44535]; NIH [T32AR007605]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007605, P30AR044535, R01AR044924] Funding Source: NIH RePORTER	USPHS/NIH from NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)United States Public Health Service); skin Disease Research Center at Columbia University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to the family members for their participation in this study. We would like to thank Dr. Robert H. Rice for his valuable discussion, comments, and ideas and H. Lam and M. Zhang for technical assistance. We appreciate the collaboration with K. Fantauzzo, C. Higgins, K. Inoue, and other members of the A.M.C. laboratory. Supported in part by USPHS/NIH grant RO1AR44924 from NIAMS (to A.M.C.) and the skin Disease Research Center at Columbia University (P30AR44535). M.K. was a trainee on NIH Institutional Research Training Grant T32AR007605 (P.I. D. Bickers, Department of Dermatology, Columbia University).	ALBRIGHT SD, 1964, ARCH DERMATOL, V90, P392, DOI 10.1001/archderm.1964.01600040020003; BART RS, 1967, NEW ENGL J MED, V276, P202, DOI 10.1056/NEJM196701262760403; BASARAN E, 1995, BRIT J DERMATOL, V133, P636, DOI 10.1111/j.1365-2133.1995.tb02720.x; Bergmann C, 2006, AM J HUM GENET, V79, P1105, DOI 10.1086/509789; BUSHKELL LL, 1975, ARCH DERMATOL, V111, P899, DOI 10.1001/archderm.111.7.899; CROSBY EF, 1976, JOHNS HOPKINS MED J, V139, P90; GALADARI I, 1993, INT J DERMATOL, V32, P524, DOI 10.1111/j.1365-4362.1993.tb02841.x; GIUSTINA TA, 1985, CUTIS, V35, P533; GROSSMAN M, 1990, INT J DERMATOL, V29, P535, DOI 10.1111/j.1365-4362.1990.tb03463.x; Has C, 2006, J INVEST DERMATOL, V126, P1912, DOI 10.1038/sj.jid.5700312; Hu XY, 2009, NUCLEOS NUCLEOT NUCL, V28, P1, DOI 10.1080/15257770802581633; JUHLIN L, 1963, ACTA DERM-VENEREOL, V43, P136; Le Corre Y, 2009, EUR J MED GENET, V52, P229, DOI 10.1016/j.ejmg.2009.04.003; Lee YB, 2011, INT J DERMATOL, V50, P233, DOI 10.1111/j.1365-4632.2010.04306.x; Mecklenburg L, 2004, J INVEST DERMATOL, V123, P1001, DOI 10.1111/j.0022-202X.2004.23442.x; Morello R, 2001, NAT GENET, V27, P205, DOI 10.1038/84853; Nakamura Y, 2003, EMBO J, V22, P2981, DOI 10.1093/emboj/cdg302; Nakamura Y, 2008, FASEB J, V22, P841, DOI 10.1096/fj.07-9239com; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Norgett EE, 2004, BRIT J DERMATOL, V151, P65, DOI 10.1111/j.1365-2133.2004.05994.x; PAUS R, 2007, DERMATOLOGY, P965; Rice RH, 2010, J PROTEOME RES, V9, P6752, DOI 10.1021/pr1009349; Sambrook J, 1989, MOL CLONING LAB MANU; Slee JJ, 1997, CLIN DYSMORPHOL, V6, P229, DOI 10.1097/00019605-199707000-00005; Smirnov DA, 2008, AM J HUM GENET, V83, P243, DOI 10.1016/j.ajhg.2008.07.003; Stevens KR, 1998, J AM ACAD DERMATOL, V39, P509, DOI 10.1016/S0190-9622(98)70341-X; Stewart AJ, 2005, INT J MOL MED, V15, P117; Terrinoni A, 2001, J INVEST DERMATOL, V117, P1391, DOI 10.1046/j.0022-202x.2001.01565.x; Xiang TX, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.5.12726; Yasukawa K, 2002, J BIOL CHEM, V277, P23670, DOI 10.1074/jbc.M200974200	31	29	31	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN 10	2011	88	6					839	844		10.1016/j.ajhg.2011.05.014	http://dx.doi.org/10.1016/j.ajhg.2011.05.014			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	779HK	21665001	Green Published, Bronze			2022-12-18	WOS:000291768500016
J	Gigarel, N; Hesters, L; Samuels, DC; Monnot, S; Burlet, P; Kerbrat, V; Lamazou, F; Benachi, A; Frydman, R; Feingold, J; Rotig, A; Munnich, A; Bonnefont, JP; Frydman, N; Steffann, J				Gigarel, Nadine; Hesters, Laetitia; Samuels, David C.; Monnot, Sophie; Burlet, Philippe; Kerbrat, Violaine; Lamazou, Frederic; Benachi, Alexandra; Frydman, Rene; Feingold, Josue; Rotig, Agnes; Munnich, Arnold; Bonnefont, Jean-Paul; Frydman, Nelly; Steffann, Julie			Poor Correlations in the Levels of Pathogenic Mitochondrial DNA Mutations in Polar Bodies versus Oocytes and Blastomeres in Humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PREIMPLANTATION GENETIC DIAGNOSIS; SINGLE OOCYTES; MTDNA; BOTTLENECK; DISEASE; MOUSE; CELLS; COAMPLIFICATION; QUANTIFICATION; REARRANGEMENTS	Because the mtDNA amount remains stable in the early embryo until uterine implantation, early human development is completely dependent on the mtDNA pool of the mature oocyte. Both quantitative and qualitative mtDNA defects therefore may negatively impact oocyte competence or early embryonic development. However, nothing is known about segregation of mutant and wild-type mtDNA molecules during human meiosis. To investigate this point, we compared the mutant levels in 51 first polar bodies (PBs) and their counterpart (oocytes, blastomeres, or whole embryos), at risk of having (1) the "MELAS" m.3243A > G mutation in MT-TL1 (n = 30), (2) the "MERRF" m.8344A > G mutation in MT-TK (n = 15), and (3) the m.9185T > G mutation located in MT-ATP6 (n = 6). Seven out of 51 of the PBs were mutation free and had homoplasmic wild-type counterparts. In the heteroplasmic PBs, measurement of the mutant load was a rough estimate of the counterpart mutation level (R-2 = 0.52), and high mutant-load differentials between the two populations were occasionally observed (ranging from -34% to +34%). The mutant-load differentials between the PB and its counterpart were higher in highly mutated PBs, suggestive of a selection process acting against highly mutated cells during gametogenesis or early embryonic development. Finally, individual discrepancies in mutant loads between PBs and their counterparts make PB-based preconception diagnosis unreliable for the prevention of mtDNA disorder transmission. Such differences were not observed in animal models, and they emphasize the need to conduct thorough studies on mtDNA segregation in humans.	[Gigarel, Nadine; Monnot, Sophie; Burlet, Philippe; Feingold, Josue; Rotig, Agnes; Munnich, Arnold; Bonnefont, Jean-Paul; Steffann, Julie] Univ Paris 05, Fac Med, Unite INSERM U781, Serv Genet Med,Hop Necker Enfants Malad,AP HP, F-75743 Paris 15, France; [Hesters, Laetitia; Frydman, Nelly] Hop Antoine Beclere, AP HP, Serv Biol & Genet Reprod, Unite INSERM U782, F-92141 Clamart, France; [Kerbrat, Violaine; Lamazou, Frederic; Benachi, Alexandra; Frydman, Rene] Hop Antoine Beclere, AP HP, Serv Gynecol Obstet & Med Reprod, Unite INSERM U782, F-92141 Clamart, France; [Samuels, David C.] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN 37232 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Vanderbilt University	Steffann, J (corresponding author), Univ Paris 05, Fac Med, Unite INSERM U781, Serv Genet Med,Hop Necker Enfants Malad,AP HP, 149 Rue Sevres, F-75743 Paris 15, France.	julie.steffann@inserm.fr	monnot, sophie/H-6152-2017; Rötig, Agnès/G-9592-2017; Steffann, Julie/I-2820-2017; Samuels, David/AHC-8381-2022; Samuels, David C/A-5393-2008	monnot, sophie/0000-0002-1872-8089; Rötig, Agnès/0000-0003-0589-0703; Steffann, Julie/0000-0001-9493-3239; Samuels, David/0000-0003-3529-7791; Samuels, David C/0000-0003-3529-7791; Achour Frydman, Nelly/0000-0002-9027-0586; BONNEFONT, Jean-Paul/0000-0002-4235-1197	l'Association Francaise contre les Myopathies; Agence de la Biomedecine	l'Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Agence de la Biomedecine	This work was funded in part by a grant from l'Association Francaise contre les Myopathies (to S.M.) and by the Agence de la Biomedecine.	Barritt JA, 1999, MOL HUM REPROD, V5, P927, DOI 10.1093/molehr/5.10.927; Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453; Briggs DA, 2000, LANCET, V355, P1520, DOI 10.1016/S0140-6736(00)02171-1; Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190; Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970; Cao LQ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000756; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; CUI XF, 1989, P NATL ACAD SCI USA, V86, P9389, DOI 10.1073/pnas.86.23.9389; Dean NL, 2003, MOL HUM REPROD, V9, P631, DOI 10.1093/molehr/gag077; Emmerson CF, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.2.e1; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; Fiorentino F, 2008, PRENATAL DIAG, V28, P62, DOI 10.1002/pd.1905; Gigarel N, 2005, MOL GENET METAB, V84, P289, DOI 10.1016/j.ymgme.2004.10.008; Gigarel N, 2004, HUM GENET, V114, P298, DOI 10.1007/s00439-003-1063-9; Hsieh RH, 2002, FERTIL STERIL, V77, P1012, DOI 10.1016/S0015-0282(02)02994-1; Marchington D, 2010, J MED GENET, V47, P257, DOI 10.1136/jmg.2009.072900; Marchington DR, 1997, AM J HUM GENET, V60, P408; May-Panloup P, 2005, HUM REPROD, V20, P593, DOI 10.1093/humrep/deh667; McConnell JML, 2004, REPROD BIOMED ONLINE, V9, P418, DOI 10.1016/S1472-6483(10)61277-1; Monnot S, 2011, HUM MUTAT, V32, P116, DOI 10.1002/humu.21417; Parfait B, 1998, BIOCHEM BIOPH RES CO, V247, P57, DOI 10.1006/bbrc.1998.8666; Poulton J, 2010, NEUROMUSCULAR DISORD, V20, P559, DOI 10.1016/j.nmd.2010.05.008; Reynier P, 2001, MOL HUM REPROD, V7, P425, DOI 10.1093/molehr/7.5.425; Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102; St John JC, 2010, HUM REPROD UPDATE, V16, P488, DOI 10.1093/humupd/dmq002; Steffann J, 2007, J MED GENET, V44, P664, DOI 10.1136/jmg.2006.048553; Steuerwald N, 2000, ZYGOTE, V8, P209, DOI 10.1017/S0967199400001003; Van Blerkom J, 2002, HUM REPROD, V17, P393, DOI 10.1093/humrep/17.2.393; Verlinsky Y, 1997, BIOCHEM MOL MED, V62, P182, DOI 10.1006/bmme.1997.2635; Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; White HE, 2005, GENET TEST, V9, P190, DOI 10.1089/gte.2005.9.190	32	29	30	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR 8	2011	88	4					494	498		10.1016/j.ajhg.2011.03.010	http://dx.doi.org/10.1016/j.ajhg.2011.03.010			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	752BY	21473984	Green Published, Bronze			2022-12-18	WOS:000289664300010
J	Siddiqui, RA; Sauermann, U; Altmuller, J; Fritzer, E; Nothnagel, M; Dalibor, N; Fellay, J; Kaup, FJ; Stahl-Hennig, C; Nurnberg, P; Krawczak, M; Platzer, M				Siddiqui, Roman A.; Sauermann, Ulrike; Altmueller, Janine; Fritzer, Elfriede; Nothnagel, Michael; Dalibor, Nina; Fellay, Jacques; Kaup, Franz-Josef; Stahl-Hennig, Christiane; Nuernberg, Peter; Krawczak, Michael; Platzer, Matthias			X Chromosomal Variation Is Associated with Slow Progression to AIDS in HIV-1-Infected Women	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; ACTIVE ANTIRETROVIRAL THERAPY; WHOLE-GENOME ASSOCIATION; SIMIAN IMMUNODEFICIENCY; DISEASE PROGRESSION; GENDER-DIFFERENCES; RNA LEVELS; HIV-1 INFECTION; GENE-EXPRESSION; SEX-DIFFERENCES	AIDS has changed from a mostly male-specific health problem to one that predominantly affects females. Although sex differences in HIV-1 susceptibility are beyond doubt, the extent to which sex affects the onset and progression of AIDS has remained elusive. Here, we provide evidence for an influence of X chromosomal variation on the course of retroviral infection, both in HIV-1-infected patients and in the rhesus macaque model of AIDS. A two-stage, Microsatellite-based GWAS of SIV-infected monkeys revealed MHC class I markers and a hitherto-unknown X chromosomal locus as being associated with a nominal score measuring progression to AIDS (Fisher's exact p < 10(-6)). The X chromosomal association was subsequently confirmed in HIV-1-infected patients with published SNP genotype data. SNP rs5968255, located at human Xq21.1 in a conserved sequence element near the RPS6KA6 and CYLC1 genes, was identified as a significant genetic determinant of disease progression in females (ANOVA p = 8.8 x 10(-5)), but not in males (p = 0.19). Heterozygous female carriers of the C allele showed significantly slower CD4 cell decline and a lower viral load at set point than 17 homozygous females and than males. Inspection of HapMap revealed that the CT genotype is significantly more frequent among Asians than among Europeans or Africans. Our results suggest that, in addition to the individual innate and adaptive immunity status, sex-linked genetic variation impacts upon the rate of progression to AIDS. Elucidating the mechanisms underlying this sex-specific effect will promote the development of antiretroviral therapies with high efficacy in both sexes.	[Siddiqui, Roman A.; Platzer, Matthias] Leibniz Inst Age Res Fritz Lipmann Inst, D-07745 Jena, Germany; [Sauermann, Ulrike; Kaup, Franz-Josef; Stahl-Hennig, Christiane] Leibniz Inst Primate Res, German Primate Ctr, D-37077 Gottingen, Germany; [Altmueller, Janine; Dalibor, Nina; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50674 Cologne, Germany; [Fritzer, Elfriede; Nothnagel, Michael; Krawczak, Michael] Univ Kiel, Inst Med Informat & Stat, D-24105 Kiel, Germany; [Fellay, Jacques] Duke Univ, Duke Inst Genome Sci & Policy, Ctr Human Genome Variat, Durhani, NC 27710 USA; [Nuernberg, Peter] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Nuernberg, Peter] Univ Cologne, CECAD, D-50674 Cologne, Germany	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Deutsches Primatenzentrum (DPZ); University of Cologne; University of Kiel; Duke University; University of Cologne; University of Cologne	Siddiqui, RA (corresponding author), Leibniz Inst Age Res Fritz Lipmann Inst, Beutenbergstr 11, D-07745 Jena, Germany.	rsidd@fli-leibniz.de	Krawczak, Michael/A-8964-2010; Nothnagel, Michael/L-7187-2019; Fellay, Jacques/A-6681-2009; Nothnagel, Michael/G-6545-2014; Nothnagel, Michael/A-7759-2011; Nothnagel, Michael/H-6887-2012	Krawczak, Michael/0000-0003-2603-1502; Nothnagel, Michael/0000-0001-8305-7114; Fellay, Jacques/0000-0002-8240-939X; Altmuller, Janine/0000-0003-4372-1521	German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN) [0313360]	German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN)(Federal Ministry of Education & Research (BMBF))	This Study was supported by the German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN), grant 0313360. We gratefully acknowledge the genotype access provided to us by the CHAVI consortium and the help of David B. Goldstein, Dongliang Ge, and AmalioTelenti. We thank I-IolgerThiele for retrieving inicrosatellites from the Mactica mulatta genome, Ivonne Heinze, Nicole Leuchte and Heidi Meyer for expert technical assistance, and Monika Franz for Continuous support of the animal experiments. There are no financial conflicts of interest that might be construed to influence the results or interpretation of our manuscript.	Ahmed RKS, 2005, MOL IMMUNOL, V42, P251, DOI 10.1016/j.molimm.2004.06.027; AMADORI A, 1995, NAT MED, V1, P1279, DOI 10.1038/nm1295-1279; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Carriere A, 2008, FRONT BIOSCI-LANDMRK, V13, P4258, DOI 10.2741/3003; Catano G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003636; Collazos J, 2007, AIDS, V21, P835, DOI 10.1097/QAD.0b013e3280b0774a; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Dummler BA, 2005, J BIOL CHEM, V280, P13304, DOI 10.1074/jbc.M408194200; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Foca M, 2006, PEDIATRICS, V118, P146, DOI 10.1542/peds.2005-0294; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Ge DL, 2008, GENOME RES, V18, P640, DOI 10.1101/gr.071571.107; Hirsch VM, 2004, J VIROL, V78, P275, DOI 10.1128/JVI.78.1.275-284.2004; HOLM S, 1979, SCAND J STAT, V6, P65; Jarrin I, 2008, AM J EPIDEMIOL, V168, P532, DOI 10.1093/aje/kwn179; Jiang GC, 2007, J VIROL, V81, P10914, DOI 10.1128/JVI.01208-07; Knudsen PS, 2007, CYTOGENET GENOME RES, V116, P24, DOI 10.1159/000097414; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Korenromp EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005950; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Limou S, 2009, J INFECT DIS, V199, P419, DOI 10.1086/596067; Lu TS, 2008, J IMMUNOL, V181, P6406, DOI 10.4049/jimmunol.181.9.6406; LYON MF, 1974, NATURE, V250, P651, DOI 10.1038/250651a0; Madkan VK, 2006, ARCH DERMATOL, V142, P365, DOI 10.1001/archderm.142.3.365; Martin MP, 2005, CURR OPIN IMMUNOL, V17, P510, DOI 10.1016/j.coi.2005.07.012; Mofenson LM, 1999, AIDS, V13, P31, DOI 10.1097/00002030-199901140-00005; Morgan C, 2008, PLOS MED, V5, P1200, DOI 10.1371/journal.pmed.0050173; Muhl T, 2002, J IMMUNOL, V169, P3438, DOI 10.4049/jimmunol.169.6.3438; Napravnik S, 2002, JAIDS-J ACQ IMM DEF, V31, P11, DOI 10.1097/00126334-200209010-00002; Nicastri E, 2005, AIDS, V19, P577, DOI 10.1097/01.aids.0000163934.22273.06; Nicastri E, 2007, J ANTIMICROB CHEMOTH, V60, P724, DOI 10.1093/jac/dkm302; O'Brien SJ, 2004, NAT GENET, V36, P565, DOI 10.1038/ng1369; O'Connor DH, 2003, J VIROL, V77, P9029, DOI 10.1128/JVI.77.16.9029-9040.2003; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Pal R, 2002, J VIROL, V76, P292, DOI 10.1128/JVI.76.1.292-302.2002; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Quinn TC, 2005, SCIENCE, V308, P1582, DOI 10.1126/science.1112489; Rogers J, 2006, GENOMICS, V87, P30, DOI 10.1016/j.ygeno.2005.10.004; Sauermann U, 2008, GENES IMMUN, V9, P69, DOI 10.1038/sj.gene.6364448; Sauermann U, 2000, J INFECT DIS, V182, P716, DOI 10.1086/315800; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Squires KE, 2007, GENDER MED, V4, P294, DOI 10.1016/S1550-8579(07)80060-X; Squires Kathleen E, 2003, AIDS Read, V13, P228; Sterling TR, 2001, NEW ENGL J MED, V344, P720, DOI 10.1056/NEJM200103083441003; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Szafranski K, 2006, BIOINFORMATICS, V22, P1917, DOI 10.1093/bioinformatics/btl277; Team RC., 2022, R LANG ENV STAT COMP; Thakur A, 2008, CLIN CANCER RES, V14, P4427, DOI 10.1158/1078-0432.CCR-08-0458; van Manen D, 2009, AIDS, V23, P19, DOI 10.1097/QAD.0b013e32831db247; Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047; Watkins DI, 2008, NAT MED, V14, P617, DOI 10.1038/nm.f.1759; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Zheng JY, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-79; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	63	29	32	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 14	2009	85	2					228	239		10.1016/j.ajhg.2009.07.013	http://dx.doi.org/10.1016/j.ajhg.2009.07.013			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488EV	19679225	Green Published, Bronze			2022-12-18	WOS:000269332900011
J	Gitschier, J				Gitschier, Jane			Inferential Genotyping of Y Chromosomes in Latter-Day Saints Founders and Comparison to Utah Samples in the HapMap Project	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE MAPS; MARKERS; SCIENCE; ETHICS; LOCI	One concern in human genetics research is maintaining the privacy of study participants. The growth in genealogical registries may contribute to loss of privacy, given that genotypic information is accessible online to facilitate discovery of genetic relationships. Through iterative use of two such web archives, FamilySearch and Sorenson Molecular Genealogy Foundation, I was able to discern the likely haplotypes for the Y chromosomes of two men, Joseph Smith and Brigham Young, who were instrumental in the founding of the Latter-Day Saints Church. I then determined whether any of the Utahns who contributed to the HapMap project (the "CEU" set) is related to either man, on the basis of haplotype analysis of the Y chromosome. Although none of the CEU contributors appear to be a male-line relative, I discovered that predictions Could be made for the surnames of the CEU participants by a similar process. For 20 of the 30 unrelated CEU samples, at least one exact match was revealed, and for 17 of these, a potential ancestor from Utah or a neighboring state could be identified. For the remaining ten samples, a match was nearly perfect, typically deviating by only one marker repeat unit. The same query performed in two other large databases revealed fewer individual matches and helped to clarify which surname predictions are more likely to be correct. Because large data sets of genotypes from both consenting research subjects and individuals pursuing genetic genealogy will be accessible online, this type of triangulation between databases may compromise the privacy of research subjects.	[Gitschier, Jane] Univ Calif San Francisco, Dept Med & Pediat, San Francisco, CA 94143 USA; [Gitschier, Jane] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Gitschier, J (corresponding author), Univ Calif San Francisco, Dept Med & Pediat, San Francisco, CA 94143 USA.	jane.gitschier@ucsf.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Foster MW, 2004, NAT REV GENET, V5, P467, DOI 10.1038/nrg1351; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gusmao L, 2006, FORENSIC SCI INT, V157, P187, DOI 10.1016/j.forsciint.2005.04.002; HE M, 2009, PLOS ONE IN PRESS; Kayser M, 2000, AM J HUM GENET, V66, P1580, DOI 10.1086/302905; Lowrance WW, 2007, SCIENCE, V317, P600, DOI 10.1126/science.1147699; Perego Ugo A., 2005, J MORMON HIST, V31, P42; Prescott SM, 2008, ANNU REV GENOM HUM G, V9, P347, DOI 10.1146/annurev.genom.9.081307.164441; Roewer L, 2000, FORENSIC SCI INT, V114, P31, DOI 10.1016/S0379-0738(00)00287-5; Spurdle AB, 1996, AM J HUM GENET, V59, P1126; WHITE R, 1985, NATURE, V313, P101, DOI 10.1038/313101a0; Zerjal T, 2003, AM J HUM GENET, V72, P717, DOI 10.1086/367774	13	29	31	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB 13	2009	84	2					251	258		10.1016/j.ajhg.2009.01.018	http://dx.doi.org/10.1016/j.ajhg.2009.01.018			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	413NL	19215731	Green Published, Bronze			2022-12-18	WOS:000263799700014
J	Sherman, EA; Strauss, KA; Tortorelli, S; Bennett, MJ; Knerr, I; Morton, DH; Puffenberger, EG				Sherman, Eric A.; Strauss, Kevin A.; Tortorelli, Silvia; Bennett, Michael J.; Knerr, Ina; Morton, D. Holmes; Puffenberger, Erik G.			Genetic Mapping of Glutaric Aciduria, Type 3, to Chromosome 7 and Identification of Mutations in C7orf10	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALPHA-KETOADIPIC ACIDURIA; DEHYDROGENASE-DEFICIENCY; COA OXIDASE; PENNSYLVANIA; DEGRADATION; METABOLISM; EPILEPSY; ACIDEMIA; ERROR; AMISH	While screening Old Order Amish children for glutaric aciduria type 1 (GA1) between 1989 and 1993, we found three healthy children who excreted abnormal quantities of glutaric acid but low 3-hydroxyglutaric acid, a pattern consistent with glutaricaciduria type 3 (GA3) None of these children had the GCDHc.1262C -> T mutation that causes GA1 among the Amish. Using single-nucleotide polymorphism (SNP) genotypes, we identified a shared homozygous 4.7 Mb region on chromosome 7. This region contained 25 genes including C7orf10, an open reading frame with a putative mitochondrial targeting sequence and coenzyme-A transferase domain. Direct sequencing of C7orf10 revealed that the three Amish individuals were homozygous for a nonsynonymous sequence variant (c.895C -> T, Arg299Trp). We then sequenced three non-Amish children with GA3 and discovered two nonsense mutations (c.322C -> T, Arg108Ter, and c.424C -> T, Arg142Ter) in addition to the Amish mutation. Two pathogenicalleles were identified in each of the six patients. There was no consistent clinical phenotype associated with GA3. In affected individuals, urine molar ratios of glutarate to its derivatives (3-hydroxyglutarate, glutarylcarnitine, and glutarylglycine) were elevated, suggesting impaired formation of glutaryl-CoA. These observations refine our understanding of the lysine-tryptophan degradation pathway and have important implications for the pathophysiology of GA1.	[Strauss, Kevin A.; Morton, D. Holmes; Puffenberger, Erik G.] Clin Special Children, Strasburg, PA 17579 USA; [Sherman, Eric A.] Ephrata High Sch, Ephrata, PA 17522 USA; [Strauss, Kevin A.; Morton, D. Holmes; Puffenberger, Erik G.] Franklin & Marshall Coll, Dept Biol, Lancaster, PA 17604 USA; [Strauss, Kevin A.; Morton, D. Holmes] Lancaster Gen Hosp, Lancaster, PA 17604 USA; [Tortorelli, Silvia] Mayo Clin, Sch Med, Dept Lab Med & Pathol, Biochem Genet Lab, Rochester, MN 55905 USA; [Bennett, Michael J.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Bennett, Michael J.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Knerr, Ina] Univ Erlangen Nurnberg, Childrens & Adolescents Hosp, D-91054 Erlangen, Germany	Franklin & Marshall College; Mayo Clinic; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Erlangen Nuremberg	Puffenberger, EG (corresponding author), Clin Special Children, Strasburg, PA 17579 USA.	epuffenberger@clinicforspecialchildren.org	Knerr, Ina/S-5784-2019	Knerr, Ina/0000-0002-4015-0658; Sherman, Erin/0000-0002-1835-8604; Puffenberger, Erik/0000-0002-6388-9148				BENNETT MJ, 1991, J INHERIT METAB DIS, V14, P165, DOI 10.1007/BF01800589; Broman KW, 1999, AM J HUM GENET, V65, P1493, DOI 10.1086/302661; Itoh T, 1996, TOHOKU J EXP MED, V179, P101, DOI 10.1620/tjem.179.101; Knerr I, 2002, J INHERIT METAB DIS, V25, P483, DOI 10.1023/A:1021207419125; MORTON DH, 1991, AM J MED GENET, V41, P89, DOI 10.1002/ajmg.1320410122; PRZYREMBEL H, 1975, CLIN CHIM ACTA, V58, P257, DOI 10.1016/0009-8981(75)90445-3; Puffenberger EG, 2004, P NATL ACAD SCI USA, V101, P11689, DOI 10.1073/pnas.0401194101; Puffenberger EG, 2003, AM J MED GENET C, V121C, P18, DOI 10.1002/ajmg.c.20003; Puffenberger EG, 2007, BRAIN, V130, P1929, DOI 10.1093/brain/awm100; RINALDO P, 2004, TIETZ TXB CLIN CHEM; Sauer SW, 2005, J BIOL CHEM, V280, P21830, DOI 10.1074/jbc.M502845200; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Strauss KA, 2005, AM J MED GENET A, V138A, P262, DOI 10.1002/ajmg.a.30961; Strauss KA, 2007, BRAIN, V130, P1905, DOI 10.1093/brain/awm058; Tortorelli S, 2005, MOL GENET METAB, V84, P137, DOI 10.1016/j.ymgme.2004.09.016; VANVELDHOVEN PP, 1992, J BIOL CHEM, V267, P20065; WANDERS RJA, 1993, J BIOCHEM-TOKYO, V113, P577; WENDEL U, 1975, CLIN CHIM ACTA, V58, P271, DOI 10.1016/0009-8981(75)90446-5; WILSON RW, 1975, PEDIATR RES, V9, P522, DOI 10.1203/00006450-197506000-00002	19	29	32	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2008	83	5					604	609		10.1016/j.ajhg.2008.09.018	http://dx.doi.org/10.1016/j.ajhg.2008.09.018			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	373XN	18926513	Bronze, Green Published			2022-12-18	WOS:000261006900006
J	Wang, J; Shete, S				Wang, Jian; Shete, Sanjay			A test for genetic association that incorporates information about deviation from Hardy-Weinberg proportions in cases	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LUNG-CANCER; PROSTATE-CANCER; RISK MODEL; EQUILIBRIUM; VARIANTS; DISEQUILIBRIUM; POLYMORPHISMS; PREDICTION; ALLELES	For assessment of genetic association between single-nucleotide polymorphisms (SNPs) and disease status, the logistic-regression model or generalized linear model is typically employed. However, testing for deviation from Hardy-Weinberg proportion in a patient group could be another approach for genetic-association studies. The Hardy-Weinberg proportion is one of the most important principles in population genetics. Deviation from Hardy-Weinberg proportion among cases (patients) could provide additional evidence for the association between SNPs and diseases. To develop a more powerful statistical test for genetic-association studies, we combined evidence about deviation from Hardy-Weinberg proportion in case subjects and standard regression approaches that use case and control subjects. In this paper, we propose two approaches for combining such information: the mean-based tail-strength measure and the median-based tail-strength measure. These measures integrate logistic regression and Hardy-Weinberg-proportion tests for the study of the association between a binary disease outcome and an SNP on the basis of case- and control-subject data. For both mean-based and median-based tail-strength measures, we derived exact formulas to compute p values. We also developed an approach for obtaining empirical p values with the use of a resampling procedure. Results from simulation studies and real-disease studies demonstrate that the proposed approach is more powerful than the traditional logistic-regression model. The type I error probabilities of our approach were also well controlled.	[Wang, Jian; Shete, Sanjay] Univ Texas Houston, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Shete, S (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Dept Epidemiol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	sshete@mdanderson.org	Wang, Jian/A-3276-2013					BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cassidy A, 2008, BRIT J CANCER, V98, P270, DOI 10.1038/sj.bjc.6604158; Cheng I, 2007, CANCER EPIDEM BIOMAR, V16, P352, DOI 10.1158/1055-9965.EPI-06-0429; Cheung CL, 2008, HUM HERED, V65, P1, DOI 10.1159/000106057; Czika W, 2004, BIOMETRICS, V60, P69, DOI 10.1111/j.0006-341X.2004.00166.x; David H. A, 1981, ORDER STAT; Engels EA, 2007, CANCER RES, V67, P6520, DOI 10.1158/0008-5472.CAN-07-0370; Escabias M, 2007, COMPUT STAT DATA AN, V51, P4891, DOI 10.1016/j.csda.2006.08.011; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Gomes I, 1999, ANN HUM GENET, V63, P535, DOI 10.1017/S0003480099007824; Graffelman J, 2008, HUM HERED, V65, P77, DOI 10.1159/000108939; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Harber P, 2007, AM J RESP CRIT CARE, V176, P994, DOI 10.1164/rccm.200605-730OC; Hosking L, 2004, EUR J HUM GENET, V12, P395, DOI 10.1038/sj.ejhg.5201164; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jiang R, 2001, ANN HUM GENET, V65, P207, DOI 10.1017/S0003480001008570; Keith SW, 2008, OBESITY, V16, P377, DOI 10.1038/oby.2007.32; Kozyrev SV, 2008, NAT GENET, V40, P211, DOI 10.1038/ng.79; Lethbridge-Cejku M, 2004, VITAL HLTH STAT, V10, P1; Neumann AS, 2005, INT J CANCER, V115, P131, DOI 10.1002/ijc.20888; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; Poynter JN, 2007, CANCER RES, V67, P11128, DOI 10.1158/0008-5472.CAN-07-3239; Ramsey SD, 2006, GENET MED, V8, P571, DOI 10.1097/01.gim.0000237867.34011.12; Ruano-Ravina A, 2004, THORAX, V59, P981, DOI 10.1136/thx.2003.018861; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sellers TA, 2007, AM J EPIDEMIOL, V166, P456, DOI 10.1093/aje/kwm112; SHOPLAND DR, 1991, JNCI-J NATL CANCER I, V83, P1142, DOI 10.1093/jnci/83.16.1142; Spitz MR, 2007, JNCI-J NATL CANCER I, V99, P715, DOI 10.1093/jnci/djk153; Tapper W, 2005, P NATL ACAD SCI USA, V102, P11835, DOI 10.1073/pnas.0505262102; Taylor J, 2006, BIOSTATISTICS, V7, P167, DOI 10.1093/biostatistics/kxj009; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Weir BS, 1996, SINAUER ASS SUNDERL; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wittke-Thompson JK, 2005, AM J HUM GENET, V76, P967, DOI 10.1086/430507	34	29	29	2	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2008	83	1					53	63		10.1016/j.ajhg.2008.06.010	http://dx.doi.org/10.1016/j.ajhg.2008.06.010			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	328FO	18589394	Green Published, Bronze			2022-12-18	WOS:000257784000007
J	Mullin, BH; Prince, RL; Dick, IM; Hart, DJ; Spector, TD; Dudbridge, F; Wilson, SG				Mullin, Ben H.; Prince, Richard L.; Dick, Ian M.; Hart, Deborah J.; Spector, Tim D.; Dudbridge, Frank; Wilson, Scott G.			Identification of a role for the ARHGEF3 gene in postmenopausal osteoporosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BONE-MINERAL DENSITY; QUANTITATIVE TRAIT LOCI; NUCLEOTIDE-EXCHANGE FACTORS; WIDE LINKAGE SCAN; GENOME SCREEN; SUGGESTIVE LINKAGE; RESORPTION CYCLE; RHO-GTPASES; MASS; DETERMINANTS	Osteoporosis is a common and debilitating bone disease characterized by low bone mineral density (BMD), a highly heritable and polygenic trait. Genome-wide linkage studies have identified 3p14-p21 as a quantitative trait locus for BMD. The ARHGEF3 gene is situated within this region and was identified as a strong positional candidate. The aim of this study was to evaluate the role of variation in ARHGEF3 on bone density in women. Sequence variation within ARHGEF3 was analyzed with 17 single-nucleotide polymorphisms (SNPs) in a discovery cohort of 769 female sibs. Significant associations were found with family-based association tests between five SNPs and various measures of age-adjusted BMD (p = 0.0007-0.041) with rs7646054 showing maximal association. Analysis of the data with QPDTPHASE suggested that the more common G allele at rs7646054 is associated with decreased age-adjusted BMD. Significant associations were also demonstrated between 3-SNP haplotypes and age-adjusted spine and femoral-neck BMD (p = 0.002 and 0.003, respectively). rs7646054 was then genotyped in a replication cohort, and significant associations with hip and spine BMD were confirmed (p = 0.003-0.038), as well as an association with fracture rate (p = 0.02). Again, the G allele was associated with a decrease in age-adjusted BMD at each site studied. In conclusion, genetic variation in ARHGEF3 plays a role in the determination of bone density in Caucasian women. This data implicates the RhoGTPase-RhoGEF pathway in osteoporosis.	[Mullin, Ben H.; Prince, Richard L.; Dick, Ian M.; Wilson, Scott G.] Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Nedlands, WA 6009, Australia; [Dick, Ian M.] Sir Charles Gairdner Hosp, Western Australian Inst Med Res, Nedlands, WA 6009, Australia; [Dick, Ian M.; Wilson, Scott G.] Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6009, Australia; [Hart, Deborah J.; Spector, Tim D.; Wilson, Scott G.] Kings Coll London, Twin & Genet Epidemiol Res Unit, London WC2R 2LS, England; [Dudbridge, Frank] Inst Publ Hlth, MRC Biostat Unit, Cambridge CB2 0SR, England	University of Western Australia; University of Western Australia; University of Western Australia; University of London; King's College London; MRC Biostatistics Unit; University of Cambridge	Wilson, SG (corresponding author), Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Nedlands, WA 6009, Australia.	wilsonsg@cyllene.uwa.edu.au	Mullin, Benjamin/H-5493-2014	Mullin, Benjamin/0000-0003-0743-770X; Wilson, Scott/0000-0002-0357-1373	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Arden NK, 1996, BRIT J RHEUMATOL, V35, P1299; Arthur WT, 2002, J BIOL CHEM, V277, P42964, DOI 10.1074/jbc.M207401200; Carter KW, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-60; Chellaiah MA, 2000, J BIOL CHEM, V275, P11993, DOI 10.1074/jbc.275.16.11993; Deng HW, 2002, J CLIN ENDOCR METAB, V87, P5151, DOI 10.1210/jc.2002-020474; Denoyelle C, 2003, BRIT J CANCER, V88, P1631, DOI 10.1038/sj.bjc.6600925; Devoto M, 1998, EUR J HUM GENET, V6, P151, DOI 10.1038/sj.ejhg.5200169; Devoto M, 2001, HUM MOL GENET, V10, P2447, DOI 10.1093/hmg/10.21.2447; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; EVANS RA, 1988, ANN INTERN MED, V109, P870, DOI 10.7326/0003-4819-109-11-870; FLICKER L, 1995, J BONE MINER RES, V10, P1607; Gebhard PM, 2004, FRONT BIOSCI-LANDMRK, V9, P827, DOI 10.2741/1254; HART DJ, 1993, J RHEUMATOL, V20, P331; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; *ILL, 2004, ILL TECHN B PUB; Ioannidis JPA, 2007, J BONE MINER RES, V22, P173, DOI 10.1359/JBMR.060806; JOHNS MB, 1989, ANAL BIOCHEM, V180, P276, DOI 10.1016/0003-2697(89)90430-2; Kammerer CM, 2003, J BONE MINER RES, V18, P2245, DOI 10.1359/jbmr.2003.18.12.2245; KANEHISA J, 1988, BONE, V9, P73, DOI 10.1016/8756-3282(88)90106-8; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Karasik D, 2002, J BONE MINER RES, V17, P1718, DOI 10.1359/jbmr.2002.17.9.1718; Keen RW, 1999, OSTEOPOROSIS INT, V10, P161, DOI 10.1007/s001980050211; Kim HJ, 2006, J CLIN INVEST, V116, P2152, DOI 10.1172/JCI28084; Koller DL, 2000, J CLIN ENDOCR METAB, V85, P3116, DOI 10.1210/jc.85.9.3116; KRALL EA, 1993, J BONE MINER RES, V8, P1; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lakkakorpi PT, 1996, MICROSC RES TECHNIQ, V33, P171, DOI 10.1002/(SICI)1097-0029(19960201)33:2<171::AID-JEMT7>3.0.CO;2-W; LAKKAKORPI PT, 1991, J BONE MINER RES, V6, P817; LAKKAKORPI PT, 1993, J CELL SCI, V104, P663; Mahr S, 2006, AM J HUM GENET, V78, P793, DOI 10.1086/503849; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Meyers VE, 2005, J BONE MINER RES, V20, P1858, DOI 10.1359/JBMR.050611; Michaelsson K, 2005, ARCH INTERN MED, V165, P1825, DOI 10.1001/archinte.165.16.1825; Mullin BH, 2005, CALCIFIED TISSUE INT, V77, P145, DOI 10.1007/s00223-004-0291-x; Orrico A, 2007, AM J MED GENET A, V143A, P58, DOI 10.1002/ajmg.a.31562; POCOCK NA, 1987, J CLIN INVEST, V80, P706, DOI 10.1172/JCI113125; Prince RL, 1997, OSTEOPOROSIS INT, V7, P150, DOI 10.1007/BF03194362; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Ralston SH, 2005, HUM MOL GENET, V14, P943, DOI 10.1093/hmg/ddi088; Reszka AA, 2004, MINI-REV MED CHEM, V4, P711; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Seeman E, 1996, AM J PHYSIOL-ENDOC M, V270, pE320, DOI 10.1152/ajpendo.1996.270.2.E320; Shen H, 2004, J MED GENET, V41, P743, DOI 10.1136/jmg.2004.020396; SMITH DM, 1973, J CLIN INVEST, V52, P2800, DOI 10.1172/JCI107476; Wilson SG, 2003, AM J HUM GENET, V72, P144, DOI 10.1086/345819; Wynne F, 2003, CALCIFIED TISSUE INT, V72, P651, DOI 10.1007/s00223-002-2086-2; YOUNG D, 1995, J BONE MINER RES, V10, P558	51	29	30	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2008	82	6					1262	1269		10.1016/j.ajhg.2008.04.016	http://dx.doi.org/10.1016/j.ajhg.2008.04.016			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	312CP	18499081	Green Published, Bronze			2022-12-18	WOS:000256647000004
J	Gerber, S; Bonneau, D; Gilbert, B; Munnich, A; Dufier, JL; Rozet, JM; Kaplan, J				Gerber, S; Bonneau, D; Gilbert, B; Munnich, A; Dufier, JL; Rozet, JM; Kaplan, J			USH1A: Chronicle of a slow death	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							SYNDROME TYPE-I; USHER-SYNDROME; GENETIC-HETEROGENEITY; HUMAN HOMOLOG; POPULATION; MUTATIONS; CLONING; LOCUS		Hop Necker Enfants Malad, INSERM, U393, Unite Rech Handicaps Genet Enfant, F-75743 Paris 15, France; Hop Necker Enfants Malad, Serv Ophthalmol, F-75743 Paris 15, France; CHU Angers, Gen Med Serv, Angers, France; CHU Poitiers, Gen Med Serv, Poitiers, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Poitiers; Universite de Poitiers	Kaplan, J (corresponding author), Hop Necker Enfants Malad, INSERM, U393, Unite Rech Handicaps Genet Enfant, 149 Rue Sevres, F-75743 Paris 15, France.	kaplan@necker.fr	ROZET, Jean-Michel/E-5737-2016; Bonneau, Dominique/K-6110-2015; KAPLAN, Josseline/I-2622-2017	ROZET, Jean-Michel/0000-0001-7951-7886; GERBER, Sylvie/0000-0002-6827-1769; KAPLAN, Josseline/0000-0002-1849-8658				CABEZAARVELAIZ Y, 1993, DNA CELL BIOL, V12, P881, DOI 10.1089/dna.1993.12.881; Deng Y, 2000, GENOMICS, V63, P133, DOI 10.1006/geno.1999.6045; Edwards MC, 1997, GENETICS, V147, P1063; Eudy JD, 1997, GENOMICS, V43, P104, DOI 10.1006/geno.1997.4779; FISHMAN GA, 1983, ARCH OPHTHALMOL-CHIC, V101, P1367, DOI 10.1001/archopht.1983.01040020369005; Janecke AR, 1999, HUM MUTAT, V13, P133, DOI 10.1002/(SICI)1098-1004(1999)13:2<133::AID-HUMU5>3.0.CO;2-U; KAPLAN J, 1992, GENOMICS, V14, P979, DOI 10.1016/S0888-7543(05)80120-X; Keats BJB, 2004, AM J MED GENET A, V130A, P13, DOI 10.1002/ajmg.a.30052; KIMBERLING WJ, 1992, GENOMICS, V14, P988, DOI 10.1016/S0888-7543(05)80121-1; Lanford PJ, 1999, NAT GENET, V21, P289, DOI 10.1038/6804; LARGETPIET D, 1994, GENOMICS, V21, P138, DOI 10.1006/geno.1994.1235; Oda T, 1997, GENOMICS, V43, P376, DOI 10.1006/geno.1997.4820; Ouyang XM, 2005, HUM GENET, V116, P292, DOI 10.1007/s00439-004-1227-2; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Woods MO, 1999, GENOMICS, V55, P2, DOI 10.1006/geno.1998.5626	15	29	31	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2006	78	2					357	359		10.1086/500275	http://dx.doi.org/10.1086/500275			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	031ZY	16400615	Green Published, Bronze			2022-12-18	WOS:000236744900017
J	Schneider, KU; Sabherwal, N; Jantz, K; Roth, R; Muncke, N; Blum, WF; Cutler, GB; Rappold, G				Schneider, KU; Sabherwal, N; Jantz, K; Roth, R; Muncke, N; Blum, WF; Cutler, GB; Rappold, G			Identification of a major recombination hotspot in patients with short stature and SHOX deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISTAL SHORT ARM; CONTAINING GENE SHOX; LERI-WEILL; PSEUDOAUTOSOMAL REGION; FREQUENT DELETIONS; GROWTH FAILURE; MUTATIONS; DYSCHONDROSTEOSIS; HOMEOBOX; HETEROGENEITY	Human growth is influenced not only by environmental and internal factors but also by a large number of different genes. One of these genes, SHOX, is believed to play a major role in growth, since defects in this homeobox-containing gene on the sex chromosomes lead to syndromal short stature ( Leri- Weill dyschondrosteosis, Langer mesomelic dysplasia, and Turner syndrome) as well as to idiopathic short stature. We have analyzed 118 unrelated patients with Leri- Weill dyschondrosteosis and 11,500 patients with idiopathic short stature for deletions encompassing SHOX. Deletions were detected in 34% of the patients with Leri- Weill dyschondrosteosis and in 2% of the patients with idiopathic short stature. For 27 patients with Leri- Weill dyschondrosteosis and for 6 with idiopathic short stature, detailed deletion mapping was performed. Analysis was performed by polymerase chain reaction with the use of pseudoautosomal polymorphic markers and by fluorescence in situ hybridization with the use of cosmid clones. Here, we show that, although the identified deletions vary in size, the vast majority ( 73%) of patients tested share a distinct proximal deletion breakpoint. We propose that the sequence present within this proximal deletion breakpoint " hotspot" region predisposes to recurrent breaks.	Heidelberg Univ, Inst Human Genet, D-69120 Heidelberg, Germany; Eli Lilly & Co, Lilly Res Labs, Bad Homburg, Germany; Univ Childrens Hosp, Giessen, Germany; Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA	Ruprecht Karls University Heidelberg; Eli Lilly; Lilly Deutschland GmbH; University of Hamburg; University Medical Center Hamburg-Eppendorf; Eli Lilly	Rappold, G (corresponding author), Heidelberg Univ, Inst Human Genet, Im Neuenheimer Feld 366, D-69120 Heidelberg, Germany.	gudrun_rappold@med.uni-heidelberg.de						Antonarakis SE, 2000, EUR J PEDIATR, V159, pS173, DOI 10.1007/PL00014395; BALLABIO A, 1989, P NATL ACAD SCI USA, V86, P10001, DOI 10.1073/pnas.86.24.10001; Belin V, 1998, NAT GENET, V19, P67, DOI 10.1038/ng0198-67; Binder G, 2003, J CLIN ENDOCR METAB, V88, P4891, DOI 10.1210/jc.2003-030136; Blaschke RJ, 2000, TRENDS ENDOCRIN MET, V11, P227, DOI 10.1016/S1043-2760(00)00262-9; BLONDEN LAJ, 1989, NUCLEIC ACIDS RES, V17, P5611, DOI 10.1093/nar/17.14.5611; Bogdanovich S, 2004, J MOL MED, V82, P102, DOI 10.1007/s00109-003-0484-1; Cooper DN, 1998, NUCLEIC ACIDS RES, V26, P285, DOI 10.1093/nar/26.1.285; Cormier-Daire V, 1999, ACTA PAEDIATR, V88, P55, DOI 10.1111/j.1651-2227.1999.tb14404.x; Cormier-Daire V, 2001, AM J MED GENET, V106, P272, DOI 10.1002/ajmg.10228; Ellison JW, 1997, HUM MOL GENET, V6, P1341, DOI 10.1093/hmg/6.8.1341; Falcinelli C, 2002, J Med Genet, V39, pE33, DOI 10.1136/jmg.39.6.e33; Flanagan SF, 2002, J MED GENET, V39, P758, DOI 10.1136/jmg.39.10.758; Grigelioniene G, 2001, HUM GENET, V109, P551, DOI 10.1007/s00439-001-0609-y; Grigelioniene G, 2000, HUM GENET, V107, P145, DOI 10.1007/s004390000352; Hernandez-Martin A, 1999, BRIT J DERMATOL, V141, P617; Huber C, 2001, J MED GENET, V38, P323, DOI 10.1136/jmg.38.5.323; Klein S, 1996, NAT GENET, V13, P481, DOI 10.1038/ng0896-481; KLINK A, 1993, HUM MOL GENET, V2, P339, DOI 10.1093/hmg/2.3.339-a; LI XM, 1992, NUCLEIC ACIDS RES, V20, P1117, DOI 10.1093/nar/20.5.1117; LICHTER P, 1992, HUMAN CYTOGENETICS P; May CA, 2002, NAT GENET, V31, P272, DOI 10.1038/ng918; Morizio E, 2003, AM J MED GENET A, V119A, P293, DOI 10.1002/ajmg.a.20198; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Rao E, 1997, HUM GENET, V100, P236, DOI 10.1007/s004390050497; Rao E, 1997, NAT GENET, V16, P54, DOI 10.1038/ng0597-54; RAPPOLD GA, 1994, HUM MOL GENET, V3, P1337, DOI 10.1093/hmg/3.8.1337; Rappold GA, 2002, J CLIN ENDOCR METAB, V87, P1402, DOI 10.1210/jc.87.3.1402; Ross JL, 2001, J CLIN ENDOCR METAB, V86, P5674, DOI 10.1210/jc.86.12.5674; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Schiller S, 2000, EUR J HUM GENET, V8, P54, DOI 10.1038/sj.ejhg.5200402; SHAPIRO LJ, 1989, P NATL ACAD SCI USA, V86, P8477, DOI 10.1073/pnas.86.21.8477; Shears DJ, 1998, NAT GENET, V19, P70, DOI 10.1038/ng0198-70; Spranger S, 1999, AM J MED GENET, V83, P367, DOI 10.1002/(SICI)1096-8628(19990423)83:5<367::AID-AJMG5>3.0.CO;2-K; WAPENAAR MC, 1992, GENOMICS, V13, P167, DOI 10.1016/0888-7543(92)90217-G; YEN PH, 1990, CELL, V61, P603, DOI 10.1016/0092-8674(90)90472-Q; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	37	29	29	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2005	77	1					89	96		10.1086/431655	http://dx.doi.org/10.1086/431655			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	935PP	15931595	Bronze, Green Published			2022-12-18	WOS:000229794500008
J	Yingling, J; Toyo-oka, K; Wynshaw-Boris, A				Yingling, J; Toyo-oka, K; Wynshaw-Boris, A			Miller-Dieker syndrome: Analysis of a human contiguous gene syndrome in the mouse	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							TUMOR-SUPPRESSOR GENE; PHOSPHATIDYLINOSITOL TRANSFER PROTEINS; NF-KAPPA-B; PIGMENT EPITHELIUM; NEURONAL MIGRATION; CYTOPLASMIC DYNEIN; LISSENCEPHALY GENE; CHROMOSOME 17P13.3; ASPERGILLUS-NIDULANS; CORTICAL DEVELOPMENT		Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Wynshaw-Boris, A (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA.		Toyooka, Kazuhito/AAH-7175-2019; Toyooka, Kazuhito/AAQ-6928-2020	Toyooka, Kazuhito/0000-0002-0173-0430; Toyooka, Kazuhito/0000-0002-0173-0430				Adachi H, 2002, J BIOL CHEM, V277, P24014, DOI 10.1074/jbc.M201854200; ALB JGJ, 2003, J BIOL CHEM     0604; Araki T, 1998, J NEUROSCI RES, V53, P7, DOI 10.1002/(SICI)1097-4547(19980701)53:1<7::AID-JNR2>3.3.CO;2-H; Baldini A, 2002, HUM MOL GENET, V11, P2363, DOI 10.1093/hmg/11.20.2363; Broadie K, 1997, NEURON, V19, P391, DOI 10.1016/S0896-6273(00)80948-4; Cahana A, 2001, P NATL ACAD SCI USA, V98, P6429, DOI 10.1073/pnas.101122598; Cardoso C, 2003, AM J HUM GENET, V72, P918, DOI 10.1086/374320; Cardoso C, 2000, HUM MOL GENET, V9, P3019, DOI 10.1093/hmg/9.20.3019; Carter MG, 2000, HUM MOL GENET, V9, P413, DOI 10.1093/hmg/9.3.413; Chang HC, 1997, GENE DEV, V11, P1132, DOI 10.1101/gad.11.9.1132; Chen WY, 2003, NAT GENET, V33, P197, DOI 10.1038/ng1077; Chong SS, 1997, HUM MOL GENET, V6, P147, DOI 10.1093/hmg/6.2.147; CHUANG TH, 1995, P NATL ACAD SCI USA, V92, P10282, DOI 10.1073/pnas.92.22.10282; Cockcroft S, 2001, SEMIN CELL DEV BIOL, V12, P183, DOI 10.1006/scdb.2000.0235; Cockcroft S, 1999, CHEM PHYS LIPIDS, V98, P23, DOI 10.1016/S0009-3084(99)00015-8; DAVIS A, 1993, BIOESSAYS, V15, P273, DOI 10.1002/bies.950150408; De Miranda J, 2000, GENE, V256, P183, DOI 10.1016/S0378-1119(00)00356-5; Deltour S, 2002, MOL CELL BIOL, V22, P4890, DOI 10.1128/MCB.22.13.4890-4901.2002; DERIJKVANANDEL JF, 1990, DEV MED CHILD NEUROL, V32, P707; DOBYNS WB, 1983, J PEDIATR-US, V102, P552, DOI 10.1016/S0022-3476(83)80183-8; DOBYNS WB, 1991, AM J HUM GENET, V48, P584; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Feller SM, 2001, ONCOGENE, V20, P6348, DOI 10.1038/sj.onc.1204779; Fleck MW, 2000, J NEUROSCI, V20, P2439; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gambello MJ, 2003, J NEUROSCI, V23, P1719; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Grimm C, 1999, HUM MOL GENET, V8, P697, DOI 10.1093/hmg/8.4.697; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Guris DL, 2001, NAT GENET, V27, P293, DOI 10.1038/85855; Hamilton BA, 1997, NEURON, V18, P711, DOI 10.1016/S0896-6273(00)80312-8; HATTORI M, 1994, NATURE, V370, P216, DOI 10.1038/370216a0; Hirota K, 2000, BIOCHEM BIOPH RES CO, V274, P177, DOI 10.1006/bbrc.2000.3106; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Houenou LJ, 1999, J COMP NEUROL, V412, P506; Hurlin PJ, 1997, GENE DEV, V11, P44, DOI 10.1101/gad.11.1.44; Ijuin T, 2000, J BIOL CHEM, V275, P10870, DOI 10.1074/jbc.275.15.10870; Issa JPJ, 1997, CANCER RES, V57, P1678; Jablonski MM, 2001, GLIA, V35, P14, DOI 10.1002/glia.1066; Jelinek T, 1996, MOL CELL BIOL, V16, P1027; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Kaartinen V, 2002, DEV DYNAM, V223, P517, DOI 10.1002/dvdy.10071; Kaartinen V, 2001, DEVELOPMENT, V128, P4217; Kerner B, 1999, AM J MED GENET, V87, P440, DOI 10.1002/(SICI)1096-8628(19991222)87:5<440::AID-AJMG14>3.3.CO;2-R; Korteweg N, 2000, EUR J NEUROSCI, V12, P165, DOI 10.1046/j.1460-9568.2000.00898.x; Kuhn AN, 2002, P NATL ACAD SCI USA, V99, P9145, DOI 10.1073/pnas.102304299; LEDBETTER SA, 1992, AM J HUM GENET, V50, P182; Liu GZ, 2000, INT J CANCER, V88, P356; Liu YC, 1996, J BIOL CHEM, V271, P14591, DOI 10.1074/jbc.271.24.14591; Liu Z, 1999, DEVELOPMENT, V126, P4477; MCCONNELL JE, 1995, DEV BIOL, V169, P218, DOI 10.1006/dbio.1995.1139; Melki JR, 1999, LEUKEMIA, V13, P877, DOI 10.1038/sj.leu.2401401; Moore B.W., 1967, PHYSL BIOCH ASPECTS, P343; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Paylor R, 1999, LEARN MEMORY, V6, P521, DOI 10.1101/lm.6.5.521; Phillips NJ, 1996, CANCER LETT, V102, P85, DOI 10.1016/0304-3835(96)04169-9; Prowse AH, 2002, INT J CANCER, V99, P185, DOI 10.1002/ijc.10334; Queva C, 1999, CELL GROWTH DIFFER, V10, P785; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Schultz DC, 1996, CANCER RES, V56, P1997; SCHWARTZ CE, 1988, AM J HUM GENET, V43, P597; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; Skoulakis EMC, 1998, MOL NEUROBIOL, V16, P269, DOI 10.1007/BF02741386; Skowron JF, 1999, J EXP ZOOL, V283, P242, DOI 10.1002/(SICI)1097-010X(19990215)283:3<242::AID-JEZ3>3.3.CO;2-6; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Smith JS, 1999, GENOMICS, V59, P97, DOI 10.1006/geno.1999.5864; Snyder SH, 2000, NEUROCHEM RES, V25, P553, DOI 10.1023/A:1007586314648; Stoffler HE, 1998, J CELL SCI, V111, P2779; TAN EC, 1993, J BIOL CHEM, V268, P27291; Toyo-oka K, 2003, NAT GENET, V34, P274, DOI 10.1038/ng1169; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Umezu K, 1998, GENETICS, V148, P989; Verhage M, 1997, NEURON, V18, P453, DOI 10.1016/S0896-6273(00)81245-3; WATANABE M, 1993, MOL BRAIN RES, V17, P135, DOI 10.1016/0169-328X(93)90082-Z; WEIMAR WR, 1982, BRAIN RES, V251, P357, DOI 10.1016/0006-8993(82)90754-5; Weinstein DE, 1999, DEV BRAIN RES, V116, P29, DOI 10.1016/S0165-3806(99)00072-3; Willins DA, 1997, MOL GEN GENET, V255, P194, DOI 10.1007/s004380050489; Wiper DW, 1998, GYNECOL ONCOL, V71, P77, DOI 10.1006/gyno.1998.5110; Wynshaw-Boris A, 2001, GENE DEV, V15, P639, DOI 10.1101/gad.886801; XIANG X, 1995, MOL BIOL CELL, V6, P297, DOI 10.1091/mbc.6.3.297; Yabe T, 2001, J BIOL CHEM, V276, P43313, DOI 10.1074/jbc.M107831200; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0	83	29	30	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2003	73	3					475	488		10.1086/378096	http://dx.doi.org/10.1086/378096			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	718FG	12905154	Green Published, Bronze			2022-12-18	WOS:000185134000002
J	Etzel, CJ; Guerra, R				Etzel, CJ; Guerra, R			Meta-analysis of genetic-linkage analysis of quantitative-trait loci	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							THRESHOLDS; DISSECTION	Meta-analysis is an important tool in linkage analysis. The pooling of results across primary linkage studies allows greater statistical power to detect quantitative-trait loci (QTLs) and more-precise estimation of their genetic effects and, hence, yields conclusions that are stronger relative to those of individual studies. Previous methods for the meta-analysis of linkage studies have been proposed, and, although some methods address the problem of between-study heterogeneity, most methods still require linkage analysis at the same marker or set of markers across studies, whereas others do not result in an estimate of genetic variance. In this study, we present a meta-analytic procedure to evaluate evidence from several studies that report Haseman-Elston statistics for linkage to a QTL at multiple, possibly distinct, markers on a chromosome. This technique accounts for between-study heterogeneity and estimates both the location of the QTL and the magnitude of the genetic effect more precisely than does an individual study. We also provide standard errors for the genetic effect and for the location (in cM) of the QTL, using a resampling method. The approach can be applied under other conditions, provided that the various studies use the same linkage statistic.	Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; Rice Univ, Dept Stat, Houston, TX 77251 USA	University of Texas System; UTMD Anderson Cancer Center; Rice University	Etzel, CJ (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, Box 189,1515 Holcombe Blvd, Houston, TX 77030 USA.	cetzel@mdanderson.org			NATIONAL CANCER INSTITUTE [R25CA057730] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059506] Funding Source: NIH RePORTER; NCI NIH HHS [R25 CA057730, R25 CA57730] Funding Source: Medline; NHGRI NIH HHS [HG02275, R01 HG002275] Funding Source: Medline; NIEHS NIH HHS [R01 ES009912, ES09912] Funding Source: Medline; NIGMS NIH HHS [R01 GM59506] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allison DB, 1998, GENETICS, V148, P859; Badner JA, 1999, GENET EPIDEMIOL, V17, pS485; Elston RC, 2000, GENET EPIDEMIOL, V19, P1, DOI 10.1002/1098-2272(200007)19:1<1::AID-GEPI1>3.0.CO;2-E; Etzel CJ, 2001, GENET EPIDEMIOL, V21, pS97, DOI 10.1002/gepi.2001.21.s1.s97; FEINGOLD E, 1993, AM J HUM GENET, V53, P234; FISHER RA, 1925, STAT METHODFS RES WO; FOLKS JL, 1984, HDB STATISTICS, V4, P113, DOI DOI 10.1016/S0169-7161(84)04008-6; Gu C, 1998, GENET EPIDEMIOL, V15, P609, DOI 10.1002/(SICI)1098-2272(1998)15:6<609::AID-GEPI5>3.0.CO;2-N; Guerra R, 1999, GENET EPIDEMIOL, V17, pS605; GUERRA R, 2002, BIOSTATISTICAL GENET; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Hedges L.V., 2014, STAT METHODS META AN; Kruglyak L, 1998, AM J HUM GENET, V62, P994, DOI 10.1086/301792; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Li ZH, 1996, GENET EPIDEMIOL, V13, P377, DOI 10.1002/(SICI)1098-2272(1996)13:4<377::AID-GEPI6>3.3.CO;2-5; Province MA, 2001, AM J HUM GENET, V69, P660, DOI 10.1086/323316; Rice JP, 1997, AM J MED GENET, V74, P112, DOI 10.1002/(SICI)1096-8628(19970221)74:1<112::AID-AJMG22>3.0.CO;2-T; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; Sawcer S, 1998, AM J HUM GENET, V62, P996, DOI 10.1086/301808; Sawcer S, 1997, GENET EPIDEMIOL, V14, P223, DOI 10.1002/(SICI)1098-2272(1997)14:3<223::AID-GEPI1>3.0.CO;2-6; Wise LH, 1999, ANN HUM GENET, V63, P263, DOI 10.1046/j.1469-1809.1999.6330263.x	22	29	34	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2002	71	1					56	65		10.1086/341126	http://dx.doi.org/10.1086/341126			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	564GY	12037716	Green Published, Bronze			2022-12-18	WOS:000176307700006
J	Mateu, E; Calafell, F; Ramos, MD; Casals, T; Bertranpetit, J				Mateu, E; Calafell, F; Ramos, MD; Casals, T; Bertranpetit, J			Can a place of origin of the main cystic fibrosis mutations be identified?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR GENE; EUROPEAN POPULATIONS; FIRST INTRON; CA REPEAT; DNA; VARIABILITY; CHROMOSOME; DELTA-F508; ALLELES	The genetic background of the mutations that most often cause cystic fibrosis (CF) is different from that of non-CF chromosomes in populations of European origin. It is not known whether these haplotype backgrounds could be found at high frequencies in populations in which CF is, at present, not common; such populations would be candidates for the place of origin of CF mutations. An analysis of haplotypes of CF transmembrane conductance regulator, together with their variation in specific CF chromosomes, in a worldwide survey of normal chromosomes shows (1) a very low frequency or absence of the most common CF haplotypes in all populations analyzed and (2) a strong genetic variability and divergence, among various populations, of the chromosomes that carry disease-causing mutations. The depth of the gene genealogy associated with disease-causing mutations may be greater than that of the evolutionary process that gave rise to present-day human populations. The concept of "population of origin" lacks either spatial or temporal meaning for mutations that are likely to have been present in Europeans before the ethnogenesis of present populations; subsequent population processes may have erased the traces of their geographic origin.	Univ Pompeu Fabra, Fac Ciencies Salut & Vida, Unitat Biol Evolut, Barcelona 08003, Catalonia, Spain; Inst Recerca Oncol, Dept Mol Genet, Barcelona, Spain	Pompeu Fabra University	Bertranpetit, J (corresponding author), Univ Pompeu Fabra, Fac Ciencies Salut & Vida, Unitat Biol Evolut, Doctor Aiguader 80, Barcelona 08003, Catalonia, Spain.		Calafell, Francesc/C-8595-2014; Bertranpetit, Jaume/F-8550-2012	Calafell, Francesc/0000-0002-1083-9438; Bertranpetit, Jaume/0000-0003-0100-0590				Bertranpetit J, 1996, CIBA F SYMP, V197, P97; BONDUELLE M, 1990, HUM GENET, V85, P436; Bosch E, 1999, AM J HUM GENET, V65, P1623, DOI 10.1086/302676; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CHEHAB EF, 1991, AM J HUM GENET, V48, P223; Estivill X, 1997, HUM MUTAT, V10, P135, DOI 10.1002/(SICI)1098-1004(1997)10:2<135::AID-HUMU6>3.3.CO;2-P; ESTIVILL X, 1994, NAT GENET, V8, P216, DOI 10.1038/ng1194-216b; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; Goudet J., 2001, CLADISTICS; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; Hogenauer C, 2000, AM J HUM GENET, V67, P1422, DOI 10.1086/316911; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Mateu E, 2001, AM J HUM GENET, V68, P103, DOI 10.1086/316940; Mateu E, 1999, HUM HERED, V49, P15, DOI 10.1159/000022834; Morral N, 1996, HUM MUTAT, V8, P149, DOI 10.1002/(SICI)1098-1004(1996)8:2<149::AID-HUMU7>3.0.CO;2-6; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; MORRAL N, 1993, HUM MOL GENET, V2, P1015, DOI 10.1093/hmg/2.7.1015; MORRAL N, 1991, GENOMICS, V10, P692, DOI 10.1016/0888-7543(91)90454-M; Moulin DS, 1997, HUM HERED, V47, P295, DOI 10.1159/000154427; Payseur BA, 2000, GENETICS, V156, P1285; Pier GB, 1998, NATURE, V393, P79, DOI 10.1038/30006; Pier GB, 1999, TRENDS MICROBIOL, V7, P56, DOI 10.1016/S0966-842X(98)01441-3; Pier GB, 2000, P NATL ACAD SCI USA, V97, P8822, DOI 10.1073/pnas.97.16.8822; QUERE I, 1991, NUCLEIC ACIDS RES, V19, P5453, DOI 10.1093/nar/19.19.5453-a; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rohlf F.J., 1995, STAT TABLES; ROMEO G, 1989, HUM GENET, V84, P1, DOI 10.1007/BF00210660; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SERRE JL, 1990, HUM GENET, V84, P449; Slatkin M, 1997, AM J HUM GENET, V60, P447; Wiuf C, 2001, GENET RES, V78, P41, DOI 10.1017/S0016672301005195; ZIELENSKI J, 1991, GENOMICS, V10, P214, DOI 10.1016/0888-7543(91)90503-7; ZIELENSKI J, 1991, AM J HUM GENET, V49, P1256	34	29	34	0	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2002	70	1					257	264		10.1086/338243	http://dx.doi.org/10.1086/338243			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	499LD	11713719	Green Published, Bronze			2022-12-18	WOS:000172571900024
J	Svenson, IK; Ashley-Koch, AE; Pericak-Vance, MA; Marchuk, DA				Svenson, IK; Ashley-Koch, AE; Pericak-Vance, MA; Marchuk, DA			A second leaky splice-site mutation in the spastin gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									Duke Univ, Med Ctr, Dept Genet, Durham, NC 27710 USA; Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA	Duke University; Duke University	Svenson, IK (corresponding author), Duke Univ, Med Ctr, Dept Genet, Box 3175, Durham, NC 27710 USA.			Ashley-Koch, Allison/0000-0001-5409-9155; Marchuk, Douglas/0000-0002-3110-6671	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS026630] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS026630, 2P01-NS26630-11A1] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Svenson IK, 2001, AM J HUM GENET, V68, P1077, DOI 10.1086/320111	3	29	29	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2001	69	6					1407	1409		10.1086/324593	http://dx.doi.org/10.1086/324593			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	491AY	11704932	Green Published, Bronze			2022-12-18	WOS:000172086900026
J	Ombra, MN; Forabosco, P; Casula, S; Angius, A; Maestrale, G; Petretto, E; Casu, G; Colussi, G; Usai, E; Melis, P; Pirastu, M				Ombra, MN; Forabosco, P; Casula, S; Angius, A; Maestrale, G; Petretto, E; Casu, G; Colussi, G; Usai, E; Melis, P; Pirastu, M			Identification of a new candidate locus for uric acid nephrolithiasis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; COMPLEX DISEASE; MAPPING GENES; LOCALIZATION; CYSTINURIA; SEARCH; STONES; SCORES; POWER; RISK	Renal stone formation is a common multifactorial disorder, of unknown etiology, with an established genetic contribution. Lifetime risk for nephrolithiasis is similar to 10% in Western populations, and uric acid stones account for 5%-10% of all stones, depending on climatic, dietary, and ethnic differences. We studied a small, isolated founder population in Sardinia, characterized by an increased prevalence of uric acid stones, and performed a genomewide search in a deep-rooted pedigree comprising many members who formed uric acid renal stones. The pedigree was created by tracing common ancestors of affected individuals through a genealogical database based on archival records kept by the parish church since 1640. This genealogical information was used as the basis for the study strategy, involving screening for alleles shared among affected individuals, originating from common ancestors, and utilization of large pedigrees to obtain greater power for linkage detection. We performed multistep linkage and allele-sharing analyses. In the initial stage, 382 markers were typed in 14 closely related affected subjects; interesting regions were subsequently investigated in the whole sample. We identified two chromosomal regions that may harbor loci with susceptibility genes for uric acid stones. The strongest evidence was observed on 10q21-q22, where a LOD score of 3.07 was obtained for D10S1652 under an affected-only dominant model, and a LOD score of 3.90 was obtained using a dominant pseudomarker assignment. The localization was supported also by multipoint allele-sharing statistics and by haplotype analysis of familial cases and of unrelated affected subjects collected from the isolate. In the second region on 20q13.1-13.3, multipoint nonparametric scores yielded suggestive evidence in a similar to 20-cM region, and further analysis is needed to confirm and fine-map this putative locus. Replication studies are required to investigate the involvement of these regions in the genetic contribution to uric acid stone formation.	CNR, Inst Mol Genet, Alghero, Italy; Osped Niguarda Ca Granda, Milan, Italy; Univ Cagliari, SS Trinita Hosp, Urol Clin, Cagliari, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of Cagliari	Ombra, MN (corresponding author), CNR, Ist Genet Mol, Casella Postale, I-07040 Santa Maria La Palma, SS, Italy.	ombra@igm.ss.cnr.it	Angius, Andrea/P-9549-2015; Colussi, Giacomo/AFV-2812-2022; maestrale, giovanni battista/AAX-8187-2020; Forabosco, Paola/AAM-5540-2021; Angius, Andrea/B-8966-2015	Angius, Andrea/0000-0003-2596-6461; Colussi, Giacomo/0000-0001-6133-1899; maestrale, giovanni battista/0000-0002-1052-5113; FORABOSCO, PAOLA/0000-0002-2006-2693; OMBRA, MARIA NEVE/0000-0002-2437-9276				Asplin JR, 1996, SEMIN NEPHROL, V16, P412; Baggio B, 1999, J NEPHROL, V12, P371; Bisceglia L, 1997, AM J HUM GENET, V60, P611; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Curhan GC, 1997, J AM SOC NEPHROL, V8, P1568; Dawson C, 1996, BRIT MED J, V312, P1219; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Durner M, 1999, AM J HUM GENET, V64, P281, DOI 10.1086/302181; Dussol B, 1998, UROL INT, V60, P69, DOI 10.1159/000030214; Goring HHH, 2000, AM J HUM GENET, V66, P1310, DOI 10.1086/302845; Grases F, 1999, UROL INT, V62, P201, DOI 10.1159/000030395; Greenberg DA, 1998, AM J HUM GENET, V63, P870, DOI 10.1086/301997; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; HALABE A, 1994, MINER ELECTROL METAB, V20, P424; HAMM LL, 1987, AM J PHYSIOL, V253, pF595, DOI 10.1152/ajprenal.1987.253.4.F595; Hassapidou MN, 1999, J HUM NUTR DIET, V12, P47, DOI 10.1046/j.1365-277x.1999.00141.x; Hayashi M, 1998, INTERNAL MED, V37, P221, DOI 10.2169/internalmedicine.37.221; Hodge SE, 1997, AM J HUM GENET, V60, P217; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; Hovatta I, 1999, AM J HUM GENET, V65, P1114, DOI 10.1086/302567; Jaeger P, 1996, Curr Opin Nephrol Hypertens, V5, P342, DOI 10.1097/00041552-199607000-00009; Koka RM, 2000, AM J PHYSIOL-RENAL, V278, pF989, DOI 10.1152/ajprenal.2000.278.6.F989; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Miano MG, 2000, AM J HUM GENET, V67, P1348, DOI 10.1016/S0002-9297(07)62966-8; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NIKALI K, 1995, AM J HUM GENET, V56, P1088; Ott J, 1999, ANAL HUMAN GENETIC L; PAK CYC, 1980, AM J MED, V69, P19, DOI 10.1016/0002-9343(80)90495-7; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; POLLACK HM, 1978, RADIOLOGY, V127, P233, DOI 10.1148/127.1.233; PRAS E, 1994, NAT GENET, V6, P415, DOI 10.1038/ng0494-415; Reed BY, 1999, J CLIN ENDOCR METAB, V84, P3907, DOI 10.1210/jc.84.11.3907; Rivers K, 2000, UROL CLIN N AM, V27, P203, DOI 10.1016/S0094-0143(05)70251-2; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Scheinman SJ, 1999, SEMIN NEPHROL, V19, P381; Scott P, 1999, J AM SOC NEPHROL, V10, P1007; Serio A, 1999, NEPHRON, V81, P26, DOI 10.1159/000046295; Siddiqui AA, 1998, UROL RES, V26, P383, DOI 10.1007/s002400050073; Smith CL, 1998, CURR OPIN NEPHROL HY, V7, P703, DOI 10.1097/00041552-199811000-00014; Sobel E, 1996, AM J HUM GENET, V58, P1323; Soucie JM, 1996, AM J EPIDEMIOL, V143, P487; Stojimirovic B, 1998, Srp Arh Celok Lek, V126, P394; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; Terwilliger JD, 1998, HUM HERED, V48, P138, DOI 10.1159/000022794; TERWILLIGER JD, 1998, ENCY BIOSTATISTICS; Trembath RC, 1997, HUM MOL GENET, V6, P813, DOI 10.1093/hmg/6.5.813; Weeks DE., 1990, AM J HUM GENET, V47, pA203; Wright AF, 1999, NAT GENET, V23, P397, DOI 10.1038/70501	49	29	29	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2001	68	5					1119	1129		10.1086/320105	http://dx.doi.org/10.1086/320105			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	423HZ	11309680	Bronze, Green Published			2022-12-18	WOS:000168171200006
J	Lee, JK; Thomas, DC				Lee, JK; Thomas, DC			Performance of Markov chain-Monte Carlo approaches for mapping genes in oligogenic models with an unknown number of loci	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; BAYESIAN-ANALYSIS; LINKAGE ANALYSIS; SEGREGATION	Markov chain-Monte Carlo (MCMC) techniques for multipoint mapping of quantitative trait loci have been developed on nuclear-family and extended-pedigree data. These methods are based on repeated sampling-peeling and gene dropping of genotype vectors and random sampling of each of the model parameters from their full conditional distributions, given phenotypes, markers, and other model parameters. We further refine such approaches by improving the efficiency of the marker haplotype-updating algorithm and by adopting a new proposal for adding loci. Incorporating these refinements, we have performed an extensive simulation study on simulates nuclear-family data, varying the number of trait loci, family size, displacement, and other segregation parameters. Our simulation studies show that our MCMC algorithm identifies the locations of the true trait loci and estimates their segregation parameters well-provided that the total number of sibship pairs in the pedigree data is reasonably large, heritability of each individual trait locus is not too low and the loci are not too close together. Our MCMC algorithm was shown to be significantly more efficient than LOKI (Heath 1997) in our simulation study using nuclear-family data.	Univ Virginia, Sch Med, Dept Hlth Evaluat Sci, Charlottesville, VA 22908 USA; Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA	University of Virginia; University of Southern California	Lee, JK (corresponding author), Univ Virginia, Sch Med, Dept Hlth Evaluat Sci, POB 800717, Charlottesville, VA 22908 USA.	jacklee@virginia.edu			NCI NIH HHS [CA52862, R01 CA052862] Funding Source: Medline; NIGMS NIH HHS [GM58897] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA052862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058897] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Daw EW, 1999, GENET EPIDEMIOL, V17, pS133; Daw EW, 1999, AM J HUM GENET, V64, P839, DOI 10.1086/302276; George AW, 2000, BIOMETRICS, V56, P40, DOI 10.1111/j.0006-341X.2000.00040.x; Geyer CJ., 1992, STAT SCI, V7, P473, DOI [10.1214/ss/1177011137, DOI 10.1214/SS/1177011137]; Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.2307/2337340; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Heath SC, 1997, GENET EPIDEMIOL, V14, P1011, DOI 10.1002/(SICI)1098-2272(1997)14:6<1011::AID-GEPI75>3.3.CO;2-E; Heath SC, 1997, AM J HUM GENET, V61, P748, DOI 10.1086/515506; Hinrichs A, 1999, GENET EPIDEMIOL, V17, pS615; JANSEN RC, 1994, GENETICS, V136, P1447; Jansen RC, 1996, GENETICS, V142, P305; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; KRUGLYAK L, 1995, GENETICS, V139, P1421; LANDER ES, 1989, GENETICS, V121, P185; Lee JK, 1998, J COMPUT BIOL, V5, P505, DOI 10.1089/cmb.1998.5.505; LIN SL, 1993, IMA J MATH APPL MED, V10, P1; PLOUGHMAN LM, 1989, AM J HUM GENET, V44, P543; Richardson S, 1997, J ROY STAT SOC B MET, V59, P731, DOI 10.1111/1467-9868.00095; Satagopan JM, 1996, GENETICS, V144, P805; Sillanpaa MJ, 1999, GENETICS, V151, P1605; Sillanpaa MJ, 1998, GENETICS, V148, P1373; Stephens DA, 1998, BIOMETRICS, V54, P1334, DOI 10.2307/2533661; STEPHENS DA, 1993, ANN HUM GENET, V57, P65, DOI 10.1111/j.1469-1809.1993.tb00887.x; Thomas DC, 1997, GENET EPIDEMIOL, V14, P903, DOI 10.1002/(SICI)1098-2272(1997)14:6<903::AID-GEPI57>3.0.CO;2-Q; Uimari P, 1999, GENET EPIDEMIOL, V17, pS743; Uimari P, 1996, GENETICS, V143, P1831; Yuan B, 2000, AM J HUM GENET, V66, P1699, DOI 10.1086/302904	27	29	29	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1232	1250						19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	369WW	11032787				2022-12-18	WOS:000165091600020
J	Armstrong, SJ; Goldman, ASH; Speed, RM; Hulten, MA				Armstrong, SJ; Goldman, ASH; Speed, RM; Hulten, MA			Meiotic studies of a human male carrier of the common translocation, t(11;22), suggests postzygotic selection rather than preferential 3 : 1 MI segregation as the cause of liveborn offspring with an unbalanced translocation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IN-SITU HYBRIDIZATION; RECIPROCAL TRANSLOCATION; 11Q-22Q TRANSLOCATION; CHIASMA FREQUENCY; MEIOSIS; SPERM; SPERMATOCYTES; HETEROZYGOTE; DISJUNCTION; KARYOTYPE	The t(11;22)(q23;q11) translocation is the only non-Robertsonian rearrangement for which there are a large number of unrelated families, apparently with the same breakpoints. These families most often have been ascertained through an abnormal child with the karyotype 47,XX or XY, +der(22) t(11;22)(q23;q11). To explain the high incidence of 3:1 segregants, rarely seen in offspring of carriers of other reciprocal translocations, a number of theoretical models have been suggested. We have used both electron microscope analysis of the synaptonemal complex (SC) and dual-color FISH to investigate the meiotic chromosome behavior in a male carrier of the translocation who has the karyotype 46,XY, t(11;22)(q23;q11). Chromosome synapsis, first-meiotic chiasma configuration, and segregation behavior of this translocation have been analyzed directly. Examination of SCs by electron microscopy showed pachytene-cross formation in 49/50 nuclei. Approximately 50% (26/50) revealed a classical fully synapsed quadrivalent. A proportion of these (10/26), however, showed some central asymmetry, suggesting heterologous synapsis. The remaining cells appeared to have incomplete synapsis. FISH analysis showed only quadrivalents in all 100 metaphase I nuclei, The chiasma frequency was increased within the interstitial segments, in comparison with the same region in normal bivalents. All types of segregation category were found in metaphase II nuclei. There was no indication of preferential 3:1 anaphase I segregation. We conclude that the +der(22) constitution in offspring of carriers of t(11;22)(q23;q11) is not likely to be due to meiotic 3:1 segregation being especially common. Rather, the +der(22) constitution is more likely to be the result of postzygotic selection against other unbalanced karyotypes.	Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; Birmingham Heartlands Hosp, Reg Genet Serv, LFS Res Unit, Birmingham B9 5ST, W Midlands, England; Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	University of Birmingham; Heart of England NHS Foundation Trust; University of Birmingham; University of Sheffield; University of Edinburgh; University of Warwick	Armstrong, SJ (corresponding author), Univ Birmingham, Sch Biosci, POB 363, Birmingham B15 2TT, W Midlands, England.			Goldman, Alastair/0000-0002-0516-3197				ABELIOVICH D, 1990, AM J MED GENET, V37, P288, DOI 10.1002/ajmg.1320370227; Armstrong S. J., 1995, Chromosome Research, V3, P109; Armstrong SJ, 1998, EUR J HUM GENET, V6, P430, DOI 10.1038/sj.ejhg.5200209; CHANDLEY AC, 1976, CYTOGENET CELL GENET, V17, P98, DOI 10.1159/000130694; DANIEL A, 1989, AM J MED GENET, V31, P14; FRACCARO M, 1980, HUM GENET, V56, P21, DOI 10.1007/BF00281567; Goldman A. S. H., 1993, European Journal of Human Genetics, V1, P325; GOLDMAN ASH, 1993, CYTOGENET CELL GENET, V63, P16, DOI 10.1159/000133493; GOLDMAN ASH, 1993, CHROMOSOMA, V102, P102, DOI 10.1007/BF00356027; GOLDMAN ASH, 1992, J MED GENET, V29, P101; HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855; HULTEN M, 1974, HEREDITAS, V76, P55; HULTEN M, 1970, HUMAN POPULATION CYT, P24; HULTEN M, 1973, ADV HUM GENET, V14, P327; HULTEN MA, 1992, HUMAN CYTOGENETICS P, P193; ISELIUS L, 1983, HUM GENET, V64, P343, DOI 10.1007/BF00292366; KODURU PRK, 1989, GENOME, V32, P24, DOI 10.1139/g89-405; LAURIE DA, 1984, HUM GENET, V68, P235, DOI 10.1007/BF00418394; LINDENBAUM RH, 1990, HUM GENET, V85, P43; LOCKWOOD DH, 1989, HUM GENET, V83, P287, DOI 10.1007/BF00285174; LURIE IW, 1992, AM J MED GENET, V42, P126; MARTIN RH, 1984, CLIN GENET, V25, P357; Petkovic I, 1996, CLIN GENET, V50, P515; Shaikh TH, 1999, AM J HUM GENET, V65, P1595, DOI 10.1086/302666; SIMI P, 1992, HUM GENET, V88, P482, DOI 10.1007/BF00215688; SOLER A, 1993, PRENATAL DIAG, V13, P137, DOI 10.1002/pd.1970130209; SPEED RM, 1990, HUM GENET, V84, P547; Van Assche E, 1999, MOL HUM REPROD, V5, P682, DOI 10.1093/molehr/5.7.682; ZACKAI EH, 1980, AM J MED GENET, V7, P507, DOI 10.1002/ajmg.1320070412	29	29	31	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2000	67	3					601	609		10.1086/303052	http://dx.doi.org/10.1086/303052			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	348TJ	10936106	Green Published, Bronze			2022-12-18	WOS:000089002300007
J	Ginzberg, H; Shin, J; Ellis, L; Goobie, S; Morrison, J; Corey, M; Durie, PR; Rommens, JM				Ginzberg, H; Shin, J; Ellis, L; Goobie, S; Morrison, J; Corey, M; Durie, PR; Rommens, JM			Segregation analysis in Shwachman-Diamond syndrome: Evidence for recessive inheritance	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PATERNAL AGE; TRANSLOCATION; NEUTROPENIA; DYSFUNCTION; PATIENT	Shwachman-Diamond syndrome is a rare disorder of unknown cause. Reports have indicated the occurrence of affected siblings, but formal segregation analysis has not been performed. In families collected for genetic studies, the mean paternal age and mean difference in parental ages were found to be consistent with the general population. We determined estimates of segregation proportion in a cohort of 84 patients with complete sibship data under the assumption of complete ascertainment, using the Li and Mantel estimator, and of single ascertainment with the Davie modification. A third estimate was also computed with the expectation-maximization (EM) algorithm. All three estimates supported an autosomal recessive mode of inheritance, but complete ascertainment was found to be unlikely. Although there are no overt signs of disease in adult carriers (parents), the use of serum trypsinogen levels to indicate exocrine pancreatic dysfunction was evaluated as a potential measure for heterozygote expression. No consistent differences were found in levels between parents and a normal control population. Although genetic heterogeneity cannot be excluded, our results indicate that simulation and genetic analyses of Shwachman-Diamond syndrome should consider a recessive model of inheritance.	Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Div Gastroenterol & Nutr, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Program Populat Hlth Sci, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Program Integrat Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; Univ Toronto, Dept Pediat, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto	Rommens, JM (corresponding author), Hosp Sick Children, Program Genet & Genom Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.		Rommens, Johanna/AAT-7465-2021					AGGETT PJ, 1979, J PEDIATR-US, V94, P391, DOI 10.1016/S0022-3476(79)80578-8; AGGETT PJ, 1980, ARCH DIS CHILD, V55, P331, DOI 10.1136/adc.55.5.331; Bender R, 1993, Health Rep, V5, P341; DAVIE AM, 1979, ANN HUM GENET, V42, P507, DOI 10.1111/j.1469-1809.1979.tb00683.x; Efron B., 1993, INTRO BOOTSTRAP; Ginzberg H, 1999, J PEDIATR-US, V135, P81, DOI 10.1016/S0022-3476(99)70332-X; Goobie S, 1999, AM J MED GENET, V85, P171, DOI 10.1002/(SICI)1096-8628(19990716)85:2<171::AID-AJMG12>3.0.CO;2-K; KOMIYAMA A, 1985, BLOOD, V66, P99; Lange K., 1997, MATH STAT METHODS GE; LI CC, 1968, AM J HUM GENET, V20, P61; Mack DR, 1996, GASTROENTEROLOGY, V111, P1593, DOI 10.1016/S0016-5085(96)70022-7; MASUNO M, 1995, J MED GENET, V32, P894, DOI 10.1136/jmg.32.11.894; MODELL B, 1990, HUM GENET, V86, P198; Moll AC, 1996, HUM GENET, V98, P109, DOI 10.1007/s004390050168; MOORE DJ, 1986, GUT, V27, P1362, DOI 10.1136/gut.27.11.1362; NICHOLAS FW, 1982, J HERED, V73, P444, DOI 10.1093/oxfordjournals.jhered.a109695; REPO H, 1987, CLIN EXP IMMUNOL, V69, P204; SHMERLIN.DH, 1969, HELV PAEDIATR ACTA, V24, P547; Tellier AL, 1996, CLIN GENET, V50, P548	19	29	29	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2000	66	4					1413	1416		10.1086/302856	http://dx.doi.org/10.1086/302856			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QP	10739765	Green Published, Bronze			2022-12-18	WOS:000088373400023
J	Tu, IP; Balise, RR; Whittemore, AS				Tu, IP; Balise, RR; Whittemore, AS			Detection of disease genes by use of family data. II. Application to nuclear families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HAPLOTYPE-RELATIVE-RISK; PARENTAL-GENOTYPE RECONSTRUCTION; TRANSMISSION DISEQUILIBRIUM TEST; TRANSMISSION/DISEQUILIBRIUM TEST; LINKAGE DISEQUILIBRIUM; SIBSHIP TEST; ASSOCIATION; MARKERS	Two likelihood-based score statistics are used to detect association between a disease and a single diallelic polymorphism, on the basis of data from arbitrary types of nuclear families. The first statistic, the nonfounder statistic, extends the transmission/disequilibrium test to accommodate affected and unaffected offspring and missing parental genotypes. The second statistic, the founder statistic, compares observed or inferred parental genotypes with those of some reference population. In this comparison, the genotypes of affected parents or of those with many affected offspring are weighted more heavily than are the genotypes of unaffected parents or of those with few affected offspring. Genotypes of single unrelated cases and controls can be included in this analysis. We illustrate the two statistics by applying them to data on a polymorphism of the SDR5A2 gene in nuclear families with multiple cases of prostate cancer. We also use simulations to compare the power of the nonfounder statistic with that of the score statistic, on the basis of the conditional logistic regression of offspring genotypes.	Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA	Stanford University	Whittemore, AS (corresponding author), Stanford Univ, Sch Med, Dept Hlth Res & Policy, Redwood Bldg,Room T204, Stanford, CA 94305 USA.			Tu, I-Ping/0000-0001-8666-8391				Cox DR., 1974, THEORETICAL STAT; Curtis D, 1997, ANN HUM GENET, V61, P319, DOI 10.1017/S000348009700626X; CURTIS D, 1995, AM J HUM GENET, V56, P811; EWENS WJ, 1995, AM J HUM GENET, V57, P455; Horvath S, 1998, AM J HUM GENET, V63, P1886, DOI 10.1086/302137; KNAPP M, 1993, AM J HUM GENET, V52, P1085; Knapp M, 1999, AM J HUM GENET, V64, P861, DOI 10.1086/302285; Makridakis Nick, 1998, Proceedings of the American Association for Cancer Research Annual Meeting, V39, P365; Martin RB, 1998, GENET EPIDEMIOL, V15, P471, DOI 10.1002/(SICI)1098-2272(1998)15:5<471::AID-GEPI3>3.3.CO;2-A; OTT J, 1989, GENET EPIDEMIOL, V6, P127, DOI 10.1002/gepi.1370060124; REICHARDT JKV, 1995, CANCER RES, V55, P3973; Schaid DJ, 1997, GENET EPIDEMIOL, V14, P1113, DOI 10.1002/(SICI)1098-2272(1997)14:6<1113::AID-GEPI92>3.0.CO;2-J; Schaid DJ, 1998, AM J HUM GENET, V63, P1492, DOI 10.1086/302094; SCHAID DJ, 1994, AM J HUM GENET, V55, P402; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; Whittemore AS, 2000, AM J HUM GENET, V66, P1328, DOI 10.1086/302851	20	29	32	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2000	66	4					1341	1350		10.1086/302852	http://dx.doi.org/10.1086/302852			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QP	10739759	Bronze, Green Published			2022-12-18	WOS:000088373400016
J	Macmillan, C; Johns, TA; Fu, K; Shoubridge, EA				Macmillan, C; Johns, TA; Fu, K; Shoubridge, EA			Predominance of the T14484C mutation in French-Canadian families with Leber hereditary optic neuropathy is due to a founder effect	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							HUMAN MITOCHONDRIAL-DNA; SEQUENCE; EVOLUTION; POPULATION; LINEAGE; QUEBEC; REGION		Univ Illinois, Dept Neurol, Chicago, IL 60612 USA; Univ Illinois, Dept Pediat, Chicago, IL 60612 USA; McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; McGill Univ, Dept Human Genet, Montreal, PQ, Canada; McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; McGill University; McGill University; McGill University	Macmillan, C (corresponding author), Univ Illinois, Dept Neurol, M-C 796,912 S Wood St,Room 855N, Chicago, IL 60612 USA.							ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; AQUADRO CF, 1983, GENETICS, V103, P287; Brown MD, 1997, AM J HUM GENET, V60, P381; BROWN MD, 1992, FASEB J, V6, P2791, DOI 10.1096/fasebj.6.10.1634041; CANN RL, 1984, GENETICS, V106, P479; DEBRAEKELEER M, 1991, HUM HERED, V41, P168, DOI 10.1159/000153996; GREENBERG BD, 1983, GENE, V21, P33, DOI 10.1016/0378-1119(83)90145-2; Hofmann S, 1997, HUM MOL GENET, V6, P1835, DOI 10.1093/hmg/6.11.1835; HORAI S, 1990, AM J HUM GENET, V46, P828; HOWELL N, 1995, GENETICS, V140, P285; JOHNS DR, 1993, ARCH OPHTHALMOL-CHIC, V111, P495, DOI 10.1001/archopht.1993.01090040087038; Leber T., 1871, GRAEFES ARCH OPHTHAL, V17, P249, DOI 10.1007/BF01694557; LUM JK, 1994, HUM BIOL, V66, P567; Macmillan C, 1998, NEUROLOGY, V50, P417, DOI 10.1212/WNL.50.2.417; MOUNTAIN JL, 1995, AM J HUM GENET, V56, P979; ROZEN R, 1994, AM J HUM GENET, V55, P321; Torroni A, 1997, AM J HUM GENET, V60, P1107; UPHOLT WB, 1977, CELL, V11, P571, DOI 10.1016/0092-8674(77)90075-7; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350	19	29	32	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2000	66	1					332	335		10.1086/302716	http://dx.doi.org/10.1086/302716			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279FK	10631164	Green Published, Bronze			2022-12-18	WOS:000085033600035
J	Clark, AG				Clark, AG			The size distribution of homozygous segments in the human genome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							DNA-SEQUENCES; RECOMBINATION; NUMBER		Penn State Univ, Dept Biol, Inst Mol Evolutionary Genet, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Clark, AG (corresponding author), Penn State Univ, Dept Biol, Inst Mol Evolutionary Genet, University Pk, PA 16802 USA.			Clark, Andrew/0000-0001-7159-8511				Beerli P, 1999, GENETICS, V152, P763; BERTORELLE G, 1995, MOL BIOL EVOL, V12, P887; Broman KW, 1999, AM J HUM GENET, V65, P1493, DOI 10.1086/302661; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Donnelly PJ, 1999, AM J HUM GENET, V65, pA83; FELSENSTEIN J, 1999, IMS LECT NOTES MONOG, V33; Griffiths R., 1997, IMA VOLUMES MATH ITS, V87; Griffiths RC, 1996, J COMPUT BIOL, V3, P479, DOI 10.1089/cmb.1996.3.479; Griffiths RC, 1999, THEOR POPUL BIOL, V55, P137, DOI 10.1006/tpbi.1998.1390; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; HUDSON RR, 1985, GENETICS, V111, P147; Karlin S., 1975, 1 COURSE STOCHASTIC; Kingman J, 1982, STOCHASTIC PROCESS A, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Kuhner MK, 1998, GENETICS, V149, P429; MACARTHUR RH, 1957, P NATL ACAD SCI USA, V43, P293, DOI 10.1073/pnas.43.3.293; Martin RA, 1999, J MED GENET, V36, P633; McPeek MS, 1999, AM J HUM GENET, V65, P858, DOI 10.1086/302537; NORDBORG M, IN PRESS GENETICS; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; Smith F C, 1994, Ann Vasc Surg, V8, P1, DOI 10.1007/BF02133398; Uehara S, 1999, AM J MED GENET, V86, P107, DOI 10.1002/(SICI)1096-8628(19990910)86:2<107::AID-AJMG3>3.0.CO;2-4; Wiuf C, 1997, GENETICS, V147, P1459; Wiuf C, 1999, THEOR POPUL BIOL, V55, P248, DOI 10.1006/tpbi.1998.1403; Wiuf C, 1999, GENETICS, V151, P1217	24	29	30	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1489	1492		10.1086/302668	http://dx.doi.org/10.1086/302668			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577901	Green Published, Bronze			2022-12-18	WOS:000084282500002
J	Otterson, GA; Modi, S; Nguyen, K; Coxon, AB; Kaye, FJ				Otterson, GA; Modi, S; Nguyen, K; Coxon, AB; Kaye, FJ			Temperature-sensitive RB mutations linked to incomplete penetrance of familial retinoblastoma in 12 families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GERM-LINE MUTATIONS; HEREDITARY RETINOBLASTOMA; SPONTANEOUS REGRESSION; MILD EXPRESSION; GENE; PROTEIN; CANCER; PHENOTYPE; RETINOMA; PRODUCT	The tumor-suppressor activity of the retinoblastoma protein (RB) is encoded within a protein-binding ("pocket") domain that is targeted for mutations in all cases of familial retinoblastoma and in many common adult cancers. Although familial retinoblastoma is a paradigm for a highly penetrant, recessive model of tumorigenesis, the molecular basis for the phenotype of incomplete penetrance of familial retinoblastoma is undefined. We studied the RE pocket-binding properties of three independent, mutant RE alleles that are present in the germline of 12 kindreds with the phenotype of incomplete penetrance of familial retinoblastoma. Each arises from alterations of single codons within the RE pocket domain (designated "Delta 480," "661W," or "712R"). Under the same conditions, we studied the properties of wild-type (WT) RE, an RE point mutant isolated from a lung carcinoma sample (706F) and an adjacent, in vitro-generated point mutant (707W). The Delta 480, 661W, and 712R mutants lack pocket protein-binding activity in vitro but retain the WT ability to undergo cyclin-mediated phosphorylation in vivo. Each of the low-penetrant RE mutants exhibits marked enhancement of pocket protein binding when the cells are grown at reduced temperature. In contrast, in this temperature range, no change in binding activity is seen with WT RE, the 706F mutant, or the 707W mutant. We have demonstrated that many families with incomplete penetrance of familial retinoblastoma carry unstable, mutant RE alleles with temperature-sensitive pocket protein-binding activity. The variable frequency for tumor development in these families may result from reversible fluctuations in a threshold level of RE pocket-binding activity.	NCI, Div Clin Sci, Med Branch, Dept Genet, Bethesda, MD 20892 USA; Natl Naval Med Ctr, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Walter Reed National Military Medical Center	Kaye, FJ (corresponding author), Naval Hosp, Bldg 8-Room 5101, Bethesda, MD 20889 USA.		kaye, frederic/E-2437-2011					BALMER A, 1991, OPHTHALMIC PAED GEN, V12, P131, DOI 10.3109/13816819109029394; BALMER A, 1992, KLIN MONATSBL AUGENH, V200, P436, DOI 10.1055/s-2008-1045786; Bremner R, 1997, AM J HUM GENET, V61, P556, DOI 10.1086/515499; CHAR DH, 1974, AM J OPHTHALMOL, V78, P5, DOI 10.1016/0002-9394(74)90003-8; Chen CF, 1996, MOL CELL BIOL, V16, P4691; Cowell JK, 1996, ONCOGENE, V12, P431; Cowell JK, 1998, ONCOGENE, V16, P3211, DOI 10.1038/sj.onc.1201833; DRAPER GJ, 1992, BRIT J CANCER, V66, P211, DOI 10.1038/bjc.1992.244; DRYJA TP, 1993, AM J HUM GENET, V52, P1122; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; GALLIE BL, 1995, MOL GENETICS CANC, P1; GREGER V, 1989, HUM GENET, V83, P155, DOI 10.1007/BF00286709; Gunalp I, 1996, JPN J OPHTHALMOL, V40, P95; HARBOUR JW, 1988, SCIENCE, V241, P353, DOI 10.1126/science.2838909; HUANG Q, 1998, CHUNG HUA HSUEH CHUA, V15, P139; KAELIN WG, 1991, CELL, V64, P521, DOI 10.1016/0092-8674(91)90236-R; KAYE FJ, 1990, P NATL ACAD SCI USA, V87, P6922, DOI 10.1073/pnas.87.17.6922; Klutz M, 1999, AM J HUM GENET, V64, P667, DOI 10.1086/302254; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KRATZKE RA, 1994, ONCOGENE, V9, P1321; KRATZKE RA, 1993, CELL GROWTH DIFFER, V4, P629; KRATZKE RA, 1992, J BIOL CHEM, V267, P25998; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; LOHMANN DR, 1994, HUM GENET, V94, P349; LOMMATZSCH PK, 1993, KLIN MONATSBL AUGENH, V202, P218, DOI 10.1055/s-2008-1045586; ONADIM Z, 1992, P NATL ACAD SCI USA, V89, P6177, DOI 10.1073/pnas.89.13.6177; OTTERSON GA, 1994, ONCOGENE, V9, P3375; Otterson GA, 1997, P NATL ACAD SCI USA, V94, P12036, DOI 10.1073/pnas.94.22.12036; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; SAKAI T, 1991, NATURE, V353, P83, DOI 10.1038/353083a0; Sellers WR, 1998, GENE DEV, V12, P95, DOI 10.1101/gad.12.1.95; SEMINARA SB, 1994, HUM GENET, V93, P629; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2	33	29	30	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1999	65	4					1040	1046		10.1086/302581	http://dx.doi.org/10.1086/302581			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	241XW	10486322	Bronze, Green Published			2022-12-18	WOS:000082910000012
J	Liu, XD; Barker, DF				Liu, XD; Barker, DF			Evidence for effective suppression of recombination in the chromosome 17q21 segment spanning RNU2-BRCA1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EARLY-ONSET BREAST; CLASS-II REGION; SUSCEPTIBILITY GENE BRCA1; LINKAGE DISEQUILIBRIUM; OVARIAN-CANCER; PHYSICAL MAP; CONCERTED EVOLUTION; RNU2 LOCUS; POLYMORPHIC MICROSATELLITES; REPEAT POLYMORPHISMS	Characterization of associations between polymorphic sites located throughout the similar to 200-400-kb variable-length region spanning RNU2-BRCA1 reveals nearly complete linkage disequilibrium. This segment spans the RNU2 array, which includes 6-30 tandem copies of the U2 snRNA gene, and an adjacent region containing NBR1, the LBRCA1 pseudogene, NBR2, and BRCA1 in a tandemly duplicated structure. A series of biallelic polymorphisms define two common haplotypes that do not vary significantly, in structure or frequency, between populations of primarily European (n = 275) or Asian (n = 34) ancestry. Lower-frequency variants occurring at distantly located sites within this region also show very strong associations. The rarer haplotype classes appear to be distinguished by mutational alteration and are not recombination products of the two major classes. The two major haplotypes also exhibit significantly different allele-length distributions for local simple tandem-repeat markers. The conservation of extensive distinct chromosomal haplotypes during a long period of human population expansion and divergence indicates that selective forces or specific chromosomal mechanisms result in effective recombination suppression. The extreme degree of long-range linkage disequilibrium at this locus may be exceeded only by that reported for the human MHC locus, where allele-specific functional interactions are believed to be significant. These findings have implications for the estimation of the time of origin of BRCA1 mutations having a founder effect, the interpretation of the significance of rare allelic variants, and the study of the origins of modern populations.	Univ Utah, Hlth Sci Ctr, Dept Physiol, Salt Lake City, UT 84108 USA	Utah System of Higher Education; University of Utah	Barker, DF (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Physiol, Riin 155,410 Chipeta Way,Univ Utah Res Pk, Salt Lake City, UT 84108 USA.			Barker, David/0000-0002-1438-4100	NCI NIH HHS [CA63689, CA42014, CA77453] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA063689, R01CA077453, P30CA042014] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abeliovich D, 1997, AM J HUM GENET, V60, P505; ALBERTSEN HM, 1994, NAT GENET, V7, P472, DOI 10.1038/ng0894-472; Armour JAL, 1996, NAT GENET, V13, P154, DOI 10.1038/ng0696-154; BALNAVES ME, 1991, NUCLEIC ACIDS RES, V19, P1155, DOI 10.1093/nar/19.5.1155; Bar-Sade RB, 1998, HUM MOL GENET, V7, P801, DOI 10.1093/hmg/7.5.801; BARKER D, 1984, AM J HUM GENET, V36, P1159; Barker DF, 1996, GENOMICS, V38, P215, DOI 10.1006/geno.1996.0618; BARKER DF, 1993, GENOMICS, V18, P712, DOI 10.1016/S0888-7543(05)80381-7; Barker DF, 1996, GENET EPIDEMIOL, V13, P595; BEGOVICH AB, 1992, J IMMUNOL, V148, P249; BennettBaker PE, 1996, GENOMICS, V32, P163, DOI 10.1006/geno.1996.0097; Blackshear PE, 1998, ONCOGENE, V16, P61, DOI 10.1038/sj.onc.1201506; BLOUIN JL, 1995, AM J HUM GENET, V57, P388; Brinkmann B, 1998, AM J HUM GENET, V62, P1408, DOI 10.1086/301869; Brown MA, 1996, ONCOGENE, V12, P2507; BUETOW KH, 1991, AM J HUM GENET, V48, P911; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; CAMPBELL IG, 1994, HUM MOL GENET, V3, P589, DOI 10.1093/hmg/3.4.589; Cann RL, 1997, AM J HUM GENET, V60, P755; CASTIGLIONE CM, 1995, AM J HUM GENET, V57, P1445; CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; CHARMLEY P, 1995, GENOMICS, V29, P760, DOI 10.1006/geno.1995.9940; COUCH FJ, 1995, GENOMICS, V25, P264, DOI 10.1016/0888-7543(95)80134-8; Couch FJ, 1996, HUM MUTAT, V8, P8, DOI 10.1002/humu.1380080102; COUCH FJ, 1994, GENOMICS, V24, P419, DOI 10.1006/geno.1994.1647; Cullen M, 1997, AM J HUM GENET, V60, P397; DOHERTY DG, 1992, HUM IMMUNOL, V34, P53, DOI 10.1016/0198-8859(92)90085-2; Dunning AM, 1997, HUM MOL GENET, V6, P285, DOI 10.1093/hmg/6.2.285; Durocher F, 1996, HUM MOL GENET, V5, P835, DOI 10.1093/hmg/5.6.835; FAIN PR, 1989, AM J HUM GENET, V45, P721; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; GAO XJ, 1991, TISSUE ANTIGENS, V38, P24, DOI 10.1111/j.1399-0039.1991.tb02031.x; GYLLENSTEN UB, 1993, HUM IMMUNOL, V36, P1, DOI 10.1016/0198-8859(93)90002-I; Harding RM, 1997, AM J HUM GENET, V60, P772; HAUGE XY, 1993, HUM MOL GENET, V2, P411, DOI 10.1093/hmg/2.4.411; HILL WG, 1988, THEOR POPUL BIOL, V33, P54, DOI 10.1016/0040-5809(88)90004-4; HUMPHREY JS, 1997, P NATL ACAD SCI USA, V94, P820; INOUE R, 1995, CANCER RES, V55, P3521; JONES KA, 1994, HUM MOL GENET, V3, P1927; JORDE LB, 1993, AM J HUM GENET, V53, P1038; JORDE LB, 1994, AM J HUM GENET, V54, P884; KLITZ W, 1995, AM J HUM GENET, V57, P1436; Krawczak M, 1998, AM J HUM GENET, V63, P474, DOI 10.1086/301965; KRAWCZAK M, 1991, HUM GENET, V86, P425; Krawczak M, 1996, HUM MUTAT, V8, P23; LevyLahad E, 1997, AM J HUM GENET, V60, P1059; LEWONTIN RC, 1960, EVOLUTION, V14, P458, DOI 10.2307/2405995; Liao DQ, 1995, GENOMICS, V30, P583, DOI 10.1006/geno.1995.1280; Liao DQ, 1997, EMBO J, V16, P588, DOI 10.1093/emboj/16.3.588; Lichten M, 1995, ANNU REV GENET, V29, P423, DOI 10.1146/annurev.ge.29.120195.002231; LIFTON RP, 1990, GENOMICS, V7, P131, DOI 10.1016/0888-7543(90)90530-8; Malfroy L, 1997, GENOMICS, V43, P226, DOI 10.1006/geno.1997.4800; MARTIN M, 1995, HUM MOL GENET, V4, P423, DOI 10.1093/hmg/4.3.423; MCGINNIS RE, 1994, AM J HUM GENET, V55, P526; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Mountain JL, 1997, AM J HUM GENET, V61, P705, DOI 10.1086/515510; Nagaraja R, 1997, GENOME RES, V7, P210, DOI 10.1101/gr.7.3.210; Neuhausen SL, 1996, AM J HUM GENET, V58, P271; NEUHAUSEN SL, 1994, HUM MOL GENET, V3, P1919, DOI 10.1093/hmg/3.11.1919; Newman B, 1998, JAMA-J AM MED ASSOC, V279, P915, DOI 10.1001/jama.279.12.915; NORMAND T, 1993, HUM MOL GENET, V2, P479, DOI 10.1093/hmg/2.4.479; PAVELITZ T, 1995, EMBO J, V14, P169, DOI 10.1002/j.1460-2075.1995.tb06987.x; Rodenhiser D, 1996, ONCOGENE, V12, P2623; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; SHERRINGTON R, 1991, AM J HUM GENET, V49, P966; Smith TM, 1996, GENOME RES, V6, P1029, DOI 10.1101/gr.6.11.1029; TONIN P, 1994, HUM MOL GENET, V3, P1679, DOI 10.1093/hmg/3.9.1679; Valero MC, 1996, J MED GENET, V33, P590, DOI 10.1136/jmg.33.7.590; WATKINS WS, 1994, AM J HUM GENET, V55, P348; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Weir BS, 1990, GENETIC ANAL; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WESTIN G, 1984, P NATL ACAD SCI-BIOL, V81, P3811, DOI 10.1073/pnas.81.12.3811; Xu CF, 1997, HUM MOL GENET, V6, P1057, DOI 10.1093/hmg/6.7.1057; Xu CF, 1997, J BIOL CHEM, V272, P20994, DOI 10.1074/jbc.272.34.20994; Zabludoff SD, 1996, ONCOGENE, V13, P649	78	29	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1999	64	5					1427	1439		10.1086/302358	http://dx.doi.org/10.1086/302358			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192RP	10205276	Bronze, Green Published			2022-12-18	WOS:000080093000023
J	Sutherland, GR; Richards, RI				Sutherland, GR; Richards, RI			Fragile sites - Cytogenetic similarity with molecular diversity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							X-SYNDROME; REPEAT; CHROMOSOMES; MUTATION; LOCUS; CELLS; DNA		Womens & Childrens Hosp, Dept Cytogenet & Mol Genet, Adelaide, SA 5006, Australia	Womens & Childrens Hospital Australia	Sutherland, GR (corresponding author), Womens & Childrens Hosp, Dept Cytogenet & Mol Genet, 72 King William Rd, Adelaide, SA 5006, Australia.	gsutherland@medicine.adelaide.edu.au	Sutherland, Grant Robert/D-2606-2012; Richards, Robert/ABE-6423-2020	Richards, Robert Ian/0000-0002-5978-6453				Ashley-Koch AE, 1998, AM J HUM GENET, V63, P776, DOI 10.1086/302018; Carapeti M, 1998, BRIT J CANCER, V78, P601, DOI 10.1038/bjc.1998.547; Coquelle A, 1998, MOL CELL, V2, P259, DOI 10.1016/S1097-2765(00)80137-9; Engelman JA, 1998, FEBS LETT, V436, P403, DOI 10.1016/S0014-5793(98)01134-X; Engelman JA, 1998, AM J HUM GENET, V63, P1578, DOI 10.1086/302172; FalikZaccai TC, 1997, AM J HUM GENET, V60, P103; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; Galbiati F, 1998, EMBO J, V17, P6633, DOI 10.1093/emboj/17.22.6633; Gunter C, 1998, HUM MOL GENET, V7, P1935, DOI 10.1093/hmg/7.12.1935; Hansen RS, 1997, P NATL ACAD SCI USA, V94, P4587, DOI 10.1073/pnas.94.9.4587; Hewett DR, 1998, MOL CELL, V1, P773, DOI 10.1016/S1097-2765(00)80077-5; HIRST MC, 1994, HUM MOL GENET, V3, P1553, DOI 10.1093/hmg/3.9.1553; Huang HJ, 1998, GENE CHROMOSOME CANC, V21, P152, DOI 10.1002/(SICI)1098-2264(199802)21:2<152::AID-GCC11>3.0.CO;2-T; Inoue H, 1997, P NATL ACAD SCI USA, V94, P14584, DOI 10.1073/pnas.94.26.14584; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; JONES CPJ, 1995, MICRON, V2, P145; Le Beau MM, 1998, HUM MOL GENET, V7, P755, DOI 10.1093/hmg/7.4.755; Li ZJ, 1998, J VIROL, V72, P4205, DOI 10.1128/JVI.72.5.4205-4211.1998; Malter HE, 1997, NAT GENET, V15, P165, DOI 10.1038/ng0297-165; Mishmar D, 1998, P NATL ACAD SCI USA, V95, P8141, DOI 10.1073/pnas.95.14.8141; NANCARROW JK, 1995, HUM MOL GENET, V4, P367, DOI 10.1093/hmg/4.3.367; NANCARROW JK, 1994, SCIENCE, V264, P1938, DOI 10.1126/science.8009225; Otterson GA, 1998, J NATL CANCER I, V90, P426, DOI 10.1093/jnci/90.6.426; Palin AH, 1998, J CELL SCI, V111, P1623; RICHARDS RI, 1994, NAT GENET, V6, P114, DOI 10.1038/ng0294-114; RICHARDS RI, 1992, NAT GENET, V1, P257, DOI 10.1038/ng0792-257; ROUSSEAU F, 1991, J MED GENET, V28, P830, DOI 10.1136/jmg.28.12.830; Sarkar PS, 1998, CELL, V95, P531, DOI 10.1016/S0092-8674(00)81620-7; SCHMID M, 1986, HUM GENET, V74, P67; Sinden RR, 1999, AM J HUM GENET, V64, P346, DOI 10.1086/302271; Siprashvili Z, 1997, P NATL ACAD SCI USA, V94, P13771, DOI 10.1073/pnas.94.25.13771; SMEETS DFCM, 1986, HUM GENET, V72, P215, DOI 10.1007/BF00291880; SUTHERLAND GR, 1985, TRENDS GENET, V1, P108, DOI 10.1016/0168-9525(85)90042-3; Sutherland GR, 1998, TRENDS GENET, V14, P501, DOI 10.1016/S0168-9525(98)01628-X; SUTHERLAND GR, 1996, ENCY MOL BIOL MOL ME, V2, P313; Yu S, 1997, CELL, V88, P367, DOI 10.1016/S0092-8674(00)81875-9	36	29	29	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					354	359		10.1086/302267	http://dx.doi.org/10.1086/302267			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973272	Bronze, Green Published			2022-12-18	WOS:000078740600004
J	Lalwani, AK; Luxford, WM; Mhatre, AN; Attaie, A; Wilcox, ER; Castelein, CM				Lalwani, AK; Luxford, WM; Mhatre, AN; Attaie, A; Wilcox, ER; Castelein, CM			A new locus for nonsyndromic hereditary hearing impairment, DFNA17, maps to chromosome 22 and represents a gene for cochleosaccular degeneration	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							TEMPORAL BONE FINDINGS; MYOSIN HEAVY-CHAIN; LINKAGE; MUTATION		Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, Lab Mol Otol, San Francisco, CA 94143 USA; House Ear Clin, Los Angeles, CA USA; Natl Inst Deafness & Other Commun Disorders, Mol Genet Lab, Bethesda, MD USA	University of California System; University of California San Francisco; House Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Lalwani, AK (corresponding author), Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, Lab Mol Otol, San Francisco, CA 94143 USA.	lalwani@itsa.ucsf.edu	, Otto/P-4127-2018	, Otto/0000-0003-2101-4105	NIDCD NIH HHS [K08 DC 00112, DC00026] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000035, K08DC000112] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ARNOS KS, 1992, OTOLARYNG CLIN N AM, V25, P953; BERGSTROM L, 1980, ANN OTO RHINOL LARYN, V89, P31, DOI 10.1177/00034894800890S511; BOCK GR, 1983, ACTA OTO-LARYNGOL, V96, P39, DOI 10.3109/00016488309132873; BOEHNKE M, 1986, AM J HUM GENET, V39, P513; BROOKHOUSER PJ, 1994, CURRENT THERAPY OTOL, P44; Cohen M. M., 1995, HEREDITARY HEARING L, P9; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Denoyelle F, 1998, NATURE, V393, P319, DOI 10.1038/30639; FRASER GR, 1995, CAUSES PROFOUND DEAF; Gulya A. Julianna, 1992, Ear Nose and Throat Journal, V71, P499; KHETARPAL U, 1991, ARCH OTOLARYNGOL, V117, P1032; KHETARPAL U, 1993, ARCH OTOLARYNGOL, V119, P106; Lalwani AK, 1999, AM J OTOL, V20, P115; Lalwani AK, 1997, AUDIOL NEURO-OTOL, V2, P139, DOI 10.1159/000259237; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; Lynch ED, 1997, SCIENCE, V278, P1315, DOI 10.1126/science.278.5341.1315; Mair I W, 1973, Acta Otolaryngol Suppl, V314, P1; Manolis EN, 1996, HUM MOL GENET, V5, P1047, DOI 10.1093/hmg/5.7.1047; ORMEROD F C, 1960, J Laryngol Otol, V74, P919, DOI 10.1017/S0022215100057376; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; SAEZ CG, 1990, P NATL ACAD SCI USA, V87, P1164, DOI 10.1073/pnas.87.3.1164; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SIMONS M, 1991, CIRC RES, V69, P530, DOI 10.1161/01.RES.69.2.530; STEEL KP, 1983, ARCH OTOLARYNGOL, V109, P22; TOOTHAKER LE, 1991, BLOOD, V78, P1826; Vahava O, 1998, SCIENCE, V279, P1950, DOI 10.1126/science.279.5358.1950; Verhoeven K, 1998, NAT GENET, V19, P60, DOI 10.1038/ng0598-60; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; WEBER JL, 1989, AM J HUM GENET, V44, P388	29	29	30	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					318	323		10.1086/302216	http://dx.doi.org/10.1086/302216			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164RM	9915977	Bronze, Green Published			2022-12-18	WOS:000078477400043
J	Whittaker, JC; Lewis, CM				Whittaker, JC; Lewis, CM			The effect of family structure on linkage tests using allelic association	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PARENTS; TDT	We considered the problem of testing a marker for linkage with a disease, using tests based on the transmission-disequilibrium test (TDT). The power of such tests was investigated for a number of possible family types, for which the families were classified by the disease status of family individuals. We show that parental disease status greatly affects the power, with families containing a single affected parent often preferred over families in which neither parent is affected. Families with a pair of affected sibs are of great value for all situations considered, but extension of the TDT to allow inclusion of information from unaffected sibs rarely increases power, if the parents have been genotyped.	Univ Reading, Dept Appl Stat, Reading RG6 2FN, Berks, England; United Med & Dent Sch Guys & St Thomass Hosp, Guys Hosp, Div Med & Mol Genet, London SE1 7EH, England	University of Reading; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Whittaker, JC (corresponding author), Univ Reading, Dept Appl Stat, POB 240,Whiteknights Rd, Reading RG6 2FN, Berks, England.	j.c.whittaker@reading.ac.uk	Lewis, Cathryn/M-8766-2019; Whittaker, John C/B-8609-2012; Lewis, Cathryn M/A-5225-2010	Lewis, Cathryn/0000-0002-8249-8476; Whittaker, John C/0000-0002-3529-2379; Lewis, Cathryn M/0000-0002-8249-8476	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000571] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00571] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Boehnke M, 1997, AM J HUM GENET, V61, pA269; Boehnke M, 1998, AM J HUM GENET, V62, P950, DOI 10.1086/301787; Cox DR., 1974, THEORETICAL STAT; Curnow RN, 1998, J ROY STAT SOC C-APP, V47, P63, DOI 10.1111/1467-9876.00098; Curtis D, 1997, ANN HUM GENET, V61, P319, DOI 10.1017/S000348009700626X; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SCHAID DJ, 1994, AM J HUM GENET, V55, P402; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; SELF SG, 1991, BIOMETRICS, V47, P53, DOI 10.2307/2532495; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; Spielman RS, 1996, AM J HUM GENET, V59, P983; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; THOMPSON DJ, 1997, THESIS U READING REA	13	29	32	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1998	63	3					889	897		10.1086/302008	http://dx.doi.org/10.1086/302008			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	119VN	9718338	Green Published, Bronze			2022-12-18	WOS:000075919000028
J	Liede, A; Rehal, P; Vesprini, D; Jack, E; Abrahamson, J; Narod, SA				Liede, A; Rehal, P; Vesprini, D; Jack, E; Abrahamson, J; Narod, SA			A breast cancer patient of Scottish descent with germ-line mutations in BRCA1 and BRCA2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							FREQUENCY		Univ Toronto, Toronto, ON M5G 1N8, Canada; Womens Coll Hosp, Toronto, ON M5G 1N8, Canada; Ontario Canc Genet Network, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Liede, A (corresponding author), Univ Toronto, 790 Bay St,Suite 750A Toronto, Toronto, ON M5G 1N8, Canada.		Narod, Steven A/AAA-6112-2022					EASTON D, 1993, CANCER SURV, V18, P1; FORD D, 1995, AM J HUM GENET, V57, P1457; Ramus SJ, 1997, NAT GENET, V15, P14, DOI 10.1038/ng0197-14; Roa BB, 1996, NAT GENET, V14, P185, DOI 10.1038/ng1096-185; Tonin P, 1996, NAT MED, V2, P1179, DOI 10.1038/nm1196-1179	5	29	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1543	1544		10.1086/301889	http://dx.doi.org/10.1086/301889			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585617	Green Published, Bronze			2022-12-18	WOS:000074174700034
J	Feil, R; Kelsey, G				Feil, R; Kelsey, G			Genomic imprinting: A chromatin connection	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALLELE-SPECIFIC REPLICATION; IN-VITRO DIFFERENTIATION; EMBRYONIC STEM-CELLS; GENE-EXPRESSION; MEIOTIC RECOMBINATION; DNA METHYLATION; X-CHROMOSOME; REGION; MAMMALS; DOMAIN		Babraham Inst, Dept Genet & Dev, Cambridge CB2 4AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Feil, R (corresponding author), Babraham Inst, Dept Genet & Dev, Cambridge CB2 4AT, England.		Feil, Robert P/D-2087-2013	Feil, Robert P/0000-0002-5671-5860; Kelsey, Gavin/0000-0002-9762-5634				Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; [Anonymous], 1995, METABOLIC MOL BASES; ANTEQUERA F, 1989, CELL, V58, P509, DOI 10.1016/0092-8674(89)90431-5; BARLOW DP, 1995, SCIENCE, V270, P1610, DOI 10.1126/science.270.5242.1610; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; BICKMORE WA, 1995, J CELL SCI, V108, P2801; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; CATTANACH BM, 1997, GENOMIC IMPRINTING, P118; FEIL R, 1995, DEV GENET, V17, P240, DOI 10.1002/dvg.1020170309; Feil R, 1997, J BIOL CHEM, V272, P20893, DOI 10.1074/jbc.272.33.20893; FUNDELE RH, 1997, GENOMIC IMPRINTING, P98; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; GUNARATNE PH, 1995, GENE DEV, V9, P808, DOI 10.1101/gad.9.7.808; HEBBES TR, 1994, EMBO J, V13, P1823, DOI 10.1002/j.1460-2075.1994.tb06451.x; HENDRICH BD, 1995, HUM MOL GENET, V4, P1765, DOI 10.1093/hmg/4.suppl_1.1765; HOLMQUIST GP, 1987, AM J HUM GENET, V40, P151; IZUMIKAWA Y, 1991, HUM GENET, V87, P1, DOI 10.1007/BF01213082; Jeppesen P, 1997, BIOESSAYS, V19, P67, DOI 10.1002/bies.950190111; JEPPESEN P, 1993, CELL, V74, P281, DOI 10.1016/0092-8674(93)90419-Q; KAMAKAKA RT, 1990, EMBO J, V9, P3997, DOI 10.1002/j.1460-2075.1990.tb07621.x; KAWAME H, 1995, HUM MOL GENET, V4, P2287, DOI 10.1093/hmg/4.12.2287; KITSBERG D, 1993, NATURE, V364, P459, DOI 10.1038/364459a0; KNOLL JHM, 1994, NAT GENET, V6, P41, DOI 10.1038/ng0194-41; KOIDE T, 1994, GENOMICS, V24, P1, DOI 10.1006/geno.1994.1574; LASALLE JM, 1995, NAT GENET, V9, P386, DOI 10.1038/ng0495-386; LEDBETTER DH, 1995, HUM MOL GENET, V4, P1757, DOI 10.1093/hmg/4.suppl_1.1757; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Lyko F, 1997, NAT GENET, V16, P171, DOI 10.1038/ng0697-171; McArthur M, 1996, EMBO J, V15, P1705, DOI 10.1002/j.1460-2075.1996.tb00516.x; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Neumann B, 1996, CURR OPIN GENET DEV, V6, P159, DOI 10.1016/S0959-437X(96)80045-1; NICHOLLS RD, 1994, AM J HUM GENET, V54, P733; PALDI A, 1995, CURR BIOL, V5, P1030, DOI 10.1016/S0960-9822(95)00207-7; PEDERSEN RA, 1994, REPROD FERT DEVELOP, V6, P543, DOI 10.1071/RD9940543; RIGGS AD, 1992, TRENDS GENET, V8, P169, DOI 10.1016/0168-9525(92)90219-T; RILEY DE, 1986, SOMAT CELL MOLEC GEN, V12, P73, DOI 10.1007/BF01560729; Robertson KD, 1997, AM J HUM GENET, V61, P1220, DOI 10.1086/301658; ROBINSON WP, 1995, HUM MOL GENET, V4, P801, DOI 10.1093/hmg/4.5.801; SASAKI H, 1992, GENE DEV, V6, P1843, DOI 10.1101/gad.6.10.1843; Shibata H, 1996, GENOMICS, V35, P248, DOI 10.1006/geno.1996.0348; Squire J, 1996, SEMIN CANCER BIOL, V7, P41, DOI 10.1006/scbi.1996.0006; SZABO P, 1994, DEVELOPMENT, V120, P1651; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; Tsukiyama T, 1997, CURR OPIN GENET DEV, V7, P182, DOI 10.1016/S0959-437X(97)80127-X; vanHolde K, 1996, P NATL ACAD SCI USA, V93, P10548, DOI 10.1073/pnas.93.20.10548; WOLF SF, 1985, NATURE, V314, P467, DOI 10.1038/314467a0; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	48	29	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1997	61	6					1213	1219		10.1086/301655	http://dx.doi.org/10.1086/301655			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YT019	9399913	Bronze, Green Published			2022-12-18	WOS:000071555900001
J	Monteiro, ANA; August, A; Hanafusa, H				Monteiro, ANA; August, A; Hanafusa, H			Common BRCA1 variants and transcriptional activation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							OVARIAN-CANCER; FAMILIAL BREAST; REGION		ROCKEFELLER UNIV,MOL ONCOL LAB,NEW YORK,NY 10021	Rockefeller University			Monteiro, Alvaro N. A./A-7566-2009	Monteiro, Alvaro N. A./0000-0002-8448-4801	NATIONAL CANCER INSTITUTE [R35CA044356] Funding Source: NIH RePORTER; NCI NIH HHS [CA44356] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; Dunning AM, 1997, HUM MOL GENET, V6, P285, DOI 10.1093/hmg/6.2.285; EASTON DF, 1993, AM J HUM GENET, V52, P678; Koonin EV, 1996, NAT GENET, V13, P266, DOI 10.1038/ng0796-266; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; NEUHAUSEN SL, 1994, CANCER RES, V54, P6069; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; SMITH SA, 1992, NAT GENET, V2, P128, DOI 10.1038/ng1092-128	9	29	29	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1997	61	3					761	762		10.1086/515515	http://dx.doi.org/10.1086/515515			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY523	9326340	Bronze, Green Published			2022-12-18	WOS:A1997XY52300032
J	Bahring, S; Nagai, T; Toka, HR; Nitz, I; Toka, O; Aydin, A; Muhl, A; Wienker, TF; Schuster, H; Luft, FC				Bahring, S; Nagai, T; Toka, HR; Nitz, I; Toka, O; Aydin, A; Muhl, A; Wienker, TF; Schuster, H; Luft, FC			Deletion at 12p in a Japanese child with brachydactyly overlaps the assigned locus of brachydactyly with hypertension in a Turkish family	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							METACARPOPHALANGEAL		FRANZ VOLHARD CLIN,D-13122 BERLIN,GERMANY; HUMBOLDT UNIV BERLIN,KLINIKUM RUDOLF VIRCHOW,MAX DELBRUCK CTR MOL MED,D-13122 BERLIN,GERMANY; TOKYO METROPOLITAN KIYOSE CHILDRENS HOSP,DIV PEDIAT NEUROL,TOKYO,JAPAN	Franz-Volhard Clinical Research Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine			Toka, Hakan/AAQ-2162-2021; Schalling, Martin/F-1518-2015	Luft, Friedrich/0000-0002-8635-1199; Schalling, Martin/0000-0001-5011-2922				BILGINTURAN N, 1973, J MED GENET, V10, P253, DOI 10.1136/jmg.10.3.253; GARN SM, 1972, RADIOLOGY, V105, P375, DOI 10.1148/105.2.375; Giedion A, 1967, Ann Radiol (Paris), V10, P322; Giertion A, 1965, ANN RADIOL, V8, P135; NAGAI T, 1995, AM J MED GENET, V55, P16, DOI 10.1002/ajmg.1320550106; POZNANSK.AK, 1972, RADIOLOGY, V104, P1; Poznanski A. K., 1984, HAND RADIOLOGIC DIAG; Schuster H, 1996, NAT GENET, V13, P98, DOI 10.1038/ng0596-98; SPIEGEL AM, 1995, ANNU REV PHYSIOL, V58, P143; WILKIE AOM, 1994, J MED GENET, V31, P89, DOI 10.1136/jmg.31.2.89; ZIEGLE JS, 1992, GENOMICS, V14, P1026, DOI 10.1016/S0888-7543(05)80126-0	11	29	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1997	60	3					732	735						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK403	9042935				2022-12-18	WOS:A1997WK40300032
J	Filosa, S; Giacometti, N; Cai, WW; DeMattia, D; Pagnini, D; Alfinito, F; Schettini, F; Luzzatto, L; Martini, G				Filosa, S; Giacometti, N; Cai, WW; DeMattia, D; Pagnini, D; Alfinito, F; Schettini, F; Luzzatto, L; Martini, G			Somatic-cell selection is a major determinant of the blood-cell phenotype in heterozygotes for glucose-6-phosphate dehydrogenase mutations causing severe enzyme deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NONSPHEROCYTIC HEMOLYTIC-ANEMIA; X-CHROMOSOME INACTIVATION; G6PD DEFICIENCY; ENCODING GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; VARIANT; GENE; SUSCEPTIBILITY; EXPRESSION; APOPTOSIS; G-6-PD	X-chromosome inactivation in mammals is regarded as an essentially random process, but the resulting somatic-cell mosaicism creates the opportunity for cell selection. In most people with red-blood-cell glucose-6-phosphate dehydrogenase (G6PD) deficiency, the enzyme-deficient phenotype is only moderately expressed in nucleated cells. However, in a small subset of hemizygous males who suffer from chronic nonspherocytic hemolytic anemia, the underlying mutations (designated class I) cause more-severe G6PD deficiency, and this might provide an opportunity for selection in heterozygous females during development. In order to test this possibility we have analyzed four heterozygotes for class I G6PD mutations: two with G6PD Portici (1178G-->A) and two with G6PD Bari (1187C-->T). We found that in fractionated blood cell types (including erythroid, myeloid, and lymphoid cell lineages) there was a significant excess of G6PD-normal cells. The significant concordance that we have observed in the degree of imbalance in the different blood-cell lineages indicates that a selective mechanism is likely to operate at the level of pluripotent blood stem cells. Thus, it appears that severe G6PD deficiency affects adversely the proliferation or the survival of nucleated blood cells and that this phenotypic characteristic is critical during hematopoiesis.	CNR,IST INT GENET & BIOFIS,I-80125 NAPLES,ITALY; POLICLIN UNIV BARI,DIPARTIMENTO BIOMED ETA EVOLUT,BARI,ITALY; OSPED SAN FELICE CANCELLO,ASL CE1,CASERTA,ITALY; MEM SLOAN KETTERING CANC CTR,NEW YORK,NY 10021	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Universita degli Studi di Bari Aldo Moro; Memorial Sloan Kettering Cancer Center			Filosa, Stefania/A-4609-2014	Martini, Giuseppe/0000-0003-2871-4243; Filosa, Stefania/0000-0003-2896-3362				ALLEN RC, 1994, AM J HUM GENET, V54, P25; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; BEUTLER E, 1964, COLD SPRING HARB SYM, V29, P261, DOI 10.1101/SQB.1964.029.01.029; BEUTLER E, 1986, AM J HEMATOL, V23, P25, DOI 10.1002/ajh.2830230105; BEUTLER E, 1968, BLOOD, V31, P131, DOI 10.1182/blood.V31.2.131.131; BEUTLER E, 1988, MEDICINE, V67, P311, DOI 10.1097/00005792-198809000-00003; BEUTLER E, 1987, AM J HEMATOL, V24, P357; BEUTLER E, 1986, GLUCOSE 6 PHOSPHATE, P405; BREWER GEORGE J., 1967, BIOCHEM GENET, V1, P41, DOI 10.1007/BF00487735; CATTANACH B, 1972, GENET RES, V15, P229; CHAN TK, 1972, BIOCHEM GENET, V6, P119, DOI 10.1007/BF00486396; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COLONNAROMANO S, 1985, HUM GENET, V69, P228, DOI 10.1007/BF00293030; CORRONS JLV, 1982, BLOOD, V59, P428; CURNUTTE JT, 1992, LANCET, V339, P749, DOI 10.1016/0140-6736(92)90653-K; EFFERTH T, 1995, J MOL MED-JMM, V73, P47, DOI 10.1007/BF00203619; ELIZONDO J, 1982, HUM GENET, V62, P110; ENGSTROM PF, 1970, BLOOD-J HEMATOL, V36, P10, DOI 10.1182/blood.V36.1.10.10; FAIRBAIRN LJ, 1993, CELL, V74, P823, DOI 10.1016/0092-8674(93)90462-Y; FAIRBANKS VF, 1980, BLOOD, V55, P216; FIALKOW PJ, 1973, ANN HUM GENET, V37, P39, DOI 10.1111/j.1469-1809.1973.tb01813.x; FILOSA S, 1992, BRIT J HAEMATOL, V80, P111, DOI 10.1111/j.1365-2141.1992.tb06409.x; FILOSA S, 1994, HUM GENET, V94, P560, DOI 10.1007/BF00211027; FRAENKEL DG, 1968, J BACTERIOL, V95, P1267, DOI 10.1128/JB.95.4.1267-1271.1968; FUJII H, 1984, HUM GENET, V66, P276, DOI 10.1007/BF00286616; FUJII HMS, 1981, HUM GENET, V48, P405; GAETANI GF, 1990, HUM GENET, V84, P337; GALE RE, 1991, BRIT J HAEMATOL, V79, P193, DOI 10.1111/j.1365-2141.1991.tb04521.x; GARTLER SM, 1964, COLD SPRING HARB SYM, V29, P253, DOI 10.1101/SQB.1964.029.01.028; GVOZDEV VA, 1976, FEBS LETT, V64, P85, DOI 10.1016/0014-5793(76)80255-4; HALL K, 1988, HUM GENET, V79, P90, DOI 10.1007/BF00291720; HIRONO A, 1993, BLOOD, V82, P3250; HUGHES MB, 1977, SCIENCE, V196, P1114, DOI 10.1126/science.404711; JOHNSON GJ, 1977, BLOOD, V49, P247; KAHN A, 1977, HUM GENET, V39, P353, DOI 10.1007/BF00295431; LISKER R, 1985, HUM GENET, V69, P19, DOI 10.1007/BF00295523; LUZZATTO L, 1979, BLOOD, V54, P961; LUZZATTO L, 1995, GLUCOSE 6 PHOSPHATE, P3367; LYON MF, 1992, ANNU REV GENET, V26, P17, DOI 10.1146/annurev.ge.26.120192.000313; MENTZER WCJ, 1980, BLOOD, V2, P195; MIGEON BR, 1981, P NATL ACAD SCI-BIOL, V78, P5066, DOI 10.1073/pnas.78.8.5066; MILLER DR, 1974, BLOOD, V44, P323, DOI 10.1182/blood.V44.3.323.323; MIWA S, 1978, HUM GENET, V45, P11, DOI 10.1007/BF00277568; MORISAKI T, 1983, HUM GENET, V65, P214, DOI 10.1007/BF00286669; NANCE WE, 1964, COLD SPRING HARB SYM, V29, P415, DOI 10.1101/SQB.1964.029.01.043; NOGAE I, 1990, GENE, V96, P161, DOI 10.1016/0378-1119(90)90248-P; NYHAN WL, 1970, P NATL ACAD SCI USA, V65, P214, DOI 10.1073/pnas.65.1.214; OGURA H, 1988, HUM GENET, V78, P369, DOI 10.1007/BF00291738; PANDOLFI PP, 1995, EMBO J, V14, P5209, DOI 10.1002/j.1460-2075.1995.tb00205.x; PICAT C, 1980, HUM GENET, V55, P125, DOI 10.1007/BF00329139; POTOCNIK AJ, 1994, EMBO J, V13, P5274, DOI 10.1002/j.1460-2075.1994.tb06861.x; PRCHAL JT, 1980, BLOOD, V56, P476; PRCHAL JT, 1993, BLOOD, V81, P269; RATTAZZI MC, 1971, BLOOD-J HEMATOL, V38, P205, DOI 10.1182/blood.V38.2.205.205; RAVINDRANATH Y, 1987, AM J HEMATOL, V24, P357, DOI 10.1002/ajh.2830240405; RINALDI A, 1976, AM J HUM GENET, V28, P496; SAENZ GF, 1984, ACTA HAEMATOL-BASEL, V72, P37, DOI 10.1159/000206354; SYKES BC, 1983, LANCET, V2, P787; TAKAHASHI K, 1982, HUM GENET, V62, P368, DOI 10.1007/BF00304560; TALALAK P, 1969, BLOOD-J HEMATOL, V33, P772, DOI 10.1182/blood.V33.5.772.772; THOMAS D, 1991, EMBO J, V10, P547, DOI 10.1002/j.1460-2075.1991.tb07981.x; TOWN M, 1990, SOMAT CELL MOLEC GEN, V16, P97, DOI 10.1007/BF01233040; VACA G, 1982, HUM GENET, V61, P175, DOI 10.1007/BF00274214; VULLIAMY TJ, 1988, P NATL ACAD SCI USA, V85, P5171, DOI 10.1073/pnas.85.14.5171; WONG PWK, 1965, NATURE, V208, P1323, DOI 10.1038/2081323a0	65	29	29	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1996	59	4					887	895						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL283	8808605				2022-12-18	WOS:A1996VL28300019
J	Lindsay, S; Splitt, M; Edney, S; Berney, TP; Knight, SJL; Davies, KE; OBrien, O; Gale, M; Burn, J				Lindsay, S; Splitt, M; Edney, S; Berney, TP; Knight, SJL; Davies, KE; OBrien, O; Gale, M; Burn, J			PPM-X: A new X-linked mental retardation syndrome with psychosis, pyramidal signs, and macroorchidism maps to Xq28	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; BASAL GANGLIA DISORDER; FRAGILE-X; CHROMOSOME MARKERS; PRENATAL-DIAGNOSIS; LINKAGE; GENE; IDENTIFICATION; LOCALIZATION; PEDIGREES	We report a three-generation family manifesting a previously undescribed X-linked mental retardation syndrome. Four of the six moderately retarded males have had episodes of manic-depressive psychosis. The phenotype also includes pyramidal signs, Parkinsonian features, and macroorchidism, but there are no characteristic dysmorphic facial features. Affected males do not show fragile sites at distal Xq on cytogenetic analysis, nor do they have expansions of the CGG repeats at the FRAXA, FRAXE, or FRAXF loci. Linkage analyses were undertaken, and a maximal LOD score of 3.311 at theta = .0 was observed with the microsatellite marker DXS1123 in Xq28. A recombination was detected in one of the affected males with DXS1691 (Xq28), which gives the proximal boundary of the localization. No distal recombination has been detected at any of the loci tested.	PRUDHOE HOSP,PRUDHOE NE42 5NT,NORTHD,ENGLAND; INST MOLEC MED,OXFORD,ENGLAND	University of Oxford	Lindsay, S (corresponding author), UNIV NEWCASTLE UPON TYNE,DEPT HUMAN GENET,19-20 CLAREMONT PL,NEWCASTLE TYNE NE2 4AA,TYNE & WEAR,ENGLAND.			Lindsay, Susan/0000-0003-2980-4582; Burn, John/0000-0002-9823-2322; Knight, Samantha/0000-0002-6047-3462	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALLEN RC, 1992, HUM MOL GENET, V1, P216, DOI 10.1093/hmg/1.3.216; BARON M, 1987, NATURE, V326, P289, DOI 10.1038/326289a0; BARON M, 1993, NAT GENET, V3, P49, DOI 10.1038/ng0193-49; BERNEY T P, 1988, Australia and New Zealand Journal of Developmental Disabilities, V14, P219; BROWN WT, 1993, JAMA-J AM MED ASSOC, V270, P1569, DOI 10.1001/jama.270.13.1569; BUCKLE VJ, 1989, NEURON, V3, P645; DEBRUYN A, 1994, AM J MED GENET, V54, P411, DOI 10.1002/ajmg.1320540423; DONNELLY A, 1994, GENOMICS, V20, P363, DOI 10.1006/geno.1994.1189; FREIJE D, 1992, SCIENCE, V258, P1784, DOI 10.1126/science.1465614; GEDEON A, 1991, J MED GENET, V28, P372, DOI 10.1136/jmg.28.6.372; GEDEON AK, 1995, AM J HUM GENET, V56, P907; GREGG RG, 1991, GENOMICS, V9, P701, DOI 10.1016/0888-7543(91)90363-J; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HICKS AA, 1991, NUCLEIC ACIDS RES, V19, P4016, DOI 10.1093/nar/19.14.4016; HIRST M, 1991, LANCET, V338, P956, DOI 10.1016/0140-6736(91)91831-E; Kenwrick S, 1996, J MED GENET, V33, P59, DOI 10.1136/jmg.33.1.59; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; LALLOZ MRA, 1994, BRIT J HAEMATOL, V86, P804; LAXOVA R, 1985, AM J MED GENET, V21, P681, DOI 10.1002/ajmg.1320210409; NELSON DL, 1995, CYTOGENET CELL GENET, V71, P308; NERI G, 1994, AM J MED GENET, V51, P542, DOI 10.1002/ajmg.1320510451; NORDSTROM AM, 1992, HUM GENET, V90, P263, DOI 10.1007/BF00220075; OTT J, 1974, AM J HUM GENET, V26, P588; PAULS DL, 1993, NAT GENET, V3, P4, DOI 10.1038/ng0193-4; PORTEOUS MEM, 1992, GENOMICS, V14, P298, DOI 10.1016/S0888-7543(05)80219-8; RICHARDS B, 1991, NUCLEIC ACIDS RES, V19, P1944, DOI 10.1093/nar/19.8.1944; RIGGINS GJ, 1992, AM J MED GENET, V43, P237, DOI 10.1002/ajmg.1320430138; RITCHIE RJ, 1994, HUM MOL GENET, V3, P2115, DOI 10.1093/hmg/3.12.2115; SZYMANSKI LS, 1989, COMPREHENSIVE TXB PS, P1728; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H	31	29	30	1	23	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1996	58	6					1120	1126						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UM271	8651288				2022-12-18	WOS:A1996UM27100004
J	Petraroli, R; Pocchiari, M				Petraroli, R; Pocchiari, M			Codon 219 polymorphism of PRNP in healthy Caucasians and Creutzfeldt-Jakob disease patients	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							PRION PROTEIN GENE; POINT MUTATION; CJD		IST SUPER SANITA,VIROL LAB,SECT PERSISTENT & SLOW VIRUS INFECT,I-00161 ROME,ITALY	Istituto Superiore di Sanita (ISS)			Pocchiari, Maurizio/J-8443-2018	Pocchiari, Maurizio/0000-0002-7269-2486				BARBANTI P, 1994, NEUROBIOL AGING, V15, pS156, DOI 10.1016/0197-4580(94)93094-5; BROWN P, 1994, NEUROLOGY, V44, P291, DOI 10.1212/WNL.44.2.291; COLLINGE J, 1991, LANCET, V337, P1441, DOI 10.1016/0140-6736(91)93128-V; DOHURA K, 1991, NATURE, V353, P801, DOI 10.1038/353801b0; FURUKAWA H, 1995, MOL BRAIN RES, V30, P385, DOI 10.1016/0169-328X(95)00034-P; GABIZON R, 1993, AM J HUM GENET, V53, P828; GOLDFARB LG, 1995, ANNU REV MED, V46, P57; GOLDFARB LG, 1992, SCIENCE, V258, P806, DOI 10.1126/science.1439789; HAINFELLNER JA, 1995, BRAIN PATHOL, V5, P201, DOI 10.1111/j.1750-3639.1995.tb00596.x; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; MIYAZONO M, 1992, ACTA NEUROPATHOL, V84, P349; OWEN F, 1990, AM J HUM GENET, V46, P1215; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; POCCHIARI M, 1993, ANN NEUROL, V34, P802, DOI 10.1002/ana.410340608; POCCHIARI M, 1994, MOL ASPECTS MED, V15, P195, DOI 10.1016/0098-2997(94)90042-6; POULTER M, 1992, BRAIN, V115, P675, DOI 10.1093/brain/115.3.675; SALVATORE M, 1994, HUM GENET, V94, P375, DOI 10.1007/BF00201596	17	29	29	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1996	58	4					888	889						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UA380	8644754				2022-12-18	WOS:A1996UA38000028
J	ALLEY, TL; GRAY, BA; LEE, SH; SCHERER, SW; TSUI, LC; TINT, GS; WILLIAMS, CA; ZORI, R; WALLACE, MR				ALLEY, TL; GRAY, BA; LEE, SH; SCHERER, SW; TSUI, LC; TINT, GS; WILLIAMS, CA; ZORI, R; WALLACE, MR			IDENTIFICATION OF A YEAST ARTIFICIAL CHROMOSOME CLONE SPANNING A TRANSLOCATION BREAKPOINT AT 7Q32.1 IN A SMITH-LEMLI-OPITZ SYNDROME PATIENT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							YAC CLONES; HYBRIDIZATION; PCR	Smith-Lemli-Opitz syndrome (SLOS) is a mental retardation/multiple congenital anomaly syndrome. The gene(s) involved has not been mapped or cloned, but, recently, a biochemical abnormality in cholesterol biosynthesis has been shown to occur in most SLOS patients. The defect is suspected to occur in the penultimate step of the cholesterol pathway, involving the enzyme 7-dehydrocholesterol reductase, which has not been isolated. On the basis of the hypothesis that a de novo balanced translocation [t(7;20)(q32.1; q13.2)] in an SLOS patient directly interrupts the SLOS gene, positional cloning techniques are being employed to localize and identify the SLOS gene. We report the identification of a chromosome 7-specific YAC that spans the translocation breakpoint, as detected by FISH. This is the first study narrowing a candidate SLOS region and placing it on physical and genetic maps of the human genome.	UNIV FLORIDA,COLL MED,HLTH SCI CTR,DEPT PEDIAT,DIV GENET,GAINESVILLE,FL 32610; UNIV FLORIDA,COLL MED,DEPT BIOCHEM & MOLEC BIOL,GAINESVILLE,FL 32610; UNIV FLORIDA,COLL MED,CTR MAMMALIAN GENET,GAINESVILLE,FL 32610; UNIV FLORIDA,COLL MED,RAYMOND C PHILIPS UNIT,GAINESVILLE,FL 32610; UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO,ON,CANADA; HOSP SICK CHILDREN,DEPT GENET,TORONTO,ON M5G 1X8,CANADA; VET AFFAIRS MED CTR,DEPT MED,E ORANGE,NJ; UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,NEWARK,NJ 07103	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); US Department of Veterans Affairs; Veterans Health Administration (VHA); Rutgers State University New Brunswick; Rutgers State University Medical Center			Tsui, Lap-chee/A-1081-2010; Scherer, Stephen W./B-3785-2013	Scherer, Stephen W./0000-0002-8326-1999				BROOKSWILSON AR, 1990, GENOMICS, V7, P614, DOI 10.1016/0888-7543(90)90207-B; CHERSTVOY ED, 1984, VIRCHOWS ARCH A, V404, P413, DOI 10.1007/BF00695225; CURRY C J R, 1987, American Journal of Medical Genetics, V26, P45, DOI 10.1002/ajmg.1320260110; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HAYES KC, 1992, J PEDIATR-US, V120, pS109, DOI 10.1016/S0022-3476(05)81244-2; IRONS M, 1993, LANCET, V341, P1414, DOI 10.1016/0140-6736(93)90983-N; KUNZ J, 1994, GENOMICS, V22, P439, DOI 10.1006/geno.1994.1407; LENGAUER C, 1992, GENOMICS, V13, P826, DOI 10.1016/0888-7543(92)90160-T; LOWRY RB, 1980, AM J MED GENET, V5, P137, DOI 10.1002/ajmg.1320050205; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; SCHERER S, 1991, P33; SCHERER SW, 1992, MAMM GENOME, V3, P179, DOI 10.1007/BF00352464; SCHERER SW, 1993, HUM MOL GENET, V6, P751; SMITH DW, 1964, J PEDIATR-US, V64, P210, DOI 10.1016/S0022-3476(64)80264-X; TAGLE DA, 1992, HUM MOL GENET, V2, P121; TINT GS, 1994, NEW ENGL J MED, V330, P107, DOI 10.1056/NEJM199401133300205; WALLACE M, 1994, AM J MED GENET, V50, P368, DOI 10.1002/ajmg.1320500414; YUNIS JJ, 1974, HUMAN CHROOMOSOME ME	19	29	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1995	56	6					1411	1416						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA794	7762564				2022-12-18	WOS:A1995RA79400020
J	OTTMAN, R				OTTMAN, R			GENE-ENVIRONMENT INTERACTION AND PUBLIC-HEALTH	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							BREAST-CANCER; RISK-FACTORS; REPRODUCTIVE FACTORS; FAMILIAL BREAST; DISEASE; HISTORY; LINKAGE		COLUMBIA UNIV,SCH PUBL HLTH,DIV EPIDEMIOL,NEW YORK,NY; NEW YORK STATE PSYCHIAT INST & HOSP,EPIDEMIOL BRAIN DISORDERS RES DEPT,NEW YORK,NY	Columbia University; New York State Psychiatry Institute	OTTMAN, R (corresponding author), COLUMBIA UNIV,GERTRUDE H SERGIEVSKY CTR,630 W 168TH ST,NEW YORK,NY 10032, USA.		Ottman, Ruth/O-2371-2013	Ottman, Ruth/0000-0001-7074-242X	NINDS NIH HHS [R01 NS020656] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020656] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BRINTON LA, 1982, J NATL CANCER I, V69, P817; Byrne C, 1991, Epidemiology, V2, P276, DOI 10.1097/00001648-199107000-00007; CLARK RF, 1993, ARCH NEUROL-CHICAGO, V50, P1164, DOI 10.1001/archneur.1993.00540110044004; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DUPONT WD, 1987, AM J EPIDEMIOL, V125, P769, DOI 10.1093/oxfordjournals.aje.a114594; EASTON DF, 1993, AM J HUM GENET, V52, P678; FAREWELL VT, 1977, CANCER, V40, P931, DOI 10.1002/1097-0142(197708)40:2<931::AID-CNCR2820400251>3.0.CO;2-Y; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HASHIMOTO L, 1994, NATURE, V371, P161, DOI 10.1038/371161a0; KELSEY JL, 1993, EPIDEMIOL REV, V15, P36, DOI 10.1093/oxfordjournals.epirev.a036115; KHOURY MJ, 1995, AM J HUM GENET, V56, P835; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; OTTMAN R, 1990, GENET EPIDEMIOL, V7, P177, DOI 10.1002/gepi.1370070302; OTTMAN R, 1991, AM J EPIDEMIOL, V134, P298, DOI 10.1093/oxfordjournals.aje.a116085; OTTMAN R, 1994, GENET EPIDEMIOL, V11, P75, DOI 10.1002/gepi.1370110108; SELLERS TA, 1992, NEW ENGL J MED, V326, P1323, DOI 10.1056/NEJM199205143262004	19	29	29	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1995	56	4					821	823						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QP663	7717391				2022-12-18	WOS:A1995QP66300001
J	DIXON, J; GLADWIN, AJ; LOFTUS, SK; RILEY, JH; PERVEEN, R; WASMUTH, JJ; ANAND, R; DIXON, MJ				DIXON, J; GLADWIN, AJ; LOFTUS, SK; RILEY, JH; PERVEEN, R; WASMUTH, JJ; ANAND, R; DIXON, MJ			A YAC CONTIG ENCOMPASSING THE TREACHER-COLLINS SYNDROME CRITICAL REGION AT 5Q31.3-32	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RADIATION HYBRID MAP; MUSCULAR-ATROPHY GENE; SYNDROME LOCUS; LONG ARM; CHROMOSOME-5; CLONES; CONSTRUCTION; FRAGMENTS; SELECTION; LIBRARY	Treacher Collins syndrome (TCOF1) is an autosomal dominant disorder of craniofacial development the features of which include conductive hearing loss and cleft palate. Previous studies have localized the TCOF1 locus between D5S519 (proximal) and SPARC (distal), a region of 22 centirays as estimated by radiation hybrid mapping. In the current investigation we have created a contig across the TCOF1 critical region, using YAC clones. Isolation of a novel short tandem repeat polymorphism corresponding to the end of one of the YACs has allowed us to reduce the size of the critical region to similar to 840 kb, which has been covered with three nonchimeric YACs. Restriction mapping has revealed that the region contains a high density of clustered rare-cutter restriction sites, suggesting that it may contain a number of different genes. The results of the present investigation have further allowed us to confirm that the RPS14 locus lies proximal to the critical region and can thereby be excluded from a role in the pathogenesis of TCOF1, while ANX6 lies within the TCOF1 critical region and remains 21 potential candidate for the mutated gene.	UNIV MANCHESTER,SCH BIOL SCI,MANCHESTER M13 9PT,ENGLAND; UNIV CALIF IRVINE,CALIF COLL MED,DEPT BIOL CHEM,IRVINE,CA 92717; ZENECA PHARMACEUT,MACCLESFIELD,CHESHIRE,ENGLAND	University of Manchester; University of California System; University of California Irvine				Loftus, Stacie/0000-0002-1958-4689	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; ALTHERR MR, 1992, GENOMICS, V13, P1040, DOI 10.1016/0888-7543(92)90017-M; ANAND R, 1990, NUCLEIC ACIDS RES, V18, P1951, DOI 10.1093/nar/18.8.1951; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; BUTLER R, 1992, GENOMICS, V12, P42, DOI 10.1016/0888-7543(92)90404-G; Dixon M J, 1994, Clin Dysmorphol, V3, P96; Dixon Michael J., 1992, Human Molecular Genetics, V1, P249, DOI 10.1093/hmg/1.4.249; DIXON MJ, 1991, AM J HUM GENET, V49, P17; DIXON MJ, 1993, AM J HUM GENET, V52, P907; ELVIN P, 1990, NUCLEIC ACIDS RES, V18, P3913, DOI 10.1093/nar/18.13.3913; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRANCIS MJ, 1993, HUM MOL GENET, V2, P1161, DOI 10.1093/hmg/2.8.1161; FRAZEN LE, 1967, AM J DIS CHILD, V113, P406; JABS EW, 1991, GENOMICS, V11, P193; LOFTUS SK, 1993, HUM MOL GENET, V2, P1785, DOI 10.1093/hmg/2.11.1785; LOVETT M, 1991, P NATL ACAD SCI USA, V88, P9628, DOI 10.1073/pnas.88.21.9628; PARIMOO S, 1991, P NATL ACAD SCI USA, V88, P9623, DOI 10.1073/pnas.88.21.9623; POSWILLO D, 1975, BRIT J ORAL SURG, V13, P1, DOI 10.1016/0007-117X(75)90019-0; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; ROVIN S, 1964, J PEDIATR-US, V65, P215, DOI 10.1016/S0022-3476(64)80522-9; Sambrook J., 1989, MOL CLONING LAB MANU; SILVERMAN GA, 1989, P NATL ACAD SCI USA, V86, P7485, DOI 10.1073/pnas.86.19.7485; THOMPSON TG, 1993, HUM MOL GENET, V2, P1169, DOI 10.1093/hmg/2.8.1169; WARRINGTON JA, 1992, GENOMICS, V13, P803, DOI 10.1016/0888-7543(92)90156-M; WARRINGTON JA, 1991, GENOMICS, V11, P701, DOI 10.1016/0888-7543(91)90078-S; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z	26	29	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1994	55	2					372	378						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NZ336	8037214				2022-12-18	WOS:A1994NZ33600020
J	CHAKRABORTY, S; RAFI, MA; WENGER, DA				CHAKRABORTY, S; RAFI, MA; WENGER, DA			MUTATIONS IN THE LYSOSOMAL BETA-GALACTOSIDASE GENE THAT CAUSE THE ADULT FORM OF GMI GANGLIOSIDOSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA; CDNA; DEFICIENCY; GM1-GANGLIOSIDOSIS; NEURAMINIDASE; AMPLIFICATION; EXPRESSION; PROTEIN; DISEASE; ENZYME	Three adult patients with acid beta-galactosidase deficiency/GM1 gangliosidosis who were from two unrelated families of Scandinavian descent were found to share a common point mutation in the coding region of the corresponding gene. The patients share common clinical features, including early dysarthria, mild ataxia, and bone abnormalities. When cDNA from the two patients in family 1 was PCR amplified and sequenced, most (39/41) of the clones showed a C-to-T transition (C --> T) at nucleotide 245 (counting from the initiation codon). This mutation changes the codon for Thr(ACG) to Met(ATG). Mutant and normal sequences were also found in that position in genomic DNA, indicating the presence of another mutant allele. Genomic DNA from the patient in family 2 revealed the same point mutation in one allele. It was determined that in each family only the father carried the C --> T mutation. Expression studies showed that this mutation produced 3%-4% of beta-galactosidase activity, confirming its deleterious effects. The cDNA clones from the patients in family 1 that did not contain the C --> T revealed a 20-bp insertion of intronic sequence between nucleotides 75 and 76, the location of the first intron. Further analysis showed the insertion of a T near the 5' splice donor site which led to the use of a cryptic splice site. It appears that the C --> T mutation results in enough functional enzyme to produce a mild adult form of the disease, even in the presence of a second mutation that likely produces nonfunctional enzyme.	THOMAS JEFFERSON UNIV,DEPT MED,DIV MED GENET,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,DEPT BIOCHEM & MOLEC BIOL,PHILADELPHIA,PA 19107	Jefferson University; Jefferson University					NIDDK NIH HHS [DK 38795] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038795, R55DK038795] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; CHAKRABORTY S, 1991, AM J HUM GENET, V49, P95; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DAZZO A, 1982, P NATL ACAD SCI-BIOL, V79, P4535, DOI 10.1073/pnas.79.15.4535; GALJART NJ, 1988, CELL, V54, P755, DOI 10.1016/S0092-8674(88)90999-3; GOLDMAN JE, 1981, ANN NEUROL, V9, P465, DOI 10.1002/ana.410090509; IKUTA S, 1987, NUCLEIC ACIDS RES, V15, P797, DOI 10.1093/nar/15.2.797; LEMNA WK, 1990, NEW ENGL J MED, V322, P291, DOI 10.1056/NEJM199002013220503; LOUIE E, 1991, CLIN CHIM ACTA, V199, P7, DOI 10.1016/0009-8981(91)90003-U; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MORREAU H, 1989, J BIOL CHEM, V264, P20655; MORREAU H, 1991, DNA CELL BIOL, V10, P495, DOI 10.1089/dna.1991.10.495; MORRONE A, 1994, HUM MUTAT, V3, P112, DOI 10.1002/humu.1380030205; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NISHIMOTO J, 1991, AM J HUM GENET, V49, P566; O'Brien JS, 1989, METABOLIC BASIS INHE, P1797; OSHIMA A, 1991, AM J HUM GENET, V49, P1091; OSHIMA A, 1988, BIOCHEM BIOPH RES CO, V157, P238, DOI 10.1016/S0006-291X(88)80038-X; OSHIMA Y, 1987, J MOL BIOL, V195, P247; OVERHAUSER J, 1990, BIOTECHNIQUES, V8, P173; REITMAN ML, 1981, J CLIN INVEST, V67, P1574, DOI 10.1172/JCI110189; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; WENGER DA, 1980, CLIN GENET, V17, P323; WENGER DA, 1975, BIOCHIM BIOPHYS ACTA, V409, P297, DOI 10.1016/0005-2760(75)90025-9; WENGER DA, 1974, LANCET, V2, P1319; YAMAMOTO Y, 1990, DNA CELL BIOL, V9, P119, DOI 10.1089/dna.1990.9.119; YOSHIDA K, 1991, AM J HUM GENET, V49, P435	31	29	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1994	54	6					1004	1013						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NP053	8198123				2022-12-18	WOS:A1994NP05300008
J	GARVER, KL; GARVER, B				GARVER, KL; GARVER, B			THE HUMAN GENOME PROJECT AND EUGENE CONCERNS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEPENDENT DIABETES-MELLITUS; DOPAMINE-D2 RECEPTOR GENE; TUBE DEFECT RECURRENCES; HEALTH-CARE; SURGICAL SOLUTION; COMMON DISEASES; UNITED-STATES; ETHICS; DISCRIMINATION; ASSOCIATION	The U.S. Human Genome project is the largest scientific project funded by the federal government since the Apollo Moon Project. The overall effect from this project should be of great benefit to humankind because it will provide a better understanding both of single gene defects and multifactorial or familial diseases such as diabetes, arteriosclerosis, and cancer. At first this will lead to more exact ways of screening and diagnosing genetic disease, and later it will lead, in many if not most instances, to specific genetic cures. However, in the past, in both the U.S. and German eugenic movements genetic information has been misused. Hopefully, by remembering and understanding the past injustices and inhumanity of negative eugenics, further misuse of scientific information can be avoided.	UNIV PITTSBURGH, GRAD SCH PUBL HLTH, PITTSBURGH, PA 15260 USA; UNIV PITTSBURGH, SCH MED, PITTSBURGH, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	GARVER, KL (corresponding author), WESTERN PENN HOSP, DEPT MED GENET, 4800 FRIENDSHIP AVE, PITTSBURGH, PA 15224 USA.							ALDHOUS P, 1991, NATURE, V351, P507; ALEXANDER L, 1949, NEW ENGL J MED, V241, P39, DOI 10.1056/NEJM194907142410201; ALLAN W, 1936, SO MED SURG      AUG, P416; ALLEN G, 1979, SCI AM CONTEXT NEW P, P209; Allen G E, 1984, J Hist Biol, V17, P141; Allen G. E., 1991, EXPANSION AM BIOL, P231; ALLEN GE, 1986, OSIRIS, V2, P225, DOI 10.1086/368657; ALLEN GE, 1984, SOC RES, V51, P709; ALLEN GE, 1975, GENETICS, V79, P29; BECKWITH J, 1976, ANN NY ACAD SCI, V265, P46, DOI 10.1111/j.1749-6632.1976.tb29318.x; BILLINGS PR, 1992, AM J HUM GENET, V50, P476; Binding K, 1920, PERMITTING DESTRUCTI; Bird R D, 1981, J Hist Biol, V14, P339, DOI 10.1007/BF00141098; BLUM K, 1990, JAMA-J AM MED ASSOC, V263, P2055, DOI 10.1001/jama.263.15.2055; BOLOS AM, 1990, JAMA-J AM MED ASSOC, V264, P3156; BOWDEN DW, 1992, AM J HUM GENET, V50, P607; BOWER C, 1989, MED J AUSTRALIA, V150, P613, DOI 10.5694/j.1326-5377.1989.tb136723.x; BUNDEY S, 1990, LANCET, V335, P1406, DOI 10.1016/0140-6736(90)91288-L; BURSTIN HR, 1992, JAMA-J AM MED ASSOC, V268, P2383, DOI 10.1001/jama.268.17.2383; CANTOR CR, 1990, SCIENCE, V248, P49, DOI 10.1126/science.2181666; CHADWICK RF, 1993, J MED ETHICS, V19, P43, DOI 10.1136/jme.19.1.43; CHAPPLE JC, 1987, LANCET, V1, P1189; Childs B, 1988, Prog Med Genet, V7, P180; CLARKE A, 1990, LANCET, V336, P120, DOI 10.1016/0140-6736(90)91637-P; CLARKE A, 1990, LANCET, V335, P1145, DOI 10.1016/0140-6736(90)91139-2; CLARKE A, 1993, J MED ETHICS, V19, P47, DOI 10.1136/jme.19.1.47; CLONINGER CR, 1981, ARCH GEN PSYCHIAT, V38, P861; COPPERMAN SM, 1992, JAMA-J AM MED ASSOC, V268, P2648, DOI 10.1001/jama.1992.03490190048016; COTTON P, 1992, JAMA-J AM MED ASSOC, V267, P2719; CUNNINGHAM GC, 1990, AM J HUM GENET, V47, P899; Davenport CB, 1916, AM J INSANITY, V73, P195, DOI 10.1176/ajp.73.2.195; Davenport Charles Benedict, 1911, HEREDITY RELATION EU; DAVIS A, 1990, LANCET, V335, P1406; DELISI C, 1988, AM SCI, V76, P488; DEWAR MA, 1992, JAMA-J AM MED ASSOC, V267, P1207, DOI 10.1001/jama.1992.03480090055021; DICE LR, 1952, AM J HUM GENET, V4, P1; DICKSON D, 1989, SCIENCE, V243, P599, DOI 10.1126/science.2916115; DICKSON D, 1989, SCIENCE, V243, P1548; DUGDALE RL, 1877, JUKES STUDY CREME PA; DULBECCO R, 1986, SCIENCE, V231, P1055, DOI 10.1126/science.3945817; DUNN LC, 1962, AM J HUM GENET, V14, P1; EMSON HE, 1992, LANCET, V340, P1083, DOI 10.1016/0140-6736(92)93089-6; FIELD LL, 1988, AM J HUM GENET, V43, P793; Fisher RA, 1924, EUGEN REV, V16, P114; FRIEDMAN G., 1992, LOS ALAMOS SCI, V20, P302; Galton F, 1901, NATURE, V64, P659; Galton F, 1865, MACMILLANS MAGAZINE, V12, P318; GALTON F, 1905, EUGENICS THEN NOW, P40; Galton F., 1865, MACMILLANS MAGAZINE, V12; Garver Kenneth L, 1992, Linacre Q, V59, P24; GARVER KL, 1991, AM J HUM GENET, V49, P1109; GARVER KL, 1977, PENN MED, V80, P40; GARVER KL, 1991, AM J HUM GENET, V48, P1203; GARVER KL, 1986, GENETIC COUNSELING C; GAYLIN DS, 1993, JAMA-J AM MED ASSOC, V269, P603, DOI 10.1001/jama.269.5.603; GOLDBERG KC, 1992, JAMA-J AM MED ASSOC, V267, P1473, DOI 10.1001/jama.267.11.1473; GORDIS E, 1990, JAMA-J AM MED ASSOC, V263, P2094, DOI 10.1001/jama.263.15.2094; GOSTIN L, 1991, AM J LAW MED, V17, P109; GREEN ED, 1991, JAMA-J AM MED ASSOC, V266, P1966, DOI 10.1001/jama.266.14.1966; GUTIERREZ AA, 1992, LANCET, V339, P715, DOI 10.1016/0140-6736(92)90606-4; Hacker Andrew, 1992, 2 NATIONS BLACK WHIT; Haller Mark H., 1984, EUGENICS HEREDITARIA; HARPER PS, 1993, LANCET, V341, P224, DOI 10.1016/0140-6736(93)90080-Z; HARPER PS, 1992, J MED GENET, V29, P1, DOI 10.1136/jmg.29.1.1; HOLTZMAN NA, 1988, AM J HUM GENET, V42, P624; HOLTZMAN NA, 1992, AM J HUM GENET, V50, P457; HUBBARD R, 1986, INT J HEALTH SERV, V16, P227, DOI 10.2190/1YKE-PHP6-H69A-YRKV; HYER RN, 1991, AM J HUM GENET, V48, P243; JENSEN AR, 1969, HARVARD EDUC REV, V39, P1; JOCHEMSEN H, 1992, ISSUES LAW MED, V8, P167; JORDAN E, 1992, AM J HUM GENET, V51, P1; JUENGST ET, 1991, JAMA-J AM MED ASSOC, V266, P1835, DOI 10.1001/jama.266.13.1835; KEVLES KJ, 1985, NAME EUGENICS; KIMBALL MC, 1990, HEALTHWEEK, V4, P1; LACHAT MR, 1975, LINACRE Q        FEB, P14; LANDER ES, 1986, COLD SPRING HARB SYM, V51, P49, DOI 10.1101/SQB.1986.051.01.007; LARSON EJ, 1991, J HIST MED ALL SCI, V46, P44, DOI 10.1093/jhmas/46.1.44; LEVINSKY NG, 1990, NEW ENGL J MED, V322, P1813, DOI 10.1056/NEJM199006213222512; LINDEMAN EC, 1936, AM EUGENICS; LIPPMAN A, 1991, AM J LAW MED, V17, P15; LUBIN MB, 1990, CLIN PERINATOL, V17, P889, DOI 10.1016/S0095-5108(18)30551-7; LUDMERER K M, 1972, Bulletin of the History of Medicine, V46, P59; LUDMERER K M, 1969, Journal of the History of Biology, V2, P337, DOI 10.1007/BF00125023; Ludmerer K.M., 1972, GENETICS AM SOC HIST; MACCLUER JW, 1991, AM J HUM GENET, V49, P1139; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MARKS J, 1993, AM J HUM GENET, V52, P650; MCKUSICK VA, 1989, NEW ENGL J MED, V320, P910, DOI 10.1056/NEJM198904063201406; MEYER JE, 1988, PSYCHOL MED, V18, P575, DOI 10.1017/S0033291700008254; MILUNSKY A, 1989, JAMA-J AM MED ASSOC, V262, P2847, DOI 10.1001/jama.262.20.2847; MODELL B, 1989, CLIN GENET, V36, P286; Muller-Hill B., 1988, MURDEROUS SCI; MURPHY EA, 1975, JOHNS HOPKINS MED J, V136, P98; NATOWICZ MR, 1992, AM J HUM GENET, V50, P465; NATOWICZ MR, 1992, AM J HUM GENET, V51, P898; NOAKES J, 1984, IDEAS POLITICS ASPEC, P75; NOLAN K, 1987, HASTINGS CENT REP, V17, P5; OSBORN F, 1974, SOC BIOL, V21, P115, DOI 10.1080/19485565.1974.9988099; PAUL D, 1984, J HIST IDEAS, V45, P567, DOI 10.2307/2709374; Pelligrino E D, 1986, J Contemp Health Law Policy, V2, P23; PFAAFFLIN F, 1986, MED LAW, V5, P1; POPKIN RH, 1974, J OPER PSYCHIATR, V5, P24; POST SG, 1992, OBSTET GYNECOL, V79, P794; POST SG, 1991, HUM GENE THER, V2, P229, DOI 10.1089/hum.1991.2.3-229; POST SG, 1988, HASTINGS CENT REP, V18, P14, DOI 10.2307/3563222; Proctor R. N., 1988, RACIAL HYGIENE; PROCTOR RN, 1991, GENE MAPPING USING L, P57; Punnett RC, 1917, J HERED, V8, P464, DOI 10.1093/oxfordjournals.jhered.a111653; REED SC, 1957, AM J HUM GENET, V9, P1; REILLY P, 1983, PERSPECT BIOL MED, V26, P637; REILLY P, 1992, AM J HUM GENET, V50, P640; REILLY PR, 1987, Q REV BIOL, V62, P153, DOI 10.1086/415404; RELMAN AS, 1990, NEW ENGL J MED, V323, P991, DOI 10.1056/NEJM199010043231411; Resta Robert G, 1992, J Genet Couns, V1, P227, DOI 10.1007/BF00961584; Revo, 2022, SURG SOLUTION; ROBERTSON JA, 1984, EMORY LAW, V289, P435; Robertson John A, 1990, Emory Law J, V39, P697; Sapp J., 1983, Journal of the History of Biology, V16, P311, DOI 10.1007/BF00582405; SAUER PJJ, 1992, PEDIATRICS, V90, P729; SCOTT J, 1987, BMJ-BRIT MED J, V295, P769, DOI 10.1136/bmj.295.6601.769; SEARLE GR, 1976, SOC STUD SCI, V6, P217; SHORT EM, 1988, AM J HUM GENET, V43, P101; SMITH A, 1987, LANCET, V1, P1134; SMITH JD, 1985, MINDS MADE FEEBLE; SMITHELLS RW, 1989, LANCET, V2, P498; SMITHELLS RW, 1983, LANCET, V1, P1027; SUN M, 1989, SCIENCE, V243, P1656, DOI 10.1126/science.2928799; THIELMAN SB, 1985, PSYCHIATRY, V48, P299, DOI 10.1080/00332747.1985.11024291; UZYCH L, 1986, Journal of Public Health Policy, V7, P37, DOI 10.2307/3342124; VANCHIERI C, 1991, J NATL CANCER I, V83, P464, DOI 10.1093/jnci/83.7.464-a; WALD N, 1991, LANCET, V338, P131; WATSON JD, 1990, SCIENCE, V248, P44, DOI 10.1126/science.2181665; WEINDLING P, 1985, ANN SCI, V42, P303, DOI 10.1080/00033798500200221; WEINDLING P, 1993, AM J HUM GENET, V52, P643; Weindling P, 1989, HLTH RACE GERMAN POL; WEISS SF, 1986, ISIS, V77, P33, DOI 10.1086/354037; WEISS SF, 1987, RACE HYGIENE NATIONA; WILSON GN, 1992, AM J MED GENET, V42, P187, DOI 10.1002/ajmg.1320420211; Wilson WJ., 1990, TRULY DISADVANTAGED; 1990, PEDIATRICS, V85, P868; 1989, LANCET, V1, P856; 1989, J R COL PHYSICIANS L, V23, P215; 1991, BLOOD FACE	143	29	30	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1994	54	1					148	158						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MQ700	8279465				2022-12-18	WOS:A1994MQ70000019
J	LEANACOX, J; LEVIN, S; SURANA, R; WULFSBERG, E; KEENE, CL; RAFFEL, LJ; SULLIVAN, B; SCHWARTZ, S				LEANACOX, J; LEVIN, S; SURANA, R; WULFSBERG, E; KEENE, CL; RAFFEL, LJ; SULLIVAN, B; SCHWARTZ, S			CHARACTERIZATION OF DENOVO DUPLICATIONS IN 8 PATIENTS BY USING FLUORESCENCE INSITU HYBRIDIZATION WITH CHROMOSOME-SPECIFIC DNA LIBRARIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUPPRESSION HYBRIDIZATION; MARKER CHROMOSOMES; REARRANGEMENTS; ABERRATIONS; ORIGIN	Fluorescence in situ hybridization (FISH) with chromosome-specific DNA libraries was performed on samples from eight patients with de novo chromosomal duplications. In five cases, the clinical phenotype and/or cytogenetic evaluations suggested a likely origin of the duplicated material. In the remaining three cases, careful examination of the GTG-banding pattern indicated multiple possible origins; hybridization with more than one chromosome-specific library was performed on two of these cases. In all cases, FISH conclusively identified the chromosomal origin of the duplicated material. In addition, the hybridization pattern was useful in quantitatively delineating the duplication in two cases.	UNIV MARYLAND,SCH MED,DEPT OBSTET & GYNECOL,DIV HUMAN GENET,BALTIMORE,MD 21201; UNIV MARYLAND,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21201; WALTER REED ARMY MED CTR,WASHINGTON,DC 20307; COMMUNITY HOSP,CARILION CTR WOMEN & CHILDREN,ROANOKE VALLEY,VA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; United States Department of Defense; United States Army; Walter Reed National Military Medical Center			Sullivan, Beth A/Q-3456-2017	Sullivan, Beth A/0000-0001-5216-4603				CALLEN DF, 1990, J MED GENET, V27, P155, DOI 10.1136/jmg.27.3.155; CALLEN DF, 1991, AM J HUM GENET, V48, P769; COLLINS C, 1991, GENOMICS, V11, P997, DOI 10.1016/0888-7543(91)90025-A; DEVILEE P, 1988, CANCER RES, V48, P5825; HOPMAN AHN, 1988, HISTOCHEMISTRY, V89, P307, DOI 10.1007/BF00500631; JAUCH A, 1990, HUM GENET, V85, P145; JOHNSON GD, 1981, J IMMUNOL METHODS, V43, P349, DOI 10.1016/0022-1759(81)90183-6; KLINGER KW, 1991, AM J HUM GENET S, V49, pA23; LAVEDAN C, 1989, CYTOGENET CELL GENET, V50, P70, DOI 10.1159/000132726; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; NEDERLOF PM, 1989, CANCER GENET CYTOGEN, V42, P87, DOI 10.1016/0165-4608(89)90011-3; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; SCHWARTZ S, 1991, CLIN GENET, V40, P417; SCHWARTZ S, 1984, AM J HUM GENET, V36, P750; SCHWARTZ S, 1990, AM J HUM GENET S, V47, pA40; SEABRIGH.M, 1971, LANCET, V2, P971; SMIT VTHBM, 1991, GENE CHROMOSOME CANC, V3, P239, DOI 10.1002/gcc.2870030402; SPELEMAN F, 1991, CYTOGENET CELL GENET, V56, P129, DOI 10.1159/000133068; SULLIVAN BA, 1991, AM J HUM GENET S, V49, pA308; WARD BE, 1991, AM J HUM GENET S, V49, pA294; WHITE K, 1991, AM J HUM GENET S, V49, pA294	21	29	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1993	52	6					1067	1073						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LG133	8503441				2022-12-18	WOS:A1993LG13300007
J	MALMGREN, H; SUNDVALL, M; DAHL, N; GUSTAVSON, KH; ANNEREN, G; WADELIUS, C; STEENBONDESON, ML; PETTERSSON, U				MALMGREN, H; SUNDVALL, M; DAHL, N; GUSTAVSON, KH; ANNEREN, G; WADELIUS, C; STEENBONDESON, ML; PETTERSSON, U			LINKAGE MAPPING OF A SEVERE X-LINKED MENTAL-RETARDATION SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISMS; CHROMOSOME LONG ARM; REGIONAL LOCALIZATION; DNA MARKER; LOCUS; GENE; FREQUENCY; DIAGNOSIS; SEQUENCES; DISORDER	A four-generation Swedish family with a new type of X-linked mental retardation syndrome was recently reported by Gustavson et al. The complex syndrome includes microcephaly, severe mental retardation, optical atrophy with decreased vision or blindness, severe hearing defect, characteristic facial features, spasticity, seizures, and restricted joint motility. The patients die during infancy or early in childhood. Twenty-one family members, including two affected males, were available for study. Linkage analysis was conducted in the family by using 11 RFLP markers and 10 VNTR markers spread along the X chromosome. A hypervariable short tandem repeat of DXS294 at Xq26 showed a peak two-point lod score of 3.35 at zero recombination fraction. Calculations using the same markers revealed a multipoint peak lod score of 3.65 at DXS294. Crossover events with the centromeric marker DXS424 and the telomeric marker DXS297 delimit a probable region for the gene localization. It is noteworthy that the disease loci of two other syndromes with overlapping clinical manifestations recently were shown by Turner et al. and Pettigrew et al. to be linked to markers at Xq26.	UNIV UPPSALA HOSP,DEPT CLIN GENET,S-75014 UPPSALA,SWEDEN	Uppsala University; Uppsala University Hospital	MALMGREN, H (corresponding author), UNIV UPPSALA,DEPT MED GENET,BEIJER LAB,BOX 589,S-75123 UPPSALA,SWEDEN.							ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; ARENA JF, 1991, AM J MED GENET, V38, P190, DOI 10.1002/ajmg.1320380205; BAKKER E, 1985, LANCET, V1, P655; BOGGS BA, 1984, SOMAT CELL MOLEC GEN, V10, P607, DOI 10.1007/BF01535226; CAMERINO G, 1984, P NATL ACAD SCI-BIOL, V81, P498, DOI 10.1073/pnas.81.2.498; FRASER N, 1987, CYTOGENET CELL GENET, V46, P615; GEDEON AK, 1991, CYTOGENET CELL GENET, V58, P2065; GEDEON AK, 1991, NUCLEIC ACIDS RES, V19, P5087, DOI 10.1093/nar/19.18.5087; GLASS IA, 1991, J MED GENET, V28, P361, DOI 10.1136/jmg.28.6.361; GUSTAVSON KH, 1993, AM J MED GENET, V45, P654, DOI 10.1002/ajmg.1320450527; HEARNE CM, 1991, NUCLEIC ACIDS RES, V19, P5450; HUANG THM, 1992, GENOMICS, V13, P375, DOI 10.1016/0888-7543(92)90256-R; HUANG THM, 1991, AM J HUM GENET, V49, P1312; KEATS BJB, 1991, ANN HUM GENET, V55, P1, DOI 10.1111/j.1469-1809.1991.tb00392.x; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LITTLE RD, 1992, P NATL ACAD SCI USA, V89, P177, DOI 10.1073/pnas.89.1.177; LUTY JA, 1990, AM J HUM GENET, V46, P776; NERI G, 1992, AM J MED GENET, V43, P373, DOI 10.1002/ajmg.1320430158; OBERLE I, 1985, P NATL ACAD SCI USA, V82, P2824, DOI 10.1073/pnas.82.9.2824; PAGE DC, 1984, NATURE, V311, P119, DOI 10.1038/311119a0; PETTIGREW AL, 1991, AM J MED GENET, V38, P200, DOI 10.1002/ajmg.1320380206; RICHARDS RI, 1991, AM J HUM GENET, V48, P1051; SCHWARTZ M, 1988, HUM GENET, V78, P156, DOI 10.1007/BF00278188; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SUTHERS GK, 1989, SCIENCE, V246, P1298, DOI 10.1126/science.2573953; TURNER G, 1989, AM J MED GENET, V34, P463, DOI 10.1002/ajmg.1320340402; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4037, DOI 10.1093/nar/18.13.4037	29	29	29	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1993	52	6					1046	1052						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LG133	8503440				2022-12-18	WOS:A1993LG13300004
J	FLETCHER, JM; EVANS, K; BAILLIE, D; BYRD, P; HANRATTY, D; LEACH, S; JULIER, C; GOSDEN, JR; MUIR, W; PORTEOUS, DJ; STCLAIR, D; VANHEYNINGEN, V				FLETCHER, JM; EVANS, K; BAILLIE, D; BYRD, P; HANRATTY, D; LEACH, S; JULIER, C; GOSDEN, JR; MUIR, W; PORTEOUS, DJ; STCLAIR, D; VANHEYNINGEN, V			SCHIZOPHRENIA-ASSOCIATED CHROMOSOME 11Q21 TRANSLOCATION - IDENTIFICATION OF FLANKING MARKERS AND DEVELOPMENT OF CHROMOSOME 11Q FRAGMENT HYBRIDS AS CLONING AND MAPPING RESOURCES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; SOMATIC CELL HYBRIDS; MONOCLONAL-ANTIBODY; TYROSINASE GENE; LOCUS; DNA; EXPRESSION; REGION; MINISATELLITES; AMPLIFICATION	Genetic linkage, molecular analysis, and in situ hybridization have identified TYR and D11S388 as markers flanking the chromosome 11 breakpoint in a large pedigree where a balanced translocation, t(1;11)(q43;q21), segregates with schizophrenia and related affective disorders. Somatic cell hybrids, separating the two translocation chromosomes from each other and from the normal homologues, have been produced with the aid of immunomagnetic sorting for chromosome 1- and chromosome 11-encoded cell-surface antigens. The genes for two of these antigens map on either side of the 11q breakpoint. Immunomagnetic bead sorting was also used to isolate two stable X-irradiation hybrids for each cell-surface antigen. Each hybrid carries only chromosome 11 fragments. Translocation and X-irradiation hybrids were analyzed, mainly by PCR, for the presence of 19 chromosome 11 and 4 chromosome 1 markers. Ten newly designed primers are reported. The X-irradiation hybrids were also studied cytogenetically, for human DNA content, by in situ Cot1 DNA hybridization and by painting the Alu-PCR products from these four lines back onto normal human metaphases. The generation of the translocation hybrids and of the chromosome 11q fragment hybrids is a necessary preliminary to determining whether a schizophrenia-predisposition gene SCZD2 is encoded at this site.	WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND; CTR ETUDE POLYMORPHISME HUMAIN,PARIS,FRANCE	University of Edinburgh			Porteous, David J/C-7289-2013; fletcher, jack/Q-5975-2019; JULIER, Cécile/M-9824-2017; van Heyningen, Veronica/B-8039-2008; Porteous, David/AAA-3446-2021; St Clair, David/AAN-2412-2021; VAN HEYNINGEN, Veronica/GYE-0531-2022	Porteous, David J/0000-0003-1249-6106; JULIER, Cécile/0000-0002-1538-0240; van Heyningen, Veronica/0000-0003-0359-0141; Porteous, David/0000-0003-1249-6106; 	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANDREWS PW, 1985, ANN HUM GENET, V49, P31, DOI 10.1111/j.1469-1809.1985.tb01673.x; ANGEL P, 1987, MOL CELL BIOL, V7, P2256, DOI 10.1128/MCB.7.6.2256; BARON M, 1976, AM J PSYCHIAT, V133, P1273; BARTON CH, 1990, BIOCHEM J, V268, P161, DOI 10.1042/bj2680161; BICKMORE WA, 1989, SOMAT CELL MOLEC GEN, V15, P229, DOI 10.1007/BF01534873; BREEN M, 1992, GENOMICS, V13, P726, DOI 10.1016/0888-7543(92)90148-L; BROOKES AJ, 1991, TRENDS BIOTECHNOL, V10, P40; CLARKE DJ, 1989, BRIT J PSYCHIAT, V155, P551, DOI 10.1192/bjp.155.4.551; COTTER F, 1989, GENOMICS, V5, P470, DOI 10.1016/0888-7543(89)90011-6; COWELL IG, 1988, BIOCHEM J, V255, P79, DOI 10.1042/bj2550079; DORIN JR, 1992, HUM MOL GENET, V1, P53, DOI 10.1093/hmg/1.1.53; FLETCHER J, IN PRESS CHROMOSOME; GIEBEL LB, 1990, NUCLEIC ACIDS RES, V18, P3103, DOI 10.1093/nar/18.10.3103-a; GIEBEL LB, 1991, GENOMICS, V9, P435, DOI 10.1016/0888-7543(91)90409-8; GOODFELLOW PN, 1982, EUR J IMMUNOL, V12, P659, DOI 10.1002/eji.1830120807; GOSDEN J, 1991, TECHNIQUE, V3, P159; Gosden J R, 1990, Methods Mol Biol, V5, P487, DOI 10.1385/0-89603-150-0:487; GOSDEN JR, 1991, TECHNIQUE, V13, P66; GOTTESDIENER KM, 1988, MOL CELL BIOL, V8, P3809, DOI 10.1128/MCB.8.9.3809; GRANDY DK, 1989, AM J HUM GENET, V45, P778; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HOLLAND T, 1990, PSYCHIAT RES, V32, P1, DOI 10.1016/0165-1781(90)90129-S; JACOBS PA, 1970, ANN HUM GENET, V33, P325, DOI 10.1111/j.1469-1809.1970.tb01658.x; JANSON M, 1991, P NATL ACAD SCI USA, V88, P10609, DOI 10.1073/pnas.88.23.10609; JEFFREYS AJ, 1988, NUCLEIC ACIDS RES, V16, P10953, DOI 10.1093/nar/16.23.10953; JONES C, 1984, SOMAT CELL MOLEC GEN, V10, P423, DOI 10.1007/BF01535638; JULIER C, 1990, GENOMICS, V7, P335, DOI 10.1016/0888-7543(90)90167-S; KLEBE RJ, 1970, J CELL BIOL, V45, P74, DOI 10.1083/jcb.45.1.74; KOEFFLER HP, 1981, P NATL ACAD SCI-BIOL, V78, P7015, DOI 10.1073/pnas.78.11.7015; LEWIS W H, 1988, Genomics, V3, P25, DOI 10.1016/0888-7543(88)90154-1; LITT M, 1990, NUCLEIC ACIDS RES, V18, P5921, DOI 10.1093/nar/18.19.5921-a; MCCONVILLE CM, 1990, NUCLEIC ACIDS RES, V18, P4335, DOI 10.1093/nar/18.15.4335; MOHANDAS T, 1980, P NATL ACAD SCI-BIOL, V77, P6759, DOI 10.1073/pnas.77.11.6759; MORRIS, 1991, NUCLEIC ACIDS RES, V19, P6968; MUIR W, 1991, CYTOGENET CELL GENET, V58, P1966; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P9363, DOI 10.1093/nar/16.19.9363; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; PORTEOUS DJ, 1986, MOL CELL BIOL, V6, P2223, DOI 10.1128/MCB.6.6.2223; PORTEOUS DJ, 1987, P NATL ACAD SCI USA, V84, P5355, DOI 10.1073/pnas.84.15.5355; ROYLE NJ, 1988, GENOMICS, V3, P352, DOI 10.1016/0888-7543(88)90127-9; SEAWRIGHT A, 1988, SOMAT CELL MOLEC GEN, V14, P21, DOI 10.1007/BF01535046; SEEMAN P, 1989, P NATL ACAD SCI USA, V86, P10156, DOI 10.1073/pnas.86.24.10156; Shields J, 1982, SCHIZOPHRENIA EPIGEN; SHULMAN M, 1978, NATURE, V276, P269, DOI 10.1038/276269a0; SIRUM KL, 1989, BIOCHEMISTRY-US, V28, P8691, DOI 10.1021/bi00448a004; SMITH M, 1989, American Journal of Human Genetics, V45, pA220; SPITZER RL, 1987, RES DIAGNOSTIC CRITE; SPRITZ RA, 1990, NEW ENGL J MED, V322, P1724, DOI 10.1056/NEJM199006143222407; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; TANIGAMI A, 1992, AM J HUM GENET, V50, P56; THEUNE S, 1991, GENOMICS, V9, P511, DOI 10.1016/0888-7543(91)90418-E; VANHEYNINGEN V, IN PRESS CHROMOSOME; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P2199; WESTERVELD A, 1971, NATURE-NEW BIOL, V234, P20, DOI 10.1038/newbio234020a0; WOODROOFE MN, 1984, SOMAT CELL MOLEC GEN, V10, P535, DOI 10.1007/BF01534858; YOSHIDA T, 1987, P NATL ACAD SCI USA, V84, P7305, DOI 10.1073/pnas.84.20.7305	56	29	29	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1993	52	3					478	490						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KR720	8383424				2022-12-18	WOS:A1993KR72000005
J	MACLEAN, CJ; BISHOP, DT; SHERMAN, SL; DIEHL, SR				MACLEAN, CJ; BISHOP, DT; SHERMAN, SL; DIEHL, SR			DISTRIBUTION OF LOD SCORES UNDER UNCERTAIN MODE OF INHERITANCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN LINKAGE ANALYSIS; TESTS; SEGREGATION	We consider probability distributions of alternative lod statistics, differing in their treatment of segregation parameters when mode of inheritance is uncertain. A particular pedigree structure and a dominant genetic system displaying incomplete penetrance are analyzed. Lod scores calculated assuming an incorrect segregation model appear to conform quite well to the chi2 distribution in the absence of linkage. In the presence of linkage, some power is lost. However, if lod scores are calculated under several different segregation models and the best one is accepted, opportunity for chance occurrence of high lod scores is enhanced. The distribution is still chi2, but with extra degrees of freedom. These results hold over a wide range of sample sizes and segregation models, including small samples and low levels of penetrance.	IMPERIAL CANC RES FUND,GENET EPIDEMIOL LAB,LEEDS,ENGLAND; EMORY UNIV,DEPT HUMAN GENET,ATLANTA,GA 30322; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT HUMAN GENET,RICHMOND,VA 23298	Emory University; Virginia Commonwealth University	MACLEAN, CJ (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PSYCHIAT,BOX 710,RICHMOND,VA 23298, USA.			Bishop, Tim/0000-0002-8752-8785	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P01DE008972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH041953, R01MH045390] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE08972] Funding Source: Medline; NIMH NIH HHS [MH41953, MH45390] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; CLERGETDARPOUX F, 1990, GENET EPIDEMIOL, V7, P245, DOI 10.1002/gepi.1370070403; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; Efron B, 1982, JACKKNIFE BOOTSTRAP; Finney DJ, 1940, ANN EUGENIC, V10, P171, DOI 10.1111/j.1469-1809.1940.tb02246.x; Fleiss JL, 1981, STAT METHODS RATES P; GREENBERG DA, 1989, AM J MED GENET, V34, P480, DOI 10.1002/ajmg.1320340406; KIDD KK, 1984, CYTOGENET CELL GENET, V37, P510; MACLEAN CJ, 1984, COMPUT BIOMED RES, V17, P471, DOI 10.1016/0010-4809(84)90013-2; MORTON NE, 1955, AM J HUM GENET, V7, P277; NEYMAN J, 1928, STAT RES MEM, V2, P25; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Ott J., 1991, ANAL HUMAN GENETIC L; RISCH N, 1984, AM J HUM GENET, V36, P363; RISCH N, 1989, GENET EPIDEMIOL, V6, P473, DOI 10.1002/gepi.1370060402; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; TERWILLIGER JD, 1992, CYTOGENET CELL GENET, V59, P142, DOI 10.1159/000133228; Wald A, 1943, T AM MATH SOC, V54, P426, DOI 10.2307/1990256; WEEKS DE, 1990, GENET EPIDEMIOL, V7, P237, DOI 10.1002/gepi.1370070402; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; WILLIAMSON JA, 1990, GENET EPIDEMIOL, V7, P309, DOI 10.1002/gepi.1370070502	21	29	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1993	52	2					354	361						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KN275	8430696				2022-12-18	WOS:A1993KN27500014
J	OETTING, WS; WITKOP, CJ; BROWN, SA; COLOMER, R; FRYER, JP; BLOOM, KE; KING, RA				OETTING, WS; WITKOP, CJ; BROWN, SA; COLOMER, R; FRYER, JP; BLOOM, KE; KING, RA			A FREQUENT TYROSINASE GENE MUTATION ASSOCIATED WITH TYPE I-A (TYROSINASE-NEGATIVE) OCULOCUTANEOUS ALBINISM IN PUERTO-RICO	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TYR GENE; DNA; SEQUENCES; PATIENT; MOUSE; PCR	We have determined the mutations in the tyrosinase gene from 12 unrelated Puerto Rican individuals who have type I-A (tyrosinase-negative) oculocutaneous albinism (OCA). All but one individual are of Hispanic descent. Nine individuals were homozygous for a missense mutation (G47D) in exon I at codon 47. Two individuals were heterozygous for the G47D mutation, with one having a missense mutation at codon 373 (T373K) in the homologous allele and the other having an undetermined mutation in the homologous allele. One individual with negroid features was homozygous for a nonsense mutation (W236X). The population migration between Puerto Rico and the Canary Islands is well recognized. Analysis of three individuals with OCA from the Canary Islands showed that one was a compound heterozygote for the G47D mutation and for a novel missense mutation (L216M), one was homozygous for a missense mutation (P81L), and one was heterozygous for the missense mutation P81L. The G47D and P81L missense mutations have been previously described in extended families in the United States. Haplotypes were determined using four polymorphisms linked to the tyrosinase locus. Haplotype analysis showed that the G47D mutation occurred on a single haplotype, consistent with a common founder for all individuals having this mutation. Two different haplotypes were found associated with the P81L mutation, suggesting that this may be either a recurring mutation for the tyrosinase gene or a recombination between haplotypes.	UNIV MINNESOTA,UMHC,DEPT MED,BOX 485,420 DELAWARE ST SE,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,DEPT DENT,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,DEPT PEDIAT,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,INST HUMAN GENET,MINNEAPOLIS,MN 55455; ONCE,SERV MED EMPRESSA,CANARY ISL,SPAIN	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities			Colomer, Ramon/C-5142-2008	Colomer, Ramon/0000-0002-6393-3444	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR040001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM022167] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR40001] Funding Source: Medline; NIGMS NIH HHS [GM22167] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		GIEBEL LB, 1990, NUCLEIC ACIDS RES, V18, P3103, DOI 10.1093/nar/18.10.3103-a; GIEBEL LB, 1991, J CLIN INVEST, V87, P1119, DOI 10.1172/JCI115075; GIEBEL LB, 1991, AM J HUM GENET, V48, P1159; GIEBEL LB, 1990, P NATL ACAD SCI USA, V87, P3255, DOI 10.1073/pnas.87.9.3255; GIEBEL LB, 1991, J MED GENET, V28, P464, DOI 10.1136/jmg.28.7.464; JOHNSTON J D, 1992, Nucleic Acids Research, V20, P1433, DOI 10.1093/nar/20.6.1433; KIKUCHI H, 1990, HUM GENET, V85, P123; KING RA, 1988, DERMATOL CLIN, V6, P217, DOI 10.1016/S0733-8635(18)30668-5; KING RA, 1991, MOL BIOL MED, V8, P19; KWON BS, 1987, P NATL ACAD SCI USA, V84, P7473, DOI 10.1073/pnas.84.21.7473; LERNER AB, 1950, PHYSIOL REV, V30, P91, DOI 10.1152/physrev.1950.30.1.91; MORRIS SW, 1991, NUCLEIC ACIDS RES, V19, P6968, DOI 10.1093/nar/19.24.6968; OETTING WS, 1991, NUCLEIC ACIDS RES, V19, P5800, DOI 10.1093/nar/19.20.5800-a; OETTING WS, 1991, AM J HUM GENET, V49, P199; OETTING WS, 1991, J INVEST DERMATOL, V97, P15, DOI 10.1111/1523-1747.ep12477808; OETTING WS, IN PRESS PIGMENT CEL; OETTING WS, IN PRESS HUM GENET; ROSS PK, 1991, J AM CHEM SOC, V113, P3246, DOI 10.1021/ja00009a005; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPRITZ RA, 1990, NEW ENGL J MED, V322, P1724, DOI 10.1056/NEJM199006143222407; SPRITZ RA, 1991, AM J HUM GENET, V322, P1724; SPRITZ RA, 1991, NUCLEIC ACIDS RES, V18, P3672; TAKEDA A, 1990, J BIOL CHEM, V265, P17792; TOMITA Y, 1989, BIOCHEM BIOPH RES CO, V164, P990, DOI 10.1016/0006-291X(89)91767-1; Witkop C J, 1990, Bol Asoc Med P R, V82, P333; [No title captured]	28	29	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1993	52	1					17	23						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KK908	8434585				2022-12-18	WOS:A1993KK90800003
J	HUBERT, R; WEBER, JL; SCHMITT, K; ZHANG, L; ARNHEIM, N				HUBERT, R; WEBER, JL; SCHMITT, K; ZHANG, L; ARNHEIM, N			A NEW SOURCE OF POLYMORPHIC DNA MARKERS FOR SPERM TYPING - ANALYSIS OF MICROSATELLITE REPEATS IN SINGLE CELLS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN PREIMPLANTATION EMBRYOS; POLYMERASE CHAIN-REACTION; ENZYMATIC AMPLIFICATION; DINUCLEOTIDE REPEAT; CYSTIC-FIBROSIS; HUMAN OOCYTES; DIAGNOSIS; GENE; SEQUENCES; INVITRO	We show that dinucleotide and tetranucleotide repeat polymorphisms can be analyzed in single cells without using radioactivity or denaturing gels. This provides a rich new source of DNA polymorphisms for genetic mapping by sperm typing. The recombination fraction between two CA repeat polymorphisms was determined after whole genome amplification of single sperm, followed by typing of two different aliquots, one aliquot for each polymorphic locus. Single-cell analysis of microsatellites may also be valuable both for preimplantation genetic disease diagnosis based on single-blastomere or polar-body analysis and for the typing of forensic or ancient DNA samples containing very small amounts of nucleic acid.	UNIV SO CALIF, DEPT MOLEC BIOL, LOS ANGELES, CA 90089 USA; MARSHFIELD MED RES FDN, MARSHFIELD, WI USA	University of Southern California			Zhang, Lin/A-7389-2009	Zhang, Lin/0000-0003-0018-3903; Arnheim, Norman/0000-0003-1247-1347	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000328, R01HG000248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036745, R01GM036745] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00328, HG00248] Funding Source: Medline; NIGMS NIH HHS [GM36745] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNHEIM N, 1990, GENOMICS, V8, P415, DOI 10.1016/0888-7543(90)90026-Q; BRADBURY MW, 1990, P NATL ACAD SCI USA, V87, P4053, DOI 10.1073/pnas.87.11.4053; COUTELLE C, 1989, BRIT MED J, V299, P22, DOI 10.1136/bmj.299.6690.22; CUI XF, 1989, P NATL ACAD SCI USA, V86, P9389, DOI 10.1073/pnas.86.23.9389; GOMEZ CM, 1990, P NATL ACAD SCI USA, V87, P4481, DOI 10.1073/pnas.87.12.4481; GORADIA TM, 1991, GENOMICS, V10, P748, DOI 10.1016/0888-7543(91)90459-R; HANDYSIDE AH, 1989, LANCET, V1, P347; HANDYSIDE AH, 1990, NATURE, V344, P768, DOI 10.1038/344768a0; HOLDING C, 1989, LANCET, V2, P532; HUBERT R, 1992, GENOMICS, V12, P683, DOI 10.1016/0888-7543(92)90294-3; LI H, 1991, Methods (Orlando), V2, P49, DOI 10.1016/S1046-2023(05)80125-2; LI HH, 1988, NATURE, V335, P414, DOI 10.1038/335414a0; LI HH, 1990, P NATL ACAD SCI USA, V87, P4580, DOI 10.1073/pnas.87.12.4580; LITT M, 1989, AM J HUM GENET, V44, P397; LOVE JM, 1990, NUCLEIC ACIDS RES, V18, P4123, DOI 10.1093/nar/18.14.4123; MONK M, 1990, LANCET, V335, P985, DOI 10.1016/0140-6736(90)91060-N; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NAVIDI W, 1992, AM J HUM GENET, V50, P347; OUDET C, 1991, AM J HUM GENET, V49, P311; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; STROM CM, 1990, LANCET, V336, P306, DOI 10.1016/0140-6736(90)91835-X; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P1927, DOI 10.1093/nar/18.7.1927; WEBER JL, 1989, AM J HUM GENET, V44, P388; WILKIE PJ, 1992, GENOMICS, V12, P607, DOI 10.1016/0888-7543(92)90456-3; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	26	29	31	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1992	51	5					985	991						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JU840	1415267				2022-12-18	WOS:A1992JU84000008
J	GRODY, WW; KLEIN, D; DODSON, AE; KERN, RM; WISSMANN, PB; GOODMAN, BK; BASSAND, P; MARESCAU, B; KANG, SS; LEONARD, JV; CEDERBAUM, SD				GRODY, WW; KLEIN, D; DODSON, AE; KERN, RM; WISSMANN, PB; GOODMAN, BK; BASSAND, P; MARESCAU, B; KANG, SS; LEONARD, JV; CEDERBAUM, SD			MOLECULAR GENETIC-STUDY OF HUMAN ARGINASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								We have explored the molecular pathology in 28 individuals homozygous or heterozygous for liver arginase deficiency (hyperargininemia) by a combination of Southern analysis, western blotting, DNA sequencing, and PCR. This cohort represents the majority of arginase-deficient individuals worldwide. Only 2 of 15 homozygous patients on whom red blood cells were available had antigenically cross-reacting material as ascertained by western blot analysis using anti-liver arginase antibody. Southern blots of patient genomic DNAs, cut with a variety of restriction enzymes and probed with a near-full-length (1,450-bp) human liver arginase cDNA clone, detected no gross gene deletions. Loss of a TaqI cleavage site was identified in three individuals: in a homozygous state in a Saudi Arabian patient at one site, at a different site in homozygosity in a German patient, and in heterozygosity in a patient from Australia. The changes in the latter two were localized to exon 8, through amplification of this region by PCR and electrophoretic analysis of the amplified fragment after treatment with TaqI; the precise base changes (Arg291X and Thr290Ser) were confirmed by sequencing. It it interesting that the latter nucleotide variant (Thr290Ser) was found to lie adjacent to the TaqI site rather than within it, though whether such a conservative amino acid substitution represents a true pathologic mutation remains to be determined. We conclude that arginase deficiency, though rare, is a heterogeneous disorder at the genotypic level, generally encompassing a variety of point mutations rather than substantial structural gene deletions.	UNIV CALIF LOS ANGELES, SCH MED, DEPT PATHOL & LAB MED, DIV MOLEC PATHOL, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, DEPT PEDIAT, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, DEPT PSYCHIAT, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, MENTAL RETARDAT RES CTR, LOS ANGELES, CA 90024 USA; RUSH MED COLL, DEPT PEDIAT, CHICAGO, IL 60612 USA; INST CHILD HLTH, LONDON WC1N 1EH, ENGLAND; RUSH PRESBYTERIAN ST LUKES MED CTR, CHICAGO, IL 60612 USA; UNIV INSTELLING ANTWERP, DEPT GENEESKUNDE, B-2610 WILRIJK, BELGIUM	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Rush University; University of London; University College London; Rush University; University of Antwerp	GRODY, WW (corresponding author), UNIV CALIF LOS ANGELES, SCH MED, DEPT PATHOL & LAB MED, DIV MED GENET, LOS ANGELES, CA 90024 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD000831, P01HD006576] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-00831, HD-06576] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BERNAR J, 1986, J PEDIATR-US, V108, P432, DOI 10.1016/S0022-3476(86)80891-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROW MAD, 1990, PCR PROTOCOLS GUIDE, P189; Brusilow S.W., 1989, METABOLIC BASIS INHE, P629; CARVAJAL N, 1986, BIOCHIM BIOPHYS ACTA, V870, P181, DOI 10.1016/0167-4838(86)90219-0; CEDERBAUM SD, 1979, PEDIATR RES, V13, P827, DOI 10.1203/00006450-197907000-00007; CEDERBAUM SD, 1977, J PEDIATR-US, V90, P569, DOI 10.1016/S0022-3476(77)80368-5; DIZIKES GJ, 1986, BIOCHEM BIOPH RES CO, V141, P53, DOI 10.1016/S0006-291X(86)80333-3; DIZIKES GJ, 1986, SOMAT CELL MOLEC GEN, V12, P375, DOI 10.1007/BF01570732; DONISKELLER H, 1986, DNA PROBES APPLICATI, P73; ENDRES W, 1984, J INHERIT METAB DIS, V7, P8, DOI 10.1007/BF01805610; FREDERICK CA, 1984, NATURE, V309, P327, DOI 10.1038/309327a0; GATTI R A, 1984, Biotechniques, V2, P148; GINGERAS TR, 1983, P NATL ACAD SCI-BIOL, V80, P402, DOI 10.1073/pnas.80.2.402; GRODY WW, 1987, ISOZYMES-CURR T BIOL, V13, P181; GRODY WW, 1989, J CLIN INVEST, V83, P602, DOI 10.1172/JCI113923; HARAGUCHI Y, 1990, J CLIN INVEST, V86, P347, DOI 10.1172/JCI114707; HARAGUCHI Y, 1987, P NATL ACAD SCI USA, V84, P412, DOI 10.1073/pnas.84.2.412; HERRMANN BG, 1987, METHOD ENZYMOL, V152, P180; HERZFELD A, 1976, BIOCHEM J, V153, P469, DOI 10.1042/bj1530469; HUISMAN THJ, 1965, J CHROMATOGR, V19, P160, DOI 10.1016/S0021-9673(01)99434-8; HYLAND K, 1985, J NEUROL NEUROSUR PS, V48, P1188, DOI 10.1136/jnnp.48.11.1188-a; KANG SS, 1983, J PEDIATR-US, V103, P763, DOI 10.1016/S0022-3476(83)80481-8; KIDD JR, 1986, NUCLEIC ACIDS RES, V14, P9544, DOI 10.1093/nar/14.23.9544; KLEIN D, 1987, American Journal of Human Genetics, V41, pA221; KUMAR MR, 1991, BIOCHEMISTRY-US, V17, P369; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; MICHELS VV, 1978, CLIN GENET, V13, P61; QURESHI IA, 1981, DIABETES METAB, V7, P5; QURESHI IA, 1983, J INHERIT METAB DIS, V6, P179, DOI 10.1007/BF02310878; RUEGG UT, 1980, ANAL BIOCHEM, V102, P206, DOI 10.1016/0003-2697(80)90340-1; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHIMKE RT, 1964, J BIOL CHEM, V239, P3808; SCHIMKE RT, 1964, J BIOL CHEM, V239, P136; SKRZYPEKOSIECKA I, 1983, ACTA BIOCHIM POL, V30, P83; SNYDERMAN SE, 1977, J PEDIATR-US, V90, P563, DOI 10.1016/S0022-3476(77)80367-3; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPARKES RS, 1986, AM J HUM GENET, V39, P186; SPECTOR EB, 1980, AM J HUM GENET, V32, P79; SPECTOR EB, 1983, PEDIATR RES, V17, P941, DOI 10.1203/00006450-198312000-00003; SPENCE JE, 1988, AM J HUM GENET, V42, P217; SYMINGTON J, 1981, P NATL ACAD SCI-BIOL, V78, P177, DOI 10.1073/pnas.78.1.177; TAKIGUCHI M, 1988, NUCLEIC ACIDS RES, V16, P8789, DOI 10.1093/nar/16.18.8789; TERHEGGEN HG, 1975, ARCH DIS CHILD, V50, P57, DOI 10.1136/adc.50.1.57; VIELLEBREITBURD F, 1972, J BIOL CHEM, V247, P1227; VINOGRADOVA MN, 1987, BIOORG KHIM+, V13, P1194; YOSHINO M, 1982, ADV EXP MED BIOL, V153, P121	48	29	32	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1992	50	6					1281	1290						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HY654	1598908				2022-12-18	WOS:A1992HY65400017
J	RASSOOL, FV; LEBEAU, MM; NEILLY, ME; VANMELLE, E; ESPINOSA, R; MCKEITHAN, TW				RASSOOL, FV; LEBEAU, MM; NEILLY, ME; VANMELLE, E; ESPINOSA, R; MCKEITHAN, TW			INCREASED GENETIC INSTABILITY OF THE COMMON FRAGILE SITE AT 3P14 AFTER INTEGRATION OF EXOGENOUS DNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-CHROMOSOMES; CELLS; PLASMID; CANCER	We determined previously that the selectable marker pSV2neo is preferentially inserted into chromosomal fragile sites in human x hamster hybrid cells in the presence of an agent (aphidicolin) that induces fragile-site expression. In contrast, cells transfected without fragile-site induction showed an essentially random integration pattern. To determine whether the integration of marker DNA at fragile sites affects the frequency of fragile-site expression, the parental hybrid and three transfectants (two with pSV2neo integrated at the fragile site at 3p14.2 [FRA3B] and specific hamster fragile sites [chromosome 1, bands q26-31, or mar2, bands q11-13] and one with pSV2neo integrated at sites that are not fragile sites) were treated with aphidicolin. After 24 h the two cell lines with plasmid integration at FRA3B showed structural rearrangements at that site; these rearrangements accounted for 43%-67% of the total deletions and translocations observed. Structural rearrangments were not observed in the parental cell line. After 5 d aphidicolin treatment, the observed excess in frequency of structural rearrangements at FRA3B in the cell lines with pSV2neo integration at 3p14 over that in the two lines without FRA3B integration was less dramatic, but nonetheless significant. Fluorescent in situ hybridization (FISH) analysis of these cells, using a biotin-labeled pSV2neo probe, showed results consistent with the gross rearrangements detected cytogenetically in the lines with FRA3B integration; however, the pSV2neo sequences were frequently deleted concomitantly with translocations. In the hamster fragile sites, a significantly greater rate of chromosome aberrations (gaps, breaks, and rearrangements) was seen only at the bands containing integrated pSV2neo sequences; the hamster fragile sites that did not contain integrated pSV2neo had levels of chromosome aberrations similar to that of the parental line. The cell line with pSV2neo that was integrated randomly also demonstrated a level of chromosome aberrations equivalent to that of the parental line. These results show that integration of marker DNA into FRA3B and hamster fragile sites perturbs these sites, leading to enhanced genetic instability in these regions.	UNIV CHICAGO,DEPT PATHOL,MC 3083,5841 S MARYLAND AVE,CHICAGO,IL 60637; UNIV CHICAGO,HEMATOL SECT,CHICAGO,IL 60637	University of Chicago; University of Chicago				McKeithan, Timothy/0000-0003-2242-3074	NATIONAL CANCER INSTITUTE [R01CA041644, R35CA042557] Funding Source: NIH RePORTER; NCI NIH HHS [CA42557, CA41644] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; GLOVER TW, 1987, AM J HUM GENET, V41, P882; GLOVER TW, 1988, AM J HUM GENET, V43, P265; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; LAIRD C, 1987, TRENDS GENET, V3, P274, DOI 10.1016/0168-9525(87)90268-X; LEBEAU MM, 1984, NATURE, V308, P607, DOI 10.1038/308607a0; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; MIRO R, 1987, HUM GENET, V75, P345, DOI 10.1007/BF00284105; MURNANE JP, 1989, GENE, V84, P201, DOI 10.1016/0378-1119(89)90157-1; PERUCHO M, 1980, CELL, V22, P309, DOI 10.1016/0092-8674(80)90178-6; RASSOOL FV, 1991, P NATL ACAD SCI USA, V88, P6657, DOI 10.1073/pnas.88.15.6657; REID L, 1979, METHOD ENZYMOL, V58, P154; ROWLEY JD, 1990, P NATL ACAD SCI USA, V87, P9358, DOI 10.1073/pnas.87.23.9358; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; Sutherland G, 1985, FRAGILE SITES HUMAN; SUTHERLAND GR, 1989, CYTOGENET CELL GENET, V51, P452, DOI 10.1159/000132804; SUTHERLAND GR, 1977, SCIENCE, V197, P265, DOI 10.1126/science.877551; WARREN ST, 1987, SCIENCE, V237, P420, DOI 10.1126/science.3603029; YUNIS JJ, 1987, ONCOGENE, V1, P59; YUNIS JJ, 1984, SCIENCE, V226, P1199, DOI 10.1126/science.6239375	20	29	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1992	50	6					1243	1251						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HY654	1317992				2022-12-18	WOS:A1992HY65400012
J	KAY, AC; KUHL, W; PRCHAL, J; BEUTLER, E				KAY, AC; KUHL, W; PRCHAL, J; BEUTLER, E			THE ORIGIN OF GLUCOSE-6-PHOSPHATE-DEHYDROGENASE (G6PD) POLYMORPHISMS IN AFRICAN-AMERICANS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; ENZYMATIC AMPLIFICATION; DEHYDROGENASE; MUTATION; VARIANT; SEQUENCE; LINKAGE; LOCUS; RFLP; GENE	DNA samples from 54 male Afro-Americans were examined for glucose-6-phosphate dehydrogenase (G6PD) genotypes G6PD A(+)376G, G6PD A - 202A/376G, and G6PD B and for polymorphisms in intron 5 (PvuII), at nucleotide 1311, and at nucleotide 1116 (PstI). In the G6PD B subjects, the nucleotide 1311 mutation and the PstI site appeared to be in linkage equilibrium. No PvuII + G6PD men were encountered. The G6PD A(+) mutation was in disequilibrium with respect to both the nucleotide 1311 mutation and the PstI site. The G6PD A- nucleotide 202 mutation was in disequilibrium with all three polymorphic sites. No conclusion could be drawn with respect to the PvuII site, except that it preceded the nucleotide 202 (A-) mutation. We conclude from these and our previous studies that G6PD B is the most ancient genotype. The nucleotide 1311 mutation, with its worldwide distribution, probably occurred next. The PstI mutation, limited to Africans, probably arose next and is more ancient than the A(+) mutation, which occurred in a gene without either the PstI or the 1311 mutation. G6PD A-202A/376G is the most recent of these mutations and is still in linkage disequilibrium with all of the sites. Presumably it occurred in an individual with both the A(+) and PvuII mutations.	Scripps Res Inst, RES INST, DEPT MOLEC & EXPTL MED, 10666 N TORREY PINES RD, LA JOLLA, CA 92037 USA	Scripps Research Institute					NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL025552, R37HL025552] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00833] Funding Source: Medline; NHLBI NIH HHS [HL25552] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BEUTLER E, 1989, BLOOD, V73, P1397; BEUTLER E, 1990, HUM GENET, V85, P9; BEUTLER E, 1991, HUM GENET, V87, P462; BEUTLER E, 1989, BLOOD, V74, P2550; BEUTLER E, 1990, AM J HUM GENET, V47, P1008; BIENZLE U, 1972, LANCET, V1, P107; DURSO M, 1988, AM J HUM GENET, V42, P735; FEY MF, 1990, HUM GENET, V84, P471; HIRONO A, 1988, P NATL ACAD SCI USA, V85, P3951, DOI 10.1073/pnas.85.11.3951; KURDIHAIDAR B, 1990, AM J HUM GENET, V47, P1013; MARTINI G, 1986, EMBO J, V5, P1849, DOI 10.1002/j.1460-2075.1986.tb04436.x; REED TE, 1969, SCIENCE, V165, P762, DOI 10.1126/science.165.3895.762; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; TAKIZAWA T, 1987, Genomics, V1, P228, DOI 10.1016/0888-7543(87)90048-6; WHITE R, 1989, GENOME, V31, P1066, DOI 10.1139/g89-183; YOSHIDA A, 1988, AM J HUM GENET, V42, P872; YOSHIDA A, 1967, P NATL ACAD SCI USA, V57, P835, DOI 10.1073/pnas.57.3.835; YOSHIDA A, 1988, AM J HUM GENET, V43, P131	19	29	29	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1992	50	2					394	398						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HD001	1734718				2022-12-18	WOS:A1992HD00100015
J	INDO, Y; GLASSBERG, R; YOKOTA, I; TANAKA, K				INDO, Y; GLASSBERG, R; YOKOTA, I; TANAKA, K			MOLECULAR CHARACTERIZATION OF VARIANT ALPHA-SUBUNIT OF ELECTRON-TRANSFER FLAVOPROTEIN IN 3 PATIENTS WITH GLUTARIC ACIDEMIA TYPE-II - AND IDENTIFICATION OF GLYCINE SUBSTITUTION FOR VALINE-157 IN THE SEQUENCE OF THE PRECURSOR, PRODUCING AN UNSTABLE MATURE PROTEIN IN A PATIENT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACYL-COA DEHYDROGENASES; MEDIUM-CHAIN; DEFICIENCY; PURIFICATION; FIBROBLASTS	In our previous study of eight glutaric acidemia type II (GAII) fibroblast lines by using [S-35]methionine labeling and immunoprecipitation, three of them had a defect in the synthesis of the alpha-subunit of electron transfer flavoprotein (alpha-ETF) (Ikeda et al. 1986). In one of them (YH1313) the labeling of the mature alpha-ETF was barely detectable, while that of the precursor (p) was stronger. In another (YH605) no synthesis of immunoreactive p-alpha-ETF was detectable. In the third cell line (YH1391) the rate of variant p-alpha-ETF synthesis was comparable to normal, but its electrophoretic mobility was slightly faster than normal. In the present study, the northern blot analysis revealed that all three mutant cell lines contained p-alpha-ETF mRNA and that their size and amount were comparable to normal. In immunoblot analysis, both alpha- and beta-ETF bands were barely detectable in YH1313 and YH605 but were detectable in YH1391 in amounts comparable to normal. Sequencing of YH1313 p-alpha-ETF cDNA via PCR identified a transversion of T-470 to G. We then devised a simple PCR method for the 119-bp section (T-443/G-561) for detecting this mutation. In the upstream primer, A-466 was artificially replaced with C, to introduce a BstNI site into the amplified copies in the presence of G-470 from the variant sequence. The genomic DNA analysis using this method demonstrated that YH1313 was homozygous for T --> G-470 transversion. It was not detected either in two other alpha-ETF-deficient GAII or in seven control cell lines. The alpha-ETF cDNA sequence in YH605 was identical to normal.	YALE UNIV,SCH MED,DEPT HUMAN GENET,333 CEDAR ST,POB 3333,NEW HAVEN,CT 06510	Yale University					NIDDK NIH HHS [DK17453] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK017453, R37DK017453] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FINOCCHIARO G, 1988, J BIOL CHEM, V263, P15773; FRERMAN FE, 1985, P NATL ACAD SCI USA, V82, P4517, DOI 10.1073/pnas.82.13.4517; FRERMAN FE, 1989, METABOLIC BASIS INHE, P915; FURUTA S, 1981, J BIOCHEM, V90, P1739, DOI 10.1093/oxfordjournals.jbchem.a133651; IKEDA Y, 1986, J CLIN INVEST, V78, P997, DOI 10.1172/JCI112691; IKEDA Y, 1985, J BIOL CHEM, V260, P1311; NIEDERWIESER A, 1983, HELV PAEDIATR ACTA, V38, P9; OHURA T, 1989, AM J HUM GENET, V45, P33; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; WEXLER ID, 1988, P NATL ACAD SCI USA, V85, P7336, DOI 10.1073/pnas.85.19.7336; YOKOTA I, 1990, J CLIN INVEST, V86, P1000, DOI 10.1172/JCI114761	12	29	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1991	49	3					575	580						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GE367	1882842				2022-12-18	WOS:A1991GE36700010
J	CUPPLES, LA; RISCH, N; FARRER, LA; MYERS, RH				CUPPLES, LA; RISCH, N; FARRER, LA; MYERS, RH			ESTIMATION OF MORBID RISK AND AGE AT ONSET WITH MISSING INFORMATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUNTINGTON DISEASE; ALZHEIMERS-DISEASE; MAXIMUM-LIKELIHOOD; EM ALGORITHM; LIFE-TABLE; DISTRIBUTIONS; HETEROGENEITY; TRANSMISSION; RELATIVES; MODEL	Investigators of genetic illnesses are currently employing life-table techniques to estimate the lifetime risk of disease and the age-at-onset distribution. This methodology assumes that onset ages are known for affected individuals and that censoring ages are known for unaffected individuals. We extend these methods to incorporate affected individuals with unknown onset ages and unaffected persons with unknown censoring ages and illustrate how conventional life-table methods can produce seriously biased estimates, particularly of lifetime risk. The methodology is not restricted to genetic illnesses and can be applied to more complex illnesses with unknown etiology. We present an example for Huntington disease, which is generally assumed to be a Mendelian autosomal dominant disease, yielding estimates of lifetime risk of .503 +/- .070 and mean onset age of 47.7 +/- 3.1 years for offspring with a single affected parent. When conventional life-table techniques are employed, these estimates are .238 +/- .032 and 43.2 +/- 2.2.	BOSTON UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02118; HARVARD UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02115; YALE UNIV,SCH MED,DEPT EPIDEMIOL & PUBL HLTH,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510	Boston University; Harvard University; Harvard Medical School; Yale University; Yale University	CUPPLES, LA (corresponding author), BOSTON UNIV,SCH PUBL HLTH,DEPT EPIDEMIOL & BIOSTAT,80 E CONCORD ST,BOSTON,MA 02118, USA.		Farrer, Lindsay/AAS-1035-2020	Farrer, Lindsay/0000-0001-5533-4225; Myers, Richard/0000-0002-8365-2674	NIGMS NIH HHS [GM12912, GM39812] Funding Source: Medline; NINDS NIH HHS [NS16367] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM012912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS016367, P01NS016367] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS P, 1988, AM J HUM GENET, V43, P695; BREITNER JCS, 1988, NEUROLOGY, V38, P207; BRESLOW N, 1974, ANN STAT, V2, P437, DOI 10.1214/aos/1176342705; CHASE GA, 1983, AM J EPIDEMIOL, V117, P590, DOI 10.1093/oxfordjournals.aje.a113581; CHIDAMBARAM A, 1988, GENET EPIDEMIOL, V5, P255, DOI 10.1002/gepi.1370050407; CONNEALLY PM, 1984, AM J HUM GENET, V36, P506; CUPPLES LA, 1989, GENET EPIDEMIOL, V6, P361, DOI 10.1002/gepi.1370060206; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; ELANDTJOHNSON RC, 1973, J CHRON DIS, V26, P529, DOI 10.1016/0021-9681(73)90004-0; ELANDTJOHNSON RC, 1971, PROBABILITY MODELS S; FARRER LA, 1984, AM J MED GENET, V18, P115, DOI 10.1002/ajmg.1320180115; FARRER LA, 1985, AM J HUM GENET, V37, P350; FARRER LA, 1990, NEUROLOGY, V40, P395, DOI 10.1212/WNL.40.3_Part_1.395; HEIMBUCH RC, 1980, AM J HUM GENET, V32, P564; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; LAWLESS JF, 1982, STATISTICAL MODELS M; LOUIS TA, 1982, J ROY STAT SOC B MET, V44, P226; MCKUSICK VA, 1969, HUMAN GENETICS; MEYER JM, 1988, GENET EPIDEMIOL, V5, P265, DOI 10.1002/gepi.1370050408; MOHS RC, 1987, ARCH GEN PSYCHIAT, V44, P405; MORTON NE, 1959, AM J HUM GENET, V11, P1; MYERS RH, 1983, LANCET, V1, P208; MYERS RH, 1982, AM J HUM GENET, V34, P481; MYERS RH, 1985, AM J HUM GENET, V37, P511; PERICAKVANCE MA, 1983, AM J MED GENET, V14, P49, DOI 10.1002/ajmg.1320140109; RISCH N, 1983, BIOMETRICS, V39, P929, DOI 10.2307/2531328; Thompson EA, 1986, PEDIGREE ANAL HUMAN; THOMPSON WD, 1981, J PSYCHIAT RES, V16, P113, DOI 10.1016/0022-3956(81)90026-1; 1985, SAS IML USERS GUIDE; 1985, SAS USERS GUIDE STAT; 1985, SAS USERS GUIDE BASI	31	29	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1991	49	1					76	87						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FW511	1829582				2022-12-18	WOS:A1991FW51100010
J	VOCKLEY, J; PARIMOO, B; TANAKA, K				VOCKLEY, J; PARIMOO, B; TANAKA, K			MOLECULAR CHARACTERIZATION OF 4 DIFFERENT CLASSES OF MUTATIONS IN THE ISOVALERYL-COA DEHYDROGENASE GENE RESPONSIBLE FOR ISOVALERIC ACIDEMIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE CHAIN-REACTION; RAT-LIVER MITOCHONDRIA; NUCLEOTIDE-SEQUENCE; DNA-POLYMERASE; COENZYME-A; FIBROBLASTS; PRECURSORS; CLONING; FAMILY	Isovaleric acidemia (IVA) is an inborn error of leucine metabolism and is caused by a genetically determined deficiency of isovaleryl-CoA dehydrogenase (IVD), a mitochondrial matrix enzyme. IVD is produced as a 45-kDa precursor and then is transported into the mitochondria, where it is processed to its mature 43-kDa size. Previous [S-35]methionine-labeling studies of fibroblasts from IVA patients have revealed at least five classes of mutations within the IVD gene. In size, IVD precursor and mature proteins produced by class I mutants are indistinguishable from their normal counterparts. Class II, III, and IV mutants make IVD precursor proteins which are 23 kDa smaller than normal. Subsequent processing in class III and IV mutants is normal but proceeds inefficiently in class II mutants. Class V mutants make no detectable IVD protein. In order to further study these mutations at the molecular level, the IVD coding region from mutant fibroblast cDNA was amplified by the PCR and was analyzed by DNA sequencing. cDNA from class I mutant alleles from two of seven class I mutant cell lines each contained a different missense mutation. In cDNA from a class III mutant, a single base deletion at position 1179 of the coding region was identified which leads to a shift in reading frame, predicting the incorporation of eight abnormal amino acids followed by a premature termination codon. Sequencing of amplified IVD cDNA from a type V mutant has failed to identify any abnormalities. It most probably is deficient in translation of the IVD mRNA. A new class of IVD mutant allele which appears to be transcriptionally defective (type VI) was also identified. Additional study of this set of IVD mutations should add both to our knowledge of the biosynthetic pathway of mitochondrial proteins and to our understanding of the clinical heterogeneity seen in IVA.			VOCKLEY, J (corresponding author), YALE UNIV,SCH MED,DEPT HUMAN GENET,333 CEDAR ST,POB 3333,NEW HAVEN,CT 06510, USA.		Vockley, Jerry/B-5210-2016; Vockley, Jerry/AAF-8523-2020	Vockley, Jerry/0000-0002-8180-6457; Vockley, Jerry/0000-0002-8180-6457	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK017453, R01DK017453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM013125] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 17453] Funding Source: Medline; NIGMS NIH HHS [GM 13125, GM 07439] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; FINOCCHIARO G, 1988, J BIOL CHEM, V263, P15773; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; IKEDA Y, 1983, J BIOL CHEM, V258, P1066; IKEDA Y, 1985, P NATL ACAD SCI USA, V82, P7081, DOI 10.1073/pnas.82.20.7081; IKEDA Y, 1987, ARCH BIOCHEM BIOPHYS, V252, P662, DOI 10.1016/0003-9861(87)90072-5; IKEDA Y, 1983, J BIOL CHEM, V258, P1077; INNIS MA, 1988, P NATL ACAD SCI USA, V85, P9436, DOI 10.1073/pnas.85.24.9436; KIM JJ, 1988, P NATL ACAD SCI USA, V84, P6677; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MATSUBARA Y, 1990, J CLIN INVEST, V85, P1058, DOI 10.1172/JCI114536; MATSUBARA Y, 1989, J BIOL CHEM, V264, P16321; RHEAD WJ, 1980, P NATL ACAD SCI-BIOL, V77, P580, DOI 10.1073/pnas.77.1.580; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; TANAKA K, 1966, P NATL ACAD SCI USA, V56, P236, DOI 10.1073/pnas.56.1.236; VOCKLEY J, 1989, American Journal of Human Genetics, V45, pA227; WOLF H, 1988, COMPUT APPL BIOSCI, V4, P187	18	29	30	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1991	49	1					147	157						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FW511	2063866				2022-12-18	WOS:A1991FW51100017
J	PAW, BH; WOOD, LC; NEUFELD, EF				PAW, BH; WOOD, LC; NEUFELD, EF			A 3RD MUTATION AT THE CPG DINUCLEOTIDE OF CODON-504 AND A SILENT MUTATION AT CODON-506 OF THE HEX-A GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TAY-SACHS DISEASE; HEXOSAMINIDASE ALPHA-GENE; ADULT GM2 GANGLIOSIDOSIS; POLYMERASE CHAIN-REACTION; BETA-HEXOSAMINIDASE; ASHKENAZI-JEWISH; FRENCH-CANADIANS; LYSOSOMAL-ENZYME; NUCLEAR EXTRACTS; MOLECULAR-BASIS	Two CpG mutations at codon 504 of the gene encoding the alpha-subunit of beta-hexosaminidase (the HEX A gene) have been identified previously: (1) a C deletion resulting in premature termination of the alpha-subunit and (2) a G --> A transition resulting in 504Arg --> His substitution, in patients with infantile Tay-Sachs disease and juvenile G(M2) gangliosidosis, respectively. This prompted a search for a C --> T transition in the same dinucleotide, as would be expected from the mechanism of CpG mutagenesis. Such a mutation, which results in a substitution of cysteine for arginine, was found in a patient with chronic G(M2) gangliosidosis, in compound heterozygosity with the known 269Gly --> Ser allele. The biochemical phenotype of the 504Arg --> Cys mutation was examined by site-directed mutagenesis of the alpha-subunit cDNA and transfection of Cos-1 cells. The expression of the mutagenized cDNA with the cysteine substitution gave rise to an alpha-subunit with the same defects as those resulting from expression of mutagenized cDNA with the histidine substitution - i.e., secretion primarily as the alpha-monomer rather than as the alpha-alpha-dimer, along with absence of enzymatic activity. The 504Arg --> Cys/269Gly --> Ser genotype of the chronic G(M2) gangliosidosis patient is shared by her sibling, who has mild adult-onset G(M2) gangliosidosis, implying that the clinical differences between them must be attributed to other factors. The family is unique in yet another respect - namely, that the normal allele of the mother and of a 504Arg --> Cys heterozygous sibling has a silent mutation, a G --> A transition in the wobble position of the glutamic acid codon at position 506. The results of this study indicate both the value of searching for cognate mutations at CpG dinucleotides and a pitfall in diagnosis that uses allele-specific oligonucleotides.	UNIV CALIF LOS ANGELES,SCH MED,DEPT BIOL CHEM,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,BRAIN RES INST,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,INST MOLEC BIOL,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles				Paw, Barry/0000-0002-0492-1419	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022376] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM08042] Funding Source: Medline; NINDS NIH HHS [NS 22376] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARGOV Z, 1984, ANN NEUROL, V16, P14, DOI 10.1002/ana.410160105; ARPAIA E, 1988, NATURE, V333, P85, DOI 10.1038/333085a0; BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BAYLERAN J, 1984, CLIN CHIM ACTA, V143, P73, DOI 10.1016/0009-8981(84)90215-8; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; DAZZO A, 1984, J BIOL CHEM, V259, P1070; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; FARR CJ, 1988, P NATL ACAD SCI USA, V85, P1629, DOI 10.1073/pnas.85.5.1629; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; FUJIMURA FK, 1990, NEW ENGL J MED, V322, P61; GONZALEZNORIEGA A, 1980, J CELL BIOL, V85, P839, DOI 10.1083/jcb.85.3.839; HECHTMAN P, 1990, AM J HUM GENET, V47, P815; KOBAYASHI K, 1990, AM J HUM GENET, V47, P611; KOEBERL DD, 1989, AM J HUM GENET, V45, P448; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAU MMH, 1989, J BIOL CHEM, V264, P21376; MYEROWITZ R, 1987, J BIOL CHEM, V262, P15396; MYEROWITZ R, 1988, J BIOL CHEM, V263, P18587; MYEROWITZ R, 1988, P NATL ACAD SCI USA, V85, P3955, DOI 10.1073/pnas.85.11.3955; MYEROWITZ R, 1986, SCIENCE, V232, P1646, DOI 10.1126/science.3754980; NAKANO T, 1988, J NEUROCHEM, V51, P984, DOI 10.1111/j.1471-4159.1988.tb01836.x; NAKANO T, 1990, ANN NEUROL, V27, P465, DOI 10.1002/ana.410270503; NAVON R, 1987, BIOCHEM BIOPH RES CO, V148, P1098, DOI 10.1016/S0006-291X(87)80245-0; NAVON R, 1990, AM J HUM GENET, V46, P817; NAVON R, 1989, SCIENCE, V243, P1471, DOI 10.1126/science.2522679; NEUFELD EF, 1989, J BIOL CHEM, V264, P10927; NEUFELD EF, 1991, ANNU REV BIOCHEM, V60, P257, DOI 10.1146/annurev.biochem.60.1.257; OHNO K, 1988, BIOCHEM BIOPH RES CO, V153, P463, DOI 10.1016/S0006-291X(88)81247-6; PAW BH, 1990, AM J HUM GENET, V47, P698; PAW BH, 1990, J BIOL CHEM, V265, P9452; PAW BH, 1989, P NATL ACAD SCI USA, V86, P2413, DOI 10.1073/pnas.86.7.2413; PROIA RL, 1984, J BIOL CHEM, V259, P3350; RAGHAVAN SS, 1985, AM J HUM GENET, V37, P1071; Sandhoff KCE, 1989, METABOLIC BASIS INHE, V2, P1807; SNAGER F, 1977, P NATL ACAD SCI USA, V74, P5463; TANAKA A, 1990, AM J HUM GENET, V46, P329; TRIGGSRAINE BL, 1990, NEW ENGL J MED, V323, P6, DOI 10.1056/NEJM199007053230102; TROP I, 1990, AM J HUM GENET S, V47, pA168; WIEBAUER K, 1990, P NATL ACAD SCI USA, V87, P5842, DOI 10.1073/pnas.87.15.5842; WIEBAUER K, 1989, NATURE, V339, P234, DOI 10.1038/339234a0	42	29	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1991	48	6					1139	1146						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FP092	1827944				2022-12-18	WOS:A1991FP09200016
J	ENDO, F; KATOH, H; YAMAMOTO, S; MATSUDA, I				ENDO, F; KATOH, H; YAMAMOTO, S; MATSUDA, I			A MURINE MODEL FOR TYPE-III TYROSINEMIA - LACK OF IMMUNOLOGICALLY DETECTABLE 4-HYDROXYPHENYLPYRUVIC ACID DIOXYGENASE ENZYME PROTEIN IN A NOVEL MOUSE STRAIN WITH HYPERTYROSINEMIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PARA-HYDROXYPHENYLPYRUVATE HYDROXYLASE; HUMAN-LIVER; HEREDITARY TYROSINEMIA; AVIAN LIVER; PURIFICATION; DEFICIENCY; FUMARYLACETOACETASE	We have characterized a new mutant strain of mouse that has hypertyrosinemia. The blood tyrosine level was persistently high, and increased amounts of 4-hydroxyphenylpyruvic acid and its derivatives were excreted into the urine. Succinylacetone was not detected in urine samples from these mice. All the animals were apparently healthy, and there was no evidence of hepatorenal dysfunction. The hypertyrosinemia was transmitted through an autosomal recessive inheritance. Analyses of hepatic enzymes related to tyrosine metabolism revealed that 4-hydroxyphenylpyruvic acid dioxygenase activity was virtually absent, while fumarylacetoacetase and tyrosine aminotransferases (cytosolic and mitochondrial forms) were normal in these mutant mice. Immunoblot analysis of 4-hydroxyphenylpyruvic acid dioxygenase protein in the liver indicated that the subunit protein of the enzyme was absent. It would appear that hypertyrosinemia in this mutant strain was caused by a genetic defect in 4-hydroxyphenylpyruvic acid dioxygenase. These features are similar to type III tyrosinemia in humans. Analysis of this mutant strain of mouse is expected to provide valuable information on the pathogenesis of human type III tyrosinemia and can also serve as a useful system for studies on tyrosine metabolism.	CENT INST EXPTL ANIM, GENET LAB, KAWASAKI, JAPAN; SHIMOSHIZU NATL HOSP, DEPT PEDIAT, YOTSUKAIDO, JAPAN		ENDO, F (corresponding author), KUMAMOTO UNIV, SCH MED, DEPT PEDIAT, HONJO 1-1-1, KUMAMOTO 860, JAPAN.							BERGER R, 1981, CLIN CHIM ACTA, V114, P37, DOI 10.1016/0009-8981(81)90225-4; BUCKTHAL DJ, 1987, METHOD ENZYMOL, V142, P132; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; DEMARS R, 1976, P NATL ACAD SCI USA, V73, P1693, DOI 10.1073/pnas.73.5.1693; DIAMONDSTONE TI, 1966, ANAL BIOCHEM, V16, P395, DOI 10.1016/0003-2697(66)90220-X; EDWARDS SW, 1955, METHOD ENZYMOL, V2, P292; ENDO F, 1983, PEDIATR RES, V17, P92, DOI 10.1203/00006450-198302000-00002; ENDO F, 1990, J CLIN INVEST, V85, P162, DOI 10.1172/JCI114407; FELLMAN JH, 1987, METHOD ENZYMOL, V142, P148; FELLMAN JH, 1969, BIOCHEMISTRY-US, V8, P615, DOI 10.1021/bi00830a023; GIARDINI O, 1983, PEDIATR RES, V17, P25, DOI 10.1203/00006450-198301000-00005; GOLDSMITH LA, 1989, METABOLIC BASIS INHE, P547; KATOH H, 1989, MED IMMUNOLOGY, V17, P353; KVITTINGEN EA, 1981, CLIN CHIM ACTA, V115, P311, DOI 10.1016/0009-8981(81)90244-8; LADU BN, 1967, AM J DIS CHILD, V113, P54, DOI 10.1001/archpedi.1967.02090160104010; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDBLAD B, 1971, CLIN CHIM ACTA, V34, P113, DOI 10.1016/0009-8981(71)90074-X; LINDBLAD B, 1977, J BIOL CHEM, V252, P5073; LINDSTEDT S, 1987, METHOD ENZYMOL, V142, P139; McKusick V. A., 1986, MENDELIAN INHERITANC; Medes G, 1932, BIOCHEM J, V26, P917, DOI 10.1042/bj0260917; ROCHE PA, 1982, ARCH BIOCHEM BIOPHYS, V216, P62, DOI 10.1016/0003-9861(82)90188-6; TANAKA K, 1980, CLIN CHEM, V26, P1839; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WADA GH, 1975, J BIOL CHEM, V250, P6720	25	29	29	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1991	48	4					704	709						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK478	2014797				2022-12-18	WOS:A1991FK47800009
J	HERRING, WJ; LITWER, S; WEBER, JL; DANNER, DJ				HERRING, WJ; LITWER, S; WEBER, JL; DANNER, DJ			MOLECULAR GENETIC-BASIS OF MAPLE SYRUP URINE DISEASE IN A FAMILY WITH 2 DEFECTIVE ALLELES FOR BRANCHED-CHAIN ACYLTRANSFERASE AND LOCALIZATION OF THE GENE TO HUMAN CHROMOSOME-I	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEINS; COMPLEX; CDNA; MUTATIONS; SEQUENCE; INVITRO; IMPORT; MATRIX; RNA; RAT	Maple syrup urine disease in humans results from inherited defects in branched chain alpha-ketoacid dehydrogenase, a mitochondrial multienzyme complex. A variety of genetic changes may produce this phenotype by affecting the function of any of the three complex-specific subunits. The varied clinical expression observed in patients may be partially explained by the defects in the involved subunit. Here we report localization of the gene for the branched chain acyltransferase component of the complex to human chromosome 1 and describe a proband who is a compound heterozygote at this locus. One allele, inherited from the father, produces transcripts with 124 nucleotides deleted from the coding region. The deletion is not found in the branched chain acyltransferase gene, implying that the deleted transcripts arise by an error in transcript processing. Cells from the patient's mother contain 50% of the normal amount of mRNA for the subunit, and the proband has inherited this nonexpressing allele from her. As a result, the proband produces no acyltransferase protein and therefore has greatly impaired complex activity. A phenotypically normal sibling is shown to be genetically similar to the mother having inherited the mother's nonexpressing allele and the father's normal allele.	EMORY UNIV, SCH MED, DEPT PEDIAT, DIV MED GENET, ATLANTA, GA 30322 USA; MARSHFIELD CLIN FDN MED RES & EDUC, MARSHFIELD, WI 54449 USA	Emory University; Marshfield Clinic					NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038320] Funding Source: NIH RePORTER; NCRR NIH HHS [MO1 RR00039] Funding Source: Medline; NIDDK NIH HHS [DK38320] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ausubel F.M., 1989, SHORT PROTOCOLS MOL; DANNER DJ, 1989, J BIOL CHEM, V264, P7742; DANNER DJ, 1985, J CLIN INVEST, V75, P858, DOI 10.1172/JCI111783; DANNER DJ, 1989, METABOLIC BASIS INHE, P617; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FEKETE G, 1989, CYTOGENET CELL GENET, V50, P236, DOI 10.1159/000132768; GIBBS RA, 1989, P NATL ACAD SCI USA, V86, P1919, DOI 10.1073/pnas.86.6.1919; GILLESPIE LL, 1985, J BIOL CHEM, V260, P6045; GOUGH NM, 1988, ANAL BIOCHEM, V173, P93, DOI 10.1016/0003-2697(88)90164-9; HARRIS RA, 1988, METHOD ENZYMOL, V166, P114; INNIS MA, 1990, PCR PROTOCOLS; LITWER S, 1989, J BIOL CHEM, V264, P14597; MENKES JH, 1954, PEDIATRICS, V14, P462; MILLER RH, 1988, J BIOL CHEM, V263, P3454; ONO H, 1988, J BIOL CHEM, V263, P3188; OTULAKOWSKI G, 1988, SOMAT CELL MOLEC GEN, V14, P411, DOI 10.1007/BF01534650; PONS G, 1988, P NATL ACAD SCI USA, V85, P1422, DOI 10.1073/pnas.85.5.1422; SHORE GC, 1983, METHOD ENZYMOL, V97, P396; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868; WANG CS, 1975, ANAL BIOCHEM, V63, P414, DOI 10.1016/0003-2697(75)90363-2; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P2199; YEAMAN SJ, 1986, TRENDS BIOCHEM SCI, V11, P293, DOI 10.1016/0968-0004(86)90033-2; ZHANG B, 1990, J BIOL CHEM, V265, P2425; ZHANG B, 1989, J CLIN INVEST, V83, P1425, DOI 10.1172/JCI114033	26	29	30	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1991	48	2					342	350						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV744	1990841				2022-12-18	WOS:A1991EV74400019
J	GOODFELLOW, PJ; MYERS, S; ANDERSON, LL; BROOKSWILSON, AR; SIMPSON, NE				GOODFELLOW, PJ; MYERS, S; ANDERSON, LL; BROOKSWILSON, AR; SIMPSON, NE			A NEW DNA MARKER (D10S94) VERY TIGHTLY LINKED TO THE MULTIPLE ENDOCRINE NEOPLASIA TYPE-2A (MEN2A) LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									QUEENS UNIV,DEPT PAEDIAT,KINGSTON K7L 3N6,ONTARIO,CANADA; QUEENS UNIV,DEPT BIOL,KINGSTON K7L 3N6,ONTARIO,CANADA	Queens University - Canada; Queens University - Canada	GOODFELLOW, PJ (corresponding author), UNIV BRITISH COLUMBIA,DEPT MED GENET,318 WESBROOK BLDG,6174 UNIV BLVD,VANCOUVER V6T 1W5,BC,CANADA.		Brooks-Wilson, Angela/E-9399-2012	Brooks-Wilson, Angela/0000-0003-1009-6408				BROOKSWILSON AR, 1990, GENOMICS, V7, P614, DOI 10.1016/0888-7543(90)90207-B; BROOKSWILSON AR, IN PRESS NUCLEIC ACI; CARSON NL, 1990, AM J HUM GENET, V47, P946; DEVILEE P, 1988, Genomics, V3, P1, DOI 10.1016/0888-7543(88)90151-6; EASTON DF, 1989, AM J HUM GENET, V44, P208; FARRER LA, 1987, CANCER GENET CYTOGEN, V27, P327, DOI 10.1016/0165-4608(87)90015-X; GAGEL RF, 1988, NEW ENGL J MED, V318, P478, DOI 10.1056/NEJM198802253180804; GOODFELLOW PJ, 1990, SOMAT CELL MOLEC GEN, V16, P163, DOI 10.1007/BF01233046; GOODFELLOW PJ, 1989, ANN HUM GENET, V53, P15, DOI 10.1111/j.1469-1809.1989.tb01118.x; Hodge SE, 1979, AM J HUM GENET, V31, P761; LATHROP GM, 1988, GENOMICS, V2, P157; LIOU GI, 1987, SOMAT CELL MOLEC GEN, V13, P315, DOI 10.1007/BF01534925; MATHEW CGP, 1987, NATURE, V328, P527, DOI 10.1038/328527a0; MATHEW CGP, 1990, ANN HUM GENET, V54, P121, DOI 10.1111/j.1469-1809.1990.tb00368.x; MORTON NE, 1955, AM J HUM GENET, V7, P277; NAKAMURA Y, 1988, GENOMICS, V3, P389, DOI 10.1016/0888-7543(88)90133-4; NAKAMURA Y, 1989, GENOMICS, V5, P199, DOI 10.1016/0888-7543(89)90046-3; NAROD SA, 1989, HUM GENET, V83, P353, DOI 10.1007/BF00291380; OTT J, 1974, AM J HUM GENET, V26, P588; SIMPSON NE, 1987, NATURE, V328, P528, DOI 10.1038/328528a0; SMITH M, 1989, CYTOGENET CELL GENET, V51, P202, DOI 10.1159/000132792; WU JS, 1989, HUM GENET, V83, P383, DOI 10.1007/BF00291386; WU JS, 1990, AM J HUM GENET, V46, P624	23	29	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1990	47	6					952	956						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EK400	1978561				2022-12-18	WOS:A1990EK40000011
J	TAKAHASHI, H; CRYSTAL, RG				TAKAHASHI, H; CRYSTAL, RG			ALPHA-1-ANTITRYPSIN NULL-ISOLA-DI-PROCIDA - AN ALPHA-1-ANTITRYPSIN DEFICIENCY ALLELE CAUSED BY DELETION OF ALL ALPHA-1-ANTITRYPSIN CODING EXONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NHLBI, PULM BRANCH, ROOM 6D03, BLDG 10, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)								BAO J-J, 1988, Genomics, V2, P165, DOI 10.1016/0888-7543(88)90099-7; Bieth JG, 1986, REGULATION MATRIX AC, P217; BRANTLY M, 1988, AM J MED, V84, P13; CARRELL RW, 1982, NATURE, V298, P329, DOI 10.1038/298329a0; CARRELL RW, 1979, ESSAYS MEDICAL BIOCH, V4, P83; CILIBERTO G, 1985, CELL, V41, P531, DOI 10.1016/S0092-8674(85)80026-X; CONSTANS J, 1980, HUM GENET, V55, P119, DOI 10.1007/BF00329137; COX DW, 1980, HUM GENET, V53, P429, DOI 10.1007/BF00287070; CRYSTAL RG, 1989, TRENDS GENET, V5, P411, DOI 10.1016/0168-9525(89)90200-X; CRYSTAL RG, 1989, CHEST, V95, P196, DOI 10.1378/chest.95.1.196; CURIEL D, 1989, J CLIN INVEST, V83, P1144, DOI 10.1172/JCI113994; DALGLEISH R, 1982, J BIOL CHEM, V257, P13816; EFSTRATIADIS A, 1980, CELL, V21, P653, DOI 10.1016/0092-8674(80)90429-8; Fagerhol M K, 1981, Adv Hum Genet, V11, P1; FARABAUGH PJ, 1978, J MOL BIOL, V126, P847, DOI 10.1016/0022-2836(78)90023-2; FRAIZER G, 1988, American Journal of Human Genetics, V43, pA183; GADEK JE, 1981, J CLIN INVEST, V68, P889, DOI 10.1172/JCI110344; GARVER RI, 1986, NEW ENGL J MED, V314, P762, DOI 10.1056/NEJM198603203141207; GITSCHIER J, 1988, AM J HUM GENET, V43, P274; GORG A, 1985, AM J HUM GENET, V37, P922; HOFKER MH, 1988, BIOCHEM BIOPH RES CO, V155, P634, DOI 10.1016/S0006-291X(88)80542-4; HOLMES M, 1989, AM REV RESPIR DIS, V140, P1662, DOI 10.1164/ajrccm/140.6.1662; HORSTHEMKE B, 1987, J MED GENET, V24, P144, DOI 10.1136/jmg.24.3.144; HUMPHRIES RK, 1984, BLOOD, V64, P23; JANOFF A, 1985, AM REV RESPIR DIS, V132, P417; KAZAZIAN HH, 1988, BLOOD, V72, P1107; KELSEY GD, 1987, GENE DEV, V1, P161, DOI 10.1101/gad.1.2.161; KIDD VJ, 1986, PROTEINASE INHIBITOR, P421; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KUEPPERS F, 1978, GENETIC DETERMINANTS, P23; LANGLOIS S, 1988, AM J HUM GENET, V43, P60; LONG GL, 1984, BIOCHEMISTRY-US, V23, P4828, DOI 10.1021/bi00316a003; MAQUAT LE, 1981, CELL, V27, P543, DOI 10.1016/0092-8674(81)90396-2; MICHALSKI JP, 1985, J IMMUNOL METHODS, V83, P101, DOI 10.1016/0022-1759(85)90063-8; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; NUKIWA T, 1988, AM J HUM GENET, V43, P322; NUKIWA T, 1987, BIOCHEMISTRY-US, V26, P5259, DOI 10.1021/bi00391a008; NUKIWA T, 1987, J BIOL CHEM, V262, P11999; OKAYAMA H, 1989, J LAB CLIN MED, V114, P105; ORKIN SH, 1984, ANNU REV GENET, V18, P131; PERLINO E, 1987, EMBO J, V6, P2767, DOI 10.1002/j.1460-2075.1987.tb02571.x; RABIN M, 1986, SOMAT CELL MOLEC GEN, V12, P209, DOI 10.1007/BF01560668; REED L, 1987, American Journal of Human Genetics, V41, pA235; RUTHER U, 1987, NUCLEIC ACIDS RES, V15, P7519, DOI 10.1093/nar/15.18.7519; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATOH K, 1988, AM J HUM GENET, V42, P77; SEABRIGH.M, 1971, LANCET, V2, P971; SHEN RF, 1987, NUCLEIC ACIDS RES, V15, P8399, DOI 10.1093/nar/15.20.8399; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; TAKAHASHI H, 1988, J BIOL CHEM, V263, P15528; TAKESHITA K, 1984, BLOOD, V64, P13; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; WEWERS MD, 1987, NEW ENGL J MED, V316, P1055, DOI 10.1056/NEJM198704233161704; WOLFSON J, 1979, J BIOL CHEM, V254, P490; YOUSSOUFIAN H, 1987, P NATL ACAD SCI USA, V84, P3772, DOI 10.1073/pnas.84.11.3772; 1978, BIRTH DEFECTS ORIG 8, V14, P309	57	29	30	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1990	47	3					403	413						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX223	1975477				2022-12-18	WOS:A1990DX22300005
J	OLSON, S; SONG, BJ; HUH, TL; CHI, YT; VEECH, RL; MCBRIDE, OW				OLSON, S; SONG, BJ; HUH, TL; CHI, YT; VEECH, RL; MCBRIDE, OW			3 GENES FOR ENZYMES OF THE PYRUVATE-DEHYDROGENASE COMPLEX MAP TO HUMAN CHROMOSOME-3, CHROMOSOME-7, AND CHROMOSOME-X	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NCI,BIOCHEM LAB,BLDG 37,ROOM 4D06,9000 ROCKVILLE PIKE,BETHESDA,MD 20892; NIAAA,METAB & MOLEC BIOL LAB,ROCKVILLE,MD 20852	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)								BROWN RM, 1989, GENOMICS, V4, P174, DOI 10.1016/0888-7543(89)90297-8; DAHL HHM, 1987, J BIOL CHEM, V262, P7398; DAVIS LG, 1986, METHOD MOL BIOL, P75; ENDO H, 1989, AM J HUM GENET, V44, P358; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FELVER ME, 1980, ALCOHOL ALDEHYDE MET, V4, P229; HAMADA M, 1976, J BIOCHEM, V79, P1273, DOI 10.1093/oxfordjournals.jbchem.a131181; HAMADA M, 1975, J BIOCHEM-TOKYO, V77, P1047, DOI 10.1093/oxfordjournals.jbchem.a130805; HAYAKAWA T, 1969, J BIOL CHEM, V244, P3660; KOIKE K, 1988, P NATL ACAD SCI USA, V85, P41, DOI 10.1073/pnas.85.1.41; KRETZSCHMAR HA, 1987, PEDIATRICS, V79, P370; KUHURA T, 1983, CLIN CHIM ACTA, V133, P133; LINN TC, 1969, P NATL ACAD SCI USA, V62, P234, DOI 10.1073/pnas.62.1.234; LINN TC, 1969, P NATL ACAD SCI USA, V64, P227, DOI 10.1073/pnas.64.1.227; MATUDA S, 1984, CLIN CHIM ACTA, V140, P59; MCBRIDE OW, 1983, NUCLEIC ACIDS RES, V11, P8221, DOI 10.1093/nar/11.23.8221; MCBRIDE OW, 1982, J EXP MED, V155, P1480, DOI 10.1084/jem.155.5.1480; MCBRIDE OW, 1986, P NATL ACAD SCI USA, V83, P130, DOI 10.1073/pnas.83.1.130; MCBRIDE OW, 1982, NUCLEIC ACIDS RES, V10, P8155, DOI 10.1093/nar/10.24.8155; MCKAY N, 1986, EUR J PEDIATR, V144, P445, DOI 10.1007/BF00441736; MIYABAYASHI S, 1985, EUR J PEDIATR, V143, P278, DOI 10.1007/BF00442301; NAYLOR SL, 1988, CYTOGENET CELL GENET, V49, P1; OTULAKOWSKI G, 1987, J BIOL CHEM, V262, P17313; OTULAKOWSKI G, 1988, SOMAT CELL MOLEC GEN, V14, P411, DOI 10.1007/BF01534650; PONS G, 1988, P NATL ACAD SCI USA, V85, P1422, DOI 10.1073/pnas.85.5.1422; RANDLE PJ, 1985, DIABETOLOGIA, V28, P479, DOI 10.1007/BF00281981; REED L, 1978, MICROENVIRONMENTS ME, P305; Reed L J, 1981, Curr Top Cell Regul, V18, P95; ROBINSON BH, 1984, J INHERIT METAB DIS, V7, P69, DOI 10.1007/BF03047378; ROBINSON BH, 1977, PEDIATR RES, V11, P1198, DOI 10.1203/00006450-197712000-00006; ROBINSON BH, 1981, EUR J PEDIATR, V136, P35, DOI 10.1007/BF00441708; SAKAWAI Y, 1970, J BIOL CHEM, V245, P4453; TAYLOR J, 1978, PEDIATR RES, V12, P60, DOI 10.1203/00006450-197801000-00019; TORO-SOLA M A, 1988, American Journal of Human Genetics, V43, pA17; TRONICK SR, 1989, GENOMICS, V5, P546, DOI 10.1016/0888-7543(89)90022-0; TSAI CS, 1973, J BIOL CHEM, V248, P8348; Veech R L, 1981, Curr Top Cell Regul, V18, P151; WEXLER ID, 1988, P NATL ACAD SCI USA, V85, P7336, DOI 10.1073/pnas.85.19.7336; YEAMAN SJ, 1978, BIOCHEMISTRY-US, V17, P2364, DOI 10.1021/bi00605a017	39	29	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1990	46	2					340	349						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CM938	1967901				2022-12-18	WOS:A1990CM93800015
J	SIMON, M; PHILLIPS, M; GREEN, H; STROH, H; GLATT, K; BRUNS, G; LATT, SA				SIMON, M; PHILLIPS, M; GREEN, H; STROH, H; GLATT, K; BRUNS, G; LATT, SA			ABSENCE OF A SINGLE REPEAT FROM THE CODING REGION OF THE HUMAN INVOLUCRIN GENE LEADING TO RFLP	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HARVARD UNIV,SCH MED,DEPT CELLULAR & MOLEC PHYSIOL,25 SHATTUCK ST,BOSTON,MA 02115; HARVARD UNIV,CHILDRENS HOSP,SCH MED,HOWARD HUGHES MED INST,DEPT GENET,DIV GENET,BOSTON,MA 02115	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD018658] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R35CA040029] Funding Source: NIH RePORTER; NCI NIH HHS [CA-40029] Funding Source: Medline; NICHD NIH HHS [HD-18658] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BROOK JD, 1984, HUM GENET, V68, P282, DOI 10.1007/BF00292584; BRUNS G, 1987, HUM GENET, V76, P58; BRUNS GAP, 1979, BIOCHEM GENET, V17, P1031, DOI 10.1007/BF00504344; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; DJIAN P, 1989, MOL BIOL EVOL, V6, P469; DONLON TA, 1983, AM J HUM GENET, V35, P1097; ECKERT RL, 1986, CELL, V46, P583, DOI 10.1016/0092-8674(86)90884-6; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HARPER ME, 1981, P NATL ACAD SCI-BIOL, V78, P4458, DOI 10.1073/pnas.78.7.4458; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; KUNKEL LM, 1982, NUCLEIC ACIDS RES, V10, P1557, DOI 10.1093/nar/10.5.1557; LATT SA, 1976, CHROMOSOMA, V57, P135, DOI 10.1007/BF00292912; Maniatis T., 1982, MOL CLONING; MATOLTSY AG, 1966, J INVEST DERMATOL, V46, P127, DOI 10.1038/jid.1966.19; NICHOLLS RD, 1985, NUCLEIC ACIDS RES, V13, P7569, DOI 10.1093/nar/13.21.7569; PARENTEAU NL, 1987, P NATL ACAD SCI USA, V84, P7571, DOI 10.1073/pnas.84.21.7571; PONCZ M, 1982, P NATL ACAD SCI USA, V79, P4928; RICE RH, 1977, CELL, V11, P417, DOI 10.1016/0092-8674(77)90059-9; RICE RH, 1979, CELL, V18, P681, DOI 10.1016/0092-8674(79)90123-5; SCOTT AF, 1979, P NATL ACAD SCI USA, V76, P4563, DOI 10.1073/pnas.76.9.4563; SIMON M, 1984, CELL, V36, P827, DOI 10.1016/0092-8674(84)90032-1; SION M, 1989, J INVEST DERMATOL, V92, P721; STROH H, 1987, CYTOGENET CELL GENET, V46, P700; SUGAWARA K, 1979, AGR BIOL CHEM TOKYO, V43, P2543, DOI 10.1080/00021369.1979.10863846; SUN TT, 1976, CELL, V9, P511, DOI 10.1016/0092-8674(76)90033-7; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TEUMER J, 1989, P NATL ACAD SCI USA, V86, P1283, DOI 10.1073/pnas.86.4.1283; TSENG H, 1988, CELL, V54, P491, DOI 10.1016/0092-8674(88)90070-0; TSENG H, 1989, MOL BIOL EVOL, V6, P460; VOGELSTEIN B, 1979, P NATL ACAD SCI USA, V76, P615, DOI 10.1073/pnas.76.2.615	30	29	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1989	45	6					910	916						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CF403	2574003				2022-12-18	WOS:A1989CF40300010
J	LOBOS, EA; RUDNICK, CH; WATSON, MS; ISENBERG, KE				LOBOS, EA; RUDNICK, CH; WATSON, MS; ISENBERG, KE			LINKAGE DISEQUILIBRIUM STUDY OF RFLPS DETECTED AT THE HUMAN-MUSCLE NICOTINIC ACETYLCHOLINE-RECEPTOR SUBUNIT GENES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WASHINGTON UNIV,SCH MED,DIV BIOL & BIOMED SCI,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,EDWARD MALLINCKRODT DEPT PEDIAT,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,JAMES C MCDONNELL DEPT GENET,ST LOUIS,MO 63110	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	LOBOS, EA (corresponding author), WASHINGTON UNIV,SCH MED,DEPT PSYCHIAT,BOX 8134,4940 AUDUBON,ST LOUIS,MO 63110, USA.				NIAAA NIH HHS [AA-03539] Funding Source: Medline; NIMH NIH HHS [MH-00635, MH-31302] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH031302, P50MH031302, K11MH000635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA003539] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		BARKER D, 1984, AM J HUM GENET, V36, P1159; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BELL J, 1986, LANCET, V1, P1058; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BOULTER J, 1985, J NEUROSCI, V5, P2545; BUONANNO A, 1986, J BIOL CHEM, V261, P6451; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; CHIU HC, 1987, J IMMUNOGENET, V14, P203; CHIU HC, 1988, J NEUROL NEUROSUR PS, V51, P214, DOI 10.1136/jnnp.51.2.214; CONTITRONCONI BM, 1982, BIOCHEM BIOPH RES CO, V106, P312, DOI 10.1016/0006-291X(82)91111-1; DEVOR EJ, 1988, AM J HUM GENET, V42, P179; Dickerson R E., 1971, Journal Molec Evol, V1, P26, DOI 10.1007/BF01659392; DONLON TA, 1986, KARYOGRAM, V12, P3; ENGEL AG, 1984, ANN NEUROL, V16, P519, DOI 10.1002/ana.410160502; ESTIVILL X, 1988, AM J HUM GENET, V43, P23; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; FAMBROUGH DM, 1973, SCIENCE, V182, P293, DOI 10.1126/science.182.4109.293; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; HILL WG, 1974, HEREDITY, V33, P229, DOI 10.1038/hdy.1974.89; ISENBERG KE, 1986, NUCLEIC ACIDS RES, V14, P5111, DOI 10.1093/nar/14.12.5111; KUBO T, 1985, EUR J BIOCHEM, V149, P5, DOI 10.1111/j.1432-1033.1985.tb08885.x; LAPOLLA RJ, 1984, P NATL ACAD SCI-BIOL, V81, P7970, DOI 10.1073/pnas.81.24.7970; LINDSTROM JM, 1976, NEUROLOGY, V26, P1054, DOI 10.1212/WNL.26.11.1054; LITT M, 1986, AM J HUM GENET, V39, P166; MACLEAN C J, 1985, Genetic Epidemiology, V2, P263, DOI 10.1002/gepi.1370020304; MANIATIS T, 1982, MOL CLONING LABORATO, P324; MCCONNELL TJ, 1988, NATURE, V332, P651, DOI 10.1038/332651a0; MERLIE JP, 1983, P NATL ACAD SCI-BIOL, V80, P3845, DOI 10.1073/pnas.80.12.3845; MOSSMAN S, 1986, LANCET, V1, P116; NAKAO Y, 1980, LANCET, V1, P677; NODA M, 1983, NATURE, V305, P818, DOI 10.1038/305818a0; PATRICK J, 1973, SCIENCE, V180, P871, DOI 10.1126/science.180.4088.871; RABIN M, 1984, CYTOGENET CELL GENET, V38, P70, DOI 10.1159/000132032; RAFTERY MA, 1980, SCIENCE, V208, P1454, DOI 10.1126/science.7384786; SHIBAHARA S, 1985, EUR J BIOCHEM, V146, P15, DOI 10.1111/j.1432-1033.1985.tb08614.x; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; THOMPSON EA, 1988, AM J HUM GENET, V42, P113; WIJSMAN EM, 1984, NUCLEIC ACIDS RES, V12, P9209, DOI 10.1093/nar/12.23.9209; YAMAMOTO T, 1987, NEUROLOGY, V37, P1329, DOI 10.1212/WNL.37.8.1329; YU L, 1986, NUCLEIC ACIDS RES, V14, P3539, DOI 10.1093/nar/14.8.3539	41	29	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1989	44	4					522	533						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T8109	2564730				2022-12-18	WOS:A1989T810900012
J	BOEHNKE, M; MOLL, PP				BOEHNKE, M; MOLL, PP			IDENTIFYING PEDIGREES SEGREGATING AT A MAJOR LOCUS FOR A QUANTITATIVE TRAIT - AN EFFICIENT STRATEGY FOR LINKAGE ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MICHIGAN,DEPT EPIDEMIOL,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT HUMAN GENET,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	BOEHNKE, M (corresponding author), UNIV MICHIGAN,SCH PUBL HLTH,DEPT BIOSTAT,ANN ARBOR,MI 48109, USA.				NHLBI NIH HHS [HL39107, HL24489] Funding Source: Medline; NIGMS NIH HHS [GM41440] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL024489, R01HL039107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM041440] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEATY TH, 1986, AM J MED GENET, V24, P493, DOI 10.1002/ajmg.1320240312; BEATY TH, 1980, AM J MED GENET, V6, P229, DOI 10.1002/ajmg.1320060307; BOEHNKE M, 1988, AM J HUM GENET, V43, P336; BOEHNKE M, 1984, GENETIC EPIDEMIOLOGY, P173; BOEHNKE M, 1983, THESIS U CALIFORNIA; BURNS TL, 1984, AM J HUM GENET, V36, P1060; BURNS TL, 1982, THESIS U MICHIGAN AN; CANNINGS C, 1977, CLIN GENET, V12, P208; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Fleiss JL, 1981, STAT METHODS RATES P; HASSTEDT SJ, 1982, COMPUT BIOMED RES, V15, P295, DOI 10.1016/0010-4809(82)90064-7; Hasstedt SJ, 1981, 13 U UT DEP MED BIOP; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; LALOUEL JM, 1983, AM J HUM GENET, V35, P938; LALOUEL JM, 1979, 14 U UT DEP MED BIOP; LANGE K, 1976, AM J HUM GENET, V28, P167; MOLL PP, 1984, AM J HUM GENET, V36, P197; MOLL PP, 1989, AM J HUM GENET, V44, P124; MORTON NE, 1955, AM J HUM GENET, V7, P277; MORTON NE, 1974, AM J HUM GENET, V26, P489; ODENHEIMER DJ, 1985, THESIS U MICHIGAN AN; OTT J, 1974, AM J HUM GENET, V26, P588; OTT J, 1976, AM J HUM GENET, V28, P528; RAO DC, 1988, AM J HUM GENET, V42, P506; THOMPSON EA, 1986, PARTIAL CONDITIONAL; WILLIAMS WR, 1982, HUM HERED, V32, P24, DOI 10.1159/000153254; YOUNG MR, 1988, AM J HUM GENET, V43, P705	29	29	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1989	44	2					216	224						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R9705	2912068				2022-12-18	WOS:A1989R970500006
J	PHELAN, MC; MORTON, CC; STEVENSON, RE; TANZI, RE; STEWART, GD; WATKINS, PC; GUSELLA, JF; AMOS, JA				PHELAN, MC; MORTON, CC; STEVENSON, RE; TANZI, RE; STEWART, GD; WATKINS, PC; GUSELLA, JF; AMOS, JA			MOLECULAR AND CYTOGENETIC CHARACTERIZATION OF A DE-NOVO T(5P-21Q) IN A PATIENT PREVIOUSLY DIAGNOSED AS MONOSOMY-21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									EUNICE KENNEDY SHRIVER CTR,DIV GENET,200 TRAPELO RD,WALTHAM,MA 02254; EUNICE KENNEDY SHRIVER CTR,DEPT MOLEC NEUROGENET,WALTHAM,MA 02254; GREENWOOD GENET CTR,GREENWOOD,SC 29646; BRIGHAM & WOMENS HOSP,DEPT PATHOL,BOSTON,MA 02115; MASSACHUSETTS GEN HOSP,NEUROGENET LAB,BOSTON,MA 02114; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; HARVARD UNIV,SCH MED,NEUROSCI PROGRAM,BOSTON,MA 02115; INTEGRATED GENET INC,FRAMINGHAM,MA	Greenwood Genetic Center; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School			Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021014] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [F32CA007511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020012] Funding Source: NIH RePORTER; NCI NIH HHS [CA 07511] Funding Source: Medline; NICHD NIH HHS [HD21014] Funding Source: Medline; NINDS NIH HHS [NS 20012] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABELIOVICH D, 1979, AM J MED GENET, V4, P279, DOI 10.1002/ajmg.1320040311; AMOS JA, 1984, BIOCHIM BIOPHYS ACTA, V782, P247, DOI 10.1016/0167-4781(84)90059-9; COHEN MM, 1972, AM J DIS CHILD, V124, P908, DOI 10.1001/archpedi.1972.02110180110016; COOKSLEY WG, 1973, MED J AUSTRALIA, V2, P178, DOI 10.5694/j.1326-5377.1973.tb128755.x; DAVIS JG, 1976, CYTOGENET CELL GENET, V17, P65, DOI 10.1159/000130691; DUTRILLAUX B, 1973, ANN GENET-PARIS, V16, P11; DZIUBA P, 1976, HUM GENET, V31, P351, DOI 10.1007/BF00270866; FRYNS JP, 1977, HUM GENET, V37, P155, DOI 10.1007/BF00393578; GRIPENBERG U, 1972, J MED GENET, V9, P110, DOI 10.1136/jmg.9.1.110; HALLORAN KH, 1974, J MED GENET, V11, P386, DOI 10.1136/jmg.11.4.386; IKEUCHI T, 1976, HUM GENET, V33, P327, DOI 10.1007/BF00286861; KANEKO Y, 1975, HUMANGENETIK, V29, P1, DOI 10.1007/BF00273344; MORTON CC, 1984, AM J HUM GENET, V36, P576; MUNKE M, 1985, CYTOGENET CELL GENET, V40, P706; PAI GS, 1980, HUM GENET, V54, P41, DOI 10.1007/BF00279047; PELLISSIER MC, 1987, HUM GENET, V75, P95; PHELAN MC, 1985, P GREENWOOD GENET CT, V4, P76; PHELAN MC, 1984, P GREENWOOD GENET CT, V3, P26; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SCHINZEL A, 1976, HUM GENET, V32, P105, DOI 10.1007/BF00569984; SCHINZEL A, 1985, P GREENWOOD GENET CT, V4, P75; Schinzel A, 1983, CATALOGUE UNBALANCED; SEABRIGH.M, 1971, LANCET, V2, P971; STEWART GD, 1988, AM J HUM GENET, V42, P227; STGEORGEHYSLOP PH, 1987, SCIENCE, V238, P664, DOI 10.1126/science.2890206; TANZI RE, IN PRESS GENOMICS; TUAN D, 1979, NUCLEIC ACIDS RES, V6, P2519, DOI 10.1093/nar/6.7.2519; VANKEUREN M, 1985, CYTOGENET CELL GENET, V40, P768; WATKINS PC, 1985, NUCLEIC ACIDS RES, V13, P6075, DOI 10.1093/nar/13.17.6075; WYANDT HE, 1971, CYTOGENETICS, V10, P413, DOI 10.1159/000130162; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746	31	29	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1988	43	4					511	519						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q4736	2902789				2022-12-18	WOS:A1988Q473600019
J	GRAY, JW; TRASK, B; VANDENENGH, G; SILVA, A; LOZES, C; GRELL, S; SCHONBERG, S; YU, LC; GOLBUS, MS				GRAY, JW; TRASK, B; VANDENENGH, G; SILVA, A; LOZES, C; GRELL, S; SCHONBERG, S; YU, LC; GOLBUS, MS			APPLICATION OF FLOW KARYOTYPING IN PRENATAL DETECTION OF CHROMOSOME-ABERRATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF SAN FRANCISCO,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco	GRAY, JW (corresponding author), UNIV CALIF LAWRENCE LIVERMORE NATL LAB,DIV BIOMED SCI,POB 5507 L-452,LIVERMORE,CA 94550, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017665] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-17665] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BARTHOLDI M, 1986, ANN NY ACAD SCI, V468, P339, DOI 10.1111/j.1749-6632.1986.tb42051.x; CASPERSSON T, 1970, CHROMOSOMA, V30, P215; CONNOR MA, 1985, ESSENTIAL MED GENETI; DEAN PN, 1978, J HISTOCHEM CYTOCHEM, V26, P622, DOI 10.1177/26.8.357646; FRYNS JP, 1986, HUM GENET, V72, P1, DOI 10.1007/BF00278808; GOLBUS MS, 1979, NEW ENGL J MED, V300, P157, DOI 10.1056/NEJM197901253000402; GRAY JW, 1975, P NATL ACAD SCI USA, V72, P1231, DOI 10.1073/pnas.72.4.1231; GRAY JW, 1986, ANNU REV BIOPHYS BIO, V15, P195; GRAY JW, 1979, CHROMOSOMA, V73, P9, DOI 10.1007/BF00294840; GRAY JW, 1984, BIOL DOSIMETRY, P25; JACOBS PA, 1977, AM J EPIDEMIOL, V105, P180, DOI 10.1093/oxfordjournals.aje.a112374; LANGLOIS RG, 1982, P NATL ACAD SCI-BIOL, V79, P7876, DOI 10.1073/pnas.79.24.7876; LANGLOIS RG, 1980, CHROMOSOMA, V37, P229; LATT S, 1975, CHROMOSOMA, V51, P297; LATT SA, 1977, CAN J GENET CYTOL, V19, P603, DOI 10.1139/g77-065; LEBO RV, 1982, CYTOMETRY, V3, P213, DOI 10.1002/cyto.990030312; STUBBLEFIELD E, 1975, EXP CELL RES, V94, P464, DOI 10.1016/0014-4827(75)90519-4; SUMNER AT, 1971, NATURE-NEW BIOL, V232, P31, DOI 10.1038/newbio232031a0; VANDENENGH G, 1984, CYTOMETRY, V5, P108; VANDENENGH GJ, 1985, CYTOMETRY, V6, P92, DOI 10.1002/cyto.990060203; YOUNG BD, 1981, P NATL ACAD SCI-BIOL, V78, P7727, DOI 10.1073/pnas.78.12.7727; YU LC, 1981, NATURE, V293, P154, DOI 10.1038/293154a0; YUNIS JJ, 1981, HUM GENET, V56, P293, DOI 10.1007/BF00274682	23	29	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1988	42	1					49	59						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L8697	3337112				2022-12-18	WOS:A1988L869700007
J	LANMAN, JT; PERICAKVANCE, MA; BARTLETT, RJ; CHEN, JC; YAMAOKA, L; KOH, J; SPEER, MC; HUNG, WY; ROSES, AD				LANMAN, JT; PERICAKVANCE, MA; BARTLETT, RJ; CHEN, JC; YAMAOKA, L; KOH, J; SPEER, MC; HUNG, WY; ROSES, AD			FAMILIAL INHERITANCE OF A DXS164 DELETION MUTATION FROM A HETEROZYGOUS FEMALE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									DUKE UNIV,MED CTR,DEPT NEUROL,DURHAM,NC 27710	Duke University	LANMAN, JT (corresponding author), DUKE UNIV,MED CTR,DEPT OBSTET GYNECOL,BOX 3390,DURHAM,NC 27710, USA.				NCRR NIH HHS [RR-30] Funding Source: Medline; NINDS NIH HHS [5 RO1 NS19999-50] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019999] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAKKER E, 1985, LANCET, V1, P655; BARTLETT RJ, 1987, NEUROLOGY, V37, P355, DOI 10.1212/WNL.37.2.355; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FISCHBECK KH, 1986, LANCET, V2, P104; IKEUCHI T, 1984, CYTOGENET CELL GENET, V38, P56, DOI 10.1159/000132030; KUNKEL LM, 1986, NATURE, V322, P73, DOI 10.1038/322073a0; MONACO AP, 1985, NATURE, V316, P842, DOI 10.1038/316842a0; MURPHY EA, 1974, AM J HUM GENET, V26, P207; PERICAKVANCE MA, 1986, NEUROLOGY, V36, P1418, DOI 10.1212/WNL.36.11.1418; RAY PN, 1985, NATURE, V318, P672, DOI 10.1038/318672a0; ROSES AD, 1977, ANN NEUROL, V2, P271, DOI 10.1002/ana.410020403	11	29	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1987	41	2					138	144						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	J7575	2887110				2022-12-18	WOS:A1987J757500005
J	LUBAHN, DB; LORD, ST; BOSCO, J; KIRSHTEIN, J; JEFFRIES, OJ; PARKER, N; LEVTZOW, C; SILVERMAN, LM; GRAHAM, JB				LUBAHN, DB; LORD, ST; BOSCO, J; KIRSHTEIN, J; JEFFRIES, OJ; PARKER, N; LEVTZOW, C; SILVERMAN, LM; GRAHAM, JB			POPULATION-GENETICS OF COAGULANT FACTOR-IX - FREQUENCIES OF 2 DNA POLYMORPHISMS IN 5 ETHNIC-GROUPS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV N CAROLINA,SCH MED,DEPT PATHOL,CHAPEL HILL,NC 27514; UNIV MALAYA,DEPT MED,KUALA LUMPUR 2211,MALAYSIA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Universiti Malaya					NHLBI NIH HHS [HL-35152, HL-06350] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035152] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANSON DS, 1984, EMBO J, V3, P1053, DOI 10.1002/j.1460-2075.1984.tb01926.x; CAMERINO G, 1983, NATURE, V306, P701, DOI 10.1038/306701a0; CAMERINO G, 1984, P NATL ACAD SCI-BIOL, V81, P498, DOI 10.1073/pnas.81.2.498; CAMERINO G, 1985, HUM GENET, V71, P79, DOI 10.1007/BF00295673; CHOO KH, 1984, LANCET, V2, P349; CHOO KH, 1982, NATURE, V299, P178, DOI 10.1038/299178a0; DAVIS LM, 1987, BLOOD, V69, P140; GIANNELLI F, 1984, LANCET, V1, P239; GRAHAM JB, 1985, BLOOD, V66, P759; GRUNEBAUM L, 1984, J CLIN INVEST, V73, P1491, DOI 10.1172/JCI111354; HASSAN HJ, 1985, BLOOD, V65, P441; HAY CW, 1986, BLOOD, V67, P1508; JAGADEESWARAN P, 1984, SOMAT CELL MOLEC GEN, V10, P465, DOI 10.1007/BF01534851; JAYE M, 1983, NUCLEIC ACIDS RES, V11, P2325, DOI 10.1093/nar/11.8.2325; KURACHI K, 1982, P NATL ACAD SCI-BIOL, V79, P6461, DOI 10.1073/pnas.79.21.6461; MANIATIS T, 1982, MOL CLONING LABORATO; MCGRAW RA, 1985, P NATL ACAD SCI USA, V82, P2847, DOI 10.1073/pnas.82.9.2847; OTT J, 1985, ANAL GENETIC LINKAGE; REED TE, 1969, SCIENCE, V165, P762, DOI 10.1126/science.165.3895.762; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WINSHIP PR, 1984, NUCLEIC ACIDS RES, V12, P8861, DOI 10.1093/nar/12.23.8861; YOSHITAKE S, 1985, BIOCHEMISTRY-US, V24, P3736, DOI 10.1021/bi00335a049	22	29	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1987	40	6					527	536						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	H9693	2884869				2022-12-18	WOS:A1987H969300005
J	LESKO, JG; LEWIS, RA; NUSSBAUM, RL				LESKO, JG; LEWIS, RA; NUSSBAUM, RL			MULTIPOINT LINKAGE ANALYSIS OF LOCI IN THE PROXIMAL LONG ARM OF THE HUMAN X-CHROMOSOME - APPLICATION TO MAPPING THE CHOROIDEREMIA LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV PENN,SCH MED,DEPT HUMAN GENET,HOWARD HUGHES MED INST,37TH & HAMILTON WALK,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT PEDIAT,PHILADELPHIA,PA 19104; BAYLOR COLL MED,CULLEN EYE INST,HOUSTON,TX 77030; UNIV PENN,SCH MED,HOWARD HUGHES MED INST LABS,PHILADELPHIA,PA 19104	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; Baylor College of Medicine; Howard Hughes Medical Institute; University of Pennsylvania								ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; DAVIES KE, 1983, NUCLEIC ACIDS RES, V11, P2303, DOI 10.1093/nar/11.8.2303; DRAYNA D, 1984, P NATL ACAD SCI-BIOL, V81, P2836, DOI 10.1073/pnas.81.9.2836; DRAYNA D, 1985, SCIENCE, V230, P753, DOI 10.1126/science.4059909; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GAL A, 1986, HUM GENET, V73, P123, DOI 10.1007/BF00291600; GOODFELLOW PN, 1985, CYTOGENET CELL GENET, V40, P296, DOI 10.1159/000132178; HUTZ MH, 1984, HUM GENET, V66, P217, DOI 10.1007/BF00286604; KOENIG M, 1984, NUCLEIC ACIDS RES, V12, P4097, DOI 10.1093/nar/12.10.4097; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LESKO J G, 1985, American Journal of Human Genetics, V37, pA65; LEWIS RA, 1985, OPHTHALMOLOGY, V92, P800; Maniatis T., 1982, MOL CLONING LABORATO, P448; McCULLOCH C, 1948, Trans Am Acad Ophthalmol Otolaryngol, V52, P160; MICHELSON AM, 1983, AM J HUM GENET, V35, pA180; NUSSBAUM RL, 1985, AM J HUM GENET, V37, P473; PAGE D, 1982, P NATL ACAD SCI-BIOL, V79, P5352, DOI 10.1073/pnas.79.17.5352; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SCHMECKPEPER BJ, 1985, NUCLEIC ACIDS RES, V13, P5724, DOI 10.1093/nar/13.15.5724; SORSBY A, 1952, BRIT J OPHTHALMOL, V36, P547, DOI 10.1136/bjo.36.10.547; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WILSON JM, 1982, J CLIN INVEST, V69, P706, DOI 10.1172/JCI110499	23	29	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1987	40	4					303	311						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	H3196	2883887				2022-12-18	WOS:A1987H319600001
J	OTT, J				OTT, J			THE NUMBER OF FAMILIES REQUIRED TO DETECT OR EXCLUDE LINKAGE HETEROGENEITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											OTT, J (corresponding author), CITY STAT OFF,NAPFGASSE 6,CH-8001 ZURICH,SWITZERLAND.							CAVALLISFORZA LL, 1986, AM J HUM GENET, V38, P599; HABER M, 1980, AM J HUM GENET, V32, P754; OTT J, 1985, ANAL HUMAN GENETIC L; WARD RH, 1970, AM NAT, V104, P355, DOI 10.1086/282669	4	29	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1986	39	2					159	165						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	E1459	3752084				2022-12-18	WOS:A1986E145900001
J	GELLER, RL; SHAPIRO, LJ; MOHANDAS, TK				GELLER, RL; SHAPIRO, LJ; MOHANDAS, TK			FINE MAPPING OF THE DISTAL SHORT ARM OF THE HUMAN X-CHROMOSOME USING X/Y TRANSLOCATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF LOS ANGELES,SCH MED,DEPT BIOL CHEM,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	GELLER, RL (corresponding author), UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,DEPT PEDIAT,DIV MED GENET,TORRANCE,CA 90509, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD006561] Funding Source: NIH RePORTER; NICHD NIH HHS [HD06561] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALLDERDICE PW, 1983, AM J HUM GENET, V35, pA124; BERNSTEIN R, 1978, J MED GENET, V15, P466, DOI 10.1136/jmg.15.6.466; BERNSTEIN R, 1985, PROGR TOPICS CYTOG B, V6, P171; CURRY CJR, 1984, NEW ENGL J MED, V311, P1010, DOI 10.1056/NEJM198410183111603; DAVIDSON RL, 1976, SOMAT CELL GENET, V2, P165, DOI 10.1007/BF01542629; DISTECHE CM, 1984, HUM GENET, V66, P71, DOI 10.1007/BF00275190; FERGUSONSMITH MA, 1982, CYTOGENET CELL GENET, V32, P273; FRYNS JP, 1981, HUM GENET, V57, P385, DOI 10.1007/BF00281690; GOODFELLOW P, 1983, NATURE, V302, P346, DOI 10.1038/302346a0; GOODFELLOW P, 1980, SOMAT CELL GENET, V6, P777, DOI 10.1007/BF01538976; GOODFELLOW P, 1984, AM J HUM GENET, V36, P777; KAFFE S, 1983, PROGR TOPICS CYTOG B, V3, P341; KUCHERLAPATI RS, 1975, CYTOGENET CELL GENET, V14, P326; LEVY R, 1979, P NATL ACAD SCI USA, V76, P6552, DOI 10.1073/pnas.76.12.6552; LITTLEFIELD JW, 1964, SCIENCE, V145, P709, DOI 10.1126/science.145.3633.709; METAXOTOU C, 1983, CLIN GENET, V24, P380, DOI 10.1111/j.1399-0004.1983.tb00089.x; MOHANDAS T, 1980, P NATL ACAD SCI-BIOL, V77, P6759, DOI 10.1073/pnas.77.11.6759; MOHANDAS T, 1979, P NATL ACAD SCI USA, V76, P5779, DOI 10.1073/pnas.76.11.5779; MULLER CR, 1980, HUM GENET, V54, P201, DOI 10.1007/BF00278972; PEARSON PL, 1970, NATURE, V226, P959, DOI 10.1038/226959a0; PFEIFFER RA, 1980, CYTOGENET CELL GENET, V26, P150, DOI 10.1159/000131436; Race RR., 1975, BLOOD GROUPS MAN; SHAPIRO LJ, 1979, SCIENCE, V204, P1224, DOI 10.1126/science.156396; SHAPIRO LJ, 1978, LANCET, V2, P756; SPEEVAK M, 1985, CLIN GENET, V27, P595; SZYBALSKA EH, 1962, P NATL ACAD SCI USA, V48, P2026, DOI 10.1073/pnas.48.12.2026; TIEPOLO L, 1980, HUM GENET, V54, P205, DOI 10.1007/BF00278973; TIEPOLO L, 1977, HUM GENET, V39, P277, DOI 10.1007/BF00295420; VENOLIA L, 1982, P NATL ACAD SCI-BIOL, V79, P2352, DOI 10.1073/pnas.79.7.2352; YAMADA K, 1982, HUM GENET, V60, P85, DOI 10.1007/BF00281273; YEN PH, 1984, P NATL ACAD SCI-BIOL, V81, P1759, DOI 10.1073/pnas.81.6.1759	31	29	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1986	38	6					884	890						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D3922	3460334				2022-12-18	WOS:A1986D392200011
J	WOOLF, LI				WOOLF, LI			THE HETEROZYGOTE ADVANTAGE IN PHENYLKETONURIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter											WOOLF, LI (corresponding author), UNIV BRITISH COLUMBIA,DEPT PSYCHIAT,KINSMEN LAB,2255 WESTBROOK MALL,VANCOUVER V6T 1W5,BC,CANADA.							BROWN MH, 1976, TOXICOL APPL PHARM, V37, P331, DOI 10.1016/0041-008X(76)90096-X; BUCKLEY H. G., 1971, Ir. vet. L., V25, P194; CAHALANE SF, 1968, ARCH DIS CHILD, V43, P141, DOI 10.1136/adc.43.228.141; CARTER CO, 1961, ANN HUM GENET, V25, P57, DOI 10.1111/j.1469-1809.1961.tb01497.x; COHEN BE, 1963, PEDIATRICS, V32, P1069; CREPPY EE, 1980, TOXICOL LETT, V6, P77, DOI 10.1016/0378-4274(80)90171-X; Jervis GA, 1939, J MENT SCI, V85, P719, DOI 10.1192/bjp.85.357.719; KROGH P, 1977, ACTA PATH MICRO IM B, V85, P238; LINDSAY G, 1970, ERRORS PHENYLALANINE, P8; TENKATE LP, 1977, ANN HUM GENET, V41, P463; THALHAMMER O, 1975, HUMANGENETIK, V30, P273, DOI 10.1007/BF00275139; Woolf L I, 1978, J Inherit Metab Dis, V1, P101, DOI 10.1007/BF01805682; WOOLF LI, 1967, NATURE, V213, P882, DOI 10.1038/213882a0; WOOLF LI, 1975, ANN HUM GENET, V38, P461, DOI 10.1111/j.1469-1809.1975.tb00635.x; WOOLF LI, 1971, PHENYLKETONURIA SOME, P103; WOOLF LI, 1976, J IRISH MED ASSOC, V69, P398; 1979, ENV HLTH CRITERIA, V11, P88	17	29	31	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1986	38	5					773	775						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	C9730	3717163				2022-12-18	WOS:A1986C973000016
J	GOODE, ME; VANTUINEN, P; LEDBETTER, DH; DAIGER, SP				GOODE, ME; VANTUINEN, P; LEDBETTER, DH; DAIGER, SP			THE ANONYMOUS POLYMORPHIC DNA CLONE D1S1, PREVIOUSLY MAPPED TO HUMAN CHROMOSOME-1P36 BY INSITU HYBRIDIZATION, IS FROM CHROMOSOME-3 AND IS DUPLICATED ON CHROMOSOME-1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BAYLOR COLL MED,DEPT MED,KLEBERG CYTOGENET LAB,HOUSTON,TX 77030	Baylor College of Medicine	GOODE, ME (corresponding author), UNIV TEXAS,HLTH SCI CTR,GRAD SCH BIOMED SCI,POB 20334,HOUSTON,TX 77225, USA.				NIADDK NIH HHS [AM30471] Funding Source: Medline	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALHADEFF B, 1977, CYTOGENET CELL GENET, V19, P236, DOI 10.1159/000130814; CACCIA N, 1984, CELL, V37, P1091, DOI 10.1016/0092-8674(84)90443-4; DAIGER SP, 1982, NATURE, V298, P682, DOI 10.1038/298682a0; DONLON TA, 1984, CYTOGENET CELL GENET, V37, P454; DRACOPOLI NC, 1985, P NATL ACAD SCI USA, V82, P1470, DOI 10.1073/pnas.82.5.1470; GALL JG, 1969, P NATL ACAD SCI USA, V63, P378, DOI 10.1073/pnas.63.2.378; GERHARD DS, 1981, P NATL ACAD SCI-BIOL, V78, P3755, DOI 10.1073/pnas.78.6.3755; GOODE M E, 1983, Genetics, V104, pS30; GOODE M E, 1984, American Journal of Human Genetics, V36, p138S; HAMERTON JL, 1984, CYTOGENET CELL GENET, V37, P3, DOI 10.1159/000132001; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; HOLMQUIST G, 1982, CELL, V31, P121, DOI 10.1016/0092-8674(82)90411-1; LEBEAU MM, 1985, CELL, V41, P335, DOI 10.1016/0092-8674(85)90086-8; LEWIN B, 1980, GENE EXPRESSION, V2; MALCOLM S, 1981, ANN HUM GENET, V45, P135, DOI 10.1111/j.1469-1809.1981.tb00315.x; Maniatis T., 1982, MOL CLONING LABORATO, P76; MARMUR J, 1959, NATURE, V183, P1427, DOI 10.1038/1831427a0; MCGILL JR, UNPUB HUMAN FERRITIN; MCKUSICK VA, 1984, GENETIC MAPS 1984, P417; MORTON CC, 1984, AM J HUM GENET, V36, P576; NUSSBAUM RL, 1983, HUM GENET, V64, P148, DOI 10.1007/BF00327113; NUSSBAUM RL, 1985, AM J HUM GENET, V37, P1192; NUSSBAUM RL, 1983, P NATL ACAD SCI-BIOL, V80, P4035, DOI 10.1073/pnas.80.13.4035; PATEL PI, 1984, SOMAT CELL MOLEC GEN, V10, P483, DOI 10.1007/BF01534853; SAUNDERS GF, 1972, NATURE-NEW BIOL, V236, P244, DOI 10.1038/newbio236244a0; SKOLNICK MH, 1984, CYTOGENET CELL GENET, V37, P210, DOI 10.1159/000132011; SU TS, 1984, AM J HUM GENET, V36, P954; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; WEISLANDER L., 1979, ANAL BIOCHEM, V98, P305; ZABEL BU, 1983, P NATL ACAD SCI-BIOL, V80, P6932, DOI 10.1073/pnas.80.22.6932	30	29	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1986	38	4					437	446						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	C4893	3010710				2022-12-18	WOS:A1986C489300004
J	STUDENCKI, AB; CONNER, BJ; IMPRAIM, CC; TEPLITZ, RL; WALLACE, RB				STUDENCKI, AB; CONNER, BJ; IMPRAIM, CC; TEPLITZ, RL; WALLACE, RB			DISCRIMINATION AMONG THE HUMAN BETA-A-GLOBIN, BETA-S-GLOBIN, AND BETA-C-GLOBIN GENES USING ALLELE-SPECIFIC OLIGONUCLEOTIDE HYBRIDIZATION PROBES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CITY HOPE NATL MED CTR, DIV CYTOGENET & CYTOL, DUARTE, CA 91010 USA	City of Hope	STUDENCKI, AB (corresponding author), BECKMAN RES INST CITY HOPE, 1450 E DUARTE RD, DUARTE, CA 91010 USA.				NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER; NCI NIH HHS [CA33572] Funding Source: Medline; NHLBI NIH HHS [HL29516] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P137, DOI 10.1073/pnas.79.1.137; BAIRD M, 1981, P NATL ACAD SCI-BIOL, V78, P4218, DOI 10.1073/pnas.78.7.4218; CHANG JC, 1982, NEW ENGL J MED, V307, P30, DOI 10.1056/NEJM198207013070105; CHANG JC, 1981, LANCET, V2, P1127; CONNER BJ, 1983, P NATL ACAD SCI-BIOL, V80, P278, DOI 10.1073/pnas.80.1.278; DAVIS RW, 1980, MANUAL GENETIC ENG A, P74; GEEVER RF, 1981, P NATL ACAD SCI-BIOL, V78, P5081, DOI 10.1073/pnas.78.8.5081; KAN YW, 1978, LANCET, V2, P910; KAN YW, 1980, SCIENCE, V209, P388, DOI 10.1126/science.7384810; KAN YW, 1980, NEW ENGL J MED, V302, P185, DOI 10.1056/NEJM198001243020401; KAZAZIAN HH, 1983, AM J HUM GENET, V35, P1028; KIDD VJ, 1983, NATURE, V304, P230, DOI 10.1038/304230a0; ORKIN SH, 1982, NEW ENGL J MED, V307, P32, DOI 10.1056/NEJM198207013070106; ORKIN SH, 1983, J CLIN INVEST, V71, P775, DOI 10.1172/JCI110826; PHILLIPS JA, 1980, P NATL ACAD SCI-BIOL, V77, P2853, DOI 10.1073/pnas.77.5.2853; PHILLIPS JA, 1979, JOHNS HOPKINS MED J, V145, P57; PIRASTU M, 1983, NEW ENGL J MED, V309, P284, DOI 10.1056/NEJM198308043090506; STUDENCKI AB, 1984, DNA-J MOLEC CELL BIO, V3, P7, DOI 10.1089/dna.1.1984.3.7; TAN ZK, 1982, COLD SPRING HARB SYM, V47, P383; WAIKAN Y, 1978, P NATL ACAD SCI USA, V75, P5631, DOI 10.1073/pnas.75.11.5631; WALLACE RB, 1981, NUCLEIC ACIDS RES, V9, P3647	21	29	47	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1985	37	1					42	51						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AGY57	2983543				2022-12-18	WOS:A1985AGY5700005
J	YENCHITSOMANUS, PT; SUMMERS, KM; BHATIA, KK; CATTANI, J; BOARD, PG				YENCHITSOMANUS, PT; SUMMERS, KM; BHATIA, KK; CATTANI, J; BOARD, PG			EXTREMELY HIGH-FREQUENCIES OF ALPHA-GLOBIN GENE DELETION IN MADANG AND ON KAR-KAR ISLAND, PAPUA-NEW-GUINEA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									PAPUA NEW GUINEA INST MED RES, GOROKA, PAPUA N GUINEA; PAPUA NEW GUINEA INST MED RES, MADANG, PAPUA N GUINEA	PNG Institute Of Medical Research; PNG Institute Of Medical Research	YENCHITSOMANUS, PT (corresponding author), AUSTRALIAN NATL UNIV, JOHN CURTIN SCH MED RES, DEPT HUMAN BIOL, CANBERRA, ACT 2601, AUSTRALIA.		Summers, Kim M/M-4086-2015	Summers, Kim M/0000-0002-7084-4386				ABRAMSON RK, 1970, SCIENCE, V169, P194, DOI 10.1126/science.169.3941.194; AMATO D, 1977, PAPUA NEW GUINEA MED, V20, P26; BEAVEN GH, 1972, NATURE, V235, P46, DOI 10.1038/235046a0; BOWDEN DK, 1982, BRIT J HAEMATOL, V51, P243, DOI 10.1111/j.1365-2141.1982.tb08481.x; CHOCKKALINGAM K, 1982, HUM GENET, V60, P189, DOI 10.1007/BF00569710; DARLOW B, 1981, PAPUA NEW GUINEA MED, V24, P85; EMBURY SH, 1979, J CLIN INVEST, V63, P1307, DOI 10.1172/JCI109426; EMBURY SH, 1980, J CLIN INVEST, V66, P1319, DOI 10.1172/JCI109984; GALANELLO R, 1984, BRIT J HAEMATOL, V58, P361, DOI 10.1111/j.1365-2141.1984.tb06095.x; GRUNEBAUM L, 1984, J CLIN INVEST, V73, P1491, DOI 10.1172/JCI111354; Higgs D R, 1983, Curr Top Hematol, V4, P37; HIGGS DR, 1982, BRIT J HAEMATOL, V51, P177, DOI 10.1111/j.1365-2141.1982.tb07303.x; HILL AVS, 1985, AM J HUM GENET, V37, P571; HILL AVS, 1983, SAUDI MED J, V4, P221; HUISMAN THJ, 1975, J LAB CLIN MED, V86, P700; LAUER J, 1980, CELL, V20, P119, DOI 10.1016/0092-8674(80)90240-8; LIEINJO LE, 1982, BLOOD, V59, P370; MATHEW CGP, 1983, BRIT J HAEMATOL, V55, P103, DOI 10.1111/j.1365-2141.1983.tb01228.x; NASMYTH KA, 1982, CELL, V30, P567, DOI 10.1016/0092-8674(82)90253-7; OHENEFREMPONG K, 1980, BLOOD, V56, P931; OLD JM, 1978, NATURE, V273, P319, DOI 10.1038/273319a0; OPPENHEIMER SJ, 1984, LANCET, V1, P424; ORKIN SH, 1978, P NATL ACAD SCI USA, V75, P5950, DOI 10.1073/pnas.75.12.5950; PHILLIPS JA, 1980, BLOOD, V55, P1066; PIRASTU M, 1982, BLOOD, V60, P509; SANCAR GB, 1980, JOHNS HOPKINS MED J, V146, P264; SANCAR GB, 1983, ANN INTERN MED, V98, P933, DOI 10.7326/0003-4819-98-6-933; TRENT RJ, 1985, AM J HEMATOL, V18, P431, DOI 10.1002/ajh.2830180414; Weatherall D.J., 1981, THALASSAEMIA SYNDROM, V3rd ed.; WILSON JT, 1978, NUCLEIC ACIDS RES, V5, P563, DOI 10.1093/nar/5.2.563; WINICHAGOON P, 1984, EMBO J, V3, P1813, DOI 10.1002/j.1460-2075.1984.tb02051.x	31	29	30	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1985	37	4					778	784						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	APR18	9556666				2022-12-18	WOS:A1985APR1800015
J	DEMBURE, PP; PRIEST, JH; SNODDY, SC; ELSAS, LJ				DEMBURE, PP; PRIEST, JH; SNODDY, SC; ELSAS, LJ			GENOTYPING AND PRENATAL ASSESSMENT OF COLLAGEN LYSYL HYDROXYLASE DEFICIENCY IN A FAMILY WITH EHLERS-DANLOS SYNDROME TYPE-VI	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											DEMBURE, PP (corresponding author), EMORY UNIV,SCH MED,DEPT PEDIAT,DIV MED GENET,ATLANTA,GA 30322, USA.							AUMAILLEY M, 1980, ARCH DERMATOL RES, V269, P169, DOI 10.1007/BF00406537; BYERS PH, 1981, LAB INVEST, V44, P336; CROUCH E, 1978, BIOCHEMISTRY-US, V17, P5499, DOI 10.1021/bi00618a027; CUPO LN, 1981, AM J MED, V71, P1051, DOI 10.1016/0002-9343(81)90341-7; ELSAS LJ, 1974, AM J HUM GENET, V26, pA28; ELSAS LJ, 1978, J PEDIATR-US, V92, P378, DOI 10.1016/S0022-3476(78)80423-5; IHME A, 1983, EUR J CLIN INVEST, V13, P357, DOI 10.1111/j.1365-2362.1983.tb00113.x; JUDISCH GF, 1976, ARCH OPHTHALMOL-CHIC, V94, P1489; KRANE SM, 1972, P NATL ACAD SCI USA, V69, P2899, DOI 10.1073/pnas.69.10.2899; KRIEG T, 1981, INT J DERMATOL, V20, P415, DOI 10.1111/j.1365-4362.1981.tb02005.x; KRIEG T, 1979, HUM GENET, V46, P41, DOI 10.1007/BF00278900; LICHTENSTEIN JR, 1973, SCIENCE, V182, P298, DOI 10.1126/science.182.4109.298; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McKusick VA, 1972, EHLERS DANLOS SYNDRO, P292; MILLER RL, 1979, J INVEST DERMATOL, V72, P241, DOI 10.1111/1523-1747.ep12531702; PETERKOFSKY B, 1975, ANAL BIOCHEM, V66, P279, DOI 10.1016/0003-2697(75)90747-2; PINNELL SR, 1972, NEW ENGL J MED, V286, P1013, DOI 10.1056/NEJM197205112861901; POPE FM, 1975, P NATL ACAD SCI USA, V72, P1314, DOI 10.1073/pnas.72.4.1314; PRIEST JH, 1977, MED GENETICS CELL CU, P163; PRIEST RE, 1977, J MED GENET, V14, P157, DOI 10.1136/jmg.14.3.157; PROCKOP DJ, 1984, N ENGL J MED; QUINN RS, 1976, J CLIN INVEST, V57, P83, DOI 10.1172/JCI108273; STEINMANN B, 1980, J BIOL CHEM, V255, P8887; STEINMANN B, 1975, HELV PAEDIATR ACTA, V30, P255; STOLLE CA, 1983, AM J HUM GENET, V35, pA54; SUSSMAN M, 1974, J BONE JOINT SURG AM, VA 56, P1228, DOI 10.2106/00004623-197456060-00015; Taylor D J, 1981, Obstet Gynecol Surv, V36, P277, DOI 10.1097/00006254-198106000-00001	27	29	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	4					783	790						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TJ077	6089551				2022-12-18	WOS:A1984TJ07700007
J	ROWLEY, PT; LIPKIN, M; FISHER, L				ROWLEY, PT; LIPKIN, M; FISHER, L			SCREENING AND GENETIC-COUNSELING FOR BETA-THALASSEMIA TRAIT IN A POPULATION UNSELECTED FOR INTEREST - COMPARISON OF 3 COUNSELING METHODS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV ROCHESTER, SCH MED, DIV GENET, ROCHESTER, NY 14642 USA; UNIV ROCHESTER, DEPT MED, ROCHESTER, NY 14642 USA; UNIV ROCHESTER, DEPT PSYCHIAT, ROCHESTER, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	ROWLEY, PT (corresponding author), UNIV ROCHESTER, SCH MED, DEPT MED, ROCHESTER, NY 14642 USA.				NHLBI NIH HHS [R01-HL-17465] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1965, TENNESSEE SELF CONCE; ANTLEY MA, 1973, J PSYCHOL, V83, P335, DOI 10.1080/00223980.1973.9915623; ANTLEY RM, 1976, SOC BIOL, V23, P108, DOI 10.1080/19485565.1976.9988216; CHILDS B, 1976, AM J HUM GENET, V28, P550; Corgan R L, 1979, Birth Defects Orig Artic Ser, V15, P281; EVERSKIEBOOMS G, 1979, CLIN GENET, V15, P465; FALEK A, 1974, SOC BIOL, V21, P1; FISHER L, 1981, AM J HUM GENET, V33, P987; FISHER L, 1979, SOC BIOL, V26, P289, DOI 10.1080/19485565.1979.9988387; FRASER FC, 1974, AM J HUM GENET, V26, P636; HECHT F, 1972, NEW ENGL J MED, V287, P464, DOI 10.1056/NEJM197208312870911; Hollingshead AB., 1965, 2 FACTOR INDEX SOCIA; KALLMANN FJ, 1956, AM J HUM GENET, V8, P97; KENEN RH, 1978, AM J PUBLIC HEALTH, V68, P1116, DOI 10.2105/AJPH.68.11.1116; Kessler Seymour, 1979, GENETIC COUNSELING P; LEONARD CO, 1972, NEW ENGL J MED, V287, P433, DOI 10.1056/NEJM197208312870904; LIPKIN M, 1974, GENETIC RESPONSIBILI, P163; MCCRAE WM, 1973, LANCET, V2, P141; MEYEROWITZ S, 1976, PREVENTION FETAL PER; Morgan Jr WL, 1969, CLIN APPROACH PATIEN, P26; MURRAY RF, 1976, SOC WORK HEALTH CARE, V2, P13, DOI 10.1300/J010v02n01_03; NOWLIS V, 1970, LOYOLA S FEELINGS EM, P261; ROWLEY PT, 1979, AM J HUM GENET, V31, P718; SALK L, 1972, SOC SCI MED, V6, P491, DOI 10.1016/0037-7856(72)90092-3; SORENSON JR, 1981, BIRTH DEFECTS-ORIG, V17, P1; TARGUM SD, 1981, AM J MED GENET, V8, P281, DOI 10.1002/ajmg.1320080305; TIPS RL, 1963, JAMA-J AM MED ASSOC, V184, P183, DOI 10.1001/jama.1963.03700160059008; TIPS RL, 1964, AM J DIS CHILD, V107, P67, DOI 10.1001/archpedi.1964.02080060069010	28	29	29	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1984	36	3					677	689						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SY119	6731441				2022-12-18	WOS:A1984SY11900017
J	WELSHIMER, K; SWIFT, M				WELSHIMER, K; SWIFT, M			CONGENITAL-MALFORMATIONS AND DEVELOPMENTAL-DISABILITIES IN ATAXIA-TELANGIECTASIA, FANCONI ANEMIA, AND XERODERMA PIGMENTOSUM FAMILIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV N CAROLINA, DEPT EPIDEMIOL, CHAPEL HILL, NC 27514 USA; UNIV N CAROLINA, DEPT MED, CHAPEL HILL, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	WELSHIMER, K (corresponding author), UNIV N CAROLINA, BIOL SCI RES CTR, CHAPEL HILL, NC 27514 USA.				NCI NIH HHS [CA14235] Funding Source: Medline; NICHD NIH HHS [HD03110] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003110] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA014235] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABRAMOWICZ HK, 1975, AM J MENT DEF, V80, P18; Book JA, 1953, AM J MENT DEF, V57, P637; FANCONI G., 1967, SEMINARS HAMATOL, V4, P233; GMYREK D, 1964, Z Kinderheilkd, V91, P297, DOI 10.1007/BF00439778; KALOWSTIAN VM, 1974, J INVEST DERMATOL, V63, P392; KANE WJ, 1970, CLIN ORTHOP RELAT R, P216, DOI 10.1097/00003086-197003000-00022; KLOEPFER H. WARNER, 1964, J GENET HUMAINE, V13, P52; KRAEMER KH, 1980, CLIN DERMATOLOGY, V4; LAURENCE KM, 1968, BRIT J PREV SOC MED, V22, P146; QAZI QH, 1975, CLIN GENET, V7, P85; REED WB, 1965, ARCH DERMATOL, V91, P224, DOI 10.1001/archderm.1965.01600090032005; ROBBINS JH, 1978, JNCI-J NATL CANCER I, V61, P645; ROGALA EJ, 1978, J BONE JOINT SURG AM, V60, P173, DOI 10.2106/00004623-197860020-00005; SCHROEDER TM, 1976, HUM GENET, V32, P257, DOI 10.1007/BF00295817; Sedgewick RP, 1972, HDB CLINICAL NEUROLO, V14, P267; Silberstein AG, 1938, AM J DIS CHILD, V55, P784, DOI 10.1001/archpedi.1938.01980100120008; STEFANINI M, 1980, HUM GENET, V54, P177, DOI 10.1007/BF00278968; SWIFT M, 1976, CANCER RES, V36, P209; SWIFT M, 1980, J NATL CANCER I, V65, P863; SWIFT M, 1979, JNCI-J NATL CANCER I, V62, P1415; SWIFT M, 1974, AM J HUM GENET, V26, P304; SWIFT M, 1971, NATURE, V230, P370, DOI 10.1038/230370a0; TARJAN G, 1973, AM J MENT DEF, V77, P369; WALTIMO O, 1967, ACTA NEUROL SCAND, VS 43, P66; WYNNE-DAVIES R, 1968, Journal of Bone and Joint Surgery British Volume, V50B, P24	25	29	31	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1982	34	5					781	793						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PH242	7124732				2022-12-18	WOS:A1982PH24200009
J	CHILDS, B; HUETHER, CA; MURPHY, EA				CHILDS, B; HUETHER, CA; MURPHY, EA			HUMAN-GENETICS TEACHING IN UNITED-STATES MEDICAL-SCHOOLS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205; UNIV CINCINNATI,DEPT BIOL SCI,CINCINNATI,OH 45221	Johns Hopkins University; University System of Ohio; University of Cincinnati	CHILDS, B (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205, USA.				NICHD NIH HHS [HD-00486] Funding Source: Medline; NIGMS NIH HHS [GM-07471, GM-24736] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		DIXON WJ, 1973, BMD BIOMEDICAL COMPU; GOLDSTEIN JL, 1977, ANNU REV BIOCHEM, V46, P897, DOI 10.1146/annurev.bi.46.070177.004341; McMichael A, 1977, Prog Med Genet, V2, P39; ROSENSTOCK IM, 1975, GENETIC SCREENING ST; ROTTER JI, 1979, ANN INTERN MED, V91, P372, DOI 10.7326/0003-4819-91-3-372; 1976, AAMC DIRECTORY AM ME	6	29	30	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	1					1	10						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LA930	7468587				2022-12-18	WOS:A1981LA93000001
J	DECKER, RS; MOHRENWEISER, HW				DECKER, RS; MOHRENWEISER, HW			ORIGIN OF THE TRIOSEPHOSPHATE ISOMERASE ISOZYMES IN HUMANS - GENETIC-EVIDENCE FOR THE EXPRESSION OF A SINGLE STRUCTURAL LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											DECKER, RS (corresponding author), UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,ANN ARBOR,MI 48109, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007544] Funding Source: NIH RePORTER; NIGMS NIH HHS [5-T32-GM07544] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASAKAWA J, UNPUBLISHED; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; DIZIK M, 1977, BIOCHEM GENET, V15, P31, DOI 10.1007/BF00484546; EBER SW, 1979, EUR J CLIN INVEST, V9, P195, DOI 10.1111/j.1365-2362.1979.tb00923.x; FAROOQUI J, 1980, J BIOL CHEM, V255, P4468; FIELEK S, 1979, CLIN CHEM, V25, P384; FISCHER EH, 1959, J BIOL CHEM, V234, P1698; GOFF CG, 1974, J BIOL CHEM, V249, P6181; GRACY RW, 1980, FED PROC, V39, P1690; KAHN A, 1979, HUM GENET, V50, P1, DOI 10.1007/BF00295584; KAPLAN JC, 1968, BIOCHEM BIOPH RES CO, V31, P768, DOI 10.1016/0006-291X(68)90628-1; KESTER MV, 1977, ARCH BIOCHEM BIOPHYS, V183, P700, DOI 10.1016/0003-9861(77)90403-9; KESTER MV, 1975, BIOCHEM BIOPH RES CO, V65, P1270, DOI 10.1016/S0006-291X(75)80367-6; KESTER MV, 1977, ARCH BIOCHEM BIOPHYS, V180, P562, DOI 10.1016/0003-9861(77)90074-1; LAW ML, 1979, CYTOGENET CELL GENET, V25, P179; MOHRENWEISER HW, P NATL ACAD SCI US; NEEL JV, 1980, P NATL ACAD SCI-BIOL, V77, P6037, DOI 10.1073/pnas.77.10.6037; NEEL JV, 1980, P NATL ACAD SCI-BIOL, V77, P4221, DOI 10.1073/pnas.77.7.4221; NEEL JV, 1978, AM J HUM GENET, V30, P465; PETERS J, 1973, ANN HUM GENET, V36, P297, DOI 10.1111/j.1469-1809.1973.tb00592.x; ROGERS PA, 1980, ANN HUM GENET, V43, P213, DOI 10.1111/j.1469-1809.1980.tb01555.x; RUBINSON H, 1973, J MOL EVOL, V2, P243, DOI 10.1007/BF01654093; SAWYER TH, 1972, J BIOL CHEM, V247, P6499; SCOPES RK, 1968, BIOCHEM J, V107, P139, DOI 10.1042/bj1070139; SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6; SKALA H, 1977, BIOCHEM MED METAB B, V18, P226, DOI 10.1016/0006-2944(77)90094-1; STEINBERG RA, 1980, P NATL ACAD SCI-BIOL, V77, P910, DOI 10.1073/pnas.77.2.910; TURNER BM, 1975, ISOZYMES, V1, P781; UY R, 1977, SCIENCE, V198, P890, DOI 10.1126/science.337487; YUAN PM, 1979, ARCH BIOCHEM BIOPHYS, V198, P42, DOI 10.1016/0003-9861(79)90393-X	30	29	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	5					683	691						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MJ232	7294020				2022-12-18	WOS:A1981MJ23200003
J	MARSHALL, L; DIGEORGE, A				MARSHALL, L; DIGEORGE, A			MAPLE SYRUP URINE DISEASE IN THE OLD ORDER MENNONITES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									TEMPLE UNIV,SCH MED,PHILADELPHIA,PA 19122; ST CHRISTOPHERS HOSP CHILDREN,PHILADELPHIA,PA 19133	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University									0	29	29	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	6					A139	A139						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MV199					2022-12-18	WOS:A1981MV19900358
J	SCHAAP, T; ZLOTOGORA, J; ELIAN, E; BARAK, Y; BACH, G				SCHAAP, T; ZLOTOGORA, J; ELIAN, E; BARAK, Y; BACH, G			THE GENETICS OF THE ARYL SULFATASE-A LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									TEL AVIV UNIV, SACKLER SCH MED, HASHARON HOSP, DEPT PEDIAT, RAMAT AVIV, ISRAEL; KAPLAN HOSP, DEPT PEDIAT, REHOVOT, ISRAEL	Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem; Kaplan Medical Center	SCHAAP, T (corresponding author), HEBREW UNIV JERUSALEM, HADASSAH MED CTR, DEPT HUMAN GENET, JERUSALEM 91000, ISRAEL.							BASS NH, 1970, NEUROLOGY, V20, P52, DOI 10.1212/WNL.20.1.52; BONNETAMIR B, 1978, MAN, V13, P72, DOI 10.2307/2801066; BUTTERWORTH J, 1978, CLIN GENET, V14, P213; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; DUBOIS G, 1980, BIOMED EXPRESS, V33, P2; DUBOIS G, 1977, AM J HUM GENET, V29, P191; DULANEY JT, 1978, METABOLIC BASIS INHE, P770; FLUHARTY AL, 1978, J PEDIATR-US, V92, P782, DOI 10.1016/S0022-3476(78)80153-X; KABACK M M, 1970, New England Journal of Medicine, V282, P1336, DOI 10.1056/NEJM197006112822403; KIHARA H, 1980, PEDIATR RES, V14, P224, DOI 10.1203/00006450-198003000-00009; KIHARA H, 1980, PEDIATR RES, V14, P890; LANGENBECK U, 1977, AM J HUM GENET, V29, P639; LOTT IT, 1976, J PEDIATR-US, V89, P438, DOI 10.1016/S0022-3476(76)80546-X; PERCY AK, 1968, SCIENCE, V161, P594, DOI 10.1126/science.161.3841.594; ZLOTOGORA J, 1980, PEDIATR RES, V14, P963, DOI 10.1203/00006450-198008000-00014; ZLOTOGORA J, 1980, AM J HUM GENET, V32, P663	16	29	29	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1981	33	4					531	539						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LZ348	6114634				2022-12-18	WOS:A1981LZ34800004
J	WOLF, B; WILLARD, HF; ROSENBERG, LE				WOLF, B; WILLARD, HF; ROSENBERG, LE			KINETIC-ANALYSIS OF GENETIC COMPLEMENTATION IN HETEROKARYONS OF PROPIONYL COA CARBOXYLASE-DEFICIENT HUMAN-FIBROBLASTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510	Yale University								BARTLETT K, 1976, LANCET, V2, P804; CASE ME, 1960, P NATL ACAD SCI USA, V46, P659, DOI 10.1073/pnas.46.5.659; CHASIN LA, 1976, SOMAT CELL GENET, V2, P453, DOI 10.1007/BF01542725; CRICK FHC, 1964, J MOL BIOL, V8, P161, DOI 10.1016/S0022-2836(64)80156-X; FRANTANTONI JC, 1968, SCIENCE, V162, P570; GALJAARD H, 1974, EXP CELL RES, V87, P444, DOI 10.1016/0014-4827(74)90515-1; GRAVEL RA, 1977, AM J HUM GENET, V29, P378; GRAVEL RA, 1975, P NATL ACAD SCI USA, V72, P3181, DOI 10.1073/pnas.72.8.3181; HSIA YE, 1979, PEDIATR RES, V13, P746, DOI 10.1203/00006450-197906000-00005; KALOUSEK F, J BIOL CHEM; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAUL GG, 1976, IN VITRO, V12, P787; NADLER HL, 1970, P NATL ACAD SCI USA, V67, P976, DOI 10.1073/pnas.67.2.976; ROSENBERG LE, 1979, METABOLIC CONTROL DI; ROSENBERG LE, 1978, METABOLIC BASIS INHE, P411; SAUNDERS M, UNPUBLISHED; SEKIGUCHI T, 1975, EXP CELL RES, V93, P207, DOI 10.1016/0014-4827(75)90441-3; THOMAS GH, 1974, NATURE, V250, P580, DOI 10.1038/250580a0; WEYLER W, 1977, CLIN CHIM ACTA, V76, P321, DOI 10.1016/0009-8981(77)90158-9; WILLARD HF, 1978, AM J HUM GENET, V30, P1; WILLARD HF, 1976, HUM GENET, V34, P277, DOI 10.1007/BF00295291; WOLF B, 1978, AM J HUM GENET, V30, P455	22	29	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	1					16	25						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JH296	7361761				2022-12-18	WOS:A1980JH29600003
J	WITKOP, CJ; WHITE, JG; KING, RA; DAHL, MV; YOUNG, WG; SAUK, JJ				WITKOP, CJ; WHITE, JG; KING, RA; DAHL, MV; YOUNG, WG; SAUK, JJ			HEREDITARY MUCOEPITHELIAL DYSPLASIA - DISEASE APPARENTLY OF DESMOSOME AND GAP JUNCTION FORMATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MINNESOTA,SCH MED,DEPT PEDIAT,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,SCH MED,DEPT MED,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,SCH MED,DEPT DERMATOL,MINNEAPOLIS,MN 55455	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	WITKOP, CJ (corresponding author), UNIV MINNESOTA,SCH DENT,DIV HUMAN & ORAL GENET,MINNEAPOLIS,MN 55455, USA.			Sauk, John/0000-0002-9208-5739				BAKER JR, 1946, Q J MICROSC SCI, V87, P441; Cannnon AB, 1935, ARCH DERMATOL SYPH, V31, P365, DOI 10.1001/archderm.1935.01460210076008; CEBRA JJ, 1965, J IMMUNOL, V95, P230; CHIFFELLE TL, 1951, STAIN TECHNOL, V26, P51, DOI 10.3109/10520295109113178; Cole HN, 1930, ARCH DERMATOL SYPH, V21, P71, DOI 10.1001/archderm.1930.01440070079008; DANE ET, 1963, STAIN TECHNOL, V38, P97, DOI 10.3109/10520296309061171; Darier J., 1889, ANN DERMATOL SYPHIL, V10, P597; DAVSON H, 1972, PHYSL EYE, P86; Engman M.F., 1926, ARCH DERMATOL SYPHIL, V13, P685; GOODENOU.DA, 1974, J CELL BIOL, V61, P557, DOI 10.1083/jcb.61.2.557; GOODENOUGH DA, 1978, MOL BASIS CELL CELL, V14, P83; JADASSOHN J, 1906, IKONOGRAPHIA DERMATO, P29; KEEBLER CM, 1976, TUTORIAL P, V4; MCMANUS JFA, 1948, STAIN TECHNOL, V23, P99, DOI 10.3109/10520294809106232; Medak H., 1970, ATLAS ORAL CYTOLOGY, VFirst; OKAMOTO GA, 1977, ANNUAL REV BIRTH D B, P117; Papanicolaou G. N., 1942, Science, V95, P438, DOI 10.1126/science.95.2469.438; Papanicolaou GN, 1943, AM J OBSTET GYNECOL, V46, P421, DOI 10.1016/S0002-9378(43)90439-9; REED RJ, 1971, DERMATOLOGY GENERAL, P200; SADEGHI EM, 1977, ORAL SURG ORAL MED O, V44, P567, DOI 10.1016/0030-4220(77)90300-0; TRAYHURN P, 1971, EXP EYE RES, V12, P315, DOI 10.1016/0014-4835(71)90156-4; VONSALLMANN L, 1960, ARCH OPHTHALMOL-CHIC, V63, P421, DOI 10.1001/archopht.1960.00950020423004; White JC., 1889, J CUTAN GENITOURIN D, V7, P201; WHITE JG, 1968, BLOOD, V31, P604, DOI 10.1182/blood.V31.5.604.604; WILGRAM GF, 1967, ULTRASTRUCTURE NORMA, P335; WITKOP CJ, 1961, ARCH DERMATOL, V84, P762, DOI 10.1001/archderm.1961.01580170056008; WITKOP CJ, 1960, ARCH PATHOL, V70, P696; WITKOP CJ, 1962, 1 P INT C EXF CYT PH, P259; WITKOP CJ, 1954, THESIS U MICHIGAN; ZINSSER F, 1906, IKONOGR DERMATOL KYO, P219	30	29	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	4					414	427						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HM222	484550				2022-12-18	WOS:A1979HM22200002
J	CAVALLISFORZA, LL; DAIGER, SP; RUMMEL, DP				CAVALLISFORZA, LL; DAIGER, SP; RUMMEL, DP			DETECTION OF GENETIC-VARIATION WITH RADIOACTIVE LIGANDS .1. ELECTROPHORETIC SCREENING OF PLASMA-PROTEINS WITH A SELECTED PANEL OF COMPOUNDS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									STANFORD UNIV HOSP,MED CTR,DEPT GENET,STANFORD,CA 94305	Stanford University								CORVOL PL, 1971, J BIOL CHEM, V246, P3435; DAIGER SP, 1975, P NATL ACAD SCI USA, V72, P2076, DOI 10.1073/pnas.72.6.2076; DAIGER SP, 1977, AM J HUM GENET, V29, P593; DAIGER SP, IN PRESS; DESGREZ P, 1965, TRANSPORT FUNCTION P, V5; FAGERHOL MK, 1966, ACTA PATHOL MIC SC, V68, P434, DOI 10.1111/apm.1966.68.3.434; FAIRBANK.G, 1965, BIOCHEM BIOPH RES CO, V20, P393, DOI 10.1016/0006-291X(65)90589-9; Giblett ER., 1969, GENETIC MARKERS HUMA; HALDANE JBS, 1954, J GENET, V52, P631, DOI 10.1007/BF02985085; HARRIS H, 1972, ANN HUM GENET, V36, P9, DOI 10.1111/j.1469-1809.1972.tb00578.x; JUSKO WJ, 1969, J PHARM SCI, V58, P58, DOI 10.1002/jps.2600580110; KOCHWESER J, 1976, NEW ENGL J MED, V294, P311, DOI 10.1056/NEJM197602052940605; PIGNATTI PF, 1975, NEUROBIOLOGY, V5, P65; POWIS G, 1975, BIOCHEM PHARMACOL, V24, P707, DOI 10.1016/0006-2952(75)90247-6; RICHARDSON KSC, 1976, N ENGL J MED, V294, P114; RUMMEL DP, 1976, THESIS STANFORD U; RUMMEL DR, IN PRESS; SCANU AM, 1972, ANNU REV BIOCHEM, V41, P703, DOI 10.1146/annurev.bi.41.070172.003415; TULCHINSKY D, 1973, J CLIN ENDOCR METAB, V37, P873, DOI 10.1210/jcem-37-6-873; WAGNERJAUREGG T, 1972, VITAMINS, V5; WAXMAN S, 1973, BLOOD, V42, P281, DOI 10.1182/blood.V42.2.281.281; WEITKAMP LR, 1973, ANN HUM GENET, V36, P381, DOI 10.1111/j.1469-1809.1973.tb00602.x; WESTPHAL U, 1971, STEROID PROTEIN INTE; WILDING G, 1977, SCIENCE, V195, P991, DOI 10.1126/science.841323	24	29	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1977	29	6					581	592						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EC270	930924				2022-12-18	WOS:A1977EC27000005
J	GRAHAM, JB; MILLER, CH; REISNER, HM; ELSTON, RC; OLIVE, JA				GRAHAM, JB; MILLER, CH; REISNER, HM; ELSTON, RC; OLIVE, JA			PHENOTYPIC RANGE OF HEMOPHILIA-A CARRIERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV N CAROLINA, CHAPEL HILL, NC 27514 USA; UNIV ALABAMA, MED CTR, DEPT PATHOL, DIV CLIN PATHOL, BIRMINGHAM, AL 35233 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Alabama System; University of Alabama Birmingham				Miller, Connie H/0000-0002-3989-7973				ALLAIN JP, 1975, J LAB CLIN MED, V85, P318; BARROW EM, 1974, PHYSIOL REV, V54, P23, DOI 10.1152/physrev.1974.54.1.23; BARROW EM, 1966, P SOC EXP BIOL MED, V121, P1001; BENNETT B, 1973, NEW ENGL J MED, V288, P342, DOI 10.1056/NEJM197302152880704; CZAPEK EE, 1974, J PEDIATR-US, V84, P485, DOI 10.1016/S0022-3476(74)80665-7; ELSTON RC, 1976, THROMB RES, V8, P683, DOI 10.1016/0049-3848(76)90248-6; GRAHAM JB, 1975, ANN NY ACAD SCI, V240, P141, DOI 10.1111/j.1749-6632.1975.tb53335.x; GRAHAM JB, 1975, BLOOD, V46, P175; GRAHAM JB, 1973, THROMB DIATH HAEMOST, V30, P2, DOI 10.1055/s-0038-1649096; GRAHAM JB, 1975, NOMENCLATURE FACTOR; Ivy AC, 1935, SURG GYNECOL OBSTET, V60, P781; LANGDELL RD, 1953, J LAB CLIN MED, V41, P637; LAURELL CB, 1966, ANAL BIOCHEM, V15, P45, DOI 10.1016/0003-2697(66)90246-6; REISNER HM, 1976, FED PROC, V35, P756; REVESZ T, 1972, J MED GENET, V9, P396, DOI 10.1136/jmg.9.4.396; RIZZA CR, 1975, BRIT J HAEMAT      S, V31, P231; SARJI KE, 1974, P NATL ACAD SCI USA, V71, P2937, DOI 10.1073/pnas.71.8.2937; ZIMMERMAN TS, 1971, J CLIN INVEST, V50, P244, DOI 10.1172/JCI106480; ZIMMERMAN TS, 1971, J CLIN INVEST, V50, P255, DOI 10.1172/JCI106481	19	29	29	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1976	28	5					482	488						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CH661	984044				2022-12-18	WOS:A1976CH66100006
J	VINE, DT; YARKONI, S; COHEN, MM				VINE, DT; YARKONI, S; COHEN, MM			INVERSION HOMOZYGOSITY OF CHROMOSOME-9 IN A HIGHLY INBRED KINDRED	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HADASSAH UNIV,MED CTR,DEPT HUMAN GENET,JERUSALEM,ISRAEL; HADASSAH UNIV,MED CTR,DEPT OBSTET & GYNECOL,JERUSALEM,ISRAEL	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center								COHEN M, IN PRESS; COHEN MM, 1971, J PEDIATR-US, V79, P456, DOI 10.1016/S0022-3476(71)80156-7; DELACHAPELLE A, 1974, AM J HUM GENET, V26, P746; LUBS HA, 1971, NATURE, V233, P134, DOI 10.1038/233134a0; MADAN K, 1974, ANN GENET-PARIS, V17, P81; MUTTON DE, 1973, NATURE-NEW BIOL, V241, P80, DOI 10.1038/newbio241080a0; PATIL SR, 1971, SCIENCE, V173, P821, DOI 10.1126/science.173.3999.821; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; WAHRMAN J, 1972, CYTOGENETICS, V11, P132, DOI 10.1159/000130182	9	29	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	3					203	207						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	BS306	233959				2022-12-18	WOS:A1976BS30600001
J	HOEHN, H				HOEHN, H			ANNOTATION - FUNCTIONAL IMPLICATIONS OF DIFFERENTIAL CHROMOSOME BANDING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WASHINGTON, DEPT PATHOL, SEATTLE, WA 98195 USA	University of Washington; University of Washington Seattle								BOBROW M, 1971, NATURE, V232, P556, DOI 10.1038/232556a0; BORGAONKAR DS, 1974, AM J HUM GENET, V26, pA16; BOUE A, 1973, BIOMEDICINE, V18, P372; CALDERON D, 1973, HUMANGENETIK, V18, P63; CASPERSSON T, 1971, HEREDITAS-GENETISK A, V67, P103; CASPERSSON T, 1972, EXP CELL RES, V75, P541, DOI 10.1016/0014-4827(72)90469-7; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; COMINGS DE, 1972, ADV HUM GENET, P237; COMINGS DE, 1973, EXP CELL RES, V77, P469, DOI 10.1016/0014-4827(73)90601-0; CRAIGHOLMES AP, 1973, AM J HUM GENET, V25, P181; DUTRILLAUX B, 1971, CR ACAD SCI D NAT, V272, P2638; DUTRILLAUX B, 1973, CYTOGENET CELL GENET, V12, P245, DOI 10.1159/000130460; DUTRILLAUX B, 1973, ANN GENET-PARIS, V16, P11; DUTRILLAUX B, 1973, CHROMOSOMA, V41, P395, DOI 10.1007/BF00396497; EVANS HJ, 1974, NATURE, V251, P346, DOI 10.1038/251346a0; FERGUSON-SMITH M A, 1974, Birth Defects Original Article Series, V10, P19; FERGUSONSMITH MA, 1973, CHROMOSOMES TODAY, V4, P235; FORABOSCO A, 1974, EXP CELL RES, V88, P418, DOI 10.1016/0014-4827(74)90263-8; FRANCKE U, 1972, AM J HUM GENET, V24, P189; FRIEDRICH U, 1973, CLIN GENET, V4, P333; GANNER E, 1971, CHROMOSOMA, V35, P326, DOI 10.1007/BF00326282; GOLOMB HM, 1974, EXP CELL RES, V84, P121, DOI 10.1016/0014-4827(74)90387-5; GRANLUND GH, 1973, J THEOR BIOL, V40, P573, DOI 10.1016/0022-5193(73)90011-8; HECHT F, 1974, CELL NUCLEUS, V2, P34; HIRSCHHO.K, 1973, ANN HUM GENET, V36, P375, DOI 10.1111/j.1469-1809.1973.tb00601.x; HOEHN H, 1973, CYTOGENET CELL GENET, V12, P443, DOI 10.1159/000130487; HOLMBERG M, 1973, HEREDITAS, V74, P57; HSU TC, 1972, P NATL ACAD SCI USA, V69, P1464, DOI 10.1073/pnas.69.6.1464; JACOBS PA, 1974, J MED GENET, V11, P50, DOI 10.1136/jmg.11.1.50; JONES KW, 1973, J MED GENET, V10, P273, DOI 10.1136/jmg.10.3.273; KAJII T, 1973, AM J HUM GENET, V25, P539; KIM MA, 1974, HUMANGENETIK, V21, P331; KOSKULL HV, 1973, CYTOGENET CELL GENET, V12, P423, DOI 10.1159/000130485; LATT SA, 1974, P NATL ACAD SCI USA, V71, P3162, DOI 10.1073/pnas.71.8.3162; LEE CSN, 1974, AM J HUM GENET, V26, P93; LEJEUNE J, 1973, CHROMOSOMA, V43, P423, DOI 10.1007/BF00406748; LEJEUNE J, 1973, P16; LEJEUNE J, 1973, MODERN ASPECTS CYTOG, P191; MARTIN GM, 1974, HUM PATHOL, V5, P387, DOI 10.1016/S0046-8177(74)80019-5; MENDELSOHN ML, 1973, SCIENCE, V179, P1126, DOI 10.1126/science.179.4078.1126; MENDELSOHN ML, 1974, HUMAN CHROMOSOME MET, P311; MIKKELSEN M, 1973, CHROMOSOMES TODAY, V4, P253; NEURATH P W, 1972, Computers in Biology and Medicine, V2, P181, DOI 10.1016/0010-4825(72)90047-9; NIEBUHR E, 1974, HUMANGENETIK, V21, P99, DOI 10.1007/BF00278575; PATHAK S, 1973, CYTOGENET CELL GENET, V12, P414, DOI 10.1159/000130484; REEVES BR, 1973, HUMANGENETIK, V20, P231, DOI 10.1007/BF00385735; RETHORE MO, 1973, HUMANGENETIK, V18, P129, DOI 10.1007/BF00291480; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; ROWLEY JD, 1975, P NATL ACAD SCI USA, V72, P152, DOI 10.1073/pnas.72.1.152; RUTTEN FJ, 1974, HUMANGENETIK, V25, P163, DOI 10.1007/BF00281423; RUZICKA F, 1974, HUMANGENETIK, V22, P119; SAVAGE JRK, 1973, CHROMOSOMES TODAY, V4, P267; SCHRECK RR, 1973, P NATL ACAD SCI USA, V70, P804, DOI 10.1073/pnas.70.3.804; SEABRIGHT M, 1973, CHROMOSOMA, V40, P333, DOI 10.1007/BF00399426; STALDER GR, 1965, HUMANGENETIK, V1, P307, DOI 10.1007/BF00395663; THERKELS.AJ, 1973, ANN HUM GENET, V36, P367, DOI 10.1111/j.1469-1809.1973.tb00600.x; TURLEAU C, 1973, HUMANGENETIK, V20, P151, DOI 10.1007/BF00284851; WARBURTON D, 1973, CYTOGENET CELL GENET, V12, P453, DOI 10.1159/000130488; WELCH JP, 1975, NATURE, V255, P240; WYANDT HE, 1973, EXP CELL RES, V81, P468, DOI 10.1016/0014-4827(73)90536-3; YUNIS JJ, 1965, NATURE, V205, P311, DOI 10.1038/205311a0; YUNIS JJ, 1974, HUMAN CHROMOSOME MET, P1; 1974, CYTOGENET CELL GENET, V13, P9	63	29	29	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1975	27	5					676	686						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AR239	51585				2022-12-18	WOS:A1975AR23900011
J	TENG, YS; ANDERSON, JE; GIBLETT, ER				TENG, YS; ANDERSON, JE; GIBLETT, ER			CYTIDINE DEAMINASE - NEW GENETIC POLYMORPHISM DEMONSTRATED IN HUMAN GRANULOCYTES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									PUGET SOUND BLOOD CTR,TERRY MADISON,SEATTLE,WA 98104	Puget Sound Blood Center								ABELL CW, 1973, NATURE-NEW BIOL, V244, P217, DOI 10.1038/newbio244217a0; CAMIENER GW, 1965, BIOCHEM PHARMACOL, V14, P1405, DOI 10.1016/0006-2952(65)90175-9; CHABNER BA, 1974, J CLIN INVEST, V53, P922, DOI 10.1172/JCI107633; CHABNER BA, 1973, BIOCHEM PHARMACOL, V22, P2763, DOI 10.1016/0006-2952(73)90137-8; FARRON F, 1973, ANAL BIOCHEM, V53, P264, DOI 10.1016/0003-2697(73)90427-2; Giblett ER., 1969, GENETIC MARKERS HUMA; HARRIS H, 1970, PRINCIPLES HUMAN BIO; MALATHI VG, 1971, BIOCHIM BIOPHYS ACTA, V238, P377, DOI 10.1016/0005-2787(71)90612-5; MARKERT CL, 1963, SCIENCE, V140, P1329, DOI 10.1126/science.140.3573.1329; MCFERRAN NV, 1969, BIOCHEM J, V114, pP8, DOI 10.1042/bj1140008Pb; RAIVIO KO, 1970, CURRENT TOPICS CELLU, V2, P201; ROTHMAN IK, 1970, J CLIN INVEST, V49, P2051, DOI 10.1172/JCI106424; SILBER R, 1967, BLOOD-J HEMATOL, V29, P896, DOI 10.1182/blood.V29.6.896.896; STEUART CD, 1971, NATURE-NEW BIOL, V233, P109, DOI 10.1038/newbio233109a0; TATTERSALL MH, 1974, BRIT J HAEMATOL, V27, P39, DOI 10.1111/j.1365-2141.1974.tb06772.x; TOMCHICK B, 1968, J BIOL CHEM, V243, P2534; TUNG R, 1974, 17TH ANN M AM SOC HE; WISDOM GB, 1969, EUR J BIOCHEM, V7, P223, DOI 10.1111/j.1432-1033.1969.tb19595.x	18	29	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1975	27	4					492	497						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM544	50738				2022-12-18	WOS:A1975AM54400006
J	UCHIDA, IA; LEE, CPV; BYRNES, EM				UCHIDA, IA; LEE, CPV; BYRNES, EM			CHROMOSOME-ABERRATIONS INDUCED INVITRO BY LOW-DOSES OF RADIATION - NONDISJUNCTION IN LYMPHOCYTES OF YOUNG-ADULTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MCMASTER UNIV, DEPT PEDIAT, HAMILTON, ONTARIO, CANADA; MCMASTER UNIV, REG CYTOGENET LAB, HAMILTON, ONTARIO, CANADA	McMaster University; McMaster University								ALBERMAN E, 1972, ANN HUM GENET, V36, P195, DOI 10.1111/j.1469-1809.1972.tb00769.x; BUCKTON KE, 1964, NATURE, V202, P714, DOI 10.1038/202714a0; CARR DH, 1967, AM J OBSTET GYNECOL, V97, P283, DOI 10.1016/0002-9378(67)90488-7; CARR DH, 1965, OBSTET GYNECOL, V26, P308; CARR DH, 1970, HUMAN POPULATION CYT, P104; CARTER CO, 1961, LANCET, V2, P1042; CATTANACH BM, 1973, CYTOGENET CELL GENET, V12, P264, DOI 10.1159/000130462; COURTBROWN WM, 1966, CHROMOSOME STUDIES A; FORBES C, 1960, P NATL ACAD SCI USA, V46, P222, DOI 10.1073/pnas.46.2.222; FREY HE, 1968, RADIAT RES, V36, P59, DOI 10.2307/3572538; FREY HE, 1966, RADIAT RES, V28, P668, DOI 10.2307/3571994; GOH KO, 1968, RADIAT RES, V35, P171, DOI 10.2307/3572443; GRELL RF, 1964, SCIENCE, V145, P66, DOI 10.1126/science.145.3627.66; HAMERTON JL, 1972, CAN MED ASSOC J, V106, P776; HAMILTON HD, 1973, 4TH P INT C BIRTH DE, P92; HENDERSON SA, 1968, NATURE, V218, P22, DOI 10.1038/218022a0; HOLLOWELL JG, 1968, P SOC EXP BIOL MED, V129, P240; HOLLOWELL JG, 1967, J SC MED ASSOC, V63, P329; KAJII T, 1973, AM J HUM GENET, V25, P539; LYON MF, 1966, CYTOGENETICS, V5, P335, DOI 10.1159/000129909; Mavor JW, 1924, J EXP ZOOL, V39, P381, DOI 10.1002/jez.1400390209; Patterson JT, 1932, J HERED, V23, P325, DOI 10.1093/oxfordjournals.jhered.a103652; Penrose L.S., 1966, DOWNS ANOMALY; SANDLER L, 1968, GENETICS, V60, P525; SCHMICKE.R, 1967, AM J HUM GENET, V19, P1; SCHULL WJ, 1962, LANCET, V1, P537; SIGLER AT, 1965, B JOHNS HOPKINS HOSP, V117, P374; STEVENSON AC, 1970, LANCET, V2, P1335; UCHIDA IA, 1974, NATURE, V250, P601, DOI 10.1038/250601a0; UCHIDA IA, 1968, LANCET, V2, P1045; UCHIDA IA, 1961, LANCET, V2, P848; UCHIDA IA, 1962, CAN J GENET CYTOL, V4, P402, DOI 10.1139/g62-051; WALD N, 1970, ANN NY ACAD SCI, V171, P454, DOI 10.1111/j.1749-6632.1970.tb39355.x; YAMAMOTO M, 1973, NATURE-NEW BIOL, V244, P206, DOI 10.1038/newbio244206a0	34	29	34	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1975	27	3					419	429						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AD236	803021				2022-12-18	WOS:A1975AD23600015
J	JENKINS, MB; DAVIS, E; THELEN, TH; BOYD, L				JENKINS, MB; DAVIS, E; THELEN, TH; BOYD, L			FAMILIAL X-22 TRANSLOCATION WITH AN EXTRA X-CHROMOSOME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MINNESOTA DEPT HLTH,HUMAN GENET UNIT,MINNEAPOLIS,MN 55440; ST PAUL RAMSEY HOSP,CHILD DEV CTR,ST PAUL,MN 55101; CENT WASHINGTON STATE COLL,DEPT BIOL SCI,ELLENSBURG,WA 98926	Minnesota Department of Health (MHD); Saint Paul Ramsey Medical Center								COHEN MM, 1972, AM J HUM GENET, V24, P583; CRANDALL BF, 1973, AM J HUM GENET, V25, pA22; HSU LYF, 1970, PEDIATRICS, V45, P656; KALLIO H, 1973, ACTA OBSTET GYNE S24; MIKKELSEN M, 1966, ANN HUM GENET, V30, P147, DOI 10.1111/j.1469-1809.1966.tb00014.x; MIKKELSEN M, 1973, CYTOGENET CELL GENET, V12, P357, DOI 10.1159/000130474; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; MUKHERJEE D, 1966, NATURE, V212, P153; MULDAL S, 1963, LANCET, V1, P861; RIDLER MAC, 1965, BRIT J PSYCHIAT, V111, P183, DOI 10.1192/bjp.111.471.183; ROWLEY J, 1964, P NATL ACAD SCI USA, V51, P779, DOI 10.1073/pnas.51.5.779; RUSSELL LB, 1969, GENETICS, V63, P103; SARTO GE, 1973, AM J HUM GENET, V25, P262; SCHMID W, 1965, HUMAN CHROMOSOME MET, P91; SEABRIGHT M, 1972, CHROMOSOMA, V36, P204; SUMMITT RL, 1974, J PEDIATR-US, V84, P539, DOI 10.1016/S0022-3476(74)80674-8; THEILGAARD A, 1971, PSYCHOLOGICAL PSYCHI; THELEN TH, 1971, AM J HUM GENET, V23, P410	18	29	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1974	26	6					736	745						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	V0911	4140689				2022-12-18	WOS:A1974V091100009
J	BEUTLER, E; GUINTO, E; KUHL, W				BEUTLER, E; GUINTO, E; KUHL, W			VARIABILITY OF ALPHA-GALACTOSIDASE A AND B IN DIFFERENT TISSUES OF MAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CITY HOPE NATL MED CTR,DUARTE,CA 91010	City of Hope								BEUTLER E, 1972, AM J HUM GENET, V24, P237; BEUTLER E, 1972, J BIOL CHEM, V247, P7195; BEUTLER E, 1971, J LAB CLIN MED, V78, P987; GOLDSTON.A, 1971, FEBS LETT, V13, P68, DOI 10.1016/0014-5793(71)80667-1; HO MW, 1972, AM J HUM GENET, V24, P256; KINT J A, 1970, Science (Washington D C), V167, P1268, DOI 10.1126/science.167.3922.1268; KINT JA, 1971, ARCH INT PHYS BIOCH, V79, P633	7	29	29	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1973	25	1					42	46						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	O5774	4346241				2022-12-18	WOS:A1973O577400005
J	HAVERKORN, MJ; GOSLINGS, WR				HAVERKORN, MJ; GOSLINGS, WR			STREPTOCOCCI, ABO BLOOD GROUPS, AND SECRETOR STATUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ADDIS G J, 1959, Scott Med J, V4, P547; Brody H, 1936, J LAB CLIN MED, V21, P705; BUCKWALTER J A, 1962, Br Med J, V2, P1023; Cadness-Graves B, 1943, LANCET, V1, P736; CLARKE CA, 1960, BRIT MED J, V1, P21, DOI 10.1136/bmj.1.5165.21; DUBLIN TD, 1964, BRIT MED J, V2, P775, DOI 10.1136/bmj.2.5412.775; FINDLAY II, 1966, CAN MED ASSOC J, V94, P1027; Fisk A, 1940, BRIT J EXP PATHOL, V21, P311; GERSHOWITZ H, 1965, ACTA GENET STAT MED, V15, P261; GLYNN AA, 1959, BRIT MED J, V2, P266, DOI 10.1136/bmj.2.5147.266; GOSLINGS WR, 1963, NEW ENGL J MED, V268, P687, DOI 10.1056/NEJM196303282681301; GRIZZLE JE, 1967, AM STAT, V21, P28, DOI 10.2307/2682103; GUALANDRI V, 1965, ACTA GENET MED GEMEL, V14, P392, DOI 10.1017/S1120962300015092; HOOPER WL, 1960, BRIT MED J, V1, P565, DOI 10.1136/bmj.1.5172.565-b; KHATTAB TM, 1960, J EGYPT MED ASSOC, V43, P431; Korwer H, 1932, JAHRB KINDERHEILKD, V86, P59; LIM WN, 1965, AM J EPIDEMIOL, V83, P103; MACAFEE AL, 1965, ANN RHEUM DIS, V24, P392, DOI 10.1136/ard.24.4.392; Maxted G R, 1940, Arch Dis Child, V15, P181; MCCORKLE LP, 1962, AM J HYG, V75, P33, DOI 10.1093/oxfordjournals.aje.a120232; Nowak H., 1932, MSCHR KINDERHEILK, V54, P343; PHAMHUUTRUNG, 1961, ANN PEDIATR-PARIS, V37, P423; SARTOR V, 1964, CAN MED ASSOC J, V90, P428; Stollerman G H, 1965, Mod Concepts Cardiovasc Dis, V34, P45; STUART R D, 1954, Can J Public Health, V45, P73; VALKENBURG HA, 1963, NEW ENGL J MED, V268, P694, DOI 10.1056/NEJM196303282681302; WALSH R. J., 1956, AUSTRALASIAN ANN MED, V5, P17; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; ZUBER EUSTACHY, 1966, POL TYG LEK, V21, P101; 1955, MOD CONC CARDIOVASC, V24, P291	30	29	29	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1969	21	4					360	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D7993	4893654				2022-12-18	WOS:A1969D799300004
J	SHIH, LY; HSIA, DYY; BOWMAN, JE; SHIH, SC; SHIH, PL				SHIH, LY; HSIA, DYY; BOWMAN, JE; SHIH, SC; SHIH, PL			ELECTROPHORETIC PHENOTYPES OF RED CELL 6-PHOSPHOGLUCONATE DEHYDROGENASE AND ADENYLATE KINASE IN CHINESE POPULATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BOWMAN JE, 1967, NATURE, V214, P1156, DOI 10.1038/2141156a0; BOWMAN JE, 1967, AM J PHYS ANTHROPOL, V27, P119, DOI 10.1002/ajpa.1330270203; BOWMAN JE, 1966, NATURE, V210, P811, DOI 10.1038/210811a0; BREWER GJ, 1967, ACTA GENET STAT MED, V17, P97; DAVIDSON RG, 1967, ANN HUM GENET, V30, P355, DOI 10.1111/j.1469-1809.1967.tb00037.x; DERN RJ, 1966, J LAB CLIN MED, V67, P255; FILDES RA, 1963, NATURE, V200, P890, DOI 10.1038/200890a0; FILDES RA, 1966, NATURE, V209, P261, DOI 10.1038/209261a0; Gordon H, 1966, S Afr Med J, V40, P1031; GORDON H, 1967, NATURE, V214, P466, DOI 10.1038/214466a0; KIRKMAN HN, 1963, AM J HUM GENET, V15, P241; PARR CW, 1966, NATURE, V210, P487, DOI 10.1038/210487a0; PARR CW, 1967, ANN HUM GENET, V30, P339, DOI 10.1111/j.1469-1809.1967.tb00036.x	13	29	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1968	20	5					474	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	B8383	5710371				2022-12-18	WOS:A1968B838300007
J	STEINBERG, AG; MUIR, WA; MCINTIRE, SA				STEINBERG, AG; MUIR, WA; MCINTIRE, SA			2 UNUSUAL GM ALLELES - THEIR IMPLICATIONS FOR GENETICS OF GM ANTIGENS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BUTLER R, 1964, PATHOL MICROBIOL, V27, P558, DOI 10.1159/000161506; CROW JF, 1967, 3 P INT C HUM GEN ED, P267; DEICHER H, 1963, ACTA GENET STAT MED, V13, P124; FRANGIONE B, 1966, J EXP MED, V124, P715, DOI 10.1084/jem.124.4.715; GOLD ER, 1965, VOX SANG, V10, P299, DOI 10.1111/j.1423-0410.1965.tb01393.x; GREENWALT TJ, 1967, ADVANCES IMMUNOGE ED, P75; KLEMPERER MR, 1966, AM J HUM GENET, V18, P433; KUNKEL HG, 1964, NATURE, V203, P413, DOI 10.1038/203413a0; KUNKEL HG, 1964, COLD SPRING HARB SYM, V29, P443, DOI 10.1101/SQB.1964.029.01.046; LITWIN SD, 1967, J EXP MED, V125, P847, DOI 10.1084/jem.125.5.847; MARTENSS.L, 1966, VOX SANG, V11, P393, DOI 10.1111/j.1423-0410.1966.tb04237.x; MARTENSSON L, 1966, VOX SANG, V11, P521, DOI 10.1111/j.1423-0410.1966.tb04251.x; MARTENSSON L, 1965, J EXP MED, V122, P799, DOI 10.1084/jem.122.4.799; MUIR W. ANGUS, 1967, SEMINARS HEMATOL, V4, P156; NATVIG JB, 1967, NOBEL S, V3, P313; NIELSEN JC, 1961, VOX SANG, V6, P634, DOI 10.1111/j.1423-0410.1961.tb03217.x; Polmar S H, 1967, Biochem Genet, V1, P117, DOI 10.1007/BF00486513; ROPARTZ C, 1967, REV FR ETUD CLIN BIO, V12, P267; ROPARTZ C, 1967, REV FR ETUD CLIN BIO, V12, P185; ROPARTZ C, 1963, REV FR ETUD CLIN BIO, V8, P269; ROPARTZ C, 1962, VOX SANG, V7, P233, DOI 10.1111/j.1423-0410.1962.tb03246.x; ROPARTZ C, 1965, HUMANGENETIK, V1, P483, DOI 10.1007/BF00338339; STEINBERG AG, 1965, AM J HUM GENET, V17, P133; STEINBERG AG, 1965, AM J HUM GENET, V17, P311; STEINBERG AG, 1963, AM J HUM GENET, V15, P96; STEINBERG AG, 1965, VOX SANG, V10, P721, DOI 10.1111/j.1423-0410.1965.tb05183.x; STEINBERG AG, 1966, BLOOD-J HEMATOL, V28, P1003; STEINBERG AG, 1967, DEC AM SOC HUM GEN A, P41; STEINBERG AG, 1967, 3RD P INT C HUM GEN, P267; STEINBERG ARTHUR G., 1962, PROGR MED GENET, V2, P1; STEINBERG ARTHUR G., 1967, P75; THORPE NO, 1966, IMMUNOCHEMISTRY, V3, P329, DOI 10.1016/0019-2791(66)90094-2; WILSON JA, 1965, TRANSFUSION, V5, P516, DOI 10.1111/j.1537-2995.1965.tb01198.x; 1965, B WHO, V33, P721	34	29	29	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1968	20	3					258	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	B8693	4968648				2022-12-18	WOS:A1968B869300006
J	SIMPSON, NE				SIMPSON, NE			FACTORS INFLUENCING CHOLINESTERASE ACTIVITY IN A BRAZILIAN POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		DAVIES RO, 1960, CANAD J BIOCHEM PHYS, V38, P546; HARRIS H, 1963, ANN HUM GENET, V26, P359, DOI 10.1111/j.1469-1809.1963.tb01335.x; HARRIS H, 1961, NATURE, V191, P496, DOI 10.1038/191496a0; HARRIS H, 1962, NATURE, V196, P1296, DOI 10.1038/1961296a0; HARRIS H, 1963, LANCET, V2, P218; HARRIS H, 1963, NATURE, V200, P1185, DOI 10.1038/2001185a0; HARRIS H, 1962, ANN HUM GENET, V26, P59, DOI 10.1111/j.1469-1809.1962.tb01310.x; HODGKIN WE, 1965, J CLIN INVEST, V44, P486, DOI 10.1172/JCI105162; KALOW W, 1955, CAN J BIOCHEM PHYS, V33, P568; KALOW W, 1964, ANESTHESIOLOGY, V25, P377, DOI 10.1097/00000542-196405000-00017; KALOW W, 1957, CAN J BIOCHEM PHYS, V35, P339, DOI 10.1139/o57-041; KALOW W, 1959, ANESTHESIOLOGY, V20, P505, DOI 10.1097/00000542-195907000-00008; KALOW W, 1959, ANN HUM GENET, V23, P239, DOI 10.1111/j.1469-1809.1959.tb01467.x; KALOW W, 1956, CAN ANAESTH SOC J, V3, P22; KALOW W, 1957, CAN J BIOCHEM PHYSIO, V35, P1306; Kalow Werner, 1963, PHARMACOGENETICS HER; LEHMANN H., 1964, PROGR MED GENET, V3, P75; LIDDELL J, 1962, NATURE, V193, P561, DOI 10.1038/193561a0; LISKER R, 1964, NATURE, V202, P815, DOI 10.1038/202815a0; MORTON NE, 1964, COLD SPRING HARB SYM, V29, P69, DOI 10.1101/SQB.1964.029.01.012; MORTON NE, 1955, AM J HUM GENET, V7, P277; OMOTO K, 1965, NATURE, V205, P726, DOI 10.1038/205726a0; ROSE L, 1965, LANCET, V2, P563; SIMPSON NE, 1964, AM J HUM GENET, V16, P180; SIMPSON NE, 1963, AM J HUM GENET, V15, P280; SIMPSON NE, 1965, AM J HUM GENET, V17, P156; SIMPSON NE, IN PRESS; SMITHIES O, 1959, BIOCHEM J, V71, P585, DOI 10.1042/bj0710585; SNEDECOR GW, 1957, STATISTICAL METHODS; WETSTONE HJ, 1965, J AMER MED ASSOC, V192, P1007, DOI 10.1001/jama.1965.03080240077028; WETSTONE HJ, 1957, GASTROENTEROLOGY, V33, P41	31	29	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1966	18	3					243	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	77584	5944418				2022-12-18	WOS:A19667758400002
J	WANG, AC; SUTTON, HE; RIGGS, A				WANG, AC; SUTTON, HE; RIGGS, A			A CHEMICAL DIFFERENCE BETWEEN HUMAN TRANSFERRINS B2 AND C	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BEARN ALEXANDER G., 1966, P1321; BECKMAN L, 1963, ACTA GENET STAT MED, V13, P361; BERRY HK, 1951, DEVELOPMENT PAPER CH, P22; BERRY HK, 1951, 5109 U TEX PUBL, P22; BRIMACOMBE R, 1965, P NATL ACAD SCI USA, V54, P954, DOI 10.1073/pnas.54.3.954; GIBLETT E. R., 1962, PROGR MED GENET, V2, P34; HARRIS H, 1958, NATURE, V182, P452, DOI 10.1038/182452a0; JONES RT, 1964, ANAL BIOCHEM, V9, P377, DOI 10.1016/0003-2697(64)90194-0; PARKER WC, 1961, SCIENCE, V133, P1014, DOI 10.1126/science.133.3457.1014; ROBINSON JC, 1963, J LAB CLIN MED, V62, P762; SMITH I, 1960, CHROMATOGR ELECTROPH, V1, P97; SMITHIES O, 1957, NATURE, V180, P1482, DOI 10.1038/1801482a0; SMITHIES O, 1958, NATURE, V181, P1203, DOI 10.1038/1811203b0; STANBURY JB, 1966, METABOLIC BASIS I ED, P1321; SUTTON HE, 1965, BIOCHIM BIOPHYS ACTA, V107, P153, DOI 10.1016/0304-4165(65)90407-1; WANG AC, 1965, SCIENCE, V149, P435, DOI 10.1126/science.149.3682.435	16	29	29	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1966	18	5					454	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	83834	5927288				2022-12-18	WOS:A19668383400006
J	PEARSON, HA; MOORE, MM				PEARSON, HA; MOORE, MM			HUMAN HEMOGLOBIN GENE LINKAGE - REPORT OF A FAMILY WITH HEMOGLOBIN B2 HEMOGLOBIN S AND BETA THALASSEMIA INCLUDING A PROBABLE CROSSOVER BETWEEN THALASSEMIA AND DELTA LOCI	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BAGLIONI C, 1962, P NATL ACAD SCI USA, V48, P1880, DOI 10.1073/pnas.48.11.1880; BOYER SH, 1963, AM J HUM GENET, V15, P438; CEPPELLINI R, 1959, BIOCHEMISTRY HUMAN G, P133; GERALD PS, 1958, BLOOD, V13, P61, DOI 10.1182/blood.V13.1.61.61; HORTON BF, 1963, AM J HUM GENET, V15, P394; HUISMAN TH, 1961, BLOOD, V17, P747, DOI 10.1182/blood.V17.6.747.747; INGRAM VM, 1959, NATURE, V184, P1903, DOI 10.1038/1841903a0; LEE GR, 1964, J LAB CLIN MED, V64, P72; MCCURDY PR, 1961, AM J HUM GENET, V13, P390; MOTULSKY AG, 1962, NATURE, V194, P607, DOI 10.1038/194607b0; NEEL JV, 1961, BLOOD, V18, P769, DOI 10.1182/blood.V18.6.769.769; PEARSON H A, 1959, U S Armed Forces Med J, V10, P693; RANNEY HM, 1963, NATURE, V197, P164, DOI 10.1038/197164a0; ROBINSON AR, 1957, J LAB CLIN MED, V50, P745; SINGER K, 1951, BLOOD, V6, P413, DOI 10.1182/blood.V6.5.413.413; WEATHERALL DJ, 1964, ANN NY ACAD SCI, V119, P450; WOLSTENHOLME GEW, 1959, BIOCHEMISTRY HUMAN G, P133	17	29	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1965	17	2					125	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	62357	14262130				2022-12-18	WOS:A19656235700005
J	MACINTYRE, MN; STAPLES, WI; HEMPEL, JM; STEINBERG, AG				MACINTYRE, MN; STAPLES, WI; HEMPEL, JM; STEINBERG, AG			FAMILIAL MONGOLISM (TRISOMY-21 SYNDROME) RESULTING FROM A 15/21 CHROMOSOME TRANSLOCATION IN MORE THAN 3 GENERATIONS OF A LARGE KINDRED	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Allen G, 1961, Am J Hum Genet, V13, P426; ALLEN G, 1961, LANCET, V1, P775; ATKINS L, 1962, NEW ENGL J MED, V266, P631, DOI 10.1056/NEJM196203292661301; BOOK J A, 1959, Acta Paediatr, V48, P453; BRADEN AWH, 1958, NATURE, V181, P786, DOI 10.1038/181786a0; BUCKTON KE, 1961, LANCET, V1, P171; CARTER CO, 1960, LANCET, V2, P678; DUNN LC, 1960, MUS MUSCULUS AMER NA, V94, P385; EK JI, 1961, LANCET, V2, P526; FORD CE, 1959, LANCET, V1, P709; FORSSMAN H, 1961, LANCET, V1, P1286; GERMAN JL, 1962, AM J HUM GENET, V14, P31; Gershenson S, 1928, GENETICS, V13, P488; HAMERTON JL, 1962, LANCET, V1, P1408; HAMERTON JL, 1961, LANCET, V2, P956; JACOBS PA, 1959, LANCET, V1, P710; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P1721; MAKINO S., 1960, PROC JAPANESE ACAD, V36, P670; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; PENROSE LS, 1960, LANCET, V2, P409; POLANI PE, 1960, LANCET, V1, P721; ROTHFELS KH, 1958, STAIN TECHNOL, V33, P73, DOI 10.3109/10520295809111827; SANDLER L, 1959, GENETICS, V44, P233; SERGOVICH F, PERSONAL COMMUNICATI; Sturtevant AH, 1936, GENETICS, V21, P473; Tjio J. H., 1956, HEREDITAS, V42, P1, DOI [10.1007/978-94-011-6621-8_13, DOI 10.1111/J.1601-5223.1956.TB03010.X]; WAARDENBURG PJ, 1932, MENSCHLICHE AUGE SEI	27	29	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1962	14	4					335	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2965A	17948473				2022-12-18	WOS:A19622965A00005
J	WANG, HL; MORTON, NE; WAISMAN, HA				WANG, HL; MORTON, NE; WAISMAN, HA			INCREASED RELIABILITY FOR DETERMINATION OF CARRIER STATE IN PHENYLKETONURIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		HSIA DYY, 1956, NATURE, V178, P1239, DOI 10.1038/1781239a0; HSIA DYY, 1957, J MENT DEFIC RES, V1, P53; HSIA DYY, 1960, AM J HUM GENET, V12, P277; KNOX WE, 1958, AM J HUM GENET, V10, P53; PENROSE LS, 1951, ANN EUGENIC, V16, P134, DOI 10.1111/j.1469-1809.1951.tb02467.x; Rao C.R., 1952, ADV STAT METHODS BIO; RENWICK JH, 1960, AM J HUM GENET, V12, P287; UDENFRIEND S, 1953, J BIOL CHEM, V203, P953; UDENFRIEND S, 1952, J BIOL CHEM, V196, P227	9	29	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1961	13	2					255	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2960A	13783038				2022-12-18	WOS:A19612960A00008
J	RENWICK, JH; LAWLER, SD; COWIE, VA				RENWICK, JH; LAWLER, SD; COWIE, VA			PHENYLKETONURIA - A LINKAGE STUDY USING PHENYLALANINE TOLERANCE TESTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		HSIA DYY, 1956, NATURE, V178, P1239, DOI 10.1038/1781239a0; HSIA DYY, 1957, J MENT DEFIC RES, V1, P53; HSIA DYY, 1960, AM J HUM GENET, V12, P277; KNOX WE, 1958, AM J HUM GENET, V10, P53; MORTON NE, 1957, AM J HUM GENET, V9, P55; MORTON NE, 1955, AM J HUM GENET, V7, P277; MUNRO TA, 1947, ANN EUGENIC, V14, P60, DOI 10.1111/j.1469-1809.1947.tb02379.x; PENROSE LS, 1951, ANN EUGENIC, V16, P134, DOI 10.1111/j.1469-1809.1951.tb02467.x; PENROSE LS, 1951, ANN EUGENIC, V16, P241, DOI 10.1111/j.1469-1809.1951.tb02477.x; SIMPSON HR, 1958, ANN HUM GENET, V22, P356, DOI 10.1111/j.1469-1809.1958.tb01429.x; SMITH CAB, 1953, J R STAT SOC B, V15, P153; SMITH CAB, 1959, AM J HUM GENET, V11, P289; UDENFRIEND S, 1953, J BIOL CHEM, V203, P953; UDENFRIEND S, 1952, J BIOL CHEM, V196, P227	14	29	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1960	12	3					287	298						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF079	14437398				2022-12-18	WOS:A1960WF07900004
J	DERAEMAEKER, R				DERAEMAEKER, R			CONGENITAL DEAFNESS AND GOITER	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BERNSTEIN F, 1929, HDB VERERBSWISS; Brain WR, 1927, Q J MED, V20, P303, DOI 10.1093/qjmed/os-20.79.303	2	29	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1956	8	4					253	256						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF071	13394568				2022-12-18	WOS:A1956WF07100004
J	KLOEPFER, HW; ROSENTHAL, JW				KLOEPFER, HW; ROSENTHAL, JW			POSSIBLE GENETIC CARRIERS IN THE SPHEROPHAKIA-BRACHYMORPHIA SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ARJONA J, 1952, ARCH SOC OPTHAL HISP, V12, P1167; Cummins H, 1939, ANAT REC, V73, P407, DOI 10.1002/ar.1090730404; CUMMINS H, 1943, FINGER PRINTS PALMS; DAVENPORT CB, 1921, ARMY ANTHROPOMETRY, V15; DIETHELM W, 1947, Ophthalmologica, V114, P16; Marchesani O., 1939, KLIN MONATSBL AUGENH, V103, P392; MEYER SJ, 1941, AM J OPHTHALMOL, V24, P247; NEEL JV, 1947, MEDICINE, V26, P115, DOI 10.1097/00005792-194705000-00001; Neel JV, 1954, HUMAN HEREDITY; NEWMAN RW, 1951, 180 QUART CLIM RES L; PENROSE LS, 1954, ANN HUM GENET, V19, P10, DOI 10.1111/j.1469-1809.1954.tb01260.x; PROBERT LA, 1953, AM J OPHTHALMOL, V36, P1571, DOI 10.1016/0002-9394(53)91786-3; RANDALL FE, 1949, 149 QUART CLIM RES L; ROSENTHAL J, AM J OPHTHALMOL; ROUSSEAU H, 1949, B MEM SOC FRANC DOPH, V62, P369; SCHMID AE, 1946, OPHTHALMOLOGICA, V111, P359, DOI 10.1159/000300356; SEELEMANN K, 1949, Z KINDERHEILKD, V67, P1; STADLIN W, 1948, ANN OCUL, V181, P692; THORINGTON J, 1944, REFRACTION HUMAN EYE; WATSON EH, 1951, GROWTH DEV CHILDREN; Weill G., 1932, ANN OCUL, V169, P21	21	29	30	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1955	7	4					398	425						28	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA213	13275462				2022-12-18	WOS:A1955WA21300005
J	DICE, LR				DICE, LR			HEREDITY CLINICS - THEIR VALUE FOR PUBLIC SERVICE AND FOR RESEARCH	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		FALLS HF, 1949, SIGHT SAVING REV, V19, P2; MCDOWELL EC, 1946, BIOS, V17, P1; MULLER HJ, 1950, AM J HUM GENET, V2, P111; NEEL JV, 1951, MED CLIN N AM, P519, DOI 10.1016/S0025-7125(16)35307-X; 1949, BIRTHRIGHT PUBL, V5	5	29	29	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1952	4	1					1	13						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XS396	14933369				2022-12-18	WOS:A1952XS39600001
J	BOOK, JA				BOOK, JA			CLINICAL AND GENETICAL STUDIES OF HYPODONTIA .1. PREMOLAR APLASIA, HYPERHIDROSIS, AND CANITIES PREMATURA - A NEW HEREDITARY SYNDROME IN MAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BOOK JA, 1950, HEREDITAS, V36, P161; CLAPHAM H, 1925, BRIT DENT J, V46, P1397; CLAREMONT LE, 1924, BRIT DENT J, V45, P588; COCKAYNE EA, 1933, INHERITED ABNORMALIT, P394; DIETRICH O, 1933, THESIS ZURICH; Dolder E, 1937, DENT REC, V57; ERWIN WG, 1949, J HERED, V40, P215, DOI 10.1093/oxfordjournals.jhered.a106028; EULER H, 1940, HDB ERBBIOLOGIE MENS, V4, P527; GATES RR, 1946, HUMAN GENETICS, V1, P742; GATHERGOOD GW, 1926, BRIT DENT J, V47, P1323; Hare HJH, 1929, J HERED, V20, P31, DOI 10.1093/oxfordjournals.jhered.a103095; Hellman M., 1936, DENT COSM, V78, P750; HELWEG-LARSEN H F, 1946, Acta Derm Venereol, V26, P489; HUMBLE AD, 1925, BRIT DENT J, V46, P991; JOHR ALBERT C., 1934, ARCH JULIUS KLAUS STIFT, V9, P73; MOHR OL, 1919, CARNEGIE I WASH, V295, P1; MORAMARCO G, 1930, MUNCH FORTSCH ZAHNH, V6, P781; PLUMMER S, 1937, EUGEN NEWS, V22, P108; Serebrovskaya R. I., 1929, MEDIKO BIOLOGICHESKI, V5, P83; STRANDBERG J, 1922, ACTA DERM-VENEREOL, V3, P650; Sulzberger MB, 1938, ARCH DERMATOL SYPH, V38, P57, DOI 10.1001/archderm.1938.01480130060009; Thadani KI, 1934, J HERED, V25, P483, DOI 10.1093/oxfordjournals.jhered.a103866; THOMAS EA, 1931, AM DENT SURGEON, V51, P5; THURMAN J, 1948, T LONDON MED CHIR SO, V31, P71; Werther R., 1939, AM J ORTHODONTICS, V25, P61; WOLFLIN E, 1938, ARCH RASSENB, V32, P170	26	29	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1950	2	3					240	263						24	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XS390	14810689				2022-12-18	WOS:A1950XS39000002
J	Fan, SX; Jiao, YY; Khan, R; Jiang, XH; Javed, AR; Ali, A; Zhang, H; Zhou, JT; Naeem, M; Murtaza, G; Li, Y; Yang, G; Zaman, Q; Zubair, M; Guan, HY; Zhang, XX; Ma, H; Jiang, HW; Ali, H; Dil, S; Shah, W; Ahmad, N; Zhang, YW; Shi, QH				Fan, Suixing; Jiao, Yuying; Khan, Ranjha; Jiang, Xiaohua; Javed, Abdul Rafay; Ali, Asim; Zhang, Huan; Zhou, Jianteng; Naeem, Muhammad; Murtaza, Ghulam; Li, Yang; Yang, Gang; Zaman, Qumar; Zubair, Muhammad; Guan, Haiyang; Zhang, Xingxia; Ma, Hui; Jiang, Hanwei; Ali, Haider; Dil, Sobia; Shah, Wasim; Ahmad, Niaz; Zhang, Yuanwei; Shi, Qinghua			Homozygous mutations in C14orf39/SIX6OS1 cause non-obstructive azoospermia and premature ovarian insufficiency in humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MEIOTIC RECOMBINATION; SYNAPSIS; BRCA2; TEX11; SYCP2; GENE	Human infertility is a multifactorial disease that affects 8%-12% of reproductive-aged couples worldwide. However, the genetic causes of human infertility are still poorly understood. Synaptonemal complex (SC) is a conserved tripartite structure that holds homologous chromosomes together and plays an indispensable role in the meiotic progression. Here, we identified three homozygous mutations in the SC coding gene C14orf39/SIX6OS1 in infertile individuals from different ethnic populations by whole-exome sequencing (WES). These mutations include a frameshift mutation (c.204_205del [p.His68Glnfs*2]) from a consanguineous Pakistani family with two males suffering from non-obstructive azoospermia (NOA) and one female diagnosed with premature ovarian insufficiency (POI) as well as a nonsense mutation (c.958G>T [p.Glu320*]) and a splicing mutation (c.1180-3C>G) in two unrelated Chinese men (individual P3907 and individual P6032, respectively) with meiotic arrest. Mutations in C14orf39 resulted in truncated proteins that retained SYCE1 binding but exhibited impaired polycomplex formation between C14ORF39 and SYCE1. Further cytological analyses of meiosis in germ cells revealed that the affected familial males with the C14orf39 frameshift mutation displayed complete asynapsis between homologous chromosomes, while the affected Chinese men carrying the nonsense or splicing mutation showed incomplete synapsis. The phenotypes of NOA and POI in affected individuals were well recapitulated by Six6os1 mutant mice carrying an analogous mutation. Collectively, our findings in humans and mice highlight the conserved role of C14ORF39/SIX6OS1 in SC assembly and indicate that the homozygous mutations in C14orf39/SIX6OS1 described here are responsible for infertility of these affected individuals, thus expanding our understanding of the genetic basis of human infertility.	[Fan, Suixing; Jiao, Yuying; Khan, Ranjha; Jiang, Xiaohua; Javed, Abdul Rafay; Ali, Asim; Zhang, Huan; Zhou, Jianteng; Murtaza, Ghulam; Li, Yang; Yang, Gang; Zaman, Qumar; Zubair, Muhammad; Guan, Haiyang; Zhang, Xingxia; Ma, Hui; Jiang, Hanwei; Ali, Haider; Dil, Sobia; Shah, Wasim; Zhang, Yuanwei; Shi, Qinghua] Univ Sci & Technol China, Div Reprod & Genet,Collaborat Innovat Ctr Genet &, Affiliated Hosp USTC 1,Div Life Sci & Med,CAS Ctr, Hefei Natl Lab Phys Sci Microscale,Sch Basic Med, Hefei 230027, Anhui, Peoples R China; [Naeem, Muhammad] Quaid I Azam Univ, Dept Biotechnol, Med Genet Res Lab, Islamabad 45320, Pakistan; [Ahmad, Niaz] Shahbaz Sharif Dist Hosp, Multan 60800, Pakistan	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Quaid I Azam University	Zhang, YW; Shi, QH (corresponding author), Univ Sci & Technol China, Div Reprod & Genet,Collaborat Innovat Ctr Genet &, Affiliated Hosp USTC 1,Div Life Sci & Med,CAS Ctr, Hefei Natl Lab Phys Sci Microscale,Sch Basic Med, Hefei 230027, Anhui, Peoples R China.	zyuanwei@ustc.edu.cn; qshi@ustc.edu.cn	Zubair, Muhammad/AAX-8956-2020; Shi, Qinghua/N-2950-2013; Zhang, Yuanwei/C-7695-2016	Zhang, Yuanwei/0000-0002-2814-8061; Zubair, Muhammad/0000-0002-8296-6452; Naeem, Muhammad/0000-0002-3894-3085; Ali, Asim/0000-0001-5791-7918; MURTAZA, GHULAM/0000-0002-6371-8701; Fan, Suixing/0000-0002-6133-9759; Shi, QingHua/0000-0003-1180-9799	National Natural Science Foundation of China [31630050, 31890780, 32061143006, 31871514, 82071709]; National Key Research and Developmental Program of China [2016YFC1000600, 2018YFC1003700, 2018YFC1003900]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB19000000]; Fundamental Research Funds for the Central Universities [YD2070002006, WK9100000004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Developmental Program of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	We are very grateful to all individuals for their informed consent to donate their DNA and tissue biopsies for scientific research and to the physicians who take care of them. This work was supported by the National Natural Science Foundation of China (31630050, 31890780, 32061143006, 31871514, and 82071709), the National Key Research and Developmental Program of China (2016YFC1000600, 2018YFC1003700, and 2018YFC1003900), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB19000000), and the Fundamental Research Funds for the Central Universities (YD2070002006 and WK9100000004).	Begum F, 2016, G3-GENES GENOM GENET, V6, P3995, DOI 10.1534/g3.116.035766; Bolcun-Filas E, 2007, J CELL BIOL, V176, P741, DOI 10.1083/jcb.200610027; Bolcun-Filas E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000393; Bolor H, 2009, AM J HUM GENET, V84, P14, DOI 10.1016/j.ajhg.2008.12.002; Caburet S, 2014, NEW ENGL J MED, V370, P943, DOI 10.1056/NEJMoa1309635; de Vries FAT, 2005, GENE DEV, V19, P1376, DOI 10.1101/gad.329705; Gao JM, 2018, TRENDS GENET, V34, P232, DOI 10.1016/j.tig.2017.12.001; Geisinger A, 2016, CYTOGENET GENOME RES, V150, P77, DOI 10.1159/000453344; Gomez L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13298; Hamer G, 2008, J CELL SCI, V121, P2445, DOI 10.1242/jcs.033233; Hernandez-Lopez D, 2020, MOL HUM REPROD, V26, P485, DOI 10.1093/molehr/gaaa032; Jiang XH, 2019, FASEB J, V33, P9075, DOI 10.1096/fj.201802289RR; Jiao YY, 2020, SCI BULL, V65, P2120, DOI 10.1016/j.scib.2020.08.026; Kong A, 2014, NAT GENET, V46, P11, DOI 10.1038/ng.2833; Krausz C, 2018, EXPERT REV MOL DIAGN, V18, P331, DOI 10.1080/14737159.2018.1453358; Li JH, 2009, FERTIL STERIL, V91, P1404, DOI 10.1016/j.fertnstert.2008.04.074; Lu J, 2014, SCI REP-UK, V4, DOI 10.1038/srep07059; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Nyholt DR, 2000, AM J HUM GENET, V67, P282, DOI 10.1086/303029; Pashaei M, 2020, J ASSIST REPROD GEN, V37, P451, DOI 10.1007/s10815-019-01660-1; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Qin YY, 2019, NEW ENGL J MED, V380, P1086, DOI 10.1056/NEJMc1813800; Qin YY, 2015, HUM REPROD UPDATE, V21, P787, DOI 10.1093/humupd/dmv036; Sanchez-Saez F, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb1660; Schilit SLP, 2020, AM J HUM GENET, V106, P41, DOI 10.1016/j.ajhg.2019.11.013; Schramm S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002088; Subramanian VV, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016675; Vander Borght M, 2018, CLIN BIOCHEM, V62, P2, DOI 10.1016/j.clinbiochem.2018.03.012; Wang J, 2014, NEW ENGL J MED, V370, P972, DOI 10.1056/NEJMc1310150; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weinberg-Shukron A, 2018, NEW ENGL J MED, V379, P1042, DOI 10.1056/NEJMoa1800024; World Health Organization, 2010, WHO LAB MAN EX PROC, V5; Yang F, 2006, J CELL BIOL, V173, P497, DOI 10.1083/jcb.200603063; Yang F, 2015, EMBO MOL MED, V7, P1198, DOI 10.15252/emmm.201404967; Yao CC, 2021, J MED GENET, V58, P679, DOI 10.1136/jmedgenet-2020-107042; Yatsenko AN, 2015, NEW ENGL J MED, V372, P2097, DOI 10.1056/NEJMoa1406192; Yin H, 2019, GENET MED, V21, P62, DOI 10.1038/s41436-018-0015-7; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Zegers-Hochschild F, 2009, FERTIL STERIL, V92, P1520, DOI 10.1016/j.fertnstert.2009.09.009; Zhang YW, 2013, NUCLEIC ACIDS RES, V41, pD1055, DOI 10.1093/nar/gks1186; Zorrilla Michelle, 2013, Curr Genet Med Rep, V1, DOI 10.1007/s40142-013-0027-1	41	28	30	8	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 4	2021	108	2					324	336		10.1016/j.ajhg.2021.01.010	http://dx.doi.org/10.1016/j.ajhg.2021.01.010		FEB 2021	13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QX1UZ	33508233	Green Published, hybrid			2022-12-18	WOS:000629135400011
J	Yang, S; Zhou, X				Yang, Sheng; Zhou, Xiang			Accurate and Scalable Construction of Polygenic Scores in Large Biobank Data Sets	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; VARIABLE SELECTION; MISSING HERITABILITY; RISK PREDICTION; REGRESSION; STATISTICS; TRAITS; HUMANS; LOCI	Accurate construction of polygenic scores (PGS) can enable early diagnosis of diseases and facilitate the development of personalized medicine. Accurate PGS construction requires prediction models that are both adaptive to different genetic architectures and scalable to biobank scale datasets with millions of individuals and tens of millions of genetic variants. Here, we develop such a method called Deterministic Bayesian Sparse Linear Mixed Model (DBSLMM). DBSLMM relies on a flexible modeling assumption on the effect size distribution to achieve robust and accurate prediction performance across a range of genetic architectures. DBSLMM also relies on a simple deterministic search algorithm to yield an approximate analytic estimation solution using summary statistics only. The deterministic search algorithm, when paired with further algebraic innovations, results in substantial computational savings. With simulations, we show that DBSLMM achieves scalable and accurate prediction performance across a range of realistic genetic architectures. We then apply DBSLMM to analyze 25 traits in UK Biobank. For these traits, compared to existing approaches, DBSLMM achieves an average of 2.03%-101.09% accuracy gain in internal cross-validations. In external validations on two separate datasets, including one from BioBank Japan, DBSLMM achieves an average of 14.74%-522.74% accuracy gain. In these real data applications, DBSLMM is 1.03-28.11 times faster and uses only 7.4%-24.8% of physical memory as compared to other multiple regression-based PGS methods. Overall, DBSLMM represents an accurate and scalable method for constructing PGS in biobank scale datasets.	[Yang, Sheng] Nanjing Med Univ, Dept Biostat, Nanjing 211166, Jiangsu, Peoples R China; [Yang, Sheng; Zhou, Xiang] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Yang, Sheng; Zhou, Xiang] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA	Nanjing Medical University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Zhou, X (corresponding author), Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA.; Zhou, X (corresponding author), Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA.	xzhousph@umich.edu			National Institutes of Health (NIH) [R01HG009124]; National Science Foundation (NSF) [DMS1712933]; Welsh Assembly Government; British Heart Foundation; Diabetes UK	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); Welsh Assembly Government; British Heart Foundation(British Heart Foundation); Diabetes UK(Diabetes UK)	This study was supported by the National Institutes of Health (NIH) grant R01HG009124 and National Science Foundation (NSF) grant DMS1712933. This study has been conducted using UK Biobank resource under Application Number 30686. UK Biobank was established by the Wellcome Trust medical charity, Medical Research Council, Department of Health, Scottish Government, and the Northwest Regional Development Agency. It has also had funding from the Welsh Assembly Government, British Heart Foundation, and Diabetes UK. The authors also thank Dr. Kirsten Herold at the UM-SPH writing lab for her helpful editorial suggestions.	Akiyama M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12276-5; Akiyama M, 2017, NAT GENET, V49, P1458, DOI 10.1038/ng.3951; All Us Res Program Investigators, 2019, NEW ENGL J MED, V381, P668, DOI 10.1056/NEJMsr1809937; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Berisa T, 2016, BIOINFORMATICS, V32, P283, DOI 10.1093/bioinformatics/btv546; Boyle EA, 2017, CELL, V169, P1177, DOI 10.1016/j.cell.2017.05.038; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen ZM, 2011, INT J EPIDEMIOL, V40, P1652, DOI 10.1093/ije/dyr120; Cheng Q., 2019, YANG, DOI [10.1101/ 684746, DOI 10.1101/684746]; Choi SW, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz082; Choi SW., 2018, BIORXIV, DOI [DOI 10.1257/aer.100.2.234, 10.1101/416545, DOI 10.1101/416545]; Daetwyler HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003395; de los Campos G, 2018, TRENDS GENET, V34, P746, DOI 10.1016/j.tig.2018.07.004; de los Campos G, 2010, NAT REV GENET, V11, P880, DOI 10.1038/nrg2898; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Euesden J, 2015, BIOINFORMATICS, V31, P1466, DOI 10.1093/bioinformatics/btu848; Fan JQ, 2010, ANN STAT, V38, P3567, DOI 10.1214/10-AOS798; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Ferreira MAR, 2009, AM J HUM GENET, V85, P745, DOI 10.1016/j.ajhg.2009.10.005; Fritsche LG, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008202; Fritsche LG, 2018, AM J HUM GENET, V102, P1048, DOI 10.1016/j.ajhg.2018.04.001; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Ge T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09718-5; Gibson G, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008060; Guan YT, 2011, ANN APPL STAT, V5, P1780, DOI 10.1214/11-AOAS455; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; Hu YM, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005589; Hu YM, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006836; KAASSCHIETER EF, 1988, J COMPUT APPL MATH, V24, P265, DOI 10.1016/0377-0427(88)90358-5; Kanai M, 2018, NAT GENET, V50, P390, DOI 10.1038/s41588-018-0047-6; Khera AV, 2019, CELL, V177, P587, DOI 10.1016/j.cell.2019.03.028; Khera AV, 2018, NAT GENET, V50, P1219, DOI 10.1038/s41588-018-0183-z; Kichaev G, 2019, AM J HUM GENET, V104, P65, DOI 10.1016/j.ajhg.2018.11.008; Kim H, 2017, GENETICS, V207, P1135, DOI 10.1534/genetics.117.300271; Lloyd-Jones LR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12653-0; Locke AE, 2019, NATURE, V572, P323, DOI 10.1038/s41586-019-1457-z; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Mak TSH, 2017, GENET EPIDEMIOL, V41, P469, DOI 10.1002/gepi.22050; Makowsky R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002051; Marquez-Luna C., 2018, MODELING FUNCTIONAL, DOI [10.1101/375337, DOI 10.1101/375337]; Martin AR, 2019, NAT GENET, V51, P584, DOI 10.1038/s41588-019-0379-x; Mavaddat N, 2019, AM J HUM GENET, V104, P21, DOI 10.1016/j.ajhg.2018.11.002; Meuwissen THE, 2001, GENETICS, V157, P1819; Nagai A, 2017, J EPIDEMIOL, V27, pS2, DOI 10.1016/j.je.2016.12.005; Nagpal S, 2019, AM J HUM GENET, V105, P258, DOI 10.1016/j.ajhg.2019.05.018; Owens DK, 2019, JAMA-J AM MED ASSOC, V322, P652, DOI 10.1001/jama.2019.10987; Prive F, 2019, AM J HUM GENET, V105, P1213, DOI 10.1016/j.ajhg.2019.11.001; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Richardson TG, 2019, ELIFE, V8, DOI 10.7554/eLife.43657; Robinson MR, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-016-0016; Rosenberg N.A., 2018, EVOL MED PUBLIC HLTH, V2019, P26; Selzam S, 2019, AM J HUM GENET, V105, P351, DOI 10.1016/j.ajhg.2019.06.006; So HC, 2017, SCI REP-UK, V7, DOI 10.1038/srep41262; So HC, 2011, AM J HUM GENET, V88, P548, DOI 10.1016/j.ajhg.2011.04.001; Speed D, 2014, GENOME RES, V24, P1550, DOI 10.1101/gr.169375.113; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Torkamani A, 2019, CELL, V177, P518, DOI 10.1016/j.cell.2019.03.051; Torkamani A, 2018, NAT REV GENET, V19, P581, DOI 10.1038/s41576-018-0018-x; Toulopoulou T, 2019, BRAIN, V142, P471, DOI 10.1093/brain/awy279; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Vilhjalmsson BJ, 2015, AM J HUM GENET, V97, P576, DOI 10.1016/j.ajhg.2015.09.001; Visscher PM, 2017, AM J HUM GENET, V101, P5, DOI 10.1016/j.ajhg.2017.06.005; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wang Y., 2020, BIORXIV, DOI [10.1101/2020.01.14, DOI 10.1101/2020.01.14]; Watanabe K, 2019, NAT GENET, V51, P1339, DOI 10.1038/s41588-019-0481-0; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Wray NR, 2019, GENETICS, V211, P1131, DOI 10.1534/genetics.119.301859; Yang J, 2015, NAT GENET, V47, P1114, DOI 10.1038/ng.3390; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Young AI, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008222; Yuan Z., 2019, YANG, DOI [10.1101/691014, DOI 10.1101/691014]; Zeng P, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00470-2; Zhao Z., 2019, BIORXIV810713, DOI [10.1101/810713, DOI 10.1101/810713]; Zhou X, 2017, ANN APPL STAT, V11, P2027, DOI 10.1214/17-AOAS1052; Zhou X, 2014, NAT METHODS, V11, P407, DOI [10.1038/NMETH.2848, 10.1038/nmeth.2848]; Zhou X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003264; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	82	28	29	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 7	2020	106	5					679	693		10.1016/j.ajhg.2020.03.013	http://dx.doi.org/10.1016/j.ajhg.2020.03.013			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LK8FQ	32330416	Bronze, Green Published			2022-12-18	WOS:000531096100008
J	Schottlaender, LV; Abeti, R; Jaunmuktane, Z; Macmillan, C; Chelban, V; O'Callaghan, B; McKinley, J; Maroofian, R; Efthymiou, S; Athanasiou-Fragkouli, A; Forbes, R; Soutar, MPM; Livingston, JH; Kalmar, B; Swayne, O; Hotton, G; Pittman, A; de Oliveira, JRM; de Grandis, M; Richard-Loendt, A; Launchbury, F; Althonayan, J; McDonnell, G; Carr, A; Khan, S; Beetz, C; Bisgin, A; Bozdogan, ST; Begtrup, A; Torti, E; Greensmith, L; Giunti, P; Morrison, PJ; Brandner, S; Aurrand-Lions, M; Houlden, H				Schottlaender, Lucia, V; Abeti, Rosella; Jaunmuktane, Zane; Macmillan, Carol; Chelban, Viorica; O'Callaghan, Benjamin; McKinley, John; Maroofian, Reza; Efthymiou, Stephanie; Athanasiou-Fragkouli, Alkyoni; Forbes, Raeburn; Soutar, Marc P. M.; Livingston, John H.; Kalmar, Bernardett; Swayne, Orlando; Hotton, Gary; Pittman, Alan; Mendes de Oliveira, Joao Ricardo; de Grandis, Maria; Richard-Loendt, Angela; Launchbury, Francesca; Althonayan, Juri; McDonnell, Gavin; Carr, Aisling; Khan, Suliman; Beetz, Christian; Bisgin, Atil; Bozdogan, Sevcan Tug; Begtrup, Amber; Torti, Erin; Greensmith, Linda; Giunti, Paola; Morrison, Patrick J.; Brandner, Sebastian; Aurrand-Lions, Michel; Houlden, Henry			Bi-allelic JAM2 Variants Lead to Early-Onset Recessive Primary Familial Brain Calcification	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EXPRESSION; MUTATIONS	Primary familial brain calcification (PFBC) is a rare neurodegenerative disorder characterized by a combination of neurological, psychiatric, and cognitive decline associated with calcium deposition on brain imaging. To date, mutations in five genes have been linked to PFBC. However, more than 50% of individuals affected by PFBC have no molecular diagnosis. We report four unrelated families presenting with initial learning difficulties and seizures and later psychiatric symptoms, cerebellar ataxia, extrapyramidal signs, and extensive calcifications on brain imaging. Through a combination of homozygosity mapping and exome sequencing, we mapped this phenotype to chromosome 21q21.3 and identified bi-allelic variants in JAM2. JAM2 encodes for the junctional-adhesion-molecule-2, a key tight-junction protein in blood-brain-barrier permeability. We show that JAM2 variants lead to reduction of JAM2 mRNA expression and absence of JAM2 protein in patient's fibroblasts, consistent with a loss-of-function mechanism. We show that the human phenotype is replicated in the jam2 complete knockout mouse (jam2 KO). Furthermore, neuropathology of jam2 KO mouse showed prominent vacuolation in the cerebral cortex, thalamus, and cerebellum and particularly widespread vacuolation in the midbrain with reactive astrogliosis and neuronal density reduction. The regions of the human brain affected on neuroimaging are similar to the affected brain areas in the myorg PFBC null mouse. Along with JAM3 and OCLN, JAM2 is the third tight-junction gene in which bi-allelic variants are associated with brain calcification, suggesting that defective cell-to-cell adhesion and dysfunction of the movement of solutes through the paracellular spaces in the neurovascular unit is a key mechanism in CNS calcification.	[Schottlaender, Lucia, V; Chelban, Viorica; O'Callaghan, Benjamin; Maroofian, Reza; Efthymiou, Stephanie; Athanasiou-Fragkouli, Alkyoni; Kalmar, Bernardett; Pittman, Alan; Mendes de Oliveira, Joao Ricardo; Khan, Suliman; Greensmith, Linda; Houlden, Henry] UCL Queen Sq Inst Neurol, Dept Neuromuscular Dis, Queen Sq, London WC1N 3BG, England; [Schottlaender, Lucia, V] UCL Great Ormond St Inst Child Hlth, Dubowitz Neuromuscular Ctr, London WC1N 1EH, England; [Schottlaender, Lucia, V] Consejo Nacl Invest Cient & Tecn, Argentine Natl Sci & Technol Res Council, C1425FQB, Buenos Aires, DF, Argentina; [Schottlaender, Lucia, V] FLENI Neurol Res Inst, C1428 AQK, Buenos Aires, DF, Argentina; [Abeti, Rosella; Jaunmuktane, Zane; Swayne, Orlando; Hotton, Gary; McDonnell, Gavin; Giunti, Paola] UCL Queen Sq Inst Neurol, Dept Clin & Movement Neurosci, London WC1N 3BG, England; [Jaunmuktane, Zane; Brandner, Sebastian] Univ Coll London Hosp NHS Fdn Trust, Natl Hosp Neurol & Neurosurg, Div Neuropathol, Queen Sq, London WC1N 3BG, England; [Macmillan, Carol] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [McKinley, John] Dublin Neurol Inst, Dept Neurol, Mater Misericordiae Univ Hosp, 57 Eccles St, Dublin DO7 W7XF, Ireland; [McKinley, John; Carr, Aisling] Royal Victoria Hosp, Reg Neurosci Ctr, Belfast BT12 6BA, Antrim, North Ireland; [Forbes, Raeburn] Southern HSC Trust, Neurol Ctr, Craigavon Area Hosp, Portadown BT63 5QQ, North Ireland; [Soutar, Marc P. M.; Launchbury, Francesca; Althonayan, Juri] UCL Queen Sq Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England; [Livingston, John H.] Leeds Teaching Hosp NHS Trust, Leeds Gen Infirm, Paediat Neurol, Leeds LS1 3EX, W Yorkshire, England; [Swayne, Orlando; Hotton, Gary; Khan, Suliman; Houlden, Henry] Natl Hosp Neurol & Neurosurg, Queen Sq, London WC1N 3BG, England; [de Grandis, Maria] Univ Fed Pernambuco, Dept Neuropsiquiatria, BR-50670901 Recife, PE, Brazil; [Richard-Loendt, Angela; Aurrand-Lions, Michel] Aix Marseille Univ, INSERM, CNRS, CRCMInst Paoli Calmettes, F-13009 Marseille, France; [Beetz, Christian; Bisgin, Atil] CENTOGENE AG, D-18055 Rostock, Germany; [Bozdogan, Sevcan Tug] Cukurova Univ, Med Genet Dept, Med Fac, TR-01330 Adana, Turkey; [Bozdogan, Sevcan Tug] Cukurova Univ, AGENTEM Adana Genet Dis Diag & Treatment Ctr, TR-01330 Adana, Turkey; [Begtrup, Amber; Torti, Erin] GeneDx, 207 Perry Pkwy, Gaithersburg, MD 20877 USA; [Morrison, Patrick J.] Queens Univ, Ctr Canc Res & Cell Biol, Belfast BT9 7AE, Antrim, North Ireland; [Houlden, Henry] Natl Hosp Neurol & Neurosurg, Neurogenet Lab & Clin Serv, Queen Sq, London WC1N 3BG, England	University of London; University College London; University of London; University College London; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of Chicago; Mater Misericordiae University Hospital; University College Dublin; University of London; University College London; Leeds General Infirmary; University of Leeds; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Universidade Federal de Pernambuco; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; CENTOGENE AG; Cukurova University; Cukurova University; Queens University Belfast; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Houlden, H (corresponding author), UCL Queen Sq Inst Neurol, Dept Neuromuscular Dis, Queen Sq, London WC1N 3BG, England.; Houlden, H (corresponding author), Natl Hosp Neurol & Neurosurg, Queen Sq, London WC1N 3BG, England.; Houlden, H (corresponding author), Natl Hosp Neurol & Neurosurg, Neurogenet Lab & Clin Serv, Queen Sq, London WC1N 3BG, England.	h.houlden@ucl.ac.uk	de Oliveira, João/GWV-0126-2022; Brandner, Sebastian/J-4562-2014; Borgione, Eugenia/D-9168-2017; Jaunmuktane, Zane/ABC-9039-2020; Oliveira, João/GXN-3304-2022; Houlden, Henry J/C-1532-2008; Pittman, Alan/AAP-2534-2020; Scuderi, Carmela/D-4734-2017; Groppa, Stanislav/AAM-5905-2020; Garavaglia, Barbara/J-5257-2018; Soutar, Marc P M/G-3637-2011; Hamed, Sherifa/GPS-5310-2022	Brandner, Sebastian/0000-0002-9821-0342; Borgione, Eugenia/0000-0001-5458-7415; Jaunmuktane, Zane/0000-0001-7738-8881; Houlden, Henry J/0000-0002-2866-7777; Pittman, Alan/0000-0002-8112-2987; Scuderi, Carmela/0000-0001-5901-0041; Groppa, Stanislav/0000-0002-2120-2408; Garavaglia, Barbara/0000-0003-4323-9145; Efthymiou, Stephanie/0000-0003-4900-9877; Soutar, Marc P M/0000-0003-0008-9423; Abeti, Rosella/0000-0001-9817-8779; Kalmar, Bernadett/0000-0003-3747-4843; Breza, Marianthi/0000-0001-9213-7941; Boesch, Sylvia/0000-0003-1657-7368; Koutsis, Georgios/0000-0002-8980-8377; MARSEGLIA, GIAN LUIGI/0000-0003-3662-0159; Swayne, Orlando/0000-0001-8689-8947; Dardiotis, Efthimios/0000-0003-2957-641X; O'Callaghan, Benjamin/0000-0002-1323-6843; Hamed, Sherifa/0000-0002-1441-3530; Khan, Suliman/0000-0002-0745-7834	Medical Research Council (MRC) [MR/S01165X/1, MR/S005021/1]; Wellcome Trust (Synaptopathies Strategic Award) [WT093205MA, WT104033AIA]; Rosetree Trust; Ataxia UK; MSA Trust; Brain Research UK; Sparks GOSH Charity; Muscular Dystrophy UK (MDUK); Muscular Dystrophy Association (MDA USA); National Institute of Health Research (NIHR) UCLH/UCL Biomedical Research Centre; Dementia Biomedical Research Unit; CNP; CAPES; DECIT-MS; National Institute for Health Research (NIHR) award; MRC [MR/S01165X/1, MR/S005021/1] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust (Synaptopathies Strategic Award); Rosetree Trust(Rosetrees Trust); Ataxia UK; MSA Trust; Brain Research UK; Sparks GOSH Charity; Muscular Dystrophy UK (MDUK)(Muscular Dystrophy Association); Muscular Dystrophy Association (MDA USA)(Muscular Dystrophy Association); National Institute of Health Research (NIHR) UCLH/UCL Biomedical Research Centre(National Institute for Health Research (NIHR)); Dementia Biomedical Research Unit; CNP; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); DECIT-MS; National Institute for Health Research (NIHR) award(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to the patients for their essential help. We are grateful for the funding support from The Medical Research Council (MRC) (MR/S01165X/1, MR/S005021/1), The Wellcome Trust (Synaptopathies Strategic Award, WT093205MA, WT104033AIA), The Rosetree Trust, Ataxia UK, The MSA Trust, Brain Research UK, Sparks GOSH Charity, Muscular Dystrophy UK (MDUK), and Muscular Dystrophy Association (MDA USA). We also thank James Polke and Conceicao Bettencourt for assistance with the text and interpretation. S.B. and H.H. are partly funded by the National Institute of Health Research (NIHR) UCLH/UCL Biomedical Research Centre and Dementia Biomedical Research Unit. J.R.M.deO. receives funding from CNP, CAPES, and DECIT-MS. We thank Joanne Lau for technical support. This research was also conducted as part of the Queen Square Genomics group at UCL, supported by the National Institute for Health Research (NIHR) award to UCLH NHS Trust/UCL Biomedical Research Centre (BRC).	Aurrand-Lions M, 2001, BLOOD, V98, P3699, DOI 10.1182/blood.V98.13.3699; Batla A, 2017, PARKINSONISM RELAT D, V37, P1, DOI 10.1016/j.parkreldis.2016.12.024; Cen ZD, 2020, BRAIN, V143, P491, DOI 10.1093/brain/awz392; Grangeon L, 2019, BRAIN, V142, P1573, DOI 10.1093/brain/awz095; Jensen N, 2018, AM J PATHOL, V188, P1865, DOI 10.1016/j.ajpath.2018.04.010; Keller A, 2013, NAT GENET, V45, P1077, DOI 10.1038/ng.2723; Kimura T, 2016, NEUROPATHOLOGY, V36, P365, DOI 10.1111/neup.12280; KOBAYASHI S, 1987, ACTA NEUROPATHOL, V73, P62, DOI 10.1007/BF00695503; Legati A, 2015, NAT GENET, V47, P579, DOI 10.1038/ng.3289; Livingston JH, 2014, DEV MED CHILD NEUROL, V56, P612, DOI 10.1111/dmcn.12359; Miklossy J, 2005, ACTA NEUROPATHOL, V109, P643, DOI 10.1007/s00401-005-1007-7; Mochida GH, 2010, AM J HUM GENET, V87, P882, DOI 10.1016/j.ajhg.2010.10.026; O'Driscoll MC, 2010, AM J HUM GENET, V87, P354, DOI 10.1016/j.ajhg.2010.07.012; Redmond SA, 2016, NEURON, V91, P824, DOI 10.1016/j.neuron.2016.07.021; Taglia I, 2015, NEUROL SCI, V36, P787, DOI 10.1007/s10072-015-2110-8; Tietz S, 2018, BRAIN BEHAV IMMUN, V73, P3, DOI 10.1016/j.bbi.2018.06.014; Yao XP, 2018, NEURON, V98, P1116, DOI 10.1016/j.neuron.2018.05.037	17	28	29	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 5	2020	106	3					412	421		10.1016/j.ajhg.2020.02.007	http://dx.doi.org/10.1016/j.ajhg.2020.02.007			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KT6CT	32142645	Green Published, hybrid, Green Accepted			2022-12-18	WOS:000519101800017
J	Tian, JB; Chang, J; Gong, J; Lou, J; Fu, MP; Li, JY; Ke, JT; Zhu, Y; Gong, YJ; Yang, Y; Zou, DY; Peng, XT; Yang, N; Mei, SF; Wang, XY; Zhong, R; Cai, KL; Miao, XP				Tian, Jianbo; Chang, Jiang; Gong, Jing; Lou, Jiao; Fu, Mingpeng; Li, Jiaoyuan; Ke, Juntao; Zhu, Ying; Gong, Yajie; Yang, Yang; Zou, Danyi; Peng, Xiating; Yang, Nan; Mei, Shufang; Wang, Xiaoyang; Zhong, Rong; Cai, Kailin; Miao, Xiaoping			Systematic Functional Interrogation of Genes in GWAS Loci Identified ATF1 as a Key Driver in Colorectal Cancer Modulated by a Promoter-Enhancer Interaction	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; UNITED-STATES; LARGE-SCALE; RISK LOCI; APOPTOSIS; VARIANT; FAMILY; TUMORS; MYC	Genome-wide association studies (GWASs) have identified approximately 100 colorectal cancer (CRC) risk loci. However, the causal genes in these loci have not been systematically interrogated. We conducted a high-throughput RNA-interference functional screen to identify the genes essential for proliferation in the CRC risk loci of Asian populations. We found that ATF1, located in the 12q13.12 region, functions as an oncogene that facilitates cell proliferation; ATF1 has the most significant effect of the identified genes and promotes CRC xenograft growth by affecting cell apoptosis. Next, by integrating a fine-mapping analysis, a two-stage affected-control study consisting of 6,213 affected individuals and 10,388 controls, and multipronged experiments, we elucidated that two risk variants, dbSNP: rs61926301 and dbSNP: rs7959129, that located in the ATF1 promoter and first intron, respectively, facilitate a promoter-enhancer interaction, mediated by the synergy of SP1 and GATA3, to upregulate ATF1 expression, thus synergistically predisposing to CRC risk (OR = 1.77, 95% CI = 1.42-2.21, p = 3.16 x 10(-7); Pmultiplicative-interaction = 1.20 x 10(-22); Padditive-interaction = 6.50 x 10(-3)). Finally, we performed RNA-seq and ChIP-seq assays in CRC cells treated with ATF1 overexpression in order to dissect the target programs of ATF1. Results showed that ATF1 activates a subset of genes, including BRAF, NRAS, MYC, BIRC2, DAAM1, MAML2, STAT1, ID1, and NKD2, related to apoptosis, Wnt, TGF-beta, and MAPK pathways, and these effects could cooperatively increase the risk of CRC. These findings reveal the clinical potential of ATF1 in CRC development and illuminate a promoter-enhancer interaction module between the ATF1 regulatory elements dbSNP: rs61926301 and dbSNP: rs7959129, and they bring us closer to understanding the molecular drivers of cancer.	[Tian, Jianbo; Chang, Jiang; Gong, Jing; Lou, Jiao; Li, Jiaoyuan; Ke, Juntao; Zhu, Ying; Gong, Yajie; Yang, Yang; Zou, Danyi; Peng, Xiating; Yang, Nan; Mei, Shufang; Wang, Xiaoyang; Zhong, Rong; Miao, Xiaoping] Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Key Lab Environm & Hlth, Sch Publ Hlth,Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China; [Fu, Mingpeng] Huazhong Univ Sci & Technol, Dept Immunol, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China; [Cai, Kailin] Huazhong Univ Sci & Technol, Union Hosp, Dept Gastrointestinal Surg, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China; [Lou, Jiao] Shanghai Ctr Clin Lab, Dept Qual Management, Shanghai 200126, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Miao, XP (corresponding author), Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Key Lab Environm & Hlth, Sch Publ Hlth,Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China.	miaoxp@hust.edu.cn	Chang, Jiang/AAP-6156-2020; miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722; Zhong, Rong/0000-0002-5060-895X; Tian, Jianbo/0000-0001-9493-694X	National Key Research and Development Plan Program [2016YFC1302702, 2016YFC1302703]; National Program for Support of Top-notch Young Professionals; Program for Huazhong University of Science and Technology (HUST) Academic Frontier Youth Team; National Natural Science Foundation of China [81502875]; Fundamental Research Funds for the Central Universities, HUST [2018JYCXJJ013]	National Key Research and Development Plan Program; National Program for Support of Top-notch Young Professionals; Program for Huazhong University of Science and Technology (HUST) Academic Frontier Youth Team; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities, HUST(Fundamental Research Funds for the Central Universities)	This work was supported by the National Key Research and Development Plan Program (2016YFC1302702 and 2016YFC1302703), the National Program for Support of Top-notch Young Professionals, the Program for Huazhong University of Science and Technology (HUST) Academic Frontier Youth Team for X. M., the National Natural Science Foundation of China (81502875), and the Fundamental Research Funds for the Central Universities, HUST (2018JYCXJJ013).	Bailey CE, 2015, JAMA SURG, V150, P17, DOI 10.1001/jamasurg.2014.1756; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Chang J, 2018, CANCER RES, V78, P5164, DOI [10.1158/0008-5472.CAN-18-0910, 10.1158/0008-5472.can-18-0910]; Chang J, 2018, NAT GENET, V50, P338, DOI 10.1038/s41588-018-0045-8; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Chen XL, 2018, 2018 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS, ROBOTICS AND AUTOMATION (ICMRA), P150; Corcoran RB, 2018, CANCER DISCOV, V8, P428, DOI 10.1158/2159-8290.CD-17-1226; Davis IJ, 2006, CANCER CELL, V9, P473, DOI 10.1016/j.ccr.2006.04.021; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Gong J, 2018, ANN ONCOL, V29, P632, DOI 10.1093/annonc/mdx789; Gong J, 2016, CARCINOGENESIS, V37, P443, DOI 10.1093/carcin/bgw024; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Huyghe JR, 2019, NAT GENET, V51, P76, DOI 10.1038/s41588-018-0286-6; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Jia WH, 2013, NAT GENET, V45, P191, DOI 10.1038/ng.2505; KVIETIKOVA I, 1995, NUCLEIC ACIDS RES, V23, P4542, DOI 10.1093/nar/23.22.4542; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; McDonald ER, 2017, CELL, V170, P577, DOI 10.1016/j.cell.2017.07.005; Meyers RM, 2017, NAT GENET, V49, P1779, DOI 10.1038/ng.3984; Pearlman R, 2017, JAMA ONCOL, V3, P464, DOI 10.1001/jamaoncol.2016.5194; Peters U, 2013, GASTROENTEROLOGY, V144, P799, DOI 10.1053/j.gastro.2012.12.020; Phesse TJ, 2014, CELL DEATH DIFFER, V21, P956, DOI 10.1038/cdd.2014.15; Pulikkan JA, 2018, CELL, V174, P172, DOI 10.1016/j.cell.2018.05.048; Roe JS, 2017, CELL, V170, P875, DOI 10.1016/j.cell.2017.07.007; Sanchez-Vega F, 2018, CELL, V173, P321, DOI 10.1016/j.cell.2018.03.035; Siegel RL, 2017, JAMA-J AM MED ASSOC, V318, P572, DOI 10.1001/jama.2017.7630; Sullivan RJ, 2018, CANCER DISCOV, V8, P184, DOI 10.1158/2159-8290.CD-17-1119; Takaku M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03478-4; Takaku M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0897-0; Tammela T, 2017, NATURE, V545, P355, DOI 10.1038/nature22334; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tian JB, 2019, NUCLEIC ACIDS RES, V47, pD909, DOI 10.1093/nar/gky954; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Vizcaino C, 2015, PHARMACOL THERAPEUT, V152, P111, DOI 10.1016/j.pharmthera.2015.05.008; Wang HS, 2013, HUM MOL GENET, V22, P5048, DOI 10.1093/hmg/ddt337; Wang ML, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11478; Weintraub AS, 2017, CELL, V171, P1573, DOI 10.1016/j.cell.2017.11.008; Yamada K, 2013, J CLIN INVEST, V123, P600, DOI 10.1172/JCI63572; Yang Z, 2017, CLIN CANCER RES, V23, P6673, DOI 10.1158/1078-0432.CCR-17-0882; Zeng CJ, 2016, GASTROENTEROLOGY, V150, P1633, DOI 10.1053/j.gastro.2016.02.076; Zhang B, 2014, INT J CANCER, V135, P948, DOI 10.1002/ijc.28733; Zhang B, 2014, NAT GENET, V46, P533, DOI 10.1038/ng.2985; Zhang YB, 2013, NATURE, V504, P306, DOI 10.1038/nature12716; Zhao YJ, 2017, GASTROENTEROLOGY, V153, P1304, DOI 10.1053/j.gastro.2017.07.042	47	28	30	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 3	2019	105	1					29	47		10.1016/j.ajhg.2019.05.004	http://dx.doi.org/10.1016/j.ajhg.2019.05.004			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IG3RM	31204011	Bronze, Green Published			2022-12-18	WOS:000473723000004
J	Capri, Y; Flex, E; Krumbach, OHF; Carpentieri, G; Cecchetti, S; Lissewski, C; Adariani, SR; Schanze, D; Brinkmann, J; Piard, J; Pantaleoni, F; Lepri, FR; Goh, ESY; Chong, K; Stieglitz, E; Meyer, J; Kuechler, A; Bramswig, NC; Sacharow, S; Strullu, M; Vial, Y; Vignal, C; Kensah, G; Cuturilo, G; Jasemi, NSK; Dvorsky, R; Monaghan, KG; Vincent, LM; Cave, H; Verloes, A; Ahmadian, MR; Tartaglia, M; Zenker, M				Capri, Yline; Flex, Elisabetta; Krumbach, Oliver H. F.; Carpentieri, Giovanna; Cecchetti, Serena; Lissewski, Christina; Adariani, Soheila Rezaei; Schanze, Denny; Brinkmann, Julia; Piard, Juliette; Pantaleoni, Francesca; Lepri, Francesca R.; Goh, Elaine Suk-Ying; Chong, Karen; Stieglitz, Elliot; Meyer, Julia; Kuechler, Alma; Bramswig, Nuria C.; Sacharow, Stephanie; Strullu, Marion; Vial, Yoann; Vignal, Cedric; Kensah, George; Cuturilo, Goran; Jasemi, Neda S. Kazemein; Dvorsky, Radovan; Monaghan, Kristin G.; Vincent, Lisa M.; Cave, Helene; Verloes, Alain; Ahmadian, Mohammad R.; Tartaglia, Marco; Zenker, Martin			Activating Mutations of RRAS2 Are a Rare Cause of Noonan Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OF-FUNCTION MUTATIONS; COSTELLO SYNDROME; PHENOTYPIC SPECTRUM; MISSENSE MUTATIONS; RAS; INDIVIDUALS; GENOTYPE; SOS1; GENE; VARIANTS	Aberrant signaling through pathways controlling cell response to extracellular stimuli constitutes a central theme in disorders affecting development. Signaling through RAS and the MAPK cascade controls a variety of cell decisions in response to cytokines, hormones, and growth factors, and its upregulation causes Noonan syndrome (NS), a developmental disorder whose major features include a distinctive facies, a wide spectrum of cardiac defects, short stature, variable cognitive impairment, and predisposition to malignancies. NS is genetically heterogeneous, and mutations in more than ten genes have been reported to underlie this disorder. Despite the large number of genes implicated, about 10%-20% of affected individuals with a clinical diagnosis of NS do not have mutations in known RASopathy-associated genes, indicating that additional unidentified genes contribute to the disease, when mutated. By using a mixed strategy of functional candidacy and exome sequencing, we identify RRAS2 as a gene implicated in NS in six unrelated subjects/families. We show that the NS-causing RRAS2 variants affect highly conserved residues localized around the nucleotide binding pocket of the GTPase and are predicted to variably affect diverse aspects of RRAS2 biochemical behavior, including nucleotide binding, GTP hydrolysis, and interaction with effectors. Additionally, all pathogenic variants increase activation of the MAPK cascade and variably impact cell morphology and cytoskeletal rearrangement. Finally, we provide a characterization of the clinical phenotype associated with RRAS2 mutations.	[Capri, Yline; Strullu, Marion; Vial, Yoann; Vignal, Cedric; Cave, Helene; Verloes, Alain] Hop Robert Debre, AP HP, Dept Genet, F-75019 Paris, France; [Flex, Elisabetta; Carpentieri, Giovanna] Ist Super Sanita, Dept Oncol & Mol Med, I-00161 Rome, Italy; [Krumbach, Oliver H. F.; Adariani, Soheila Rezaei; Jasemi, Neda S. Kazemein; Dvorsky, Radovan; Ahmadian, Mohammad R.] Heinrich Heine Univ, Inst Biochem & Mol Biol 2, Med Fac, D-40225 Dusseldorf, Germany; [Carpentieri, Giovanna; Pantaleoni, Francesca; Lepri, Francesca R.; Tartaglia, Marco] IRCCS, Osped Pediat Bambino Gesu, Genet & Rare Dis Res Div, I-00146 Rome, Italy; [Cecchetti, Serena] Ist Super Sanita, Core Facil, Microscopy Area, I-00161 Rome, Italy; [Lissewski, Christina; Schanze, Denny; Brinkmann, Julia; Zenker, Martin] Univ Hosp Magdeburg, Inst Human Genet, D-39120 Magdeburg, Germany; [Piard, Juliette] CHU St Jacques, Human Genet Ctr, F-25000 Besancon, France; [Goh, Elaine Suk-Ying] Trillium Hlth Partners, Lab Med & Genet, Mississauga, ON L5M 2N1, Canada; [Chong, Karen] Mt Sinai Hosp, Prenatal Diag & Med Genet Program, Dept Obstet & Gynecol, Toronto, ON M5G 1Z5, Canada; [Stieglitz, Elliot; Meyer, Julia] Univ Calif San Francisco, Benioff Childrens Hosp, Dept Pediat, San Francisco, CA 94107 USA; [Kuechler, Alma; Bramswig, Nuria C.] Univ Duisburg Essen, Univ Klinikum Essen, Inst Humangenet, D-45147 Essen, Germany; [Sacharow, Stephanie] Boston Childrens Hosp, Boston, MA 02115 USA; [Sacharow, Stephanie] Harvard Med Sch, Boston, MA 02115 USA; [Strullu, Marion; Vial, Yoann; Cave, Helene] Univ Paris, Inst Rech St Louis, INSERM UMR 1131, F-75010 Paris, France; [Kensah, George] Univ Med Ctr Gottingen, Dept Thorac & Cardiovasc Surg, D-37075 Gottingen, Germany; [Cuturilo, Goran] Univ Belgrade, Fac Med, Belgrade 11000, Serbia; [Cuturilo, Goran] Univ Childrens Hosp, Belgrade 11000, Serbia; [Monaghan, Kristin G.; Vincent, Lisa M.] GeneDx, Gaithersburg, MD 20877 USA; [Vincent, Lisa M.] Childrens Natl Hlth Syst, Ctr Canc Blood Disorders, Washington, DC 20010 USA; [Verloes, Alain] Univ Paris, INSERM UMR 1141, F-75019 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Istituto Superiore di Sanita (ISS); Heinrich Heine University Dusseldorf; IRCCS Bambino Gesu; Istituto Superiore di Sanita (ISS); University Hospital Magdeburg; University of Toronto; Trillium Health Partners; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of California System; University of California San Francisco; University of Duisburg Essen; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; UDICE-French Research Universities; Universite Paris Cite; University of Gottingen; University of Belgrade; University of Belgrade; Children's National Health System; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Tartaglia, M (corresponding author), IRCCS, Osped Pediat Bambino Gesu, Genet & Rare Dis Res Div, I-00146 Rome, Italy.; Zenker, M (corresponding author), Univ Hosp Magdeburg, Inst Human Genet, D-39120 Magdeburg, Germany.	marco.tartaglia@opbg.net; martin.zenker@med.ovgu.de	Vial, Yoann/AFL-7359-2022; Tartaglia, Marco/K-2955-2018; Carpentieri, Giovanna/AAT-9814-2021; Lepri, Francesca Romana/AAA-6115-2020; /AAK-8500-2021; Dvorsky, Radovan/ABE-3042-2020; Flex, Elisabetta/A-5958-2017; Vial, Yoann/AAG-7320-2022; Cecchetti, Serena/N-1061-2015	Vial, Yoann/0000-0003-1437-0427; Tartaglia, Marco/0000-0001-7736-9672; Carpentieri, Giovanna/0000-0001-5526-6015; Flex, Elisabetta/0000-0002-6802-1356; Vial, Yoann/0000-0003-1437-0427; Cecchetti, Serena/0000-0002-3601-176X; Stieglitz, Elliot/0000-0001-7032-4623; Kazemein jasemi, Neda sadat/0000-0002-7842-6998; Piard, Juliette/0000-0001-5244-5325; Cave, Helene/0000-0003-2840-1511; Goh, Elaine Suk-Ying/0000-0002-2477-1665	ERN-ITHACA networking; E-Rare (NSEuroNet) [ERARE15-pp-063, 01GM1602B, 01GM1602A]; AIRC [IG21614]; Ministero della Salute; German Federal Ministry of Education and Research -BMBF (German Network for RASopathy Research "GeNeRARe") [01GM1519D, 01GM1902C, 01GM1519A]; German Research Foundation through the Collaborative Research Center 974 [SFB 974, ZE 52410/1]	ERN-ITHACA networking; E-Rare (NSEuroNet); AIRC(Fondazione AIRC per la ricerca sul cancro); Ministero della Salute(Ministry of Health, Italy); German Federal Ministry of Education and Research -BMBF (German Network for RASopathy Research "GeNeRARe"); German Research Foundation through the Collaborative Research Center 974	The authors thank the subjects and their families for participating in this study. This work was supported by the ERN-ITHACA networking (A.V. and M.T.) and grants from E-Rare (NSEuroNet, ERARE15-pp-063) to H.C., M.R.A. (01GM1602B), M.T., and M.Z. (01GM1602A), AIRC (IG21614) and Ministero della Salute (Ricerca Corrente 2017, 2018) to M.T., German Federal Ministry of Education and Research -BMBF (German Network for RASopathy Research "GeNeRARe") to M.R.A. (01GM1519D and 01GM1902C) and M.Z. (01GM1519A), and the German Research Foundation through the Collaborative Research Center 974 (SFB 974) "Communication and Systems Relevance during Liver Injury and Regeneration" to M.R.A and grant number ZE 52410/1 to M.Z.	Altmuller F, 2017, EUR J HUM GENET, V25, P823, DOI 10.1038/ejhg.2017.65; Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; Bertola D, 2017, AM J MED GENET A, V173, P1309, DOI 10.1002/ajmg.a.38178; Bigenzahn JW, 2018, SCIENCE, V362, P1171, DOI 10.1126/science.aap8210; Bos JL, 1997, BBA-REV CANCER, V1333, pM19, DOI 10.1016/S0304-419X(97)00015-2; Carta C, 2006, AM J HUM GENET, V79, P129, DOI 10.1086/504394; Ceremsak JJ, 2016, J MED GENET, V53, P728, DOI 10.1136/jmedgenet-2016-103889; Chen PC, 2014, P NATL ACAD SCI USA, V111, P11473, DOI 10.1073/pnas.1324128111; Cirstea IC, 2010, NAT GENET, V42, P27, DOI 10.1038/ng.497; Cordeddu V, 2015, HUM MUTAT, V36, P1080, DOI 10.1002/humu.22834; DRIVAS GT, 1990, MOL CELL BIOL, V10, P1793, DOI 10.1128/MCB.10.4.1793; Erdogan M, 2007, J BIOL CHEM, V282, P27713, DOI 10.1074/jbc.M703037200; Flex E, 2014, HUM MOL GENET, V23, P4315, DOI 10.1093/hmg/ddu148; GRAHAM SM, 1994, MOL CELL BIOL, V14, P4108, DOI 10.1128/MCB.14.6.4108; Graham SM, 1999, ONCOGENE, V18, P2107, DOI 10.1038/sj.onc.1202517; Grant AR, 2018, HUM MUTAT, V39, P1485, DOI 10.1002/humu.23624; Gremer L, 2008, BIOL CHEM, V389, P1163, DOI 10.1515/BC.2008.132; Gremer L, 2011, HUM MUTAT, V32, P33, DOI 10.1002/humu.21377; Gripp KW, 2016, AM J MED GENET A, V170, P2237, DOI 10.1002/ajmg.a.37781; Gripp KW, 2015, AM J MED GENET A, V167, P2085, DOI 10.1002/ajmg.a.37128; Gripp KW, 2011, AM J MED GENET A, V155A, P706, DOI 10.1002/ajmg.a.33884; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Higgins EM, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91225; HUANG Y, 1995, ONCOGENE, V11, P1255; Klockow B, 2000, ONCOGENE, V19, P5367, DOI 10.1038/sj.onc.1203909; Kouz K, 2016, GENET MED, V18, P1226, DOI 10.1038/gim.2016.32; Larive RM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4881; Larive RM, 2012, MOL BIOL CELL, V23, P2373, DOI 10.1091/mbc.E12-01-0060; Martinelli S, 2018, AM J HUM GENET, V102, P309, DOI 10.1016/j.ajhg.2017.12.015; Motta M, 2019, HUM MOL GENET, V28, P1007, DOI 10.1093/hmg/ddy412; Nakhaei-Rad S, 2018, CRIT REV BIOCHEM MOL, V53, P130, DOI 10.1080/10409238.2018.1431605; Nava C, 2007, J MED GENET, V44, P763, DOI 10.1136/jmg.2007.050450; Niihori T, 2019, AM J HUM GENET, V104, P1233, DOI 10.1016/j.ajhg.2019.04.014; Nussinov Ruth, 2018, Biophys Rev, V10, P1263, DOI 10.1007/s12551-018-0461-0; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Pantaleoni F, 2017, HUM MUTAT, V38, P798, DOI 10.1002/humu.23224; Quelin C, 2017, EUR J MED GENET, V60, P395, DOI 10.1016/j.ejmg.2017.03.014; Rauen KA, 2013, ANNU REV GENOM HUM G, V14, P355, DOI 10.1146/annurev-genom-091212-153523; Razzaque MA, 2007, NAT GENET, V39, P1013, DOI 10.1038/ng2078; Roberts AE, 2007, NAT GENET, V39, P70, DOI 10.1038/ng1926; Roberts AE, 2013, LANCET, V381, P333, DOI 10.1016/S0140-6736(12)61023-X; Sarkozy A, 2009, HUM MUTAT, V30, P695, DOI 10.1002/humu.20955; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Stark Z, 2012, CLIN GENET, V81, P590, DOI 10.1111/j.1399-0004.2011.01754.x; Steklov M, 2018, SCIENCE, V362, P1177, DOI 10.1126/science.aap7607; Stieglitz E, 2015, NAT GENET, V47, P1326, DOI 10.1038/ng.3400; Strullu M, 2014, J MED GENET, V51, P689, DOI 10.1136/jmedgenet-2014-102611; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; Tartaglia M, 2011, BEST PRACT RES CL EN, V25, P161, DOI 10.1016/j.beem.2010.09.002; Tartaglia M, 2010, ANN NY ACAD SCI, V1214, P99, DOI 10.1111/j.1749-6632.2010.05790.x; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Yamamoto GL, 2015, J MED GENET, V52, P413, DOI 10.1136/jmedgenet-2015-103018; Young LC, 2018, P NATL ACAD SCI USA, V115, pE10576, DOI 10.1073/pnas.1720352115; Zenker M, 2007, J MED GENET, V44, P651, DOI 10.1136/jmg.2007.051276; Zenker M, 2007, J MED GENET, V44, P131, DOI 10.1136/jmg.2006.046300	56	28	28	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 6	2019	104	6					1223	1232		10.1016/j.ajhg.2019.04.013	http://dx.doi.org/10.1016/j.ajhg.2019.04.013			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IB4KJ	31130282	Green Published, Bronze			2022-12-18	WOS:000470240000016
J	Calpena, E; Hervieu, A; Kaserer, T; Swagemakers, SMA; Goos, JAC; Popoola, O; Ortiz-Ruiz, MJ; Barbaro-Dieber, T; Bownass, L; Brilstra, EH; Brimble, E; Foulds, N; Grebe, TA; Harder, AVE; Lees, MM; Monaghan, KG; Newbury-Ecob, RA; Ong, KR; Osio, D; Santos, FJR; Ruzhnikov, MRZ; Telegrafi, A; van Binsbergen, E; van Dooren, MF; van der Spek, PJ; Blagg, J; Twigg, SRF; Mathijssen, IMJ; Clarke, PA; Wilkie, AOM				Calpena, Eduardo; Hervieu, Alexia; Kaserer, Teresa; Swagemakers, Sigrid M. A.; Goos, Jacqueline A. C.; Popoola, Olajumoke; Ortiz-Ruiz, Maria Jesus; Barbaro-Dieber, Tina; Bownass, Lucy; Brilstra, Eva H.; Brimble, Elise; Foulds, Nicola; Grebe, Theresa A.; Harder, Aster V. E.; Lees, Melissa M.; Monaghan, Kristin G.; Newbury-Ecob, Ruth A.; Ong, Kai-Ren; Osio, Deborah; Santos, Francis Jeshira Reynoso; Ruzhnikov, Maura R. Z.; Telegrafi, Aida; van Binsbergen, Ellen; van Dooren, Marieke F.; van der Spek, Peter J.; Blagg, Julian; Twigg, Stephen R. F.; Mathijssen, Irene M. J.; Clarke, Paul A.; Wilkie, Andrew O. M.		Deciphering Dev Disorders Study	De Novo Missense Substitutions in the Gene Encoding CDK8, a Regulator of the Mediator Complex, Cause a Syndromic Developmental Disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							KINASE INHIBITOR; DISTINCT ROLES; MUTATIONS; MED12; IDENTIFICATION; SUBCOMPLEX; SUBUNITS; DEFECTS; MODULE; DOMAIN	The Mediator is an evolutionarily conserved, multi-subunit complex that regulates multiple steps of transcription. Mediator activity is regulated by the reversible association of a four-subunit module comprising CDK8 or CDK19 kinases, together with cyclin C, MED12 or MED12L, and MED13 or MED13L. Mutations in MED12, MED13, and MED13L were previously identified in syndromic developmental disorders with overlapping phenotypes. Here, we report CDK8 mutations (located at 13q12.13) that cause a phenotypically related disorder. Using whole-exome or whole-genome sequencing, and by international collaboration, we identified eight different heterozygous missense CDK8 substitutions, including 10 shown to have arisen de novo, in 12 unrelated subjects; a recurrent mutation, c. 185C>T (p.Ser62Leu), was present in five individuals. All predicted substitutions localize to the ATP-binding pocket of the kinase domain. Affected individuals have overlapping phenotypes characterized by hypotonia, mild to moderate intellectual disability, behavioral disorders, and variable facial dysmorphism. Congenital heart disease occurred in six subjects; additional features present in multiple individuals included agenesis of the corpus callosum, ano-rectal malformations, seizures, and hearing or visual impairments. To evaluate the functional impact of the mutations, we measured phosphorylation at STAT1-Ser727, a known CDK8 substrate, in a CDK8 and CDK19 CRISPR double-knockout cell line transfected with wild-type (WT) or mutant CDK8 constructs. These experiments demonstrated a reduction in STAT1 phosphorylation by all mutants, in most cases to a similar extent as in a kinase-dead control. We conclude that missense mutations in CDK8 cause a developmental disorder that has phenotypic similarity to syndromes associated with mutations in other subunits of the Mediator kinase module, indicating probable overlap in pathogenic mechanisms.	[Calpena, Eduardo; Twigg, Stephen R. F.; Wilkie, Andrew O. M.] Univ Oxford, MRC Weatherall Inst Mol Med, Clin Genet Grp, Oxford OX3 9DS, England; [Hervieu, Alexia; Kaserer, Teresa; Popoola, Olajumoke; Ortiz-Ruiz, Maria Jesus; Blagg, Julian; Clarke, Paul A.] Inst Canc Res, Canc Res UK Canc Therapeut Unit, London SM2 5NG, England; [Swagemakers, Sigrid M. A.; van der Spek, Peter J.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Pathol, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Swagemakers, Sigrid M. A.; van der Spek, Peter J.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Bioinformat, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Goos, Jacqueline A. C.; Mathijssen, Irene M. J.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Plast & Reconstruct Surg, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Barbaro-Dieber, Tina] Cook Childrens Med Ctr, Div Genet, Ft Worth, TX 76102 USA; [Bownass, Lucy; Newbury-Ecob, Ruth A.] Univ Hosp Bristol NHS Fdn Trust, St Michaels Hosp, Dept Clin Genet, Bristol BS2 8EG, Avon, England; [Brilstra, Eva H.; Harder, Aster V. E.; van Binsbergen, Ellen] Univ Utrecht, Univ Med Ctr Utrecht, Dept Genet, NL-3508 AB Utrecht, Netherlands; [Brimble, Elise; Ruzhnikov, Maura R. Z.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Foulds, Nicola] Southampton Univ Hosp, Wessex Clin Genet Serv, Southampton SO16 5YA, Hants, England; [Grebe, Theresa A.] Univ Arizona, Coll Med, Div Genet & Metab, Dept Child Hlth,Phoenix Childrens Hosp, Phoenix, AZ 85016 USA; [Lees, Melissa M.] Great Ormond St Hosp Children NHS Fdn Trust, North Thames Reg Genet Serv, London WC1N 3EH, England; [Monaghan, Kristin G.; Telegrafi, Aida] GeneDx, Gaithersburg, MD 20877 USA; [Ong, Kai-Ren; Osio, Deborah] Birmingham Womens & Childrens NHS Fdn Trust, Dept Clin Genet, Birmingham B15 2TG, W Midlands, England; [Santos, Francis Jeshira Reynoso] Joe DiMaggio Childrens Hosp, Div Genet, Hollywood, FL 33021 USA; [Santos, Francis Jeshira Reynoso] Florida Atlantic Univ, Charles E Schmidt Coll Med, Hollywood, FL 33021 USA; [van Dooren, Marieke F.] Erasmus MC Univ Med Ctr Rotterdam, Dept Clin Genet, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Deciphering Dev Disorders Study] Wellcome Sanger Inst, Deciphering Dev Disorders Study, Cambridge CB10 1SA, England	University of Oxford; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Cook Children's Medical Center; University of Bristol; Utrecht University; Utrecht University Medical Center; Stanford University; University of Southampton; Phoenix Children's Hospital; University of Arizona; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Erasmus University Rotterdam; Erasmus MC; Wellcome Trust Sanger Institute	Wilkie, AOM (corresponding author), Univ Oxford, MRC Weatherall Inst Mol Med, Clin Genet Grp, Oxford OX3 9DS, England.; Clarke, PA (corresponding author), Inst Canc Res, Canc Res UK Canc Therapeut Unit, London SM2 5NG, England.	paul.clarke@icr.ac.uk; andrew.wilkie@imm.ox.ac.uk	Ruzhnikov, Maura RZ/L-8859-2019; Harder, Aster/A-6335-2019; Wilkie, Andrew/AAC-3820-2020; Brilstra, Eva/AAT-3092-2021; Twigg, Stephen/AAU-1135-2021; Calpena, Eduardo/HCI-9261-2022; Harder, Aster/ABG-3250-2021	Ruzhnikov, Maura RZ/0000-0001-9610-1612; Harder, Aster/0000-0002-5477-7232; Wilkie, Andrew/0000-0002-2972-5481; Twigg, Stephen/0000-0001-5024-049X; Calpena, Eduardo/0000-0001-6399-6528; Harder, Aster/0000-0002-5477-7232; Popoola, Olajumoke/0000-0003-0452-0401; Clarke, Paul/0000-0001-9342-1290; Kaserer, Teresa/0000-0003-0372-1885; /0000-0002-8061-6678	Health Innovation Challenge Fund [HICF-1009-003]; Wellcome Sanger Institute [WT098051]; National Institute for Health Research (NIHR), through the Comprehensive Clinical Research Network; Cancer Research UK Accelerator Award [C1362/A20263]; Cancer Research UK; Institute of Cancer Research (ICR); Merck; NIHR Oxford Biomedical Research Centre Programme; Wellcome Investigator Award [102731]; Wellcome; Department of Health; Wellcome Trust	Health Innovation Challenge Fund; Wellcome Sanger Institute; National Institute for Health Research (NIHR), through the Comprehensive Clinical Research Network(National Institute for Health Research (NIHR)); Cancer Research UK Accelerator Award; Cancer Research UK(Cancer Research UK); Institute of Cancer Research (ICR); Merck(Merck & Company); NIHR Oxford Biomedical Research Centre Programme; Wellcome Investigator Award; Wellcome; Department of Health; Wellcome Trust(Wellcome Trust)	The Deciphering Developmental Disorders(DDD) study presents independent research commissioned by the Health Innovation Challenge Fund (grant number HICF-1009-003), a parallel funding partnership between Wellcome and the Department of Health, and the Wellcome Sanger Institute [grant number WT098051]. The research team acknowledges the support of the National Institute for Health Research (NIHR), through the Comprehensive Clinical Research Network. This study makes use of DECIPHER, which is funded by the Wellcome Trust. T.K. was funded by the Cancer Research UK Accelerator Award C1362/A20263. M.J.O.R., J.B., and P.A.C. acknowledge support from Cancer Research UK; A.H. for post-doctoral funding from the Institute of Cancer Research (ICR); and O.P. for funding from Merck. A.O.M.W. was supported by the NIHR Oxford Biomedical Research Centre Programme and the Wellcome Investigator Award 102731. The views expressed in this publication are those of the authors and not necessarily those of Wellcome, NIHR, or the Department of Health.	Adegbola A, 2015, EUR J HUM GENET, V23, P1308, DOI 10.1038/ejhg.2015.26; Allen BL, 2015, NAT REV MOL CELL BIO, V16, P155, DOI 10.1038/nrm3951; Asadollahi R, 2017, EUR J MED GENET, V60, P451, DOI 10.1016/j.ejmg.2017.06.004; Asadollahi R, 2013, EUR J HUM GENET, V21, P1100, DOI 10.1038/ejhg.2013.17; Bancerek J, 2013, IMMUNITY, V38, P250, DOI 10.1016/j.immuni.2012.10.017; Baumli S, 2008, EMBO J, V27, P1907, DOI 10.1038/emboj.2008.121; Blok LS, 2018, HUM GENET, V137, P375, DOI 10.1007/s00439-018-1887-y; Brandler WM, 2015, ANNU REV MED, V66, P487, DOI 10.1146/annurev-med-091113-024550; Caro-Llopis A, 2016, PEDIATR RES, V80, P809, DOI 10.1038/pr.2016.162; Chemical Computing Group, 2018, MOL OP ENV MOE 2015; Cholko T, 2018, J COMPUT AID MOL DES, V32, P671, DOI 10.1007/s10822-018-0120-3; Clark AD, 2015, CRIT REV BIOCHEM MOL, V50, P393, DOI 10.3109/10409238.2015.1064854; Clarke PA, 2016, ELIFE, V5, DOI 10.7554/eLife.20722; Dale T, 2015, NAT CHEM BIOL, V11, P973, DOI 10.1038/nchembio.1952; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Graham JM, 2013, AM J MED GENET A, V161, P2734, DOI 10.1002/ajmg.a.36183; Grant BD, 1998, BIOCHEMISTRY-US, V37, P7708, DOI 10.1021/bi972987w; Hamilton MJ, 2018, J MED GENET, V55, P28, DOI 10.1136/jmedgenet-2017-104620; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Harper TM, 2018, J BIOL CHEM, V293, P13778, DOI 10.1074/jbc.R117.794438; Hemmer W, 1997, J BIOL CHEM, V272, P16946, DOI 10.1074/jbc.272.27.16946; Jeronimo C, 2017, TRENDS CELL BIOL, V27, P765, DOI 10.1016/j.tcb.2017.07.001; Jin SC, 2017, NAT GENET, V49, P1593, DOI 10.1038/ng.3970; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; Knuesel MT, 2009, MOL CELL BIOL, V29, P650, DOI 10.1128/MCB.00993-08; Koehler MFT, 2016, ACS MED CHEM LETT, V7, P223, DOI 10.1021/acsmedchemlett.5b00278; Lahiry P, 2010, NAT REV GENET, V11, P60, DOI 10.1038/nrg2707; Lariviere L, 2012, CURR OPIN CELL BIOL, V24, P305, DOI 10.1016/j.ceb.2012.01.007; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lelieveld SH, 2017, AM J HUM GENET, V101, P478, DOI 10.1016/j.ajhg.2017.08.004; LIAO SM, 1995, NATURE, V374, P193, DOI 10.1038/374193a0; Loncle N, 2007, EMBO J, V26, P1045, DOI 10.1038/sj.emboj.7601566; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; Meikrantz W, 1996, J BIOL CHEM, V271, P10205, DOI 10.1074/jbc.271.17.10205; Mondal J, 2016, J AM CHEM SOC, V138, P4608, DOI 10.1021/jacs.6b01232; Mukhopadhyay A, 2010, HUM GENET, V128, P281, DOI 10.1007/s00439-010-0848-x; Okur V, 2016, HUM GENET, V135, P699, DOI 10.1007/s00439-016-1661-y; Philip S, 2018, J MED CHEM, V61, P5073, DOI 10.1021/acs.jmedchem.7b00901; Poss ZC, 2016, CELL REP, V15, P436, DOI 10.1016/j.celrep.2016.03.030; Poss ZC, 2013, CRIT REV BIOCHEM MOL, V48, P575, DOI 10.3109/10409238.2013.840259; Putz EM, 2013, CELL REP, V4, P437, DOI 10.1016/j.celrep.2013.07.012; Quinodoz M, 2017, AM J HUM GENET, V101, P623, DOI 10.1016/j.ajhg.2017.09.001; Rocha PP, 2010, DEVELOPMENT, V137, P2723, DOI 10.1242/dev.053660; Salerno D, 2007, GENE, V405, P65, DOI 10.1016/j.gene.2007.09.010; Samocha K. E., 2017, REGIONAL MISSENSE CO, DOI [10.1101/148353, DOI 10.1101/148353]; Schneider EV, 2011, J MOL BIOL, V412, P251, DOI 10.1016/j.jmb.2011.07.020; Schneider EV, 2013, P NATL ACAD SCI USA, V110, P8081, DOI 10.1073/pnas.1305378110; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; SUROSKY RT, 1994, MOL CELL BIOL, V14, P3446, DOI 10.1128/MCB.14.5.3446; Torkamani A, 2008, P NATL ACAD SCI USA, V105, P9011, DOI 10.1073/pnas.0802403105; Tsutsui T, 2011, GENES CELLS, V16, P1208, DOI 10.1111/j.1365-2443.2011.01565.x; Twigg SRF, 2015, AM J HUM GENET, V97, P359, DOI 10.1016/j.ajhg.2015.07.006; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Westerling T, 2007, MOL CELL BIOL, V27, P6177, DOI 10.1128/MCB.01302-06; WILKIE AOM, 1994, J MED GENET, V31, P89, DOI 10.1136/jmg.31.2.89; Zhou H, 2012, P NATL ACAD SCI USA, V109, P19763, DOI 10.1073/pnas.1121120109; Zuccotto F, 2010, J MED CHEM, V53, P2681, DOI 10.1021/jm901443h	57	28	28	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 4	2019	104	4					709	720		10.1016/j.ajhg.2019.02.006	http://dx.doi.org/10.1016/j.ajhg.2019.02.006			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HR9JE	30905399	Green Published, hybrid			2022-12-18	WOS:000463474700011
J	Fard, MAF; Rebelo, AP; Buglo, E; Nemati, H; Dastsooz, H; Gehweiler, I; Reich, S; Reichbauer, J; Quintans, B; Ordonez-Ugalde, A; Cortese, A; Courel, S; Abreu, L; Powell, E; Danzi, M; Martuscelli, NB; Bis-Brewer, DM; Tao, FF; Zarei, F; Habibzadeh, P; Yavarian, M; Modarresi, F; Silawi, M; Tabatabaei, Z; Yousefi, M; Farpour, HR; Kessler, C; Mangold, E; Kobeleva, X; Mueller, AJ; Haack, TB; Tarnopolsky, M; Gan-Or, Z; Rouleau, GA; Synofzik, M; Sobrido, MJ; Jordanova, A; Schule, R; Zuchner, S; Faghihi, MA				Fard, Mohammad Ali Farazi; Rebelo, Adriana P.; Buglo, Elena; Nemati, Hamid; Dastsooz, Hassan; Gehweiler, Ina; Reich, Selina; Reichbauer, Jennifer; Quintans, Beatriz; Ordonez-Ugalde, Andres; Cortese, Andrea; Courel, Steve; Abreu, Lisa; Powell, Eric; Danzi, Matt; Martuscelli, Nicole B.; Bis-Brewer, Dana M.; Tao, Feifei; Zarei, Fariba; Habibzadeh, Parham; Yavarian, Majid; Modarresi, Farzaneh; Silawi, Mohammad; Tabatabaei, Zahra; Yousefi, Masoume; Farpour, Hamid Reza; Kessler, Christoph; Mangold, Elisabeth; Kobeleva, Xenia; Mueller, Amelie J.; Haack, Tobias B.; Tarnopolsky, Mark; Gan-Or, Ziv; Rouleau, Guy A.; Synofzik, Matthis; Sobrido, Maria-Jesus; Jordanova, Albena; Schule, Rebecca; Zuchner, Stephan; Faghihi, Mohammad Ali			Truncating Mutations in UBAP1 Cause Hereditary Spastic Paraplegia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								The diagnostic gap for rare neurodegenerative diseases is still considerable, despite continuous advances in gene identification. Many novel Mendelian genes have only been identified in a few families worldwide. Here we report the identification of an autosomal-dominant gene for hereditary spastic paraplegia (HSP) in 10 families that are of diverse geographic origin and whose affected members all carry unique truncating changes in a circumscript region of UBAP1 (ubiquitin-associated protein 1). HSP is a neurodegenerative disease characterized by progressive lower-limb spasticity and weakness, as well as frequent bladder dysfunction. At least 40% of affected persons are currently undiagnosed after exome sequencing. We identified pathological truncating variants in UBAP1 in affected persons from Iran, USA, Germany, Canada, Spain, and Bulgarian Roma. The genetic support ranges from linkage in the largest family (LOD = 8.3) to three confirmed de novo mutations. We show that mRNA in the fibroblasts of affected individuals escapes nonsense-mediated decay and thus leads to the expression of truncated proteins; in addition, concentrations of the full-length protein are reduced in comparison to those in controls. This suggests either a dominant-negative effect or haploinsufficiency. UBAP1 links endosomal trafficking to the ubiquitination machinery pathways that have been previously implicated in HSPs, and UBAP1 provides a bridge toward a more unified pathophysiology.	[Fard, Mohammad Ali Farazi; Dastsooz, Hassan; Habibzadeh, Parham; Yavarian, Majid; Silawi, Mohammad; Tabatabaei, Zahra; Yousefi, Masoume; Faghihi, Mohammad Ali] Persian BayanGene Res & Training Ctr, Shiraz, Iran; [Rebelo, Adriana P.; Buglo, Elena; Cortese, Andrea; Courel, Steve; Abreu, Lisa; Danzi, Matt; Bis-Brewer, Dana M.; Tao, Feifei; Zuchner, Stephan] Univ Miami, Dept Human Genet, Dr John T Macdonald Fdn, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Dastsooz, Hassan] Univ Turin, Italian Inst Genom Med, I-10126 Turin, Italy; [Gehweiler, Ina; Reich, Selina; Reichbauer, Jennifer; Kessler, Christoph; Synofzik, Matthis; Schule, Rebecca] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis, D-72076 Tubingen, Germany; [Gehweiler, Ina; Reich, Selina; Reichbauer, Jennifer; Kessler, Christoph; Synofzik, Matthis; Schule, Rebecca] Univ Tubingen, Ctr Neurol, D-72076 Tubingen, Germany; [Gehweiler, Ina; Reich, Selina; Reichbauer, Jennifer; Kessler, Christoph; Synofzik, Matthis; Schule, Rebecca] German Ctr Neurodegenerat Dis, D-72706 Tubingen, Germany; [Nemati, Hamid; Zarei, Fariba; Farpour, Hamid Reza] Shiraz Univ Med Sci, Shiraz, Iran; [Powell, Eric] Genesis Project Fdn Miami, Miami, FL 33136 USA; [Habibzadeh, Parham] Shiraz Univ Med Sci, Student Res Comm, Shiraz, Iran; [Modarresi, Farzaneh; Faghihi, Mohammad Ali] Univ Miami, Ctr Therapeut Innovat, Miami, FL 33136 USA; [Modarresi, Farzaneh; Faghihi, Mohammad Ali] Univ Miami, Dept Psychiat & Behav Sci, Miami, FL 33136 USA; [Tarnopolsky, Mark] McMaster Univ, Dept Pediat, Hamilton, ON L8S 4L8, Canada; [Gan-Or, Ziv; Rouleau, Guy A.] McGill Univ, Dept Human Genet, Montreal, PQ H3A 0G4, Canada; [Quintans, Beatriz; Ordonez-Ugalde, Andres; Sobrido, Maria-Jesus] Hosp Clin Santiago, Inst Invest Sanitaria, Neurogenet Grp, Santiago De Compostela 15706, Spain; [Jordanova, Albena] Univ Antwerp, Ctr Mol Neurol, Mol Neurogen Grp VIB UAntwerp, B-2000 Antwerp, Belgium; [Jordanova, Albena] Med Univ, Dept Med Chem & Biochem, Mol Med Ctr, Sofia, Bulgaria; [Martuscelli, Nicole B.] Univ Miami, Dept Biol, Miami, FL 33136 USA; [Mangold, Elisabeth] Univ Bonn, Inst Human Genet, D-53113 Bonn, Germany; [Kobeleva, Xenia] Univ Bonn, Dept Neurol, D-53113 Bonn, Germany; [Mueller, Amelie J.; Haack, Tobias B.] Univ Tubingen, Inst Med Genet & Appl Genom, D-72706 Tubingen, Germany; [Mueller, Amelie J.; Haack, Tobias B.] Univ Tubingen, Ctr Rare Dis, D-72706 Tubingen, Germany	University of Miami; Italian Institute for Genomic Medicine (IIGM); University of Turin; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Shiraz University of Medical Science; Shiraz University of Medical Science; University of Miami; University of Miami; McMaster University; McGill University; Complexo Hospitalario Universitario de Santiago de Compostela; Flanders Institute for Biotechnology (VIB); University of Antwerp; Medical University Sofia; University of Miami; University of Bonn; University of Bonn; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Faghihi, MA (corresponding author), Persian BayanGene Res & Training Ctr, Shiraz, Iran.; Faghihi, MA (corresponding author), Univ Miami, Ctr Therapeut Innovat, Miami, FL 33136 USA.	mfaghihi@med.miami.edu	Tao, Feifei/AAI-6256-2021; Faghihi, Mohammad Ali/AAH-3139-2019; Faghihi, Mohammad Ali/AAD-7159-2020; Jordanova, Albena/H-8323-2015; Cortese, Andrea/V-4371-2019; zarei, fariba/U-7426-2019; Habibzadeh, Parham/H-1983-2019; Nemati, Hamid/V-3810-2018; Schule, Rebecca/B-5763-2019	Tao, Feifei/0000-0003-4477-2304; Faghihi, Mohammad Ali/0000-0002-8330-9067; Jordanova, Albena/0000-0002-3833-3754; Cortese, Andrea/0000-0002-2208-5311; zarei, fariba/0000-0002-2654-5725; Habibzadeh, Parham/0000-0002-2086-0425; Nemati, Hamid/0000-0001-7012-244X; Schule, Rebecca/0000-0002-7781-2766; Muller, Amelie/0000-0002-3168-9811; Dastsooz, Hassan/0000-0002-0679-4425; farpour, hamid reza/0000-0001-8867-3928	National Institutes of Health [R01NS072248]; European Union's Horizon 2020 research and innovation program [779257]; German Bundesministerium fur Bildung und Forschung (BMBF) [643578, 01GM1607]; Instituto de Salud Carlos III [PS09/01830]; FEDER (Fonds Europeen de Developpement Economique et Regional); Excellence (TOP) grant of the University of Antwerp; NIMAD research grant [940714]; BMBF through the "Juniorverbund in der Systemmedizin'' "mitOmics'' [FKZ 01ZX1405C]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072248] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union's Horizon 2020 research and innovation program; German Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); FEDER (Fonds Europeen de Developpement Economique et Regional); Excellence (TOP) grant of the University of Antwerp; NIMAD research grant; BMBF through the "Juniorverbund in der Systemmedizin'' "mitOmics''(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are thankful to the families who participated in this research. We thank Els De Vriendt for the excellent technical assistance. S.Z. and R.S. are supported by National Institutes of Health grant R01NS072248. The project was further supported by the European Union's Horizon 2020 research and innovation program under grant 779257 (Solve-RD; R.S.) and in the context of the ERA-NET Cofund action No 643578 by the German Bundesministerium fur Bildung und Forschung (BMBF) (01GM1607) for the E-Rare-3 network PREPARE (M.S., S.R., and associated partner S.Z.). M.J.S. was supported by Instituto de Salud Carlos III grant PS09/01830 and FEDER (Fonds Europeen de Developpement Economique et Regional). A.J. is supported by an Excellence (TOP) grant of the University of Antwerp. The study was partly supported by NIMAD research grant (940714) awarded to MAF. The views expressed are those of the author(s) and not necessarily those of the National Health Service, the National Institute for Health Research, or the Department of Health. T.B.H. was supported by the BMBF through the "Juniorverbund in der Systemmedizin'' "mitOmics'' (FKZ 01ZX1405C to T.B.H.).	Agromayor M, 2012, STRUCTURE, V20, P414, DOI 10.1016/j.str.2011.12.013; Bis-Brewer DM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00958; Fink JK, 2013, ACTA NEUROPATHOL, V126, P307, DOI 10.1007/s00401-013-1115-8; Gonzalez M, 2015, HUM MUTAT, V36, P950, DOI 10.1002/humu.22836; Kucenas S, 2008, NEURON GLIA BIOL, V4, P71, DOI 10.1017/S1740925X09990123; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Parodi L, 2017, REV NEUROL-FRANCE, V173, P352, DOI 10.1016/j.neurol.2017.03.034; Schule R, 2016, ANN NEUROL, V79, P646, DOI 10.1002/ana.24611; Stefani F, 2011, CURR BIOL, V21, P1245, DOI 10.1016/j.cub.2011.06.028	11	28	30	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 4	2019	104	4					767	773		10.1016/j.ajhg.2019.03.001	http://dx.doi.org/10.1016/j.ajhg.2019.03.001			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HR9JE	30929741	Green Published, Bronze			2022-12-18	WOS:000463474700017
J	Verma, A; Bang, L; Miller, JE; Zhang, Y; Lee, MTM; Zhang, Y; Byrska-Bishop, M; Carey, DJ; Ritchie, MD; Pendergrass, SA; Kim, D				Verma, Anurag; Bang, Lisa; Miller, Jason E.; Zhang, Yanfei; Lee, Ming Ta Michael; Zhang, Yu; Byrska-Bishop, Marta; Carey, David J.; Ritchie, Marylyn D.; Pendergrass, Sarah A.; Kim, Dokyoon		DiscovEHR Collaboration	Human-Disease Phenotype Map Derived from PheWAS across 38,682 Individuals	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ELECTRONIC HEALTH RECORDS; MULTIPLE-SCLEROSIS; ASSOCIATION; RISK; PLEIOTROPY; CYTOKINES	Phenome-wide association studies (PheWASs) have been a useful tool for testing associations between genetic variations and multiple complex traits or diagnoses. Linking PheWAS-based associations between phenotypes and a variant or a genomic region into a network provides a new way to investigate cross-phenotype associations, and it might broaden the understanding of genetic architecture that exists between diagnoses, genes, and pleiotropy. We created a network of associations from one of the largest PheWASs on electronic health record (EHR)-derived phenotypes across 38,682 unrelated samples from the Geisinger's biobank; the samples were genotyped through the DiscovEHR project. We computed associations between 632,574 common variants and 541 diagnosis codes. Using these associations, we constructed a "disease-disease" network (DDN) wherein pairs of diseases were connected on the basis of shared associations with a given genetic variant. The DDN provides a landscape of intra-connections within the same disease classes, as well as inter-connections across disease classes. We identified clusters of diseases with known biological connections, such as autoimmune disorders (type 1 diabetes, rheumatoid arthritis, and multiple sclerosis) and cardiovascular disorders. Previously unreported relationships between multiple diseases were identified on the basis of genetic associations as well. The network approach applied in this study can be used to uncover interactions between diseases as a result of their shared, potentially pleiotropic SNPs. Additionally, this approach might advance clinical research and even clinical practice by accelerating our understanding of disease mechanisms on the basis of similar underlying genetic associations.	[Verma, Anurag; Miller, Jason E.; Ritchie, Marylyn D.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Verma, Anurag; Ritchie, Marylyn D.; Kim, Dokyoon] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Bang, Lisa; Byrska-Bishop, Marta; Pendergrass, Sarah A.; Kim, Dokyoon] Geisinger, Biomed & Translat Informat Inst, Danville, PA 17821 USA; [Zhang, Yanfei; Lee, Ming Ta Michael] Geisinger, Genom Med Ins, Danville, PA 17821 USA; [Zhang, Yu] Penn State Univ, Dept Stat, University Pk, PA 16802 USA; [Carey, David J.] Geisinger, Weis Ctr Res, Danville, PA 17821 USA; [Byrska-Bishop, Marta] New York Genome Ctr, New York, NY 10013 USA	University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kim, D (corresponding author), Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA.; Kim, D (corresponding author), Geisinger, Biomed & Translat Informat Inst, Danville, PA 17821 USA.	dkim@geisinger.edu	Zhang, Yanfei/AAL-2148-2021	Zhang, Yanfei/0000-0002-9222-7725; Verma, Anurag/0000-0002-5063-9107	National Library of Medicine (NLM) [R01 NL012535]; Pennsylvania Department of Health [SAP 4100070267]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG009495] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM012535] Funding Source: NIH RePORTER	National Library of Medicine (NLM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Pennsylvania Department of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the National Library of Medicine (NLM) R01 NL012535. This project is also funded, in part, by a grant provided by the Pennsylvania Department of Health (#SAP 4100070267). The Department of Health specifically disclaims responsibility for any analyses, interpretations, or conclusions.	ADAMS WT, 1987, J MOL BIOL, V194, P391, DOI 10.1016/0022-2836(87)90669-3; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Nguyen C, 2013, DIABETES, V62, P2135, DOI 10.2337/db12-1398; Chen HY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002514; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Cronin RM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00250; Darabos C, 2015, BIOCOMPUT-PAC SYM, P171; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Grais IM, 2014, AM J MED, V127, P691, DOI 10.1016/j.amjmed.2014.03.009; Granata M, 2017, PATHOBIOLOGY, V84, P71, DOI 10.1159/000447777; Hall MA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004678; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ising E, 1925, Z PHYS, V31, P253, DOI 10.1007/BF02980577; Jensen PB, 2012, NAT REV GENET, V13, P395, DOI 10.1038/nrg3208; Kennedy EH, 2013, MED CARE, V51, P251, DOI 10.1097/MLR.0b013e31827da594; Khaodhiar L, 1999, Clin Cornerstone, V2, P17, DOI 10.1016/S1098-3597(99)90002-9; Kindermann R., 1980, MARKOV RANDOM FIELDS, DOI [10.1090/conm/001, DOI 10.1090/CONM/001]; Kvale MN, 2015, GENETICS, V200, P1051, DOI 10.1534/genetics.115.178905; Li P, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00460; Liao KP, 2009, ARTHRITIS RHEUM-US, V60, P653, DOI 10.1002/art.24362; Lingren T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159621; Lo JC, 2007, SCIENCE, V316, P285, DOI 10.1126/science.1137221; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Mackawy AMH, 2013, INT J HEALTH SCI-IJH, V7, P267, DOI 10.12816/0006054; Markello TC, 2012, MOL GENET METAB, V105, P665, DOI 10.1016/j.ymgme.2011.12.015; Mayer MA, 2017, STUD HEALTH TECHNOL, V235, P236, DOI 10.3233/978-1-61499-753-5-236; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; Michalaki MA, 2006, THYROID, V16, P73, DOI 10.1089/thy.2006.16.73; Moore J.H., 2015, EPISTASIS METHODS PR; Moudgil KD, 2011, J INTERF CYTOK RES, V31, P695, DOI 10.1089/jir.2011.0065; Namjou B, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00401; Oetjens MT, 2016, PHARMACOGENOMICS, V17, P853, DOI 10.2217/pgs-2015-0007; Pendergrass SA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003087; Rabinovitch A, 2007, CELL BIOCHEM BIOPHYS, V48, P159, DOI 10.1007/s12013-007-0029-2; Rasouli J, 2015, J IMMUNOL, V194, P5085, DOI 10.4049/jimmunol.1403243; Rassekh SR, 2010, J CANCER EPIDEMIOL, V2010, DOI 10.1155/2010/569517; Richard-Miceli C, 2012, GENOME MED, V4, DOI 10.1186/gm305; Richesson RL, 2013, J AM MED INFORM ASSN, V20, pE319, DOI 10.1136/amiajnl-2013-001952; Roizen JD, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0668-4; Sanyal Debmalya, 2016, Indian J Endocrinol Metab, V20, P554, DOI 10.4103/2230-8210.183454; Schork AJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003449; Somers EC, 2009, AM J EPIDEMIOL, V169, P749, DOI 10.1093/aje/kwn408; Staykova Nedyalka D, 2007, Folia Med (Plovdiv), V49, P5; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Tettey P, 2015, J NEUROL SCI, V348, P126, DOI 10.1016/j.jns.2014.11.019; Todd Marie, 2009, Br J Nurs, V18, P1120; Topsakal S, 2014, J MUSCULOSKELET PAIN, V22, P38, DOI 10.3109/10582452.2014.883006; Tseng CC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003999; Tyler AL, 2016, BRIEF BIOINFORM, V17, P13, DOI 10.1093/bib/bbv050; Verma A, 2018, AM J HUM GENET, V102, P592, DOI 10.1016/j.ajhg.2018.02.017; Verma SS, 2016, BIOCOMPUT-PAC SYM, P57; Wang CX, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/390534; Wu JL, 2010, MED CARE, V48, pS106, DOI 10.1097/MLR.0b013e3181de9e17	57	28	28	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 3	2019	104	1					55	64		10.1016/j.ajhg.2018.11.006	http://dx.doi.org/10.1016/j.ajhg.2018.11.006			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HG2EH	30598166	Green Published, hybrid			2022-12-18	WOS:000454775500008
J	Danhauser, K; Alhaddad, B; Makowski, C; Piekutowska-Abramczuk, D; Syrbe, S; Gomez-Ospina, N; Manning, MA; Kostera-Pruszczyk, A; Krahn-Peper, C; Berutti, R; Kovacs-Nagy, R; Gusic, M; Graf, E; Laugwitz, L; Roblitz, M; Wroblewski, A; Hartmann, H; Das, AM; Bultmann, E; Fang, F; Xu, MT; Schatz, UA; Karall, D; Zellner, H; Haberlandt, E; Feichtinger, RG; Mayr, JA; Meitinger, T; Prokisch, H; Strom, TM; Ploski, R; Hoffmann, GF; Pronicki, M; Bonnen, PE; Morlot, S; Haack, TB				Danhauser, Katharina; Alhaddad, Bader; Makowski, Christine; Piekutowska-Abramczuk, Dorota; Syrbe, Steffen; Gomez-Ospina, Natalia; Manning, Melanie A.; Kostera-Pruszczyk, Anna; Krahn-Peper, Claudia; Berutti, Riccardo; Kovacs-Nagy, Reka; Gusic, Mirjana; Graf, Elisabeth; Laugwitz, Lucia; Roeblitz, Michaela; Wroblewski, Andreas; Hartmann, Hans; Das, Anibh M.; Bueltmann, Eva; Fang, Fang; Xu, Manting; Schatz, Ulrich A.; Karall, Daniela; Zellner, Herta; Haberlandt, Edda; Feichtinger, Rene G.; Mayr, Johannes A.; Meitinger, Thomas; Prokisch, Holger; Strom, Tim M.; Ploski, Rafal; Hoffmann, Georg F.; Pronicki, Maciej; Bonnen, Penelope E.; Morlot, Susanne; Haack, Tobias B.			Bi-allelic ADPRHL2 Mutations Cause Neurodegeneration with Developmental Delay, Ataxia, and Axonal Neuropathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLY ADP-RIBOSE; CELL-DEATH; POLY(ADP-RIBOSE); DEGRADATION; ENZYMES	ADP-ribosylation is a reversible posttranslational modification used to regulate protein function. ADP-ribosyltransferases transfer ADPribose from NAD(+) to the target protein, and ADP-ribosylhydrolases, such as ADPRHL2, reverse the reaction. We used exome sequencing to identify five different bi-allelic pathogenic ADPRHL2 variants in 12 individuals from 8 families affected by a neurodegenerative disorder manifesting in childhood or adolescence with key clinical features including developmental delay or regression, seizures, ataxia, and axonal (sensori-) motor neuropathy. ADPRHL2 was virtually absent in available affected individuals' fibroblasts, and cell viability was reduced upon hydrogen peroxide exposure, although it was rescued by expression of wild-type ADPRHL2 mRNA as well as treatment with a PARP1 inhibitor. Our findings suggest impaired protein ribosylation as another pathway that, if disturbed, causes neurodegenerative diseases.	[Danhauser, Katharina; Alhaddad, Bader; Kovacs-Nagy, Reka; Gusic, Mirjana; Schatz, Ulrich A.; Meitinger, Thomas; Prokisch, Holger; Strom, Tim M.; Haack, Tobias B.] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Danhauser, Katharina; Alhaddad, Bader; Berutti, Riccardo; Gusic, Mirjana; Graf, Elisabeth; Meitinger, Thomas; Prokisch, Holger; Strom, Tim M.] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Danhauser, Katharina] Ludwig Maximilian Univ Munich, Univ Hosp, Dr von Hauner Childrens Hosp, Dept Pediat, D-80337 Munich, Germany; [Makowski, Christine] Tech Univ Munich, Dept Pediat, D-80804 Munich, Germany; [Piekutowska-Abramczuk, Dorota] Childrens Mem Hlth Inst, Dept Med Genet, PL-04730 Warsaw, Poland; [Syrbe, Steffen; Hoffmann, Georg F.] Univ Childrens Hosp, Div Neuropediat & Metab Med, D-69120 Heidelberg, Germany; [Gomez-Ospina, Natalia; Manning, Melanie A.] Stanford Univ, Sch Med, Dept Pediat, Div Med Genet, Stanford, CA 94305 USA; [Gomez-Ospina, Natalia; Manning, Melanie A.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Kostera-Pruszczyk, Anna] Med Univ Warsaw, Dept Neurol, PL-02097 Warsaw, Poland; [Krahn-Peper, Claudia] Heilpadag Therapeut Zentrum gGmbH, Sozialpadiatr Zentrum, Neuwied D-56564, Greece; [Laugwitz, Lucia] Univ Childrens Hosp, Div Pediat Neurol & Dev Med, D-72072 Tubingen, Germany; [Laugwitz, Lucia; Haack, Tobias B.] Univ Tubingen, Inst Med Genet & Appl Genom, D-72076 Tubingen, Germany; [Roeblitz, Michaela; Wroblewski, Andreas] St Josephs Hosp, Zentrum Kinder & Jugendmed, Wusthoffstr 15, D-12101 Berlin, Germany; [Hartmann, Hans; Das, Anibh M.] Hannover Med Sch, Clin Pediat Kidney Liver & Metab Dis, D-30625 Hannover, Germany; [Bueltmann, Eva] Hannover Med Sch, Inst Diagnost & Intervent Neuroradiol, D-30625 Hannover, Germany; [Fang, Fang; Xu, Manting; Prokisch, Holger] Capital Med Univ, Beijing Childrens Hosp, Dept Pediat Neurol, Natl Ctr Childrens Hlth, Beijing 100045, Peoples R China; [Schatz, Ulrich A.] Med Univ Innsbruck, Div Human Genet, A-6020 Innsbruck, Austria; [Karall, Daniela; Zellner, Herta] Med Univ Innsbruck, Pediat Clin, Div Inherited Metab Disorders, A-6020 Innsbruck, Austria; [Haberlandt, Edda] Krankenhaus Stadt Dornbirn, Pediat Clin, A-6850 Dornbirn, Austria; [Feichtinger, Rene G.; Mayr, Johannes A.] ParacelsusMed Univ Salzburg, Dept Pediat, A-5020 Salzburg, Austria; [Meitinger, Thomas] Munich Cluster Syst Neurol SyNergy, D-81377 Munich, Germany; [Ploski, Rafal] Med Univ Warsaw, Dept Med Genet, PL-02106 Warsaw, Poland; [Pronicki, Maciej] Childrens Mem Hlth Inst, Dept Pathol, PL-04730 Warsaw, Poland; [Bonnen, Penelope E.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Morlot, Susanne] Hannover Med Sch, Inst Human Genet, D-30625 Hannover, Germany; [Haack, Tobias B.] Univ Tubingen, Ctr Rare Dis, D-72076 Tubingen, Germany	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Technical University of Munich; Children's Memorial Health Institute; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Stanford University; Stanford University; Medical University of Warsaw; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen; Hannover Medical School; Hannover Medical School; Capital Medical University; Medical University of Innsbruck; Medical University of Innsbruck; University of Munich; Medical University of Warsaw; Children's Memorial Health Institute; Baylor College of Medicine; Hannover Medical School; Eberhard Karls University of Tubingen	Haack, TB (corresponding author), Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany.; Haack, TB (corresponding author), Univ Tubingen, Inst Med Genet & Appl Genom, D-72076 Tubingen, Germany.; Haack, TB (corresponding author), Univ Tubingen, Ctr Rare Dis, D-72076 Tubingen, Germany.	tobias.haack@med.uni-tuebingen.de	Laugwitz, Lucia/ABF-4663-2021; Syrbe, Steffen/ABE-8020-2020; Alhaddad, Bader/AAJ-5504-2021	Laugwitz, Lucia/0000-0003-2506-1961; Alhaddad, Bader/0000-0003-4542-5267; Gomez-Ospina, Natalia/0000-0002-6740-1154; Pronicki, Maciej/0000-0002-5589-0456; Piekutowska-Abramczuk, Dorota/0000-0002-9786-3704; Gusic, Mirjana/0000-0002-9350-291X	German Bundesministerium fur Bildung und Forschung (BMBF) through the Juniorverbund in der Systemmedizin "mitOmics'' [FKZ 01ZX1405C]; E-Rare project GENOMIT [01GM1603, 01GM1207]; EU FP7 Mitochondrial European Educational Training Project [317433]; EU Horizon2020 Collaborative Research Project SOUND [633974]; National Science Centre (NCN) Poland [2013/11/B/NZ7/04944]; National Institute of Neurological Disorders and Stroke of the National Institutes of Health [R01NS08372]; Key Special Project of National Key Research and Development Program "Research on prevention and control of major chronic non-communicable diseases: Early identification and comprehensive intervention of brain development disorders in children'';  [S148/16];  [S145/16]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083726] Funding Source: NIH RePORTER	German Bundesministerium fur Bildung und Forschung (BMBF) through the Juniorverbund in der Systemmedizin "mitOmics''(Federal Ministry of Education & Research (BMBF)); E-Rare project GENOMIT; EU FP7 Mitochondrial European Educational Training Project; EU Horizon2020 Collaborative Research Project SOUND; National Science Centre (NCN) Poland; National Institute of Neurological Disorders and Stroke of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Key Special Project of National Key Research and Development Program "Research on prevention and control of major chronic non-communicable diseases: Early identification and comprehensive intervention of brain development disorders in children''; ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all the families for their participation. This study was supported by the German Bundesministerium fur Bildung und Forschung (BMBF) through the Juniorverbund in der Systemmedizin "mitOmics'' (FKZ 01ZX1405C to T.B.H.). H.P. was supported by the E-Rare project GENOMIT (01GM1603 and 01GM1207), by the EU FP7 Mitochondrial European Educational Training Project (317433), and by the EU Horizon2020 Collaborative Research Project SOUND (633974). D.P. was supported by the intramural grants S148/16 and S145/16. R.P. was supported by the National Science Centre (NCN) Poland grant 2013/11/B/NZ7/04944. Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number R01NS08372 to P.E.B., and F.F. and M.X. were supported by the Key Special Project of National Key Research and Development Program "Research on prevention and control of major chronic non-communicable diseases: Early identification and comprehensive intervention of brain development disorders in children.''	Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Bai P, 2012, CELL METAB, V16, P290, DOI 10.1016/j.cmet.2012.06.016; Barkauskaite E, 2015, MOL CELL, V58, P935, DOI 10.1016/j.molcel.2015.05.007; Brunyanszki A, 2016, FREE RADICAL BIO MED, V100, P257, DOI 10.1016/j.freeradbiomed.2016.02.024; Byrne AB, 2016, ELIFE, V5, DOI 10.7554/eLife.12734; Danhauser K, 2011, MOL GENET METAB, V103, P161, DOI 10.1016/j.ymgme.2011.03.004; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Haack TB, 2012, AM J HUM GENET, V91, P1144, DOI 10.1016/j.ajhg.2012.10.019; Hoch NC, 2017, NATURE, V541, P87, DOI 10.1038/nature20790; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Lee Y, 2014, BMB REP, V47, P424, DOI 10.5483/BMBRep.2014.47.8.119; Love S, 1999, BRAIN, V122, P247, DOI 10.1093/brain/122.2.247; Mashimo M, 2014, DNA REPAIR, V23, P88, DOI 10.1016/j.dnarep.2014.03.005; Mashimo M, 2013, P NATL ACAD SCI USA, V110, P18964, DOI 10.1073/pnas.1312783110; Niere M, 2012, J BIOL CHEM, V287, P16088, DOI 10.1074/jbc.M112.349183; Oka S, 2006, J BIOL CHEM, V281, P705, DOI 10.1074/jbc.M510290200; Ploski R, 2014, CIRC RES, V114, pE2, DOI 10.1161/CIRCRESAHA.114.302662; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Sharifi R, 2013, EMBO J, V32, P1225, DOI 10.1038/emboj.2013.51; Slade D, 2011, NATURE, V477, P616, DOI 10.1038/nature10404; Vyas S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3240; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Zhang S, 2007, CELL DEATH DIFFER, V14, P1001, DOI 10.1038/sj.cdd.4402088	24	28	30	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 1	2018	103	5					817	825		10.1016/j.ajhg.2018.10.005	http://dx.doi.org/10.1016/j.ajhg.2018.10.005			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GY9EO	30401461	Bronze, Green Published			2022-12-18	WOS:000448942100016
J	He, ZH; Xu, B; Lee, S; Ionita-Laza, I				He, Zihuai; Xu, Bin; Lee, Seunggeun; Ionita-Laza, Iuliana			Unified Sequence-Based Association Tests Allowing for Multiple Functional Annotations and Meta-analysis of Noncoding Variation in Metabochip Data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RARE-VARIANT ASSOCIATION; ESTIMATING RELATIVE RISKS; GENETIC-VARIANTS; GENERAL FRAMEWORK; POPULATION; MUTATIONS; TRAITS	Substantial progress has been made in the functional annotation of genetic variation in the human genome. Integrative analysis that incorporates such functional annotations into sequencing studies can aid the discovery of disease-associated genetic variants, especially those with unknown function and located outside protein-coding regions. Direct incorporation of one functional annotation as weight in existing dispersion and burden tests can suffer substantial loss of power when the functional annotation is not predictive of the risk status of a variant. Here, we have developed unified tests that can utilize multiple functional annotations simultaneously for integrative association analysis with efficient computational techniques. We show that the proposed tests significantly improve power when variant risk status can be predicted by functional annotations. Importantly, when functional annotations are not predictive of risk status, the proposed tests incur only minimal loss of power in relation to existing dispersion and burden tests, and under certain circumstances they can even have improved power by learning a weight that better approximates the underlying disease model in a data-adaptive manner. The tests can be constructed with summary statistics of existing dispersion and burden tests for sequencing data, therefore allowing meta-analysis of multiple studies without sharing individual-level data. We applied the proposed tests to a meta-analysis of noncoding rare variants in Metabochip data on 12,281 individuals from eight studies for lipid traits. By incorporating the Eigen functional score, we detected significant associations between noncoding rare variants in SLC22A3 and low-density lipoprotein and total cholesterol, associations that are missed by standard dispersion and burden tests.	[He, Zihuai; Ionita-Laza, Iuliana] Columbia Univ, Dept Biostat, New York, NY 10032 USA; [Xu, Bin] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Lee, Seunggeun] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA	Columbia University; Columbia University; University of Michigan System; University of Michigan	Ionita-Laza, I (corresponding author), Columbia Univ, Dept Biostat, New York, NY 10032 USA.	ii2135@columbia.edu		He, Zihuai/0000-0002-8220-4183	National Institutes of Health [MH095797, MH106910]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH106910, R01MH095797] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We gratefully acknowledge support by National Institutes of Health grants MH095797 (to Z.H. and I.I.-L.) and MH106910 (to I.I.-L. and B.X.). We also thank each of the participating meta-analysis consortia that contributed data to the Metabochip dataset and Mike Boehnke for sharing the dataset with us. The Swedish exome-sequencing study dataset was accessed through dbGaP: phs000473.v2.p2. We thank two reviewers for their helpful comments.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Byrnes AE, 2013, GENET EPIDEMIOL, V37, P666, DOI 10.1002/gepi.21747; Capanu M, 2008, STAT MED, V27, P1973, DOI 10.1002/sim.3196; Capanu M, 2011, BIOMETRICS, V67, P371, DOI 10.1111/j.1541-0420.2010.01469.x; Chen H, 2013, GENET EPIDEMIOL, V37, P196, DOI 10.1002/gepi.21703; Chen L, 2013, PHARMACOGENOMICS J, V13, P110, DOI 10.1038/tpj.2011.60; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Derkach A, 2014, STAT SCI, V29, P302, DOI 10.1214/13-STS456; Derkach A, 2013, GENET EPIDEMIOL, V37, P110, DOI 10.1002/gepi.21689; Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247; He ZH, 2015, BIOMETRICS, V71, P606, DOI 10.1111/biom.12310; Ionita-Laza I, 2016, NAT GENET, V48, P214, DOI 10.1038/ng.3477; Ionita-Laza I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004729; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Lee S, 2013, AM J HUM GENET, V93, P42, DOI 10.1016/j.ajhg.2013.05.010; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li M, 2014, GENET EPIDEMIOL, V38, P242, DOI 10.1002/gepi.21790; Liu DJJ, 2014, NAT GENET, V46, P200, DOI 10.1038/ng.2852; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Minica C. C., 2015, BIORXIV; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Sun JP, 2013, GENET EPIDEMIOL, V37, P334, DOI 10.1002/gepi.21717; Tewhey R, 2016, CELL, V165, P1519, DOI 10.1016/j.cell.2016.04.027; Tregouet DA, 2009, NAT GENET, V41, P283, DOI 10.1038/ng.314; Wang XF, 2013, GENET EPIDEMIOL, V37, P778, DOI 10.1002/gepi.21763; Wu MC, 2013, GENET EPIDEMIOL, V37, P267, DOI 10.1002/gepi.21715; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029	36	28	28	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 7	2017	101	3					340	352		10.1016/j.ajhg.2017.07.011	http://dx.doi.org/10.1016/j.ajhg.2017.07.011			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FG1CS	28844485	Green Published, Bronze			2022-12-18	WOS:000409530900003
J	Bayram, Y; White, JJ; Elcioglu, N; Cho, MT; Zadeh, N; Gedikbasi, A; Palanduz, S; Ozturk, S; Cefle, K; Kasapcopur, O; Akdemir, ZC; Pehlivan, D; Begtrup, A; Carvalho, CMB; Paine, IS; Mentes, A; Bektas-Kayhan, K; Karaca, E; Jhangiani, SN; Muzny, DM; Gibbs, RA; Lupski, JR				Bayram, Yavuz; White, Janson J.; Elcioglu, Nursel; Cho, Megan T.; Zadeh, Neda; Gedikbasi, Asuman; Palanduz, Sukru; Ozturk, Sukru; Cefle, Kivanc; Kasapcopur, Ozgur; Akdemir, Zeynep Coban; Pehlivan, Davut; Begtrup, Amber; Carvalho, Claudia M. B.; Paine, Ingrid Sophie; Mentes, Ali; Bektas-Kayhan, Kivanc; Karaca, Ender; Jhangiani, Shalini N.; Muzny, Donna M.; Gibbs, Richard A.; Lupski, James R.		Baylor-Hopkins Ctr Mendelian	REST Final-Exon-Truncating Mutations Cause Hereditary Gingival Fibromatosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSCRIPTION FACTOR REST; RESTRICTIVE SILENCER FACTOR; GENE-EXPRESSION; NEUROENDOCRINE DIFFERENTIATION; SIGNALING PATHWAY; REPRESSOR; CANCER; FIBROBLASTS; PROTEIN; TUMOR	Hereditary gingival fibromatosis (HGF) is the most common genetic form of gingival fibromatosis that develops as a slowly progressive, benign, localized or generalized enlargement of keratinized gingiva. HGF is a genetically heterogeneous disorder and can be transmitted either as an autosomal-dominant or autosomal-recessive trait or appear sporadically. To date, four loci (2p22.1, 2p23.3-p22.3, 5q13-q22, and 11p15) have been mapped to autosomes and one gene (SOS1) has been associated with the HGF trait observed to segregate in a dominant inheritance pattern. Here we report 11 individuals with HGF from three unrelated families. Whole-exome sequencing (WES) revealed three different truncating mutations including two frameshifts and one nonsense variant in RE1-silencing transcription factor (REST) in the probands from all families and further genetic and genomic analyses confirmed the WES-identified findings. REST is a transcriptional repressor that is expressed throughout the body; it has different roles in different cellular contexts, such as oncogenic and tumor-suppressor functions and hematopoietic and cardiac differentiation. Here we show the consequences of germline final-exontruncating mutations in REST for organismal development and the association with the HGF phenotype.	[Bayram, Yavuz; White, Janson J.; Akdemir, Zeynep Coban; Pehlivan, Davut; Carvalho, Claudia M. B.; Paine, Ingrid Sophie; Karaca, Ender; Gibbs, Richard A.; Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Elcioglu, Nursel] Marmara Univ, Sch Med, Dept Pediat Genet, TR-34899 Istanbul, Turkey; [Elcioglu, Nursel] Eastern Mediterranean Univ, Sch Med, Gazimagusa, Cyprus; [Cho, Megan T.; Begtrup, Amber] GeneDx, 207 Perry Pkwy, Gaithersburg, MD 20877 USA; [Zadeh, Neda] Genet Ctr, Orange, CA 92868 USA; [Zadeh, Neda] Childrens Hosp Orange Cty, Div Med Genet, Orange, CA 92868 USA; [Gedikbasi, Asuman; Palanduz, Sukru; Ozturk, Sukru; Cefle, Kivanc] Istanbul Univ, Istanbul Fac Med, Dept Internal Med, Div Med Genet, TR-34093 Istanbul, Turkey; [Kasapcopur, Ozgur] Istanbul Univ, Cerrahpasa Med Sch, Dept Child Rheumatol, TR-34093 Istanbul, Turkey; [Pehlivan, Davut; Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA; [Mentes, Ali] Marmara Univ, Dept Pediat Dent, Fac Dent, TR-34854 Istanbul, Turkey; [Bektas-Kayhan, Kivanc] Istanbul Univ, Dept Oral & Maxillofacial Surg, Fac Dent, TR-34899 Istanbul, Turkey; [Jhangiani, Shalini N.; Muzny, Donna M.; Gibbs, Richard A.; Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Baylor College of Medicine; Marmara University; Eastern Mediterranean University; Childrens Hospital of Orange County; Istanbul University; Istanbul University; Istanbul University - Cerrahpasa; Baylor College of Medicine; Marmara University; Istanbul University; Baylor College of Medicine; Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Lupski, JR (corresponding author), Texas Childrens Hosp, Houston, TX 77030 USA.; Lupski, JR (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.; Lupski, JR (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.	jlupski@bcm.edu	ÖZTÜRK, ŞÜKRÜ/ABH-7947-2020; Palanduz, Sukru/AAC-6863-2020; Öztürk, Şükrü/AAE-5548-2020; Pehlivan, Davut/I-3235-2019; Kayhan, Kivanc Bektas/AAC-8435-2020; Kasapcopur, Ozgur/A-8888-2018; Gedikbasi, Asuman/AAE-3613-2020; Ozturk, Sukru/AAC-5001-2020	ÖZTÜRK, ŞÜKRÜ/0000-0002-8809-7462; Palanduz, Sukru/0000-0002-9435-009X; Kayhan, Kivanc Bektas/0000-0001-7149-9230; Kasapcopur, Ozgur/0000-0002-1125-7720; Gedikbasi, Asuman/0000-0001-7121-6077; mentes, ali/0000-0002-2778-6803	National Human Genome Research Institute (NHGRI); National Heart Lung and Blood Institute (NHBLI) [UM1 HG006542]; NHGRI [U54HG003273]; National Institute of Neurological Disorders and Stroke (NINDS) [R01NS05829]; NHGRI of the United States NIH; NHBLI of the United States NIH; NINDS of the United States NIH; Regeneron Pharmaceuticals; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006542, U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058529] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart Lung and Blood Institute (NHBLI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHGRI of the United States NIH; NHBLI of the United States NIH; NINDS of the United States NIH; Regeneron Pharmaceuticals(Regeneron); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the families for participation in this study. This work was supported in part by funding from the National Human Genome Research Institute (NHGRI) and National Heart Lung and Blood Institute (NHBLI) to the Baylor-Hopkins Center for Mendelian Genomics (BHCMG, UM1 HG006542); NHGRI grant to Baylor College of Medicine Human Genome Sequencing Center (U54HG003273), National Institute of Neurological Disorders and Stroke (NINDS) (R01NS05829 to J.R.L.), and NHGRI, NHBLI, and NINDS, all Institutes of the United States NIH.; J.R.L. has stock ownership in 23andMe and Lasergen, is a paid consultant for Regeneron Pharmaceuticals, and is a coinventor on multiple United States and European patents related to molecular diagnostics for inherited neuropathies, eye diseases, and bacterial genomic fingerprinting. The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from the chromosomal microarray analysis (CMA) and clinical exome sequencing offered in the Baylor Genetics Laboratory. M.T.C. and A.B. are employees of GeneDx.	Bahn S, 2002, LANCET, V359, P310, DOI 10.1016/S0140-6736(02)07497-4; Bainbridge MN, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r68; BONNAUREMALLET M, 1995, ARCH ORAL BIOL, V40, P393, DOI 10.1016/0003-9969(94)00187-G; Challis D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-8; Chang PC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088556; Cho E, 2015, ONCOL REP, V33, P1459, DOI 10.3892/or.2014.3675; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Coulson JM, 2005, CURR BIOL, V15, pR665, DOI 10.1016/j.cub.2005.08.032; Coulson JM, 1999, CANCER RES, V59, P5123; Gawron K, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0395-1; Hart TC, 2002, AM J HUM GENET, V70, P943, DOI 10.1086/339689; Huang Z, 2012, FEBS LETT, V586, P1602, DOI 10.1016/j.febslet.2012.04.052; Kataoka M, 2005, BIOL PHARM BULL, V28, P1817, DOI 10.1248/bpb.28.1817; Khera P, 2005, J AM ACAD DERMATOL, V52, P491, DOI 10.1016/j.jaad.2004.09.035; Kong QR, 2016, J BIOL CHEM, V291, P27334, DOI 10.1074/jbc.M116.743849; Kuwahara K, 2013, CIRC J, V77, P2682, DOI 10.1253/circj.CJ-13-1210; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liu B, 2015, J CELL BIOCHEM, V116, P1932, DOI 10.1002/jcb.25148; Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163; Lupski JR, 2013, GENOME MED, V5, DOI 10.1186/gm461; Lv H, 2010, J CELL BIOCHEM, V110, P968, DOI 10.1002/jcb.22610; Mahamdallie SS, 2015, NAT GENET, V47, P1471, DOI 10.1038/ng.3440; Majumder P, 2013, CASE REP DENT, V2013, DOI 10.1155/2013/432864; Martelli-Junior H, 2003, J PERIODONTOL, V74, P296, DOI 10.1902/jop.2003.74.3.296; Negrini S, 2013, TRENDS CELL BIOL, V23, P289, DOI 10.1016/j.tcb.2013.01.006; Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100; Pehlivan D, 2009, J HARD TISSUE BIOL, V18, P131, DOI 10.2485/jhtb.18.131; Reid JG, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-30; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; TAKAGI M, 1991, CANCER-AM CANCER SOC, V68, P2202, DOI 10.1002/1097-0142(19911115)68:10<2202::AID-CNCR2820681019>3.0.CO;2-O; Tawadros T, 2005, CELL SIGNAL, V17, P929, DOI 10.1016/j.cellsig.2004.11.013; Taylor P, 2012, MOL CANCER THER, V11, P1713, DOI 10.1158/1535-7163.MCT-11-0990; Thakore-Shah K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145280; Thompson K, 2010, J DENT RES, V89, P1450, DOI 10.1177/0022034510379020; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tipton DA, 1997, J PERIODONTOL, V68, P524, DOI 10.1902/jop.1997.68.6.524; Trackman PC, 2015, J DENT RES, V94, P540, DOI 10.1177/0022034515571265; Wang Zuoheng, 2013, Frontiers in Genetics, V4, P160, DOI 10.3389/fgene.2013.00160; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Zhou ZC, 2014, CANCER-AM CANCER SOC, V120, P579, DOI 10.1002/cncr.28555; Zhu YZ, 2014, PROSTATE, V74, P1086, DOI 10.1002/pros.22819; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219	43	28	30	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 6	2017	101	1					149	156		10.1016/j.ajhg.2017.06.006	http://dx.doi.org/10.1016/j.ajhg.2017.06.006			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EZ7FK	28686854	Green Published, Bronze			2022-12-18	WOS:000404886800013
J	O'Grady, GL; Best, HA; Sztal, TE; Schartner, V; Sanjuan-Vazquez, T; Donkervoort, S; Neto, OA; Sutton, RB; Ilkovski, B; Romero, NB; Stojkovic, T; Dastgir, J; Waddell, LB; Boland, A; Hu, Y; Williams, C; Ruparelia, AA; Maisonobe, T; Peduto, AJ; Reddel, SW; Lek, M; Tukiainen, T; Cummings, BB; Joshi, H; Nectoux, J; Brammah, S; Deleuze, JF; Ing, VO; Ramm, G; Ardicli, D; Nowak, KJ; Talim, B; Topaloglu, H; Laing, NG; North, KN; MacArthur, DG; Friant, S; Clarke, NF; Bryson-Richardson, RJ; Bonnemann, CG; Laporte, J; Cooper, ST				O'Grady, Gina L.; Best, Heather A.; Sztal, Tamar E.; Schartner, Vanessa; Sanjuan-Vazquez, Tvlyriam; Donkervoort, Sandra; Neto, Osorio Abath; Sutton, Roger Bryan; Ilkovski, Biljana; Romero, Norma Beatriz; Stojkovic, Tanya; Dastgir, Jahannaz; Waddell, Leigh B.; Boland, Anne; Hu, Ying; Williams, Caitlin; Ruparelia, Avnika A.; Maisonobe, Thierry; Peduto, Anthony J.; Reddel, Stephen W.; Lek, Monkol; Tukiainen, Tam; Cummings, Beryl B.; Joshi, Himanshu; Nectoux, Juliette; Brammah, Susan; Deleuze, Jean-Francois; Ing, Viola Oorschot; Ramm, Georg; Ardicli, Didem; Nowak, Kristen J.; Talim, Beril; Topaloglu, Haluk; Laing, Nigel G.; North, Kathryn N.; MacArthur, Daniel G.; Friant, Sylvie; Clarke, Nigel F.; Bryson-Richardson, Robert J.; Bonnemann, Carsten G.; Laporte, Jocelyn; Cooper, Sandra T.			Variants in the Oxidoreductase PYROXD1 Cause Early-Onset Myopathy with Internalized Nuclei and Myofibrillar Disorganization	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL MYOPATHIES; PHYLOGENETIC ANALYSIS; NEMALINE MYOPATHY; ZEBRAFISH MODELS; GENETIC-VARIANTS; GENERATION; DIAGNOSIS; DISEASE; MUSCLE	This study establishes PYROXD1 variants as a cause of early-onset myopathy and uses biospecimens and cell lines, yeast, and zebrafish models to elucidate the fundamental role of PYROXD1 in skeletal muscle. Exome sequencing identified recessive variants in PYROXD1 in nine probands from five families. Affected individuals presented in infancy or childhood with slowly progressive proximal and distal weakness, facial weakness, nasal speech, swallowing difficulties, and normal to moderately elevated creatine kinase. Distinctive histopathology showed abundant internalized nuclei, myofibrillar disorganization, desmin-positive inclusions, and thickened Z-bands. PYROXD1 is a nuclear-cytoplasmic pyridine nucleotide-disulphide reductase (PNDR). PNDRs are flavoproteins (FAD-binding) and catalyze pyridine-nucleotide-dependent (NAD/NADH) reduction of thiol residues in other proteins. Complementation experiments in yeast lacking glutathione reductase girl show that human PYROXD1 has reductase activity that is strongly impaired by the disease-associated missense mutations. Immunolocalization studies in human muscle and zebrafish myofibers demonstrate that PYROXD1 localizes to the nucleus and to striated sarcomeric compartments. Zebrafish with ryroxD1 knock-down recapitulate features of PYROXD1 myopathy with sarcomeric disorganization, myofibrillar aggregates, and marked swimming defect. We characterize variants in the oxidoreductase PYROXD1 as a cause of early-onset myopathy with distinctive histopathology and introduce altered redox regulation as a primary cause of congenital muscle disease.	[O'Grady, Gina L.; Best, Heather A.; Ilkovski, Biljana; Waddell, Leigh B.; Joshi, Himanshu; North, Kathryn N.; Clarke, Nigel F.; Cooper, Sandra T.] Childrens Hosp Westmead, Kids Res Inst, Inst Neurosci & Muscle Res, Sydney, NSW 2145, Australia; [O'Grady, Gina L.; Best, Heather A.; Clarke, Nigel F.; Cooper, Sandra T.] Univ Sydney, Discipline Paediat & Child Hlth, Fac Med, Sydney, NSW 2006, Australia; [O'Grady, Gina L.] Starship Childrens Hlth, Paediat Neurol Serv, Auckland 1023, New Zealand; [Sztal, Tamar E.; Williams, Caitlin; Ruparelia, Avnika A.; Bryson-Richardson, Robert J.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3800, Australia; [Schartner, Vanessa; Neto, Osorio Abath; Laporte, Jocelyn] IGBMC, F-67400 Illkirch Graffenstaden, France; [Sanjuan-Vazquez, Tvlyriam; Friant, Sylvie] Univ Strasbourg, CNRS, UMR7156, Dept Mol & Cellular Genet, F-67081 Strasbourg, France; [Donkervoort, Sandra; Dastgir, Jahannaz; Hu, Ying; Bonnemann, Carsten G.] NINDS, Neurogenet Branch, Neuromuscular & Neurogenet Disorders Childhood Se, NIH, Bethesda, MD 20892 USA; [Sutton, Roger Bryan] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA; [Sutton, Roger Bryan] Texas Tech Univ, Hlth Sci Ctr, Ctr Membrane Prot Res, Lubbock, TX 79430 USA; [Romero, Norma Beatriz] UPMC Univ Paris 06, INSERM, UMRS974,CNRS FRE3617, Sorbonne Univ,Ctr Res Myol,GH Pitie Salpetriere, 47 Blvd Hop, F-75013 Paris, France; [Romero, Norma Beatriz; Stojkovic, Tanya; Maisonobe, Thierry] GHU La Pitie Salpetriere, AP HP, Inst Myol, Ctr Reference Pathol Neuromusculaire Paris Est, F-7503 Paris, France; [Boland, Anne; Deleuze, Jean-Francois] CEA, Ctr Natl Genotypage, Inst Genom, CP5721, F-91057 Evry, France; [Peduto, Anthony J.] Univ Sydney, Dept Radiol, Westmead Hosp, Western Clin Sch, Sydney, NSW 1024, Australia; [Reddel, Stephen W.] Univ Sydney, Concord Clin Sch, Dept Neurol, Sydney, NSW 2139, Australia; [Lek, Monkol; Tukiainen, Tam; Cummings, Beryl B.; MacArthur, Daniel G.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Lek, Monkol; Tukiainen, Tam; Cummings, Beryl B.; MacArthur, Daniel G.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA; [Nectoux, Juliette] HUPC Hop Cochin, Serv Biochim & Genet Mol, F-75014 Paris, France; [Nectoux, Juliette] Univ Paris 05, INSERM, U1016, Inst Cochin,CNRS UMR8104, F-75014 Paris, France; [Brammah, Susan] Concord Repatriat Gen Hosp, Electron Microscope Unit, Concord, NSW 2139, Australia; [Ing, Viola Oorschot; Ramm, Georg] Monash Univ, Clive & Vera Ramaciotti Ctr Struct Cryoelectron M, Melbourne, Vic 3800, Australia; [Ramm, Georg] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia; [Ardicli, Didem; Talim, Beril; Topaloglu, Haluk] Hacettepe Univ, Dept Pediat Neurol, Childrens Hosp, TR-06100 Ankara, Turkey; [Nowak, Kristen J.; Laing, Nigel G.] Univ Western Australia, Ctr Med Res, Perth, WA 6009, Australia; [Nowak, Kristen J.; Laing, Nigel G.] Harry Perkins Inst Med Res, Perth, WA 6009, Australia; [North, Kathryn N.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia; [Laporte, Jocelyn] Univ Strasbourg, F-67081 Illkirch Graffenstaden, France	University of Sydney; University of Sydney; Starship Children's Hospital; Monash University; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Sydney; University of Sydney; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Concord Repatriation General Hospital; Monash University; Monash University; Hacettepe University; University of Western Australia; Harry Perkins Institute of Medical Research; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Cooper, ST (corresponding author), Childrens Hosp Westmead, Kids Res Inst, Inst Neurosci & Muscle Res, Sydney, NSW 2145, Australia.; Cooper, ST (corresponding author), Univ Sydney, Discipline Paediat & Child Hlth, Fac Med, Sydney, NSW 2006, Australia.	sandra.cooper@sydney.edu.au	Ruparelia, Avnika/GOV-4202-2022; Waddell, Leigh/L-3037-2017; North, Kathryn N/K-6476-2012; Abath Neto, Osorio/H-1420-2017; Friant, Sylvie/L-9244-2019; Friant, Sylvie/F-5409-2019; STOJKOVIC, Tanya/AAA-3967-2021; Laporte, Jocelyn/H-6801-2016; laporte, jocelyn/O-4888-2019; Hu, Ying/GQZ-8100-2022; Bryson-Richardson, Robert/B-7556-2008; TOPALOGLU, HALUK AYDIN/I-9318-2013	Waddell, Leigh/0000-0003-2970-6624; North, Kathryn N/0000-0003-0841-8009; Abath Neto, Osorio/0000-0003-2787-5483; Friant, Sylvie/0000-0002-5412-6288; Friant, Sylvie/0000-0002-5412-6288; Bryson-Richardson, Robert/0000-0002-9501-8208; Ruparelia, Avnika/0000-0002-1012-0079; laporte, jocelyn/0000-0001-8256-5862; Tukiainen, Taru/0000-0002-5404-8398; MacArthur, Daniel/0000-0002-5771-2290; Cooper, Sandra/0000-0002-7314-5097; Ramm, Georg/0000-0003-3596-2288; Cummings, Beryl/0000-0001-6346-1646; Best, Heather/0000-0002-7180-6170; Laing, Nigel/0000-0001-5111-3732; Sztal, Tamar/0000-0001-9745-3580	Australian National Health and Medical Research Council (NHMRC) [1080587, 1022707, 1031893, 1048816, 1056285]; Muscular Dystrophy New South Wales; Royal Australasian College of Physicians; Australian Research Council [FT100100734]; National Human Genome Research Institute of the NIH [U54 HG003067]; Division of Intramural Research of the National Institutes of Neurological Disorders and Stroke, France Genomique National infrastructure grant Investissements d'Avenir and Agence Nationale pour la Recherche [ANR-10-INBS-09, ANR-11-BSV1-026]; Fondation Maladies Rares "Myocapture" sequencing project; Association Frangaise contre les Myopathies [AFM-15352, AFM-16551]; Muscular Dystrophy Association [MDA-186985]; Myotubular Trust; IDEX-Universite de Strasbourg PhD fellowship; NINDS/NIH; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG008900, R01HG009141, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003129] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Muscular Dystrophy New South Wales; Royal Australasian College of Physicians(General Electric); Australian Research Council(Australian Research Council); National Human Genome Research Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Division of Intramural Research of the National Institutes of Neurological Disorders and Stroke, France Genomique National infrastructure grant Investissements d'Avenir and Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation Maladies Rares "Myocapture" sequencing project; Association Frangaise contre les Myopathies; Muscular Dystrophy Association(Muscular Dystrophy Association); Myotubular Trust; IDEX-Universite de Strasbourg PhD fellowship; NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the following funding: The Australian National Health and Medical Research Council (NHMRC) 1080587 (S.T.C., N.F.C., D.G.M., K.N.N., R.B.R., K.J.N., N.G.L.), 1022707 and 1031893 (K.N.N., N.F.C., and N.G.L.), 1048816 (S.T.C.), and 1056285 (G.L.O.), Muscular Dystrophy New South Wales (G.L.O.), Royal Australasian College of Physicians (G.L.O.), Australian Research Council FT100100734 (K.J.N.), National Human Genome Research Institute of the NIH (D.G.M., Medical Sequencing Program grant U54 HG003067 to the Broad Institute principal investigator, Lander), Division of Intramural Research of the National Institutes of Neurological Disorders and Stroke, France Genomique National infrastructure grant Investissements d'Avenir and Agence Nationale pour la Recherche (ANR-10-INBS-09 and ANR-11-BSV1-026), Fondation Maladies Rares "Myocapture" sequencing project, Association Frangaise contre les Myopathies (AFM-15352 and AFM-16551), Muscular Dystrophy Association (MDA-186985), Myotubular Trust and IDEX-Universite de Strasbourg PhD fellowship (M.S.-V), and intramural funds of the NINDS/NIH (C.G.B. and S.D.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Amburgey K, 2011, ANN NEUROL, V70, P662, DOI 10.1002/ana.22510; Amoasii L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002965; Argyrou A, 2004, PROG NUCLEIC ACID RE, V78, P89, DOI 10.1016/S0079-6603(04)78003-4; Chae JH, 2015, J MED GENET, V52, P208, DOI 10.1136/jmedgenet-2014-102819; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Geoffroy V, 2015, PEERJ, V3, DOI 10.7717/peerj.796; Ghaoui R, 2015, JAMA NEUROL, V72, P1424, DOI 10.1001/jamaneurol.2015.2274; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Higashijima S, 1997, DEV BIOL, V192, P289, DOI 10.1006/dbio.1997.8779; Kachroo AH, 2015, SCIENCE, V348, P921, DOI 10.1126/science.aaa0769; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; KURIYAN J, 1991, NATURE, V352, P172, DOI 10.1038/352172a0; Lek M, 2015, BIORXIV; Liu WZ, 2015, BIOINFORMATICS, V31, P3359, DOI 10.1093/bioinformatics/btv362; Nance JR, 2012, CURR NEUROL NEUROSCI, V12, P165, DOI 10.1007/s11910-012-0255-x; Ng SB, 2010, HUM MOL GENET, V19, pR119, DOI 10.1093/hmg/ddq390; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Redpath GMI, 2016, TRAFFIC, V17, P245, DOI 10.1111/tra.12370; Ruparelia A.A., 2016, HUM MOL GENET; Ruparelia AA, 2012, HUM MOL GENET, V21, P4073, DOI 10.1093/hmg/dds231; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Sztal TE, 2015, ACTA NEUROPATHOL, V130, P389, DOI 10.1007/s00401-015-1430-3; Sztal TE, 2012, HUM MOL GENET, V21, P4718, DOI 10.1093/hmg/dds312; Teer JK, 2010, GENOME RES, V20, P1420, DOI 10.1101/gr.106716.110; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trotter EW, 2005, EUKARYOT CELL, V4, P392, DOI 10.1128/EC.4.2.392-400.2005; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; Webb B., 2002, CURRENT PROTOCOLS BI; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Xu D, 2011, BIOPHYS J, V101, P2525, DOI 10.1016/j.bpj.2011.10.024; Yuen M, 2014, J CLIN INVEST, V124, P4693, DOI 10.1172/JCI75199	35	28	30	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 3	2016	99	5					1086	1105		10.1016/j.ajhg.2016.09.005	http://dx.doi.org/10.1016/j.ajhg.2016.09.005			20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EB6XT	27745833	Green Published, Bronze			2022-12-18	WOS:000387529600007
J	Seymen, F; Kim, YJ; Lee, YJ; Kang, J; Kim, TH; Choi, H; Koruyucu, M; Kasimoglu, Y; Tuna, EB; Gencay, K; Shin, TJ; Hyun, HK; Kim, YJ; Lee, SH; Lee, ZH; Zhang, H; Hu, JCC; Simmer, JP; Cho, ES; Kim, JW				Seymen, Figen; Kim, Youn Jung; Lee, Ye Ji; Kang, Jenny; Kim, Tak-Heun; Choi, Hwajung; Koruyucu, Mine; Kasimoglu, Yelda; Tuna, Elif Bahar; Gencay, Koray; Shin, Teo Jeon; Hyun, Hong-Keun; Kim, Young-Jae; Lee, Sang-Hoon; Lee, Zang Hee; Zhang, Hong; Hu, Jan C-C.; Simmer, James P.; Cho, Eui-Sic; Kim, Jung-Wook			Recessive Mutations in ACPT, Encoding Testicular Acid Phosphatase, Cause Hypoplastic Amelogenesis Imperfecta	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							JUNCTIONAL EPIDERMOLYSIS-BULLOSA; ENAMEL DEFECTS; CANDIDATE GENES; MINERALIZATION; IDENTIFICATION; FAMILIES; DELETION; LAMB3; LAMA3; TOOTH	Amelogenesis imperfecta (AI) is a heterogeneous group of genetic disorders affecting tooth enamel. The affected enamel can be hypo plastic and/or hypomineralized. In this study, we identified ACPT (testicular acid phosphatase) biallelic mutations causing non-syndromic, generalized hypoplastic autosomal-recessive amelogenesis imperfecta (AI) in individuals from six apparently unrelated Turkish families. Families 1, 4, and 5 were affected by the homozygous ACPT mutation c.713C>T (p.Ser238Leu), family 2 by the homozygous ACPT mutation c.331C>T (p.Arg111Cys), family 3 by the homozygous ACPT mutation c.226C>T (p.Arg76Cys), and family 6 by the compound heterozygous ACPT mutations c.382G>C (p.Ala128Pro) and 397G>A (p.Glu133Lys). Analysis of the ACPT crystal structure suggests that these mutations damaged the activity of ACPT by altering the sizes and charges of key amino acid side chains, limiting accessibility of the catalytic core, and interfering with homodimerization. Immunohistochemical analysis confirmed localization of ACPT in secretory-stage ameloblasts. The study results provide evidence for the crucial function of ACPT during amelogenesis.	[Seymen, Figen; Koruyucu, Mine; Kasimoglu, Yelda; Tuna, Elif Bahar; Gencay, Koray] Istanbul Univ, Dept Pedodont, Fac Dent, TR-34093 Istanbul, Turkey; [Kim, Youn Jung; Kim, Jung-Wook] Seoul Natl Univ, Sch Dent, Dept Mol Genet, Seoul 03080, South Korea; [Kim, Youn Jung; Lee, Ye Ji; Kang, Jenny; Shin, Teo Jeon; Hyun, Hong-Keun; Kim, Young-Jae; Lee, Sang-Hoon; Lee, Zang Hee; Kim, Jung-Wook] Seoul Natl Univ, Sch Dent, Dent Res Inst, Seoul 03080, South Korea; [Lee, Ye Ji; Kang, Jenny; Shin, Teo Jeon; Hyun, Hong-Keun; Kim, Young-Jae; Lee, Sang-Hoon; Kim, Jung-Wook] Seoul Natl Univ, Sch Dent, Dept Pediat Dent, Seoul 03080, South Korea; [Kim, Tak-Heun; Choi, Hwajung; Cho, Eui-Sic] Chonbuk Natl Univ, Sch Dent, Cluster Craniofacial Dev & Regenerat Res, Inst Oral Biosci, Jeonju 54896, South Korea; [Lee, Zang Hee] Seoul Natl Univ, Sch Dent, Dept Cell & Dev Biol, Seoul 03080, South Korea; [Zhang, Hong; Hu, Jan C-C.; Simmer, James P.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, 1210 Eisenhower Pl, Ann Arbor, MI 48108 USA	Istanbul University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Jeonbuk National University; Seoul National University (SNU); University of Michigan System; University of Michigan	Kim, JW (corresponding author), Seoul Natl Univ, Sch Dent, Dept Mol Genet, Seoul 03080, South Korea.; Kim, JW (corresponding author), Seoul Natl Univ, Sch Dent, Dent Res Inst, Seoul 03080, South Korea.; Kim, JW (corresponding author), Seoul Natl Univ, Sch Dent, Dept Pediat Dent, Seoul 03080, South Korea.; Cho, ES (corresponding author), Chonbuk Natl Univ, Sch Dent, Cluster Craniofacial Dev & Regenerat Res, Inst Oral Biosci, Jeonju 54896, South Korea.	oasis@jbnu.ac.kr; pedoman@snu.ac.kr	Seymen, Figen/AAC-6736-2020; Hyun, Hong-Keun/D-6385-2012; Kasımoğlu, Yelda/V-6411-2019; Koruyucu, M/AAC-6713-2020	Seymen, Figen/0000-0001-7010-2035; Hyun, Hong-Keun/0000-0003-3478-3210; Kasımoğlu, Yelda/0000-0003-1022-2486; Koruyucu, M/0000-0002-2077-5095	National Research Foundation of Korea (NRF) - Korean government [2014R1A2A1A11049931]; National Institute of Dental and Craniofacial Research [DE015846]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015846] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF) - Korean government; National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors sincerely thank all the family members for their participation in this study. This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (2014R1A2A1A11049931) and funding from the National Institute of Dental and Craniofacial Research (DE015846).	Chan HC, 2011, EUR J ORAL SCI, V119, P311, DOI 10.1111/j.1600-0722.2011.00857.x; Cho ES, 2014, J DENT RES, V93, P980, DOI 10.1177/0022034514547272; Cho SH, 2012, HUM MUTAT, V33, P91, DOI 10.1002/humu.21621; Choi H, 2016, CELL TISSUE RES, V364, P95, DOI 10.1007/s00441-015-2310-9; Crawford PJM, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-17; El-Sayed W, 2009, AM J HUM GENET, V85, P699, DOI 10.1016/j.ajhg.2009.09.014; Fleisig H, 2004, NEUROSCIENCE, V127, P91, DOI 10.1016/j.neuroscience.2004.04.060; Hart PS, 2004, J MED GENET, V41, P545, DOI 10.1136/jmg.2003.017657; Kim JW, 2013, J DENT RES, V92, P899, DOI 10.1177/0022034513502054; Kim JW, 2006, EUR J ORAL SCI, V114, P3, DOI 10.1111/j.1600-0722.2006.00278.x; Kim JW, 2008, AM J HUM GENET, V82, P489, DOI 10.1016/j.ajhg.2007.09.020; Kim JW, 2005, J MED GENET, V42, P271, DOI 10.1136/jmg.2004.024505; Kim JW, 2004, J DENT RES, V83, P378, DOI 10.1177/154405910408300505; Kim JW, 2005, J DENT RES, V84, P278, DOI 10.1177/154405910508400314; KIVIRIKKO S, 1995, HUM MOL GENET, V4, P959, DOI 10.1093/hmg/4.5.959; Lacruz RS, 2012, J CELL PHYSIOL, V227, P2264, DOI 10.1002/jcp.22965; LAGERSTROM M, 1991, GENOMICS, V10, P971, DOI 10.1016/0888-7543(91)90187-J; McGrath JA, 1996, AM J PATHOL, V148, P1787; Parry DA, 2013, AM J HUM GENET, V92, P307, DOI 10.1016/j.ajhg.2013.01.003; Parry DA, 2012, AM J HUM GENET, V91, P565, DOI 10.1016/j.ajhg.2012.07.020; PORVARI KS, 1994, J BIOL CHEM, V269, P22642; Poulter JA, 2014, HUM MOL GENET, V23, P5317, DOI 10.1093/hmg/ddu247; Poulter JA, 2014, HUM MOL GENET, V23, P2189, DOI 10.1093/hmg/ddt616; Poulter JA, 2014, EUR J HUM GENET, V22, P132, DOI 10.1038/ejhg.2013.76; Rajpar MH, 2001, HUM MOL GENET, V10, P1673, DOI 10.1093/hmg/10.16.1673; ROMAS NA, 1979, HUM PATHOL, V10, P501, DOI 10.1016/S0046-8177(79)80094-5; Schrodinger L., 2017, PYMOL MOL GRAPHICS S; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; Wang SK, 2014, HUM MOL GENET, V23, P2157, DOI 10.1093/hmg/ddt611; WITKOP CJ, 1988, J ORAL PATHOL MED, V17, P547, DOI 10.1111/j.1600-0714.1988.tb01332.x; Wright JT, 2015, J DENT RES, V94, P52, DOI 10.1177/0022034514556708; Wright JT, 2011, CELLS TISSUES ORGANS, V194, P279, DOI 10.1159/000324339; Yousef GM, 2001, GENOMICS, V74, P385, DOI 10.1006/geno.2001.6556; Yuen WY, 2012, ACTA DERM-VENEREOL, V92, P695, DOI 10.2340/00015555-1341; Zhang YR, 2014, INT J ORAL SCI, V6, P61, DOI 10.1038/ijos.2014.21	35	28	33	1	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 3	2016	99	5					1199	1205		10.1016/j.ajhg.2016.09.018	http://dx.doi.org/10.1016/j.ajhg.2016.09.018			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EB6XT	27843125	Green Published, Bronze			2022-12-18	WOS:000387529600017
J	Kennedy, H; Haack, TB; Hartill, V; Matakovic, L; Baumgartner, ER; Potter, H; Mackay, R; Alston, CL; O'Sullivan, S; McFarland, R; Connolly, G; Gannon, C; King, R; Mead, S; Crozier, I; Chan, W; Florkowski, CM; Sage, M; Hofken, T; Alhaddad, B; Kremer, LS; Kopajtich, R; Feichtinger, RG; Sperl, W; Rodenburg, RJ; Minet, JC; Dobbie, A; Strom, TM; Meitinger, T; George, PM; Johnson, CA; Taylor, RW; Prokisch, H; Doudney, K; Mayr, JA				Kennedy, Hannah; Haack, Tobias B.; Hartill, Verity; Matakovic, Lavinija; Baumgartner, E. Regula; Potter, Howard; Mackay, Richard; Alston, Charlotte L.; O'Sullivan, Siobhan; McFarland, Robert; Connolly, Grainne; Gannon, Caroline; King, Richard; Mead, Scott; Crozier, Ian; Chan, Wandy; Florkowski, Chris M.; Sage, Martin; Hofken, Thomas; Alhaddad, Bader; Kremer, Laura S.; Kopajtich, Robert; Feichtinger, Rene G.; Sperl, Wolfgang; Rodenburg, Richard J.; Minet, Jean Claude; Dobbie, Angus; Strom, Tim M.; Meitinger, Thomas; George, Peter M.; Johnson, Colin A.; Taylor, Robert W.; Prokisch, Holger; Doudney, Kit; Mayr, Johannes A.			Sudden Cardiac Death Due to Deficiency of the Mitochondrial Inorganic Pyrophosphatase PPA2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ATP SYNTHASE DEFICIENCY; SACCHAROMYCES-CEREVISIAE; MUTATIONS; GENE; DEPLETION; SUBUNIT; ACETATE; LIVER; HEART	We have used whole-exome sequencing in ten individuals from four unrelated pedigrees to identify biallelic missense mutations in the nuclear-encoded mitochondrial inorganic pyrophosphatase (PPA2) that are associated with mitochondrial disease. These individuals show a range of severity, indicating that PPA2 mutations may cause a spectrum of mitochondrial disease phenotypes. Severe symptoms include seizures, lactic acidosis, cardiac arrhythmia, and death within days of birth. In the index family, presentation was milder and manifested as cardiac fibrosis and an exquisite sensitivity to alcohol, leading to sudden arrhythmic cardiac death in the second decade of life. Comparison of normal and mutant PPA2-containing mitochondria from fibroblasts showed that the activity of inorganic pyrophosphatase was significantly reduced in affected individuals. Recombinant PPA2 enzymes modeling hypomorphic missense mutations had decreased activity that correlated with disease severity. These findings confirm the pathogenicity of PPA2 mutations and suggest that PPA2 is a cardiomyopathy-associated protein, which has a greater physiological importance in mitochondrial function than previously recognized.	[Kennedy, Hannah; Potter, Howard; Mackay, Richard; King, Richard; Mead, Scott; Florkowski, Chris M.; George, Peter M.; Doudney, Kit] Canterbury Dist Hlth Board, Canterbury Hlth Labs, Mol Pathol Lab, Christchurch 8140, New Zealand; [Kennedy, Hannah; George, Peter M.] Univ Otago, Dept Pathol, Christchurch 8140, New Zealand; [Haack, Tobias B.; Alhaddad, Bader; Kremer, Laura S.; Kopajtich, Robert; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] German Res Ctr Environm Hlth, Inst Human Genet, Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany; [Haack, Tobias B.; Alhaddad, Bader; Kremer, Laura S.; Kopajtich, Robert; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Hartill, Verity; Johnson, Colin A.] Univ Leeds, Leeds Inst Biomed & Clin Sci, Sect Ophthalmol & Neurosci, Leeds LS9 7TF, W Yorkshire, England; [Matakovic, Lavinija; Feichtinger, Rene G.; Sperl, Wolfgang; Mayr, Johannes A.] Paracelsus Med Univ Salzburg, Dept Pediat, A-5020 Salzburg, Austria; [Baumgartner, E. Regula] Univ Childrens Hosp Basel UKBB, Metab Unit, CH-4056 Basel, Switzerland; [Alston, Charlotte L.; McFarland, Robert; Taylor, Robert W.] Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [O'Sullivan, Siobhan] Royal Hosp Sick Children, Dept Metab Paediat, Belfast BT12 6BA, Antrim, North Ireland; [Connolly, Grainne] Royal Victoria Hosp, Dept Clin Biochem, Belfast BT12 6BA, Antrim, North Ireland; [Gannon, Caroline] Royal Victoria Hosp, Dept Pathol, Belfast BT12 6BA, Antrim, North Ireland; [Crozier, Ian; Chan, Wandy] Christchurch Hosp, Canterbury Dist Hlth Board, Dept Cardiol, Christchurch 8140, New Zealand; [Chan, Wandy] Univ Queensland, Sch Med, Brisbane, Qld 4006, Australia; [Sage, Martin] Christchurch Hosp, Dept Anat Pathol, Canterbury Dist Hlth Board, Christchurch 8140, New Zealand; [Hofken, Thomas] Brunel Univ London, Dept Life Sci, Uxbridge UB8 3PH, Middx, England; [Rodenburg, Richard J.] Radboud Univ Nijmegen Med Ctr, Nijmegen Ctr Mitochondrial Disorders, Dept Pediat, NL-6500 HB Nijmegen, Netherlands; [Minet, Jean Claude] Univ Childrens Hosp Basel, Dept Neonatol UKBB Bruderholz, CH-4056 Basel, Switzerland; [Dobbie, Angus] Chapel Allerton Hosp, Yorkshire Reg Genet Serv, Leeds LS7 4SA, W Yorkshire, England; [Meitinger, Thomas] DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, D-80802 Munich, Germany; [Mead, Scott] Prince Wales Hosp, SEALS Genet Lab, Sydney, NSW 2031, Australia; [Sage, Martin] New Zealand Natl Forens Pathol Serv, Christchurch 8013, New Zealand	Canterbury Health Laboratories; University of Otago; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Leeds; Paracelsus Private Medical University; University of Basel; Newcastle University - UK; Christchurch Hospital New Zealand; University of Queensland; Christchurch Hospital New Zealand; Brunel University; Radboud University Nijmegen; University of Basel; Chapel Allerton Hospital; German Centre for Cardiovascular Research; Munich Heart Alliance	George, PM (corresponding author), Canterbury Dist Hlth Board, Canterbury Hlth Labs, Mol Pathol Lab, Christchurch 8140, New Zealand.; George, PM (corresponding author), Univ Otago, Dept Pathol, Christchurch 8140, New Zealand.; Mayr, JA (corresponding author), Paracelsus Med Univ Salzburg, Dept Pediat, A-5020 Salzburg, Austria.	peter.george@cdhb.health.nz; h.mayr@salk.at	Meitinger, Thomas/O-1318-2015; Alston, Charlotte/ABG-9602-2020; Doudney, Kit/Q-9728-2019; Alhaddad, Bader/AAJ-5504-2021; Florkowski, Christopher/ABF-9504-2020; Rodenburg, Richard/N-3579-2014	Alston, Charlotte/0000-0003-2095-5464; Doudney, Kit/0000-0002-0089-1152; Alhaddad, Bader/0000-0003-4542-5267; Rodenburg, Richard/0000-0001-5227-3527; Kennedy, Hannah/0000-0002-5393-8348; McFarland, Robert/0000-0002-8833-2688; Mayr, Johannes/0000-0001-6970-336X; Prokisch, Holger/0000-0003-2379-6286; Johnson, Colin/0000-0002-2979-8234; Meitinger, Thomas/0000-0002-8838-8403; Kremer, Laura/0000-0002-1647-7538	Maia Health Foundation; British Heart Foundation [FS/13/32/30069]; Sir Jules Thorn Award [09/JTA]; EC FP7-PEOPLE-ITN Mitochondrial European Educational Training (MEET) Project (GA) [317433]; Add-On-Project of the PMU-FFF [A-12/01/005-SPE]; Vereinigung zur Forderung padiatrischer Forschung und Fortbildung; German Bundesministerium fur Bildung und Forschung (BMBF) through the German Network for mitochondrial disorders [mitoNET 01GM1113C]; E-Rare project GENOMIT [01GM1207]; BMBF through the Juniorverbund in der Systemmedizin "mitOmics" [FKZ 01ZX1405C]; BMBF through the DZHK (German Centre for Cardiovascular Research) [Z76010017300, Z56010015300]; Wellcome Trust Centre for Mitochondrial Research [096919Z/11/Z]; Medical Research Council (UK) Centre for Translational Muscle Disease Research [G0601943]; Lily Foundation; UK NHS Highly Specialised Commissioners; National Institute for Health Research (NIHR) [NIHR-HCS-D12-03-04]; MRC [G0601943] Funding Source: UKRI; Medical Research Council [G0601943] Funding Source: researchfish; National Institute for Health Research [NIHR-HCS-D12-03-04] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish	Maia Health Foundation; British Heart Foundation(British Heart Foundation); Sir Jules Thorn Award; EC FP7-PEOPLE-ITN Mitochondrial European Educational Training (MEET) Project (GA); Add-On-Project of the PMU-FFF; Vereinigung zur Forderung padiatrischer Forschung und Fortbildung; German Bundesministerium fur Bildung und Forschung (BMBF) through the German Network for mitochondrial disorders(Federal Ministry of Education & Research (BMBF)); E-Rare project GENOMIT; BMBF through the Juniorverbund in der Systemmedizin "mitOmics"(Federal Ministry of Education & Research (BMBF)); BMBF through the DZHK (German Centre for Cardiovascular Research); Wellcome Trust Centre for Mitochondrial Research(Wellcome Trust); Medical Research Council (UK) Centre for Translational Muscle Disease Research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lily Foundation; UK NHS Highly Specialised Commissioners; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); The Sir Jules Thorn Charitable Trust	We thank Dr. Kym Mina and Gabe Kolle for data processing advice, Prof. Werner Wegmann (Institute of Pathology, Kantonsspital Baselland/Liestal, Switzerland) for careful autopsy work-up, and Eilidh Jackson and Ruth Charlton (Yorkshire Regional Genetics Service, Leeds Teaching Hospitals NHS Trust) for performing Sanger sequencing. This work was supported by the Maia Health Foundation, a British Heart Foundation clinical training fellowship (FS/13/32/30069 to V.H.), a Sir Jules Thorn Award (09/JTA to C.A.J.), the EC FP7-PEOPLE-ITN Mitochondrial European Educational Training (MEET) Project (GA #317433 to H. Prokisch and J.A.M.), the Add-On-Project of the PMU-FFF (A-12/01/005-SPE to W.S.), the Vereinigung zur Forderung padiatrischer Forschung und Fortbildung, by the German Bundesministerium fur Bildung und Forschung (BMBF) through the German Network for mitochondrial disorders (mitoNET 01GM1113C to T.M. and H. Prokisch), the E-Rare project GENOMIT (01GM1207 to T.M. and H. Prokisch), by the BMBF through the Juniorverbund in der Systemmedizin "mitOmics" (FKZ 01ZX1405C to T.B.H.), by the BMBF through the DZHK (German Centre for Cardiovascular Research, Z76010017300 and Z56010015300 to T.M.), and by grants to R.W.T. from The Wellcome Trust Centre for Mitochondrial Research (096919Z/11/Z), the Medical Research Council (UK) Centre for Translational Muscle Disease Research (G0601943), The Lily Foundation, and the UK NHS Highly Specialised Commissioners, which funds the "Rare Mitochondrial Disorders of Adults and Children" Diagnostic Service in Newcastle upon Tyne. C.L.A. is the recipient of a National Institute for Health Research (NIHR) doctoral fellowship (NIHR-HCS-D12-03-04). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.	Banka S, 2014, MOL GENET METAB, V113, P301, DOI 10.1016/j.ymgme.2014.09.010; Bentlage HACM, 1996, NEUROLOGY, V47, P243, DOI 10.1212/WNL.47.1.243; Bindoff LA, 2012, EPILEPSIA, V53, P92, DOI 10.1111/j.1528-1167.2012.03618.x; Cameron JM, 2006, AM J MED GENET A, V140A, P1542, DOI 10.1002/ajmg.a.31313; Cizkova A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246; Curbo S, 2006, GENOMICS, V87, P410, DOI 10.1016/j.ygeno.2005.09.017; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Heikinheimo P, 1996, EUR J BIOCHEM, V239, P138, DOI 10.1111/j.1432-1033.1996.0138u.x; Holzerova E, 2016, BRAIN, V139, P346, DOI 10.1093/brain/awv350; Jose T, 2011, INT J CARDIOL, V149, pE24, DOI 10.1016/j.ijcard.2009.03.057; KUGE S, 1994, EMBO J, V13, P655, DOI 10.1002/j.1460-2075.1994.tb06304.x; LUNDIN M, 1991, J BIOL CHEM, V266, P12168; Mayr JA, 2010, HUM MOL GENET, V19, P3430, DOI 10.1093/hmg/ddq254; Rahman S, 2013, J INHERIT METAB DIS, V36, P659, DOI 10.1007/s10545-013-9614-2; Serrano-Bueno G, 2013, J BIOL CHEM, V288, P13082, DOI 10.1074/jbc.M112.439349; Stockbridge RB, 2011, J BIOL CHEM, V286, P18538, DOI 10.1074/jbc.M110.214510; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X; VOLK SE, 1983, BIOCHIM BIOPHYS ACTA, V744, P127, DOI 10.1016/0167-4838(83)90081-X; Yamashita H, 2001, BBA-MOL CELL BIOL L, V1532, P79, DOI 10.1016/S1388-1981(01)00117-2	20	28	31	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 1	2016	99	3					674	682		10.1016/j.ajhg.2016.06.027	http://dx.doi.org/10.1016/j.ajhg.2016.06.027			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DV7KM	27523597	Green Submitted, Green Published, hybrid			2022-12-18	WOS:000383114800012
J	Tokita, MJ; Braxton, AA; Shao, YR; Lewis, AM; Vincent, M; Kury, S; Besnard, T; Isidor, B; Latypova, X; Bezieau, S; Liu, P; Motter, CS; Melver, CW; Robin, NH; Infante, EM; McGuire, M; El-Gharbawy, A; Littlejohn, RO; McLean, SD; Bi, WM; Bacino, CA; Lalani, SR; Scott, DA; Eng, CM; Yang, YP; Schaaf, CP; Walkiewicz, MA				Tokita, Mari J.; Braxton, Alicia A.; Shao, Yunru; Lewis, Andrea M.; Vincent, Marie; Kury, Sebastien; Besnard, Thomas; Isidor, Bertrand; Latypova, Xenia; Bezieau, Stephane; Liu, Pengfei; Motter, Connie S.; Melver, Catherine Ward; Robin, Nathaniel H.; Infante, Elena M.; McGuire, Marianne; El-Gharbawy, Areeg; Littlejohn, Rebecca O.; McLean, Scott D.; Bi, Weimin; Bacino, Carlos A.; Lalani, Seema R.; Scott, Daryl A.; Eng, Christine M.; Yang, Yaping; Schaaf, Christian P.; Walkiewicz, Magdalena A.			De Novo Truncating Variants in SON Cause Intellectual Disability, Congenital Malformations, and Failure to Thrive	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTERCHROMATIN GRANULE CLUSTERS; MENTAL-RETARDATION; DELETION; PHENOTYPE; 21Q22.11; DISEASE; PROTEIN; 21Q; HAPLOINSUFFICIENCY; THROMBOCYTOPENIA	SON is a key component of the spliceosomal complex and a critical mediator of constitutive and alternative splicing. Additionally, SON has been shown to influence cell-cycle progression, genomic integrity, and maintenance of pluripotency in stem cell populations. The clear functional relevance of SON in coordinating essential cellular processes and its presence in diverse human tissues suggests that intact SON might be crucial for normal growth and development. However, the phenotypic effects of deleterious germline variants in SON have not been clearly defined. Herein, we describe seven unrelated individuals with de novo variants in SON and propose that deleterious variants in SON are associated with a severe multisystem disorder characterized by developmental delay, persistent feeding difficulties, and congenital malformations, including brain anomalies.	[Tokita, Mari J.; Braxton, Alicia A.; Shao, Yunru; Lewis, Andrea M.; Liu, Pengfei; Bi, Weimin; Bacino, Carlos A.; Lalani, Seema R.; Scott, Daryl A.; Eng, Christine M.; Yang, Yaping; Schaaf, Christian P.; Walkiewicz, Magdalena A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Tokita, Mari J.; Braxton, Alicia A.; Liu, Pengfei; McGuire, Marianne; Bi, Weimin; Eng, Christine M.; Yang, Yaping; Walkiewicz, Magdalena A.] Baylor Miraca Genet Labs, Houston, TX 77021 USA; [Shao, Yunru; Lewis, Andrea M.; Bacino, Carlos A.; Lalani, Seema R.; Scott, Daryl A.; Eng, Christine M.; Schaaf, Christian P.] Texas Childrens Hosp, Houston, TX 77030 USA; [Vincent, Marie; Kury, Sebastien; Besnard, Thomas; Isidor, Bertrand; Latypova, Xenia; Bezieau, Stephane] Ctr Hosp Univ Nantes, Gen Med Serv, F-44093 Nantes 1, France; [Isidor, Bertrand] INSERM, UMR S 957, 1 Rue Gaston Veil, F-44035 Nantes, France; [Motter, Connie S.; Melver, Catherine Ward] Akron Childrens Hosp, Genet Ctr, Akron, OH 44302 USA; [Robin, Nathaniel H.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Infante, Elena M.; McGuire, Marianne; El-Gharbawy, Areeg] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15224 USA; [Infante, Elena M.; McGuire, Marianne; El-Gharbawy, Areeg] Childrens Hosp Pittsburgh, Pittsburgh, PA 15224 USA; [Littlejohn, Rebecca O.; McLean, Scott D.] Childrens Hosp San Antonio, San Antonio, TX 78207 USA; [Scott, Daryl A.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Schaaf, Christian P.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Akron Children's Hospital; University of Alabama System; University of Alabama Birmingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Baylor College of Medicine; Baylor College of Medicine	Schaaf, CP; Walkiewicz, MA (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Schaaf, CP (corresponding author), Texas Childrens Hosp, Houston, TX 77030 USA.; Schaaf, CP (corresponding author), Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA.	schaaf@bcm.edu; mwalkiew@bcm.edu	Lalani, Seema/AAI-5090-2020; Isidor, Bertrand/AAJ-3456-2021; El-gharbawy, Areeg/N-5134-2017; Besnard, Thomas/L-2303-2019; BESNARD, Thomas/D-1329-2018; KÜRY, Sébastien/G-5971-2015; Schaaf, Christian P/AAJ-7318-2021; Vincent, Marie/K-7342-2018	Isidor, Bertrand/0000-0001-6480-126X; Besnard, Thomas/0000-0003-4804-5147; BESNARD, Thomas/0000-0003-4804-5147; KÜRY, Sébastien/0000-0001-5497-0465; Schaaf, Christian P/0000-0002-2148-7490; Vincent, Marie/0000-0003-1010-5618				Ahn EY, 2011, MOL CELL, V42, P185, DOI 10.1016/j.molcel.2011.03.014; Beri-Dexheimer M, 2008, EUR J HUM GENET, V16, P1014, DOI 10.1038/ejhg.2008.89; Bernier FP, 2012, AM J HUM GENET, V90, P925, DOI 10.1016/j.ajhg.2012.04.004; Bimey E, 1993, NUCLEIC ACIDS RES, V21, P5803; Carrascosa-Romero MC, 2013, AM J MED GENET A, V161, P2281, DOI 10.1002/ajmg.a.35862; Fukai R, 2014, AM J MED GENET A, V164, P1021, DOI 10.1002/ajmg.a.36377; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Hickey CJ, 2014, J CELL BIOCHEM, V115, P224, DOI 10.1002/jcb.24672; Hoyer J, 2007, J MED GENET, V44, P629, DOI 10.1136/jmg.2007.050914; Huen MSY, 2010, CELL CYCLE, V9, P2679, DOI 10.4161/cc.9.13.12151; Izumi K, 2012, AM J MED GENET A, V158A, P1535, DOI 10.1002/ajmg.a.35368; Katzaki E, 2010, AM J MED GENET A, V152A, P1711, DOI 10.1002/ajmg.a.33478; KHAN IM, 1994, ANN HUM GENET, V58, P25, DOI 10.1111/j.1469-1809.1994.tb00723.x; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; Lehalle D, 2015, CLIN GENET, V88, P405, DOI 10.1111/cge.12596; Lek M, 2015, BIORXIV; Lindstrand A, 2010, CLIN GENET, V77, P145, DOI 10.1111/j.1399-0004.2009.01289.x; Lu XY, 2014, WIRES RNA, V5, P637, DOI 10.1002/wrna.1235; Lyle R, 2009, EUR J HUM GENET, V17, P454, DOI 10.1038/ejhg.2008.214; MATTIONI T, 1992, CHROMOSOMA, V101, P618, DOI 10.1007/BF00360539; Padgett RA, 2012, TRENDS GENET, V28, P147, DOI 10.1016/j.tig.2012.01.001; Roberson EDO, 2011, EUR J HUM GENET, V19, P235, DOI 10.1038/ejhg.2010.150; Sacco-Bubulya P, 2002, J CELL BIOL, V156, P425, DOI 10.1083/jcb.200107017; Saitoh N, 2004, MOL BIOL CELL, V15, P3876, DOI 10.1091/mbc.E04-03-0253; Sawyer SL, 2016, CLIN GENET, V89, P275, DOI 10.1111/cge.12654; Sharma A, 2011, J CELL SCI, V124, P4286, DOI 10.1242/jcs.092239; Shinawi M, 2008, BLOOD, V112, P1042, DOI 10.1182/blood-2008-01-135970; Spector DL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000646; Thevenon J, 2011, AM J MED GENET A, V155A, P126, DOI 10.1002/ajmg.a.33809; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wynn SL, 2000, GENOMICS, V68, P57, DOI 10.1006/geno.2000.6254; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Zhong XY, 2009, MOL CELL, V35, P1, DOI 10.1016/j.molcel.2009.06.016; Zhu XL, 2015, GENET MED, V17, P774, DOI 10.1038/gim.2014.191	35	28	31	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 1	2016	99	3					720	727		10.1016/j.ajhg.2016.06.035	http://dx.doi.org/10.1016/j.ajhg.2016.06.035			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DV7KM	27545676	Green Published, Bronze			2022-12-18	WOS:000383114800017
J	Coppieters, F; Ascari, G; Dannhausen, K; Nikopoulos, K; Peelman, F; Karlstetter, M; Xu, MC; Brachet, C; Meunier, I; Tsilimbaris, MK; Tsika, C; Blazaki, SV; Vergult, S; Farinelli, P; Van Laethem, T; Bauwens, M; De Bruyne, M; Chen, R; Langmann, T; Sui, RF; Meire, F; Rivolta, C; Hamel, CP; Leroy, BP; De Baere, E				Coppieters, Frauke; Ascari, Giulia; Dannhausen, Katharina; Nikopoulos, Konstantinos; Peelman, Frank; Karlstetter, Marcus; Xu, Mingchu; Brachet, Cecile; Meunier, Isabelle; Tsilimbaris, Miltiadis K.; Tsika, Chrysanthi; Blazaki, Styliani V.; Vergult, Sarah; Farinelli, Pietro; Van Laethem, Thalia; Bauwens, Miriam; De Bruyne, Marieke; Chen, Rui; Langmann, Thomas; Sui, Ruifang; Meire, Francoise; Rivolta, Carlo; Hamel, Christian P.; Leroy, Bart P.; De Baere, Elfride			Isolated and Syndromic Retinal Dystrophy Caused by Biallelic Mutations in RCBTB1, a Gene Implicated in Ubiquitination	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOMINANT RETINITIS-PIGMENTOSA; TRANSCRIPTION FACTOR NRF2; CONJUGATING ENZYME; EXPRESSION ANALYSIS; PROTEASOME SYSTEM; CHROMOSOME 13Q14; RESPONSE ELEMENT; PROTEIN; DISEASE; TOPORS	Inherited retinal dystrophies (iRDs) are a group of genetically and clinically heterogeneous conditions resulting from mutations in over 250 genes. Here, homozygosity mapping and whole-exome sequencing (WES) in a consanguineous family revealed a homozygous missense mutation, c.973C>T (p.His325Tyr), in RCBTB1. In affected individuals, it was found to segregate with retinitis pigmentosa (RP), goiter, primary ovarian insufficiency, and mild intellectual disability. Subsequent analysis of WES data in different cohorts uncovered four additional homozygous missense mutations in five unrelated families in whom iRD segregates with or without syndromic features. Ocular phenotypes ranged from typical RP starting in the second decade to chorioretinal dystrophy with a later age of onset. The five missense mutations affect highly conserved residues either in the sixth repeat of the RCC1 domain or in the BTB1 domain. A founder haplotype was identified for mutation c.919G>A (p.Val307Met), occurring in two families of Mediterranean origin. We showed ubiquitous mRNA expression of RCBTB1 and demonstrated predominant RCBTB1 localization in human inner retina. RCBTB1 was very recently shown to be involved in ubiquitination, more specifically as a CUL3 substrate adaptor. Therefore, the effect on different components of the CUL3 and NFE2L2 (NRF2) pathway was assessed in affected individuals' lymphocytes, revealing decreased mRNA expression of NFE2L2 and several NFE2L2 target genes. In conclusion, our study puts forward mutations in RCBTB1 as a cause of autosomal-recessive non-syndromic and syndromic iRD. Finally, our data support a role for impaired ubiquitination in the pathogenetic mechanism of RCBTB1 mutations.	[Coppieters, Frauke; Ascari, Giulia; Vergult, Sarah; Van Laethem, Thalia; Bauwens, Miriam; De Bruyne, Marieke; Leroy, Bart P.; De Baere, Elfride] Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium; [Coppieters, Frauke; Ascari, Giulia; Vergult, Sarah; Van Laethem, Thalia; Bauwens, Miriam; De Bruyne, Marieke; Leroy, Bart P.; De Baere, Elfride] Ghent Univ Hosp, B-9000 Ghent, Belgium; [Coppieters, Frauke] Pxlence BVBA, B-9200 Dendermonde, Belgium; [Dannhausen, Katharina; Karlstetter, Marcus; Langmann, Thomas] Univ Cologne, Dept Ophthalmol, D-50931 Cologne, Germany; [Nikopoulos, Konstantinos; Farinelli, Pietro; Rivolta, Carlo] Univ Lausanne, Dept Computat Biol, Unit Med Genet, CH-1011 Lausanne, Switzerland; [Peelman, Frank] Univ Ghent, Flanders Inst Biotechnol VIB, Dept Med Prot Res, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Karlstetter, Marcus] Bayer Pharma AG, Therapeut Res Grp Ophthalmol, D-42096 Wuppertal, Germany; [Xu, Mingchu; Chen, Rui] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Brachet, Cecile] Univ Libre Bruxelles, Pediat Endocrinol Unit, Hop Univ Enfants Reine Fabiola, B-1000 Brussels, Belgium; [Meunier, Isabelle; Hamel, Christian P.] Ctr Hosp Univ Montpellier, Genet Sensory Dis, F-34295 Montpellier, France; [Meunier, Isabelle; Hamel, Christian P.] Univ Montpellier, F-34090 Montpellier, France; [Meunier, Isabelle; Hamel, Christian P.] INSERM, Inst Neurosci Montpellier, U1051, F-34091 Montpellier, France; [Tsilimbaris, Miltiadis K.; Tsika, Chrysanthi; Blazaki, Styliani V.] Univ Crete, Sch Med, Dept Ophthalmol, Iraklion 71409, Greece; [Chen, Rui] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Sui, Ruifang] Chinese Acad Med Sci, Dept Ophthalmol, Peking Union Med Coll Hosp, Peking Union Med Coll, Beijing 100730, Peoples R China; [Meire, Francoise] Hop Univ Enfants Reine Fabiola, Dept Ophthalmol, B-1000 Brussels, Belgium; [Leroy, Bart P.] Ghent Univ Hosp, Dept Ophthalmol, B-9000 Ghent, Belgium; [Leroy, Bart P.] Univ Ghent, B-9000 Ghent, Belgium; [Leroy, Bart P.] Childrens Hosp Philadelphia, Div Ophthalmol, Philadelphia, PA 19104 USA	Ghent University; Ghent University; Ghent University Hospital; University of Cologne; University of Lausanne; Flanders Institute for Biotechnology (VIB); Ghent University; Bayer AG; Bayer Healthcare Pharmaceuticals; Baylor College of Medicine; Universite Libre de Bruxelles; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Crete; Baylor College of Medicine; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Ghent University; Ghent University Hospital; Ghent University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Coppieters, F; De Baere, E (corresponding author), Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium.; Coppieters, F; De Baere, E (corresponding author), Ghent Univ Hosp, B-9000 Ghent, Belgium.; Coppieters, F (corresponding author), Pxlence BVBA, B-9200 Dendermonde, Belgium.	frauke.coppieters@ugent.be; elfride.debaere@ugent.be	Ascari, Giulia/AAS-8571-2020; Xu, Mingchu/J-9369-2019; Farinelli, Pietro/G-8000-2017; Brachet, Cécile/AAL-2105-2020; De Baere, Elfride/E-7405-2017	Farinelli, Pietro/0000-0002-4242-3090; De Baere, Elfride/0000-0002-5609-6895; Rivolta, Carlo/0000-0002-0733-9950; Vergult, Sarah/0000-0002-0816-6262; De Bruyne, Marieke/0000-0001-6636-5537; Brachet, Cecile/0000-0001-7955-2534; Nikopoulos, Konstantinos/0000-0002-1856-2752; Ascari, Giulia/0000-0001-6175-6774; Coppieters, Frauke/0000-0001-7224-0992; Tsilimbaris, Miltiadis/0000-0002-0130-1150	Funds for Research in Ophthalmology; Research Foundation Flanders (FWO) [FWO 3G079711, FWO 1520913N, 1515615N]; Ghent University [BOF15/GOA/011]; Belspo IAP project (Belgian Medical Genomics Initiative) [P7/43]; programme EyeTN [FP7-PEOPLE-446 2012-ITN, 317472]; Hercules Foundation [AUGE/13/023]; NIH [1S10RR026550]; National Eye Institute (NEI) [R01EY022356, R01EY018571]; Foundation Fighting Blindness [BR-GE-0613-0618-BCM]; NEI-NIH [EY-002520]; National Natural Science Foundation of China [81470669]; Foundation Fighting Blindness USA [CD-CL-0214-0631-PUMCH]; EyeTN programme [317472]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026550] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY002520, R01EY018571, R01EY022356] Funding Source: NIH RePORTER	Funds for Research in Ophthalmology; Research Foundation Flanders (FWO)(FWO); Ghent University(Ghent University); Belspo IAP project (Belgian Medical Genomics Initiative); programme EyeTN; Hercules Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Foundation Fighting Blindness(European Commission); NEI-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation Fighting Blindness USA; EyeTN programme; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We are most grateful to the family members who participated in this study. This work was supported by grants from the Funds for Research in Ophthalmology (to G.A.), the Research Foundation Flanders (FWO) (FWO 3G079711 to E.D.B. and FWO 1520913N and 1515615N to F.C.), the Ghent University Special Research Fund (BOF15/GOA/011), Belspo IAP project P7/43 (Belgian Medical Genomics Initiative), the FP7-PEOPLE-446 2012-ITN programme EyeTN (317472 to E.D.B., F.C., B.P.L., and C.P.H.), the Hercules Foundation (AUGE/13/023 to E.D.B.), the NIH (1S10RR026550 to R.C.), the National Eye Institute (NEI, R01EY022356 and R01EY018571 to R.C.), the Foundation Fighting Blindness (BR-GE-0613-0618-BCM to R.C.), the NEI-NIH Core Grant for Vision Research (EY-002520), the National Natural Science Foundation of China (81470669 to R.S.), and the Foundation Fighting Blindness USA (CD-CL-0214-0631-PUMCH to R.S.). F.C. is senior postdoctoral fellow of the FWO, S.V. is a postdoctoral fellow of the Special Research Fund (BOF) from Ghent University, M.B. is a doctoral fellow of the FWO, and E.D.B. and B.P.L. are senior clinical investigators of the FWO. G.A. is a doctoral fellow of the EyeTN programme (grant no. 317472).	Aijaz S, 2005, GENOMICS, V86, P86, DOI 10.1016/j.ygeno.2005.03.002; Al-Sawaf O, 2015, CLIN SCI, V129, P989, DOI 10.1042/CS20150436; Berger W, 2010, PROG RETIN EYE RES, V29, P335, DOI 10.1016/j.preteyeres.2010.03.004; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Burke TR, 2011, OPHTHALMIC GENET, V32, P165, DOI 10.3109/13816810.2011.565397; Campello L, 2013, MOL NEUROBIOL, V47, P790, DOI 10.1007/s12035-012-8391-5; Casey JP, 2016, HUM MOL GENET, V25, P1824, DOI 10.1093/hmg/ddw054; Chakarova CF, 2011, HUM MOL GENET, V20, P975, DOI 10.1093/hmg/ddq543; De Leeneer K, 2015, HUM MUTAT, V36, P379, DOI 10.1002/humu.22739; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Friedman JS, 2009, AM J HUM GENET, V84, P792, DOI 10.1016/j.ajhg.2009.05.007; Genschik P, 2013, EMBO J, V32, P2307, DOI 10.1038/emboj.2013.173; German OL, 2013, J LIPID RES, V54, P2236, DOI 10.1194/jlr.M039040; Guo DF, 2004, J BIOL CHEM, V279, P21109, DOI 10.1074/jbc.M401544200; Hadjebi O, 2008, BBA-MOL CELL RES, V1783, P1467, DOI 10.1016/j.bbamcr.2008.03.015; Himori N, 2013, J NEUROCHEM, V127, P669, DOI 10.1111/jnc.12325; HSU JH, 1995, ENDOCRINOLOGY, V136, P421, DOI 10.1210/en.136.2.421; Hu XM, 2006, MOL CELL BIOL, V26, P940, DOI 10.1128/MCB.26.3.940-954.2006; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Janssen JJM, 1999, CURR EYE RES, V19, P338, DOI 10.1076/ceyr.19.4.338.5307; Karlstetter M, 2014, HUM MOL GENET, V23, P5197, DOI 10.1093/hmg/ddu242; Kasahara K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6081; Kaspar JW, 2010, J BIOL CHEM, V285, P21349, DOI 10.1074/jbc.M110.121863; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kigoshi Y, 2011, J BIOL CHEM, V286, P33613, DOI 10.1074/jbc.M111.245126; Krieger E, 2015, J COMPUT CHEM, V36, P996, DOI 10.1002/jcc.23899; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Lee K, 2015, GENET MED, V17, P245, DOI 10.1038/gim.2015.15; Lenassi E, 2015, EUR J HUM GENET, V23, P1318, DOI 10.1038/ejhg.2014.283; Lim J, 2015, REPROD TOXICOL, V58, P24, DOI 10.1016/j.reprotox.2015.07.080; Mabuchi H, 2001, CANCER RES, V61, P2870; Mirza S, 2010, MOL VIS, V16, P2425; Murugan AK, 2010, BIOCHEM BIOPH RES CO, V393, P555, DOI 10.1016/j.bbrc.2010.02.095; Perez-Torrado R, 2006, BIOESSAYS, V28, P1194, DOI 10.1002/bies.20500; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Petty HR, 2010, J NEUROSCI METH, V191, P222, DOI 10.1016/j.jneumeth.2010.07.001; Plafker KS, 2015, MOL BIOL CELL, V26, P327, DOI 10.1091/mbc.E14-06-1057; Plafker KS, 2009, BIOCHEMISTRY-US, V48, P3527, DOI 10.1021/bi801971m; Plafker KS, 2008, INVEST OPHTH VIS SCI, V49, P5611, DOI 10.1167/iovs.08-1698; Poncin S, 2010, AM J PATHOL, V176, P1355, DOI 10.2353/ajpath.2010.090682; Poncin S, 2009, J ENDOCRINOL, V201, P161, DOI 10.1677/JOE-08-0470; Rajendra R, 2004, J BIOL CHEM, V279, P36440, DOI 10.1074/jbc.C400300200; Ramachandran PS, 2015, J CLIN INVEST, V125, P1390, DOI 10.1172/JCI80821; Renner AB, 2009, AM J OPHTHALMOL, V147, P518, DOI 10.1016/j.ajo.2008.09.007; Roosing S, 2015, OPHTHALMOLOGY, V122, P170, DOI 10.1016/j.ophtha.2014.07.040; Sachdeva MM, 2014, EXP EYE RES, V119, P111, DOI 10.1016/j.exer.2013.10.024; Schrauwen I, 2016, HEARING RES, V333, P266, DOI 10.1016/j.heares.2015.08.013; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Solomou EE, 2003, LEUKEMIA LYMPHOMA, V44, P1579, DOI 10.1080/1042819031000099670; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Suzuki T, 2013, TRENDS PHARMACOL SCI, V34, P340, DOI 10.1016/j.tips.2013.04.005; Teshiba R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065141; Vasireddy V, 2009, EXP EYE RES, V89, P905, DOI 10.1016/j.exer.2009.07.021; Wang LY, 2014, ARTERIOSCL THROM VAS, V34, P219, DOI 10.1161/ATVBAHA.113.302706; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Weger S, 2005, FEBS LETT, V579, P5007, DOI 10.1016/j.febslet.2005.07.088; Wheway G, 2015, NAT CELL BIOL, V17, P1074, DOI 10.1038/ncb3201; Wu JH, 2016, HUM MOL GENET, V25, P1637, DOI 10.1093/hmg/ddw041; Xiong WJ, 2015, J CLIN INVEST, V125, P1433, DOI 10.1172/JCI79735; Xu MC, 2016, HUM MOL GENET, V25, P1479, DOI 10.1093/hmg/ddw022; Zalli D, 2012, HUM MOL GENET, V21, P1155, DOI 10.1093/hmg/ddr544; Zhao YG, 2003, P NATL ACAD SCI USA, V100, P9005, DOI 10.1073/pnas.1537759100; Zhao ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019456; Zhong Q, 2013, INVEST OPHTH VIS SCI, V54, P3941, DOI 10.1167/iovs.13-11598; Zhou XB, 2010, CANCER RES, V70, P9434, DOI 10.1158/0008-5472.CAN-10-1960	66	28	29	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 4	2016	99	2					470	480		10.1016/j.ajhg.2016.06.017	http://dx.doi.org/10.1016/j.ajhg.2016.06.017			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TO	27486781	hybrid, Green Published, Green Accepted			2022-12-18	WOS:000381617200019
J	Breuss, MW; Sultan, T; James, KN; Rosti, RO; Scott, E; Musaev, D; Furia, B; Reis, A; Sticht, H; Al-Owain, M; Alkuraya, FS; Reuter, MS; Abou Jamra, R; Trotta, CR; Gleeson, JG				Breuss, Martin W.; Sultan, Tipu; James, Kiely N.; Rosti, Rasim O.; Scott, Eric; Musaev, Damir; Furia, Bansri; Reis, Andre; Sticht, Heinrich; Al-Owain, Mohammed; Alkuraya, Fowzan S.; Reuter, Miriam S.; Abou Jamra, Rami; Trotta, Christopher R.; Gleeson, Joseph G.			Autosomal- Recessive Mutations in the tRNA Splicing Endonuclease Subunit TSEN15 Cause Pontocerebellar Hypoplasia and Progressive Microcephaly	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONSANGUINEOUS FAMILIES; ACTIVE-SITE; REVEALS; DISEASE; GENE; NEURODEGENERATION; SYNTHETASE; DISORDERS; ENZYME; TYPE-2	The tRNA splicing endonuclease is a highly evolutionarily conserved protein complex, involved in the cleavage of intron-containing tRNAs. In human it consists of the catalytic subunits TSEN2 and TSEN34, as well as the non-catalytic TSEN54 and TSEN15. Recessive mutations in the corresponding genes of the first three are known to cause pontocerebellar hypoplasia (PCH) types 2A-C, 4, and 5. Here, we report three homozygous TSEN15 variants that cause a milder version of PCH2. The affected individuals showed progressive microcephaly, delayed developmental milestones, intellectual disability, and, in two out of four cases, epilepsy. None, however, displayed the central visual failure seen in PCH case subjects where other subunits of the TSEN are mutated, and only one was affected by the extensive motor defects that are typical in other forms of PCH2. The three amino acid substitutions impacted the protein level of TSEN15 and the stoichiometry of the interacting subunits in different ways, but all resulted in an almost complete loss of in vitro tRNA cleavage activity. Taken together, our results demonstrate that mutations in any known subunit of the TSEN complex can cause PCH and progressive microcephaly, emphasizing the importance of its function during brain development.	[Breuss, Martin W.; James, Kiely N.; Rosti, Rasim O.; Scott, Eric; Musaev, Damir; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Neurosci, La Jolla, CA 92093 USA; [Breuss, Martin W.; James, Kiely N.; Rosti, Rasim O.; Scott, Eric; Musaev, Damir; Gleeson, Joseph G.] Rady Childrens Inst Genom Med, San Diego, CA 92025 USA; [Sultan, Tipu] Inst Child Hlth, Dept Pediat Neurol, Lahore 54000, Pakistan; [Sultan, Tipu] Childrens Hosp, Lahore 54000, Pakistan; [Furia, Bansri; Trotta, Christopher R.] PTC Therapeut, South Plainfield, NJ 07080 USA; [Reis, Andre; Reuter, Miriam S.; Abou Jamra, Rami] Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; [Sticht, Heinrich] Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany; [Al-Owain, Mohammed; Alkuraya, Fowzan S.] Alfaisal Univ, Dept Anat & Cell Biol, Coll Med, Riyadh 11211, Saudi Arabia; [Al-Owain, Mohammed] King Faisal Specialist Hosp & Res Ctr, Dept Med Genet, Riyadh 11211, Saudi Arabia; [Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Abou Jamra, Rami] Univ Leipzig Hosp & Clin, Inst Human Genet, D-04103 Leipzig, Germany	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Alfaisal University; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; Leipzig University	Gleeson, JG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Dept Neurosci, La Jolla, CA 92093 USA.; Gleeson, JG (corresponding author), Rady Childrens Inst Genom Med, San Diego, CA 92025 USA.	jogleeson@ucsd.edu	Reis, André/D-2309-2009; Abou Jamra, Rami/AAC-8192-2019; Breuss, Martin/AAL-9509-2021	Reis, André/0000-0002-6301-6363; Abou Jamra, Rami/0000-0002-1542-1399; Reis, AlessanRSS/0000-0001-8486-7469; Sticht, Heinrich/0000-0001-5644-045X; Breuss, Martin Werner/0000-0003-2200-8604	US NIH [P01HD070494, R01NS098004, R01NS083823]; Simons Foundation for Autism Research [275275]; Howard Hughes Medical Institute; KACST [13-BIO1113-20]; Saudi Human Genome Project; EMBO Long-Term Fellowship [ALTF 174-2015]; Marie Curie Actions of the European Commission (LTFCOFUND) [GA-2013-609409]; Deutsche Forschungsgemeinschaft (DFG) [AB393/1-2, AB393/2-2]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101, R01NS048453, R01NS083823, R01NS098004] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation for Autism Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); KACST; Saudi Human Genome Project; EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Marie Curie Actions of the European Commission (LTFCOFUND); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are indebted to the families for their participation in this study. This work was supported by the US NIH (grants P01HD070494, R01NS098004, and R01NS083823; J.G.G.), the Simons Foundation for Autism Research (grant no. 275275; J.G.G.), the Howard Hughes Medical Institute (J.G.G.), the KACST grant 13-BIO1113-20 (F.S.A.), and the Saudi Human Genome Project (F.S.A.). M.W.B. is supported by an EMBO Long-Term Fellowship (ALTF 174-2015), which is co-funded by the Marie Curie Actions of the European Commission (LTFCOFUND2013, GA-2013-609409). R.A.J. was supported by the Deutsche Forschungsgemeinschaft (DFG; AB393/1-2 and AB393/2-2). We thank Guoliang Chai and Anide Johansson for helpful discussions.	Abbott JA, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00158; Abelson J, 1998, J BIOL CHEM, V273, P12685, DOI 10.1074/jbc.273.21.12685; Abou Jamra R, 2011, EUR J HUM GENET, V19, P1161, DOI 10.1038/ejhg.2011.98; Alazami AM, 2015, CELL REP, V10, P148, DOI 10.1016/j.celrep.2014.12.015; Bierhals T, 2013, EUR J MED GENET, V56, P325, DOI 10.1016/j.ejmg.2013.03.009; Budde BS, 2008, NAT GENET, V40, P1113, DOI 10.1038/ng.204; Cassandrini D, 2010, NEUROLOGY, V75, P1459, DOI 10.1212/WNL.0b013e3181f88173; Dixon-Salazar TJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003544; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; Ishimura R, 2014, SCIENCE, V345, P455, DOI 10.1126/science.1249749; Karaca E, 2014, CELL, V157, P636, DOI 10.1016/j.cell.2014.02.058; Kirchner S, 2015, NAT REV GENET, V16, P98, DOI 10.1038/nrg3861; Li H, 1998, SCIENCE, V280, P279, DOI 10.1126/science.280.5361.279; Maras-Genc H, 2015, TURKISH J PEDIATR, V57, P286; Namavar Y, 2011, EUR J HUM GENET, V19, P724, DOI 10.1038/ejhg.2011.8; Novarino G, 2014, SCIENCE, V343, P506, DOI 10.1126/science.1247363; Paushkin SV, 2004, CELL, V117, P311, DOI 10.1016/S0092-8674(04)00342-3; Puffenberger EG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028936; Schaffer AE, 2014, CELL, V157, P651, DOI 10.1016/j.cell.2014.03.049; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Seelow D, 2012, NUCLEIC ACIDS RES, V40, pW516, DOI 10.1093/nar/gks487; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Shaheen R, 2016, HUM GENET, V135, P707, DOI 10.1007/s00439-016-1665-7; Song JK, 2007, J MOL BIOL, V366, P155, DOI 10.1016/j.jmb.2006.11.024; SZWEYKOWSKAKULINSKA Z, 1994, EMBO J, V13, P4636, DOI 10.1002/j.1460-2075.1994.tb06786.x; Trotta CR, 2006, NATURE, V441, P375, DOI 10.1038/nature04741; Trotta CR, 1997, CELL, V89, P849, DOI 10.1016/S0092-8674(00)80270-6; Zhang XC, 2014, AM J HUM GENET, V94, P547, DOI 10.1016/j.ajhg.2014.03.003; Zhou M, 2013, NATURE, V495, P111, DOI 10.1038/nature11833	29	28	29	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 7	2016	99	1					228	235		10.1016/j.ajhg.2016.05.023	http://dx.doi.org/10.1016/j.ajhg.2016.05.023			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TI	27392077	Green Published, Bronze			2022-12-18	WOS:000381616600020
J	Gee, HY; Jun, I; Braun, DA; Lawson, JA; Halbritter, J; Shril, S; Nelson, CP; Tan, WZ; Stein, D; Wassner, AJ; Ferguson, MA; Gucev, Z; Sayer, JA; Milosevic, D; Baum, M; Tasic, V; Lee, MG; Hildebrandt, F				Gee, Heon Yung; Jun, Ikhyun; Braun, Daniela A.; Lawson, Jennifer A.; Halbritter, Jan; Shril, Shirlee; Nelson, Caleb P.; Tan, Weizhen; Stein, Deborah; Wassner, Ari J.; Ferguson, Michael A.; Gucev, Zoran; Sayer, John A.; Milosevic, Danko; Baum, Michelle; Tasic, Velibor; Lee, Min Goo; Hildebrandt, Friedhelm			Mutations in SLC26A1 Cause Nephrolithiasis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							KIDNEY-STONES; ANION-EXCHANGER; SULFATE; BICARBONATE; PREVALENCE; CLONING; DISEASE; SAT-1; TWIN	Nephrolithiasis, a condition in which urinary supersaturation leads to stone formation in the urinary system, affects about 5%-10% of individuals worldwide at some point in their lifetime and results in significant medical costs and morbidity. To date, mutations in more than 30 genes have been described as being associated with nephrolithiasis, and these mutations explain about 15% of kidney stone cases, suggesting that additional nephrolithiasis-associated genes remain to be discovered. To identify additional genes whose mutations are linked to nephrolithiasis, we performed targeted next-generation sequencing of 18 hypothesized candidate genes in 348 unrelated individuals with kidney stones. We detected biallelic mutations in SLC26A1 (solute carrier family 26 member 1) in two unrelated individuals with calcium oxalate kidney stones. We show by immunofluorescence, immunoblotting, and glycosylation analysis that the variant protein mimicking p.Thr185Met has defects in protein folding or trafficking. In addition, by measuring anion exchange activity of SLC26A1, we demonstrate that all the identified mutations in SLC26A1 result in decreased transporter activity. Our data identify SLC26A1 mutations as causing a recessive Mendelian form of nephrolithiasis.	[Gee, Heon Yung; Jun, Ikhyun; Lee, Min Goo] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Dept Pharmacol, Seoul 03722, South Korea; [Gee, Heon Yung; Braun, Daniela A.; Lawson, Jennifer A.; Halbritter, Jan; Shril, Shirlee; Tan, Weizhen; Stein, Deborah; Ferguson, Michael A.; Baum, Michelle; Hildebrandt, Friedhelm] Boston Childrens Hosp, Dept Med, Div Nephrol, Boston, MA 02115 USA; [Gee, Heon Yung; Braun, Daniela A.; Lawson, Jennifer A.; Halbritter, Jan; Shril, Shirlee; Nelson, Caleb P.; Tan, Weizhen; Stein, Deborah; Wassner, Ari J.; Ferguson, Michael A.; Baum, Michelle; Hildebrandt, Friedhelm] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Jun, Ikhyun] Yonsei Univ, Coll Med, Dept Ophthalmol, Inst Vis Res, Seoul 03722, South Korea; [Halbritter, Jan] Univ Clin Leipzig, Dept Internal Med, Div Endocrinol & Nephrol, D-04103 Leipzig, Germany; [Nelson, Caleb P.] Boston Childrens Hosp, Dept Med, Div Urol & Gen Pediat, Boston, MA 02115 USA; [Wassner, Ari J.] Boston Childrens Hosp, Dept Med, Div Endocrinol, Boston, MA 02115 USA; [Gucev, Zoran; Tasic, Velibor] Univ Childrens Hosp, Med Fac Skopje, Skopje 1000, Macedonia; [Sayer, John A.] Newcastle Univ, Int Ctr Life, Inst Med Genet, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Milosevic, Danko] Univ Zagreb, Sch Med, Clin Hosp Ctr Zagreb, Dept Pediat Nephrol Dialysis & Transpl, Zagreb 10000, Croatia	Yonsei University; Yonsei University Health System; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Yonsei University; Yonsei University Health System; Leipzig University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Newcastle University - UK; University of Zagreb	Lee, MG (corresponding author), Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Dept Pharmacol, Seoul 03722, South Korea.; Hildebrandt, F (corresponding author), Boston Childrens Hosp, Dept Med, Div Nephrol, Boston, MA 02115 USA.; Hildebrandt, F (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	mlee@yuhs.ac; friedhelm.hildebrandt@childrens.harvard.edu	Tasic, Velibor/H-8714-2019; Lee, Min Goo/D-5635-2012; Lee, Min Goo/AAS-4636-2020; Shril, Shirlee/Q-5825-2016; Gee, Heon Yung/K-7781-2019; Braun, Daniela A/R-2259-2017; Sayer, John A./AAN-2729-2020	Tasic, Velibor/0000-0002-3377-1245; Lee, Min Goo/0000-0001-7436-012X; Lee, Min Goo/0000-0001-7436-012X; Gee, Heon Yung/0000-0002-8741-6177; Braun, Daniela A/0000-0003-3146-1566; Sayer, John A./0000-0003-1881-3782; Jun, Ikhyun/0000-0002-2160-1679; Wassner, Ari/0000-0003-0894-9301	NIH [DK1069274, DK1068306, DK064614]; March of Dimes Foundation [6-FY11-241]; National Research Foundation of Korea, Ministry of Science, ICT and Future Planning [2013R1A3A2042197, 2015R1D1A1A01056685]; Yonsei University College of Medicine [2015-32-0047]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007726, R01DK068306, R01DK064614] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); National Research Foundation of Korea, Ministry of Science, ICT and Future Planning; Yonsei University College of Medicine(General Electric); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the physicians and the participating families for their contributions. We also thank Catherine Matero, Elizabeth Andrews, Brittany Fisher, Leslie Spaneas, and Jennifer Drucker for their help with patient enrollment and clinical information. F.H. is the Warren E. Grupe Professor of Pediatrics. This research was supported by grants DK1069274, DK1068306, and DK064614 (to F.H.) from the NIH, 6-FY11-241 (to F.H.) from the March of Dimes Foundation, 2013R1A3A2042197 (to M.G.L.) and 2015R1D1A1A01056685 (to H.Y.G) from the National Research Foundation of Korea, Ministry of Science, ICT and Future Planning, and 2015-32-0047 (to H.Y.G) from the Yonsei University College of Medicine.	BISSIG M, 1994, J BIOL CHEM, V269, P3017; Braun DA, 2016, CLIN J AM SOC NEPHRO, V11, P664, DOI 10.2215/CJN.07540715; Dawson PA, 2013, SCI WORLD J, DOI 10.1155/2013/541710; Dawson PA, 2010, J CLIN INVEST, V120, P706, DOI 10.1172/JCI31474; Dwyer ME, 2012, J UROLOGY, V188, P247, DOI 10.1016/j.juro.2012.03.021; Edvardsson VO, 2013, PEDIATR NEPHROL, V28, P1923, DOI 10.1007/s00467-012-2329-z; Goldfarb DS, 2005, KIDNEY INT, V67, P1053, DOI 10.1111/j.1523-1755.2005.00170.x; Halbritter J, 2015, J AM SOC NEPHROL, V26, P543, DOI 10.1681/ASN.2014040388; Halbritter J, 2012, J MED GENET, V49, P756, DOI 10.1136/jmedgenet-2012-100973; Hunter DJ, 2002, CLIN SCI, V103, P259, DOI 10.1042/cs1030259; Karniski LP, 1998, AM J PHYSIOL-RENAL, V275, pF79, DOI 10.1152/ajprenal.1998.275.1.F79; Krick W, 2009, AM J PHYSIOL-RENAL, V297, pF145, DOI 10.1152/ajprenal.90401.2008; Lee A, 2003, DNA CELL BIOL, V22, P19, DOI 10.1089/104454903321112460; Lotan Y, 2009, ADV CHRONIC KIDNEY D, V16, P5, DOI 10.1053/j.ackd.2008.10.002; Markovich D, 2012, PHYSIOLOGY, V27, P7, DOI 10.1152/physiol.00041.2011; Park HW, 2010, GASTROENTEROLOGY, V139, P620, DOI 10.1053/j.gastro.2010.04.004; Quondamatteo F, 2006, AM J PHYSIOL-GASTR L, V290, pG1075, DOI 10.1152/ajpgi.00492.2005; Sayer JA, 2008, NEPHRON EXP NEPHROL, V110, pE37, DOI 10.1159/000151730; Scales CD, 2012, EUR UROL, V62, P160, DOI 10.1016/j.eururo.2012.03.052; Xie QH, 2002, AM J PHYSIOL-RENAL, V283, pF826, DOI 10.1152/ajprenal.00079.2002	20	28	35	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 2	2016	98	6					1228	1234		10.1016/j.ajhg.2016.03.026	http://dx.doi.org/10.1016/j.ajhg.2016.03.026			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN7US	27210743	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000377286000016
J	Shamseldin, HE; Faqeih, E; Alasmari, A; Zaki, MS; Gleeson, JG; Alkuraya, FS				Shamseldin, Hanan E.; Faqeih, Eissa; Alasmari, Ali; Zaki, Maha S.; Gleeson, Joseph G.; Alkuraya, Fowzan S.			Mutations in UNC80, Encoding Part of the UNC79-UNC80-NALCN Channel Complex, Cause Autosomal-Recessive Severe Infantile Encephalopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NALCN CAUSE; ABNORMALITIES; IMPAIRMENT; HYPOTONIA; ATAXIA	Brain channelopathies represent a growing class of brain disorders that usually result in paroxysmal disorders, although their role in other neurological phenotypes, including the recently described NALCN-related infantile encephalopathy, is increasingly recognized. In three Saudi Arabian families and one Egyptian family all affected by a remarkably similar phenotype (infantile encephalopathy and largely normal brain MRI) to that of NALCN-related infantile encephalopathy, we identified a locus on 2q34 in which whole-exome sequencing revealed three, including two apparently loss-of-function, recessive mutations in UNC80. UNC80 encodes a large protein that is necessary for the stability and function of NALCN and for bridging NALCN to UNC79 to form a functional complex. Our results expand the clinical relevance of the UNC79-UNC80-NALCN channel complex.	[Shamseldin, Hanan E.; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Faqeih, Eissa; Alasmari, Ali] King Fahad Med City, Dept Pediat Specialties, Riyadh 11525, Saudi Arabia; [Zaki, Maha S.] Natl Res Ctr, Dept Clin Genet, Human Genet & Genome Res Div, Cairo 12311, Egypt; [Gleeson, Joseph G.] Rockefeller Univ, Howard Hughes Med Inst, Lab Pediat Brain Dis, New York, NY 10065 USA; [Alkuraya, Fowzan S.] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh 11533, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Fahad Medical City; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Howard Hughes Medical Institute; Rockefeller University; Alfaisal University	Alkuraya, FS (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.	falkuraya@kfshrc.edu.sa	Zaki, Maha S/B-9361-2013	Zaki, Maha/0000-0001-7840-0002	King Abdulaziz City for Science and Technology (KACST) grant [13-BIO1113-20]; King Salman Center for Disability Research grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	King Abdulaziz City for Science and Technology (KACST) grant; King Salman Center for Disability Research grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the study families for their enthusiastic participation. We thank the Genotyping and Sequencing Core Facilities at King Faisal Specialist Hospital and Research Center for their technical help. This work was supported by a King Abdulaziz City for Science and Technology (KACST) grant 13-BIO1113-20 (F.S.A.) and a King Salman Center for Disability Research grant (F.S.A.).	Al-Owain M, 2011, CLIN GENET, V80, P489, DOI 10.1111/j.1399-0004.2010.01573.x; Al-Sayed MD, 2013, AM J HUM GENET, V93, P721, DOI 10.1016/j.ajhg.2013.08.001; Alazami AM, 2015, CELL REP, V10, P148, DOI 10.1016/j.celrep.2014.12.015; Alkuraya F.S., 2012, CURRENT PROTOCOLS HU; Alkuraya FS, 2013, HUM GENET, V132, P1197, DOI 10.1007/s00439-013-1344-x; Alkuraya FS, 2010, GENET MED, V12, P765, DOI 10.1097/GIM.0b013e3181fbfcc4; Chong JX, 2015, AM J HUM GENET, V96, P462, DOI 10.1016/j.ajhg.2015.01.003; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Kasperaviciute D, 2013, BRAIN, V136, P3140, DOI 10.1093/brain/awt233; Koroglu C, 2013, J MED GENET, V50, P515, DOI 10.1136/jmedgenet-2013-101634; Kortum F, 2015, NAT GENET, V47, P661, DOI 10.1038/ng.3282; Kullmann DM, 2010, ANNU REV NEUROSCI, V33, P151, DOI 10.1146/annurev-neuro-060909-153122; Lear BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078147; Lu BX, 2007, CELL, V129, P371, DOI 10.1016/j.cell.2007.02.041; Lu BX, 2010, NEURON, V68, P488, DOI 10.1016/j.neuron.2010.09.014; Masotti A, 2015, AM J HUM GENET, V96, P295, DOI 10.1016/j.ajhg.2014.12.011; Romaniello R, 2010, J NEUROL NEUROSUR PS, V81, P840, DOI 10.1136/jnnp.2008.163402; Ryan DP, 2010, NEURON, V68, P282, DOI 10.1016/j.neuron.2010.10.008; Speca DJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001057; Takano K, 2012, HUM MOL GENET, V21, P4497, DOI 10.1093/hmg/dds292; Trudeau MM, 2006, J MED GENET, V43, P527, DOI 10.1136/jmg.2005.035667; Yeh E, 2008, PLOS BIOL, V6, P552, DOI 10.1371/journal.pbio.0060055	23	28	30	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 7	2016	98	1					210	215		10.1016/j.ajhg.2015.11.013	http://dx.doi.org/10.1016/j.ajhg.2015.11.013			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DA8JL	26708753	Green Published, Bronze			2022-12-18	WOS:000368050800015
J	Foo, JN; Smedby, KE; Akers, NK; Berglund, M; Irwan, ID; Jia, XM; Li, Y; Conde, L; Darabi, H; Bracci, PM; Melbye, M; Adami, HO; Glimelius, B; Khor, CC; Hjalgrim, H; Padyukov, L; Humphreys, K; Enblad, G; Skibola, CF; de Bakker, PIW; Liu, JJ				Foo, Jia Nee; Smedby, Karin E.; Akers, Nicholas K.; Berglund, Mattias; Irwan, Ishak D.; Jia, Xiaoming; Li, Yi; Conde, Lucia; Darabi, Hatef; Bracci, Paige M.; Melbye, Mads; Adami, Hans-Olov; Glimelius, Bengt; Khor, Chiea Chuen; Hjalgrim, Henrik; Padyukov, Leonid; Humphreys, Keith; Enblad, Gunilla; Skibola, Christine F.; de Bakker, Paul I. W.; Liu, Jianjun			Coding Variants at Hexa-allelic Amino Acid 13 of HLA-DRB1 Explain Independent SNP Associations with Follicular Lymphoma Risk	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; HLA CLASS-I; RHEUMATOID-ARTHRITIS; MHC; MAP	Non-Hodgkin lymphoma represents a diverse group of blood malignancies, of which follicular lymphoma (FL) is a common subtype. Previous genome-wide association studies (GWASs) have identified in the human leukocyte antigen (HLA) class II region multiple independent SNPs that are significantly associated with FL risk. To dissect these signals and determine whether coding variants in HLA genes are responsible for the associations, we conducted imputation, HLA typing, and sequencing in three independent populations for a total of 689 cases and 2,446 controls. We identified a hexa-allelic amino acid polymorphism at position 13 of the HLA-DR beta chain that showed the strongest association with FL within the major histocompatibility complex (MHC) region (multiallelic p = 2.3 x 10(-15)). Out of six possible amino acids that occurred at that position within the population, we classified two as high risk (Tyr and Phe), two as low risk (Ser and Arg), and two as moderate risk (His and Gly). There was a 4.2-fold difference in risk (95% confidence interval = 2.9-6.1) between subjects carrying two alleles encoding high-risk amino acids and those carrying two alleles encoding low-risk amino acids (p = 1.01 x 10(-14)). This coding variant might explain the complex SNP associations identified by GWASs and suggests a common HLA-DR antigen-driven mechanism for the pathogenesis of FL and rheumatoid arthritis.	[Foo, Jia Nee; Irwan, Ishak D.; Li, Yi; Khor, Chiea Chuen; Liu, Jianjun] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore 138672, Singapore; [Smedby, Karin E.] Karolinska Inst, Dept Med, Clin Epidemiol Unit, SE-17177 Stockholm, Sweden; [Akers, Nicholas K.] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA; [Berglund, Mattias; Glimelius, Bengt; Enblad, Gunilla] Uppsala Univ, Dept Radiol Oncol & Radiat Sci, SE-75185 Uppsala, Sweden; [Jia, Xiaoming; de Bakker, Paul I. W.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA; [Jia, Xiaoming; de Bakker, Paul I. W.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Conde, Lucia; Skibola, Christine F.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [Darabi, Hatef; Adami, Hans-Olov; Humphreys, Keith] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; [Bracci, Paige M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94107 USA; [Melbye, Mads; Hjalgrim, Henrik] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Adami, Hans-Olov] Harvard Univ, Dept Epidemiol, Boston, MA 02115 USA; [Khor, Chiea Chuen] Singapore Eye Res Inst, Singapore 168751, Singapore; [Khor, Chiea Chuen] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 119074, Singapore; [Khor, Chiea Chuen; Liu, Jianjun] Natl Univ Singapore, Natl Univ Hlth Syst, Saw Swee Hock Sch Publ Hlth, Singapore 117597, Singapore; [Padyukov, Leonid] Karolinska Inst, Dept Med, Rheumatol Unit, SE-17176 Stockholm, Sweden; [Padyukov, Leonid] Karolinska Univ Hosp Solna, SE-17176 Stockholm, Sweden; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Med Genet & Epidemiol, NL-3584 CX Utrecht, Netherlands	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Karolinska Institutet; University of California System; University of California Berkeley; Uppsala University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Alabama System; University of Alabama Birmingham; Karolinska Institutet; University of California System; University of California San Francisco; Statens Serum Institut; Harvard University; National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Utrecht University; Utrecht University Medical Center	Liu, JJ (corresponding author), Agcy Sci Technol & Res, Genome Inst Singapore, Singapore 138672, Singapore.	liuj3@gis.a-star.edu.sg	Conde, Lucia/D-9295-2011; Liu, Jianjun/AAK-4989-2020; Foo, Jia Nee/D-6069-2014; de Bakker, Paul IW/B-8730-2009; Hjalgrim, Henrik/AAG-4973-2021; Padyukov, Leonid/A-4890-2009	Liu, Jianjun/0000-0002-3255-3019; Foo, Jia Nee/0000-0001-9899-2308; de Bakker, Paul IW/0000-0001-7735-7858; Jia, Xiaoming/0000-0002-5104-5431; Conde, Lucia/0000-0001-5180-543X; melbye, mads/0000-0001-8264-6785; Khor, Chiea Chuen/0000-0002-1128-4729; Padyukov, Leonid/0000-0003-2950-5670	Agency for Science and Technology and Research of Singapore; Swedish Cancer Society [090659]; Swedish Research Council [K2008-64X-20737-01-2, 523-2006-972]; Danish Medical Research Council [FSS 09-63424]; National Cancer Institute (NCI) [CA069269-01]; Swedish Council for Working life [2008-0567]; AFA Insurance; COMBINE project; Vinnova; NCI, National Institutes of Health [CA122663, CA104682, CA45614, CA89745]; Lions Cancer Research Foundation; Selanders Research Foundation; Research Foundation of the Department of Oncology of Uppsala University Hospital; VIDI Award from the Netherlands Organization for Scientific Research [NWO-016.126.354]; NATIONAL CANCER INSTITUTE [R01CA104682, R03CA089745, R01CA069269, R01CA045614, R01CA154643, R01CA122663] Funding Source: NIH RePORTER	Agency for Science and Technology and Research of Singapore; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swedish Council for Working life(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); AFA Insurance; COMBINE project; Vinnova(Vinnova); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lions Cancer Research Foundation; Selanders Research Foundation; Research Foundation of the Department of Oncology of Uppsala University Hospital; VIDI Award from the Netherlands Organization for Scientific Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the Agency for Science and Technology and Research of Singapore, the Swedish Cancer Society (090659), the Swedish Research Council (K2008-64X-20737-01-2, 523-2006-972), and the Danish Medical Research Council (FSS 09-63424). The collection of blood samples in the founding case-control study was supported by the National Cancer Institute (NCI) (CA069269-01). Sample collection in the Epidemiological Investigation of Rheumatoid Arthritis study was supported by the Swedish Council for Working life (2008-0567), AFA Insurance, and the COMBINE project, funded by Vinnova. The San Francisco study was supported by the NCI, National Institutes of Health (CA122663, CA104682, CA45614, and CA89745). The Uppsala study was supported by the Lions Cancer Research Foundation, the Selanders Research Foundation, and the Research Foundation of the Department of Oncology of Uppsala University Hospital. P.I.W.d.B. is supported, in part, by a VIDI Award from the Netherlands Organization for Scientific Research (NWO-016.126.354).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Baecklund E, 2006, ARTHRITIS RHEUM-US, V54, P3774, DOI 10.1002/art.22277; Conde L, 2013, AM J HUM GENET, V92, P126, DOI 10.1016/j.ajhg.2012.11.009; Conde L, 2010, NAT GENET, V42, P661, DOI 10.1038/ng.626; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Jia XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064683; Lundstrom E, 2009, ARTHRITIS RHEUM-US, V60, P924, DOI 10.1002/art.24410; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Sayer D, 2001, TISSUE ANTIGENS, V57, P46, DOI 10.1034/j.1399-0039.2001.057001046.x; Sayer DC, 2004, TISSUE ANTIGENS, V63, P412, DOI 10.1111/j.0001-2815.2004.00214.x; Skibola CF, 2012, TISSUE ANTIGENS, V79, P279, DOI 10.1111/j.1399-0039.2012.01845.x; Skibola CF, 2009, NAT GENET, V41, P873, DOI 10.1038/ng.419; Smedby KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Thunberg U, 2010, LEUKEMIA LYMPHOMA, V51, P1563, DOI 10.3109/10428194.2010.492486; Vijai J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003220	20	28	29	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 11	2013	93	1					167	172		10.1016/j.ajhg.2013.05.020	http://dx.doi.org/10.1016/j.ajhg.2013.05.020			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	183HG	23791106	Green Published, Bronze			2022-12-18	WOS:000321804500017
J	Ke, XY				Ke, Xiayi			Presence of Multiple Independent Effects in Risk Loci of Common Complex Human Diseases	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; RHEUMATOID-ARTHRITIS RISK; SUSCEPTIBILITY LOCI; CROHNS-DISEASE; DIABETES SUSCEPTIBILITY; GENETIC-VARIANTS; HUMAN HEIGHT; METAANALYSIS; SNPS; HERITABILITY	Many genetic loci and SNPs associated with many common complex human diseases and traits are now identified. The total genetic variance explained by these loci for a trait or disease, however, has often been very small. Much of the "missing heritability" has been revealed to be hidden in the genome among the large number of variants with small effects. Several recent studies have reported the presence of multiple independent SNPs and genetic heterogeneity in trait-associated loci. It is therefore reasonable to speculate that such a phenomenon could be common among loci known to be associated with a complex trait or disease. For testing this hypothesis, a total of 117 loci known to be associated with rheumatoid arthritis (RA), Crohn disease (CD), type 1 diabetes (T1D), or type 2 diabetes (T2D) were selected. The presence of multiple independent effects was assessed in the case-control samples genotyped by the Wellcome Trust Case Control Consortium study and imputed with SNP genotype information from the HapMap Project and the 1000 Genomes Project. Eleven loci with evidence of multiple independent effects were identified in the study, and the number was expected to increase at larger sample sizes and improved statistical power. The variance explained by the multiple effects in a locus was much higher than the variance explained by the single reported SNP effect. The results thus significantly improve our understanding of the allelic structure of these individual disease-associated loci, as well as our knowledge of the general genetic mechanisms of common complex traits and diseases.	[Ke, Xiayi] UCL, MRC, Ctr Epidemiol Child Hlth, London WC1N 1EH, England; [Ke, Xiayi] UCL, Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England	University of London; University College London; University of London; University College London	Ke, XY (corresponding author), UCL, MRC, Ctr Epidemiol Child Hlth, 30 Guilford St, London WC1N 1EH, England.	x.ke@ucl.ac.uk			UK Medical Research Council (MRC); MRC [G0400546] Funding Source: UKRI; Medical Research Council [G0400546] Funding Source: researchfish	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The UK Medical Research Council (MRC) provides funding to the MRC Centre of Epidemiology for Child Health. The author also wishes to thank the Wellcome Trust Case Control Consortium for providing the genotyping data in the study.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Ding B, 2009, ARTHRITIS RHEUM, V60, P30, DOI 10.1002/art.24135; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Goeman JJ, 2010, BIOMETRICAL J, V52, P70, DOI 10.1002/bimj.200900028; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI [DOI 10.2307/1267351, DOI 10.1080/00401706.1970.10488634]; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McGovern DPB, 2010, HUM MOL GENET, V19, P3468, DOI 10.1093/hmg/ddq248; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Orozco G, 2009, HUM MOL GENET, V18, P2693, DOI 10.1093/hmg/ddp193; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; So HC, 2011, GENET EPIDEMIOL, V35, P310, DOI 10.1002/gepi.20579; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wood AR, 2011, HUM MOL GENET, V20, P4082, DOI 10.1093/hmg/ddr328; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	35	28	29	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 13	2012	91	1					185	192		10.1016/j.ajhg.2012.05.020	http://dx.doi.org/10.1016/j.ajhg.2012.05.020			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	974OE	22770979	Green Published, hybrid			2022-12-18	WOS:000306445000017
J	Braun, A; Breuss, M; Salzer, MC; Flint, J; Cowan, NJ; Keays, DA				Braun, Andreas; Breuss, Martin; Salzer, Marion C.; Flint, Jonathan; Cowan, Nicholas J.; Keays, David A.			Tuba8 Is Expressed at Low Levels in the Developing Mouse and Human Brain	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							ALPHA-TUBULIN; MUTATIONS		[Braun, Andreas; Breuss, Martin; Salzer, Marion C.; Keays, David A.] Inst Mol Pathol, A-1030 Vienna, Austria; [Flint, Jonathan] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Cowan, Nicholas J.] NYU, Med Ctr, Dept Biochem, New York, NY 10016 USA	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Oxford; Wellcome Centre for Human Genetics; New York University	Keays, DA (corresponding author), Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	keays@imp.ac.at	Salzer, Marion/AAB-1844-2020	Breuss, Martin Werner/0000-0003-2200-8604	Austrian Science Fund FWF [P 21092] Funding Source: Medline; NICHD NIH HHS [R01 HD057028, R01HD057028] Funding Source: Medline; Wellcome Trust [084655] Funding Source: Medline; Department of Health Funding Source: Medline; Austrian Science Fund (FWF) [P 21092] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD057028] Funding Source: NIH RePORTER	Austrian Science Fund FWF(Austrian Science Fund (FWF)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome Trust); Department of Health; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abdollahi MR, 2009, AM J HUM GENET, V85, P737, DOI 10.1016/j.ajhg.2009.10.007; Boda E, 2009, J MOL NEUROSCI, V37, P238, DOI 10.1007/s12031-008-9128-9; Gloster A, 1999, J COMP NEUROL, V405, P45, DOI 10.1002/(SICI)1096-9861(19990301)405:1<45::AID-CNE4>3.0.CO;2-M; Jaglin XH, 2009, TRENDS GENET, V25, P555, DOI 10.1016/j.tig.2009.10.003; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Khodiyar VK, 2007, GENOMICS, V90, P285, DOI 10.1016/j.ygeno.2007.04.008; Murtaugh LC, 1999, GENE DEV, V13, P225, DOI 10.1101/gad.13.2.225; Stanchi F, 2000, BIOCHEM BIOPH RES CO, V270, P1111, DOI 10.1006/bbrc.2000.2571; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034	11	28	30	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 14	2010	86	5					819	822		10.1016/j.ajhg.2010.03.019	http://dx.doi.org/10.1016/j.ajhg.2010.03.019			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601GC	20466094	Green Published, Bronze			2022-12-18	WOS:000278045300020
J	Sved, JA; McRae, AF; Visscher, PM				Sved, John A.; McRae, Allan F.; Visscher, Peter M.			Divergence between Human Populations Estimated from Linkage Disequilibrium	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENOME; HUMAN-EVOLUTION; POSITIVE SELECTION; HAPLOTYPE MAP; MODELS; GENETICS; SIZE; SNPS	Observed linkage disequilibrium (LD) between genetic markers in different Populations descended independently from a common ancestral population can be used to estimate their absolute time of divergence, because the correlation of LD between populations will be reduced each generation by an amount that, approximately, depends only on the recombination rate between markers. Although drift leads to divergence in allele frequencies, it has less effect on divergence in LD values. We derived the relationship between LD and time of divergence and verified it with coalescent simulations. We then used HapMap Phase II data to estimate time of divergence between human populations. Summed over large numbers of pairs of loci, we find a positive correlation of LD between African and non-African populations at levels of up to similar to 0.3 cM. We estimate that the observed correlation of LD is consistent with an effective separation time of approximately 1,000 generations or similar to 25,000 years before present. The most likely explanation for such relatively low separation times is the existence of substantial levels of migration between populations after the initial separation. Theory and results from coalescent simulations confirm that low levels of migration can lead to a downward bias in the estimate of separation time.	[McRae, Allan F.; Visscher, Peter M.] Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Sved, John A.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	QIMR Berghofer Medical Research Institute; University of Sydney	Visscher, PM (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4029, Australia.	peter.visscher@qhnr.edu.au	McRae, Allan F/J-2644-2014; Visscher, Peter/ABB-6151-2020	McRae, Allan F/0000-0001-5286-5485; Visscher, Peter/0000-0002-2143-8760	Australian Research Council [DP0770096]; Australian National Health and Medical Research Council	Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by Australian Research Council grant DP0770096. We thank Bill Hill, Warren Ewens, and Mike Goddard for helpful comments and discussions and the referees for their Suggestions. A.F.M. and RM.V. are supported by the Australian National Health and Medical Research Council.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Andreescu C, 2007, GENETICS, V177, P2161, DOI 10.1534/genetics.107.082206; Becquet C, 2007, GENOME RES, V17, P1505, DOI 10.1101/gr.6409707; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Crawford DC, 2004, AM J HUM GENET, V74, P610, DOI 10.1086/382227; de Roos APW, 2008, GENETICS, V179, P1503, DOI 10.1534/genetics.107.084301; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Garrigan D, 2006, NAT REV GENET, V7, P669, DOI 10.1038/nrg1941; Garrigan Daniel, 2008, Proc Natl Acad Sci U S A, V105, pE4, DOI 10.1073/pnas.0710521105; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; Hall P, 1927, BIOMETRIKA, V19, P100, DOI 10.2307/2332179; Hayes BJ, 2003, GENOME RES, V13, P635, DOI 10.1101/gr.387103; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; HILL WG, 1977, THEOR POPUL BIOL, V11, P239, DOI 10.1016/0040-5809(77)90026-0; HUDSON RR, 1985, GENETICS, V109, P611; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; King TE, 2007, EUR J HUM GENET, V15, P288, DOI 10.1038/sj.ejhg.5201771; LITTLER RA, 1973, THEOR POPUL BIOL, V4, P259, DOI 10.1016/0040-5809(73)90011-7; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Nielsen R, 2000, EVOLUTION, V54, P44, DOI 10.1111/j.0014-3820.2000.tb00006.x; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; SVED J A, 1971, Theoretical Population Biology, V2, P125; Templeton AR, 2007, EVOLUTION, V61, P1507, DOI 10.1111/j.1558-5646.2007.00164.x; Templeton AR, 2005, YEARB PHYS ANTHROPOL, V48, P33, DOI 10.1002/ajpa.20351; Templeton AR, 2002, NATURE, V416, P45, DOI 10.1038/416045a; Tenesa A, 2007, GENOME RES, V17, P520, DOI 10.1101/gr.6023607; Uimari P, 2005, TWIN RES HUM GENET, V8, P185, DOI 10.1375/1832427054253086; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; WEIR BS, 1980, GENETICS, V95, P477	37	28	28	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 12	2008	83	6					737	743		10.1016/j.ajhg.2008.10.019	http://dx.doi.org/10.1016/j.ajhg.2008.10.019			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	385NY	19012875	Green Published, Bronze			2022-12-18	WOS:000261822100008
J	Cheng, Q; Cheng, C; Crews, KR; Ribeiro, RC; Pui, CH; Relling, MV; Evans, WE				Cheng, Qing; Cheng, Cheng; Crews, Kristine R.; Ribeiro, Raul C.; Pui, Ching-Hon; Relling, Mary V.; Evans, William E.			Epigenetic regulation of human gamma-glutamyl hydrolase activity in acute lymphoblastic leukemia cells	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							METHOTREXATE-POLYGLUTAMATE ACCUMULATION; DNA METHYLATION PATTERNS; CPG-ISLAND; IN-VIVO; GENE; CANCER; PROMOTER; ASSOCIATION; MECHANISMS; DIFFERS	gamma-Glutamyl hydrolase (GGH) catalyzes degradation of the active polyglutamates of natural folates and the antifolate methotrexate (MTX). We found that GGH activity is directly related to GGH messenger RNA expression in acute lymphoblastic leukemia (ALL) cells of patients with a wild-type germline GGH genotype. We identified two CpG islands (CpG1 and CpG2) in the region extending from the GGH promoter through the first exon and into intron 1 and showed that methylation of both CpG islands in the GGH promoter (seen in leukemia cells from similar to 15% of patients with non-hyperdiploid B-lineage ALL) is associated with significantly reduced GGH mRNA expression and catalytic activity and with significantly higher accumulation of MTX polyglutamates (MTXPG(4-7)) in ALL cells. Furthermore, methylation of CpG1 was leukemia-cell specific and had a pronounced effect on GGH expression, whereas methylation of CpG2 was common in leukemia cells and normal leukocytes but did not significantly alter GGH expression. These findings indicate that GGH activity in human leukemia cells is regulated by epigenetic changes, in addition to previously recognized genetic polymorphisms and karyotypic abnormalities, which collectively determine interindividual differences in GGH activity and influence MTXPG accumulation in leukemia cells.	St Jude Childrens Res Hosp, Hematol Malignancies Program, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Evans, WE (corresponding author), St Jude Childrens Res Hosp, Hematol Malignancies Program, 332 N Lauderdale St, Memphis, TN 38105 USA.	william.evans@stjude.org	Relling, Mary/N-5032-2018; Cheng, Cheng/N-8075-2018; Evans, William E./C-2069-2012; Pui, Ching-Hon/N-8076-2018	Evans, William E./0000-0002-9333-5322; Pui, Ching-Hon/0000-0003-0303-5658; Crews, Kristine/0000-0002-7558-558X	NATIONAL CANCER INSTITUTE [P30CA021765, R01CA078224, R01CA051001, R01CA036401, R37CA036401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA78224, R01 CA51001, CA21765, R37 CA36401, P30 CA021765, R01 CA051001, R01 CA036401, R01 CA078224, R37 CA036401] Funding Source: Medline; NIGMS NIH HHS [U01 GM61393, U01 GM061393] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Banelli B, 2005, ONCOGENE, V24, P5619, DOI 10.1038/sj.onc.1208722; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Cheng Q, 2005, CELL CYCLE, V4, P1506, DOI 10.4161/cc.4.11.2160; Cheng Q, 2005, NAT GENET, V37, P878, DOI 10.1038/ng1612; Cheng Q, 2004, PHARMACOGENETICS, V14, P557, DOI 10.1097/01.fpc.0000114761.78957.7e; Cheok MH, 2003, NAT GENET, V34, P85, DOI 10.1038/ng1151; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Crews KR, 2002, J CLIN ONCOL, V20, P4217, DOI 10.1200/JCO.2002.10.006; CROSS SH, 1994, NAT GENET, V6, P236, DOI 10.1038/ng0394-236; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Galivan J, 1999, SEMIN ONCOL, V26, P33; Galivan J, 2000, PHARMACOL THERAPEUT, V85, P207, DOI 10.1016/S0163-7258(99)00063-7; He P, 2004, HUM PATHOL, V35, P1196, DOI 10.1016/j.humpath.2004.06.014; Heisler LE, 2005, NUCLEIC ACIDS RES, V33, P2952, DOI 10.1093/nar/gki582; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Huang THM, 1999, HUM MOL GENET, V8, P459, DOI 10.1093/hmg/8.3.459; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jones PA, 1997, P NATL ACAD SCI USA, V94, P2103, DOI 10.1073/pnas.94.6.2103; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kager L, 2005, J CLIN INVEST, V115, P110, DOI 10.1172/JCI200522477; KAWAI J, 1994, MOL CELL BIOL, V14, P7421, DOI 10.1128/MCB.14.11.7421; Kawasaki H, 2004, NATURE, V431, P211, DOI 10.1038/nature02889; Kimura N, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh057; Laird PW, 2005, HUM MOL GENET, V14, pR65, DOI 10.1093/hmg/ddi113; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lightfoot TJ, 2004, TOXICOL APPL PHARM, V199, P104, DOI 10.1016/j.taap.2003.12.032; Masson E, 1996, J CLIN INVEST, V97, P73, DOI 10.1172/JCI118409; Melki JR, 1999, LEUKEMIA, V13, P877, DOI 10.1038/sj.leu.2401401; Millar DS, 2000, J BIOL CHEM, V275, P24893, DOI 10.1074/jbc.M906538199; Mitelman F, 1995, ISCN INT SYSTEM HUMA; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Mummaneni P, 1998, NUCLEIC ACIDS RES, V26, P5163, DOI 10.1093/nar/26.22.5163; Panetta JC, 2002, CLIN CANCER RES, V8, P2423; Pao MM, 2001, HUM MOL GENET, V10, P903, DOI 10.1093/hmg/10.9.903; Plass C, 2002, HUM MOL GENET, V11, P2479, DOI 10.1093/hmg/11.20.2479; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rots MG, 1999, BLOOD, V93, P1677, DOI 10.1182/blood.V93.5.1677.405a16_1677_1683; SYNOLD TW, 1994, J CLIN INVEST, V94, P1996, DOI 10.1172/JCI117552; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; WHITEHEAD VM, 1990, BLOOD, V76, P44; Whitehead VM, 2001, LEUKEMIA, V15, P1081, DOI 10.1038/sj.leu.2402165; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Yin DZ, 1999, GENE, V238, P463, DOI 10.1016/S0378-1119(99)00362-5; Zhao RB, 2003, ONCOGENE, V22, P7431, DOI 10.1038/sj.onc.1206946	50	28	29	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2006	79	2					264	274		10.1086/505645	http://dx.doi.org/10.1086/505645			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	063SR	16826517	Green Published, Bronze			2022-12-18	WOS:000239040400008
J	Jackson, MS; Oliver, K; Loveland, J; Humphray, S; Dunham, I; Rocchi, M; Viggiano, L; Park, JP; Hurles, ME; Santibanez-Koref, M				Jackson, MS; Oliver, K; Loveland, J; Humphray, S; Dunham, I; Rocchi, M; Viggiano, L; Park, JP; Hurles, ME; Santibanez-Koref, M			Evidence for widespread reticulate evolution within human duplicons	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RECENT SEGMENTAL DUPLICATIONS; GENE CONVERSION; HUMAN GENOME; DNA-SEQUENCE; DETECTING RECOMBINATION; CHROMOSOME; REGION; REARRANGEMENTS; INSTABILITY	Approximately 5% of the human genome consists of segmental duplications that can cause genomic mutations and may play a role in gene innovation. Reticulate evolutionary processes, such as unequal crossing-over and gene conversion, are known to occur within specific duplicon families, but the broader contribution of these processes to the evolution of human duplications remains poorly characterized. Here, we use phylogenetic profiling to analyze multiple alignments of 24 human duplicon families that span > 8 Mb of DNA. Our results indicate that none of them are evolving independently, with all alignments showing sharp discontinuities in phylogenetic signal consistent with reticulation. To analyze these results in more detail, we have developed a quartet method that estimates the relative contribution of nucleotide substitution and reticulate processes to sequence evolution. Our data indicate that most of the duplications show a highly significant excess of sites consistent with reticulate evolution, compared with the number expected by nucleotide substitution alone, with 15 of 30 alignments showing a > 20-fold excess over that expected. Using permutation tests, we also show that at least 5% of the total sequence shares 100% sequence identity because of reticulation, a figure that includes 74 independent tracts of perfect identity > 2 kb in length. Furthermore, analysis of a subset of alignments indicates that the density of reticulation events is as high as 1 every 4 kb. These results indicate that phylogenetic relationships within recently duplicated human DNA can be rapidly disrupted by reticulate evolution. This finding has important implications for efforts to finish the human genome sequence, complicates comparative sequence analysis of duplicon families, and could profoundly influence the tempo of gene-family evolution.	Newcastle Univ, Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; Wellcome Trust Sanger Inst, Cambridge, England; Univ Bari, Dept Genet & Microbiol, Bari, Italy; Dartmouth Hitchcock Med Ctr, Dept Pathol, Lebanon, NH 03766 USA	Newcastle University - UK; Wellcome Trust Sanger Institute; Universita degli Studi di Bari Aldo Moro; Dartmouth College	Jackson, MS (corresponding author), Newcastle Univ, Int Ctr Life, Inst Human Genet, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.	m.s.jackson@ncl.ac.uk		Dunham, Ian/0000-0003-2525-5598; Jackson, Michael/0000-0001-7179-1354; Rocchi, Mariano/0000-0002-9451-5616; Loveland, Jane/0000-0002-7669-2934; Viggiano, Luigi/0000-0002-2067-5166	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bagnall RD, 2005, GENOME RES, V15, P214, DOI 10.1101/gr.2946205; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bosch E, 2004, GENOME RES, V14, P835, DOI 10.1101/gr.2177404; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; Ciccarelli FD, 2005, GENOME RES, V15, P343, DOI 10.1101/gr.3266405; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Courseaux A, 2003, GENOME RES, V13, P369, DOI 10.1101/gr.490303; Crosier M, 2002, GENOME RES, V12, P67, DOI 10.1101/gr.213702; Cserpan I, 2002, NUCLEIC ACIDS RES, V30, P2899, DOI 10.1093/nar/gkf382; DeSilva U, 1999, GENOME RES, V9, P428; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; Drouin G, 1999, MOL BIOL EVOL, V16, P1369, DOI 10.1093/oxfordjournals.molbev.a026047; Eichler EE, 1996, HUM MOL GENET, V5, P899, DOI 10.1093/hmg/5.7.899; Fan YX, 2002, GENOME RES, V12, P1663, DOI 10.1101/gr.338402; Fryxell KJ, 2005, MOL BIOL EVOL, V22, P650, DOI 10.1093/molbev/msi043; Gimelli G, 2003, HUM MOL GENET, V12, P849, DOI 10.1093/hmg/ddg101; GUTTMAN DS, 1994, SCIENCE, V266, P1380, DOI 10.1126/science.7973728; Han LL, 2000, HUM MOL GENET, V9, P1881, DOI 10.1093/hmg/9.12.1881; HEIN J, 1993, J MOL EVOL, V36, P396, DOI 10.1007/BF00182187; Humphray SJ, 2004, NATURE, V429, P369, DOI 10.1038/nature02465; Hurles M E, 2001, BMC Genomics, V2, P11, DOI 10.1186/1471-2164-2-11; Hurles ME, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r55; Husmeier D, 2003, MOL BIOL EVOL, V20, P315, DOI 10.1093/molbev/msg039; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jaatinen T, 2002, J IMMUNOL, V168, P5652, DOI 10.4049/jimmunol.168.11.5652; Jakobsen IB, 1997, MOL BIOL EVOL, V14, P474, DOI 10.1093/oxfordjournals.molbev.a025784; Jakobsen IB, 1998, IMMUNOGENETICS, V48, P312, DOI 10.1007/s002510050438; Jeffreys AJ, 2004, PHILOS T ROY SOC B, V359, P141, DOI 10.1098/rstb.2003.1372; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Martin J, 2004, NATURE, V432, P988, DOI 10.1038/nature03187; McGuire G, 2000, BIOINFORMATICS, V16, P130, DOI 10.1093/bioinformatics/16.2.130; Newman T, 2003, GENOME RES, V13, P781, DOI 10.1101/gr.769003; Orti R, 1998, CYTOGENET CELL GENET, V83, P262, DOI 10.1159/000015201; Proutski V, 1998, BIOINFORMATICS, V14, P467, DOI 10.1093/bioinformatics/14.5.467; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235; Rhodes TD, 2005, J VIROL, V79, P1666, DOI 10.1128/JVI.79.3.1666-1677.2005; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Ruault M, 2003, GENOMICS, V81, P391, DOI 10.1016/S0888-7543(03)00025-9; Saitta SC, 2004, HUM MOL GENET, V13, P417, DOI 10.1093/hmg/ddh041; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Schildkraut E, 2005, NUCLEIC ACIDS RES, V33, P1574, DOI 10.1093/nar/gki295; Schmutz J, 2004, NATURE, V431, P268, DOI 10.1038/nature02919; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Shaffer LG, 2000, ANNU REV GENET, V34, P297, DOI 10.1146/annurev.genet.34.1.297; Shaikh TH, 2001, GENET MED, V3, P6, DOI 10.1097/00125817-200101000-00003; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; She XW, 2004, NATURE, V430, P857, DOI 10.1038/nature02806; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Smith JM, 1998, MOL BIOL EVOL, V15, P590, DOI 10.1093/oxfordjournals.molbev.a025960; Stankiewicz P, 2004, GENOME RES, V14, P2209, DOI 10.1101/gr.2746604; Stankiewicz P, 2002, CURR OPIN GENET DEV, V12, P312, DOI 10.1016/S0959-437X(02)00304-0; Swofford D.L., 2003, PAUP PHYLOGENETIC AN; Taudien S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-92; Ventura M, 2003, GENOME RES, V13, P2059, DOI 10.1101/gr.1155103; Verrelli BC, 2004, AM J HUM GENET, V75, P363, DOI 10.1086/423287; Vidal N, 2000, AIDS RES HUM RETROV, V16, P2059, DOI 10.1089/088922200750054800; Webster MT, 2005, MOL BIOL EVOL, V22, P1468, DOI 10.1093/molbev/msi136; Weiller GF, 1998, MOL BIOL EVOL, V15, P326, DOI 10.1093/oxfordjournals.molbev.a025929; WILLIAMS GW, 1998, NIX NUCLEOTIDE IDENT; Wiuf C, 2001, MOL BIOL EVOL, V18, P1929, DOI 10.1093/oxfordjournals.molbev.a003733	64	28	28	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2005	77	5					824	840		10.1086/497704	http://dx.doi.org/10.1086/497704			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	974CT	16252241	Bronze, Green Published			2022-12-18	WOS:000232569600011
J	Elston, RC; Song, DH; Iyengar, SK				Elston, RC; Song, DH; Iyengar, SK			Mathematical assumptions versus biological reality: Myths in affected sib pair linkage analysis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							2-LOCUS HETEROGENEITY; EPISTASIS; DISTORTION; TRAITS; GENOME	Affected sib pair ( ASP) analysis has become common ever since it was shown that, under very specific assumptions, ASPs afford a powerful design for linkage analysis. In 2003, Vieland and Huang, on the basis of a "fundamental heterogeneity equation," proved that heterogeneity and epistasis are confounded in ASP linkage analysis. A much more serious limitation of ASP linkage analysis is the implicit assumption that randomly sampled sib pairs share half their alleles identical by descent at any locus, whereas a critical assumption underlying Vieland and Huang's proof is that of joint Hardy-Weinberg equilibrium proportions at two trait loci. These are considered as examples of mathematical assumptions that may not always reflect biological reality. More-robust sib-pair designs and appropriate methods for their analysis have long been available.	Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA	Case Western Reserve University	Elston, RC (corresponding author), Case Western Reserve Univ, Dept Epidemiol & Biostat, 2103 Cornell Rd, Cleveland, OH 44106 USA.	rce@darwin.case.edu	/S-1190-2019	/0000-0001-7488-250X	NCRR NIH HHS [RR 03655, P41 RR003655] Funding Source: Medline; NIDDK NIH HHS [DK 54644, DK 57292, U01 DK057292] Funding Source: Medline; NIGMS NIH HHS [R01 GM028356, GM 28356, R37 GM028356] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK057292, R01DK054644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028356, R01GM028356] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALOYSIA M, 1961, TRANSFUSION, V1, P212; BHENDE YM, 1952, LANCET, V262, P903; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; Cordell HJ, 2003, AM J HUM GENET, V73, P1468, DOI 10.1086/380312; Croteau S, 2002, MAMM GENOME, V13, P24, DOI 10.1007/s00335-001-2095-x; Edwards JH, 2003, CLIN GENET, V63, P1, DOI 10.1034/j.1399-0004.2003.630101.x; ELSTON RC, 1973, BEHAV GENET, V3, P101, DOI 10.1007/BF01067650; Elston RC, 1996, GENET EPIDEMIOL, V13, P535, DOI 10.1002/(SICI)1098-2272(1996)13:6<535::AID-GEPI2>3.3.CO;2-R; Farrall M, 2003, AM J HUM GENET, V73, P1467, DOI 10.1086/380310; Forrest WF, 2000, AM J HUM GENET, V66, P1642, DOI 10.1086/302897; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Koda Y, 1997, BIOCHEM BIOPH RES CO, V238, P21, DOI 10.1006/bbrc.1997.7232; Lemire M, 2004, AM J HUM GENET, V75, P571, DOI 10.1086/424528; Leutenegger AL, 2002, GENET EPIDEMIOL, V23, P413, DOI 10.1002/gepi.10190; LEVINE P, 1955, BLOOD, V10, P1100, DOI 10.1182/blood.V10.11.1100.1100; Penrose LS, 1935, ANN EUGENIC, V4, P133; Schaid DJ, 2003, HUM HERED, V55, P86, DOI 10.1159/000072313; Vieland VJ, 2003, AM J HUM GENET, V73, P1471, DOI 10.1086/380313; Vieland VJ, 2003, AM J HUM GENET, V73, P223, DOI 10.1086/376563; Wiesner GL, 2003, P NATL ACAD SCI USA, V100, P12961, DOI 10.1073/pnas.2132286100; Zeegers MPA, 2003, HUM HERED, V55, P125, DOI 10.1159/000072317; Zollner S, 2004, AM J HUM GENET, V74, P62, DOI 10.1086/381131	22	28	28	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2005	76	1					152	156		10.1086/426872	http://dx.doi.org/10.1086/426872			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	878JR	15540158	Bronze, Green Published			2022-12-18	WOS:000225643600014
J	Chen, WM; Liu, YF; Lin, MW; Chen, IC; Lin, PY; Lin, GL; Jou, YS; Lin, YT; Fann, CSJ; Wu, JY; Hsiao, KJ; Tsai, SF				Chen, WM; Liu, YF; Lin, MW; Chen, IC; Lin, PY; Lin, GL; Jou, YS; Lin, YT; Fann, CSJ; Wu, JY; Hsiao, KJ; Tsai, SF			Autosomal dominant avascular necrosis of femoral head in two Taiwanese pedigrees and linkage to chromosome 12q13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR; PROTEIN-S DEFICIENCY; LEGG-PERTHES DISEASE; IDIOPATHIC OSTEONECROSIS; BONE NECROSIS; HYPOFIBRINOLYSIS; GENE; THROMBOPHILIA; HIP; PATHOGENESIS	Avascular necrosis of the femoral head (ANFH) is a debilitating disease that commonly leads to destruction of the hip joint in adults. The etiology of ANFH is unknown, but previous studies have indicated that heritable thrombophilia ( increased tendency to form thrombi) and hypofibrinolysis ( reduced ability to lyse thrombi), alcohol intake, and steroid use are risk factors for ANFH. We recently identified two families with ANFH showing autosomal dominant inheritance. By applying linkage analysis to a four-generation pedigree, we excluded linkage between the family and three genes related to thrombophilia and hypofibrinolysis: protein C, protein S, and plasminogen activator inhibitor. Furthermore, by a genomewide scan, a significant two-point LOD score of 3.45 ( recombination fraction [theta] = 0) was obtained between the family with ANFH and marker D12S85 on chromosome 12. High-resolution mapping was conducted in a second family with ANFH and replicated the linkage to D12S368 ( pedigree I: LOD score 2.47, theta = 0.05 pedigree II: LOD score 2.81, theta = 0.10). When an age-dependent-penetrance model was applied, the combined multipoint LOD score was 6.43 between D12S1663 and D12S85. Thus, we mapped the candidate gene for autosomal dominant ANFH to a 15-cM region between D12S1663 and D12S1632 on chromosome 12q13.	Natl Hlth Res Inst, Div Mol & Genom Med, Taipei 115, Taiwan; Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; Taipei Vet Gen Hosp, Dept Orthopaed & Traumatol, Taipei, Taiwan; Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan; Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan; Natl Yang Ming Univ, Genet Inst, Taipei 112, Taiwan; Natl Yang Ming Univ, Genome Res Ctr, Taipei 112, Taiwan; Chain An MIS Med Ctr, Chungli, Taiwan; China Med Univ Hosp, Dept Med Res, Taichung, Taiwan	National Health Research Institutes - Taiwan; Academia Sinica - Taiwan; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Tsai, SF (corresponding author), Natl Hlth Res Inst, Div Mol & Genom Med, 128,Yen Chiu Yuan Rd,Sect 2, Taipei 115, Taiwan.	petsai@nhri.org.tw	Wu, Jer-Yuarn/S-7010-2018; Tsai, Shih-Feng/E-3997-2010; Jou, Yuh-Shan/O-5921-2018; Fann, Cathy SJ/F-9410-2010	Jou, Yuh-Shan/0000-0001-5090-3732; Fann, Cathy SJ/0000-0001-9025-2276				Abu-Shakra M, 2003, CLIN REV ALLERG IMMU, V25, P13, DOI 10.1385/CRIAI:25:1:13; AHMAD NN, 1991, P NATL ACAD SCI USA, V88, P6624, DOI 10.1073/pnas.88.15.6624; Assouline-Dayan Y, 2002, SEMIN ARTHRITIS RHEU, V32, P94, DOI 10.1053/sarh.2002.33724; ATSUMI T, 1992, CLIN ORTHOP RELAT R, P22; Bachiller FGC, 2002, CLIN ORTHOP RELAT R, P87; BENJAMIN B, 1994, J BONE JOINT SURG BR, V76B, P544, DOI 10.1302/0301-620X.76B4.8027136; BONAVENTURE J, 1995, BIOCHEM J, V307, P823, DOI 10.1042/bj3070823; FICAT RP, 1985, J BONE JOINT SURG BR, V67, P3, DOI 10.1302/0301-620X.67B1.3155745; FISHER DE, 1978, CLIN ORTHOP RELAT R, P68; Glueck CJ, 2001, CLIN ORTHOP RELAT R, P19; GLUECK CJ, 1993, THROMB HAEMOSTASIS, V69, P460; GLUECK CJ, 1994, PEDIATR RES, V35, P383, DOI 10.1203/00006450-199404000-00001; GLUECK CJ, 1994, THROMB HAEMOSTASIS, V71, P195; Glueck CJ, 1996, ORAL SURG ORAL MED O, V81, P557, DOI 10.1016/S1079-2104(96)80047-3; Glueck CJ, 1996, J BONE JOINT SURG AM, V78A, P3, DOI 10.2106/00004623-199601000-00002; Glueck CJ, 1997, CLIN ORTHOP RELAT R, P43; GLUECK CJ, 1994, AM J HEMATOL, V45, P156, DOI 10.1002/ajh.2830450212; HUGHES MR, 1988, SCIENCE, V242, P1702, DOI 10.1126/science.2849209; HUSTMYER FG, 1994, J CLIN INVEST, V94, P2130, DOI 10.1172/JCI117568; Jones J.P., 1997, OSTEONECROSIS ETIOLO, P89; Jones LC, 2003, J RHEUMATOL, V30, P783; KLINGER KW, 1987, P NATL ACAD SCI USA, V84, P8548, DOI 10.1073/pnas.84.23.8548; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MANKIN HJ, 1992, NEW ENGL J MED, V326, P1473; MASSIN P, 1995, J BONE JOINT SURG BR, V77B, P847, DOI 10.1302/0301-620X.77B6.7593093; MILNER PF, 1991, NEW ENGL J MED, V325, P1476, DOI 10.1056/NEJM199111213252104; MONT MA, 1995, J BONE JOINT SURG AM, V77A, P459, DOI 10.2106/00004623-199503000-00018; MORRISON NA, 1994, NATURE, V367, P284, DOI 10.1038/367284a0; NOBILLOT R, 1994, ANN RHEUM DIS, V53, P702, DOI 10.1136/ard.53.10.702; PATRACCHINI P, 1989, HUM GENET, V81, P191, DOI 10.1007/BF00293902; PEDEUTOUR F, 1994, GENOMICS, V22, P512, DOI 10.1006/geno.1994.1424; PierreJacques H, 1997, J BONE JOINT SURG AM, V79A, P1079, DOI 10.2106/00004623-199707000-00017; WANG TY, 1988, AM J MED, V84, P1085, DOI 10.1016/0002-9343(88)90319-1; Wang YS, 2003, CLIN ORTHOP RELAT R, P213, DOI 10.1097/01.blo.0000063602.67412.83; WATKINS PC, 1988, BLOOD, V71, P238	35	28	32	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2004	75	2					310	317		10.1086/422702	http://dx.doi.org/10.1086/422702			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	838GR	15179599	Bronze, Green Published			2022-12-18	WOS:000222702000015
J	Rickard, SJ; Wilson, LC				Rickard, SJ; Wilson, LC			Analysis of GNAS1 and overlapping transcripts identifies the parental origin of mutations in patients with sporadic Albright hereditary osteodystrophy and reveals a model system in which to observe the effects of splicing mutations on translated and untranslated messenger RNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GS-ALPHA GENE; CYCLASE COUPLING PROTEIN; DEFICIENT ACTIVITY; PSEUDOHYPOPARATHYROIDISM; METHYLATION; RESISTANCE; DELETION; DEFECT	`Albright hereditary osteodystrophy (AHO) is caused by heterozygous deactivating GNAS1 mutations. There is a parent-of-origin effect. Maternally derived mutations are usually associated with resistance to parathyroid hormone termed "pseudohypoparathyroidism type Ia." Paternally derived mutations are associated with AHO but usually normal hormone responsiveness, known as "pseudo-pseudohypoparathyroidism." These observations can be explained by tissue-specific GNAS1 imprinting. Regulation of the genomic region that encompasses GNAS1 is complex. At least three upstream exons that splice to exon 2 of GNAS1 and that are imprinted have been reported. NESP55 is exclusively maternally expressed, whereas exon 1A and XLalphas are exclusively paternally expressed. We set out to identify the parental origin of GNAS1 mutations in patients with AHO by searching for their mutation in the overlapping transcripts. This information would be of value in patients with sporadic disease, for predicting their endocrine phenotype and planning follow-up. In doing so, we identified mutations that resulted in nonsense-mediated decay of the mutant Gsalpha transcript but that were detectable in NESP55 messenger RNA ( mRNA), probably because they lie within its 3' untranslated region. Analysis of the NESP55 transcripts revealed the creation of a novel splice site in one patient and an unusual intronic mutation that caused retention of the intron in a further patient, neither of which could be detected by analysis of the Gsalpha complementary DNA. This cluster of overlapping transcripts represents a useful model system in which to analyze the effects that mutant sequence has on mRNA - in particular, splicing - and the mechanisms of nonsense-mediated mRNA decay.	Inst Child Hlth, Clin & Mol Genet Unit, London WC1N 1EH, England; Great Ormond St Hosp Sick Children, London WC1N 3JH, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Wilson, LC (corresponding author), Inst Child Hlth, Clin & Mol Genet Unit, 30 Guilford St, London WC1N 1EH, England.	l.wilson@ich.ucl.ac.uk						Ahmed SF, 1998, CLIN ENDOCRINOL, V49, P525, DOI 10.1046/j.1365-2265.1998.00572.x; Aldred MA, 2000, HUM MUTAT, V16, P183, DOI 10.1002/1098-1004(200009)16:3<183::AID-HUMU1>3.0.CO;2-L; ANTEQUERA F, 1990, CELL, V62, P503, DOI 10.1016/0092-8674(90)90015-7; BOURNE HR, 1981, J CLIN ENDOCR METAB, V53, P636, DOI 10.1210/jcem-53-3-636; BOURNE HR, 1992, NATURE, V358, P541, DOI 10.1038/358541a0; CRAWFORD JA, 1993, J BIOL CHEM, V268, P9879; DAVIES SJ, 1993, J MED GENET, V30, P101, DOI 10.1136/jmg.30.2.101; FARFEL Z, 1982, J CLIN ENDOCR METAB, V55, P113, DOI 10.1210/jcem-55-1-113; FARFEL Z, 1980, J CLIN ENDOCR METAB, V51, P1202, DOI 10.1210/jcem-51-5-1202; Germain-Lee EL, 2002, BIOCHEM BIOPH RES CO, V296, P67, DOI 10.1016/S0006-291X(02)00833-1; Hannula K, 2001, GENOMICS, V73, P1, DOI 10.1006/geno.2001.6502; Hayward BE, 2000, HUM MOL GENET, V9, P835, DOI 10.1093/hmg/9.5.835; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P15475, DOI 10.1073/pnas.95.26.15475; Hayward BE, 2001, J CLIN INVEST, V107, pR31, DOI 10.1172/JCI11887; KOZASA T, 1988, P NATL ACAD SCI USA, V85, P2081, DOI 10.1073/pnas.85.7.2081; KRAINER AR, 1988, RNA SPLICING; Kubota T, 1996, J MED GENET, V33, P1011, DOI 10.1136/jmg.33.12.1011; LEVINE MA, 1980, BIOCHEM BIOPH RES CO, V94, P1319, DOI 10.1016/0006-291X(80)90563-X; LEVINE MA, 1983, AM J MED, V74, P545, DOI 10.1016/0002-9343(83)91008-2; Liu J, 2000, J CLIN INVEST, V106, P1167, DOI 10.1172/JCI10431; LUTTIKHUIS MEMO, 1994, GENOMICS, V21, P455, DOI 10.1006/geno.1994.1297; Mantovani G, 2002, J CLIN ENDOCR METAB, V87, P4736, DOI 10.1210/jc.2002-020183; Maquat LE, 2002, CURR BIOL, V12, pR196, DOI 10.1016/S0960-9822(02)00747-9; OHSHIMA Y, 1987, J MOL BIOL, V195, P247, DOI 10.1016/0022-2836(87)90647-4; PENNINGTON SR, 1994, GTP BINDING PROTEINS; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; SCHUSTER V, 1994, J MED GENET, V31, P84, DOI 10.1136/jmg.31.1.84; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Warner DR, 1999, J BIOL CHEM, V274, P4977, DOI 10.1074/jbc.274.8.4977; WEINSTEIN LS, 1992, GENOMICS, V13, P1319, DOI 10.1016/0888-7543(92)90056-X; WILSON LC, 1994, J MED GENET, V31, P779, DOI 10.1136/jmg.31.10.779; WILSON LC, 1994, J MED GENET, V31, P835, DOI 10.1136/jmg.31.11.835; YU SH, 1995, HUM MOL GENET, V4, P2001, DOI 10.1093/hmg/4.10.2001; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715	34	28	29	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2003	72	4					961	974		10.1086/374566	http://dx.doi.org/10.1086/374566			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662WT	12624854	Green Published, Bronze			2022-12-18	WOS:000181972600016
J	Tarazona-Santos, E; Santos, FR				Tarazona-Santos, E; Santos, FR			The peopling of the Americas: A second major migration?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							Y-CHROMOSOME HAPLOTYPE; NEW-WORLD; MITOCHONDRIAL-DNA; AMERINDIANS; HISTORY; ORIGIN; POPULATION; DIVERSITY; ADMIXTURE; FOUNDERS		Univ Maryland, Dept Biol, College Pk, MD 20742 USA; Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil	University System of Maryland; University of Maryland College Park; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Tarazona-Santos, E (corresponding author), Univ Maryland, Dept Biol, 1210 Biol Psychol Bldg, College Pk, MD 20742 USA.		Tarazona-Santos, Eduardo/AAF-1110-2019; Santos, Fabrício Rodrigues/H-2370-2011	Santos, Fabrício Rodrigues/0000-0001-9088-1750; Tarazona, Eduardo/0000-0003-3508-3160				Bianchi NO, 1997, AM J PHYS ANTHROPOL, V102, P79; Bonatto SL, 1997, P NATL ACAD SCI USA, V94, P1866, DOI 10.1073/pnas.94.5.1866; Bonatto SL, 1997, AM J HUM GENET, V61, P1413, DOI 10.1086/301629; Carvajal-Carmona LG, 2000, AM J HUM GENET, V67, P1287, DOI 10.1016/S0002-9297(07)62956-5; Carvalho-Silva DR, 2001, AM J HUM GENET, V68, P281, DOI 10.1086/316931; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; CRAWFORD MH, 1998, ORIGIN NATIVE AM EVI; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Helgason A, 2000, AM J HUM GENET, V66, P999, DOI 10.1086/302816; Huoponen K, 1997, EUR J HUM GENET, V5, P25, DOI 10.1159/000484728; Hurles ME, 1999, AM J HUM GENET, V65, P1437, DOI 10.1086/302617; Karafet TM, 1999, AM J HUM GENET, V64, P817, DOI 10.1086/302282; Lell JT, 2002, AM J HUM GENET, V70, P192, DOI 10.1086/338457; Merriwether DA, 1997, AM J PHYS ANTHROPOL, V102, P153, DOI 10.1002/(SICI)1096-8644(199702)102:2<153::AID-AJPA1>3.0.CO;2-#; PENA SDJ, 1995, NAT GENET, V11, P15, DOI 10.1038/ng0995-15; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Ruiz-Linares A, 1999, P NATL ACAD SCI USA, V96, P6312, DOI 10.1073/pnas.96.11.6312; Salzano FM, 1988, S AM INDIANS CASE ST; Sans M, 2000, HUM BIOL, V72, P155; Santos FR, 1996, GENOME RES, V6, P601, DOI 10.1101/gr.6.7.601; Santos FR, 1996, AM J HUM GENET, V58, P1369; Santos FR, 1995, BRAZ J GENET, V18, P669; Santos FR, 1999, AM J HUM GENET, V64, P619, DOI 10.1086/302242; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; WALLACE DC, 1985, AM J PHYS ANTHROPOL, V68, P149, DOI 10.1002/ajpa.1330680202	27	28	28	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2002	70	5					1377	1380		10.1086/340388	http://dx.doi.org/10.1086/340388			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	541XT	11951181	Bronze, Green Published			2022-12-18	WOS:000175012400030
J	Sperandeo, MP; Ungaro, P; Vernucci, M; Pedone, PV; Cerrato, F; Perone, L; Casola, S; Cubellis, MV; Bruni, CB; Andria, G; Sebastio, G; Riccio, A				Sperandeo, MP; Ungaro, P; Vernucci, M; Pedone, PV; Cerrato, F; Perone, L; Casola, S; Cubellis, MV; Bruni, CB; Andria, G; Sebastio, G; Riccio, A			Relaxation of insulin-like growth factor 2 imprinting and discordant methylation at KvDMR1 in two first cousins affected by Beckwith-Wiedemann and Klippel-Trenaunay-Weber syndromes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FACTOR-II GENE; HUMAN IGF2R GENE; HISTONE ACETYLATION; DNA METHYLATION; HUMAN CANCER; WILMS-TUMOR; H19 GENE; EXPRESSION; POLYMORPHISM; MICE	Beckwith-Wiedeman syndrome (BWS) and Klippel-Trenaunay-Weber syndrome (KTWS) are different human disorders characterized, among other features, by tissue overgrowth. Deregulation of one or more imprinted genes located at chromosome 11p15.5, of which insulin-like growth factor 2 (IGF2) is the most likely candidate, is believed to cause BWS, whereas the etiology of KTWS is completely obscure. We report a case of BWS and a case of KTWS in a single family. The probands, sons of two sisters, showed relaxation of the maternal IGF2, imprinting, although they inherited different 11p15.5 alleles from their mothers and did not show any chromosome rearrangement. The patient with BWS also displayed hypomethylation at KvDMR1, a maternally methylated CpG island within an intron of the KvLQT1 gene. The unaffected brother of the BWS proband shared the same maternal and paternal 11p15.5 haplotype with his brother, but the KvDMR1 locus was normally methylated. Methylation of the H19 gene was normal in both the BWS and KTWS probands. Linkage between the insulin-like growth factor 2 receptor (IGF2R) gene and the tissue overgrowth was also excluded. These results raise the possibility that a defective modifier or regulatory gene unlinked to 11p15.5 caused a spectrum of epigenetic alterations in the germ line or early development of both cousins, ranging from the relaxation of IGF2 imprinting in the KTWS proband to disruption of both the imprinted expression of IGF2 and the imprinted methylation of KvDMR1 in the BWS proband. Analysis of these data also indicates that loss of IGF2 imprinting is not necessarily linked to alteration of methylation at the KvDMR1 or H19 loci and supports the notion that IGF2 overexpression is involved in the etiology of the tissue hypertrophy observed in different overgrowth disorders, including KTWS.	Univ Naples 2, Dipartimento Pediat, Naples, Italy; Univ Naples 2, Ctr Endocrinol & Oncol Sperimentale G Salvatore, CNR, Naples, Italy; Univ Naples 2, Dipartimento Sci Ambientali, Naples, Italy; Univ Naples Federico II, Ctr Biocristallog, CNR, Naples, Italy; Univ Naples Federico II, Dipartimento Chim Organ & Biol, Naples, Italy	Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II; University of Naples Federico II	Riccio, A (corresponding author), Univ Naples Federico II, Dipartimento Biol & Patol Cellulaire & Mol, CNR, Ctr Endocrinol & Oncol Sperimentale, Via S Pansini 5, I-80131 Naples, Italy.		Riccio, Andrea/A-4991-2015; Riccio, Andrea/AAY-7571-2020; Casola, Stefano/AAN-8319-2021; andria, generoso/V-7172-2019; Casola, Stefano/O-3922-2014; Melis, Daniela/AAD-3623-2019	Riccio, Andrea/0000-0001-7990-3576; Riccio, Andrea/0000-0001-7990-3576; Casola, Stefano/0000-0001-5580-0986; Melis, Daniela/0000-0002-9458-3926; Pedone, Paolo Vincenzo/0000-0002-0828-5843; cubellis, maria vittoria/0000-0001-6147-6553				AELVOET GE, 1992, BRIT J DERMATOL, V126, P603; BRONCHUD MH, 1996, EUR CANC NEW, V9, P5; Casola S, 1997, ONCOGENE, V14, P1503, DOI 10.1038/sj.onc.1200956; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; EDWARDS A, 1991, AM J HUM GENET, V49, P746; Eggenschwiler J, 1997, GENE DEV, V11, P3128, DOI 10.1101/gad.11.23.3128; Feinberg AP, 1999, CANCER RES, V59, p1743S; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GOSDEN CM, 1982, HUMAN CYTOGENETICS P, P31; HAPPLE R, 1993, BRIT J DERMATOL, V128, P465, DOI 10.1111/j.1365-2133.1993.tb00214.x; HAUGE XY, 1993, HUM MOL GENET, V2, P411, DOI 10.1093/hmg/2.4.411; Hol F. A., 1992, Human Molecular Genetics, V1, P347, DOI 10.1093/hmg/1.5.347; Hu JF, 1997, MOL ENDOCRINOL, V11, P1891, DOI 10.1210/me.11.13.1891; Hu JF, 1998, BIOCHEM BIOPH RES CO, V251, P403, DOI 10.1006/bbrc.1998.9401; Joyce JA, 1997, HUM MOL GENET, V6, P1543, DOI 10.1093/hmg/6.9.1543; LAU MMH, 1994, GENE DEV, V8, P2953, DOI 10.1101/gad.8.24.2953; Lee MP, 1999, P NATL ACAD SCI USA, V96, P5203, DOI 10.1073/pnas.96.9.5203; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Li Madeline, 1997, Current Opinion in Pediatrics, V9, P623, DOI 10.1097/00008480-199712000-00012; Morison IM, 1996, NAT MED, V2, P311, DOI 10.1038/nm0396-311; MOULTON T, 1994, NAT GENET, V7, P440, DOI 10.1038/ng0794-440; PEDONE PV, 1994, HUM MOL GENET, V3, P1117, DOI 10.1093/hmg/3.7.1117; Pedone PV, 1999, FEBS LETT, V458, P45, DOI 10.1016/S0014-5793(99)01124-2; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; Rechler M. M., 1990, PEPTIDE GROWTH FACTO, P263; Reik W, 1997, TRENDS GENET, V13, P330, DOI 10.1016/S0168-9525(97)01200-6; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; STEENMAN MJ, 1994, NAT GENET, V3, P433; Sun FL, 1997, NATURE, V389, P809, DOI 10.1038/39797; TADOKORO K, 1991, NUCLEIC ACIDS RES, V19, P6967, DOI 10.1093/nar/19.24.6967; TANIGUCHI T, 1995, P NATL ACAD SCI USA, V92, P2159, DOI 10.1073/pnas.92.6.2159; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Tilghman SM, 1999, CELL, V96, P185, DOI 10.1016/S0092-8674(00)80559-0; Toretsky JA, 1996, J ENDOCRINOL, V149, P367, DOI 10.1677/joe.0.1490367; Weaver D.D, 1994, GROWTH GENET HORM, V10, P1; WEKSBERG R, 1993, NAT GENET, V5, P143, DOI 10.1038/ng1093-143; WHELAN AJ, 1995, AM J MED GENET, V59, P492, DOI 10.1002/ajmg.1320590416; XU YQ, 1993, BIOCHEM BIOPH RES CO, V197, P747, DOI 10.1006/bbrc.1993.2542	39	28	30	0	9	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2000	66	3					841	847		10.1086/302811	http://dx.doi.org/10.1086/302811			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QM	10712200	Bronze, Green Published			2022-12-18	WOS:000088373200008
J	Celli, J; van Beusekom, E; Hennekam, RCM; Gallardo, ME; Smeets, DFCM; de Cordoba, SR; Innis, JW; Frydman, M; Konig, R; Kingston, H; Tolmie, J; Govaerts, LCP; van Bokhoven, H; Brunner, HG				Celli, J; van Beusekom, E; Hennekam, RCM; Gallardo, ME; Smeets, DFCM; de Cordoba, SR; Innis, JW; Frydman, M; Konig, R; Kingston, H; Tolmie, J; Govaerts, LCP; van Bokhoven, H; Brunner, HG			Familial syndromic esophageal atresia maps to 2p23-p24	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SHORT PALPEBRAL FISSURES; DIGITAL ANOMALIES; DUODENAL ATRESIA; RETINOIC ACID; TRACHEOESOPHAGEAL FISTULA; NORMAL INTELLIGENCE; FEINGOLD-SYNDROME; SONIC HEDGEHOG; ABNORMALITIES; IDENTIFICATION	Esophageal atresia (EA) is a common life-threatening congenital anomaly that occurs in 1/3,000 newborns. Little is known of the genetic factors that underlie EA. Oculodigitoesophageoduodenal (ODED) syndrome (also known as "Feingold syndrome") is a rare autosomal dominant disorder with digital abnormalities, microcephaly, short palpebral fissures, mild learning disability, and esophageal/duodenal atresia. We studied four pedigrees, including a three-generation Dutch family with 11 affected members. Linkage analysis was initially aimed at chromosomal regions harboring candidate genes for this disorder. Twelve different genomic regions covering 15 candidate genes (similar to 15% of the genome) were excluded from involvement in the ODED syndrome, A subsequent nondirective mapping approach revealed evidence for linkage between the syndrome and marker D2S390 (maximum LOD score 4.51 at recombination fraction 0). A submicroscopic deletion in a fourth family with ODED provided independent confirmation of this genetic localization and narrowed the critical region to 7.3 cM in the 2p23-p24 region. These results show that haploinsufficiency for a gene or genes in 2p23-p24 is associated with syndromic EA.	Univ Nijmegen, Dept Human Genet, Nijmegen, Netherlands; Univ Utrecht, Utrecht, Netherlands; Univ Maastricht, Dept Clin Genet, Veldhoven, Netherlands; Univ Rotterdam Hosp, Dept Clin Genet, Rotterdam, Netherlands; Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Chaim Sheba Med Ctr, Inst Genet, IL-52621 Tel Hashomer, Israel; Chaim Sheba Med Ctr, Dept Radiol, IL-52621 Tel Hashomer, Israel; Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; Fdn Jimenez Diaz, Dept Immunol, Complement Genet Lab, Ctr Invest Biol, E-28040 Madrid, Spain; Fdn Jimenez Diaz, Unit Mol Pathol, E-28040 Madrid, Spain; Univ Frankfurt, Inst Human Genet, D-6000 Frankfurt, Germany; St Marys Hosp, Reg Genet Serv, Manchester M13 0JH, Lancs, England; Duncan Guthrie Inst Med Genet, Glasgow G3 8SJ, Lanark, Scotland	Radboud University Nijmegen; Utrecht University; Maastricht University; Erasmus University Rotterdam; Erasmus MC; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Goethe University Frankfurt; University of Manchester	Celli, J (corresponding author), Univ Nijmegen Hosp, Geert Grooteplein 10, NL-6500 HB Nijmegen, Netherlands.		de Cordoba, Santiago Rodriguez/K-6727-2014; Brunner, Han/C-9928-2013; van Beusekom, Ellen/AAF-2687-2019; van Bokhoven, Hans/D-8764-2012; Smeets, D.F.C.M./L-4653-2015; Gallardo, M. Esther/AFK-7298-2022; Bokhoven, J.H.L.M. van van/H-8015-2014	de Cordoba, Santiago Rodriguez/0000-0001-6401-1874; Gallardo, M. Esther/0000-0002-8699-8734; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254				Bavik C, 1997, MECH DEVELOP, V69, P155, DOI 10.1016/S0925-4773(97)00167-6; Beasley S, 1997, PEDIATR SURG INT, V12, P550; BOLES RG, 1995, AM J MED GENET, V55, P155, DOI 10.1002/ajmg.1320550204; Boulet AM, 1996, DEV BIOL, V177, P232, DOI 10.1006/dbio.1996.0159; Brewer C, 1998, AM J HUM GENET, V63, P1153, DOI 10.1086/302041; Brickell P, 1997, SEMIN CELL DEV BIOL, V8, P437, DOI 10.1006/scdb.1997.0167; BRUNNER HG, 1991, J MED GENET, V28, P389, DOI 10.1136/jmg.28.6.389; Casteels K, 1993, Tijdschr Kindergeneeskd, V61, P100; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Courtens W, 1997, AM J MED GENET, V73, P55; DAVID G, 1993, DEVELOPMENT, V119, P841; DAVID TJ, 1975, J MED GENET, V12, P1, DOI 10.1136/jmg.12.1.1; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dickman ED, 1997, DEVELOPMENT, V124, P3111; Digilio MC, 1999, J MED GENET, V36, P137; Feingold M, 1997, AM J MED GENET, V69, P245, DOI 10.1002/(SICI)1096-8628(19970331)69:3<245::AID-AJMG7>3.3.CO;2-U; FEINGOLD M, 1975, SYND IDENT, V3, P16; Frydman M, 1997, AM J MED GENET, V71, P251, DOI 10.1002/(SICI)1096-8628(19970822)71:3<251::AID-AJMG1>3.0.CO;2-X; Innis JW, 1997, AM J MED GENET, V71, P150, DOI 10.1002/(SICI)1096-8628(19970808)71:2<150::AID-AJMG6>3.0.CO;2-1; Kawame H, 1997, AM J MED GENET, V69, P240, DOI 10.1002/(SICI)1096-8628(19970331)69:3<240::AID-AJMG6>3.0.CO;2-P; Kimble RM, 1997, PEDIATR SURG INT, V12, P565; KONIG R, 1990, DYSMORPHOL CLIN GENE, V4, P83; Litingtung Y, 1998, NAT GENET, V20, P58, DOI 10.1038/1717; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MITSIADIS TA, 1995, DEVELOPMENT, V121, P37; Motoyama J, 1998, NAT GENET, V20, P54, DOI 10.1038/1711; OLIVER G, 1995, DEVELOPMENT, V121, P693; Peters H, 1997, MAMM GENOME, V8, P62, DOI 10.1007/s003359900351; PLETCHER BA, 1991, AM J MED GENET, V39, P380, DOI 10.1002/ajmg.1320390403; Pulkkinen L, 1997, HUM MOL GENET, V6, P669, DOI 10.1093/hmg/6.5.669; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; ROSSI LN, 1987, AM J DIS CHILD, V141, P655, DOI 10.1001/archpedi.1987.04460060071037; SUIJKERBUIJK RF, 1992, CANCER GENET CYTOGEN, V63, P8, DOI 10.1016/0165-4608(92)90056-E; SZENDREY T, 1985, HUM GENET, V70, P51, DOI 10.1007/BF00389459; VANSTAEY M, 1984, HUM GENET, V66, P260, DOI 10.1007/BF00286613	35	28	30	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					436	444		10.1086/302779	http://dx.doi.org/10.1086/302779			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677303	Green Published, Bronze			2022-12-18	WOS:000088373100010
J	Holt, D; Dreimanis, M; Pfeiffer, M; Firgaira, F; Morley, A; Turner, D				Holt, D; Dreimanis, M; Pfeiffer, M; Firgaira, F; Morley, A; Turner, D			Interindividual variation in mitotic recombination	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HLA-A LOCUS; HUMAN-LYMPHOCYTES; SOMATIC MUTATION; BLOOMS-SYNDROME; FREQUENCY; ASSAY; SPECTRUM; AGE	Mitotic recombination (MR) between homologous chromosomes is a mutational event that results in loss of heterozygosity in half of the segregants at mitosis. Loss of heterozygosity may have important biological consequences. The purpose of this study was to describe human variation in the spontaneous frequency of MR. Using an immunoselection technique for isolating the somatic mutations that result in loss of expression of one of the codominant alleles at the HLA-A locus, we have measured the frequency and molecular basis of somatic mutations in lymphocytes from a population of young adults. Mutations were classified as being the result of intragenic changes, major deletions, or MR. Here we show that the MR mutation frequency in females was significantly greater than that in males but that intragenic mutation frequency showed no association with sex. Individual variation in MR frequency ranged over more than two orders of magnitude and was not normally distributed. Furthermore, the observed number of individuals from whom no mutants resulting from MR were obtained was significantly greater than was expected. The endogenous level of MR may be under genetic control. Given the association of loss of heterozygosity with cancer initiation and progression, low endogenous MR may confer a reduced lifetime risk of cancer, and the converse may apply.	Flinders Univ S Australia, Sch Med, Dept Haematol & Genet Pathol, Adelaide, SA 5001, Australia	Flinders University South Australia	Turner, D (corresponding author), Flinders Univ S Australia, Sch Med, Dept Haematol & Genet Pathol, GPO Box 2100, Adelaide, SA 5001, Australia.							AKIYAMA M, 1995, MUTAT RES-DNAGING G, V338, P141, DOI 10.1016/0921-8734(95)00019-3; BurkhartSchultz KJ, 1996, CARCINOGENESIS, V17, P1871, DOI 10.1093/carcin/17.9.1871; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FIRGAIRA FA, 1994, IMMUNOGENETICS, V40, P445; German J, 1997, CANCER GENET CYTOGEN, V93, P100, DOI 10.1016/S0165-4608(96)00336-6; GRIST SA, 1992, MUTAT RES, V266, P189, DOI 10.1016/0027-5107(92)90186-6; Gupta PK, 1997, CANCER RES, V57, P1188; Jensen R H, 1986, Prog Clin Biol Res, V209B, P177; JOSEPH G, 1993, ENVIRON MOL MUTAGEN, V22, P152, DOI 10.1002/em.2850220307; KUSHIRO J, 1992, MUTAT RES, V272, P17, DOI 10.1016/0165-1161(92)90005-7; KUSUNOKI Y, 1994, JPN J CANCER RES, V85, P610, DOI 10.1111/j.1349-7006.1994.tb02403.x; KYOIZUMI S, 1990, J EXP MED, V171, P1981, DOI 10.1084/jem.171.6.1981; LANGLOIS RG, 1989, P NATL ACAD SCI USA, V86, P670, DOI 10.1073/pnas.86.2.670; MALE D, 1997, THESIS FLINDERS U S; MCCARRON MA, 1989, MUTAT RES, V225, P189, DOI 10.1016/0165-7992(89)90118-8; MORELY AA, 1990, CANCER RES, V50, P4584; MORLEY AA, 1983, NATURE, V302, P155, DOI 10.1038/302155a0; Morley AA, 1996, MUTAT RES-FUND MOL M, V357, P167, DOI 10.1016/0027-5107(96)00096-6; Qian F, 1997, AM J HUM GENET, V61, P1000, DOI 10.1086/301618; TRAINOR KJ, 1984, MECH AGEING DEV, V27, P83, DOI 10.1016/0047-6374(84)90084-8	20	28	28	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1999	65	5					1423	1427		10.1086/302614	http://dx.doi.org/10.1086/302614			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252YZ	10521309	Bronze, Green Published			2022-12-18	WOS:000083531000025
J	Zhao, JH; Sham, PC; Curtis, D				Zhao, JH; Sham, PC; Curtis, D			A program for the Monte Carlo evaluation of significance of the extended transmission/disequilibrium test	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							TRANSMISSION-DISEQUILIBRIUM; ALLELES; LOCI; TDT		Inst Psychiat, Dept Psychol Med, London SE5 8AF, England; Royal London Hosp, St Bartholomews & Royal London Sch Med & Dent, Acad Dept Psychol Med, London E1 1BB, England	University of London; King's College London; Barts Health NHS Trust; Royal London Hospital; University of London; King's College London; Queen Mary University London	Zhao, JH (corresponding author), Inst Psychiat, Dept Psychol Med, Crespigny Pk, London SE5 8AF, England.		Curtis, David/HGB-3921-2022	Curtis, David/0000-0002-4089-9183				Cleves MA, 1997, GENET EPIDEMIOL, V14, P337, DOI 10.1002/(SICI)1098-2272(1997)14:4<337::AID-GEPI1>3.3.CO;2-S; Kaplan NL, 1997, AM J HUM GENET, V61, P778; Kaplan NL, 1997, AM J HUM GENET, V60, P691; Lazzeroni LC, 1998, HUM HERED, V48, P67, DOI 10.1159/000022784; *MATHW INC, 1993, MATLAB VERS 4 0; Miller MB, 1997, GENET EPIDEMIOL, V14, P851; Sham P, 1997, AM J HUM GENET, V61, P774; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; Spielman RS, 1996, AM J HUM GENET, V59, P983; STUART A, 1955, BIOMETRIKA, V42, P412, DOI 10.2307/2333387; Vallada H, 1998, SCHIZOPHR RES, V32, P115	12	28	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1999	64	5					1484	1485		10.1086/302378	http://dx.doi.org/10.1086/302378			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192RP	10205285	Green Published, Bronze			2022-12-18	WOS:000080093000033
J	Laan, M; Paabo, S				Laan, M; Paabo, S			Mapping genes by drift-generated linkage disequilibrium	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							HUMAN GENOME		Max Planck Inst Evolut Anthropol, D-80333 Munich, Germany; Univ Munich, Inst Zool, D-80333 Munich, Germany	Max Planck Society; University of Munich	Paabo, S (corresponding author), Max Planck Inst Evolut Anthropol, Luisenstr 14, D-80333 Munich, Germany.		Laan, Maris/A-4100-2011	Laan, Maris/0000-0002-8519-243X				Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Esposito T, 1997, GENE, V187, P185, DOI 10.1016/S0378-1119(96)00772-X; Knoll A, 1997, HUM MOL GENET, V6, P1527, DOI 10.1093/hmg/6.9.1527; Laan M, 1997, NAT GENET, V17, P435, DOI 10.1038/ng1297-435; Nagaraja R, 1997, GENOME RES, V7, P210, DOI 10.1101/gr.7.3.210; NELSON DL, 1995, CYTOGENET CELL GENET, V71, P308; Peltonen L, 1995, BIOL CHEM H-S, V376, P697; Sajantila A, 1996, P NATL ACAD SCI USA, V93, P12035, DOI 10.1073/pnas.93.21.12035; SCHNEIDER S, 1997, ARLEQUIN VERSION 1 1; SLATKIN M, 1994, GENETICS, V137, P331; Terwilliger JD, 1998, HUM HERED, V48, P138, DOI 10.1159/000022794; vonHaeseler A, 1996, NAT GENET, V14, P135, DOI 10.1038/ng1096-135; Weir B., 1996, GENETIC DATA ANAL	13	28	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					654	656		10.1086/301972	http://dx.doi.org/10.1086/301972			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683603	Bronze, Green Published			2022-12-18	WOS:000075360800042
J	Kant, SG; Polinkovsky, A; Mundlos, S; Zabel, B; Thomeer, RTWM; Zonderland, HM; Shih, LY; van Haeringen, A; Warman, ML				Kant, SG; Polinkovsky, A; Mundlos, S; Zabel, B; Thomeer, RTWM; Zonderland, HM; Shih, LY; van Haeringen, A; Warman, ML			Acromesomelic dysplasia Maroteaux type maps to human chromosome 9	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DWARFISM; PATIENT; FAMILY; MOUSE	Acromesomelic dysplasias are skeletal disorders that disproportionately affect the middle and distal segments of the appendicular skeleton. We report genetic mapping studies in four families with acromesomelic dysplasia Maroteaux type (AMDM), an autosomal recessive osteochondrodysplasia. A peak LOD score of 5.1 at recombination fraction 0 was obtained with fury informative markers on human chromosome 9. In three of the four families, the affected offspring are products of consanguineous marriages; if it is assumed that these affected offspring are homozygous by descent for the region containing the AMDM locus, a 6.9-cM AMDM candidate interval can be defined by markers D9S1853 and D9S1874. The mapping of the AMDM locus to human chromosome 9 indicates that AMDM is genetically distinct from the two other mapped acromesomelic dysplasias, Hunter-Thompson type and Grebe type, which are caused by mutations in CDMP1 on human chromosome 20.	Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Neurosurg, Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; Univ Hosp Cleveland, Ctr Human Genet, Cleveland, OH 44106 USA; Univ Mainz, Kinderklin, D-6500 Mainz, Germany; Univ Med & Dent New Jersey, Ctr Human & Mol Genet, Newark, NJ 07103 USA	Case Western Reserve University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University Hospitals of Cleveland; Johannes Gutenberg University of Mainz; Rutgers State University New Brunswick; Rutgers State University Medical Center	Warman, ML (corresponding author), Case Western Reserve Univ, Dept Genet, BRB-719,2109 Adelbert Rd, Cleveland, OH 44106 USA.		Mundlos, Stefan/ABH-9585-2020; Kant, Sarina/F-8596-2010		NIAMS NIH HHS [AR 43827] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043827] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BEIGHTON P, 1974, CLIN GENET, V5, P363; BORRELLI P, 1983, PEDIATR RADIOL, V13, P165, DOI 10.1007/BF01624409; BRAHIMI L, 1988, PEDIATR RADIOL, V18, P67, DOI 10.1007/BF02395764; Cantu J M, 1977, Birth Defects Orig Artic Ser, V13, P139; DELMORAL RF, 1989, AM J MED GENET, V33, P415, DOI 10.1002/ajmg.1320330326; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Ferraz FG, 1997, J PEDIATR ORTHOP B, V6, P27, DOI 10.1097/01202412-199701000-00007; GREBE H, 1952, FOLIA HERED PATHOL, V2, P23; HALL CM, 1980, BRIT J RADIOL, V53, P999, DOI 10.1259/0007-1285-53-634-999; HUNTER AGW, 1976, HUM GENET, V34, P107; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LANGER LO, 1989, HUM GENET, V81, P323, DOI 10.1007/BF00283684; LANGER LO, 1977, AM J MED GENET, V1, P87, DOI 10.1002/ajmg.1320010110; LANGER LO, 1980, RADIOLOGY, V137, P349, DOI 10.1148/radiology.137.2.7433666; LATHROP GM, 1984, P NATL ACAD SCI USA, V81, P3433; MAROTEAUX P, 1971, PRESSE MED, V79, P1839; MINTY IL, 1993, BRIT J RADIOL, V66, P1061, DOI 10.1259/0007-1285-66-791-1061; Mundlos S, 1997, FASEB J, V11, P227, DOI 10.1096/fasebj.11.4.9068611; Mundlos S, 1997, FASEB J, V11, P125, DOI 10.1096/fasebj.11.2.9039954; NEUHAUS H, 1994, DEV BIOL, V166, P531, DOI 10.1006/dbio.1994.1335; OSEBOLD WR, 1985, AM J MED GENET, V22, P791, DOI 10.1002/ajmg.1320220414; Pfeiffer R A, 1995, Clin Dysmorphol, V4, P38; PILZ A, 1995, GENOMICS, V25, P139, DOI 10.1016/0888-7543(95)80119-7; Povey S, 1997, ANN HUM GENET, V61, P183, DOI 10.1017/S0003480097006106; RIMOIN DL, 1997, IN PRESS AM J MED GE; SENER RN, 1993, PEDIATR RADIOL, V23, P321, DOI 10.1007/BF02010928; SPRANGER J, 1985, ENDOCRINE GENETICS G, P315; SULISALO T, 1994, AM J HUM GENET, V55, P937; Thomas JT, 1997, NAT GENET, V17, P58, DOI 10.1038/ng0997-58; Thomas JT, 1996, NAT GENET, V12, P315, DOI 10.1038/ng0396-315; Walder RY, 1997, HUM MOL GENET, V6, P1491, DOI 10.1093/hmg/6.9.1491	31	28	29	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					155	162		10.1086/301917	http://dx.doi.org/10.1086/301917			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	9634515	Green Published, Bronze			2022-12-18	WOS:000074761000023
J	Kaplan, NL; Martin, ER; Morris, RW; Weir, BS				Kaplan, NL; Martin, ER; Morris, RW; Weir, BS			Marker selection for the transmission/disequilibrium test, in recently admixed populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; INSULIN GENE; SUSCEPTIBILITY; LOCI; INDEPENDENCE; ADMIXTURE; IDDM; TDT	Recent admixture between genetically differentiated populations can result in high levels of association between alleles at loci that are less than or equal to 10 cM apart. The transmission/disequilibrium test (TDT) proposed by Spielman et al. (1993) can be a powerful test of linkage between disease and marker loci in the presence of association and therefore could be a useful test of linkage in admired populations. The degree of association between alleles at two loci depends on the differences in allele frequencies, at the two loci, in the founding populations; therefore, the choice of marker is important. For a multiallelic marker, one strategy that may improve the power of the TDT is to group marker alleles within a locus, on the basis of information about the founding populations and the admired population, thereby collapsing the marker into one with fewer alleles. We ha cie examined the consequences of collapsing a microsatellite into a two-allele marker, when two founding populations are assumed for the admired population, and have found that if there is random mating in the admired population, then typically there is a collapsing for which the power of the TDT is greater than that for the original microsatellite marker. A method is presented for finding the optimal collapsing that has minimal dependence on the disease and that uses estimates either of marker allele frequencies in the two founding populations or of marker allele frequencies in the current, admired population and in one of the founding populations. Furthermore, this optimal collapsing is not always the collapsing with the largest difference in allele frequencies in the founding populations. To demonstrate this strategy, we considered a recent data set, published previously, that provides frequency estimates for 30 microsatellites in 13 populations.	NIEHS, Biostat Branch, Res Triangle Pk, NC 27709 USA; N Carolina State Univ, Program Biomath, Dept Stat, Raleigh, NC 27695 USA; N Carolina State Univ, Program Stat Genet, Dept Stat, Raleigh, NC 27695 USA; Analyt Sci Inc, Durham, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Kaplan, NL (corresponding author), NIEHS, Biostat Branch, POB 12233, Res Triangle Pk, NC 27709 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM045344] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 45344] Funding Source: Medline; NINDS NIH HHS [NS 23760] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BODMER WF, 1986, COLD SPRING HARB SYM, V51, P1; BRISCOE D, 1994, J HERED, V85, P59; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P3071, DOI 10.1073/pnas.85.9.3071; COPEMAN JB, 1995, NAT GENET, V9, P80, DOI 10.1038/ng0195-80; COX NJ, 1989, GENET EPIDEMIOL, V6, P65, DOI 10.1002/gepi.1370060113; EWENS WJ, 1995, AM J HUM GENET, V57, P455; JORDE LB, 1995, AM J HUM GENET, V57, P523; Kaplan NL, 1997, AM J HUM GENET, V60, P691; MAISTE PJ, 1995, GENETICA, V96, P125, DOI 10.1007/BF01441158; McKeigue PM, 1997, AM J HUM GENET, V60, P188; Risch N., 1992, American Journal of Human Genetics, V51, pA13; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; WEIR BS, 1992, GENETICS, V130, P873; Yuan B, 1997, AM J HUM GENET, V60, P459	20	28	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1998	62	3					703	712		10.1086/301760	http://dx.doi.org/10.1086/301760			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZF407	9497257	Green Published, Bronze			2022-12-18	WOS:000072894400025
J	Palmour, RM; Mulligan, J; Howbert, JJ; Ervin, F				Palmour, RM; Mulligan, J; Howbert, JJ; Ervin, F			Of monkeys and men: Vervets and the genetics of human-like behaviors	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OLD-WORLD MONKEYS; PRIMATE NUCLEUS BASALIS; CERCOPITHECUS-AETHIOPS; CHOLECYSTOKININ-TETRAPEPTIDE; CHOLINERGIC NEURONS; PANIC DISORDER; HYPERTENSION; APES; CHROMOSOMES; MODEL		MCGILL UNIV, DEPT HUMAN GENET, MONTREAL, PQ H3A 1A1, CANADA; BEHAV SCI FDN, ST KITTS, W IND ASSOC ST; DARWIN MOL CORP, DARWIN DISCOVERY, BOTHELL, WA USA	McGill University	Palmour, RM (corresponding author), MCGILL UNIV, DEPT PSYCHIAT, 1033 PINE AVE W, MONTREAL, PQ H3A 1A1, CANADA.							ANDREWS CM, 1922, J LADY QUALITY NARRA; ASHTON EH, 1951, PROC R SOC SER B-BIO, V138, P204, DOI 10.1098/rspb.1951.0015; ASHTON EH, 1950, PROC R SOC SER B-BIO, V137, P212, DOI 10.1098/rspb.1950.0031; BRADWEJN J, 1991, ARCH GEN PSYCHIAT, V48, P603; BRADWEJN J, 1990, CAN J PSYCHIAT, V35, P83, DOI 10.1177/070674379003500115; BRADWEJN J, 1992, J PSYCHOPHARMACOL, V6, P345, DOI 10.1177/026988119200600301; Chaudhuri A, 1997, P NATL ACAD SCI USA, V94, P2671, DOI 10.1073/pnas.94.6.2671; Chaudhuri A, 1996, BRAIN RES, V709, P17, DOI 10.1016/0006-8993(95)01217-6; CHILDS B, 1983, PROG MED GENET, V5, P1; CONTRERAS C, 1981, B I BIOMED, V31, P484; Coote T, 1996, J HERED, V87, P406, DOI 10.1093/oxfordjournals.jhered.a023026; DEGROUCHY J, 1987, GENETICA, V73, P37, DOI 10.1007/BF00057436; DESJARDINS GC, 1995, EXP GERONTOL, V30, P253; ELSWORTH JD, 1987, LIFE SCI, V40, P193, DOI 10.1016/0024-3205(87)90359-6; ERVIN FR, 1990, PHARMACOL BIOCHEM BE, V36, P367, DOI 10.1016/0091-3057(90)90417-G; Fedigan LM, 1982, PRIMATE PARADIGMS SE; Gartlan JS., 1968, PRIMATES STUDIES ADA, P253; HAMET P, 1989, AM J HYPERTENS, V2, P690; HAMET P, 1993, CLIN EXP HYPERTENS, V15, P1327, DOI 10.3109/10641969309037115; HIGLEY JD, 1989, HDB TEMPERAMENT CHIL, P153; JUAREZ J, 1993, PHARMACOL BIOCH BEHA, V33, P267; KRAFTSCHREYER N, 1985, AM J PRIMATOL, V9, P285, DOI 10.1002/ajp.1350090405; KRAFTSCHREYER N, 1987, HYPERTENSION, V9, P57, DOI 10.1161/01.HYP.9.6_Pt_2.III57; KUNES J, 1992, INT SOC HYPERTENS, V3, P422; Labat Jean-Baptiste, 1722, NOUVEAU VOYAGE ILES; LANCASTER JB, 1975, PRIMATE BEHAVIOR EME; LIBERINI P, 1993, NEUROSCIENCE, V53, P625, DOI 10.1016/0306-4522(93)90611-I; MARTIN S, 1990, AM J HYPERTENS, V3, P27, DOI 10.1093/ajh/3.1.27; Mash DC, 1996, NEUROREPORT, V7, P457, DOI 10.1097/00001756-199601310-00020; MCGUIRE MT, 1974, MONOGRAPHS PRIMATOLO; MERANI S, IN PRESS SOC NEUROSC; NAGY LE, 1988, P NATL ACAD SCI USA, V85, P6973, DOI 10.1073/pnas.85.18.6973; PALMOUR RM, IN PRESS PSYCHOPHARM; PALMOUR RM, 1993, SOC NEUROSCI, V23, P578; PALMOUR RM, 1990, INT J HYPERTENS, V4, P326; PALMOUR RM, 1995, PSYCHIAT GENET S, V5, pS23; Perelygin AA, 1996, CYTOGENET CELL GENET, V75, P207, DOI 10.1159/000134484; PIORO EP, 1993, NEUROSCIENCE, V53, P49, DOI 10.1016/0306-4522(93)90283-L; POIRIER FE, 1972, FOLIA PRIMATOL, V17, P20, DOI 10.1159/000155415; RALEIGH MJ, 1979, EXP NEUROL, V66, P158, DOI 10.1016/0014-4886(79)90071-2; RALEIGH MJ, 1992, NEUROPSYCHOPHARMACOL, V7, P295; REDMOND DE, 1986, LANCET, V1, P1125; Redmond Jr D. E., 1987, PSYCHOPHARMACOLOGY 3, P967; RIED T, 1993, GENOMICS, V18, P381, DOI 10.1006/geno.1993.1479; Rogers J, 1997, AM J HUM GENET, V61, P489, DOI 10.1086/515527; ROGERS J, 1995, GENOMICS, V28, P251, DOI 10.1006/geno.1995.1138; Seyfarth Robert M., 1990, MONKEYS SEE WORLD IN; Sladek John R. Jr., 1995, P269; STANYON R, 1995, CYTOGENET CELL GENET, V68, P74, DOI 10.1159/000133894; STEKLIS HD, 1975, ADV MED PRIMATOLOGY, P276; STRUHSAK.TT, 1967, ECOLOGY, V48, P891, DOI 10.2307/1934531; STRUHSAKER TT, 1967, SCIENCE, V156, P1197, DOI 10.1126/science.156.3779.1197; Suomi S.J., 1982, P171; Tabakoff B, 1996, ALCOHOL CLIN EXP RES, V20, pA243, DOI 10.1111/j.1530-0277.1996.tb01784.x; TIIHONEN J, 1995, NAT MED, V1, P654, DOI 10.1038/nm0795-654; VIRKKUNEN M, 1993, J STUD ALCOHOL, P163, DOI 10.15288/jsas.1993.s11.163; YOUNG SN, 1984, J NEUROCHEM, V42, P1570, DOI 10.1111/j.1471-4159.1984.tb12743.x; Zhong F, 1996, BIOTECHNIQUES, V21, P580	58	28	28	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1997	61	3					481	488		10.1086/515526	http://dx.doi.org/10.1086/515526			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY523	9326311	Green Published, Bronze			2022-12-18	WOS:A1997XY52300003
J	Sham, P				Sham, P			Transmission/disequilibrium tests for multiallelic loci	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							GAMETIC DISEQUILIBRIUM; LINKAGE DISEQUILIBRIUM; NATURAL-POPULATIONS; DROSOPHILA; SAMPLE				Sham, P (corresponding author), INST PSYCHIAT,DEPT PSYCHOL MED,DECRESPIGNY PK,LONDON SE5 8AF,ENGLAND.							BROWN AHD, 1975, THEOR POPUL BIOL, V8, P184, DOI 10.1016/0040-5809(75)90031-3; CHAKRABORTY R, 1984, GENETICS, V108, P719; Devlin B, 1996, GENOMICS, V36, P1, DOI 10.1006/geno.1996.0419; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Hedrick P., 1978, Evolutionary biology. Volume 11., P101; HEDRICK PW, 1988, HEREDITY, V60, P435, DOI 10.1038/hdy.1988.61; HEDRICK PW, 1987, GENETICS, V117, P331; HEDRICK PW, 1986, GENETICS, V112, P135; HILL WG, 1974, HEREDITY, V33, P229, DOI 10.1038/hdy.1974.89; KENDALL MG, 1977, ADV THEORY STATISTIC, V1; LEWONTIN RC, 1988, GENETICS, V120, P849; LEWONTIN RC, 1960, EVOLUTION, V14, P458, DOI 10.2307/2405995; LEWONTIN RC, 1964, GENETICS, V49, P49; Sokal R. R., 1995, BIOMETRY; Zapata C, 1997, ANN HUM GENET, V61, P71, DOI 10.1017/S0003480096005969; Zapata C, 1997, EVOLUTION, V51, P606, DOI [10.2307/2411132, 10.1111/j.1558-5646.1997.tb02447.x]; ZAPATA C, 1995, AM J HUM GENET, V57, P190; ZAPATA C, 1992, EVOLUTION, V46, P1900, DOI [10.2307/2410039, 10.1111/j.1558-5646.1992.tb01177.x]; ZAPATA C, 1993, MOL BIOL EVOL, V10, P823	19	28	28	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1997	61	3					774	778						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY523	9326345				2022-12-18	WOS:A1997XY52300037
J	Gu, C; Rao, DC				Gu, C; Rao, DC			A linkage strategy for detection of human quantitative-trait loci .2. Optimization of study designs based on extreme sib pairs and generalized relative risk ratios	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								We are concerned here with practical issues in the application of extreme sib-pair (ESP) methods to quantitative traits. Two important factors-namely, the way extreme trait values are defined and the proportions in which different types of ESPs are pooled, in the analysis-are shown to determine the power and the cost effectiveness of a study design. We found that, in general, combining reasonable numbers of both extremely discordant and extremely concordant sib pairs that were available in the sample is more powerful and more cost effective than pursuing only a single type of ESP. We also found that dividing trait values with a less extreme threshold at one end or at both ends of the trait distribution leads to more cost-effective designs. The notion of generalized relative risk ratios (the lambda method, as described in the first part of this series of two articles) is used to calculate the power and sample size for various choices of polychotomization of trait values and for the combination of different types of ESPs. A balance then can be struck among these choices, to attain an optimum design.	WASHINGTON UNIV,SCH MED,DEPT PSYCHIAT,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT GENET,ST LOUIS,MO 63110	Washington University (WUSTL); Washington University (WUSTL)	Gu, C (corresponding author), WASHINGTON UNIV,SCH MED,DIV BIOSTAT,BOX 8067,660 S EUCLID AVE,ST LOUIS,MO 63110, USA.		Gu, C. Charles/A-7934-2010	Gu, C. Charles/0000-0002-8527-8145	NIGMS NIH HHS [GM28719] Funding Source: Medline; NIMH NIH HHS [MH31302] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH031302, P50MH031302] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; CAREY G, 1991, AM J HUM GENET, V49, P786; EAVES L, 1994, BEHAV GENET, V24, P443, DOI 10.1007/BF01076180; ELSTON RC, 1994, GENETIC APPROACHES M, P3; ELSTON RC, 1992, 16TH P INT BIOM C HA, P39; FULKER DW, 1991, READ WRIT, V3, P299, DOI 10.1007/BF00354964; Gu C, 1996, GENET EPIDEMIOL, V13, P513, DOI 10.1002/(SICI)1098-2272(1996)13:6<513::AID-GEPI1>3.0.CO;2-1; Gu C, 1997, AM J HUM GENET, V61, P200, DOI 10.1086/513908; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; Zhang HP, 1996, AM J HUM GENET, V59, P951	10	28	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1997	61	1					211	222		10.1086/513909	http://dx.doi.org/10.1086/513909			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM728	9246002	Green Published, Bronze			2022-12-18	WOS:A1997XM72800029
J	Leeflang, EP; McPeek, MS; Arnheim, N				Leeflang, EP; McPeek, MS; Arnheim, N			Analysis of meiotic segregation, using single-sperm typing: Meiotic drive at the myotonic dystrophy locus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CTG REPEAT; MUTATION; GENE; EXPANSION; ALLELE; ORIGIN; REGION; MODEL	Meiotic drive at the myotonic dystrophy (DM) locus has recently been suggested as being responsible for maintaining the frequency, in the human population, of DM chromosomes capable of expansion to the disease state. In order to test this hypothesis, we have studied samples of single sperm from three individuals heterozygous at the DM locus, each with one allele larger and one allele smaller than 19 CTG repeats. To guard against the possible problem of differential PCR amplification rates based on the lengths of the alleles, the sperm were also typed at another closely linked marker whose allele size was unrelated to the allele size at the DM locus. Using statistical models specifically designed to study single-sperm segregation data, we find no evidence of meiotic segregation distortion. The upper limit of the two-sided 95% confidence interval for the estimate of the common segregation probability for the three donors is at or below .515 for all models considered, and no statistically significant difference from .5 is detected in any of the models. This suggests that any greater amount of segregation distortion at the myotonic dystrophy locus must result from events following sperm ejaculation. The mathematical models developed make it possible to study segregation distortion with high resolution by using sperm-typing data from any locus.	UNIV CHICAGO,DEPT STAT,CHICAGO,IL 60637; UNIV SO CALIF,DEPT BIOL SCI,PROGRAM MOL BIOL,LOS ANGELES,CA 90089; UNIV SO CALIF,DEPT MATH,LOS ANGELES,CA 90089	University of Chicago; University of Southern California; University of Southern California				Arnheim, Norman/0000-0003-1247-1347	NIGMS NIH HHS [R37GM36745] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036745] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akaike, 1972, 2ND P INT S INF THEO, P267; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; CAREY N, 1994, NAT GENET, V6, P117, DOI 10.1038/ng0294-117; CUI XF, 1989, P NATL ACAD SCI USA, V86, P9389, DOI 10.1073/pnas.86.23.9389; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; GENNARELLI M, 1994, J MED GENET, V31, P980, DOI 10.1136/jmg.31.12.980; GORADIA TM, 1991, GENOMICS, V10, P748, DOI 10.1016/0888-7543(91)90459-R; HURST GDD, 1995, NAT GENET, V10, P132, DOI 10.1038/ng0695-132; IMBERT G, 1993, NAT GENET, V4, P72, DOI 10.1038/ng0593-72; JANSEN G, 1992, GENOMICS, V13, P509, DOI 10.1016/0888-7543(92)90118-C; JANSEN G, 1993, HUM MOL GENET, V2, P333, DOI 10.1093/hmg/2.3.333; LAZZERONI LC, 1994, AM J HUM GENET, V55, P431; LEEFLANG EP, 1995, HUM MOL GENET, V4, P135; LI HH, 1988, NATURE, V335, P414, DOI 10.1038/335414a0; LYTTLE TW, 1993, TRENDS GENET, V9, P205, DOI 10.1016/0168-9525(93)90120-7; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MONCKTON DG, 1995, HUM MOL GENET, V4, P1; NEVILLE CE, 1994, HUM MOL GENET, V3, P45; SCHMITT K, 1994, AM J HUM GENET, V55, P423; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SHAW AM, 1995, J MED GENET, V32, P145; SILVER LM, 1993, TRENDS GENET, V9, P250, DOI 10.1016/0168-9525(93)90090-5; SPEED TP, 1993, ANN I STAT MATH, V45, P35, DOI 10.1007/BF00773667; WEISBERG S, 1985, APPLIED LINEAR REGRE; WILLIAMS C, 1993, HUM MOL GENET, V2, P445, DOI 10.1093/hmg/2.4.445	26	28	28	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1996	59	4					896	904						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL283	8808606				2022-12-18	WOS:A1996VL28300020
J	Gschwend, M; Levran, O; Kruglyak, L; Ranade, K; Verlander, PC; Shen, S; Faure, S; Weissenbach, J; Altay, C; Lander, ES; Auerbach, AD; Botstein, D				Gschwend, M; Levran, O; Kruglyak, L; Ranade, K; Verlander, PC; Shen, S; Faure, S; Weissenbach, J; Altay, C; Lander, ES; Auerbach, AD; Botstein, D			A locus for Fanconi anemia on 16q determined by homozygosity mapping	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIGH-RESOLUTION MAPS; LINKAGE ANALYSIS; STATISTICAL-METHODS; RECESSIVE TRAITS; COMPLEX TRAITS; GENE; COMPLEMENTATION; FAMILIES; FACC; LOCALIZATION	We report the results of a genomewide scan using homozygosity mapping to identify genes causing Fanconi anemia, a genetically heterogeneous recessive disorder. By studying 23 inbred families, we detected linkage to a locus causing Fanconi anemia near marker D16S520 (16q24.3). Although similar to 65% of our families displayed clear linkage to D16S520, we found strong evidence (P = .0013) of genetic heterogeneity. This result independently confirms the recent mapping of the FAA gene to chromosome 16 by Pronk et al. Family ascertainment was biased against a previously identified FAC gene on chromosome 9, and no linkage was observed to this locus. Simultaneous search analysis suggested several additional chromosomal regions that could account for a small fraction of Fanconi anemia in our families, but the sample size is insufficient to provide statistical significance. We also demonstrate the strong effect of marker allele frequencies on LOD scores obtained in homozygosity mapping and discuss ways to avoid false positives arising from this effect.	STANFORD UNIV, SCH MED,DEPT GENET, STANFORD, CA 94305 USA; ROCKEFELLER UNIV, LAB HUMAN GENET & HEMATOL, NEW YORK, NY 10021 USA; MIT, DEPT BIOL, CAMBRIDGE, MA USA; GENETHON, EVRY, FRANCE; HACETTEPE UNIV, FAC MED, TR-06100 ANKARA, TURKEY	Stanford University; Rockefeller University; Massachusetts Institute of Technology (MIT); Hacettepe University			Levran, Orna/H-2772-2019	Auerbach, Arleen/0000-0002-6911-8379	NHGRI NIH HHS [HG00098, HG00017] Funding Source: Medline; NHLBI NIH HHS [HL 32987] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL032987, R01HL032987] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTER BP, 1992, AM J PEDIAT HEMATOL, V14, P170; AUERBACH AD, 1989, BLOOD, V73, P391; AUERBACH AD, 1993, EXP HEMATOL, V21, P731; BENHAMIDA C, 1993, NAT GENET, V5, P195, DOI 10.1038/ng1093-195; BOEHNKE M, 1991, AM J HUM GENET, V49, P1174; BUCHWALD M, 1995, NAT GENET, V11, P228, DOI 10.1038/ng1195-228; CERVENKA J, 1981, PEDIATRICS, V67, P119; CLARK C, 1995, CURRENT PROTOCOLS HU, V1; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; DUPUIS J, 1995, GENETICS, V140, P843; GERMAN J, 1994, P NATL ACAD SCI USA, V91, P6669, DOI 10.1073/pnas.91.14.6669; GIAMPIETRO PF, 1993, PEDIATRICS, V91, P1116; GIBSON RA, 1994, J MED GENET, V31, P868, DOI 10.1136/jmg.31.11.868; Gordon-Smith E C, 1989, Baillieres Clin Haematol, V2, P139, DOI 10.1016/S0950-3536(89)80011-3; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; JOENJE H, 1995, BLOOD, V86, P2156, DOI 10.1182/blood.V86.6.2156.bloodjournal8662156; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1986, COLD SPRING HARB SYM, V51, P49, DOI 10.1101/SQB.1986.051.01.007; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; POLLAK MR, 1993, NAT GENET, V5, P201, DOI 10.1038/ng1093-201; PRONK JC, 1995, NAT GENET, V11, P338, DOI 10.1038/ng1195-338; ROGATKO A, 1988, AM J HUM GENET, V42, P889; SCHROEDER TM, 1976, HUM GENET, V32, P257, DOI 10.1007/BF00295817; SMITH CAB, 1953, J R STAT SOC B, V15, P153; STRATHDEE CA, 1992, NAT GENET, V1, P196, DOI 10.1038/ng0692-196; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; SWIFT M, 1971, NATURE, V230, P370, DOI 10.1038/230370a0; TERWILLIGER JD, 1994, HDB HUMAN LINKAGE AN; VANAGAITE L, 1995, HUM GENET, V95, P451; VERLANDER PC, 1994, AM J HUM GENET, V54, P595; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WHITNEY M, 1995, NAT GENET, V11, P341, DOI 10.1038/ng1195-341	33	28	30	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1996	59	2					377	384						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VM288	8755924				2022-12-18	WOS:A1996VM28800013
J	Mehlman, MJ; Kodish, ED; Whitehouse, P; Zinn, AB; Sollitto, S; Berger, J; Chiao, EJ; Dosick, MS; Cassidy, SB				Mehlman, MJ; Kodish, ED; Whitehouse, P; Zinn, AB; Sollitto, S; Berger, J; Chiao, EJ; Dosick, MS; Cassidy, SB			The need for anonymous genetic counseling and testing	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIV	Concerns are mounting about the risks of genetic discrimination resulting from the release of predictive and presymptomatic genetic test results to employers, insurers, and others. The ability to keep this information confidential is questionable, particularly in view of the expansion of electronic medical databases. One solution is to afford individuals access to anonymous genetic counseling and testing. Probands would be identified only by a code that would not reveal personal information, and test results would be stored, retrieved, and released solely on the basis of this code. The experience with anonymous HIV testing, while not completely analogous, suggests that such an approach would be both practical and effective.	RAINBOW BABIES & CHILDRENS HOSP,DEPT PEDIAT,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,SCH MED,CTR BIOMED ETH,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,SCH MED,DEPT GENET,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,SCH MED,CTR HUMAN GENET,CLEVELAND,OH 44106; UNIV CLEVELAND HOSP,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,DEPT NEUROL,CLEVELAND,OH 44106	Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Mehlman, MJ (corresponding author), CASE WESTERN RESERVE UNIV,SCH LAW,LAW MED CTR,11075 E BLVD,CLEVELAND,OH 44106, USA.							Bernstein T, 1994, RADON RENTAL HOUSING; DOUGHTY R, 1994, CALIF LAW REV, V82, P132; FEHRS LJ, 1988, LANCET, V2, P379; GOSTIN LO, 1993, JAMA-J AM MED ASSOC, V270, P2487; JOLLY DH, 1990, INT C AIDS, V6, P332; JONES L, 1994, AM MED NEWS     0516, P3; KASSLER WJ, 1992, INT C AIDS, V8, pC379; KEGELES SM, 1990, AIDS, V4, P585, DOI 10.1097/00002030-199006000-00016; LEBACQZ K, 1994, DIALOGUE, V33, P39; MACKLIN R, 1992, GENE MAPPING USING L, P157; MAJOR CB, 1993, INT C AIDS, V9, P758; MEYER PA, 1994, S MED J; PARINGER L, 1991, INQUIRY-J HEALTH CAR, V28, P226; ROSES AD, 1995, ANN NEUROL, V38, P6, DOI 10.1002/ana.410380105; ROTHFELDER J, 1992, PRIVACY SALE COMPUTE; SIEGLER M, 1982, NEW ENGL J MED, V307, P1518, DOI 10.1056/NEJM198212093072411; SUTER SM, 1993, MICH LAW REV, V91, P1884; WERTZ DC, 1994, JAMA-J AM MED ASSOC, V272, P875, DOI 10.1001/jama.272.11.875; 1993, CTS CLIENT RECORD DA; 1991, AMA36 AM MED ASS REP; 1995, WALL STREET J   0512, pA1; 1993, MMWR MORB MORTA 0129, P53; 1994, HIV COUNSELING TESTI; 1995, EEOC915002 EQ EMPL O	24	28	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1996	58	2					393	397						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	TR791	8571966				2022-12-18	WOS:A1996TR79100016
J	COCK, HR; COOPER, JM; SCHAPIRA, AHV				COCK, HR; COOPER, JM; SCHAPIRA, AHV			THE 14484-ND6 MTDNA MUTATION IN LEBER HEREDITARY OPTIC NEUROPATHY DOES NOT AFFECT FIBROBLAST COMPLEX-I ACTIVITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							NADH				COCK, HR (corresponding author), ROYAL FREE HOSP,SCH MED,DEPT CLIN NEUROSCI,ROWLAND HILL ST,LONDON NW3 2PF,ENGLAND.		Schapira, Anthony H V/A-1245-2010; Cooper, J Mark/D-5826-2013; Cock, Hannah/ABB-1573-2021; Cooper, Jonathan/E-9000-2010	Schapira, Anthony H V/0000-0002-3018-3966; Cooper, J Mark/0000-0002-3007-3054; Cooper, Jonathan/0000-0002-2358-1050; Cock, Hannah/0000-0002-5656-0141				Brown M. D., 1994, American Journal of Human Genetics, V55, pA214; COCK HR, 1995, NEUROLOGY, V45, pA294; ESPOSTI MD, 1994, FEBS LETT, V352, P375, DOI 10.1016/0014-5793(94)00971-6; HOWELL N, 1991, AM J HUM GENET, V48, P935; LARSSON N, 1991, ANN NEUROL, V30, P704; MACKEY D, 1992, AM J HUM GENET, V51, P1218; MAJANDER A, 1991, FEBS LETT, V292, P289, DOI 10.1016/0014-5793(91)80886-8; PARKER WD, 1989, NEW ENGL J MED, V320, P1331, DOI 10.1056/NEJM198905183202007; RIORDANEVA P, 1995, J MED GENET, V32, P81, DOI 10.1136/jmg.32.2.81; SMITH PR, 1994, J NEUROL SCI, V122, P80, DOI 10.1016/0022-510X(94)90055-8; WALLACE DC, 1970, BRAIN, V93, P121, DOI 10.1093/brain/93.1.121	11	28	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1995	57	6					1501	1502						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TE655	8533781				2022-12-18	WOS:A1995TE65500029
J	ELSEA, SH; JUYAL, RC; JIRALERSPONG, S; FINUCANE, BM; PANDOLFO, M; GREENBERG, F; BALDINI, A; STOVER, P; PATEL, PI				ELSEA, SH; JUYAL, RC; JIRALERSPONG, S; FINUCANE, BM; PANDOLFO, M; GREENBERG, F; BALDINI, A; STOVER, P; PATEL, PI			HAPLOINSUFFICIENCY OF CYTOSOLIC SERINE HYDROXYMETHYLTRANSFERASE IN THE SMITH-MAGENIS SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ONE-CARBON METABOLISM; MARIE-TOOTH DISEASE; NMDA RECEPTOR; DELETION; GLYCINE; GENE; MITOCHONDRIAL; MODULATION; CANDIDATE; REGIONS	Folate-dependent one-carbon metabolism is critical for the synthesis of numerous cellular constituents required for cell growth, and serine hydroxymethyltransferase (SHMT) is central to this process. Our studies reveal that the gene for cytosolic SHMT (cSHMT) maps to the critical interval for Smith-Magenis syndrome (SMS) on chromosome 17p11.2. The basic organization of the cSHMT locus on chromosome 17 was determined and was found to span similar to 40 kb. The gene for cSHMT was found to be deleted in all 26 SMS patients examined by PCR, FISH, and/or Southern analysis. Furthermore, with respect to haploinsufficiency, cSHMT enzyme activity in patient lymphoblasts was determined to be similar to 50% that of unaffected parent lymphoblasts. Serine, glycine, and folate levels were also assessed in three SMS patients and were found to be within normal ranges. The possible effects of cSHMT hemizygosity on the SMS phenotype are discussed.	BAYLOR COLL MED,DEPT NEUROL,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT MOLEC & HUMAN GENET,HOUSTON,TX 77030; BAYLOR COLL MED,CTR HUMAN GENOME,HOUSTON,TX 77030; NATL NEUROL INST C BESTA,MILAN,ITALY; CORNELL UNIV,DIV NUTR SCI,ITHACA,NY 14853	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; IRCCS Istituto Neurologico Besta; Cornell University			Pandolfo, Massimo/B-2853-2010; genes, anthony/F-2541-2012; Baldini, Antonio/M-2355-2015; Patel, Pragna/H-9129-2017	Baldini, Antonio/0000-0002-5330-0256; Elsea, Sarah/0000-0002-1400-8519; Patel, Pragna/0000-0003-3584-1072; Finucane, Brenda/0000-0003-4841-669X	NICHD NIH HHS [HD28458] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028458] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; CHEN KS, 1995, AM J HUM GENET, V56, P175; CHEVILLARD C, 1993, HUM MOL GENET, V2, P1235, DOI 10.1093/hmg/2.8.1235; DALY EC, 1974, J NEUROCHEM, V22, P877, DOI 10.1111/j.1471-4159.1974.tb04312.x; DEUTSCH SI, 1989, CLIN NEUROPHARMACOL, V12, P1, DOI 10.1097/00002826-198902000-00001; DEVOR EJ, 1993, BIOL PSYCHIAT, V34, P221, DOI 10.1016/0006-3223(93)90075-O; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; EICHLER HG, 1981, BIOSCIENCE REP, V1, P101, DOI 10.1007/BF01117006; FAIN P R, 1987, Genomics, V1, P340, DOI 10.1016/0888-7543(87)90034-6; FINUCANE BM, 1993, AM J MED GENET, V45, P447, DOI 10.1002/ajmg.1320450410; FINUCANE BM, 1993, AM J MED GENET, V45, P443, DOI 10.1002/ajmg.1320450409; FINUCANE BM, 1994, DEV MED CHILD NEUROL, V36, P70; GARROW TA, 1993, J BIOL CHEM, V268, P11910; GREENBERG F, 1991, AM J HUM GENET, V49, P1207; GUZZETTA V, 1992, GENOMICS, V13, P551, DOI 10.1016/0888-7543(92)90124-B; IJDO JW, 1992, GENOMICS, V14, P1019, DOI 10.1016/S0888-7543(05)80125-9; JUYAL RC, 1995, AM J MED GENET, V58, P286, DOI 10.1002/ajmg.1320580317; JUYAL RC, IN PRESS AM J MED GE; KALLIONIEMI OP, 1994, GENOMICS, V20, P125, DOI 10.1006/geno.1994.1138; KEMP JA, 1993, TRENDS PHARMACOL SCI, V14, P20, DOI 10.1016/0165-6147(93)90108-V; LEESON PD, 1994, J MED CHEM, V37, P4053, DOI 10.1021/jm00050a001; LIN BF, 1993, J BIOL CHEM, V268, P21674; PATEL PI, 1990, AM J HUM GENET, V46, P801; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; PFENDNER W, 1980, ARCH BIOCHEM BIOPHYS, V200, P503, DOI 10.1016/0003-9861(80)90382-3; REYNOLDS IJ, 1990, LIFE SCI, V47, P1785, DOI 10.1016/0024-3205(90)90280-5; SCATTON B, 1993, FUND CLIN PHARMACOL, V7, P389, DOI 10.1111/j.1472-8206.1993.tb01036.x; SCHIRCH L, 1982, ADV ENZYMOL RAMB, V53, P83; SHANK RP, 1970, J NEUROCHEM, V49, P1461; SMITH ACM, 1986, AM J MED GENET, V24, P393, DOI 10.1002/ajmg.1320240303; SNELL K, 1984, ADV ENZYME REGUL, V22, P325, DOI 10.1016/0065-2571(84)90021-9; SNELL K, 1987, BIOCHEM J, V245, P609, DOI 10.1042/bj2450609; STOVER P, 1991, J BIOL CHEM, V266, P1543; STOVER P, 1992, BIOCHEMISTRY-US, V31, P2156; USHA R, 1994, BBA-PROTEIN STRUCT M, V1204, P75, DOI 10.1016/0167-4838(94)90035-3; WAZIRI R, 1990, NEUROSCI LETT, V120, P237, DOI 10.1016/0304-3940(90)90048-E; WAZIRI R, 1992, SCHIZOPHR RES, V8, P233; WRIGHT EC, 1990, GENOMICS, V7, P103, DOI 10.1016/0888-7543(90)90524-X; ZHAO ZY, 1995, HUM MOL GENET, V4, P589, DOI 10.1093/hmg/4.4.589; ZORI RT, 1993, AM J MED GENET, V47, P504, DOI 10.1002/ajmg.1320470414	40	28	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1995	57	6					1342	1350						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TE655	8533763				2022-12-18	WOS:A1995TE65500011
J	KAPLAN, NL; WIER, BS				KAPLAN, NL; WIER, BS			ARE MOMENT BOUNDS ON THE RECOMBINATION FRACTION BETWEEN A MARKER AND A DISEASE LOCUS TOO GOOD TO BE TRUE - ALLELIC ASSOCIATION MAPPING REVISITED FOR SIMPLE GENETIC-DISEASES IN THE FINNISH POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; HAPLOTYPES; FINLAND	In the past several years, allelic association has helped map a number of rare genetic diseases in the human genome. A commonly used upper bound on the recombination fraction between the disease gene and an associated marker is known to be biased downward, so there is the possibility that an investigator could be misled. This upper bound is based on a moment equation that can be derived within the context of a Poisson branching process, so its performance can be compared with a recently proposed likelihood bound. We show that the confidence level of the moment upper bound is much lower than expected, while the confidence level of the likelihood bound is in line with expectation. The effects of mutation at either the marker or disease locus on the upper bounds are also investigated. Results indicate that mutation is not an important force for typical mutation rates, unless the recombination fraction between the marker and disease locus is very small or the disease allele is very rare in the general population. Finally, the impact of sample size on the likelihood bound is investigated. The results are illustrated with data on 10 simple genetic diseases in the Finnish population.	N CAROLINA STATE UNIV, DEPT STAT, PROGRAM STAT GENET, RALEIGH, NC 27695 USA	University of North Carolina; North Carolina State University	KAPLAN, NL (corresponding author), NIEHS, STAT & BIOMATH BRANCH, POB 12233, RES TRIANGLE PK, NC 27709 USA.				NIGMS NIH HHS [GM45344] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AALTONEN J, 1994, NAT GENET, V8, P83, DOI 10.1038/ng0994-83; BENGTSSON BO, 1981, TISSUE ANTIGENS, V18, P356, DOI 10.1111/j.1399-0039.1981.tb01404.x; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; Ewens W.J., 1979, MATH POPULATION GENE; HAATAJA L, 1994, AM J HUM GENET, V54, P1042; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HELLSTEN E, 1993, GENOMICS, V16, P720, DOI 10.1006/geno.1993.1253; KAPLAN NL, 1995, AM J HUM GENET, V56, P18; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KESTILA M, 1994, AM J HUM GENET, V54, P757; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; MITCHISON HM, 1995, AM J HUM GENET, V56, P654; MOTULSKY AG, 1995, NAT GENET, P999; NEVANLINNA H R, 1980, Haematologia, V13, P65; RAMSAY M, 1993, HUM MOL GENET, V2, P1007, DOI 10.1093/hmg/2.7.1007; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; SAVUKOSKI M, 1994, AM J HUM GENET, V55, P695; SIRUGO G, 1992, AM J HUM GENET, V50, P559; SULISALO T, 1994, AM J HUM GENET, V55, P937; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	23	28	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1995	57	6					1486	1498						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TE655	8533779				2022-12-18	WOS:A1995TE65500027
J	AMINOFF, M; TAHVANAINEN, E; GRASBECK, R; WEISSENBACH, J; BROCH, H; DELACHAPELLE, A				AMINOFF, M; TAHVANAINEN, E; GRASBECK, R; WEISSENBACH, J; BROCH, H; DELACHAPELLE, A			SELECTIVE INTESTINAL MALABSORPTION OF VITAMIN-B12 DISPLAYS RECESSIVE MENDELIAN INHERITANCE - ASSIGNMENT OF A LOCUS TO CHROMOSOME-10 BY LINKAGE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IMERSLUND-GRASBECK SYNDROME; INTRINSIC FACTOR-COBALAMIN; HUMAN GENOME; RECEPTOR	Juvenile megaloblastic anemia caused by selective intestinal malabsorption of vitamin B12 has been considered a distinct condition displaying autosomal recessive inheritance. It appears to have a worldwide distribution, and comparatively high incidences were reported 30 years ago in Finland and Norway. More recently, the Mendelian inheritance of the condition has been questioned because almost no new cases have occurred in these populations. Here we report linkage studies assigning a recessive-gene locus for the disease to chromosome 10 in previously diagnosed multiplex families from Finland and Norway, proving the Mendelian mode of inheritance. The locus is tentatively assigned to the 6-cM interval between markers D10S548 and D10S46G, with a multipoint maximum lod score (Z(max)) of 5.36 near marker D10S1477. By haplotype analysis, the healthy sibs in these families did not appear to constitute any examples of nonpenetrance. We hypothesize that the paucity of new cases in these populations is due either to a dietary effect on the gene penetrance that has changed with time, or to a drop in the birth rate in subpopulations showing enrichment of the mutation, or to both of these causes.	UNIV HELSINKI,FOLKHALSAN INST GENET,DEPT MED GENET,SF-00014 HELSINKI,FINLAND; MINERVA FDN,MED RES INST,HELSINKI,FINLAND; KUWAIT UNIV,FAC MED,DEPT BIOCHEM,KUWAIT,KUWAIT; GENETHON,CNRS,URA 1922,F-91011 EVRY,FRANCE; VESTFOLD CENT HOSP,DEPT PAEDIAT,TONSBERG,NORWAY	University of Helsinki; Kuwait University; Centre National de la Recherche Scientifique (CNRS)								ABDELAAL MA, 1991, ACTA PAEDIATR SCAND, V80, P1109; ANTTILA R, 1967, ACTA PAEDIATR SCAND, V52, P238; BENBASSA.I, 1969, ISRAEL J MED SCI, V5, P62; BROCH H, 1984, ACTA PAEDIATR SCAND, V73, P248, DOI 10.1111/j.1651-2227.1984.tb09937.x; BURMAN JF, 1985, GUT, V26, P311, DOI 10.1136/gut.26.3.311; CHANARIN I, 1979, MEGALOBLASTIC ANAEMI, P76; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; CUTICCHIA AJ, 1993, NUCLEIC ACIDS RES, V21, P3003, DOI 10.1093/nar/21.13.3003; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; FURUHJELM U, 1973, SCAND J HAEMATOL, V11, P27; FYFE JC, 1989, J AM ANIM HOSP ASSOC, V25, P533; FYFE JC, 1991, PEDIATR RES, V29, P24, DOI 10.1203/00006450-199101000-00006; FYFE JC, 1991, J BIOL CHEM, V226, P4489; GEDDEDAHL T, 1991, FINSKA LAKASELSKAPET, V135, P199; GRASBECK R, 1960, ACTA MED SCAND, V167, P289; Grasbeck R, 1967, Cah Coll Med Hop Paris, V8, P935; GUEANT JL, 1995, GASTROENTEROLOGY, V108, P1622, DOI 10.1016/0016-5085(95)90122-1; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; IMERSLUND O, 1963, ACTA HAEMATOL-BASEL, V30, P1; IMERSLUND O, 1960, ACTA PAEDIATR S, V49, P3; IMERSLUND O, 1959, IDIOPATHIC CHRONIC M; KAPSETAKI M, 1994, EUROGEM MAP HUMAN CH, V2, P193; KOUVONEN I, 1979, BIOCHEM BIOPH RES CO, V86, P358, DOI 10.1016/0006-291X(79)90873-8; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MACKENZI.IL, 1972, NEW ENGL J MED, V286, P1021, DOI 10.1056/NEJM197205112861902; McKusick V.A., 1992, MENDELIAN INHERITANC; NORIO R, 1991, FINSKA LAKARESALLSLE, V135, P186; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; PEARSON PL, 1991, NUCLEIC ACIDS RES, V19, P2237, DOI 10.1093/nar/19.suppl.2237; PEARSON PL, 1992, NUCLEIC ACIDS RES, V20, P2201, DOI 10.1093/nar/20.suppl.2201; SEETHARAM B, 1981, J BIOL CHEM, V256, P3785; SEETHARAM B, 1991, INDIAN J BIOCHEM BIO, V28, P324; SEETHARAM B, 1988, J BIOL CHEM, V263, P4443; VISAKORPI JK, 1968, MOD PROBL PEDIATR, V11, P150; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEEKS DE, 1980, AM J HUM GENET S, V47, pA204; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WULFFRAAT NM, 1994, AM J PEDIAT HEMATOL, V16, P177	38	28	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1995	57	4					824	831						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RV793	7573042				2022-12-18	WOS:A1995RV79300012
J	POULTON, J				POULTON, J			TRANSMISSION OF MTDNA - CRACKS IN THE BOTTLENECK	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							HUMAN MITOCHONDRIAL-DNA; SEGREGATION; SEQUENCE; LOOP				POULTON, J (corresponding author), UNIV OXFORD,JOHN RADCLIFFE HOSP,DEPT PAEDIAT,OXFORD OX3 9DU,ENGLAND.			Poulton, Joanna/0000-0002-2460-5587				BENDALL KE, 1995, AM J HUM GENET, V57, P248; BROCKINGTON M, 1993, NAT GENET, V4, P67, DOI 10.1038/ng0593-67; CHEN X, 1995, AM J HUM GENET, V57, P239; CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370; Hauswirth W., 1985, ACHIEVEMENT PERSPECT, V2, P49; HAUSWIRTH WW, 1985, NUCLEIC ACIDS RES, V13, P8093, DOI 10.1093/nar/13.22.8093; HOWELL N, 1992, HUM GENET, V90, P117; LAIPIS PJ, 1988, P NATL ACAD SCI USA, V85, P8107, DOI 10.1073/pnas.85.21.8107; LARSSON NG, 1992, AM J HUM GENET, V51, P1201; LOCKSON D, IN PRESS CELL; MONNAT RJ, 1985, P NATL ACAD SCI USA, V82, P2895, DOI 10.1073/pnas.82.9.2895; POULTON J, 1994, NAT GENET, V8, P313, DOI 10.1038/ng1294-313; TORRONI A, 1994, AM J HUM GENET, V55, P760; WILLEMS PJ, 1994, NAT GENET, V8, P213, DOI 10.1038/ng1194-213	14	28	28	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1995	57	2					224	226						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RL771	7668245				2022-12-18	WOS:A1995RL77100002
J	WANG, CH; KLEYN, PW; VITALE, E; ROSS, BM; LIEN, L; XU, J; CARTER, TA; BRZUSTOWICZ, LM; OBICI, S; SELIG, S; PAVONE, L; PARANO, E; PENCHASZADEH, GK; MUNSAT, T; KUNKEL, LM; GILLIAM, TC				WANG, CH; KLEYN, PW; VITALE, E; ROSS, BM; LIEN, L; XU, J; CARTER, TA; BRZUSTOWICZ, LM; OBICI, S; SELIG, S; PAVONE, L; PARANO, E; PENCHASZADEH, GK; MUNSAT, T; KUNKEL, LM; GILLIAM, TC			REFINEMENT OF THE SPINAL MUSCULAR-ATROPHY LOCUS BY GENETIC AND PHYSICAL MAPPING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RAPID METHOD; REGION; CONSTRUCTION; CHROMOSOME-5; CONTIG; MAP1B; 5Q13	We report the mapping and characterization of 12 microsatellite markers including 11 novel markers. All markers were generated from overlapping YAC clones that span the spinal muscular atrophy (SMA) locus. PCR amplification of 32 overlapping YAC clones shows that 9 of the new markers (those set in italics) map to the interval between the two previous closest flanking markers (D5S629 and D5S557) : cen - D5S6 - D5S125 - D5S435 - D5S1407 - D5S629 - D5S1410 - D5S1411 /D5S1412-D5S1413-D5S1414-D5Z8-D5Z9-CATT1-D5Z10 D5Z6-D5S557-D5S1408-D5S1409-D5S637-D5S351-MAP1B-tel. Four of these new markers detect multiple loci in and out of the SMA gene region. Genetic analysis of recombinant SMA families indicates that D5S1413 is a new proximal flanking locus for the SMA gene. Interestingly, among the 40 physically mapped loci, the 14 multilocus markers map contiguously to a genomic region that overlaps, and perhaps helps define, the minimum genetic region encompassing the SMA gene(s).	COLUMBIA UNIV,COLL PHYS & SURG,DEPT PSYCHIAT,NEW YORK,NY 10032; COLUMBIA UNIV,COLL PHYS & SURG,DEPT GENET & DEV,NEW YORK,NY 10032; COLUMBIA UNIV,COLL PHYS & SURG,DEPT PEDIAT,NEW YORK,NY 10032; COLUMBIA UNIV,COLL PHYS & SURG,DEPT NEUROL,NEW YORK,NY 10032; NEW YORK STATE PSYCHIAT INST & HOSP,NEW YORK,NY; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA; CHILDRENS HOSP,DEPT PEDIAT,DIV GENET,BOSTON,MA 02115; CHILDRENS HOSP,HOWARD HUGHES MED INST,BOSTON,MA 02115; TUFTS UNIV,NEW ENGLAND MED CTR,DEPT NEUROL,BOSTON,MA 02111; UNIV CATANIA,PEDIAT CLIN,CATANIA,ITALY	Columbia University; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Tufts Medical Center; Tufts University; University of Catania			vitale, emilia/A-5282-2011	PARANO, ENRICO/0000-0002-0713-7339; Vitale, Emilia/0000-0003-4651-3875	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023740, R01NS028877] Funding Source: NIH RePORTER; NINDS NIH HHS [NSO1576, NS28877, NS23740] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; BRZUSTOWICZ LM, 1992, GENOMICS, V13, P991, DOI 10.1016/0888-7543(92)90012-H; BRZUSTOWICZ LM, 1990, NATURE, V344, P540, DOI 10.1038/344540a0; BRZUSTOWICZ LM, 1995, AM J HUM GENET, V56, P210; BURGHES AHM, 1994, GENOMICS, V21, P394, DOI 10.1006/geno.1994.1282; CLERMONT O, 1994, AM J HUM GENET, V54, P687; FRANCIS MJ, 1993, HUM MOL GENET, V2, P1161, DOI 10.1093/hmg/2.8.1161; GILLIAM TC, 1990, NATURE, V345, P823, DOI 10.1038/345823a0; GILLIAM TC, 1989, GENOMICS, V5, P940, DOI 10.1016/0888-7543(89)90138-9; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; KLEYN PW, 1993, P NATL ACAD SCI USA, V90, P6801, DOI 10.1073/pnas.90.14.6801; LIEN LL, 1991, P NATL ACAD SCI USA, V88, P7873, DOI 10.1073/pnas.88.17.7873; MELKI J, 1990, LANCET, V336, P271, DOI 10.1016/0140-6736(90)91803-I; MELKI J, 1990, NATURE, V344, P767, DOI 10.1038/344767a0; MELKI J, 1994, SCIENCE, V264, P1474, DOI 10.1126/science.7910982; MUNSAT TL, 1992, NEUROMUSCULAR DISORD, V2, P423, DOI 10.1016/S0960-8966(06)80015-5; Ott J., 1991, ANAL HUMAN GENETIC L; PANDOLFO M, 1992, NUCLEIC ACIDS RES, V20, P1154, DOI 10.1093/nar/20.5.1154; PEDEUTOUR F, 1994, GENOMICS, V19, P31, DOI 10.1006/geno.1994.1008; PIZZUTI A, 1993, BIOCHEM BIOPH RES CO, V197, P154, DOI 10.1006/bbrc.1993.2454; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; SOARES VM, 1993, GENOMICS, V15, P365, DOI 10.1006/geno.1993.1069; THOMPSON TG, 1993, HUM MOL GENET, V2, P1169, DOI 10.1093/hmg/2.8.1169	24	28	30	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					202	209						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825579				2022-12-18	WOS:A1995QC10100026
J	ROOTWELT, H; BERGER, R; GRAY, G; KELLY, DA; COSKUN, T; KVITTINGEN, EA				ROOTWELT, H; BERGER, R; GRAY, G; KELLY, DA; COSKUN, T; KVITTINGEN, EA			NOVEL SPLICE, MISSENSE, AND NONSENSE MUTATIONS IN THE FUMARYLACETOACETASE GENE CAUSING TYROSINEMIA TYPE-I	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY TYROSINEMIA; HYDROLASE GENE; IDENTIFICATION; DNA	six unrelated patients with hereditary tyrosinemia type 1 (HT1), three different disease-causing mutations were found by DNA sequencing. Two Pakistani patients, with acute and intermediate forms of HT1, were homozygous for a G(192)-->T mutation in the last nucleotide of exon 2. This caused aberrant splicing with partial intron 2 retention and premature termination. Three Turkish patients with chronic and intermediate forms of HT1 were homezygous for an A(698)-->T mutation substituting aspartic acid 233 with valine. A Norwegian patient with an intermediate clinical phenotype was heterozygous for G(786)-->A, introducing a TGA stop codon for Trp262 (W262X). Site-directed mutagenesis and expression in a rabbit reticulocyte lysate system demonstrated that the nonsense and missense mutations abolished fumarylacetoacetase activity and gave reduced amounts of a truncated and a full-length protein, respectively. Simple tests were established to identify the three mutations by restriction digestion of PCR-amplified genomic DNA. Among 30 additional HT1 patients investigated, 2 were found to be homozygous and 1 heterozygous for G(192)-->T. Two other patients were homozygous and one was heterozygous for W262X.	WILHELMINA CHILDRENS HOSP,UTRECHT,NETHERLANDS; CHILDRENS HOSP,LIVER UNIT,BIRMINGHAM B16 8ET,W MIDLANDS,ENGLAND; CHILDRENS HOSP,DEPT CLIN CHEM,BIRMINGHAM B16 8ET,W MIDLANDS,ENGLAND; HACETTEPE UNIV,INST CHILD HLTH,ANKARA,TURKEY	Wilhelmina Kinderziekenhuis; Hacettepe University	ROOTWELT, H (corresponding author), UNIV OSLO,RIKSHOSP,INST CLIN BIOCHEM,N-0027 OSLO,NORWAY.							BALNAVES ME, 1991, NUCLEIC ACIDS RES, V19, P1155, DOI 10.1093/nar/19.5.1155; BERGER R, 1987, PEDIATR RES, V22, P394, DOI 10.1203/00006450-198710000-00005; CLEVELAND DW, 1980, CELL, V20, P95, DOI 10.1016/0092-8674(80)90238-X; COSKUN T, 1991, J INHERIT METAB DIS, V14, P765, DOI 10.1007/BF01799947; GOLDSMITH LA, 1989, METABOLIC BASIS INHE, P547; GROMPE M, 1993, HUM MUTAT, V2, P85, DOI 10.1002/humu.1380020205; HULTMAN T, 1991, BIOTECHNIQUES, V10, P84; KRISTENSEN T, 1988, NUCLEIC ACIDS RES, V16, P3487, DOI 10.1093/nar/16.8.3487; KVITTINGEN EA, 1986, SCAND J CLIN LAB INV, V46, P35; KVITTINGEN EA, 1993, J CLIN INVEST, V91, P1816, DOI 10.1172/JCI116393; LABELLE Y, 1993, HUM MOL GENET, V2, P941, DOI 10.1093/hmg/2.7.941; LINDSTEDT S, 1992, LANCET, V340, P813, DOI 10.1016/0140-6736(92)92685-9; MITCHELL G, 1990, NEW ENGL J MED, V322, P432, DOI 10.1056/NEJM199002153220704; PENOTTI FE, 1991, J THEOR BIOL, V150, P385, DOI 10.1016/S0022-5193(05)80436-9; PHANEUF D, 1992, J CLIN INVEST, V90, P1185, DOI 10.1172/JCI115979; PHANEUF D, 1991, AM J HUM GENET, V48, P525; ROOTWELT H, 1994, HUM GENET, V93, P615, DOI 10.1007/BF00201558; ROOTWELT H, 1992, HUM GENET, V89, P229, DOI 10.1007/BF00217128; ROOTWELT H, IN PRESS HUM GENET; STLOUIS M, 1994, HUM MOL GENET, V3, P69, DOI 10.1093/hmg/3.1.69; WEINBERG AG, 1976, J PEDIATR-US, V88, P434, DOI 10.1016/S0022-3476(76)80259-4	21	28	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1994	55	4					653	658						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PJ027	7942842				2022-12-18	WOS:A1994PJ02700007
J	CHUANG, JL; FISHER, CR; COX, RP; CHUANG, DT				CHUANG, JL; FISHER, CR; COX, RP; CHUANG, DT			MOLECULAR-BASIS OF MAPLE-SYRUP-URINE-DISEASE - NOVEL MUTATIONS AT THE E1-ALPHA LOCUS THAT IMPAIR E1(ALPHA(2)BETA(2)) ASSEMBLY OR DECREASE STEADY-STATE E1-ALPHA MESSENGER-RNA LEVELS OF BRANCHED-CHAIN ALPHA-KETO ACID DEHYDROGENASE COMPLEX	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PREMATURE TRANSLATION TERMINATION; ISOMERASE MESSENGER-RNA; NONSENSE MUTATIONS; Y393N MUTATION; GENE; DEFICIENCY; SEQUENCE; SUBUNIT	We report the occurrence of three novel mutations in the Ela (BCKDHA) locus of the branched-chain alpha-keto acid dehydrogenase (BCKAD) complex that cause maple syrup urine disease (MSUD). An 8-bp deletion in exon 7 is present in one allele of a compound-heterozygous patient (GM-649). A single C nucleotide insertion in exon 2 occurs in one allele of an intermediate-MSUD patient (Lo). The second allele of patient Lo carries an A-to-G transition in exon 9 of the E1 alpha gene. This missense mutation changes Tyr-368 to Cys (Y368C) in the E1 alpha subunit. Both the 8-bp deletion and the single C insertion generate a downstream nonsense codon. Both mutations appear to be associated with a low abundance of the mutant E1 alpha mRNA, as determined by allele-specific oligonucleotide probing. Transfection studies strongly suggest that the Y368C substitution in the E1 alpha subunit impairs its proper assembly with the normal E1 beta. Unassembled as well as misassembled E1 alpha and E1 beta subunits are degraded in the cell.	UNIV TEXAS, SW MED CTR, DEPT BIOCHEM, DALLAS, TX 75235 USA; UNIV TEXAS, SW MED CTR, DEPT INTERNAL MED, DALLAS, TX USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas					NIDDK NIH HHS [DK-26758] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026758] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BASERGA SJ, 1988, P NATL ACAD SCI USA, V85, P2056, DOI 10.1073/pnas.85.7.2056; BELGRADER P, 1993, P NATL ACAD SCI USA, V90, P482, DOI 10.1073/pnas.90.2.482; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHUANG DT, 1982, AM J HUM GENET, V34, P416; CHUANG DT, IN PRESS METABOLIC B, V1; CHUANG JL, 1993, J BIOL CHEM, V268, P8309; CHUANG JL, 1990, FEBS LETT, V262, P305, DOI 10.1016/0014-5793(90)80215-5; DAAR IO, 1988, MOL CELL BIOL, V8, P802, DOI 10.1128/MCB.8.2.802; DANCIS J, 1960, BIOCHIM BIOPHYS ACTA, V43, P342, DOI 10.1016/0006-3002(60)90448-0; DENNIS JA, 1989, P NATL ACAD SCI USA, V86, P7947, DOI 10.1073/pnas.86.20.7947; FATANIA HR, 1982, FEBS LETT, V147, P35, DOI 10.1016/0014-5793(82)81006-5; FISHER CR, 1991, J CLIN INVEST, V88, P1034, DOI 10.1172/JCI115363; FISHER CR, 1991, AM J HUM GENET, V49, P429; FISHER CW, 1989, J BIOL CHEM, V264, P3448; FISHER CW, 1993, AM J HUM GENET, V52, P414; GONZALEZRIOS MD, 1985, CLIN GENET, V27, P153; HAWKINS CF, 1989, FEBS LETT, V255, P77, DOI 10.1016/0014-5793(89)81064-6; KUIPERS OP, 1990, PROTEIN ENG, V4, P199, DOI 10.1093/protein/4.2.199; LINDSAY JG, 1989, ANN NY ACAD SCI, V573, P254, DOI 10.1111/j.1749-6632.1989.tb15002.x; MARSHALL L, 1981, AM J HUM GENET, V33, pA139; MASHIMA Y, 1992, AM J HUM GENET, V51, P81; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; RANDLE PJ, 1984, ENZYME REGULATION RE, P1; TSUJINO S, 1993, NEW ENGL J MED, V329, P241, DOI 10.1056/NEJM199307223290404; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868; WEXLER ID, 1991, FEBS LETT, V282, P209, DOI 10.1016/0014-5793(91)80479-M; WYNN RM, 1992, J BIOL CHEM, V267, P12400; YEAMAN SJ, 1989, BIOCHEM J, V257, P625, DOI 10.1042/bj2570625; YEAMAN SJ, 1984, FEBS LETT, V172, P38, DOI 10.1016/0014-5793(84)80868-6; ZHANG B, 1990, J BIOL CHEM, V265, P2425; ZHANG B, 1989, J CLIN INVEST, V83, P1425, DOI 10.1172/JCI114033	32	28	30	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1994	55	2					297	304						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NZ336	8037208				2022-12-18	WOS:A1994NZ33600010
J	STRAIN, L; GOSDEN, CM; BROCK, DJH; BONTHRON, DT				STRAIN, L; GOSDEN, CM; BROCK, DJH; BONTHRON, DT			GENETIC-HETEROGENEITY IN X-LINKED HYDROCEPHALUS - LINKAGE TO MARKERS WITHIN XQ27.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGMENT LENGTH POLYMORPHISMS; FRAGILE-X; MASA SYNDROME; DINUCLEOTIDE REPEAT; MENTAL-RETARDATION; DNA; XQ28; CHROMOSOME; LOCUS; SITE	X-linked hydrocephalus is a well-defined disorder which accounts for greater than or equal to 7% of hydrocephalus in males. Pathologically, the condition is characterized by stenosis or obliteration of the aqueduct of Sylvius. Previous genetic linkage studies have suggested the likelihood of genetic homogeneity for this condition, with close linkage to the DXS52 and F8C markers in Xq28. We have investigated a family with typical X-linked aqueductal stenosis, in which no linkage to these markers was present. In this family, close linkage was established to the DXS548 and FRAXA loci in Xq27.3. Our findings demonstrate that X-linked aqueductal stenosis may result from mutations at two different loci on the X chromosome. Caution is indicated in using linkage for the prenatal diagnosis of X-linked hydrocephalus.	WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,EDINBURGH,MIDLOTHIAN,SCOTLAND	University of Edinburgh	STRAIN, L (corresponding author), UNIV EDINBURGH,WESTERN GEN HOSP,HUMAN GENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND.			Bonthron, David/0000-0001-8132-8179				ARVEILER B, 1988, AM J HUM GENET, V42, P380; BICKERS DS, 1949, BRAIN, V72, P246, DOI 10.1093/brain/72.2.246; BOGGS BA, 1984, SOMAT CELL MOLEC GEN, V10, P607, DOI 10.1007/BF01535226; DAHL N, 1989, NUCLEIC ACIDS RES, V17, P2884, DOI 10.1093/nar/17.7.2884; DRAYNA D, 1984, P NATL ACAD SCI-BIOL, V81, P2836, DOI 10.1073/pnas.81.9.2836; EDWARDS JH, 1961, ARCH DIS CHILD, V36, P486, DOI 10.1136/adc.36.189.486; FEIL R, 1990, AM J HUM GENET, V46, P720; FERRIE RM, 1991, NUCLEIC ACIDS RES, V19, P2505, DOI 10.1093/nar/19.9.2505; FRYNS JP, 1991, J MED GENET, V28, P429, DOI 10.1136/jmg.28.6.429-a; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GOSDEN CM, 1992, HUMAN CYTOGENETICS P, V1, P31; HALLIDAY J, 1986, J MED GENET, V23, P23, DOI 10.1136/jmg.23.1.23; HEILIG R, 1988, AM J MED GENET, V30, P543, DOI 10.1002/ajmg.1320300156; HOLDEN JJA, 1990, AM J HUM GENET S, V47, pA183; JANSEN J, 1975, DEV MED CHILD NEUROL, V17, P633; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; JOUET M, 1993, J MED GENET, V30, P214, DOI 10.1136/jmg.30.3.214; LALLOZ MRA, 1991, LANCET, V338, P207, DOI 10.1016/0140-6736(91)90348-S; LANDRIEU P, 1979, DEV MED CHILD NEUROL, V21, P637; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LYONNET S, 1992, GENOMICS, V14, P508, DOI 10.1016/S0888-7543(05)80254-X; MACIAS VR, 1992, AM J MED GENET, V43, P408, DOI 10.1002/ajmg.1320430162; MANDEL JL, 1986, COLD SPRING HARB SYM, V51, P195, DOI 10.1101/SQB.1986.051.01.024; McKusick V.A., 1992, MENDELIAN INHERITANC; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; OOSTRA BA, 1990, GENOMICS, V6, P129, DOI 10.1016/0888-7543(90)90457-6; ORTH U, 1991, CYTOGENET CELL GENET, V58, P2079; OTT J, 1978, ANN HUM GENET, V42, P255, DOI 10.1111/j.1469-1809.1978.tb00657.x; Ott J., 1991, ANAL HUMAN GENETIC L; PIPER J, 1989, CYTOMETRY, V10, P242, DOI 10.1002/cyto.990100303; RICHARDS RI, 1991, J MED GENET, V28, P818, DOI 10.1136/jmg.28.12.818; RIGGINS GJ, 1992, AM J MED GENET, V43, P237, DOI 10.1002/ajmg.1320430138; ROSENTHAL A, 1992, NAT GENET, V2, P107, DOI 10.1038/ng1092-107; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; SCHRANDERSTUMPEL C, 1990, J MED GENET, V27, P688, DOI 10.1136/jmg.27.11.688; SERVILLE F, 1992, EUR J PEDIATR, V151, P515, DOI 10.1007/BF01957757; SUTHERS GK, 1991, GENOMICS, V9, P37, DOI 10.1016/0888-7543(91)90218-4; SUTHERS GK, 1989, SCIENCE, V246, P1298, DOI 10.1126/science.2573953; WEHNERT M, 1990, HUM GENET, V6, P59; WILLEMS PJ, 1992, AM J HUM GENET, V51, P307; WILLEMS PJ, 1990, GENOMICS, V8, P367, DOI 10.1016/0888-7543(90)90294-5; WILLIAMSON R, 1991, CYTOGENET CELL GENET, V58, P1190, DOI 10.1159/000133727; WINTER RM, 1989, HUM GENET, V82, P367	44	28	28	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1994	54	2					236	243						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU315	8304340				2022-12-18	WOS:A1994MU31500008
J	TASSONE, F; CHENG, S; GARDINER, K				TASSONE, F; CHENG, S; GARDINER, K			ANALYSIS OF CHROMOSOME-21 YEAST ARTIFICIAL CHROMOSOME (YAC) CLONES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL ALZHEIMERS-DISEASE; POLYMERASE CHAIN-REACTION; CPG ISLANDS; PRECURSOR PROTEIN; LONG ARM; GENE; REGION; SEQUENCES; DNA; EXPRESSION	Chromosome 21 contains genes relevant to several important diseases. Yeast artificial chromosome (YAC) clones, because they span >100 kbp, will provide attractive material for initiating searches for such genes. Twenty-two YAC clones, each of which maps to a region of potential relevance either to aspects of the Down syndrome phenotype or to one of the other chromosome 21-associated genetic diseases, have been analyzed in detail. Clones total approximately 6,000 kb and derive from all parts of the long arm. Rare restriction-site maps have been constructed for each clone and have been used to determine regional variations in clonability, methylation frequency, CpG island density, and CpG island frequency versus gene density. This information will be useful for the isolation and mapping of new genes to chromosome 21 and for walking in YAC libraries.	ELEANOR ROOSEVELT INST CANC RES,1899 GAYLORD ST,DENVER,CO 80206; A GEMELLI SCH MED,INST HUMAN GENET,ROME,ITALY		GARDINER, K (corresponding author), ELEANOR ROOSEVELT INST CANC RES,1899 GAYLORD ST,DENVER,CO 80206, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD017449] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K04HG000001] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00001] Funding Source: Medline; NICHD NIH HHS [HD17449] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BERDICHEVSKII F B, 1988, Molekulyarnaya Biologiya (Moscow), V22, P794; BIRD AP, 1989, NUCLEIC ACIDS RES, V17, P9485, DOI 10.1093/nar/17.22.9485; BIRD AP, 1987, TRENDS GENET, V3, P342, DOI 10.1016/0168-9525(87)90294-0; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BRAHE C, 1990, AM J MED GENET S, V7, P120; BROWNSTEIN BH, 1989, SCIENCE, V244, P1348, DOI 10.1126/science.2544027; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; BURMEISTER M, 1991, GENOMICS, V9, P19, DOI 10.1016/0888-7543(91)90216-2; BUTLER R, 1992, GENOMICS, V12, P42, DOI 10.1016/0888-7543(92)90404-G; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; DAVIDSON JN, 1985, ANN NY ACAD SCI, V450, P43, DOI 10.1111/j.1749-6632.1985.tb21482.x; Epstein C.J, 1986, CONSEQUENCES CHROMOS; ESTABROOKS LL, 1990, AM J MED GENET, V36, P306, DOI 10.1002/ajmg.1320360312; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GAO JZ, 1991, P NATL ACAD SCI USA, V88, P4882, DOI 10.1073/pnas.88.11.4882; GAO JZ, 1991, GENOMICS, V10, P166, DOI 10.1016/0888-7543(91)90497-3; GARDINER K, 1990, EMBO J, V9, P1853, DOI 10.1002/j.1460-2075.1990.tb08310.x; GARDINER K, 1990, EMBO J, V9, P25, DOI 10.1002/j.1460-2075.1990.tb08076.x; GARDINER K, 1990, MOL GENETICS CHROMOS, P1; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GNIRKE A, 1991, EMBO J, V10, P1629, DOI 10.1002/j.1460-2075.1991.tb07685.x; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; IMAI T, 1990, GENOMICS, V8, P297, DOI 10.1016/0888-7543(90)90285-3; KORENBERG JR, 1990, AM J HUM GENET, V47, P236; KORENBERG JR, 1992, AM J HUM GENET, V50, P294; KORENBERG JR, 1991, MORPHOGENESIS DOWN S, P43; LEHESJOKI AE, 1991, P NATL ACAD SCI USA, V88, P3696, DOI 10.1073/pnas.88.9.3696; LEHRACH H., 1990, GENOME ANAL, P39; LEMAIRE HG, 1989, NUCLEIC ACIDS RES, V17, P517, DOI 10.1093/nar/17.2.517; LUTFALLA G, 1992, J BIOL CHEM, V267, P2802; MCCORMICK MK, 1989, GENOMICS, V5, P325, DOI 10.1016/0888-7543(89)90065-7; MENDEZ MJ, 1991, GENOMICS, V10, P661, DOI 10.1016/0888-7543(91)90449-O; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; NELSON DL, 1989, P NATL ACAD SCI USA, V86, P6686, DOI 10.1073/pnas.86.17.6686; NEVE RL, 1986, GENE, V49, P361, DOI 10.1016/0378-1119(86)90372-0; OWEN MJ, 1990, AM J HUM GENET, V46, P316; PATTERSON D, 1991, CYTOGENET CELL GENET, V57, P167; PUESCHEL SM, 1982, DOWN SYNDROME ADV BI; RAHMANI Z, 1989, P NATL ACAD SCI USA, V86, P5958, DOI 10.1073/pnas.86.15.5958; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; SALBAUM JM, 1988, EMBO J, V7, P2807, DOI 10.1002/j.1460-2075.1988.tb03136.x; SCHELLENBERG GD, 1991, AM J HUM GENET, V49, P511; SCHWARTZ DC, 1989, NATURE, V342, P575, DOI 10.1038/342575a0; SIDDIQUE T, 1991, NEW ENGL J MED, V324, P1381, DOI 10.1056/NEJM199105163242001; STEFANI L, 1988, NUCLEIC ACIDS RES, V16, P2885, DOI 10.1093/nar/16.7.2885; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; TRASK B, 1989, GENOMICS, V5, P710, DOI 10.1016/0888-7543(89)90112-2; VANCAMP G, 1992, GENOMICS, V12, P158, DOI 10.1016/0888-7543(92)90420-W	50	28	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1992	51	6					1251	1264						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KC995	1463009				2022-12-18	WOS:A1992KC99500008
J	UCHINO, T; HARAGUCHI, Y; APARICIO, JM; MIZUTANI, N; HIGASHIKAWA, M; NAITOH, H; MORI, M; MATSUDA, I				UCHINO, T; HARAGUCHI, Y; APARICIO, JM; MIZUTANI, N; HIGASHIKAWA, M; NAITOH, H; MORI, M; MATSUDA, I			3 NOVEL MUTATIONS IN THE LIVER-TYPE ARGINASE GENE IN 3 UNRELATED JAPANESE PATIENTS WITH ARGININEMIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HYPERARGININEMIA; DNA; PROTEINS; EXPRESSION; SEQUENCE; TISSUES	Argininemia is caused by a hereditary deficiency of liver-type arginase (E.C.3.5.3.1) and is characterized by psychomotor retardation and spastic tetraplegia. We examined findings in three Japanese patients with argininemia, by using the PCR, cloning, and sequencing procedures. We found three different mutations-G-to-A-365 in exon 4, G-to-C-703 in exon 7, and C-del-842 in exon 8-thereby leading to mutant arginase proteins of W122X, G235R, and L282FS, respectively. Patient 1 was a compound heterozygote, inheriting the allele with G-to-A-365 from his mother and the allele with G-to-C-703 from his father. Patients. 2 and 3 were homozygotes of the allele with G-to-C-703 and of the allele with C-del-842, respectively. Expression tests of these mutant arginases in Escherichia coli indicated that the mutant arginase of W122X did not remain a stable product. The other two mutant arginases-G235R and L282FS-were detected by immunoblot analyses. There was no evidence of activity of the three mutant arginases expressed in E. coli. We tentatively conclude that argininemia is heterogeneous, at the molecular level.	KUMAMOTO UNIV,SCH MED,DEPT PEDIAT,1-1-1 HONJO,KUMAMOTO 860,JAPAN; NATL SUZUKA HOSP,SUZUKA,JAPAN; NATL CHILDRENS HOSP,DEPT NEUROL,TOKYO 154,JAPAN; KUMAMOTO UNIV,SCH MED,INST MED GENET,KUMAMOTO 860,JAPAN; NAGOYA UNIV,SCH MED,DEPT PEDIAT,NAGOYA,AICHI 466,JAPAN	Kumamoto University; National Center for Child Health & Development - Japan; Kumamoto University; Nagoya University	MATSUDA, I (corresponding author), KUMAMOTO UNIV,SCH MED,DEPT PEDIAT,1-1-1 HONJO,KUMAMOTO 860,JAPAN.							Brusilow S.W., 1989, METABOLIC BASIS INHE, P629; GRODY WW, 1989, J CLIN INVEST, V83, P602, DOI 10.1172/JCI113923; HARAGUCHI Y, 1988, JPN J HUM GENET, V33, P305, DOI 10.1007/BF02032860; HARAGUCHI Y, 1990, J CLIN INVEST, V86, P347, DOI 10.1172/JCI114707; HARAGUCHI Y, 1987, P NATL ACAD SCI USA, V84, P412, DOI 10.1073/pnas.84.2.412; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; HAYAKAWA C, 1991, EUR J PEDIATR, V150, P800, DOI 10.1007/BF02026716; HERZFELD A, 1976, BIOCHEM J, V153, P469, DOI 10.1042/bj1530469; IKEMOTO M, 1990, BIOCHEM J, V270, P697, DOI 10.1042/bj2700697; KUBO M, 1987, JPN SOC INHERITED ME, V3, P41; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARUTA H, 1991, J BIOL CHEM, V266, P11661; MIZUTANI N, 1983, BRAIN DEV-JPN, V5, P555, DOI 10.1016/S0387-7604(83)80059-X; NAGATA N, 1991, AM J MED GENET, V39, P228, DOI 10.1002/ajmg.1320390226; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHIMKE RT, 1962, J BIOL CHEM, V237, P459; SCHRELL A, 1989, EUR J BIOCHEM, V184, P635, DOI 10.1111/j.1432-1033.1989.tb15060.x; SHIBUI H, 1986, BRAIN DEV-JPN, V8, P207; SPARKES RS, 1986, AM J HUM GENET, V39, P186; SPECTOR EB, 1983, PEDIATR RES, V17, P941, DOI 10.1203/00006450-198312000-00003; TAKIGUCHI M, 1988, NUCLEIC ACIDS RES, V16, P8789, DOI 10.1093/nar/16.18.8789; TAKIGUCHI M, 1987, P NATL ACAD SCI USA, V88, P6136; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350	27	28	30	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1992	51	6					1406	1412						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KC995	1463019				2022-12-18	WOS:A1992KC99500024
J	HOWELL, N; MCCULLOUGH, D; BODISWOLLNER, I				HOWELL, N; MCCULLOUGH, D; BODISWOLLNER, I			MOLECULAR GENETIC-ANALYSIS OF A SPORADIC CASE OF LEBER HEREDITARY OPTIC NEUROPATHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							MITOCHONDRIAL-DNA MUTATION; NEURORETINOPATHY; SEGREGATION; GENOTYPE; DISEASE		CUNY MT SINAI SCH MED,DEPT OPHTHALMOL,DEPT NEUROL,NEW YORK,NY 10029	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	HOWELL, N (corresponding author), UNIV TEXAS,MED BRANCH,DEPT RADIAT THERAPY,DIV BIOL,GALVESTON,TX 77550, USA.		bodis-wollner, ivan/AAH-2631-2020		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD008315] Funding Source: NIH RePORTER; NICHD NIH HHS [P01 HD08315] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ASHLEY MV, 1989, NUCLEIC ACIDS RES, V17, P7325, DOI 10.1093/nar/17.18.7325; BOLHUIS PA, 1990, BIOCHEM BIOPH RES CO, V170, P994, DOI 10.1016/0006-291X(90)90490-E; HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739; HOWELL N, 1991, AM J HUM GENET, V48, P935; HOWELL N, 1991, AM J HUM GENET, V49, P939; HOWELL N, 1990, AM J HUM GENET, V47, P629; HUOPONEN K, 1991, AM J HUM GENET, V48, P1147; LOTT MT, 1990, AM J OPHTHALMOL, V109, P625, DOI 10.1016/S0002-9394(14)72429-8; LUNDSGARD R, 1944, ACTA OPHTHALMOL S3, V21, P3; NEWMAN NJ, 1991, AM J OPHTHALMOL, V111, P750, DOI 10.1016/S0002-9394(14)76784-4; NIKOSKELAINEN E, 1985, T OPHTHAL SOC UK, V104, P845; NIKOSKELAINEN E, 1988, J CLIN NEURO-OPHTHAL, V8, P225; NIKOSKELAINEN EK, 1987, ARCH OPHTHALMOL-CHIC, V105, P665, DOI 10.1001/archopht.1987.01060050083043; POULTON J, IN PRESS J MED GENET; SEEDORFF T, 1970, ACTA OPHTHALMOL, V163, P133; SINGH G, 1989, NEW ENGL J MED, V320, P1300, DOI 10.1056/NEJM198905183202002; VAN SENUS A. H. C., 1963, DOC OPHTHALMOL, V17, P1; VILKKI J, 1990, AM J HUM GENET, V47, P95; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231	19	28	28	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1992	50	2					443	446						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HD001	1734726				2022-12-18	WOS:A1992HD00100026
J	NAJFELD, V; BALLARD, SG; MENNINGER, J; WARD, DC; BOUHASSIRA, EE; SCHWARTZ, RS; NAGEL, RL; RYBICKI, AC				NAJFELD, V; BALLARD, SG; MENNINGER, J; WARD, DC; BOUHASSIRA, EE; SCHWARTZ, RS; NAGEL, RL; RYBICKI, AC			THE GENE FOR HUMAN ERYTHROCYTE PROTEIN-4.2 MAPS TO CHROMOSOME-15Q15	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; MEMBRANE; HYBRIDIZATION; CLONING; ANKYRIN	Protein 4.2 (P4.2), one of the major components of the red-blood-cell membrane, is located on the interior surface, where it binds with high affinity to the cytoplasmic domain of band 3. Individuals whose red blood cells are deficient in P4.2 have osmotically fragile, abnormally shaped cells and moderate hemolytic anemia. cDNA clones from both the 5' and the 3' coding regions of the P4.2 gene were used to map its chromosomal location by fluorescence in situ hybridization. The probes, individually or in combination, gave specific hybridization signals on chromosome 15. The hybridization locus was identified by combining fluorescence images of the probe signals with fluorescence banding patterns generated by Alu-PCR (R-like) probe and by DAPI staining (G-like). Our results demonstrate that the locus of the P4.2 gene is located within 15q15.	YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510; MONTEFIORE MED CTR,ALBERT EINSTEIN COLL MED,DIV HEMATOL,BRONX,NY 10467	Yale University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	NAJFELD, V (corresponding author), MT SINAI MED CTR,SCH MED,POLLY ANNENBERG LEVEE HEMATOL CTR,TUMOR CYTOGENET LAB,BOX 1079,NEW YORK,NY 10029, USA.		Bouhassira, Eric/AAZ-4184-2021		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL041382, P60HL038655] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000272] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG00272] Funding Source: Medline; NHLBI NIH HHS [HL 38655, HL 41382] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BALDINI A, 1991, GENOMICS, V9, P770, DOI 10.1016/0888-7543(91)90374-N; BOUHASSIRA EE, IN PRESS CLIN RES; BRIGATI DJ, 1983, VIROLOGY, V126, P32, DOI 10.1016/0042-6822(83)90460-9; CONBOY J, 1986, NEW ENGL J MED, V315, P680, DOI 10.1056/NEJM198609113151105; KORENBERG JR, 1988, CELL, V53, P391, DOI 10.1016/0092-8674(88)90159-6; KORSGREN C, 1990, P NATL ACAD SCI USA, V87, P613, DOI 10.1073/pnas.87.2.613; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; LUX SE, 1990, NATURE, V345, P736, DOI 10.1038/345736a0; LUX SE, 1989, P NATL ACAD SCI USA, V86, P9089, DOI 10.1073/pnas.86.23.9089; MATTEI MG, 1986, HUM GENET, V74, P420, DOI 10.1007/BF00280497; MOORE G, 1989, GENOMICS, V4, P152, DOI 10.1016/0888-7543(89)90294-2; NADEAR JH, 1990, LINKAGE SYNTENY HOMO; NELSON DL, 1989, P NATL ACAD SCI USA, V86, P6686, DOI 10.1073/pnas.86.17.6686; OBRIEN SJ, 1990, GENETIC MAPS; ROWLEY JD, 1977, INT J CANCER, V20, P869, DOI 10.1002/ijc.2910200608; RYBICKI AC, 1988, J CLIN INVEST, V81, P893, DOI 10.1172/JCI113400; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J., 1989, MOL CLONING LAB MANU; SHOWE L C, 1987, Genomics, V1, P71, DOI 10.1016/0888-7543(87)90107-8; SUNG LA, 1990, P NATL ACAD SCI USA, V87, P955, DOI 10.1073/pnas.87.3.955	20	28	28	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1992	50	1					71	75						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HA040	1729896				2022-12-18	WOS:A1992HA04000008
J	MUELLER, OT; HARTSFIELD, JK; GALLARDO, LA; ESSIG, YP; MILLER, KL; PAPENHAUSEN, PR; TEDESCO, TA				MUELLER, OT; HARTSFIELD, JK; GALLARDO, LA; ESSIG, YP; MILLER, KL; PAPENHAUSEN, PR; TEDESCO, TA			LOWE OCULOCEREBRORENAL SYNDROME IN A FEMALE WITH A BALANCED X-20 TRANSLOCATION - MAPPING OF THE X-CHROMOSOME BREAKPOINT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKED FLANKING MARKERS; XQ24-Q26; GIRL	A Hispanic girl with Lowe oculocerebrorenal syndrome (OCRL), an X-linked recessive condition characterized by cataracts, glaucoma, mental retardation, and proteinuria, is reported. A balanced X;20 chromosomal translocation with the X chromosome breakpoint at q26.1 was found with high-resolution trypsin-Giemsa banding. Somatic cell hybridization was used to separate the X chromosome derivative and the chromosome 20 derivative in order to position, with respect to the translocation breakpoint, several DNA loci that are linked to the Lowe syndrome locus (Xq24-q26). DXS10 and DXS53 were found to be distal to the breakpoint, whereas DXS37 and DXS42 were located proximal to it. These studies suggest that the OCRL locus lies in the region between these probes. The translocation chromosome originated from an unaffected male without a visible translocation, indicating that the most likely cause of OCRL in this patient is the de novo translocation that disrupted the OCRL locus.	UNIV S FLORIDA,COLL MED,PEDIAT LABS,TAMPA,FL 33612	State University System of Florida; University of South Florida	MUELLER, OT (corresponding author), UNIV S FLORIDA,COLL MED,DEPT PEDIAT,REG GENET PROGRAM,12901 BRUCE B DOWNS BLVD,TAMPA,FL 33612, USA.		Hartsfield, J.K./G-3770-2011	Hartsfield, J.K./0000-0001-9117-5508	NIDCR NIH HHS [DE00243] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K11DE000243] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		CYVIN KB, 1973, ACTA PAEDIATR SCAND, V62, P309, DOI 10.1111/j.1651-2227.1973.tb08109.x; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HARRIS LS, 1970, BRIT J OPHTHALMOL, V54, P278, DOI 10.1136/bjo.54.4.278; HARTSFIELD JK, 1989, CLIN RES, V37, pA52; HODGSON SV, 1986, AM J MED GENET, V23, P837, DOI 10.1002/ajmg.1320230311; MCKUSICK VA, 1989, MENDELIAN INHERITANC, P1335; MUELLER OT, 1989, JUL MARCH DIM BIRTH; REILLY D S, 1989, American Journal of Human Genetics, V45, pA158; REILLY D S, 1988, American Journal of Human Genetics, V43, pA94; REILLY DS, 1988, AM J HUM GENET, V42, P748; REILLY DS, 1990, GENOMICS, V8, P62, DOI 10.1016/0888-7543(90)90226-K; SAGEL I, 1970, J PEDIATR-US, V77, P124, DOI 10.1016/S0022-3476(70)80056-7; SCHOLTEN H G, 1960, Maandschr Kindergeneeskd, V28, P251; SILVER DN, 1987, J CLIN INVEST, V79, P282, DOI 10.1172/JCI112795; SILVER DN, 1987, CYTOGENET CELL GENET, V46, P692; SVORC J, 1967, AM J DIS CHILD, V114, P186, DOI 10.1001/archpedi.1967.02090230116015; WADELIUS C, 1989, AM J HUM GENET, V44, P241; YAMASHINA I, 1983, MOL CELL BIOCHEM, V52, P107; YUNIS JJ, 1981, NEW ENGL J MED, V305, P135, DOI 10.1056/NEJM198107163050304	19	28	29	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1991	49	4					804	810						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG665	1897526				2022-12-18	WOS:A1991GG66500012
J	OKAYAMA, H; BRANTLY, M; HOLMES, M; CRYSTAL, RG				OKAYAMA, H; BRANTLY, M; HOLMES, M; CRYSTAL, RG			CHARACTERIZATION OF THE MOLECULAR-BASIS OF THE ALPHA-1-ANTITRYPSIN F-ALLELE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALPHA-1-ANTITRYPSIN DEFICIENCY; ENZYMATIC AMPLIFICATION; EMPHYSEMA; INHIBITOR; DISEASE; GENE; DNA; POLYMERASE; PHENOTYPES; VARIANTS	Alpha-1-antitrypsin (alpha-1-AT), the major serum inhibitor of neutrophil elastase, is a highly polymorphic serum protein associated with characteristic isoelectric-focusing (IEF) patterns for most variants. To characterize the molecular basis of the anodal F variant, the DNA sequence of the coding exons of an FZ individual was determined. The F allele differed from the normal M1(Val213) alpha-1-AT allele by a single nucleotide transversion of cytosine to thymidine, which results in the amino acid substitution Arg223 CGT --> Cys TGT. Inheritance of the F mutation was confirmed by family analysis using allele-specific amplification. In the context that the normal alpha-1-AT molecule has only one cysteine residue, a mutation resulting in the addition of a second cysteine may influence the three-dimensional form of the protein and/or permit interaction with other plasma proteins with free-SH groups and may be responsible for the observation that the major F alpha-1-AT bands often migrate as doublets in IEF gels.	NHLBI,PULM BRANCH,BLDG 10,ROOM 6D03,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)			Brantly, Mark/AAH-2922-2020					BECKMAN G, 1984, CLIN GENET, V25, P491; BILLINGSLEY GD, 1982, HUM GENET, V61, P118, DOI 10.1007/BF00274200; BOUTIN B, 1985, AM J HUM GENET, V37, P1098; CARRELL RW, 1982, NATURE, V298, P329, DOI 10.1038/298329a0; COCKCROFT DW, 1981, CAN MED ASSOC J, V124, P737; CONSTANS J, 1980, HUM GENET, V55, P119, DOI 10.1007/BF00329137; COX DW, 1980, HUM GENET, V53, P429, DOI 10.1007/BF00287070; Cox DW, 1989, METABOLIC BASIS INHE, P2409; CRYSTAL RG, 1990, J CLIN INVEST, V85, P1343, DOI 10.1172/JCI114578; CRYSTAL RG, 1989, TRENDS GENET, V5, P411, DOI 10.1016/0168-9525(89)90200-X; FAGERHOL MK, 1965, SCIENCE, V149, P986, DOI 10.1126/science.149.3687.986; FAGERHOL MK, 1974, POUMON COEUR, V27, P41; GRAHAM A, 1989, HUM GENET, V84, P55, DOI 10.1007/BF00210671; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; KELLY CP, 1989, THORAX, V44, P758, DOI 10.1136/thx.44.9.758; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; LONG GL, 1984, BIOCHEMISTRY-US, V23, P4828, DOI 10.1021/bi00316a003; MITTMAN C, 1973, ARCH ENVIRON HEALTH, V27, P201, DOI 10.1080/00039896.1973.10666352; MITTMAN C, 1972, Clinical Research, V20, P242; NUKIWA T, 1986, J BIOL CHEM, V261, P5989; NUKIWA T, 1987, BIOCHEMISTRY-US, V26, P5259, DOI 10.1021/bi00391a008; OKAYAMA H, 1989, J LAB CLIN MED, V114, P105; PIERCE JA, 1975, JAMA-J AM MED ASSOC, V231, P609, DOI 10.1001/jama.231.6.609; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TALAMO RC, 1978, DHEW NIH781420 PHS P; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; WEWERS MD, 1987, NEW ENGL J MED, V316, P1055, DOI 10.1056/NEJM198704233161704	29	28	29	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1991	48	6					1154	1158						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FP092	2035534				2022-12-18	WOS:A1991FP09200018
J	HIMMELBAUER, H; GERMINO, GG; CECCHERINI, I; ROMEO, G; REEDERS, ST; FRISCHAUF, AM				HIMMELBAUER, H; GERMINO, GG; CECCHERINI, I; ROMEO, G; REEDERS, ST; FRISCHAUF, AM			SATURATING THE REGION OF THE POLYCYSTIC KIDNEY-DISEASE GENE WITH NOTI LINKING CLONES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN ALPHA-GLOBIN; HUMAN CHROMOSOME-16; SHORT ARM; DNA; MARKERS; ISLANDS; LOCUS; MAP; CONSTRUCTION; LOCALIZATION	A NotI-linking library was constructed from a radiation hybrid containing fragments of human chromosome 16. The clones were mapped on a panel of somatic cell hybrids, and 10 different NotI site-containing clones were localized close to and between genetic markers flanking the PKD1 locus. With pulsed-field gel analysis the clones were shown to be distributed over four adjacent ClaI fragments covering 1,200 kb.	IMPERIAL CANC RES FUND,POB 123,LINCOLNS INN FIELDS,LONDON WC2A 3PX,ENGLAND; YALE UNIV,SCH MED,HOWARD HUGHES MED INST,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT INTERNAL MED,NEUROL SECT,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT GENET,NEW HAVEN,CT 06510; IST GIANNIAN GASLINI,GENET MOLEC LAB,GENOA,ITALY	Cancer Research UK; Howard Hughes Medical Institute; Yale University; Yale University; Yale University; University of Genoa; IRCCS Istituto Giannina Gaslini			Ceccherini, Isabella/P-8195-2014	Ceccherini, Isabella/0000-0001-8732-1955; Germino, Gregory/0000-0002-3609-5588; Himmelbauer, Heinz/0000-0001-8897-2928				BIRD AP, 1987, EMBO J, V6, P999, DOI 10.1002/j.1460-2075.1987.tb04851.x; BIRD AP, 1987, TRENDS GENET, V3, P342, DOI 10.1016/0168-9525(87)90294-0; BREUNING MH, 1987, LANCET, V2, P1359; BREUNING MH, 1990, J MED GENET, V27, P603, DOI 10.1136/jmg.27.10.603; BREUNING MH, 1988, APPROACHES PATHOGENE, P17; BROWN WRA, 1988, EMBO J, V7, P2377, DOI 10.1002/j.1460-2075.1988.tb03082.x; BUCAN M, 1990, GENOMICS, V6, P1; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; BURMEISTER M, 1988, Genomics, V2, P189, DOI 10.1016/0888-7543(88)90002-X; CALLEN DF, 1986, ANN GENET-PARIS, V29, P235; CALLEN DF, 1989, GENOMICS, V4, P348, DOI 10.1016/0888-7543(89)90341-8; CECCHERINI I, 1989, CYTOGENET CELL GENET, V51, P975; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; ELVIN P, 1990, NUCLEIC ACIDS RES, V18, P3913, DOI 10.1093/nar/18.13.3913; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FISCHELGHODSIAN N, 1987, NUCLEIC ACIDS RES, V15, P9215, DOI 10.1093/nar/15.22.9215; Frischauf A. M., 1989, Technique, a Journal of Methods in Cell and Molecular Biology, V1, P3; GAL A, 1989, CLIN GENET, V35, P13; GERMINO GG, 1990, KIDNEY INT, V37, P248; GERMINO GG, 1990, AM J HUM GENET, V46, P925; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; HARRIS PC, 1990, GENOMICS, V7, P195, DOI 10.1016/0888-7543(90)90541-2; HERRMANN BG, 1987, METHOD ENZYMOL, V152, P180; HERRMANN BG, 1987, CELL, V48, P813, DOI 10.1016/0092-8674(87)90078-X; HYLAND VJ, 1988, AM J HUM GENET, V42, P373; HYLAND VJ, 1990, HUM GENET, V3, P286; JARMAN AP, 1986, EMBO J, V5, P1857, DOI 10.1002/j.1460-2075.1986.tb04437.x; KIEVITS T, 1990, CYTOGENET CELL GENET, V53, P134, DOI 10.1159/000132913; KOEFFLER HP, 1981, P NATL ACAD SCI-BIOL, V78, P7015, DOI 10.1073/pnas.78.11.7015; LATHROP M, 1988, CYTOGENET CELL GENET, V46, P643; LINDSAY S, 1987, NATURE, V327, P336, DOI 10.1038/327336a0; LITT M, 1985, P NATL ACAD SCI USA, V82, P6206, DOI 10.1073/pnas.82.18.6206; Maniatis T., 1982, MOL CLONING; MANSOURI A, 1988, DIFFERENTIATION, V38, P67, DOI 10.1111/j.1432-0436.1988.tb00593.x; MONACO AP, 1987, TRENDS GENET, V3, P33, DOI 10.1016/0168-9525(87)90163-6; MOYZIS RK, 1987, CHROMOSOMA, V95, P375, DOI 10.1007/BF00333988; PETIT C, 1988, EMBO J, V7, P2369, DOI 10.1002/j.1460-2075.1988.tb03081.x; POHL TM, 1988, NUCLEIC ACIDS RES, V16, P9185, DOI 10.1093/nar/16.19.9185; POUSTKA A, 1986, TRENDS GENET, V2, P174, DOI 10.1016/0168-9525(86)90219-2; REEDERS S T, 1988, Genomics, V3, P150, DOI 10.1016/0888-7543(88)90146-2; REEDERS ST, 1985, NATURE, V317, P542, DOI 10.1038/317542a0; REEDERS ST, 1989, MOL BIOL MED, V6, P81; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; RYYNANEN M, 1987, J MED GENET, V24, P462, DOI 10.1136/jmg.24.8.462; SMITH CL, 1987, METHOD ENZYMOL, V151, P461; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; WESTPHAL EM, 1988, HUM GENET, V79, P260, DOI 10.1007/BF00366248; XIAO GH, 1988, CYTOGENET CELL GENET, V46, P721; ZERRES K, 1984, HUM GENET, V68, P104, DOI 10.1007/BF00279301	49	28	30	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1991	48	2					325	334						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV744	1990840				2022-12-18	WOS:A1991EV74400017
J	CASSIDY, SB; GAINEY, AJ; BUTLER, MG				CASSIDY, SB; GAINEY, AJ; BUTLER, MG			OCCUPATIONAL HYDROCARBON EXPOSURE AMONG FATHERS OF PRADER-WILLI SYNDROME PATIENTS WITH AND WITHOUT DELETIONS OF 15Q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CONNECTICUT,SCH MED,DEPT PEDIAT,DIV HUMAN GENET,FARMINGTON,CT 06032; VANDERBILT UNIV,MED CTR,SCH MED,DEPT PEDIAT,DIV GENET,NASHVILLE,TN 37232	University of Connecticut; Vanderbilt University	CASSIDY, SB (corresponding author), UNIV ARIZONA,COLL MED,DEPT PEDIAT,GENET DYSMORPHOL SECT,2504 E ELM ST,SUITE 104,TUCSON,AZ 85716, USA.							BAUCHINGER M, 1982, MUTAT RES, V102, P439, DOI 10.1016/0165-1218(82)90106-9; BUTLER MG, 1987, CANCER GENET CYTOGEN, V24, P129, DOI 10.1016/0165-4608(87)90089-6; BUTLER MG, 1983, LANCET, V1, P1285; BUTLER MG, 1986, AM J MED GENET, V23, P793, DOI 10.1002/ajmg.1320230307; Cassidy S B, 1984, Curr Probl Pediatr, V14, P1; GOLD EB, 1982, J OCCUP ENVIRON MED, V24, P578, DOI 10.1097/00043764-198208000-00011; HAGLUND U, 1980, SCAND J WORK ENV HEA, V6, P291, DOI 10.5271/sjweh.2606; HANSTEEN IL, 1978, MUTAT RES, V51, P271, DOI 10.1016/S0027-5107(78)80022-0; KANTOR AF, 1979, J EPIDEMIOL COMMUN H, V33, P253, DOI 10.1136/jech.33.4.253; KUCEROVA M, 1979, MUTAT RES, V67, P97; LABIDI F, 1986, AM J HUM GENET, V39, P452; LEDBETTER DH, 1982, AM J HUM GENET, V34, P278; LEDBETTER DH, 1981, NEW ENGL J MED, V304, P325, DOI 10.1056/NEJM198102053040604; LEDBETTER DH, 1988, PRADERWILLI SYNDROME; MAGENIS RE, 1988, AM J HUM GENET, V42, P529; MAKIPAAKKANEN J, 1980, J TOXICOL ENV HEALTH, V6, P775, DOI 10.1080/15287398009529896; MIETTINEN O, 1976, AM J EPIDEMIOL, V103, P226, DOI 10.1093/oxfordjournals.aje.a112220; NIIKAWA N, 1985, HUM GENET, V69, P22, DOI 10.1007/BF00295524; RYBAK J, 1982, HUM GENET, V60, P328, DOI 10.1007/BF00569213; STRAKOWSKI SM, 1987, LANCET, V2, P1458; YU RL, 1981, CYTOGENET CELL GENET, V31, P111, DOI 10.1159/000131634; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746	22	28	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1989	44	6					806	810						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	U8549	2729276				2022-12-18	WOS:A1989U854900005
J	ZENG, YT; HUANG, SZ; REN, ZR; LI, HJ				ZENG, YT; HUANG, SZ; REN, ZR; LI, HJ			IDENTIFICATION OF HB D-PUNJAB GENE - APPLICATION OF DNA AMPLIFICATION IN THE STUDY OF ABNORMAL-HEMOGLOBINS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									GEN HOSP URUMCHI MIL AREA, MED GENET LAB, XINJIANG, PEOPLES R CHINA		ZENG, YT (corresponding author), SHANGHAI CHILDRENS HOSP, MED GENET LAB, 380 KANG DING RD, SHANGHAI 200040, PEOPLES R CHINA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL029623] Funding Source: NIH RePORTER; NHLBI NIH HHS [HLB-29623] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAGLIONI C, 1962, BIOCHIM BIOPHYS ACTA, V59, P437, DOI 10.1016/0006-3002(62)90194-4; BRITTENHAM GM, 1987, HEMOGLOBIN VARIANTS, V2, P79; BUNN HF, 1977, HUMAN HEMOGLOBIN, V12, P225; FORGET BG, 1977, HEMOGLOBIN, V1, P879, DOI 10.3109/03630267709003915; HUANG SZ, 1988, SHANGHAI MED J, V11, P559; HUANG SZ, 1986, SHANGHAI MED J, V9, P346; ITANO HA, 1951, P NATL ACAD SCI USA, V37, P775, DOI 10.1073/pnas.37.12.775; Lehmann H, 1974, MANS HAEMOGLOBINS; LI H, 1987, Acta Genetica Sinica, V14, P225; LI HJ, 1986, HEMOGLOBIN, V10, P667, DOI 10.3109/03630268609036571; LI HJ, 1986, HEMOGLOBIN, V10, P435, DOI 10.3109/03630268608996875; MCCABE ERB, 1987, HUM GENET, V75, P213, DOI 10.1007/BF00281061; PHILLIPS JA, 1979, JOHNS HOPKINS MED J, V145, P57; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; ZENG YT, 1986, HEMOGLOBIN, V10, P87, DOI 10.3109/03630268609072474; ZENG YT, 1987, J MED GENET, V24, P578, DOI 10.1136/jmg.24.10.578; ZENG YT, 1984, ACTA BIOCH BIOPH SIN, V16, P270	18	28	31	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1989	44	6					886	889						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	U8549	2729278				2022-12-18	WOS:A1989U854900014
J	BERNHARDT, BA; PYERITZ, RE				BERNHARDT, BA; PYERITZ, RE			THE ECONOMICS OF CLINICAL GENETICS SERVICES .3. COGNITIVE GENETICS SERVICES ARE NOT SELF-SUPPORTING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHNS HOPKINS UNIV,DIV MED GENET,BALTIMORE,MD 21205	Johns Hopkins University			Pyeritz, Reed/A-1364-2010		PHS HHS [MCJ-241004] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BERENSON RA, 1987, ANN INTERN MED, V107, P929, DOI 10.7326/0003-4819-107-6-929; BERNHARDT BA, 1987, AM J HUM GENET, V41, P559; BERNHARDT BA, 1988, CHALLENGE PROVIDE GE, P83; COLLINS D, 1987, PERSPECT GENET COUNS, V9, P1; FINLEY WH, 1987, AM J HUM GENET, V40, P374; GREENSTEIN RM, 1988, CHALLENGE PROVIDE GE, P175; HOLTZMAN NA, 1988, AM J HUM GENET, V42, P624; IREYS HT, 1985, AM J PUBLIC HEALTH, V75, P375, DOI 10.2105/AJPH.75.4.375; KEELER EB, 1982, MED CARE, V20, P1101, DOI 10.1097/00005650-198211000-00005; MYERS TL, 1987, AM J MED GENET, V26, P521, DOI 10.1002/ajmg.1320260303; PYERITZ RE, 1987, AM J HUM GENET, V41, P549	11	28	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1989	44	2					288	293						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	R9705	2912071				2022-12-18	WOS:A1989R970500015
J	SHUTE, NCE; EWENS, WJ				SHUTE, NCE; EWENS, WJ			A RESOLUTION OF THE ASCERTAINMENT SAMPLING PROBLEM .3. PEDIGREES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MONASH UNIV, DEPT MATH, CLAYTON, VIC 3168, AUSTRALIA; UNIV PENN, DEPT BIOL, PHILADELPHIA, PA 19104 USA	Monash University; University of Pennsylvania								EWENS WJ, 1986, THEOR POPUL BIOL, V30, P388, DOI 10.1016/0040-5809(86)90042-0; EWENS WJ, 1986, ANN HUM GENET, V50, P399, DOI 10.1111/j.1469-1809.1986.tb01760.x; EWENS WJ, 1986, GENET EPIDEMIOL, P319; Fisher RA, 1934, ANN EUGENIC, V6, P13, DOI 10.1111/j.1469-1809.1934.tb02105.x; MORTON NE, 1984, HUMAN POPULATION GEN, P83; SHUTE NCE, 1988, AM J HUM GENET, V43, P374; SHUTE NCE, 1988, THESIS MONASH U MELB; WEINBERG W, 1928, Z INDUKIVE ABSTAMMUN, V48, P178	8	28	28	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1988	43	4					387	395						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q4736	3177381				2022-12-18	WOS:A1988Q473600004
J	JABS, EW; CARPENTER, N				JABS, EW; CARPENTER, N			MOLECULAR CYTOGENETIC EVIDENCE FOR AMPLIFICATION OF CHROMOSOME-SPECIFIC ALPHOID SEQUENCES AT ENLARGED C-BANDS ON CHROMOSOME-6	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,GENET UNIT,BALTIMORE,MD 21205; CHILDRENS MED CTR,H ALLEN CHAPMAN INST MED GENET,TULSA,OK	Johns Hopkins University				Jabs, Ethylin/0000-0001-8983-5466	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD022819] Funding Source: NIH RePORTER; NICHD NIH HHS [HD22819] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BABU A, 1986, AM J HUM GENET, V38, P549; BRUTLAG DL, 1980, ANNU REV GENET, V14, P121, DOI 10.1146/annurev.ge.14.120180.001005; CASPERSSON T, 1971, HEREDITAS-GENETISK A, V67, P89; CHERRY LM, 1987, HUM GENET, V75, P155, DOI 10.1007/BF00591078; CRAIGHOLMES AP, 1975, AM J HUM GENET, V27, P178; GOSDEN JR, 1981, CYTOGENET CELL GENET, V29, P32, DOI 10.1159/000131549; HULTEN MA, 1982, ANN HUM GENET, V46, P167, DOI 10.1111/j.1469-1809.1982.tb00707.x; JABS EW, 1986, AM J HUM GENET, V38, P297; JABS EW, 1984, P NATL ACAD SCI-BIOL, V81, P4884, DOI 10.1073/pnas.81.15.4884; JABS EW, 1987, AM J HUM GENET, V41, P374; JABS EW, 1984, SOMAT CELL MOLEC GEN, V10, P93, DOI 10.1007/BF01534476; Jacobs P A, 1977, Prog Med Genet, V2, P251; JACOBS PA, 1975, CLIN GENET, V8, P169; John B, 1979, Int Rev Cytol, V58, P1, DOI 10.1016/S0074-7696(08)61473-4; KURNIT DM, 1979, HUM GENET, V47, P169, DOI 10.1007/BF00273199; MADAN K, 1979, CLIN GENET, V15, P193; Maniatis T., 1982, MOL CLONING LABORATO, P86; MANUELIDIS L, 1978, CHROMOSOMA, V66, P1, DOI 10.1007/BF00285812; PAGE BM, 1973, CYTOGENET CELL GENET, V12, P254, DOI 10.1159/000130461; QUACK B, 1987, ANN GENET-PARIS, V30, P85; SCHMID M, 1983, CYTOGENET CELL GENET, V36, P554, DOI 10.1159/000131972; SINGER MF, 1982, INT REV CYTOL, V76, P67, DOI 10.1016/S0074-7696(08)61789-1; SUMMER A T, 1972, Experimental Cell Research, V75, P304; WILLARD HF, 1986, P NATL ACAD SCI USA, V83, P5611, DOI 10.1073/pnas.83.15.5611; YUNIS JJ, 1978, CHROMOSOMA, V67, P293, DOI 10.1007/BF00285963; YUNIS JJ, 1977, PROGR CLIN PATHOL, V7, P267; YUROV YB, 1987, HUM GENET, V76, P157, DOI 10.1007/BF00284914	27	28	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1988	43	1					69	74						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N9863	3163891				2022-12-18	WOS:A1988N986300010
J	TRENT, RJ; BUCHANAN, JG; WEBB, A; GOUNDAR, RPS; SERUVATU, LM; MICKLESON, KNP				TRENT, RJ; BUCHANAN, JG; WEBB, A; GOUNDAR, RPS; SERUVATU, LM; MICKLESON, KNP			GLOBIN GENES ARE USEFUL MARKERS TO IDENTIFY GENETIC SIMILARITIES BETWEEN FIJIANS AND PACIFIC ISLANDERS FROM POLYNESIA AND MELANESIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV AUCKLAND,DEPT IMMUNOBIOL,AUCKLAND,NEW ZEALAND; MIDDLEMORE HOSP,DEPT NEONATAL PAEDIAT,AUCKLAND 6,NEW ZEALAND; COLONIAL WAR MEM HOSP,PATHOL LAB,SUVA,FIJI; LAUTOKA HOSP,PATHOL LAB,LAUTOKA,FIJI	University of Auckland	TRENT, RJ (corresponding author), UNIV SYDNEY,CLIN IMMUNOL RES CTR,MOLEC BIOL LAB,SYDNEY,NSW 2006,AUSTRALIA.							[Anonymous], 1980, ESSENTIAL MALARIOLOG; ANTONARAKIS SE, 1985, HUM GENET, V69, P1, DOI 10.1007/BF00295521; Bellwood P., 1978, MANS CONQUEST PACIFI; Bellwood P, 1978, POLYNESIANS PREHISTO; BOWDEN DK, 1987, J CLIN INVEST, V79, P39, DOI 10.1172/JCI112804; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; FLINT J, 1986, NATURE, V321, P744, DOI 10.1038/321744a0; GOOSSENS M, 1980, P NATL ACAD SCI-BIOL, V77, P518, DOI 10.1073/pnas.77.1.518; GROSSBELLARD M, 1973, EUR J BIOCHEM, V36, P21; HARANO K, 1985, FEBS LETT, V190, P45, DOI 10.1016/0014-5793(85)80424-5; Higgs D R, 1983, Curr Top Hematol, V4, P37; HIGGS DR, 1986, P NATL ACAD SCI USA, V83, P5165, DOI 10.1073/pnas.83.14.5165; HIGGS DR, 1984, NUCLEIC ACIDS RES, V12, P6965, DOI 10.1093/nar/12.18.6965; HILL AVS, 1987, AM J HUM GENET, V40, P453; HILL AVS, 1985, AM J HUM GENET, V37, P571; HILL AVS, 1986, BLOOD, V67, P1611; JAGADEESWARAN P, 1982, NATURE, V296, P469, DOI 10.1038/296469a0; JEFFREYS AJ, 1981, GENETIC ENG, V2, P1; MORTON CC, 1984, AM J HUM GENET, V36, P576; NICHOLLS RD, 1987, CELL, V49, P369, DOI 10.1016/0092-8674(87)90289-3; Old JM., 1983, METHODS HEMATOLOGY T, V6, P74; SERJEANTSON SW, 1982, AM J HUM GENET, V34, P904; SUKUMARAN PK, 1983, NUCLEIC ACIDS RES, V11, P4635; TRENT RJ, 1986, AM J HUM GENET, V39, P350; TRENT RJ, 1981, NUCLEIC ACIDS RES, V9, P6723, DOI 10.1093/nar/9.24.6723; WINICHAGOON P, 1982, NUCLEIC ACIDS RES, V10, P5853, DOI 10.1093/nar/10.19.5853; YENCHITSOMANUS P, 1986, HUM GENET, V74, P432, DOI 10.1007/BF00280500	27	28	29	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1988	42	4					601	607						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M6316	2894762				2022-12-18	WOS:A1988M631600011
J	STEWART, GD; HASSOLD, TJ; BERG, A; WATKINS, P; TANZI, R; KURNIT, DM				STEWART, GD; HASSOLD, TJ; BERG, A; WATKINS, P; TANZI, R; KURNIT, DM			TRISOMY-21 (DOWN SYNDROME) - STUDYING NONDISJUNCTION AND MEIOTIC RECOMBINATION BY USING CYTOGENETIC AND MOLECULAR POLYMORPHISMS THAT SPAN CHROMOSOME-21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CORNELL UNIV,SCH MED,DEPT PEDIAT,NEW YORK,NY 10021; CHILDRENS HOSP MED CTR,DIV GENET,BOSTON,MA 02115; INTEGRATED GENET INC,FRAMINGHAM,MA	Cornell University; Harvard University; Boston Children's Hospital	STEWART, GD (corresponding author), UNIV MICHIGAN,MED CTR,HOWARD HUGHES MED INST,1150 W MED CTR DR,MSRB I,ROOM 3520,ANN ARBOR,MI 48109, USA.		Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454	NHLBI NIH HHS [R01 HL 37703] Funding Source: Medline; NICHD NIH HHS [R01 HD20118, HD21341] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020118, R01HD021341] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL037703] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANTONARAKIS SE, 1986, COLD SPRING HARB SYM, V51, P185, DOI 10.1101/SQB.1986.051.01.022; AYME S, 1982, AM J HUM GENET, V39, P558; AYME S, 1986, 7TH INT C HUM GEN 1; BIDDLE F G, 1986, American Journal of Human Genetics, V39, pA104; BOTT CE, 1975, AM J HUM GENET, V27, pA20; CAROTHERS AD, 1987, AM J HUM GENET, V40, P147; DAVIES KE, 1984, HUM GENET, V66, P54, DOI 10.1007/BF00275186; DEGAU J, 1978, AM J HUM GENET, V30, pA78; DELMAZO J, 1982, HUM GENET, V62, P316, DOI 10.1007/BF00304546; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HANSSON A, 1978, CYTOGENET CELL GENET, V20, P194, DOI 10.1159/000130851; HASSOLD T, 1980, ANN HUM GENET, V44, P151, DOI 10.1111/j.1469-1809.1980.tb00955.x; HASSOLD T, 1987, HUM GENET, V76, P381, DOI 10.1007/BF00272449; HASSOLD T, 1984, ANN HUM GENET, V48, P129, DOI 10.1111/j.1469-1809.1984.tb01008.x; HASSOLD T, 1980, ANN HUM GENET, V44, P19; HENDERSON SA, 1968, NATURE, V218, P22, DOI 10.1038/218022a0; HOOK EB, 1983, AM J HUM GENET, V35, P1307; HOUGHTON JA, 1981, IRISH J MED SCI, V150, P357, DOI 10.1007/BF02938274; JACOBS PA, 1981, ANN HUM GENET, V45, P49; JAGIELLO G, 1979, CYTOGENET CELL GENET, V23, P53, DOI 10.1159/000131302; John B, 1979, Int Rev Cytol, V58, P1, DOI 10.1016/S0074-7696(08)61473-4; JUBERG RC, 1983, AM J MED GENET, V16, P111, DOI 10.1002/ajmg.1320160117; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1249; KURNIT DM, 1979, HUM GENET, V47, P169, DOI 10.1007/BF00273199; KURNIT DM, 1986, CYTOGENET CELL GENET, V43, P109, DOI 10.1159/000132305; KURNIT DM, 1984, CYTOGENET CELL GENET, V38, P99, DOI 10.1159/000132039; LAURIE DA, 1985, ANN HUM GENET, V49, P189, DOI 10.1111/j.1469-1809.1985.tb01693.x; LIEMANHURWITZ J, 1982, P NATL ACAD SCI-BIOL, V79, P2808, DOI 10.1073/pnas.79.9.2808; LUTHARDT FW, 1973, CYTOGENET CELL GENET, V12, P68, DOI 10.1159/000130440; LUTHARDT FW, 1977, AM J HUM GENET, V29, pA71; MAGENIS RE, 1977, HUM GENET, V37, P7, DOI 10.1007/BF00293766; MATTEI JF, 1980, J MED GENET, V17, P368, DOI 10.1136/jmg.17.5.368; MIKKELSEN M, 1980, ANN HUM GENET, V44, P17, DOI 10.1111/j.1469-1809.1980.tb00942.x; NEVE RL, 1983, GENE, V23, P343, DOI 10.1016/0378-1119(83)90023-9; NEVE RL, 1983, GENE, V23, P355, DOI 10.1016/0378-1119(83)90024-0; NEVE RL, 1986, GENE, V49, P361, DOI 10.1016/0378-1119(86)90372-0; Penrose LS, 1933, J GENET, V27, P219, DOI 10.1007/BF02984413; POLANI PE, 1976, CYTOGENET CELL GENET, V16, P505, DOI 10.1159/000130668; ROBERTS DF, 1980, J MED GENET, V39, P68; SEED B, 1983, NUCLEIC ACIDS RES, V11, P2427, DOI 10.1093/nar/11.8.2427; SPEED RM, 1977, CHROMOSOMA, V64, P241, DOI 10.1007/BF00328080; SPEED RM, 1983, CHROMOSOMA, V88, P184, DOI 10.1007/BF00285618; STEIN Z, 1986, LANCET, V1, P944; STEWART GD, 1985, NUCLEIC ACIDS RES, V13, P4125, DOI 10.1093/nar/13.11.4125; STEWART GD, 1984, THESIS U GLASGOW; SUGAWARA S, 1983, CYTOGENET CELL GENET, V35, P34, DOI 10.1159/000131833; TANZI RE, UNPUB GENETIC LINKAG, V21; VANKEUREN ML, 1986, AM J HUM GENET, V38, P793; VEKEMANS M, 1985, American Journal of Human Genetics, V37, pA128; WAGENBICHLER P, 1976, HUM GENET, V32, P13, DOI 10.1007/BF00569971; WATKINS PC, 1985, NUCLEIC ACIDS RES, V13, P6075, DOI 10.1093/nar/13.17.6075	51	28	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1988	42	2					227	236						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M3133	2893544				2022-12-18	WOS:A1988M313300003
J	AZEN, EA; KIM, HS; GOODMAN, P; FLYNN, S; MAEDA, N				AZEN, EA; KIM, HS; GOODMAN, P; FLYNN, S; MAEDA, N			ALLELES AT THE PRH1 LOCUS CODING FOR THE HUMAN SALIVARY-ACIDIC PROLINE-RICH PROTEINS PA,DB, AND PIF	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WISCONSIN,GENET LAB,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison	AZEN, EA (corresponding author), UNIV WISCONSIN,DEPT MED,214 GENET BLDG,MADISON,WI 53706, USA.				NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE003658, R01DE003658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020069, R37GM020069] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE03658-22] Funding Source: Medline; NIGMS NIH HHS [GM20069] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AZEN E, 1984, P NATL ACAD SCI-BIOL, V81, P5561, DOI 10.1073/pnas.81.17.5561; AZEN EA, 1985, AM J HUM GENET, V37, P418; AZEN EA, 1977, BIOCHEM GENET, V15, P9, DOI 10.1007/BF00484545; AZEN EA, 1981, BIOCHEM GENET, V19, P475, DOI 10.1007/BF00484620; AZEN EA, 1978, BIOCHEM GENET, V16, P79, DOI 10.1007/BF00484386; AZEN EA, 1974, BIOCHEM GENET, V12, P109, DOI 10.1007/BF00487820; AZEN EA, IN PRESS CLIN CHEM H; BENNICK A, 1982, MOL CELL BIOCHEM, V45, P83; BLATTNER FR, 1977, SCIENCE, V196, P161, DOI 10.1126/science.847462; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FRIEDMAN RD, 1975, AM J HUM GENET, V27, P304; GOODMAN PA, 1985, AM J HUM GENET, V37, P785; Hoogendoorn H, 1985, LACTOPEROXIDASE SYST, P217; KIM HS, 1986, J BIOL CHEM, V261, P6712; LOENEN WAM, 1983, GENE, V26, P171, DOI 10.1016/0378-1119(83)90187-7; LYONS K M, 1985, Genetics, V110, pS31; MAEDA N, 1985, J BIOL CHEM, V260, P1123; MAEDA N, 1985, BIOCHEM GENET, V23, P455, DOI 10.1007/BF00499086; MAMULA PW, 1985, CYTOGENET CELL GENET, V39, P279, DOI 10.1159/000132158; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; SLIGHTOM JL, 1980, CELL, V21, P627, DOI 10.1016/0092-8674(80)90426-2; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; VANIN EF, 1983, CELL, V35, P701, DOI 10.1016/0092-8674(83)90103-4; WONG RSC, 1980, J BIOL CHEM, V255, P5943; WONG RSC, 1983, BIOCHEM J, V211, P35, DOI 10.1042/bj2110035; YU PI, 1986, GENET EPIDEMIOL, V3, P147, DOI 10.1002/gepi.1370030302	26	28	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1987	41	6					1035	1047						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L2984	3687941				2022-12-18	WOS:A1987L298400007
J	PETROVABENEDICT, R; ROBINSON, BH; STACEY, TE; MISTRY, J; CHALMERS, RA				PETROVABENEDICT, R; ROBINSON, BH; STACEY, TE; MISTRY, J; CHALMERS, RA			DEFICIENT FUMARASE ACTIVITY IN AN INFANT WITH FUMARICACIDEMIA AND ITS DISTRIBUTION BETWEEN THE DIFFERENT FORMS OF THE ENZYME SEEN ON ISOELECTRIC-FOCUSING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TORONTO,DEPT PEDIAT & BIOCHEM,TORONTO M5S 1A1,ONTARIO,CANADA; HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ONTARIO,CANADA; CLIN RES CTR,DIV INHERITED METAB DIS,HARROW HA1 3UJ,MIDDX,ENGLAND	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)								CHALMERS RA, IN PRESS J INHERITED; EDWARDS YH, 1979, ANN HUM GENET, V43, P103, DOI 10.1111/j.1469-1809.1979.tb02002.x; EDWARDS YH, 1979, ANN HUM GENET, V42, P303, DOI 10.1111/j.1469-1809.1979.tb00664.x; FREIDEN C, 1954, J AM CHEM SOC, V76, P2482; Hill R. L., 1971, ENZYMES, V5, P539; KOBAYASHI K, 1981, J BIOCHEM, V89, P1923, DOI 10.1093/oxfordjournals.jbchem.a133394; OHARE MC, 1985, BIOCHIM BIOPHYS ACTA, V827, P127, DOI 10.1016/0167-4838(85)90080-9; ONO H, 1985, J BIOL CHEM, V260, P3402; OSBORN M, 1977, EXP CELL RES, V106, P339, DOI 10.1016/0014-4827(77)90179-3; TOLLEY E, 1975, BIOCHEM GENET, V13, P867, DOI 10.1007/BF00484417; VESTERBERG O, 1972, BIOCHIM BIOPHYS ACTA, V257, P11, DOI 10.1016/0005-2795(72)90248-6; WAH AMLH, 1983, AM J HUM GENET, V35, P889; WHELAN DT, 1983, CLIN CHIM ACTA, V132, P301, DOI 10.1016/0009-8981(83)90008-6	13	28	28	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1987	40	3					257	266						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	H0854	3578275				2022-12-18	WOS:A1987H085400006
J	WANG, HS; GREENBERG, CR; HEWITT, J; KALOUSEK, D; HAYDEN, MR				WANG, HS; GREENBERG, CR; HEWITT, J; KALOUSEK, D; HAYDEN, MR			SUBREGIONAL ASSIGNMENT OF THE LINKED MARKER G8 (D4S10) FOR HUNTINGTON DISEASE TO CHROMOSOME 4P16.1-16.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV BRITISH COLUMBIA,DEPT MED GENET,VANCOUVER V6T 1W5,BC,CANADA; UNIV MANITOBA,DEPT HUMAN GENET,WINNIPEG R3T 2N2,MANITOBA,CANADA; UNIV MANITOBA,DEPT PEDIAT,WINNIPEG R3T 2N2,MANITOBA,CANADA; UNIV BRITISH COLUMBIA,DEPT INTERNAL MED,VANCOUVER V6T 1W5,BC,CANADA; UNIV BRITISH COLUMBIA,DEPT PATHOL,VANCOUVER V6T 1W5,BC,CANADA	University of British Columbia; University of Manitoba; University of Manitoba; University of British Columbia; University of British Columbia			Hayden, Michael R/D-8581-2011	Hayden, Michael R/0000-0001-5159-1419				GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; GUSELLA JF, 1984, SCIENCE, V225, P1320, DOI 10.1126/science.6089346; GUSELLA JF, 1985, NATURE, V318, P75, DOI 10.1038/318075a0; Hayden MR., 1981, HUNTINGTONS CHOREA, P45; MAGENIS E, 1985, CYTOGENET CELL GENET, V40, P685; RAY M, 1984, J MED GENET, V21, P223, DOI 10.1136/jmg.21.3.223; ZABEL BU, 1985, CYTOGENET CELL GENET, V40, P787	7	28	28	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1986	39	3					392	396						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	E3644	2945429				2022-12-18	WOS:A1986E364400011
J	FOX, JE; HACK, AM; FENTON, WA; ROSENBERG, LE				FOX, JE; HACK, AM; FENTON, WA; ROSENBERG, LE			IDENTIFICATION AND APPLICATION OF ADDITIONAL RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISMS AT THE HUMAN ORNITHINE TRANSCARBAMYLASE LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											FOX, JE (corresponding author), YALE UNIV,SCH MED,DEPT HUMAN GENET,333 CEDAR ST,POB 3333,NEW HAVEN,CT 06510, USA.				NIGMS NIH HHS [GM-07439, GM-32156] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM032156] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BATSHAW ML, 1981, JOHNS HOPKINS MED J, V148, P34; BATSHAW ML, 1980, NEW ENGL J MED, V302, P482, DOI 10.1056/NEJM198002283020902; BATSHAW ML, 1982, NEW ENGL J MED, V306, P1387, DOI 10.1056/NEJM198206103062303; BRUSILOW SW, 1984, NEW ENGL J MED, V310, P1630, DOI 10.1056/NEJM198406213102503; GEEVER RF, 1981, P NATL ACAD SCI-BIOL, V78, P5081, DOI 10.1073/pnas.78.8.5081; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; HOKANSON JT, 1978, J PEDIATR-US, V93, P75, DOI 10.1016/S0022-3476(78)80606-4; HOLZGREVE W, 1984, AM J HUM GENET, V36, P320; HORWICH AL, 1984, SCIENCE, V224, P1068, DOI 10.1126/science.6372096; HORWICH AL, 1983, P NATL ACAD SCI-BIOL, V80, P4258, DOI 10.1073/pnas.80.14.4258; KUNKEL LM, 1982, NUCLEIC ACIDS RES, V10, P1557, DOI 10.1093/nar/10.5.1557; MSALL M, 1984, NEW ENGL J MED, V310, P1500, DOI 10.1056/NEJM198406073102304; RICCIUTI FC, 1976, AM J HUM GENET, V28, P332; RODECK CH, 1982, LANCET, V2, P297; ROZEN R, 1985, NATURE, V313, P815, DOI 10.1038/313815a0; SHORT EM, 1973, NEW ENGL J MED, V288, P7, DOI 10.1056/NEJM197301042880102; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WALSER M, 1983, METABOLIC BASIS INHE, P402	18	28	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1986	38	6					841	847						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D3922	3014867				2022-12-18	WOS:A1986D392200006
J	YU, MT; CHIH, YY; YU, CX; MAIDMAN, J; WARBURTON, D				YU, MT; CHIH, YY; YU, CX; MAIDMAN, J; WARBURTON, D			IMPROVED METHODS OF DIRECT AND CULTURED CHROMOSOME PREPARATIONS FROM CHORIONIC VILLOUS SAMPLES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note									PRESBYTERIAN HOSP,NEW YORK,NY 10032; COLUMBIA UNIV,DEPT HUMAN GENET & DEV,NEW YORK,NY 10027; COLUMBIA UNIV,DEPT OBSTET & GYNECOL,NEW YORK,NY 10027; COLUMBIA UNIV,DEPT PEDIAT,NEW YORK,NY 10027	NewYork-Presbyterian Hospital; Columbia University; Columbia University; Columbia University	YU, MT (corresponding author), NEW YORK STATE PSYCHIAT INST,RES FDN MENTAL HYG,NEW YORK,NY 10032, USA.							BLAKEMORE KJ, 1985, HUM GENET, V69, P380, DOI 10.1007/BF00291660; GREGSON NM, 1983, LANCET, V2, P1491; SIMONI G, 1983, HUM GENET, V63, P349, DOI 10.1007/BF00274761; SUN NC, 1974, CARYOLOGIA, V27, P315, DOI 10.1080/00087114.1974.10796584	4	28	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1986	38	4					576	581						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	C4893	3706303				2022-12-18	WOS:A1986C489300018
J	DELACHAPELLE, A; PAGE, DC; BROWN, L; KASKI, U; PARVINEN, T; TIPPETT, PA				DELACHAPELLE, A; PAGE, DC; BROWN, L; KASKI, U; PARVINEN, T; TIPPETT, PA			THE ORIGIN OF 45,X MALES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TURKU, CENT HOSP, DEPT PEDIAT SURG, SF-20520 TURKU 52, FINLAND; MRC, BLOOD GRP UNIT, LONDON WC1E 6AS, ENGLAND; WHITEHEAD INST, CAMBRIDGE, MA USA; ETELA POHJANMAA CENT HOSP, DEPT PEDIAT, SEINAJOKI, FINLAND	University of Turku; Massachusetts Institute of Technology (MIT); Whitehead Institute	DELACHAPELLE, A (corresponding author), UNIV HELSINKI, DEPT MED GENET, SF-00100 HELSINKI 10, FINLAND.							ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; BISHOP C, 1984, J MOL BIOL, V173, P403, DOI 10.1016/0022-2836(84)90388-7; BOSTOCK CJ, 1978, NATURE, V272, P324, DOI 10.1038/272324a0; BURGOYNE P, 1984, NATURE, V307, P109, DOI 10.1038/307109a0; CURTO FL, 1974, AM J DIS CHILD, V128, P90, DOI 10.1001/archpedi.1974.02110260092018; DAVIES KE, 1983, NUCLEIC ACIDS RES, V11, P2303, DOI 10.1093/nar/11.8.2303; DELACHAPELLE A, 1984, NATURE, V307, P170, DOI 10.1038/307170a0; DELACHAPELLE A, 1981, HUM GENET, V58, P105, DOI 10.1007/BF00284157; DRAYNA D, 1984, P NATL ACAD SCI-BIOL, V81, P2836, DOI 10.1073/pnas.81.9.2836; FERGUSONSMITH MA, 1966, LANCET, V2, P475; FORABOSCO A, 1977, CLIN GENET, V12, P97; FORABOSCO A, 1978, LANCET, V2, P313; FRACCARO M, 1966, ANN HUM GENET, V29, P281, DOI 10.1111/j.1469-1809.1966.tb00523.x; GUELLAEN G, 1984, NATURE, V307, P172, DOI 10.1038/307172a0; KOO GC, 1976, CYTOGENET CELL GENET, V16, P175, DOI 10.1159/000130583; KUNKEL LM, 1983, NUCLEIC ACIDS RES, V11, P7961, DOI 10.1093/nar/11.22.7961; LAU YF, 1984, LANCET, V1, P14; MCKAY RDG, 1978, CYTOGENET CELL GENET, V21, P19, DOI 10.1159/000130875; MURRAY JM, 1982, NATURE, V300, P69, DOI 10.1038/300069a0; PAGE D, 1982, P NATL ACAD SCI-BIOL, V79, P5352, DOI 10.1073/pnas.79.17.5352; PAGE DC, 1984, AM J HUM GENET, V36, P565; PAGE DC, 1985, NATURE, V315, P224, DOI 10.1038/315224a0; SCHMIDTKE J, 1980, HUM GENET, V55, P255, DOI 10.1007/BF00291774; TOLKSDORF M, 1980, EUR J PEDIATR, V133, P293, DOI 10.1007/BF00496093; TURLEAU C, 1980, HUM GENET, V53, P299, DOI 10.1007/BF00287044; VERGNAUD G, 1986, AM J HUM GENET, V38, P109	26	28	28	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1986	38	3					330	340						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	A5781	3006482				2022-12-18	WOS:A1986A578100007
J	HIRSCHHORN, R; ELLENBOGEN, A				HIRSCHHORN, R; ELLENBOGEN, A			GENETIC-HETEROGENEITY IN ADENOSINE-DEAMINASE (ADA) DEFICIENCY - 5 DIFFERENT MUTATIONS IN 5 NEW PATIENTS WITH PARTIAL ADA DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											HIRSCHHORN, R (corresponding author), NYU,SCH MED,DEPT MED,550 1ST AVE,NEW YORK,NY 10016, USA.				PHS HHS [10343] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AMMAN AJ, 1983, MARCH DIMES BIRTH DE, V19, P117; BORKOWSKY W, 1980, PEDIATR RES, V14, P885, DOI 10.1203/00006450-198014070-00009; COHEN A, 1978, P NATL ACAD SCI USA, V75, P472, DOI 10.1073/pnas.75.1.472; DADDONA PE, 1983, J CLIN INVEST, V72, P483, DOI 10.1172/JCI110996; GIBLETT ER, 1972, LANCET, V2, P1067; HERSHFIELD MS, 1983, METABOLIC BASIS INHE, P1157; HIRSCHHORN R, 1979, J CLIN INVEST, V64, P1130, DOI 10.1172/JCI109552; HIRSCHHORN R, 1982, PEDIATR RES, V16, P362, DOI 10.1203/00006450-198205000-00009; HIRSCHHORN R, 1983, J CLIN INVEST, V71, P1887, DOI 10.1172/JCI110944; HIRSCHHORN R, 1980, J CLIN INVEST, V65, P768, DOI 10.1172/JCI109725; HIRSCHHORN R, 1978, NATURE NEW BIOL, V246, P200; HIRSCHHORN R, 1979, CIBA F S, V68, P209; HOPKINSON DA, 1969, ANN HUM GENET, V32, P361, DOI 10.1111/j.1469-1809.1969.tb00087.x; JENKINS T, 1973, LANCET, V2, P736; JENKINS T, 1976, J PEDIATR-US, V89, P732, DOI 10.1016/S0022-3476(76)80792-5; JENKINS T, 1979, ANN HUM GENET, V42, P425, DOI 10.1111/j.1469-1809.1979.tb00676.x; OSBORNE WRA, 1973, BIOCHEM J, V133, P117, DOI 10.1042/bj1330117; PERIGNON J, 1979, J CLIN CHEM CLIN BIO, V17, P406; POLLARA B, 1979, INBORN ERRORS SPECIF; SPENCER N, 1968, ANN HUM GENET, V32, P9, DOI 10.1111/j.1469-1809.1968.tb00044.x	20	28	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1986	38	1					13	25						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AYP17	3946419				2022-12-18	WOS:A1986AYP1700002
J	AZEN, EA; GOODMAN, PA; LALLEY, PA				AZEN, EA; GOODMAN, PA; LALLEY, PA			HUMAN SALIVARY PROLINE-RICH PROTEIN GENES ON CHROMOSOME-12	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note									UNIV WISCONSIN,DEPT MED GENET,MADISON,WI 53706; OAK RIDGE NATL LAB,DIV BIOL,OAK RIDGE,TN 37830	University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); Oak Ridge National Laboratory	AZEN, EA (corresponding author), UNIV WISCONSIN,DEPT MED,MADISON,WI 53706, USA.				NIDCR NIH HHS [DEO-3658-19] Funding Source: Medline; NIGMS NIH HHS [GM-20069] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE003658, R37DE003658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020069, R37GM020069] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AZEN EA, 1984, BIOCHEM GENET, V22, P1065, DOI 10.1007/BF00499632; AZEN EA, 1984, BIOCHEM GENET, V22, P1, DOI 10.1007/BF00499283; AZEN EA, 1984, SCIENCE, V226, P967, DOI 10.1126/science.6095444; AZEN EA, 1984, P NATL ACAD SCI US, V91, P5571; BALAZS I, 1984, HUM GENET, V68, P57, DOI 10.1007/BF00293873; BENNETT KL, 1982, P NATL ACAD SCI-BIOL, V79, P1220, DOI 10.1073/pnas.79.4.1220; BENNICK A, 1982, MOL CELL BIOCHEM, V45, P83; GERALD PS, 1984, CYTOGENET CELL GENET, V37, P103, DOI 10.1159/000132006; GOODFELLOW PN, 1984, CYTOGENET CELL GENET, V37, P481; GOODMAN PA, 1982, AM J HUM GENET, V34, pA182; GOODMAN PA, UNPUB HUMAN SALIVARY; KAUFFMAN D, 1982, BIOCHEMISTRY-US, V21, P6558, DOI 10.1021/bi00268a036; LALLEY PA, 1982, CYTOGENET CELL GENET, V32, P293; LALLEY PA, 1978, NATURE, V274, P160, DOI 10.1038/274160a0; LALLEY PA, 1974, P NATL ACAD SCI USA, V71, P1569, DOI 10.1073/pnas.71.4.1569; MANIATIS T, 1980, ANNU REV GENET, V14, P145, DOI 10.1146/annurev.ge.14.120180.001045; MINNA JD, 1976, IN VITRO CELL DEV B, V12, P726, DOI 10.1007/BF02835447; NADEAU JH, 1984, P NATL ACAD SCI-BIOL, V81, P814, DOI 10.1073/pnas.81.3.814; SHIMOMURA H, 1983, J BIOCHEM-TOKYO, V93, P857, DOI 10.1093/jb/93.3.857; SHOWS TB, 1982, ADV HUM GENET, V12, P341; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; VANIN EF, 1983, CELL, V35, P701, DOI 10.1016/0092-8674(83)90103-4; WARNER TF, 1984, AM REV RESPIR DIS, V130, P115; WONG RSC, 1980, J BIOL CHEM, V255, P5943; YU PL, 1980, AM J HUM GENET, V32, P555	26	28	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	2					418	424						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AGY59	2984928				2022-12-18	WOS:A1985AGY5900015
J	JAGIELLO, GM; FANG, JS				JAGIELLO, GM; FANG, JS			COMPLETE AUTOSOMAL CHROMOMERE MAPS OF HUMAN EARLY AND MID LATE PACHYTENE SPERMATOCYTES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									COLUMBIA UNIV COLL PHYS & SURG,INT INST STUDY HUMAN REPROD,CTR REPROD SCI,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT OBSTET & GYNECOL,NEW YORK,NY 10032	Columbia University; Columbia University	JAGIELLO, GM (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,DEPT HUMAN GENET & DEV,NEW YORK,NY 10032, USA.				NICHD NIH HHS [5R01-HD-05862, 5R01-HD-10037, 5P50-HD-05077] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD005077, R01HD010037] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BOBROW M, 1972, NATURE-NEW BIOL, V238, P122, DOI 10.1038/newbio238122a0; BORDJADZE VK, 1971, CYTOGENETICS, V10, P38, DOI 10.1159/000130125; BURDICK AB, 1974, CAN J GENET CYTOL, V16, P481, DOI 10.1139/g74-054; DETORRES ML, 1978, HUM GENET, V42, P283; DUBIN L, 1977, MALE INFERTILITY, P159; FERGUSON-SMITH M. A., 1964, CYTOGENETICS, V3, P124, DOI 10.1159/000129803; FORD L, 1968, NUCLEUS, V11, P83; FRANCKE U, 1978, HUM GENET, V45, P137, DOI 10.1007/BF00286957; GAGNE R, 1974, EXP CELL RES, V85, P111, DOI 10.1016/0014-4827(74)90219-5; HUNGERFORD DA, 1971, ANN GENET-PARIS, V14, P257; HUNGERFORD DA, 1979, HUM GENET, V52, P153; HUNGERFORD DA, 1980, CYTOGENET CELL GENET, V27, P197, DOI 10.1159/000131484; HUNGERFORD DA, 1971, CYTOGENETICS, V10, P33, DOI 10.1159/000130124; HUNGERFORD DA, 1978, CYTOGENET CELL GENET, V21, P212, DOI 10.1159/000130898; LUCIANI JM, 1975, CHROMOSOMA, V52, P275, DOI 10.1007/BF00332116; PAGE BM, 1973, CYTOGENET CELL GENET, V12, P254, DOI 10.1159/000130461; RASMUSSEN SW, 1978, CARLSBERG RES COMMUN, V43, P275, DOI 10.1007/BF02906106; SCHULTZ JACK, 1949, JOUR HEREDITY, V40, P31; YERGANIAN G, 1957, AM J HUM GENET, V9, P42; YUNIS JJ, 1980, CANCER GENET CYTOGEN, V2, P221, DOI 10.1016/0165-4608(80)90029-1; 1978, BIRTH DEFECTS ORIG A, V14	21	28	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	1					112	124						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ585	7081213				2022-12-18	WOS:A1982MZ58500009
J	LEON, PE; BONILLA, JA; SANCHEZ, JR; VANEGAS, R; VILLALOBOS, M; TORRES, L; LEON, F; HOWELL, AL; RODRIGUEZ, JA				LEON, PE; BONILLA, JA; SANCHEZ, JR; VANEGAS, R; VILLALOBOS, M; TORRES, L; LEON, F; HOWELL, AL; RODRIGUEZ, JA			LOW-FREQUENCY HEREDITARY DEAFNESS IN MAN WITH CHILDHOOD ONSET	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV COSTA RICA,SCH MED,SAN JOSE,COSTA RICA; ESCUELA ENSENANZA ESPECIAL FERNANDO CENTENO GUELL,SAN JOSE,COSTA RICA	Universidad Costa Rica	LEON, PE (corresponding author), UNIV COSTA RICA,CTR INVEST BIOL CELULAR & MOLEC,SAN JOSE,COSTA RICA.							Bruneaud D, 1975, JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac, V24, P301; DEOL MS, 1973, J MED GENET, V10, P235, DOI 10.1136/jmg.10.3.235; FRASER G R, 1971, Birth Defects Original Article Series, V7, P52; GOODENOUGH U, 1975, GENETICS; ILINUMA T, 1967, ARCH OTOLARYNGOL, V86, P110; KONIGSMARK B W, 1971, Birth Defects Original Article Series, V7, P2; KONIGSMARK BW, 1969, NEW ENGL J MED, V281, P713, DOI 10.1056/NEJM196909252811306; KONIGSMARK BW, 1971, LARYNGOSCOPE, V81, P759, DOI 10.1288/00005537-197105000-00017; KONIGSMARK BW, 1969, NEW ENGL J MED, V281, P774, DOI 10.1056/NEJM196910022811407; KONIGSMARK BW, 1969, NEW ENGL J MED, V281, P827, DOI 10.1056/NEJM196910092811506; Makino S, 1975, HUMAN CHROMOSOMES; MAKISHIMA K, 1975, ARCH OTOLARYNGOL, V101, P600; NANCE WE, 1975, OTOLARYNG CLIN N AM, V8, P19; PARVING A, 1978, ACTA OTO-LARYNGOL, V85, P184, DOI 10.3109/00016487809121440; RITTER FRANK N., 1960, LARYNGOSCOPE, V70, P393; Schuknecht H.F., 1974, PATHOLOGY EAR; SUGA F, 1976, J LARYNGOL OTOL, V90, P667, DOI 10.1017/S0022215100082566; TAYLOR IG, 1975, J LARYNGOL OTOL, V89, P899, DOI 10.1017/S0022215100081184; 1968, ARCH OTOLARYNGOL, V88, P242	19	28	29	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	2					209	214						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LH910	7211837				2022-12-18	WOS:A1981LH91000007
J	SALMON, DB; BROCTEUR, J				SALMON, DB; BROCTEUR, J			PROBABILITY OF PATERNITY EXCLUSION WHEN RELATIVES ARE INVOLVED	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV LIEGE,GROUPES SANGUINS & TRANSFUS LAB,B-4000 LIEGE,BELGIUM	University of Liege	SALMON, DB (corresponding author), METHODOL INFORMAT & STAT MED,91 BLVD HOPITAL,F-75634 PARIS 13,FRANCE.							CAMPBELL MA, 1971, ANN HUM GENET, V35, P225, DOI 10.1111/j.1469-1809.1956.tb01395.x; CHAKRABO.R, 1974, AM J HUM GENET, V26, P477; LI CC, 1954, BIOMETRICS, V10, P347, DOI 10.2307/3001590; LI CC, 1976, 1ST COURSE POPULATIO; MACLEAN CJ, 1973, ANN HUM GENET, V36, P323, DOI 10.1111/j.1469-1809.1973.tb00594.x; MEULDERS MT, 1973, ANN DROIT, V33, P285; SALMON C, 1974, MEDECINE LEGALE; SALMON D, 1976, CR ACAD SCI D NAT, V283, P1609; SALMON D, 1976, AM J HUM GENET, V28, P622; SALMON D, 1977, THESIS U PARIS	10	28	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	1					65	75						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EL575	623104				2022-12-18	WOS:A1978EL57500008
J	DREYFUS, JC; POENARU, L; VIBERT, M; RAVISE, N; BOUE, J				DREYFUS, JC; POENARU, L; VIBERT, M; RAVISE, N; BOUE, J			CHARACTERIZATION OF A VARIANT OF BETA-HEXOSAMINIDASE - HEXOSAMINIDASE PARIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV PARIS 5,INST PATHOL MOLEC,INSERM,UNITE 129,CNRS,LAB 85,F-75014 PARIS,FRANCE; INSERM,UNITE 73,F-75016 PARIS,FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)								BEUTLER E, 1975, NATURE, V258, P262, DOI 10.1038/258262a0; BOUE J, 1973, NOUV PRESSE MED, V2, P3097; DREYFUS JC, 1975, ARCH FR PEDIATR, V32, P503; DREYFUS JC, 1975, NEW ENGL J MED, V292, P61, DOI 10.1056/NEJM197501092920201; HOOGHWIN.GJ, 1972, H-S Z PHYSIOL CHEM, V353, P839; HUDDLESTON JF, 1971, AM J OBSTET GYNECOL, V109, P1017, DOI 10.1016/0002-9378(71)90283-3; IKONNE JU, 1975, AM J HUM GENET, V27, P639; NAVON R, 1973, AM J HUM GENET, V25, P287; OBRIEN JS, 1970, NEW ENGL J MED, V283, P15, DOI 10.1056/NEJM197007022830104; OKADA S, 1969, SCIENCE, V165, P698, DOI 10.1126/science.165.3894.698; PENTON E, 1975, BIOCHIM BIOPHYS ACTA, V391, P162, DOI 10.1016/0005-2744(75)90162-X; POENARU L, 1973, CLIN CHIM ACTA, V43, P439; ROBINSON D, 1968, BIOCHEM J, V107, P321, DOI 10.1042/bj1070321; SANDHOFF K, 1971, J NEUROCHEM, V18, P2469, DOI 10.1111/j.1471-4159.1971.tb00204.x; SRIVASTA.SK, 1974, J BIOL CHEM, V249, P2054; VIDGOFF J, 1973, AM J HUM GENET, V25, P372	16	28	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1977	29	3					287	293						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DG794	868875				2022-12-18	WOS:A1977DG79400008
J	KING, RA; WITKOP, CJ				KING, RA; WITKOP, CJ			DETECTION OF HETEROZYGOTES FOR TYROSINASE-NEGATIVE OCULOCUTANEOUS ALBINISM BY HAIRBULB TYROSINASE ASSAY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MINNESOTA,SCH MED,DEPT MED,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,SCH DENT,DIV HUMAN & ORAL GENETICS,MINNEAPOLIS,MN 55455	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities								BURNETT JB, 1971, J BIOL CHEM, V246, P3079; BURNETT JB, 1967, CANCER RES, V27, P880; CHASE HB, 1951, PHYSIOL ZOOL, V21, P1; FROGGATT P, 1960, ANN HUM GENET, V24, P213, DOI 10.1111/j.1469-1809.1960.tb01734.x; KING RA, 1976, NATURE, V263, P69, DOI 10.1038/263069a0; LERNER AB, 1949, J BIOL CHEM, V178, P185; LERNER AB, 1950, PHYSIOL REV, V30, P91, DOI 10.1152/physrev.1950.30.1.91; MENON IA, 1970, ARCH BIOCHEM BIOPHYS, V137, P231, DOI 10.1016/0003-9861(70)90430-3; MONTAGNA W, 1974, STRUCTURE FUNCTION S, P186; POMERANT.SH, 1966, J BIOL CHEM, V241, P161; SEIJI M, 1963, ANN NY ACAD SCI, V100, P497, DOI 10.1111/j.1749-6632.1963.tb42911.x; SEIJI M, 1961, J BIOCHEM-TOKYO, V49, P700, DOI 10.1093/oxfordjournals.jbchem.a127360; SEIJI M, 1967, ADVANCES BIOLOGY SKI, V8, P189; VARGA JM, 1976, P NATL ACAD SCI USA, V73, P559, DOI 10.1073/pnas.73.2.559; WAARDENBURG PJ, 1970, REMARKABLE FACTS HUM, P14; Witkop CK, 1974, HERITABLE DISORDERS, P177	16	28	29	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1977	29	2					164	168						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DB507	15451				2022-12-18	WOS:A1977DB50700005
J	HATCHER, NH; HOOK, EB				HATCHER, NH; HOOK, EB			EARLY INVITRO DIVISION OF PHA STIMULATED CORD BLOOD-LYMPHOCYTES - IMPLICATIONS FOR STUDY OF CHROMOSOME BREAKAGE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note									NEW YORK STATE DEPT HLTH,INST BIRTH DEFECTS,EPIDEMIOL & HUMAN ECOL SECT,ALBANY,NY 12237; UNION UNIV ALBANY MED COLL,DEPT PEDIAT,ALBANY,NY 12208	State University of New York (SUNY) System; Albany Medical College								BLOOM AD, 1972, ADV HUM GENET, V3, P99; BUCKTON KE, 1964, INT J RADIAT BIOL RE, V8, P439, DOI 10.1080/09553006414550551; BUCKTON KE, 1973, METHODS ANALYSIS HUM, P13; EVANS HJ, 1970, HUMAN POPULATION CYT, V5, P192; LATT SA, 1974, SCIENCE, V185, P74, DOI 10.1126/science.185.4145.74; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0	6	28	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	3					290	293						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	BS306	1266856				2022-12-18	WOS:A1976BS30600011
J	MESTRINER, MA; SALZANO, FM; NEEL, JV; AYRES, M				MESTRINER, MA; SALZANO, FM; NEEL, JV; AYRES, M			ESTERASE-D IN SOUTH-AMERICAN INDIANS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV SAO PAULO,FAC MED,DEPT GENET,14100 RIBEIRAO PRETO,SP,BRAZIL; UNIV FED RIO GRANDE DO SUL,INST BIOCIENCIAS,DEPT GENET,90000 PORTO ALEGRE,RIO GRANDE SUL,BRAZIL; UNIV FED PARA,CTR CIENCIAS BIOL,GENET LAB,66000 BELEM,PARA,BRAZIL; UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,ANN ARBOR,MI 48104	Universidade de Sao Paulo; Universidade Federal do Rio Grande do Sul; Universidade Federal do Para; University of Michigan System; University of Michigan			Salzano, Francisco M/L-7916-2015					BENDER K, 1974, HUMANGENETIK, V23, P315, DOI 10.1007/BF00272516; BENKMANN HG, 1975, HUMANGENETIK, V27, P343; BENKMANN HG, 1974, HUMANGENETIK, V24, P325, DOI 10.1007/BF00297597; GERSHOWITZ H, 1970, AM J HUM GENET, V22, P515; GERSHOWITZ H, 1972, ANN HUM GENET, V35, P261, DOI 10.1111/j.1469-1809.1957.tb01400.x; HOPKINSON DA, 1973, ANN HUM GENET, V37, P119, DOI 10.1111/j.1469-1809.1973.tb01820.x; ISHIMOTO G, 1974, JPN J HUM GENET, V19, P157; KOSTER B, 1975, HUMANGENETIK, V28, P75, DOI 10.1007/BF00272486; MARTIN W, 1975, BLUT, V30, P299, DOI 10.1007/BF01633825; NEEL JV, 1973, ISRAEL J MED SCI, V9, P1216; SMITH CAB, 1969, ANN HUM GENET, V32, P251, DOI 10.1111/j.1469-1809.1969.tb00074.x; WARD RH, 1975, AM J HUM GENET, V27, P1; WARD RH, 1972, ANN HUM GENET, V36, P21, DOI 10.1111/j.1469-1809.1972.tb00579.x; WELCH S, 1974, HUMANGENETIK, V21, P365; WELCH S, 1974, HUMANGENETIK, V24, P329, DOI 10.1007/BF00297598; WELCH SG, 1975, VOX SANG, V28, P366, DOI 10.1111/j.1423-0410.1975.tb02781.x	16	28	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	3					257	261						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	BS306	1266853				2022-12-18	WOS:A1976BS30600007
J	BADEN, HP; LEE, LD; KUBILUS, J				BADEN, HP; LEE, LD; KUBILUS, J			GENETIC ELECTROPHORETIC VARIANT OF HUMAN HAIR ALPHA POLYPEPTIDES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HARVARD UNIV,MASSACHUSETTS GEN HOSP,MED SCH,DEPT DERMATOL,BOSTON,MA 02114	Harvard University; Harvard Medical School; Massachusetts General Hospital								BADEN HP, 1973, BIOCHIM BIOPHYS ACTA, V322, P269, DOI 10.1016/0005-2795(73)90303-6; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; GOLDSMIT.LA, 1970, J INVEST DERMATOL, V55, P256, DOI 10.1111/1523-1747.ep12259955; HARRIS H, 1970, ENZYME PROTEIN DIVER, V8, P211; HIRS CHW, 1967, METHOD ENZYMOL, V11, P199; INGRAM VM, 1957, NATURE, V180, P326, DOI 10.1038/180326a0; JOUBERT FJ, 1968, S FIBROUS PROTEINS, P343; MARKERT CL, 1959, P NATL ACAD SCI USA, V45, P753, DOI 10.1073/pnas.45.5.753; MARKS PA, 1962, NATURE, V194, P454, DOI 10.1038/194454a0	9	28	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1975	27	4					472	477						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM544	1155456				2022-12-18	WOS:A1975AM54400003
J	FRIEDMAN, RD; MERRITT, AD				FRIEDMAN, RD; MERRITT, AD			PARTIAL-PURIFICATION AND CHARACTERIZATION OF A POLYMORPHIC PROTEIN (PA) IN HUMAN PAROTID SALIVA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									TEMPLE UNIV,SCH DENT,DEPT BIOCHEM,PHILADELPHIA,PA 19140; INDIANA UNIV,MED CTR,DEPT MED GENET,INDIANAPOLIS,IN 46202	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; Indiana University System; Indiana University-Purdue University Indianapolis					NIGMS NIH HHS [P01 GM 19178, P01 GM 21054] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AZEN EA, 1973, SCIENCE, V180, P1067, DOI 10.1126/science.180.4090.1067; AZEN EA, 1974, BIOCHEM GENET, V12, P109, DOI 10.1007/BF00487820; AZEN EA, 1972, SCIENCE, V176, P673, DOI 10.1126/science.176.4035.673; BENNICK A, 1971, BIOCHEM J, V123, P455, DOI 10.1042/bj1230455; BURGESS RC, 1966, J DENT RES, V45, P613, DOI 10.1177/00220345660450032501; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; FRIEDMAN RD, 1975, AM J HUM GENET, V27, P292; FRIEDMAN RD, 1972, AM J HUM GENET, V24, pA42; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MASSON PL, 1965, BIOCHIM BIOPHYS ACTA, V107, P485, DOI 10.1016/0304-4165(65)90192-3; OPPENHEIM FG, 1971, BIOCHEMISTRY-US, V10, P4233, DOI 10.1021/bi00799a013; SUNG M, 1969, BIOPOLYMERS, V7, P39, DOI 10.1002/bip.1969.360070105	13	28	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1975	27	3					304	314						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AD236	803013				2022-12-18	WOS:A1975AD23600006
J	WAGENER, DK; CAVALISFORZA, LL				WAGENER, DK; CAVALISFORZA, LL			ETHNIC VARIATION IN GENETIC DISEASE - POSSIBLE ROLES OF HITCHHIKING AND EPISTASIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									STANFORD UNIV, DEPT GENET, STANFORD, CA 94305 USA	Stanford University					NIGMS NIH HHS [GM 20467-01] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BECROFT D M O, 1969, New Zealand Medical Journal, V69, P212; BERMAN JL, 1969, AM J DIS CHILD, V117, P54, DOI 10.1001/archpedi.1969.02100030056006; BICKEL H, 1967, C PHENYLKETONURIA AL, P99; BODMER WF, 1962, ADV GENET, V11, P1; BODMER WF, 1967, GENETICS, V57, P237; BOWMAN BH, 1974, AM J HUM GENET, V26, pA17; CAHALANE SF, 1968, ARCH DIS CHILD, V43, P141, DOI 10.1136/adc.43.228.141; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; CAVALLISFORZA LL, 1972, P RAI, P15; CHASE GA, 1972, AM J HUM GENET, V24, P339; CLOW C, 1969, AM J DIS CHILD, V117, P48, DOI 10.1001/archpedi.1969.02100030050005; CONNEALLY PM, 1973, TEX REP BIOL MED, V31, P639; Cunningham G C, 1971, CRC Crit Rev Clin Lab Sci, V2, P45, DOI 10.3109/10408367109151304; DAMON A, 1969, SOC BIOL, V16, P69, DOI 10.1080/19485565.1969.9987804; DANKS DM, 1965, ANN HUM GENET, V28, P323, DOI 10.1111/j.1469-1809.1965.tb00489.x; EFRON ML, 1967, AMINO ACID METABOLIS, P219; EWENS WJ, 1965, HEREDITY, V20, P443, DOI 10.1038/hdy.1965.55; HALL BD, 1969, 5TH P INT C CYST FIB, P82; HANLEY WB, 1969, CAN MED ASSOC J, V101, P185; HASHIMOTO S, 1973, POPULAR MED        S, V4, P196; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; HSIA DY, 1971, HOSP PRACT, V6, P101; HULTEN M, 1973, ADV HUM GENET, P327; KOJIMA K, 1964, EVOLUTION, V18, P127, DOI 10.2307/2406427; KOJIMA KI, 1967, EVOLUTION, V21, P518, DOI 10.1111/j.1558-5646.1967.tb03408.x; KRAMM ER, 1962, AM J PUBLIC HEALTH N, V52, P2041, DOI 10.2105/AJPH.52.12.2041; LEVIN S, 1963, GENETICS MIGRANT ISO, P294; LEVY HL, 1970, NEW ENGL J MED, V282, P1455, DOI 10.1056/NEJM197006252822604; LOBECK CC, 1972, METABOLIC BASIS INHE, P1605; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672300014634, 10.1017/S0016672308009579]; MCBEAN MS, 1968, ARCH DIS CHILD, V43, P1, DOI 10.1136/adc.43.227.1; McKusick V A, 1966, Ala J Med Sci, V3, P408; MCKUSICK VA, 1973, ISRAEL J MED SCI, V9, P1375; MCKUSICK VA, 1967, J CHRON DIS, V20, P115, DOI 10.1016/0021-9681(67)90045-8; MCKUSICK VA, 1971, MENDELIAN INHERITANC; MYRIANTHOPOULOS NC, 1972, AM J HUM GENET, V24, P341; MYRIANTHOPOULOS NC, 1966, AM J HUM GENET, V18, P313; MYRIANTHOPOULOS NC, 1972, 4TH P INT S SPHING, P561; PITT D, 1970, MED J AUSTRALIA, V1, P1073; PUGH RJ, 1967, ARCH DIS CHILD, V42, P544, DOI 10.1136/adc.42.225.544; RAO DC, 1973, AM J HUM GENET, V25, P594; SCHANFIE.MS, 1973, AM J HUM GENET, V25, pA65; SCHANFIELD MS, IN PRESS; SELANDER P, 1962, ACTA PAEDIATR SCAND, V51, P65, DOI 10.1111/j.1651-2227.1962.tb06510.x; STEINBERG AG, 1960, AM J HUM GENET, V12, P416; SULTZ HA, 1968, AM J PUBLIC HEALTH N, V58, P491, DOI 10.2105/AJPH.58.3.491; SZEINBERG A, 1969, AM J DIS CHILD, V118, P559, DOI 10.1001/archpedi.1969.02100040561003; TANAKA K, 1961, Jinrui Idengaku Zasshi, V6, P65; TURNER B, 1970, MED J AUSTRALIA, V1, P11, DOI 10.5694/j.1326-5377.1970.tb77687.x; WAGENER DK, IN PRESS; WRIGHT SW, 1968, AM J HUM GENET, V20, P157; WRIGHT SW, 1969, 5TH P INT CF C, P91; 1966, UNESCO STATISTICAL Y	53	28	28	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1975	27	3					348	364						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AD236	803016				2022-12-18	WOS:A1975AD23600010
J	CHEN, SH; ANDERSON, J; GIBLETT, ER; LEWIS, M				CHEN, SH; ANDERSON, J; GIBLETT, ER; LEWIS, M			PHOSPHOGLYCERIC ACID MUTASE - RARE GENETIC VARIANTS AND TISSUE DISTRIBUTION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WASHINGTON,SCH MED,DEPT PEDIAT,SEATTLE,WA 98195; KING CTY CENT BLOOD BANK,TERRY & MADISON,SEATTLE,WA 98104; RH LAB,735 NOTRE DAME AVE,WINNIPEG R3E OL8,MANITOBA,CANADA	University of Washington; University of Washington Seattle								CHEN S, 1971, BIOCHEM GENET, V5, P481, DOI 10.1007/BF00487137; CHEN SH, 1971, AM J HUM GENET, V23, P419; FILDES RA, 1966, NATURE, V209, P261, DOI 10.1038/209261a0; GRISOLIA S, 1958, J BIOL CHEM, V234, P1335; HARKNESS DR, 1970, ARCH BIOCHEM BIOPHYS, V138, P208, DOI 10.1016/0003-9861(70)90300-0; HARKNESS DR, 1969, ARCH BIOCHEM BIOPHYS, V134, P113, DOI 10.1016/0003-9861(69)90257-4; MANTLE J, 1969, J BIOL CHEM, V244, P3884; TORRALBA A, 1966, J BIOL CHEM, V241, P1713	8	28	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1974	26	1					73	77						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	S0166	4811757				2022-12-18	WOS:A1974S016600008
J	GEERDINK, RA; NIJENHUIS, LE; VANLOGHE.E; LIFOSJOE, E				GEERDINK, RA; NIJENHUIS, LE; VANLOGHE.E; LIFOSJOE, E			BLOOD-GROUPS AND IMMUNOGLOBULIN GROUPS IN TRIO AND WAJANA INDIANS FROM SURINAM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									ACADEMIC HOSP, DEPT MED, UNIT MED GENET, UTRECHT, NETHERLANDS; NETHERLANDS RED CROSS BLOOD TRANSF SERV, CENT LAB, AMSTERDAM, NETHERLANDS; ACADEMIC HOSP, DEPT BIOCHEM, PARAMARIBO, SURINAME									CEPPELLINI R, 1955, ANN HUM GENET, V20, P97; FITCH WM, 1969, AM J HUM GENET, V21, P384; GERSHOWITZ H, 1967, AM J HUM GENET, V19, P502; GERSHOWITZ H, 1972, ANN HUM GENET, V35, P261, DOI 10.1111/j.1469-1809.1957.tb01400.x; JUNQUEIRA PC, 1957, ANN HUM GENET, V22, P22, DOI 10.1111/j.1469-1809.1957.tb01295.x; LAYRISSE M, 1963, HUM BIOL, V35, P140; NIJENHUIS LE, 1961, THESIS AMSTERDAM; Pantin AM, 1952, AM J PHYS ANTHROP-NE, V10, P395, DOI 10.1002/ajpa.1330100403	8	28	28	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1974	26	1					45	53						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	S0166	4204535				2022-12-18	WOS:A1974S016600004
J	MCKUSICK, VA				MCKUSICK, VA			PHENOTYPIC DIVERSITY OF HUMAN DISEASES RESULTING FROM ALLELIC SERIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHNS HOPKINS UNIV,SCH MED,DEPT MED,DIV MED GENET,BALTIMORE,MD 21205; JOHNS HOPKINS HOSP,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine								BACH G, 1972, P NATL ACAD SCI USA, V69, P2048, DOI 10.1073/pnas.69.8.2048; CARLSEN RB, 1972, J BIOL CHEM, V247, P23; CORNU P, 1963, BRIT J HAEMATOL, V9, P189, DOI 10.1111/j.1365-2141.1963.tb05457.x; DARNALL DW, 1972, ARCH BIOCHEM BIOPHYS, V149, P1, DOI 10.1016/0003-9861(72)90293-7; DEWEERDK.EA, 1972, NATURE-NEW BIOL, V238, P80, DOI 10.1038/newbio238080a0; DURAND P, 1969, J PEDIATR, V75, P665, DOI 10.1016/S0022-3476(69)80464-6; FREEMAN JM, 1970, ARCH NEUROL-CHICAGO, V23, P430, DOI 10.1001/archneur.1970.00480290050006; FREITAG F, 1971, VIRCHOWS ARCH B, V7, P99; GERHART JC, 1965, BIOCHEMISTRY-US, V4, P1054, DOI 10.1021/bi00882a012; HICKMAN S, 1972, BIOCHEM BIOPH RES CO, V49, P992, DOI 10.1016/0006-291X(72)90310-5; HOWELL RR, 1972, METABOLIC BASIS INHE; ITANO HA, 1959, NATURE, V184, P1468, DOI 10.1038/1841468a0; KASHIWAMATA S, 1970, BIOCHIM BIOPHYS ACTA, V212, P501; KELLY S, 1972, J MED GENET, V9, P129, DOI 10.1136/jmg.9.1.129; KLEE WA, 1970, BIOCHEM BIOPH RES CO, V39, P833, DOI 10.1016/0006-291X(70)90398-0; LAPIERE CM, 1971, P NATL ACAD SCI USA, V68, P3054, DOI 10.1073/pnas.68.12.3054; MCKUSICK VA, 1973, J MED GENET, V10, P11, DOI 10.1136/jmg.10.1.11; MCKUSICK VA, 1969, PERSPECT BIOL MED, V12, P298; MCKUSICK VA, 1972, LANCET, V1, P993; MCKUSICK VA, 1971, MENDELIAN INHERITANC; MORTON NE, 1956, AM J HUM GENET, V8, P80; MUDD SH, 1970, J CLIN INVEST, V49, P1762, DOI 10.1172/JCI106394; NADLER HL, 1970, P NATL ACAD SCI USA, V67, P976, DOI 10.1073/pnas.67.2.976; NEUFELD EF, 1970, SCIENCE, V169, P141, DOI 10.1126/science.169.3941.141; PAIGEN K, 1971, ENZYME SYNTHESIS DEG; PATEL V, 1972, SCIENCE, V176, P426, DOI 10.1126/science.176.4033.426; PORTER MT, 1971, BIOCHEM BIOPH RES CO, V44, P660, DOI 10.1016/S0006-291X(71)80134-1; ROBINSON E, 1960, NATURE, V185, P547, DOI 10.1038/185547b0; ROSENBERG LE, 1966, SCIENCE, V154, P1341, DOI 10.1126/science.154.3754.1341; SCHAFER IA, 1971, PEDIATR RES, V5, P391, DOI 10.1203/00006450-197108000-00086; SCHWARTZ ML, 1971, J BIOL CHEM, V246, P5851; SIA CL, 1969, ARCH BIOCHEM BIOPHYS, V132, P325, DOI 10.1016/0003-9861(69)90369-5; SMITH EL, 1970, ENZYMES, V1; STEINBERG AG, 1970, AM J HUM GENET, V22, P597; SWALLOW DM, 1972, ANN HUM GENET, V36, P141, DOI 10.1111/j.1469-1809.1972.tb00765.x; TROTTA PP, 1971, P NATL ACAD SCI USA, V68, P2599, DOI 10.1073/pnas.68.10.2599; WHITTAKER DL, 1962, AM J HUM GENET, V14, P149; WIESMANN U, 1970, SCIENCE, V169, P72, DOI 10.1126/science.169.3940.72	38	28	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1973	25	4					446	456						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q0158	4577464				2022-12-18	WOS:A1973Q015800012
J	ROBINSON, MG; TOLCHIN, D; HALPERN, C				ROBINSON, MG; TOLCHIN, D; HALPERN, C			ENTERIC BACTERIAL AGENTS AND ABO BLOOD GROUPS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		AIRD I, 1953, BRIT MED J, V1, P799, DOI 10.1136/bmj.1.4814.799; CRUZCOKE R, 1965, J MED GENET, V2, P185; EICHNER ER, 1963, NATURE, V198, P164, DOI 10.1038/198164a0; GRUNDBACHER FJ, 1970, AM J HUM GENET, V22, P194; HALDANE JBS, 1956, ANN HUM GENET, V20, P309; MATSUNAGA E, 1962, EUGEN QUART, V9, P36, DOI 10.1080/19485565.1962.9987499; MUSCHEL LH, 1959, P SOC EXP BIOL MED, V101, P614, DOI 10.3181/00379727-101-25036; PAVILLARD ERJ, 1964, AUST J EXP BIOL MED, V42, P62, DOI 10.1038/icb.1964.6; REED TE, 1962, P C GENETIC POLYMORP, P80; SCHIFF F., 1934, Zeitschrift fur Immunitatsforschung und Experimentelle Therapie, V82, P46; SOCHA W, 1969, Folia Biologica (Cracow), V17, P259; SPRINGER GF, 1969, J CLIN INVEST, V48, P1280, DOI 10.1172/JCI106094; SPRINGER GF, 1961, J EXP MED, V113, P1077, DOI 10.1084/jem.113.6.1077; VOGEL F., 1960, ACTA GENET ET STATIST MED, V10, P267; VOGEL F, 1964, HUMANGENETIK, V1, P31, DOI 10.1007/BF00289363; VOGEL F, 1970, AM J HUM GENET, V22, P464; WIENER AS, 1970, AM J HUM GENET, V22, P476; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x	18	28	28	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1971	23	2					135	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	J1653	4933519				2022-12-18	WOS:A1971J165300003
J	RATTAZZI, MC; LENZERINI, L; KHAN, PM; LUZZATTO, L				RATTAZZI, MC; LENZERINI, L; KHAN, PM; LUZZATTO, L			CHARACTERIZATION OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE VARIANTS .2. G6PD KEPHALONIA G6PD ATTICA AND G6PD SEATTLE-LIKE FOUND IN GREECE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		AZEVEDO E, 1968, ANN HUM GENET, V31, P373, DOI 10.1111/j.1469-1809.1968.tb00569.x; BEUTLER E, 1968, BLOOD, V31, P131, DOI 10.1182/blood.V31.2.131.131; BLUMBERG BS, 1961, P C GENETIC POLYM ED, P159; DAYHOFF MO, 1968, ATLAS PROTEIN SEQUEN, P49; GALL JC, 1965, AM J HUM GENET, V17, P359; KIRKMAN HN, 1965, J LAB CLIN MED, V66, P834; KIRKMAN HN, 1968, HERED DISORD, P126; LENZERINI L, 1969, AM J HUM GENET, V21, P142; LUZZATTO L, 1965, BIOCHEM BIOPH RES CO, V21, P547, DOI 10.1016/0006-291X(65)90520-6; LUZZATTO L, 1968, J CLIN INVEST, V47, P1833, DOI 10.1172/JCI105873; LUZZATTO L, 1967, BIOCHIM BIOPHYS ACTA, V146, P18, DOI 10.1016/0005-2744(67)90069-1; LUZZATTO L, 1967, BIOCHEM BIOPH RES CO, V29, P705, DOI 10.1016/0006-291X(67)90274-4; MARTIN RG, 1961, J BIOL CHEM, V236, P1372; MCCURDY PR, 1966, J LAB CLIN MED, V67, P374; MOTULSKY AG, 1966, AM J HUM GENET, V18, P514; Motulsky AG, 1961, P C GENETIC POLYMORP, P159; PEETERS H, 1966, PROTIDES BIOLOGICAL, V14, P649; PORTER IH, 1964, LANCET, V1, P895; RATTAZZI MC, 1967, NATURE, V213, P79, DOI 10.1038/213079b0; RATTAZZI MC, TO BE PUBLISHED; STAMATOYANNOPOULOS G, 1967, SCIENCE, V157, P831, DOI 10.1126/science.157.3790.831; YOSHIDA A, 1967, SCIENCE, V155, P97, DOI 10.1126/science.155.3758.97; YOSHIDA A, 1966, J BIOL CHEM, V241, P4966; 1967, 366 WORLD HEALTH ORG	24	28	28	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1969	21	2					154	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D3696	5770172				2022-12-18	WOS:A1969D369600005
J	COREY, MJ; MILLER, JR; MACLEAN, JR; CHOWN, B				COREY, MJ; MILLER, JR; MACLEAN, JR; CHOWN, B			A CASE OF XX/XY MOSAICISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Austin C.R., 1961, MAMMALIAN EGG; BAIN AD, 1965, LANCET, V1, P1035; BEATTIE KM, 1964, TRANSFUSION, V4, P77, DOI 10.1111/j.1537-2995.1964.tb02835.x; BRADEN A. W. H., 1957, JOUR GENETICS, V55, P476, DOI 10.1007/BF02984065; CHOWN B, 1965, CASE GEMINISM; COREY MARGARET J., 1966, J MED GENET, V3, P230, DOI 10.1136/jmg.3.3.230; DE GROUCHY J, 1964, Ann Genet, V7, P25; DUNSFORD I, 1957, Vox Sang, V2, P414; GALATIUSJENSEN F, 1958, ACTA GENET, V8, P248; GARTLER SM, 1962, P NATL ACAD SCI USA, V48, P332, DOI 10.1073/pnas.48.3.332; GIBLETT ER, 1964, COLD SPRING HARB SYM, V29, P321, DOI 10.1101/SQB.1964.029.01.034; GIBLETT ER, 1963, AM J HUM GENET, V15, P62; HARRIS H, 1959, BIOCHEMISTRY HUMAN G, P151; JOSSO N, 1965, J CLIN ENDOCR METAB, V25, P114, DOI 10.1210/jcem-25-1-114; MYHRE BA, 1965, TRANSFUSION, V5, P501, DOI 10.1111/j.1537-2995.1965.tb01194.x; OVERZIER C, 1964, KLIN WOCHENSCHR, V42, P1052, DOI 10.1007/BF01486344; RACE RR, 1962, BLOOD GROUPS MAN; SEGNI G, 1965, MINERVA PEDIATR, V17, P983; SUTTON HE, 1965, SCIENCE, V150, P858, DOI 10.1126/science.150.3698.858; TARKOWSKI AK, 1964, J EMBRYOL EXP MORPH, V12, P735; TARKOWSKI AK, 1961, NATURE, V190, P857, DOI 10.1038/190857a0; WAXMAN SH, 1962, LANCET, V1, P161; WAXMAN SH, 1962, J PEDIATR-US, V60, P540, DOI 10.1016/S0022-3476(62)80115-2; WOLSTENHOLME GEW, 1959, BIOCHEMISTRY HUMA ED, P151; ZUELZER WW, 1964, AM J HUM GENET, V16, P38	25	28	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1967	19	3P2					378	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	96074	6026930				2022-12-18	WOS:A19679607400002
J	MURPHY, EA; BOLLING, DR				MURPHY, EA; BOLLING, DR			TESTING OF SINGLE LOCUS HYPOTHESES WHERE THERE IS INCOMPLETE SEPARATION OF PHENOTYPES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract																		Baker GA, 1930, ANN MATH STAT, V1, P334, DOI 10.1214/aoms/1177733063; EVANS DAP, 1961, J HOPKINS B, V108, P60; HARRIS H., 1960, ACTA GENET ET STATIST MED, V10, P1; HOOKE R, 1961, J ACM, V8, P212, DOI 10.1145/321062.321069; KIEFER J, 1956, ANN MATH STAT, V27, P887, DOI 10.1214/aoms/1177728066; MURPHY EA, 1964, J CHRON DIS, V17, P301, DOI 10.1016/0021-9681(64)90073-6; Pearson K., 1894, Philosophical Transactions, V185a, P71, DOI 10.1098/rsta.1894.0003; PLATT R, 1963, LANCET, V1, P899; RAO CR, 1952, ADVANCED STATISTICAL, P300; SUNAHARA S, 1959, QUART PROG REP VETER, V14, P6; WILKS S, 1962, MATHEMATICAL STATIST, P256	11	28	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1967	19	3P1					322	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	96073	6026586				2022-12-18	WOS:A19679607300010
J	NISWANDER, JD; KEITER, F; NEEL, JV				NISWANDER, JD; KEITER, F; NEEL, JV			FURTHER STUDIES ON XAVANTE INDIANS .2. SOME ANTHROPOMETRIC DERMATOGLYPHIC AND NONQUANTITATIVE MORPHOLOGICAL TRAITS OF XAVANTES OF SIMOES LOPES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ARENDS T, 1967, P NATL ACAD SCI USA, V57, P1252, DOI 10.1073/pnas.57.5.1252; Cummins H, 1935, AM J PHYS ANTHROPOL, V20, P19, DOI 10.1002/ajpa.1330200106; GEIPEL G, 1935, ANLEITUNG ERBBIOLOGI; Hertzberg HTE, 1963, ANTHROPOMETRIC SURVE; HOLT SB, 1952, ANN EUGENIC, V17, P140; KEITER F., 1963, EUGEN QUART, V10, P22; KEITER F., 1960, MITTEIL ANTHROPOL GES WIEN, V90, P55; KEITER F, 1965, 8 TAG D GES ANTHR GO, P249; KEITER F, 1957, ARZTL FORSCH, V11, P537; Keiter F, 1954, Z MORPHOL ANTHROPOL, V46, P170; KEITER FRIEDRICH, 1966, Z MORPHOL ANTHROPOL, V57, P215; Keiter F, 1950, Z MORPHOL ANTHROPOL, V42, P169; NEEL JV, 1964, AM J HUM GENET, V16, P52; PARSONS PA, 1965, GROWTH, V29, P207; SALZANO FM, 1967, AM J HUM GENET, V19, P463; VINCI A, 1959, RED CLOTH GREEN FORE; ZERRIES O, 1959, Z MORPHOL ANTHROPOL, V50, P31	17	28	28	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1967	19	4					490	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	98570	6036270				2022-12-18	WOS:A19679857000002
J	DEGROUCHY, J; AUSSANNAIRE, M; BRISSAUD, H; LAMY, M				DEGROUCHY, J; AUSSANNAIRE, M; BRISSAUD, H; LAMY, M			ANEUSOMIE DE RECOMBINAISON - 3 FURTHER EXAMPLES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		DE GROUCHY J, 1963, Ann Genet, V6, P21; DEGROUCH.J, 1965, AM J HUM GENET, V17, P501; DEGROUCHY J, 1965, ANN GENET-PARIS, V8, pG31; LEJEUNE J, 1965, ANN GENET-PARIS, V8, pG21; LELE KP, 1965, LANCET, V1, P576; MORISHIMA A, 1964, J PEDIATR-US, V65, P1096, DOI 10.1016/S0022-3476(64)80098-6	6	28	28	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1966	18	5					467	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	83834	5927289				2022-12-18	WOS:A19668383400008
J	SUMMITT, RL				SUMMITT, RL			FAMILIAL 2/3 TRANSLOCATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BAVIN JTR, 1963, J MENT DEFIC RES, V7, P84; BECKER KL, 1963, MAYO CLIN PROC, V38, P261; BENIRSCHKE K., 1962, CYTOGENETICS, V1, P75, DOI 10.1159/000129717; BOEOEK JA, 1961, LANCET, V1, P167; BREG WR, 1962, NEW ENGL J MED, V266, P845, DOI 10.1056/NEJM196204262661701; BUHLER EM, 1964, LANCET, V1, P170; CARTER CO, 1960, LANCET, V2, P678; CLARKE G, 1964, J Med Genet, V1, P27, DOI 10.1136/jmg.1.1.27; DE GROUCHY J, 1964, Pathol Biol, V12, P579; de Grouchy J., 1963, CR HEBD ACAD SCI, V258, P1028; EDWARDS JH, 1962, ANN HUM GENET, V26, P163, DOI 10.1111/j.1469-1809.1962.tb01323.x; FORD CE, 1964, 2 INT C CONG MALF NE, P22; FORSSMAN H, 1962, ACTA PAEDIATR SCAND, V51, P180, DOI 10.1111/j.1651-2227.1962.tb06527.x; FRACCARO M, 1960, LANCET, V1, P724; GUSTAVSON KH, 1964, ACTA PAEDIATR, V53, P172, DOI 10.1111/j.1651-2227.1964.tb07224.x; LEE CSN, 1964, NEW ENGL J MED, V271, P12, DOI 10.1056/NEJM196407022710102; LEJEUNE J, 1964, Sem Hop, V40, P1069; LEJEUNE J, 1963, CR HEBD ACAD SCI, V257, P3098; LEJEUNE J, 1964, CR HEBD ACAD SCI, V258, P5767; LEJEUNE J, 1963, ANN GENET-PARIS, V6, pG3; MACINTYRE MN, 1962, AM J HUM GENET, V14, P335; MERCER ROBERT D., 1963, CLEVELAND CLIN QUART, V30, P225; MILLER JR, 1963, ANNUAL M AMERICAN SO; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; PATAU K, 1961, AM J HUM GENET, V13, P287; PATAU K, 1964, 2 INT C CONG MALF, P52; PENROSE LS, 1961, ANN HUM GENET, V25, P243; POLANI PE, 1960, LANCET, V1, P721; SALONIUS AL, 1964, ANNUAL M AMERICAN SO; SCHMID W., 1962, CYTOGENETICS, V1, P210, DOI 10.1159/000129730; SHAW MARGERY W., 1962, CYTOGENETICS, V1, P141, DOI 10.1159/000129726; SUMMITT RL, 1964, CYTOGENETICS, V3, P201, DOI 10.1159/000129811; UCHIDA IA, 1962, AM J HUM GENET, V14, P345; UCHIDA IRENE A., 1964, CYTOGENETICS, V3, P81, DOI 10.1159/000129800; VISLIE H, 1962, LANCET, V2, P76	35	28	28	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1966	18	2					172	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	74253	4379334				2022-12-18	WOS:A19667425300005
J	REED, TE; GERSHOWITZ, H; SONI, A; NAPIER, J				REED, TE; GERSHOWITZ, H; SONI, A; NAPIER, J			SEARCH FOR NATURAL SELECTION IN 6 BLOOD GROUP SYSTEM + ABH SECRETION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BARTLETT MS, 1947, BIOMETRICS, V3, P39, DOI 10.2307/3001536; BEHRMAN SJ, 1960, AM J OBSTET GYNECOL, V79, P847, DOI 10.1016/0002-9378(60)90677-3; BENNETT JH, 1956, ANN HUM GENET, V20, P299; BLUMBERG BS, 1961, P C GENETIC POLYMORP; CARTER C, 1957, Br J Prev Soc Med, V11, P214; CHUNG CS, 1961, AM J HUM GENET, V13, P9; CHUNG CS, 1960, JPN J HUM GENET, V5, P124; CHUNG CS, 1961, JPN J HUM GENET, V6, P1; EPSTEIN FH, 1960, U MICH MED B, V26, P307; FRANCIS T, 1961, PUBLIC HEALTH REP, V76, P963, DOI 10.2307/4591334; GLASS B, 1950, AM J HUM GENET, V2, P269; HAGA H, 1959, JPN J HUM GENET, V4, P1; HIRAIZUMI Y, 1962, SCIENCE, V137, P861, DOI 10.1126/science.137.3533.861; MATSUNAGA E, 1962, SCIENCE, V135, P432, DOI 10.1126/science.135.3502.432-a; MATSUNAGA E, 1957, ANN HUM GENET, V22, P111, DOI 10.1111/j.1469-1809.1957.tb01926.x; MCNEIL C, 1957, AM J CLIN PATHOL, V28, P145, DOI 10.1093/ajcp/28.2.145; MORTON NE, 1959, AM J HUM GENET, V11, P237; MOURANT AE, 1959, COLD SPRING HARB SYM, V24, P57, DOI 10.1101/SQB.1959.024.01.008; MURRAY S, 1961, BRIT MED J, V2, P1472, DOI 10.1136/bmj.2.5265.1472; NAPIER JA, 1962, AM J PUBLIC HEALTH N, V52, P208, DOI 10.2105/AJPH.52.2.208; OPPENHEIM F, 1926, KRANKHEITSFORSCHG, V3, P306; RACE RR, 1962, BLOOD GROUPS MAN; REED TE, 1957, ANN HUM GENET, V22, P165, DOI 10.1111/j.1469-1809.1957.tb01932.x; REED TE, 1963, SCIENCE, V139, P406, DOI 10.1126/science.139.3553.406; REED TE, 1959, NATURE, V184, P611, DOI 10.1038/184611a0; REED TE, 1961, P C GENETIC POLYMORP; REED TE, 1963, 11 P INT C GEN, V1; REED TE, 1963, 2 P INT C HUM GEN, V2, P876; ROBERTS JAF, 1948, ANN EUGENIC, V14, P109; SHEPPARD PM, 1959, BRIT MED BULL, V15, P134, DOI 10.1093/oxfordjournals.bmb.a069737; SNEDECOR GW, 1956, STATISTICAL METHODS; Struthers D, 1951, BR J SOC MED, V5, P223	32	28	28	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1964	16	2					161	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2972A	14174798				2022-12-18	WOS:A19642972A00010
J	DAVIES, SH; HARDISTY, RM; HAMPER, J; INGRAM, GIC; GOLDSMITH, KL; TIPPETT, P; OBRIEN, JR; GRAHAM, JB; MCAFEE, LA; GAVIN, J; JONES, TG; SANGER, R; HOLMAN, CA; HARRIS, JB; MCKUSICK, VA; RACE, RR				DAVIES, SH; HARDISTY, RM; HAMPER, J; INGRAM, GIC; GOLDSMITH, KL; TIPPETT, P; OBRIEN, JR; GRAHAM, JB; MCAFEE, LA; GAVIN, J; JONES, TG; SANGER, R; HOLMAN, CA; HARRIS, JB; MCKUSICK, VA; RACE, RR			LINKAGE RELATIONS OF HEMOPHILIA A AND HEMOPHILIA B (CHRISTMAS DISEASE) TO XG BLOOD GROUP SYSTEM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ADAM A, 1963, ANN HUM GENET, V26, P187, DOI 10.1111/j.1469-1809.1963.tb01974.x; ADAM A, 1961, NATURE, V189, P686, DOI 10.1038/189686a0; BIGGS R, 1957, LANCET, V2, P311; BIGGS R, 1953, J CLIN PATHOL, V6, P23, DOI 10.1136/jcp.6.1.23; BIGGS R, 1955, BRIT J HAEMATOL, V1, P20, DOI 10.1111/j.1365-2141.1955.tb05484.x; Biggs R., 1962, HUMAN BLOOD COAGULAT; FORD CE, 1956, NATURE, V178, P1020, DOI 10.1038/1781020a0; GIANNELLI F, 1963, LANCET, V1, P863; GRAHAM JB, 1962, NATURE, V195, P834, DOI 10.1038/195834a0; Haldane JBS, 1919, J GENET, V8, P299; HARDISTY RM, 1962, THROMB DIATH HAEMOST, V7, P215; JACKSON C, TO BE PUBLISHED; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; LINDSTEN J, 1963, NATURE, V197, P648, DOI 10.1038/197648a0; MANN JD, 1962, LANCET, V1, P8; MARGOLIUS A, 1961, MEDICINE, V40, P145, DOI 10.1097/00005792-196105000-00002; MAYNARDSMITH S, 1961, HUMAN GENETICS; MORTON NE, 1955, AM J HUM GENET, V7, P277; MULDAL S, 1963, LANCET, V1, P861; OBRIEN JR, 1962, LANCET, V1, P1026; OHNO S., 1962, CYTOGENETICS, V1, P129, DOI 10.1159/000129725; PORTER IH, 1962, NATURE, V193, P506, DOI 10.1038/193506a0; PORTER IH, 1962, ANN HUM GENET, V26, P107, DOI 10.1111/j.1469-1809.1962.tb01316.x; RACE RR, 1962, BLOOD GROUPS MAN; RODMAN NF, 1958, AM J CLIN PATHOL, V29, P525; SINISCALCO M, 1960, RC LINCEI, V28, P1; STEWART JS, 1961, LANCET, V2, P104; WHITTAKER DL, 1962, AM J HUM GENET, V14, P149	28	28	28	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1963	15	4					481	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2968A	14097242				2022-12-18	WOS:A19632968A00005
J	LI, CC				LI, CC			GENETIC LOAD - 3 VIEWS .3. WAY LOAD RATIO WORKS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		CROW JAMES F., 1958, HUMAN BIOL, V30, P1; CROW JF, 1963, AM J HUM GENET, V15, P310; DOBZHANSKY T, 1963, GENETICS; LI CC, 1963, AM J MED, V34, P702, DOI 10.1016/0002-9343(63)90109-8; LI CC, 1963, P NATL ACAD SCI USA, V49, P439, DOI 10.1073/pnas.49.4.439; SANGHVI LD, 1963, AM J HUM GENET, V15, P298	6	28	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1963	15	3					316	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2967A	13930379				2022-12-18	WOS:A19632967A00006
J	LEVINE, P; ROSENFIELD, RE; WHITE, J				LEVINE, P; ROSENFIELD, RE; WHITE, J			FIRST EXAMPLE OF RH PHENOTYPE RGRG	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALLEN F H Jr, 1958, Vox Sang, V3, P321; ALLEN HH, 1958, PROC AM ASSO BLOOD; GUNSON HH, 1956, PROC 5 CON INT BLO T, P123; KEVEY SV, 1959, VOX SANG, V4, P257; LEVINE SV, 1957, PHAF, P144; LEVINE SV, 1954, BLOOD, V9, P817; RACE RR, 1950, NATURE, V166, P520, DOI 10.1038/166520a0; ROSENFIELD RE, 1953, BRIT MED J, V1, P975, DOI 10.1136/bmj.1.4817.975; ROSENFIELD RE, 1958, AM J HUM GENET, V10, P474; SANGER R, 1960, NATURE, V186, P171, DOI 10.1038/186171a0; SANGER R, 1953, PROC NAT ACAD SCI, V30, P824; SHAPIRO MAURICE, 1960, JOUR FORENSIC MED, V7, P96; STERN K, 1961, AM J CLIN PATHOL, V35, P520; WIENER AS, 1958, HEREDITY BLOOD GROUP	14	28	28	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1961	13	3					299	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2961A	13761494				2022-12-18	WOS:A19612961A00003
J	SARKAR, SS; STERN, C; BHATTACHARJEE, P; BANERJEE, AR				SARKAR, SS; STERN, C; BHATTACHARJEE, P; BANERJEE, AR			CONTRIBUTION TO GENETICS OF HYPERTRICHOSIS OF EAR RIMS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		GATES R R, 1957, Acta Genet Med Gemellol (Roma), V6, P103; GATES RR, 1960, SCIENCE, V132, P145, DOI 10.1126/science.132.3420.145; STERN C, 1957, AM J HUM GENET, V9, P147; TOMMASI C, 1907, GIORN PSYCH CLIN TEC, V35, P1; Tommasi C, 1907, ARCH PSICHIATR NEURO, V28, P60	5	28	28	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1961	13	2					214	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2960A	13746524				2022-12-18	WOS:A19612960A00005
J	FORSSMAN, H				FORSSMAN, H			2 DIFFERENT MUTATIONS OF THE X-CHROMOSOME CAUSING DIABETES INSIPIDUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BLOTNER H, 1951, DIABETES INSIPIDUS; BONNET R, 1936, THESIS LYON; CAMERER J. W., 1935, ARCH ROSS U GES BIOL, V28, P382; CHASE L, 1927, CANAD M ASS J, V56, P212; Chester W, 1933, J AMER MED ASSOC, V100, P806, DOI 10.1001/jama.1933.02740110018007; de LANGE CORNELIA, 1935, JAHRB KINDERHEILK, V145, P1; DOLLE W, 1951, Z MENSCHLICHE VERERB, V30, P372; Ellermann M, 1939, ACTA PSYCH NEUROL, V14, P233, DOI 10.1111/j.1600-0447.1939.tb06638.x; FONTAN, 1944, J MED BORDEAUX, V121, P161; FORD EB, 1948, GENETICS MEDICAL STU; FORSSMAN H, 1945, ACTA MED SCAND  S159; GANSSLEN M, 1924, KLIN WCHNSCHR, V3, P22; HANHART E, 1940, HDB ERBBIOLOGIE ME 2, V4, P798; HARDING FE, 1943, W J SURG, V51, P269; JANSEN E, 1921, NEDERL TSCHR GENES 2, V65, P2519; KNOPFELMACHER W, 1905, MUNCH MED WSCHR, V52, P629; KOMAI T, 1934, CITED INDIRECTLY; LACOMBE LU, 1841, J MED CHIR, V7, P339; LACOMBE LU, 1841, J MED CHIR, V7, P305; Lacombe UL., 1841, J MED CHIR, V7, P323; LAURITZEN M, 1893, HOSPITALSTID, V1, P423; LAURITZEN M, 1893, HOSPITALSTID, V1, P451; LAURITZEN M, 1893, HOSPITALSTID, V1, P392; LAURITZEN M, 1893, HOSPITALSTIDENDE   4, V1, P352; Levit SG, 1936, J HERED, V27, P445, DOI 10.1093/oxfordjournals.jhered.a104159; LIEBMANN A, 1888, THESIS BERLIN; MARTINEZ GN, 1922, REV CIRC MED CORDOBA, V10, P78; McIlraith CH, 1892, LANCET 140, P767, DOI [10.1016/S0140-6736(01)87712-6, DOI 10.1016/S0140-6736(01)87712-6, 10.1016/s0140-6736(01)87712-6]; PAIN G, 1879, THESIS PARIS; PENDER CB, 1953, PEDIATRICS, V11, P246; PETERMAN MG, 1929, AM J DIS CHILD, V38, P1335; SCHERRER J, 1940, THESIS ZURICH; Smith H. W., 1951, KIDNEY; SORSBY A, 1953, CLIN GENETICS; STEINER F, 1939, ERBARZT, V7, P89; THADDEA S, 1942, ENDOKRINOLOGY, V25, P57; Warkany J, 1939, AM J DIS CHILD, V57, P603, DOI 10.1001/archpedi.1939.01990030117013; Weil A, 1908, DTSCH ARCH KLIN MED, V93, P180; Weil A, 1884, ARCH PATHOLOGISCHE A, V95, P70; WEITZ W, 1936, VEREBUNG INNERER KRA; WELLER CG, 1950, J UROLOGY, V64, P716, DOI 10.1016/S0022-5347(17)68700-7; WILKINS L, 1950, DIAGNOSIS TREATMENT, P293; WILLIAMS RH, 1947, ANN INTERN MED, V27, P84, DOI 10.7326/0003-4819-27-1-84	43	28	28	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1955	7	1					21	27						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA210	14361390				2022-12-18	WOS:A1955WA21000003
J	NEEL, JV				NEEL, JV			DATA PERTAINING TO THE POPULATION DYNAMICS OF SICKLE CELL DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ASHLEYMONTAGU MF, 1944, PSYCHIATRY, V7, P163; Ashman R, 1952, AM J PHYS ANTHROP-NE, V10, P217, DOI 10.1002/ajpa.1330100219; BEET EA, 1949, ANN EUGENIC, V14, P279; BRZEZINSKI A, 1952, ANN EUGENIC, V16, P335; CABRAL JMH, 1950, REV MED DOMINICANA, V5, P336; CAMINOPETROS J, 1952, LANCET, V262, P687; CHOREMIS C, 1951, LANCET, V260, P1147; DREYFUSS F, 1951, NATURE, V167, P950, DOI 10.1038/167950a0; FOY H, 1952, T ROY SOC TROP MED H, V46, P327, DOI 10.1016/0035-9203(52)90079-5; GATES RR, 1949, PEDIGREES NEGRO FAMI; GLASS B, 1950, AM J HUM GENET, V2, P269; Herskovits MJ, 1941, MYTH NEGRO PAST; HODGES JH, 1950, BLOOD, V5, P804, DOI 10.1182/blood.V5.9.804.804; ITANO HA, 1950, P NATL ACAD SCI USA, V36, P613, DOI 10.1073/pnas.36.11.613; KAPLAN E, 1951, BLOOD, V6, P1240, DOI 10.1182/blood.V6.12.1240.1240; LAMBOTTELEGRAND J, 1951, MEM I R COLONIAL BEL, V19; LEHMANN H, 1952, T ROY SOC TROP MED H, V46, P380; LEHMANN H, 1951, NATURE, V167, P931, DOI 10.1038/167931a0; LEHMANN H, 1952, BMJ-BRIT MED J, V2, P433; MARGOLIES MP, 1951, MEDICINE, V30, P357, DOI 10.1097/00005792-195112000-00003; Meier A, 1949, AM J PHYS ANTHROP-NE, V7, P227, DOI 10.1002/ajpa.1330070206; MOURANT AE, 1952, BMJ-BRIT MED J, V1, P426; NEEL JV, 1952, BLOOD, V7, P467, DOI 10.1182/blood.V7.4.467.467; NEEL JV, 1947, MEDICINE, V26, P115, DOI 10.1097/00005792-194705000-00001; NEEL JV, 1953, BLOOD, V8, P434, DOI 10.1182/blood.V8.5.434.434; NEEL JV, 1949, SCIENCE, V110, P64, DOI 10.1126/science.110.2846.64; NEEL JV, 1951, BLOOD, V6, P389, DOI 10.1182/blood.V6.5.389.389; NEEL JV, 1950, COLD SPRING HARB SYM, V15, P141, DOI 10.1101/SQB.1950.015.01.017; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; RAPER AB, 1951, LANCET, V261, P225; RAPER ALAN B., 1950, JOUR TROP MED AND HYG, V53, P49; THIEME FP, 1952, AM J HUM GENET, V4, P94; WEISS W, 1952, AM REV TUBERC PULM, V65, P735	33	28	28	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1953	5	2					154	167						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XW630	13065263				2022-12-18	WOS:A1953XW63000005
J	MONTAGU, MFA				MONTAGU, MFA			PAGETS DISEASE (OSTEITIS-DEFORMANS) AND HEREDITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BOYD W, 1947, TXB PATHOLOGY, P980; CAMURATI L, 1922, CHIRURGIA DELGI ORGA; DICKSON DD, 1945, RADIOLOGY, V44, P449, DOI 10.1148/44.5.449; GATES RR, 1946, HUMAN GENETICS, V1, P473; Kay HD, 1934, ARCH INTERN MED, V53, P208, DOI 10.1001/archinte.1934.00160080045003; Moehlig RC, 1935, ENDOCRINOLOGY, V19, P515, DOI 10.1210/endo-19-5-515; Roberts R E, 1926, Proc R Soc Med, V19, P13; van Bogaert L, 1933, Z GESAMTE NEUROL PSY, V147, P327, DOI 10.1007/BF02870451; WEBER FP, 1939, DTSCH ARCH KLIN MED, V184, P78	9	28	29	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1949	1	1					94	95						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU075	17948387				2022-12-18	WOS:A1949XU07500009
J	NEEL, JV				NEEL, JV			THE DETECTION OF THE GENETIC CARRIERS OF HEREDITARY DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review																		ANDREASSEN M, 1943, OPERA DOMO BIOL HERE, V6, P168; Angelini V., 1937, MINERVA MED, V28, P331; BAUR E, 1931, HUM HERED, P734; Bell J, 1937, PROC R SOC SER B-BIO, V123, P119, DOI 10.1098/rspb.1937.0046; BELL J, 1926, TREASURY HUMAN INH 2, V2, P124; BELL J, 1934, TREASURY HUMAN INHER, V4, P1; BERGLUND H., 1935, Acta Medica Scandinavica, V86, P233; BERNSTEIN F, 1931, Z INDUKT ABSTAMM VER, V57, P113; Boyd WC, 1947, SOUTHWEST J ANTHROP, V3, P32, DOI 10.1086/soutjanth.3.1.3628533; Burks BS, 1941, GENETICS, V26, P223; Burks BS, 1938, P NATL ACAD SCI USA, V24, P512, DOI 10.1073/pnas.24.11.512; Caminopetros J., 1938, ANN MED, V43, P104; Caminopetros J., 1938, ANN MED, V43, P27; CHINI V, 1941, B SOC ITAL BIOL SPER, V16, P305; CHINI V, 1946, GAZZ MED ITAL, V105, P202; Cooley T. B., 1925, T AM PEDIATRIC SOCIE, V37, P29; Dameshek W, 1943, AM J MED SCI, V205, P643, DOI 10.1097/00000441-194305000-00003; Dameshek W, 1940, AM J MED SCI, V200, P445, DOI 10.1097/00000441-194010000-00002; Davenport CB, 1916, AM J INSANITY, V73, P195, DOI 10.1176/ajp.73.2.195; Davenport CB, 1930, GENETICS, V15, P401; ENTRES J, 1921, MONOGR NEUR PSYCHIAT, V27, P1; FALLS HF, 1948, ARCH OPHTHALMOL-CHIC, V40, P685, DOI 10.1001/archopht.1948.00900030700009; FALLS HF, 1948, COMMUNICATION; Ferguson LC, 1942, J IMMUNOL, V44, P147; Finney DJ, 1940, ANN EUGENIC, V10, P171, DOI 10.1111/j.1469-1809.1940.tb02246.x; Fisher RA, 1936, ANN EUGENIC, V7, P17, DOI 10.1111/j.1469-1809.1936.tb02125.x; Fisher RA, 1934, ANN EUGENIC, V6, P66, DOI 10.1111/j.1469-1809.1934.tb02107.x; Fisher RA, 1935, ANN EUGENIC, V4, P187; FISHER RA, 1935, P INT C LIFE ASS MED; Folin O, 1915, ARCH INTERN MED, V16, P33; FOSTER DB, IN PRESS; GARROD AE, 1931, INBORN FACTORS DISEA, P160; GATES R. R., 1946, Human genetics., V1; 2, P1; GATES RR, 1946, HUM GENET, V2, P1518; Gatto I., 1942, ARCH ITAL PEDIAT EPU, V9, P128; Geratovitsch M, 1927, ARCH PSYCHIAT NERVEN, V80, P513, DOI 10.1007/BF01832697; Gibbs F. A, 1941, ATLAS ELECTROENCEPHA, P221; Goedbloed J., 1942, OPHTHALMOLOGICA, V104, P308; GREPPI E, 1928, MINERVA MED TOR, V19, P1; GUNDER R., 1938, ARCH RASS U GES BIOL, V32, P10; HALDANE JBS, 1946, ANN EUGENIC, V13, P122, DOI 10.1111/j.1469-1809.1946.tb02348.x; HALDANE JBS, 1948, PROC R SOC SER B-BIO, V135, P147, DOI 10.1098/rspb.1948.0002; Haldane JBS, 1934, ANN EUGENIC, V6, P26, DOI 10.1111/j.1469-1809.1934.tb02106.x; HALDANE JBS, 1947, ANN EUGENIC, V14, P10, DOI 10.1111/j.1469-1809.1947.tb02374.x; Hogben L, 1934, P R SOC LOND B-CONTA, V114, P340, DOI 10.1098/rspb.1934.0011; Hogben L, 1935, J GENET, V31, P353, DOI 10.1007/BF02982406; HOOGVLIET B, 1942, GENETICA, V23, P93; Hughes EM, 1925, AM J PSYCHIAT, V4, P537; Jacobson BM, 1938, ANN INTERN MED, V11, P1277, DOI 10.7326/0003-4819-11-7-1277; KLOEPFER HW, 1946, ANN EUGENIC, V13, P35, DOI 10.1111/j.1469-1809.1946.tb02342.x; MADLENDER M., 1928, ARCH RASSEN U GES BIOL, V20, P390; McCULLOCH C, 1948, Trans Am Acad Ophthalmol Otolaryngol, V52, P160; Meggendorfer F, 1923, Z GESAMTE NEUROLOGIE, V87, P1; Minski L, 1938, J MENT SCI, V84, P21, DOI 10.1192/bjp.84.348.21; Mortensen KB, 1940, MEDICINE, V19, P161; MULLER HJ, 1947, GENETICS MED MAN, P158; MUNRO TA, 1941, 7 P INT C GEN ED, P224; NEEL JV, 1947, MEDICINE, V26, P115, DOI 10.1097/00005792-194705000-00001; NEEL JV, 1947, GENETICS, V32, P38; NEEL JV, 1945, AM J MED SCI, V209, P568; Okey R, 1926, J BIOL CHEM, V68, P687; Owen R. D., 1944, JOUR ANIMAL SCI, V3, P315; PATTERSON RM, 1948, AM J PSYCHIAT, V104, P786, DOI 10.1176/ajp.104.12.786; PENROSE LS, 1946, ANN EUGENIC, V13, P25, DOI 10.1111/j.1469-1809.1946.tb02340.x; Penrose LS, 1935, ANN EUGENIC, V4, P133; RIDDELL WJB, 1946, ANN EUGENIC, V13, P30, DOI 10.1111/j.1469-1809.1946.tb02341.x; Riddell WJB, 1938, J GENET, V36, P45, DOI 10.1007/BF02982373; RIETTI F, 1925, ATTI ACCAD SC MED NA, V2, P13; RIFE DAVID C., 1941, SCIENCE, V94, P187, DOI 10.1126/science.94.2434.187-a; SCHLOESSMANN H, 1924, ARCH KLIN CHIR, V133, P686; SCHULTZ J, 1948, COMMUNICATION; SCHUTZBACH M, 1938, A VANGRAEFES ARCH OP, V138, P315; SILVESTRONI E, 1947, Policlinico Prat, V54, P1147; SILVESTRONI E, 1947, RICER SC, V17, P2021; SILVESTRONI E, 1946, B ACCAD MED ROMA, V72, P32; SILVESTRONI E, 1946, RICER MORF, V22, P217; SILVESTRONI E, 1944, POLICLINICO M, V51, P197; SILVESTRONI E, 1945, POLICLINICO SEZ PRAT, V52, P137; SJOGREN I, 1935, Z MENSCHL VERERBUNGS, V19, P135; Smith CH, 1942, J PEDIATR-US, V20, P370, DOI 10.1016/S0022-3476(42)80194-8; SMITH HE, 1916, ROY LOND OPHTH HOSP, V20, P157; SMYTH CJ, 1948, J CLIN INVEST, V27, P749, DOI 10.1172/JCI102025; Smyth CJ, 1942, ANN INTERN MED, V16, P46, DOI 10.7326/0003-4819-16-1-46; SNYDER LH, 1947, SCIENCE, V106, P347, DOI 10.1126/science.106.2754.347-a; SNYDER LH, 1931, EUGEN NEWS, V16, P117; Spodaro A, 1933, ARCH INTERN MED, V52, P593, DOI 10.1001/archinte.1933.00160040099005; STECHER RM, 1945, GENETICS, V30, P24; Stephens DJ, 1935, J LAB CLIN MED, V20, P375; Strauss MB, 1941, AM J MED SCI, V201, P30, DOI 10.1097/00000441-194101000-00003; STRAUSS MB, 1948, BLOOD N Y, V3, P438; Talbott JH, 1940, J CLIN INVEST, V19, P645, DOI 10.1172/JCI101167; Usher C, 1935, T OPHTHAL SOC UK, V55, P164; Valentine WN, 1944, ARCH INTERN MED, V74, P185, DOI 10.1001/archinte.1944.00210210032005; VALENTINE WN, 1948, AM J MED SCI, V215, P456, DOI 10.1097/00000441-194804000-00016; Vessie PR, 1932, J NERV MENT DIS, V76, P553, DOI 10.1097/00005053-193212000-00001; VONPLANTA P, 1938, ARCH OPHTH BERL, V120, P253; VONRATH B, 1938, ARCH RASSENB, V32, P397; Whipple GH, 1936, J PEDIATR-US, V9, P279, DOI 10.1016/S0022-3476(36)80021-3; White T, 1940, J GENET, V40, P403, DOI 10.1007/BF03028229; Wiener AS, 1932, GENETICS, V17, P0335; Wiener AS, 1936, ANN EUGENIC, V7, P141, DOI 10.1111/j.1469-1809.1936.tb02135.x; Wintrobe MM, 1940, J AMER MED ASSOC, V114, P1530; WINTROBE MM, 1942, CLIN HEMATOLOGY, P792; YEAGER CL, 1937, P MAYO CLIN, V12, P705; ZORN B, 1920, ARCH OPHTHALMOL-CHIC, V101, P1	105	28	28	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1949	1	1					19	36						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU075	17948380				2022-12-18	WOS:A1949XU07500002
J	Chen, N; Zhao, S; Jolly, A; Wang, LL; Pan, HX; Yuan, J; Chen, SK; Koch, A; Ma, CC; Tian, WJ; Jia, ZQ; Kang, J; Zhao, LN; Qin, CL; Fan, X; Rall, K; Coban-Akdemir, Z; Chen, ZF; Jhangiani, S; Liang, Z; Niu, YC; Li, XX; Yan, ZH; Wu, Y; Dong, SS; Song, CC; Qiu, GX; Zhang, SY; Liu, PF; Posey, JE; Zhang, F; Luo, GN; Wu, ZH; Su, JZ; Zhang, JG; Chen, EY; Rouskas, K; Glentis, S; Bacopoulou, F; Deligeoroglou, E; Chrousos, G; Lyonnet, S; Polak, M; Rosenberg, C; Dingeldein, I; Bonilla, X; Borel, C; Gibbs, RA; Dietrich, JE; Dimas, AS; Antonarakis, SE; Brucker, SY; Lupski, JR; Wu, N; Zhu, L				Chen, Na; Zhao, Sen; Jolly, Angad; Wang, Lianlei; Pan, Hongxin; Yuan, Jian; Chen, Shaoke; Koch, Andre; Ma, Congcong; Tian, Weijie; Jia, Ziqi; Kang, Jia; Zhao, Lina; Qin, Chenglu; Fan, Xin; Rall, Katharina; Coban-Akdemir, Zeynep; Chen, Zefu; Jhangiani, Shalini; Liang, Ze; Niu, Yuchen; Li, Xiaoxin; Yan, Zihui; Wu, Yong; Dong, Shuangshuang; Song, Chengcheng; Qiu, Guixing; Zhang, Shuyang; Liu, Pengfei; Posey, Jennifer E.; Zhang, Feng; Luo, Guangnan; Wu, Zhihong; Su, Jianzhong; Zhang, Jianguo; Chen, Eugenia Y.; Rouskas, Konstantinos; Glentis, Stavros; Bacopoulou, Flora; Deligeoroglou, Efthymios; Chrousos, George; Lyonnet, Stanislas; Polak, Michel; Rosenberg, Carla; Dingeldein, Irene; Bonilla, Ximena; Borel, Christelle; Gibbs, Richard A.; Dietrich, Jennifer E.; Dimas, Antigone S.; Antonarakis, Stylianos E.; Brucker, Sara Y.; Lupski, James R.; Wu, Nan; Zhu, Lan		Deciphering Disorders Involving Sc	Perturbations of genes essential for Mullerian duct and Wolffian duct development in Mayer-Rokitansky-Kuster-Hauser syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUTATIONS; KIDNEY; WNT9B; REQUIREMENT; VARIANTS	Mayer-Rokitansky-Kuster-Hauser syndrome (MRKHS) is associated with congenital absence of the uterus, cervix, and the upper part of the vagina; it is a sex-limited trait. Disrupted development of the Mullerian ducts (MD)/Wolffian ducts (WD) through multifactorial mechanisms has been proposed to underlie MRKHS. In this study, exome sequencing (ES) was performed on a Chinese discovery cohort (442 affected subjects and 941 female control subjects) and a replication MRKHS cohort (150 affected subjects of mixed ethnicity from North America, South America, and Europe). Phenotypic follow-up of the female reproductive system was performed on an additional cohort of PAX8-associated congenital hypothyroidism (CH) (n = 5, Chinese). By analyzing 19 candidate genes essential for MD/WD development, we identified 12 likely gene-disrupting (LGD) variants in 7 genes: PAX8 (n = 4), BMP4 (n = 2), BMP7 (n = 2), TBX6 (n = 1), HOXA10 (n = 1), EMX2 (n = 1), and WNT9B (n = 1), while LGD variants in these genes were not detected in control samples (p = 1.27E-06). Interestingly, a sex-limited penetrance with paternal inheritance was observed in multiple families. One additional PAX8 LGD variant from the replication cohort and two missense variants from both cohorts were revealed to cause loss-of-function of the protein. From the PAX8-associated CH cohort, we identified one individual presenting a syndromic condition characterized by CH and MRKHS (CH-MRKHS). Our study demonstrates the comprehensive utilization of knowledge from developmental biology toward elucidating genetic perturbations, i.e., rare pathogenic alleles involving the same loci, contributing to human birth defects.	[Chen, Na; Ma, Congcong; Tian, Weijie; Jia, Ziqi; Kang, Jia; Liang, Ze; Zhu, Lan] Peking Union Med Coll & Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Obstet & Gynaecol, State Key Lab Complex Severe & Rare Dis, Beijing 100730, Peoples R China; [Zhao, Sen; Wang, Lianlei; Zhao, Lina; Chen, Zefu; Yan, Zihui; Qiu, Guixing; Zhang, Jianguo; Wu, Nan] Peking Union Med Coll & Chinese Acad Med Sci, Peking Union Med Coll Hosp, State Key Lab Complex Severe & Rare Dis, Dept Orthoped Surg, Beijing 100730, Peoples R China; [Zhao, Sen; Wang, Lianlei; Zhao, Lina; Chen, Zefu; Niu, Yuchen; Li, Xiaoxin; Yan, Zihui; Wu, Yong; Qiu, Guixing; Wu, Zhihong; Zhang, Jianguo; Wu, Nan] Beijing Key Lab Genet Res Skeletal Deform, Beijing 100730, Peoples R China; [Jolly, Angad; Coban-Akdemir, Zeynep; Jhangiani, Shalini; Liu, Pengfei; Posey, Jennifer E.; Gibbs, Richard A.; Lupski, James R.; Wu, Nan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Jolly, Angad] Baylor Coll Med, MD PhD Med Scientist Training Program, Houston, TX 77030 USA; [Wang, Lianlei] Shandong Univ, Dept Orthoped Surg, Qilu Hosp, Jinan 250012, Shandong, Peoples R China; [Pan, Hongxin; Qin, Chenglu; Luo, Guangnan] Shenzhen Univ, Luohu Hosp, Affiliated Hosp 2, Dept Obstet & Gynaecol, Shenzhen 518000, Guangdong, Peoples R China; [Yuan, Jian; Su, Jianzhong] Wenzhou Med Univ, Inst Biomed Big Data, Wenzhou 325027, Peoples R China; [Chen, Shaoke; Fan, Xin] Guangxi Med Univ, Dept Pediat, Affiliated Hosp 2, Nanning 530003, Guangxi, Peoples R China; [Koch, Andre; Rall, Katharina; Brucker, Sara Y.] Tubingen Univ Hosp, Res Ctr Womens Hlth, Dept Gynecol & Obstet, D-72076 Tubingen, Germany; [Dong, Shuangshuang; Song, Chengcheng; Zhang, Feng] Shanghai Inst Planned Parenthood Res, Sch Life Sci, NHC Key Lab Reprod Regulat, Obstet & Gynecol Hosp, Shanghai 200011, Peoples R China; [Qiu, Guixing; Wu, Zhihong; Wu, Nan] Chinese Acad Med Sci, Key Lab Big Data Spinal Deform, Beijing 100730, Peoples R China; [Zhang, Shuyang] Peking Union Med Coll & Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Cardiol, Beijing 100730, Peoples R China; [Liu, Pengfei] Baylor Genet, Houston, TX 77021 USA; [Wu, Zhihong; Wu, Nan] Peking Union Med Coll & Chinese Acad Med Sci, Peking Union Med Coll Hosp, Med Res Ctr, Beijing 100730, Peoples R China; [Chen, Eugenia Y.] Baylor Coll Med, Houston, TX 77030 USA; [Chen, Eugenia Y.; Dietrich, Jennifer E.; Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Chen, Eugenia Y.; Dietrich, Jennifer E.] Texas Childrens Hosp, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Rouskas, Konstantinos; Glentis, Stavros; Dimas, Antigone S.] Biomed Sci Res Ctr AI Fleming, Inst Bioinnovat, Athens 16672, Greece; [Bacopoulou, Flora; Chrousos, George] Natl & Kapodistrian Univ Athens, Aghia Sophia Childrens Hosp, Ctr Adolescent Med, Athens 11527, Greece; [Bacopoulou, Flora; Chrousos, George] Natl & Kapodistrian Univ Athens, Aghia Sophia Childrens Hosp, UNESCO Chair Adolescent Hlth Care, Dept Pediat 1,Sch Med, Athens 11527, Greece; [Deligeoroglou, Efthymios] Natl & Kapodistrian Univ Athens, Aretaie Hosp, Sch Med, Dept Obstet & Gynecol 2,Div Pediat Adolescent Gyn, Athens 10679, Greece; [Lyonnet, Stanislas; Polak, Michel] INSERM, Inst Imagine, UMR 1163, F-75015 Paris, France; [Lyonnet, Stanislas; Polak, Michel] Univ Paris, Hosp Univ Necker Enfants Malad, F-75015 Paris, France; [Rosenberg, Carla] Univ Sao Paulo, Inst Biosci, Dept Genet & Evolutionary Biol, BR-05508090 Sao Paulo, Brazil; [Dingeldein, Irene] Univ Bern, Inselspital, Frauen Klin, CH-3012 Bern, Switzerland; [Bonilla, Ximena; Borel, Christelle; Antonarakis, Stylianos E.] Univ Geneva, Med Sch, Dept Genet Med & Dev, CH-1205 Geneva, Switzerland; [Gibbs, Richard A.; Lupski, James R.] Baylor Coll Med, Human Genome Seuencing Ctr, Houston, TX 77030 USA; [Dietrich, Jennifer E.; Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA; [Antonarakis, Stylianos E.] Univ Geneva, Inst Genet & Genom Geneva, CH-1205 Geneva, Switzerland; [Rouskas, Konstantinos] Ctr Res & Technol Hellas, Inst Appl Biosci, Thessaloniki 57001, Greece; [Glentis, Stavros] Univ Athens, Aghia Sophia Childrens Hosp, Dept Pediat 1, Div Pediat Hematol Oncol, Athens 11527, Greece	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Baylor College of Medicine; Baylor College of Medicine; Shandong University; Shenzhen University; Wenzhou Medical University; Guangxi Medical University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Fudan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital; Athens Medical School; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital; Athens Medical School; National & Kapodistrian University of Athens; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universidade de Sao Paulo; University of Bern; University Hospital of Bern; University of Geneva; Baylor College of Medicine; Baylor College of Medicine; University of Geneva; Centre for Research & Technology Hellas; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital	Zhu, L (corresponding author), Peking Union Med Coll & Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Obstet & Gynaecol, State Key Lab Complex Severe & Rare Dis, Beijing 100730, Peoples R China.; Wu, N (corresponding author), Peking Union Med Coll & Chinese Acad Med Sci, Peking Union Med Coll Hosp, State Key Lab Complex Severe & Rare Dis, Dept Orthoped Surg, Beijing 100730, Peoples R China.; Wu, N (corresponding author), Beijing Key Lab Genet Res Skeletal Deform, Beijing 100730, Peoples R China.; Wu, N (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Wu, N (corresponding author), Chinese Acad Med Sci, Key Lab Big Data Spinal Deform, Beijing 100730, Peoples R China.; Wu, N (corresponding author), Peking Union Med Coll & Chinese Acad Med Sci, Peking Union Med Coll Hosp, Med Res Ctr, Beijing 100730, Peoples R China.	dr.wunan@pumch.cn; zhu_julie@vip.sina.com	Bonilla, Ximena/AAI-7910-2021; wu, zhi/GXH-3041-2022; pan, hongxin/AAM-5283-2020; Jia, Ziqi/GRF-0134-2022; Zhang, Feng/C-7735-2009; Wu, Nan/R-2186-2017	pan, hongxin/0000-0003-2004-4169; Zhang, Feng/0000-0003-4556-8276; Bonilla, Ximena/0000-0002-4950-6825; Yuan, Jian/0000-0002-1896-2561; ROUSKAS, KONSTANTINOS/0000-0003-2549-6834; Wu, Nan/0000-0002-9429-2889	National Natural Science Foundation of China [81822030, 82072391, 81772299, 81930068, 31625015, 31771396, 81772301, 81972132, 81801401, 81672123, 81972037]; Beijing Natural Science Foundation [JQ20032, 7191007]; 2016 Milstein Medical Asian American Partnership Foundation Fellowship Award in Translational Medicine; National Science and Technology Support Program [2015BAI13B04]; CAMS Initiative Fund for Medical Sciences [2016-I2M-3-003, 2017-12M-1-002, 2016-I2M-2-006, 2017-I2M-2-001]; Central Level Public Interest Program for Scientific Research Institute [2018RC31003]; National Key Research and Development Program of China [2016YFC0901501, 2018YFC0910506]; Sanming Project of Medicine in Shenzhen, Health and Family Planning Commission of Guangdong Province [A2018431]; Shenzhen Healthcare Research Project [201601055, SZLY2017020]; Shanghai Medical Center of Key Programs for Female Reproductive Diseases [2017ZZ01016]; Shanghai Municipal Science and Technology Major Project [2017SHZDZX01]; US National Institutes of Health, National Institute of Neurological Disorders and Stroke [NINDS R35 NS105078]; National Human Genome Research Institute/National Heart, Lung, and Blood Institute [NHGRI/NHLBI UM1 HG006542]; National Human Genome Research Institute (NHGRI) [K08 HG008986]; Foundation Sante' Biomedical Research Grant; Latsis Foundation Research Grant; Stavros Niarchos Foundation; Deutsche Forschungsgemeinschaft [DFG 351381475]; European Research Council [ERC 2199678, 2015/14821-1, 2017/16283-2]; Faculty of Medicine at the University of Geneva Medical School; Fundacao de Amparo a` Pesquisa do Estado de Sao Paulo [2017/16283-2, FAPESP: 2015/14821-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); 2016 Milstein Medical Asian American Partnership Foundation Fellowship Award in Translational Medicine; National Science and Technology Support Program; CAMS Initiative Fund for Medical Sciences; Central Level Public Interest Program for Scientific Research Institute; National Key Research and Development Program of China; Sanming Project of Medicine in Shenzhen, Health and Family Planning Commission of Guangdong Province; Shenzhen Healthcare Research Project; Shanghai Medical Center of Key Programs for Female Reproductive Diseases; Shanghai Municipal Science and Technology Major Project; US National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Human Genome Research Institute/National Heart, Lung, and Blood Institute; National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Foundation Sante' Biomedical Research Grant; Latsis Foundation Research Grant; Stavros Niarchos Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Faculty of Medicine at the University of Geneva Medical School; Fundacao de Amparo a` Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	We appreciate all of the patients, their families, and clinical research coordinators who participated in this project. We thank GeneSeeq Inc. for exome sequencing technical support. We thank Beijing Ekitech Co. Ltd. for support in bioinformatic analyses. This work was supported by the National Natural Science Foundation of China (81822030 and 82072391 to N.W., 81772299 and 81930068 to Z.W., 31625015 and 31771396 to F.Z., 81772301 and 81972132 to G.Q., 81801401 to N.C., and 81672123 and 81972037 to J.Z.), Beijing Natural Science Foundation (JQ20032 to N.W., 7191007 to Z.W.), 2016 Milstein Medical Asian American Partnership Foundation Fellowship Award in Translational Medicine (to N.W.), National Science and Technology Support Program (2015BAI13B04 to L. Zhu), CAMS Initiative Fund for Medical Sciences (2016-I2M-3-003 to G.Q. and N.W., 2017-12M-1-002 to L. Zhu, 2016-I2M-2-006 and 2017-I2M-2-001 to Z.W.), the Central Level Public Interest Program for Scientific Research Institute (2018RC31003 to N.W.), the National Key Research and Development Program of China(2016YFC0901501 to S. Zhang, 2018YFC0910506 to N.W. and Z.W.), Sanming Project of Medicine in Shenzhen, Health and Family Planning Commission of Guangdong Province (A2018431), Shenzhen Healthcare Research Project (201601055 and SZLY2017020), Shanghai Medical Center of Key Programs for Female Reproductive Diseases (2017ZZ01016 to F.Z.), and Shanghai Municipal Science and Technology Major Project (2017SHZDZX01 to F.Z.). Also supported by the US National Institutes of Health, National Institute of Neurological Disorders and Stroke (NINDS R35 NS105078 to J.R.L.), National Human Genome Research Institute/National Heart, Lung, and Blood Institute (NHGRI/NHLBI UM1 HG006542 to J.R.L.), the National Human Genome Research Institute (NHGRI K08 HG008986 to J.E.P.), the Foundation Sante ' Biomedical Research Grant (to A.S.D.), Latsis Foundation Research Grant (to A.S.D.), Stavros Niarchos Foundation (startup funds to A.S.D.), the Deutsche Forschungsgemeinschaft (DFG 351381475), European Research Council (ERC 2199678), Fundacao de Amparo a` Pesquisa do Estado de Sao Paulo (FAPESP: 2015/14821-1, 2017/16283-2), and an Institutional grant from the Faculty of Medicine at the University of Geneva Medical School.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; [Anonymous], [No title captured]; Atsuta Y, 2016, DEVELOPMENT, V143, P3549, DOI 10.1242/dev.137067; Bernardini L, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-25; Biason-Lauber A, 2004, NEW ENGL J MED, V351, P792, DOI 10.1056/NEJMoa040533; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Cheroki C, 2006, AM J MED GENET A, V140A, P1339, DOI 10.1002/ajmg.a.31254; Coban-Akdemir Z, 2018, AM J HUM GENET, V103, P171, DOI 10.1016/j.ajhg.2018.06.009; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Fu CY, 2015, CLIN CHIM ACTA, V450, P322, DOI 10.1016/j.cca.2015.09.008; Grimbizis GF, 2013, HUM REPROD, V28, P2032, DOI 10.1093/humrep/det098; Hwang DY, 2014, KIDNEY INT, V85, P1429, DOI 10.1038/ki.2013.508; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kobayashi A, 2004, DEVELOPMENT, V131, P539, DOI 10.1242/dev.00951; Liu JQ, 2019, GENET MED, V21, P1548, DOI 10.1038/s41436-018-0377-x; Macchia PE, 1998, NAT GENET, V19, P83, DOI 10.1038/ng0598-83; Mittag J, 2007, ENDOCRINOLOGY, V148, P719, DOI 10.1210/en.2006-1054; Morcel K, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-13; Mullen RD, 2014, SEX DEV, V8, P281, DOI 10.1159/000364935; Nacke S, 2000, DEV DYNAM, V219, P192, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1046>3.0.CO;2-9; Nik-Zainal S, 2011, J MED GENET, V48, P197, DOI 10.1136/jmg.2010.082412; Orvis GD, 2007, DEV BIOL, V306, P493, DOI 10.1016/j.ydbio.2007.03.027; Sandbacka M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-125; Sanna-Cherchi S, 2017, AM J HUM GENET, V101, P789, DOI 10.1016/j.ajhg.2017.09.018; Vaser R, 2016, NAT PROTOC, V11, P1, DOI 10.1038/nprot.2015.123; Wang M, 2014, REPROD BIOMED ONLINE, V28, P80, DOI 10.1016/j.rbmo.2013.09.022; Waschk DEJ, 2016, CLIN GENET, V89, P590, DOI 10.1111/cge.12701; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Wu N, 2015, NEW ENGL J MED, V372, P341, DOI 10.1056/NEJMoa1406829; Yang N, 2019, HUM MOL GENET, V28, P539, DOI 10.1093/hmg/ddy358	30	27	28	3	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 4	2021	108	2					337	345		10.1016/j.ajhg.2020.12.014	http://dx.doi.org/10.1016/j.ajhg.2020.12.014		FEB 2021	9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QX1UZ	33434492	Green Published, Bronze			2022-12-18	WOS:000629135400012
J	Middleton, A; Milne, R; Almarri, MA; Anwer, S; Atutornu, J; Baranova, EE; Bevan, P; Cerezo, M; Cong, YL; Critchley, C; Fernow, J; Goodhand, P; Hasan, Q; Hibino, A; Houeland, G; Howard, HC; Hussain, SZ; Malmgren, CI; Izhevskaya, VL; Jedrzejak, A; Cao, JH; Kimura, M; Kleiderman, E; Leach, B; Liu, KY; Mascalzoni, D; Mendes, A; Minari, J; Wang, N; Nicol, D; Niemiec, E; Patch, C; Pollard, J; Prainsack, B; Riviere, M; Robarts, L; Roberts, J; Romano, V; Sheerah, HA; Smith, J; Soulier, A; Steed, C; Stefansdottir, V; Tandre, C; Thorogood, A; Voigt, TH; West, AV; Yoshizawa, G; Morley, KI				Middleton, Anna; Milne, Richard; Almarri, Mohamed A.; Anwer, Shamim; Atutornu, Jerome; Baranova, Elena E.; Bevan, Paul; Cerezo, Maria; Cong, Yali; Critchley, Christine; Fernow, Josepine; Goodhand, Peter; Hasan, Qurratulain; Hibino, Aiko; Houeland, Gry; Howard, Heidi C.; Hussain, S. Zakir; Malmgren, Charlotta Ingvoldstad; Izhevskaya, Vera L.; Jedrzejak, Aleksandra; Cao Jinhong; Kimura, Megumi; Kleiderman, Erika; Leach, Brandi; Liu, Keying; Mascalzoni, Deborah; Mendes, Alvaro; Minari, Jusaku; Wang, Nan; Nicol, Dianne; Niemiec, Emilia; Patch, Christine; Pollard, Jack; Prainsack, Barbara; Riviere, Marie; Robarts, Lauren; Roberts, Jonathan; Romano, Virginia; Sheerah, Haytham A.; Smith, James; Soulier, Alexandra; Steed, Claire; Stefansdottir, Vigdis; Tandre, Cornelia; Thorogood, Adrian; Voigt, Torsten H.; West, Anne, V; Yoshizawa, Go; Morley, Katherine, I			Global Public Perceptions of Genomic Data Sharing: What Shapes the Willingness to Donate DNA and Health Data?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC EXCEPTIONALISM; BROAD CONSENT; PERSPECTIVES; PARTICIPATE; ATTITUDES; TRUST	Analyzing genomic data across populations is central to understanding the role of genetic factors in health and disease. Successful data sharing relies on public support, which requires attention to whether people around the world are willing to donate their data that are then subsequently shared with others for research. However, studies of such public perceptions are geographically limited and do not enable comparison. This paper presents results from a very large public survey on attitudes toward genomic data sharing. Data from 36,268 individuals across 22 countries (gathered in 15 languages) are presented. In general, publics across the world do not appear to be aware of, nor familiar with, the concepts of DNA, genetics, and genomics. Willingness to donate one's DNA and health data for research is relatively low, and trust in the process of data's being shared with multiple users (e.g., doctors, researchers, governments) is also low. Participants were most willing to donate DNA or health information for research when the recipient was specified as a medical doctor and least willing to donate when the recipient was a for-profit researcher. Those who were familiar with genetics and who were trusting of the users asking for data were more likely to be willing to donate. However, less than half of participants trusted more than one potential user of data, although this varied across countries. Genetic information was not uniformly seen as different from other forms of health information, but there was an association between seeing genetic information as special in some way compared to other health data and increased willingness to donate. The global perspective provided by our "Your DNA, Your Say" study is valuable for informing the development of international policy and practice for sharing genomic data. It highlights that the research community not only needs to be worthy of trust by the public, but also urgent steps need to be taken to authentically communicate why genomic research is necessary and how data donation, and subsequent sharing, is integral to this.	[Middleton, Anna; Milne, Richard; Atutornu, Jerome; Patch, Christine; Robarts, Lauren; Roberts, Jonathan] Connecting Sci, Soc & Eth Res Grp, Wellcome Genome Campus, Cambridge CB10 1SA, England; [Middleton, Anna] Univ Cambridge, Fac Educ, Cambridge CB2 8PQ, England; [Milne, Richard] Univ Cambridge, Inst Publ Hlth, Cambridge CB2 0SR, England; [Almarri, Mohamed A.; Bevan, Paul; Smith, James; Steed, Claire] Wellcome Sanger Inst, Cambridge CB10 1SA, England; [Anwer, Shamim] Keynote IAS, New Delhi 110060, India; [Baranova, Elena E.] Russian Med Acad Continuous Profess Educ, Moscow 119049, Russia; [Cerezo, Maria] EMBL EBI, Wellcome Genome Campus, Cambridge CB10 1SA, England; [Cong, Yali; Wang, Nan] Peking Univ, Hlth Sci Ctr, Med Eth Program, Beijing 100191, Peoples R China; [Critchley, Christine] Swinburne Univ Technol, Dept Psychol Sci, Melbourne, Vic 3122, Australia; [Critchley, Christine; Nicol, Dianne] Univ Tasmania, Ctr Law & Genet, Hobart, Tas 7001, Australia; [Fernow, Josepine; Houeland, Gry; Howard, Heidi C.; Mascalzoni, Deborah; Niemiec, Emilia; Romano, Virginia; Soulier, Alexandra; Tandre, Cornelia] Uppsala Univ, Ctr Eth & Bioeth, SE-75122 Uppsala, Sweden; [Goodhand, Peter] MaRS Ctr, Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada; [Hasan, Qurratulain] Kamineni Hosp, Dept Genet & Mol Med, Hyderabad 500068, India; [Hasan, Qurratulain; Hussain, S. Zakir] SAAZ Genet, Hyderabad 500033, India; [Hibino, Aiko] Hirosaki Univ, Fac Humanities & Social Sci, Hirosaki, Aomori 0368560, Japan; [Malmgren, Charlotta Ingvoldstad] Uppsala Univ, Dept Publ Hlth & Caring Sci, S-75122 Uppsala, Sweden; [Malmgren, Charlotta Ingvoldstad] Karolinska Inst, Dept Mol Med & Surg, S-17176 Solna, Sweden; [Izhevskaya, Vera L.] Res Ctr Med Genet, Moscow 115522, Russia; [Cao Jinhong] Wuhan Univ, Sch Hlth Sci, Dept Epidemiol & Biostat, Wuhan 430071, Peoples R China; [Kimura, Megumi] Hitotsubashi Univ, Inst Innovat Res, Tokyo 1868603, Japan; [Kleiderman, Erika; Thorogood, Adrian] McGill Univ, Ctr Genom & Policy, Montreal, PQ H3A 0G1, Canada; [Leach, Brandi; Pollard, Jack; Morley, Katherine, I] RAND Europe, Cambridge CB4 1YG, England; [Liu, Keying; Sheerah, Haytham A.] Osaka Univ, Grad Sch Med, Dept Social Med, Publ Hlth, Suita, Osaka 5650871, Japan; [Liu, Keying] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Beijing 100191, Peoples R China; [Mascalzoni, Deborah; Romano, Virginia] EURAC, Inst Biomed, I-39100 Bolzano, Italy; [Mendes, Alvaro] Univ Porto, I3S Inst Invest & Inovacao Saude, IBMC Inst Mol & Cell Biol, UnIGENe, P-4200135 Porto, Portugal; [Mendes, Alvaro] Univ Porto, I3S Inst Invest & Inovacao Saude, IBMC Inst Mol & Cell Biol, CGPP Ctr Predict & Prevent Genet, P-4200135 Porto, Portugal; [Minari, Jusaku] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Uehiro Res Div iPS Cell Eth, Kyoto 6068507, Japan; [Patch, Christine] Queen Mary Univ London, Genom England, London EC1M 6BQ, England; [Prainsack, Barbara] Univ Vienna, Dept Polit Sci, A-1010 Vienna, Austria; [Prainsack, Barbara] Kings Coll London, Dept Global Hlth & Social Med, London WC2R 2LS, England; [Riviere, Marie] Sorbonne Nouvelle, Diltec, F-75005 Paris, France; [Stefansdottir, Vigdis] Landspitali, IS-101 Reykjavik, Iceland; [Voigt, Torsten H.] Rhein Westfal TH Aachen, Inst Sociol, D-52062 Aachen, Germany; [West, Anne, V] Indiana Univ, Maurer Sch Law, Bloomington, IN 47405 USA; [Yoshizawa, Go] Oslo Metropolitan Univ, Work Res Inst AFI, N-0130 Oslo, Norway; [Morley, Katherine, I] Kings Coll London, Inst Psychiat Psychol & Neurosci, London SE5 8AF, England; [Morley, Katherine, I] Univ Melbourne, Ctr Epidemiol & Biostat, Melbourne Sch Global & Populat Hlth, Melbourne, Vic 3010, Australia; [Howard, Heidi C.] Lund Univ, Med Eth, SE-22100 Lund, Sweden	University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); Peking University; Swinburne University of Technology; University of Tasmania; Uppsala University; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Hirosaki University; Uppsala University; Karolinska Institutet; Research Centre for Medical Genetics; Wuhan University; Hitotsubashi University; McGill University; RAND Corporation; RAND Europe; Osaka University; Peking University; European Academy of Bozen-Bolzano; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Kyoto University; University of London; Queen Mary University London; University of Vienna; University of London; King's College London; Universite Sorbonne Nouvelle - Paris 3; RWTH Aachen University; Indiana University System; Indiana University Bloomington; Oslo Metropolitan University (OsloMet); University of London; King's College London; University of Melbourne; Lund University	Middleton, A (corresponding author), Connecting Sci, Soc & Eth Res Grp, Wellcome Genome Campus, Cambridge CB10 1SA, England.; Middleton, A (corresponding author), Univ Cambridge, Fac Educ, Cambridge CB2 8PQ, England.	am33@sanger.ac.uk	Voigt, Torsten/M-8647-2013; Yoshizawa, Go/O-7898-2017; cao, jinhong/GWD-0620-2022; Niemiec, Emilia/AAT-5311-2021; Izhevskaya, Vera/AAZ-6982-2020; Prainsack, Barbara/AAF-5739-2021; Mendes, Álvaro/K-4394-2013; Nicol, Dianne/J-7253-2014; Morley, Katherine/A-2986-2011	Voigt, Torsten/0000-0002-6033-2862; Yoshizawa, Go/0000-0002-1436-8493; Niemiec, Emilia/0000-0001-6401-3925; Izhevskaya, Vera/0000-0002-7246-5144; Prainsack, Barbara/0000-0002-6335-1532; Mendes, Álvaro/0000-0002-8766-7646; Thorogood, Adrian/0000-0001-5078-8164; Nicol, Dianne/0000-0002-6553-2839; Riviere, Marie/0000-0002-6626-2631; Morley, Katherine/0000-0002-2725-5535; Middleton, Anna/0000-0003-3103-8098; Cerezo Fernandez, Maria/0000-0003-3073-1130; Mascalzoni, Deborah/0000-0003-4156-1464; Patch, Christine/0000-0002-4191-0663; Fernow, Josepine/0000-0003-4653-7084; Atutornu, Jerome/0000-0003-4033-5406; Sheerah, Haytham/0000-0001-5949-6803; Milne, Richard/0000-0002-8770-2384	Wellcome grant [206194]	Wellcome grant	This work was supported by Wellcome grant 206194 to Society and Ethics Research, Connecting Science, Wellcome Genome Campus. We'd also like to acknowledge the input of Noe ' mie Aubert Bonn, Universiteit Hasselt, Belgium.	Bagenal J, 2018, LANCET, V392, P2420, DOI 10.1016/S0140-6736(18)32942-8; Condit CM, 2010, ANNU REV GENOM HUM G, V11, P339, DOI 10.1146/annurev-genom-082509-141740; Critchley C, 2015, PUBLIC HEALTH GENOM, V18, P160, DOI 10.1159/000375441; Debray TPA, 2015, RES SYNTH METHODS, V6, P293, DOI 10.1002/jrsm.1160; Dheensa S, 2018, J MED ETHICS, V44, P397, DOI 10.1136/medethics-2017-104588; Evans JP, 2008, GENET MED, V10, P500, DOI [10.1097/GIM.0b013e31817f280a, 10.1097GIM.0b013e31817f280a]; FICCI; and EY, 2016, REENG IND HLTH CAR E; Garrison NA, 2016, GENET MED, V18, P663, DOI 10.1038/gim.2015.138; Gaskell G, 2013, EUR J HUM GENET, V21, P14, DOI 10.1038/ejhg.2012.104; Gottweis H, 2011, HUM GENET, V130, P433, DOI 10.1007/s00439-011-1065-y; Greenland S, 2016, EUR J EPIDEMIOL, V31, P337, DOI 10.1007/s10654-016-0149-3; Gurdasani D, 2019, NAT REV GENET, V20, P520, DOI 10.1038/s41576-019-0144-0; Hishiyama Y, 2019, J HUM GENET, V64, P397, DOI 10.1038/s10038-019-0587-3; Howe N, 2018, J HEALTH SERV RES PO, V23, P123, DOI 10.1177/1355819617751555; Ipsos MORI, 2018, GEN ENGL POLL; Ipsos MORI, 2016, ON WAY MIRR PUBL ATT; Johnsson L, 2010, EUR J HUM GENET, V18, P1261, DOI 10.1038/ejhg.2010.106; Kim J, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.9550; Knoppers BM, 2018, HUM GENET, V137, P569, DOI 10.1007/s00439-018-1923-y; Lawler M, 2018, LANCET ONCOL, V19, P1014, DOI 10.1016/S1470-2045(18)30425-X; Middleton A, 2020, EUR J HUM GENET, V28, P424, DOI 10.1038/s41431-019-0550-y; Middleton A, 2018, PERS MED, V15, P311, DOI 10.2217/pme-2018-0032; Milne R, 2019, HUM GENET, V138, P1237, DOI 10.1007/s00439-019-02062-0; Oliver JM, 2012, PUBLIC HEALTH GENOM, V15, P106, DOI 10.1159/000334718; R Core Team, 2019, R LANG ENV STAT COMP; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Schwarzer G., 2007, R NEWS, V7, P40, DOI DOI 10.1007/978-3-319-21416-0; Skovgaard LL, 2019, HEALTH POLICY, V123, P564, DOI 10.1016/j.healthpol.2019.03.012; Sobreira Nara L M, 2017, Curr Protoc Hum Genet, V95, DOI 10.1002/cphg.50; Stark Z, 2019, AM J HUM GENET, V104, P13, DOI 10.1016/j.ajhg.2018.11.014; Sulmasy DP, 2015, GENET MED, V17, P331, DOI 10.1038/gim.2014.111; Tindana P, 2016, ANNU REV GENOM HUM G, V17, P375, DOI 10.1146/annurev-genom-083115-022456; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03	33	27	28	3	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 1	2020	107	4					743	752		10.1016/j.ajhg.2020.08.023	http://dx.doi.org/10.1016/j.ajhg.2020.08.023			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NZ5IY	32946764	Green Published, hybrid, Green Accepted			2022-12-18	WOS:000577135400013
J	Kim, KH; Hong, EP; Shin, JW; Chao, MJ; Loupe, J; Gillis, T; Mysore, JS; Holmans, P; Jones, L; Orth, M; Monckton, DG; Long, JD; Kwak, S; Lee, R; Gusella, JF; MacDonald, ME; Lee, JM				Kim, Kyung-Hee; Hong, Eun Pyo; Shin, Jun Wan; Chao, Michael J.; Loupe, Jacob; Gillis, Tammy; Mysore, Jayalakshmi S.; Holmans, Peter; Jones, Lesley; Orth, Michael; Monckton, Darren G.; Long, Jeffrey D.; Kwak, Seung; Lee, Ramee; Gusella, James F.; MacDonald, Marcy E.; Lee, Jong-Min			Genetic and Functional Analyses Point to FAN1 as the Source of Multiple Huntington Disease Modifier Effects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA-REPAIR; TRINUCLEOTIDE REPEAT; DETERMINES AGE; ONSET; NUCLEASE; IDENTIFICATION; KIAA1018/FAN1; ASSOCIATION; EXPANSION; MECHANISM	A recent genome-wide association study of Huntington disease (HD) implicated genes involved in DNA maintenance processes as modifiers of onset, including multiple genome-wide significant signals in a chr15 region containing the DNA repair gene Fanconi-Associated Nuclease 1 (FAN1). Here, we have carried out detailed genetic, molecular, and cellular investigation of the modifiers at this locus. We find that missense changes within or near the DNA-binding domain (p.Arg507His and p.Arg377Trp) reduce FAN1's DNA-binding activity and its capacity to rescue mitomycin C-induced cytotoxicity, accounting for two infrequent onset-hastening modifier signals. We also idenified a third onset-hastening modifier signal whose mechanism of action remains uncertain but does not involve an amino acid change in FAN1. We present additional evidence that a frequent onset-delaying modifier signal does not alter FAN1 coding sequence but is associated with increased FAN1 mRNA expression in the cerebral cortex. Consistent with these findings and other cellular overexpression and/or suppression studies, knockout of FAN1 increased CAG repeat expansion in HD-induced pluripotent stem cells. Together, these studies support the process of somatic CAG repeat expansion as a therapeutic target in HD, and they clearly indicate that multiple genetic variations act by different means through FAN1 to influence HD onset in a manner that is largely additive, except in the rare circumstance that two onset-hastening alleles are present. Thus, an individual's particular combination of FAN1 haplotypes may influence their suitability for HD clinical trials, particularly if the therapeutic agent aims to reduce CAG repeat instability.	[Kim, Kyung-Hee; Hong, Eun Pyo; Shin, Jun Wan; Chao, Michael J.; Loupe, Jacob; Gillis, Tammy; Mysore, Jayalakshmi S.; Gusella, James F.; MacDonald, Marcy E.; Lee, Jong-Min] Massachusetts Gen Hosp, Ctr Genom Med, Mol Neurogenet Unit, Boston, MA 02114 USA; [Kim, Kyung-Hee; Hong, Eun Pyo; Shin, Jun Wan; Chao, Michael J.; Loupe, Jacob; MacDonald, Marcy E.; Lee, Jong-Min] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [Holmans, Peter; Jones, Lesley] Cardiff Univ, Ctr Neuropsychiat Genet & Genom, Sch Med, Dept Psychol Med & Neurol,MRC, Cardiff CF24 4HQ, Wales; [Holmans, Peter; Jones, Lesley; Orth, Michael; Monckton, Darren G.; Long, Jeffrey D.; Kwak, Seung; Gusella, James F.; MacDonald, Marcy E.; Lee, Jong-Min] Univ Ulm, GeM HD Consortium, D-89081 Ulm, Germany; [Orth, Michael] Univ Ulm, Dept Neurol, D-89081 Ulm, Germany; [Monckton, Darren G.] Univ Glasgow, Coll Med Vet & Life Sci, Lnstitute Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland; [Long, Jeffrey D.] Univ Iowa, Coll Publ Hlth, Dept Biostat, Iowa City, IA 52242 USA; [Long, Jeffrey D.] Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA; [Kwak, Seung; Lee, Ramee] CHDI Fdn, Princeton, NJ 08540 USA; [Gusella, James F.; MacDonald, Marcy E.; Lee, Jong-Min] Broad Inst MIT & Harvard, Med & Populat Genet Program, Cambridge, MA 02142 USA; [Gusella, James F.] Harvard Med Sch, Blavatnik Inst, Dept Genet, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Cardiff University; Ulm University; Ulm University; University of Glasgow; University of Iowa; University of Iowa; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School	Lee, JM (corresponding author), Massachusetts Gen Hosp, Ctr Genom Med, Mol Neurogenet Unit, Boston, MA 02114 USA.; Lee, JM (corresponding author), Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA.; Lee, JM (corresponding author), Univ Ulm, GeM HD Consortium, D-89081 Ulm, Germany.; Lee, JM (corresponding author), Broad Inst MIT & Harvard, Med & Populat Genet Program, Cambridge, MA 02142 USA.	jlee51@mgh.harvard.edu	; Monckton, Darren/B-4943-2013	Long, Jeffrey/0000-0001-7181-9652; Monckton, Darren/0000-0002-8298-8264	National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) [NS091161, NS105709, NS049206]; Cure Huntington's Disease Initiative (CHDI) Foundation	National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Cure Huntington's Disease Initiative (CHDI) Foundation	We are grateful to Huntington disease families and clinicians who participate in HD genetic research. This research was funded by National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) grants NS091161, NS105709, and NS049206, by an anonymous donor, and by the Cure Huntington's Disease Initiative (CHDI) Foundation.	ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Bastarache L, 2018, SCIENCE, V359, P1233, DOI 10.1126/science.aal4043; Bates GP, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.5; Bettencourt C, 2016, ANN NEUROL, V79, P983, DOI 10.1002/ana.24656; Chao MJ, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007274; Ciosi M, 2019, EBIOMEDICINE, V48, P568, DOI 10.1016/j.ebiom.2019.09.020; Correia K, 2015, J HUNTINGTONS DIS, V4, P279, DOI 10.3233/JHD-150169; Deng WG, 2003, ANAL BIOCHEM, V323, P12, DOI 10.1016/j.ab.2003.08.007; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Goold R, 2019, HUM MOL GENET, V28, P650, DOI 10.1093/hmg/ddy375; HD iPSC Consortium, 2012, CELL STEM CELL, V11, P264, DOI 10.1016/j.stem.2012.04.027; Hlavin EM, 2010, ENVIRON MOL MUTAGEN, V51, P604, DOI 10.1002/em.20559; Keum JW, 2016, AM J HUM GENET, V98, P287, DOI 10.1016/j.ajhg.2015.12.018; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Lee JM, 2012, NEUROLOGY, V78, P690, DOI 10.1212/WNL.0b013e318249f683; Lee JM, 2019, CELL, V178, P887, DOI 10.1016/j.cell.2019.06.036; Lee JM, 2015, CELL, V162, P516, DOI 10.1016/j.cell.2015.07.003; Lee JM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-29; Long JD, 2018, AM J HUM GENET, V103, P349, DOI 10.1016/j.ajhg.2018.07.017; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; O'Donnell L, 2010, MOL CELL, V39, P167, DOI 10.1016/j.molcel.2010.07.010; Park DJ, 2011, BREAST CANCER RES TR, V130, P1043, DOI 10.1007/s10549-011-1704-y; Persichetti F, 1994, Neurobiol Dis, V1, P159, DOI 10.1006/nbdi.1994.0019; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023; Wang R, 2014, SCIENCE, V346, P1127, DOI 10.1126/science.1258973; Zhao XN, 2018, DNA REPAIR, V69, P1, DOI 10.1016/j.dnarep.2018.07.001	29	27	27	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 2	2020	107	1					96	110		10.1016/j.ajhg.2020.05.012	http://dx.doi.org/10.1016/j.ajhg.2020.05.012			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MH4EU	32589923	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000546685300009
J	Popejoy, AB; Crooks, KR; Fullerton, SM; Hindorff, LA; Hooker, GW; Koenig, BA; Pino, N; Ramos, EM; Ritter, DI; Wand, H; Wright, MW; Yudell, M; Zou, JY; Plon, SE; Bustamante, CD; Ormond, KE				Popejoy, Alice B.; Crooks, Kristy R.; Fullerton, Stephanie M.; Hindorff, Lucia A.; Hooker, Gillian W.; Koenig, Barbara A.; Pino, Natalie; Ramos, Erin M.; Ritter, Deborah, I; Wand, Hannah; Wright, Matt W.; Yudell, Michael; Zou, James Y.; Plon, Sharon E.; Bustamante, Carlos D.; Ormond, Kelly E.		Clinical Genome Resource ClinGen A	Clinical Genetics Lacks Standard Definitions and Protocols for the Collection and Use of Diversity Measures	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RACE; ETHNICITY; ANCESTRY	Genetics researchers and clinical professionals rely on diversity measures such as race, ethnicity, and ancestry (REA) to stratify study participants and patients for a variety of applications in research and precision medicine. However, there are no comprehensive, widely accepted standards or guidelines for collecting and using such data in clinical genetics practice. Two NIH-funded research consortia, the Clinical Genome Resource (ClinGen) and Clinical Sequencing Evidence-generating Research (CSER), have partnered to address this issue and report how REA are currently collected, conceptualized, and used. Surveying clinical genetics professionals and researchers (n = 448), we found heterogeneity in the way REA are perceived, defined, and measured, with variation in the perceived importance of REA in both clinical and research settings. The majority of respondents (>55%) felt that REA are at least somewhat important for clinical variant interpretation, ordering genetic tests, and communicating results to patients. However, there was no consensus on the relevance of REA, including how each of these measures should be used in different scenarios and what information they can convey in the context of human genetics. A lack of common definitions and applications of REA across the precision medicine pipeline may contribute to inconsistencies in data collection, missing or inaccurate classifications, and misleading or inconclusive results. Thus, our findings support the need for standardization and harmonization of REA data collection and use in clinical genetics and precision health research.	[Popejoy, Alice B.; Wright, Matt W.; Zou, James Y.; Bustamante, Carlos D.] Stanford Univ, Dept Biomed Data Sci, Sch Med, Stanford, CA 94305 USA; [Popejoy, Alice B.; Ormond, Kelly E.] Stanford Univ, Stanford Ctr Biomed Eth, Sch Med, Stanford, CA 94305 USA; [Crooks, Kristy R.] Univ Colorado, Dept Pathol, Aurora, CO 80045 USA; [Fullerton, Stephanie M.] Univ Washington, Dept Bioeth & Humanities, Sch Med, Seattle, WA 98195 USA; [Hindorff, Lucia A.; Pino, Natalie; Ramos, Erin M.] NHGRI, Div Genom Med, NIH, Bethesda, MD 20892 USA; [Hooker, Gillian W.] Concert Genet, Nashville, TN 37204 USA; [Koenig, Barbara A.] Univ Calif San Francisco Laurel Hts, Program Bioeth, San Francisco, CA 94118 USA; [Ritter, Deborah, I; Plon, Sharon E.] Baylor Coll Med, Dept Pediat, Oncol Sect, Houston, TX 77030 USA; [Wand, Hannah] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Wand, Hannah] Stanford Healthcare, Dept Cardiol, Stanford, CA 94305 USA; [Yudell, Michael] Drexel Univ, Dornsife Sch Publ Hlth, Dept Community Hlth & Prevent, Philadelphia, PA 19104 USA; [Ormond, Kelly E.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Baylor College of Medicine; Stanford University; Drexel University; Stanford University	Popejoy, AB (corresponding author), Stanford Univ, Dept Biomed Data Sci, Sch Med, Stanford, CA 94305 USA.; Popejoy, AB (corresponding author), Stanford Univ, Stanford Ctr Biomed Eth, Sch Med, Stanford, CA 94305 USA.	apopejoy@stanford.edu	Ormond, Kelly E/I-5676-2019	Ormond, Kelly E/0000-0002-1033-0818; Popejoy, Alice B/0000-0003-4976-0628; Fullerton, Stephanie/0000-0002-0938-6048; Wright, Mathew/0000-0002-2650-2426; Wand, Hannah/0000-0001-8662-3353; Bustamante, Carlos D./0000-0002-4187-7920	National Human Genome Research Institute (NHGRI) Clinical Genome Resource (ClinGen) [5U41HG009649-03]; Clinical Sequencing Evidence-generating Research (CSER) Coordinating Center [U24HG007307]; UCSF Program in Prenatal and Pediatric Genome Sequencing (P3EGS) [U01HG009599]; Chan-Zuckerberg Investigator Award	National Human Genome Research Institute (NHGRI) Clinical Genome Resource (ClinGen); Clinical Sequencing Evidence-generating Research (CSER) Coordinating Center; UCSF Program in Prenatal and Pediatric Genome Sequencing (P3EGS); Chan-Zuckerberg Investigator Award	Funding for this study was provided by the National Human Genome Research Institute (NHGRI) Clinical Genome Resource (ClinGen): 5U41HG009649-03; the Clinical Sequencing Evidence-generating Research (CSER) Coordinating Center: U24HG007307; the UCSF Program in Prenatal and Pediatric Genome Sequencing (P3EGS): U01HG009599; and a Chan-Zuckerberg Investigator Award (J.Y.Z.).	[Anonymous], 2011, CLIN PRACT GUID WE C; Berg K, 2005, AM J HUM GENET, V77, P519; Bonham VL, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-456; Bonham VL, 2009, GENET MED, V11, P279, DOI 10.1097/GIM.0b013e318195aaf4; Braun L, 2007, PLOS MED, V4, P1423, DOI 10.1371/journal.pmed.0040271; Cunningham BA, 2014, MED CARE, V52, P728, DOI 10.1097/MLR.0000000000000157; Jorde LB, 2020, JAMA-J AM MED ASSOC, V323, P1089, DOI 10.1001/jama.2020.0517; Klinger EV, 2015, J GEN INTERN MED, V30, P719, DOI 10.1007/s11606-014-3102-8; Kumar R, 2010, NEW ENGL J MED, V363, P321, DOI 10.1056/NEJMoa0907897; Landry LG, 2018, HEALTH AFFAIR, V37, P780, DOI 10.1377/hlthaff.2017.1595; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Mays VM, 2003, ANNU REV PUBL HEALTH, V24, P83, DOI 10.1146/annurev.publhealth.24.100901.140927; National Institutes of Health, 2015, NOTOD15089; Nelson Sarah C, 2018, AJOB Empir Bioeth, V9, P222, DOI 10.1080/23294515.2018.1544177; Omi M., 2014, RACIAL FORMATION US; Popejoy AB, 2018, HUM MUTAT, V39, P1713, DOI 10.1002/humu.23644; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Roth WD, 2016, ETHNIC RACIAL STUD, V39, P1310, DOI 10.1080/01419870.2016.1140793; Royal CD, 2010, AM J HUM GENET, V86, P661, DOI 10.1016/j.ajhg.2010.03.011; Smedley A., 2012, RACE N AM ORIGINS EV	20	27	27	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 2	2020	107	1					72	82		10.1016/j.ajhg.2020.05.005	http://dx.doi.org/10.1016/j.ajhg.2020.05.005			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MH4EU	32504544	hybrid, Green Submitted, Green Published			2022-12-18	WOS:000546685300007
J	Zhao, YJ; Diacou, A; Johnston, HR; Musfee, FI; McDonald-McGinn, DM; McGinn, D; Crowley, TB; Repetto, GM; Swillen, A; Breckpot, J; Vermeesch, JR; Kates, WR; Digilio, MC; Unolt, M; Marino, B; Pontillo, M; Armando, M; Di Fabio, F; Vicari, S; van den Bree, M; Moss, H; Owen, MJ; Murphy, KC; Murphy, CM; Murphy, D; Schoch, K; Shashi, V; Tassone, F; Simon, TJ; Shprintzen, RJ; Campbell, L; Philip, N; Heine-Suner, D; Garcia-Minaur, S; Fernandez, L; Bearden, CE; Vingerhoets, C; van Amelsvoort, T; Eliez, S; Schneider, M; Vorstman, JAS; Gothelf, D; Zackai, E; Agopian, AJ; Gur, RE; Bassett, AS; Emanuel, BS; Goldmuntz, E; Mitchell, LE; Wang, T; Morrow, BE				Zhao, Yingjie; Diacou, Alexander; Johnston, H. Richard; Musfee, Fadi I.; McDonald-McGinn, Donna M.; McGinn, Daniel; Crowley, T. Blaine; Repetto, Gabriela M.; Swillen, Ann; Breckpot, Jeroen; Vermeesch, Joris R.; Kates, Wendy R.; Digilio, M. Cristina; Unolt, Marta; Marino, Bruno; Pontillo, Maria; Armando, Marco; Di Fabio, Fabio; Vicari, Stefano; van den Bree, Marianne; Moss, Hayley; Owen, Michael J.; Murphy, Kieran C.; Murphy, Clodagh M.; Murphy, Declan; Schoch, Kelly; Shashi, Vandana; Tassone, Flora; Simon, Tony J.; Shprintzen, Robert J.; Campbell, Linda; Philip, Nicole; Heine-Suner, Damian; Garcia-Minaur, Sixto; Fernandez, Luis; Bearden, Carrie E.; Vingerhoets, Claudia; van Amelsvoort, Therese; Eliez, Stephan; Schneider, Maude; Vorstman, Jacob A. S.; Gothelf, Doron; Zackai, Elaine; Agopian, A. J.; Gur, Raquel E.; Bassett, Anne S.; Emanuel, Beverly S.; Goldmuntz, Elizabeth; Mitchell, Laura E.; Wang, Tao; Morrow, Bernice E.		Int 22q11 2 Brain Behav Consortium	Complete Sequence of the 22q11.2 Allele in 1,053 Subjects with 22q11.2 Deletion Syndrome Reveals Modifiers of Conotruncal Heart Defects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CARDIO-FACIAL SYNDROME; LOW-COPY REPEATS; TBX1 HAPLOINSUFFICIENCY; MOLECULAR DEFINITION; II DEFICIENCY; ASSOCIATION; VARIANTS; CRKL; PREVALENCE; PREDICTION	The 22q11.2 deletion syndrome (22q11.2DS) results from non-allelic homologous recombination between low-copy repeats termed LCR22. About 60%-70% of individuals with the typical 3 megabase (Mb) deletion from LCR22A-D have congenital heart disease, mostly of the conotruncal type (CTD), whereas others have normal cardiac anatomy. In this study, we tested whether variants in the hemizygous LCR22A-D region are associated with risk for CTDs on the basis of the sequence of the 22q11.2 region from 1,053 22q11.2DS individuals. We found a significant association (FDR p < 0.05) of the CTD subset with 62 common variants in a single linkage disequilibrium (LD) block in a 350 kb interval harboring CRKL. A total of 45 of the 62 variants were associated with increased risk for CTDs (odds ratio [OR) ranges: 1.64-4.75). Associations of four variants were replicated in a meta-analysis of three genome-wide association studies of CTDs in affected individuals without 22q11.2DS. One of the replicated variants, rs178252, is located in an open chromatin region and resides in the double-elite enhancer, GH22J020947, that is predicted to regulate CRKL (CRK-like proto-oncogene, cytoplasmic adaptor) expression. Approximately 23% of patients with nested LCR22C-D deletions have CTDs, and inactivation of Crkl in mice causes CTDs, thus implicating this gene as a modifier. Rs178252 and rs6004160 are expression quantitative trait loci (eQTLs) of CRKL. Furthermore, set-based tests identified an enhancer that is predicted to target CRKL and is significantly associated with CTD risk (GH22J020946, sequence kernal association test (SKAT) p = 7.21 x 10(-5)) in the 22q11.2DS cohort. These findings suggest that variance in CTD penetrance in the 22q11.2DS population can be explained in part by variants affecting CRKL expression.	[Zhao, Yingjie; Diacou, Alexander; Morrow, Bernice E.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Johnston, H. Richard] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Musfee, Fadi I.; Agopian, A. J.; Mitchell, Laura E.] UTHlth Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77225 USA; [McDonald-McGinn, Donna M.; McGinn, Daniel; Crowley, T. Blaine; Zackai, Elaine; Emanuel, Beverly S.] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [McDonald-McGinn, Donna M.; McGinn, Daniel; Crowley, T. Blaine; Zackai, Elaine; Emanuel, Beverly S.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Repetto, Gabriela M.] Univ Desarrollo, Fac Med Clin Alemana, Ctr Genet & Genom, Santiago 7710162, Chile; [Swillen, Ann; Breckpot, Jeroen; Vermeesch, Joris R.] Katholieke Univ Leuven, Univ Leuven, Ctr Human Genet, B-3000 Leuven, Belgium; [Kates, Wendy R.] SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY 13202 USA; [Kates, Wendy R.] SUNY Upstate Med Univ, Program Neurosci, Syracuse, NY 13202 USA; [Digilio, M. Cristina; Unolt, Marta] Bambino Gesu Pediat Hosp, Dept Med Genet, I-00165 Rome, Italy; [Unolt, Marta; Marino, Bruno; Di Fabio, Fabio] Univ Roma La Sapienza, Dept Pediat Gynecol & Obstet, I-00185 Rome, Italy; [Pontillo, Maria; Armando, Marco; Vicari, Stefano] Bambino Gesu Pediat Hosp, Dept Neurosci, I-00165 Rome, Italy; [Armando, Marco; Eliez, Stephan; Schneider, Maude] Univ Geneva, Dev Imaging & Psychopathol Lab, CH-1211 Geneva, Switzerland; [Vicari, Stefano] Catholic Univ, Dept Psychiat, I-00153 Rome, Italy; [van den Bree, Marianne; Moss, Hayley; Owen, Michael J.] Cardiff Univ, Med Res Council Ctr Neuropsychiatr Genet & Genom, Div Psychol Med & Clin Neurosci, Cardiff CF24 4HQ, S Glam, Wales; [Murphy, Kieran C.] Royal Coll Surgeons Ireland, Dept Psychiat, Dublin 505095, Ireland; [Murphy, Clodagh M.; Murphy, Declan] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Forens & Neurodev Sci, London SE5 8AF, England; [Murphy, Clodagh M.; Murphy, Declan] South London & Maudsley Fdn Natl Hlth Serv Trust, Behav & Dev Psychiat Clin Acad Grp, Behav Genet Clin, Natl Adult Autism & ADHD Serv, London SE5 8AZ, England; [Schoch, Kelly; Shashi, Vandana] Duke Univ, Dept Pediat, Durham, NC 27710 USA; [Tassone, Flora; Simon, Tony J.] Univ Calif Davis, MIND Inst, Dept Psychiat & Behav Sci, Sacramento, CA 95817 USA; [Shprintzen, Robert J.] Virtual Ctr Velocardiofacial Syndrome, Syracuse, NY 13206 USA; [Campbell, Linda] Univ Newcastle, Sch Psychol, Newcastle, NSW 2258, Australia; [Philip, Nicole] Aix Marseille Univ, Dept Med Genet, F-13284 Marseille, France; [Heine-Suner, Damian] Son Espases Univ Hosp, Balear Isl Hlth Res Inst, Genom Hlth, Palma De Mallorca 07120, Spain; [Heine-Suner, Damian] Son Espases Univ Hosp, Balear Isl Hlth Res Inst, Unit Mol Diag & Clin Genet, Palma De Mallorca 07120, Spain; [Garcia-Minaur, Sixto; Fernandez, Luis] Univ Hosp La Paz, Inst Med & Mol Genet, Madrid 28046, Spain; [Bearden, Carrie E.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Vingerhoets, Claudia; van Amelsvoort, Therese] Maastricht Univ, Dept Psychiat & Psychol, NL-6200 MD Maastricht, Netherlands; [Vorstman, Jacob A. S.] Res Inst, Program Genet & Genome Biol, Toronto, ON, Canada; [Vorstman, Jacob A. S.] Hosp Sick Children, Dept Psychiat, Toronto, ON, Canada; [Vorstman, Jacob A. S.] Univ Toronto, Dept Psychiat, Toronto, ON M5S 1A1, Canada; [Vorstman, Jacob A. S.] Univ Med Ctr Utrecht, Brain Ctr, Dept Psychiat, NL-3584 CG Utrecht, Netherlands; [Gothelf, Doron] Tel Aviv Univ, Sackler Fac Med, Edmond & Lily Sapfra Childrens Hosp, Child Psychiat Unit, IL-52621 Tel Aviv, Israel; [Gothelf, Doron] Sheba Med Ctr, IL-52621 Tel Aviv, Israel; [Gur, Raquel E.] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Gur, Raquel E.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Bassett, Anne S.] Dalglish Family 22q Clin, Clin Genet Res Program, Toronto, ON M5T 1L8, Canada; [Bassett, Anne S.] Toronto Gen Hosp, Ctr Addict & Mental Hlth, Toronto, ON M5T 1L8, Canada; [Bassett, Anne S.] Univ Toronto, Dept Psychiat, Toronto, ON M5T 1L8, Canada; [Goldmuntz, Elizabeth] Childrens Hosp Philadelphia, Div Cardiol, 34th St & Civic Ctr Blvd, Philadelphia, PA 19104 USA; [Goldmuntz, Elizabeth] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Wang, Tao] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Emory University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Universidad del Desarrollo; KU Leuven; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; IRCCS Bambino Gesu; Sapienza University Rome; IRCCS Bambino Gesu; University of Geneva; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Cardiff University; Royal College of Surgeons - Ireland; University of London; King's College London; Duke University; University of California System; University of California Davis; University of Newcastle; UDICE-French Research Universities; Aix-Marseille Universite; Hospital Universitari Son Espases; Institut Investigacio Sanitaria Illes Balears (IdISBa); Hospital Universitari Son Espases; Institut Investigacio Sanitaria Illes Balears (IdISBa); Hospital Universitario La Paz; University of California System; University of California Los Angeles; Maastricht University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Utrecht University; Utrecht University Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Yeshiva University; Albert Einstein College of Medicine	Morrow, BE (corresponding author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA.	bernice.morrow@einsteinmed.org	Vicari, Stefano/J-3008-2012; Weizman, Abraham/AAK-6450-2020; Di Fabio, Fabio/AAH-8099-2021; Heine-Suñer, Damian/J-8045-2012; Montero, Rosemarie Fritsch/C-3519-2009; Unolt, Marta/AAB-5685-2020; Dallapiccola, Bruno/K-8692-2016	Weizman, Abraham/0000-0002-9765-8938; Di Fabio, Fabio/0000-0003-3285-5401; Heine-Suñer, Damian/0000-0001-9374-1219; Montero, Rosemarie Fritsch/0000-0001-7694-1470; Unolt, Marta/0000-0002-4133-714X; Dallapiccola, Bruno/0000-0002-5031-1013; BUSA, Tiffany/0000-0003-4454-1979; Schneider, Maude/0000-0001-7147-8915; Lattanzi, Guido Maria/0000-0001-7366-683X; McDonald-McGinn, Donna/0000-0003-4077-250X; Armando, Marco/0000-0001-7074-7212; Murphy, Declan/0000-0002-6664-7451; pontillo, maria/0000-0002-0083-0093; Swillen, Ann/0000-0003-4258-4537; Vermeesch, Joris/0000-0002-3071-1191; Bearden, Carrie/0000-0002-8516-923X	Leducq Foundation; National Institutes of Health [R01HL132577, R01HL084410, U01MH101720, U54HD090260, P01HD070454]; MRC [MR/N026063/1] Funding Source: UKRI	Leducq Foundation(Leducq Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank the 22q11.2DS-affected families who provided DNA and clinical information for this study. We acknowledge the Genomics and Molecular Cytogenetics Cores at the Albert Einstein College of Medicine. We thank the Pediatric Cardiac Genomics Consortium for data collection and management and for the use of published data, without which the replication of the findings in our 22q11.2DS cohort in CTD cohorts without a 22q11.2 deletion would have never been possible. Dr. Morrow was supported by a Leducq Foundation grant and National Institutes of Health grants R01HL132577, R01HL084410, U01MH101720, U54HD090260, and P01HD070454. Other funding sources are detailed in the Supplemental Information.	Agopian AJ, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.116.001449; Aihara K, 2007, J CLIN INVEST, V117, P1514, DOI 10.1172/JCI27095; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Botto LD, 2003, PEDIATRICS, V112, P101, DOI 10.1542/peds.112.1.101; Burn J, 1996, CURR OPIN GENET DEV, V6, P322, DOI 10.1016/S0959-437X(96)80009-8; Burnside RD, 2015, CYTOGENET GENOME RES, V146, P89, DOI 10.1159/000438708; Carlson C, 1997, AM J HUM GENET, V61, P620, DOI 10.1086/515508; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Dixon JR, 2018, NAT GENET, V50, P1388, DOI 10.1038/s41588-018-0195-8; Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733; Edelmann L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/hmg/8.7.1157; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; Fishilevich S., 2017, GENEHANCER GENOME WI; Gong W, 2001, J Med Genet, V38, pE45, DOI 10.1136/jmg.38.12.e45; Grati FR, 2015, PRENATAL DIAG, V35, P801, DOI 10.1002/pd.4613; Guo TW, 2018, HUM MOL GENET, V27, P1150, DOI 10.1093/hmg/ddy028; Guo TW, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.116.001690; Guo TW, 2015, AM J HUM GENET, V97, P869, DOI 10.1016/j.ajhg.2015.10.013; Guo TW, 2011, HUM MUTAT, V32, P1278, DOI 10.1002/humu.21568; Gur RE, 2017, MOL PSYCHIATR, V22, P1664, DOI 10.1038/mp.2017.161; Guris DL, 2006, DEV CELL, V10, P81, DOI 10.1016/j.devcel.2005.12.002; Guris DL, 2001, NAT GENET, V27, P293, DOI 10.1038/85855; Huang YF, 2017, NAT GENET, V49, P618, DOI 10.1038/ng.3810; Ionita-Laza I, 2013, AM J HUM GENET, V92, P841, DOI 10.1016/j.ajhg.2013.04.015; Johnston HR, 2017, P NATL ACAD SCI USA, V114, pE8323, DOI 10.1073/pnas.1714535114; KIRBY ML, 1995, CIRC RES, V77, P211, DOI 10.1161/01.RES.77.2.211; Kotlar AV, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1387-3; Lee S, 2016, BIOSTATISTICS, V17, P1, DOI 10.1093/biostatistics/kxv033; Lees JA, 2017, P NATL ACAD SCI USA, V114, P13720, DOI 10.1073/pnas.1718471115; Lin JR, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007142; LINDSAY EA, 1995, AM J MED GENET, V57, P514, DOI 10.1002/ajmg.1320570339; Lindsay EA, 2001, NATURE, V410, P97, DOI 10.1038/35065105; Liu Q, 2017, CIRC RES, V121, P376, DOI 10.1161/CIRCRESAHA.116.310456; Liu XM, 2016, HUM MUTAT, V37, P235, DOI 10.1002/humu.22932; Ma H, 2009, J CELL SCI, V122, P4303, DOI 10.1242/jcs.057646; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Maisenbacher MK, 2017, MOL CYTOGENET, V10, DOI 10.1186/s13039-017-0308-6; McDonald-McGinn DM, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.71; Merscher S, 2001, CELL, V104, P619, DOI 10.1016/S0092-8674(01)00247-1; Mlynarski EE, 2016, HUM GENET, V135, P273, DOI 10.1007/s00439-015-1623-9; Mlynarski EE, 2015, AM J HUM GENET, V96, P753, DOI 10.1016/j.ajhg.2015.03.007; Moon AM, 2006, DEV CELL, V10, P71, DOI 10.1016/j.devcel.2005.12.003; MORROW B, 1995, AM J HUM GENET, V56, P1391; Nakagomi H, 2018, CANCER SCI, V109, P453, DOI 10.1111/cas.13464; Nakatsu F, 2012, J CELL BIOL, V199, P1003, DOI 10.1083/jcb.201206095; Ogata T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091598; Oskarsdottir S, 2004, ARCH DIS CHILD, V89, P148, DOI 10.1136/adc.2003.026880; Pagnamenta AT, 2015, HUM MOL GENET, V24, P3732, DOI 10.1093/hmg/ddv117; Papaioannou VE, 2014, DEVELOPMENT, V141, P3819, DOI 10.1242/dev.104471; Paylor R, 2006, P NATL ACAD SCI USA, V103, P7729, DOI 10.1073/pnas.0600206103; Peyvandi S, 2013, PEDIATR CARDIOL, V34, P1687, DOI 10.1007/s00246-013-0694-4; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Racedo SE, 2015, AM J HUM GENET, V96, P235, DOI 10.1016/j.ajhg.2014.12.025; Rauch R, 2010, J MED GENET, V47, P321, DOI 10.1136/jmg.2009.070391; Rentzsch P, 2019, NUCLEIC ACIDS RES, V47, pD886, DOI 10.1093/nar/gky1016; Rump P, 2014, AM J MED GENET A, V164, P2707, DOI 10.1002/ajmg.a.36711; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; SIE P, 1985, LANCET, V2, P414; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Sprecher E, 2005, AM J HUM GENET, V77, P242, DOI 10.1086/432556; Steegmaier M, 1998, J BIOL CHEM, V273, P34171, DOI 10.1074/jbc.273.51.34171; Torres-Juan L, 2007, EUR J HUM GENET, V15, P658, DOI 10.1038/sj.ejhg.5201819; TRAN TH, 1985, LANCET, V2, P413; Unolt M, 2018, AM J MED GENET A, V176, P2087, DOI 10.1002/ajmg.a.38662; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Vaser R, 2016, NAT PROTOC, V11, P1, DOI 10.1038/nprot.2015.123; Verhagen JMA, 2012, AM J MED GENET A, V158A, P2412, DOI 10.1002/ajmg.a.35517; Vicente CP, 2004, BLOOD, V104, P3965, DOI 10.1182/blood-2004-02-0598; Vincent SD, 2010, CURR TOP DEV BIOL, V90, P1, DOI 10.1016/S0070-2153(10)90001-X; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6	72	27	28	2	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 2	2020	106	1					26	40		10.1016/j.ajhg.2019.11.010	http://dx.doi.org/10.1016/j.ajhg.2019.11.010			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JZ5VM	31870554	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000505170800003
J	Vossaert, L; Wang, Q; Salman, R; McCombs, AK; Patel, V; Qu, CJ; Mancini, MA; Edwards, DP; Malovannaya, A; Liu, PF; Shaw, CA; Levy, B; Wapner, RJ; Bi, WM; Breman, AM; Van den Veyver, IB; Beaudet, AL				Vossaert, Liesbeth; Wang, Qun; Salman, Roseen; McCombs, Anne K.; Patel, Vipulkumar; Qu, Chunjing; Mancini, Michael A.; Edwards, Dean P.; Malovannaya, Anna; Liu, Pengfei; Shaw, Chad A.; Levy, Brynn; Wapner, Ronald J.; Bi, Weimin; Breman, Amy M.; Van den Veyver, Ignatia B.; Beaudet, Arthur L.			Validation Studies for Single Circulating Trophoblast Genetic Testing as a Form of Noninvasive Prenatal Diagnosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MATERNAL BLOOD; FETAL CELLS	It has long been appreciated that genetic analysis of fetal or trophoblast cells in maternal blood could revolutionize prenatal diagnosis. We implemented a protocol for single circulating trophoblast (SCT) testing using positive selection by magnetic-activated cell sorting and single-cell low-coverage whole-genome sequencing to detect fetal aneuploidies and copy-number variants (CNVs) at similar to 1 Mb resolution. In 95 validation cases, we identified on average 0.20 putative trophoblasts/mL, of which 55% were of high quality and scorable for both aneuploidy and CNVs. We emphasize the importance of analyzing individual cells because some cells are apoptotic, in S-phase, or otherwise of poor quality. When two or more high-quality trophoblast cells were available for singleton pregnancies, there was complete concordance between all trophoblasts unless there was evidence of confined placental mosaicism. SCT results were highly concordant with available clinical data from chorionic villus sampling (CVS) or amniocentesis procedures. Although determining the exact sensitivity and specificity will require more data, this study further supports the potential for SCT testing to become a diagnostic prenatal test.	[Vossaert, Liesbeth; Wang, Qun; Salman, Roseen; McCombs, Anne K.; Liu, Pengfei; Shaw, Chad A.; Bi, Weimin; Van den Veyver, Ignatia B.; Beaudet, Arthur L.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Patel, Vipulkumar; Qu, Chunjing; Liu, Pengfei; Shaw, Chad A.; Bi, Weimin] Baylor Genet, Houston, TX 77021 USA; [Mancini, Michael A.; Edwards, Dean P.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Malovannaya, Anna] Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA; [Levy, Brynn] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Wapner, Ronald J.] Columbia Univ, Med Ctr, Dept Obstet & Gynecol, New York, NY 10032 USA; [Breman, Amy M.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Van den Veyver, Ignatia B.] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Van den Veyver, Ignatia B.; Beaudet, Arthur L.] Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Columbia University; Columbia University; Indiana University System; Indiana University Bloomington; Baylor College of Medicine; Baylor College of Medicine	Beaudet, AL (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Beaudet, AL (corresponding author), Texas Childrens Hosp, Houston, TX 77030 USA.	abeaudet@bcm.edu	Patel, Vipulkumar/ABD-2846-2020; Van den Veyver, Ignatia B/AAF-4510-2021	Patel, Vipulkumar/0000-0001-6708-6812; Van den Veyver, Ignatia B/0000-0002-0651-5924; Vossaert, Liesbeth/0000-0002-8888-8563	Baylor College of Medicine; Protein and Monoclonal Antibody Production and Integrated Microscopy Cores at Baylor College of Medicine (NCI) [P30 CA125123]; Mass Spectrometry Proteomics Core at BCM for the identification of EpCAM as the antigen (NCI) [P30 CA125123]; Mass Spectrometry Proteomics Core at BCM for the identification of EpCAM as the antigen (CPRIT Core Facility Award) [RP170005]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER	Baylor College of Medicine; Protein and Monoclonal Antibody Production and Integrated Microscopy Cores at Baylor College of Medicine (NCI); Mass Spectrometry Proteomics Core at BCM for the identification of EpCAM as the antigen (NCI); Mass Spectrometry Proteomics Core at BCM for the identification of EpCAM as the antigen (CPRIT Core Facility Award); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This publication is dedicated to Dr. Laird G. Jackson in recognition of a decade of contributions to this work. The authors thank the research coordinators and genetic counselors at Baylor College of Medicine, Texas Children's Hospital, and the Columbia University Medical Center for help in enrolling subjects. We thank William Mahony for his technical assistance in the lab and Hadi Erfani for help with the statistical analyses. We acknowledge multiple individuals at BioDiscovery for their help with the implementation of the NxClinical software. Thanks to Kurt Christensen and Karen Moberg at Baylor College of Medicine for the production of the monoclonal antibody. This work was funded by internal institutional funds at Baylor College of Medicine. This project was also supported by the Protein and Monoclonal Antibody Production and Integrated Microscopy Cores at Baylor College of Medicine (funding by the NCI P30 CA125123 grant) for the development and screening of one of the anti-EpCAM monoclonal enrichment antibodies and by the Mass Spectrometry Proteomics Core at BCM for the identification of EpCAM as the antigen (funding by the NCI P30 CA125123 grant and CPRIT Core Facility Award RP170005).	Bartova E, 2003, CELL MOL LIFE SCI, V60, P979, DOI 10.1007/s00018-003-2365-x; Bianchi DW, 2002, PRENATAL DIAG, V22, P609, DOI 10.1002/pd.347; Breman AM, 2016, PRENATAL DIAG, V36, P1009, DOI 10.1002/pd.4924; Degner K, 2017, REPROD SCI, V24, P753, DOI 10.1177/1933719116669056; Dimitriadou E, 2014, MOL CYTOGENET, V7, DOI 10.1186/1755-8166-7-46; Grati FR, 2017, BEST PRACT RES CL OB, V42, P39, DOI 10.1016/j.bpobgyn.2017.02.004; Hartwig TS, 2017, PRENATAL DIAG, V37, P527, DOI 10.1002/pd.5049; Hou S, 2017, ACS NANO, V11, P8167, DOI 10.1021/acsnano.7b03073; Kolialexi A, 2001, FETAL DIAGN THER, V16, P32, DOI 10.1159/000053877; Kolvraa S, 2016, PRENATAL DIAG, V36, P1127, DOI 10.1002/pd.4948; Krabchi K, 2001, CLIN GENET, V60, P145, DOI 10.1034/j.1399-0004.2001.600209.x; Kruckow S, 2019, FETAL DIAGN THER, V45, P353, DOI 10.1159/000492028; Moser G, 2018, HISTOCHEM CELL BIOL, V150, P361, DOI 10.1007/s00418-018-1699-0; Neofytou MC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171319; Scott FP, 2018, J MATERN-FETAL NEO M, V31, P1865, DOI 10.1080/14767058.2017.1330881; Toutain J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195905; Van Opstal D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146794; Vossaert L, 2018, PRENATAL DIAG, V38, P1069, DOI 10.1002/pd.5377	18	27	28	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 5	2019	105	6					1262	1273		10.1016/j.ajhg.2019.11.004	http://dx.doi.org/10.1016/j.ajhg.2019.11.004			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JT4BB	31785788	Green Published, hybrid			2022-12-18	WOS:000500935400015
J	van Karnebeek, CDM; Ramos, RJ; Wen, XY; Tarailo-Graovac, M; Gleeson, JG; Skrypnyk, C; Brand-Arzamendi, K; Karbassi, F; Issa, MY; van der Lee, R; Drogemoller, BI; Koster, J; Rousseau, J; Campeau, PM; Wang, YD; Cao, F; Li, M; Ruiter, J; Ciapaite, J; Kluijtmans, LAJ; Willemsen, MAAP; Jans, JJ; Ross, CJ; Wintjes, LT; Rodenburg, RJ; Huigen, MCDG; Jia, ZP; Waterham, HR; Wasserman, WW; Wanders, RJA; Verhoeven-Duif, NM; Zaki, MS; Wevers, RA				van Karnebeek, Clara D. M.; Ramos, Ruben J.; Wen, Xiao-Yan; Tarailo-Graovac, Maja; Gleeson, Joseph G.; Skrypnyk, Cristina; Brand-Arzamendi, Koroboshka; Karbassi, Farhad; Issa, Mahmoud Y.; van der Lee, Robin; Drogemoller, Britt, I; Koster, Janet; Rousseau, Justine; Campeau, Philippe M.; Wang, Youdong; Cao, Feng; Li, Meng; Ruiter, Jos; Ciapaite, Jolita; Kluijtmans, Leo A. J.; Willemsen, Michel A. A. P.; Jans, Judith J.; Ross, Colin J.; Wintjes, Liesbeth T.; Rodenburg, Richard J.; Huigen, Marleen C. D. G.; Jia, Zhengping; Waterham, Hans R.; Wasserman, Wyeth W.; Wanders, Ronald J. A.; Verhoeven-Duif, Nanda M.; Zaki, Maha S.; Wevers, Ron A.			Bi-allelic GOT2 Mutations Cause a Treatable Malate-Aspartate Shuttle-Related Encephalopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							II CITRULLINEMIA; CITRIN DEFICIENCY; AGC1 DEFICIENCY; MITOCHONDRIAL; ALIGNMENT; DISEASE; GENOME; SERINE; ACID	Early-infantile encephalopathies with epilepsy are devastating conditions mandating an accurate diagnosis to guide proper management. Whole-exome sequencing was used to investigate the disease etiology in four children from independent families with intellectual disability and epilepsy, revealing bi-allelic GOT2 mutations. In-depth metabolic studies in individual 1 showed low plasma serine, hypercitrullinemia, hyperlactatemia, and hyperammonemia. The epilepsy was serine and pyridoxine responsive. Functional consequences of observed mutations were tested by measuring enzyme activity and by cell and animal models. Zebrafish and mouse models were used to validate brain developmental and functional defects and to test therapeutic strategies. GOT2 encodes the mitochondrial glutamate oxaloacetate transaminase. GOT2 enzyme activity was deficient in fibroblasts with bi-allelic mutations. GOT2, a member of the malate-aspartate shuttle, plays an essential role in the intracellular NAD(H) redox balance. De novo serine biosynthesis was impaired in fibroblasts with GOT2 mutations and GOT2-knockout HEK293 cells. Correcting the highly oxidized cytosolic NAD-redox state by pyruvate supplementation restored serine biosynthesis in GOT2-deficient cells. Knockdown of got2a in zebrafish resulted in a brain developmental defect associated with seizure-like electroencephalography spikes, which could be rescued by supplying pyridoxine in embryo water. Both pyridoxine and serine synergistically rescued embryonic developmental defects in zebrafish got2a morphants. The two treated individuals reacted favorably to their treatment. Our data provide a mechanistic basis for the biochemical abnormalities in GOT2 deficiency that may also hold for other MAS defects.	[van Karnebeek, Clara D. M.] Univ Amsterdam, Med Ctr, Amsterdam Gastroenterol & Metab, Emma Childrens Hosp,Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; [van Karnebeek, Clara D. M.] Univ Amsterdam, Med Ctr, Amsterdam Gastroenterol & Metab, Emma Childrens Hosp,Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands; [van Karnebeek, Clara D. M.] Univ British Columbia, Ctr Mol Med & Therapeut, BC Childrens Hosp Res Inst, Dept Pediat Med Genet, Vancouver, BC V5Z 4H4, Canada; [van Karnebeek, Clara D. M.; Ramos, Ruben J.; Ciapaite, Jolita; Kluijtmans, Leo A. J.; Willemsen, Michel A. A. P.; Jans, Judith J.; Wintjes, Liesbeth T.; Rodenburg, Richard J.; Huigen, Marleen C. D. G.; Waterham, Hans R.; Wanders, Ronald J. A.; Verhoeven-Duif, Nanda M.; Wevers, Ron A.] United Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Ramos, Ruben J.; Ciapaite, Jolita; Jans, Judith J.; Verhoeven-Duif, Nanda M.] Univ Med Ctr Utrecht, Dept Genet, NL-3584 EA Utrecht, Netherlands; [Wen, Xiao-Yan; Brand-Arzamendi, Koroboshka; Karbassi, Farhad; Wang, Youdong; Li, Meng] St Michaels Hosp, Zebrafish Ctr Adv Drug Discovery, Keenan Res Ctr Biomed Sci, Li Ka Sheng Knowledge Inst, Toronto, ON M5B 1T8, Canada; [Wen, Xiao-Yan] Univ Toronto, Dept Med Physiol & LMP, Toronto, ON M5G 2C4, Canada; [Wen, Xiao-Yan] Univ Toronto, Inst Med Sci, Toronto, ON M5G 2C4, Canada; [Tarailo-Graovac, Maja] Univ Calgary, Cumming Sch Med, Dept Biochem, Calgary, AB T2N 4N1, Canada; [Tarailo-Graovac, Maja] Univ Calgary, Cumming Sch Med, Dept Mol Biol, Calgary, AB T2N 4N1, Canada; [Tarailo-Graovac, Maja] Univ Calgary, Cumming Sch Med, Dept Med Genet, Calgary, AB T2N 4N1, Canada; [Tarailo-Graovac, Maja] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB T2N 4N1, Canada; [Gleeson, Joseph G.] Univ Calif San Diego, Dept Neurosci & Pediat, Howard Hughes Med Inst, San Diego, CA 92093 USA; [Gleeson, Joseph G.] Rady Childrens Inst Genom Med, San Diego, CA 92093 USA; [Skrypnyk, Cristina] Arabian Gulf Univ, Coll Med & Med Sci, Dept Mol Med, Manama 328, Bahrain; [Skrypnyk, Cristina] Arabian Gulf Univ, Coll Med & Med Sci, Al Jawhara Ctr Mol Med Genet & Inherited Dis, Manama 328, Bahrain; [Issa, Mahmoud Y.; Zaki, Maha S.] Natl Res Ctr, Human Genet & Genome Res Div, Clin Genet Dept, Cairo 12311, Egypt; [van der Lee, Robin; Wasserman, Wyeth W.] Univ British Columbia, BC Childrens Hosp Res Inst, Dept Med Genet, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada; [Drogemoller, Britt, I; Ross, Colin J.] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC V6T 1Z3, Canada; [Drogemoller, Britt, I] BC Childrens Hosp Res Inst, Vancouver, BC V5Z 4H4, Canada; [Koster, Janet; Ruiter, Jos; Waterham, Hans R.; Wanders, Ronald J. A.] Univ Amsterdam, Med Ctr, Amsterdam Gastroenterol & Metab, Lab Genet Metab Dis,Dept Clin Chem, NL-1105 AZ Amsterdam, Netherlands; [Rousseau, Justine; Campeau, Philippe M.] CHU St Justine Res Ctr, Montreal, PQ H3T 1C5, Canada; [Cao, Feng; Jia, Zhengping] Univ Toronto, Hosp Sick Children, Dept Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Cao, Feng; Jia, Zhengping] Univ Toronto, Dept Physiol, Toronto, ON M5G 1X8, Canada; [Kluijtmans, Leo A. J.; Wintjes, Liesbeth T.; Rodenburg, Richard J.; Huigen, Marleen C. D. G.; Wevers, Ron A.] Radboud Univ Nijmegen, Med Ctr, Translat Metab Lab, Dept Lab Med, NL-6525 GA Nijmegen, Netherlands; [van Karnebeek, Clara D. M.; Willemsen, Michel A. A. P.; Rodenburg, Richard J.] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, Amalia Childrens Hosp, NL-6525 GA Nijmegen, Netherlands; [Wintjes, Liesbeth T.; Rodenburg, Richard J.] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, Radboud Ctr Mitochondrial Med, NL-6525 GA Nijmegen, Netherlands	Emma Children's Hospital; University of Amsterdam; Vrije Universiteit Amsterdam; Emma Children's Hospital; University of Amsterdam; University of British Columbia; Utrecht University; Utrecht University Medical Center; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Calgary; University of Calgary; University of Calgary; University of Calgary; Howard Hughes Medical Institute; University of California System; University of California San Diego; Arabian Gulf University; Arabian Gulf University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); University of British Columbia; University of British Columbia; University of Amsterdam; Vrije Universiteit Amsterdam; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	van Karnebeek, CDM; Wevers, RA (corresponding author), United Metab Dis, NL-1105 AZ Amsterdam, Netherlands.; Wevers, RA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Translat Metab Lab, Dept Lab Med, NL-6525 GA Nijmegen, Netherlands.	c.d.vankarnebeek@amsterdamumc.nl; ron.wevers@radboudumc.nl	Zaki, Maha S/B-9361-2013; Huigen, C.D.G./L-4395-2015; van der Lee, Robin/P-6920-2015; Rodenburg, Richard/N-3579-2014; Issa, Mahmoud/AAL-5118-2020; Jia, zhengping/AAZ-4190-2021; SKRYPNYK, CRISTINA/GLS-0546-2022; Willemsen, Michel A.A.P./H-8119-2014; Wevers, Ron A./H-8116-2014; Campeau, Philippe/J-8614-2015	van der Lee, Robin/0000-0001-7391-9438; Rodenburg, Richard/0000-0001-5227-3527; Issa, Mahmoud/0000-0002-3899-2821; SKRYPNYK, CRISTINA/0000-0003-3469-1973; Wevers, Ron A./0000-0003-2278-9746; Campeau, Philippe/0000-0001-9713-7107; Zaki, Maha/0000-0001-7840-0002; Ross, Colin/0000-0003-1476-7037; Ciapaite, Jolita/0000-0001-8761-9233; Wasserman, Wyeth/0000-0001-6098-6412; Jans, Judith/0000-0003-0960-6263; Rousseau, Justine/0000-0002-3554-2673	Canadian Institutes of Health Research [301221]; Rare Diseases Foundation [1788]; National Ataxia Foundation; Canadian Rare Diseases Model Organisms and Mechanisms Network; Michael Smith Foundation for Health Foundation Research Scholar Award; Foundation Metakids salary award; Rubicon fellowship from the Netherlands Organization for Scientific Research (NWO); Rubicon fellowship from the Netherlands Organization for Scientific Research (ZONMW) [40-45200-98-015]; Genome Canada [255ONT]; Canadian Institutes of Health Research (CIHR) [BOP-149430]; Engineering Research Council of Canada (NSERC) [RGPIN 05389-14]; Brain Canada Foundation [PSG14-350]; Canada Foundation for Innovation (CFI) [26233]; Foundation Metakids [2013-046]; NIH [R01NS098004, NS048453]; QNRF [NPRP6-1463]; Simons Foundation Autism Research Initiative [275275]; Rady Children's Institute for Genomic Medicine; Howard Hughes Medical Institute; E.C. Noyons foundation; Broad Institute [UM1HG008900]; Yale Center for Mendelian Disorders [U54HG006504]; Genome British Columbia; Genome Canada (ABC4DE Project); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG008900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS098004, R01NS048453] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Rare Diseases Foundation; National Ataxia Foundation; Canadian Rare Diseases Model Organisms and Mechanisms Network; Michael Smith Foundation for Health Foundation Research Scholar Award(Michael Smith Foundation for Health Research); Foundation Metakids salary award; Rubicon fellowship from the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Rubicon fellowship from the Netherlands Organization for Scientific Research (ZONMW); Genome Canada(Genome Canada); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Brain Canada Foundation; Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Foundation Metakids; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); QNRF(National Research Foundation of KoreaQatar National Research Fund (QNRF)); Simons Foundation Autism Research Initiative; Rady Children's Institute for Genomic Medicine; Howard Hughes Medical Institute(Howard Hughes Medical Institute); E.C. Noyons foundation; Broad Institute; Yale Center for Mendelian Disorders; Genome British Columbia; Genome Canada (ABC4DE Project)(Genome Canada); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding to C.D.M.v.K. was provided by the Canadian Institutes of Health Research (grant number #301221), Rare Diseases Foundation (microgrant 1788), National Ataxia Foundation, and Canadian Rare Diseases Model Organisms and Mechanisms Network. Informatics infrastructure supported by Genome British Columbia and Genome Canada (ABC4DE Project). C..D.M.v.K. is a recipient of the Michael Smith Foundation for Health Foundation Research Scholar Award and a Foundation Metakids salary award. R.v.d.L. and W.W.W. were supported by a Rubicon fellowship from the Netherlands Organization for Scientific Research (NWO and ZONMW, 40-45200-98-015, to R.v.d.L.), Genome Canada (255ONT), and Canadian Institutes of Health Research (CIHR; BOP-149430). X.-Y.W. was funded by Engineering Research Council of Canada (NSERC) (RGPIN 05389-14), Brain Canada Foundation (PSG14-3505), and Canada Foundation for Innovation (CFI #26233). This work was supported by Foundation Metakids (2013-046 to J.J.J. and N.M.V.-D.), NIH R01NS098004, NS048453, QNRF NPRP6-1463, the Simons Foundation Autism Research Initiative 275275, the Rady Children's Institute for Genomic Medicine, and Howard Hughes Medical Institute (to J.G.G.), and by the E.C. Noyons foundation (to R.A.W.). We thank the Broad Institute (UM1HG008900 to D. MacArthur) and the Yale Center for Mendelian Disorders (U54HG006504 to R. Lifton and M. Gunel).	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Ait-El-Mkadem S, 2017, AM J HUM GENET, V100, P151, DOI 10.1016/j.ajhg.2016.11.014; Baraban S. C., 2013, JOVE-J VIS EXP, V71, P2; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Dahlin M, 2015, EPILEPSIA, V56, pe176, DOI 10.1111/epi.13193; DAWSON AG, 1979, TRENDS BIOCHEM SCI, V4, P171, DOI 10.1016/0968-0004(79)90417-1; De Koning TJ, 2003, BIOCHEM J, V371, P653, DOI 10.1042/BJ20021785; Fiermonte G, 2011, MOL GENET METAB, V104, P501, DOI 10.1016/j.ymgme.2011.08.022; Han Q, 2011, BIOSCIENCE REP, V31, P323, DOI 10.1042/BSR20100117; Hayasaka K, 2014, MOLEC GENET METAB RE, V1, P42, DOI 10.1016/j.ymgmr.2013.12.002; Jay JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160519; Jiang XP, 2016, BIOSCI TRENDS, V10, P79, DOI 10.5582/bst.2015.01150; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kobayashi K, 1999, NAT GENET, V22, P159, DOI 10.1038/9667; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lu M, 2008, J THEOR BIOL, V254, P466, DOI 10.1016/j.jtbi.2008.05.033; Mutoh K, 2008, J INHERIT METAB DIS, V31, pS343, DOI 10.1007/s10545-008-0914-x; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Pena IA, 2017, EXPERT REV ENDOCRINO, V12, P5, DOI 10.1080/17446651.2017.1273107; Prinsen HCMT, 2016, J INHERIT METAB DIS, V39, P651, DOI 10.1007/s10545-016-9935-z; PURVIS JL, 1961, J BIOL CHEM, V236, P2794; Rahman J, 2018, LANCET, V391, P2560, DOI 10.1016/S0140-6736(18)30727-X; Ramos RJ, 2017, J INHERIT METAB DIS, V40, P883, DOI 10.1007/s10545-017-0061-3; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Renkema GH, 2015, EUR J HUM GENET, V23, P202, DOI 10.1038/ejhg.2014.80; Saheki T, 2002, J HUM GENET, V47, P333, DOI 10.1007/s100380200046; Sharma S, 2017, INT J MOL SCI, V18, P18; Tarailo-Graovac M, 2016, NEW ENGL J MED, V374, P2246, DOI 10.1056/NEJMoa1515792; van Karnebeek CDM, 2016, NAT GENET, V48, P777, DOI 10.1038/ng.3578; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wen XY, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.122373; Wibom R, 2009, NEW ENGL J MED, V361, P489, DOI 10.1056/NEJMoa0900591; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Zabinyakov N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186645	38	27	28	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 5	2019	105	3					534	548		10.1016/j.ajhg.2019.07.015	http://dx.doi.org/10.1016/j.ajhg.2019.07.015			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IV7GX	31422819	Green Published, Bronze			2022-12-18	WOS:000484435700008
J	Niihori, T; Nagai, K; Fujita, A; Ohashi, H; Okamoto, N; Okada, S; Harada, A; Kihara, H; Arbogast, T; Funayama, R; Shirota, M; Nakayama, K; Abe, T; Inoue, S; Tsai, IC; Matsumoto, N; Davis, EE; Katsanis, N; Aoki, Y				Niihori, Tetsuya; Nagai, Koki; Fujita, Atsushi; Ohashi, Hirofumi; Okamoto, Nobuhiko; Okada, Satoshi; Harada, Atsuko; Kihara, Hirotaka; Arbogast, Thomas; Funayama, Ryo; Shirota, Matsuyuki; Nakayama, Keiko; Abe, Taiki; Inoue, Shin-ichi; Tsai, I-Chun; Matsumoto, Naomichi; Davis, Erica E.; Katsanis, Nicholas; Aoki, Yoko			Germline-Activating RRAS2 Mutations Cause Noonan Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RAS/MAPK PATHWAY; TRANSFORMATION; EXPRESSION; DEFECTS; KRAS	Noonan syndrome (NS) is characterized by distinctive craniofacial appearance, short stature, and congenital heart disease. Approximately 80% of individuals with NS harbor mutations in genes whose products are involved in the RAS/mitogen-activating protein kinase (MAPK) pathway. However, the underlying genetic causes in nearly 20% of individuals with NS phenotype remain unexplained. Here, we report four de novo RRAS2 variants in three individuals with NS. RRAS2 is a member of the RAS subfamily and is ubiquitously expressed. Three variants, c.70_78dup (p.Gly24_Gly26dup), c.216A>T (p.Gln72His), and c.215A>T (p.Gln72Leu), have been found in cancers; our functional analyses showed that these three changes induced elevated association of RAF1 and that they activated ERK1/2 and ELK1. Notably, prominent activation of ERK1/2 and ELK1 by p.Gln72Leu associates with the severe phenotype of the individual harboring this change. To examine variant pathogenicity in vivo, we generated zebrafish models. Larvae overexpressing c.70_78dup (p.Gly24_Gly26dup) or c.216A>T (p.Gln72His) variants, but not wild-type RRAS2 RNAs, showed craniofacial defects and macrocephaly. The same dose injection of mRNA encoding c.215A>T (p.Gln72Leu) caused severe developmental impairments and low dose overexpression of this variant induced craniofacial defects. In contrast, the RRAS2 c.224T>G (p.Phe75Cys) change, located on the same allele with p.Gln72His in an individual with NS, resulted in no aberrant in vitro or in vivo phenotypes by itself. Together, our findings suggest that activating RRAS2 mutations can cause NS and expand the involvement of RRAS2 proto-oncogene to rare germline disorders.	[Niihori, Tetsuya; Nagai, Koki; Abe, Taiki; Inoue, Shin-ichi; Aoki, Yoko] Tohoku Univ, Dept Med Genet, Sch Med, Sendai, Miyagi 9808574, Japan; [Niihori, Tetsuya; Arbogast, Thomas; Tsai, I-Chun; Davis, Erica E.; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Med Ctr, Durham, NC 27701 USA; [Fujita, Atsushi; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 2360004, Japan; [Ohashi, Hirofumi] Saitama Childrens Med Ctr, Div Med Genet, Saitama 3308777, Japan; [Okamoto, Nobuhiko] OsakaWomens & Childrens Hosp, Dept Med Genet, Osaka 5941101, Japan; [Okada, Satoshi] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pediat, Hiroshima 7348551, Japan; [Harada, Atsuko] Takatsuki Gen Hosp, Dept Pediat Neurosurg, Osaka 5691192, Japan; [Kihara, Hirotaka] Onomichi Gen Hosp, Dept Pediat, Hiroshima 7228508, Japan; [Funayama, Ryo; Nakayama, Keiko] Tohoku Univ, Grad Sch Med, Dept Cell Proliferat, United Ctr Adv Res & Translat Med, Sendai, Miyagi 9808575, Japan; [Shirota, Matsuyuki] Tohoku Univ, Grad Sch Med, Div Interdisciplinary Med Sci, United Ctr Adv Res & Translat Med, Sendai, Miyagi 9808575, Japan	Tohoku University; Duke University; Yokohama City University; Saitama Children's Medical Center; Hiroshima University; Tohoku University; Tohoku University	Niihori, T (corresponding author), Tohoku Univ, Dept Med Genet, Sch Med, Sendai, Miyagi 9808574, Japan.; Niihori, T; Katsanis, N (corresponding author), Duke Univ, Ctr Human Dis Modeling, Med Ctr, Durham, NC 27701 USA.	tniihori@med.tohoku.ac.jp; katsanis@cellbio.duke.edu	Okada, Satoshi/B-8901-2011; Niihori, Tetsuya/ABE-2350-2021	Okada, Satoshi/0000-0002-4622-5657; Niihori, Tetsuya/0000-0002-2118-9776; Abe, Taiki/0000-0001-6580-3734; Davis, Erica/0000-0002-2412-8397	US National Institutes of Health [MH106826]; AMED [JP18ek0109241, JP18ek0109278, JP18ek0109280, JP18dm0107090, JP18ek0109301, JP18ek0109348, JP18kk020501]; Japan Society for the Promotion of Science (JSPS) KAKENHI [JP16K15522, JP17H01539, JP17H06994, JP15KK0293]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH106826] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AMED(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank the individuals who participated in this study and their families. We also thank Drs. Kenji Kurosawa, Seiji Mizuno, Hiroshi Kawame, Tsutomu Ogata, Yoichi Matsubara, and other physicians for sending samples of patients, and Ikumi Umeki, Yoko Tateda, Kumi Kato, Miyuki Tsuda, Mami Kikuchi, Makiko Nakagawa, and Kiyotaka Kuroda for their technical assistance. We also acknowledge the technical support of the Biomedical Research Core of Tohoku University Graduate School of Medicine. This work was supported by US National Institutes of Health grant MH106826 to E.E.D., AMED under grants to Y.A. (JP18ek0109241 and JP18ek0109278) and N.M. (JP18ek0109280, JP18dm0107090, JP18ek0109301, JP18ek0109348, and JP18kk020501), and Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Numbers JP16K15522 to Y.A., JP17H01539 to N.M., JP17H06994 to A.F., and JP15KK0293 to T.N.	Anastasaki C, 2009, HUM MOL GENET, V18, P2543, DOI 10.1093/hmg/ddp186; Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; Aoki Y, 2008, HUM MUTAT, V29, P992, DOI 10.1002/humu.20748; Aoki Y, 2016, J HUM GENET, V61, P33, DOI 10.1038/jhg.2015.114; Aoki Y, 2013, AM J HUM GENET, V93, P173, DOI 10.1016/j.ajhg.2013.05.021; Bogershausen N, 2015, J CLIN INVEST, V125, P3585, DOI 10.1172/JCI80102; Capri Y, 2019, AM J HUM GENET, V104, P1223, DOI 10.1016/j.ajhg.2019.04.013; CHAN AML, 1994, P NATL ACAD SCI USA, V91, P7558, DOI 10.1073/pnas.91.16.7558; Gelb BD, 2018, GENET MED, V20, P1334, DOI 10.1038/gim.2018.3; Graham SM, 1996, MOL CELL BIOL, V16, P6132; GRAHAM SM, 1994, MOL CELL BIOL, V14, P4108, DOI 10.1128/MCB.14.6.4108; Gripp KW, 2016, AM J MED GENET A, V170, P2237, DOI 10.1002/ajmg.a.37781; Higgins EM, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91225; HUANG Y, 1995, ONCOGENE, V11, P1255; Hutson MR, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal4055; Inoue S, 2014, HUM MOL GENET, V23, P6553, DOI 10.1093/hmg/ddu376; Johnston JJ, 2018, GENET MED, V20, P1175, DOI 10.1038/gim.2017.249; Jopling C, 2007, PLOS GENET, V3, P2468, DOI 10.1371/journal.pgen.0030225; Magini P, 2014, HUM MOL GENET, V23, P3607, DOI 10.1093/hmg/ddu070; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Rong R, 2002, ONCOGENE, V21, P1062, DOI 10.1038/sj.onc.1205154; Runtuwene V, 2011, DIS MODEL MECH, V4, P393, DOI 10.1242/dmm.007112; Santoriello C, 2009, DIS MODEL MECH, V2, P56, DOI 10.1242/dmm.001016; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Stieglitz E, 2015, NAT GENET, V47, P1326, DOI 10.1038/ng.3400; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; Tsai IC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28709-y; van der Burgt I, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-4; Vissers LELM, 2015, EUR J HUM GENET, V23, P317, DOI 10.1038/ejhg.2014.115	32	27	27	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 6	2019	104	6					1233	1240		10.1016/j.ajhg.2019.04.014	http://dx.doi.org/10.1016/j.ajhg.2019.04.014			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IB4KJ	31130285	Green Published, Bronze			2022-12-18	WOS:000470240000017
J	De Franco, E; Watson, RA; Weninger, WJ; Wong, CC; Flanagan, SE; Caswell, R; Green, A; Tudor, C; Lelliott, CJ; Geyer, SH; Maurer-Gesek, B; Reissig, LF; Allen, HL; Caliebe, A; Siebert, R; Holterhus, PM; Deeb, A; Prin, F; Hilbrands, R; Heimberg, H; Ellard, S; Hattersley, AT; Barroso, I				De Franco, Elisa; Watson, Rachel A.; Weninger, Wolfgang J.; Wong, Chi C.; Flanagan, Sarah E.; Caswell, Richard; Green, Angela; Tudor, Catherine; Lelliott, Christopher J.; Geyer, Stefan H.; Maurer-Gesek, Barbara; Reissig, Lukas F.; Allen, Hana Lango; Caliebe, Almuth; Siebert, Reiner; Holterhus, Paul Martin; Deeb, Asma; Prin, Fabrice; Hilbrands, Robert; Heimberg, Harry; Ellard, Sian; Hattersley, Andrew T.; Barroso, Ines			A Specific CNOT1 Mutation Results in a Novel Syndrome of Pancreatic Agenesis and Holoprosencephaly through Impaired Pancreatic and Neurological Development	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DIFFERENTIATION; ENDODERM; IDENTITY; MOUSE	We report a recurrent CNOT1 de novo missense mutation, GenBank: NM_016284.4; c.1603C>T (p.Arg535Cys), resulting in a syndrome of pancreatic agenesis and abnormal forebrain development in three individuals and a similar phenotype in mice. CNOT1 is a transcriptional repressor that has been suggested as being critical for maintaining embryonic stem cells in a pluripotent state. These findings suggest that CNOT1 plays a critical role in pancreatic and neurological development and describe a novel genetic syndrome of pancreatic agenesis and holoprosencephaly.	[De Franco, Elisa; Flanagan, Sarah E.; Caswell, Richard; Allen, Hana Lango; Ellard, Sian; Hattersley, Andrew T.] Univ Exeter, Med Sch, Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England; [Watson, Rachel A.; Wong, Chi C.; Green, Angela; Tudor, Catherine; Lelliott, Christopher J.; Barroso, Ines] Wellcome Sanger Inst, Hinxton CB10 1SA, England; [Weninger, Wolfgang J.; Geyer, Stefan H.; Maurer-Gesek, Barbara; Reissig, Lukas F.] Med Univ Vienna, Ctr Anat & Cell Biol, A-1090 Vienna, Austria; [Weninger, Wolfgang J.; Geyer, Stefan H.; Maurer-Gesek, Barbara; Reissig, Lukas F.] Med Univ Vienna, MIC, A-1090 Vienna, Austria; [Caliebe, Almuth; Siebert, Reiner] Univ Kiel, Inst Human Genet, D-24105 Kiel, Germany; [Caliebe, Almuth; Siebert, Reiner; Holterhus, Paul Martin] Univ Hosp Schleswig Holstein, D-24105 Kiel, Germany; [Siebert, Reiner] Ulm Univ, Inst Human Genet, D-89081 Ulm, Germany; [Siebert, Reiner] Ulm Univ, Med Ctr, D-89081 Ulm, Germany; [Holterhus, Paul Martin] Univ Kiel, Div Pediat Endocrinol & Diabet, Dept Pediat, D-24105 Kiel, Germany; [Deeb, Asma] Mafraq Hosp, Paediat Endocrinol Dept, Abu Dhabi 2951, U Arab Emirates; [Prin, Fabrice] Francis Crick Inst, London NW1 1ST, England; [Hilbrands, Robert; Heimberg, Harry] Vrije Univ Brussel, B-1090 Brussels, Belgium; [Hilbrands, Robert] Univ Ziekenhuis Brussel, B-1090 Brussels, Belgium; [Barroso, Ines] Univ Cambridge, Inst Metab Sci, MRC Epidemiol Unit, Cambridge CB2 0SL, England	University of Exeter; Wellcome Trust Sanger Institute; Medical University of Vienna; Medical University of Vienna; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; Ulm University; Ulm University; University of Kiel; Francis Crick Institute; Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel; University of Cambridge	Hattersley, AT (corresponding author), Univ Exeter, Med Sch, Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England.; Barroso, I (corresponding author), Wellcome Sanger Inst, Hinxton CB10 1SA, England.; Barroso, I (corresponding author), Univ Cambridge, Inst Metab Sci, MRC Epidemiol Unit, Cambridge CB2 0SL, England.	a.t.hattersley@exeter.ac.uk; ines.barroso@mrc-epid.cam.ac.uk	Caliebe, Almuth/G-1248-2018; Siebert, Reiner/A-8049-2010; Hilbrands, Robert/B-7561-2014	Caliebe, Almuth/0000-0003-2157-425X; Reissig, Lukas F/0000-0001-5833-8176; Caswell, Richard/0000-0003-0713-4602; Weninger, Wolfgang J/0000-0003-0575-0073; Hilbrands, Robert/0000-0003-0228-699X; Heimberg, Harry/0000-0003-1954-7375; Watson, Rachel/0000-0002-6745-4539; Barroso, Ines/0000-0001-5800-4520; De Franco, Elisa/0000-0002-1437-7891; Hattersley, Andrew/0000-0001-5620-473X; Geyer, Stefan/0000-0003-2283-4439	Wellcome [WT206194]; Wellcome Trust Senior Investigator award [WT098395/Z/12/Z]; NIHR; Wellcome Trust; Royal Society [105636/Z/14/Z]; Wellcome Trust Intermediate Clinical Fellowship [105914/Z/14/Z]; Research Foundation-Flanders (FWO); VUB Research Council; Stichting Diabetes Onderzoek Nederland;  [50565]	Wellcome; Wellcome Trust Senior Investigator award(Wellcome Trust); NIHR(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Wellcome Trust Intermediate Clinical Fellowship(Wellcome Trust); Research Foundation-Flanders (FWO)(FWO); VUB Research Council; Stichting Diabetes Onderzoek Nederland; 	I.B. is funded by Wellcome (WT206194). A.T.H. and S.E. are the recipients of a Wellcome Trust Senior Investigator award (grant WT098395/Z/12/Z) and A.T.H. is employed as a core member of staff within the NIHR funded Exeter Clinical Research Facility and is an NIHR senior investigator. E.D.F. was a Naomi Berrie Fellow in Diabetes Research (grant 50565) during the study. S.E.F. has a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (grant number 105636/Z/14/Z). C.C.W. holds a Wellcome Trust Intermediate Clinical Fellowship (grant number 105914/Z/14/Z). H.H. is funded by the Research Foundation-Flanders (FWO), the VUB Research Council, and Stichting Diabetes Onderzoek Nederland.	Allen HL, 2012, NAT GENET, V44, P20, DOI 10.1038/ng.1035; Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; De Franco E, 2015, PEDIATR CLIN N AM, V62, P1037, DOI 10.1016/j.pcl.2015.04.012; Firth HV, 2011, DEV MED CHILD NEUROL, V53, P702, DOI 10.1111/j.1469-8749.2011.04032.x; Hilbrands R, 2017, BMC MED GENET, V18, DOI 10.1186/s12881-017-0419-2; Huang X, 2007, HUM MOL GENET, V16, P1454, DOI 10.1093/hmg/ddm096; Jennings RE, 2013, DIABETES, V62, P3514, DOI 10.2337/db12-1479; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; van de Bunt M, 2016, ISLETS, V8, P83, DOI 10.1080/19382014.2016.1182276; Winkler GS, 2006, EMBO J, V25, P3089, DOI 10.1038/sj.emboj.7601194; Xuan SH, 2016, DEVELOPMENT, V143, P780, DOI 10.1242/dev.127217; Zheng XF, 2012, STEM CELLS, V30, P910, DOI 10.1002/stem.1070	12	27	27	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 2	2019	104	5					985	989		10.1016/j.ajhg.2019.03.018	http://dx.doi.org/10.1016/j.ajhg.2019.03.018			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HW3QV	31006513	Green Submitted, Green Published, hybrid			2022-12-18	WOS:000466608700017
J	Wambach, JA; Wegner, DJ; Patni, N; Kircher, M; Willing, MC; Baldridge, D; Xing, C; Agarwal, AK; Vergano, SAS; Patel, C; Grange, DK; Kenney, A; Najaf, T; Nickerson, DA; Bamshad, MJ; Cole, FS; Garg, A				Wambach, Jennifer A.; Wegner, Daniel J.; Patni, Nivedita; Kircher, Martin; Willing, Marcia C.; Baldridge, Dustin; Xing, Chao; Agarwal, Anil K.; Vergano, Samantha A. Schrier; Patel, Chirag; Grange, Dorothy K.; Kenney, Amy; Najaf, Tasnim; Nickerson, Deborah A.; Bamshad, Michael J.; Cole, F. Sessions; Garg, Abhimanyu			Bi-allelic POLR3A Loss-of-Function Variants Cause Autosomal-Recessive Wiedemann-Rautenstrauch Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEONATAL PROGEROID SYNDROME; CONGENITAL LIPODYSTROPHY; MARFAN-SYNDROME; 3' END; MUTATIONS; APPEARANCE; FEATURES	Wiedemann-Rautenstrauch syndrome (WRS), also known as neonatal progeroid syndrome, is a rare disorder of unknown etiology. It has been proposed to be autosomal-recessive and is characterized by variable clinical features, such as intrauterine growth restriction and poor postnatal weight gain, characteristic facial features (triangular appearance to the face, convex nasal profile or pinched nose, and small mouth), widened fontanelles, pseudohydrocephalus, prominent scalp veins, lipodystrophy, and teeth abnormalities. A previous report described a single WRS patient with bi-allelic truncating and splicing variants in POLR3A. Here we present seven additional infants, children, and adults with WRS and bi-allelic truncating and/or splicing variants in POLR3A. POLR3A, the largest subunit of RNA polymerase III, is a DNA-directed RNA polymerase that transcribes many small noncoding RNAs that regulate transcription, RNA processing, and translation. Bi-allelic missense variants in POLR3A have been associated with phenotypes distinct from WRS: hypogonadotropic hypogonadism and hypomyelinating leukodystrophy with or without oligodontia. Our findings confirm the association of bi-allelic POLR3A variants with WRS, expand the clinical phenotype of WRS, and suggest specific POLR3A genotypes associated with WRS and hypomyelinating leukodystrophy.	[Wambach, Jennifer A.; Wegner, Daniel J.; Willing, Marcia C.; Baldridge, Dustin; Grange, Dorothy K.; Najaf, Tasnim; Cole, F. Sessions] Washington Univ, Sch Med, Edward Mallinckrodt Dept Pediat, St Louis, MO 63110 USA; [Wambach, Jennifer A.; Wegner, Daniel J.; Willing, Marcia C.; Baldridge, Dustin; Grange, Dorothy K.; Najaf, Tasnim; Cole, F. Sessions] St Louis Childrens Hosp, St Louis, MO 63110 USA; [Patni, Nivedita] UT Southwestern Med Ctr, Dept Pediat, Dallas, TX 75390 USA; [Patni, Nivedita] UT Southwestern Med Ctr, Ctr Human Nutr, Dallas, TX 75390 USA; [Kircher, Martin; Nickerson, Deborah A.; Bamshad, Michael J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Xing, Chao] UT Southwestern Med Ctr, McDermott Ctr Human Growth & Dev, Dept Bioinformat, Dallas, TX 75390 USA; [Xing, Chao] UT Southwestern Med Ctr, Dept Clin Sci, Dallas, TX 75390 USA; [Agarwal, Anil K.; Garg, Abhimanyu] Univ Texas Southwestern Med Ctr Dallas, Ctr Human Nutr, Dept Internal Med, Div Nutr Metab Dis, Dallas, TX 75390 USA; [Vergano, Samantha A. Schrier; Kenney, Amy] Eastern Virginia Med Sch, Dept Pediat, Childrens Hosp Kings Daughters, Div Med Genet & Metab, Norfolk, VA 23507 USA; [Patel, Chirag] Royal Brisbane & Womens Hosp, Genet Hlth Queensland, Brisbane, Qld 4029, Australia; [Bamshad, Michael J.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Najaf, Tasnim] Washington Univ, Sch Med, Fetal Care Ctr, St Louis, MO 63110 USA	Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Eastern Virginia Medical School; Royal Brisbane & Women's Hospital; University of Washington; University of Washington Seattle; Washington University (WUSTL)	Wambach, JA (corresponding author), Washington Univ, Sch Med, Edward Mallinckrodt Dept Pediat, St Louis, MO 63110 USA.; Wambach, JA (corresponding author), St Louis Childrens Hosp, St Louis, MO 63110 USA.; Garg, A (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Ctr Human Nutr, Dept Internal Med, Div Nutr Metab Dis, Dallas, TX 75390 USA.	wambachj@wustl.edu; abhimanyu.garg@utsouthwestern.edu	Kircher, Martin/H-6909-2019; Patel, Chirag/AAF-4953-2019; Kircher, Martin/HDL-9392-2022	Kircher, Martin/0000-0001-9278-5471; Patel, Chirag/0000-0002-6374-5224; Patni, Nivedita/0000-0002-5926-7784; Xing, Chao/0000-0002-1838-0502	National Heart, Lung, and Blood Institute [HG006493]; National Institutes of Health [K08 HL105891, K12 HL120002, R01 HL065174, R21/33 HL120760, R01-DK105448, UL1RR024982, UL1TR001105, U54 HG006493]; Children's Discovery Institute; University of Texas Southwestern Medical Foundation; National Human Genome Research Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL120760] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105448] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Discovery Institute; University of Texas Southwestern Medical Foundation; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank the families and referring physicians for participation in these studies. The authors thank Hillary Heins and Ping Yang of Washington University for their assistance with DNA isolation and preparation. The authors also thank Pei-Yun Tseng, Mary Tunison, and Claudia Quittner of UT Southwestern for help with DNA isolation, RNA analysis, and nursing support. The authors thank GeneDx for sharing VCF and BAM files from a non-diagnostic, clinician-referred, whole exome for research analysis performed at Washington University School of Medicine. Some sequencing was provided by the University of Washington Center for Mendelian Genomics (UW-CMG) and was funded by the National Human Genome Research Institute and the National Heart, Lung, and Blood Institute grant HG006493 to Debbie Nickerson, Michael Bamshad, and Suzanne Leal. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors thank the Exome Aggregation Consortium and the groups that provided exome variant data for comparison; a full list of contributing groups can be found at http://exac.broadinstitute.org/about.This work was also supported by grants from the National Institutes of Health (K08 HL105891 [J.A.W.], K12 HL120002 [F.S.C.], R01 HL065174 [F.S.C.], R21/33 HL120760 [F.S.C.], R01-DK105448 [A.G., A.K.A.], CTSA grants UL1RR024982, UL1TR001105 to UT Southwestern Medical Center, and U54 HG006493 to the University of Washington Center for Mendelian Genomics [D.A.N., M.J.B.]), the Children's Discovery Institute (F.S.C.) and University of Texas Southwestern Medical Foundation (A.G.).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Atrouni S, 2003, AM J MED GENET A, V118A, P76, DOI 10.1002/ajmg.a.10019; Bernard G, 2011, AM J HUM GENET, V89, P415, DOI 10.1016/j.ajhg.2011.07.014; Choquet K, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0294-y; DEVOS EA, 1981, EUR J PEDIATR, V136, P245, DOI 10.1007/BF00442991; Dumay-Odelot H, 2010, CELL CYCLE, V9, P3687, DOI 10.4161/cc.9.18.13203; Ehmke N, 2017, AM J HUM GENET, V101, P833, DOI 10.1016/j.ajhg.2017.09.016; Garg A, 2015, AM J MED GENET A, V167, P1796, DOI 10.1002/ajmg.a.37115; Garg A, 2014, AM J MED GENET A, V164, P1341, DOI 10.1002/ajmg.a.36449; Goldblatt J, 2011, AM J MED GENET A, V155A, P717, DOI 10.1002/ajmg.a.33906; Graul-Neumann LM, 2010, AM J MED GENET A, V152A, P2749, DOI 10.1002/ajmg.a.33690; Horn D, 2011, AM J MED GENET A, V155A, P721, DOI 10.1002/ajmg.a.33905; Jacquinet A, 2014, EUR J MED GENET, V57, P230, DOI 10.1016/j.ejmg.2014.02.012; Jay AM, 2016, AM J MED GENET A, V170, P3343, DOI 10.1002/ajmg.a.37960; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; O'Neill B, 2007, AM J MED GENET A, V143A, P1421, DOI 10.1002/ajmg.a.31840; Paolacci S, 2017, AM J MED GENET A, V173, P1763, DOI 10.1002/ajmg.a.38246; Pivnick EK, 2000, AM J MED GENET, V90, P131, DOI 10.1002/(SICI)1096-8628(20000117)90:2<131::AID-AJMG9>3.3.CO;2-5; RAUTENSTRAUCH T, 1977, EUR J PEDIATR, V124, P101, DOI 10.1007/BF00477545; Saitsu H, 2011, AM J HUM GENET, V89, P644, DOI 10.1016/j.ajhg.2011.10.003; Spurdle AB, 2008, HUM MUTAT, V29, P1304, DOI 10.1002/humu.20901; Takenouchi T, 2013, AM J MED GENET A, V161, P3057, DOI 10.1002/ajmg.a.36157; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; WIEDEMANN HR, 1979, EUR J PEDIATR, V130, P65, DOI 10.1007/BF00441901; Wolf NI, 2014, NEUROLOGY, V83, P1898, DOI 10.1212/WNL.0000000000001002	25	27	30	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 6	2018	103	6					968	975		10.1016/j.ajhg.2018.10.010	http://dx.doi.org/10.1016/j.ajhg.2018.10.010			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HD4YX	30414627	Green Published, Bronze			2022-12-18	WOS:000452535600010
J	Wang, D; Fan, Y; Malhi, M; Bi, R; Wu, Y; Xu, M; Yu, XF; Long, H; Li, YY; Zhang, DF; Yao, YG				Wang, Dong; Fan, Yu; Malhi, Mahadev; Bi, Rui; Wu, Yong; Xu, Min; Yu, Xiu-Feng; Long, Heng; Li, Yu-Ye; Zhang, Deng-Feng; Yao, Yong-Gang			Missense Variants in HIF1A and LACC1 Contribute to Leprosy Risk in Han Chinese	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GENETIC ARCHITECTURE; SUSCEPTIBILITY GENES; CROHNS-DISEASE; IDENTIFICATION; LOCI; MUTATION; HETEROGENEITY; INFLAMMATION; HIF-1-ALPHA	Genome-wide association studies (GWASs) and genome-wide linkage studies (GWLSs) have identified numerous risk genes affecting the susceptibility to leprosy. However, most of the reported GWAS hits are noncoding variants and account for only part of the estimated heritability for this disease. In order to identify additional risk genes and map the potentially functional variants within the GWAS loci, we performed a three-stage study combining whole-exome sequencing (WES; discovery stage), targeted next-generation sequencing (NGS; screening stage), and refined validation of risk missense variants in 1,433 individuals with leprosy and 1,625 healthy control individuals from Yunnan Province, Southwest China. We identified and validated a rare damaging variant, rs142179458 (c.1045G>A [p.Asp349Asn]) in HIF1A, as contributing to leprosy risk (p = 4.95 x 10(-9), odds ratio [OR] = 2.266). We were able to show that affected individuals harboring the risk allele presented with multibacillary leprosy at an earlier age (p = 0.025). We also confirmed the association between missense variant rs3764147 (c.760A>G [p.Ile254Val]) in the GWAS hit LACC1 (formerly Cl3orf31) and leprosy (p = 6.11 x 10(-18), OR = 1.605). By using the population attributable fraction, we have shown that HIF1A and LACC1 are the major genes with missense variants contributing to leprosy risk in our study groups. Consistently, mRNA expression levels of both HIF1A and LA CCI were upregulated in the skin lesions of individuals with leprosy and in Mycobacterium leprae-stimulated cells, indicating an active role of HIF1A and LACCI in leprosy pathogenesis.	[Wang, Dong; Fan, Yu; Malhi, Mahadev; Bi, Rui; Wu, Yong; Xu, Min; Zhang, Deng-Feng; Yao, Yong-Gang] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China; [Wang, Dong] Chengdu Univ Tradit Chinese Med, Coll Fundamental Med, Chengdu 610072, Sichuan, Peoples R China; [Fan, Yu; Bi, Rui; Zhang, Deng-Feng; Yao, Yong-Gang] Chinese Acad Sci, Ctr Excellence Anim Evolut & Genet, Kunming 650223, Yunnan, Peoples R China; [Yu, Xiu-Feng; Long, Heng] Wenshan Inst Dermatol, Wenshan 663000, Yunnan, Peoples R China; [Li, Yu-Ye] Kunming Med Univ, Dept Dermatol, Affiliated Hosp 1, Kunming 650032, Yunnan, Peoples R China; [Malhi, Mahadev; Wu, Yong; Xu, Min; Yao, Yong-Gang] Univ Chinese Acad Sci, Kunm Coll Life Sci, Kunming 650204, Yunnan, Peoples R China; [Yao, Yong-Gang] KIZ CUHK Joint Lab Bioresources & Mol Res Common, Kunming 650223, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chengdu University of Traditional Chinese Medicine; Chinese Academy of Sciences; Kunming Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, DF; Yao, YG (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China.; Zhang, DF; Yao, YG (corresponding author), Chinese Acad Sci, Ctr Excellence Anim Evolut & Genet, Kunming 650223, Yunnan, Peoples R China.; Yao, YG (corresponding author), Univ Chinese Acad Sci, Kunm Coll Life Sci, Kunming 650204, Yunnan, Peoples R China.; Yao, YG (corresponding author), KIZ CUHK Joint Lab Bioresources & Mol Res Common, Kunming 650223, Yunnan, Peoples R China.	zhangdengfeng@mail.kiz.ac.cn; yaoyg@mail.kiz.ac.cn	Yao, Yong-Gang/AAH-2303-2021	Yao, Yong-Gang/0000-0002-2955-0693; Zhang, Deng-Feng/0000-0002-0777-5859; Fan, Yu/0000-0002-5978-5004	National Natural Science Foundation of China [81573034, 31271346]; West Light Foundation of the Chinese Academy of Sciences; CAS-TWAS	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences); CAS-TWAS(Chinese Academy of Sciences)	We are grateful to the subjects who donated DNA samples, as well as two anonymous reviewers and the handling editor for their helpful comments. We thank Ian Logan for language editing and Guo-Dong Li and Li-Li Kong for technical assistance. This study was supported by the National Natural Science Foundation of China (81573034 and 31271346), the West Light Foundation of the Chinese Academy of Sciences, and the CAS-TWAS President's Fellowship for International PhD Students. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ajdukovic J., 2016, Experimental Oncology, V38, P9; Alter A, 2008, HUM GENET, V123, P227, DOI 10.1007/s00439-008-0474-z; Alter A, 2011, MAMM GENOME, V22, P19, DOI 10.1007/s00335-010-9287-1; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; [Anonymous], 2015, Wkly Epidemiol Rec, V91, P405; [Anonymous], 1994, World Health Organ Tech Rep Ser, V847, P1; [Anonymous], 2009, LANCET NEUROL, V8, P217; Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Belone ADF, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00334; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7; Cader MZ, 2016, NAT IMMUNOL, V17, P1046, DOI 10.1038/ni.3532; Chan CHT, 2017, CANCER RES, V77, P5428, DOI 10.1158/0008-5472.CAN-17-0992; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Deshmane SL, 2009, J BIOL CHEM, V284, P11364, DOI 10.1074/jbc.M809266200; Dong SY, 2016, BIOCHEM BIOPH RES CO, V470, P453, DOI 10.1016/j.bbrc.2016.01.013; Fava VM, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006637; Ferreira JV, 2013, AUTOPHAGY, V9, P1349, DOI 10.4161/auto.25190; Gaschignard J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004345; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Grant AV, 2012, J INFECT DIS, V206, P1763, DOI 10.1093/infdis/jis588; Hellwig-Burgel T, 2005, J INTERF CYTOK RES, V25, P297, DOI 10.1089/jir.2005.25.297; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Jyothi P, 2008, Indian J Dermatol Venereol Leprol, V74, P80; Karlsson EK, 2014, NAT REV GENET, V15, P379, DOI 10.1038/nrg3734; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lahiri A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15614; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YY, 2011, LEPROSY REV, V82, P6; Liu H, 2017, J INVEST DERMATOL, V137, P2544, DOI 10.1016/j.jid.2017.08.004; Liu H, 2015, NAT GENET, V47, P267, DOI 10.1038/ng.3212; Liu H, 2013, HUM MOL GENET, V22, P4430, DOI 10.1093/hmg/ddt286; Liu H, 2012, AM J HUM GENET, V91, P935, DOI 10.1016/j.ajhg.2012.09.010; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Madigan CA, 2017, CELL, V170, P973, DOI 10.1016/j.cell.2017.07.030; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Manry J, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006952; Masaki T, 2013, CELL, V152, P51, DOI 10.1016/j.cell.2012.12.014; Mazini PS, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00658; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Metheni M, 2015, CELL MICROBIOL, V17, P467, DOI 10.1111/cmi.12421; Mira MT, 2003, NAT GENET, V33, P412, DOI 10.1038/ng1096; Mira MT, 2004, NATURE, V427, P636, DOI 10.1038/nature02326; Misch EA, 2010, MICROBIOL MOL BIOL R, V74, P589, DOI 10.1128/MMBR.00025-10; Mladenova DN, 2015, DIS MODEL MECH, V8, P1093, DOI 10.1242/dmm.019000; Modlin RL, 2010, CURR OPIN IMMUNOL, V22, P48, DOI 10.1016/j.coi.2009.12.001; Movafagh S, 2015, J CELL BIOCHEM, V116, P696, DOI 10.1002/jcb.25074; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nuytemans K, 2010, HUM MUTAT, V31, P763, DOI 10.1002/humu.21277; Patel N, 2014, GUT, V63, P1831, DOI 10.1136/gutjnl-2014-307859; Rajagopalan S, 2016, J NEUROSCI, V36, P1086, DOI 10.1523/JNEUROSCI.3117-15.2016; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Sales-Marques C, 2014, HUM GENET, V133, P1525, DOI 10.1007/s00439-014-1502-9; Schalcher TR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085712; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Siddiqui MR, 2001, NAT GENET, V27, P439, DOI 10.1038/86958; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Timpson NJ, 2018, NAT REV GENET, V19, P110, DOI 10.1038/nrg.2017.101; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wakil SM, 2015, ARTHRITIS RHEUMATOL, V67, P288, DOI 10.1002/art.38877; Wang D, 2018, BRIT J DERMATOL, V178, P931, DOI 10.1111/bjd.16020; Wang D, 2015, GENES IMMUN, V16, P112, DOI 10.1038/gene.2014.72; Wang DS, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15017453; Wang D, 2017, J DERMATOL SCI, V88, P349, DOI 10.1016/j.jdermsci.2017.09.001; Wang D, 2012, HUM GENET, V131, P1251, DOI 10.1007/s00439-012-1153-7; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang ZZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13760; Wong SH, 2010, NEW ENGL J MED, V362, P1446, DOI 10.1056/NEJMc1001451; Xiang YL, 2015, J DERMATOL SCI, V80, P133, DOI 10.1016/j.jdermsci.2015.09.001; Xiong JH, 2016, INT J DERMATOL, V55, P65, DOI 10.1111/ijd.12981; Yang DG, 2014, INFLAMMATION, V37, P593, DOI 10.1007/s10753-013-9773-1; Yuan YH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16422-1; Zhang DF, 2016, J DERMATOL SCI, V82, P18, DOI 10.1016/j.jdermsci.2016.01.001; Zhang FR, 2013, NEW ENGL J MED, V369, P1620, DOI 10.1056/NEJMoa1213096; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zhang FR, 2011, NAT GENET, V43, P1247, DOI 10.1038/ng.973	82	27	27	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 3	2018	102	5					794	805		10.1016/j.ajhg.2018.03.006	http://dx.doi.org/10.1016/j.ajhg.2018.03.006			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG1IH	29706348	Green Published, Bronze			2022-12-18	WOS:000432440100006
J	Yang, CF; Lin, SP; Chiang, CP; Wu, YH; H'ng, WS; Chang, CP; Chen, YT; Wu, JY				Yang, Chi-Fan; Lin, Shuan-Pei; Chiang, Chien-Ping; Wu, Yu-Hung; H'ng, Weng Siong; Chang, Chun-Ping; Chen, Yuan-Tsong; Wu, Jer-Yuarn			Loss of GPNMB Causes Autosomal-Recessive Amyloidosis Cutis Dyschromica in Humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOCALIZED-CUTANEOUS-AMYLOIDOSIS; MELANOMA PROTEIN-B; FORMATION IN-VIVO; PIGMENTARY GLAUCOMA; DC-HIL; ALZHEIMERS-DISEASE; OSTEOBLAST DIFFERENTIATION; TRANSMEMBRANE PROTEIN; GLYCOPROTEIN; DNA	Amyloidosis cutis dyschromica (ACD) is a distinct form of primary cutaneous amyloidosis characterized by generalized hyperpigmentation mottled with small hypopigmented macules on the trunks and limbs. Affected families and sporadic case subjects have been reported predominantly in East and Southeast Asian ethnicities; however, the genetic cause has not been elucidated. We report here that the compound heterozygosity or homozygosity of GPNMB truncating alleles is the cause of autosomal-recessive ACD. Six nonsense or frameshift mutations were identified in nine individuals diagnosed with ACD. Immunofluorescence analysis of skin biopsies showed that GPNMB is expressed in all epidermal cells, with the highest staining observed in melanocytes. GPNMB staining is significantly reduced in the lesional skin of affected individuals. Hyperpigmented lesions exhibited significantly increased amounts of DNA/keratin-positive amyloid deposits in the papillary dermis and infiltrating macrophages compared with hypo-or depigmented macules. Depigmentation of the lesions was attributable to loss of melanocytes. Intracytoplasmic fibrillary aggregates were observed in keratinocytes scattered in the lesional epidermis. Thus, our analysis indicates that loss of GPNMB, which has been implicated in melanosome formation, autophagy, phagocytosis, tissue repair, and negative regulation of inflammation, underlies autosomal-recessive ACD and provides insights into the etiology of amyloidosis and pigment dyschromia.	[Yang, Chi-Fan; H'ng, Weng Siong; Chang, Chun-Ping; Chen, Yuan-Tsong; Wu, Jer-Yuarn] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Lin, Shuan-Pei] MacKay Mem Hosp, Dept Med Res, Taipei 104, Taiwan; [Lin, Shuan-Pei] MacKay Mem Hosp, Dept Pediat, Taipei 104, Taiwan; [Lin, Shuan-Pei; Wu, Yu-Hung] MacKay Med Coll, Dept Med, New Taipei 252, Taiwan; [Chiang, Chien-Ping] Triserv Gen Hosp, Dept Dermatol, Taipei 114, Taiwan; [Chiang, Chien-Ping] Natl Def Med Ctr, Dept Biochem, Taipei 114, Taiwan; [Wu, Yu-Hung] MacKay Mem Hosp, Dept Dermatol, Taipei 104, Taiwan	Academia Sinica - Taiwan; Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Medical College; Tri-Service General Hospital; National Defense Medical Center; Mackay Memorial Hospital	Wu, JY (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan.	jywu@ibms.sinica.edu.tw	Wu, Jer-Yuarn/S-7010-2018; Wu, Yu-Hung/AAD-3124-2019	Wu, Yu-Hung/0000-0001-5579-2197	Academia Sinica Genomic Medicine Multicenter Study, Taiwan [40-05-GMM]; National Center for Genome Medicine of the National Core Facility Program for Biotechnology, Ministry of Science and Technology [NSC106-2319-B-001-001]	Academia Sinica Genomic Medicine Multicenter Study, Taiwan(Academia Sinica - Taiwan); National Center for Genome Medicine of the National Core Facility Program for Biotechnology, Ministry of Science and Technology	The authors thank the families and control individuals for their cooperation in this study. This work was supported by Academia Sinica Genomic Medicine Multicenter Study (40-05-GMM), Taiwan. We gratefully acknowledge the support from the National Center for Genome Medicine (NSC106-2319-B-001-001) of the National Core Facility Program for Biotechnology, Ministry of Science and Technology.	Abdelmagid SM, 2008, EXP CELL RES, V314, P2334, DOI 10.1016/j.yexcr.2008.02.006; Abdelmagid SM, 2014, AM J PATHOL, V184, P697, DOI 10.1016/j.ajpath.2013.11.031; Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Anderson MG, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-20; Arita K, 2008, AM J HUM GENET, V82, P73, DOI 10.1016/j.ajhg.2007.09.002; Bandari PS, 2003, REGUL PEPTIDES, V111, P169, DOI 10.1016/S0167-0115(02)00288-4; Barrantes A, 2007, J ALZHEIMERS DIS, V12, P345; Camero S, 2013, INT J BIOL MACROMOL, V55, P201, DOI 10.1016/j.ijbiomac.2013.01.007; Cantarini L, 2012, AUTOIMMUN REV, V12, P38, DOI 10.1016/j.autrev.2012.07.020; Chung JS, 2007, J IMMUNOL, V179, P5778, DOI 10.4049/jimmunol.179.9.5778; Chung JS, 2007, BLOOD, V109, P4320, DOI 10.1182/blood-2006-11-053769; Chung JS, 2014, J INVEST DERMATOL, V134, P2784, DOI 10.1038/jid.2014.254; Demirkaya E, 2016, RHEUMATOL INT, V36, P325, DOI 10.1007/s00296-015-3408-9; Dhawan G, 2012, NEUROBIOL AGING, V33, P2247, DOI 10.1016/j.neurobiolaging.2011.10.027; Di Domizio J, 2012, P NATL ACAD SCI USA, V109, P14550, DOI 10.1073/pnas.1206923109; Di Domizio J, 2012, J BIOL CHEM, V287, P736, DOI 10.1074/jbc.M111.238477; Doens D, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-48; Eikelenboom P, 2002, GLIA, V40, P232, DOI 10.1002/glia.10146; Fernandes NF, 2011, J CUTAN PATHOL, V38, P827, DOI 10.1111/j.1600-0560.2011.01719.x; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Frara N, 2016, J CELL PHYSIOL, V231, P72, DOI 10.1002/jcp.25020; Hoashi T, 2010, FASEB J, V24, P1616, DOI 10.1096/fj.09-151019; Huang WH, 2009, INT J DERMATOL, V48, P518, DOI 10.1111/j.1365-4632.2009.03844.x; Kamphuis W, 2016, BBA-MOL BASIS DIS, V1862, P1847, DOI 10.1016/j.bbadis.2016.07.007; Kumagai K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143413; Lascaratos G, 2013, SURV OPHTHALMOL, V58, P164, DOI 10.1016/j.survophthal.2012.08.002; Lee JW, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-37; Li B, 2010, FASEB J, V24, P4767, DOI 10.1096/fj.10-154757; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin MW, 2010, EUR J HUM GENET, V18, P26, DOI 10.1038/ejhg.2009.135; Lynch S, 2002, MOL VIS, V8, P127; Mahon C, 2016, AUSTRALAS J DERMATOL, V57, P307, DOI 10.1111/ajd.12342; Mereuta OM., 2015, AMYLOID RELATED DISO, V2nd; Miura Y, 2013, EXP DERMATOL, V22, P36, DOI 10.1111/exd.12065; Mo JS, 2003, J EXP MED, V197, P1335, DOI 10.1084/jem.20022041; MORIWAKI S, 1992, ARCH DERMATOL, V128, P966, DOI 10.1001/archderm.128.7.966; Ono K, 2014, J BIOL CHEM, V289, P29195, DOI 10.1074/jbc.M114.592998; Ozcan A, 2005, J DERMATOL, V32, P474, DOI 10.1111/j.1346-8138.2005.tb00783.x; Patel-Chamberlin M, 2011, KIDNEY INT, V79, P1138, DOI 10.1038/ki.2011.28; Philippens IH, 2017, J ALZHEIMERS DIS, V55, P101, DOI 10.3233/JAD-160673; Qiao JJ, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-95; Reemann P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115717; Ripoll VM, 2008, GENE, V413, P32, DOI 10.1016/j.gene.2008.01.014; Ripoll VM, 2007, J IMMUNOL, V178, P6557, DOI 10.4049/jimmunol.178.10.6557; Safadi FF, 2002, J CELL BIOCHEM, V84, P12, DOI 10.1002/jcb.1259; Sasaki F, 2015, MOL MED REP, V12, P7503, DOI 10.3892/mmr.2015.4408; Sheng MHC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035280; Shikano S, 2001, J BIOL CHEM, V276, P8125, DOI 10.1074/jbc.M008539200; Sondag CM, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-1; Theos AC, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12084; Tomihari M, 2009, EXP DERMATOL, V18, P586, DOI 10.1111/j.1600-0625.2008.00830.x; Turque N, 1996, EMBO J, V15, P3338, DOI 10.1002/j.1460-2075.1996.tb00699.x; Watt B, 2013, PIGM CELL MELANOMA R, V26, P300, DOI 10.1111/pcmr.12067; WETERMAN MAJ, 1995, INT J CANCER, V60, P73, DOI 10.1002/ijc.2910600111; Zhang P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042955; Zhou LT, 2017, CELL IMMUNOL, V316, P53, DOI 10.1016/j.cellimm.2017.03.006	56	27	31	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 1	2018	102	2					219	232		10.1016/j.ajhg.2017.12.012	http://dx.doi.org/10.1016/j.ajhg.2017.12.012			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FV2OL	29336782	Bronze, Green Published			2022-12-18	WOS:000424407600003
J	Bourcier, R; Le Scouarnec, S; Bonnaud, S; Karakachoff, M; Bourcereau, E; Heurtebise-Chretien, S; Menguy, C; Dina, C; Simonet, F; Moles, A; Lenoble, C; Lindenbaum, P; Chatel, S; Isidor, B; Genin, E; Deleuze, JF; Schott, JJ; Le Marec, H; Loirand, G; Desal, H; Redon, R				Bourcier, Romain; Le Scouarnec, Solena; Bonnaud, Stephanie; Karakachoff, Matilde; Bourcereau, Emmanuelle; Heurtebise-Chretien, Sandrine; Menguy, Celine; Dina, Christian; Simonet, Floriane; Moles, Alexis; Lenoble, Cedric; Lindenbaum, Pierre; Chatel, Stephanie; Isidor, Bertrand; Genin, Emmanuelle; Deleuze, Jean-Francois; Schott, Jean-Jacques; Le Marec, Herve; Loirand, Gervaise; Desal, Hubert; Redon, Richard		ICAN Study Grp	Rare Coding Variants in ANGPTL6 Are Associated with Familial Forms of Intracranial Aneurysm	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SMOOTH-MUSCLE-CELLS; SEQUENCING DATA; GROWTH-FACTOR; SUBARACHNOID HEMORRHAGE; RISK-FACTORS; ANGIOGENESIS; METAANALYSIS; RUPTURE; AGE; RNF213	Intracranial aneurysms (IAs) are acquired cerebrovascular abnormalities characterized by localized dilation and wall thinning in intracranial arteries, possibly leading to subarachnoid hemorrhage and severe outcome in case of rupture. Here, we identified one rare nonsense variant (c.1378A>T) in the last exon of ANGPTL6 (Angiopoietin-Like 6)-which encodes a circulating pro-angiogenic factor mainly secreted from the liver-shared by the four tested affected members of a large pedigree with multiple IA-affected case subjects. We showed a 50% reduction of ANGPTL6 serum concentration in individuals heterozygous for the c. 1378A>T allele (p. Lys460Ter) compared to relatives homozygous for the normal allele, probably due to the non-secretion of the truncated protein produced by the c. 1378A>T transcripts. Sequencing ANGPTL6 in a series of 94 additional index case subjects with familial IA identified three other rare coding variants in five case subjects. Overall, we detected a significant enrichment (p = 0.023) in rare coding variants within this gene among the 95 index case subjects with familial IA, compared to a reference population of 404 individuals with French ancestry. Among the 6 recruited families, 12 out of 13 (92%) individuals carrying IA also carry such variants in ANGPTL6, versus 15 out of 41 (37%) unaffected ones. We observed a higher rate of individuals with a history of high blood pressure among affected versus healthy individuals carrying ANGPTL6 variants, suggesting that ANGPTL6 could trigger cerebrovascular lesions when combined with other risk factors such as hypertension. Altogether, our results indicate that rare coding variants in ANGPTL6 are causally related to familial forms of IA.	[Bourcier, Romain; Le Scouarnec, Solena; Bonnaud, Stephanie; Karakachoff, Matilde; Heurtebise-Chretien, Sandrine; Menguy, Celine; Dina, Christian; Simonet, Floriane; Lindenbaum, Pierre; Chatel, Stephanie; Schott, Jean-Jacques; Le Marec, Herve; Loirand, Gervaise; Desal, Hubert; Redon, Richard] Univ Nantes, CNRS, INSERM, Inst Thorax, F-44007 Nantes, France; [Bourcier, Romain; Lenoble, Cedric; Desal, Hubert] CHU Nantes, Dept Neuroradiol, F-44093 Nantes, France; [Bonnaud, Stephanie; Karakachoff, Matilde; Bourcereau, Emmanuelle; Dina, Christian; Simonet, Floriane; Chatel, Stephanie; Schott, Jean-Jacques; Le Marec, Herve; Loirand, Gervaise; Redon, Richard] CHU Nantes, Inst Thorax, F-44093 Nantes, France; [Moles, Alexis] CHU Nantes, Dept Neurosurg, F-44093 Nantes, France; [Isidor, Bertrand] CHU Nantes, Dept Med Genet, F-44093 Nantes, France; [Genin, Emmanuelle] Univ Bretagne Occidentale, Inserm UMR 1078, Ctr Hosp Reg Univ Brest, Etab Francais Sang, F-29238 Brest, France; [Deleuze, Jean-Francois] CEA, Ctr Natl Rech Genom Humaine, F-91057 Evry, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; CHU Brest; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; CEA; UDICE-French Research Universities; Universite Paris Saclay	Desal, H; Redon, R (corresponding author), Univ Nantes, CNRS, INSERM, Inst Thorax, F-44007 Nantes, France.; Desal, H (corresponding author), CHU Nantes, Dept Neuroradiol, F-44093 Nantes, France.; Redon, R (corresponding author), CHU Nantes, Inst Thorax, F-44093 Nantes, France.	hubert.desal@chu-nantes.fr; richard.redon@inserm.fr	Le Scouarnec, Solena/D-3547-2015; Le Marec, Hervé/D-2718-2015; Loirand, Gervaise/K-1834-2014; Desal, Hubert/T-2089-2019; Redon, Richard/F-3303-2014; Hassen, Wagih Ben/ABH-8248-2020; Schott, jean-Jacques/F-8842-2013; Dina, Christian R/D-3535-2015; Genin, Emmanuelle/C-4974-2013; Lindenbaum, Pierre/A-7154-2008; CHATEL, Stephanie/D-2536-2015; Isidor, Bertrand/AAJ-3456-2021; bourcier, romain/T-1900-2019; Desal, Hubert/D-3705-2015	Le Scouarnec, Solena/0000-0003-3444-2125; Le Marec, Hervé/0000-0002-8288-8693; Loirand, Gervaise/0000-0002-2306-3931; Redon, Richard/0000-0001-7751-2280; Schott, jean-Jacques/0000-0002-9578-9475; Dina, Christian R/0000-0002-7722-7348; Genin, Emmanuelle/0000-0003-4117-2813; Lindenbaum, Pierre/0000-0003-0148-9787; CHATEL, Stephanie/0000-0003-0677-5627; Isidor, Bertrand/0000-0001-6480-126X; bourcier, romain/0000-0002-6506-4019; BONNAUD, Stephanie/0000-0001-9571-7693; Desal, Hubert/0000-0002-4665-1461; Gentric, Jean-christophe/0000-0002-1655-1371; OGNARD, Julien/0000-0003-4495-7464; Simonet, Floriane/0000-0002-6366-7211; MARNAT, Gaultier/0000-0002-7611-7753; Biondi, Alessandra/0000-0002-3185-0740	French Regional Council of Pays-de-la-Loire (VaCaRMe program); Fondation Genavie; Agence Nationale de la Recherche [ANR-15-CE17-0008-01]; French Ministry of Health [NCT02848495]; Societe Francaise de Radiologie; Societe francaise de Neuroradiologie	French Regional Council of Pays-de-la-Loire (VaCaRMe program); Fondation Genavie; Agence Nationale de la Recherche(French National Research Agency (ANR)); French Ministry of Health; Societe Francaise de Radiologie; Societe francaise de Neuroradiologie	We are grateful to the genomics and bioinformatics core facility (GenoBiRD) and to the cellular and tissue imaging core facility (MicroPICell) of Nantes for their expert services. We would like to thank the Genome Aggregation Database (gnomAD) and the groups that provided exome and genome variant data to this resource. A full list of contributing groups can be found at http://gnomad.broadinstitute.org/about. We acknowledge the Center of Biological Resources (CHU Nantes, Hotel-Dieu, CBR, Nantes, France) as well as Martine and Marie-France Le Cunff and the Clinical Investigation Center 1413 of Nantes for their assistance in managing the ICAN and PREGO biobanks. This work was supported by the French Regional Council of Pays-de-la-Loire (VaCaRMe program to S.B., S.C., F.S., P.L., H.L.M., and R.R.), the Fondation Genavie (to G.L. and R.R.), the Agence Nationale de la Recherche (ANR-15-CE17-0008-01 to G.L.), the French Ministry of Health (clinical trial NCT02848495 to H.D.), the Societe Francaise de Radiologie, and the Societe francaise de Neuroradiologie (both to R.B.).	Alg VS, 2013, NEUROLOGY, V80, P2154, DOI 10.1212/WNL.0b013e318295d751; Bacigaluppi S, 2014, NEUROSURG REV, V37, P1, DOI 10.1007/s10143-013-0501-y; Bourcier R, 2017, J NEUROSURG, V126, P1598, DOI 10.3171/2016.4.JNS153032; Bourcier R, 2017, NEUROSURGERY, V80, P621, DOI 10.1093/neuros/nyw135; Bourcier R, 2015, J NEURORADIOLOGY, V42, P67, DOI 10.1016/j.neurad.2015.01.002; Frosen J, 2014, TRANSL STROKE RES, V5, P347, DOI 10.1007/s12975-014-0340-3; Han L, 2011, GENET EPIDEMIOL, V35, P557, DOI 10.1002/gepi.20606; Hato T, 2008, TRENDS CARDIOVAS MED, V18, P6, DOI 10.1016/j.tcm.2007.10.003; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Huttunen T, 2010, NEUROSURGERY, V66, P631, DOI 10.1227/01.NEU.0000367634.89384.4B; Kamada F, 2011, J HUM GENET, V56, P34, DOI 10.1038/jhg.2010.132; Karakachoff M, 2015, EUR J HUM GENET, V23, P831, DOI 10.1038/ejhg.2014.175; Laaksamo E, 2012, NEUROSURGERY, V70, P1565, DOI 10.1227/NEU.0b013e31824c057e; Leblanc GG, 2009, STROKE, V40, pE694, DOI 10.1161/STROKEAHA.109.563692; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lindenbaum P, 2011, BIOINFORMATICS, V27, P3200, DOI 10.1093/bioinformatics/btr554; Liu WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022542; Mackey J, 2013, STROKE, V44, P38, DOI 10.1161/STROKEAHA.112.667261; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Nguyen HL, 2011, LAB INVEST, V91, P1554, DOI 10.1038/labinvest.2011.124; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; Oike Y, 2005, NAT MED, V11, P400, DOI 10.1038/nm1214; Oike Y, 2004, BLOOD, V103, P3760, DOI 10.1182/blood-2003-04-1272; Pierot L, 2008, STROKE, V39, P2497, DOI 10.1161/STROKEAHA.107.512756; Raab S, 2004, THROMB HAEMOSTASIS, V91, P595, DOI 10.1160/TH03-09-0582; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Santiago-Sim T, 2016, STROKE, V47, P3005, DOI 10.1161/STROKEAHA.116.014161; Santulli G, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00004; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Vlak MHM, 2013, STROKE, V44, P984, DOI 10.1161/STROKEAHA.111.000329; Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yasuno K, 2011, P NATL ACAD SCI USA, V108, P19707, DOI 10.1073/pnas.1117137108; Zhou SR, 2016, AM J HUM GENET, V99, P1072, DOI 10.1016/j.ajhg.2016.09.001	36	27	29	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 4	2018	102	1					133	141		10.1016/j.ajhg.2017.12.006	http://dx.doi.org/10.1016/j.ajhg.2017.12.006			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FR8DU	29304371	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000419305500010
J	Gillentine, MA; Yin, JN; Bajic, A; Zhang, P; Cummock, S; Kim, JJ; Schaaf, CP				Gillentine, Madelyn A.; Yin, Jiani; Bajic, Aleksandar; Zhang, Ping; Cummock, Steven; Kim, Jean J.; Schaaf, Christian P.			Functional Consequences of CHRNA7 Copy-Number Alterations in Induced Pluripotent Stem Cells and Neural Progenitor Cells	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; DEFICIT HYPERACTIVITY DISORDER; PELIZAEUS-MERZBACHER DISEASE; ER STRESS; HOMOZYGOUS MICRODELETION; 15Q13.3; ALPHA-7; EXPRESSION; PHENOTYPES; RIC-3	Copy-number variants (CNVs) of chromosome 15q13.3 manifest clinically as neuropsychiatric disorders with variable expressivity. CHRNA7, encoding for the alpha 7 nicotinic acetylcholine receptor (nAChR), has been suggested as a candidate gene for the phenotypes observed. Here, we used induced pluripotent stem cells (iPSCs) and neural progenitor cells (NPCs) derived from individuals with heterozygous 15q13.3 deletions and heterozygous 15q13.3 duplications to investigate the CHRNA7-dependent molecular consequences of the respective CNVs. Unexpectedly, both deletions and duplications lead to decreased alpha 7 nAChR-associated calcium flux. For deletions, this decrease in alpha 7 nAChR-dependent calcium flux is expected due to haploinsufficiency of CHRNA7. For duplications, we found that increased expression of CHRNA7 mRNA is associated with higher expression of nAChR-specific and resident ER chaperones, indicating increased ER stress. This is likely a consequence of inefficient chaperoning and accumulation of alpha 7 subunits in the ER, as opposed to being incorporated into functional alpha 7 nAChRs at the cell membrane. Here, we showed that alpha 7 nAChR-dependent calcium signal cascades are downregulated in both 15q13.3 deletion and duplication NPCs. While it may seem surprising that genomic changes in opposite direction have consequences on downstream pathways that are in similar direction, it aligns with clinical data, which suggest that both individuals with deletions and duplications of 15q13.3 manifest neuropsychiatric disease and cognitive deficits.	[Gillentine, Madelyn A.; Yin, Jiani; Bajic, Aleksandar; Schaaf, Christian P.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Gillentine, Madelyn A.; Yin, Jiani; Bajic, Aleksandar; Cummock, Steven; Schaaf, Christian P.] Jan & Dan Neurol Res Inst, Houston, TX 77030 USA; [Zhang, Ping; Kim, Jean J.] Baylor Coll Med, Ctr Cell & Gene Therapy, Stem Cells & Regenerat Med Ctr, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Cummock, Steven] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Zhang, Ping; Kim, Jean J.] Baylor Coll Med, Adv Technol Cores, Human Stem Cell Core, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Schaaf, CP (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Schaaf, CP (corresponding author), Jan & Dan Neurol Res Inst, Houston, TX 77030 USA.	schaaf@bcm.edu	Kim, Jean Jieun/G-5774-2018; Schaaf, Christian P/AAJ-7318-2021	Kim, Jean Jieun/0000-0003-4709-262X; Schaaf, Christian P/0000-0002-2148-7490; Gillentine, Madelyn/0000-0002-8989-2214	IDDRC from Eunice Kennedy Shriver National Institute of Child Health & Human Development [1U54 HD083092]; National Institute of General Medical Sciences [T32GM008307]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064, U54HD083092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008307] Funding Source: NIH RePORTER	IDDRC from Eunice Kennedy Shriver National Institute of Child Health & Human Development; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by IDDRC grant number 1U54 HD083092 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. M.A.G. was supported by Award Number T32GM008307 from the National Institute of General Medical Sciences. The IDDRC Microscopy Core was used for this project. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. We would like to thank Emeline Crutcher, Ezequiel Sztainberg, and Ricky Lozoya for helping maintaining cells, as well as Dr. Frank Horrigan for training and use of the FLIPR<SUP>Tetra</SUP>.	Adams CE, 2012, NEUROSCIENCE, V207, P274, DOI 10.1016/j.neuroscience.2012.01.033; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Araud T, 2011, BIOCHEM PHARMACOL, V82, P904, DOI 10.1016/j.bcp.2011.06.018; Arredondo J, 2002, J CELL BIOL, V159, P325, DOI 10.1083/jcb.200206096; Ben-David Y, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0231-5; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chatzidaki A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125116; Cubells JF, 2011, AM J MED GENET A, V155A, P805, DOI 10.1002/ajmg.a.33917; Dage JL, 2014, PSYCHOPHARMACOLOGY, V231, P1105, DOI 10.1007/s00213-013-3384-2; Dickinson JA, 2007, J NEUROCHEM, V100, P1089, DOI 10.1111/j.1471-4159.2006.04273.x; Forsingdal A, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.125; Freedman R, 2014, ANNU REV MED, V65, P245, DOI 10.1146/annurev-med-092112-142937; Gee KW, 2017, J PSYCHOPHARMACOL, V31, P434, DOI 10.1177/0269881117691590; Gillentine MA, 2017, J AUTISM DEV DISORD, V47, P549, DOI 10.1007/s10803-016-2961-8; Gillentine MA, 2015, BIOCHEM PHARMACOL, V97, P352, DOI 10.1016/j.bcp.2015.06.012; Gu SY, 2016, NEURON, V89, P948, DOI 10.1016/j.neuron.2016.01.018; Hiroi T, 2005, PHARMACOGENOMICS J, V5, P102, DOI 10.1038/sj.tpj.6500296; Kim JE, 2011, P NATL ACAD SCI USA, V108, P3005, DOI 10.1073/pnas.1007753108; LePichon JB, 2010, AM J MED GENET A, V152A, P1300, DOI 10.1002/ajmg.a.33374; Lewis AS, 2013, PSYCHOPHARMACOLOGY, V229, P477, DOI 10.1007/s00213-013-3126-5; Liao J, 2011, AM J MED GENET A, V155A, P2795, DOI 10.1002/ajmg.a.34237; Liu XS, 2017, MOL NEUROBIOL, V54, P227, DOI 10.1007/s12035-015-9655-7; Lorenz C, 2017, CELL STEM CELL, V20, P659, DOI 10.1016/j.stem.2016.12.013; Lowther C, 2015, GENET MED, V17, P149, DOI 10.1038/gim.2014.83; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Marrero MB, 2009, BRAIN RES, V1256, P1, DOI 10.1016/j.brainres.2008.11.053; Masurel-Paulet A, 2014, AM J MED GENET A, V164, P1537, DOI 10.1002/ajmg.a.36471; Millar NS, 2003, BIOCHEM SOC T, V31, P869, DOI 10.1042/BST0310869; Moser N, 2007, J NEUROCHEM, V102, P479, DOI 10.1111/j.1471-4159.2007.04498.x; Numasawa-Kuroiwa Y, 2014, STEM CELL REP, V2, P648, DOI 10.1016/j.stemcr.2014.03.007; Olincy A, 2016, J AUTISM DEV DISORD, V46, P3812, DOI 10.1007/s10803-016-2890-6; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Parada E, 2010, FREE RADICAL BIO MED, V49, P1815, DOI 10.1016/j.freeradbiomed.2010.09.017; Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576; Paylor R, 1998, LEARN MEMORY, V5, P302; Resende RR, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-20; Rex EB, 2017, SLAS DISCOV, V22, P155, DOI 10.1177/1087057116676086; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Sadigh-Eteghad S, 2015, EUR J PHARMACOL, V755, P34, DOI 10.1016/j.ejphar.2015.02.047; Schaaf CP, 2014, GENET MED, V16, P649, DOI 10.1038/gim.2014.9; Severance EG, 2007, NEUROSCIENCE, V148, P454, DOI 10.1016/j.neuroscience.2007.06.008; Shao L, 2006, LIFE SCI, V78, P1317, DOI 10.1016/j.lfs.2005.07.007; Shaw S, 2002, J BIOL CHEM, V277, P44920, DOI 10.1074/jbc.M204610200; Shen JX, 2009, ACTA PHARMACOL SIN, V30, P673, DOI 10.1038/aps.2009.64; Shimojima K, 2012, J HUM GENET, V57, P580, DOI 10.1038/jhg.2012.71; Shinawi M, 2009, NAT GENET, V41, P1269, DOI 10.1038/ng.481; Sinkus ML, 2015, NEUROPHARMACOLOGY, V96, P274, DOI 10.1016/j.neuropharm.2015.02.006; Spielmann M, 2011, EUR J MED GENET, V54, pE441, DOI 10.1016/j.ejmg.2011.04.004; Srinivasan R, 2014, PHARMACOL RES, V83, P20, DOI 10.1016/j.phrs.2014.02.005; Srinivasan R, 2012, MOL PHARMACOL, V81, P759, DOI 10.1124/mol.112.077792; Srinivasan R, 2011, J GEN PHYSIOL, V137, P59, DOI 10.1085/jgp.201010532; Stern S., 2017, MOL PSYCHIAT; Szafranski P, 2010, HUM MUTAT, V31, P840, DOI 10.1002/humu.21284; Tran NN, 2013, SCHIZOPHRENIA BULL, V39, P4, DOI 10.1093/schbul/sbs127; Treinin Millet, 2008, Biotechnology Journal, V3, P1539, DOI 10.1002/biot.200800179; van Galen P, 2014, NATURE, V510, P268, DOI 10.1038/nature13228; Walstab J, 2010, J BIOL CHEM, V285, P26956, DOI 10.1074/jbc.M110.122838; Wang Y, 2014, J BIOL CHEM, V289, P26451, DOI 10.1074/jbc.M114.582858; Wiley JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009135; Williams NM, 2012, AM J PSYCHIAT, V169, P195, DOI 10.1176/appi.ajp.2011.11060822; Williams NM, 2010, LANCET, V376, P1401, DOI 10.1016/S0140-6736(10)61109-9; Xiao CT, 2011, DIABETES, V60, P918, DOI 10.2337/db10-1433; Yin JN, 2017, SCI REP-UK, V7, DOI 10.1038/srep39941; Ziats MN, 2016, GENET MED, V18, P1111, DOI 10.1038/gim.2016.9	64	27	29	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 7	2017	101	6					874	887		10.1016/j.ajhg.2017.09.024	http://dx.doi.org/10.1016/j.ajhg.2017.09.024			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	FP5FD	29129316	Green Published, Bronze			2022-12-18	WOS:000417644500001
J	Chelban, V; Patel, N; Vandrovcova, J; Zanetti, MN; Lynch, DS; Ryten, M; Botia, JA; Bello, O; Tribollet, E; Efthymiou, S; Davagnanam, I; Grp, SS; Bashiri, FA; Wood, NW; Rothman, JE; Alkuraya, FS; Houlden, H				Chelban, Viorica; Patel, Nisha; Vandrovcova, Jana; Zanetti, M. Natalia; Lynch, David S.; Ryten, Mina; Botia, Juan A.; Bello, Oscar; Tribollet, Eloise; Efthymiou, Stephanie; Davagnanam, Indran; Grp, S. Y. N. A. P. S. E. Study; Bashiri, Fahad A.; Wood, Nicholas W.; Rothman, James E.; Alkuraya, Fowzan S.; Houlden, Henry			Mutations in NKX6-2 Cause Progressive Spastic Ataxia and Hypomyelination	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HOMEODOMAIN PROTEIN; REPRESSOR ACTIVITY; PSYCHIATRIC-DISORDERS; WHITE-MATTER; MOTOR-NEURON; HUMAN BRAIN; IDENTITY; GENE; GTX; ABNORMALITIES	Progressive limb spasticity and cerebellar ataxia are frequently found together in clinical practice and form a heterogeneous group of degenerative disorders that are classified either as pure spastic ataxia or as complex spastic ataxia with additional neurological signs. Inheritance is either autosomal dominant or autosomal recessive. Hypomyelinating features on MRI are sometimes seen with spastic ataxia, but this is usually mild in adults and severe and life limiting in children. We report seven individuals with an early-onset spastic-ataxia phenotype. The individuals come from three families of different ethnic backgrounds. Affected members of two families had childhood onset disease with very slow progression. They are still alive in their 30s and 40s and show predominant ataxia and cerebellar atrophy features on imaging. Affected members of the third family had a similar but earlier-onset presentation associated with brain hypomyelination. Using a combination of homozygozity mapping and exome sequencing, we mapped this phenotype to deleterious nonsense or homeobox domain missense mutations in NKX6-2. NKX6-2 encodes a transcriptional repressor with early high general and late focused CNS expression. Deficiency of its mouse ortholog results in widespread hypomyelination in the brain and optic nerve, as well as in poor motor coordination in a pattern consistent with the observed human phenotype. In-silico analysis of human brain expression and network data provides evidence that NKX6-2 is involved in oligodendrocyte maturation and might act within the same pathways of genes already associated with central hypomyelination. Our results support a non-redundant developmental role of NKX6-2 in humans and imply that NKX6-2 mutations should be considered in the differential diagnosis of spastic ataxia and hypomyelination.	[Chelban, Viorica; Vandrovcova, Jana; Lynch, David S.; Tribollet, Eloise; Efthymiou, Stephanie; Wood, Nicholas W.; Houlden, Henry] UCL, Dept Mol Neurosci, London WC1N 3BG, England; [Patel, Nisha; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Dev Genet Unit, MBC 03,POB 3354, Riyadh 11211, Saudi Arabia; [Zanetti, M. Natalia; Bello, Oscar; Rothman, James E.] UCL, Dept Clin & Expt Epilepsy, London WC1N 3BG, England; [Wood, Nicholas W.; Houlden, Henry] Natl Hosp Neurol & Neurosurg, Neurogenet Lab, London WC1N 3BG, England; [Alkuraya, Fowzan S.] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh 11533, Saudi Arabia; [Bashiri, Fahad A.] King Saud Univ, Coll Med, Dept Pediat, Riyadh 11451, Saudi Arabia; [Chelban, Viorica] Inst Emergency Med, Dept Neurol & Neurosurg, Toma Ciorba 1, Kishinev 2052, Moldova; [Davagnanam, Indran] UCL, Dept Brain Repair & Rehabil, London WC1N 3BG, England; [Ryten, Mina; Botia, Juan A.] UCL, Inst Neurol, Reta Lila Weston Res Labs, London WC1N 3BG, England; [Botia, Juan A.] Univ Murcia, Dept Informat & Commun Engn, Campus Espinardo, E-30100 Murcia, Spain; [Ryten, Mina] Guys Hosp, Kings Coll London, Dept Med & Mol Genet, London SE1 9RT, England; [Rothman, James E.] Yale Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Alkuraya, Fowzan S.] King Abdulaziz City Sci & Technol, Saudi Human Genome Program, Riyadh 12371, Saudi Arabia	University of London; University College London; King Faisal Specialist Hospital & Research Center; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Alfaisal University; King Saud University; University of London; University College London; University of London; University College London; University of Murcia; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Yale University	Chelban, V (corresponding author), UCL, Dept Mol Neurosci, London WC1N 3BG, England.; Alkuraya, FS (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Dev Genet Unit, MBC 03,POB 3354, Riyadh 11211, Saudi Arabia.; Alkuraya, FS (corresponding author), Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh 11533, Saudi Arabia.; Chelban, V (corresponding author), Inst Emergency Med, Dept Neurol & Neurosurg, Toma Ciorba 1, Kishinev 2052, Moldova.; Alkuraya, FS (corresponding author), King Abdulaziz City Sci & Technol, Saudi Human Genome Program, Riyadh 12371, Saudi Arabia.	v.chelban@ucl.ac.uk; falkuraya@kfshrc.edu.sa	Wood, Nicholas W/C-2505-2009; Bello, Oscar/K-5605-2014; Bashiri, Fahad A./AAY-1953-2020; Houlden, Henry J/C-1532-2008	Wood, Nicholas W/0000-0002-9500-3348; Bello, Oscar/0000-0001-5701-8365; Bashiri, Fahad A./0000-0003-1436-6727; Houlden, Henry J/0000-0002-2866-7777; Chelban, Viorica/0000-0002-5817-6290; Efthymiou, Stephanie/0000-0003-4900-9877; Botia, Juan A./0000-0002-6992-598X; Zanetti, Maria Natalia/0000-0002-3992-7167	Saudi Human Genome Program; Wellcome Trust [104033]; EU [104033, 2012-305121]; National Institute for Health Research (NIHR); University College London Hospitals (UCLH); Biomedical Research Centre (BRC); MRC [G108/638, G0802462, MR/K01417X/1, MR/J004758/1, G0802760, G1001253, MR/N008324/1] Funding Source: UKRI; Medical Research Council [MR/K01417X/1, G0802760, G108/638, MR/N008324/1, G0802462, MR/J004758/1, G1001253] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10082, NF-SI-0507-10376, ACF-2012-17-017, NF-SI-0513-10064] Funding Source: researchfish; Parkinson&quot;s UK [G-1107] Funding Source: researchfish; Rosetrees Trust [M584] Funding Source: researchfish; Brain Research UK [UCCHoulden] Funding Source: researchfish; Muscular Dystrophy UK [16GRO-PS36-0055] Funding Source: researchfish	Saudi Human Genome Program; Wellcome Trust(Wellcome TrustEuropean Commission); EU(European Commission); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); University College London Hospitals (UCLH); Biomedical Research Centre (BRC); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Parkinson&quot;s UK(Parkinson&apos;s UK); Rosetrees Trust(Rosetrees Trust); Brain Research UK; Muscular Dystrophy UK	The authors would like to thank the participants and their families for their essential help with this work. We also thank the Sequencing and Genotyping Core Facilities at KFSHRC for their technical help. We acknowledge the support of the Saudi Human Genome Program. We are grateful to The Spastic Paraplegia Foundation, The Brain Research Trust (BRT), The UK HSP Society, The Medical Research Council (MRC UK MR/J004758/1, G0802760, G1001253), The Wellcome Trust (equipment and the Synaptopathies strategic award [104033]) and the EU FP7/2007-2013 under grant agreement number 2012-305121 (NEUROMICS), The Muscular Dystrophy Association (MDA) USA, Muscular Dystrophy UK, the Association of British Neurologists, the MSA Trust, Rosetrees Trust, Ataxia UK, British Neurological Surveillance Unit (BNSU), and King Salman Center for Disability Research (FSA). We are also supported by the National Institute for Health Research (NIHR), University College London Hospitals (UCLH), and Biomedical Research Centre (BRC). Additionally, we thank Malcolm Corbett for his contribution to the current paper.	Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Awatramani R, 2000, J NEUROSCI RES, V61, P376, DOI 10.1002/1097-4547(20000815)61:4<376::AID-JNR4>3.0.CO;2-#; Awatramani R, 1997, J NEUROSCI, V17, P6657; Boespflug-Tanguy O, 2013, HAND CLINIC, V113, P1581, DOI 10.1016/B978-0-444-59565-2.00027-7; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Dupree JL, 1998, J NEUROCYTOL, V27, P649, DOI 10.1023/A:1006908013972; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; FRIEDRIC.VL, 1974, BRAIN RES, V82, P168, DOI 10.1016/0006-8993(74)90902-0; GEHRING WJ, 1990, TRENDS GENET, V6, P323, DOI 10.1016/0168-9525(90)90253-3; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Glusman G, 2011, BIOINFORMATICS, V27, P3216, DOI 10.1093/bioinformatics/btr540; Harris Chris, 2006, Semin Ophthalmol, V21, P63, DOI 10.1080/08820530600613746; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; KOMURO I, 1993, EMBO J, V12, P1387, DOI 10.1002/j.1460-2075.1993.tb05783.x; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Pires DEV, 2014, NUCLEIC ACIDS RES, V42, pW314, DOI 10.1093/nar/gku411; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; ROSENBLUTH J, 1987, J NEUROCYTOL, V16, P497, DOI 10.1007/BF01668504; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; Southwood C, 2004, J NEUROSCI, V24, P11215, DOI 10.1523/JNEUROSCI.3479-04.2004; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; Vanderver A, 2016, ANN NEUROL, V79, P1031, DOI 10.1002/ana.24650; Wegner M, 2008, J MOL NEUROSCI, V35, P3, DOI 10.1007/s12031-007-9008-8	26	27	29	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 1	2017	100	6					969	977		10.1016/j.ajhg.2017.05.009	http://dx.doi.org/10.1016/j.ajhg.2017.05.009			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EW7NL	28575651	Green Submitted, Green Published, hybrid			2022-12-18	WOS:000402700600012
J	Delmaghani, S; Aghaie, A; Bouyacoub, Y; El Hachmi, H; Bonnet, C; Riahi, Z; Chardenoux, S; Perfettini, I; Hardelin, JP; Houmeida, A; Herbomel, P; Petit, C				Delmaghani, Sedigheh; Aghaie, Asadollah; Bouyacoub, Yosra; El Hachmi, Hala; Bonnet, Crystel; Riahi, Zied; Chardenoux, Sebastien; Perfettini, Isabelle; Hardelin, Jean-Pierre; Houmeida, Ahmed; Herbomel, Philippe; Petit, Christine			Mutations in CDC14A, Encoding a Protein Phosphatase Involved in Hair Cell Ciliogenesis, Cause Autosomal-Recessive Severe to Profound Deafness	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOME SEGREGATION; DISEASE; CILIUM; FAMILY; REPAIR; LENGTH; CYCLE	By genetic linkage analysis in a large consanguineous Iranian family with eleven individuals affected by severe to profound congenital deafness, we were able to define a 2.8 Mb critical interval (at chromosome 1p21.2-1p21.1) for an autosomal-recessive nonsyndromic deafness locus (DFNB). Whole-exome sequencing allowed us to identify a CDC14A biallelic nonsense mutation, c.1126C>T (p.Arg376*), which was present in the eight clinically affected individuals still alive. Subsequent screening of 115 unrelated individuals affected by severe or profound congenital deafness of unknown genetic cause led us to identify another CDC14A biallelic nonsense mutation, c.1015C>T (p.Arg339*), in an individual originating from Mauritania. CDC14A encodes a protein tyrosine phosphatase. Immunofluorescence analysis of the protein distribution in the mouse inner ear showed a strong labeling of the hair cells' kinocilia. By using a morpholino strategy to knockdown cdc14a in zebrafish larvae, we found that the length of the kinocilia was reduced in inner-ear hair cells. Therefore, deafness caused by loss-of-function mutations in CDC14A probably arises from a morphogenetic defect of the auditory sensory cells' hair bundles, whose differentiation critically depends on the proper growth of their kinocilium.	[Delmaghani, Sedigheh; Chardenoux, Sebastien; Perfettini, Isabelle; Hardelin, Jean-Pierre; Petit, Christine] Inst Pasteur, Unite Genet & Physiol Audit, F-75015 Paris, France; [Delmaghani, Sedigheh; Aghaie, Asadollah; Bonnet, Crystel; Riahi, Zied; Chardenoux, Sebastien; Perfettini, Isabelle; Hardelin, Jean-Pierre; Petit, Christine] INSERM, UMRS 1120, F-75015 Paris, France; [Delmaghani, Sedigheh; Aghaie, Asadollah; Bonnet, Crystel; Riahi, Zied; Chardenoux, Sebastien; Perfettini, Isabelle; Hardelin, Jean-Pierre; Herbomel, Philippe; Petit, Christine] Univ Paris 06, Sorbonne Univ, F-75005 Paris, France; [Aghaie, Asadollah; Bonnet, Crystel; Riahi, Zied; Petit, Christine] Inst Vis, Syndrome Usher & Autres Atteintes Retino Cochleai, F-75012 Paris, France; [Bouyacoub, Yosra] Inst Pasteur, Biomed Genom & Oncogenet Lab, LR11IPT05, Tunis 1002, Tunisia; [Bouyacoub, Yosra] Univ Monastir, Inst Super Biotechnol, BP 56, Monastir 5000, Tunisia; [El Hachmi, Hala; Houmeida, Ahmed] Fac Sci & Tech, Lab Biochimi & Biol Mol, Nouakchott 5026, Mauritania; [Herbomel, Philippe] Inst Pasteur, Unite Macrophages & Dev Immun, F-75015 Paris, France; [Herbomel, Philippe] CNRS, UMR 3738, F-75015 Paris, France; [Petit, Christine] Coll France, F-75005 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Monastir; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; College de France	Petit, C (corresponding author), Inst Pasteur, Unite Genet & Physiol Audit, F-75015 Paris, France.; Petit, C (corresponding author), INSERM, UMRS 1120, F-75015 Paris, France.; Petit, C (corresponding author), Univ Paris 06, Sorbonne Univ, F-75005 Paris, France.; Petit, C (corresponding author), Inst Vis, Syndrome Usher & Autres Atteintes Retino Cochleai, F-75012 Paris, France.; Petit, C (corresponding author), Coll France, F-75005 Paris, France.	christine.petit@pasteur.fr	Bonnet, Crystel/AAN-5950-2021	Bonnet, Crystel/0000-0002-1916-9119; Aghaie, Asadollah Alain/0000-0002-3247-7087; Delmaghani, Sedigheh/0000-0003-2092-5097; El Hachimi, Hala/0000-0001-8331-9591; Petit, Christine/0000-0002-9069-002X; BOUYACOUB, Yosra/0000-0003-2423-199X	French state program "Investissements d'Avenir" [ANR-10-LABX-65]; BNP Paribas; Bucodes SurdiFrance	French state program "Investissements d'Avenir"(French National Research Agency (ANR)); BNP Paribas; Bucodes SurdiFrance	The authors are grateful to the family members and clinicians who collaborated in this study. We also thank Emi Murayama for expert advice on zebrafish embryos. This work was supported by the French state program "Investissements d'Avenir" (ANR-10-LABX-65), BNP Paribas, and Bucodes SurdiFrance.	Baker K, 2009, AM J MED GENET C, V151C, P281, DOI 10.1002/ajmg.c.30231; Broekhuis JR, 2013, INT REV CEL MOL BIO, V303, P101, DOI 10.1016/B978-0-12-407697-6.00003-9; Chen NP, 2016, P NATL ACAD SCI USA, V113, P990, DOI 10.1073/pnas.1515605113; Clement A, 2012, DEV DYNAM, V241, P1911, DOI 10.1002/dvdy.23876; Davis EE, 2012, CURR OPIN GENET DEV, V22, P290, DOI 10.1016/j.gde.2012.04.006; Dirks DD, 2000, EAR: COMPREHENSIVE OTOLOGY, P231; Grati M, 2015, HUM MOL GENET, V24, P2482, DOI 10.1093/hmg/ddv009; Kaiser BK, 2002, MOL BIOL CELL, V13, P2289, DOI 10.1091/mbc.01-11-0535; Kemp DT, 2002, BRIT MED BULL, V63, P223, DOI 10.1093/bmb/63.1.223; Ko HW, 2012, BMB REP, V45, P427, DOI 10.5483/BMBRep.2012.45.8.167; Lelli A, 2016, J CELL BIOL, V212, P231, DOI 10.1083/jcb.201509017; Lenz DR, 2011, HEARING RES, V281, P3, DOI 10.1016/j.heares.2011.05.021; Lin H, 2015, MOL CELL BIOL, V35, P3657, DOI 10.1128/MCB.00233-15; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Marston AL, 2003, DEV CELL, V4, P711, DOI 10.1016/S1534-5807(03)00130-8; Mocciaro A, 2010, J CELL SCI, V123, P2867, DOI 10.1242/jcs.074815; Mocciaro A, 2010, J CELL BIOL, V189, P631, DOI 10.1083/jcb.200910057; Nayak GD, 2007, INT J DEV BIOL, V51, P597, DOI 10.1387/ijdb.072392gn; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Pepermans E, 2014, EMBO MOL MED, V6, P984, DOI 10.15252/emmm.201403976; Richardson GP, 2011, ANNU REV PHYSIOL, V73, P311, DOI 10.1146/annurev-physiol-012110-142228; Sacristan MP, 2011, CELL CYCLE, V10, P387, DOI 10.4161/cc.10.3.14643; Schindler K, 2009, CELL CYCLE, V8, P1090, DOI 10.4161/cc.8.7.8144; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Trautmann S, 2002, CURR BIOL, V12, pR733, DOI 10.1016/S0960-9822(02)01250-2; Trinkle-Mulcahy L, 2006, CURR OPIN CELL BIOL, V18, P623, DOI 10.1016/j.ceb.2006.09.001; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5	27	27	30	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 2	2016	98	6					1266	1270		10.1016/j.ajhg.2016.04.015	http://dx.doi.org/10.1016/j.ajhg.2016.04.015			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN7US	27259055	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000377286000021
J	Chong, JX; Caputo, V; Phelps, IG; Stella, L; Worgan, L; Dempsey, JC; Nguyen, A; Leuzzi, V; Webster, R; Pizzuti, A; Marvin, CT; Ishak, GE; Ardern-Holmes, S; Richmond, Z; Bamshad, MJ; Ortiz-Gonzalez, XR; Tartaglia, M; Chopra, M; Doherty, D				Chong, Jessica X.; Caputo, Viviana; Phelps, Ian G.; Stella, Lorenzo; Worgan, Lisa; Dempsey, Jennifer C.; Alina Nguyen; Leuzzi, Vincenzo; Webster, Richard; Pizzuti, Antonio; Marvin, Colby T.; Ishak, Gisele E.; Ardern-Holmes, Simone; Richmond, Zara; Bamshad, Michael J.; Ortiz-Gonzalez, Xilma R.; Tartaglia, Marco; Chopra, Maya; Doherty, Dan		Univ Washington	Recessive Inactivating Mutations in TBCK, Encoding a Rab GTPase-Activating Protein, Cause Severe Infantile Syndromic Encephalopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DE-NOVO MUTATIONS; INTELLECTUAL DISABILITY; BRAIN MALFORMATIONS; GENE DISCOVERY; NALCN CAUSE; MTOR; HYPOTONIA; COMPLEX; DELAY; GAPS	Infantile encephalopathies are a group of clinically and biologically heterogeneous disorders for which the genetic basis remains largely unknown. Here, we report a syndromic neonatal encephalopathy characterized by profound developmental disability, severe hypotonia, seizures, diminished respiratory drive requiring mechanical ventilation, brain atrophy, dysgenesis of the corpus callosum, cerebellar vermis hypoplasia, and facial dysmorphism. Biallelic inactivating mutations in TBCK (TBC1-domain-containing kinase) were independently identified by whole-exome sequencing as the cause of this condition in four unrelated families. Matching these families was facilitated by the sharing of phenotypic profiles and WES data in a recently released web-based tool (Geno(2)MP) that links phenotypic information to rare variants in families with Mendelian traits. TBCK is a putative GTPase-activating protein (GAP) for small GTPases of the Rab family and has been shown to control cell growth and proliferation, actin-cytoskeleton dynamics, and mTOR signaling. Two of the three mutations (c.376C>T [p.Arg126*] and c.1363A>T [p.Lys455*]) are predicted to truncate the protein, and loss of the major TBCK isoform was confirmed in primary fibroblasts from one affected individual. The third mutation, c.1532G>A (p.Arg511His), alters a conserved residue within the TBC1 domain. Structural analysis implicated Arg511 as a required residue for Rab-GAP function, and in silico homology modeling predicted impaired GAP function in the corresponding mutant. These results suggest that loss of Rab-GAP activity is the underlying mechanism of disease. In contrast to other disorders caused by dysregulated mTOR signaling associated with focal or global brain overgrowth, impaired TBCK function results in progressive loss of brain volume.	[Chong, Jessica X.; Phelps, Ian G.; Dempsey, Jennifer C.; Alina Nguyen; Marvin, Colby T.; Bamshad, Michael J.; Doherty, Dan] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Caputo, Viviana; Pizzuti, Antonio] Univ Roma La Sapienza, Dipartimento Med Sperimentale, I-00161 Rome, Italy; [Stella, Lorenzo] Univ Roma Tor Vergata, Dipartimento Sci & Tecnol Chim, I-00133 Rome, Italy; [Worgan, Lisa] Liverpool Hosp, Dept Clin Genet, Liverpool, NSW 2170, Australia; [Leuzzi, Vincenzo] Univ Roma La Sapienza, Dipartimento Pediat & Neuropsichiatria Infantile, I-00185 Rome, Italy; [Webster, Richard; Ardern-Holmes, Simone] Childrens Hosp, TY Nelson Dept Neurol & Neurosurg, Westmead, NSW 2145, Australia; [Webster, Richard; Ardern-Holmes, Simone] Childrens Hosp, Inst Neurosci & Muscle Res, Westmead, NSW 2145, Australia; [Ishak, Gisele E.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Richmond, Zara; Chopra, Maya] Royal Prince Alfred Hosp, Dept Genom Med, Missenden Rd, Sydney, NSW 2050, Australia; [Bamshad, Michael J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Bamshad, Michael J.; Doherty, Dan] Seattle Childrens Hosp, Div Genet Med, Seattle, WA 98105 USA; [Ortiz-Gonzalez, Xilma R.] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA; [Ortiz-Gonzalez, Xilma R.] Univ Penn, Philadelphia, PA 19104 USA; [Ortiz-Gonzalez, Xilma R.] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Tartaglia, Marco] Ist Ricovero & Cura Carattere Sci, Osped Pediat Bambino Gesu, Area Ric Genet & Malattie Rare, I-00146 Rome, Italy; [Chopra, Maya] Univ Sydney, Discipline Genet Med, Sydney, NSW 2050, Australia; [Tartaglia, Marco; Chopra, Maya] Tongji Univ, Sch Med, Shanghai Matern & Infant Hosp 1, West Gaoke Rd, Shanghai 200040, Peoples R China	University of Washington; University of Washington Seattle; Sapienza University Rome; University of Rome Tor Vergata; Liverpool Hospital; Sapienza University Rome; University of Sydney; University of Sydney; University of Washington; University of Washington Seattle; University of Sydney; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; IRCCS Bambino Gesu; University of Sydney; Tongji University	Doherty, D (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.; Doherty, D (corresponding author), Seattle Childrens Hosp, Div Genet Med, Seattle, WA 98105 USA.; Tartaglia, M (corresponding author), Ist Ricovero & Cura Carattere Sci, Osped Pediat Bambino Gesu, Area Ric Genet & Malattie Rare, I-00146 Rome, Italy.	marco.tartaglia@opbg.net; ddoher@uw.edu	Ortiz-Gonzalez, Xilma/AAD-2211-2021; Stella, Lorenzo/A-7996-2010; Chong, Jessica/GZH-1625-2022; Tartaglia, Marco/K-2955-2018	Ortiz-Gonzalez, Xilma/0000-0002-1710-4696; Stella, Lorenzo/0000-0002-5489-7381; Tartaglia, Marco/0000-0001-7736-9672; Chong, Jessica/0000-0002-1616-2448; PIZZUTI, Antonio/0000-0003-3245-1925; Chopra, Maya/0000-0002-2574-3375	NIH National Human Genome Research Institute and National Heart, Lung, and Blood Institute [1U54HG006493, 1RC2HG005608]; NIH National Institute of Neurological Diseases and Stroke [K12NS049453-09]; NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development [U54HD083091, 6849]; Telethon-Italy [GGP13107]; Ospedale Pediatrico Bambino Gesa (GeneRare and Ricerca Corrente); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083091] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006493, RC2HG005608, UM1HG006493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K12NS049453] Funding Source: NIH RePORTER	NIH National Human Genome Research Institute and National Heart, Lung, and Blood Institute; NIH National Institute of Neurological Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Telethon-Italy(Fondazione Telethon); Ospedale Pediatrico Bambino Gesa (GeneRare and Ricerca Corrente); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the families for their participation and support. Our work was supported in part by grants from the NIH National Human Genome Research Institute and National Heart, Lung, and Blood Institute (1U54HG006493 to M.B., D.N., and J.S. and 1RC2HG005608 to M.B., D.N., and J.S.), the NIH National Institute of Neurological Diseases and Stroke (K12NS049453-09 to X.O.G.), the NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD083091 [Genetics Core and Sub-project 6849] to D.D.), Telethon-Italy (GGP13107 to M.T.), and the Ospedale Pediatrico Bambino Gesa (GeneRare and Ricerca Corrente 2016 to M.T.). The authors would like to thank the University of Washington Center for Mendelian Genomics and all contributors to Geno2MP for the use of data included in Geno2MP. The authors would also like to thank the Exome Aggregation Consortium and the groups that provided exome variant data for comparison. A full list of contributing groups can be found at http://exac.broadinstitute.org/about.	Al-Sayed MD, 2013, AM J HUM GENET, V93, P721, DOI 10.1016/j.ajhg.2013.08.001; Alazami AM, 2015, CELL REP, V10, P148, DOI 10.1016/j.celrep.2014.12.015; Bachmann-Gagescu R, 2015, J MED GENET, V52, P514, DOI 10.1136/jmedgenet-2015-103087; Baynam G, 2015, AM J MED GENET A, V167, P1659, DOI 10.1002/ajmg.a.37070; Bhogaraju S, 2014, PROTEINS, V82, P2282, DOI 10.1002/prot.24597; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bockaert J, 2015, PHYSIOL REV, V95, P1157, DOI 10.1152/physrev.00038.2014; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Chadt A, 2008, NAT GENET, V40, P1354, DOI 10.1038/ng.244; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Chong JX, 2015, AM J HUM GENET, V97, P199, DOI 10.1016/j.ajhg.2015.06.009; Chong JX, 2015, AM J HUM GENET, V96, P841, DOI 10.1016/j.ajhg.2015.04.004; Chong JX, 2015, AM J HUM GENET, V96, P462, DOI 10.1016/j.ajhg.2015.01.003; Chotard L, 2010, MOL BIOL CELL, V21, P2285, DOI 10.1091/mbc.E09-11-0947; Cordeddu V, 2014, NAT GENET, V46, P815, DOI 10.1038/ng.3035; Creighton T.E., 1993, PROTEINS; Crino PB, 2011, TRENDS MOL MED, V17, P734, DOI 10.1016/j.molmed.2011.07.008; Crino PB, 2009, EPILEPSIA, V50, P3, DOI 10.1111/j.1528-1167.2009.02289.x; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Frasa MAM, 2012, NAT REV MOL CELL BIO, V13, P67, DOI 10.1038/nrm3267; Fukuda M, 2011, BIOSCIENCE REP, V31, P159, DOI 10.1042/BSR20100112; Gavriljuk K, 2012, P NATL ACAD SCI USA, V109, P21348, DOI 10.1073/pnas.1214431110; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; Hunt D, 2014, J MED GENET, V51, P806, DOI 10.1136/jmedgenet-2014-102798; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Koroglu C, 2013, J MED GENET, V50, P515, DOI 10.1136/jmedgenet-2013-101634; Kortum F, 2015, NAT GENET, V47, P661, DOI 10.1038/ng.3282; Krawitz P, 2015, HUM MUTAT, V36, P989, DOI 10.1002/humu.22848; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; Lalani SR, 2014, AM J HUM GENET, V95, P579, DOI 10.1016/j.ajhg.2014.09.014; Liegel RP, 2013, AM J HUM GENET, V93, P1001, DOI 10.1016/j.ajhg.2013.10.011; Liu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071349; Niceta M, 2015, AM J HUM GENET, V96, P816, DOI 10.1016/j.ajhg.2015.03.001; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Perez Y, 2015, J MED GENET, DOI [10.1136/jmedgenet-2015-103352, DOI 10.1136/JMEDGENET-2015-103352]; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Philippakis AA, 2015, HUM MUTAT, V36, P915, DOI 10.1002/humu.22858; Scheeff ED, 2009, STRUCTURE, V17, P128, DOI 10.1016/j.str.2008.10.018; Seelow D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003874; Shamseldin HE, 2016, AM J HUM GENET, V98, P210, DOI 10.1016/j.ajhg.2015.11.013; Smith LD, 2013, J GENOMES EXOMES, V2, P63; Stray-Pedersen A, 2016, AM J HUM GENET, V98, P202, DOI 10.1016/j.ajhg.2015.11.004; Tan S., 2015, ETIOLOGY PATHOGENESI; Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269; Wu J, 2014, J GENET GENOMICS, V41, P69, DOI 10.1016/j.jgg.2013.12.006	45	27	28	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 7	2016	98	4					772	781		10.1016/j.ajhg.2016.01.016	http://dx.doi.org/10.1016/j.ajhg.2016.01.016			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DJ4UO	27040692	Green Published, Bronze			2022-12-18	WOS:000374203800015
J	Lu, XM; Zoller, EE; Weirauch, MT; Wu, ZG; Namjou, B; Williams, AH; Ziegler, JT; Comeau, ME; Marion, MC; Glenn, SB; Adler, A; Shen, N; Nath, SK; Stevens, AM; Freedman, BI; Tsao, BP; Jacob, CO; Kamen, DL; Brown, EE; Gilkeson, GS; Alarcon, GS; Reveille, JD; Anaya, JM; James, JA; Sivils, KL; Criswell, LA; Vila, LM; Alarcon-Riquelme, ME; Petri, M; Scofield, RH; Kimberly, RP; Ramsey-Goldman, R; Joo, YB; Choi, J; Bae, SC; Boackle, SA; Graham, DC; Vyse, TJ; Guthridge, JM; Gaffney, PM; Langefeld, CD; Kelly, JA; Greis, KD; Kaufman, KM; Harley, JB; Kottyan, LC				Lu, Xiaoming; Zoller, Erin E.; Weirauch, Matthew T.; Wu, Zhiguo; Namjou, Bahram; Williams, Adrienne H.; Ziegler, Julie T.; Comeau, Mary E.; Marion, Miranda C.; Glenn, Stuart B.; Adler, Adam; Shen, Nan; Nath, Swapan K.; Stevens, Anne M.; Freedman, Barry I.; Tsao, Betty P.; Jacob, Chaim O.; Kamen, Diane L.; Brown, Elizabeth E.; Gilkeson, Gary S.; Alarcon, Graciela S.; Reveille, John D.; Anaya, Juan-Manuel; James, Judith A.; Sivils, Kathy L.; Criswell, Lindsey A.; Vila, Luis M.; Alarcon-Riquelme, Marta E.; Petri, Michelle; Scofield, R. Hal; Kimberly, Robert P.; Ramsey-Goldman, Rosalind; Joo, Young Bin; Choi, Jeongim; Bae, Sang-Cheol; Boackle, Susan A.; Graham, Deborah Cunninghame; Vyse, Timothy J.; Guthridge, Joel M.; Gaffney, Patrick M.; Langefeld, Carl D.; Kelly, Jennifer A.; Greis, Kenneth D.; Kaufman, Kenneth M.; Harley, John B.; Kottyan, Leah C.			Lupus Risk Variant Increases pSTAT1 Binding and Decreases ETS1 Expression	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CELL DIFFERENTIATION; CLINICAL-FEATURES; ERYTHEMATOSUS; ADMIXTURE; PREVALENCE; LOCI; SUSCEPTIBILITY; COMPONENTS; DISORDERS	Genetic variants at chromosomal region 11q23.3, near the gene ETS1, have been associated with systemic lupus erythematosus ( SLE), or lupus, in independent cohorts of Asian ancestry. Several recent studies have implicated ETS1 as a critical driver of immune cell function and differentiation, and mice deficient in ETS1 develop an SLE-like autoimmunity. We performed a fine-mapping study of 14,551 subjects from multi-ancestral cohorts by starting with genotyped variants and imputing to all common variants spanning ETS1. By constructing genetic models via frequentist and Bayesian association methods, we identified 16 variants that are statistically likely to be causal. We functionally assessed each of these variants on the basis of their likelihood of affecting transcription factor binding, miRNA binding, or chromatin state. Of the four variants that we experimentally examined, only rs6590330 differentially binds lysate from B cells. Using mass spectrometry, we found more binding of the transcription factor signal transducer and activator of transcription 1 ( STAT1) to DNA near the risk allele of rs6590330 than near the non-risk allele. Immunoblot analysis and chromatin immunoprecipitation of pSTAT1 in B cells heterozygous for rs6590330 confirmed that the risk allele increased binding to the active form of STAT1. Analysis with expression quantitative trait loci indicated that the risk allele of rs6590330 is associated with decreased ETS1 expression in Han Chinese, but not other ancestral cohorts. We propose a model in which the risk allele of rs6590330 is associated with decreased ETS1 expression and increases SLE risk by enhancing the binding of pSTAT1.	[Lu, Xiaoming] Univ Cincinnati, Coll Med, Grad Program Immunol, Cincinnati, OH 45229 USA; [Lu, Xiaoming; Zoller, Erin E.; Weirauch, Matthew T.; Namjou, Bahram; Shen, Nan; Kaufman, Kenneth M.; Harley, John B.; Kottyan, Leah C.] Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol, Cincinnati, OH 45229 USA; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Wu, Zhiguo] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Williams, Adrienne H.; Ziegler, Julie T.; Comeau, Mary E.; Marion, Miranda C.; Langefeld, Carl D.] Wake Forest Baptist Med Ctr, Wake Forest Sch Med, Ctr Publ Hlth Genom, Winston Salem, NC 27157 USA; [Williams, Adrienne H.; Ziegler, Julie T.; Comeau, Mary E.; Marion, Miranda C.; Langefeld, Carl D.] Wake Forest Baptist Med Ctr, Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC 27157 USA; [Glenn, Stuart B.; Adler, Adam; Nath, Swapan K.; James, Judith A.; Sivils, Kathy L.; Alarcon-Riquelme, Marta E.; Scofield, R. Hal; Guthridge, Joel M.; Gaffney, Patrick M.; Kelly, Jennifer A.] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, Oklahoma City, OK 73104 USA; [Shen, Nan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Biol Sci, Joint Mol Rheumatol Lab,Inst Hlth Sci, Shanghai 200031, Peoples R China; [Shen, Nan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Biol Sci, Shanghai Renji Hosp, Shanghai 200031, Peoples R China; [Shen, Nan] Chinese Acad Sci, Shanghai 200031, Peoples R China; [Stevens, Anne M.] Seattle Childrens Res Inst, Ctr Immun & Immunotherapies, Seattle, WA 98101 USA; [Stevens, Anne M.] Univ Washington, Div Rheumatol, Dept Pediat, Seattle, WA 98195 USA; [Freedman, Barry I.] Wake Forest Baptist Med Ctr, Wake Forest Sch Med, Dept Internal Med, Nephrol Sect, Winston Salem, NC 27157 USA; [Tsao, Betty P.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Rheumatol, Los Angeles, CA 90095 USA; [Jacob, Chaim O.] Univ So Calif, Keck Sch Med, Dept Med, Los Angeles, CA 90089 USA; [Kamen, Diane L.; Gilkeson, Gary S.] Med Univ S Carolina, Div Rheumatol, Charleston, SC 29425 USA; [Brown, Elizabeth E.] Univ Alabama Birmingham, Dept Pathol, Div Mol & Cellular Pathol, Birmingham, AL 35294 USA; [Brown, Elizabeth E.; Alarcon, Graciela S.; Kimberly, Robert P.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Reveille, John D.] Univ Texas Hlth Sci Ctr Houston, Rheumatol & Clin Immunogenet, Houston, TX 77030 USA; [Anaya, Juan-Manuel] Univ Rosario, Ctr Autoimmune Dis Res, Bogota 110010, Colombia; [James, Judith A.; Scofield, R. Hal] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73104 USA; [Criswell, Lindsey A.] Univ Calif San Francisco, Dept Med, Rosalind Russell Ephraim P Engleman Rheumatol Res, San Francisco, CA 94117 USA; [Vila, Luis M.] Univ Puerto Rico, Sch Med, Dept Med, Div Rheumatol, San Juan, PR 00936 USA; [Alarcon-Riquelme, Marta E.] Pfizer Univ Granada Junta de Andalucia, Ctr Genom & Oncol Res, Granada 18016, Spain; [Petri, Michelle] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21224 USA; [Scofield, R. Hal] Oklahoma City Vet Affairs Med Ctr, Oklahoma City, OK 73104 USA; [Ramsey-Goldman, Rosalind] Northwestern Univ, Feinberg Sch Med, Div Rheumatol, Chicago, IL 60611 USA; [Joo, Young Bin; Choi, Jeongim; Bae, Sang-Cheol] Hanyang Univ, Hosp Rheumat Dis, Dept Rheumatol, Seoul 133792, South Korea; [Boackle, Susan A.] Univ Colorado, Sch Med, Div Rheumatol, Aurora, CO 80045 USA; [Graham, Deborah Cunninghame; Vyse, Timothy J.] Kings Coll London, Div Genet, London WC2R 2LS, England; [Graham, Deborah Cunninghame; Vyse, Timothy J.] Kings Coll London, Div Mol Med & Immunol, London WC2R 2LS, England; [Greis, Kenneth D.] Univ Cincinnati, Med Ctr, Canc Biol, Cincinnati, OH 45267 USA; [Kaufman, Kenneth M.; Harley, John B.; Kottyan, Leah C.] Cincinnati Vet Affairs Med Ctr, Cincinnati, OH 45220 USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Oklahoma Medical Research Foundation; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Wake Forest University; Wake Forest Baptist Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Southern California; Medical University of South Carolina; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Texas System; University of Texas Health Science Center Houston; Universidad del Rosario; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of California System; University of California San Francisco; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Pfizer; University of Granada; Johns Hopkins University; University of Oklahoma System; University of Oklahoma Health Sciences Center; Northwestern University; Feinberg School of Medicine; Hanyang University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of London; King's College London; University of London; King's College London; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Kottyan, LC (corresponding author), Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol, Cincinnati, OH 45229 USA.	leah.kottyan@cchmc.org	Shen, Nan/AGK-6807-2022; Anaya, Juan-Manuel/J-1960-2016; Weirauch, Matthew/M-5459-2019; Alarcón-Riquelme, Marta E./ABF-8163-2020; Bae, Sang-Cheol/P-2051-2015; Lu, Xiaoming/I-5426-2018; Scofield, Robert Hal/AEJ-8314-2022; Kottyan, Leah C./H-3050-2019	Anaya, Juan-Manuel/0000-0002-6444-1249; Alarcón-Riquelme, Marta E./0000-0002-7632-4154; Lu, Xiaoming/0000-0002-0830-2826; Kottyan, Leah C./0000-0003-3979-2220; Kimberly, Robert/0000-0002-5330-3086; Kelly, Jennifer/0000-0002-3203-2467; Tsao, Betty/0000-0001-7938-5975; Bae, Sang-Cheol/0000-0003-4658-1093; Shen, Nan/0000-0002-5875-4417; Guthridge, Joel/0000-0002-9308-237X; Gaffney, Patrick/0000-0002-1580-869X; Greis, Kenneth/0000-0002-5316-3351; Universidad del Rosario, Biblioteca/0000-0003-3491-9392	NIH [AI024717, AI063274, AI082714, AI083194, AR043274, AR043727, AR043814, AR051545, AR053483, AR056360, AR057172, AR058959, AR060366, AR063124, AR065626, AR62277, GM103456, GM104938, HG006828, K24AI078004, K24AR02318, MD007909, P01AR49084, P30AR053483, P30AR055385, P30GM103510]; United States Departments of Veteran Affairs and Defense [PR094002]; Kirkland Scholar Award; National Basic Research Program of China (973 program) [2014CB541901]; National Natural Science Foundation of China [81230072, 81421001]; State Key Laboratory of Oncogenes and Related Genes [91-14-05]; Chinese Academy of Sciences [KJZD-EW-L01-3]; Shanghai Commission of Science and Technology [12JC1406000, 12431900703]; Instituto de Salud Carlos III; Fonds Europeen de Developpement Regional funds from the European Union [02558]; Proyecto de Excelencia of the Junta de Andalucia [CTS2548]; Arthritis Foundation; Alliance for Lupus Research; Korea Healthcare Technology R&D Project of the Ministry for Health and Welfare, Republic of Korea [HI13C2124]; The NIH [P60AR053308, P60AR062755, P60AR064464, R01AR44804, R21AI070304, S10RR027015, TR000077, U01AI101934, U01HG006828, U19AI082714, U54GM104938, UL1RR029882, UL1TR000004, UL1TR000150]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000150, UL1TR001082, UL1TR000077, UL1TR001425, UL1TR000154, UL1TR000004] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027015, UL1RR029882, S10RR027190, P20RR020143] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024717, U01AI101934, R21AI070304, P01AI083194, U19AI082714, K24AI078004, R56AI063274, R37AI024717, R01AI063274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR053308, R55AR043727, P30AR053483, R01AR043727, R01AR056360, R01AR060366, R55AR043814, P60AR062755, R21AR065626, P50AR048940, R01AR042460, P01AR049084, R01AR043274, R01AR057172, R01AR051545, N01AR012253, RC2AR058959, P60AR064464, R01AR044804, R01AR063124, R01AR043814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103456, P30GM103510, U54GM104938] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007909] Funding Source: NIH RePORTER; Versus Arthritis [19289] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Departments of Veteran Affairs and Defense; Kirkland Scholar Award; National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Oncogenes and Related Genes; Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fonds Europeen de Developpement Regional funds from the European Union; Proyecto de Excelencia of the Junta de Andalucia(Junta de Andalucia); Arthritis Foundation; Alliance for Lupus Research; Korea Healthcare Technology R&D Project of the Ministry for Health and Welfare, Republic of Korea; The NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Versus Arthritis(Versus Arthritis)	We are grateful for support from the NIH (AI024717, AI063274, AI082714, AI083194, AR043274, AR043727, AR043814, AR051545, AR053483, AR056360, AR057172, AR058959, AR060366, AR063124, AR065626, AR62277, GM103456, GM104938, HG006828, K24AI078004, K24AR02318, MD007909, P01AR49084, P30AR053483, P30AR055385, P30GM103510, P60AR053308, P60AR062755, P60AR064464, R01AR44804, R21AI070304, S10RR027015, TR000077, U01AI101934, U01HG006828, U19AI082714, U54GM104938, UL1RR029882, UL1TR000004, and UL1TR000150). Support for this project was also provided by the United States Departments of Veteran Affairs and Defense (PR094002), a Kirkland Scholar Award, the National Basic Research Program of China (973 program, 2014CB541901), the National Natural Science Foundation of China (81230072 and 81421001), the State Key Laboratory of Oncogenes and Related Genes (grant 91-14-05), the Key Research Program of the Chinese Academy of Sciences (KJZD-EW-L01-3), the Program of the Shanghai Commission of Science and Technology (12JC1406000 and 12431900703), the Instituto de Salud Carlos III (partly financed by Fonds Europeen de Developpement Regional funds from the European Union [02558]), the Proyecto de Excelencia of the Junta de Andalucia (CTS2548), the Arthritis Foundation, the Alliance for Lupus Research, and the Korea Healthcare Technology R&D Project of the Ministry for Health and Welfare, Republic of Korea (HI13C2124).	Alarcon-Segovia D, 2005, ARTHRITIS RHEUM-US, V52, P1138, DOI 10.1002/art.20999; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett Jeffrey C, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.ip71; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Chakravarty EF, 2007, ARTHRITIS RHEUM, V56, P2092, DOI 10.1002/art.22641; Cui Y, 2013, J AUTOIMMUN, V41, P25, DOI 10.1016/j.jaut.2013.01.008; Dorner T, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3433; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Halder I, 2008, HUM MUTAT, V29, P648, DOI 10.1002/humu.20695; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; He CF, 2010, LUPUS, V19, P1181, DOI 10.1177/0961203310367918; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Hu XL, 2011, AM J HUM GENET, V89, P496, DOI 10.1016/j.ajhg.2011.09.002; Jakes RW, 2012, ARTHRIT CARE RES, V64, P159, DOI 10.1002/acr.20683; John SA, 2008, J BIOL CHEM, V283, P951, DOI 10.1074/jbc.M705262200; Kottyan LC, 2015, HUM MOL GENET, V24, P582, DOI 10.1093/hmg/ddu455; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; Lee HS, 2014, ANN RHEUM DIS, V73, P1240, DOI 10.1136/annrheumdis-2012-202675; Leng RX, 2011, AUTOIMMUN REV, V10, P439, DOI 10.1016/j.autrev.2011.01.007; Lessard CJ, 2011, AM J HUM GENET, V88, P83, DOI 10.1016/j.ajhg.2010.11.014; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li G, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r22; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McKeigue PM, 2000, ANN HUM GENET, V64, P171, DOI 10.1017/S0003480000008022; Moisan J, 2007, J EXP MED, V204, P2825, DOI 10.1084/jem.20070994; Pons-Estel GJ, 2010, SEMIN ARTHRITIS RHEU, V39, P257, DOI 10.1016/j.semarthrit.2008.10.007; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramana CV, 2000, ONCOGENE, V19, P2619, DOI 10.1038/sj.onc.1203525; Rasmussen A, 2011, RHEUMATOLOGY, V50, P47, DOI 10.1093/rheumatology/keq302; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Wang D, 2005, INT IMMUNOL, V17, P1179, DOI 10.1093/intimm/dxh295; Wang HJ, 2005, CELL IMMUNOL, V235, P117, DOI 10.1016/j.cellimm.2005.08.031; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Wijeratne AB, 2013, J PROTEOME RES, V12, P4268, DOI 10.1021/pr400835k; Yang WL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000841; Zhong H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3514	46	27	27	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 7	2015	96	5					731	739		10.1016/j.ajhg.2015.03.002	http://dx.doi.org/10.1016/j.ajhg.2015.03.002			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CH7AZ	25865496	Bronze, Green Published			2022-12-18	WOS:000354189300004
J	Popadin, KY; Gutierrez-Arcelus, M; Lappalainen, T; Buil, A; Steinberg, J; Nikolaev, SI; Lukowski, SW; Bazykin, GA; Seplyarskiy, VB; Ioannidis, P; Zdobnov, EM; Dermitzakis, ET; Antonarakis, SE				Popadin, Konstantin Y.; Gutierrez-Arcelus, Maria; Lappalainen, Tuuli; Buil, Alfonso; Steinberg, Julia; Nikolaev, Sergey I.; Lukowski, Samuel W.; Bazykin, Georgii A.; Seplyarskiy, Vladimir B.; Ioannidis, Panagiotis; Zdobnov, Evgeny M.; Dermitzakis, Emmanouil T.; Antonarakis, Stylianos E.			Gene Age Predicts the Strength of Purifying Selection Acting on Gene Expression Variation in Humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN-PROTEIN INTERACTIONS; EVOLUTIONARY RATE; REGULATORY VARIATION; DOSAGE-SENSITIVITY; NATURAL-SELECTION; NETWORK ANALYSIS; RAPID EVOLUTION; HUMAN GENOME; DIVERGENCE; DISEASE	Gene expression levels can be subject to selection. We hypothesized that the age of gene origin is associated with expression constraints, given that it affects the level of gene integration into the functional cellular environment. By studying the genetic variation affecting gene expression levels (cis expression quantitative trait loci [cis-eQTLs]) and protein levels (cis protein QTLs [cis-pQTLs]), we determined that young, primate-specific genes are enriched in cis-eQTLs and cis-pQTLs. Compared to cis-eQTLs of old genes originating before the zebrafish divergence, cis-eQTLs of young genes have a higher effect size, are located closer to the transcription start site, are more significant, and tend to influence genes in multiple tissues and populations. These results suggest that the expression constraint of each gene increases throughout its lifespan. We also detected a positive correlation between expression constraints (approximated by cis-eQTL properties) and coding constraints (approximated by K-a/K-s) and observed that this correlation might be driven by gene age. To uncover factors associated with the increase in gene-age-related expression constraints, we demonstrated that gene connectivity, gene involvement in complex regulatory networks, gene haploinsufficiency, and the strength of posttranscriptional regulation increase with gene age. We also observed an increase in heritability of gene expression levels with age, implying a reduction of the environmental component. In summary, we show that gene age shapes key gene properties during evolution and is therefore an important component of genome function.	[Popadin, Konstantin Y.; Gutierrez-Arcelus, Maria; Lappalainen, Tuuli; Buil, Alfonso; Nikolaev, Sergey I.; Lukowski, Samuel W.; Ioannidis, Panagiotis; Zdobnov, Evgeny M.; Dermitzakis, Emmanouil T.; Antonarakis, Stylianos E.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Popadin, Konstantin Y.; Gutierrez-Arcelus, Maria; Lappalainen, Tuuli; Buil, Alfonso; Nikolaev, Sergey I.; Lukowski, Samuel W.; Ioannidis, Panagiotis; Zdobnov, Evgeny M.; Dermitzakis, Emmanouil T.; Antonarakis, Stylianos E.] Inst Genet & Genom Geneva, CH-1211 Geneva, Switzerland; [Popadin, Konstantin Y.; Bazykin, Georgii A.; Seplyarskiy, Vladimir B.] Russian Acad Sci, Inst Informat Transmiss Problems, Kharkevich Inst, Moscow 127994, Russia; [Gutierrez-Arcelus, Maria; Lappalainen, Tuuli; Buil, Alfonso; Ioannidis, Panagiotis; Zdobnov, Evgeny M.; Dermitzakis, Emmanouil T.] Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland; [Lappalainen, Tuuli] New York Genome Ctr, New York, NY 10013 USA; [Lappalainen, Tuuli] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA; [Steinberg, Julia] Univ Oxford, Dept Physiol Anat & Genet, Funct Genom Unit, MRC, Oxford OX1 3PT, England; [Steinberg, Julia] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Bazykin, Georgii A.; Seplyarskiy, Vladimir B.] Moscow MV Lomonosov State Univ, Sch Bioengn & Bioinformat, Moscow 119992, Russia; [Dermitzakis, Emmanouil T.] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah 21589, Saudi Arabia	University of Geneva; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Swiss Institute of Bioinformatics; Columbia University; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Lomonosov Moscow State University; King Abdulaziz University	Popadin, KY (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, 1 Rue Michel Servet, CH-1211 Geneva, Switzerland.	konstantin.popadin@unige.ch; stylianos.antonaralds@unige.ch	Zdobnov, Evgeny M/K-1133-2012; Lappalainen, Tuuli/AAE-6532-2020; Zdobnov, Evgeny/AAB-2745-2022; Steinberg, Julia/S-2007-2019; Lukowski, Samuel W/D-2029-2017; Bazykin, Georgii/E-4601-2012; Antonarakis, Stylianos E/N-8866-2014; Popadin, Konstantin/L-7459-2017; Ioannidis, Panagiotis/I-4281-2014	Lappalainen, Tuuli/0000-0002-7746-8109; Zdobnov, Evgeny/0000-0002-5178-1498; Steinberg, Julia/0000-0002-0585-2312; Lukowski, Samuel W/0000-0002-8598-7902; Bazykin, Georgii/0000-0003-2334-2751; Antonarakis, Stylianos E/0000-0001-8907-5823; Buil, Alfonso/0000-0002-3097-1014; Ioannidis, Panagiotis/0000-0003-0939-6745	Swiss National Science Foundation (SNSF) [144082]; European Research Council (ERC) [249968]; SNSF [31003A_130342, 31003A-125350, 31003A-143936]; ERC [260927]; Louis-Jeantet foundation; European Molecular Biology Organization [ALTF 527-2010]; Novartis [N3A15, N14B065]; Wellcome Trust [093941/Z/10/Z, 090532/Z/09/Z]; Russian Ministry of Education and Science [11.G34.31.0008]; Molecular and Cellular Biology Program of the Russian Academy of Sciences	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); European Research Council (ERC)(European Research Council (ERC)European Commission); SNSF(Swiss National Science Foundation (SNSF)); ERC(European Research Council (ERC)European Commission); Louis-Jeantet foundation; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Novartis(Novartis); Wellcome Trust(Wellcome TrustEuropean Commission); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); Molecular and Cellular Biology Program of the Russian Academy of Sciences(Russian Academy of Sciences)	We acknowledge Y. Gilad, A. McLysaght, M. Garieri, and E Santoni for discussions and Joshua Plotkin and two anonymous reviewers for constructive criticisms. This study was supported by Swiss National Science Foundation (SNSF) grant 144082 and European Research Council (ERC) grant 249968 to S.E.A. and by SNSF grant 31003A_130342, ERC grant 260927 POPRNASEQ and the Louis-Jeantet foundation to E.T.D. K.Y.P. was supported by European Molecular Biology Organization long-term fellowship program ALTF 527-2010 and Novartis grants N3A15 and N14B065. J.S. was supported by the Wellcome Trust (grants 093941/Z/10/Z to J.S. and 090532/Z/09/Z to the Wellcome Trust Centre for Human Genetics). G.A.B. and V.B.S. were supported by the Russian Ministry of Education and Science (grant 11.G34.31.0008, http://eng.mon.gov.ru/) and the Molecular and Cellular Biology Program of the Russian Academy of Sciences (http://molbiol.edu.ru/). P.I. was supported by the SNSF award 31003A-125350 and 31003A-143936 to E.M.Z. The computations were performed at the Vital-IT Center for high-performance computing of the Swiss Institute of Bioinformatics.	Alba MM, 2005, MOL BIOL EVOL, V22, P598, DOI 10.1093/molbev/msi045; [Anonymous], 1984, AM NAT; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Cai JJ, 2006, J MOL EVOL, V63, P1, DOI 10.1007/s00239-004-0372-5; Cai JJ, 2010, GENOME BIOL EVOL, V2, P815, DOI 10.1093/gbe/evq064; Capra JA, 2013, TRENDS GENET, V29, P659, DOI 10.1016/j.tig.2013.07.001; Capra JA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r127; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Cooper David N., 2011, Human Genomics, V5, P99; Dang VT, 2008, EUR J HUM GENET, V16, P1350, DOI 10.1038/ejhg.2008.111; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Domazet-Loso T, 2010, NATURE, V468, P815, DOI 10.1038/nature09632; Drummond DA, 2006, MOL BIOL EVOL, V23, P327, DOI 10.1093/molbev/msj038; Edger PP, 2009, CHROMOSOME RES, V17, P699, DOI 10.1007/s10577-009-9055-9; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Fraser HB, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-11; Fraser HB, 2013, GENOME RES, V23, P1089, DOI 10.1101/gr.152710.112; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gilad Y, 2006, NATURE, V440, P242, DOI 10.1038/nature04559; Gilad Y, 2006, TRENDS GENET, V22, P456, DOI 10.1016/j.tig.2006.06.002; Gout JF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000944; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Gu X, 2005, P NATL ACAD SCI USA, V102, P707, DOI 10.1073/pnas.0409186102; Gu X, 2007, P NATL ACAD SCI USA, V104, P2779, DOI 10.1073/pnas.0610797104; Gutierrez-Arcelus M, 2013, ELIFE, V2, DOI 10.7554/eLife.00523; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Khan Z, 2013, SCIENCE, V342, P1100, DOI 10.1126/science.1242379; Kim WK, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000232; Kondrashov FA, 2006, J THEOR BIOL, V239, P141, DOI 10.1016/j.jtbi.2005.08.033; Kudaravalli S, 2009, MOL BIOL EVOL, V26, P649, DOI 10.1093/molbev/msn289; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lappalainen T, 2011, AM J HUM GENET, V89, P459, DOI 10.1016/j.ajhg.2011.08.004; Leach LJ, 2007, MOL BIOL EVOL, V24, P2556, DOI 10.1093/molbev/msm188; Lemos B, 2005, MOL BIOL EVOL, V22, P1345, DOI 10.1093/molbev/msi122; Liao BY, 2006, MOL BIOL EVOL, V23, P1119, DOI 10.1093/molbev/msj119; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Makino T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3283; Makino T, 2010, P NATL ACAD SCI USA, V107, P9270, DOI 10.1073/pnas.0914697107; Necsulea A, 2014, NATURE, V505, P635, DOI 10.1038/nature12943; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Obayashi T, 2013, NUCLEIC ACIDS RES, V41, pD1014, DOI 10.1093/nar/gks1014; OHTA T, 1992, ANNU REV ECOL SYST, V23, P263, DOI 10.1146/annurev.es.23.110192.001403; Pai AA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003000; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Popadin K, 2013, AM J HUM GENET, V93, P1015, DOI 10.1016/j.ajhg.2013.10.022; Powell JE, 2012, GENOME RES, V22, P456, DOI 10.1101/gr.126540.111; Romero IG, 2012, NAT REV GENET, V13, P505, DOI 10.1038/nrg3229; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Vishnoi A, 2010, GENOME RES, V20, P1574, DOI 10.1101/gr.109595.110; Warnefors M, 2013, GENOME BIOL EVOL, V5, P1324, DOI 10.1093/gbe/evt093; Warnefors M, 2011, GENOME BIOL EVOL, V3, P667, DOI 10.1093/gbe/evr019; Wolf YI, 2009, P NATL ACAD SCI USA, V106, P7273, DOI 10.1073/pnas.0901808106; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Wu LF, 2013, NATURE, V499, P79, DOI 10.1038/nature12223; Yang SJ, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-13, 10.1186/1471-2164-15-146]; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang YE, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000494	61	27	27	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 4	2014	95	6					660	674		10.1016/j.ajhg.2014.11.003	http://dx.doi.org/10.1016/j.ajhg.2014.11.003			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AX0DH	25480033	Green Published, Bronze			2022-12-18	WOS:000346623100003
J	Minikel, EV; Zerr, I; Collins, SJ; Ponto, C; Boyd, A; Klug, G; Karch, A; Kenny, J; Collinge, J; Takada, LT; Forner, S; Fong, JC; Mead, S; Geschwind, MD				Minikel, Eric Vallabh; Zerr, Inga; Collins, Steven J.; Ponto, Claudia; Boyd, Alison; Klug, Genevieve; Karch, Andre; Kenny, Joanna; Collinge, John; Takada, Leonel T.; Forner, Sven; Fong, Jamie C.; Mead, Simon; Geschwind, Michael D.			Ascertainment Bias Causes False Signal of Anticipation in Genetic Prion Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CREUTZFELDT-JAKOB-DISEASE; AT-ONSET ANTICIPATION; HUNTINGTONS-DISEASE; PROTEIN GENE; LIBYAN JEWS; AGE; MUTATION; CODON-200; POLYMORPHISM; EXPERIENCE	Anticipation is the phenomenon whereby age of onset in genetic disease decreases in successive generations. Three independent reports have claimed anticipation in Creutzfeldt-Jakob disease (CJD) caused by the c.598G>A mutation in PRNP encoding a p.Glu200Lys (E200K) substitution in the prion protein. If confirmed, this finding would carry clear implications for genetic counseling. We analyzed pedigrees with this mutation from four prion centers worldwide (n = 217 individuals with the mutation) to analyze age of onset and death in affected and censored individuals. We show through simulation that selective ascertainment of individuals whose onset falls within the historical window since the mutation's 1989 discovery is sufficient to create robust false signals both of anticipation and of heritability of age of onset. In our data set, the number of years of anticipation observed depends upon how strictly the data are limited by the ascertainment window. Among individuals whose disease was directly observed at a study center, a 28-year difference between parent and child age of onset is observed (p = 0.002), but including individuals ascertained retrospectively through family history reduces this figure to 7 years (p = 0.005). Applying survival analysis to the most thoroughly ascertained subset of data eliminates the signal of anticipation. Moreover, even non-CJD deaths exhibit 16 years anticipation (p = 0.002), indicating that ascertainment bias can entirely explain observed anticipation. We suggest that reports of anticipation in genetic prion disease are driven entirely by ascertainment bias. Guidelines for future studies claiming statistical evidence for anticipation are suggested.	[Minikel, Eric Vallabh] Prion Alliance, Cambridge, MA 02139 USA; [Minikel, Eric Vallabh] Broad Inst, Cambridge, MA 02142 USA; [Minikel, Eric Vallabh] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Zerr, Inga; Ponto, Claudia; Karch, Andre] Univ Gottingen, Natl Reference Ctr TSE, D-37073 Gottingen, Germany; [Zerr, Inga] German Ctr Neurodegenerat Dis DZNE, D-37073 Gottingen, Germany; [Collins, Steven J.; Boyd, Alison; Klug, Genevieve] Univ Melbourne, Australian Natl Creutzfeldt Jakob Dis Registry, Parkville, Vic 3010, Australia; [Kenny, Joanna; Collinge, John; Mead, Simon] UCL, Inst Neurol, Dept Neurodegenerat Dis, MRC Prion Unit, London WC1N 3BG, England; [Kenny, Joanna; Collinge, John; Mead, Simon] UCL Hosp NHS Trust, Natl Hosp Neurol & Neurosurg, NHS Natl Prion Clin, London WC1N 3BG, England; [Takada, Leonel T.; Forner, Sven; Fong, Jamie C.; Geschwind, Michael D.] Univ Calif San Francisco, Memory & Aging Ctr, Dept Neurol, San Francisco, CA 94158 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; University of Gottingen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Melbourne; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of California System; University of California San Francisco	Minikel, EV (corresponding author), Prion Alliance, Cambridge, MA 02139 USA.	eric.minikel@prionalliance.org	Karch, André/D-6973-2017; Takada, Leonel/H-7124-2013	Karch, André/0000-0003-3014-8543; Mead, Simon/0000-0002-4326-1468; Takada, Leonel/0000-0002-0121-9253; Minikel, Eric Vallabh/0000-0003-2206-1608; Kenny, Joanna/0000-0002-2271-1941; Collins, Steven/0000-0002-5245-6611	Commonwealth Department of Health; Robert Koch Institute by Federal Ministry of Health [1369-341]; Medical Research Council UK; National Institute for Health Research's Biomedical Research Centre at UCLH; NIH through NIH/NIA [R01 AG-031189, K23 AG021989, P50AG023501]; NIH/NCRR [UL1 RR024131]; NIH/NIA [AG021601]; NIH/NINDS [N01-NS-0-2328]; Michael J. Homer Family Fund; MRC [MC_U123160651, G0400713] Funding Source: UKRI; Medical Research Council [G0400713, MC_U123160651] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [N01NS002328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG021989, P01AG021601, R01AG031189, P50AG023501] Funding Source: NIH RePORTER	Commonwealth Department of Health; Robert Koch Institute by Federal Ministry of Health; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research's Biomedical Research Centre at UCLH; NIH through NIH/NIA; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Michael J. Homer Family Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank all affected individuals and their families for contributing to this research; physicians who referred or reported cases to surveillance and provided pertinent clinical, neuroradiological, and neuropathological data; the staff of the Goettingen research unit and the Center for Neuropathology and Prion Research at the Ludwig-Maximilian University Munich; the U.S. National Prion Disease Pathology and Surveillance Center for providing genotyping services; and Michael E. Talkowski, Benjamin M. Neale, Mark J. Daly, and Daniel G. MacArthur for their contributions to this study. The Australian National Creutzfeldt-Jakob Disease Registry is funded by the Commonwealth Department of Health. German CJD Surveillance is supported by grants from the Robert Koch Institute by funds of the Federal Ministry of Health (grant no 1369-341). MRC Prion Unit is funded by Medical Research Council UK; the UK clinical studies were supported in part by the National Institute for Health Research's Biomedical Research Centre at UCLH. This work from UCSF was supported by NIH through NIH/NIA R01 AG-031189, K23 AG021989, P50AG023501, NIH/NCRR Grant Number UL1 RR024131, NIH/NIA AG021601, NIH/NINDS Contract N01-NS-0-2328, and Michael J. Homer Family Fund. E.V.M. received no specific funding for this work and volunteers his time on behalf of Prion Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. M.D.G. has served as a consultant for Lundbeck, MedaCorp, The Council of Advisors, and Neurophage.	BAKER HF, 1991, LANCET, V337, P1286, DOI 10.1016/0140-6736(91)92953-Y; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Beck JA, 2010, HUM MUTAT, V31, pE1551, DOI 10.1002/humu.21281; Belay ED, 1999, ANNU REV MICROBIOL, V53, P283, DOI 10.1146/annurev.micro.53.1.283; Boonstra PS, 2010, GENET EPIDEMIOL, V34, P756, DOI 10.1002/gepi.20534; BROWN P, 1992, LANCET, V340, P24, DOI 10.1016/0140-6736(92)92431-E; CHAPMAN J, 1994, NEUROLOGY, V44, P1683, DOI 10.1212/WNL.44.9.1683; Collins S, 1999, LANCET, V353, P693, DOI 10.1016/S0140-6736(98)08138-0; Collins S, 2002, NEUROLOGY, V59, P1365, DOI 10.1212/01.WNL.0000031793.11602.8C; GABIZON R, 1993, AM J HUM GENET, V53, P828; GAJDUSEK DC, 1977, SCIENCE, V197, P943, DOI 10.1126/science.142303; Geschwind MD, 2008, ANN NEUROL, V64, P97, DOI 10.1002/ana.21430; Geschwind MD, 2007, NEUROL CLIN, V25, P783, DOI 10.1016/j.ncl.2007.04.001; Goizet C, 2002, NEUROLOGY, V59, P1330, DOI 10.1212/01.WNL.0000032255.75650.C2; GOLDFARB LG, 1990, LANCET, V336, P514, DOI 10.1016/0140-6736(90)92073-Q; GOLDFARB LG, 1990, LANCET, V336, P637, DOI 10.1016/0140-6736(90)93443-S; GOLDGABER D, 1989, EXP NEUROL, V106, P204, DOI 10.1016/0014-4886(89)90095-2; Grasbon-Frodl E, 2004, ACTA NEUROPATHOL, V108, P476, DOI 10.1007/s00401-004-0913-4; Harper PS, 2000, J MED GENET, V37, P567, DOI 10.1136/jmg.37.8.567; Heiman GA, 1996, PSYCHIAT GENET, V6, P61, DOI 10.1097/00041444-199622000-00005; Hewitt PE, 2006, VOX SANG, V91, P221, DOI 10.1111/j.1423-0410.2006.00833.x; HODGE SE, 1995, PSYCHIATR GENET, V5, P43, DOI 10.1097/00041444-199521000-00007; Holman RC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008521; HSIAO K, 1991, NEW ENGL J MED, V324, P1091, DOI 10.1056/NEJM199104183241604; Kong Q, 2004, PRION BIOL DIS; Kovacs GG, 2005, HUM GENET, V118, P166, DOI 10.1007/s00439-005-0020-1; La Spada AR, 2010, NAT REV GENET, V11, P247, DOI 10.1038/nrg2748; Laccone F, 1999, NEUROLOGY, V53, P801, DOI 10.1212/WNL.53.4.801; Martinez-Delgado B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002182; Morrison PJ, 2011, CLIN GENET, V80, P281, DOI 10.1111/j.1399-0004.2010.01538.x; Murray K, 2011, J NEUROL NEUROSUR PS, V82, P729, DOI 10.1136/jnnp.2009.172148; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Owen J., 2014, EUR J HUM GENET; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Paterson RW, 2012, ARCH NEUROL-CHICAGO, V69, P1578, DOI 10.1001/2013.jamaneurol.79; PENROSE LS, 1948, ANN EUGENIC, V14, P125; Pocchiari M, 2004, BRAIN, V127, P2348, DOI 10.1093/brain/awh249; Pocchiari M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060376; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; PSYCHIATR, PSYCHIAT GENET, V5, P43; Rabinovici GD, 2006, NEUROLOGY, V66, P286, DOI 10.1212/01.wnl.0000196440.00297.67; Rabinowitz D, 1999, BIOMETRICS, V55, P834, DOI 10.1111/j.0006-341X.1999.00834.x; Rosenmann H, 1999, NEUROLOGY, V53, P1328, DOI 10.1212/WNL.53.6.1328; Ryman DC, 2014, NEUROLOGY, V83, P253, DOI 10.1212/WNL.0000000000000596; Schelzke G, 2012, EUR J EPIDEMIOL, V27, P147, DOI 10.1007/s10654-012-9660-3; SPUDICH S, 1995, MOL MED, V1, P607, DOI 10.1007/BF03401601; Squitieri F, 2000, AM J MED GENET, V95, P366, DOI 10.1002/1096-8628(20001211)95:4<366::AID-AJMG13>3.0.CO;2-2; Tassicker RJ, 2006, CLIN GENET, V70, P480, DOI 10.1111/j.1399-0004.2006.00701.x; Tsai WY, 2005, GENET EPIDEMIOL, V28, P256, DOI 10.1002/gepi.20057; Vieland VJ, 1998, AM J HUM GENET, V62, P1212, DOI 10.1086/301823; Vulliamy T, 2004, NAT GENET, V36, P447, DOI 10.1038/ng1346; Windl O, 1999, HUM GENET, V105, P244, DOI 10.1007/s004390051096; Xiao XZ, 2009, AM J PATHOL, V174, P1602, DOI 10.2353/ajpath.2009.081045; Zerr I, 2009, BRAIN, V132, P2659, DOI 10.1093/brain/awp191	54	27	27	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 2	2014	95	4					371	382		10.1016/j.ajhg.2014.09.003	http://dx.doi.org/10.1016/j.ajhg.2014.09.003			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AQ2XW	25279981	Bronze, Green Published			2022-12-18	WOS:000342654300003
J	Sumner, CJ; d'Ydewalle, C; Wooley, J; Fawcett, KA; Hernandez, D; Gardiner, AR; Kalmar, B; Baloh, RH; Gonzalez, M; Zuchner, S; Stanescu, HC; Kleta, R; Mankodi, A; Cornblath, DR; Boylan, KB; Reilly, MM; Greensmith, L; Singleton, AB; Harms, MB; Rossor, AM; Houlden, H				Sumner, Charlotte J.; d'Ydewalle, Constantin; Wooley, Joe; Fawcett, Katherine A.; Hernandez, Dena; Gardiner, Alice R.; Kalmar, Bernadett; Baloh, Robert H.; Gonzalez, Michael; Zuechner, Stephan; Stanescu, Horia C.; Kleta, Robert; Mankodi, Ami; Cornblath, David R.; Boylan, Kevin B.; Reilly, Mary M.; Greensmith, Linda; Singleton, Andrew B.; Harms, Matthew B.; Rossor, Alexander M.; Houlden, Henry			A Dominant Mutation in FBXO38 Causes Distal Spinal Muscular Atrophy with Calf Predominance	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSCRIPTION FACTOR KLF7; AXON REGENERATION; GENE-EXPRESSION; KRUPPEL; RNA; IDENTIFICATION; NEUROPATHIES; FAMILY; MOUSE; MOKA	Spinal muscular atrophies (SMAs) are a heterogeneous group of inherited disorders characterized by degeneration of anterior horn cells and progressive muscle weakness. In two unrelated families affected by a distinct form of autosomal-dominant distal SMA initially manifesting with calf weakness, we identified by genetic linkage analysis and exome sequencing a heterozygous missense mutation, c.616T>C (p.Cys206Arg), in F-box protein 38 (FBXO38). FBXO38 is a known coactivator of the transcription factor Kruppel-like factor 7 (KLF7), which regulates genes required for neuronal axon outgrowth and repair. The p.Cys206Arg substitution did not alter the subcellular localization of FBXO38 but did impair KLF7-mediated transactivation of a KLF7-responsive promoter construct and endogenous KLF7 target genes in both heterologously expressing human embryonic kidney 293T cells and fibroblasts derived from individuals with the FBXO38 missense mutation. This transcriptional dysregulation was associated with an impairment of neurite outgrowth in primary motor neurons. Together, these results suggest that a transcriptional regulatory pathway that has a well-established role in axonal development could also be critical for neuronal maintenance and highlight the importance of FBXO38 and KLF7 activity in motor neurons.	[Sumner, Charlotte J.; d'Ydewalle, Constantin; Wooley, Joe; Cornblath, David R.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Sumner, Charlotte J.] Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [d'Ydewalle, Constantin] VIB, Vesalius Res Ctr, Neurobiol Lab, B-3000 Louvain, Belgium; [d'Ydewalle, Constantin] Katholieke Univ Leuven, B-3000 Louvain, Belgium; [Fawcett, Katherine A.; Gardiner, Alice R.; Reilly, Mary M.; Houlden, Henry] Natl Hosp Neurol & Neurosurg, Dept Mol Neurosci, London WC1N 3BG, England; [Fawcett, Katherine A.; Gardiner, Alice R.; Kalmar, Bernadett; Reilly, Mary M.; Greensmith, Linda; Rossor, Alexander M.; Houlden, Henry] UCL Inst Neurol, London WC1N 3BG, England; [Fawcett, Katherine A.; Gardiner, Alice R.; Kalmar, Bernadett; Reilly, Mary M.; Greensmith, Linda; Rossor, Alexander M.; Houlden, Henry] Natl Hosp Neurol & Neurosurg, MRC, Ctr Neuromuscular Dis, London WC1N 3BG, England; [Hernandez, Dena; Singleton, Andrew B.] NIA, NIH, Neurogenet Lab, Bethesda, MD 20892 USA; [Baloh, Robert H.] Cedars Sinai Med Ctr, Dept Neurol, Los Angeles, CA 90095 USA; [Gonzalez, Michael; Zuechner, Stephan] Univ Miami, Miller Sch Med, Dr John T MacDonald Dept Human Genet, Miami, FL 33136 USA; [Gonzalez, Michael; Zuechner, Stephan] Univ Miami, Miller Sch Med, Hussman Inst Human Genom, Miami, FL 33136 USA; [Stanescu, Horia C.; Kleta, Robert] UCL, Ctr Nephrol, London WC1N 3BG, England; [Mankodi, Ami] NINDS, Neurogenet Branch, Bethesda, MD 20892 USA; [Boylan, Kevin B.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Harms, Matthew B.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Cedars Sinai Medical Center; University of Miami; University of Miami; University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Mayo Clinic; Washington University (WUSTL)	Sumner, CJ (corresponding author), Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA.	csumner1@jhmi.edu; h.houlden@ucl.ac.uk	Singleton, Andrew B/C-3010-2009; Rossor, Alexander/AAH-6870-2019; Houlden, Henry J/C-1532-2008	Rossor, Alexander/0000-0003-4648-2896; Houlden, Henry J/0000-0002-2866-7777; Mankodi, Ami/0000-0002-5131-7767; Kalmar, Bernadett/0000-0003-3747-4843; Fawcett, Katherine/0000-0002-6675-2112; Reilly, Mary/0000-0003-0686-905X	National Institute of Neurological Disorders and Stroke (NINDS) [R01NS062869]; Research Council of KU Leuven; NINDS [K08-NS-075094]; Office of Rare Diseases [U54NS065712]; Ipsen clinical research fellowship; Wellcome Trust; Muscular Dystrophy Campaign; Medical Research Council; French Muscular Dystrophy Association; National Institute on Aging, National Institutes of Health, Department of Health and Human Services [ZO1 AG000958-10]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448, KL2TR000450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003131, ZIANS002974, K08NS075094, U54NS065712, R01NS062869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000958] Funding Source: NIH RePORTER; Medical Research Council [MR/K000608/1, G1001253, G108/638, MR/J004758/1, G0802760] Funding Source: researchfish; MRC [G1001253, MR/J004758/1, G108/638, G0802760, MR/K000608/1] Funding Source: UKRI	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Research Council of KU Leuven(KU Leuven); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Office of Rare Diseases; Ipsen clinical research fellowship(Ipsen); Wellcome Trust(Wellcome Trust); Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); French Muscular Dystrophy Association(Association Francaise contre les Myopathies); National Institute on Aging, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors would like to thank Kenneth Fischbeck for advice about genetics, Vinay Chaudhry and Zeng Wang for clinical care, Chris Dorsey and Jamal Garrison for muscle histology, and Peggy Allred for aid in DNA-sample collection. C.J.S. is supported by National Institute of Neurological Disorders and Stroke (NINDS) grant R01NS062869. C.d.Y. is supported by the Research Council of KU Leuven (Special Research Fund). M.B.H. is funded by the NINDS (K08-NS-075094). A.M.R. is funded by the NINDS and Office of Rare Diseases (U54NS065712), as well as an Ipsen clinical research fellowship. H.H. is supported by The Wellcome Trust, the Muscular Dystrophy Campaign, the Medical Research Council, and The French Muscular Dystrophy Association. We would also like to thank the University College London Hospitals National Institute for Health Research Biomedical Research Centre funding scheme. This work was also supported in part by the Intramural Research Program of the National Institute on Aging, National Institutes of Health, Department of Health and Human Services (project ZO1 AG000958-10).	Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Blackmore MG, 2012, P NATL ACAD SCI USA, V109, P7517, DOI 10.1073/pnas.1120684109; Blumen SC, 2012, ANN NEUROL, V71, P509, DOI 10.1002/ana.22684; BOYLAN KB, 1995, NEUROLOGY, V45, P699, DOI 10.1212/WNL.45.4.699; Chen J, 2007, BRAIN, V130, P954, DOI 10.1093/brain/awm049; di Sanguinetto SADT, 2008, CURR OPIN NEUROBIOL, V18, P36, DOI 10.1016/j.conb.2008.04.002; Dierick I, 2008, BRAIN, V131, P1217, DOI 10.1093/brain/awn029; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Guernsey DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001081; Harms MB, 2012, NEUROLOGY, V78, P1714, DOI 10.1212/WNL.0b013e3182556c05; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kajimura D, 2007, GENE, V388, P34, DOI 10.1016/j.gene.2006.09.027; Kingsbury TJ, 2007, MOL CELL NEUROSCI, V35, P447, DOI 10.1016/j.mcn.2007.04.004; Laub F, 2001, DEV BIOL, V233, P305, DOI 10.1006/dbio.2001.0243; Laub F, 2005, MOL CELL BIOL, V25, P5699, DOI 10.1128/MCB.25.13.5699-5711.2005; Lei L, 2005, GENE DEV, V19, P1354, DOI 10.1101/gad.1227705; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Moore DL, 2011, DEV NEUROBIOL, V71, P1186, DOI 10.1002/dneu.20934; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; ROSENTHAL A, 1992, NAT GENET, V2, P107, DOI 10.1038/ng1092-107; Rossor AM, 2012, J NEUROL NEUROSUR PS, V83, P6, DOI 10.1136/jnnp-2011-300952; Shilatifard A, 1998, FASEB J, V12, P1437, DOI 10.1096/fasebj.12.14.1437; Skaar JR, 2009, CURR OPIN CELL BIOL, V21, P816, DOI 10.1016/j.ceb.2009.08.004; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Smaldone S, 2004, MOL CELL BIOL, V24, P1058, DOI 10.1128/MCB.24.3.1058-1069.2004; Smaldone S, 2006, NUCLEIC ACIDS RES, V34, P5060, DOI 10.1093/nar/gkl659; Timmerman V, 2013, EXP NEUROL, V246, P14, DOI 10.1016/j.expneurol.2012.01.010; Veldman MB, 2007, DEV BIOL, V312, P596, DOI 10.1016/j.ydbio.2007.09.019; Wee CD, 2010, CURR OPIN NEUROL, V23, P450, DOI 10.1097/WCO.0b013e32833e1765; Weterman MAJ, 2012, HUM MOL GENET, V21, P358, DOI 10.1093/hmg/ddr471; Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280; Ylikallio E, 2013, HUM MOL GENET, V22, P2975, DOI 10.1093/hmg/ddt149; Zimon M, 2010, BRAIN, V133, P1798, DOI 10.1093/brain/awq109	35	27	29	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2013	93	5					976	983		10.1016/j.ajhg.2013.10.006	http://dx.doi.org/10.1016/j.ajhg.2013.10.006			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252HU	24207122	Green Published, Bronze			2022-12-18	WOS:000326996600018
J	Chen, LS; Hsu, L; Gamazon, ER; Cox, NJ; Nicolae, DL				Chen, Lin S.; Hsu, Li; Gamazon, Eric R.; Cox, Nancy J.; Nicolae, Dan L.			An Exponential Combination Procedure for Set-Based Association Tests in Sequencing Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; INDUCED CYTOTOXICITY; COMMON DISEASES; CISPLATIN; CARBOPLATIN; VARIANTS	State-of-the-art next-generation-sequencing technologies can facilitate in-depth explorations of the human genome by investigating both common and rare variants. For the identification of genetic factors that are associated with disease risk or other complex phenotypes, methods have been proposed for jointly analyzing variants in a set (e.g., all coding SNPs in a gene). Variants in a properly defined set could be associated with risk or phenotype in a concerted fashion, and by accumulating information from them, one can improve power to detect genetic risk factors. Many set-based methods in the literature are based on statistics that can be written as the summation of variant statistics. Here, we propose taking the summation of the exponential of variant statistics as the set summary for association testing. From both Bayesian and frequentist perspectives, we provide theoretical justification for taking the sum of the exponential of variant statistics because it is particularly powerful for sparse alternatives-that is, compared with the large number of variants being tested in a set, only relatively few variants are associated with disease risk-a distinctive feature of genetic data. We applied the exponential combination gene-based test to a sequencing study in anticancer pharmacogenomics and uncovered mechanistic insights into genes and pathways related to chemotherapeutic susceptibility for an important class of oncologic drugs.	[Chen, Lin S.] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Hsu, Li] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Biostat & Biomath Program, Seattle, WA 98109 USA; [Gamazon, Eric R.; Cox, Nancy J.; Nicolae, Dan L.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Nicolae, Dan L.] Univ Chicago, Dept Stat, Chicago, IL 60637 USA	University of Chicago; Fred Hutchinson Cancer Center; University of Chicago; University of Chicago	Chen, LS (corresponding author), Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA.	lchen@health.bsd.uchicago.edu	Gamazon, Eric/I-6873-2018	Gamazon, Eric/0000-0003-4204-8734; Nicolae, Dan/0000-0002-0918-4630	 [UC2HL102924];  [R01AG014358];  [P01CA53996];  [U01HG005773];  [MH090937];  [HG005773]; NATIONAL CANCER INSTITUTE [P01CA053996] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG005773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014358] Funding Source: NIH RePORTER	; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank R.L. Prentice for insightful comments and suggestions. We also thank H. Cao, C.R. King, B. Pierce, D. Huo, and Q.A. Fu for their comments on the paper. L. Hsu was supported by UC2HL102924, R01AG014358, and P01CA53996. E.R. Gamazon, N.J. Cox, and D.L. Nicolae are supported by U01HG005773, MH090937, and HG005773.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; [Anonymous], 1932, STAT METHODS RES WOR; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Biernacka JM, 2012, EUR J HUM GENET, V20, P565, DOI 10.1038/ejhg.2011.236; Celik I, 1996, J CLIN ONCOL, V14, P1043, DOI 10.1200/JCO.1996.14.3.1043; Chen LS, 2010, AM J HUM GENET, V86, P860, DOI 10.1016/j.ajhg.2010.04.014; Dolan ME, 2004, CANCER RES, V64, P4353, DOI 10.1158/0008-5472.CAN-04-0340; Gamazon ER, 2010, P NATL ACAD SCI USA, V107, P9287, DOI 10.1073/pnas.1001827107; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang RS, 2008, MOL CANCER THER, V7, P3038, DOI 10.1158/1535-7163.MCT-08-0248; Huang RS, 2007, AM J HUM GENET, V81, P427, DOI 10.1086/519850; King CR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001202; KOZIOL JA, 1978, J AM STAT ASSOC, V73, P753, DOI 10.2307/2286276; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Lehmann E. L., 1997, TESTING STAT HYPOTHE; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li M, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-34; Luna A, 2007, BIOINFORMATICS, V23, P774, DOI 10.1093/bioinformatics/btl657; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McWhinney SR, 2009, MOL CANCER THER, V8, P10, DOI 10.1158/1535-7163.MCT-08-0840; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Nakano Y, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000610; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Owonikoko TK, 2010, INT J CANCER, V126, P743, DOI 10.1002/ijc.24759; Peters D, 2005, MOL CANCER THER, V4, P1605, DOI 10.1158/1535-7163.MCT-04-0311; Rademaker-Lakhai JM, 2006, J CLIN ONCOL, V24, P918, DOI 10.1200/JCO.2006.10.077; Tippett L.H.C., 1931, METHODS STAT; VANZWET WR, 1967, ANN MATH STAT, V38, P659, DOI 10.1214/aoms/1177698861; Welsh M, 2009, PHARMACOL REV, V61, P413, DOI 10.1124/pr.109.001461; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422; Zaykin DV, 2007, PHARM STAT, V6, P217, DOI 10.1002/pst.304; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042	37	27	28	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 7	2012	91	6					977	986		10.1016/j.ajhg.2012.09.017	http://dx.doi.org/10.1016/j.ajhg.2012.09.017			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	055LI	23159251	Bronze, Green Published			2022-12-18	WOS:000312417400001
J	Vandeweyer, G; Van der Aa, N; Reyniers, E; Kooy, RF				Vandeweyer, Geert; Van der Aa, Nathalie; Reyniers, Edwin; Kooy, R. Frank			The Contribution of CLIP2 Haploinsufficiency to the Clinical Manifestations of the Williams-Beuren Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUPRAVALVULAR AORTIC-STENOSIS; POINT MUTATIONS; SYNDROME REGION; ELASTIN GENE; 7Q11.23; GTF2IRD1; DELETION; PROFILE; ADULTS; MICE	Williams-Beuren syndrome is a rare contiguous gene syndrome, characterized by intellectual disability, facial dysmorphisms, connective-tissue abnormalities, cardiac defects, structural brain abnormalities, and transient infantile hypercalcemia. Genes lying telomeric to RFC2, including CLIP2, GTF2I and GTF2IRD1, are currently thought to be the most likely major contributors to the typical Williams syndrome cognitive profile, characterized by a better-than-expected auditory rote-memory ability, a relative sparing of language capabilities, and a severe visual-spatial constructive impairment. Atypical deletions in the region have helped to establish genotype-phenotype correlations. So far, however, hardly any deletions affecting only a single gene in the disease region have been described. We present here two healthy siblings with a pure, hemizygous deletion of CLIP2. A putative role in the cognitive and behavioral abnormalities seen in Williams-Beuren patients has been suggested for this gene on the basis of observations in a knock-out mouse model. The presented siblings did not show any of the clinical features associated with the syndrome. Cognitive testing showed an average IQ for both and no indication of the Williams syndrome cognitive profile. This shows that CLIP2 haploinsufficiency by itself does not lead to the physical or cognitive characteristics of the Williams-Beuren syndrome, nor does it lead to the Williams syndrome cognitive profile. Although contribution of CLIP2 to the phenotype cannot be excluded when it is deleted in combination with other genes, our results support the hypothesis that GTF2IRD1 and GTF2I are the main genes causing the cognitive defects associated with Williams-Beuren syndrome.	[Vandeweyer, Geert; Van der Aa, Nathalie; Reyniers, Edwin; Kooy, R. Frank] Univ Antwerp, Univ Antwerp Hosp, Dept Med Genet, B-2650 Edegem, Belgium	University of Antwerp	Kooy, RF (corresponding author), Univ Antwerp, Univ Antwerp Hosp, Dept Med Genet, Prins Boudewijnlaan 43, B-2650 Edegem, Belgium.	frank.kooy@ua.ac.be	Kooy, Frank/F-5276-2014	Kooy, Frank/0000-0003-2024-0485; Vandeweyer, Geert/0000-0002-6262-6522	Belgian National Fund for Scientific Research - Flanders (FWO); Marguerite-Marie Delacroix foundation	Belgian National Fund for Scientific Research - Flanders (FWO)(Fonds de la Recherche Scientifique - FNRSFWO); Marguerite-Marie Delacroix foundation	We are grateful to the patient and his family for participation in this study. We thank Sien Braat for help with the real-time experiments and our tissue-culture laboratory for providing cell cultures. Our work is supported by the Belgian National Fund for Scientific Research - Flanders (FWO) and the Marguerite-Marie Delacroix foundation.	Antonell A, 2010, J MED GENET, V47, P312, DOI 10.1136/jmg.2009.071712; Ashe A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r182; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Bellugi U, 2000, J COGNITIVE NEUROSCI, V12, P7, DOI 10.1162/089892900561959; CURRAN ME, 1993, CELL, V73, P159, DOI 10.1016/0092-8674(93)90168-P; Cusco I, 2008, GENOME RES, V18, P683, DOI 10.1101/gr.073197.107; Dai L, 2009, AM J MED GENET A, V149A, P302, DOI 10.1002/ajmg.a.32652; Edelmann L, 2007, J MED GENET, V44, P136, DOI 10.1136/jmg.2006.044537; Elison S, 2010, RES DEV DISABIL, V31, P587, DOI 10.1016/j.ridd.2009.12.013; Ferrero GB, 2010, EUR J HUM GENET, V18, P33, DOI 10.1038/ejhg.2009.108; Gagliardi C, 2003, J MED GENET, V40, P526, DOI 10.1136/jmg.40.7.526; Gao MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010292; Henrichsen CN, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001054; Hirota H, 2003, GENET MED, V5, P311, DOI 10.1097/01.GIM.0000076975.10224.67; Hoogenraad CC, 2002, NAT GENET, V32, P116, DOI 10.1038/ng954; Hoogenraad SC, 2004, BIOESSAYS, V26, P141, DOI 10.1002/bies.10402; Howald C, 2006, J MED GENET, V43, P266, DOI 10.1136/jmg.2005.034009; Howlin P, 1998, J CHILD PSYCHOL PSYC, V39, P183, DOI 10.1017/S0021963097001789; Howlin P, 2010, J APPL RES INTELLECT, V23, P322, DOI 10.1111/j.1468-3148.2009.00536.x; Iizuka K, 2008, ENDOCR J, V55, P617, DOI 10.1507/endocrj.K07E-110; Jackowski AP, 2009, EUR J PAEDIATR NEURO, V13, P305, DOI 10.1016/j.ejpn.2008.07.002; Jacquemont S, 2011, NATURE, V478, P97, DOI 10.1038/nature10406; Jaworski J, 2008, INT J BIOCHEM CELL B, V40, P619, DOI 10.1016/j.biocel.2007.10.015; Lam PPL, 2005, DIABETES, V54, P2744, DOI 10.2337/diabetes.54.9.2744; Li DY, 1997, HUM MOL GENET, V6, P1021, DOI 10.1093/hmg/6.7.1021; Li DY, 1998, J CLIN INVEST, V102, P1783, DOI 10.1172/JCI4487; Merla G, 2006, AM J HUM GENET, V79, P332, DOI 10.1086/506371; Merla G, 2010, HUM GENET, V128, P3, DOI 10.1007/s00439-010-0827-2; Mervis CB, 2000, BRAIN COGNITION, V44, P604, DOI 10.1006/brcg.2000.1232; Morris CA, 2003, AM J MED GENET A, V123A, P45, DOI 10.1002/ajmg.a.20496; Munch C, 2004, NEUROLOGY, V63, P724, DOI 10.1212/01.WNL.0000134608.83927.B1; OLSON TM, 1995, HUM MOL GENET, V4, P1677, DOI 10.1093/hmg/4.9.1677; Osborne LR, 2010, AM J MED GENET C, V154C, P209, DOI 10.1002/ajmg.c.30257; Palmer SJ, 2010, J BIOL CHEM, V285, P4715, DOI 10.1074/jbc.M109.086660; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Pober BR, 2007, AM J MED GENET C, V145C, P280, DOI 10.1002/ajmg.c.30139; Pober BR, 2010, NEW ENGL J MED, V362, P239, DOI 10.1056/NEJMra0903074; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Rhodes SM, 2011, BRAIN COGNITION, V77, P208, DOI 10.1016/j.bandc.2011.08.009; Rooms L, 2011, AM J MED GENET A, V155A, P343, DOI 10.1002/ajmg.a.33810; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Shinawi M, 2010, J MED GENET, V47, P332, DOI 10.1136/jmg.2009.073015; Smit A. F. A., 1996, REPEATMASKER OPEN 3; Somerville MJ, 2005, NEW ENGL J MED, V353, P1694, DOI 10.1056/NEJMoa051962; Tassabehji M, 2005, SCIENCE, V310, P1184, DOI 10.1126/science.1116142; Tassabehji M, 2003, HUM MOL GENET, V12, pR229, DOI 10.1093/hmg/ddg299; Van der Aa N, 2009, EUR J MED GENET, V52, P94, DOI 10.1016/j.ejmg.2009.02.006; van Hagen JM, 2007, NEUROBIOL DIS, V26, P112, DOI 10.1016/j.nbd.2006.12.009; Vandeweyer G, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-4	49	27	32	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 8	2012	90	6					1071	1078		10.1016/j.ajhg.2012.04.020	http://dx.doi.org/10.1016/j.ajhg.2012.04.020			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	958TC	22608712	Green Published, Bronze			2022-12-18	WOS:000305262600011
J	Cheng, J; Zhu, YH; He, SD; Lu, YP; Chen, J; Han, B; Petrillo, M; Wrzeszczynski, KO; Yang, SM; Dai, P; Zhai, SQ; Han, DY; Zhang, MQ; Li, W; Liu, XZ; Li, HW; Chen, ZY; Yuan, HJ				Cheng, Jing; Zhu, Yuhua; He, Sudan; Lu, Yanping; Chen, Jing; Han, Bing; Petrillo, Marco; Wrzeszczynski, Kazimierz O.; Yang, Shiming; Dai, Pu; Zhai, Suoqiang; Han, Dongyi; Zhang, Michael Q.; Li, Wei; Liu, Xuezhong; Li, Huawei; Chen, Zheng-Yi; Yuan, Huijun			Functional Mutation of SMAC/DIABLO, Encoding a Mitochondrial Proapoptotic Protein, Causes Human Progressive Hearing Loss DFNA64	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INDUCED APOPTOSIS; OXIDATIVE STRESS; CELL-DEATH; DEAFNESS; ACTIVATION; EXPRESSION; DISCOVERY; COCHLEA; GENES; LOCUS	SMAC/DIABLO is a mitochondrial proapoptotic protein that is released from mitochondria during apoptosis and counters the inhibitory activities of inhibitor of apoptosis proteins, IAPs. By linkage analysis and candidate screening, we identified a heterozygous SMAC/DIABLO mutation, c.377C>T (p.Ser126Leu, refers to p.Ser71Leu in the mature protein) in a six-generation Chinese kindred characterized by dominant progressive nonsyndromic hearing loss, designated as DFNA64. SMAC/DIABLO is highly expressed in human embryonic ears and is enriched in the developing mouse inner-ear hair cells, suggesting it has a role in the development and homeostasis of hair cells. We used a functional study to demonstrate that the SMAC/DIABLO(S71L) mutant, while retaining the proapoptotic function, triggers significant degradation of both wild-type and mutant SMAC/DIABLO and renders host mitochondria susceptible to calcium-induced loss of the membrane potential. Our work identifies DFNA64 as the human genetic disorder associated with SMAC/DIABLO malfunction and suggests that mutant SMAC/DIABLO(S71L) might cause mitochondrial dysfunction.	[Cheng, Jing; Zhu, Yuhua; Chen, Jing; Han, Bing; Yang, Shiming; Dai, Pu; Zhai, Suoqiang; Han, Dongyi; Yuan, Huijun] Chinese Peoples Liberat Army Gen Hosp, Inst Otolaryngol, Beijing 100853, Peoples R China; [He, Sudan] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [He, Sudan] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Cyrus Tang Hematol Ctr, Suzhou 215325, Peoples R China; [Lu, Yanping] Chinese Peoples Liberat Army Gen Hosp, Dept Obstet & Gynecol, Beijing 100853, Peoples R China; [Petrillo, Marco; Chen, Zheng-Yi] Harvard Univ, Eaton Peabody Lab, Massachusetts Eye & Ear Infirm, Dept Otolaryngol,Med Sch, Boston, MA 02114 USA; [Wrzeszczynski, Kazimierz O.; Zhang, Michael Q.] Cold Spring Harbor Lab, Michael Zhang Lab, Cold Spring Harbor, NY 11724 USA; [Li, Wei] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100101, Peoples R China; [Liu, Xuezhong] Univ Miami, Dept Otolaryngol, Miami, FL 33136 USA; [Li, Huawei] Fudan Univ, Affiliated Eye & Otolaryngol Hosp, Dept Otol & Skull Base Surg, Shanghai 200031, Peoples R China	Chinese People's Liberation Army General Hospital; National Institute of Biological Sciences, Beijing; Soochow University - China; Chinese People's Liberation Army General Hospital; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Cold Spring Harbor Laboratory; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; University of Miami; Fudan University	Yuan, HJ (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Inst Otolaryngol, Beijing 100853, Peoples R China.	yuanhj301@yahoo.com.cn		petrillo, marco/0000-0003-2526-6166	National High Technology Research and Development Program of China (863 Program) [2007AA02E466]; National Natural Science Foundation of China [81030017, 30728030]; National Institutes of Health [R01 DC006908, R01 DC05575]; Fredrick and Ines Yeatts Inner Ear Hair Cell Regeneration Fellowship; Chinese National Programs for Fundamental Research and Development (973 Program) [2011CB504506]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006908, R01DC005575] Funding Source: NIH RePORTER	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fredrick and Ines Yeatts Inner Ear Hair Cell Regeneration Fellowship; Chinese National Programs for Fundamental Research and Development (973 Program)(National Basic Research Program of China); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We sincerely thank Xiaodong Wang for extensive help in invaluable scientific input and manuscript revision, Xue Zhang and Hui Jiang for helpful discussions, and Yueshuai Song and Chunhua Xu for technical assistance with the figure preparation and graphical artwork. These investigations were supported by grants from the National High Technology Research and Development Program of China (863 Program, 2007AA02E466) and the Key Project of National Natural Science Foundation of China (81030017) to H.J.Y., grants from the National Natural Science Foundation of China (30728030) and National Institutes of Health (R01 DC006908) to Z.Y.C., a grant from the Fredrick and Ines Yeatts Inner Ear Hair Cell Regeneration Fellowship to M.P., a grant from the National Institutes of Health (R01 DC05575) to X.Z.L., and a grant from the Chinese National Programs for Fundamental Research and Development (973 Program, 2011CB504506) to H.W.L. We thank all the family members for their participation and support in this study.	[Anonymous], DBSNP; [Anonymous], MORTON COCHLEAR EST; Blanton SH, 2002, J MED GENET, V39, P567, DOI 10.1136/jmg.39.8.567; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Distelmaier F, 2008, CYTOM PART A, V73A, P129, DOI 10.1002/cyto.a.20503; Dror AA, 2009, ANNU REV GENET, V43, P411, DOI 10.1146/annurev-genet-102108-134135; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Greene CC, 2001, AM J HUM GENET, V68, P254, DOI 10.1086/316925; Lallemend F, 2005, CURR PHARM DESIGN, V11, P2257, DOI 10.2174/1381612054367346; Liu XZ, 2007, J PATHOL, V211, P188, DOI 10.1002/path.2102; Nicotera TM, 2003, JARO-J ASSOC RES OTO, V4, P466, DOI 10.1007/s10162-002-3038-2; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Petersen MB, 2002, CLIN GENET, V62, P1, DOI 10.1034/j.1399-0004.2002.620101.x; Pieper AA, 2010, CELL, V142, P39, DOI 10.1016/j.cell.2010.06.018; Resendes BL, 2001, AM J HUM GENET, V69, P923, DOI 10.1086/324122; Sage C, 2005, SCIENCE, V307, P1114, DOI 10.1126/science.1106642; Skvorak AB, 1999, HUM MOL GENET, V8, P439, DOI 10.1093/hmg/8.3.439; Someya S, 2009, P NATL ACAD SCI USA, V106, P19432, DOI 10.1073/pnas.0908786106; Steel KP, 2001, NAT GENET, V27, P143, DOI 10.1038/84758; Sun Xi-bin, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P643; Van De Water TR, 2004, OTOL NEUROTOL, V25, P627, DOI 10.1097/00129492-200407000-00035; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Walsh T, 2010, AM J HUM GENET, V87, P101, DOI 10.1016/j.ajhg.2010.05.011; Williams A, 2006, CURR TOP DEV BIOL, V76, P89, DOI 10.1016/S0070-2153(06)76003-3; Zhu XW, 2006, J ALZHEIMERS DIS, V9, P147	26	27	37	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 15	2011	89	1					56	66		10.1016/j.ajhg.2011.05.027	http://dx.doi.org/10.1016/j.ajhg.2011.05.027			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	796HF	21722859	Green Published, Bronze			2022-12-18	WOS:000293041700005
J	Shlien, A; Baskin, B; Achatz, MIW; Stavropoulos, DJ; Nichols, KE; Hudgins, L; Morel, CF; Adam, MP; Zhukova, N; Rotin, L; Novokmet, A; Druker, H; Shago, M; Ray, PN; Hainaut, P; Malkin, D				Shlien, Adam; Baskin, Berivan; Achatz, Maria Isabel W.; Stavropoulos, Dimitrios J.; Nichols, Kim E.; Hudgins, Louanne; Morel, Chantal F.; Adam, Margaret P.; Zhukova, Nataliya; Rotin, Lianne; Novokmet, Ana; Druker, Harriet; Shago, Mary; Ray, Peter N.; Hainaut, Pierre; Malkin, David			A Common Molecular Mechanism Underlies Two Phenotypically Distinct 17p13 1 Microdeletion Syndromes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LI-FRAUMENI-SYNDROME; COPY NUMBER VARIATION; ALU REPEATS; CANCER; DNA; MUTATIONS; GENE; REARRANGEMENTS; DELETION; 1Q21.1	DNA copy number variations (CNVs) underlie many neuropsychiatric conditions, but they have been less studied in cancer We report the association of a 17p13 1 CNV childhood onset developmental delay (DD), and cancer Through a screen of over 4000 patients with diverse diagnoses, we identified eight probands harboring microdeletions at TP53 (17p13 1) We used a purpose built high resolution array with 93 75% breakpoint accuracy to fine map these microdeletions Four patients were found to have a common phenotype including DD, hypotonia and hand and foot abnormalities constituting a unique syndrome Notably, these patients were not affected with cancer Moreover none of the TP53 deletion patients affected with cancer (n = 4) had neurocognitive impairments DD patients have larger deletions, which encompass but do not disrupt TP53, whereas cancer affected patients harbor CNVs with at least one break point within TP53 Most 17p13 1 deletions arise by Alu mediated nonallelic homologous recombination Furthermore, we identify a critical genomic region associated with DD and containing six underexpressed genes We conclude that, although they overlap, 17p13 1 CNVs are associated with distinct phenotypes depending on the position of the breakpoint with respect to TP53 Further, detailed characterization of breakpoints revealed a common formation signature Future studies should consider whether other loci in the genome also give rise to phenotypically distinct disorders by means of a common mechanism, resulting in a similar formation signature	[Shlien, Adam; Zhukova, Nataliya; Rotin, Lianne; Ray, Peter N.; Malkin, David] Hosp Sick Children, Genet & Genome Biol Program, Toronto, ON M5G 1X8, Canada; [Shlien, Adam; Malkin, David] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1X8, Canada; [Baskin, Berivan; Stavropoulos, Dimitrios J.; Shago, Mary; Ray, Peter N.] Hosp Sick Children, Div Mol Genet, Dept Paediat Lab Med, Toronto, ON M5G 1X8, Canada; [Achatz, Maria Isabel W.] Hosp AC Camargo Fund Antonio Prudente, BR-01509010 Sao Paulo, Brazil; [Stavropoulos, Dimitrios J.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X8, Canada; [Nichols, Kim E.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Hudgins, Louanne] Stanford Univ, Dept Pediat, Div Med Genet, Sch Med, Stanford, CA 94305 USA; [Morel, Chantal F.] Univ Toronto, Dept Med, Univ Hlth Network, Toronto, ON M5G 1X8, Canada; [Adam, Margaret P.] Emory Univ, Dept Human Genet, Sch Med, Atlanta, GA 30033 USA; [Novokmet, Ana; Druker, Harriet; Malkin, David] Univ Toronto, Hosp Sick Children, Div Hematol Oncol, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Ray, Peter N.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1X8, Canada; [Hainaut, Pierre] Int Agcy Res Canc, Mol Carcinogenesis & Biomarkers Grp, F-69372 Lyon, France	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); A.C.Camargo Cancer Center; University of Toronto; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Stanford University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Emory University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; World Health Organization; International Agency for Research on Cancer (IARC)	Malkin, D (corresponding author), Hosp Sick Children, Genet & Genome Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.		Achatz, Maria Isabel/C-5751-2013; Nichols, Kim/E-9353-2016; Hainaut, Pierre/B-6018-2012; Nichols, Kim/AAP-8592-2020; Malkin, David/AAW-8715-2021	Achatz, Maria Isabel/0000-0001-6894-1219; Nichols, Kim/0000-0002-5581-6555; Hainaut, Pierre/0000-0002-1303-1610; Nichols, Kim/0000-0002-5581-6555; 	Canadian Cancer Society Research Institute; Canadian Institutes for Health Research; SickKids Foundation; Canada Foundation; Canadian Cancer Society	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); SickKids Foundation; Canada Foundation; Canadian Cancer Society(Canadian Cancer Society (CCS))	Thanks to members of the Malkin Lab for assistance and proof reading and to Stephen Meyn, Stephen Scherer, Christian Marshall, and Dalila Pinto for critical review of the manuscript and discussion I hanks also to Megan Kowalski for help with sample coordination and pedigree ascertainment and to the Cyto genomics Laboratory at the Children's Hospital of Philadelphia The Centre for Applied Genomics (Toronto, Canada) is acknowl edged for technical support The research was supported by grants from the Canadian Cancer Society Research Institute (with funds from the Canadian Cancer Society), the Canadian Institutes for Health Research (D M) the SickKids Foundation Canada Foundation for Innovation (D M), and the Grundy Vision for Life fund (K EN) AS is supported by a Canadian Institutes of Health Research Frederick Banting & Charles H Best Doctoral Student ship Award	Adam MP, 2009, J PEDIATR, V154, P143, DOI 10.1016/j.jpeds.2008.07.045; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Bayani Jane, 2004, Curr Protoc Cell Biol, VChapter 22, DOI 10.1002/0471143030.cb2204s23; BOLARD CS, 2010, AM J MED GENET A, V152, P1278; Bougeard G, 2008, J MED GENET, V45, P535, DOI 10.1136/jmg.2008.057570; Bougeard G, 2003, ONCOGENE, V22, P840, DOI 10.1038/sj.onc.1206155; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Chompret A, 2000, BRIT J CANCER, V82, P1932; Conrad DF, 2010, NAT GENET, V42, P385, DOI 10.1038/ng.564; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Darnell JC, 2009, HUM MOL GENET, V18, P3164, DOI 10.1093/hmg/ddp255; de Vries A, 2002, P NATL ACAD SCI USA, V99, P2948, DOI 10.1073/pnas.052713099; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Greenway SC, 2009, NAT GENET, V41, P931, DOI 10.1038/ng.415; Hainaut P, 2009, LANCET ONCOL, V10, P913, DOI 10.1016/S1470-2045(09)70198-6; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kranz C, 2001, J CLIN INVEST, V108, P1613, DOI 10.1172/JCI200113635; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; Li Lili, 2006, Hum Mutat, V27, P388, DOI 10.1002/humu.9417; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Mahmoudi S, 2009, MOL CELL, V33, P462, DOI 10.1016/j.molcel.2009.01.028; Malinge S, 2009, BLOOD, V113, P2619, DOI 10.1182/blood-2008-11-163501; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; MOSNER J, 1995, EMBO J, V14, P4442, DOI 10.1002/j.1460-2075.1995.tb00123.x; Nagy R, 2004, ONCOGENE, V23, P6445, DOI 10.1038/sj.onc.1207714; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; PLUMMER SJ, 1994, ONCOGENE, V9, P3273; SANTOS ACK, 2009, CYTOGENET GENOME RES, V125, P1; Scherer SW, 2007, NAT GENET, V39, pS7, DOI 10.1038/ng2093; Schwarzbraun T, 2009, J MED GENET, V46, P341, DOI 10.1136/jmg.2008.064972; Sen SK, 2006, AM J HUM GENET, V79, P41, DOI 10.1086/504600; Shlien A, 2008, P NATL ACAD SCI USA, V105, P11264, DOI 10.1073/pnas.0802970105; Shlien A, 2009, GENOME MED, V1, DOI 10.1186/gm62; Slebos RJC, 1998, CANCER RES, V58, P5333; Smith TM, 1996, GENOME RES, V6, P1029, DOI 10.1101/gr.6.11.1029; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Vilborg A, 2010, J MOL MED, V88, P645, DOI 10.1007/s00109-010-0609-2	42	27	27	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 12	2010	87	5					631	642		10.1016/j.ajhg.2010.10.007	http://dx.doi.org/10.1016/j.ajhg.2010.10.007			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	686AE	21056402	Green Published, Bronze			2022-12-18	WOS:000284668400008
J	Rohlfs, RV; Swanson, WJ; Weir, BS				Rohlfs, Rori V.; Swanson, Willie J.; Weir, Bruce S.			Detecting Coevolution through Allelic Association between Physically Unlinked Loci	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN-PROTEIN INTERACTIONS; CO-EVOLUTIONARY ANALYSIS; MAMMALIAN FERTILIZATION; LINKAGE DISEQUILIBRIUM; ZP3-BINDING PROTEIN; REVEALS INSIGHTS; MOUSE SPERM; SELECTION; POLYMORPHISMS; SPECIATION	Coevolving interacting genes undergo complementary mutations to maintain their interaction. Distinct combinations of alleles in coevolving genes interact differently, conferring varying degrees of fitness. If this fitness differential is adequately large, the resulting selection for allele matching could maintain allelic association, even between physically unlinked loci. Allelic association is often observed in a population with the use of gametic linkage disequilibrium. However, because the coevolving genes are not necessarily in physical linkage, this is not an appropriate measure of coevolution-induced allelic association. Instead, we propose using both composite linkage disequilibrium (CLD) and a measure of association between genotypes, which we call genotype association (GA). Using a simple selective model, we simulated loci and calculated power for tests of CLD and GA, showing that the tests can detect the allelic association expected under realistic selective pressure. We apply CLD and GA tests to the polymorphic, physically unlinked, and putatively coevolving human gamete-recognition genes ZP3 and ZP3R. We observe unusual allelic association, not attributable to population structure, between ZP3 and ZP3R. This study shows that selection for allele matching can drive allelic association between unlinked loci in a contemporary human population, and that selection can be detected with the use of CLD and GA tests. The observation of this selection is surprising, but reasonable in the highly selected system of fertilization. If confirmed, this sort of selection provides an exception to the paradigm of chromosomal independent assortment.	[Rohlfs, Rori V.; Swanson, Willie J.; Weir, Bruce S.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Weir, Bruce S.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rohlfs, RV (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	rrohlfs@u.washington.edu	Weir, Bruce S/A-2894-2013	Swanson, Willie/0000-0002-6553-0921; Rohlfs, Rori/0000-0002-2625-192X	Wellcome Trust [076113]; National Institutes of Health [R01 GM 75091, T32 GM07735, HD042563]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007735, R01GM075091] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J.M. Akey for his thoughtful comments, G. McVicker for the use of his parsed gene list, and the three anonymous reviewers for their challenging questions. This study makes use of data generated by the Wellcome Trust Case-Control Consortium. A full list of the investigators who contributed to the generation of the data is available from http://www.wtccc.org.uk. Funding for the project was provided by the Wellcome Trust under award 076113. This work was supported in part by National Institutes of Health grants R01 GM 75091, T32 GM07735, and HD042563.	BLEIL JD, 1990, P NATL ACAD SCI USA, V87, P5563, DOI 10.1073/pnas.87.14.5563; Buffone MG, 2008, J BIOL CHEM, V283, P12438, DOI 10.1074/jbc.M706421200; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clark NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000570; Cohen N, 2001, INT J DEV BIOL, V45, P569; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gavrilets S, 2002, P NATL ACAD SCI USA, V99, P10533, DOI 10.1073/pnas.152011499; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; Goh CS, 2002, J MOL BIOL, V324, P177, DOI 10.1016/S0022-2836(02)01038-0; Haig D, 2008, PLACENTA, V29, pS36, DOI 10.1016/j.placenta.2007.09.010; Harada Y, 2008, SCIENCE, V320, P548, DOI 10.1126/science.1152488; Jothi R, 2006, J MOL BIOL, V362, P861, DOI 10.1016/j.jmb.2006.07.072; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.2307/2408842; Laurie CC, 2007, PLOS GENET, V3, P1487, DOI 10.1371/journal.pgen.0030144; Levitan DR, 2006, SCIENCE, V312, P267, DOI 10.1126/science.1122183; LEWONTIN RC, 1960, EVOLUTION, V14, P458, DOI 10.2307/2405995; LEWONTIN RC, 1964, GENETICS, V49, P49; Makalowski W, 1998, P NATL ACAD SCI USA, V95, P9407, DOI 10.1073/pnas.95.16.9407; Monne M, 2008, NATURE, V456, P653, DOI 10.1038/nature07599; OTT J, 1985, Genetic Epidemiology, V2, P79, DOI 10.1002/gepi.1370020108; Palumbi SR, 2009, HEREDITY, V102, P66, DOI 10.1038/hdy.2008.104; Palumbi SR, 1999, P NATL ACAD SCI USA, V96, P12632, DOI 10.1073/pnas.96.22.12632; Paoletti M, 2007, CURR BIOL, V17, P1384, DOI 10.1016/j.cub.2007.07.012; Pazos F, 1997, J MOL BIOL, V271, P511, DOI 10.1006/jmbi.1997.1198; Pazos F, 2001, PROTEIN ENG, V14, P609, DOI 10.1093/protein/14.9.609; Petkov PM, 2005, PLOS GENET, V1, P312, DOI 10.1371/journal.pgen.0010033; RHEAD B, UCSC GENOME BROWSER; Rohlfs RV, 2008, GENETICS, V180, P1609, DOI 10.1534/genetics.108.088005; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; Single RM, 2007, NAT GENET, V39, P1114, DOI 10.1038/ng2077; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P2509, DOI 10.1073/pnas.051605998; Wassarman PM, 2008, J BIOL CHEM, V283, P24285, DOI 10.1074/jbc.R800027200; Wassarman PM, 2009, BIOESSAYS, V31, P153, DOI 10.1002/bies.200800152; Wassarman PM, 1999, CELL, V96, P175, DOI 10.1016/S0092-8674(00)80558-9; Weir B., 1996, GENETIC DATA ANAL; WEIR BS, 1979, BIOMETRICS, V35, P235, DOI 10.2307/2529947; Zapata C, 2002, GENETICS, V161, P1539	40	27	27	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 14	2010	86	5					674	685		10.1016/j.ajhg.2010.03.001	http://dx.doi.org/10.1016/j.ajhg.2010.03.001			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601GC	20381007	Bronze, Green Published			2022-12-18	WOS:000278045300004
J	Xing, C; Cohen, JC; Boerwinkle, E				Xing, Chao; Cohen, Jonathan C.; Boerwinkle, Eric			A Weighted False Discovery Rate Control Procedure Reveals Alleles at FOXA2 that Influence Fasting Glucose Levels	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GENETIC-VARIATION; VARIANT; TRAITS; MTNR1B; TESTS; MAP	Association signals in GWAS are Usually prioritized solely by p values. Here, we attempt to improve the power of GWAS by using a weighted false discovery rate control procedure to detect associations of low-frequency variants with effect sizes similar to or even larger than those of common variants. We used the Affymetrix Genorne-Wide Human SNP Array 6.0 to test for association with fasting glucose levels in the Atherosclerosis Risk in Communities Study (ARIC) population. In addition to finding several previously identified sequence variations, we identified a low-frequency variant (rs1209523; minor allele frequency = 0.043) near FOXA2 that was associated with fasting glucose levels in European Americans (EAs) (n = 7428, p value 1.3 x 10(-5)). The association between rs1209523 and glucose levels was also significant in African Americans (AAs) (n = 2029, p value 6.7 x 10(-3)) of the ARIC and was confirmed by replication in both EAs and AAs of the Dallas Heart Study (n = 963 and 1571, respectively; p values = 5.3 x 10(-3) and 5.8 x 10(-4), respectively) and in EAs of the Cooper Center Longitudinal Study (n = 2862; p value = 1.6 x 10(-2)). A meta-analysis of these five populations yielded an estimated effect size of -1.31 mg/dl per minor allele (p value = 2.2 x 10(-11)). This study reveals that there is a cache of less-frequent variants in GWAS arrays that can be identified via analytical approaches accounting for allele frequencies.	[Xing, Chao; Cohen, Jonathan C.] Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA; [Xing, Chao] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Ctr Human Genet, Houston, TX 77030 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Health Science Center Houston	Xing, C (corresponding author), Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA.	chao.xing@utsouthwestern.edu		Xing, Chao/0000-0002-1838-0502; Ballantyne, Christie/0000-0002-6432-1730	Donald W. Reynolds Foundation; U.S. National Heart, Lung, and blood Institute (NHLBI) [HL082896, HL092550, N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, R01HL087641, R01HL59367, R01HL086694]; National Human Genome Research Institute [U01HG004402]; National Institutes of Health (NIH) [HHSN268200625226C, UL1RR025005]; Roadmap for Medical Research; National Center for Research Resources [UL1RR024982]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055019, N01HC055022, N01HC055015, N01HC055020, N01HC055016, N01HC055021, N01HC055018] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024982, UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R41HL055018, R01HL087641, R01HL086694, R01HL059367, RL1HL092550, R42HL055018, R41HL055019, R01HL082896] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER	Donald W. Reynolds Foundation; U.S. National Heart, Lung, and blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roadmap for Medical Research; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the reviewers for their insightful comments in improving the manuscript. We thank Tom Hyatt for technical assistance and Helen Hobbs for helpful discussions. We are grateful to the staff and participants of the DHS, the ARIC, and the CCLS for their contributions. This work was supported by grants from the Donald W. Reynolds Foundation and the U.S. National Heart, Lung, and blood Institute (NHLBI) (HL082896, HL092550). The ARIC Study is carried out as a collaborative study supported by NHLBI contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, R01HL087641, R01HL59367, and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health (NIH) contract HHSN268200625226C. Infrastructure was partly supported by grant no. UL1RR025005, a component of the NIH and the Roadmap for Medical Research. C.X. was partially supported by a Pilot Award from UL1RR024982 from the National Center for Research Resources.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Benjamini Y, 2001, ANN STAT, V29, P1165; Benjamini Y, 2005, GENETICS, V171, P783, DOI 10.1534/genetics.104.036699; Benjamini Y, 1997, SCAND J STAT, V24, P407, DOI 10.1111/1467-9469.00072; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Bouatia-Naji N, 2008, SCIENCE, V320, P1085, DOI 10.1126/science.1156849; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Chen WM, 2008, J CLIN INVEST, V118, P2620, DOI 10.1172/JCI34566; Dalmasso C, 2008, GENETICS, V180, P697, DOI 10.1534/genetics.108.089839; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Genovese CR, 2006, BIOMETRIKA, V93, P509, DOI 10.1093/biomet/93.3.509; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; HEDGES LV, 1992, J EDUC STAT, V17, P279, DOI 10.2307/1165125; Hindorff LA, CATALOG PUBLISHED GE; Hoggart CJ, 2008, GENET EPIDEMIOL, V32, P179, DOI 10.1002/gepi.20292; HOLM S, 1979, SCAND J STAT, V6, P65; Ioannidis JPA, 2009, NAT REV GENET, V10, P318, DOI 10.1038/nrg2544; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Orho-Melander M, 2008, DIABETES, V57, P3112, DOI 10.2337/db08-0516; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wong GKS, 2003, GENOME RES, V13, P1873, DOI 10.1101/gr.1324303	49	27	28	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 12	2010	86	3					440	446		10.1016/j.ajhg.2010.01.025	http://dx.doi.org/10.1016/j.ajhg.2010.01.025			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	570LG	20152958	Green Published, Bronze			2022-12-18	WOS:000275678800015
J	Yang, QH; Flanders, WD; Moonesinghe, R; Ioannidis, JPA; Guessous, I; Khoury, MJ				Yang, Quanhe; Flanders, W. Dana; Moonesinghe, Ramal; Ioannidis, John P. A.; Guessous, Idris; Khoury, Muin J.			Using Lifetime Risk Estimates in Personal Genomic Profiles: Estimation of Uncertainty	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AGE-CONDITIONAL PROBABILITIES; BREAST-CANCER; WIDE ASSOCIATION; SENSITIVITY-ANALYSIS; COMMON VARIANTS; GENETIC TESTS; SAMPLE-SIZE; MEDICINE; SUSCEPTIBILITY; DISEASES	Personal genome tests are now offered direct-to-consumer (DTC) via genetic variants identified by genome-wide association studies (GWAS) for common diseases. Tests report risk estimates (age-specific and lifetime) for various diseases based on genotypes at multiple loci. However, uncertainty surrounding such risk estimates has not been systematically investigated. With breast cancer as an example, we examined the combined effect of uncertainties in population incidence rates, genotype frequency, effect sizes, and models of joint effects among genetic variants on lifetime risk estimates. We performed simulations to estimate lifetime breast cancer risk for carriers and noncarriers of genetic variants. We derived population-based cancer incidence rates from Surveillance, Epidemiology, and End Results (SEER) Program and comparative international data. We used data for non-Hispanic white women from 2003 to 2005. We derived genotype frequencies and effect sizes from published GWAS and meta-analyses. For a single genetic variant in FGFR2 gene (rs2981582), combination of uncertainty in these parameters produced risk estimates where upper and lower 95% simulation intervals differed by more than 3-fold. Difference in population incidence rates was the largest contributor to variation in risk estimates. For a panel of five genetic variants, estimated lifetime risk of developing breast cancer before age 80 for a woman that carried all risk variants ranged from 6.1% to 21%, depending on assumptions of additive or multiplicative joint effects and breast cancer incidence rates. Epidemiologic parameters involved in computation of disease risk have substantial uncertainty, and cumulative uncertainty should be properly recognized. Reliance on point estimates alone could be seriously misleading.	[Yang, Quanhe; Khoury, Muin J.] Ctr Dis Control & Prevent, Off Publ Hlth Genom, Atlanta, GA 30333 USA; [Moonesinghe, Ramal] Ctr Dis Control & Prevent, Off Minor Hlth, Atlanta, GA 30333 USA; [Flanders, W. Dana; Guessous, Idris] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Ioannidis, John P. A.] Univ Ioannina, Sch Med, Clin & Mol Epidemiol Unit, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Ioannidis, John P. A.] Fdn Res & Technol Hellas, Biomed Res Inst, Ioannina 45110, Greece; [Ioannidis, John P. A.] Tufts Univ, Sch Med, Tufts Clin & Translat Sci Inst, Boston, MA 02155 USA; [Ioannidis, John P. A.] Tufts Univ, Sch Med, Ctr Genet Epidemiol & Modeling, Tufts Med Ctr, Boston, MA 02155 USA; [Ioannidis, John P. A.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02155 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Emory University; Rollins School Public Health; University of Ioannina; Foundation for Research & Technology - Hellas (FORTH); Tufts University; Tufts Medical Center; Tufts University; Tufts University	Yang, QH (corresponding author), Ctr Dis Control & Prevent, Off Publ Hlth Genom, Atlanta, GA 30333 USA.	qay0@cdc.gov	Moonesinghe, Ramal/W-2534-2019; Ioannidis, John P. A./G-9836-2011	Moonesinghe, Ramal/0000-0001-5327-533X				Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Antoniou AC, 2009, HUM MOL GENET, V18, P4442, DOI 10.1093/hmg/ddp372; Bjornvold M, 2008, DIABETOLOGIA, V51, P589, DOI 10.1007/s00125-008-0932-0; Botto LD, 2000, AM J EPIDEMIOL, V151, P862; Burke W, 2007, JAMA-J AM MED ASSOC, V298, P1682, DOI 10.1001/jama.298.14.1682; Burton PR, 2009, INT J EPIDEMIOL, V38, P263, DOI 10.1093/ije/dyn147; Collins FS, 2006, AM J HUM GENET, V79, P421, DOI 10.1086/507611; Collins FS, 2003, SCIENCE, V300, P286, DOI 10.1126/science.1084564; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Fay MP, 2003, STAT MED, V22, P1837, DOI 10.1002/sim.1428; Feero WG, 2008, JAMA-J AM MED ASSOC, V299, P1351, DOI 10.1001/jama.299.11.1351; FEUER EJ, 1993, J NATL CANCER I, V85, P892, DOI 10.1093/jnci/85.11.892; Fu RW, 2007, STAT MED, V26, P1775, DOI 10.1002/sim.2811; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gail MH, 2008, LIFETIME DATA ANAL, V14, P18, DOI 10.1007/s10985-007-9070-0; Gail MH, 2008, J NATL CANCER I, V100, P1037, DOI 10.1093/jnci/djn180; Garcia-Closas M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000054; Geiss LS, 2006, AM J PREV MED, V30, P371, DOI 10.1016/j.amepre.2005.12.009; Goddard KAB, 2007, GENET MED, V9, P510, DOI 10.1097/GIM.0b013e31812e6ac3; Gordis L, 1997, J NATL CANCER I, V89, P1015, DOI 10.1093/jnci/89.14.1015; Greenland S, 2001, RISK ANAL, V21, P579, DOI 10.1111/0272-4332.214136; Guttmacher AE, 2002, NEW ENGL J MED, V347, P1512, DOI 10.1056/NEJMra012240; Guttmacher AE, 2005, JAMA-J AM MED ASSOC, V294, P1399, DOI 10.1001/jama.294.11.1399; Heck K E, 1997, Matern Child Health J, V1, P81, DOI 10.1023/A:1026218322723; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Hogarth S, 2008, ANNU REV GENOM HUM G, V9, P161, DOI 10.1146/annurev.genom.9.081307.164319; Holtzman NA., 1998, PROMOTING SAFE EFFEC; Hudson K, 2007, AM J HUM GENET, V81, P635, DOI 10.1086/521634; Hunter DJ, 2008, NEW ENGL J MED, V358, P105, DOI 10.1056/NEJMp0708162; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Janssens ACJW, 2007, GENET MED, V9, P528, DOI 10.1097/GIM.0b013e31812eece0; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jones HB, 2005, HUM HERED, V59, P176, DOI 10.1159/000086118; Jones Steve, 2003, Healthplan, V44, P20; Jurek AM, 2007, J EPIDEMIOL COMMUN H, V61, P650, DOI 10.1136/jech.2006.053660; Kaye J, 2008, HUM MOL GENET, V17, pR180, DOI 10.1093/hmg/ddn253; Khoury MJ, 2003, NEW ENGL J MED, V348, P50, DOI 10.1056/NEJMra013182; Khoury MJ, 2007, GENET MED, V9, P665, DOI 10.1097/GIM.0b013e31815699d0; Khoury MJ, 2009, GENET MED, V11, P559, DOI 10.1097/GIM.0b013e3181b13a6c; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McGuire AL, 2008, JAMA-J AM MED ASSOC, V300, P2669, DOI 10.1001/jama.2008.803; Melzer D, 2008, BRIT MED J, V336, P590, DOI 10.1136/bmj.39506.601053.BE; Moonesinghe R, 2008, P NATL ACAD SCI USA, V105, P617, DOI 10.1073/pnas.0705554105; Myles S, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-22; Narayan KMV, 2006, DIABETES CARE, V29, P2114, DOI 10.2337/dc06-1136; Ng PC, 2009, NATURE, V461, P724, DOI 10.1038/461724a; Offit K, 2008, JAMA-J AM MED ASSOC, V299, P1353, DOI 10.1001/jama.299.11.1353; Paracchini V, 2005, AM J EPIDEMIOL, V162, P101, DOI 10.1093/aje/kwi174; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rothman K., 1998, MODERN EPIDEMIOLOGY; Rothman KJ, 2002, EPIDEMIOLOGY INTRO; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Satagopan JM, 2001, CANCER EPIDEM BIOMAR, V10, P467; Scheuner MT, 2008, JAMA-J AM MED ASSOC, V299, P1320, DOI 10.1001/jama.299.11.1320; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Steenland K, 2004, AM J EPIDEMIOL, V160, P384, DOI 10.1093/aje/kwh211; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Wun LM, 1998, LIFETIME DATA ANAL, V4, P169, DOI 10.1023/A:1009685507602; Yang QH, 2005, INT J EPIDEMIOL, V34, P1129, DOI 10.1093/ije/dyi130; Yang QH, 1997, EPIDEMIOL REV, V19, P33, DOI 10.1093/oxfordjournals.epirev.a017944; Yang QH, 2000, GENET MED, V2, P186, DOI 10.1097/00125817-200005000-00005; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819	70	27	27	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 11	2009	85	6					786	800		10.1016/j.ajhg.2009.10.017	http://dx.doi.org/10.1016/j.ajhg.2009.10.017			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	533BN	19931039	Green Published, Bronze			2022-12-18	WOS:000272797100003
J	Cagliani, R; Fumagalli, M; Pozzoli, U; Riva, S; Comi, GP; Torri, F; Macciardi, F; Bresolin, N; Sironi, M				Cagliani, Rachele; Fumagalli, Matteo; Pozzoli, Uberto; Riva, Stefania; Comi, Giacomo P.; Torri, Federica; Macciardi, Fabio; Bresolin, Nereo; Sironi, Manuela			Diverse Evolutionary Histories for beta-adrenoreceptor Genes in Humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								In humans, three genes-ADRB1, ADRB2 and ADRB3-encode beta-adrenoreceptors (ADRB); these molecules mediate the action of catecholamines in multiple tissues and play pivotal roles in cardiovascular, respiratory, metabolic, and immunological functions. Genetic variants in ADRB genes have been associated with widespread diseases and conditions, but inconsistent results have often been obtained. Here, we addressed the recent evolutionary history of ADRB genes in human populations. Although ADRB1 is neutrally evolving, most tests rejected neutral evolution for ADRB2 in European, African, and Asian population samples. Analysis of inferred haplotypes for ADRB2 revealed three major clades with a coalescence time of 1-1.5 million years, suggesting that the gene is either subjected to balancing selection or undergoing a selective sweep. Haplotype analysis also revealed ethnicity-specific differences. Additionally, we observed significant deviations from Hardy-Weinberg equilibrium (HWE) for ADRB2 genotypes in distinct European cohorts; HWE deviation depends on sex (only females are in disequilibrium), and genotypes displaying maximum and minimum relative fitness differ across Population samples, suggesting a complex situation possibly involving epistasis or maternal selection. Overall, our data indicate that future association studies involving ADRB2 will benefit from taking into account ethnicity-specific haplotype distributions and sex-based effects. With respect to ADRB3, our data indicate that the gene has been subjected to a selective sweep in African populations, the Trp64 variant possibly representing the selection target. Given the previous association of the ancestral ADRB3 Arg64 allele with obesity and type 2 diabetes, dietary adaptations might represent the underlying selective force.	[Cagliani, Rachele; Fumagalli, Matteo; Pozzoli, Uberto; Riva, Stefania; Bresolin, Nereo; Sironi, Manuela] Sci Inst IRCCS E Medea, Bioinformat Lab, I-23842 Bosisio Parini, LC, Italy; [Fumagalli, Matteo] Politecn Milan, Dept Bioengn, I-20133 Milan, Italy; [Comi, Giacomo P.; Bresolin, Nereo] Univ Milan, IRCCS Osped Maggiore Policlin, Mangiagalli & Regina Elena Fdn, Dept Neurol Sci,Dino Ferrari Ctr, I-20100 Milan, Italy; [Torri, Federica; Macciardi, Fabio] Univ Milan, Dept Sci & Biomed Technol, I-20100 Milan, Italy; [Torri, Federica; Macciardi, Fabio] Filarete Fdn, I-20139 Milan, Italy	IRCCS Eugenio Medea; Polytechnic University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Milan	Sironi, M (corresponding author), Sci Inst IRCCS E Medea, Bioinformat Lab, Via don L Monza 20, I-23842 Bosisio Parini, LC, Italy.	manuela.sironi@bp.lnf.it	Pozzoli, Uberto/K-6587-2016; Pozzoli, Uberto/AAH-5492-2019; Fumagalli, Matteo/H-6448-2019; Sironi, manuela/K-5633-2016; Comi, Giacomo P/K-5702-2016; Cagliani, Rachele/K-4545-2016; Macciardi, Fabio/N-3768-2014	Pozzoli, Uberto/0000-0003-0670-7106; Pozzoli, Uberto/0000-0003-0670-7106; Fumagalli, Matteo/0000-0002-4084-2953; Sironi, manuela/0000-0002-2267-5266; Comi, Giacomo P/0000-0002-1383-5248; Cagliani, Rachele/0000-0003-2670-3532; Macciardi, Fabio/0000-0003-0537-4266; Bresolin, Nereo/0000-0001-6694-3595	Italian Ministry of Health [RF-IEM-2007-633627]; Fondazione Telethon Funding Source: Custom	Italian Ministry of Health(Ministry of Health, Italy); Fondazione Telethon(Fondazione Telethon)	We are grateful to Alessandra Frigerio, Cristina Barlassina, Roberto Giorda, and Massimo Molteni for collecting DNA samples and for helpful discussion on the manuscript, and we also wish to thank Roberto Del Bo and Dario Ronchi for providing and purifying DNA samples. This work was supported by the Italian Ministry of Health (grant RF-IEM-2007-633627). M.S. is part of the Doctorate School in Molecular Medicine, University of Milan.	[Anonymous], 1984, AM NAT; Arner P, 1999, J INTERN MED, V245, P667, DOI 10.1046/j.1365-2796.1999.00495.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barnes KC, 2005, CURR OPIN ALLERGY CL, V5, P379, DOI 10.1097/01.all.0000182543.37724.7b; Brodde OE, 2005, PHARMACOGENET GENOM, V15, P267, DOI 10.1097/01213011-200505000-00001; BRODDE OE, 2008, PHARMACOL THERAPEUT, V1, P1; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Cheslack-Postava K, 2007, MOL PSYCHIATR, V12, P283, DOI 10.1038/sj.mp.4001940; Chio A, 2009, HUM MOL GENET, V18, P1524, DOI 10.1093/hmg/ddp059; Connors SL, 2005, J CHILD NEUROL, V20, P876, DOI 10.1177/08830738050200110401; Dallongeville J, 2003, J CLIN ENDOCR METAB, V88, P4862, DOI 10.1210/jc.2003-030173; Di Rienzo A, 2005, TRENDS GENET, V21, P596, DOI 10.1016/j.tig.2005.08.007; Di Rienzo A, 2006, CURR OPIN GENET DEV, V16, P630, DOI 10.1016/j.gde.2006.10.002; Diatchenko L, 2006, AM J MED GENET B, V141B, P449, DOI 10.1002/ajmg.b.30324; DIONNE IJ, 2002, INT J OBESITY, V5, P633; Doh K, 2004, J PERINAT MED, V32, P413, DOI 10.1515/JPM.2004.138; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Evans PD, 2005, SCIENCE, V309, P1717, DOI 10.1126/science.1113722; Fay JC, 2000, GENETICS, V155, P1405; Festa A, 1999, J CLIN ENDOCR METAB, V84, P1695, DOI 10.1210/jc.84.5.1695; FU YX, 1993, GENETICS, V133, P693; Fujisawa T, 1996, DIABETOLOGIA, V39, P349, DOI 10.1007/s001250050452; Garcia-Rubi E, 1999, ARCH MED RES, V30, P459, DOI 10.1016/S0188-4409(99)00077-6; Gavrilets S, 1998, GENETICS, V149, P1147; Gibson CS, 2008, PEDIATRICS, V122, P1079, DOI 10.1542/peds.2007-3758; Gibson CS, 2007, OBSTET GYNECOL, V109, P384, DOI 10.1097/01.AOG.0000252712.62241.1a; Glazko GV, 2003, MOL BIOL EVOL, V20, P424, DOI 10.1093/molbev/msg050; Gloria-Bottini F, 2001, AM J HUM BIOL, V13, P9, DOI 10.1002/1520-6300(200101/02)13:1<9::AID-AJHB1001>3.0.CO;2-1; Gloria-Bottini F, 2001, AM J HUM BIOL, V13, P417, DOI 10.1002/ajhb.1066; GREEN SA, 1994, BIOCHEMISTRY-US, V33, P9414, DOI 10.1021/bi00198a006; GREEN SA, 1993, J BIOL CHEM, V268, P23116; GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079; GRIFFITHS RC, 1995, MATH BIOSCI, V127, P77, DOI 10.1016/0025-5564(94)00044-Z; Guimaraes S, 2001, PHARMACOL REV, V53, P319; Harrison T, 2003, SCIENCE, V301, P1734, DOI 10.1126/science.1089324; HASTINGS A, 1981, P NATL ACAD SCI-BIOL, V78, P7224, DOI 10.1073/pnas.78.11.7224; Haygood R, 2007, NAT GENET, V39, P1140, DOI 10.1038/ng2104; Healey CS, 2000, NAT GENET, V26, P362, DOI 10.1038/81691; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; HUDSON RR, 1994, GENETICS, V136, P1329; Hudson RR, 2001, GENETICS, V159, P1805; HUDSON RR, 1992, GENETICS, V132, P583; Ioannidis JPA, 2004, NAT GENET, V36, P1312, DOI 10.1038/ng1474; Jensen JD, 2005, GENETICS, V170, P1401, DOI 10.1534/genetics.104.038224; JOHNATTY SE, 2002, BRIT J PHARMACOL, V8, P1213; Kim Y, 2002, GENETICS, V160, P765; Landau R, 2002, AM J OBSTET GYNECOL, V187, P1294, DOI 10.1067/mob.2002.128524; Liggett SB, 2004, AM J MED, V117, P525, DOI 10.1016/j.amjmed.2004.07.039; Litonjua AA, 2006, CURR OPIN PULM MED, V12, P12, DOI 10.1097/01.mcp.0000198068.50457.95; Lowell BB, 2003, J BIOL CHEM, V278, P29385, DOI 10.1074/jbc.R300011200; Malysheva O, 2008, ANN RHEUM DIS, V67, P1759, DOI 10.1136/ard.2007.083782; Mason DA, 1999, J BIOL CHEM, V274, P12670, DOI 10.1074/jbc.274.18.12670; Meiklejohn CD, 2004, GENETICS, V168, P265, DOI 10.1534/genetics.103.025494; Mitchell BD, 1998, J CLIN INVEST, V101, P584, DOI 10.1172/JCI512; Munoz-Moran E, 1998, LANCET, V352, P1120, DOI 10.1016/S0140-6736(05)79761-0; Murphy SC, 2006, PLOS MED, V3, P2403, DOI 10.1371/journal.pmed.0030528; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Ozkur M, 2002, INT J GYNECOL OBSTET, V77, P209, DOI 10.1016/S0020-7292(02)00035-8; Perez JM, 2003, NAT MED, V9, P1300, DOI 10.1038/nm930; Ramsay CE, 1999, HUM GENET, V104, P269, DOI 10.1007/s004390050947; Ruiz-Narvaez E, 2005, J MED GENET, V42, P547, DOI 10.1136/jmg.2004.026765; RYDEN M, 2001, INT J OBESITY, V11, P1599; Sandilands AJ, 2005, BRIT J CLIN PHARMACO, V60, P235, DOI 10.1111/j.1365-2125.2005.02438.x; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Sethi AA, 2005, PHARMACOGENET GENOM, V15, P633, DOI 10.1097/01.fpc.0000172243.27299.78; Silver K, 1997, HUM GENET, V101, P306, DOI 10.1007/s004390050633; Spencer HG, 2003, GENETICS, V164, P1689; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; TAJIMA F, 1989, GENETICS, V123, P585; Taylor MRG, 2007, PHARMACOGENOMICS J, V7, P29, DOI 10.1038/sj.tpj.6500393; Team RC., 2022, R LANG ENV STAT COMP; Thornton K, 2003, BIOINFORMATICS, V19, P2325, DOI 10.1093/bioinformatics/btg316; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; Vander Molen J, 2005, AM J HUM GENET, V76, P548, DOI 10.1086/428784; Walston J, 2003, OBES RES, V11, P509, DOI 10.1038/oby.2003.71; WALSTON J, 1995, NEW ENGL J MED, V333, P343, DOI 10.1056/NEJM199508103330603; Wang RL, 1996, GENETICS, V144, P1113; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WIDEN E, 1995, NEW ENGL J MED, V333, P348, DOI 10.1056/NEJM199508103330604; Wilcken B, 2003, J MED GENET, V40, P619, DOI 10.1136/jmg.40.8.619; WRIGHT S, 1950, NATURE, V166, P247, DOI 10.1038/166247a0; Xu BY, 2005, ANN RHEUM DIS, V64, P773, DOI 10.1136/ard.2004.027532; Young JH, 2005, PLOS GENET, V1, P730, DOI 10.1371/journal.pgen.0010082	86	27	28	3	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 10	2009	85	1					64	75		10.1016/j.ajhg.2009.06.005	http://dx.doi.org/10.1016/j.ajhg.2009.06.005			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	470RO	19576569	Green Published, Bronze			2022-12-18	WOS:000267997600008
J	Cheung, VG; Bruzel, A; Burdick, JT; Morley, M; Devlin, JL; Spielman, RS				Cheung, Vivian G.; Bruzel, Alan; Burdick, Joshua T.; Morley, Michael; Devlin, James L.; Spielman, Richard S.			Monozygotic twins reveal germline contribution to allelic expression differences	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENE-EXPRESSION; X-CHROMOSOME INACTIVATION; GENOME	Variation in the level of gene expression is a major determinant of a cell's function and characteristics. Common allelic variants of genes can be expressed at different levels and thus contribute to phenotypic diversity. We have measured allelic expression differences at heterozygous loci in monozygotic twins and in unrelated individuals. We show that the extent of differential allelic expression is highly similar within monozygotic twin pairs for many loci, implying that allelic differences in gene expression are under genetic control. We also show that even subtle departures from equal allelic expression are often genetically determined.	[Cheung, Vivian G.; Devlin, James L.; Spielman, Richard S.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Cheung, Vivian G.; Bruzel, Alan] Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; [Cheung, Vivian G.; Morley, Michael] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [Burdick, Joshua T.] Univ Penn, Genom & Computat Biol Grad Program, Philadelphia, PA 19104 USA	University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Spielman, RS (corresponding author), Univ Penn, Dept Genet, Philadelphia, PA 19104 USA.	spielman@pobox.upenn.edu	Cheung, Vivian G./AAT-3115-2020	Morley, Michael/0000-0002-0958-7376	Howard Hughes Medical Institute Funding Source: Medline; NIEHS NIH HHS [R01 ES015733-01, R01 ES015733] Funding Source: Medline; NIGMS NIH HHS [R01 GM081930-08, R01 GM081930] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081930] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Naumova AK, 1998, EUR J HUM GENET, V6, P552, DOI 10.1038/sj.ejhg.5200255; Pant PVK, 2006, GENOME RES, V16, P331, DOI 10.1101/gr.4559106; Plenge RM, 1997, NAT GENET, V17, P353, DOI 10.1038/ng1197-353; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545	12	27	28	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2008	82	6					1357	1360		10.1016/j.ajhg.2008.05.003	http://dx.doi.org/10.1016/j.ajhg.2008.05.003			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	312CP	18513681	Green Published, Bronze			2022-12-18	WOS:000256647000013
J	Daley, D; Lewis, S; Platzer, P; MacMillen, M; Willis, J; Elston, RC; Markowitz, SD; Wiesner, GL				Daley, Denise; Lewis, Susan; Platzer, Petra; MacMillen, Melissa; Willis, Joseph; Elston, Robert C.; Markowitz, Sanford D.; Wiesner, Georgia L.			Identification of susceptibility genes for cancer in a genome-wide scan: Results from the colon neoplasia sibling study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; MIXED POLYPOSIS SYNDROME; COLORECTAL-CANCER; ADENOMATOUS POLYPOSIS; LINKAGE ANALYSIS; FAMILY HISTORY; BODY-MASS; RISK; MUTATIONS; POPULATION	Colorectal cancer (CRC) is the third most commonly diagnosed cancer in Americans and is the second leading cause of cancer mortality. Only a minority (similar to 5%) of familial CRC can be explained by known genetic variants. To identify susceptibility genes for familial colorectal neoplasia, the colon neoplasia sibling study conducted a comprehensive, genome-wide linkage scan of 194 kindreds. Clinical information (histopathology, size and number of polyps, and other primary cancers) was used in conjunction with age at onset and family history for classification of the families into five phenotypic subgroups (severe histopathology, oligopolyposis, young, colon/breast, and multiple cancer) prior to analysis. By expanding the traditional affected-sib-pair design to include unaffected and discordant sib pairs, analytical power and robustness to type I error were increased. Sib-pair linkage statistics and Haseman-Elston regression identified 19 linkage peaks, with interesting results for chromosomes lp3l.1, 15q14-q22, 17p13.3, and 21. At marker D1S1665 (1p31.1), there was strong evidence for linkage in the multiple-cancer subgroup (p = 0.00007). For chromosome 15q14-q22, a linkage peak was identified in the full-sample (p = 0.018), oligopolyposis (p = 0.003), and young (p = 0.0009) phenotypes. This region includes the HMPS/CRAC1 locus associated with hereditary mixed polyposis syndrome (HMPS) in families of Ashkenazi descent. We provide compelling evidence linking this region in families of European descent with oligopolyposis and/or young age at onset (<= 51) phenotypes. We found linkage to BRCA2 in the colon/breast phenotypic subgroup and identified a second locus in the region of D21S1437 segregating with, but distinct from, BRCA2. Linkage to 17p13.3 at marker D17S1308 in the breast/colon subgroup identified HIC1 as a candidate gene. We demonstrated that using clinical information, unaffected siblings, and family history can increase the analytical power of a linkage study.	[Daley, Denise; Elston, Robert C.] Case Western Reserve Univ, Univ Hosp Cleveland, Dept Epidemiol, Cleveland, OH 44106 USA; [Daley, Denise; Elston, Robert C.] Case Western Reserve Univ, Univ Hosp Cleveland, Dept Biostat, Cleveland, OH 44106 USA; [Lewis, Susan] Case Western Reserve Univ, Univ Hosp Cleveland, Dept Genet, Cleveland, OH 44106 USA; [Platzer, Petra; MacMillen, Melissa; Wiesner, Georgia L.] Case Western Reserve Univ, Univ Hosp Cleveland, Dept Med, Cleveland, OH 44106 USA; [Markowitz, Sanford D.; Wiesner, Georgia L.] Case Western Reserve Univ, Univ Hosp Cleveland, Dept Pathol, Cleveland, OH 44106 USA; [Willis, Joseph] Case Western Reserve Univ, Univ Hosp Cleveland, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Elston, Robert C.; Markowitz, Sanford D.; Wiesner, Georgia L.] Case Western Reserve Univ, Univ Hosp Cleveland, Ctr Human Genet, Cleveland, OH 44106 USA; [Wiesner, Georgia L.] Howard Hughes Med Inst, Cleveland, OH 44195 USA; [Markowitz, Sanford D.] Cleveland Clin Fdn, Genom Med Inst, Cleveland, OH 44195 USA; [Daley, Denise] Univ British Columbia, Vancouver, BC V6T 1Z4, Canada	Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Howard Hughes Medical Institute; Cleveland Clinic Foundation; University of British Columbia	Daley, D (corresponding author), Case Western Reserve Univ, Univ Hosp Cleveland, Dept Epidemiol, Cleveland, OH 44106 USA.	ddaley@mrl.ubc.ca			NATIONAL CANCER INSTITUTE [U01CA082901, K23CA081308, P30CA043703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028356, R37GM028356] Funding Source: NIH RePORTER; NCI NIH HHS [U01 CA82901, K23 1K23CA81308, P30 CA043703, P30CA43703, K23 CA081308, U01 CA082901] Funding Source: Medline; NCRR NIH HHS [P41 RR0365] Funding Source: Medline; NIGMS NIH HHS [R01 GM028356, GM28356, R37 GM028356] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams KF, 2007, AM J EPIDEMIOL, V166, P36, DOI 10.1093/aje/kwm049; American Cancer Society, 2005, COL CANC FACTS FIG S; ATKIN WS, 1992, NEW ENGL J MED, V326, P658, DOI 10.1056/NEJM199203053261002; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; Bodmer WF, 2006, J HUM GENET, V51, P391, DOI 10.1007/s10038-006-0373-x; Bouguen G, 2007, DIS COLON RECTUM, V50, P1612, DOI 10.1007/s10350-007-9027-0; Britschgi C, 2006, ONCOGENE, V25, P2030, DOI 10.1038/sj.onc.1209240; Brose MS, 2002, J NATL CANCER I, V94, P1365, DOI 10.1093/jnci/94.18.1365; Cao X, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.034827; Chen WY, 2003, NAT GENET, V33, P197, DOI 10.1038/ng1077; Cybulski C, 2004, AM J HUM GENET, V75, P1131, DOI 10.1086/426403; Dong CH, 2001, INT J CANCER, V92, P883, DOI 10.1002/ijc.1261; Edwards JH, 2003, CLIN GENET, V63, P1, DOI 10.1034/j.1399-0004.2003.630101.x; Ehrmann-Josko A, 2006, SCAND J GASTROENTERO, V41, P1079, DOI 10.1080/00365520600587444; Elston RC, 2000, GENET EPIDEMIOL, V19, P1, DOI 10.1002/1098-2272(200007)19:1<1::AID-GEPI1>3.0.CO;2-E; Elston RC, 2005, AM J HUM GENET, V76, P152, DOI 10.1086/426872; Fasouliotis S J, 2000, Obstet Gynecol Surv, V55, P373, DOI 10.1097/00006254-200006000-00023; Friedenson Bernard, 2005, MedGenMed, V7, P60; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; Jaeger EEM, 2003, AM J HUM GENET, V72, P1261, DOI 10.1086/375144; Kadouri L, 2007, J MED GENET, V44, P467, DOI 10.1136/jmg.2006.048173; Kemp Z, 2004, HUM MOL GENET, V13, pR177, DOI 10.1093/hmg/ddh247; Kemp ZE, 2006, CANCER RES, V66, P5003, DOI 10.1158/0008-5472.CAN-05-4074; Kerber RA, 1997, AM J EPIDEMIOL, V146, P244; Kim S, 2006, CANCER CAUSE CONTROL, V17, P1299, DOI 10.1007/s10552-006-0075-x; Kram A, 2001, LAB INVEST, V81, P1039, DOI 10.1038/labinvest.3780315; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Larsen IK, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-5; Liberti SE, 2004, MOL CANCER RES, V2, P427; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Liede A, 2004, J CLIN ONCOL, V22, P735, DOI 10.1200/JCO.2004.05.055; Lipton L, 2001, Fam Cancer, V1, P189, DOI 10.1023/A:1021101014264; LYNCH HT, 1977, CANCER, V40, P1849, DOI 10.1002/1097-0142(197710)40:4+<1849::AID-CNCR2820400813>3.0.CO;2-U; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Orsetti B, 2006, BRIT J CANCER, V95, P1439, DOI 10.1038/sj.bjc.6603433; Otchy DP, 1996, AM J GASTROENTEROL, V91, P448; Platte P, 2003, AM J MED GENET C, V121C, P71, DOI 10.1002/ajmg.c.20005; Rex DK, 1996, GASTROENTEROLOGY, V111, P1178, DOI 10.1053/gast.1996.v111.pm8898630; Rex DK, 2000, AM J GASTROENTEROL, V95, P868, DOI 10.1111/j.1572-0241.2000.02059.x; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; SIDAK Z, 1971, ANN MATH STAT, V42, P169, DOI 10.1214/aoms/1177693504; SIDAK Z, 1968, ANN MATH STAT, V39, P1425, DOI 10.1214/aoms/1177698122; Sieber OM, 2003, NEW ENGL J MED, V348, P791, DOI 10.1056/NEJMoa025283; Skoglund J, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.033928; SLATTERY ML, 1994, J NATL CANCER I, V86, P1618, DOI 10.1093/jnci/86.21.1618; *STAT SOL LTD, 2003, STAT AN GEN EP REL 4; Strul H, 2006, AM J GASTROENTEROL, V101, P255, DOI 10.1111/j.1572-0241.2006.00430.x; Struski S, 2002, CANCER GENET CYTOGEN, V135, P63, DOI 10.1016/S0165-4608(01)00624-0; Tavassoli M, 1996, BRIT J CANCER, V74, P115, DOI 10.1038/bjc.1996.324; Thirlwell C, 2007, BRIT J CANCER, V96, P1729, DOI 10.1038/sj.bjc.6603789; Tomlinson I, 1999, GASTROENTEROLOGY, V116, P789, DOI 10.1016/S0016-5085(99)70061-2; Wang VW, 2001, CANCER RES, V61, P4169; Webb EL, 2006, HUM MOL GENET, V15, P3263, DOI 10.1093/hmg/ddl401; Wiesner GL, 2003, P NATL ACAD SCI USA, V100, P12961, DOI 10.1073/pnas.2132286100; Winawer SJ, 1996, NEW ENGL J MED, V334, P82, DOI 10.1056/NEJM199601113340204; Yamamoto H, 2005, CARCINOGENESIS, V26, P411, DOI 10.1093/carcin/bgh335; Zhang QH, 2007, P NATL ACAD SCI USA, V104, P829, DOI 10.1073/pnas.0610590104; Zollner S, 2004, AM J HUM GENET, V74, P62, DOI 10.1086/381131	60	27	27	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2008	82	3					723	736		10.1016/j.ajhg.2008.01.007	http://dx.doi.org/10.1016/j.ajhg.2008.01.007			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	275JN	18313025	Green Published, Bronze			2022-12-18	WOS:000254067800016
J	Craig, DW; Itty, A; Panganiban, C; Szelinger, S; Kruer, MC; Sekar, A; Reiman, D; Narayanan, V; Stephan, DA; Kerrigan, JF				Craig, David W.; Itty, Abraham; Panganiban, Corrie; Szelinger, Szabolcs; Kruer, Michael C.; Sekar, Aswin; Reiman, David; Narayanan, Vinodh; Stephan, Dietrich A.; Kerrigan, John F.			Identification of somatic chromosomal abnormalities in hypothalamic hamartoma tissue at the GL13 locus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PALLISTER-HALL-SYNDROME; GELASTIC SEIZURES; PRECOCIOUS PUBERTY; GLI3 MUTATIONS; EPILEPSY; CHILDREN; GENE; PHEOCHROMOCYTOMA; DISORDERS; CARCINOMA	Hypothalamic hamartomas (HH) are rare, benign congenital tumors associated with intractable epilepsy. Most cases are sporadic and nonsyndromic. Approximately 5% of HH cases are associated with Pallister-Hall syndrome (PHS), which is caused by haploinsufficiency of GLI3. We have investigated the possibility that HH pathogenesis in sporadic cases is due to a somatic (tumor-only) mutation in GLI3. We isolated genomic DNA from peripheral blood and surgically resected HH tissue in 55 patients with sporadic HH and intractable epilepsy. A genome-wide screen for loss of heterozygosity (LOH) and chromosomal abnormalities was performed with parallel analysis of blood and HH tissue with Affymetrix 10K SNP microarrays. Additionally, resequencing and fine mapping with SNP genotyping were completed for the GLI3 gene with comparisons between peripheral blood and HH tissue pairs. By analyzing chromosomal copy-number data for paired samples on the Affymetrix 10K array, we identified a somatic chromosomal abnormality on chromosome 7p in one HH tissue sample. Resequencing of GLI3 did not identify causative germline mutations but did identify LOH within the GLI3 gene in the HH tissue samples of three patients. Further genotyping of 28 SNPs within and surrounding GLI3 identified five additional patients exhibiting LOH. Together, these data provide evidence that the development of chromosomal abnormalities within GLI3 is associated with the pathogenesis of HH lesions in sporadic, nonsyndromic patients with HH and intractable epilepsy. Chromosomal abnormalities including the GLI3 locus were seen in 8 of 55 (15%) of the resected HH tissue samples. These somatic mutations appear to be highly variable.	[Craig, David W.; Itty, Abraham; Panganiban, Corrie; Szelinger, Szabolcs; Sekar, Aswin; Reiman, David; Stephan, Dietrich A.] Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ 85004 USA; [Kruer, Michael C.] Phoenix Childrens Hosp, Dept Pediat, Phoenix, AZ 85016 USA; [Kerrigan, John F.] St Joseph Hosp & Med Ctr, Div Pediat Neurol, Phoenix, AZ 85013 USA; [Kerrigan, John F.] St Joseph Hosp & Med Ctr, Barrow Neurol Inst & Childrens Hlth Ctr, Comprehens Epilepsy Program, Phoenix, AZ 85013 USA	Translational Genomics Research Institute; Phoenix Children's Hospital; St. Joseph's Hospital and Medical Center; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center	Craig, DW (corresponding author), Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ 85004 USA.	dcraig@tgen.org	Craig, David Wesley/K-6961-2019	Craig, David Wesley/0000-0003-2040-1955; Narayanan, Vinodh/0000-0002-0658-3847				Arita K, 1999, J NEUROSURG, V91, P212, DOI 10.3171/jns.1999.91.2.0212; Arzimanoglou AA, 2003, EPILEPTIC DISORD, V5, P187; Berkovic SF, 2003, EPILEPSIA, V44, P969, DOI 10.1046/j.1528-1157.2003.59102.x; BERKOVIC SF, 1988, ANN NEUROL, V23, P429, DOI 10.1002/ana.410230502; Biesecker LG, 2006, J MED GENET, V43, P465, DOI 10.1136/jmg.2004.029181; Biesecker LG, 1996, AM J MED GENET, V65, P76, DOI 10.1002/(SICI)1096-8628(19961002)65:1<76::AID-AJMG12>3.0.CO;2-O; Biesecker LG, 2003, EPILEPTIC DISORD, V5, P235; Brandberg G, 2004, EUR J PAEDIATR NEURO, V8, P35, DOI 10.1016/j.ejpn.2003.10.003; Delalande O, 2003, NEUROL MED-CHIR, V43, P61, DOI 10.2176/nmc.43.61; Deonna T, 2000, EPILEPTIC DISORD, V2, P33; Di XJ, 2005, BIOINFORMATICS, V21, P1958, DOI 10.1093/bioinformatics/bti275; ENG C, 1994, HUM MOL GENET, V3, P237, DOI 10.1093/hmg/3.2.237; FENOGLIO KA, 2007, PEDIATR NEUROL, V14, P51; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Hofstra RMW, 1996, J CLIN ENDOCR METAB, V81, P2881, DOI 10.1210/jc.81.8.2881; Huentelman MJ, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-149; Johnston JJ, 2005, AM J HUM GENET, V76, P609, DOI 10.1086/429346; Jung H, 2003, J CLIN ENDOCR METAB, V88, P4590, DOI 10.1210/jc.2002-022018; Kang S, 1997, NAT GENET, V15, P266, DOI 10.1038/ng0397-266; Kang SM, 1997, J MED GENET, V34, P441, DOI 10.1136/jmg.34.6.441; Kangas O, 1997, EUR SOCIOL REV, V13, P101, DOI 10.1093/oxfordjournals.esr.a018199; Kelberman D, 2006, J CLIN INVEST, V116, P2442, DOI 10.1172/JCI28658; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Kerrigan JF, 2007, EPILEPSY RES, V75, P70, DOI 10.1016/j.eplepsyres.2007.04.002; Kerrigan John F, 2005, Semin Pediatr Neurol, V12, P119, DOI 10.1016/j.spen.2005.04.002; Kletter G. B., 1992, American Journal of Human Genetics, V51, pA100; Leykin I, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-7; Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maher ER, 2002, HUM MOL GENET, V11, P2347, DOI 10.1093/hmg/11.20.2347; Ng YT, 2006, EPILEPSIA, V47, P1192, DOI 10.1111/j.1528-1167.2006.00516.x; Shin SH, 1999, P NATL ACAD SCI USA, V96, P2880, DOI 10.1073/pnas.96.6.2880; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; VALDUEZA JM, 1994, NEUROSURGERY, V34, P949, DOI 10.1227/00006123-199406000-00001; Wang J, 2005, BIOTECHNIQUES, V39, P885, DOI 10.2144/000112028; Wu J, 2005, ANN NEUROL, V58, P371, DOI 10.1002/ana.20580	36	27	30	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2008	82	2					366	374		10.1016/j.ajhg.2007.10.006	http://dx.doi.org/10.1016/j.ajhg.2007.10.006			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NN	18252217	Bronze, Green Published			2022-12-18	WOS:000253223900009
